city_name,city_code,age,sex,measurement_date,name,value,unit
Wien,AT13,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,860.27,Rate
Wien,AT13,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,884.4,Rate
Wien,AT13,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,872.69,Rate
Wien,AT13,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,838.31,Rate
Wien,AT13,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,841.58,Rate
Wien,AT13,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,820.75,Rate
Wien,AT13,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,835.68,Rate
Wien,AT13,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,837.5,Rate
Wien,AT13,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,782.56,Rate
Wien,AT13,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,858.39,Rate
Wien,AT13,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.09,Rate
Wien,AT13,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.12,Rate
Wien,AT13,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.02,Rate
Wien,AT13,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.94,Rate
Wien,AT13,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.99,Rate
Wien,AT13,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.48,Rate
Wien,AT13,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.05,Rate
Wien,AT13,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.34,Rate
Wien,AT13,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.0,Rate
Wien,AT13,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.19,Rate
Wien,AT13,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",41.21,Rate
Wien,AT13,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",41.46,Rate
Wien,AT13,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",39.24,Rate
Wien,AT13,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",46.65,Rate
Wien,AT13,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",43.13,Rate
Wien,AT13,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",46.71,Rate
Wien,AT13,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",43.46,Rate
Wien,AT13,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",45.86,Rate
Wien,AT13,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",45.94,Rate
Wien,AT13,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",47.96,Rate
Wien,AT13,Total,Females,2011,Malignant melanoma of skin,4.13,Rate
Wien,AT13,Total,Females,2012,Malignant melanoma of skin,2.46,Rate
Wien,AT13,Total,Females,2013,Malignant melanoma of skin,2.18,Rate
Wien,AT13,Total,Females,2014,Malignant melanoma of skin,2.56,Rate
Wien,AT13,Total,Females,2015,Malignant melanoma of skin,2.21,Rate
Wien,AT13,Total,Females,2016,Malignant melanoma of skin,2.87,Rate
Wien,AT13,Total,Females,2017,Malignant melanoma of skin,3.44,Rate
Wien,AT13,Total,Females,2018,Malignant melanoma of skin,2.82,Rate
Wien,AT13,Total,Females,2019,Malignant melanoma of skin,2.95,Rate
Wien,AT13,Total,Females,2020,Malignant melanoma of skin,2.93,Rate
Wien,AT13,Total,Females,2011,Malignant neoplasm of breast,37.04,Rate
Wien,AT13,Total,Females,2012,Malignant neoplasm of breast,36.33,Rate
Wien,AT13,Total,Females,2013,Malignant neoplasm of breast,39.58,Rate
Wien,AT13,Total,Females,2014,Malignant neoplasm of breast,37.65,Rate
Wien,AT13,Total,Females,2015,Malignant neoplasm of breast,34.9,Rate
Wien,AT13,Total,Females,2016,Malignant neoplasm of breast,37.48,Rate
Wien,AT13,Total,Females,2017,Malignant neoplasm of breast,33.34,Rate
Wien,AT13,Total,Females,2018,Malignant neoplasm of breast,35.55,Rate
Wien,AT13,Total,Females,2019,Malignant neoplasm of breast,33.54,Rate
Wien,AT13,Total,Females,2020,Malignant neoplasm of breast,34.1,Rate
Wien,AT13,Total,Females,2011,Diabetes mellitus,24.63,Rate
Wien,AT13,Total,Females,2012,Diabetes mellitus,27.42,Rate
Wien,AT13,Total,Females,2013,Diabetes mellitus,28.14,Rate
Wien,AT13,Total,Females,2014,Diabetes mellitus,32.53,Rate
Wien,AT13,Total,Females,2015,Diabetes mellitus,35.35,Rate
Wien,AT13,Total,Females,2016,Diabetes mellitus,38.17,Rate
Wien,AT13,Total,Females,2017,Diabetes mellitus,33.99,Rate
Wien,AT13,Total,Females,2018,Diabetes mellitus,31.07,Rate
Wien,AT13,Total,Females,2019,Diabetes mellitus,26.83,Rate
Wien,AT13,Total,Females,2020,Diabetes mellitus,26.88,Rate
Wien,AT13,Total,Females,2011,Mental and behavioural disorders (F00-F99),6.01,Rate
Wien,AT13,Total,Females,2012,Mental and behavioural disorders (F00-F99),7.84,Rate
Wien,AT13,Total,Females,2013,Mental and behavioural disorders (F00-F99),11.6,Rate
Wien,AT13,Total,Females,2014,Mental and behavioural disorders (F00-F99),10.68,Rate
Wien,AT13,Total,Females,2015,Mental and behavioural disorders (F00-F99),12.77,Rate
Wien,AT13,Total,Females,2016,Mental and behavioural disorders (F00-F99),16.46,Rate
Wien,AT13,Total,Females,2017,Mental and behavioural disorders (F00-F99),32.74,Rate
Wien,AT13,Total,Females,2018,Mental and behavioural disorders (F00-F99),36.58,Rate
Wien,AT13,Total,Females,2019,Mental and behavioural disorders (F00-F99),28.52,Rate
Wien,AT13,Total,Females,2020,Mental and behavioural disorders (F00-F99),25.52,Rate
Wien,AT13,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Wien,AT13,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Wien,AT13,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Wien,AT13,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Wien,AT13,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Wien,AT13,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Wien,AT13,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Wien,AT13,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.59,Rate
Wien,AT13,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Wien,AT13,Total,Females,2011,Other ischaemic heart diseases,147.62,Rate
Wien,AT13,Total,Females,2012,Other ischaemic heart diseases,162.48,Rate
Wien,AT13,Total,Females,2013,Other ischaemic heart diseases,159.22,Rate
Wien,AT13,Total,Females,2014,Other ischaemic heart diseases,156.14,Rate
Wien,AT13,Total,Females,2015,Other ischaemic heart diseases,147.73,Rate
Wien,AT13,Total,Females,2016,Other ischaemic heart diseases,135.84,Rate
Wien,AT13,Total,Females,2017,Other ischaemic heart diseases,128.94,Rate
Wien,AT13,Total,Females,2018,Other ischaemic heart diseases,117.04,Rate
Wien,AT13,Total,Females,2019,Other ischaemic heart diseases,104.96,Rate
Wien,AT13,Total,Females,2020,Other ischaemic heart diseases,96.04,Rate
Wien,AT13,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,33.15,Rate
Wien,AT13,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,31.56,Rate
Wien,AT13,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,26.83,Rate
Wien,AT13,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,27.42,Rate
Wien,AT13,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,24.78,Rate
Wien,AT13,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,26.3,Rate
Wien,AT13,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,24.64,Rate
Wien,AT13,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,23.42,Rate
Wien,AT13,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,20.44,Rate
Wien,AT13,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,26.09,Rate
Wien,AT13,Total,Females,2011,Cerebrovascular diseases,48.6,Rate
Wien,AT13,Total,Females,2012,Cerebrovascular diseases,49.49,Rate
Wien,AT13,Total,Females,2013,Cerebrovascular diseases,55.37,Rate
Wien,AT13,Total,Females,2014,Cerebrovascular diseases,48.06,Rate
Wien,AT13,Total,Females,2015,Cerebrovascular diseases,49.25,Rate
Wien,AT13,Total,Females,2016,Cerebrovascular diseases,43.06,Rate
Wien,AT13,Total,Females,2017,Cerebrovascular diseases,48.02,Rate
Wien,AT13,Total,Females,2018,Cerebrovascular diseases,49.24,Rate
Wien,AT13,Total,Females,2019,Cerebrovascular diseases,42.87,Rate
Wien,AT13,Total,Females,2020,Cerebrovascular diseases,44.62,Rate
Wien,AT13,Total,Females,2011,Chronic lower respiratory diseases,31.38,Rate
Wien,AT13,Total,Females,2012,Chronic lower respiratory diseases,29.69,Rate
Wien,AT13,Total,Females,2013,Chronic lower respiratory diseases,30.32,Rate
Wien,AT13,Total,Females,2014,Chronic lower respiratory diseases,26.98,Rate
Wien,AT13,Total,Females,2015,Chronic lower respiratory diseases,28.75,Rate
Wien,AT13,Total,Females,2016,Chronic lower respiratory diseases,34.49,Rate
Wien,AT13,Total,Females,2017,Chronic lower respiratory diseases,39.19,Rate
Wien,AT13,Total,Females,2018,Chronic lower respiratory diseases,41.45,Rate
Wien,AT13,Total,Females,2019,Chronic lower respiratory diseases,43.85,Rate
Wien,AT13,Total,Females,2020,Chronic lower respiratory diseases,40.15,Rate
Wien,AT13,Total,Females,2011,Asthma and status asthmaticus,1.17,Rate
Wien,AT13,Total,Females,2012,Asthma and status asthmaticus,1.06,Rate
Wien,AT13,Total,Females,2013,Asthma and status asthmaticus,1.06,Rate
Wien,AT13,Total,Females,2014,Asthma and status asthmaticus,0.56,Rate
Wien,AT13,Total,Females,2015,Asthma and status asthmaticus,1.12,Rate
Wien,AT13,Total,Females,2016,Asthma and status asthmaticus,0.96,Rate
Wien,AT13,Total,Females,2017,Asthma and status asthmaticus,1.26,Rate
Wien,AT13,Total,Females,2018,Asthma and status asthmaticus,0.42,Rate
Wien,AT13,Total,Females,2019,Asthma and status asthmaticus,1.24,Rate
Wien,AT13,Total,Females,2020,Asthma and status asthmaticus,0.69,Rate
Wien,AT13,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3715.81,Rate
Wien,AT13,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3893.51,Rate
Wien,AT13,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3843.97,Rate
Wien,AT13,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3668.22,Rate
Wien,AT13,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3738.86,Rate
Wien,AT13,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3623.84,Rate
Wien,AT13,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3756.18,Rate
Wien,AT13,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3717.59,Rate
Wien,AT13,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3491.84,Rate
Wien,AT13,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3856.65,Rate
Wien,AT13,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.4,Rate
Wien,AT13,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.51,Rate
Wien,AT13,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.92,Rate
Wien,AT13,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.39,Rate
Wien,AT13,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.47,Rate
Wien,AT13,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.05,Rate
Wien,AT13,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.38,Rate
Wien,AT13,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.95,Rate
Wien,AT13,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.63,Rate
Wien,AT13,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.99,Rate
Wien,AT13,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",132.5,Rate
Wien,AT13,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",142.92,Rate
Wien,AT13,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",127.39,Rate
Wien,AT13,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",155.49,Rate
Wien,AT13,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",144.6,Rate
Wien,AT13,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",170.0,Rate
Wien,AT13,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",159.15,Rate
Wien,AT13,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",165.3,Rate
Wien,AT13,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",164.21,Rate
Wien,AT13,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",189.74,Rate
Wien,AT13,65 years or over,Females,2011,Malignant melanoma of skin,14.5,Rate
Wien,AT13,65 years or over,Females,2012,Malignant melanoma of skin,6.5,Rate
Wien,AT13,65 years or over,Females,2013,Malignant melanoma of skin,7.64,Rate
Wien,AT13,65 years or over,Females,2014,Malignant melanoma of skin,10.85,Rate
Wien,AT13,65 years or over,Females,2015,Malignant melanoma of skin,7.54,Rate
Wien,AT13,65 years or over,Females,2016,Malignant melanoma of skin,9.98,Rate
Wien,AT13,65 years or over,Females,2017,Malignant melanoma of skin,12.63,Rate
Wien,AT13,65 years or over,Females,2018,Malignant melanoma of skin,10.19,Rate
Wien,AT13,65 years or over,Females,2019,Malignant melanoma of skin,13.05,Rate
Wien,AT13,65 years or over,Females,2020,Malignant melanoma of skin,11.26,Rate
Wien,AT13,65 years or over,Females,2011,Malignant neoplasm of breast,123.55,Rate
Wien,AT13,65 years or over,Females,2012,Malignant neoplasm of breast,127.34,Rate
Wien,AT13,65 years or over,Females,2013,Malignant neoplasm of breast,145.61,Rate
Wien,AT13,65 years or over,Females,2014,Malignant neoplasm of breast,131.24,Rate
Wien,AT13,65 years or over,Females,2015,Malignant neoplasm of breast,130.77,Rate
Wien,AT13,65 years or over,Females,2016,Malignant neoplasm of breast,136.72,Rate
Wien,AT13,65 years or over,Females,2017,Malignant neoplasm of breast,120.64,Rate
Wien,AT13,65 years or over,Females,2018,Malignant neoplasm of breast,134.16,Rate
Wien,AT13,65 years or over,Females,2019,Malignant neoplasm of breast,130.11,Rate
Wien,AT13,65 years or over,Females,2020,Malignant neoplasm of breast,134.19,Rate
Wien,AT13,65 years or over,Females,2011,Diabetes mellitus,113.59,Rate
Wien,AT13,65 years or over,Females,2012,Diabetes mellitus,130.18,Rate
Wien,AT13,65 years or over,Females,2013,Diabetes mellitus,131.37,Rate
Wien,AT13,65 years or over,Females,2014,Diabetes mellitus,157.73,Rate
Wien,AT13,65 years or over,Females,2015,Diabetes mellitus,174.05,Rate
Wien,AT13,65 years or over,Females,2016,Diabetes mellitus,182.22,Rate
Wien,AT13,65 years or over,Females,2017,Diabetes mellitus,161.78,Rate
Wien,AT13,65 years or over,Females,2018,Diabetes mellitus,144.78,Rate
Wien,AT13,65 years or over,Females,2019,Diabetes mellitus,132.4,Rate
Wien,AT13,65 years or over,Females,2020,Diabetes mellitus,130.5,Rate
Wien,AT13,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),10.91,Rate
Wien,AT13,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),26.51,Rate
Wien,AT13,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),39.63,Rate
Wien,AT13,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),36.41,Rate
Wien,AT13,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),44.66,Rate
Wien,AT13,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),70.31,Rate
Wien,AT13,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),153.09,Rate
Wien,AT13,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),176.27,Rate
Wien,AT13,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),133.89,Rate
Wien,AT13,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),119.55,Rate
Wien,AT13,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Wien,AT13,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.59,Rate
Wien,AT13,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Wien,AT13,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Wien,AT13,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Wien,AT13,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Wien,AT13,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.0,Rate
Wien,AT13,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Wien,AT13,65 years or over,Females,2011,Other ischaemic heart diseases,730.45,Rate
Wien,AT13,65 years or over,Females,2012,Other ischaemic heart diseases,813.38,Rate
Wien,AT13,65 years or over,Females,2013,Other ischaemic heart diseases,800.15,Rate
Wien,AT13,65 years or over,Females,2014,Other ischaemic heart diseases,777.93,Rate
Wien,AT13,65 years or over,Females,2015,Other ischaemic heart diseases,740.12,Rate
Wien,AT13,65 years or over,Females,2016,Other ischaemic heart diseases,683.2,Rate
Wien,AT13,65 years or over,Females,2017,Other ischaemic heart diseases,646.01,Rate
Wien,AT13,65 years or over,Females,2018,Other ischaemic heart diseases,577.29,Rate
Wien,AT13,65 years or over,Females,2019,Other ischaemic heart diseases,526.71,Rate
Wien,AT13,65 years or over,Females,2020,Other ischaemic heart diseases,478.43,Rate
Wien,AT13,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,148.42,Rate
Wien,AT13,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,146.58,Rate
Wien,AT13,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,121.62,Rate
Wien,AT13,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,125.07,Rate
Wien,AT13,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,118.84,Rate
Wien,AT13,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,115.05,Rate
Wien,AT13,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,107.13,Rate
Wien,AT13,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,111.41,Rate
Wien,AT13,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,92.18,Rate
Wien,AT13,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,114.3,Rate
Wien,AT13,65 years or over,Females,2011,Cerebrovascular diseases,226.42,Rate
Wien,AT13,65 years or over,Females,2012,Cerebrovascular diseases,233.01,Rate
Wien,AT13,65 years or over,Females,2013,Cerebrovascular diseases,261.3,Rate
Wien,AT13,65 years or over,Females,2014,Cerebrovascular diseases,233.14,Rate
Wien,AT13,65 years or over,Females,2015,Cerebrovascular diseases,237.02,Rate
Wien,AT13,65 years or over,Females,2016,Cerebrovascular diseases,204.84,Rate
Wien,AT13,65 years or over,Females,2017,Cerebrovascular diseases,231.99,Rate
Wien,AT13,65 years or over,Females,2018,Cerebrovascular diseases,238.35,Rate
Wien,AT13,65 years or over,Females,2019,Cerebrovascular diseases,203.79,Rate
Wien,AT13,65 years or over,Females,2020,Cerebrovascular diseases,216.38,Rate
Wien,AT13,65 years or over,Females,2011,Chronic lower respiratory diseases,138.12,Rate
Wien,AT13,65 years or over,Females,2012,Chronic lower respiratory diseases,128.01,Rate
Wien,AT13,65 years or over,Females,2013,Chronic lower respiratory diseases,134.7,Rate
Wien,AT13,65 years or over,Females,2014,Chronic lower respiratory diseases,122.06,Rate
Wien,AT13,65 years or over,Females,2015,Chronic lower respiratory diseases,126.95,Rate
Wien,AT13,65 years or over,Females,2016,Chronic lower respiratory diseases,158.95,Rate
Wien,AT13,65 years or over,Females,2017,Chronic lower respiratory diseases,178.33,Rate
Wien,AT13,65 years or over,Females,2018,Chronic lower respiratory diseases,177.83,Rate
Wien,AT13,65 years or over,Females,2019,Chronic lower respiratory diseases,204.5,Rate
Wien,AT13,65 years or over,Females,2020,Chronic lower respiratory diseases,186.69,Rate
Wien,AT13,65 years or over,Females,2011,Asthma and status asthmaticus,4.11,Rate
Wien,AT13,65 years or over,Females,2012,Asthma and status asthmaticus,3.05,Rate
Wien,AT13,65 years or over,Females,2013,Asthma and status asthmaticus,4.87,Rate
Wien,AT13,65 years or over,Females,2014,Asthma and status asthmaticus,1.72,Rate
Wien,AT13,65 years or over,Females,2015,Asthma and status asthmaticus,3.96,Rate
Wien,AT13,65 years or over,Females,2016,Asthma and status asthmaticus,4.33,Rate
Wien,AT13,65 years or over,Females,2017,Asthma and status asthmaticus,4.71,Rate
Wien,AT13,65 years or over,Females,2018,Asthma and status asthmaticus,1.1,Rate
Wien,AT13,65 years or over,Females,2019,Asthma and status asthmaticus,4.22,Rate
Wien,AT13,65 years or over,Females,2020,Asthma and status asthmaticus,3.0,Rate
Wien,AT13,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,168.55,Rate
Wien,AT13,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,155.48,Rate
Wien,AT13,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,152.94,Rate
Wien,AT13,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,152.81,Rate
Wien,AT13,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,139.76,Rate
Wien,AT13,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,141.75,Rate
Wien,AT13,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,128.23,Rate
Wien,AT13,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,139.84,Rate
Wien,AT13,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,126.28,Rate
Wien,AT13,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,132.1,Rate
Wien,AT13,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.63,Rate
Wien,AT13,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.4,Rate
Wien,AT13,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.82,Rate
Wien,AT13,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.42,Rate
Wien,AT13,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.2,Rate
Wien,AT13,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.39,Rate
Wien,AT13,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.53,Rate
Wien,AT13,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.93,Rate
Wien,AT13,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.17,Rate
Wien,AT13,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.16,Rate
Wien,AT13,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",19.1,Rate
Wien,AT13,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.89,Rate
Wien,AT13,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",17.89,Rate
Wien,AT13,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",20.28,Rate
Wien,AT13,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",18.55,Rate
Wien,AT13,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",16.84,Rate
Wien,AT13,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",15.43,Rate
Wien,AT13,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",16.92,Rate
Wien,AT13,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",17.29,Rate
Wien,AT13,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",13.62,Rate
Wien,AT13,Less than 65 years,Females,2011,Malignant melanoma of skin,1.62,Rate
Wien,AT13,Less than 65 years,Females,2012,Malignant melanoma of skin,1.48,Rate
Wien,AT13,Less than 65 years,Females,2013,Malignant melanoma of skin,0.86,Rate
Wien,AT13,Less than 65 years,Females,2014,Malignant melanoma of skin,0.55,Rate
Wien,AT13,Less than 65 years,Females,2015,Malignant melanoma of skin,0.92,Rate
Wien,AT13,Less than 65 years,Females,2016,Malignant melanoma of skin,1.15,Rate
Wien,AT13,Less than 65 years,Females,2017,Malignant melanoma of skin,1.21,Rate
Wien,AT13,Less than 65 years,Females,2018,Malignant melanoma of skin,1.03,Rate
Wien,AT13,Less than 65 years,Females,2019,Malignant melanoma of skin,0.5,Rate
Wien,AT13,Less than 65 years,Females,2020,Malignant melanoma of skin,0.91,Rate
Wien,AT13,Less than 65 years,Females,2011,Malignant neoplasm of breast,16.09,Rate
Wien,AT13,Less than 65 years,Females,2012,Malignant neoplasm of breast,14.28,Rate
Wien,AT13,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.9,Rate
Wien,AT13,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.97,Rate
Wien,AT13,Less than 65 years,Females,2015,Malignant neoplasm of breast,11.67,Rate
Wien,AT13,Less than 65 years,Females,2016,Malignant neoplasm of breast,13.44,Rate
Wien,AT13,Less than 65 years,Females,2017,Malignant neoplasm of breast,12.19,Rate
Wien,AT13,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.66,Rate
Wien,AT13,Less than 65 years,Females,2019,Malignant neoplasm of breast,10.15,Rate
Wien,AT13,Less than 65 years,Females,2020,Malignant neoplasm of breast,9.85,Rate
Wien,AT13,Less than 65 years,Females,2011,Diabetes mellitus,3.09,Rate
Wien,AT13,Less than 65 years,Females,2012,Diabetes mellitus,2.53,Rate
Wien,AT13,Less than 65 years,Females,2013,Diabetes mellitus,3.14,Rate
Wien,AT13,Less than 65 years,Females,2014,Diabetes mellitus,2.2,Rate
Wien,AT13,Less than 65 years,Females,2015,Diabetes mellitus,1.76,Rate
Wien,AT13,Less than 65 years,Females,2016,Diabetes mellitus,3.28,Rate
Wien,AT13,Less than 65 years,Females,2017,Diabetes mellitus,3.03,Rate
Wien,AT13,Less than 65 years,Females,2018,Diabetes mellitus,3.52,Rate
Wien,AT13,Less than 65 years,Females,2019,Diabetes mellitus,1.26,Rate
Wien,AT13,Less than 65 years,Females,2020,Diabetes mellitus,1.78,Rate
Wien,AT13,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),4.82,Rate
Wien,AT13,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),3.32,Rate
Wien,AT13,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),4.81,Rate
Wien,AT13,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),4.44,Rate
Wien,AT13,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),5.05,Rate
Wien,AT13,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),3.41,Rate
Wien,AT13,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),3.58,Rate
Wien,AT13,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.74,Rate
Wien,AT13,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.0,Rate
Wien,AT13,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.75,Rate
Wien,AT13,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Wien,AT13,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Wien,AT13,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Wien,AT13,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Wien,AT13,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Wien,AT13,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Wien,AT13,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.25,Rate
Wien,AT13,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Wien,AT13,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,Less than 65 years,Females,2011,Other ischaemic heart diseases,6.43,Rate
Wien,AT13,Less than 65 years,Females,2012,Other ischaemic heart diseases,4.81,Rate
Wien,AT13,Less than 65 years,Females,2013,Other ischaemic heart diseases,3.96,Rate
Wien,AT13,Less than 65 years,Females,2014,Other ischaemic heart diseases,5.52,Rate
Wien,AT13,Less than 65 years,Females,2015,Other ischaemic heart diseases,4.23,Rate
Wien,AT13,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.25,Rate
Wien,AT13,Less than 65 years,Females,2017,Other ischaemic heart diseases,3.69,Rate
Wien,AT13,Less than 65 years,Females,2018,Other ischaemic heart diseases,5.55,Rate
Wien,AT13,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.79,Rate
Wien,AT13,Less than 65 years,Females,2020,Other ischaemic heart diseases,3.41,Rate
Wien,AT13,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.22,Rate
Wien,AT13,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,3.69,Rate
Wien,AT13,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.87,Rate
Wien,AT13,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.77,Rate
Wien,AT13,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.0,Rate
Wien,AT13,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.79,Rate
Wien,AT13,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.66,Rate
Wien,AT13,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.1,Rate
Wien,AT13,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,3.06,Rate
Wien,AT13,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.72,Rate
Wien,AT13,Less than 65 years,Females,2011,Cerebrovascular diseases,5.53,Rate
Wien,AT13,Less than 65 years,Females,2012,Cerebrovascular diseases,5.03,Rate
Wien,AT13,Less than 65 years,Females,2013,Cerebrovascular diseases,5.48,Rate
Wien,AT13,Less than 65 years,Females,2014,Cerebrovascular diseases,3.23,Rate
Wien,AT13,Less than 65 years,Females,2015,Cerebrovascular diseases,3.77,Rate
Wien,AT13,Less than 65 years,Females,2016,Cerebrovascular diseases,3.87,Rate
Wien,AT13,Less than 65 years,Females,2017,Cerebrovascular diseases,3.46,Rate
Wien,AT13,Less than 65 years,Females,2018,Cerebrovascular diseases,3.43,Rate
Wien,AT13,Less than 65 years,Females,2019,Cerebrovascular diseases,3.89,Rate
Wien,AT13,Less than 65 years,Females,2020,Cerebrovascular diseases,3.01,Rate
Wien,AT13,Less than 65 years,Females,2011,Chronic lower respiratory diseases,5.53,Rate
Wien,AT13,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.87,Rate
Wien,AT13,Less than 65 years,Females,2013,Chronic lower respiratory diseases,5.03,Rate
Wien,AT13,Less than 65 years,Females,2014,Chronic lower respiratory diseases,3.94,Rate
Wien,AT13,Less than 65 years,Females,2015,Chronic lower respiratory diseases,4.96,Rate
Wien,AT13,Less than 65 years,Females,2016,Chronic lower respiratory diseases,4.34,Rate
Wien,AT13,Less than 65 years,Females,2017,Chronic lower respiratory diseases,5.48,Rate
Wien,AT13,Less than 65 years,Females,2018,Chronic lower respiratory diseases,8.41,Rate
Wien,AT13,Less than 65 years,Females,2019,Chronic lower respiratory diseases,4.94,Rate
Wien,AT13,Less than 65 years,Females,2020,Chronic lower respiratory diseases,4.65,Rate
Wien,AT13,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.45,Rate
Wien,AT13,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.58,Rate
Wien,AT13,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.14,Rate
Wien,AT13,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.28,Rate
Wien,AT13,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.43,Rate
Wien,AT13,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.14,Rate
Wien,AT13,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.42,Rate
Wien,AT13,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.26,Rate
Wien,AT13,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.52,Rate
Wien,AT13,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.12,Rate
Wien,AT13,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1304.38,Rate
Wien,AT13,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1292.48,Rate
Wien,AT13,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1291.78,Rate
Wien,AT13,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1239.49,Rate
Wien,AT13,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1264.02,Rate
Wien,AT13,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1166.39,Rate
Wien,AT13,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1167.35,Rate
Wien,AT13,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1204.99,Rate
Wien,AT13,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1146.73,Rate
Wien,AT13,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1263.31,Rate
Wien,AT13,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.51,Rate
Wien,AT13,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.51,Rate
Wien,AT13,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.29,Rate
Wien,AT13,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.39,Rate
Wien,AT13,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.05,Rate
Wien,AT13,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.72,Rate
Wien,AT13,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.61,Rate
Wien,AT13,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.65,Rate
Wien,AT13,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.02,Rate
Wien,AT13,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.11,Rate
Wien,AT13,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",80.67,Rate
Wien,AT13,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",85.15,Rate
Wien,AT13,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",81.0,Rate
Wien,AT13,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",86.54,Rate
Wien,AT13,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",80.72,Rate
Wien,AT13,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",77.67,Rate
Wien,AT13,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",75.4,Rate
Wien,AT13,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",77.01,Rate
Wien,AT13,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",71.28,Rate
Wien,AT13,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",74.87,Rate
Wien,AT13,Total,Males,2011,Malignant melanoma of skin,7.62,Rate
Wien,AT13,Total,Males,2012,Malignant melanoma of skin,6.86,Rate
Wien,AT13,Total,Males,2013,Malignant melanoma of skin,7.56,Rate
Wien,AT13,Total,Males,2014,Malignant melanoma of skin,5.95,Rate
Wien,AT13,Total,Males,2015,Malignant melanoma of skin,5.88,Rate
Wien,AT13,Total,Males,2016,Malignant melanoma of skin,6.12,Rate
Wien,AT13,Total,Males,2017,Malignant melanoma of skin,7.04,Rate
Wien,AT13,Total,Males,2018,Malignant melanoma of skin,4.52,Rate
Wien,AT13,Total,Males,2019,Malignant melanoma of skin,5.24,Rate
Wien,AT13,Total,Males,2020,Malignant melanoma of skin,6.87,Rate
Wien,AT13,Total,Males,2011,Malignant neoplasm of breast,0.79,Rate
Wien,AT13,Total,Males,2012,Malignant neoplasm of breast,0.49,Rate
Wien,AT13,Total,Males,2013,Malignant neoplasm of breast,0.93,Rate
Wien,AT13,Total,Males,2014,Malignant neoplasm of breast,0.52,Rate
Wien,AT13,Total,Males,2015,Malignant neoplasm of breast,0.9,Rate
Wien,AT13,Total,Males,2016,Malignant neoplasm of breast,1.23,Rate
Wien,AT13,Total,Males,2017,Malignant neoplasm of breast,0.67,Rate
Wien,AT13,Total,Males,2018,Malignant neoplasm of breast,0.25,Rate
Wien,AT13,Total,Males,2019,Malignant neoplasm of breast,0.82,Rate
Wien,AT13,Total,Males,2011,Diabetes mellitus,45.51,Rate
Wien,AT13,Total,Males,2012,Diabetes mellitus,37.49,Rate
Wien,AT13,Total,Males,2013,Diabetes mellitus,39.84,Rate
Wien,AT13,Total,Males,2014,Diabetes mellitus,41.54,Rate
Wien,AT13,Total,Males,2015,Diabetes mellitus,51.35,Rate
Wien,AT13,Total,Males,2016,Diabetes mellitus,57.38,Rate
Wien,AT13,Total,Males,2017,Diabetes mellitus,51.04,Rate
Wien,AT13,Total,Males,2018,Diabetes mellitus,48.01,Rate
Wien,AT13,Total,Males,2019,Diabetes mellitus,42.28,Rate
Wien,AT13,Total,Males,2020,Diabetes mellitus,47.14,Rate
Wien,AT13,Total,Males,2011,Mental and behavioural disorders (F00-F99),20.44,Rate
Wien,AT13,Total,Males,2012,Mental and behavioural disorders (F00-F99),24.99,Rate
Wien,AT13,Total,Males,2013,Mental and behavioural disorders (F00-F99),22.93,Rate
Wien,AT13,Total,Males,2014,Mental and behavioural disorders (F00-F99),24.17,Rate
Wien,AT13,Total,Males,2015,Mental and behavioural disorders (F00-F99),20.7,Rate
Wien,AT13,Total,Males,2016,Mental and behavioural disorders (F00-F99),23.95,Rate
Wien,AT13,Total,Males,2017,Mental and behavioural disorders (F00-F99),31.51,Rate
Wien,AT13,Total,Males,2018,Mental and behavioural disorders (F00-F99),44.87,Rate
Wien,AT13,Total,Males,2019,Mental and behavioural disorders (F00-F99),31.11,Rate
Wien,AT13,Total,Males,2020,Mental and behavioural disorders (F00-F99),33.15,Rate
Wien,AT13,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Wien,AT13,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Wien,AT13,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.25,Rate
Wien,AT13,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Wien,AT13,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Wien,AT13,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Wien,AT13,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Wien,AT13,Total,Males,2011,Other ischaemic heart diseases,253.29,Rate
Wien,AT13,Total,Males,2012,Other ischaemic heart diseases,223.99,Rate
Wien,AT13,Total,Males,2013,Other ischaemic heart diseases,249.64,Rate
Wien,AT13,Total,Males,2014,Other ischaemic heart diseases,234.21,Rate
Wien,AT13,Total,Males,2015,Other ischaemic heart diseases,239.48,Rate
Wien,AT13,Total,Males,2016,Other ischaemic heart diseases,212.56,Rate
Wien,AT13,Total,Males,2017,Other ischaemic heart diseases,189.0,Rate
Wien,AT13,Total,Males,2018,Other ischaemic heart diseases,189.07,Rate
Wien,AT13,Total,Males,2019,Other ischaemic heart diseases,171.56,Rate
Wien,AT13,Total,Males,2020,Other ischaemic heart diseases,172.09,Rate
Wien,AT13,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,76.45,Rate
Wien,AT13,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,78.22,Rate
Wien,AT13,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,77.61,Rate
Wien,AT13,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,63.11,Rate
Wien,AT13,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,60.77,Rate
Wien,AT13,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,52.09,Rate
Wien,AT13,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,58.29,Rate
Wien,AT13,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,53.82,Rate
Wien,AT13,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,51.17,Rate
Wien,AT13,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,60.96,Rate
Wien,AT13,Total,Males,2011,Cerebrovascular diseases,59.38,Rate
Wien,AT13,Total,Males,2012,Cerebrovascular diseases,64.79,Rate
Wien,AT13,Total,Males,2013,Cerebrovascular diseases,65.07,Rate
Wien,AT13,Total,Males,2014,Cerebrovascular diseases,53.57,Rate
Wien,AT13,Total,Males,2015,Cerebrovascular diseases,58.32,Rate
Wien,AT13,Total,Males,2016,Cerebrovascular diseases,50.5,Rate
Wien,AT13,Total,Males,2017,Cerebrovascular diseases,54.11,Rate
Wien,AT13,Total,Males,2018,Cerebrovascular diseases,58.85,Rate
Wien,AT13,Total,Males,2019,Cerebrovascular diseases,54.67,Rate
Wien,AT13,Total,Males,2020,Cerebrovascular diseases,53.47,Rate
Wien,AT13,Total,Males,2011,Chronic lower respiratory diseases,49.6,Rate
Wien,AT13,Total,Males,2012,Chronic lower respiratory diseases,47.16,Rate
Wien,AT13,Total,Males,2013,Chronic lower respiratory diseases,49.42,Rate
Wien,AT13,Total,Males,2014,Chronic lower respiratory diseases,52.75,Rate
Wien,AT13,Total,Males,2015,Chronic lower respiratory diseases,48.88,Rate
Wien,AT13,Total,Males,2016,Chronic lower respiratory diseases,47.07,Rate
Wien,AT13,Total,Males,2017,Chronic lower respiratory diseases,51.68,Rate
Wien,AT13,Total,Males,2018,Chronic lower respiratory diseases,58.33,Rate
Wien,AT13,Total,Males,2019,Chronic lower respiratory diseases,64.41,Rate
Wien,AT13,Total,Males,2020,Chronic lower respiratory diseases,63.48,Rate
Wien,AT13,Total,Males,2011,Asthma and status asthmaticus,0.88,Rate
Wien,AT13,Total,Males,2012,Asthma and status asthmaticus,0.83,Rate
Wien,AT13,Total,Males,2013,Asthma and status asthmaticus,0.67,Rate
Wien,AT13,Total,Males,2014,Asthma and status asthmaticus,0.72,Rate
Wien,AT13,Total,Males,2015,Asthma and status asthmaticus,0.29,Rate
Wien,AT13,Total,Males,2016,Asthma and status asthmaticus,0.26,Rate
Wien,AT13,Total,Males,2017,Asthma and status asthmaticus,1.05,Rate
Wien,AT13,Total,Males,2018,Asthma and status asthmaticus,0.9,Rate
Wien,AT13,Total,Males,2019,Asthma and status asthmaticus,1.1,Rate
Wien,AT13,Total,Males,2020,Asthma and status asthmaticus,0.6,Rate
Wien,AT13,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5433.81,Rate
Wien,AT13,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5458.89,Rate
Wien,AT13,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5497.21,Rate
Wien,AT13,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5227.1,Rate
Wien,AT13,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5432.65,Rate
Wien,AT13,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4981.14,Rate
Wien,AT13,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5050.17,Rate
Wien,AT13,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5189.74,Rate
Wien,AT13,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4958.3,Rate
Wien,AT13,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5496.72,Rate
Wien,AT13,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",178.27,Rate
Wien,AT13,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.46,Rate
Wien,AT13,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",174.99,Rate
Wien,AT13,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",190.71,Rate
Wien,AT13,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",174.17,Rate
Wien,AT13,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.55,Rate
Wien,AT13,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.71,Rate
Wien,AT13,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.76,Rate
Wien,AT13,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.2,Rate
Wien,AT13,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.35,Rate
Wien,AT13,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",277.99,Rate
Wien,AT13,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",315.11,Rate
Wien,AT13,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",308.44,Rate
Wien,AT13,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",311.78,Rate
Wien,AT13,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",304.21,Rate
Wien,AT13,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",286.12,Rate
Wien,AT13,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",286.0,Rate
Wien,AT13,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",289.87,Rate
Wien,AT13,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",288.6,Rate
Wien,AT13,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",276.2,Rate
Wien,AT13,65 years or over,Males,2011,Malignant melanoma of skin,31.4,Rate
Wien,AT13,65 years or over,Males,2012,Malignant melanoma of skin,30.14,Rate
Wien,AT13,65 years or over,Males,2013,Malignant melanoma of skin,32.49,Rate
Wien,AT13,65 years or over,Males,2014,Malignant melanoma of skin,22.72,Rate
Wien,AT13,65 years or over,Males,2015,Malignant melanoma of skin,25.9,Rate
Wien,AT13,65 years or over,Males,2016,Malignant melanoma of skin,23.65,Rate
Wien,AT13,65 years or over,Males,2017,Malignant melanoma of skin,29.21,Rate
Wien,AT13,65 years or over,Males,2018,Malignant melanoma of skin,15.9,Rate
Wien,AT13,65 years or over,Males,2019,Malignant melanoma of skin,20.16,Rate
Wien,AT13,65 years or over,Males,2020,Malignant melanoma of skin,27.01,Rate
Wien,AT13,65 years or over,Males,2011,Malignant neoplasm of breast,3.36,Rate
Wien,AT13,65 years or over,Males,2012,Malignant neoplasm of breast,1.92,Rate
Wien,AT13,65 years or over,Males,2013,Malignant neoplasm of breast,4.22,Rate
Wien,AT13,65 years or over,Males,2014,Malignant neoplasm of breast,2.65,Rate
Wien,AT13,65 years or over,Males,2015,Malignant neoplasm of breast,2.4,Rate
Wien,AT13,65 years or over,Males,2016,Malignant neoplasm of breast,5.08,Rate
Wien,AT13,65 years or over,Males,2017,Malignant neoplasm of breast,2.88,Rate
Wien,AT13,65 years or over,Males,2018,Malignant neoplasm of breast,0.64,Rate
Wien,AT13,65 years or over,Males,2019,Malignant neoplasm of breast,3.68,Rate
Wien,AT13,65 years or over,Males,2011,Diabetes mellitus,209.74,Rate
Wien,AT13,65 years or over,Males,2012,Diabetes mellitus,171.4,Rate
Wien,AT13,65 years or over,Males,2013,Diabetes mellitus,179.36,Rate
Wien,AT13,65 years or over,Males,2014,Diabetes mellitus,185.76,Rate
Wien,AT13,65 years or over,Males,2015,Diabetes mellitus,232.84,Rate
Wien,AT13,65 years or over,Males,2016,Diabetes mellitus,260.7,Rate
Wien,AT13,65 years or over,Males,2017,Diabetes mellitus,244.73,Rate
Wien,AT13,65 years or over,Males,2018,Diabetes mellitus,224.48,Rate
Wien,AT13,65 years or over,Males,2019,Diabetes mellitus,205.04,Rate
Wien,AT13,65 years or over,Males,2020,Diabetes mellitus,223.96,Rate
Wien,AT13,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),33.63,Rate
Wien,AT13,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),54.45,Rate
Wien,AT13,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),54.07,Rate
Wien,AT13,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),63.93,Rate
Wien,AT13,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),61.63,Rate
Wien,AT13,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),79.31,Rate
Wien,AT13,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),127.47,Rate
Wien,AT13,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),191.19,Rate
Wien,AT13,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),121.32,Rate
Wien,AT13,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),129.47,Rate
Wien,AT13,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Wien,AT13,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Wien,AT13,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.62,Rate
Wien,AT13,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.86,Rate
Wien,AT13,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.72,Rate
Wien,AT13,65 years or over,Males,2011,Other ischaemic heart diseases,1208.77,Rate
Wien,AT13,65 years or over,Males,2012,Other ischaemic heart diseases,1073.33,Rate
Wien,AT13,65 years or over,Males,2013,Other ischaemic heart diseases,1214.69,Rate
Wien,AT13,65 years or over,Males,2014,Other ischaemic heart diseases,1125.86,Rate
Wien,AT13,65 years or over,Males,2015,Other ischaemic heart diseases,1167.44,Rate
Wien,AT13,65 years or over,Males,2016,Other ischaemic heart diseases,1032.18,Rate
Wien,AT13,65 years or over,Males,2017,Other ischaemic heart diseases,919.29,Rate
Wien,AT13,65 years or over,Males,2018,Other ischaemic heart diseases,892.3,Rate
Wien,AT13,65 years or over,Males,2019,Other ischaemic heart diseases,826.42,Rate
Wien,AT13,65 years or over,Males,2020,Other ischaemic heart diseases,827.57,Rate
Wien,AT13,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,278.87,Rate
Wien,AT13,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,316.4,Rate
Wien,AT13,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,300.13,Rate
Wien,AT13,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,236.88,Rate
Wien,AT13,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,242.84,Rate
Wien,AT13,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,203.95,Rate
Wien,AT13,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,223.31,Rate
Wien,AT13,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,214.29,Rate
Wien,AT13,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,196.94,Rate
Wien,AT13,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,244.02,Rate
Wien,AT13,65 years or over,Males,2011,Cerebrovascular diseases,278.46,Rate
Wien,AT13,65 years or over,Males,2012,Cerebrovascular diseases,298.56,Rate
Wien,AT13,65 years or over,Males,2013,Cerebrovascular diseases,297.35,Rate
Wien,AT13,65 years or over,Males,2014,Cerebrovascular diseases,245.64,Rate
Wien,AT13,65 years or over,Males,2015,Cerebrovascular diseases,269.09,Rate
Wien,AT13,65 years or over,Males,2016,Cerebrovascular diseases,234.45,Rate
Wien,AT13,65 years or over,Males,2017,Cerebrovascular diseases,257.27,Rate
Wien,AT13,65 years or over,Males,2018,Cerebrovascular diseases,276.48,Rate
Wien,AT13,65 years or over,Males,2019,Cerebrovascular diseases,255.22,Rate
Wien,AT13,65 years or over,Males,2020,Cerebrovascular diseases,254.16,Rate
Wien,AT13,65 years or over,Males,2011,Chronic lower respiratory diseases,218.51,Rate
Wien,AT13,65 years or over,Males,2012,Chronic lower respiratory diseases,213.42,Rate
Wien,AT13,65 years or over,Males,2013,Chronic lower respiratory diseases,210.06,Rate
Wien,AT13,65 years or over,Males,2014,Chronic lower respiratory diseases,245.71,Rate
Wien,AT13,65 years or over,Males,2015,Chronic lower respiratory diseases,219.58,Rate
Wien,AT13,65 years or over,Males,2016,Chronic lower respiratory diseases,214.02,Rate
Wien,AT13,65 years or over,Males,2017,Chronic lower respiratory diseases,235.17,Rate
Wien,AT13,65 years or over,Males,2018,Chronic lower respiratory diseases,254.54,Rate
Wien,AT13,65 years or over,Males,2019,Chronic lower respiratory diseases,295.48,Rate
Wien,AT13,65 years or over,Males,2020,Chronic lower respiratory diseases,288.65,Rate
Wien,AT13,65 years or over,Males,2011,Asthma and status asthmaticus,2.47,Rate
Wien,AT13,65 years or over,Males,2012,Asthma and status asthmaticus,2.47,Rate
Wien,AT13,65 years or over,Males,2013,Asthma and status asthmaticus,3.43,Rate
Wien,AT13,65 years or over,Males,2014,Asthma and status asthmaticus,2.65,Rate
Wien,AT13,65 years or over,Males,2015,Asthma and status asthmaticus,0.95,Rate
Wien,AT13,65 years or over,Males,2016,Asthma and status asthmaticus,0.73,Rate
Wien,AT13,65 years or over,Males,2017,Asthma and status asthmaticus,4.25,Rate
Wien,AT13,65 years or over,Males,2018,Asthma and status asthmaticus,2.36,Rate
Wien,AT13,65 years or over,Males,2019,Asthma and status asthmaticus,4.43,Rate
Wien,AT13,65 years or over,Males,2020,Asthma and status asthmaticus,1.94,Rate
Wien,AT13,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,304.08,Rate
Wien,AT13,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,283.22,Rate
Wien,AT13,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,273.07,Rate
Wien,AT13,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,273.55,Rate
Wien,AT13,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,254.23,Rate
Wien,AT13,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,242.31,Rate
Wien,AT13,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,226.79,Rate
Wien,AT13,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,239.74,Rate
Wien,AT13,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,223.43,Rate
Wien,AT13,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,237.82,Rate
Wien,AT13,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.38,Rate
Wien,AT13,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.3,Rate
Wien,AT13,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.42,Rate
Wien,AT13,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.7,Rate
Wien,AT13,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.32,Rate
Wien,AT13,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.33,Rate
Wien,AT13,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.61,Rate
Wien,AT13,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.53,Rate
Wien,AT13,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.73,Rate
Wien,AT13,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.57,Rate
Wien,AT13,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",32.88,Rate
Wien,AT13,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",29.44,Rate
Wien,AT13,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",25.9,Rate
Wien,AT13,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",31.97,Rate
Wien,AT13,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",26.58,Rate
Wien,AT13,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",27.17,Rate
Wien,AT13,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",24.38,Rate
Wien,AT13,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",25.45,Rate
Wien,AT13,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",18.64,Rate
Wien,AT13,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",26.1,Rate
Wien,AT13,Less than 65 years,Males,2011,Malignant melanoma of skin,1.85,Rate
Wien,AT13,Less than 65 years,Males,2012,Malignant melanoma of skin,1.22,Rate
Wien,AT13,Less than 65 years,Males,2013,Malignant melanoma of skin,1.53,Rate
Wien,AT13,Less than 65 years,Males,2014,Malignant melanoma of skin,1.88,Rate
Wien,AT13,Less than 65 years,Males,2015,Malignant melanoma of skin,1.03,Rate
Wien,AT13,Less than 65 years,Males,2016,Malignant melanoma of skin,1.88,Rate
Wien,AT13,Less than 65 years,Males,2017,Malignant melanoma of skin,1.67,Rate
Wien,AT13,Less than 65 years,Males,2018,Malignant melanoma of skin,1.76,Rate
Wien,AT13,Less than 65 years,Males,2019,Malignant melanoma of skin,1.62,Rate
Wien,AT13,Less than 65 years,Males,2020,Malignant melanoma of skin,2.0,Rate
Wien,AT13,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.17,Rate
Wien,AT13,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.15,Rate
Wien,AT13,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.13,Rate
Wien,AT13,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Wien,AT13,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.54,Rate
Wien,AT13,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.3,Rate
Wien,AT13,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.14,Rate
Wien,AT13,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.16,Rate
Wien,AT13,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.13,Rate
Wien,AT13,Less than 65 years,Males,2011,Diabetes mellitus,5.73,Rate
Wien,AT13,Less than 65 years,Males,2012,Diabetes mellitus,5.05,Rate
Wien,AT13,Less than 65 years,Males,2013,Diabetes mellitus,6.04,Rate
Wien,AT13,Less than 65 years,Males,2014,Diabetes mellitus,6.6,Rate
Wien,AT13,Less than 65 years,Males,2015,Diabetes mellitus,7.38,Rate
Wien,AT13,Less than 65 years,Males,2016,Diabetes mellitus,8.13,Rate
Wien,AT13,Less than 65 years,Males,2017,Diabetes mellitus,4.12,Rate
Wien,AT13,Less than 65 years,Males,2018,Diabetes mellitus,5.27,Rate
Wien,AT13,Less than 65 years,Males,2019,Diabetes mellitus,2.85,Rate
Wien,AT13,Less than 65 years,Males,2020,Diabetes mellitus,4.3,Rate
Wien,AT13,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),17.24,Rate
Wien,AT13,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),17.86,Rate
Wien,AT13,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),15.39,Rate
Wien,AT13,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),14.54,Rate
Wien,AT13,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),10.79,Rate
Wien,AT13,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),10.54,Rate
Wien,AT13,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),8.27,Rate
Wien,AT13,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),9.42,Rate
Wien,AT13,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),9.26,Rate
Wien,AT13,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),9.82,Rate
Wien,AT13,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Wien,AT13,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Wien,AT13,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Wien,AT13,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Wien,AT13,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Wien,AT13,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Wien,AT13,Less than 65 years,Males,2011,Other ischaemic heart diseases,21.83,Rate
Wien,AT13,Less than 65 years,Males,2012,Other ischaemic heart diseases,18.24,Rate
Wien,AT13,Less than 65 years,Males,2013,Other ischaemic heart diseases,15.87,Rate
Wien,AT13,Less than 65 years,Males,2014,Other ischaemic heart diseases,18.22,Rate
Wien,AT13,Less than 65 years,Males,2015,Other ischaemic heart diseases,14.69,Rate
Wien,AT13,Less than 65 years,Males,2016,Other ischaemic heart diseases,14.01,Rate
Wien,AT13,Less than 65 years,Males,2017,Other ischaemic heart diseases,12.1,Rate
Wien,AT13,Less than 65 years,Males,2018,Other ischaemic heart diseases,18.72,Rate
Wien,AT13,Less than 65 years,Males,2019,Other ischaemic heart diseases,12.93,Rate
Wien,AT13,Less than 65 years,Males,2020,Other ischaemic heart diseases,13.31,Rate
Wien,AT13,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,27.42,Rate
Wien,AT13,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,20.52,Rate
Wien,AT13,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,23.7,Rate
Wien,AT13,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,21.01,Rate
Wien,AT13,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,16.67,Rate
Wien,AT13,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,15.3,Rate
Wien,AT13,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,18.32,Rate
Wien,AT13,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,14.95,Rate
Wien,AT13,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,15.86,Rate
Wien,AT13,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,16.61,Rate
Wien,AT13,Less than 65 years,Males,2011,Cerebrovascular diseases,6.31,Rate
Wien,AT13,Less than 65 years,Males,2012,Cerebrovascular diseases,8.16,Rate
Wien,AT13,Less than 65 years,Males,2013,Cerebrovascular diseases,8.81,Rate
Wien,AT13,Less than 65 years,Males,2014,Cerebrovascular diseases,7.04,Rate
Wien,AT13,Less than 65 years,Males,2015,Cerebrovascular diseases,7.26,Rate
Wien,AT13,Less than 65 years,Males,2016,Cerebrovascular diseases,5.94,Rate
Wien,AT13,Less than 65 years,Males,2017,Cerebrovascular diseases,4.9,Rate
Wien,AT13,Less than 65 years,Males,2018,Cerebrovascular diseases,6.13,Rate
Wien,AT13,Less than 65 years,Males,2019,Cerebrovascular diseases,6.09,Rate
Wien,AT13,Less than 65 years,Males,2020,Cerebrovascular diseases,4.85,Rate
Wien,AT13,Less than 65 years,Males,2011,Chronic lower respiratory diseases,8.69,Rate
Wien,AT13,Less than 65 years,Males,2012,Chronic lower respiratory diseases,6.89,Rate
Wien,AT13,Less than 65 years,Males,2013,Chronic lower respiratory diseases,10.5,Rate
Wien,AT13,Less than 65 years,Males,2014,Chronic lower respiratory diseases,6.0,Rate
Wien,AT13,Less than 65 years,Males,2015,Chronic lower respiratory diseases,7.53,Rate
Wien,AT13,Less than 65 years,Males,2016,Chronic lower respiratory diseases,6.63,Rate
Wien,AT13,Less than 65 years,Males,2017,Chronic lower respiratory diseases,7.23,Rate
Wien,AT13,Less than 65 years,Males,2018,Chronic lower respiratory diseases,10.8,Rate
Wien,AT13,Less than 65 years,Males,2019,Chronic lower respiratory diseases,8.44,Rate
Wien,AT13,Less than 65 years,Males,2020,Chronic lower respiratory diseases,8.94,Rate
Wien,AT13,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.49,Rate
Wien,AT13,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.43,Rate
Wien,AT13,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Wien,AT13,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.26,Rate
Wien,AT13,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.13,Rate
Wien,AT13,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.15,Rate
Wien,AT13,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.27,Rate
Wien,AT13,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.54,Rate
Wien,AT13,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.29,Rate
Wien,AT13,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.27,Rate
Wien,AT13,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1031.19,Rate
Wien,AT13,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1048.34,Rate
Wien,AT13,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1037.2,Rate
Wien,AT13,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,998.5,Rate
Wien,AT13,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1010.43,Rate
Wien,AT13,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,959.82,Rate
Wien,AT13,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,974.0,Rate
Wien,AT13,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,987.69,Rate
Wien,AT13,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,931.16,Rate
Wien,AT13,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1025.31,Rate
Wien,AT13,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.41,Rate
Wien,AT13,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.17,Rate
Wien,AT13,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.77,Rate
Wien,AT13,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.36,Rate
Wien,AT13,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.77,Rate
Wien,AT13,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.04,Rate
Wien,AT13,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.61,Rate
Wien,AT13,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.06,Rate
Wien,AT13,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.9,Rate
Wien,AT13,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.28,Rate
Wien,AT13,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",57.56,Rate
Wien,AT13,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",59.38,Rate
Wien,AT13,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",56.65,Rate
Wien,AT13,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",63.17,Rate
Wien,AT13,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",58.67,Rate
Wien,AT13,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",59.86,Rate
Wien,AT13,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",56.51,Rate
Wien,AT13,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",59.16,Rate
Wien,AT13,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",56.48,Rate
Wien,AT13,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",60.06,Rate
Wien,AT13,Total,Total,2011,Malignant melanoma of skin,5.34,Rate
Wien,AT13,Total,Total,2012,Malignant melanoma of skin,4.09,Rate
Wien,AT13,Total,Total,2013,Malignant melanoma of skin,4.2,Rate
Wien,AT13,Total,Total,2014,Malignant melanoma of skin,4.08,Rate
Wien,AT13,Total,Total,2015,Malignant melanoma of skin,3.58,Rate
Wien,AT13,Total,Total,2016,Malignant melanoma of skin,4.02,Rate
Wien,AT13,Total,Total,2017,Malignant melanoma of skin,4.76,Rate
Wien,AT13,Total,Total,2018,Malignant melanoma of skin,3.52,Rate
Wien,AT13,Total,Total,2019,Malignant melanoma of skin,3.86,Rate
Wien,AT13,Total,Total,2020,Malignant melanoma of skin,4.52,Rate
Wien,AT13,Total,Total,2011,Malignant neoplasm of breast,22.34,Rate
Wien,AT13,Total,Total,2012,Malignant neoplasm of breast,21.66,Rate
Wien,AT13,Total,Total,2013,Malignant neoplasm of breast,23.89,Rate
Wien,AT13,Total,Total,2014,Malignant neoplasm of breast,22.53,Rate
Wien,AT13,Total,Total,2015,Malignant neoplasm of breast,21.04,Rate
Wien,AT13,Total,Total,2016,Malignant neoplasm of breast,22.48,Rate
Wien,AT13,Total,Total,2017,Malignant neoplasm of breast,19.76,Rate
Wien,AT13,Total,Total,2018,Malignant neoplasm of breast,21.03,Rate
Wien,AT13,Total,Total,2019,Malignant neoplasm of breast,20.02,Rate
Wien,AT13,Total,Total,2020,Malignant neoplasm of breast,20.07,Rate
Wien,AT13,Total,Total,2011,Diabetes mellitus,32.87,Rate
Wien,AT13,Total,Total,2012,Diabetes mellitus,31.71,Rate
Wien,AT13,Total,Total,2013,Diabetes mellitus,32.87,Rate
Wien,AT13,Total,Total,2014,Diabetes mellitus,36.79,Rate
Wien,AT13,Total,Total,2015,Diabetes mellitus,42.13,Rate
Wien,AT13,Total,Total,2016,Diabetes mellitus,45.9,Rate
Wien,AT13,Total,Total,2017,Diabetes mellitus,40.78,Rate
Wien,AT13,Total,Total,2018,Diabetes mellitus,37.84,Rate
Wien,AT13,Total,Total,2019,Diabetes mellitus,33.2,Rate
Wien,AT13,Total,Total,2020,Diabetes mellitus,35.0,Rate
Wien,AT13,Total,Total,2011,Mental and behavioural disorders (F00-F99),12.67,Rate
Wien,AT13,Total,Total,2012,Mental and behavioural disorders (F00-F99),15.83,Rate
Wien,AT13,Total,Total,2013,Mental and behavioural disorders (F00-F99),17.42,Rate
Wien,AT13,Total,Total,2014,Mental and behavioural disorders (F00-F99),16.83,Rate
Wien,AT13,Total,Total,2015,Mental and behavioural disorders (F00-F99),16.75,Rate
Wien,AT13,Total,Total,2016,Mental and behavioural disorders (F00-F99),20.41,Rate
Wien,AT13,Total,Total,2017,Mental and behavioural disorders (F00-F99),34.4,Rate
Wien,AT13,Total,Total,2018,Mental and behavioural disorders (F00-F99),40.68,Rate
Wien,AT13,Total,Total,2019,Mental and behavioural disorders (F00-F99),31.21,Rate
Wien,AT13,Total,Total,2020,Mental and behavioural disorders (F00-F99),29.67,Rate
Wien,AT13,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Wien,AT13,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Wien,AT13,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Wien,AT13,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Wien,AT13,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Wien,AT13,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Wien,AT13,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Wien,AT13,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Wien,AT13,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Wien,AT13,Total,Total,2011,Other ischaemic heart diseases,183.55,Rate
Wien,AT13,Total,Total,2012,Other ischaemic heart diseases,186.49,Rate
Wien,AT13,Total,Total,2013,Other ischaemic heart diseases,191.55,Rate
Wien,AT13,Total,Total,2014,Other ischaemic heart diseases,185.91,Rate
Wien,AT13,Total,Total,2015,Other ischaemic heart diseases,180.83,Rate
Wien,AT13,Total,Total,2016,Other ischaemic heart diseases,164.52,Rate
Wien,AT13,Total,Total,2017,Other ischaemic heart diseases,151.95,Rate
Wien,AT13,Total,Total,2018,Other ischaemic heart diseases,144.88,Rate
Wien,AT13,Total,Total,2019,Other ischaemic heart diseases,130.83,Rate
Wien,AT13,Total,Total,2020,Other ischaemic heart diseases,125.13,Rate
Wien,AT13,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,51.0,Rate
Wien,AT13,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,50.45,Rate
Wien,AT13,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,47.32,Rate
Wien,AT13,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,42.87,Rate
Wien,AT13,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,39.86,Rate
Wien,AT13,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,37.06,Rate
Wien,AT13,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,39.52,Rate
Wien,AT13,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,36.46,Rate
Wien,AT13,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,33.57,Rate
Wien,AT13,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,41.03,Rate
Wien,AT13,Total,Total,2011,Cerebrovascular diseases,52.25,Rate
Wien,AT13,Total,Total,2012,Cerebrovascular diseases,55.45,Rate
Wien,AT13,Total,Total,2013,Cerebrovascular diseases,59.86,Rate
Wien,AT13,Total,Total,2014,Cerebrovascular diseases,51.07,Rate
Wien,AT13,Total,Total,2015,Cerebrovascular diseases,54.05,Rate
Wien,AT13,Total,Total,2016,Cerebrovascular diseases,46.68,Rate
Wien,AT13,Total,Total,2017,Cerebrovascular diseases,50.71,Rate
Wien,AT13,Total,Total,2018,Cerebrovascular diseases,53.24,Rate
Wien,AT13,Total,Total,2019,Cerebrovascular diseases,47.75,Rate
Wien,AT13,Total,Total,2020,Cerebrovascular diseases,48.21,Rate
Wien,AT13,Total,Total,2011,Chronic lower respiratory diseases,38.29,Rate
Wien,AT13,Total,Total,2012,Chronic lower respiratory diseases,36.16,Rate
Wien,AT13,Total,Total,2013,Chronic lower respiratory diseases,38.2,Rate
Wien,AT13,Total,Total,2014,Chronic lower respiratory diseases,36.24,Rate
Wien,AT13,Total,Total,2015,Chronic lower respiratory diseases,35.91,Rate
Wien,AT13,Total,Total,2016,Chronic lower respiratory diseases,39.57,Rate
Wien,AT13,Total,Total,2017,Chronic lower respiratory diseases,44.69,Rate
Wien,AT13,Total,Total,2018,Chronic lower respiratory diseases,47.89,Rate
Wien,AT13,Total,Total,2019,Chronic lower respiratory diseases,52.12,Rate
Wien,AT13,Total,Total,2020,Chronic lower respiratory diseases,49.52,Rate
Wien,AT13,Total,Total,2011,Asthma and status asthmaticus,1.09,Rate
Wien,AT13,Total,Total,2012,Asthma and status asthmaticus,0.92,Rate
Wien,AT13,Total,Total,2013,Asthma and status asthmaticus,0.93,Rate
Wien,AT13,Total,Total,2014,Asthma and status asthmaticus,0.64,Rate
Wien,AT13,Total,Total,2015,Asthma and status asthmaticus,0.77,Rate
Wien,AT13,Total,Total,2016,Asthma and status asthmaticus,0.69,Rate
Wien,AT13,Total,Total,2017,Asthma and status asthmaticus,1.21,Rate
Wien,AT13,Total,Total,2018,Asthma and status asthmaticus,0.64,Rate
Wien,AT13,Total,Total,2019,Asthma and status asthmaticus,1.24,Rate
Wien,AT13,Total,Total,2020,Asthma and status asthmaticus,0.65,Rate
Wien,AT13,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4323.9,Rate
Wien,AT13,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4480.37,Rate
Wien,AT13,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4448.23,Rate
Wien,AT13,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4249.54,Rate
Wien,AT13,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4376.0,Rate
Wien,AT13,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4136.23,Rate
Wien,AT13,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4267.84,Rate
Wien,AT13,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4286.18,Rate
Wien,AT13,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4056.89,Rate
Wien,AT13,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4498.41,Rate
Wien,AT13,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.58,Rate
Wien,AT13,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.87,Rate
Wien,AT13,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.47,Rate
Wien,AT13,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.94,Rate
Wien,AT13,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.99,Rate
Wien,AT13,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.54,Rate
Wien,AT13,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.1,Rate
Wien,AT13,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.26,Rate
Wien,AT13,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.41,Rate
Wien,AT13,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.59,Rate
Wien,AT13,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",189.09,Rate
Wien,AT13,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",210.07,Rate
Wien,AT13,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",200.87,Rate
Wien,AT13,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",217.26,Rate
Wien,AT13,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",208.66,Rate
Wien,AT13,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",217.25,Rate
Wien,AT13,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",208.77,Rate
Wien,AT13,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",216.7,Rate
Wien,AT13,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",215.58,Rate
Wien,AT13,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",226.66,Rate
Wien,AT13,65 years or over,Total,2011,Malignant melanoma of skin,20.2,Rate
Wien,AT13,65 years or over,Total,2012,Malignant melanoma of skin,15.31,Rate
Wien,AT13,65 years or over,Total,2013,Malignant melanoma of skin,16.66,Rate
Wien,AT13,65 years or over,Total,2014,Malignant melanoma of skin,15.96,Rate
Wien,AT13,65 years or over,Total,2015,Malignant melanoma of skin,14.39,Rate
Wien,AT13,65 years or over,Total,2016,Malignant melanoma of skin,14.47,Rate
Wien,AT13,65 years or over,Total,2017,Malignant melanoma of skin,18.47,Rate
Wien,AT13,65 years or over,Total,2018,Malignant melanoma of skin,12.3,Rate
Wien,AT13,65 years or over,Total,2019,Malignant melanoma of skin,15.42,Rate
Wien,AT13,65 years or over,Total,2020,Malignant melanoma of skin,17.24,Rate
Wien,AT13,65 years or over,Total,2011,Malignant neoplasm of breast,79.78,Rate
Wien,AT13,65 years or over,Total,2012,Malignant neoplasm of breast,80.26,Rate
Wien,AT13,65 years or over,Total,2013,Malignant neoplasm of breast,92.64,Rate
Wien,AT13,65 years or over,Total,2014,Malignant neoplasm of breast,83.48,Rate
Wien,AT13,65 years or over,Total,2015,Malignant neoplasm of breast,81.98,Rate
Wien,AT13,65 years or over,Total,2016,Malignant neoplasm of breast,86.08,Rate
Wien,AT13,65 years or over,Total,2017,Malignant neoplasm of breast,75.38,Rate
Wien,AT13,65 years or over,Total,2018,Malignant neoplasm of breast,82.99,Rate
Wien,AT13,65 years or over,Total,2019,Malignant neoplasm of breast,81.13,Rate
Wien,AT13,65 years or over,Total,2020,Malignant neoplasm of breast,82.3,Rate
Wien,AT13,65 years or over,Total,2011,Diabetes mellitus,150.73,Rate
Wien,AT13,65 years or over,Total,2012,Diabetes mellitus,147.23,Rate
Wien,AT13,65 years or over,Total,2013,Diabetes mellitus,150.02,Rate
Wien,AT13,65 years or over,Total,2014,Diabetes mellitus,170.8,Rate
Wien,AT13,65 years or over,Total,2015,Diabetes mellitus,197.65,Rate
Wien,AT13,65 years or over,Total,2016,Diabetes mellitus,212.23,Rate
Wien,AT13,65 years or over,Total,2017,Diabetes mellitus,194.41,Rate
Wien,AT13,65 years or over,Total,2018,Diabetes mellitus,176.03,Rate
Wien,AT13,65 years or over,Total,2019,Diabetes mellitus,161.8,Rate
Wien,AT13,65 years or over,Total,2020,Diabetes mellitus,167.1,Rate
Wien,AT13,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),19.93,Rate
Wien,AT13,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),38.2,Rate
Wien,AT13,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),47.97,Rate
Wien,AT13,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),47.7,Rate
Wien,AT13,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),53.58,Rate
Wien,AT13,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),76.38,Rate
Wien,AT13,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),152.15,Rate
Wien,AT13,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),183.76,Rate
Wien,AT13,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),134.91,Rate
Wien,AT13,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),126.45,Rate
Wien,AT13,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Wien,AT13,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Wien,AT13,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Wien,AT13,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Wien,AT13,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Wien,AT13,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Wien,AT13,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.67,Rate
Wien,AT13,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.59,Rate
Wien,AT13,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.25,Rate
Wien,AT13,65 years or over,Total,2011,Other ischaemic heart diseases,884.57,Rate
Wien,AT13,65 years or over,Total,2012,Other ischaemic heart diseases,910.09,Rate
Wien,AT13,65 years or over,Total,2013,Other ischaemic heart diseases,942.36,Rate
Wien,AT13,65 years or over,Total,2014,Other ischaemic heart diseases,905.47,Rate
Wien,AT13,65 years or over,Total,2015,Other ischaemic heart diseases,889.19,Rate
Wien,AT13,65 years or over,Total,2016,Other ischaemic heart diseases,809.01,Rate
Wien,AT13,65 years or over,Total,2017,Other ischaemic heart diseases,747.25,Rate
Wien,AT13,65 years or over,Total,2018,Other ischaemic heart diseases,693.68,Rate
Wien,AT13,65 years or over,Total,2019,Other ischaemic heart diseases,638.99,Rate
Wien,AT13,65 years or over,Total,2020,Other ischaemic heart diseases,607.65,Rate
Wien,AT13,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,196.25,Rate
Wien,AT13,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,210.08,Rate
Wien,AT13,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,187.58,Rate
Wien,AT13,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,170.29,Rate
Wien,AT13,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,166.97,Rate
Wien,AT13,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,149.26,Rate
Wien,AT13,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,155.94,Rate
Wien,AT13,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,152.4,Rate
Wien,AT13,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,133.65,Rate
Wien,AT13,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,166.79,Rate
Wien,AT13,65 years or over,Total,2011,Cerebrovascular diseases,243.5,Rate
Wien,AT13,65 years or over,Total,2012,Cerebrovascular diseases,257.51,Rate
Wien,AT13,65 years or over,Total,2013,Cerebrovascular diseases,277.8,Rate
Wien,AT13,65 years or over,Total,2014,Cerebrovascular diseases,241.08,Rate
Wien,AT13,65 years or over,Total,2015,Cerebrovascular diseases,254.68,Rate
Wien,AT13,65 years or over,Total,2016,Cerebrovascular diseases,219.28,Rate
Wien,AT13,65 years or over,Total,2017,Cerebrovascular diseases,242.91,Rate
Wien,AT13,65 years or over,Total,2018,Cerebrovascular diseases,253.45,Rate
Wien,AT13,65 years or over,Total,2019,Cerebrovascular diseases,224.4,Rate
Wien,AT13,65 years or over,Total,2020,Cerebrovascular diseases,231.07,Rate
Wien,AT13,65 years or over,Total,2011,Chronic lower respiratory diseases,167.52,Rate
Wien,AT13,65 years or over,Total,2012,Chronic lower respiratory diseases,159.19,Rate
Wien,AT13,65 years or over,Total,2013,Chronic lower respiratory diseases,164.34,Rate
Wien,AT13,65 years or over,Total,2014,Chronic lower respiratory diseases,165.64,Rate
Wien,AT13,65 years or over,Total,2015,Chronic lower respiratory diseases,158.7,Rate
Wien,AT13,65 years or over,Total,2016,Chronic lower respiratory diseases,180.52,Rate
Wien,AT13,65 years or over,Total,2017,Chronic lower respiratory diseases,203.04,Rate
Wien,AT13,65 years or over,Total,2018,Chronic lower respiratory diseases,206.02,Rate
Wien,AT13,65 years or over,Total,2019,Chronic lower respiratory diseases,239.84,Rate
Wien,AT13,65 years or over,Total,2020,Chronic lower respiratory diseases,226.06,Rate
Wien,AT13,65 years or over,Total,2011,Asthma and status asthmaticus,3.67,Rate
Wien,AT13,65 years or over,Total,2012,Asthma and status asthmaticus,2.62,Rate
Wien,AT13,65 years or over,Total,2013,Asthma and status asthmaticus,4.49,Rate
Wien,AT13,65 years or over,Total,2014,Asthma and status asthmaticus,2.15,Rate
Wien,AT13,65 years or over,Total,2015,Asthma and status asthmaticus,2.75,Rate
Wien,AT13,65 years or over,Total,2016,Asthma and status asthmaticus,2.97,Rate
Wien,AT13,65 years or over,Total,2017,Asthma and status asthmaticus,4.74,Rate
Wien,AT13,65 years or over,Total,2018,Asthma and status asthmaticus,1.64,Rate
Wien,AT13,65 years or over,Total,2019,Asthma and status asthmaticus,4.69,Rate
Wien,AT13,65 years or over,Total,2020,Asthma and status asthmaticus,2.54,Rate
Wien,AT13,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,233.58,Rate
Wien,AT13,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,216.98,Rate
Wien,AT13,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,210.92,Rate
Wien,AT13,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,210.98,Rate
Wien,AT13,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,195.17,Rate
Wien,AT13,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,190.37,Rate
Wien,AT13,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,176.11,Rate
Wien,AT13,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,188.67,Rate
Wien,AT13,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,174.0,Rate
Wien,AT13,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,184.0,Rate
Wien,AT13,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.9,Rate
Wien,AT13,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.78,Rate
Wien,AT13,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.07,Rate
Wien,AT13,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.51,Rate
Wien,AT13,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.22,Rate
Wien,AT13,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.81,Rate
Wien,AT13,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.48,Rate
Wien,AT13,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.67,Rate
Wien,AT13,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.92,Rate
Wien,AT13,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.34,Rate
Wien,AT13,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",25.7,Rate
Wien,AT13,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",22.87,Rate
Wien,AT13,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",21.72,Rate
Wien,AT13,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",25.85,Rate
Wien,AT13,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",22.34,Rate
Wien,AT13,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",21.73,Rate
Wien,AT13,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",19.62,Rate
Wien,AT13,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",21.0,Rate
Wien,AT13,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",17.94,Rate
Wien,AT13,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",19.71,Rate
Wien,AT13,Less than 65 years,Total,2011,Malignant melanoma of skin,1.74,Rate
Wien,AT13,Less than 65 years,Total,2012,Malignant melanoma of skin,1.37,Rate
Wien,AT13,Less than 65 years,Total,2013,Malignant melanoma of skin,1.18,Rate
Wien,AT13,Less than 65 years,Total,2014,Malignant melanoma of skin,1.2,Rate
Wien,AT13,Less than 65 years,Total,2015,Malignant melanoma of skin,0.96,Rate
Wien,AT13,Less than 65 years,Total,2016,Malignant melanoma of skin,1.49,Rate
Wien,AT13,Less than 65 years,Total,2017,Malignant melanoma of skin,1.44,Rate
Wien,AT13,Less than 65 years,Total,2018,Malignant melanoma of skin,1.39,Rate
Wien,AT13,Less than 65 years,Total,2019,Malignant melanoma of skin,1.06,Rate
Wien,AT13,Less than 65 years,Total,2020,Malignant melanoma of skin,1.44,Rate
Wien,AT13,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.42,Rate
Wien,AT13,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.46,Rate
Wien,AT13,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.24,Rate
Wien,AT13,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.76,Rate
Wien,AT13,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.28,Rate
Wien,AT13,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.07,Rate
Wien,AT13,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.28,Rate
Wien,AT13,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.02,Rate
Wien,AT13,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.21,Rate
Wien,AT13,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.0,Rate
Wien,AT13,Less than 65 years,Total,2011,Diabetes mellitus,4.32,Rate
Wien,AT13,Less than 65 years,Total,2012,Diabetes mellitus,3.73,Rate
Wien,AT13,Less than 65 years,Total,2013,Diabetes mellitus,4.5,Rate
Wien,AT13,Less than 65 years,Total,2014,Diabetes mellitus,4.33,Rate
Wien,AT13,Less than 65 years,Total,2015,Diabetes mellitus,4.46,Rate
Wien,AT13,Less than 65 years,Total,2016,Diabetes mellitus,5.61,Rate
Wien,AT13,Less than 65 years,Total,2017,Diabetes mellitus,3.56,Rate
Wien,AT13,Less than 65 years,Total,2018,Diabetes mellitus,4.36,Rate
Wien,AT13,Less than 65 years,Total,2019,Diabetes mellitus,2.05,Rate
Wien,AT13,Less than 65 years,Total,2020,Diabetes mellitus,3.0,Rate
Wien,AT13,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),10.91,Rate
Wien,AT13,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),10.41,Rate
Wien,AT13,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),10.02,Rate
Wien,AT13,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),9.36,Rate
Wien,AT13,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),7.82,Rate
Wien,AT13,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),6.85,Rate
Wien,AT13,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),5.87,Rate
Wien,AT13,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),6.02,Rate
Wien,AT13,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),6.09,Rate
Wien,AT13,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),6.23,Rate
Wien,AT13,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Wien,AT13,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Wien,AT13,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.19,Rate
Wien,AT13,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Wien,AT13,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Wien,AT13,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Wien,AT13,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Wien,AT13,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Wien,AT13,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.06,Rate
Wien,AT13,Less than 65 years,Total,2011,Other ischaemic heart diseases,13.74,Rate
Wien,AT13,Less than 65 years,Total,2012,Other ischaemic heart diseases,11.21,Rate
Wien,AT13,Less than 65 years,Total,2013,Other ischaemic heart diseases,9.67,Rate
Wien,AT13,Less than 65 years,Total,2014,Other ischaemic heart diseases,11.6,Rate
Wien,AT13,Less than 65 years,Total,2015,Other ischaemic heart diseases,9.24,Rate
Wien,AT13,Less than 65 years,Total,2016,Other ischaemic heart diseases,8.4,Rate
Wien,AT13,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.74,Rate
Wien,AT13,Less than 65 years,Total,2018,Other ischaemic heart diseases,11.94,Rate
Wien,AT13,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.74,Rate
Wien,AT13,Less than 65 years,Total,2020,Other ischaemic heart diseases,8.25,Rate
Wien,AT13,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,15.82,Rate
Wien,AT13,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,11.78,Rate
Wien,AT13,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,13.34,Rate
Wien,AT13,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,12.01,Rate
Wien,AT13,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,9.07,Rate
Wien,AT13,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.88,Rate
Wien,AT13,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,11.32,Rate
Wien,AT13,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,8.37,Rate
Wien,AT13,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,9.33,Rate
Wien,AT13,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,10.57,Rate
Wien,AT13,Less than 65 years,Total,2011,Cerebrovascular diseases,5.92,Rate
Wien,AT13,Less than 65 years,Total,2012,Cerebrovascular diseases,6.51,Rate
Wien,AT13,Less than 65 years,Total,2013,Cerebrovascular diseases,7.07,Rate
Wien,AT13,Less than 65 years,Total,2014,Cerebrovascular diseases,5.04,Rate
Wien,AT13,Less than 65 years,Total,2015,Cerebrovascular diseases,5.46,Rate
Wien,AT13,Less than 65 years,Total,2016,Cerebrovascular diseases,4.87,Rate
Wien,AT13,Less than 65 years,Total,2017,Cerebrovascular diseases,4.15,Rate
Wien,AT13,Less than 65 years,Total,2018,Cerebrovascular diseases,4.75,Rate
Wien,AT13,Less than 65 years,Total,2019,Cerebrovascular diseases,4.96,Rate
Wien,AT13,Less than 65 years,Total,2020,Cerebrovascular diseases,3.92,Rate
Wien,AT13,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.99,Rate
Wien,AT13,Less than 65 years,Total,2012,Chronic lower respiratory diseases,6.35,Rate
Wien,AT13,Less than 65 years,Total,2013,Chronic lower respiratory diseases,7.65,Rate
Wien,AT13,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.9,Rate
Wien,AT13,Less than 65 years,Total,2015,Chronic lower respiratory diseases,6.16,Rate
Wien,AT13,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.43,Rate
Wien,AT13,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.33,Rate
Wien,AT13,Less than 65 years,Total,2018,Chronic lower respiratory diseases,9.59,Rate
Wien,AT13,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.64,Rate
Wien,AT13,Less than 65 years,Total,2020,Chronic lower respiratory diseases,6.75,Rate
Wien,AT13,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.47,Rate
Wien,AT13,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.51,Rate
Wien,AT13,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.07,Rate
Wien,AT13,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.27,Rate
Wien,AT13,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.29,Rate
Wien,AT13,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.14,Rate
Wien,AT13,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.36,Rate
Wien,AT13,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.4,Rate
Wien,AT13,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.4,Rate
Wien,AT13,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.2,Rate
Vorarlberg,AT34,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,704.92,Rate
Vorarlberg,AT34,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,734.37,Rate
Vorarlberg,AT34,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,762.51,Rate
Vorarlberg,AT34,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,690.13,Rate
Vorarlberg,AT34,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,744.31,Rate
Vorarlberg,AT34,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,712.72,Rate
Vorarlberg,AT34,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,735.94,Rate
Vorarlberg,AT34,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,724.03,Rate
Vorarlberg,AT34,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,686.39,Rate
Vorarlberg,AT34,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,749.64,Rate
Vorarlberg,AT34,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.84,Rate
Vorarlberg,AT34,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.87,Rate
Vorarlberg,AT34,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.13,Rate
Vorarlberg,AT34,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.82,Rate
Vorarlberg,AT34,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.74,Rate
Vorarlberg,AT34,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.81,Rate
Vorarlberg,AT34,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.53,Rate
Vorarlberg,AT34,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.02,Rate
Vorarlberg,AT34,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.66,Rate
Vorarlberg,AT34,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.59,Rate
Vorarlberg,AT34,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",31.96,Rate
Vorarlberg,AT34,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",24.18,Rate
Vorarlberg,AT34,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",26.04,Rate
Vorarlberg,AT34,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",31.86,Rate
Vorarlberg,AT34,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",32.02,Rate
Vorarlberg,AT34,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",32.7,Rate
Vorarlberg,AT34,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",35.06,Rate
Vorarlberg,AT34,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",28.77,Rate
Vorarlberg,AT34,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",32.98,Rate
Vorarlberg,AT34,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",27.24,Rate
Vorarlberg,AT34,Total,Females,2011,Malignant melanoma of skin,2.87,Rate
Vorarlberg,AT34,Total,Females,2012,Malignant melanoma of skin,4.58,Rate
Vorarlberg,AT34,Total,Females,2013,Malignant melanoma of skin,1.12,Rate
Vorarlberg,AT34,Total,Females,2014,Malignant melanoma of skin,1.92,Rate
Vorarlberg,AT34,Total,Females,2015,Malignant melanoma of skin,3.38,Rate
Vorarlberg,AT34,Total,Females,2016,Malignant melanoma of skin,2.37,Rate
Vorarlberg,AT34,Total,Females,2017,Malignant melanoma of skin,3.11,Rate
Vorarlberg,AT34,Total,Females,2018,Malignant melanoma of skin,1.55,Rate
Vorarlberg,AT34,Total,Females,2019,Malignant melanoma of skin,2.91,Rate
Vorarlberg,AT34,Total,Females,2020,Malignant melanoma of skin,2.81,Rate
Vorarlberg,AT34,Total,Females,2011,Malignant neoplasm of breast,22.14,Rate
Vorarlberg,AT34,Total,Females,2012,Malignant neoplasm of breast,27.39,Rate
Vorarlberg,AT34,Total,Females,2013,Malignant neoplasm of breast,36.21,Rate
Vorarlberg,AT34,Total,Females,2014,Malignant neoplasm of breast,35.6,Rate
Vorarlberg,AT34,Total,Females,2015,Malignant neoplasm of breast,33.87,Rate
Vorarlberg,AT34,Total,Females,2016,Malignant neoplasm of breast,31.24,Rate
Vorarlberg,AT34,Total,Females,2017,Malignant neoplasm of breast,26.04,Rate
Vorarlberg,AT34,Total,Females,2018,Malignant neoplasm of breast,30.52,Rate
Vorarlberg,AT34,Total,Females,2019,Malignant neoplasm of breast,30.15,Rate
Vorarlberg,AT34,Total,Females,2020,Malignant neoplasm of breast,28.58,Rate
Vorarlberg,AT34,Total,Females,2011,Diabetes mellitus,30.85,Rate
Vorarlberg,AT34,Total,Females,2012,Diabetes mellitus,29.62,Rate
Vorarlberg,AT34,Total,Females,2013,Diabetes mellitus,25.32,Rate
Vorarlberg,AT34,Total,Females,2014,Diabetes mellitus,19.7,Rate
Vorarlberg,AT34,Total,Females,2015,Diabetes mellitus,27.89,Rate
Vorarlberg,AT34,Total,Females,2016,Diabetes mellitus,23.14,Rate
Vorarlberg,AT34,Total,Females,2017,Diabetes mellitus,20.02,Rate
Vorarlberg,AT34,Total,Females,2018,Diabetes mellitus,14.09,Rate
Vorarlberg,AT34,Total,Females,2019,Diabetes mellitus,14.78,Rate
Vorarlberg,AT34,Total,Females,2020,Diabetes mellitus,16.52,Rate
Vorarlberg,AT34,Total,Females,2011,Mental and behavioural disorders (F00-F99),16.21,Rate
Vorarlberg,AT34,Total,Females,2012,Mental and behavioural disorders (F00-F99),15.69,Rate
Vorarlberg,AT34,Total,Females,2013,Mental and behavioural disorders (F00-F99),27.96,Rate
Vorarlberg,AT34,Total,Females,2014,Mental and behavioural disorders (F00-F99),27.58,Rate
Vorarlberg,AT34,Total,Females,2015,Mental and behavioural disorders (F00-F99),36.19,Rate
Vorarlberg,AT34,Total,Females,2016,Mental and behavioural disorders (F00-F99),36.75,Rate
Vorarlberg,AT34,Total,Females,2017,Mental and behavioural disorders (F00-F99),48.16,Rate
Vorarlberg,AT34,Total,Females,2018,Mental and behavioural disorders (F00-F99),51.15,Rate
Vorarlberg,AT34,Total,Females,2019,Mental and behavioural disorders (F00-F99),40.76,Rate
Vorarlberg,AT34,Total,Females,2020,Mental and behavioural disorders (F00-F99),42.27,Rate
Vorarlberg,AT34,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.59,Rate
Vorarlberg,AT34,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Vorarlberg,AT34,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Vorarlberg,AT34,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.44,Rate
Vorarlberg,AT34,Total,Females,2011,Other ischaemic heart diseases,82.16,Rate
Vorarlberg,AT34,Total,Females,2012,Other ischaemic heart diseases,101.25,Rate
Vorarlberg,AT34,Total,Females,2013,Other ischaemic heart diseases,98.68,Rate
Vorarlberg,AT34,Total,Females,2014,Other ischaemic heart diseases,72.55,Rate
Vorarlberg,AT34,Total,Females,2015,Other ischaemic heart diseases,91.28,Rate
Vorarlberg,AT34,Total,Females,2016,Other ischaemic heart diseases,82.19,Rate
Vorarlberg,AT34,Total,Females,2017,Other ischaemic heart diseases,73.36,Rate
Vorarlberg,AT34,Total,Females,2018,Other ischaemic heart diseases,66.77,Rate
Vorarlberg,AT34,Total,Females,2019,Other ischaemic heart diseases,65.2,Rate
Vorarlberg,AT34,Total,Females,2020,Other ischaemic heart diseases,78.14,Rate
Vorarlberg,AT34,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,39.19,Rate
Vorarlberg,AT34,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,38.85,Rate
Vorarlberg,AT34,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,36.13,Rate
Vorarlberg,AT34,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.77,Rate
Vorarlberg,AT34,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,33.03,Rate
Vorarlberg,AT34,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,27.97,Rate
Vorarlberg,AT34,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,29.71,Rate
Vorarlberg,AT34,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,28.54,Rate
Vorarlberg,AT34,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.2,Rate
Vorarlberg,AT34,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,21.68,Rate
Vorarlberg,AT34,Total,Females,2011,Cerebrovascular diseases,58.97,Rate
Vorarlberg,AT34,Total,Females,2012,Cerebrovascular diseases,59.57,Rate
Vorarlberg,AT34,Total,Females,2013,Cerebrovascular diseases,57.12,Rate
Vorarlberg,AT34,Total,Females,2014,Cerebrovascular diseases,62.13,Rate
Vorarlberg,AT34,Total,Females,2015,Cerebrovascular diseases,53.63,Rate
Vorarlberg,AT34,Total,Females,2016,Cerebrovascular diseases,59.43,Rate
Vorarlberg,AT34,Total,Females,2017,Cerebrovascular diseases,61.44,Rate
Vorarlberg,AT34,Total,Females,2018,Cerebrovascular diseases,51.41,Rate
Vorarlberg,AT34,Total,Females,2019,Cerebrovascular diseases,47.52,Rate
Vorarlberg,AT34,Total,Females,2020,Cerebrovascular diseases,39.5,Rate
Vorarlberg,AT34,Total,Females,2011,Chronic lower respiratory diseases,15.23,Rate
Vorarlberg,AT34,Total,Females,2012,Chronic lower respiratory diseases,20.87,Rate
Vorarlberg,AT34,Total,Females,2013,Chronic lower respiratory diseases,14.86,Rate
Vorarlberg,AT34,Total,Females,2014,Chronic lower respiratory diseases,10.52,Rate
Vorarlberg,AT34,Total,Females,2015,Chronic lower respiratory diseases,20.32,Rate
Vorarlberg,AT34,Total,Females,2016,Chronic lower respiratory diseases,15.74,Rate
Vorarlberg,AT34,Total,Females,2017,Chronic lower respiratory diseases,24.18,Rate
Vorarlberg,AT34,Total,Females,2018,Chronic lower respiratory diseases,27.3,Rate
Vorarlberg,AT34,Total,Females,2019,Chronic lower respiratory diseases,23.66,Rate
Vorarlberg,AT34,Total,Females,2020,Chronic lower respiratory diseases,13.66,Rate
Vorarlberg,AT34,Total,Females,2011,Asthma and status asthmaticus,0.65,Rate
Vorarlberg,AT34,Total,Females,2012,Asthma and status asthmaticus,0.95,Rate
Vorarlberg,AT34,Total,Females,2014,Asthma and status asthmaticus,0.6,Rate
Vorarlberg,AT34,Total,Females,2015,Asthma and status asthmaticus,0.48,Rate
Vorarlberg,AT34,Total,Females,2016,Asthma and status asthmaticus,0.57,Rate
Vorarlberg,AT34,Total,Females,2017,Asthma and status asthmaticus,0.46,Rate
Vorarlberg,AT34,Total,Females,2018,Asthma and status asthmaticus,0.49,Rate
Vorarlberg,AT34,Total,Females,2019,Asthma and status asthmaticus,1.39,Rate
Vorarlberg,AT34,Total,Females,2020,Asthma and status asthmaticus,0.44,Rate
Vorarlberg,AT34,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3178.83,Rate
Vorarlberg,AT34,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3379.14,Rate
Vorarlberg,AT34,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3458.12,Rate
Vorarlberg,AT34,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3121.96,Rate
Vorarlberg,AT34,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3380.58,Rate
Vorarlberg,AT34,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3251.25,Rate
Vorarlberg,AT34,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3364.64,Rate
Vorarlberg,AT34,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3305.67,Rate
Vorarlberg,AT34,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3148.89,Rate
Vorarlberg,AT34,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3421.4,Rate
Vorarlberg,AT34,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",64.19,Rate
Vorarlberg,AT34,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.2,Rate
Vorarlberg,AT34,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.35,Rate
Vorarlberg,AT34,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.18,Rate
Vorarlberg,AT34,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.84,Rate
Vorarlberg,AT34,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.28,Rate
Vorarlberg,AT34,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.12,Rate
Vorarlberg,AT34,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",59.77,Rate
Vorarlberg,AT34,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.12,Rate
Vorarlberg,AT34,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.44,Rate
Vorarlberg,AT34,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",92.97,Rate
Vorarlberg,AT34,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",80.29,Rate
Vorarlberg,AT34,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",103.55,Rate
Vorarlberg,AT34,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",100.53,Rate
Vorarlberg,AT34,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",107.35,Rate
Vorarlberg,AT34,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",101.97,Rate
Vorarlberg,AT34,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",126.63,Rate
Vorarlberg,AT34,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",97.83,Rate
Vorarlberg,AT34,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",127.06,Rate
Vorarlberg,AT34,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",100.79,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Malignant melanoma of skin,11.68,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Malignant melanoma of skin,20.82,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Malignant melanoma of skin,5.75,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Malignant melanoma of skin,7.28,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Malignant melanoma of skin,11.74,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Malignant melanoma of skin,12.16,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Malignant melanoma of skin,8.17,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Malignant melanoma of skin,5.56,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Malignant melanoma of skin,9.99,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Malignant melanoma of skin,9.62,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Malignant neoplasm of breast,84.62,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Malignant neoplasm of breast,113.38,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Malignant neoplasm of breast,124.33,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Malignant neoplasm of breast,133.14,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Malignant neoplasm of breast,101.86,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Malignant neoplasm of breast,118.82,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Malignant neoplasm of breast,83.3,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Malignant neoplasm of breast,106.31,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Malignant neoplasm of breast,103.07,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Malignant neoplasm of breast,111.97,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Diabetes mellitus,146.03,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Diabetes mellitus,149.23,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Diabetes mellitus,126.81,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Diabetes mellitus,89.52,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Diabetes mellitus,140.36,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Diabetes mellitus,116.29,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Diabetes mellitus,99.86,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Diabetes mellitus,69.72,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Diabetes mellitus,73.47,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Diabetes mellitus,79.95,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),56.88,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),78.11,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),135.36,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),133.65,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),177.26,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),185.59,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),241.79,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),247.2,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),199.13,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),207.13,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.24,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Other ischaemic heart diseases,415.28,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Other ischaemic heart diseases,516.59,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Other ischaemic heart diseases,500.7,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Other ischaemic heart diseases,366.58,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Other ischaemic heart diseases,456.88,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Other ischaemic heart diseases,413.7,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Other ischaemic heart diseases,370.64,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Other ischaemic heart diseases,329.53,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Other ischaemic heart diseases,329.75,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Other ischaemic heart diseases,381.75,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,189.43,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,190.91,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,168.43,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,136.98,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,149.91,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,137.93,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,142.35,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,136.54,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,126.92,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,101.55,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Cerebrovascular diseases,293.96,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Cerebrovascular diseases,294.41,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Cerebrovascular diseases,282.51,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Cerebrovascular diseases,305.74,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Cerebrovascular diseases,272.33,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Cerebrovascular diseases,289.99,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Cerebrovascular diseases,301.56,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Cerebrovascular diseases,255.89,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Cerebrovascular diseases,229.04,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Cerebrovascular diseases,190.18,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Chronic lower respiratory diseases,65.95,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Chronic lower respiratory diseases,95.95,Rate
Vorarlberg,AT34,65 years or over,Females,2013,Chronic lower respiratory diseases,70.33,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Chronic lower respiratory diseases,45.44,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Chronic lower respiratory diseases,98.35,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Chronic lower respiratory diseases,70.64,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Chronic lower respiratory diseases,118.4,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Chronic lower respiratory diseases,127.39,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Chronic lower respiratory diseases,116.08,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Chronic lower respiratory diseases,65.01,Rate
Vorarlberg,AT34,65 years or over,Females,2011,Asthma and status asthmaticus,3.34,Rate
Vorarlberg,AT34,65 years or over,Females,2012,Asthma and status asthmaticus,2.21,Rate
Vorarlberg,AT34,65 years or over,Females,2014,Asthma and status asthmaticus,3.07,Rate
Vorarlberg,AT34,65 years or over,Females,2015,Asthma and status asthmaticus,2.47,Rate
Vorarlberg,AT34,65 years or over,Females,2016,Asthma and status asthmaticus,2.91,Rate
Vorarlberg,AT34,65 years or over,Females,2017,Asthma and status asthmaticus,2.38,Rate
Vorarlberg,AT34,65 years or over,Females,2018,Asthma and status asthmaticus,2.5,Rate
Vorarlberg,AT34,65 years or over,Females,2019,Asthma and status asthmaticus,4.49,Rate
Vorarlberg,AT34,65 years or over,Females,2020,Asthma and status asthmaticus,2.24,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,105.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,93.71,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,109.53,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,101.05,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,105.71,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,97.8,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,99.18,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,98.67,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,89.89,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,102.44,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.13,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.63,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.77,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.7,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.01,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.43,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.18,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.49,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.43,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",17.19,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",10.58,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",7.27,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",15.23,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",13.77,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",15.92,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",12.88,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",12.04,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",10.19,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",9.42,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Malignant melanoma of skin,0.73,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Malignant melanoma of skin,0.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Malignant melanoma of skin,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Malignant melanoma of skin,0.62,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Malignant melanoma of skin,1.36,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Malignant melanoma of skin,1.89,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Malignant melanoma of skin,0.58,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Malignant melanoma of skin,1.2,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Malignant melanoma of skin,1.17,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Malignant neoplasm of breast,7.01,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Malignant neoplasm of breast,6.56,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Malignant neoplasm of breast,14.87,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Malignant neoplasm of breast,11.97,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Malignant neoplasm of breast,17.4,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Malignant neoplasm of breast,10.02,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Malignant neoplasm of breast,12.17,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Malignant neoplasm of breast,12.16,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Malignant neoplasm of breast,12.49,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Malignant neoplasm of breast,8.38,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Diabetes mellitus,2.95,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Diabetes mellitus,0.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Diabetes mellitus,0.73,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Diabetes mellitus,2.79,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Diabetes mellitus,0.65,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Diabetes mellitus,0.57,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Diabetes mellitus,0.68,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Diabetes mellitus,0.61,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Diabetes mellitus,0.56,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Diabetes mellitus,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),6.36,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.57,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.94,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.89,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.02,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.69,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.26,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),3.66,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.39,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.34,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.47,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.3,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.32,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.72,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.89,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.35,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Other ischaemic heart diseases,3.12,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.12,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Other ischaemic heart diseases,4.6,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,2.8,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,2.02,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.08,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.56,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.72,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,1.34,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.43,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.38,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.56,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.33,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Cerebrovascular diseases,2.05,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Cerebrovascular diseases,2.68,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Cerebrovascular diseases,2.52,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Cerebrovascular diseases,3.11,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Cerebrovascular diseases,0.65,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Cerebrovascular diseases,3.58,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Cerebrovascular diseases,3.27,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Cerebrovascular diseases,1.88,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Cerebrovascular diseases,3.55,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Cerebrovascular diseases,2.99,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Chronic lower respiratory diseases,2.94,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Chronic lower respiratory diseases,2.68,Rate
Vorarlberg,AT34,Less than 65 years,Females,2013,Chronic lower respiratory diseases,1.43,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Chronic lower respiratory diseases,2.06,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.42,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Chronic lower respiratory diseases,2.44,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.35,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Chronic lower respiratory diseases,3.05,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.27,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.22,Rate
Vorarlberg,AT34,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.64,Rate
Vorarlberg,AT34,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1124.14,Rate
Vorarlberg,AT34,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1143.48,Rate
Vorarlberg,AT34,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1097.3,Rate
Vorarlberg,AT34,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1095.41,Rate
Vorarlberg,AT34,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1077.34,Rate
Vorarlberg,AT34,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1049.31,Rate
Vorarlberg,AT34,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1063.56,Rate
Vorarlberg,AT34,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1020.54,Rate
Vorarlberg,AT34,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1001.91,Rate
Vorarlberg,AT34,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1093.88,Rate
Vorarlberg,AT34,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.11,Rate
Vorarlberg,AT34,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.41,Rate
Vorarlberg,AT34,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.53,Rate
Vorarlberg,AT34,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.71,Rate
Vorarlberg,AT34,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.28,Rate
Vorarlberg,AT34,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.72,Rate
Vorarlberg,AT34,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.74,Rate
Vorarlberg,AT34,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.08,Rate
Vorarlberg,AT34,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.23,Rate
Vorarlberg,AT34,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.16,Rate
Vorarlberg,AT34,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",64.52,Rate
Vorarlberg,AT34,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",68.03,Rate
Vorarlberg,AT34,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",71.68,Rate
Vorarlberg,AT34,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",69.71,Rate
Vorarlberg,AT34,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",62.03,Rate
Vorarlberg,AT34,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",52.21,Rate
Vorarlberg,AT34,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",61.59,Rate
Vorarlberg,AT34,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",61.23,Rate
Vorarlberg,AT34,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",46.3,Rate
Vorarlberg,AT34,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",49.5,Rate
Vorarlberg,AT34,Total,Males,2011,Malignant melanoma of skin,5.03,Rate
Vorarlberg,AT34,Total,Males,2012,Malignant melanoma of skin,6.42,Rate
Vorarlberg,AT34,Total,Males,2013,Malignant melanoma of skin,5.7,Rate
Vorarlberg,AT34,Total,Males,2014,Malignant melanoma of skin,7.86,Rate
Vorarlberg,AT34,Total,Males,2015,Malignant melanoma of skin,4.91,Rate
Vorarlberg,AT34,Total,Males,2016,Malignant melanoma of skin,4.09,Rate
Vorarlberg,AT34,Total,Males,2017,Malignant melanoma of skin,5.32,Rate
Vorarlberg,AT34,Total,Males,2018,Malignant melanoma of skin,5.87,Rate
Vorarlberg,AT34,Total,Males,2019,Malignant melanoma of skin,4.7,Rate
Vorarlberg,AT34,Total,Males,2020,Malignant melanoma of skin,4.4,Rate
Vorarlberg,AT34,Total,Males,2013,Malignant neoplasm of breast,1.33,Rate
Vorarlberg,AT34,Total,Males,2015,Malignant neoplasm of breast,1.34,Rate
Vorarlberg,AT34,Total,Males,2011,Diabetes mellitus,29.74,Rate
Vorarlberg,AT34,Total,Males,2012,Diabetes mellitus,34.73,Rate
Vorarlberg,AT34,Total,Males,2013,Diabetes mellitus,24.66,Rate
Vorarlberg,AT34,Total,Males,2014,Diabetes mellitus,36.48,Rate
Vorarlberg,AT34,Total,Males,2015,Diabetes mellitus,32.42,Rate
Vorarlberg,AT34,Total,Males,2016,Diabetes mellitus,22.17,Rate
Vorarlberg,AT34,Total,Males,2017,Diabetes mellitus,18.54,Rate
Vorarlberg,AT34,Total,Males,2018,Diabetes mellitus,19.21,Rate
Vorarlberg,AT34,Total,Males,2019,Diabetes mellitus,18.58,Rate
Vorarlberg,AT34,Total,Males,2020,Diabetes mellitus,23.97,Rate
Vorarlberg,AT34,Total,Males,2011,Mental and behavioural disorders (F00-F99),21.19,Rate
Vorarlberg,AT34,Total,Males,2012,Mental and behavioural disorders (F00-F99),30.68,Rate
Vorarlberg,AT34,Total,Males,2013,Mental and behavioural disorders (F00-F99),42.27,Rate
Vorarlberg,AT34,Total,Males,2014,Mental and behavioural disorders (F00-F99),30.57,Rate
Vorarlberg,AT34,Total,Males,2015,Mental and behavioural disorders (F00-F99),42.58,Rate
Vorarlberg,AT34,Total,Males,2016,Mental and behavioural disorders (F00-F99),44.42,Rate
Vorarlberg,AT34,Total,Males,2017,Mental and behavioural disorders (F00-F99),47.99,Rate
Vorarlberg,AT34,Total,Males,2018,Mental and behavioural disorders (F00-F99),58.46,Rate
Vorarlberg,AT34,Total,Males,2019,Mental and behavioural disorders (F00-F99),49.52,Rate
Vorarlberg,AT34,Total,Males,2020,Mental and behavioural disorders (F00-F99),32.92,Rate
Vorarlberg,AT34,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.17,Rate
Vorarlberg,AT34,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Vorarlberg,AT34,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Vorarlberg,AT34,Total,Males,2011,Other ischaemic heart diseases,171.71,Rate
Vorarlberg,AT34,Total,Males,2012,Other ischaemic heart diseases,145.23,Rate
Vorarlberg,AT34,Total,Males,2013,Other ischaemic heart diseases,154.76,Rate
Vorarlberg,AT34,Total,Males,2014,Other ischaemic heart diseases,173.02,Rate
Vorarlberg,AT34,Total,Males,2015,Other ischaemic heart diseases,163.44,Rate
Vorarlberg,AT34,Total,Males,2016,Other ischaemic heart diseases,147.99,Rate
Vorarlberg,AT34,Total,Males,2017,Other ischaemic heart diseases,135.63,Rate
Vorarlberg,AT34,Total,Males,2018,Other ischaemic heart diseases,122.63,Rate
Vorarlberg,AT34,Total,Males,2019,Other ischaemic heart diseases,159.78,Rate
Vorarlberg,AT34,Total,Males,2020,Other ischaemic heart diseases,130.6,Rate
Vorarlberg,AT34,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,76.36,Rate
Vorarlberg,AT34,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,69.62,Rate
Vorarlberg,AT34,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,74.75,Rate
Vorarlberg,AT34,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,71.65,Rate
Vorarlberg,AT34,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,56.6,Rate
Vorarlberg,AT34,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,56.85,Rate
Vorarlberg,AT34,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,64.1,Rate
Vorarlberg,AT34,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,50.31,Rate
Vorarlberg,AT34,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,49.58,Rate
Vorarlberg,AT34,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,45.93,Rate
Vorarlberg,AT34,Total,Males,2011,Cerebrovascular diseases,70.23,Rate
Vorarlberg,AT34,Total,Males,2012,Cerebrovascular diseases,85.72,Rate
Vorarlberg,AT34,Total,Males,2013,Cerebrovascular diseases,75.16,Rate
Vorarlberg,AT34,Total,Males,2014,Cerebrovascular diseases,69.21,Rate
Vorarlberg,AT34,Total,Males,2015,Cerebrovascular diseases,69.57,Rate
Vorarlberg,AT34,Total,Males,2016,Cerebrovascular diseases,63.6,Rate
Vorarlberg,AT34,Total,Males,2017,Cerebrovascular diseases,66.56,Rate
Vorarlberg,AT34,Total,Males,2018,Cerebrovascular diseases,58.99,Rate
Vorarlberg,AT34,Total,Males,2019,Cerebrovascular diseases,48.98,Rate
Vorarlberg,AT34,Total,Males,2020,Cerebrovascular diseases,41.29,Rate
Vorarlberg,AT34,Total,Males,2011,Chronic lower respiratory diseases,40.06,Rate
Vorarlberg,AT34,Total,Males,2012,Chronic lower respiratory diseases,44.2,Rate
Vorarlberg,AT34,Total,Males,2013,Chronic lower respiratory diseases,46.22,Rate
Vorarlberg,AT34,Total,Males,2014,Chronic lower respiratory diseases,43.86,Rate
Vorarlberg,AT34,Total,Males,2015,Chronic lower respiratory diseases,41.25,Rate
Vorarlberg,AT34,Total,Males,2016,Chronic lower respiratory diseases,41.05,Rate
Vorarlberg,AT34,Total,Males,2017,Chronic lower respiratory diseases,43.65,Rate
Vorarlberg,AT34,Total,Males,2018,Chronic lower respiratory diseases,46.71,Rate
Vorarlberg,AT34,Total,Males,2019,Chronic lower respiratory diseases,33.76,Rate
Vorarlberg,AT34,Total,Males,2020,Chronic lower respiratory diseases,38.27,Rate
Vorarlberg,AT34,Total,Males,2012,Asthma and status asthmaticus,0.48,Rate
Vorarlberg,AT34,Total,Males,2014,Asthma and status asthmaticus,3.06,Rate
Vorarlberg,AT34,Total,Males,2015,Asthma and status asthmaticus,0.68,Rate
Vorarlberg,AT34,Total,Males,2017,Asthma and status asthmaticus,0.61,Rate
Vorarlberg,AT34,Total,Males,2018,Asthma and status asthmaticus,0.67,Rate
Vorarlberg,AT34,Total,Males,2020,Asthma and status asthmaticus,1.01,Rate
Vorarlberg,AT34,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,4974.01,Rate
Vorarlberg,AT34,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,4986.23,Rate
Vorarlberg,AT34,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4767.65,Rate
Vorarlberg,AT34,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4857.15,Rate
Vorarlberg,AT34,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4754.38,Rate
Vorarlberg,AT34,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4613.45,Rate
Vorarlberg,AT34,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4617.67,Rate
Vorarlberg,AT34,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4508.51,Rate
Vorarlberg,AT34,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4436.4,Rate
Vorarlberg,AT34,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4840.29,Rate
Vorarlberg,AT34,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.5,Rate
Vorarlberg,AT34,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",157.63,Rate
Vorarlberg,AT34,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",148.52,Rate
Vorarlberg,AT34,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.09,Rate
Vorarlberg,AT34,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.08,Rate
Vorarlberg,AT34,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.05,Rate
Vorarlberg,AT34,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.85,Rate
Vorarlberg,AT34,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",143.5,Rate
Vorarlberg,AT34,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.61,Rate
Vorarlberg,AT34,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.67,Rate
Vorarlberg,AT34,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",269.27,Rate
Vorarlberg,AT34,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",269.49,Rate
Vorarlberg,AT34,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",250.16,Rate
Vorarlberg,AT34,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",275.93,Rate
Vorarlberg,AT34,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",248.23,Rate
Vorarlberg,AT34,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",199.95,Rate
Vorarlberg,AT34,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",256.79,Rate
Vorarlberg,AT34,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",238.77,Rate
Vorarlberg,AT34,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",168.97,Rate
Vorarlberg,AT34,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",197.91,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Malignant melanoma of skin,18.14,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Malignant melanoma of skin,22.0,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Malignant melanoma of skin,22.93,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Malignant melanoma of skin,28.67,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Malignant melanoma of skin,15.17,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Malignant melanoma of skin,20.99,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Malignant melanoma of skin,24.31,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Malignant melanoma of skin,27.23,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Malignant melanoma of skin,19.53,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Malignant melanoma of skin,17.77,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Malignant neoplasm of breast,4.3,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Malignant neoplasm of breast,3.69,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Diabetes mellitus,140.12,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Diabetes mellitus,166.54,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Diabetes mellitus,108.58,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Diabetes mellitus,172.86,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Diabetes mellitus,158.39,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Diabetes mellitus,105.73,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Diabetes mellitus,92.58,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Diabetes mellitus,90.56,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Diabetes mellitus,82.14,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Diabetes mellitus,118.14,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),63.44,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),99.27,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),154.21,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),123.96,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),183.65,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),178.52,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),214.73,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),273.01,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),232.53,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),140.28,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),14.37,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.11,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Other ischaemic heart diseases,829.95,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Other ischaemic heart diseases,701.16,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Other ischaemic heart diseases,741.32,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Other ischaemic heart diseases,839.8,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Other ischaemic heart diseases,791.34,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Other ischaemic heart diseases,714.82,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Other ischaemic heart diseases,635.34,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Other ischaemic heart diseases,585.25,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Other ischaemic heart diseases,764.29,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Other ischaemic heart diseases,609.18,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,331.71,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,316.01,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,341.37,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,325.27,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,245.06,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,245.78,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,272.05,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,216.44,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,189.9,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,173.87,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Cerebrovascular diseases,337.01,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Cerebrovascular diseases,420.11,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Cerebrovascular diseases,362.73,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Cerebrovascular diseases,338.8,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Cerebrovascular diseases,345.37,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Cerebrovascular diseases,300.71,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Cerebrovascular diseases,313.01,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Cerebrovascular diseases,279.02,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Cerebrovascular diseases,233.66,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Cerebrovascular diseases,192.5,Rate
Vorarlberg,AT34,65 years or over,Males,2011,Chronic lower respiratory diseases,183.52,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Chronic lower respiratory diseases,206.48,Rate
Vorarlberg,AT34,65 years or over,Males,2013,Chronic lower respiratory diseases,221.62,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Chronic lower respiratory diseases,199.4,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Chronic lower respiratory diseases,199.32,Rate
Vorarlberg,AT34,65 years or over,Males,2016,Chronic lower respiratory diseases,190.58,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Chronic lower respiratory diseases,197.07,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Chronic lower respiratory diseases,215.72,Rate
Vorarlberg,AT34,65 years or over,Males,2019,Chronic lower respiratory diseases,157.74,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Chronic lower respiratory diseases,184.06,Rate
Vorarlberg,AT34,65 years or over,Males,2012,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,65 years or over,Males,2014,Asthma and status asthmaticus,15.69,Rate
Vorarlberg,AT34,65 years or over,Males,2015,Asthma and status asthmaticus,3.48,Rate
Vorarlberg,AT34,65 years or over,Males,2017,Asthma and status asthmaticus,3.11,Rate
Vorarlberg,AT34,65 years or over,Males,2018,Asthma and status asthmaticus,3.41,Rate
Vorarlberg,AT34,65 years or over,Males,2020,Asthma and status asthmaticus,5.19,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,191.56,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,212.63,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,208.21,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,184.18,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,186.63,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,185.95,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,202.63,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,175.63,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,169.95,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,186.37,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.25,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.8,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.68,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.51,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.4,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.11,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.79,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.09,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.07,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.28,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",14.92,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",19.23,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",28.45,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",19.76,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",16.92,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",16.43,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",14.3,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",18.22,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",16.58,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",13.55,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Malignant melanoma of skin,1.86,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Malignant melanoma of skin,2.64,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Malignant melanoma of skin,1.53,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Malignant melanoma of skin,2.82,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Malignant melanoma of skin,2.43,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Malignant melanoma of skin,0.72,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Malignant melanoma of skin,0.69,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Malignant melanoma of skin,1.11,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Malignant melanoma of skin,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.61,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.77,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Diabetes mellitus,3.01,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Diabetes mellitus,2.81,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Diabetes mellitus,4.34,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Diabetes mellitus,3.44,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Diabetes mellitus,1.9,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Diabetes mellitus,1.93,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Diabetes mellitus,0.6,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Diabetes mellitus,1.92,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Diabetes mellitus,3.18,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Diabetes mellitus,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),10.96,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),14.06,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),15.15,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),7.95,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),8.41,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),11.93,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),7.59,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),6.48,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),5.19,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),6.92,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Other ischaemic heart diseases,12.27,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Other ischaemic heart diseases,10.56,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Other ischaemic heart diseases,12.68,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Other ischaemic heart diseases,11.5,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Other ischaemic heart diseases,11.34,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Other ischaemic heart diseases,10.68,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Other ischaemic heart diseases,14.58,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Other ischaemic heart diseases,10.57,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Other ischaemic heart diseases,13.35,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Other ischaemic heart diseases,14.67,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,14.5,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,9.93,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,10.16,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,10.21,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,10.95,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,11.08,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,13.73,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,10.06,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,15.59,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,14.94,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Cerebrovascular diseases,5.61,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Cerebrovascular diseases,4.73,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Cerebrovascular diseases,5.5,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Cerebrovascular diseases,3.9,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Cerebrovascular diseases,2.76,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Cerebrovascular diseases,6.17,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Cerebrovascular diseases,6.87,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Cerebrovascular diseases,5.69,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Cerebrovascular diseases,4.24,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Cerebrovascular diseases,4.66,Rate
Vorarlberg,AT34,Less than 65 years,Males,2011,Chronic lower respiratory diseases,5.3,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Chronic lower respiratory diseases,4.89,Rate
Vorarlberg,AT34,Less than 65 years,Males,2013,Chronic lower respiratory diseases,3.73,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Chronic lower respiratory diseases,6.18,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Chronic lower respiratory diseases,2.97,Rate
Vorarlberg,AT34,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.82,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.49,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.76,Rate
Vorarlberg,AT34,Less than 65 years,Males,2019,Chronic lower respiratory diseases,3.72,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.95,Rate
Vorarlberg,AT34,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.59,Rate
Vorarlberg,AT34,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,878.11,Rate
Vorarlberg,AT34,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,903.15,Rate
Vorarlberg,AT34,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,910.86,Rate
Vorarlberg,AT34,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,852.33,Rate
Vorarlberg,AT34,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,885.55,Rate
Vorarlberg,AT34,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,855.4,Rate
Vorarlberg,AT34,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,875.69,Rate
Vorarlberg,AT34,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,851.98,Rate
Vorarlberg,AT34,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,820.64,Rate
Vorarlberg,AT34,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,900.38,Rate
Vorarlberg,AT34,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.7,Rate
Vorarlberg,AT34,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.04,Rate
Vorarlberg,AT34,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.83,Rate
Vorarlberg,AT34,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.64,Rate
Vorarlberg,AT34,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.55,Rate
Vorarlberg,AT34,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.39,Rate
Vorarlberg,AT34,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.62,Rate
Vorarlberg,AT34,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.87,Rate
Vorarlberg,AT34,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.5,Rate
Vorarlberg,AT34,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.46,Rate
Vorarlberg,AT34,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",44.84,Rate
Vorarlberg,AT34,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",43.0,Rate
Vorarlberg,AT34,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",46.82,Rate
Vorarlberg,AT34,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",48.13,Rate
Vorarlberg,AT34,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",45.07,Rate
Vorarlberg,AT34,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",40.92,Rate
Vorarlberg,AT34,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",45.26,Rate
Vorarlberg,AT34,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",43.3,Rate
Vorarlberg,AT34,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",38.9,Rate
Vorarlberg,AT34,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",37.13,Rate
Vorarlberg,AT34,Total,Total,2011,Malignant melanoma of skin,3.77,Rate
Vorarlberg,AT34,Total,Total,2012,Malignant melanoma of skin,5.69,Rate
Vorarlberg,AT34,Total,Total,2013,Malignant melanoma of skin,3.16,Rate
Vorarlberg,AT34,Total,Total,2014,Malignant melanoma of skin,4.09,Rate
Vorarlberg,AT34,Total,Total,2015,Malignant melanoma of skin,4.13,Rate
Vorarlberg,AT34,Total,Total,2016,Malignant melanoma of skin,3.44,Rate
Vorarlberg,AT34,Total,Total,2017,Malignant melanoma of skin,3.87,Rate
Vorarlberg,AT34,Total,Total,2018,Malignant melanoma of skin,3.35,Rate
Vorarlberg,AT34,Total,Total,2019,Malignant melanoma of skin,3.63,Rate
Vorarlberg,AT34,Total,Total,2020,Malignant melanoma of skin,3.34,Rate
Vorarlberg,AT34,Total,Total,2011,Malignant neoplasm of breast,13.09,Rate
Vorarlberg,AT34,Total,Total,2012,Malignant neoplasm of breast,16.03,Rate
Vorarlberg,AT34,Total,Total,2013,Malignant neoplasm of breast,21.51,Rate
Vorarlberg,AT34,Total,Total,2014,Malignant neoplasm of breast,20.39,Rate
Vorarlberg,AT34,Total,Total,2015,Malignant neoplasm of breast,19.88,Rate
Vorarlberg,AT34,Total,Total,2016,Malignant neoplasm of breast,17.37,Rate
Vorarlberg,AT34,Total,Total,2017,Malignant neoplasm of breast,14.2,Rate
Vorarlberg,AT34,Total,Total,2018,Malignant neoplasm of breast,16.78,Rate
Vorarlberg,AT34,Total,Total,2019,Malignant neoplasm of breast,17.05,Rate
Vorarlberg,AT34,Total,Total,2020,Malignant neoplasm of breast,15.95,Rate
Vorarlberg,AT34,Total,Total,2011,Diabetes mellitus,31.86,Rate
Vorarlberg,AT34,Total,Total,2012,Diabetes mellitus,32.67,Rate
Vorarlberg,AT34,Total,Total,2013,Diabetes mellitus,25.97,Rate
Vorarlberg,AT34,Total,Total,2014,Diabetes mellitus,27.14,Rate
Vorarlberg,AT34,Total,Total,2015,Diabetes mellitus,29.87,Rate
Vorarlberg,AT34,Total,Total,2016,Diabetes mellitus,23.41,Rate
Vorarlberg,AT34,Total,Total,2017,Diabetes mellitus,19.62,Rate
Vorarlberg,AT34,Total,Total,2018,Diabetes mellitus,15.56,Rate
Vorarlberg,AT34,Total,Total,2019,Diabetes mellitus,16.41,Rate
Vorarlberg,AT34,Total,Total,2020,Diabetes mellitus,19.32,Rate
Vorarlberg,AT34,Total,Total,2011,Mental and behavioural disorders (F00-F99),19.17,Rate
Vorarlberg,AT34,Total,Total,2012,Mental and behavioural disorders (F00-F99),24.02,Rate
Vorarlberg,AT34,Total,Total,2013,Mental and behavioural disorders (F00-F99),36.25,Rate
Vorarlberg,AT34,Total,Total,2014,Mental and behavioural disorders (F00-F99),31.58,Rate
Vorarlberg,AT34,Total,Total,2015,Mental and behavioural disorders (F00-F99),39.98,Rate
Vorarlberg,AT34,Total,Total,2016,Mental and behavioural disorders (F00-F99),42.28,Rate
Vorarlberg,AT34,Total,Total,2017,Mental and behavioural disorders (F00-F99),48.95,Rate
Vorarlberg,AT34,Total,Total,2018,Mental and behavioural disorders (F00-F99),54.57,Rate
Vorarlberg,AT34,Total,Total,2019,Mental and behavioural disorders (F00-F99),45.48,Rate
Vorarlberg,AT34,Total,Total,2020,Mental and behavioural disorders (F00-F99),41.81,Rate
Vorarlberg,AT34,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Vorarlberg,AT34,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Vorarlberg,AT34,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.25,Rate
Vorarlberg,AT34,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Vorarlberg,AT34,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Vorarlberg,AT34,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Vorarlberg,AT34,Total,Total,2011,Other ischaemic heart diseases,116.12,Rate
Vorarlberg,AT34,Total,Total,2012,Other ischaemic heart diseases,121.42,Rate
Vorarlberg,AT34,Total,Total,2013,Other ischaemic heart diseases,121.92,Rate
Vorarlberg,AT34,Total,Total,2014,Other ischaemic heart diseases,109.63,Rate
Vorarlberg,AT34,Total,Total,2015,Other ischaemic heart diseases,117.96,Rate
Vorarlberg,AT34,Total,Total,2016,Other ischaemic heart diseases,107.05,Rate
Vorarlberg,AT34,Total,Total,2017,Other ischaemic heart diseases,99.09,Rate
Vorarlberg,AT34,Total,Total,2018,Other ischaemic heart diseases,88.87,Rate
Vorarlberg,AT34,Total,Total,2019,Other ischaemic heart diseases,101.63,Rate
Vorarlberg,AT34,Total,Total,2020,Other ischaemic heart diseases,99.78,Rate
Vorarlberg,AT34,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,55.1,Rate
Vorarlberg,AT34,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,51.61,Rate
Vorarlberg,AT34,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,52.55,Rate
Vorarlberg,AT34,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,45.74,Rate
Vorarlberg,AT34,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,43.97,Rate
Vorarlberg,AT34,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,39.42,Rate
Vorarlberg,AT34,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,44.85,Rate
Vorarlberg,AT34,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,38.9,Rate
Vorarlberg,AT34,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,37.53,Rate
Vorarlberg,AT34,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,33.17,Rate
Vorarlberg,AT34,Total,Total,2011,Cerebrovascular diseases,63.49,Rate
Vorarlberg,AT34,Total,Total,2012,Cerebrovascular diseases,68.74,Rate
Vorarlberg,AT34,Total,Total,2013,Cerebrovascular diseases,63.38,Rate
Vorarlberg,AT34,Total,Total,2014,Cerebrovascular diseases,65.29,Rate
Vorarlberg,AT34,Total,Total,2015,Cerebrovascular diseases,60.19,Rate
Vorarlberg,AT34,Total,Total,2016,Cerebrovascular diseases,62.34,Rate
Vorarlberg,AT34,Total,Total,2017,Cerebrovascular diseases,64.51,Rate
Vorarlberg,AT34,Total,Total,2018,Cerebrovascular diseases,55.77,Rate
Vorarlberg,AT34,Total,Total,2019,Cerebrovascular diseases,49.31,Rate
Vorarlberg,AT34,Total,Total,2020,Cerebrovascular diseases,40.39,Rate
Vorarlberg,AT34,Total,Total,2011,Chronic lower respiratory diseases,25.29,Rate
Vorarlberg,AT34,Total,Total,2012,Chronic lower respiratory diseases,28.61,Rate
Vorarlberg,AT34,Total,Total,2013,Chronic lower respiratory diseases,27.27,Rate
Vorarlberg,AT34,Total,Total,2014,Chronic lower respiratory diseases,22.54,Rate
Vorarlberg,AT34,Total,Total,2015,Chronic lower respiratory diseases,28.97,Rate
Vorarlberg,AT34,Total,Total,2016,Chronic lower respiratory diseases,25.61,Rate
Vorarlberg,AT34,Total,Total,2017,Chronic lower respiratory diseases,32.66,Rate
Vorarlberg,AT34,Total,Total,2018,Chronic lower respiratory diseases,35.65,Rate
Vorarlberg,AT34,Total,Total,2019,Chronic lower respiratory diseases,27.5,Rate
Vorarlberg,AT34,Total,Total,2020,Chronic lower respiratory diseases,24.62,Rate
Vorarlberg,AT34,Total,Total,2011,Asthma and status asthmaticus,0.37,Rate
Vorarlberg,AT34,Total,Total,2012,Asthma and status asthmaticus,0.8,Rate
Vorarlberg,AT34,Total,Total,2014,Asthma and status asthmaticus,1.08,Rate
Vorarlberg,AT34,Total,Total,2015,Asthma and status asthmaticus,0.6,Rate
Vorarlberg,AT34,Total,Total,2016,Asthma and status asthmaticus,0.29,Rate
Vorarlberg,AT34,Total,Total,2017,Asthma and status asthmaticus,0.55,Rate
Vorarlberg,AT34,Total,Total,2018,Asthma and status asthmaticus,0.54,Rate
Vorarlberg,AT34,Total,Total,2019,Asthma and status asthmaticus,0.77,Rate
Vorarlberg,AT34,Total,Total,2020,Asthma and status asthmaticus,0.61,Rate
Vorarlberg,AT34,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,3889.86,Rate
Vorarlberg,AT34,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4000.92,Rate
Vorarlberg,AT34,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4018.2,Rate
Vorarlberg,AT34,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3783.79,Rate
Vorarlberg,AT34,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3939.99,Rate
Vorarlberg,AT34,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3803.14,Rate
Vorarlberg,AT34,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3868.45,Rate
Vorarlberg,AT34,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3804.18,Rate
Vorarlberg,AT34,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3672.57,Rate
Vorarlberg,AT34,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4020.68,Rate
Vorarlberg,AT34,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.92,Rate
Vorarlberg,AT34,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.58,Rate
Vorarlberg,AT34,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.43,Rate
Vorarlberg,AT34,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.2,Rate
Vorarlberg,AT34,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.94,Rate
Vorarlberg,AT34,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.84,Rate
Vorarlberg,AT34,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.88,Rate
Vorarlberg,AT34,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.17,Rate
Vorarlberg,AT34,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.67,Rate
Vorarlberg,AT34,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.4,Rate
Vorarlberg,AT34,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",163.53,Rate
Vorarlberg,AT34,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",159.12,Rate
Vorarlberg,AT34,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",167.12,Rate
Vorarlberg,AT34,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",174.46,Rate
Vorarlberg,AT34,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",167.75,Rate
Vorarlberg,AT34,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",143.14,Rate
Vorarlberg,AT34,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",176.25,Rate
Vorarlberg,AT34,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",159.91,Rate
Vorarlberg,AT34,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",144.33,Rate
Vorarlberg,AT34,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",143.02,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Malignant melanoma of skin,13.91,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Malignant melanoma of skin,22.46,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Malignant melanoma of skin,13.11,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Malignant melanoma of skin,13.97,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Malignant melanoma of skin,13.28,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Malignant melanoma of skin,17.66,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Malignant melanoma of skin,14.47,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Malignant melanoma of skin,14.58,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Malignant melanoma of skin,13.82,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Malignant melanoma of skin,12.37,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Malignant neoplasm of breast,52.74,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Malignant neoplasm of breast,68.6,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Malignant neoplasm of breast,78.05,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Malignant neoplasm of breast,79.46,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Malignant neoplasm of breast,64.56,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Malignant neoplasm of breast,68.27,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Malignant neoplasm of breast,47.42,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Malignant neoplasm of breast,60.82,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Malignant neoplasm of breast,61.71,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Malignant neoplasm of breast,64.47,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Diabetes mellitus,151.05,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Diabetes mellitus,160.46,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Diabetes mellitus,122.84,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Diabetes mellitus,126.23,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Diabetes mellitus,147.93,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Diabetes mellitus,114.94,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Diabetes mellitus,97.92,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Diabetes mellitus,74.65,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Diabetes mellitus,76.53,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Diabetes mellitus,94.27,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),62.58,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),93.11,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),150.86,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),141.72,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),183.63,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),190.75,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),232.87,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),258.79,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),217.54,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),195.24,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.49,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.61,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Other ischaemic heart diseases,567.25,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Other ischaemic heart diseases,599.82,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Other ischaemic heart diseases,596.72,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Other ischaemic heart diseases,536.01,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Other ischaemic heart diseases,576.1,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Other ischaemic heart diseases,523.41,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Other ischaemic heart diseases,475.52,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Other ischaemic heart diseases,427.66,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Other ischaemic heart diseases,491.5,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Other ischaemic heart diseases,471.97,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,247.02,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,240.2,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,240.21,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,208.48,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,193.13,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,176.81,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,196.82,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,174.0,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,159.29,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,134.42,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Cerebrovascular diseases,309.86,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Cerebrovascular diseases,337.22,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Cerebrovascular diseases,308.59,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Cerebrovascular diseases,320.41,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Cerebrovascular diseases,301.73,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Cerebrovascular diseases,299.9,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Cerebrovascular diseases,309.82,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Cerebrovascular diseases,270.47,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Cerebrovascular diseases,236.88,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Cerebrovascular diseases,191.34,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Chronic lower respiratory diseases,112.7,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Chronic lower respiratory diseases,131.16,Rate
Vorarlberg,AT34,65 years or over,Total,2013,Chronic lower respiratory diseases,129.31,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Chronic lower respiratory diseases,99.01,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Chronic lower respiratory diseases,139.57,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Chronic lower respiratory diseases,116.56,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Chronic lower respiratory diseases,151.42,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Chronic lower respiratory diseases,164.74,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Chronic lower respiratory diseases,130.75,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Chronic lower respiratory diseases,117.65,Rate
Vorarlberg,AT34,65 years or over,Total,2011,Asthma and status asthmaticus,1.92,Rate
Vorarlberg,AT34,65 years or over,Total,2012,Asthma and status asthmaticus,1.55,Rate
Vorarlberg,AT34,65 years or over,Total,2014,Asthma and status asthmaticus,5.56,Rate
Vorarlberg,AT34,65 years or over,Total,2015,Asthma and status asthmaticus,3.09,Rate
Vorarlberg,AT34,65 years or over,Total,2016,Asthma and status asthmaticus,1.5,Rate
Vorarlberg,AT34,65 years or over,Total,2017,Asthma and status asthmaticus,2.82,Rate
Vorarlberg,AT34,65 years or over,Total,2018,Asthma and status asthmaticus,2.75,Rate
Vorarlberg,AT34,65 years or over,Total,2019,Asthma and status asthmaticus,2.61,Rate
Vorarlberg,AT34,65 years or over,Total,2020,Asthma and status asthmaticus,3.13,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,148.55,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,152.76,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,158.15,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,142.22,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,145.66,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,141.35,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,150.73,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,136.85,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,129.8,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,144.53,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.17,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.26,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.12,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.61,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.47,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.54,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.12,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.6,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.26,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.36,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",16.1,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",14.87,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",17.68,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",17.53,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",15.35,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.15,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",13.52,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",15.05,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",13.36,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",11.48,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Malignant melanoma of skin,1.31,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Malignant melanoma of skin,1.63,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Malignant melanoma of skin,0.75,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Malignant melanoma of skin,1.69,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Malignant melanoma of skin,1.91,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Malignant melanoma of skin,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Malignant melanoma of skin,1.3,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Malignant melanoma of skin,0.63,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Malignant melanoma of skin,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Malignant melanoma of skin,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Malignant neoplasm of breast,3.49,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Malignant neoplasm of breast,3.3,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.82,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.08,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Malignant neoplasm of breast,9.06,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.04,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.15,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.11,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.24,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.2,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Diabetes mellitus,2.99,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Diabetes mellitus,1.71,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Diabetes mellitus,2.51,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Diabetes mellitus,3.13,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Diabetes mellitus,1.27,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Diabetes mellitus,1.24,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Diabetes mellitus,0.65,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Diabetes mellitus,1.25,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Diabetes mellitus,1.85,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Diabetes mellitus,1.16,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),8.66,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),7.28,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),8.48,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.9,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.19,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),6.32,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.4,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),5.09,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.81,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.64,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.38,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Other ischaemic heart diseases,6.84,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Other ischaemic heart diseases,5.54,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Other ischaemic heart diseases,6.9,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.35,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Other ischaemic heart diseases,6.99,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Other ischaemic heart diseases,6.2,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.91,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Other ischaemic heart diseases,6.81,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.19,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Other ischaemic heart diseases,9.62,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.62,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,5.92,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,7.09,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,6.32,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,7.84,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,6.14,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,8.04,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,6.17,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,8.04,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,8.64,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Cerebrovascular diseases,3.81,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Cerebrovascular diseases,3.7,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Cerebrovascular diseases,3.98,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Cerebrovascular diseases,3.49,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Cerebrovascular diseases,1.68,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Cerebrovascular diseases,4.8,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Cerebrovascular diseases,5.08,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Cerebrovascular diseases,3.76,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Cerebrovascular diseases,3.88,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Cerebrovascular diseases,3.82,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.11,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Chronic lower respiratory diseases,3.77,Rate
Vorarlberg,AT34,Less than 65 years,Total,2013,Chronic lower respiratory diseases,2.56,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.02,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Chronic lower respiratory diseases,2.17,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.57,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.89,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Chronic lower respiratory diseases,4.38,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Chronic lower respiratory diseases,2.49,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Chronic lower respiratory diseases,2.09,Rate
Vorarlberg,AT34,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.62,Rate
Vorarlberg,AT34,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Vorarlberg,AT34,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.32,Rate
Vorarlberg,AT34,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,839.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,882.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,832.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,780.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,809.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,762.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,756.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,765.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,758.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,933.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",37.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",33.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",37.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",34.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",36.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",36.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",33.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",28.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",35.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",30.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Malignant melanoma of skin,3.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Malignant melanoma of skin,2.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Malignant melanoma of skin,3.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Malignant melanoma of skin,2.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Malignant melanoma of skin,1.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Malignant melanoma of skin,1.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Malignant melanoma of skin,1.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Malignant melanoma of skin,2.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Malignant melanoma of skin,1.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Malignant melanoma of skin,1.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Malignant neoplasm of breast,49.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Malignant neoplasm of breast,38.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Malignant neoplasm of breast,39.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Malignant neoplasm of breast,39.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Malignant neoplasm of breast,35.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Malignant neoplasm of breast,36.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Malignant neoplasm of breast,33.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Malignant neoplasm of breast,35.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Malignant neoplasm of breast,32.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Malignant neoplasm of breast,29.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Diabetes mellitus,12.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Diabetes mellitus,14.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Diabetes mellitus,13.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Diabetes mellitus,12.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Diabetes mellitus,14.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Diabetes mellitus,9.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Diabetes mellitus,9.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Diabetes mellitus,10.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Diabetes mellitus,11.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Diabetes mellitus,12.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Mental and behavioural disorders (F00-F99),26.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Mental and behavioural disorders (F00-F99),41.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Mental and behavioural disorders (F00-F99),35.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Mental and behavioural disorders (F00-F99),34.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Mental and behavioural disorders (F00-F99),40.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Mental and behavioural disorders (F00-F99),37.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Mental and behavioural disorders (F00-F99),41.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Mental and behavioural disorders (F00-F99),42.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Mental and behavioural disorders (F00-F99),43.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Mental and behavioural disorders (F00-F99),43.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),4.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),3.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),5.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),6.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),4.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),4.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Other ischaemic heart diseases,25.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Other ischaemic heart diseases,23.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Other ischaemic heart diseases,19.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Other ischaemic heart diseases,21.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Other ischaemic heart diseases,19.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Other ischaemic heart diseases,18.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Other ischaemic heart diseases,21.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Other ischaemic heart diseases,19.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Other ischaemic heart diseases,19.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Other ischaemic heart diseases,14.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,35.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,35.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,29.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,21.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,27.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,21.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,20.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,17.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,19.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Cerebrovascular diseases,62.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Cerebrovascular diseases,53.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Cerebrovascular diseases,54.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Cerebrovascular diseases,47.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Cerebrovascular diseases,53.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Cerebrovascular diseases,48.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Cerebrovascular diseases,43.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Cerebrovascular diseases,49.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Cerebrovascular diseases,44.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Cerebrovascular diseases,40.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Chronic lower respiratory diseases,34.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Chronic lower respiratory diseases,42.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Chronic lower respiratory diseases,33.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Chronic lower respiratory diseases,30.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Chronic lower respiratory diseases,37.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Chronic lower respiratory diseases,31.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Chronic lower respiratory diseases,34.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Chronic lower respiratory diseases,41.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Chronic lower respiratory diseases,31.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Chronic lower respiratory diseases,26.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2011,Asthma and status asthmaticus,1.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2012,Asthma and status asthmaticus,2.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2013,Asthma and status asthmaticus,2.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2014,Asthma and status asthmaticus,1.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2015,Asthma and status asthmaticus,2.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2016,Asthma and status asthmaticus,2.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2017,Asthma and status asthmaticus,2.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2018,Asthma and status asthmaticus,2.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2019,Asthma and status asthmaticus,1.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Females,2020,Asthma and status asthmaticus,0.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3648.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3872.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3670.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3440.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3617.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3406.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3370.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3388.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3392.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4258.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",113.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",116.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",133.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",119.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",134.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",141.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",129.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",97.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",131.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",106.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Malignant melanoma of skin,10.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Malignant melanoma of skin,7.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Malignant melanoma of skin,9.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Malignant melanoma of skin,8.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Malignant melanoma of skin,8.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Malignant melanoma of skin,3.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Malignant melanoma of skin,4.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Malignant melanoma of skin,12.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Malignant melanoma of skin,6.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Malignant melanoma of skin,5.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Malignant neoplasm of breast,173.67,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Malignant neoplasm of breast,133.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Malignant neoplasm of breast,138.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Malignant neoplasm of breast,134.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Malignant neoplasm of breast,135.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Malignant neoplasm of breast,141.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Malignant neoplasm of breast,111.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Malignant neoplasm of breast,122.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Malignant neoplasm of breast,113.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Malignant neoplasm of breast,110.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Diabetes mellitus,59.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Diabetes mellitus,65.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Diabetes mellitus,65.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Diabetes mellitus,59.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Diabetes mellitus,67.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Diabetes mellitus,45.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Diabetes mellitus,48.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Diabetes mellitus,47.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Diabetes mellitus,56.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Diabetes mellitus,57.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),129.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),206.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),178.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),168.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),199.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),180.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),204.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),209.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),216.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),213.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),7.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),12.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),11.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),15.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),19.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),12.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),26.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),29.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),24.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),19.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Other ischaemic heart diseases,123.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Other ischaemic heart diseases,117.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Other ischaemic heart diseases,100.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Other ischaemic heart diseases,104.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Other ischaemic heart diseases,96.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Other ischaemic heart diseases,90.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Other ischaemic heart diseases,100.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Other ischaemic heart diseases,95.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Other ischaemic heart diseases,95.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Other ischaemic heart diseases,71.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,162.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,160.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,141.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,130.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,97.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,123.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,96.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,95.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,81.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,94.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Cerebrovascular diseases,296.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Cerebrovascular diseases,255.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Cerebrovascular diseases,259.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Cerebrovascular diseases,228.86,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Cerebrovascular diseases,256.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Cerebrovascular diseases,230.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Cerebrovascular diseases,202.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Cerebrovascular diseases,228.86,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Cerebrovascular diseases,209.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Cerebrovascular diseases,191.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Chronic lower respiratory diseases,154.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Chronic lower respiratory diseases,195.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Chronic lower respiratory diseases,139.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Chronic lower respiratory diseases,139.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Chronic lower respiratory diseases,172.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Chronic lower respiratory diseases,144.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Chronic lower respiratory diseases,168.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Chronic lower respiratory diseases,189.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Chronic lower respiratory diseases,137.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Chronic lower respiratory diseases,120.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2011,Asthma and status asthmaticus,5.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2012,Asthma and status asthmaticus,10.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2013,Asthma and status asthmaticus,8.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2014,Asthma and status asthmaticus,8.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2015,Asthma and status asthmaticus,10.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2016,Asthma and status asthmaticus,9.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2017,Asthma and status asthmaticus,10.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2018,Asthma and status asthmaticus,11.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2019,Asthma and status asthmaticus,5.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Females,2020,Asthma and status asthmaticus,4.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,158.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,157.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,145.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,135.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,129.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,121.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,123.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,129.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,120.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,127.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",18.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",13.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",14.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",14.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",12.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",10.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",10.67,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",12.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",11.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",12.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Malignant melanoma of skin,1.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Malignant melanoma of skin,1.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Malignant melanoma of skin,1.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Malignant melanoma of skin,1.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Malignant melanoma of skin,0.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Malignant melanoma of skin,1.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Malignant melanoma of skin,1.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Malignant melanoma of skin,0.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Malignant melanoma of skin,0.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Malignant neoplasm of breast,18.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Malignant neoplasm of breast,15.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Malignant neoplasm of breast,16.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Malignant neoplasm of breast,11.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Malignant neoplasm of breast,14.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Diabetes mellitus,1.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Diabetes mellitus,2.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Diabetes mellitus,1.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Diabetes mellitus,1.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Diabetes mellitus,1.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Diabetes mellitus,0.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Diabetes mellitus,0.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Diabetes mellitus,1.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Diabetes mellitus,0.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Diabetes mellitus,1.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,2.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,1.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,1.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Cerebrovascular diseases,6.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Cerebrovascular diseases,4.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Cerebrovascular diseases,4.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Cerebrovascular diseases,3.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Cerebrovascular diseases,4.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Cerebrovascular diseases,4.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Cerebrovascular diseases,4.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Cerebrovascular diseases,5.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Cerebrovascular diseases,4.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Cerebrovascular diseases,3.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Chronic lower respiratory diseases,4.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Chronic lower respiratory diseases,7.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Chronic lower respiratory diseases,3.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Chronic lower respiratory diseases,4.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Chronic lower respiratory diseases,4.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Chronic lower respiratory diseases,5.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Chronic lower respiratory diseases,5.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Chronic lower respiratory diseases,3.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1217.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1289.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1261.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1231.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1233.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1226.86,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1205.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1147.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1142.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1472.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",95.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",87.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",89.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",87.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",80.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",81.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",79.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",66.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",72.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",68.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Malignant melanoma of skin,3.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Malignant melanoma of skin,3.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Malignant melanoma of skin,2.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Malignant melanoma of skin,2.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Malignant melanoma of skin,1.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Malignant melanoma of skin,3.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Malignant melanoma of skin,3.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Malignant melanoma of skin,3.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Malignant melanoma of skin,3.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Malignant melanoma of skin,2.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Malignant neoplasm of breast,0.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Malignant neoplasm of breast,0.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Malignant neoplasm of breast,0.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Malignant neoplasm of breast,0.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Malignant neoplasm of breast,0.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Malignant neoplasm of breast,0.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Malignant neoplasm of breast,0.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Malignant neoplasm of breast,0.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Diabetes mellitus,17.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Diabetes mellitus,21.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Diabetes mellitus,20.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Diabetes mellitus,20.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Diabetes mellitus,21.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Diabetes mellitus,22.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Diabetes mellitus,19.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Diabetes mellitus,23.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Diabetes mellitus,20.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Diabetes mellitus,23.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Mental and behavioural disorders (F00-F99),31.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Mental and behavioural disorders (F00-F99),39.67,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Mental and behavioural disorders (F00-F99),39.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Mental and behavioural disorders (F00-F99),42.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Mental and behavioural disorders (F00-F99),56.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Mental and behavioural disorders (F00-F99),45.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Mental and behavioural disorders (F00-F99),47.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Mental and behavioural disorders (F00-F99),48.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Mental and behavioural disorders (F00-F99),50.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Mental and behavioural disorders (F00-F99),40.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),6.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.92,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),5.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),6.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Other ischaemic heart diseases,48.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Other ischaemic heart diseases,57.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Other ischaemic heart diseases,56.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Other ischaemic heart diseases,51.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Other ischaemic heart diseases,55.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Other ischaemic heart diseases,52.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Other ischaemic heart diseases,53.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Other ischaemic heart diseases,52.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Other ischaemic heart diseases,45.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Other ischaemic heart diseases,40.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,69.92,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,75.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,64.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,60.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,59.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,49.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,47.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,38.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,42.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,42.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Cerebrovascular diseases,68.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Cerebrovascular diseases,69.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Cerebrovascular diseases,63.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Cerebrovascular diseases,73.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Cerebrovascular diseases,64.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Cerebrovascular diseases,63.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Cerebrovascular diseases,72.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Cerebrovascular diseases,66.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Cerebrovascular diseases,63.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Cerebrovascular diseases,45.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Chronic lower respiratory diseases,63.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Chronic lower respiratory diseases,64.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Chronic lower respiratory diseases,78.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Chronic lower respiratory diseases,72.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Chronic lower respiratory diseases,65.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Chronic lower respiratory diseases,62.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Chronic lower respiratory diseases,57.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Chronic lower respiratory diseases,59.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Chronic lower respiratory diseases,50.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Chronic lower respiratory diseases,49.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2011,Asthma and status asthmaticus,2.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2012,Asthma and status asthmaticus,1.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2013,Asthma and status asthmaticus,2.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2014,Asthma and status asthmaticus,3.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2015,Asthma and status asthmaticus,1.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2016,Asthma and status asthmaticus,1.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2017,Asthma and status asthmaticus,0.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2018,Asthma and status asthmaticus,0.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2019,Asthma and status asthmaticus,1.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Males,2020,Asthma and status asthmaticus,0.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5222.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5523.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5411.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5364.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5347.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5343.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5244.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4994.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5020.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6532.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",164.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",163.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",167.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",370.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",341.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",343.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",336.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",315.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",322.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",317.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",274.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",292.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",281.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Malignant melanoma of skin,13.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Malignant melanoma of skin,13.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Malignant melanoma of skin,7.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Malignant melanoma of skin,10.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Malignant melanoma of skin,6.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Malignant melanoma of skin,14.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Malignant melanoma of skin,15.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Malignant melanoma of skin,14.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Malignant melanoma of skin,12.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Malignant melanoma of skin,10.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Malignant neoplasm of breast,3.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Malignant neoplasm of breast,3.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Malignant neoplasm of breast,1.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Malignant neoplasm of breast,1.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Malignant neoplasm of breast,4.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Malignant neoplasm of breast,1.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Malignant neoplasm of breast,5.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Diabetes mellitus,73.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Diabetes mellitus,97.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Diabetes mellitus,92.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Diabetes mellitus,93.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Diabetes mellitus,101.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Diabetes mellitus,103.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Diabetes mellitus,80.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Diabetes mellitus,111.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Diabetes mellitus,86.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Diabetes mellitus,112.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),145.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),186.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),160.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),190.92,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),246.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),207.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),214.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),225.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),235.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),179.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),11.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),13.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),10.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),11.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),16.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),28.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),9.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),26.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),16.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),24.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Other ischaemic heart diseases,226.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Other ischaemic heart diseases,275.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Other ischaemic heart diseases,268.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Other ischaemic heart diseases,237.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Other ischaemic heart diseases,251.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Other ischaemic heart diseases,248.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Other ischaemic heart diseases,255.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Other ischaemic heart diseases,240.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Other ischaemic heart diseases,214.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Other ischaemic heart diseases,183.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,299.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,316.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,277.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,258.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,253.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,209.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,193.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,161.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,171.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,180.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Cerebrovascular diseases,317.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Cerebrovascular diseases,333.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Cerebrovascular diseases,272.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Cerebrovascular diseases,339.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Cerebrovascular diseases,302.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Cerebrovascular diseases,299.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Cerebrovascular diseases,341.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Cerebrovascular diseases,308.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Cerebrovascular diseases,301.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Cerebrovascular diseases,210.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Chronic lower respiratory diseases,294.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Chronic lower respiratory diseases,305.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Chronic lower respiratory diseases,363.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Chronic lower respiratory diseases,343.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Chronic lower respiratory diseases,305.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Chronic lower respiratory diseases,288.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Chronic lower respiratory diseases,270.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Chronic lower respiratory diseases,276.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Chronic lower respiratory diseases,233.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Chronic lower respiratory diseases,224.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2011,Asthma and status asthmaticus,8.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2012,Asthma and status asthmaticus,3.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2013,Asthma and status asthmaticus,8.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2014,Asthma and status asthmaticus,12.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2015,Asthma and status asthmaticus,6.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2016,Asthma and status asthmaticus,7.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2017,Asthma and status asthmaticus,1.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2018,Asthma and status asthmaticus,2.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2019,Asthma and status asthmaticus,5.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Males,2020,Asthma and status asthmaticus,1.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,247.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,263.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,256.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,230.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,236.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,229.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,227.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,216.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,203.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,247.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",28.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",26.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",28.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",27.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",23.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",22.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",21.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",16.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",19.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",17.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Malignant melanoma of skin,0.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Malignant melanoma of skin,0.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Malignant melanoma of skin,0.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Malignant melanoma of skin,1.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Malignant melanoma of skin,0.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Malignant melanoma of skin,0.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Malignant melanoma of skin,0.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Malignant melanoma of skin,1.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Malignant melanoma of skin,0.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Malignant melanoma of skin,0.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Diabetes mellitus,4.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Diabetes mellitus,3.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Diabetes mellitus,2.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Diabetes mellitus,3.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Diabetes mellitus,1.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Diabetes mellitus,3.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Diabetes mellitus,4.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Diabetes mellitus,2.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Diabetes mellitus,4.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Diabetes mellitus,2.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),3.86,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),4.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),9.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),6.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),10.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),6.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),6.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),5.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),6.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),7.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Other ischaemic heart diseases,4.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Other ischaemic heart diseases,4.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Other ischaemic heart diseases,5.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Other ischaemic heart diseases,6.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Other ischaemic heart diseases,7.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Other ischaemic heart diseases,5.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Other ischaemic heart diseases,5.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Other ischaemic heart diseases,6.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Other ischaemic heart diseases,4.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Other ischaemic heart diseases,5.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,14.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,17.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,13.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,12.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,11.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,10.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,12.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,8.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,11.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,9.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Cerebrovascular diseases,8.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Cerebrovascular diseases,5.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Cerebrovascular diseases,12.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Cerebrovascular diseases,9.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Cerebrovascular diseases,7.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Cerebrovascular diseases,6.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Cerebrovascular diseases,6.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Cerebrovascular diseases,8.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Cerebrovascular diseases,5.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Cerebrovascular diseases,5.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Chronic lower respiratory diseases,7.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Chronic lower respiratory diseases,6.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Chronic lower respiratory diseases,9.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Chronic lower respiratory diseases,7.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Chronic lower respiratory diseases,7.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Chronic lower respiratory diseases,5.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Chronic lower respiratory diseases,6.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Chronic lower respiratory diseases,6.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Chronic lower respiratory diseases,7.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,985.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1046.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1002.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,956.81,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,980.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,944.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,933.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,916.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,914.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1150.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",60.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",55.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",58.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",55.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",54.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",54.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",52.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",44.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",51.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",46.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Malignant melanoma of skin,3.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Malignant melanoma of skin,2.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Malignant melanoma of skin,2.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Malignant melanoma of skin,2.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Malignant melanoma of skin,2.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Malignant melanoma of skin,2.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Malignant melanoma of skin,2.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Malignant melanoma of skin,3.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Malignant melanoma of skin,2.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Malignant melanoma of skin,1.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Malignant neoplasm of breast,29.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Malignant neoplasm of breast,22.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Malignant neoplasm of breast,23.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Malignant neoplasm of breast,23.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Malignant neoplasm of breast,21.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Malignant neoplasm of breast,21.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Malignant neoplasm of breast,19.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Malignant neoplasm of breast,21.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Malignant neoplasm of breast,19.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Malignant neoplasm of breast,17.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Diabetes mellitus,15.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Diabetes mellitus,17.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Diabetes mellitus,16.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Diabetes mellitus,15.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Diabetes mellitus,17.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Diabetes mellitus,14.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Diabetes mellitus,13.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Diabetes mellitus,15.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Diabetes mellitus,15.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Diabetes mellitus,16.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Mental and behavioural disorders (F00-F99),28.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Mental and behavioural disorders (F00-F99),42.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Mental and behavioural disorders (F00-F99),38.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Mental and behavioural disorders (F00-F99),38.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Mental and behavioural disorders (F00-F99),47.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Mental and behavioural disorders (F00-F99),41.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Mental and behavioural disorders (F00-F99),45.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Mental and behavioural disorders (F00-F99),45.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Mental and behavioural disorders (F00-F99),46.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Mental and behavioural disorders (F00-F99),43.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),4.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),5.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),4.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),5.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Other ischaemic heart diseases,33.95,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Other ischaemic heart diseases,36.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Other ischaemic heart diseases,33.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Other ischaemic heart diseases,32.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Other ischaemic heart diseases,33.14,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Other ischaemic heart diseases,30.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Other ischaemic heart diseases,33.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Other ischaemic heart diseases,31.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Other ischaemic heart diseases,29.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Other ischaemic heart diseases,25.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,48.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,51.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,43.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,36.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,36.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,32.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,28.32,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,27.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,29.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Cerebrovascular diseases,65.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Cerebrovascular diseases,60.35,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Cerebrovascular diseases,58.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Cerebrovascular diseases,57.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Cerebrovascular diseases,58.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Cerebrovascular diseases,55.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Cerebrovascular diseases,54.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Cerebrovascular diseases,56.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Cerebrovascular diseases,52.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Cerebrovascular diseases,42.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Chronic lower respiratory diseases,44.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Chronic lower respiratory diseases,50.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Chronic lower respiratory diseases,50.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Chronic lower respiratory diseases,45.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Chronic lower respiratory diseases,47.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Chronic lower respiratory diseases,42.85,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Chronic lower respiratory diseases,43.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Chronic lower respiratory diseases,47.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Chronic lower respiratory diseases,39.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Chronic lower respiratory diseases,35.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2011,Asthma and status asthmaticus,1.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2012,Asthma and status asthmaticus,1.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2013,Asthma and status asthmaticus,2.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2014,Asthma and status asthmaticus,2.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2015,Asthma and status asthmaticus,2.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2016,Asthma and status asthmaticus,2.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2017,Asthma and status asthmaticus,1.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2018,Asthma and status asthmaticus,2.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2019,Asthma and status asthmaticus,1.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Total,Total,2020,Asthma and status asthmaticus,0.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4221.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4501.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4319.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4155.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4278.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4122.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4067.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3988.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4024.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5126.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.8,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.68,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",212.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",204.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",214.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",202.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",203.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",212.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",205.67,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",169.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",197.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",175.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Malignant melanoma of skin,11.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Malignant melanoma of skin,9.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Malignant melanoma of skin,9.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Malignant melanoma of skin,9.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Malignant melanoma of skin,7.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Malignant melanoma of skin,6.58,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Malignant melanoma of skin,8.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Malignant melanoma of skin,12.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Malignant melanoma of skin,9.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Malignant melanoma of skin,7.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Malignant neoplasm of breast,109.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Malignant neoplasm of breast,82.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Malignant neoplasm of breast,85.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Malignant neoplasm of breast,83.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Malignant neoplasm of breast,83.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Malignant neoplasm of breast,87.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Malignant neoplasm of breast,68.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Malignant neoplasm of breast,77.52,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Malignant neoplasm of breast,70.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Malignant neoplasm of breast,70.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Diabetes mellitus,65.91,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Diabetes mellitus,77.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Diabetes mellitus,75.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Diabetes mellitus,70.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Diabetes mellitus,81.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Diabetes mellitus,67.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Diabetes mellitus,60.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Diabetes mellitus,69.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Diabetes mellitus,67.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Diabetes mellitus,77.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),135.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),203.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),177.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),179.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),219.26,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),194.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),213.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),217.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),224.53,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),205.86,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),8.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),13.4,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),11.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),13.07,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),17.93,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),19.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),21.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),28.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),21.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),20.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Other ischaemic heart diseases,160.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Other ischaemic heart diseases,174.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Other ischaemic heart diseases,158.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Other ischaemic heart diseases,151.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Other ischaemic heart diseases,152.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Other ischaemic heart diseases,145.17,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Other ischaemic heart diseases,155.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Other ischaemic heart diseases,147.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Other ischaemic heart diseases,138.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Other ischaemic heart diseases,115.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,208.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,218.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,193.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,182.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,155.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,155.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,135.76,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,123.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,115.74,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,126.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Cerebrovascular diseases,307.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Cerebrovascular diseases,290.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Cerebrovascular diseases,264.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Cerebrovascular diseases,270.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Cerebrovascular diseases,276.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Cerebrovascular diseases,261.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Cerebrovascular diseases,255.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Cerebrovascular diseases,258.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Cerebrovascular diseases,247.59,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Cerebrovascular diseases,198.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Chronic lower respiratory diseases,204.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Chronic lower respiratory diseases,231.64,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Chronic lower respiratory diseases,221.13,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Chronic lower respiratory diseases,211.71,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Chronic lower respiratory diseases,220.79,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Chronic lower respiratory diseases,195.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Chronic lower respiratory diseases,204.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Chronic lower respiratory diseases,220.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Chronic lower respiratory diseases,174.97,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Chronic lower respiratory diseases,159.08,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2011,Asthma and status asthmaticus,7.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2012,Asthma and status asthmaticus,7.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2013,Asthma and status asthmaticus,8.56,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2014,Asthma and status asthmaticus,9.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2015,Asthma and status asthmaticus,9.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2016,Asthma and status asthmaticus,8.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2017,Asthma and status asthmaticus,6.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2018,Asthma and status asthmaticus,8.25,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2019,Asthma and status asthmaticus,6.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,65 years or over,Total,2020,Asthma and status asthmaticus,3.38,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,201.29,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,209.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,198.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,181.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,181.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,174.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,173.94,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,172.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,161.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,187.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",23.37,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",19.84,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",21.15,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.46,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",18.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.77,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",15.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",14.23,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",15.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Malignant melanoma of skin,1.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Malignant melanoma of skin,0.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Malignant melanoma of skin,1.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Malignant melanoma of skin,1.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Malignant melanoma of skin,0.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Malignant melanoma of skin,1.12,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Malignant melanoma of skin,1.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Malignant melanoma of skin,0.83,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Malignant melanoma of skin,0.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Malignant melanoma of skin,0.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Malignant neoplasm of breast,9.62,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.04,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Malignant neoplasm of breast,8.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.69,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Diabetes mellitus,2.7,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Diabetes mellitus,3.16,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Diabetes mellitus,2.01,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Diabetes mellitus,2.22,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Diabetes mellitus,1.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Diabetes mellitus,1.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Diabetes mellitus,2.24,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Diabetes mellitus,2.05,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Diabetes mellitus,2.54,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Diabetes mellitus,1.98,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),2.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),3.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),5.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.36,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),6.39,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),4.78,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),3.65,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.63,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.75,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Other ischaemic heart diseases,3.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.66,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Other ischaemic heart diseases,2.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Other ischaemic heart diseases,4.02,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Other ischaemic heart diseases,4.18,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Other ischaemic heart diseases,3.21,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Other ischaemic heart diseases,3.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Other ischaemic heart diseases,4.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.96,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Other ischaemic heart diseases,3.33,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,9.28,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,10.88,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,7.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,7.55,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,7.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,7.45,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,7.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,6.47,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,5.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Cerebrovascular diseases,7.0,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Cerebrovascular diseases,4.72,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Cerebrovascular diseases,8.31,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Cerebrovascular diseases,6.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Cerebrovascular diseases,5.73,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Cerebrovascular diseases,5.06,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Cerebrovascular diseases,5.61,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Cerebrovascular diseases,6.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Cerebrovascular diseases,5.43,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Cerebrovascular diseases,4.42,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Chronic lower respiratory diseases,6.11,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Chronic lower respiratory diseases,8.57,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.3,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Chronic lower respiratory diseases,5.99,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.89,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Chronic lower respiratory diseases,4.09,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Chronic lower respiratory diseases,5.9,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.27,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Chronic lower respiratory diseases,5.19,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.5,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.34,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.87,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.49,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.48,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.2,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.51,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.44,Rate
Rgion de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest,BE10,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.23,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,812.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,827.97,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,814.44,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,746.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,800.99,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,742.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,747.32,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,742.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,725.32,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,818.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.61,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.88,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.0,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.44,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.56,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.19,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",26.31,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",23.28,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",31.07,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",28.79,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",23.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",26.89,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",27.07,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",29.64,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",25.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",29.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Malignant melanoma of skin,3.55,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Malignant melanoma of skin,2.61,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Malignant melanoma of skin,4.24,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Malignant melanoma of skin,3.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Malignant melanoma of skin,3.88,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Malignant melanoma of skin,2.52,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Malignant melanoma of skin,2.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Malignant melanoma of skin,2.89,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Malignant melanoma of skin,2.35,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Malignant melanoma of skin,1.86,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Malignant neoplasm of breast,43.47,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Malignant neoplasm of breast,41.22,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Malignant neoplasm of breast,37.5,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Malignant neoplasm of breast,40.81,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Malignant neoplasm of breast,40.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Malignant neoplasm of breast,36.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Malignant neoplasm of breast,30.09,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Malignant neoplasm of breast,37.58,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Malignant neoplasm of breast,34.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Malignant neoplasm of breast,35.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Diabetes mellitus,15.05,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Diabetes mellitus,16.18,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Diabetes mellitus,16.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Diabetes mellitus,14.25,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Diabetes mellitus,14.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Diabetes mellitus,12.32,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Diabetes mellitus,10.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Diabetes mellitus,11.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Diabetes mellitus,11.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Diabetes mellitus,11.69,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Mental and behavioural disorders (F00-F99),41.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Mental and behavioural disorders (F00-F99),42.77,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Mental and behavioural disorders (F00-F99),57.21,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Mental and behavioural disorders (F00-F99),47.52,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Mental and behavioural disorders (F00-F99),54.32,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Mental and behavioural disorders (F00-F99),49.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Mental and behavioural disorders (F00-F99),52.71,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Mental and behavioural disorders (F00-F99),54.56,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Mental and behavioural disorders (F00-F99),57.62,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Mental and behavioural disorders (F00-F99),53.99,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.65,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.99,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.57,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),4.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.81,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Other ischaemic heart diseases,23.35,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Other ischaemic heart diseases,21.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Other ischaemic heart diseases,17.98,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Other ischaemic heart diseases,15.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Other ischaemic heart diseases,20.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Other ischaemic heart diseases,15.64,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Other ischaemic heart diseases,14.96,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Other ischaemic heart diseases,16.12,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Other ischaemic heart diseases,13.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Other ischaemic heart diseases,11.71,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,35.68,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,32.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,28.53,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.69,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,24.09,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,23.36,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,23.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,22.48,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,21.93,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,17.82,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Cerebrovascular diseases,64.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Cerebrovascular diseases,65.57,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Cerebrovascular diseases,61.11,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Cerebrovascular diseases,59.97,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Cerebrovascular diseases,59.48,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Cerebrovascular diseases,61.92,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Cerebrovascular diseases,55.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Cerebrovascular diseases,51.89,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Cerebrovascular diseases,49.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Cerebrovascular diseases,49.27,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Chronic lower respiratory diseases,22.55,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Chronic lower respiratory diseases,25.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Chronic lower respiratory diseases,25.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Chronic lower respiratory diseases,21.59,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Chronic lower respiratory diseases,24.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Chronic lower respiratory diseases,21.53,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Chronic lower respiratory diseases,23.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Chronic lower respiratory diseases,22.06,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Chronic lower respiratory diseases,19.14,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Chronic lower respiratory diseases,18.34,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2011,Asthma and status asthmaticus,0.24,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2012,Asthma and status asthmaticus,0.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2013,Asthma and status asthmaticus,1.23,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2014,Asthma and status asthmaticus,0.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2015,Asthma and status asthmaticus,1.07,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2016,Asthma and status asthmaticus,0.24,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2017,Asthma and status asthmaticus,0.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2018,Asthma and status asthmaticus,0.53,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2019,Asthma and status asthmaticus,0.98,Rate
Prov. Oost-Vlaanderen,BE23,Total,Females,2020,Asthma and status asthmaticus,0.68,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3563.79,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3675.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3587.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3321.76,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3565.85,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3311.98,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3329.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3301.89,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3225.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3730.36,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.03,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.97,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.94,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",66.81,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.87,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.86,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",77.33,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",58.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",93.65,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",93.57,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",78.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",89.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",91.59,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",94.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",96.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",104.55,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Malignant melanoma of skin,11.16,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Malignant melanoma of skin,9.25,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Malignant melanoma of skin,14.08,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Malignant melanoma of skin,13.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Malignant melanoma of skin,11.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Malignant melanoma of skin,8.08,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Malignant melanoma of skin,12.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Malignant melanoma of skin,10.1,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Malignant melanoma of skin,8.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Malignant melanoma of skin,5.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Malignant neoplasm of breast,138.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Malignant neoplasm of breast,142.28,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Malignant neoplasm of breast,124.56,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Malignant neoplasm of breast,153.12,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Malignant neoplasm of breast,141.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Malignant neoplasm of breast,132.61,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Malignant neoplasm of breast,114.6,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Malignant neoplasm of breast,136.5,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Malignant neoplasm of breast,125.34,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Malignant neoplasm of breast,122.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Diabetes mellitus,74.34,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Diabetes mellitus,78.76,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Diabetes mellitus,79.24,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Diabetes mellitus,70.94,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Diabetes mellitus,73.25,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Diabetes mellitus,60.47,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Diabetes mellitus,51.46,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Diabetes mellitus,58.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Diabetes mellitus,55.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Diabetes mellitus,57.95,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),200.11,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),211.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),277.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),231.22,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),264.11,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),242.55,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),253.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),265.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),283.53,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),263.66,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),9.31,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),7.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),9.73,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),11.38,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),12.5,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),6.97,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),10.83,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),8.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),13.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),8.9,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Other ischaemic heart diseases,114.74,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Other ischaemic heart diseases,104.56,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Other ischaemic heart diseases,90.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Other ischaemic heart diseases,75.36,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Other ischaemic heart diseases,101.39,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Other ischaemic heart diseases,78.24,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Other ischaemic heart diseases,75.41,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Other ischaemic heart diseases,78.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Other ischaemic heart diseases,68.87,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Other ischaemic heart diseases,56.82,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,168.18,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,148.94,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,130.74,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,135.29,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,112.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,107.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,103.48,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,104.74,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,102.08,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,80.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Cerebrovascular diseases,317.96,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Cerebrovascular diseases,316.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Cerebrovascular diseases,292.97,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Cerebrovascular diseases,290.64,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Cerebrovascular diseases,284.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Cerebrovascular diseases,296.3,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Cerebrovascular diseases,267.52,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Cerebrovascular diseases,253.4,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Cerebrovascular diseases,235.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Cerebrovascular diseases,238.67,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Chronic lower respiratory diseases,104.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Chronic lower respiratory diseases,112.85,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Chronic lower respiratory diseases,116.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Chronic lower respiratory diseases,96.83,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Chronic lower respiratory diseases,108.6,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Chronic lower respiratory diseases,94.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Chronic lower respiratory diseases,111.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Chronic lower respiratory diseases,100.08,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Chronic lower respiratory diseases,85.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Chronic lower respiratory diseases,85.14,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2011,Asthma and status asthmaticus,0.47,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2012,Asthma and status asthmaticus,3.95,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2013,Asthma and status asthmaticus,4.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2014,Asthma and status asthmaticus,2.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2015,Asthma and status asthmaticus,4.81,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2016,Asthma and status asthmaticus,1.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2017,Asthma and status asthmaticus,3.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2018,Asthma and status asthmaticus,2.72,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2019,Asthma and status asthmaticus,3.7,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Females,2020,Asthma and status asthmaticus,3.47,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,145.43,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,138.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,142.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,123.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,131.24,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,119.67,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,121.74,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,122.4,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,119.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,112.53,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.65,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.13,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.56,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.72,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.74,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.62,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",13.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",14.72,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",15.92,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",13.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",10.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",11.65,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",11.45,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",13.86,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",10.91,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Malignant melanoma of skin,1.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Malignant melanoma of skin,1.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Malignant melanoma of skin,1.86,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Malignant melanoma of skin,1.67,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Malignant melanoma of skin,2.03,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Malignant melanoma of skin,1.18,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Malignant melanoma of skin,0.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Malignant melanoma of skin,1.15,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Malignant melanoma of skin,0.98,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Malignant melanoma of skin,0.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Malignant neoplasm of breast,20.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Malignant neoplasm of breast,16.75,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Malignant neoplasm of breast,16.41,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Malignant neoplasm of breast,13.6,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Malignant neoplasm of breast,16.04,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.75,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Malignant neoplasm of breast,9.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Malignant neoplasm of breast,13.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Malignant neoplasm of breast,12.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Malignant neoplasm of breast,13.79,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Diabetes mellitus,0.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Diabetes mellitus,1.02,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Diabetes mellitus,1.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Diabetes mellitus,0.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Diabetes mellitus,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Diabetes mellitus,0.65,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Diabetes mellitus,0.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Diabetes mellitus,0.49,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Diabetes mellitus,0.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Diabetes mellitus,0.48,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.94,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),3.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),3.02,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),3.5,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),3.14,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),4.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),3.39,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.89,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.2,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.99,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.8,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.47,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.21,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.86,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.5,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.35,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.48,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.11,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.47,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.79,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,3.59,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,3.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.93,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.63,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.56,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Cerebrovascular diseases,3.09,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Cerebrovascular diseases,4.8,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Cerebrovascular diseases,4.94,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Cerebrovascular diseases,4.09,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Cerebrovascular diseases,4.97,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Cerebrovascular diseases,5.15,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Cerebrovascular diseases,4.13,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Cerebrovascular diseases,3.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Cerebrovascular diseases,4.97,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Cerebrovascular diseases,3.4,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Chronic lower respiratory diseases,2.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Chronic lower respiratory diseases,3.93,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Chronic lower respiratory diseases,3.73,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Chronic lower respiratory diseases,3.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Chronic lower respiratory diseases,4.5,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Chronic lower respiratory diseases,3.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.59,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Chronic lower respiratory diseases,3.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Chronic lower respiratory diseases,3.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Chronic lower respiratory diseases,2.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.18,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1278.41,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1301.99,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1289.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1176.27,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1196.05,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1144.19,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1127.26,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1115.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1086.25,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1194.96,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.28,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.98,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.06,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.68,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.36,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.34,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.45,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",110.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",103.18,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",98.02,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",102.61,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",93.34,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",88.69,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",73.26,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",76.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",78.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",72.07,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Malignant melanoma of skin,4.45,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Malignant melanoma of skin,3.26,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Malignant melanoma of skin,4.44,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Malignant melanoma of skin,3.7,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Malignant melanoma of skin,4.12,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Malignant melanoma of skin,3.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Malignant melanoma of skin,3.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Malignant melanoma of skin,3.74,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Malignant melanoma of skin,4.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Malignant melanoma of skin,2.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Malignant neoplasm of breast,0.45,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Malignant neoplasm of breast,0.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Malignant neoplasm of breast,0.46,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Malignant neoplasm of breast,0.31,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Malignant neoplasm of breast,0.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Malignant neoplasm of breast,0.44,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Malignant neoplasm of breast,0.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Malignant neoplasm of breast,0.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Malignant neoplasm of breast,0.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Diabetes mellitus,20.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Diabetes mellitus,19.62,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Diabetes mellitus,17.94,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Diabetes mellitus,14.36,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Diabetes mellitus,13.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Diabetes mellitus,15.21,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Diabetes mellitus,15.25,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Diabetes mellitus,14.92,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Diabetes mellitus,12.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Diabetes mellitus,11.94,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Mental and behavioural disorders (F00-F99),41.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Mental and behavioural disorders (F00-F99),54.43,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Mental and behavioural disorders (F00-F99),47.78,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Mental and behavioural disorders (F00-F99),44.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Mental and behavioural disorders (F00-F99),47.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Mental and behavioural disorders (F00-F99),48.21,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Mental and behavioural disorders (F00-F99),57.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Mental and behavioural disorders (F00-F99),58.19,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Mental and behavioural disorders (F00-F99),54.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Mental and behavioural disorders (F00-F99),49.18,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.45,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.57,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.34,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),3.82,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.77,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.66,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Other ischaemic heart diseases,42.66,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Other ischaemic heart diseases,48.14,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Other ischaemic heart diseases,47.25,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Other ischaemic heart diseases,42.34,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Other ischaemic heart diseases,45.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Other ischaemic heart diseases,41.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Other ischaemic heart diseases,38.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Other ischaemic heart diseases,38.8,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Other ischaemic heart diseases,37.25,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Other ischaemic heart diseases,27.66,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,69.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,69.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,68.58,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,58.81,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,52.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,44.64,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,51.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,43.58,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,44.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,38.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Cerebrovascular diseases,76.21,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Cerebrovascular diseases,78.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Cerebrovascular diseases,71.56,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Cerebrovascular diseases,74.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Cerebrovascular diseases,66.77,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Cerebrovascular diseases,68.52,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Cerebrovascular diseases,62.19,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Cerebrovascular diseases,53.66,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Cerebrovascular diseases,52.03,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Cerebrovascular diseases,52.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Chronic lower respiratory diseases,68.62,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Chronic lower respiratory diseases,65.6,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Chronic lower respiratory diseases,74.49,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Chronic lower respiratory diseases,57.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Chronic lower respiratory diseases,54.53,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Chronic lower respiratory diseases,55.98,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Chronic lower respiratory diseases,65.29,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Chronic lower respiratory diseases,54.43,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Chronic lower respiratory diseases,51.41,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Chronic lower respiratory diseases,47.75,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2011,Asthma and status asthmaticus,0.73,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2012,Asthma and status asthmaticus,0.51,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2013,Asthma and status asthmaticus,1.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2014,Asthma and status asthmaticus,0.28,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2015,Asthma and status asthmaticus,0.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2016,Asthma and status asthmaticus,0.65,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2017,Asthma and status asthmaticus,0.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2018,Asthma and status asthmaticus,0.56,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2019,Asthma and status asthmaticus,0.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Males,2020,Asthma and status asthmaticus,0.44,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5533.73,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5671.28,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5636.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5136.85,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5210.73,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4971.44,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4922.86,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4887.21,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4773.36,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5333.9,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",178.44,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.31,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.9,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.79,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.01,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.96,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.65,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.11,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.74,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",464.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",419.98,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",400.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",421.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",384.33,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",378.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",294.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",321.29,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",330.47,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",298.29,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Malignant melanoma of skin,15.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Malignant melanoma of skin,11.87,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Malignant melanoma of skin,17.35,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Malignant melanoma of skin,14.28,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Malignant melanoma of skin,15.79,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Malignant melanoma of skin,10.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Malignant melanoma of skin,10.88,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Malignant melanoma of skin,15.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Malignant melanoma of skin,15.3,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Malignant melanoma of skin,10.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Malignant neoplasm of breast,0.9,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Malignant neoplasm of breast,3.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Malignant neoplasm of breast,2.34,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Malignant neoplasm of breast,0.89,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Malignant neoplasm of breast,2.01,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Malignant neoplasm of breast,1.54,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Malignant neoplasm of breast,1.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Malignant neoplasm of breast,0.89,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Malignant neoplasm of breast,2.49,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Diabetes mellitus,93.29,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Diabetes mellitus,88.71,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Diabetes mellitus,78.88,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Diabetes mellitus,68.19,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Diabetes mellitus,58.98,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Diabetes mellitus,69.88,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Diabetes mellitus,71.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Diabetes mellitus,66.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Diabetes mellitus,60.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Diabetes mellitus,54.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),193.54,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),258.22,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),218.33,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),212.95,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),220.79,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),228.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),280.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),262.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),264.01,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),227.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),10.41,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),16.34,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),10.62,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),7.89,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),14.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.55,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),12.22,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),10.2,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),12.16,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),7.64,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Other ischaemic heart diseases,202.7,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Other ischaemic heart diseases,223.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Other ischaemic heart diseases,228.46,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Other ischaemic heart diseases,204.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Other ischaemic heart diseases,217.03,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Other ischaemic heart diseases,200.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Other ischaemic heart diseases,184.75,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Other ischaemic heart diseases,181.37,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Other ischaemic heart diseases,172.87,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Other ischaemic heart diseases,131.57,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,295.4,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,306.05,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,304.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,250.58,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,221.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,194.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,221.14,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,182.72,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,195.02,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,158.65,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Cerebrovascular diseases,358.5,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Cerebrovascular diseases,370.65,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Cerebrovascular diseases,338.6,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Cerebrovascular diseases,361.76,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Cerebrovascular diseases,318.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Cerebrovascular diseases,320.14,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Cerebrovascular diseases,292.93,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Cerebrovascular diseases,249.48,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Cerebrovascular diseases,252.55,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Cerebrovascular diseases,255.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Chronic lower respiratory diseases,324.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Chronic lower respiratory diseases,312.52,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Chronic lower respiratory diseases,349.18,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Chronic lower respiratory diseases,271.61,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Chronic lower respiratory diseases,259.04,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Chronic lower respiratory diseases,260.16,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Chronic lower respiratory diseases,316.0,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Chronic lower respiratory diseases,260.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Chronic lower respiratory diseases,245.68,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Chronic lower respiratory diseases,228.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2011,Asthma and status asthmaticus,1.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2012,Asthma and status asthmaticus,2.62,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2013,Asthma and status asthmaticus,3.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2014,Asthma and status asthmaticus,1.46,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2015,Asthma and status asthmaticus,0.85,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2016,Asthma and status asthmaticus,1.96,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2018,Asthma and status asthmaticus,2.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2019,Asthma and status asthmaticus,0.68,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Males,2020,Asthma and status asthmaticus,2.26,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,247.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,243.59,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,236.84,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,216.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,223.55,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,217.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,207.82,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,201.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,193.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,192.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.81,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.83,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.22,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.11,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.49,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.03,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.21,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.55,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",25.05,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",26.44,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",24.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",25.42,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",22.85,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",18.55,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",19.6,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",17.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",17.62,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",17.27,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Malignant melanoma of skin,1.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Malignant melanoma of skin,1.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Malignant melanoma of skin,1.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Malignant melanoma of skin,1.13,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Malignant melanoma of skin,1.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Malignant melanoma of skin,1.81,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Malignant melanoma of skin,1.46,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Malignant melanoma of skin,0.8,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Malignant melanoma of skin,1.27,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Malignant melanoma of skin,0.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.35,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.31,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Diabetes mellitus,2.37,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Diabetes mellitus,2.89,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Diabetes mellitus,3.18,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Diabetes mellitus,1.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Diabetes mellitus,2.47,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Diabetes mellitus,1.96,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Diabetes mellitus,1.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Diabetes mellitus,2.37,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Diabetes mellitus,0.61,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Diabetes mellitus,1.72,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),4.42,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),5.07,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),6.46,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),4.11,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),5.07,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),4.55,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),4.03,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),8.82,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),3.18,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),6.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.99,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Other ischaemic heart diseases,3.89,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Other ischaemic heart diseases,5.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Other ischaemic heart diseases,3.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.11,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Other ischaemic heart diseases,3.45,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Other ischaemic heart diseases,2.58,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Other ischaemic heart diseases,3.51,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Other ischaemic heart diseases,4.27,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Other ischaemic heart diseases,4.39,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.49,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,14.21,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,12.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,11.35,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,12.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,11.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,8.44,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,10.83,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,9.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.03,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,9.45,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Cerebrovascular diseases,7.83,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Cerebrovascular diseases,7.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Cerebrovascular diseases,6.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Cerebrovascular diseases,4.5,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Cerebrovascular diseases,5.69,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Cerebrovascular diseases,7.57,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Cerebrovascular diseases,6.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Cerebrovascular diseases,6.22,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Cerebrovascular diseases,3.46,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Cerebrovascular diseases,2.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Chronic lower respiratory diseases,6.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Chronic lower respiratory diseases,5.79,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Chronic lower respiratory diseases,7.96,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Chronic lower respiratory diseases,5.23,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.99,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Chronic lower respiratory diseases,6.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Chronic lower respiratory diseases,4.56,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Chronic lower respiratory diseases,4.57,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Chronic lower respiratory diseases,4.36,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.98,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.5,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1003.86,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1024.69,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1009.61,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,926.68,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,968.42,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,912.18,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,908.65,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,898.47,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,877.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,979.36,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.53,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.7,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.7,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.55,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.22,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.31,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.47,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.19,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",61.99,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",57.21,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",59.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",61.01,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",54.06,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",53.51,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",47.2,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",49.76,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",48.38,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",47.94,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Malignant melanoma of skin,3.93,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Malignant melanoma of skin,2.79,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Malignant melanoma of skin,4.38,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Malignant melanoma of skin,3.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Malignant melanoma of skin,3.86,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Malignant melanoma of skin,3.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Malignant melanoma of skin,3.05,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Malignant melanoma of skin,3.3,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Malignant melanoma of skin,3.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Malignant melanoma of skin,2.31,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Malignant neoplasm of breast,24.27,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Malignant neoplasm of breast,23.27,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Malignant neoplasm of breast,21.11,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Malignant neoplasm of breast,23.09,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Malignant neoplasm of breast,22.64,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Malignant neoplasm of breast,20.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Malignant neoplasm of breast,17.24,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Malignant neoplasm of breast,21.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Malignant neoplasm of breast,19.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Malignant neoplasm of breast,19.35,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Diabetes mellitus,17.61,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Diabetes mellitus,17.68,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Diabetes mellitus,17.7,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Diabetes mellitus,14.78,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Diabetes mellitus,14.76,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Diabetes mellitus,13.58,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Diabetes mellitus,12.65,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Diabetes mellitus,13.58,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Diabetes mellitus,12.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Diabetes mellitus,12.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Mental and behavioural disorders (F00-F99),41.72,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Mental and behavioural disorders (F00-F99),47.79,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Mental and behavioural disorders (F00-F99),54.98,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Mental and behavioural disorders (F00-F99),46.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Mental and behavioural disorders (F00-F99),52.68,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Mental and behavioural disorders (F00-F99),49.92,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Mental and behavioural disorders (F00-F99),55.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Mental and behavioural disorders (F00-F99),56.85,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Mental and behavioural disorders (F00-F99),57.09,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Mental and behavioural disorders (F00-F99),54.04,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.74,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.08,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.9,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.75,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.88,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.16,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.22,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.54,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Other ischaemic heart diseases,31.12,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Other ischaemic heart diseases,31.16,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Other ischaemic heart diseases,29.02,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Other ischaemic heart diseases,25.26,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Other ischaemic heart diseases,30.36,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Other ischaemic heart diseases,25.83,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Other ischaemic heart diseases,24.5,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Other ischaemic heart diseases,25.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Other ischaemic heart diseases,23.47,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Other ischaemic heart diseases,18.41,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,50.59,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,47.56,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,44.59,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.23,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,36.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,32.32,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,35.07,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,32.03,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,31.45,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,27.17,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Cerebrovascular diseases,70.84,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Cerebrovascular diseases,71.69,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Cerebrovascular diseases,66.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Cerebrovascular diseases,66.14,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Cerebrovascular diseases,63.4,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Cerebrovascular diseases,65.13,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Cerebrovascular diseases,57.93,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Cerebrovascular diseases,53.41,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Cerebrovascular diseases,50.87,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Cerebrovascular diseases,51.12,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Chronic lower respiratory diseases,39.79,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Chronic lower respiratory diseases,41.24,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Chronic lower respiratory diseases,43.77,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Chronic lower respiratory diseases,35.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Chronic lower respiratory diseases,36.52,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Chronic lower respiratory diseases,35.0,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Chronic lower respiratory diseases,39.76,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Chronic lower respiratory diseases,34.37,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Chronic lower respiratory diseases,31.6,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Chronic lower respiratory diseases,30.16,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2011,Asthma and status asthmaticus,0.48,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2012,Asthma and status asthmaticus,0.81,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2013,Asthma and status asthmaticus,1.1,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2014,Asthma and status asthmaticus,0.38,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2015,Asthma and status asthmaticus,0.79,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2016,Asthma and status asthmaticus,0.39,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2017,Asthma and status asthmaticus,0.47,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2018,Asthma and status asthmaticus,0.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2019,Asthma and status asthmaticus,0.63,Rate
Prov. Oost-Vlaanderen,BE23,Total,Total,2020,Asthma and status asthmaticus,0.64,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4335.1,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4465.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4392.75,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4048.8,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4232.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3981.16,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3978.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3938.19,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3850.79,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4391.82,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.77,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.64,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.32,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.37,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.86,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.33,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.28,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.83,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.61,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.84,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",237.29,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",208.36,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",220.56,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",233.2,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",208.01,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",212.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",177.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",191.23,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",193.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",187.65,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Malignant melanoma of skin,13.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Malignant melanoma of skin,9.81,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Malignant melanoma of skin,15.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Malignant melanoma of skin,14.21,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Malignant melanoma of skin,12.94,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Malignant melanoma of skin,9.43,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Malignant melanoma of skin,11.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Malignant melanoma of skin,12.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Malignant melanoma of skin,11.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Malignant melanoma of skin,7.95,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Malignant neoplasm of breast,82.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Malignant neoplasm of breast,84.7,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Malignant neoplasm of breast,74.67,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Malignant neoplasm of breast,90.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Malignant neoplasm of breast,83.31,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Malignant neoplasm of breast,78.2,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Malignant neoplasm of breast,68.37,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Malignant neoplasm of breast,79.57,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Malignant neoplasm of breast,73.49,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Malignant neoplasm of breast,70.97,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Diabetes mellitus,83.99,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Diabetes mellitus,82.59,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Diabetes mellitus,80.68,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Diabetes mellitus,71.98,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Diabetes mellitus,70.19,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Diabetes mellitus,64.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Diabetes mellitus,60.89,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Diabetes mellitus,63.73,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Diabetes mellitus,59.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Diabetes mellitus,57.85,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),198.72,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),230.41,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),260.57,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),225.44,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),252.47,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),240.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),265.74,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),266.25,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),280.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),257.91,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),8.95,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),10.3,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),9.34,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),9.36,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),12.37,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),5.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),10.83,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),9.17,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),13.45,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),8.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Other ischaemic heart diseases,149.0,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Other ischaemic heart diseases,146.06,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Other ischaemic heart diseases,140.76,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Other ischaemic heart diseases,122.06,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Other ischaemic heart diseases,145.76,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Other ischaemic heart diseases,126.14,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Other ischaemic heart diseases,117.7,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Other ischaemic heart diseases,119.07,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Other ischaemic heart diseases,110.27,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Other ischaemic heart diseases,87.6,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,222.51,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,209.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,197.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,179.84,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,157.42,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,142.15,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,149.87,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,138.52,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,139.4,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,114.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Cerebrovascular diseases,340.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Cerebrovascular diseases,342.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Cerebrovascular diseases,316.06,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Cerebrovascular diseases,321.47,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Cerebrovascular diseases,303.1,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Cerebrovascular diseases,307.73,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Cerebrovascular diseases,275.56,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Cerebrovascular diseases,254.63,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Cerebrovascular diseases,243.48,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Cerebrovascular diseases,249.42,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Chronic lower respiratory diseases,184.5,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Chronic lower respiratory diseases,191.4,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Chronic lower respiratory diseases,200.3,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Chronic lower respiratory diseases,163.78,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Chronic lower respiratory diseases,167.69,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Chronic lower respiratory diseases,158.22,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Chronic lower respiratory diseases,189.13,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Chronic lower respiratory diseases,160.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Chronic lower respiratory diseases,146.84,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Chronic lower respiratory diseases,142.0,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2011,Asthma and status asthmaticus,1.04,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2012,Asthma and status asthmaticus,3.82,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2013,Asthma and status asthmaticus,4.26,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2014,Asthma and status asthmaticus,1.93,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2015,Asthma and status asthmaticus,3.38,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2016,Asthma and status asthmaticus,1.32,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2017,Asthma and status asthmaticus,2.09,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2018,Asthma and status asthmaticus,2.92,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2019,Asthma and status asthmaticus,2.53,Rate
Prov. Oost-Vlaanderen,BE23,65 years or over,Total,2020,Asthma and status asthmaticus,3.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,196.92,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,191.2,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,190.09,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,170.39,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,177.75,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,168.76,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,165.05,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,162.14,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,156.65,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,152.74,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.73,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.97,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.44,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.45,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.26,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.92,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.13,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.32,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.57,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.14,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",19.52,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",20.59,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",20.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",19.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",16.77,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",15.53,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",15.49,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",13.18,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Malignant melanoma of skin,1.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Malignant melanoma of skin,1.09,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Malignant melanoma of skin,1.58,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Malignant melanoma of skin,1.4,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Malignant melanoma of skin,1.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Malignant melanoma of skin,1.49,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Malignant melanoma of skin,1.06,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Malignant melanoma of skin,0.97,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Malignant melanoma of skin,1.12,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Malignant melanoma of skin,0.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Malignant neoplasm of breast,10.25,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.39,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.14,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.83,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.4,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Malignant neoplasm of breast,4.86,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.91,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.28,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.84,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Diabetes mellitus,1.53,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Diabetes mellitus,1.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Diabetes mellitus,2.45,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Diabetes mellitus,0.92,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Diabetes mellitus,1.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Diabetes mellitus,1.31,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Diabetes mellitus,0.97,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Diabetes mellitus,1.43,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Diabetes mellitus,0.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Diabetes mellitus,1.1,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),3.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),3.55,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),5.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),3.57,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),4.29,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),3.85,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.05,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),6.12,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.03,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.57,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.31,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.78,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.14,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.81,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Other ischaemic heart diseases,2.56,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Other ischaemic heart diseases,3.33,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Other ischaemic heart diseases,1.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Other ischaemic heart diseases,1.82,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Other ischaemic heart diseases,2.41,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Other ischaemic heart diseases,1.54,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Other ischaemic heart diseases,1.92,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.7,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.44,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.65,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.95,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,8.28,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,7.6,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,7.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,7.04,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,5.71,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,7.26,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,6.23,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,5.29,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,6.11,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Cerebrovascular diseases,5.48,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Cerebrovascular diseases,6.06,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Cerebrovascular diseases,5.91,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Cerebrovascular diseases,4.29,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Cerebrovascular diseases,5.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Cerebrovascular diseases,6.37,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Cerebrovascular diseases,5.21,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Cerebrovascular diseases,4.66,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Cerebrovascular diseases,4.21,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Cerebrovascular diseases,3.09,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.73,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Chronic lower respiratory diseases,4.86,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Chronic lower respiratory diseases,5.85,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.3,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Chronic lower respiratory diseases,4.74,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.15,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.58,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.87,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Chronic lower respiratory diseases,3.68,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Chronic lower respiratory diseases,3.07,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.34,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.17,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.08,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.16,Rate
Prov. Oost-Vlaanderen,BE23,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,773.08,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,779.44,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,773.54,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,729.38,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,735.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,718.56,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,709.25,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,715.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,701.55,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,767.8,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.39,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.76,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.14,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.56,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.55,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.07,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.95,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",26.43,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",26.97,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",22.56,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",26.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",25.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",24.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",25.67,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",22.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",31.6,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",26.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Malignant melanoma of skin,3.01,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Malignant melanoma of skin,2.23,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Malignant melanoma of skin,2.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Malignant melanoma of skin,3.0,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Malignant melanoma of skin,2.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Malignant melanoma of skin,2.51,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Malignant melanoma of skin,2.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Malignant melanoma of skin,2.01,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Malignant melanoma of skin,2.29,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Malignant melanoma of skin,1.88,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Malignant neoplasm of breast,43.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Malignant neoplasm of breast,39.9,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Malignant neoplasm of breast,36.02,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Malignant neoplasm of breast,31.32,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Malignant neoplasm of breast,27.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Malignant neoplasm of breast,33.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Malignant neoplasm of breast,34.7,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Malignant neoplasm of breast,36.05,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Malignant neoplasm of breast,34.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Malignant neoplasm of breast,30.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Diabetes mellitus,14.85,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Diabetes mellitus,14.93,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Diabetes mellitus,14.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Diabetes mellitus,10.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Diabetes mellitus,10.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Diabetes mellitus,10.6,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Diabetes mellitus,10.29,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Diabetes mellitus,9.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Diabetes mellitus,9.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Diabetes mellitus,8.94,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Mental and behavioural disorders (F00-F99),41.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Mental and behavioural disorders (F00-F99),54.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Mental and behavioural disorders (F00-F99),56.01,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Mental and behavioural disorders (F00-F99),47.12,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Mental and behavioural disorders (F00-F99),49.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Mental and behavioural disorders (F00-F99),55.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Mental and behavioural disorders (F00-F99),51.85,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Mental and behavioural disorders (F00-F99),61.73,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Mental and behavioural disorders (F00-F99),50.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Mental and behavioural disorders (F00-F99),50.49,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.95,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),3.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),3.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.34,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.27,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.7,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Other ischaemic heart diseases,22.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Other ischaemic heart diseases,20.64,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Other ischaemic heart diseases,16.08,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Other ischaemic heart diseases,17.58,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Other ischaemic heart diseases,18.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Other ischaemic heart diseases,15.25,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Other ischaemic heart diseases,15.88,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Other ischaemic heart diseases,13.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Other ischaemic heart diseases,15.81,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Other ischaemic heart diseases,12.43,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,34.09,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,28.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,28.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,24.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,22.85,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,21.28,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,20.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,20.34,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,18.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,14.04,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Cerebrovascular diseases,70.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Cerebrovascular diseases,61.27,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Cerebrovascular diseases,62.5,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Cerebrovascular diseases,58.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Cerebrovascular diseases,57.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Cerebrovascular diseases,51.71,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Cerebrovascular diseases,46.09,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Cerebrovascular diseases,46.41,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Cerebrovascular diseases,45.97,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Cerebrovascular diseases,43.46,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Chronic lower respiratory diseases,19.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Chronic lower respiratory diseases,20.13,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Chronic lower respiratory diseases,22.85,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Chronic lower respiratory diseases,21.43,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Chronic lower respiratory diseases,22.09,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Chronic lower respiratory diseases,20.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Chronic lower respiratory diseases,21.39,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Chronic lower respiratory diseases,22.14,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Chronic lower respiratory diseases,20.1,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Chronic lower respiratory diseases,18.47,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2011,Asthma and status asthmaticus,1.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2012,Asthma and status asthmaticus,1.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2013,Asthma and status asthmaticus,0.77,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2014,Asthma and status asthmaticus,0.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2015,Asthma and status asthmaticus,1.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2016,Asthma and status asthmaticus,0.75,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2017,Asthma and status asthmaticus,0.62,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2018,Asthma and status asthmaticus,1.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2019,Asthma and status asthmaticus,0.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Females,2020,Asthma and status asthmaticus,1.42,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3423.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3455.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3439.59,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3251.55,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3302.49,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3250.53,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3192.94,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3203.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3152.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3525.16,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.22,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.61,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.75,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",68.65,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.51,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",64.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",86.21,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",76.55,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",67.84,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",86.14,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",73.38,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",83.38,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",87.39,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",82.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",125.48,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",109.33,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Malignant melanoma of skin,8.14,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Malignant melanoma of skin,7.88,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Malignant melanoma of skin,9.84,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Malignant melanoma of skin,10.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Malignant melanoma of skin,9.75,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Malignant melanoma of skin,7.69,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Malignant melanoma of skin,7.51,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Malignant melanoma of skin,5.93,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Malignant melanoma of skin,4.06,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Malignant melanoma of skin,8.85,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Malignant neoplasm of breast,147.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Malignant neoplasm of breast,139.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Malignant neoplasm of breast,128.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Malignant neoplasm of breast,100.85,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Malignant neoplasm of breast,89.12,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Malignant neoplasm of breast,124.87,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Malignant neoplasm of breast,119.1,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Malignant neoplasm of breast,127.71,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Malignant neoplasm of breast,116.51,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Malignant neoplasm of breast,122.05,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Diabetes mellitus,71.6,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Diabetes mellitus,73.87,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Diabetes mellitus,73.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Diabetes mellitus,52.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Diabetes mellitus,52.15,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Diabetes mellitus,52.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Diabetes mellitus,49.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Diabetes mellitus,47.75,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Diabetes mellitus,46.93,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Diabetes mellitus,40.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),206.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),261.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),279.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),230.78,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),244.4,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),277.44,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),260.53,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),305.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),247.88,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),248.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),8.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),9.89,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),10.87,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),12.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),13.59,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),10.4,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),8.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),7.84,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),7.78,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),11.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Other ischaemic heart diseases,112.62,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Other ischaemic heart diseases,104.04,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Other ischaemic heart diseases,77.14,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Other ischaemic heart diseases,83.77,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Other ischaemic heart diseases,90.13,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Other ischaemic heart diseases,75.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Other ischaemic heart diseases,76.31,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Other ischaemic heart diseases,65.87,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Other ischaemic heart diseases,77.48,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Other ischaemic heart diseases,60.39,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,163.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,134.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,132.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,113.89,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,109.21,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,102.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,95.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,94.12,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,86.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,69.55,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Cerebrovascular diseases,341.34,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Cerebrovascular diseases,296.69,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Cerebrovascular diseases,298.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Cerebrovascular diseases,284.72,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Cerebrovascular diseases,278.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Cerebrovascular diseases,252.83,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Cerebrovascular diseases,225.06,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Cerebrovascular diseases,219.65,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Cerebrovascular diseases,217.49,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Cerebrovascular diseases,211.95,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Chronic lower respiratory diseases,87.37,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Chronic lower respiratory diseases,88.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Chronic lower respiratory diseases,106.08,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Chronic lower respiratory diseases,104.5,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Chronic lower respiratory diseases,102.7,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Chronic lower respiratory diseases,95.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Chronic lower respiratory diseases,96.78,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Chronic lower respiratory diseases,105.65,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Chronic lower respiratory diseases,91.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Chronic lower respiratory diseases,79.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2011,Asthma and status asthmaticus,6.42,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2012,Asthma and status asthmaticus,6.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2013,Asthma and status asthmaticus,3.94,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2014,Asthma and status asthmaticus,5.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2015,Asthma and status asthmaticus,5.17,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2016,Asthma and status asthmaticus,2.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2017,Asthma and status asthmaticus,3.17,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2018,Asthma and status asthmaticus,4.89,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2019,Asthma and status asthmaticus,2.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Females,2020,Asthma and status asthmaticus,6.38,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,131.02,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,131.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,127.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,118.43,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,113.31,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,105.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,107.61,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,112.51,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,107.8,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,99.87,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.32,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.66,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.13,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.81,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.79,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.29,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.12,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.87,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",11.95,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",14.96,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",11.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",11.71,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",14.26,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",9.99,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",10.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",8.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",6.53,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Malignant melanoma of skin,1.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Malignant melanoma of skin,0.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Malignant melanoma of skin,0.66,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Malignant melanoma of skin,1.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Malignant melanoma of skin,0.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Malignant melanoma of skin,1.25,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Malignant melanoma of skin,1.31,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Malignant melanoma of skin,1.05,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Malignant melanoma of skin,1.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Malignant melanoma of skin,0.19,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Malignant neoplasm of breast,17.92,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Malignant neoplasm of breast,15.81,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.48,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Malignant neoplasm of breast,12.76,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.3,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Malignant neoplasm of breast,14.25,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Malignant neoplasm of breast,13.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Malignant neoplasm of breast,14.25,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Malignant neoplasm of breast,8.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Diabetes mellitus,1.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Diabetes mellitus,0.65,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Diabetes mellitus,0.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Diabetes mellitus,0.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Diabetes mellitus,0.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Diabetes mellitus,0.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Diabetes mellitus,0.9,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Diabetes mellitus,0.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Diabetes mellitus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Diabetes mellitus,1.4,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),3.94,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.64,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.93,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),1.3,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.3,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.56,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.28,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.18,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.35,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.12,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.29,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.08,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.65,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.04,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.87,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.82,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,2.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,2.43,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.71,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.07,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,1.93,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,1.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.98,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,1.64,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,0.6,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Cerebrovascular diseases,5.35,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Cerebrovascular diseases,4.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Cerebrovascular diseases,5.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Cerebrovascular diseases,3.32,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Cerebrovascular diseases,3.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Cerebrovascular diseases,2.99,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Cerebrovascular diseases,2.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Cerebrovascular diseases,4.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Cerebrovascular diseases,4.43,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Cerebrovascular diseases,2.65,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Chronic lower respiratory diseases,2.96,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Chronic lower respiratory diseases,3.57,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Chronic lower respiratory diseases,1.31,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Chronic lower respiratory diseases,2.57,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Chronic lower respiratory diseases,2.94,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Chronic lower respiratory diseases,3.13,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.91,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Chronic lower respiratory diseases,2.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Chronic lower respiratory diseases,3.63,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.2,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1161.27,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1197.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1190.37,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1093.75,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1134.78,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1080.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1068.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1071.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1003.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1113.24,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.83,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.32,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.09,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.1,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",86.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",88.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",87.05,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",82.82,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",80.69,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",78.07,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",71.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",75.35,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",68.56,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",62.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Malignant melanoma of skin,3.19,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Malignant melanoma of skin,3.43,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Malignant melanoma of skin,4.75,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Malignant melanoma of skin,3.66,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Malignant melanoma of skin,4.03,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Malignant melanoma of skin,3.69,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Malignant melanoma of skin,4.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Malignant melanoma of skin,3.34,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Malignant melanoma of skin,1.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Malignant melanoma of skin,3.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Malignant neoplasm of breast,0.44,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Malignant neoplasm of breast,0.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Malignant neoplasm of breast,1.03,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Malignant neoplasm of breast,0.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Malignant neoplasm of breast,0.63,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Malignant neoplasm of breast,0.44,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Malignant neoplasm of breast,0.36,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Malignant neoplasm of breast,0.36,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Malignant neoplasm of breast,0.39,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Diabetes mellitus,14.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Diabetes mellitus,12.35,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Diabetes mellitus,16.02,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Diabetes mellitus,17.28,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Diabetes mellitus,16.54,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Diabetes mellitus,14.59,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Diabetes mellitus,17.31,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Diabetes mellitus,13.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Diabetes mellitus,12.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Diabetes mellitus,9.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Mental and behavioural disorders (F00-F99),38.67,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Mental and behavioural disorders (F00-F99),54.37,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Mental and behavioural disorders (F00-F99),55.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Mental and behavioural disorders (F00-F99),42.07,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Mental and behavioural disorders (F00-F99),52.27,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Mental and behavioural disorders (F00-F99),51.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Mental and behavioural disorders (F00-F99),52.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Mental and behavioural disorders (F00-F99),52.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Mental and behavioural disorders (F00-F99),48.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Mental and behavioural disorders (F00-F99),42.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.95,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.04,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),3.12,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.18,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.31,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Other ischaemic heart diseases,50.1,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Other ischaemic heart diseases,40.75,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Other ischaemic heart diseases,45.66,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Other ischaemic heart diseases,45.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Other ischaemic heart diseases,49.08,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Other ischaemic heart diseases,46.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Other ischaemic heart diseases,37.95,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Other ischaemic heart diseases,41.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Other ischaemic heart diseases,36.81,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Other ischaemic heart diseases,32.1,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,64.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,62.67,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,60.82,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,50.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,49.35,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,44.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,42.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,43.31,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,35.7,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,36.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Cerebrovascular diseases,75.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Cerebrovascular diseases,65.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Cerebrovascular diseases,70.23,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Cerebrovascular diseases,64.13,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Cerebrovascular diseases,63.32,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Cerebrovascular diseases,57.63,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Cerebrovascular diseases,55.75,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Cerebrovascular diseases,55.99,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Cerebrovascular diseases,55.24,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Cerebrovascular diseases,47.97,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Chronic lower respiratory diseases,59.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Chronic lower respiratory diseases,58.04,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Chronic lower respiratory diseases,50.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Chronic lower respiratory diseases,55.36,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Chronic lower respiratory diseases,58.82,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Chronic lower respiratory diseases,55.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Chronic lower respiratory diseases,52.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Chronic lower respiratory diseases,51.83,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Chronic lower respiratory diseases,46.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2020,Chronic lower respiratory diseases,38.12,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2011,Asthma and status asthmaticus,0.23,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2012,Asthma and status asthmaticus,0.35,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2013,Asthma and status asthmaticus,0.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2014,Asthma and status asthmaticus,0.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2015,Asthma and status asthmaticus,0.76,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2016,Asthma and status asthmaticus,0.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2017,Asthma and status asthmaticus,0.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2018,Asthma and status asthmaticus,0.81,Rate
Prov. Vlaams-Brabant,BE24,Total,Males,2019,Asthma and status asthmaticus,0.17,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5110.97,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5289.54,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5269.6,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4806.51,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4982.63,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4766.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4754.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4838.96,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4485.86,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4989.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",162.83,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.1,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",153.39,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.38,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.68,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.45,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",362.55,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",355.59,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",351.5,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",348.11,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",332.16,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",313.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",309.68,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",321.09,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",295.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",266.37,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Malignant melanoma of skin,12.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Malignant melanoma of skin,15.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Malignant melanoma of skin,17.97,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Malignant melanoma of skin,12.33,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Malignant melanoma of skin,16.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Malignant melanoma of skin,10.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Malignant melanoma of skin,19.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Malignant melanoma of skin,12.84,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Malignant melanoma of skin,5.78,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Malignant melanoma of skin,11.59,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Malignant neoplasm of breast,2.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Malignant neoplasm of breast,1.12,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Malignant neoplasm of breast,3.37,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Malignant neoplasm of breast,1.05,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Malignant neoplasm of breast,3.23,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Malignant neoplasm of breast,2.27,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Malignant neoplasm of breast,1.86,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Malignant neoplasm of breast,0.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Malignant neoplasm of breast,1.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Diabetes mellitus,68.49,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Diabetes mellitus,53.12,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Diabetes mellitus,75.14,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Diabetes mellitus,76.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Diabetes mellitus,77.66,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Diabetes mellitus,68.56,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Diabetes mellitus,85.21,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Diabetes mellitus,64.92,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Diabetes mellitus,52.71,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Diabetes mellitus,43.62,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),177.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),253.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),261.57,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),202.17,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),253.62,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),249.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),252.12,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),260.89,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),238.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),207.38,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),9.42,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),15.11,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),9.29,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),12.15,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),20.9,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),12.97,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),13.92,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),12.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),19.5,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),10.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Other ischaemic heart diseases,240.84,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Other ischaemic heart diseases,195.56,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Other ischaemic heart diseases,213.29,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Other ischaemic heart diseases,211.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Other ischaemic heart diseases,239.83,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Other ischaemic heart diseases,223.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Other ischaemic heart diseases,179.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Other ischaemic heart diseases,200.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Other ischaemic heart diseases,178.7,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Other ischaemic heart diseases,156.31,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,270.18,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,281.85,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,252.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,211.48,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,221.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,188.15,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,190.08,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,186.05,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,151.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,149.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Cerebrovascular diseases,366.59,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Cerebrovascular diseases,312.63,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Cerebrovascular diseases,330.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Cerebrovascular diseases,309.27,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Cerebrovascular diseases,300.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Cerebrovascular diseases,273.92,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Cerebrovascular diseases,265.95,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Cerebrovascular diseases,275.97,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Cerebrovascular diseases,264.69,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Cerebrovascular diseases,229.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Chronic lower respiratory diseases,288.43,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Chronic lower respiratory diseases,277.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Chronic lower respiratory diseases,246.05,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Chronic lower respiratory diseases,270.88,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Chronic lower respiratory diseases,281.76,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Chronic lower respiratory diseases,269.77,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Chronic lower respiratory diseases,253.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Chronic lower respiratory diseases,245.75,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Chronic lower respiratory diseases,222.53,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2020,Chronic lower respiratory diseases,179.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2011,Asthma and status asthmaticus,1.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2012,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2013,Asthma and status asthmaticus,5.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2014,Asthma and status asthmaticus,2.06,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2015,Asthma and status asthmaticus,2.95,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2016,Asthma and status asthmaticus,2.31,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2017,Asthma and status asthmaticus,4.69,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2018,Asthma and status asthmaticus,3.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Males,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,204.51,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,206.48,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,202.23,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,194.39,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,202.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,187.6,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,175.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,159.39,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,159.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,174.39,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.5,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.03,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.58,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.35,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.45,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.14,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.38,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",19.2,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",23.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",22.99,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",18.56,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",19.78,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",21.14,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",14.4,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",15.82,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",13.62,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",12.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Malignant melanoma of skin,0.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Malignant melanoma of skin,0.63,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Malignant melanoma of skin,1.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Malignant melanoma of skin,1.56,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Malignant melanoma of skin,1.06,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Malignant melanoma of skin,1.93,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Malignant melanoma of skin,0.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Malignant melanoma of skin,1.04,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Malignant melanoma of skin,0.4,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Malignant melanoma of skin,1.62,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Diabetes mellitus,1.32,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Diabetes mellitus,2.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Diabetes mellitus,1.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Diabetes mellitus,2.88,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Diabetes mellitus,1.74,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Diabetes mellitus,1.52,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Diabetes mellitus,0.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Diabetes mellitus,1.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Diabetes mellitus,2.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Diabetes mellitus,1.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),4.99,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),6.16,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),5.34,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),3.29,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),3.5,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),3.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),3.9,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),2.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),2.34,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),3.09,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.74,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Other ischaemic heart diseases,3.9,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Other ischaemic heart diseases,3.25,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Other ischaemic heart diseases,5.05,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Other ischaemic heart diseases,5.78,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Other ischaemic heart diseases,2.88,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Other ischaemic heart diseases,3.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Other ischaemic heart diseases,3.6,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Other ischaemic heart diseases,3.35,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Other ischaemic heart diseases,2.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.01,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,14.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,9.58,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,14.46,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,11.09,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,7.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,9.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,7.35,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,8.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,7.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,9.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Cerebrovascular diseases,5.51,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Cerebrovascular diseases,5.67,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Cerebrovascular diseases,7.13,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Cerebrovascular diseases,4.75,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Cerebrovascular diseases,5.79,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Cerebrovascular diseases,5.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Cerebrovascular diseases,4.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Cerebrovascular diseases,2.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Cerebrovascular diseases,4.51,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Cerebrovascular diseases,3.92,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Chronic lower respiratory diseases,4.08,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Chronic lower respiratory diseases,4.98,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Chronic lower respiratory diseases,3.16,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Chronic lower respiratory diseases,3.15,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.81,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.04,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Chronic lower respiratory diseases,3.51,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Chronic lower respiratory diseases,4.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Chronic lower respiratory diseases,3.48,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.82,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.23,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.21,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,935.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,950.73,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,947.35,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,883.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,906.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,874.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,861.28,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,867.54,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,830.83,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,916.47,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.14,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.82,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.92,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.66,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.49,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.38,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.85,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.62,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",52.67,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",53.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",50.86,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",51.05,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",49.73,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",47.94,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",45.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",45.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",47.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",41.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Malignant melanoma of skin,3.03,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Malignant melanoma of skin,2.71,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Malignant melanoma of skin,3.51,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Malignant melanoma of skin,3.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Malignant melanoma of skin,3.26,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Malignant melanoma of skin,3.1,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Malignant melanoma of skin,3.31,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Malignant melanoma of skin,2.64,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Malignant melanoma of skin,1.88,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Malignant melanoma of skin,2.73,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Malignant neoplasm of breast,24.23,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Malignant neoplasm of breast,22.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Malignant neoplasm of breast,20.94,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Malignant neoplasm of breast,17.4,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Malignant neoplasm of breast,15.37,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Malignant neoplasm of breast,18.96,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Malignant neoplasm of breast,19.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Malignant neoplasm of breast,19.96,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Malignant neoplasm of breast,19.16,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Malignant neoplasm of breast,17.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Diabetes mellitus,15.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Diabetes mellitus,14.41,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Diabetes mellitus,15.58,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Diabetes mellitus,13.8,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Diabetes mellitus,13.51,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Diabetes mellitus,12.49,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Diabetes mellitus,12.99,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Diabetes mellitus,11.36,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Diabetes mellitus,10.74,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Diabetes mellitus,9.25,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Mental and behavioural disorders (F00-F99),41.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Mental and behavioural disorders (F00-F99),55.07,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Mental and behavioural disorders (F00-F99),56.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Mental and behavioural disorders (F00-F99),45.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Mental and behavioural disorders (F00-F99),51.2,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Mental and behavioural disorders (F00-F99),54.9,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Mental and behavioural disorders (F00-F99),52.81,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Mental and behavioural disorders (F00-F99),59.14,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Mental and behavioural disorders (F00-F99),50.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Mental and behavioural disorders (F00-F99),48.25,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),3.61,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.66,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.22,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.56,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.55,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.03,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.12,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.77,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Other ischaemic heart diseases,33.57,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Other ischaemic heart diseases,28.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Other ischaemic heart diseases,27.49,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Other ischaemic heart diseases,29.13,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Other ischaemic heart diseases,30.52,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Other ischaemic heart diseases,28.33,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Other ischaemic heart diseases,24.69,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Other ischaemic heart diseases,24.89,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Other ischaemic heart diseases,24.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Other ischaemic heart diseases,20.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,47.55,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,41.73,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,42.47,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,35.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,33.8,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,31.69,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,30.48,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,30.3,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,25.98,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,23.91,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Cerebrovascular diseases,72.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Cerebrovascular diseases,63.42,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Cerebrovascular diseases,65.94,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Cerebrovascular diseases,61.53,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Cerebrovascular diseases,60.18,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Cerebrovascular diseases,55.05,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Cerebrovascular diseases,51.08,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Cerebrovascular diseases,49.88,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Cerebrovascular diseases,49.68,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Cerebrovascular diseases,46.17,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Chronic lower respiratory diseases,34.83,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Chronic lower respiratory diseases,34.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Chronic lower respiratory diseases,34.67,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Chronic lower respiratory diseases,34.46,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Chronic lower respiratory diseases,36.79,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Chronic lower respiratory diseases,34.81,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Chronic lower respiratory diseases,33.72,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Chronic lower respiratory diseases,34.15,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Chronic lower respiratory diseases,30.45,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Chronic lower respiratory diseases,26.71,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2011,Asthma and status asthmaticus,0.97,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2012,Asthma and status asthmaticus,1.03,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2013,Asthma and status asthmaticus,0.87,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2014,Asthma and status asthmaticus,0.77,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2015,Asthma and status asthmaticus,1.04,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2016,Asthma and status asthmaticus,0.65,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2017,Asthma and status asthmaticus,0.76,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2018,Asthma and status asthmaticus,1.08,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2019,Asthma and status asthmaticus,0.59,Rate
Prov. Vlaams-Brabant,BE24,Total,Total,2020,Asthma and status asthmaticus,0.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4107.72,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4179.39,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4177.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3884.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3997.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3881.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3833.13,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3887.83,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3708.88,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4134.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.19,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.22,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.41,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.77,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",205.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",193.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",189.64,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",199.46,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",184.9,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",181.75,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",183.45,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",185.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",199.18,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",175.33,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Malignant melanoma of skin,10.11,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Malignant melanoma of skin,10.8,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Malignant melanoma of skin,13.45,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Malignant melanoma of skin,11.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Malignant melanoma of skin,12.83,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Malignant melanoma of skin,9.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Malignant melanoma of skin,12.55,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Malignant melanoma of skin,9.2,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Malignant melanoma of skin,4.96,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Malignant melanoma of skin,10.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Malignant neoplasm of breast,87.09,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Malignant neoplasm of breast,82.24,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Malignant neoplasm of breast,77.96,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Malignant neoplasm of breast,59.14,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Malignant neoplasm of breast,52.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Malignant neoplasm of breast,73.78,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Malignant neoplasm of breast,70.27,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Malignant neoplasm of breast,73.6,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Malignant neoplasm of breast,68.25,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Malignant neoplasm of breast,71.3,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Diabetes mellitus,72.97,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Diabetes mellitus,67.47,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Diabetes mellitus,75.41,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Diabetes mellitus,64.43,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Diabetes mellitus,63.96,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Diabetes mellitus,60.02,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Diabetes mellitus,62.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Diabetes mellitus,54.79,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Diabetes mellitus,50.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Diabetes mellitus,42.06,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),199.63,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),261.6,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),275.22,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),223.19,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),251.41,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),271.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),260.1,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),292.86,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),247.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),236.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),8.65,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),12.19,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),9.93,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),13.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),15.07,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),11.1,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),10.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),9.81,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),12.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),11.22,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Other ischaemic heart diseases,161.85,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Other ischaemic heart diseases,140.74,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Other ischaemic heart diseases,127.9,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Other ischaemic heart diseases,134.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Other ischaemic heart diseases,148.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Other ischaemic heart diseases,135.99,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Other ischaemic heart diseases,116.65,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Other ischaemic heart diseases,118.57,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Other ischaemic heart diseases,117.81,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Other ischaemic heart diseases,99.01,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,207.98,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,189.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,180.46,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,152.81,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,153.39,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,139.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,135.0,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,132.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,114.37,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,102.46,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Cerebrovascular diseases,349.58,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Cerebrovascular diseases,304.77,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Cerebrovascular diseases,312.72,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Cerebrovascular diseases,298.91,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Cerebrovascular diseases,289.27,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Cerebrovascular diseases,265.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Cerebrovascular diseases,246.35,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Cerebrovascular diseases,241.03,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Cerebrovascular diseases,236.32,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Cerebrovascular diseases,223.26,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Chronic lower respiratory diseases,164.09,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Chronic lower respiratory diseases,160.05,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Chronic lower respiratory diseases,165.73,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Chronic lower respiratory diseases,167.57,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Chronic lower respiratory diseases,173.5,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Chronic lower respiratory diseases,164.11,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Chronic lower respiratory diseases,159.19,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Chronic lower respiratory diseases,161.23,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Chronic lower respiratory diseases,143.4,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Chronic lower respiratory diseases,121.61,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2011,Asthma and status asthmaticus,4.52,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2012,Asthma and status asthmaticus,4.36,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2013,Asthma and status asthmaticus,4.48,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2014,Asthma and status asthmaticus,3.93,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2015,Asthma and status asthmaticus,4.41,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2016,Asthma and status asthmaticus,2.9,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2017,Asthma and status asthmaticus,3.88,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2018,Asthma and status asthmaticus,4.61,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2019,Asthma and status asthmaticus,1.67,Rate
Prov. Vlaams-Brabant,BE24,65 years or over,Total,2020,Asthma and status asthmaticus,3.58,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,167.53,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,168.64,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,164.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,156.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,157.72,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,146.19,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,141.39,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,135.91,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,133.66,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,136.94,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.4,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.41,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.86,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.18,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.19,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.64,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.12,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",15.54,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",19.3,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",17.24,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",15.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",16.99,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.52,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",12.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",12.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",11.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",9.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Malignant melanoma of skin,1.32,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Malignant melanoma of skin,0.75,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Malignant melanoma of skin,1.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Malignant melanoma of skin,1.34,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Malignant melanoma of skin,0.94,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Malignant melanoma of skin,1.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Malignant melanoma of skin,1.07,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Malignant melanoma of skin,1.05,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Malignant melanoma of skin,1.13,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Malignant melanoma of skin,0.91,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Malignant neoplasm of breast,9.01,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.06,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.13,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.29,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.41,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.68,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.17,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.96,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.28,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.44,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Diabetes mellitus,1.21,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Diabetes mellitus,1.55,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Diabetes mellitus,1.09,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Diabetes mellitus,1.53,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Diabetes mellitus,1.29,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Diabetes mellitus,0.98,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Diabetes mellitus,0.88,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Diabetes mellitus,0.84,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Diabetes mellitus,1.23,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Diabetes mellitus,1.31,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),3.28,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),5.05,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),3.54,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),2.97,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),2.71,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),2.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),2.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),2.53,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.81,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),2.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.53,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Other ischaemic heart diseases,2.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Other ischaemic heart diseases,1.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Other ischaemic heart diseases,3.16,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Other ischaemic heart diseases,3.65,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Other ischaemic heart diseases,1.97,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.25,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Other ischaemic heart diseases,2.41,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.19,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Other ischaemic heart diseases,1.65,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.41,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.69,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,5.98,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,9.04,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,7.06,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,4.83,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,5.7,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,5.16,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.59,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.57,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,4.89,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Cerebrovascular diseases,5.42,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Cerebrovascular diseases,4.95,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Cerebrovascular diseases,6.16,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Cerebrovascular diseases,4.02,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Cerebrovascular diseases,4.68,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Cerebrovascular diseases,4.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Cerebrovascular diseases,3.78,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Cerebrovascular diseases,3.58,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Cerebrovascular diseases,4.47,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Cerebrovascular diseases,3.28,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Chronic lower respiratory diseases,3.52,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Chronic lower respiratory diseases,4.27,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Chronic lower respiratory diseases,2.92,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Chronic lower respiratory diseases,2.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Chronic lower respiratory diseases,3.68,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.49,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.33,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.37,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Chronic lower respiratory diseases,3.09,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Chronic lower respiratory diseases,3.73,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.11,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.1,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.22,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.33,Rate
Prov. Vlaams-Brabant,BE24,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.11,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,878.76,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,914.44,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,894.88,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,803.94,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,910.9,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,838.96,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,852.84,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,839.79,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,794.54,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,914.04,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.88,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.7,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.56,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.41,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.77,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.42,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.42,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.96,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.19,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.82,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",36.21,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",39.0,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",34.32,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",35.82,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",38.63,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",28.82,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",35.73,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",24.31,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",31.47,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",38.08,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Malignant melanoma of skin,2.38,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Malignant melanoma of skin,1.3,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Malignant melanoma of skin,2.9,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Malignant melanoma of skin,6.76,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Malignant melanoma of skin,2.58,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Malignant melanoma of skin,0.58,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Malignant melanoma of skin,2.31,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Malignant melanoma of skin,4.6,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Malignant melanoma of skin,1.91,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Malignant neoplasm of breast,45.55,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Malignant neoplasm of breast,37.1,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Malignant neoplasm of breast,42.8,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Malignant neoplasm of breast,29.72,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Malignant neoplasm of breast,41.03,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Malignant neoplasm of breast,36.66,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Malignant neoplasm of breast,38.72,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Malignant neoplasm of breast,31.75,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Malignant neoplasm of breast,29.73,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Malignant neoplasm of breast,31.48,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Diabetes mellitus,20.59,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Diabetes mellitus,13.6,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Diabetes mellitus,13.99,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Diabetes mellitus,17.65,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Diabetes mellitus,11.83,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Diabetes mellitus,14.27,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Diabetes mellitus,17.3,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Diabetes mellitus,13.99,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Diabetes mellitus,9.59,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Diabetes mellitus,9.56,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Mental and behavioural disorders (F00-F99),24.1,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Mental and behavioural disorders (F00-F99),28.25,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Mental and behavioural disorders (F00-F99),32.66,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Mental and behavioural disorders (F00-F99),14.71,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Mental and behavioural disorders (F00-F99),25.89,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Mental and behavioural disorders (F00-F99),34.6,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Mental and behavioural disorders (F00-F99),20.86,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Mental and behavioural disorders (F00-F99),23.38,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Mental and behavioural disorders (F00-F99),25.44,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Mental and behavioural disorders (F00-F99),27.03,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),6.0,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),4.45,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),6.26,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),4.36,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),8.27,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.92,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.16,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.41,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),4.07,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Other ischaemic heart diseases,27.8,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Other ischaemic heart diseases,27.87,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Other ischaemic heart diseases,24.89,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Other ischaemic heart diseases,24.33,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Other ischaemic heart diseases,17.78,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Other ischaemic heart diseases,16.38,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Other ischaemic heart diseases,25.07,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Other ischaemic heart diseases,18.94,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Other ischaemic heart diseases,17.46,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Other ischaemic heart diseases,23.6,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,29.04,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,26.67,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,27.85,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,25.43,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,24.98,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,23.54,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,16.88,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,19.39,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,19.29,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,21.84,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Cerebrovascular diseases,59.41,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Cerebrovascular diseases,67.11,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Cerebrovascular diseases,47.38,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Cerebrovascular diseases,57.44,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Cerebrovascular diseases,40.14,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Cerebrovascular diseases,47.09,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Cerebrovascular diseases,51.03,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Cerebrovascular diseases,44.81,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Cerebrovascular diseases,41.41,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Cerebrovascular diseases,40.71,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2011,Chronic lower respiratory diseases,32.67,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Chronic lower respiratory diseases,38.42,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Chronic lower respiratory diseases,39.14,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Chronic lower respiratory diseases,28.61,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Chronic lower respiratory diseases,39.94,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Chronic lower respiratory diseases,31.85,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Chronic lower respiratory diseases,26.98,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Chronic lower respiratory diseases,46.99,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Chronic lower respiratory diseases,31.68,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2020,Chronic lower respiratory diseases,30.81,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2012,Asthma and status asthmaticus,1.7,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2013,Asthma and status asthmaticus,1.75,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2014,Asthma and status asthmaticus,0.56,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2015,Asthma and status asthmaticus,0.57,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2016,Asthma and status asthmaticus,0.71,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2017,Asthma and status asthmaticus,1.9,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2018,Asthma and status asthmaticus,0.48,Rate
Prov. Luxembourg (BE),BE34,Total,Females,2019,Asthma and status asthmaticus,1.19,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3844.8,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3896.41,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3791.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3524.88,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3885.02,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3540.24,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3747.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3685.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3458.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4042.65,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.7,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.31,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.94,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.46,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",107.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",110.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",98.95,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",99.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",118.48,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",66.7,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",124.94,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",77.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",93.34,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",117.33,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Malignant melanoma of skin,12.19,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Malignant melanoma of skin,6.68,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Malignant melanoma of skin,7.01,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Malignant melanoma of skin,27.18,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Malignant melanoma of skin,9.35,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Malignant melanoma of skin,2.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Malignant melanoma of skin,11.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Malignant melanoma of skin,23.59,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Malignant melanoma of skin,9.8,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Malignant neoplasm of breast,153.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Malignant neoplasm of breast,144.94,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Malignant neoplasm of breast,169.81,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Malignant neoplasm of breast,83.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Malignant neoplasm of breast,112.48,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Malignant neoplasm of breast,110.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Malignant neoplasm of breast,147.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Malignant neoplasm of breast,100.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Malignant neoplasm of breast,108.88,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Malignant neoplasm of breast,101.5,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Diabetes mellitus,101.72,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Diabetes mellitus,57.77,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Diabetes mellitus,67.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Diabetes mellitus,86.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Diabetes mellitus,49.58,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Diabetes mellitus,65.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Diabetes mellitus,81.43,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Diabetes mellitus,71.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Diabetes mellitus,45.68,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Diabetes mellitus,45.59,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),115.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),122.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),125.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),67.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),114.06,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),148.02,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),88.59,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),105.1,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),123.27,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),124.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),30.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),22.83,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),13.16,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),22.34,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),31.28,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),9.1,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),12.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),8.84,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),20.85,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Other ischaemic heart diseases,134.83,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Other ischaemic heart diseases,138.91,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Other ischaemic heart diseases,123.85,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Other ischaemic heart diseases,120.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Other ischaemic heart diseases,83.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Other ischaemic heart diseases,69.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Other ischaemic heart diseases,110.05,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Other ischaemic heart diseases,93.57,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Other ischaemic heart diseases,86.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Other ischaemic heart diseases,113.86,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,133.23,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,129.06,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,116.07,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,123.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,116.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,117.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,86.55,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,84.98,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,91.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,97.04,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Cerebrovascular diseases,277.64,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Cerebrovascular diseases,316.55,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Cerebrovascular diseases,224.1,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Cerebrovascular diseases,271.47,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Cerebrovascular diseases,205.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Cerebrovascular diseases,222.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Cerebrovascular diseases,235.9,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Cerebrovascular diseases,207.5,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Cerebrovascular diseases,201.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Cerebrovascular diseases,183.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2011,Chronic lower respiratory diseases,127.88,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Chronic lower respiratory diseases,166.3,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Chronic lower respiratory diseases,161.4,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Chronic lower respiratory diseases,127.64,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Chronic lower respiratory diseases,178.69,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Chronic lower respiratory diseases,126.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Chronic lower respiratory diseases,120.22,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Chronic lower respiratory diseases,212.29,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Chronic lower respiratory diseases,148.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2020,Chronic lower respiratory diseases,133.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2012,Asthma and status asthmaticus,5.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2013,Asthma and status asthmaticus,8.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2014,Asthma and status asthmaticus,2.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2015,Asthma and status asthmaticus,2.9,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2016,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2017,Asthma and status asthmaticus,6.06,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2018,Asthma and status asthmaticus,2.45,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Females,2019,Asthma and status asthmaticus,6.09,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,160.27,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,192.1,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,193.31,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,144.83,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,190.46,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,184.62,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,151.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,150.39,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,149.21,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,156.18,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.77,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.59,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.96,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.3,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.7,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.27,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.45,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.23,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.77,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",19.06,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",21.68,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.66,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",20.34,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",19.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",19.64,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",14.13,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",11.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",16.48,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",18.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Malignant melanoma of skin,1.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Malignant melanoma of skin,1.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Malignant melanoma of skin,0.94,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Malignant neoplasm of breast,19.34,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Malignant neoplasm of breast,10.98,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Malignant neoplasm of breast,12.03,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Malignant neoplasm of breast,16.78,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Malignant neoplasm of breast,23.72,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Malignant neoplasm of breast,18.86,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Malignant neoplasm of breast,12.37,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.98,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Malignant neoplasm of breast,10.56,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Malignant neoplasm of breast,14.53,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Diabetes mellitus,0.94,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Diabetes mellitus,2.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Diabetes mellitus,0.92,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Diabetes mellitus,0.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Diabetes mellitus,2.68,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Diabetes mellitus,1.79,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Diabetes mellitus,1.76,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Diabetes mellitus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Diabetes mellitus,0.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Diabetes mellitus,0.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),5.45,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),10.26,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.92,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),4.53,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),7.12,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),4.46,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),3.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.51,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),4.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.7,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.67,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.87,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.98,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.92,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.96,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.57,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Other ischaemic heart diseases,4.48,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.86,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.73,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,3.8,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,1.87,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,6.48,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,1.8,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,0.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.5,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,1.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.63,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Cerebrovascular diseases,6.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Cerebrovascular diseases,6.68,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Cerebrovascular diseases,4.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Cerebrovascular diseases,5.6,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Cerebrovascular diseases,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Cerebrovascular diseases,4.51,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Cerebrovascular diseases,6.25,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Cerebrovascular diseases,5.39,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Cerebrovascular diseases,2.63,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Cerebrovascular diseases,6.15,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2011,Chronic lower respiratory diseases,9.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Chronic lower respiratory diseases,7.44,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Chronic lower respiratory diseases,9.52,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Chronic lower respiratory diseases,4.63,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Chronic lower respiratory diseases,6.32,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Chronic lower respiratory diseases,9.03,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Chronic lower respiratory diseases,4.39,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Chronic lower respiratory diseases,6.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Chronic lower respiratory diseases,3.41,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2020,Chronic lower respiratory diseases,6.05,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1432.4,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1432.88,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1409.28,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1327.08,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1279.36,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1402.13,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1302.23,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1316.38,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1235.62,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1375.13,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.73,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.7,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.85,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.62,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.7,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.56,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.37,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.74,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.94,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.54,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",137.03,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",121.99,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",112.18,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",107.16,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",110.78,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",94.92,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",105.39,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",99.91,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",92.81,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",74.23,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Malignant melanoma of skin,3.15,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Malignant melanoma of skin,3.0,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Malignant melanoma of skin,6.05,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Malignant melanoma of skin,8.19,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Malignant melanoma of skin,2.91,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Malignant melanoma of skin,3.45,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Malignant melanoma of skin,0.69,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Malignant melanoma of skin,1.78,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Malignant melanoma of skin,3.77,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Malignant melanoma of skin,4.61,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Malignant neoplasm of breast,1.67,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Diabetes mellitus,30.64,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Diabetes mellitus,32.21,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Diabetes mellitus,20.67,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Diabetes mellitus,26.75,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Diabetes mellitus,10.01,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Diabetes mellitus,17.39,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Diabetes mellitus,29.01,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Diabetes mellitus,19.95,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Diabetes mellitus,20.2,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Diabetes mellitus,14.2,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Mental and behavioural disorders (F00-F99),37.84,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Mental and behavioural disorders (F00-F99),32.07,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Mental and behavioural disorders (F00-F99),39.52,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Mental and behavioural disorders (F00-F99),39.91,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Mental and behavioural disorders (F00-F99),42.34,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Mental and behavioural disorders (F00-F99),33.15,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Mental and behavioural disorders (F00-F99),38.35,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Mental and behavioural disorders (F00-F99),22.6,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Mental and behavioural disorders (F00-F99),38.65,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Mental and behavioural disorders (F00-F99),31.5,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),9.82,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),5.99,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.55,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.55,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),8.24,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),8.44,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),7.23,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),5.14,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.07,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.35,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Other ischaemic heart diseases,85.83,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Other ischaemic heart diseases,70.95,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Other ischaemic heart diseases,42.95,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Other ischaemic heart diseases,46.71,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Other ischaemic heart diseases,62.73,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Other ischaemic heart diseases,66.65,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Other ischaemic heart diseases,72.48,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Other ischaemic heart diseases,42.05,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Other ischaemic heart diseases,36.69,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Other ischaemic heart diseases,59.69,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,92.87,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,61.47,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,69.15,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,64.34,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,48.02,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,58.39,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,49.89,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,42.19,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,44.36,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,32.42,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Cerebrovascular diseases,62.93,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Cerebrovascular diseases,78.54,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Cerebrovascular diseases,76.67,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Cerebrovascular diseases,55.2,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Cerebrovascular diseases,55.45,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Cerebrovascular diseases,49.29,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Cerebrovascular diseases,61.04,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Cerebrovascular diseases,66.12,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Cerebrovascular diseases,63.67,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Cerebrovascular diseases,49.53,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2011,Chronic lower respiratory diseases,59.69,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Chronic lower respiratory diseases,89.41,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Chronic lower respiratory diseases,75.04,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Chronic lower respiratory diseases,51.48,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2015,Chronic lower respiratory diseases,51.49,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Chronic lower respiratory diseases,72.22,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Chronic lower respiratory diseases,73.12,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Chronic lower respiratory diseases,69.27,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Chronic lower respiratory diseases,60.2,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2020,Chronic lower respiratory diseases,68.96,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2012,Asthma and status asthmaticus,4.94,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2013,Asthma and status asthmaticus,3.51,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2014,Asthma and status asthmaticus,1.22,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2016,Asthma and status asthmaticus,2.46,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2017,Asthma and status asthmaticus,1.01,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2018,Asthma and status asthmaticus,0.89,Rate
Prov. Luxembourg (BE),BE34,Total,Males,2019,Asthma and status asthmaticus,0.75,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5891.75,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,6098.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5825.88,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5565.77,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5284.37,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5912.43,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5455.02,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5681.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5134.84,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5989.85,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.97,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",193.22,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",159.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",171.37,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.52,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.62,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",195.66,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.2,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.29,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.27,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",528.55,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",489.33,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",414.43,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",400.08,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",432.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",370.82,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",424.64,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",428.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",370.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",307.42,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Malignant melanoma of skin,16.17,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Malignant melanoma of skin,11.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Malignant melanoma of skin,15.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Malignant melanoma of skin,35.19,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Malignant melanoma of skin,14.9,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Malignant melanoma of skin,17.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Malignant melanoma of skin,9.11,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Malignant melanoma of skin,19.33,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Malignant melanoma of skin,20.12,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Malignant neoplasm of breast,8.58,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Diabetes mellitus,137.37,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Diabetes mellitus,145.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Diabetes mellitus,94.63,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Diabetes mellitus,103.04,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Diabetes mellitus,36.56,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Diabetes mellitus,73.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Diabetes mellitus,137.98,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Diabetes mellitus,79.86,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Diabetes mellitus,96.38,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Diabetes mellitus,58.84,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),137.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),130.74,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),165.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),163.56,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),179.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),109.58,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),153.33,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),104.94,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),148.88,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),118.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),42.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),26.74,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),10.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),5.2,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),34.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),22.07,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),33.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),22.64,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),17.53,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),14.95,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Other ischaemic heart diseases,420.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Other ischaemic heart diseases,352.43,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Other ischaemic heart diseases,196.86,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Other ischaemic heart diseases,220.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Other ischaemic heart diseases,303.4,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Other ischaemic heart diseases,312.26,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Other ischaemic heart diseases,357.08,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Other ischaemic heart diseases,197.94,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Other ischaemic heart diseases,163.16,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Other ischaemic heart diseases,281.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,386.28,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,257.8,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,278.17,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,285.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,167.15,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,222.3,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,219.65,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,184.07,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,159.72,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,120.64,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Cerebrovascular diseases,269.28,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Cerebrovascular diseases,375.7,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Cerebrovascular diseases,369.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Cerebrovascular diseases,268.4,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Cerebrovascular diseases,239.4,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Cerebrovascular diseases,234.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Cerebrovascular diseases,266.05,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Cerebrovascular diseases,310.52,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Cerebrovascular diseases,304.8,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Cerebrovascular diseases,236.31,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2011,Chronic lower respiratory diseases,249.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Chronic lower respiratory diseases,423.21,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Chronic lower respiratory diseases,342.68,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Chronic lower respiratory diseases,241.24,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2015,Chronic lower respiratory diseases,237.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Chronic lower respiratory diseases,359.39,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Chronic lower respiratory diseases,349.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Chronic lower respiratory diseases,322.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Chronic lower respiratory diseases,268.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2020,Chronic lower respiratory diseases,315.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2012,Asthma and status asthmaticus,21.4,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2013,Asthma and status asthmaticus,14.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2014,Asthma and status asthmaticus,6.26,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2016,Asthma and status asthmaticus,12.63,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2017,Asthma and status asthmaticus,5.16,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2018,Asthma and status asthmaticus,4.57,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Males,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,352.19,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,302.73,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,339.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,300.32,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,309.2,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,309.57,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,296.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,259.09,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,291.09,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,257.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.33,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.73,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.1,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.59,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.24,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.17,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.99,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",42.19,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",33.01,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",38.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",36.2,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",32.82,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",28.09,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",28.06,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",20.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",25.67,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",17.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Malignant melanoma of skin,0.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Malignant melanoma of skin,3.79,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Malignant melanoma of skin,1.65,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Malignant melanoma of skin,0.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Malignant melanoma of skin,0.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Diabetes mellitus,4.78,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Diabetes mellitus,4.7,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Diabetes mellitus,2.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Diabetes mellitus,8.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Diabetes mellitus,3.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Diabetes mellitus,3.73,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Diabetes mellitus,2.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Diabetes mellitus,5.44,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Diabetes mellitus,1.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Diabetes mellitus,3.39,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),13.7,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),8.17,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),9.12,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),9.96,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),9.01,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),14.63,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),10.5,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),2.65,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),11.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),10.33,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.91,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.76,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),5.14,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.79,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Other ischaemic heart diseases,4.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Other ischaemic heart diseases,2.76,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Other ischaemic heart diseases,5.67,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Other ischaemic heart diseases,4.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Other ischaemic heart diseases,4.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Other ischaemic heart diseases,7.16,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Other ischaemic heart diseases,3.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Other ischaemic heart diseases,4.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Other ischaemic heart diseases,6.06,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Other ischaemic heart diseases,5.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,21.79,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,13.91,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,18.52,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,10.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,19.17,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,18.69,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,8.77,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,7.82,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,16.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,11.05,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Cerebrovascular diseases,12.94,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Cerebrovascular diseases,6.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Cerebrovascular diseases,5.62,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Cerebrovascular diseases,3.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Cerebrovascular diseases,10.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Cerebrovascular diseases,4.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Cerebrovascular diseases,11.38,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Cerebrovascular diseases,6.92,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Cerebrovascular diseases,5.26,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Cerebrovascular diseases,4.29,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2011,Chronic lower respiratory diseases,13.6,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Chronic lower respiratory diseases,8.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Chronic lower respiratory diseases,10.2,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Chronic lower respiratory diseases,5.51,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2015,Chronic lower respiratory diseases,6.54,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.65,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.08,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Chronic lower respiratory diseases,7.86,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Chronic lower respiratory diseases,9.69,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2020,Chronic lower respiratory diseases,9.3,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.82,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.93,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1115.72,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1123.86,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1111.75,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1020.9,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1065.21,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1069.19,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1045.85,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1041.27,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,988.99,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1114.21,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.79,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.72,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.62,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.03,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.54,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.37,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.93,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.03,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.77,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.69,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",80.07,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",73.98,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",67.39,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",66.99,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",68.97,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",57.01,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",66.63,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",56.66,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",57.61,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",54.15,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Malignant melanoma of skin,2.72,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Malignant melanoma of skin,2.17,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Malignant melanoma of skin,4.31,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Malignant melanoma of skin,6.8,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Malignant melanoma of skin,2.56,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Malignant melanoma of skin,1.75,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Malignant melanoma of skin,1.62,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Malignant melanoma of skin,3.24,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Malignant melanoma of skin,1.54,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Malignant melanoma of skin,3.28,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Malignant neoplasm of breast,25.57,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Malignant neoplasm of breast,21.72,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Malignant neoplasm of breast,24.68,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Malignant neoplasm of breast,16.61,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Malignant neoplasm of breast,22.15,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Malignant neoplasm of breast,20.87,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Malignant neoplasm of breast,21.63,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Malignant neoplasm of breast,17.4,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Malignant neoplasm of breast,17.13,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Malignant neoplasm of breast,18.21,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Diabetes mellitus,25.95,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Diabetes mellitus,20.93,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Diabetes mellitus,15.36,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Diabetes mellitus,21.19,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Diabetes mellitus,11.14,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Diabetes mellitus,15.84,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Diabetes mellitus,21.72,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Diabetes mellitus,17.59,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Diabetes mellitus,13.7,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Diabetes mellitus,11.92,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Mental and behavioural disorders (F00-F99),30.12,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Mental and behavioural disorders (F00-F99),29.45,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Mental and behavioural disorders (F00-F99),33.3,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Mental and behavioural disorders (F00-F99),23.38,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Mental and behavioural disorders (F00-F99),32.25,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Mental and behavioural disorders (F00-F99),36.78,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Mental and behavioural disorders (F00-F99),28.97,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Mental and behavioural disorders (F00-F99),24.48,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Mental and behavioural disorders (F00-F99),32.11,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Mental and behavioural disorders (F00-F99),29.55,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),6.77,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),5.47,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),5.09,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),5.79,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),9.06,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),4.98,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.79,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.1,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),4.58,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Other ischaemic heart diseases,47.94,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Other ischaemic heart diseases,43.92,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Other ischaemic heart diseases,33.62,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Other ischaemic heart diseases,33.75,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Other ischaemic heart diseases,35.64,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Other ischaemic heart diseases,35.79,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Other ischaemic heart diseases,44.02,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Other ischaemic heart diseases,28.06,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Other ischaemic heart diseases,25.69,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Other ischaemic heart diseases,37.15,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,52.37,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,41.37,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,44.91,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.27,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,36.69,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,38.5,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,29.78,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,28.4,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,30.77,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,26.57,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Cerebrovascular diseases,62.97,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Cerebrovascular diseases,70.61,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Cerebrovascular diseases,58.36,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Cerebrovascular diseases,58.06,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Cerebrovascular diseases,47.89,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Cerebrovascular diseases,47.68,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Cerebrovascular diseases,55.86,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Cerebrovascular diseases,53.6,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Cerebrovascular diseases,50.77,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Cerebrovascular diseases,44.88,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2011,Chronic lower respiratory diseases,42.79,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Chronic lower respiratory diseases,55.33,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Chronic lower respiratory diseases,51.36,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Chronic lower respiratory diseases,36.96,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Chronic lower respiratory diseases,43.02,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Chronic lower respiratory diseases,47.0,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Chronic lower respiratory diseases,44.02,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Chronic lower respiratory diseases,54.25,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Chronic lower respiratory diseases,43.54,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2020,Chronic lower respiratory diseases,45.36,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2012,Asthma and status asthmaticus,3.04,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2013,Asthma and status asthmaticus,2.87,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2014,Asthma and status asthmaticus,0.91,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2015,Asthma and status asthmaticus,0.34,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2016,Asthma and status asthmaticus,1.11,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2017,Asthma and status asthmaticus,1.55,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2018,Asthma and status asthmaticus,0.62,Rate
Prov. Luxembourg (BE),BE34,Total,Total,2019,Asthma and status asthmaticus,1.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4659.31,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4739.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4599.14,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4313.08,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4429.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4460.26,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4435.95,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4493.75,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4160.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4858.8,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.71,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",135.26,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",124.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.82,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.77,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.72,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.65,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.95,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.66,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.67,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",283.98,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",266.51,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",226.54,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",226.83,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",246.16,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",193.97,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",254.42,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",225.2,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",208.58,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",202.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Malignant melanoma of skin,13.97,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Malignant melanoma of skin,9.2,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Malignant melanoma of skin,10.33,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Malignant melanoma of skin,27.74,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Malignant melanoma of skin,11.2,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Malignant melanoma of skin,8.97,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Malignant melanoma of skin,6.52,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Malignant melanoma of skin,16.63,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Malignant melanoma of skin,7.92,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Malignant melanoma of skin,15.07,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Malignant neoplasm of breast,91.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Malignant neoplasm of breast,89.02,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Malignant neoplasm of breast,101.93,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Malignant neoplasm of breast,50.69,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Malignant neoplasm of breast,64.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Malignant neoplasm of breast,68.23,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Malignant neoplasm of breast,85.52,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Malignant neoplasm of breast,58.15,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Malignant neoplasm of breast,66.27,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Malignant neoplasm of breast,63.48,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Diabetes mellitus,121.24,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Diabetes mellitus,91.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Diabetes mellitus,71.21,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Diabetes mellitus,89.65,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Diabetes mellitus,44.21,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Diabetes mellitus,69.93,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Diabetes mellitus,102.34,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Diabetes mellitus,79.11,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Diabetes mellitus,64.85,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Diabetes mellitus,52.36,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),122.06,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),122.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),130.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),95.23,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),137.41,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),143.35,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),117.47,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),112.66,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),136.26,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),122.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),30.81,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),26.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),13.03,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.69,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),26.0,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),30.05,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),18.32,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),15.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),12.41,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),19.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Other ischaemic heart diseases,232.16,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Other ischaemic heart diseases,217.48,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Other ischaemic heart diseases,158.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Other ischaemic heart diseases,161.63,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Other ischaemic heart diseases,169.87,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Other ischaemic heart diseases,161.38,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Other ischaemic heart diseases,209.15,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Other ischaemic heart diseases,133.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Other ischaemic heart diseases,117.48,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Other ischaemic heart diseases,174.79,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,215.41,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,179.38,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,178.56,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,185.3,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,142.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,156.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,134.54,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,122.28,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,120.41,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,105.86,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Cerebrovascular diseases,282.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Cerebrovascular diseases,334.78,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Cerebrovascular diseases,278.22,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Cerebrovascular diseases,278.84,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Cerebrovascular diseases,223.11,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Cerebrovascular diseases,226.09,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Cerebrovascular diseases,249.96,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Cerebrovascular diseases,249.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Cerebrovascular diseases,244.15,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Cerebrovascular diseases,208.74,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2011,Chronic lower respiratory diseases,171.49,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Chronic lower respiratory diseases,250.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Chronic lower respiratory diseases,222.67,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Chronic lower respiratory diseases,168.6,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Chronic lower respiratory diseases,194.08,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Chronic lower respiratory diseases,216.89,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Chronic lower respiratory diseases,204.06,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Chronic lower respiratory diseases,247.76,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Chronic lower respiratory diseases,196.25,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2020,Chronic lower respiratory diseases,201.02,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2012,Asthma and status asthmaticus,11.84,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2013,Asthma and status asthmaticus,12.99,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2014,Asthma and status asthmaticus,4.68,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2015,Asthma and status asthmaticus,1.75,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2016,Asthma and status asthmaticus,3.92,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2017,Asthma and status asthmaticus,6.1,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2018,Asthma and status asthmaticus,3.19,Rate
Prov. Luxembourg (BE),BE34,65 years or over,Total,2019,Asthma and status asthmaticus,3.65,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,257.33,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,247.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,266.98,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,223.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,250.15,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,247.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,224.64,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,204.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,220.83,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,207.13,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.07,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.64,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.21,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.16,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.67,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.25,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.46,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.86,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",30.68,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",27.34,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",28.83,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",28.27,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",26.04,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",23.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",21.14,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",15.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",21.04,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",18.27,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Malignant melanoma of skin,0.47,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Malignant melanoma of skin,2.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Malignant melanoma of skin,1.73,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Malignant melanoma of skin,0.47,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Malignant melanoma of skin,0.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Malignant melanoma of skin,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Malignant melanoma of skin,0.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Malignant neoplasm of breast,9.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Malignant neoplasm of breast,5.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Malignant neoplasm of breast,8.36,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Malignant neoplasm of breast,11.8,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Malignant neoplasm of breast,9.39,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.15,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.53,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.23,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.25,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Diabetes mellitus,2.87,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Diabetes mellitus,3.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Diabetes mellitus,1.83,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Diabetes mellitus,4.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Diabetes mellitus,3.13,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Diabetes mellitus,2.74,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Diabetes mellitus,2.19,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Diabetes mellitus,2.69,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Diabetes mellitus,1.3,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Diabetes mellitus,2.12,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),7.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),6.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),9.66,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),5.98,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),6.78,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),10.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),7.53,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),3.12,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),6.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),6.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.17,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.97,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.75,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Other ischaemic heart diseases,3.31,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Other ischaemic heart diseases,1.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Other ischaemic heart diseases,3.28,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.78,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Other ischaemic heart diseases,3.13,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Other ischaemic heart diseases,5.36,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Other ischaemic heart diseases,4.02,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Other ischaemic heart diseases,3.46,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Other ischaemic heart diseases,3.81,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,12.88,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,7.94,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,12.54,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,6.38,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,10.95,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.8,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,4.4,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.66,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,9.06,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,7.36,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Cerebrovascular diseases,9.77,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Cerebrovascular diseases,6.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Cerebrovascular diseases,5.1,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Cerebrovascular diseases,4.58,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Cerebrovascular diseases,5.45,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Cerebrovascular diseases,4.46,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Cerebrovascular diseases,8.84,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Cerebrovascular diseases,6.15,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Cerebrovascular diseases,3.93,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Cerebrovascular diseases,5.18,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2011,Chronic lower respiratory diseases,11.61,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Chronic lower respiratory diseases,7.99,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Chronic lower respiratory diseases,9.86,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.07,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Chronic lower respiratory diseases,6.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.85,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Chronic lower respiratory diseases,5.25,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Chronic lower respiratory diseases,7.38,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.55,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2020,Chronic lower respiratory diseases,7.66,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.9,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.42,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.43,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.45,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Luxembourg (BE),BE34,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.47,Rate
Prov. Namur,BE35,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,923.65,Rate
Prov. Namur,BE35,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,916.95,Rate
Prov. Namur,BE35,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,964.52,Rate
Prov. Namur,BE35,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,913.21,Rate
Prov. Namur,BE35,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,924.1,Rate
Prov. Namur,BE35,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,894.74,Rate
Prov. Namur,BE35,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,896.6,Rate
Prov. Namur,BE35,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,855.69,Rate
Prov. Namur,BE35,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,857.72,Rate
Prov. Namur,BE35,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,983.65,Rate
Prov. Namur,BE35,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.34,Rate
Prov. Namur,BE35,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.25,Rate
Prov. Namur,BE35,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.38,Rate
Prov. Namur,BE35,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.07,Rate
Prov. Namur,BE35,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.53,Rate
Prov. Namur,BE35,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.31,Rate
Prov. Namur,BE35,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.75,Rate
Prov. Namur,BE35,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.83,Rate
Prov. Namur,BE35,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.49,Rate
Prov. Namur,BE35,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.54,Rate
Prov. Namur,BE35,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",38.53,Rate
Prov. Namur,BE35,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",32.57,Rate
Prov. Namur,BE35,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",40.85,Rate
Prov. Namur,BE35,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",38.57,Rate
Prov. Namur,BE35,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",30.59,Rate
Prov. Namur,BE35,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",44.67,Rate
Prov. Namur,BE35,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",42.39,Rate
Prov. Namur,BE35,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",39.26,Rate
Prov. Namur,BE35,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",38.53,Rate
Prov. Namur,BE35,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",38.85,Rate
Prov. Namur,BE35,Total,Females,2011,Malignant melanoma of skin,1.93,Rate
Prov. Namur,BE35,Total,Females,2012,Malignant melanoma of skin,2.5,Rate
Prov. Namur,BE35,Total,Females,2013,Malignant melanoma of skin,3.8,Rate
Prov. Namur,BE35,Total,Females,2014,Malignant melanoma of skin,2.49,Rate
Prov. Namur,BE35,Total,Females,2015,Malignant melanoma of skin,4.65,Rate
Prov. Namur,BE35,Total,Females,2016,Malignant melanoma of skin,1.02,Rate
Prov. Namur,BE35,Total,Females,2017,Malignant melanoma of skin,1.44,Rate
Prov. Namur,BE35,Total,Females,2018,Malignant melanoma of skin,2.09,Rate
Prov. Namur,BE35,Total,Females,2019,Malignant melanoma of skin,1.73,Rate
Prov. Namur,BE35,Total,Females,2020,Malignant melanoma of skin,1.63,Rate
Prov. Namur,BE35,Total,Females,2011,Malignant neoplasm of breast,40.86,Rate
Prov. Namur,BE35,Total,Females,2012,Malignant neoplasm of breast,37.1,Rate
Prov. Namur,BE35,Total,Females,2013,Malignant neoplasm of breast,38.18,Rate
Prov. Namur,BE35,Total,Females,2014,Malignant neoplasm of breast,34.48,Rate
Prov. Namur,BE35,Total,Females,2015,Malignant neoplasm of breast,35.3,Rate
Prov. Namur,BE35,Total,Females,2016,Malignant neoplasm of breast,36.12,Rate
Prov. Namur,BE35,Total,Females,2017,Malignant neoplasm of breast,33.8,Rate
Prov. Namur,BE35,Total,Females,2018,Malignant neoplasm of breast,34.82,Rate
Prov. Namur,BE35,Total,Females,2019,Malignant neoplasm of breast,33.75,Rate
Prov. Namur,BE35,Total,Females,2020,Malignant neoplasm of breast,27.73,Rate
Prov. Namur,BE35,Total,Females,2011,Diabetes mellitus,15.36,Rate
Prov. Namur,BE35,Total,Females,2012,Diabetes mellitus,18.59,Rate
Prov. Namur,BE35,Total,Females,2013,Diabetes mellitus,14.93,Rate
Prov. Namur,BE35,Total,Females,2014,Diabetes mellitus,15.66,Rate
Prov. Namur,BE35,Total,Females,2015,Diabetes mellitus,10.01,Rate
Prov. Namur,BE35,Total,Females,2016,Diabetes mellitus,12.34,Rate
Prov. Namur,BE35,Total,Females,2017,Diabetes mellitus,15.55,Rate
Prov. Namur,BE35,Total,Females,2018,Diabetes mellitus,12.07,Rate
Prov. Namur,BE35,Total,Females,2019,Diabetes mellitus,8.97,Rate
Prov. Namur,BE35,Total,Females,2020,Diabetes mellitus,8.21,Rate
Prov. Namur,BE35,Total,Females,2011,Mental and behavioural disorders (F00-F99),27.42,Rate
Prov. Namur,BE35,Total,Females,2012,Mental and behavioural disorders (F00-F99),34.88,Rate
Prov. Namur,BE35,Total,Females,2013,Mental and behavioural disorders (F00-F99),35.88,Rate
Prov. Namur,BE35,Total,Females,2014,Mental and behavioural disorders (F00-F99),31.3,Rate
Prov. Namur,BE35,Total,Females,2015,Mental and behavioural disorders (F00-F99),32.37,Rate
Prov. Namur,BE35,Total,Females,2016,Mental and behavioural disorders (F00-F99),32.84,Rate
Prov. Namur,BE35,Total,Females,2017,Mental and behavioural disorders (F00-F99),35.78,Rate
Prov. Namur,BE35,Total,Females,2018,Mental and behavioural disorders (F00-F99),22.62,Rate
Prov. Namur,BE35,Total,Females,2019,Mental and behavioural disorders (F00-F99),29.94,Rate
Prov. Namur,BE35,Total,Females,2020,Mental and behavioural disorders (F00-F99),30.66,Rate
Prov. Namur,BE35,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),4.18,Rate
Prov. Namur,BE35,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),7.74,Rate
Prov. Namur,BE35,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),4.09,Rate
Prov. Namur,BE35,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Prov. Namur,BE35,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.65,Rate
Prov. Namur,BE35,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),4.54,Rate
Prov. Namur,BE35,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),5.88,Rate
Prov. Namur,BE35,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.19,Rate
Prov. Namur,BE35,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.68,Rate
Prov. Namur,BE35,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),4.61,Rate
Prov. Namur,BE35,Total,Females,2011,Other ischaemic heart diseases,31.05,Rate
Prov. Namur,BE35,Total,Females,2012,Other ischaemic heart diseases,22.76,Rate
Prov. Namur,BE35,Total,Females,2013,Other ischaemic heart diseases,29.07,Rate
Prov. Namur,BE35,Total,Females,2014,Other ischaemic heart diseases,21.83,Rate
Prov. Namur,BE35,Total,Females,2015,Other ischaemic heart diseases,31.35,Rate
Prov. Namur,BE35,Total,Females,2016,Other ischaemic heart diseases,22.81,Rate
Prov. Namur,BE35,Total,Females,2017,Other ischaemic heart diseases,22.72,Rate
Prov. Namur,BE35,Total,Females,2018,Other ischaemic heart diseases,15.74,Rate
Prov. Namur,BE35,Total,Females,2019,Other ischaemic heart diseases,25.64,Rate
Prov. Namur,BE35,Total,Females,2020,Other ischaemic heart diseases,20.94,Rate
Prov. Namur,BE35,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,30.88,Rate
Prov. Namur,BE35,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,38.33,Rate
Prov. Namur,BE35,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,28.64,Rate
Prov. Namur,BE35,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,29.39,Rate
Prov. Namur,BE35,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,35.6,Rate
Prov. Namur,BE35,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,28.39,Rate
Prov. Namur,BE35,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,24.97,Rate
Prov. Namur,BE35,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,31.29,Rate
Prov. Namur,BE35,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.87,Rate
Prov. Namur,BE35,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,17.85,Rate
Prov. Namur,BE35,Total,Females,2011,Cerebrovascular diseases,64.92,Rate
Prov. Namur,BE35,Total,Females,2012,Cerebrovascular diseases,62.72,Rate
Prov. Namur,BE35,Total,Females,2013,Cerebrovascular diseases,51.99,Rate
Prov. Namur,BE35,Total,Females,2014,Cerebrovascular diseases,61.08,Rate
Prov. Namur,BE35,Total,Females,2015,Cerebrovascular diseases,52.4,Rate
Prov. Namur,BE35,Total,Females,2016,Cerebrovascular diseases,56.09,Rate
Prov. Namur,BE35,Total,Females,2017,Cerebrovascular diseases,51.56,Rate
Prov. Namur,BE35,Total,Females,2018,Cerebrovascular diseases,55.64,Rate
Prov. Namur,BE35,Total,Females,2019,Cerebrovascular diseases,43.12,Rate
Prov. Namur,BE35,Total,Females,2020,Cerebrovascular diseases,42.23,Rate
Prov. Namur,BE35,Total,Females,2011,Chronic lower respiratory diseases,31.01,Rate
Prov. Namur,BE35,Total,Females,2012,Chronic lower respiratory diseases,38.21,Rate
Prov. Namur,BE35,Total,Females,2013,Chronic lower respiratory diseases,38.89,Rate
Prov. Namur,BE35,Total,Females,2014,Chronic lower respiratory diseases,34.83,Rate
Prov. Namur,BE35,Total,Females,2015,Chronic lower respiratory diseases,35.42,Rate
Prov. Namur,BE35,Total,Females,2016,Chronic lower respiratory diseases,37.56,Rate
Prov. Namur,BE35,Total,Females,2017,Chronic lower respiratory diseases,36.28,Rate
Prov. Namur,BE35,Total,Females,2018,Chronic lower respiratory diseases,37.03,Rate
Prov. Namur,BE35,Total,Females,2019,Chronic lower respiratory diseases,36.62,Rate
Prov. Namur,BE35,Total,Females,2020,Chronic lower respiratory diseases,36.77,Rate
Prov. Namur,BE35,Total,Females,2011,Asthma and status asthmaticus,2.19,Rate
Prov. Namur,BE35,Total,Females,2012,Asthma and status asthmaticus,3.01,Rate
Prov. Namur,BE35,Total,Females,2013,Asthma and status asthmaticus,2.32,Rate
Prov. Namur,BE35,Total,Females,2014,Asthma and status asthmaticus,1.42,Rate
Prov. Namur,BE35,Total,Females,2015,Asthma and status asthmaticus,2.84,Rate
Prov. Namur,BE35,Total,Females,2016,Asthma and status asthmaticus,1.02,Rate
Prov. Namur,BE35,Total,Females,2017,Asthma and status asthmaticus,1.66,Rate
Prov. Namur,BE35,Total,Females,2018,Asthma and status asthmaticus,1.42,Rate
Prov. Namur,BE35,Total,Females,2019,Asthma and status asthmaticus,0.7,Rate
Prov. Namur,BE35,Total,Females,2020,Asthma and status asthmaticus,1.7,Rate
Prov. Namur,BE35,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3981.51,Rate
Prov. Namur,BE35,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3915.13,Rate
Prov. Namur,BE35,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4188.55,Rate
Prov. Namur,BE35,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3950.71,Rate
Prov. Namur,BE35,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3990.0,Rate
Prov. Namur,BE35,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3837.98,Rate
Prov. Namur,BE35,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3870.29,Rate
Prov. Namur,BE35,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3727.28,Rate
Prov. Namur,BE35,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3727.97,Rate
Prov. Namur,BE35,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4409.14,Rate
Prov. Namur,BE35,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.81,Rate
Prov. Namur,BE35,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.92,Rate
Prov. Namur,BE35,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.49,Rate
Prov. Namur,BE35,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.48,Rate
Prov. Namur,BE35,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.19,Rate
Prov. Namur,BE35,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.43,Rate
Prov. Namur,BE35,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.77,Rate
Prov. Namur,BE35,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.52,Rate
Prov. Namur,BE35,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.71,Rate
Prov. Namur,BE35,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.62,Rate
Prov. Namur,BE35,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",121.43,Rate
Prov. Namur,BE35,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",97.32,Rate
Prov. Namur,BE35,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",131.75,Rate
Prov. Namur,BE35,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",124.55,Rate
Prov. Namur,BE35,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",84.42,Rate
Prov. Namur,BE35,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",144.37,Rate
Prov. Namur,BE35,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",131.61,Rate
Prov. Namur,BE35,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",132.38,Rate
Prov. Namur,BE35,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",143.0,Rate
Prov. Namur,BE35,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",140.69,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Malignant melanoma of skin,1.58,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Malignant melanoma of skin,6.63,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Malignant melanoma of skin,10.9,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Malignant melanoma of skin,6.37,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Malignant melanoma of skin,15.37,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Malignant melanoma of skin,5.22,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Malignant melanoma of skin,1.37,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Malignant melanoma of skin,6.85,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Malignant melanoma of skin,6.72,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Malignant melanoma of skin,6.32,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Malignant neoplasm of breast,137.18,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Malignant neoplasm of breast,138.1,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Malignant neoplasm of breast,138.59,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Malignant neoplasm of breast,117.23,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Malignant neoplasm of breast,122.54,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Malignant neoplasm of breast,130.06,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Malignant neoplasm of breast,117.62,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Malignant neoplasm of breast,136.59,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Malignant neoplasm of breast,108.57,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Malignant neoplasm of breast,98.41,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Diabetes mellitus,68.47,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Diabetes mellitus,87.2,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Diabetes mellitus,68.53,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Diabetes mellitus,78.26,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Diabetes mellitus,45.39,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Diabetes mellitus,55.48,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Diabetes mellitus,73.5,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Diabetes mellitus,60.0,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Diabetes mellitus,39.89,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Diabetes mellitus,37.76,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),132.31,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),137.31,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),161.24,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),149.94,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),149.76,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),148.02,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),159.39,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),110.1,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),143.62,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),149.33,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),15.13,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),23.35,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),8.53,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),6.99,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),14.75,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),19.33,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),22.08,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),14.44,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),9.96,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),21.75,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Other ischaemic heart diseases,151.02,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Other ischaemic heart diseases,104.51,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Other ischaemic heart diseases,132.81,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Other ischaemic heart diseases,99.83,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Other ischaemic heart diseases,148.58,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Other ischaemic heart diseases,109.05,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Other ischaemic heart diseases,108.66,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Other ischaemic heart diseases,74.94,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Other ischaemic heart diseases,119.0,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Other ischaemic heart diseases,103.17,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,135.57,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,171.99,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,134.8,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,132.57,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,164.48,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,121.89,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,105.89,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,141.86,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,115.0,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,76.28,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Cerebrovascular diseases,304.2,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Cerebrovascular diseases,296.72,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Cerebrovascular diseases,258.25,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Cerebrovascular diseases,290.54,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Cerebrovascular diseases,237.98,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Cerebrovascular diseases,265.55,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Cerebrovascular diseases,236.54,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Cerebrovascular diseases,251.11,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Cerebrovascular diseases,206.99,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Cerebrovascular diseases,205.28,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Chronic lower respiratory diseases,131.98,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Chronic lower respiratory diseases,171.22,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Chronic lower respiratory diseases,166.86,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Chronic lower respiratory diseases,160.55,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Chronic lower respiratory diseases,149.6,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Chronic lower respiratory diseases,156.96,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Chronic lower respiratory diseases,170.51,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Chronic lower respiratory diseases,156.97,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Chronic lower respiratory diseases,151.35,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Chronic lower respiratory diseases,165.61,Rate
Prov. Namur,BE35,65 years or over,Females,2011,Asthma and status asthmaticus,9.07,Rate
Prov. Namur,BE35,65 years or over,Females,2012,Asthma and status asthmaticus,9.11,Rate
Prov. Namur,BE35,65 years or over,Females,2013,Asthma and status asthmaticus,3.67,Rate
Prov. Namur,BE35,65 years or over,Females,2014,Asthma and status asthmaticus,7.29,Rate
Prov. Namur,BE35,65 years or over,Females,2015,Asthma and status asthmaticus,12.54,Rate
Prov. Namur,BE35,65 years or over,Females,2016,Asthma and status asthmaticus,3.21,Rate
Prov. Namur,BE35,65 years or over,Females,2017,Asthma and status asthmaticus,8.49,Rate
Prov. Namur,BE35,65 years or over,Females,2018,Asthma and status asthmaticus,7.29,Rate
Prov. Namur,BE35,65 years or over,Females,2019,Asthma and status asthmaticus,3.58,Rate
Prov. Namur,BE35,65 years or over,Females,2020,Asthma and status asthmaticus,6.84,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,182.92,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,190.69,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,183.54,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,177.42,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,181.43,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,181.79,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,176.27,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,160.09,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,162.44,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,153.88,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.48,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.55,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.46,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.47,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.35,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.42,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.4,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.31,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.58,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",18.45,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.88,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.83,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",17.74,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",17.55,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",20.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",20.77,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",16.7,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",13.23,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",14.18,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Malignant melanoma of skin,2.02,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Malignant melanoma of skin,1.5,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Malignant melanoma of skin,2.08,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Malignant melanoma of skin,1.55,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Malignant melanoma of skin,2.05,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Malignant melanoma of skin,1.46,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Malignant melanoma of skin,0.93,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Malignant melanoma of skin,0.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Malignant melanoma of skin,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Malignant neoplasm of breast,17.53,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Malignant neoplasm of breast,12.63,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.86,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.43,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Malignant neoplasm of breast,14.16,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Malignant neoplasm of breast,13.36,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.5,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Malignant neoplasm of breast,10.16,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Malignant neoplasm of breast,15.63,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.61,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Diabetes mellitus,2.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Diabetes mellitus,1.97,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Diabetes mellitus,1.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Diabetes mellitus,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Diabetes mellitus,1.45,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Diabetes mellitus,1.89,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Diabetes mellitus,1.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Diabetes mellitus,0.46,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Diabetes mellitus,1.48,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Diabetes mellitus,1.05,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.02,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),10.07,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),5.51,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.57,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),3.94,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),4.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),5.84,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.43,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.41,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.91,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),3.96,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),3.02,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.99,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.96,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Other ischaemic heart diseases,3.93,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.93,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.92,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.9,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.39,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Other ischaemic heart diseases,3.02,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.02,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.95,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,2.93,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.4,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.39,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,5.74,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,5.37,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,4.5,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.28,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.7,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Cerebrovascular diseases,6.96,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Cerebrovascular diseases,6.03,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Cerebrovascular diseases,2.03,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Cerebrovascular diseases,5.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Cerebrovascular diseases,7.45,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Cerebrovascular diseases,5.35,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Cerebrovascular diseases,6.75,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Cerebrovascular diseases,8.29,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Cerebrovascular diseases,3.43,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Cerebrovascular diseases,2.73,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Chronic lower respiratory diseases,6.55,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.99,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Chronic lower respiratory diseases,7.89,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Chronic lower respiratory diseases,4.38,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Chronic lower respiratory diseases,7.77,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Chronic lower respiratory diseases,8.63,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Chronic lower respiratory diseases,3.76,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Chronic lower respiratory diseases,7.97,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Chronic lower respiratory diseases,8.83,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Chronic lower respiratory diseases,5.56,Rate
Prov. Namur,BE35,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.52,Rate
Prov. Namur,BE35,Less than 65 years,Females,2012,Asthma and status asthmaticus,1.53,Rate
Prov. Namur,BE35,Less than 65 years,Females,2013,Asthma and status asthmaticus,1.99,Rate
Prov. Namur,BE35,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.45,Rate
Prov. Namur,BE35,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1400.99,Rate
Prov. Namur,BE35,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1497.38,Rate
Prov. Namur,BE35,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1471.37,Rate
Prov. Namur,BE35,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1348.95,Rate
Prov. Namur,BE35,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1445.23,Rate
Prov. Namur,BE35,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1335.95,Rate
Prov. Namur,BE35,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1345.59,Rate
Prov. Namur,BE35,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1367.39,Rate
Prov. Namur,BE35,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1300.0,Rate
Prov. Namur,BE35,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1541.9,Rate
Prov. Namur,BE35,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.52,Rate
Prov. Namur,BE35,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.62,Rate
Prov. Namur,BE35,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.26,Rate
Prov. Namur,BE35,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.03,Rate
Prov. Namur,BE35,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.99,Rate
Prov. Namur,BE35,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.41,Rate
Prov. Namur,BE35,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.61,Rate
Prov. Namur,BE35,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.46,Rate
Prov. Namur,BE35,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.86,Rate
Prov. Namur,BE35,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.88,Rate
Prov. Namur,BE35,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",123.73,Rate
Prov. Namur,BE35,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",107.33,Rate
Prov. Namur,BE35,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",119.81,Rate
Prov. Namur,BE35,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",107.51,Rate
Prov. Namur,BE35,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",111.68,Rate
Prov. Namur,BE35,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",103.8,Rate
Prov. Namur,BE35,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",105.66,Rate
Prov. Namur,BE35,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",92.48,Rate
Prov. Namur,BE35,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",90.36,Rate
Prov. Namur,BE35,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",89.91,Rate
Prov. Namur,BE35,Total,Males,2011,Malignant melanoma of skin,4.62,Rate
Prov. Namur,BE35,Total,Males,2012,Malignant melanoma of skin,3.67,Rate
Prov. Namur,BE35,Total,Males,2013,Malignant melanoma of skin,4.96,Rate
Prov. Namur,BE35,Total,Males,2014,Malignant melanoma of skin,6.71,Rate
Prov. Namur,BE35,Total,Males,2015,Malignant melanoma of skin,3.38,Rate
Prov. Namur,BE35,Total,Males,2016,Malignant melanoma of skin,5.7,Rate
Prov. Namur,BE35,Total,Males,2017,Malignant melanoma of skin,3.06,Rate
Prov. Namur,BE35,Total,Males,2018,Malignant melanoma of skin,2.16,Rate
Prov. Namur,BE35,Total,Males,2019,Malignant melanoma of skin,3.53,Rate
Prov. Namur,BE35,Total,Males,2020,Malignant melanoma of skin,5.92,Rate
Prov. Namur,BE35,Total,Males,2011,Malignant neoplasm of breast,0.58,Rate
Prov. Namur,BE35,Total,Males,2012,Malignant neoplasm of breast,0.61,Rate
Prov. Namur,BE35,Total,Males,2014,Malignant neoplasm of breast,0.66,Rate
Prov. Namur,BE35,Total,Males,2015,Malignant neoplasm of breast,0.4,Rate
Prov. Namur,BE35,Total,Males,2016,Malignant neoplasm of breast,0.57,Rate
Prov. Namur,BE35,Total,Males,2018,Malignant neoplasm of breast,0.4,Rate
Prov. Namur,BE35,Total,Males,2020,Malignant neoplasm of breast,1.19,Rate
Prov. Namur,BE35,Total,Males,2011,Diabetes mellitus,20.22,Rate
Prov. Namur,BE35,Total,Males,2012,Diabetes mellitus,17.91,Rate
Prov. Namur,BE35,Total,Males,2013,Diabetes mellitus,16.34,Rate
Prov. Namur,BE35,Total,Males,2014,Diabetes mellitus,19.73,Rate
Prov. Namur,BE35,Total,Males,2015,Diabetes mellitus,16.16,Rate
Prov. Namur,BE35,Total,Males,2016,Diabetes mellitus,14.54,Rate
Prov. Namur,BE35,Total,Males,2017,Diabetes mellitus,23.83,Rate
Prov. Namur,BE35,Total,Males,2018,Diabetes mellitus,13.17,Rate
Prov. Namur,BE35,Total,Males,2019,Diabetes mellitus,16.03,Rate
Prov. Namur,BE35,Total,Males,2020,Diabetes mellitus,17.23,Rate
Prov. Namur,BE35,Total,Males,2011,Mental and behavioural disorders (F00-F99),39.48,Rate
Prov. Namur,BE35,Total,Males,2012,Mental and behavioural disorders (F00-F99),35.07,Rate
Prov. Namur,BE35,Total,Males,2013,Mental and behavioural disorders (F00-F99),39.69,Rate
Prov. Namur,BE35,Total,Males,2014,Mental and behavioural disorders (F00-F99),37.25,Rate
Prov. Namur,BE35,Total,Males,2015,Mental and behavioural disorders (F00-F99),44.24,Rate
Prov. Namur,BE35,Total,Males,2016,Mental and behavioural disorders (F00-F99),48.41,Rate
Prov. Namur,BE35,Total,Males,2017,Mental and behavioural disorders (F00-F99),34.94,Rate
Prov. Namur,BE35,Total,Males,2018,Mental and behavioural disorders (F00-F99),30.04,Rate
Prov. Namur,BE35,Total,Males,2019,Mental and behavioural disorders (F00-F99),35.86,Rate
Prov. Namur,BE35,Total,Males,2020,Mental and behavioural disorders (F00-F99),37.26,Rate
Prov. Namur,BE35,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),4.19,Rate
Prov. Namur,BE35,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.79,Rate
Prov. Namur,BE35,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.37,Rate
Prov. Namur,BE35,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.46,Rate
Prov. Namur,BE35,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),9.0,Rate
Prov. Namur,BE35,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),6.05,Rate
Prov. Namur,BE35,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Prov. Namur,BE35,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),6.35,Rate
Prov. Namur,BE35,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.14,Rate
Prov. Namur,BE35,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),3.06,Rate
Prov. Namur,BE35,Total,Males,2011,Other ischaemic heart diseases,54.26,Rate
Prov. Namur,BE35,Total,Males,2012,Other ischaemic heart diseases,73.4,Rate
Prov. Namur,BE35,Total,Males,2013,Other ischaemic heart diseases,59.57,Rate
Prov. Namur,BE35,Total,Males,2014,Other ischaemic heart diseases,65.45,Rate
Prov. Namur,BE35,Total,Males,2015,Other ischaemic heart diseases,61.58,Rate
Prov. Namur,BE35,Total,Males,2016,Other ischaemic heart diseases,60.43,Rate
Prov. Namur,BE35,Total,Males,2017,Other ischaemic heart diseases,61.68,Rate
Prov. Namur,BE35,Total,Males,2018,Other ischaemic heart diseases,55.63,Rate
Prov. Namur,BE35,Total,Males,2019,Other ischaemic heart diseases,54.9,Rate
Prov. Namur,BE35,Total,Males,2020,Other ischaemic heart diseases,59.77,Rate
Prov. Namur,BE35,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,70.55,Rate
Prov. Namur,BE35,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,85.08,Rate
Prov. Namur,BE35,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,63.57,Rate
Prov. Namur,BE35,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,54.88,Rate
Prov. Namur,BE35,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,71.97,Rate
Prov. Namur,BE35,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,62.06,Rate
Prov. Namur,BE35,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,62.89,Rate
Prov. Namur,BE35,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,54.06,Rate
Prov. Namur,BE35,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,51.86,Rate
Prov. Namur,BE35,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,50.42,Rate
Prov. Namur,BE35,Total,Males,2011,Cerebrovascular diseases,83.75,Rate
Prov. Namur,BE35,Total,Males,2012,Cerebrovascular diseases,78.63,Rate
Prov. Namur,BE35,Total,Males,2013,Cerebrovascular diseases,70.99,Rate
Prov. Namur,BE35,Total,Males,2014,Cerebrovascular diseases,60.13,Rate
Prov. Namur,BE35,Total,Males,2015,Cerebrovascular diseases,66.05,Rate
Prov. Namur,BE35,Total,Males,2016,Cerebrovascular diseases,70.12,Rate
Prov. Namur,BE35,Total,Males,2017,Cerebrovascular diseases,60.4,Rate
Prov. Namur,BE35,Total,Males,2018,Cerebrovascular diseases,69.43,Rate
Prov. Namur,BE35,Total,Males,2019,Cerebrovascular diseases,60.69,Rate
Prov. Namur,BE35,Total,Males,2020,Cerebrovascular diseases,54.36,Rate
Prov. Namur,BE35,Total,Males,2011,Chronic lower respiratory diseases,76.53,Rate
Prov. Namur,BE35,Total,Males,2012,Chronic lower respiratory diseases,92.3,Rate
Prov. Namur,BE35,Total,Males,2013,Chronic lower respiratory diseases,80.58,Rate
Prov. Namur,BE35,Total,Males,2014,Chronic lower respiratory diseases,72.48,Rate
Prov. Namur,BE35,Total,Males,2015,Chronic lower respiratory diseases,76.98,Rate
Prov. Namur,BE35,Total,Males,2016,Chronic lower respiratory diseases,59.67,Rate
Prov. Namur,BE35,Total,Males,2017,Chronic lower respiratory diseases,65.15,Rate
Prov. Namur,BE35,Total,Males,2018,Chronic lower respiratory diseases,59.19,Rate
Prov. Namur,BE35,Total,Males,2019,Chronic lower respiratory diseases,67.77,Rate
Prov. Namur,BE35,Total,Males,2020,Chronic lower respiratory diseases,74.67,Rate
Prov. Namur,BE35,Total,Males,2011,Asthma and status asthmaticus,1.86,Rate
Prov. Namur,BE35,Total,Males,2012,Asthma and status asthmaticus,0.81,Rate
Prov. Namur,BE35,Total,Males,2013,Asthma and status asthmaticus,0.8,Rate
Prov. Namur,BE35,Total,Males,2015,Asthma and status asthmaticus,1.11,Rate
Prov. Namur,BE35,Total,Males,2016,Asthma and status asthmaticus,0.4,Rate
Prov. Namur,BE35,Total,Males,2017,Asthma and status asthmaticus,1.69,Rate
Prov. Namur,BE35,Total,Males,2019,Asthma and status asthmaticus,0.8,Rate
Prov. Namur,BE35,Total,Males,2020,Asthma and status asthmaticus,0.52,Rate
Prov. Namur,BE35,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5777.91,Rate
Prov. Namur,BE35,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,6164.68,Rate
Prov. Namur,BE35,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,6117.09,Rate
Prov. Namur,BE35,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5560.75,Rate
Prov. Namur,BE35,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,6102.62,Rate
Prov. Namur,BE35,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5583.26,Rate
Prov. Namur,BE35,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5632.67,Rate
Prov. Namur,BE35,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5721.98,Rate
Prov. Namur,BE35,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5551.11,Rate
Prov. Namur,BE35,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6775.89,Rate
Prov. Namur,BE35,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",166.57,Rate
Prov. Namur,BE35,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.14,Rate
Prov. Namur,BE35,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",215.18,Rate
Prov. Namur,BE35,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",200.9,Rate
Prov. Namur,BE35,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.8,Rate
Prov. Namur,BE35,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",150.6,Rate
Prov. Namur,BE35,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.79,Rate
Prov. Namur,BE35,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.58,Rate
Prov. Namur,BE35,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.3,Rate
Prov. Namur,BE35,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",144.13,Rate
Prov. Namur,BE35,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",494.51,Rate
Prov. Namur,BE35,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",423.46,Rate
Prov. Namur,BE35,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",444.51,Rate
Prov. Namur,BE35,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",385.88,Rate
Prov. Namur,BE35,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",436.89,Rate
Prov. Namur,BE35,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",388.59,Rate
Prov. Namur,BE35,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",414.8,Rate
Prov. Namur,BE35,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",366.05,Rate
Prov. Namur,BE35,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",359.88,Rate
Prov. Namur,BE35,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",372.48,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Malignant melanoma of skin,15.22,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Malignant melanoma of skin,14.83,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Malignant melanoma of skin,14.87,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Malignant melanoma of skin,23.86,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Malignant melanoma of skin,15.2,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Malignant melanoma of skin,22.99,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Malignant melanoma of skin,13.7,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Malignant melanoma of skin,11.1,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Malignant melanoma of skin,13.85,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Malignant melanoma of skin,15.64,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Malignant neoplasm of breast,2.99,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Malignant neoplasm of breast,3.12,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Malignant neoplasm of breast,3.36,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Malignant neoplasm of breast,2.92,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Malignant neoplasm of breast,2.04,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Malignant neoplasm of breast,2.04,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Diabetes mellitus,85.09,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Diabetes mellitus,77.2,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Diabetes mellitus,69.32,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Diabetes mellitus,86.75,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Diabetes mellitus,68.49,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Diabetes mellitus,64.22,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Diabetes mellitus,115.83,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Diabetes mellitus,49.11,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Diabetes mellitus,70.26,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Diabetes mellitus,78.63,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),150.04,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),146.02,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),149.14,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),159.67,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),204.0,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),212.93,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),136.12,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),125.13,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),154.35,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),162.99,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),15.31,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),15.21,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),5.61,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),15.58,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),35.8,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),22.73,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),10.86,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),22.21,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.64,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),15.71,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Other ischaemic heart diseases,253.39,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Other ischaemic heart diseases,332.8,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Other ischaemic heart diseases,278.63,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Other ischaemic heart diseases,302.63,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Other ischaemic heart diseases,278.8,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Other ischaemic heart diseases,272.88,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Other ischaemic heart diseases,291.45,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Other ischaemic heart diseases,263.14,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Other ischaemic heart diseases,247.51,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Other ischaemic heart diseases,288.91,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,278.71,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,332.28,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,261.7,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,213.19,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,290.6,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,248.72,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,236.8,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,219.84,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,212.96,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,218.25,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Cerebrovascular diseases,396.15,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Cerebrovascular diseases,355.41,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Cerebrovascular diseases,325.04,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Cerebrovascular diseases,275.18,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Cerebrovascular diseases,297.36,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Cerebrovascular diseases,318.94,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Cerebrovascular diseases,273.0,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Cerebrovascular diseases,323.42,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Cerebrovascular diseases,289.2,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Cerebrovascular diseases,251.16,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Chronic lower respiratory diseases,355.12,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Chronic lower respiratory diseases,427.93,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Chronic lower respiratory diseases,367.74,Rate
Prov. Namur,BE35,65 years or over,Males,2014,Chronic lower respiratory diseases,336.62,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Chronic lower respiratory diseases,359.89,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Chronic lower respiratory diseases,275.23,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Chronic lower respiratory diseases,299.74,Rate
Prov. Namur,BE35,65 years or over,Males,2018,Chronic lower respiratory diseases,281.56,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Chronic lower respiratory diseases,319.46,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Chronic lower respiratory diseases,349.6,Rate
Prov. Namur,BE35,65 years or over,Males,2011,Asthma and status asthmaticus,9.55,Rate
Prov. Namur,BE35,65 years or over,Males,2012,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,65 years or over,Males,2013,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,65 years or over,Males,2015,Asthma and status asthmaticus,5.68,Rate
Prov. Namur,BE35,65 years or over,Males,2016,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,65 years or over,Males,2017,Asthma and status asthmaticus,4.7,Rate
Prov. Namur,BE35,65 years or over,Males,2019,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,65 years or over,Males,2020,Asthma and status asthmaticus,2.69,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,340.75,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,366.8,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,346.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,328.7,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,317.05,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,307.1,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,307.11,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,312.55,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,270.23,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,274.03,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.02,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.58,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.52,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.93,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.52,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.76,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.25,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.17,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",33.92,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",30.75,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",41.16,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",40.08,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",32.9,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",34.81,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",30.78,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",26.22,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",25.08,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",21.45,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Malignant melanoma of skin,2.05,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Malignant melanoma of skin,0.96,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Malignant melanoma of skin,2.56,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Malignant melanoma of skin,2.56,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Malignant melanoma of skin,0.52,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Malignant melanoma of skin,1.51,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Malignant melanoma of skin,0.48,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Malignant melanoma of skin,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Malignant melanoma of skin,1.03,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Malignant melanoma of skin,3.57,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.98,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Diabetes mellitus,4.51,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Diabetes mellitus,3.55,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Diabetes mellitus,3.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Diabetes mellitus,3.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Diabetes mellitus,3.48,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Diabetes mellitus,2.51,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Diabetes mellitus,1.54,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Diabetes mellitus,4.47,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Diabetes mellitus,2.9,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Diabetes mellitus,2.35,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),12.69,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),8.19,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),13.17,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),7.59,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),5.54,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),8.56,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),10.43,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),7.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),7.16,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),6.8,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.49,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.58,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.51,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.54,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Other ischaemic heart diseases,6.03,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Other ischaemic heart diseases,10.56,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Other ischaemic heart diseases,6.51,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Other ischaemic heart diseases,8.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Other ischaemic heart diseases,8.96,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Other ischaemic heart diseases,8.96,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Other ischaemic heart diseases,6.02,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Other ischaemic heart diseases,5.36,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Other ischaemic heart diseases,8.24,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Other ischaemic heart diseases,4.26,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,20.13,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,25.2,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,15.58,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,16.53,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,19.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,16.85,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,20.76,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,13.9,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,12.84,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,9.76,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Cerebrovascular diseases,8.07,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Cerebrovascular diseases,11.58,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Cerebrovascular diseases,9.45,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Cerebrovascular diseases,8.03,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Cerebrovascular diseases,10.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Cerebrovascular diseases,9.84,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Cerebrovascular diseases,8.91,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Cerebrovascular diseases,7.91,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Cerebrovascular diseases,5.33,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Cerebrovascular diseases,6.68,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Chronic lower respiratory diseases,9.05,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Chronic lower respiratory diseases,11.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Chronic lower respiratory diseases,11.02,Rate
Prov. Namur,BE35,Less than 65 years,Males,2014,Chronic lower respiratory diseases,8.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Chronic lower respiratory diseases,8.45,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.45,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Chronic lower respiratory diseases,8.33,Rate
Prov. Namur,BE35,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.32,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Chronic lower respiratory diseases,6.8,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Chronic lower respiratory diseases,8.07,Rate
Prov. Namur,BE35,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2012,Asthma and status asthmaticus,1.01,Rate
Prov. Namur,BE35,Less than 65 years,Males,2013,Asthma and status asthmaticus,1.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.5,Rate
Prov. Namur,BE35,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.96,Rate
Prov. Namur,BE35,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.99,Rate
Prov. Namur,BE35,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1122.03,Rate
Prov. Namur,BE35,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1157.68,Rate
Prov. Namur,BE35,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1178.48,Rate
Prov. Namur,BE35,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1101.97,Rate
Prov. Namur,BE35,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1135.06,Rate
Prov. Namur,BE35,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1080.04,Rate
Prov. Namur,BE35,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1085.41,Rate
Prov. Namur,BE35,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1066.45,Rate
Prov. Namur,BE35,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1040.25,Rate
Prov. Namur,BE35,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1209.53,Rate
Prov. Namur,BE35,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.46,Rate
Prov. Namur,BE35,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.66,Rate
Prov. Namur,BE35,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.26,Rate
Prov. Namur,BE35,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.06,Rate
Prov. Namur,BE35,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.72,Rate
Prov. Namur,BE35,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.29,Rate
Prov. Namur,BE35,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.51,Rate
Prov. Namur,BE35,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.77,Rate
Prov. Namur,BE35,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.09,Rate
Prov. Namur,BE35,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.89,Rate
Prov. Namur,BE35,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",72.35,Rate
Prov. Namur,BE35,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",64.08,Rate
Prov. Namur,BE35,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",74.83,Rate
Prov. Namur,BE35,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",68.55,Rate
Prov. Namur,BE35,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",64.9,Rate
Prov. Namur,BE35,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",68.69,Rate
Prov. Namur,BE35,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",69.28,Rate
Prov. Namur,BE35,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",62.11,Rate
Prov. Namur,BE35,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",60.35,Rate
Prov. Namur,BE35,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",60.41,Rate
Prov. Namur,BE35,Total,Total,2011,Malignant melanoma of skin,2.89,Rate
Prov. Namur,BE35,Total,Total,2012,Malignant melanoma of skin,3.12,Rate
Prov. Namur,BE35,Total,Total,2013,Malignant melanoma of skin,4.11,Rate
Prov. Namur,BE35,Total,Total,2014,Malignant melanoma of skin,4.32,Rate
Prov. Namur,BE35,Total,Total,2015,Malignant melanoma of skin,4.07,Rate
Prov. Namur,BE35,Total,Total,2016,Malignant melanoma of skin,2.94,Rate
Prov. Namur,BE35,Total,Total,2017,Malignant melanoma of skin,1.97,Rate
Prov. Namur,BE35,Total,Total,2018,Malignant melanoma of skin,2.08,Rate
Prov. Namur,BE35,Total,Total,2019,Malignant melanoma of skin,2.59,Rate
Prov. Namur,BE35,Total,Total,2020,Malignant melanoma of skin,3.6,Rate
Prov. Namur,BE35,Total,Total,2011,Malignant neoplasm of breast,23.81,Rate
Prov. Namur,BE35,Total,Total,2012,Malignant neoplasm of breast,22.06,Rate
Prov. Namur,BE35,Total,Total,2013,Malignant neoplasm of breast,22.17,Rate
Prov. Namur,BE35,Total,Total,2014,Malignant neoplasm of breast,20.15,Rate
Prov. Namur,BE35,Total,Total,2015,Malignant neoplasm of breast,20.8,Rate
Prov. Namur,BE35,Total,Total,2016,Malignant neoplasm of breast,20.96,Rate
Prov. Namur,BE35,Total,Total,2017,Malignant neoplasm of breast,19.4,Rate
Prov. Namur,BE35,Total,Total,2018,Malignant neoplasm of breast,19.93,Rate
Prov. Namur,BE35,Total,Total,2019,Malignant neoplasm of breast,18.87,Rate
Prov. Namur,BE35,Total,Total,2020,Malignant neoplasm of breast,16.4,Rate
Prov. Namur,BE35,Total,Total,2011,Diabetes mellitus,17.4,Rate
Prov. Namur,BE35,Total,Total,2012,Diabetes mellitus,19.3,Rate
Prov. Namur,BE35,Total,Total,2013,Diabetes mellitus,15.92,Rate
Prov. Namur,BE35,Total,Total,2014,Diabetes mellitus,17.86,Rate
Prov. Namur,BE35,Total,Total,2015,Diabetes mellitus,12.5,Rate
Prov. Namur,BE35,Total,Total,2016,Diabetes mellitus,13.45,Rate
Prov. Namur,BE35,Total,Total,2017,Diabetes mellitus,18.69,Rate
Prov. Namur,BE35,Total,Total,2018,Diabetes mellitus,13.28,Rate
Prov. Namur,BE35,Total,Total,2019,Diabetes mellitus,12.37,Rate
Prov. Namur,BE35,Total,Total,2020,Diabetes mellitus,11.99,Rate
Prov. Namur,BE35,Total,Total,2011,Mental and behavioural disorders (F00-F99),34.31,Rate
Prov. Namur,BE35,Total,Total,2012,Mental and behavioural disorders (F00-F99),34.9,Rate
Prov. Namur,BE35,Total,Total,2013,Mental and behavioural disorders (F00-F99),38.15,Rate
Prov. Namur,BE35,Total,Total,2014,Mental and behavioural disorders (F00-F99),34.94,Rate
Prov. Namur,BE35,Total,Total,2015,Mental and behavioural disorders (F00-F99),36.52,Rate
Prov. Namur,BE35,Total,Total,2016,Mental and behavioural disorders (F00-F99),39.7,Rate
Prov. Namur,BE35,Total,Total,2017,Mental and behavioural disorders (F00-F99),36.8,Rate
Prov. Namur,BE35,Total,Total,2018,Mental and behavioural disorders (F00-F99),26.24,Rate
Prov. Namur,BE35,Total,Total,2019,Mental and behavioural disorders (F00-F99),32.66,Rate
Prov. Namur,BE35,Total,Total,2020,Mental and behavioural disorders (F00-F99),33.75,Rate
Prov. Namur,BE35,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.34,Rate
Prov. Namur,BE35,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),5.98,Rate
Prov. Namur,BE35,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.25,Rate
Prov. Namur,BE35,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.94,Rate
Prov. Namur,BE35,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),5.64,Rate
Prov. Namur,BE35,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),5.15,Rate
Prov. Namur,BE35,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),4.88,Rate
Prov. Namur,BE35,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Prov. Namur,BE35,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.57,Rate
Prov. Namur,BE35,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),4.12,Rate
Prov. Namur,BE35,Total,Total,2011,Other ischaemic heart diseases,40.04,Rate
Prov. Namur,BE35,Total,Total,2012,Other ischaemic heart diseases,42.41,Rate
Prov. Namur,BE35,Total,Total,2013,Other ischaemic heart diseases,41.44,Rate
Prov. Namur,BE35,Total,Total,2014,Other ischaemic heart diseases,37.62,Rate
Prov. Namur,BE35,Total,Total,2015,Other ischaemic heart diseases,43.87,Rate
Prov. Namur,BE35,Total,Total,2016,Other ischaemic heart diseases,38.25,Rate
Prov. Namur,BE35,Total,Total,2017,Other ischaemic heart diseases,37.48,Rate
Prov. Namur,BE35,Total,Total,2018,Other ischaemic heart diseases,30.43,Rate
Prov. Namur,BE35,Total,Total,2019,Other ischaemic heart diseases,37.14,Rate
Prov. Namur,BE35,Total,Total,2020,Other ischaemic heart diseases,36.01,Rate
Prov. Namur,BE35,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,46.32,Rate
Prov. Namur,BE35,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,57.02,Rate
Prov. Namur,BE35,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,43.1,Rate
Prov. Namur,BE35,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.13,Rate
Prov. Namur,BE35,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,50.37,Rate
Prov. Namur,BE35,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,42.12,Rate
Prov. Namur,BE35,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,41.21,Rate
Prov. Namur,BE35,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,41.42,Rate
Prov. Namur,BE35,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,36.57,Rate
Prov. Namur,BE35,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,31.77,Rate
Prov. Namur,BE35,Total,Total,2011,Cerebrovascular diseases,73.22,Rate
Prov. Namur,BE35,Total,Total,2012,Cerebrovascular diseases,69.53,Rate
Prov. Namur,BE35,Total,Total,2013,Cerebrovascular diseases,59.33,Rate
Prov. Namur,BE35,Total,Total,2014,Cerebrovascular diseases,63.03,Rate
Prov. Namur,BE35,Total,Total,2015,Cerebrovascular diseases,58.15,Rate
Prov. Namur,BE35,Total,Total,2016,Cerebrovascular diseases,63.01,Rate
Prov. Namur,BE35,Total,Total,2017,Cerebrovascular diseases,54.82,Rate
Prov. Namur,BE35,Total,Total,2018,Cerebrovascular diseases,61.95,Rate
Prov. Namur,BE35,Total,Total,2019,Cerebrovascular diseases,50.83,Rate
Prov. Namur,BE35,Total,Total,2020,Cerebrovascular diseases,48.06,Rate
Prov. Namur,BE35,Total,Total,2011,Chronic lower respiratory diseases,47.44,Rate
Prov. Namur,BE35,Total,Total,2012,Chronic lower respiratory diseases,58.13,Rate
Prov. Namur,BE35,Total,Total,2013,Chronic lower respiratory diseases,54.15,Rate
Prov. Namur,BE35,Total,Total,2014,Chronic lower respiratory diseases,48.72,Rate
Prov. Namur,BE35,Total,Total,2015,Chronic lower respiratory diseases,51.37,Rate
Prov. Namur,BE35,Total,Total,2016,Chronic lower respiratory diseases,45.55,Rate
Prov. Namur,BE35,Total,Total,2017,Chronic lower respiratory diseases,47.1,Rate
Prov. Namur,BE35,Total,Total,2018,Chronic lower respiratory diseases,43.77,Rate
Prov. Namur,BE35,Total,Total,2019,Chronic lower respiratory diseases,47.5,Rate
Prov. Namur,BE35,Total,Total,2020,Chronic lower respiratory diseases,50.63,Rate
Prov. Namur,BE35,Total,Total,2011,Asthma and status asthmaticus,2.04,Rate
Prov. Namur,BE35,Total,Total,2012,Asthma and status asthmaticus,2.04,Rate
Prov. Namur,BE35,Total,Total,2013,Asthma and status asthmaticus,1.65,Rate
Prov. Namur,BE35,Total,Total,2014,Asthma and status asthmaticus,0.88,Rate
Prov. Namur,BE35,Total,Total,2015,Asthma and status asthmaticus,2.19,Rate
Prov. Namur,BE35,Total,Total,2016,Asthma and status asthmaticus,0.86,Rate
Prov. Namur,BE35,Total,Total,2017,Asthma and status asthmaticus,1.78,Rate
Prov. Namur,BE35,Total,Total,2018,Asthma and status asthmaticus,0.87,Rate
Prov. Namur,BE35,Total,Total,2019,Asthma and status asthmaticus,0.78,Rate
Prov. Namur,BE35,Total,Total,2020,Asthma and status asthmaticus,1.22,Rate
Prov. Namur,BE35,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4674.95,Rate
Prov. Namur,BE35,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4787.75,Rate
Prov. Namur,BE35,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4952.44,Rate
Prov. Namur,BE35,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4608.67,Rate
Prov. Namur,BE35,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4794.31,Rate
Prov. Namur,BE35,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4531.56,Rate
Prov. Namur,BE35,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4570.19,Rate
Prov. Namur,BE35,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4495.62,Rate
Prov. Namur,BE35,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4443.1,Rate
Prov. Namur,BE35,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5321.16,Rate
Prov. Namur,BE35,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.11,Rate
Prov. Namur,BE35,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.05,Rate
Prov. Namur,BE35,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.61,Rate
Prov. Namur,BE35,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",131.52,Rate
Prov. Namur,BE35,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.77,Rate
Prov. Namur,BE35,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.63,Rate
Prov. Namur,BE35,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.39,Rate
Prov. Namur,BE35,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.09,Rate
Prov. Namur,BE35,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",120.63,Rate
Prov. Namur,BE35,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.23,Rate
Prov. Namur,BE35,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",263.31,Rate
Prov. Namur,BE35,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",230.54,Rate
Prov. Namur,BE35,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",260.42,Rate
Prov. Namur,BE35,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",232.84,Rate
Prov. Namur,BE35,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",229.29,Rate
Prov. Namur,BE35,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",238.61,Rate
Prov. Namur,BE35,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",249.32,Rate
Prov. Namur,BE35,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",230.3,Rate
Prov. Namur,BE35,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",230.72,Rate
Prov. Namur,BE35,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",236.5,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Malignant melanoma of skin,6.42,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Malignant melanoma of skin,10.89,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Malignant melanoma of skin,11.54,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Malignant melanoma of skin,13.72,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Malignant melanoma of skin,15.59,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Malignant melanoma of skin,12.0,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Malignant melanoma of skin,6.09,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Malignant melanoma of skin,8.7,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Malignant melanoma of skin,10.09,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Malignant melanoma of skin,10.1,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Malignant neoplasm of breast,85.68,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Malignant neoplasm of breast,86.97,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Malignant neoplasm of breast,84.84,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Malignant neoplasm of breast,73.36,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Malignant neoplasm of breast,76.13,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Malignant neoplasm of breast,79.74,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Malignant neoplasm of breast,71.4,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Malignant neoplasm of breast,81.04,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Malignant neoplasm of breast,64.26,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Malignant neoplasm of breast,60.03,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Diabetes mellitus,74.81,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Diabetes mellitus,87.6,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Diabetes mellitus,70.45,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Diabetes mellitus,83.41,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Diabetes mellitus,54.0,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Diabetes mellitus,59.94,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Diabetes mellitus,89.58,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Diabetes mellitus,58.04,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Diabetes mellitus,54.46,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Diabetes mellitus,54.54,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),145.8,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),141.18,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),157.11,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),158.17,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),167.76,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),175.72,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),155.16,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),117.21,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),147.76,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),155.18,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),16.07,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),20.36,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),7.15,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),10.96,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),21.8,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),20.29,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),18.92,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),17.62,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),8.07,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),20.18,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Other ischaemic heart diseases,188.87,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Other ischaemic heart diseases,189.69,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Other ischaemic heart diseases,191.02,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Other ischaemic heart diseases,170.54,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Other ischaemic heart diseases,200.56,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Other ischaemic heart diseases,173.88,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Other ischaemic heart diseases,175.9,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Other ischaemic heart diseases,142.22,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Other ischaemic heart diseases,167.4,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Other ischaemic heart diseases,173.89,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,184.85,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,228.4,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,183.03,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,167.98,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,210.32,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,169.69,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,157.81,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,174.7,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,152.35,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,135.22,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Cerebrovascular diseases,344.5,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Cerebrovascular diseases,320.24,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Cerebrovascular diseases,280.75,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Cerebrovascular diseases,295.45,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Cerebrovascular diseases,262.31,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Cerebrovascular diseases,291.98,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Cerebrovascular diseases,248.84,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Cerebrovascular diseases,284.27,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Cerebrovascular diseases,242.68,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Cerebrovascular diseases,227.13,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Chronic lower respiratory diseases,211.18,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Chronic lower respiratory diseases,263.13,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Chronic lower respiratory diseases,238.8,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Chronic lower respiratory diseases,223.38,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Chronic lower respiratory diseases,229.98,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Chronic lower respiratory diseases,200.38,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Chronic lower respiratory diseases,216.68,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Chronic lower respiratory diseases,196.95,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Chronic lower respiratory diseases,211.22,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Chronic lower respiratory diseases,231.61,Rate
Prov. Namur,BE35,65 years or over,Total,2011,Asthma and status asthmaticus,9.38,Rate
Prov. Namur,BE35,65 years or over,Total,2012,Asthma and status asthmaticus,5.23,Rate
Prov. Namur,BE35,65 years or over,Total,2013,Asthma and status asthmaticus,2.29,Rate
Prov. Namur,BE35,65 years or over,Total,2014,Asthma and status asthmaticus,4.5,Rate
Prov. Namur,BE35,65 years or over,Total,2015,Asthma and status asthmaticus,10.21,Rate
Prov. Namur,BE35,65 years or over,Total,2016,Asthma and status asthmaticus,2.39,Rate
Prov. Namur,BE35,65 years or over,Total,2017,Asthma and status asthmaticus,7.19,Rate
Prov. Namur,BE35,65 years or over,Total,2018,Asthma and status asthmaticus,4.45,Rate
Prov. Namur,BE35,65 years or over,Total,2019,Asthma and status asthmaticus,2.0,Rate
Prov. Namur,BE35,65 years or over,Total,2020,Asthma and status asthmaticus,5.31,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,261.38,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,278.34,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,264.29,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,252.52,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,248.66,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,243.96,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,241.28,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,235.78,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,215.96,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,213.55,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.75,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.25,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.01,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.97,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.12,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.44,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.46,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.53,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.91,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.94,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",26.09,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",23.75,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",29.88,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",28.75,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",25.08,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",27.53,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",25.67,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",21.37,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",19.08,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",17.76,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Malignant melanoma of skin,2.03,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Malignant melanoma of skin,1.24,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Malignant melanoma of skin,2.31,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Malignant melanoma of skin,2.04,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Malignant melanoma of skin,1.28,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Malignant melanoma of skin,0.75,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Malignant melanoma of skin,0.97,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Malignant melanoma of skin,0.48,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Malignant melanoma of skin,0.77,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Malignant melanoma of skin,2.03,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.83,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.34,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.99,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.26,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.39,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.73,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.8,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.13,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.87,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.84,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Diabetes mellitus,3.5,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Diabetes mellitus,2.76,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Diabetes mellitus,2.71,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Diabetes mellitus,1.98,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Diabetes mellitus,2.45,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Diabetes mellitus,2.19,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Diabetes mellitus,1.52,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Diabetes mellitus,2.44,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Diabetes mellitus,2.17,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Diabetes mellitus,1.69,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),7.3,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),9.16,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),9.33,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),5.09,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),4.73,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),6.75,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),8.13,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),4.2,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),4.78,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.34,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.5,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.31,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.0,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.73,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.49,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.23,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Other ischaemic heart diseases,3.99,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Other ischaemic heart diseases,6.73,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Other ischaemic heart diseases,5.2,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.43,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.92,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Other ischaemic heart diseases,5.4,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Other ischaemic heart diseases,3.95,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Other ischaemic heart diseases,3.35,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Other ischaemic heart diseases,5.58,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Other ischaemic heart diseases,2.62,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,12.76,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,15.51,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,9.21,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,10.41,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.63,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,11.22,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,12.97,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,9.14,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,8.52,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,6.71,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Cerebrovascular diseases,7.51,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Cerebrovascular diseases,8.8,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Cerebrovascular diseases,5.7,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Cerebrovascular diseases,6.73,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Cerebrovascular diseases,8.7,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Cerebrovascular diseases,7.54,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Cerebrovascular diseases,7.83,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Cerebrovascular diseases,8.1,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Cerebrovascular diseases,4.36,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Cerebrovascular diseases,4.69,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Chronic lower respiratory diseases,7.77,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Chronic lower respiratory diseases,8.47,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Chronic lower respiratory diseases,9.43,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Chronic lower respiratory diseases,6.41,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Chronic lower respiratory diseases,8.11,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Chronic lower respiratory diseases,8.05,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.02,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Chronic lower respiratory diseases,6.67,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Chronic lower respiratory diseases,7.85,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Chronic lower respiratory diseases,6.79,Rate
Prov. Namur,BE35,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.26,Rate
Prov. Namur,BE35,Less than 65 years,Total,2012,Asthma and status asthmaticus,1.27,Rate
Prov. Namur,BE35,Less than 65 years,Total,2013,Asthma and status asthmaticus,1.49,Rate
Prov. Namur,BE35,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.25,Rate
Prov. Namur,BE35,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.47,Rate
Prov. Namur,BE35,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Prov. Namur,BE35,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.49,Rate
Prov. Namur,BE35,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.23,Rate
Kypros,CY00,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,909.11,Rate
Kypros,CY00,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,916.04,Rate
Kypros,CY00,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,794.57,Rate
Kypros,CY00,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,845.27,Rate
Kypros,CY00,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,899.62,Rate
Kypros,CY00,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,831.92,Rate
Kypros,CY00,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,904.04,Rate
Kypros,CY00,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,811.5,Rate
Kypros,CY00,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,834.63,Rate
Kypros,CY00,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,854.84,Rate
Kypros,CY00,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.9,Rate
Kypros,CY00,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.19,Rate
Kypros,CY00,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.16,Rate
Kypros,CY00,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.15,Rate
Kypros,CY00,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.56,Rate
Kypros,CY00,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.73,Rate
Kypros,CY00,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.15,Rate
Kypros,CY00,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.75,Rate
Kypros,CY00,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.79,Rate
Kypros,CY00,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.45,Rate
Kypros,CY00,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",15.26,Rate
Kypros,CY00,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",14.6,Rate
Kypros,CY00,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",9.48,Rate
Kypros,CY00,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",14.03,Rate
Kypros,CY00,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",15.15,Rate
Kypros,CY00,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",16.61,Rate
Kypros,CY00,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",14.97,Rate
Kypros,CY00,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",15.55,Rate
Kypros,CY00,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.41,Rate
Kypros,CY00,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",14.52,Rate
Kypros,CY00,Total,Females,2011,Malignant melanoma of skin,1.72,Rate
Kypros,CY00,Total,Females,2012,Malignant melanoma of skin,1.25,Rate
Kypros,CY00,Total,Females,2013,Malignant melanoma of skin,2.62,Rate
Kypros,CY00,Total,Females,2014,Malignant melanoma of skin,1.94,Rate
Kypros,CY00,Total,Females,2015,Malignant melanoma of skin,2.19,Rate
Kypros,CY00,Total,Females,2016,Malignant melanoma of skin,1.38,Rate
Kypros,CY00,Total,Females,2017,Malignant melanoma of skin,2.75,Rate
Kypros,CY00,Total,Females,2018,Malignant melanoma of skin,0.49,Rate
Kypros,CY00,Total,Females,2019,Malignant melanoma of skin,2.51,Rate
Kypros,CY00,Total,Females,2020,Malignant melanoma of skin,0.97,Rate
Kypros,CY00,Total,Females,2011,Malignant neoplasm of breast,32.28,Rate
Kypros,CY00,Total,Females,2012,Malignant neoplasm of breast,31.14,Rate
Kypros,CY00,Total,Females,2013,Malignant neoplasm of breast,30.49,Rate
Kypros,CY00,Total,Females,2014,Malignant neoplasm of breast,26.62,Rate
Kypros,CY00,Total,Females,2015,Malignant neoplasm of breast,30.96,Rate
Kypros,CY00,Total,Females,2016,Malignant neoplasm of breast,29.42,Rate
Kypros,CY00,Total,Females,2017,Malignant neoplasm of breast,33.44,Rate
Kypros,CY00,Total,Females,2018,Malignant neoplasm of breast,32.53,Rate
Kypros,CY00,Total,Females,2019,Malignant neoplasm of breast,32.65,Rate
Kypros,CY00,Total,Females,2020,Malignant neoplasm of breast,29.47,Rate
Kypros,CY00,Total,Females,2011,Diabetes mellitus,68.15,Rate
Kypros,CY00,Total,Females,2012,Diabetes mellitus,62.23,Rate
Kypros,CY00,Total,Females,2013,Diabetes mellitus,64.86,Rate
Kypros,CY00,Total,Females,2014,Diabetes mellitus,66.04,Rate
Kypros,CY00,Total,Females,2015,Diabetes mellitus,59.49,Rate
Kypros,CY00,Total,Females,2016,Diabetes mellitus,41.61,Rate
Kypros,CY00,Total,Females,2017,Diabetes mellitus,53.95,Rate
Kypros,CY00,Total,Females,2018,Diabetes mellitus,52.31,Rate
Kypros,CY00,Total,Females,2019,Diabetes mellitus,51.22,Rate
Kypros,CY00,Total,Females,2020,Diabetes mellitus,51.47,Rate
Kypros,CY00,Total,Females,2011,Mental and behavioural disorders (F00-F99),18.07,Rate
Kypros,CY00,Total,Females,2012,Mental and behavioural disorders (F00-F99),20.28,Rate
Kypros,CY00,Total,Females,2013,Mental and behavioural disorders (F00-F99),16.24,Rate
Kypros,CY00,Total,Females,2014,Mental and behavioural disorders (F00-F99),27.84,Rate
Kypros,CY00,Total,Females,2015,Mental and behavioural disorders (F00-F99),34.49,Rate
Kypros,CY00,Total,Females,2016,Mental and behavioural disorders (F00-F99),38.69,Rate
Kypros,CY00,Total,Females,2017,Mental and behavioural disorders (F00-F99),39.53,Rate
Kypros,CY00,Total,Females,2018,Mental and behavioural disorders (F00-F99),51.03,Rate
Kypros,CY00,Total,Females,2019,Mental and behavioural disorders (F00-F99),53.86,Rate
Kypros,CY00,Total,Females,2020,Mental and behavioural disorders (F00-F99),45.27,Rate
Kypros,CY00,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.59,Rate
Kypros,CY00,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.83,Rate
Kypros,CY00,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Kypros,CY00,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.7,Rate
Kypros,CY00,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Kypros,CY00,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Kypros,CY00,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Kypros,CY00,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.52,Rate
Kypros,CY00,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.5,Rate
Kypros,CY00,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.95,Rate
Kypros,CY00,Total,Females,2011,Other ischaemic heart diseases,55.39,Rate
Kypros,CY00,Total,Females,2012,Other ischaemic heart diseases,44.5,Rate
Kypros,CY00,Total,Females,2013,Other ischaemic heart diseases,28.35,Rate
Kypros,CY00,Total,Females,2014,Other ischaemic heart diseases,36.06,Rate
Kypros,CY00,Total,Females,2015,Other ischaemic heart diseases,41.65,Rate
Kypros,CY00,Total,Females,2016,Other ischaemic heart diseases,36.38,Rate
Kypros,CY00,Total,Females,2017,Other ischaemic heart diseases,30.18,Rate
Kypros,CY00,Total,Females,2018,Other ischaemic heart diseases,28.82,Rate
Kypros,CY00,Total,Females,2019,Other ischaemic heart diseases,26.39,Rate
Kypros,CY00,Total,Females,2020,Other ischaemic heart diseases,35.47,Rate
Kypros,CY00,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,33.21,Rate
Kypros,CY00,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,28.69,Rate
Kypros,CY00,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,36.04,Rate
Kypros,CY00,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,32.84,Rate
Kypros,CY00,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,31.62,Rate
Kypros,CY00,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,24.84,Rate
Kypros,CY00,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,29.27,Rate
Kypros,CY00,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,26.67,Rate
Kypros,CY00,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,21.79,Rate
Kypros,CY00,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,27.77,Rate
Kypros,CY00,Total,Females,2011,Cerebrovascular diseases,83.89,Rate
Kypros,CY00,Total,Females,2012,Cerebrovascular diseases,81.93,Rate
Kypros,CY00,Total,Females,2013,Cerebrovascular diseases,70.55,Rate
Kypros,CY00,Total,Females,2014,Cerebrovascular diseases,74.34,Rate
Kypros,CY00,Total,Females,2015,Cerebrovascular diseases,63.7,Rate
Kypros,CY00,Total,Females,2016,Cerebrovascular diseases,67.1,Rate
Kypros,CY00,Total,Females,2017,Cerebrovascular diseases,62.82,Rate
Kypros,CY00,Total,Females,2018,Cerebrovascular diseases,59.2,Rate
Kypros,CY00,Total,Females,2019,Cerebrovascular diseases,55.43,Rate
Kypros,CY00,Total,Females,2020,Cerebrovascular diseases,49.44,Rate
Kypros,CY00,Total,Females,2011,Chronic lower respiratory diseases,13.15,Rate
Kypros,CY00,Total,Females,2012,Chronic lower respiratory diseases,12.27,Rate
Kypros,CY00,Total,Females,2013,Chronic lower respiratory diseases,14.93,Rate
Kypros,CY00,Total,Females,2014,Chronic lower respiratory diseases,15.97,Rate
Kypros,CY00,Total,Females,2015,Chronic lower respiratory diseases,12.72,Rate
Kypros,CY00,Total,Females,2016,Chronic lower respiratory diseases,18.65,Rate
Kypros,CY00,Total,Females,2017,Chronic lower respiratory diseases,14.42,Rate
Kypros,CY00,Total,Females,2018,Chronic lower respiratory diseases,12.34,Rate
Kypros,CY00,Total,Females,2019,Chronic lower respiratory diseases,14.78,Rate
Kypros,CY00,Total,Females,2020,Chronic lower respiratory diseases,15.35,Rate
Kypros,CY00,Total,Females,2011,Asthma and status asthmaticus,5.46,Rate
Kypros,CY00,Total,Females,2012,Asthma and status asthmaticus,2.12,Rate
Kypros,CY00,Total,Females,2013,Asthma and status asthmaticus,4.9,Rate
Kypros,CY00,Total,Females,2014,Asthma and status asthmaticus,2.64,Rate
Kypros,CY00,Total,Females,2015,Asthma and status asthmaticus,2.19,Rate
Kypros,CY00,Total,Females,2016,Asthma and status asthmaticus,4.12,Rate
Kypros,CY00,Total,Females,2017,Asthma and status asthmaticus,4.39,Rate
Kypros,CY00,Total,Females,2018,Asthma and status asthmaticus,5.09,Rate
Kypros,CY00,Total,Females,2019,Asthma and status asthmaticus,5.18,Rate
Kypros,CY00,Total,Females,2020,Asthma and status asthmaticus,3.44,Rate
Kypros,CY00,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4278.23,Rate
Kypros,CY00,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4324.54,Rate
Kypros,CY00,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3752.84,Rate
Kypros,CY00,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3952.35,Rate
Kypros,CY00,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4203.92,Rate
Kypros,CY00,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3911.03,Rate
Kypros,CY00,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,4231.62,Rate
Kypros,CY00,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3756.25,Rate
Kypros,CY00,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3875.75,Rate
Kypros,CY00,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3959.29,Rate
Kypros,CY00,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.33,Rate
Kypros,CY00,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.92,Rate
Kypros,CY00,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.47,Rate
Kypros,CY00,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.4,Rate
Kypros,CY00,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.66,Rate
Kypros,CY00,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.48,Rate
Kypros,CY00,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.28,Rate
Kypros,CY00,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.15,Rate
Kypros,CY00,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.86,Rate
Kypros,CY00,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.89,Rate
Kypros,CY00,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",54.79,Rate
Kypros,CY00,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",47.35,Rate
Kypros,CY00,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",35.77,Rate
Kypros,CY00,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",55.21,Rate
Kypros,CY00,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",53.34,Rate
Kypros,CY00,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",62.09,Rate
Kypros,CY00,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",55.28,Rate
Kypros,CY00,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",51.13,Rate
Kypros,CY00,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",50.1,Rate
Kypros,CY00,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",50.71,Rate
Kypros,CY00,65 years or over,Females,2011,Malignant melanoma of skin,5.17,Rate
Kypros,CY00,65 years or over,Females,2012,Malignant melanoma of skin,6.43,Rate
Kypros,CY00,65 years or over,Females,2013,Malignant melanoma of skin,8.42,Rate
Kypros,CY00,65 years or over,Females,2014,Malignant melanoma of skin,6.13,Rate
Kypros,CY00,65 years or over,Females,2015,Malignant melanoma of skin,8.64,Rate
Kypros,CY00,65 years or over,Females,2016,Malignant melanoma of skin,5.82,Rate
Kypros,CY00,65 years or over,Females,2017,Malignant melanoma of skin,9.04,Rate
Kypros,CY00,65 years or over,Females,2018,Malignant melanoma of skin,1.25,Rate
Kypros,CY00,65 years or over,Females,2019,Malignant melanoma of skin,3.88,Rate
Kypros,CY00,65 years or over,Females,2020,Malignant melanoma of skin,3.75,Rate
Kypros,CY00,65 years or over,Females,2011,Malignant neoplasm of breast,96.04,Rate
Kypros,CY00,65 years or over,Females,2012,Malignant neoplasm of breast,100.56,Rate
Kypros,CY00,65 years or over,Females,2013,Malignant neoplasm of breast,104.43,Rate
Kypros,CY00,65 years or over,Females,2014,Malignant neoplasm of breast,86.1,Rate
Kypros,CY00,65 years or over,Females,2015,Malignant neoplasm of breast,106.95,Rate
Kypros,CY00,65 years or over,Females,2016,Malignant neoplasm of breast,103.77,Rate
Kypros,CY00,65 years or over,Females,2017,Malignant neoplasm of breast,116.62,Rate
Kypros,CY00,65 years or over,Females,2018,Malignant neoplasm of breast,109.67,Rate
Kypros,CY00,65 years or over,Females,2019,Malignant neoplasm of breast,104.9,Rate
Kypros,CY00,65 years or over,Females,2020,Malignant neoplasm of breast,97.28,Rate
Kypros,CY00,65 years or over,Females,2011,Diabetes mellitus,338.83,Rate
Kypros,CY00,65 years or over,Females,2012,Diabetes mellitus,307.72,Rate
Kypros,CY00,65 years or over,Females,2013,Diabetes mellitus,322.72,Rate
Kypros,CY00,65 years or over,Females,2014,Diabetes mellitus,331.31,Rate
Kypros,CY00,65 years or over,Females,2015,Diabetes mellitus,301.28,Rate
Kypros,CY00,65 years or over,Females,2016,Diabetes mellitus,204.37,Rate
Kypros,CY00,65 years or over,Females,2017,Diabetes mellitus,269.13,Rate
Kypros,CY00,65 years or over,Females,2018,Diabetes mellitus,261.94,Rate
Kypros,CY00,65 years or over,Females,2019,Diabetes mellitus,252.71,Rate
Kypros,CY00,65 years or over,Females,2020,Diabetes mellitus,248.45,Rate
Kypros,CY00,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),91.33,Rate
Kypros,CY00,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),104.02,Rate
Kypros,CY00,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),79.4,Rate
Kypros,CY00,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),141.56,Rate
Kypros,CY00,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),174.61,Rate
Kypros,CY00,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),197.15,Rate
Kypros,CY00,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),201.45,Rate
Kypros,CY00,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),256.6,Rate
Kypros,CY00,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),274.95,Rate
Kypros,CY00,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),228.39,Rate
Kypros,CY00,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Kypros,CY00,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),9.36,Rate
Kypros,CY00,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),12.61,Rate
Kypros,CY00,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.84,Rate
Kypros,CY00,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),4.9,Rate
Kypros,CY00,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Kypros,CY00,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.96,Rate
Kypros,CY00,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),6.46,Rate
Kypros,CY00,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),12.68,Rate
Kypros,CY00,65 years or over,Females,2011,Other ischaemic heart diseases,281.35,Rate
Kypros,CY00,65 years or over,Females,2012,Other ischaemic heart diseases,225.61,Rate
Kypros,CY00,65 years or over,Females,2013,Other ischaemic heart diseases,144.12,Rate
Kypros,CY00,65 years or over,Females,2014,Other ischaemic heart diseases,183.61,Rate
Kypros,CY00,65 years or over,Females,2015,Other ischaemic heart diseases,208.44,Rate
Kypros,CY00,65 years or over,Females,2016,Other ischaemic heart diseases,181.46,Rate
Kypros,CY00,65 years or over,Females,2017,Other ischaemic heart diseases,151.0,Rate
Kypros,CY00,65 years or over,Females,2018,Other ischaemic heart diseases,146.58,Rate
Kypros,CY00,65 years or over,Females,2019,Other ischaemic heart diseases,134.08,Rate
Kypros,CY00,65 years or over,Females,2020,Other ischaemic heart diseases,177.09,Rate
Kypros,CY00,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,140.07,Rate
Kypros,CY00,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,118.56,Rate
Kypros,CY00,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,170.17,Rate
Kypros,CY00,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,134.29,Rate
Kypros,CY00,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,131.89,Rate
Kypros,CY00,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,108.2,Rate
Kypros,CY00,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,127.28,Rate
Kypros,CY00,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,111.09,Rate
Kypros,CY00,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,95.03,Rate
Kypros,CY00,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,117.74,Rate
Kypros,CY00,65 years or over,Females,2011,Cerebrovascular diseases,422.93,Rate
Kypros,CY00,65 years or over,Females,2012,Cerebrovascular diseases,409.8,Rate
Kypros,CY00,65 years or over,Females,2013,Cerebrovascular diseases,354.2,Rate
Kypros,CY00,65 years or over,Females,2014,Cerebrovascular diseases,370.13,Rate
Kypros,CY00,65 years or over,Females,2015,Cerebrovascular diseases,303.43,Rate
Kypros,CY00,65 years or over,Females,2016,Cerebrovascular diseases,331.55,Rate
Kypros,CY00,65 years or over,Females,2017,Cerebrovascular diseases,312.28,Rate
Kypros,CY00,65 years or over,Females,2018,Cerebrovascular diseases,282.63,Rate
Kypros,CY00,65 years or over,Females,2019,Cerebrovascular diseases,276.61,Rate
Kypros,CY00,65 years or over,Females,2020,Cerebrovascular diseases,243.5,Rate
Kypros,CY00,65 years or over,Females,2011,Chronic lower respiratory diseases,67.44,Rate
Kypros,CY00,65 years or over,Females,2012,Chronic lower respiratory diseases,60.45,Rate
Kypros,CY00,65 years or over,Females,2013,Chronic lower respiratory diseases,75.28,Rate
Kypros,CY00,65 years or over,Females,2014,Chronic lower respiratory diseases,81.91,Rate
Kypros,CY00,65 years or over,Females,2015,Chronic lower respiratory diseases,61.42,Rate
Kypros,CY00,65 years or over,Females,2016,Chronic lower respiratory diseases,89.32,Rate
Kypros,CY00,65 years or over,Females,2017,Chronic lower respiratory diseases,70.13,Rate
Kypros,CY00,65 years or over,Females,2018,Chronic lower respiratory diseases,59.47,Rate
Kypros,CY00,65 years or over,Females,2019,Chronic lower respiratory diseases,72.17,Rate
Kypros,CY00,65 years or over,Females,2020,Chronic lower respiratory diseases,76.19,Rate
Kypros,CY00,65 years or over,Females,2011,Asthma and status asthmaticus,27.98,Rate
Kypros,CY00,65 years or over,Females,2012,Asthma and status asthmaticus,10.88,Rate
Kypros,CY00,65 years or over,Females,2013,Asthma and status asthmaticus,25.11,Rate
Kypros,CY00,65 years or over,Females,2014,Asthma and status asthmaticus,13.52,Rate
Kypros,CY00,65 years or over,Females,2015,Asthma and status asthmaticus,11.21,Rate
Kypros,CY00,65 years or over,Females,2016,Asthma and status asthmaticus,20.05,Rate
Kypros,CY00,65 years or over,Females,2017,Asthma and status asthmaticus,19.98,Rate
Kypros,CY00,65 years or over,Females,2018,Asthma and status asthmaticus,24.79,Rate
Kypros,CY00,65 years or over,Females,2019,Asthma and status asthmaticus,25.38,Rate
Kypros,CY00,65 years or over,Females,2020,Asthma and status asthmaticus,16.29,Rate
Kypros,CY00,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,92.99,Rate
Kypros,CY00,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,90.38,Rate
Kypros,CY00,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,77.97,Rate
Kypros,CY00,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,92.63,Rate
Kypros,CY00,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,99.2,Rate
Kypros,CY00,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,86.05,Rate
Kypros,CY00,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,97.99,Rate
Kypros,CY00,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,98.17,Rate
Kypros,CY00,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,97.96,Rate
Kypros,CY00,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,102.84,Rate
Kypros,CY00,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.86,Rate
Kypros,CY00,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.05,Rate
Kypros,CY00,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.7,Rate
Kypros,CY00,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.06,Rate
Kypros,CY00,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.46,Rate
Kypros,CY00,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.85,Rate
Kypros,CY00,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.22,Rate
Kypros,CY00,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.75,Rate
Kypros,CY00,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.57,Rate
Kypros,CY00,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.72,Rate
Kypros,CY00,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",5.69,Rate
Kypros,CY00,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",6.67,Rate
Kypros,CY00,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",3.11,Rate
Kypros,CY00,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",4.05,Rate
Kypros,CY00,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",5.9,Rate
Kypros,CY00,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",5.59,Rate
Kypros,CY00,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",5.2,Rate
Kypros,CY00,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",6.94,Rate
Kypros,CY00,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",3.28,Rate
Kypros,CY00,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",5.75,Rate
Kypros,CY00,Less than 65 years,Females,2011,Malignant melanoma of skin,0.89,Rate
Kypros,CY00,Less than 65 years,Females,2012,Malignant melanoma of skin,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2013,Malignant melanoma of skin,1.21,Rate
Kypros,CY00,Less than 65 years,Females,2014,Malignant melanoma of skin,0.93,Rate
Kypros,CY00,Less than 65 years,Females,2015,Malignant melanoma of skin,0.63,Rate
Kypros,CY00,Less than 65 years,Females,2016,Malignant melanoma of skin,0.31,Rate
Kypros,CY00,Less than 65 years,Females,2017,Malignant melanoma of skin,1.22,Rate
Kypros,CY00,Less than 65 years,Females,2018,Malignant melanoma of skin,0.3,Rate
Kypros,CY00,Less than 65 years,Females,2019,Malignant melanoma of skin,2.17,Rate
Kypros,CY00,Less than 65 years,Females,2020,Malignant melanoma of skin,0.29,Rate
Kypros,CY00,Less than 65 years,Females,2011,Malignant neoplasm of breast,16.84,Rate
Kypros,CY00,Less than 65 years,Females,2012,Malignant neoplasm of breast,14.33,Rate
Kypros,CY00,Less than 65 years,Females,2013,Malignant neoplasm of breast,12.58,Rate
Kypros,CY00,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.22,Rate
Kypros,CY00,Less than 65 years,Females,2015,Malignant neoplasm of breast,12.55,Rate
Kypros,CY00,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.41,Rate
Kypros,CY00,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.29,Rate
Kypros,CY00,Less than 65 years,Females,2018,Malignant neoplasm of breast,13.84,Rate
Kypros,CY00,Less than 65 years,Females,2019,Malignant neoplasm of breast,15.15,Rate
Kypros,CY00,Less than 65 years,Females,2020,Malignant neoplasm of breast,13.04,Rate
Kypros,CY00,Less than 65 years,Females,2011,Diabetes mellitus,2.58,Rate
Kypros,CY00,Less than 65 years,Females,2012,Diabetes mellitus,2.77,Rate
Kypros,CY00,Less than 65 years,Females,2013,Diabetes mellitus,2.4,Rate
Kypros,CY00,Less than 65 years,Females,2014,Diabetes mellitus,1.78,Rate
Kypros,CY00,Less than 65 years,Females,2015,Diabetes mellitus,0.92,Rate
Kypros,CY00,Less than 65 years,Females,2016,Diabetes mellitus,2.18,Rate
Kypros,CY00,Less than 65 years,Females,2017,Diabetes mellitus,1.82,Rate
Kypros,CY00,Less than 65 years,Females,2018,Diabetes mellitus,1.53,Rate
Kypros,CY00,Less than 65 years,Females,2019,Diabetes mellitus,2.41,Rate
Kypros,CY00,Less than 65 years,Females,2020,Diabetes mellitus,3.75,Rate
Kypros,CY00,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.32,Rate
Kypros,CY00,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.94,Rate
Kypros,CY00,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.29,Rate
Kypros,CY00,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.55,Rate
Kypros,CY00,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.31,Rate
Kypros,CY00,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.31,Rate
Kypros,CY00,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.24,Rate
Kypros,CY00,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.3,Rate
Kypros,CY00,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.91,Rate
Kypros,CY00,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Kypros,CY00,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Kypros,CY00,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Kypros,CY00,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Kypros,CY00,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Kypros,CY00,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Kypros,CY00,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Kypros,CY00,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Kypros,CY00,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.65,Rate
Kypros,CY00,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.64,Rate
Kypros,CY00,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.31,Rate
Kypros,CY00,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.32,Rate
Kypros,CY00,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.24,Rate
Kypros,CY00,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.24,Rate
Kypros,CY00,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.91,Rate
Kypros,CY00,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.29,Rate
Kypros,CY00,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.3,Rate
Kypros,CY00,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.17,Rate
Kypros,CY00,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,7.32,Rate
Kypros,CY00,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,6.92,Rate
Kypros,CY00,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.56,Rate
Kypros,CY00,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,8.27,Rate
Kypros,CY00,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,7.32,Rate
Kypros,CY00,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.64,Rate
Kypros,CY00,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,5.53,Rate
Kypros,CY00,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,6.22,Rate
Kypros,CY00,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.04,Rate
Kypros,CY00,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,5.97,Rate
Kypros,CY00,Less than 65 years,Females,2011,Cerebrovascular diseases,1.76,Rate
Kypros,CY00,Less than 65 years,Females,2012,Cerebrovascular diseases,2.52,Rate
Kypros,CY00,Less than 65 years,Females,2013,Cerebrovascular diseases,1.84,Rate
Kypros,CY00,Less than 65 years,Females,2014,Cerebrovascular diseases,2.69,Rate
Kypros,CY00,Less than 65 years,Females,2015,Cerebrovascular diseases,5.62,Rate
Kypros,CY00,Less than 65 years,Females,2016,Cerebrovascular diseases,3.04,Rate
Kypros,CY00,Less than 65 years,Females,2017,Cerebrovascular diseases,2.39,Rate
Kypros,CY00,Less than 65 years,Females,2018,Cerebrovascular diseases,5.08,Rate
Kypros,CY00,Less than 65 years,Females,2019,Cerebrovascular diseases,1.86,Rate
Kypros,CY00,Less than 65 years,Females,2020,Cerebrovascular diseases,2.43,Rate
Kypros,CY00,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.6,Rate
Kypros,CY00,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.31,Rate
Kypros,CY00,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.93,Rate
Kypros,CY00,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.52,Rate
Kypros,CY00,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.93,Rate
Kypros,CY00,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.92,Rate
Kypros,CY00,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.88,Rate
Kypros,CY00,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.61,Rate
Kypros,CY00,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.26,Rate
Kypros,CY00,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.61,Rate
Kypros,CY00,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.32,Rate
Kypros,CY00,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.29,Rate
Kypros,CY00,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.32,Rate
Kypros,CY00,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1160.28,Rate
Kypros,CY00,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1221.25,Rate
Kypros,CY00,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1140.4,Rate
Kypros,CY00,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1139.73,Rate
Kypros,CY00,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1231.28,Rate
Kypros,CY00,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1126.29,Rate
Kypros,CY00,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1202.88,Rate
Kypros,CY00,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1100.37,Rate
Kypros,CY00,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1124.02,Rate
Kypros,CY00,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1148.33,Rate
Kypros,CY00,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.61,Rate
Kypros,CY00,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.67,Rate
Kypros,CY00,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.71,Rate
Kypros,CY00,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.32,Rate
Kypros,CY00,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.59,Rate
Kypros,CY00,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.06,Rate
Kypros,CY00,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.72,Rate
Kypros,CY00,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.68,Rate
Kypros,CY00,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.95,Rate
Kypros,CY00,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.33,Rate
Kypros,CY00,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",67.26,Rate
Kypros,CY00,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",70.2,Rate
Kypros,CY00,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",67.46,Rate
Kypros,CY00,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",63.51,Rate
Kypros,CY00,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",59.06,Rate
Kypros,CY00,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",61.55,Rate
Kypros,CY00,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",74.6,Rate
Kypros,CY00,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",61.89,Rate
Kypros,CY00,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",51.84,Rate
Kypros,CY00,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",71.5,Rate
Kypros,CY00,Total,Males,2011,Malignant melanoma of skin,1.61,Rate
Kypros,CY00,Total,Males,2012,Malignant melanoma of skin,2.15,Rate
Kypros,CY00,Total,Males,2013,Malignant melanoma of skin,3.23,Rate
Kypros,CY00,Total,Males,2014,Malignant melanoma of skin,4.42,Rate
Kypros,CY00,Total,Males,2015,Malignant melanoma of skin,2.17,Rate
Kypros,CY00,Total,Males,2016,Malignant melanoma of skin,4.34,Rate
Kypros,CY00,Total,Males,2017,Malignant melanoma of skin,4.23,Rate
Kypros,CY00,Total,Males,2018,Malignant melanoma of skin,3.27,Rate
Kypros,CY00,Total,Males,2019,Malignant melanoma of skin,4.95,Rate
Kypros,CY00,Total,Males,2020,Malignant melanoma of skin,3.31,Rate
Kypros,CY00,Total,Males,2011,Malignant neoplasm of breast,0.68,Rate
Kypros,CY00,Total,Males,2012,Malignant neoplasm of breast,0.67,Rate
Kypros,CY00,Total,Males,2013,Malignant neoplasm of breast,0.39,Rate
Kypros,CY00,Total,Males,2014,Malignant neoplasm of breast,0.76,Rate
Kypros,CY00,Total,Males,2015,Malignant neoplasm of breast,0.27,Rate
Kypros,CY00,Total,Males,2016,Malignant neoplasm of breast,0.61,Rate
Kypros,CY00,Total,Males,2018,Malignant neoplasm of breast,1.83,Rate
Kypros,CY00,Total,Males,2019,Malignant neoplasm of breast,0.26,Rate
Kypros,CY00,Total,Males,2020,Malignant neoplasm of breast,0.83,Rate
Kypros,CY00,Total,Males,2011,Diabetes mellitus,79.52,Rate
Kypros,CY00,Total,Males,2012,Diabetes mellitus,80.9,Rate
Kypros,CY00,Total,Males,2013,Diabetes mellitus,74.64,Rate
Kypros,CY00,Total,Males,2014,Diabetes mellitus,79.51,Rate
Kypros,CY00,Total,Males,2015,Diabetes mellitus,71.44,Rate
Kypros,CY00,Total,Males,2016,Diabetes mellitus,67.44,Rate
Kypros,CY00,Total,Males,2017,Diabetes mellitus,61.59,Rate
Kypros,CY00,Total,Males,2018,Diabetes mellitus,56.79,Rate
Kypros,CY00,Total,Males,2019,Diabetes mellitus,60.75,Rate
Kypros,CY00,Total,Males,2020,Diabetes mellitus,71.06,Rate
Kypros,CY00,Total,Males,2011,Mental and behavioural disorders (F00-F99),18.67,Rate
Kypros,CY00,Total,Males,2012,Mental and behavioural disorders (F00-F99),18.72,Rate
Kypros,CY00,Total,Males,2013,Mental and behavioural disorders (F00-F99),22.26,Rate
Kypros,CY00,Total,Males,2014,Mental and behavioural disorders (F00-F99),17.62,Rate
Kypros,CY00,Total,Males,2015,Mental and behavioural disorders (F00-F99),22.48,Rate
Kypros,CY00,Total,Males,2016,Mental and behavioural disorders (F00-F99),24.41,Rate
Kypros,CY00,Total,Males,2017,Mental and behavioural disorders (F00-F99),36.76,Rate
Kypros,CY00,Total,Males,2018,Mental and behavioural disorders (F00-F99),42.09,Rate
Kypros,CY00,Total,Males,2019,Mental and behavioural disorders (F00-F99),32.09,Rate
Kypros,CY00,Total,Males,2020,Mental and behavioural disorders (F00-F99),32.44,Rate
Kypros,CY00,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.39,Rate
Kypros,CY00,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),2.03,Rate
Kypros,CY00,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.78,Rate
Kypros,CY00,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Kypros,CY00,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Kypros,CY00,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Kypros,CY00,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Kypros,CY00,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.81,Rate
Kypros,CY00,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Kypros,CY00,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Kypros,CY00,Total,Males,2011,Other ischaemic heart diseases,90.19,Rate
Kypros,CY00,Total,Males,2012,Other ischaemic heart diseases,86.15,Rate
Kypros,CY00,Total,Males,2013,Other ischaemic heart diseases,75.25,Rate
Kypros,CY00,Total,Males,2014,Other ischaemic heart diseases,88.67,Rate
Kypros,CY00,Total,Males,2015,Other ischaemic heart diseases,80.06,Rate
Kypros,CY00,Total,Males,2016,Other ischaemic heart diseases,73.83,Rate
Kypros,CY00,Total,Males,2017,Other ischaemic heart diseases,78.74,Rate
Kypros,CY00,Total,Males,2018,Other ischaemic heart diseases,73.19,Rate
Kypros,CY00,Total,Males,2019,Other ischaemic heart diseases,56.37,Rate
Kypros,CY00,Total,Males,2020,Other ischaemic heart diseases,68.01,Rate
Kypros,CY00,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,83.12,Rate
Kypros,CY00,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,81.31,Rate
Kypros,CY00,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,76.39,Rate
Kypros,CY00,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,70.08,Rate
Kypros,CY00,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,71.19,Rate
Kypros,CY00,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,72.79,Rate
Kypros,CY00,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,80.01,Rate
Kypros,CY00,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,70.89,Rate
Kypros,CY00,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,63.25,Rate
Kypros,CY00,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,55.78,Rate
Kypros,CY00,Total,Males,2011,Cerebrovascular diseases,85.61,Rate
Kypros,CY00,Total,Males,2012,Cerebrovascular diseases,82.21,Rate
Kypros,CY00,Total,Males,2013,Cerebrovascular diseases,71.87,Rate
Kypros,CY00,Total,Males,2014,Cerebrovascular diseases,64.26,Rate
Kypros,CY00,Total,Males,2015,Cerebrovascular diseases,71.04,Rate
Kypros,CY00,Total,Males,2016,Cerebrovascular diseases,63.37,Rate
Kypros,CY00,Total,Males,2017,Cerebrovascular diseases,81.04,Rate
Kypros,CY00,Total,Males,2018,Cerebrovascular diseases,64.28,Rate
Kypros,CY00,Total,Males,2019,Cerebrovascular diseases,64.98,Rate
Kypros,CY00,Total,Males,2020,Cerebrovascular diseases,56.72,Rate
Kypros,CY00,Total,Males,2011,Chronic lower respiratory diseases,37.33,Rate
Kypros,CY00,Total,Males,2012,Chronic lower respiratory diseases,40.11,Rate
Kypros,CY00,Total,Males,2013,Chronic lower respiratory diseases,47.72,Rate
Kypros,CY00,Total,Males,2014,Chronic lower respiratory diseases,36.87,Rate
Kypros,CY00,Total,Males,2015,Chronic lower respiratory diseases,40.75,Rate
Kypros,CY00,Total,Males,2016,Chronic lower respiratory diseases,39.75,Rate
Kypros,CY00,Total,Males,2017,Chronic lower respiratory diseases,39.98,Rate
Kypros,CY00,Total,Males,2018,Chronic lower respiratory diseases,31.53,Rate
Kypros,CY00,Total,Males,2019,Chronic lower respiratory diseases,34.57,Rate
Kypros,CY00,Total,Males,2020,Chronic lower respiratory diseases,36.58,Rate
Kypros,CY00,Total,Males,2011,Asthma and status asthmaticus,6.47,Rate
Kypros,CY00,Total,Males,2012,Asthma and status asthmaticus,3.96,Rate
Kypros,CY00,Total,Males,2013,Asthma and status asthmaticus,5.02,Rate
Kypros,CY00,Total,Males,2014,Asthma and status asthmaticus,3.48,Rate
Kypros,CY00,Total,Males,2015,Asthma and status asthmaticus,1.21,Rate
Kypros,CY00,Total,Males,2016,Asthma and status asthmaticus,2.26,Rate
Kypros,CY00,Total,Males,2017,Asthma and status asthmaticus,2.79,Rate
Kypros,CY00,Total,Males,2018,Asthma and status asthmaticus,2.07,Rate
Kypros,CY00,Total,Males,2019,Asthma and status asthmaticus,2.01,Rate
Kypros,CY00,Total,Males,2020,Asthma and status asthmaticus,1.83,Rate
Kypros,CY00,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5223.85,Rate
Kypros,CY00,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5498.54,Rate
Kypros,CY00,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5092.04,Rate
Kypros,CY00,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5111.58,Rate
Kypros,CY00,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5530.41,Rate
Kypros,CY00,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5041.25,Rate
Kypros,CY00,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5385.5,Rate
Kypros,CY00,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4936.89,Rate
Kypros,CY00,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4991.13,Rate
Kypros,CY00,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5042.44,Rate
Kypros,CY00,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.56,Rate
Kypros,CY00,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.8,Rate
Kypros,CY00,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.6,Rate
Kypros,CY00,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.88,Rate
Kypros,CY00,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.63,Rate
Kypros,CY00,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.02,Rate
Kypros,CY00,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.91,Rate
Kypros,CY00,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.52,Rate
Kypros,CY00,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.4,Rate
Kypros,CY00,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.19,Rate
Kypros,CY00,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",268.12,Rate
Kypros,CY00,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",281.46,Rate
Kypros,CY00,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",270.61,Rate
Kypros,CY00,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",260.64,Rate
Kypros,CY00,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",227.91,Rate
Kypros,CY00,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",257.9,Rate
Kypros,CY00,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",306.85,Rate
Kypros,CY00,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",246.42,Rate
Kypros,CY00,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",196.93,Rate
Kypros,CY00,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",259.33,Rate
Kypros,CY00,65 years or over,Males,2011,Malignant melanoma of skin,1.87,Rate
Kypros,CY00,65 years or over,Males,2012,Malignant melanoma of skin,5.25,Rate
Kypros,CY00,65 years or over,Males,2013,Malignant melanoma of skin,11.6,Rate
Kypros,CY00,65 years or over,Males,2014,Malignant melanoma of skin,13.67,Rate
Kypros,CY00,65 years or over,Males,2015,Malignant melanoma of skin,7.07,Rate
Kypros,CY00,65 years or over,Males,2016,Malignant melanoma of skin,13.47,Rate
Kypros,CY00,65 years or over,Males,2017,Malignant melanoma of skin,16.57,Rate
Kypros,CY00,65 years or over,Males,2018,Malignant melanoma of skin,6.49,Rate
Kypros,CY00,65 years or over,Males,2019,Malignant melanoma of skin,20.11,Rate
Kypros,CY00,65 years or over,Males,2020,Malignant melanoma of skin,8.21,Rate
Kypros,CY00,65 years or over,Males,2011,Malignant neoplasm of breast,2.2,Rate
Kypros,CY00,65 years or over,Males,2012,Malignant neoplasm of breast,2.12,Rate
Kypros,CY00,65 years or over,Males,2013,Malignant neoplasm of breast,2.02,Rate
Kypros,CY00,65 years or over,Males,2014,Malignant neoplasm of breast,3.88,Rate
Kypros,CY00,65 years or over,Males,2015,Malignant neoplasm of breast,1.37,Rate
Kypros,CY00,65 years or over,Males,2016,Malignant neoplasm of breast,3.13,Rate
Kypros,CY00,65 years or over,Males,2018,Malignant neoplasm of breast,9.41,Rate
Kypros,CY00,65 years or over,Males,2019,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,65 years or over,Males,2020,Malignant neoplasm of breast,2.99,Rate
Kypros,CY00,65 years or over,Males,2011,Diabetes mellitus,386.12,Rate
Kypros,CY00,65 years or over,Males,2012,Diabetes mellitus,388.84,Rate
Kypros,CY00,65 years or over,Males,2013,Diabetes mellitus,368.14,Rate
Kypros,CY00,65 years or over,Males,2014,Diabetes mellitus,383.82,Rate
Kypros,CY00,65 years or over,Males,2015,Diabetes mellitus,340.72,Rate
Kypros,CY00,65 years or over,Males,2016,Diabetes mellitus,320.28,Rate
Kypros,CY00,65 years or over,Males,2017,Diabetes mellitus,290.94,Rate
Kypros,CY00,65 years or over,Males,2018,Diabetes mellitus,266.53,Rate
Kypros,CY00,65 years or over,Males,2019,Diabetes mellitus,287.91,Rate
Kypros,CY00,65 years or over,Males,2020,Diabetes mellitus,333.14,Rate
Kypros,CY00,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),93.03,Rate
Kypros,CY00,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),95.98,Rate
Kypros,CY00,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),110.22,Rate
Kypros,CY00,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),87.69,Rate
Kypros,CY00,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),113.93,Rate
Kypros,CY00,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),121.21,Rate
Kypros,CY00,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),185.92,Rate
Kypros,CY00,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),212.12,Rate
Kypros,CY00,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),161.69,Rate
Kypros,CY00,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),159.9,Rate
Kypros,CY00,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),4.44,Rate
Kypros,CY00,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),10.4,Rate
Kypros,CY00,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),6.54,Rate
Kypros,CY00,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.45,Rate
Kypros,CY00,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.32,Rate
Kypros,CY00,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.73,Rate
Kypros,CY00,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Kypros,CY00,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.82,Rate
Kypros,CY00,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Kypros,CY00,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),7.34,Rate
Kypros,CY00,65 years or over,Males,2011,Other ischaemic heart diseases,439.59,Rate
Kypros,CY00,65 years or over,Males,2012,Other ischaemic heart diseases,424.73,Rate
Kypros,CY00,65 years or over,Males,2013,Other ischaemic heart diseases,360.87,Rate
Kypros,CY00,65 years or over,Males,2014,Other ischaemic heart diseases,433.39,Rate
Kypros,CY00,65 years or over,Males,2015,Other ischaemic heart diseases,384.91,Rate
Kypros,CY00,65 years or over,Males,2016,Other ischaemic heart diseases,350.85,Rate
Kypros,CY00,65 years or over,Males,2017,Other ischaemic heart diseases,377.42,Rate
Kypros,CY00,65 years or over,Males,2018,Other ischaemic heart diseases,363.65,Rate
Kypros,CY00,65 years or over,Males,2019,Other ischaemic heart diseases,269.89,Rate
Kypros,CY00,65 years or over,Males,2020,Other ischaemic heart diseases,314.08,Rate
Kypros,CY00,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,292.13,Rate
Kypros,CY00,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,274.4,Rate
Kypros,CY00,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,272.85,Rate
Kypros,CY00,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,237.09,Rate
Kypros,CY00,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,239.96,Rate
Kypros,CY00,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,243.45,Rate
Kypros,CY00,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,271.67,Rate
Kypros,CY00,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,251.14,Rate
Kypros,CY00,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,191.47,Rate
Kypros,CY00,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,176.43,Rate
Kypros,CY00,65 years or over,Males,2011,Cerebrovascular diseases,420.39,Rate
Kypros,CY00,65 years or over,Males,2012,Cerebrovascular diseases,402.9,Rate
Kypros,CY00,65 years or over,Males,2013,Cerebrovascular diseases,347.69,Rate
Kypros,CY00,65 years or over,Males,2014,Cerebrovascular diseases,308.6,Rate
Kypros,CY00,65 years or over,Males,2015,Cerebrovascular diseases,345.51,Rate
Kypros,CY00,65 years or over,Males,2016,Cerebrovascular diseases,297.88,Rate
Kypros,CY00,65 years or over,Males,2017,Cerebrovascular diseases,383.58,Rate
Kypros,CY00,65 years or over,Males,2018,Cerebrovascular diseases,315.65,Rate
Kypros,CY00,65 years or over,Males,2019,Cerebrovascular diseases,289.78,Rate
Kypros,CY00,65 years or over,Males,2020,Cerebrovascular diseases,265.06,Rate
Kypros,CY00,65 years or over,Males,2011,Chronic lower respiratory diseases,187.32,Rate
Kypros,CY00,65 years or over,Males,2012,Chronic lower respiratory diseases,200.47,Rate
Kypros,CY00,65 years or over,Males,2013,Chronic lower respiratory diseases,234.06,Rate
Kypros,CY00,65 years or over,Males,2014,Chronic lower respiratory diseases,183.82,Rate
Kypros,CY00,65 years or over,Males,2015,Chronic lower respiratory diseases,202.25,Rate
Kypros,CY00,65 years or over,Males,2016,Chronic lower respiratory diseases,195.84,Rate
Kypros,CY00,65 years or over,Males,2017,Chronic lower respiratory diseases,199.76,Rate
Kypros,CY00,65 years or over,Males,2018,Chronic lower respiratory diseases,161.68,Rate
Kypros,CY00,65 years or over,Males,2019,Chronic lower respiratory diseases,168.2,Rate
Kypros,CY00,65 years or over,Males,2020,Chronic lower respiratory diseases,186.22,Rate
Kypros,CY00,65 years or over,Males,2011,Asthma and status asthmaticus,33.18,Rate
Kypros,CY00,65 years or over,Males,2012,Asthma and status asthmaticus,20.29,Rate
Kypros,CY00,65 years or over,Males,2013,Asthma and status asthmaticus,25.72,Rate
Kypros,CY00,65 years or over,Males,2014,Asthma and status asthmaticus,17.85,Rate
Kypros,CY00,65 years or over,Males,2015,Asthma and status asthmaticus,6.18,Rate
Kypros,CY00,65 years or over,Males,2016,Asthma and status asthmaticus,11.57,Rate
Kypros,CY00,65 years or over,Males,2017,Asthma and status asthmaticus,14.29,Rate
Kypros,CY00,65 years or over,Males,2018,Asthma and status asthmaticus,10.62,Rate
Kypros,CY00,65 years or over,Males,2019,Asthma and status asthmaticus,10.32,Rate
Kypros,CY00,65 years or over,Males,2020,Asthma and status asthmaticus,9.36,Rate
Kypros,CY00,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,175.94,Rate
Kypros,CY00,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,185.13,Rate
Kypros,CY00,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,183.17,Rate
Kypros,CY00,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,177.61,Rate
Kypros,CY00,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,189.88,Rate
Kypros,CY00,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,177.95,Rate
Kypros,CY00,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,189.7,Rate
Kypros,CY00,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,171.03,Rate
Kypros,CY00,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,187.26,Rate
Kypros,CY00,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,205.04,Rate
Kypros,CY00,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.91,Rate
Kypros,CY00,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.14,Rate
Kypros,CY00,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.46,Rate
Kypros,CY00,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.44,Rate
Kypros,CY00,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.26,Rate
Kypros,CY00,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.23,Rate
Kypros,CY00,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.08,Rate
Kypros,CY00,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.89,Rate
Kypros,CY00,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.04,Rate
Kypros,CY00,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.71,Rate
Kypros,CY00,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",18.61,Rate
Kypros,CY00,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",19.03,Rate
Kypros,CY00,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",18.25,Rate
Kypros,CY00,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",15.76,Rate
Kypros,CY00,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",18.16,Rate
Kypros,CY00,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",13.99,Rate
Kypros,CY00,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",18.35,Rate
Kypros,CY00,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",17.2,Rate
Kypros,CY00,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",16.7,Rate
Kypros,CY00,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",26.0,Rate
Kypros,CY00,Less than 65 years,Males,2011,Malignant melanoma of skin,1.54,Rate
Kypros,CY00,Less than 65 years,Males,2012,Malignant melanoma of skin,1.4,Rate
Kypros,CY00,Less than 65 years,Males,2013,Malignant melanoma of skin,1.2,Rate
Kypros,CY00,Less than 65 years,Males,2014,Malignant melanoma of skin,2.18,Rate
Kypros,CY00,Less than 65 years,Males,2015,Malignant melanoma of skin,0.98,Rate
Kypros,CY00,Less than 65 years,Males,2016,Malignant melanoma of skin,2.13,Rate
Kypros,CY00,Less than 65 years,Males,2017,Malignant melanoma of skin,1.24,Rate
Kypros,CY00,Less than 65 years,Males,2018,Malignant melanoma of skin,2.49,Rate
Kypros,CY00,Less than 65 years,Males,2019,Malignant melanoma of skin,1.27,Rate
Kypros,CY00,Less than 65 years,Males,2020,Malignant melanoma of skin,2.12,Rate
Kypros,CY00,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.31,Rate
Kypros,CY00,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.32,Rate
Kypros,CY00,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.33,Rate
Kypros,CY00,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.3,Rate
Kypros,CY00,Less than 65 years,Males,2011,Diabetes mellitus,5.25,Rate
Kypros,CY00,Less than 65 years,Males,2012,Diabetes mellitus,6.31,Rate
Kypros,CY00,Less than 65 years,Males,2013,Diabetes mellitus,3.54,Rate
Kypros,CY00,Less than 65 years,Males,2014,Diabetes mellitus,5.8,Rate
Kypros,CY00,Less than 65 years,Males,2015,Diabetes mellitus,6.21,Rate
Kypros,CY00,Less than 65 years,Males,2016,Diabetes mellitus,6.19,Rate
Kypros,CY00,Less than 65 years,Males,2017,Diabetes mellitus,6.04,Rate
Kypros,CY00,Less than 65 years,Males,2018,Diabetes mellitus,5.99,Rate
Kypros,CY00,Less than 65 years,Males,2019,Diabetes mellitus,5.72,Rate
Kypros,CY00,Less than 65 years,Males,2020,Diabetes mellitus,7.58,Rate
Kypros,CY00,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.65,Rate
Kypros,CY00,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.95,Rate
Kypros,CY00,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.65,Rate
Kypros,CY00,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.32,Rate
Kypros,CY00,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.97,Rate
Kypros,CY00,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.63,Rate
Kypros,CY00,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),0.9,Rate
Kypros,CY00,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.7,Rate
Kypros,CY00,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),1.56,Rate
Kypros,CY00,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.65,Rate
Kypros,CY00,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Kypros,CY00,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Kypros,CY00,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Kypros,CY00,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Kypros,CY00,Less than 65 years,Males,2011,Other ischaemic heart diseases,5.56,Rate
Kypros,CY00,Less than 65 years,Males,2012,Other ischaemic heart diseases,4.13,Rate
Kypros,CY00,Less than 65 years,Males,2013,Other ischaemic heart diseases,6.06,Rate
Kypros,CY00,Less than 65 years,Males,2014,Other ischaemic heart diseases,5.16,Rate
Kypros,CY00,Less than 65 years,Males,2015,Other ischaemic heart diseases,6.21,Rate
Kypros,CY00,Less than 65 years,Males,2016,Other ischaemic heart diseases,6.72,Rate
Kypros,CY00,Less than 65 years,Males,2017,Other ischaemic heart diseases,6.39,Rate
Kypros,CY00,Less than 65 years,Males,2018,Other ischaemic heart diseases,2.83,Rate
Kypros,CY00,Less than 65 years,Males,2019,Other ischaemic heart diseases,4.65,Rate
Kypros,CY00,Less than 65 years,Males,2020,Other ischaemic heart diseases,8.4,Rate
Kypros,CY00,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,32.49,Rate
Kypros,CY00,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,34.53,Rate
Kypros,CY00,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,28.8,Rate
Kypros,CY00,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,29.63,Rate
Kypros,CY00,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,30.31,Rate
Kypros,CY00,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,31.46,Rate
Kypros,CY00,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,33.58,Rate
Kypros,CY00,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,27.23,Rate
Kypros,CY00,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,32.18,Rate
Kypros,CY00,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,26.56,Rate
Kypros,CY00,Less than 65 years,Males,2011,Cerebrovascular diseases,4.51,Rate
Kypros,CY00,Less than 65 years,Males,2012,Cerebrovascular diseases,4.53,Rate
Kypros,CY00,Less than 65 years,Males,2013,Cerebrovascular diseases,5.05,Rate
Kypros,CY00,Less than 65 years,Males,2014,Cerebrovascular diseases,5.08,Rate
Kypros,CY00,Less than 65 years,Males,2015,Cerebrovascular diseases,4.55,Rate
Kypros,CY00,Less than 65 years,Males,2016,Cerebrovascular diseases,6.56,Rate
Kypros,CY00,Less than 65 years,Males,2017,Cerebrovascular diseases,7.75,Rate
Kypros,CY00,Less than 65 years,Males,2018,Cerebrovascular diseases,3.39,Rate
Kypros,CY00,Less than 65 years,Males,2019,Cerebrovascular diseases,10.52,Rate
Kypros,CY00,Less than 65 years,Males,2020,Cerebrovascular diseases,6.25,Rate
Kypros,CY00,Less than 65 years,Males,2011,Chronic lower respiratory diseases,1.0,Rate
Kypros,CY00,Less than 65 years,Males,2012,Chronic lower respiratory diseases,1.27,Rate
Kypros,CY00,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.58,Rate
Kypros,CY00,Less than 65 years,Males,2014,Chronic lower respiratory diseases,1.28,Rate
Kypros,CY00,Less than 65 years,Males,2015,Chronic lower respiratory diseases,1.63,Rate
Kypros,CY00,Less than 65 years,Males,2016,Chronic lower respiratory diseases,1.94,Rate
Kypros,CY00,Less than 65 years,Males,2017,Chronic lower respiratory diseases,1.27,Rate
Kypros,CY00,Less than 65 years,Males,2018,Chronic lower respiratory diseases,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.2,Rate
Kypros,CY00,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.34,Rate
Kypros,CY00,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1024.77,Rate
Kypros,CY00,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1055.78,Rate
Kypros,CY00,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,951.52,Rate
Kypros,CY00,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,980.1,Rate
Kypros,CY00,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1047.48,Rate
Kypros,CY00,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,966.21,Rate
Kypros,CY00,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1042.15,Rate
Kypros,CY00,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,944.02,Rate
Kypros,CY00,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,970.26,Rate
Kypros,CY00,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,991.95,Rate
Kypros,CY00,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.9,Rate
Kypros,CY00,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.6,Rate
Kypros,CY00,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.57,Rate
Kypros,CY00,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.73,Rate
Kypros,CY00,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.31,Rate
Kypros,CY00,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.95,Rate
Kypros,CY00,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.76,Rate
Kypros,CY00,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.69,Rate
Kypros,CY00,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.46,Rate
Kypros,CY00,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.61,Rate
Kypros,CY00,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",39.14,Rate
Kypros,CY00,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",40.19,Rate
Kypros,CY00,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",36.16,Rate
Kypros,CY00,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",36.9,Rate
Kypros,CY00,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",35.42,Rate
Kypros,CY00,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",37.5,Rate
Kypros,CY00,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",42.78,Rate
Kypros,CY00,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",36.87,Rate
Kypros,CY00,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",30.78,Rate
Kypros,CY00,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",40.96,Rate
Kypros,CY00,Total,Total,2011,Malignant melanoma of skin,1.68,Rate
Kypros,CY00,Total,Total,2012,Malignant melanoma of skin,1.73,Rate
Kypros,CY00,Total,Total,2013,Malignant melanoma of skin,2.98,Rate
Kypros,CY00,Total,Total,2014,Malignant melanoma of skin,3.04,Rate
Kypros,CY00,Total,Total,2015,Malignant melanoma of skin,2.17,Rate
Kypros,CY00,Total,Total,2016,Malignant melanoma of skin,2.69,Rate
Kypros,CY00,Total,Total,2017,Malignant melanoma of skin,3.37,Rate
Kypros,CY00,Total,Total,2018,Malignant melanoma of skin,1.8,Rate
Kypros,CY00,Total,Total,2019,Malignant melanoma of skin,3.46,Rate
Kypros,CY00,Total,Total,2020,Malignant melanoma of skin,2.04,Rate
Kypros,CY00,Total,Total,2011,Malignant neoplasm of breast,17.58,Rate
Kypros,CY00,Total,Total,2012,Malignant neoplasm of breast,17.1,Rate
Kypros,CY00,Total,Total,2013,Malignant neoplasm of breast,16.75,Rate
Kypros,CY00,Total,Total,2014,Malignant neoplasm of breast,14.7,Rate
Kypros,CY00,Total,Total,2015,Malignant neoplasm of breast,16.84,Rate
Kypros,CY00,Total,Total,2016,Malignant neoplasm of breast,16.18,Rate
Kypros,CY00,Total,Total,2017,Malignant neoplasm of breast,18.19,Rate
Kypros,CY00,Total,Total,2018,Malignant neoplasm of breast,18.35,Rate
Kypros,CY00,Total,Total,2019,Malignant neoplasm of breast,17.62,Rate
Kypros,CY00,Total,Total,2020,Malignant neoplasm of breast,16.26,Rate
Kypros,CY00,Total,Total,2011,Diabetes mellitus,73.54,Rate
Kypros,CY00,Total,Total,2012,Diabetes mellitus,70.75,Rate
Kypros,CY00,Total,Total,2013,Diabetes mellitus,69.7,Rate
Kypros,CY00,Total,Total,2014,Diabetes mellitus,72.36,Rate
Kypros,CY00,Total,Total,2015,Diabetes mellitus,65.48,Rate
Kypros,CY00,Total,Total,2016,Diabetes mellitus,53.3,Rate
Kypros,CY00,Total,Total,2017,Diabetes mellitus,58.01,Rate
Kypros,CY00,Total,Total,2018,Diabetes mellitus,55.25,Rate
Kypros,CY00,Total,Total,2019,Diabetes mellitus,56.06,Rate
Kypros,CY00,Total,Total,2020,Diabetes mellitus,60.29,Rate
Kypros,CY00,Total,Total,2011,Mental and behavioural disorders (F00-F99),18.42,Rate
Kypros,CY00,Total,Total,2012,Mental and behavioural disorders (F00-F99),19.5,Rate
Kypros,CY00,Total,Total,2013,Mental and behavioural disorders (F00-F99),18.78,Rate
Kypros,CY00,Total,Total,2014,Mental and behavioural disorders (F00-F99),23.76,Rate
Kypros,CY00,Total,Total,2015,Mental and behavioural disorders (F00-F99),29.9,Rate
Kypros,CY00,Total,Total,2016,Mental and behavioural disorders (F00-F99),33.06,Rate
Kypros,CY00,Total,Total,2017,Mental and behavioural disorders (F00-F99),38.78,Rate
Kypros,CY00,Total,Total,2018,Mental and behavioural disorders (F00-F99),47.67,Rate
Kypros,CY00,Total,Total,2019,Mental and behavioural disorders (F00-F99),45.33,Rate
Kypros,CY00,Total,Total,2020,Mental and behavioural disorders (F00-F99),40.26,Rate
Kypros,CY00,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Kypros,CY00,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.9,Rate
Kypros,CY00,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.17,Rate
Kypros,CY00,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.62,Rate
Kypros,CY00,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Kypros,CY00,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Kypros,CY00,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.44,Rate
Kypros,CY00,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Kypros,CY00,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Kypros,CY00,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.44,Rate
Kypros,CY00,Total,Total,2011,Other ischaemic heart diseases,70.84,Rate
Kypros,CY00,Total,Total,2012,Other ischaemic heart diseases,62.99,Rate
Kypros,CY00,Total,Total,2013,Other ischaemic heart diseases,48.91,Rate
Kypros,CY00,Total,Total,2014,Other ischaemic heart diseases,58.59,Rate
Kypros,CY00,Total,Total,2015,Other ischaemic heart diseases,58.42,Rate
Kypros,CY00,Total,Total,2016,Other ischaemic heart diseases,52.98,Rate
Kypros,CY00,Total,Total,2017,Other ischaemic heart diseases,51.72,Rate
Kypros,CY00,Total,Total,2018,Other ischaemic heart diseases,48.1,Rate
Kypros,CY00,Total,Total,2019,Other ischaemic heart diseases,39.76,Rate
Kypros,CY00,Total,Total,2020,Other ischaemic heart diseases,50.05,Rate
Kypros,CY00,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,56.12,Rate
Kypros,CY00,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,53.15,Rate
Kypros,CY00,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,55.27,Rate
Kypros,CY00,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,50.14,Rate
Kypros,CY00,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,49.34,Rate
Kypros,CY00,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,47.09,Rate
Kypros,CY00,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,53.14,Rate
Kypros,CY00,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,47.39,Rate
Kypros,CY00,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,41.74,Rate
Kypros,CY00,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,41.36,Rate
Kypros,CY00,Total,Total,2011,Cerebrovascular diseases,85.1,Rate
Kypros,CY00,Total,Total,2012,Cerebrovascular diseases,82.55,Rate
Kypros,CY00,Total,Total,2013,Cerebrovascular diseases,71.86,Rate
Kypros,CY00,Total,Total,2014,Cerebrovascular diseases,70.66,Rate
Kypros,CY00,Total,Total,2015,Cerebrovascular diseases,66.91,Rate
Kypros,CY00,Total,Total,2016,Cerebrovascular diseases,66.52,Rate
Kypros,CY00,Total,Total,2017,Cerebrovascular diseases,70.96,Rate
Kypros,CY00,Total,Total,2018,Cerebrovascular diseases,61.33,Rate
Kypros,CY00,Total,Total,2019,Cerebrovascular diseases,60.72,Rate
Kypros,CY00,Total,Total,2020,Cerebrovascular diseases,53.16,Rate
Kypros,CY00,Total,Total,2011,Chronic lower respiratory diseases,23.28,Rate
Kypros,CY00,Total,Total,2012,Chronic lower respiratory diseases,24.02,Rate
Kypros,CY00,Total,Total,2013,Chronic lower respiratory diseases,28.84,Rate
Kypros,CY00,Total,Total,2014,Chronic lower respiratory diseases,25.08,Rate
Kypros,CY00,Total,Total,2015,Chronic lower respiratory diseases,24.33,Rate
Kypros,CY00,Total,Total,2016,Chronic lower respiratory diseases,27.68,Rate
Kypros,CY00,Total,Total,2017,Chronic lower respiratory diseases,25.24,Rate
Kypros,CY00,Total,Total,2018,Chronic lower respiratory diseases,20.77,Rate
Kypros,CY00,Total,Total,2019,Chronic lower respiratory diseases,23.24,Rate
Kypros,CY00,Total,Total,2020,Chronic lower respiratory diseases,24.5,Rate
Kypros,CY00,Total,Total,2011,Asthma and status asthmaticus,5.84,Rate
Kypros,CY00,Total,Total,2012,Asthma and status asthmaticus,2.95,Rate
Kypros,CY00,Total,Total,2013,Asthma and status asthmaticus,4.94,Rate
Kypros,CY00,Total,Total,2014,Asthma and status asthmaticus,2.9,Rate
Kypros,CY00,Total,Total,2015,Asthma and status asthmaticus,1.73,Rate
Kypros,CY00,Total,Total,2016,Asthma and status asthmaticus,3.39,Rate
Kypros,CY00,Total,Total,2017,Asthma and status asthmaticus,3.69,Rate
Kypros,CY00,Total,Total,2018,Asthma and status asthmaticus,3.83,Rate
Kypros,CY00,Total,Total,2019,Asthma and status asthmaticus,3.83,Rate
Kypros,CY00,Total,Total,2020,Asthma and status asthmaticus,2.75,Rate
Kypros,CY00,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4704.29,Rate
Kypros,CY00,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4850.95,Rate
Kypros,CY00,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4346.22,Rate
Kypros,CY00,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4473.39,Rate
Kypros,CY00,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4779.73,Rate
Kypros,CY00,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4414.71,Rate
Kypros,CY00,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4754.9,Rate
Kypros,CY00,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4288.28,Rate
Kypros,CY00,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4389.68,Rate
Kypros,CY00,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4454.81,Rate
Kypros,CY00,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.78,Rate
Kypros,CY00,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.58,Rate
Kypros,CY00,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.63,Rate
Kypros,CY00,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",62.25,Rate
Kypros,CY00,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.33,Rate
Kypros,CY00,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.58,Rate
Kypros,CY00,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.12,Rate
Kypros,CY00,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.18,Rate
Kypros,CY00,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.0,Rate
Kypros,CY00,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.26,Rate
Kypros,CY00,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",151.01,Rate
Kypros,CY00,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",153.46,Rate
Kypros,CY00,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",142.06,Rate
Kypros,CY00,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",148.94,Rate
Kypros,CY00,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",132.4,Rate
Kypros,CY00,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",152.18,Rate
Kypros,CY00,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",171.31,Rate
Kypros,CY00,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",139.7,Rate
Kypros,CY00,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",117.03,Rate
Kypros,CY00,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",145.14,Rate
Kypros,CY00,65 years or over,Total,2011,Malignant melanoma of skin,3.66,Rate
Kypros,CY00,65 years or over,Total,2012,Malignant melanoma of skin,6.04,Rate
Kypros,CY00,65 years or over,Total,2013,Malignant melanoma of skin,10.25,Rate
Kypros,CY00,65 years or over,Total,2014,Malignant melanoma of skin,9.29,Rate
Kypros,CY00,65 years or over,Total,2015,Malignant melanoma of skin,7.89,Rate
Kypros,CY00,65 years or over,Total,2016,Malignant melanoma of skin,8.81,Rate
Kypros,CY00,65 years or over,Total,2017,Malignant melanoma of skin,12.17,Rate
Kypros,CY00,65 years or over,Total,2018,Malignant melanoma of skin,3.58,Rate
Kypros,CY00,65 years or over,Total,2019,Malignant melanoma of skin,10.62,Rate
Kypros,CY00,65 years or over,Total,2020,Malignant melanoma of skin,5.55,Rate
Kypros,CY00,65 years or over,Total,2011,Malignant neoplasm of breast,54.03,Rate
Kypros,CY00,65 years or over,Total,2012,Malignant neoplasm of breast,56.82,Rate
Kypros,CY00,65 years or over,Total,2013,Malignant neoplasm of breast,59.16,Rate
Kypros,CY00,65 years or over,Total,2014,Malignant neoplasm of breast,49.55,Rate
Kypros,CY00,65 years or over,Total,2015,Malignant neoplasm of breast,59.79,Rate
Kypros,CY00,65 years or over,Total,2016,Malignant neoplasm of breast,58.78,Rate
Kypros,CY00,65 years or over,Total,2017,Malignant neoplasm of breast,65.18,Rate
Kypros,CY00,65 years or over,Total,2018,Malignant neoplasm of breast,65.06,Rate
Kypros,CY00,65 years or over,Total,2019,Malignant neoplasm of breast,57.95,Rate
Kypros,CY00,65 years or over,Total,2020,Malignant neoplasm of breast,55.35,Rate
Kypros,CY00,65 years or over,Total,2011,Diabetes mellitus,361.16,Rate
Kypros,CY00,65 years or over,Total,2012,Diabetes mellitus,344.23,Rate
Kypros,CY00,65 years or over,Total,2013,Diabetes mellitus,345.15,Rate
Kypros,CY00,65 years or over,Total,2014,Diabetes mellitus,355.61,Rate
Kypros,CY00,65 years or over,Total,2015,Diabetes mellitus,321.3,Rate
Kypros,CY00,65 years or over,Total,2016,Diabetes mellitus,256.23,Rate
Kypros,CY00,65 years or over,Total,2017,Diabetes mellitus,281.42,Rate
Kypros,CY00,65 years or over,Total,2018,Diabetes mellitus,267.95,Rate
Kypros,CY00,65 years or over,Total,2019,Diabetes mellitus,270.79,Rate
Kypros,CY00,65 years or over,Total,2020,Diabetes mellitus,285.91,Rate
Kypros,CY00,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),92.45,Rate
Kypros,CY00,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),100.0,Rate
Kypros,CY00,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),92.38,Rate
Kypros,CY00,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),119.88,Rate
Kypros,CY00,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),151.44,Rate
Kypros,CY00,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),166.93,Rate
Kypros,CY00,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),196.93,Rate
Kypros,CY00,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),240.04,Rate
Kypros,CY00,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),230.42,Rate
Kypros,CY00,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),201.35,Rate
Kypros,CY00,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Kypros,CY00,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),9.72,Rate
Kypros,CY00,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Kypros,CY00,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),7.68,Rate
Kypros,CY00,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.52,Rate
Kypros,CY00,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.67,Rate
Kypros,CY00,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.59,Rate
Kypros,CY00,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.59,Rate
Kypros,CY00,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),4.14,Rate
Kypros,CY00,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),10.56,Rate
Kypros,CY00,65 years or over,Total,2011,Other ischaemic heart diseases,350.66,Rate
Kypros,CY00,65 years or over,Total,2012,Other ischaemic heart diseases,313.29,Rate
Kypros,CY00,65 years or over,Total,2013,Other ischaemic heart diseases,237.87,Rate
Kypros,CY00,65 years or over,Total,2014,Other ischaemic heart diseases,289.38,Rate
Kypros,CY00,65 years or over,Total,2015,Other ischaemic heart diseases,284.41,Rate
Kypros,CY00,65 years or over,Total,2016,Other ischaemic heart diseases,255.42,Rate
Kypros,CY00,65 years or over,Total,2017,Other ischaemic heart diseases,250.43,Rate
Kypros,CY00,65 years or over,Total,2018,Other ischaemic heart diseases,240.29,Rate
Kypros,CY00,65 years or over,Total,2019,Other ischaemic heart diseases,193.84,Rate
Kypros,CY00,65 years or over,Total,2020,Other ischaemic heart diseases,237.1,Rate
Kypros,CY00,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,206.84,Rate
Kypros,CY00,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,188.79,Rate
Kypros,CY00,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,218.31,Rate
Kypros,CY00,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,180.57,Rate
Kypros,CY00,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,176.82,Rate
Kypros,CY00,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,168.4,Rate
Kypros,CY00,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,193.1,Rate
Kypros,CY00,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,174.75,Rate
Kypros,CY00,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,140.12,Rate
Kypros,CY00,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,145.64,Rate
Kypros,CY00,65 years or over,Total,2011,Cerebrovascular diseases,423.6,Rate
Kypros,CY00,65 years or over,Total,2012,Cerebrovascular diseases,408.88,Rate
Kypros,CY00,65 years or over,Total,2013,Cerebrovascular diseases,354.44,Rate
Kypros,CY00,65 years or over,Total,2014,Cerebrovascular diseases,346.38,Rate
Kypros,CY00,65 years or over,Total,2015,Cerebrovascular diseases,322.09,Rate
Kypros,CY00,65 years or over,Total,2016,Cerebrovascular diseases,321.47,Rate
Kypros,CY00,65 years or over,Total,2017,Cerebrovascular diseases,343.2,Rate
Kypros,CY00,65 years or over,Total,2018,Cerebrovascular diseases,296.94,Rate
Kypros,CY00,65 years or over,Total,2019,Cerebrovascular diseases,286.07,Rate
Kypros,CY00,65 years or over,Total,2020,Cerebrovascular diseases,254.77,Rate
Kypros,CY00,65 years or over,Total,2011,Chronic lower respiratory diseases,117.37,Rate
Kypros,CY00,65 years or over,Total,2012,Chronic lower respiratory diseases,119.33,Rate
Kypros,CY00,65 years or over,Total,2013,Chronic lower respiratory diseases,142.03,Rate
Kypros,CY00,65 years or over,Total,2014,Chronic lower respiratory diseases,126.1,Rate
Kypros,CY00,65 years or over,Total,2015,Chronic lower respiratory diseases,119.49,Rate
Kypros,CY00,65 years or over,Total,2016,Chronic lower respiratory diseases,134.79,Rate
Kypros,CY00,65 years or over,Total,2017,Chronic lower respiratory diseases,124.91,Rate
Kypros,CY00,65 years or over,Total,2018,Chronic lower respiratory diseases,104.61,Rate
Kypros,CY00,65 years or over,Total,2019,Chronic lower respiratory diseases,112.85,Rate
Kypros,CY00,65 years or over,Total,2020,Chronic lower respiratory diseases,123.68,Rate
Kypros,CY00,65 years or over,Total,2011,Asthma and status asthmaticus,29.94,Rate
Kypros,CY00,65 years or over,Total,2012,Asthma and status asthmaticus,15.14,Rate
Kypros,CY00,65 years or over,Total,2013,Asthma and status asthmaticus,25.34,Rate
Kypros,CY00,65 years or over,Total,2014,Asthma and status asthmaticus,14.85,Rate
Kypros,CY00,65 years or over,Total,2015,Asthma and status asthmaticus,8.89,Rate
Kypros,CY00,65 years or over,Total,2016,Asthma and status asthmaticus,16.8,Rate
Kypros,CY00,65 years or over,Total,2017,Asthma and status asthmaticus,17.65,Rate
Kypros,CY00,65 years or over,Total,2018,Asthma and status asthmaticus,18.99,Rate
Kypros,CY00,65 years or over,Total,2019,Asthma and status asthmaticus,19.01,Rate
Kypros,CY00,65 years or over,Total,2020,Asthma and status asthmaticus,13.41,Rate
Kypros,CY00,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,133.46,Rate
Kypros,CY00,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,136.45,Rate
Kypros,CY00,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,129.2,Rate
Kypros,CY00,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,133.9,Rate
Kypros,CY00,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,143.39,Rate
Kypros,CY00,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,130.86,Rate
Kypros,CY00,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,142.79,Rate
Kypros,CY00,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,133.92,Rate
Kypros,CY00,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,141.95,Rate
Kypros,CY00,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,153.12,Rate
Kypros,CY00,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.85,Rate
Kypros,CY00,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.1,Rate
Kypros,CY00,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.57,Rate
Kypros,CY00,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.7,Rate
Kypros,CY00,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.83,Rate
Kypros,CY00,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.51,Rate
Kypros,CY00,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.65,Rate
Kypros,CY00,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.31,Rate
Kypros,CY00,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.79,Rate
Kypros,CY00,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.68,Rate
Kypros,CY00,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",12.04,Rate
Kypros,CY00,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",12.75,Rate
Kypros,CY00,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",10.51,Rate
Kypros,CY00,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",9.76,Rate
Kypros,CY00,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",11.92,Rate
Kypros,CY00,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",9.71,Rate
Kypros,CY00,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",11.65,Rate
Kypros,CY00,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",11.96,Rate
Kypros,CY00,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",9.89,Rate
Kypros,CY00,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.72,Rate
Kypros,CY00,Less than 65 years,Total,2011,Malignant melanoma of skin,1.2,Rate
Kypros,CY00,Less than 65 years,Total,2012,Malignant melanoma of skin,0.68,Rate
Kypros,CY00,Less than 65 years,Total,2013,Malignant melanoma of skin,1.22,Rate
Kypros,CY00,Less than 65 years,Total,2014,Malignant melanoma of skin,1.52,Rate
Kypros,CY00,Less than 65 years,Total,2015,Malignant melanoma of skin,0.79,Rate
Kypros,CY00,Less than 65 years,Total,2016,Malignant melanoma of skin,1.2,Rate
Kypros,CY00,Less than 65 years,Total,2017,Malignant melanoma of skin,1.23,Rate
Kypros,CY00,Less than 65 years,Total,2018,Malignant melanoma of skin,1.37,Rate
Kypros,CY00,Less than 65 years,Total,2019,Malignant melanoma of skin,1.73,Rate
Kypros,CY00,Less than 65 years,Total,2020,Malignant melanoma of skin,1.19,Rate
Kypros,CY00,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.75,Rate
Kypros,CY00,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.48,Rate
Kypros,CY00,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.48,Rate
Kypros,CY00,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.26,Rate
Kypros,CY00,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.43,Rate
Kypros,CY00,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.87,Rate
Kypros,CY00,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.8,Rate
Kypros,CY00,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.03,Rate
Kypros,CY00,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.85,Rate
Kypros,CY00,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.79,Rate
Kypros,CY00,Less than 65 years,Total,2011,Diabetes mellitus,3.87,Rate
Kypros,CY00,Less than 65 years,Total,2012,Diabetes mellitus,4.51,Rate
Kypros,CY00,Less than 65 years,Total,2013,Diabetes mellitus,2.97,Rate
Kypros,CY00,Less than 65 years,Total,2014,Diabetes mellitus,3.75,Rate
Kypros,CY00,Less than 65 years,Total,2015,Diabetes mellitus,3.51,Rate
Kypros,CY00,Less than 65 years,Total,2016,Diabetes mellitus,4.14,Rate
Kypros,CY00,Less than 65 years,Total,2017,Diabetes mellitus,3.9,Rate
Kypros,CY00,Less than 65 years,Total,2018,Diabetes mellitus,3.72,Rate
Kypros,CY00,Less than 65 years,Total,2019,Diabetes mellitus,4.05,Rate
Kypros,CY00,Less than 65 years,Total,2020,Diabetes mellitus,5.63,Rate
Kypros,CY00,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.49,Rate
Kypros,CY00,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.95,Rate
Kypros,CY00,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.48,Rate
Kypros,CY00,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.45,Rate
Kypros,CY00,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.63,Rate
Kypros,CY00,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.47,Rate
Kypros,CY00,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.07,Rate
Kypros,CY00,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.5,Rate
Kypros,CY00,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.24,Rate
Kypros,CY00,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Kypros,CY00,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Kypros,CY00,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Kypros,CY00,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kypros,CY00,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Kypros,CY00,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Kypros,CY00,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Kypros,CY00,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Kypros,CY00,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Kypros,CY00,Less than 65 years,Total,2011,Other ischaemic heart diseases,3.06,Rate
Kypros,CY00,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.35,Rate
Kypros,CY00,Less than 65 years,Total,2013,Other ischaemic heart diseases,3.14,Rate
Kypros,CY00,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.69,Rate
Kypros,CY00,Less than 65 years,Total,2015,Other ischaemic heart diseases,3.67,Rate
Kypros,CY00,Less than 65 years,Total,2016,Other ischaemic heart diseases,3.94,Rate
Kypros,CY00,Less than 65 years,Total,2017,Other ischaemic heart diseases,3.59,Rate
Kypros,CY00,Less than 65 years,Total,2018,Other ischaemic heart diseases,1.54,Rate
Kypros,CY00,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.44,Rate
Kypros,CY00,Less than 65 years,Total,2020,Other ischaemic heart diseases,4.74,Rate
Kypros,CY00,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,19.61,Rate
Kypros,CY00,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,20.3,Rate
Kypros,CY00,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,15.78,Rate
Kypros,CY00,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,18.54,Rate
Kypros,CY00,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,18.46,Rate
Kypros,CY00,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,17.7,Rate
Kypros,CY00,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,19.23,Rate
Kypros,CY00,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,16.54,Rate
Kypros,CY00,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,17.91,Rate
Kypros,CY00,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,16.1,Rate
Kypros,CY00,Less than 65 years,Total,2011,Cerebrovascular diseases,3.1,Rate
Kypros,CY00,Less than 65 years,Total,2012,Cerebrovascular diseases,3.5,Rate
Kypros,CY00,Less than 65 years,Total,2013,Cerebrovascular diseases,3.41,Rate
Kypros,CY00,Less than 65 years,Total,2014,Cerebrovascular diseases,3.87,Rate
Kypros,CY00,Less than 65 years,Total,2015,Cerebrovascular diseases,5.1,Rate
Kypros,CY00,Less than 65 years,Total,2016,Cerebrovascular diseases,4.76,Rate
Kypros,CY00,Less than 65 years,Total,2017,Cerebrovascular diseases,5.01,Rate
Kypros,CY00,Less than 65 years,Total,2018,Cerebrovascular diseases,4.25,Rate
Kypros,CY00,Less than 65 years,Total,2019,Cerebrovascular diseases,6.13,Rate
Kypros,CY00,Less than 65 years,Total,2020,Cerebrovascular diseases,4.32,Rate
Kypros,CY00,Less than 65 years,Total,2011,Chronic lower respiratory diseases,0.49,Rate
Kypros,CY00,Less than 65 years,Total,2012,Chronic lower respiratory diseases,0.93,Rate
Kypros,CY00,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.42,Rate
Kypros,CY00,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.62,Rate
Kypros,CY00,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.28,Rate
Kypros,CY00,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.73,Rate
Kypros,CY00,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.09,Rate
Kypros,CY00,Less than 65 years,Total,2018,Chronic lower respiratory diseases,0.47,Rate
Kypros,CY00,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.53,Rate
Kypros,CY00,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.47,Rate
Kypros,CY00,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Kypros,CY00,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.14,Rate
Kypros,CY00,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.31,Rate
Kypros,CY00,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.16,Rate
Kypros,CY00,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.15,Rate
Kypros,CY00,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.16,Rate
Praha,CZ01,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,992.62,Rate
Praha,CZ01,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,994.43,Rate
Praha,CZ01,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,962.55,Rate
Praha,CZ01,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,943.07,Rate
Praha,CZ01,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,949.97,Rate
Praha,CZ01,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,910.14,Rate
Praha,CZ01,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,902.49,Rate
Praha,CZ01,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,898.28,Rate
Praha,CZ01,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,868.62,Rate
Praha,CZ01,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,956.3,Rate
Praha,CZ01,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.26,Rate
Praha,CZ01,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.82,Rate
Praha,CZ01,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.96,Rate
Praha,CZ01,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.01,Rate
Praha,CZ01,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.46,Rate
Praha,CZ01,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.33,Rate
Praha,CZ01,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.28,Rate
Praha,CZ01,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.01,Rate
Praha,CZ01,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.41,Rate
Praha,CZ01,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.59,Rate
Praha,CZ01,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",41.82,Rate
Praha,CZ01,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",38.78,Rate
Praha,CZ01,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",38.03,Rate
Praha,CZ01,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",37.33,Rate
Praha,CZ01,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",34.27,Rate
Praha,CZ01,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",40.23,Rate
Praha,CZ01,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",36.95,Rate
Praha,CZ01,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",39.53,Rate
Praha,CZ01,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",37.8,Rate
Praha,CZ01,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",36.51,Rate
Praha,CZ01,Total,Females,2011,Malignant melanoma of skin,3.11,Rate
Praha,CZ01,Total,Females,2012,Malignant melanoma of skin,3.63,Rate
Praha,CZ01,Total,Females,2013,Malignant melanoma of skin,2.25,Rate
Praha,CZ01,Total,Females,2014,Malignant melanoma of skin,2.06,Rate
Praha,CZ01,Total,Females,2015,Malignant melanoma of skin,2.61,Rate
Praha,CZ01,Total,Females,2016,Malignant melanoma of skin,4.51,Rate
Praha,CZ01,Total,Females,2017,Malignant melanoma of skin,5.21,Rate
Praha,CZ01,Total,Females,2018,Malignant melanoma of skin,2.56,Rate
Praha,CZ01,Total,Females,2019,Malignant melanoma of skin,3.16,Rate
Praha,CZ01,Total,Females,2020,Malignant melanoma of skin,2.04,Rate
Praha,CZ01,Total,Females,2011,Malignant neoplasm of breast,38.71,Rate
Praha,CZ01,Total,Females,2012,Malignant neoplasm of breast,32.84,Rate
Praha,CZ01,Total,Females,2013,Malignant neoplasm of breast,34.4,Rate
Praha,CZ01,Total,Females,2014,Malignant neoplasm of breast,35.32,Rate
Praha,CZ01,Total,Females,2015,Malignant neoplasm of breast,37.66,Rate
Praha,CZ01,Total,Females,2016,Malignant neoplasm of breast,32.79,Rate
Praha,CZ01,Total,Females,2017,Malignant neoplasm of breast,33.85,Rate
Praha,CZ01,Total,Females,2018,Malignant neoplasm of breast,30.29,Rate
Praha,CZ01,Total,Females,2019,Malignant neoplasm of breast,34.86,Rate
Praha,CZ01,Total,Females,2020,Malignant neoplasm of breast,31.39,Rate
Praha,CZ01,Total,Females,2011,Diabetes mellitus,15.0,Rate
Praha,CZ01,Total,Females,2012,Diabetes mellitus,13.73,Rate
Praha,CZ01,Total,Females,2013,Diabetes mellitus,31.45,Rate
Praha,CZ01,Total,Females,2014,Diabetes mellitus,25.59,Rate
Praha,CZ01,Total,Females,2015,Diabetes mellitus,27.28,Rate
Praha,CZ01,Total,Females,2016,Diabetes mellitus,28.18,Rate
Praha,CZ01,Total,Females,2017,Diabetes mellitus,22.49,Rate
Praha,CZ01,Total,Females,2018,Diabetes mellitus,25.52,Rate
Praha,CZ01,Total,Females,2019,Diabetes mellitus,24.03,Rate
Praha,CZ01,Total,Females,2020,Diabetes mellitus,25.6,Rate
Praha,CZ01,Total,Females,2011,Mental and behavioural disorders (F00-F99),12.32,Rate
Praha,CZ01,Total,Females,2012,Mental and behavioural disorders (F00-F99),12.92,Rate
Praha,CZ01,Total,Females,2013,Mental and behavioural disorders (F00-F99),18.9,Rate
Praha,CZ01,Total,Females,2014,Mental and behavioural disorders (F00-F99),16.75,Rate
Praha,CZ01,Total,Females,2015,Mental and behavioural disorders (F00-F99),19.4,Rate
Praha,CZ01,Total,Females,2016,Mental and behavioural disorders (F00-F99),16.91,Rate
Praha,CZ01,Total,Females,2017,Mental and behavioural disorders (F00-F99),27.16,Rate
Praha,CZ01,Total,Females,2018,Mental and behavioural disorders (F00-F99),17.64,Rate
Praha,CZ01,Total,Females,2019,Mental and behavioural disorders (F00-F99),22.26,Rate
Praha,CZ01,Total,Females,2020,Mental and behavioural disorders (F00-F99),24.38,Rate
Praha,CZ01,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Praha,CZ01,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Praha,CZ01,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Praha,CZ01,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Praha,CZ01,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Praha,CZ01,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Praha,CZ01,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Praha,CZ01,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Praha,CZ01,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Praha,CZ01,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Praha,CZ01,Total,Females,2011,Other ischaemic heart diseases,211.6,Rate
Praha,CZ01,Total,Females,2012,Other ischaemic heart diseases,216.47,Rate
Praha,CZ01,Total,Females,2013,Other ischaemic heart diseases,231.36,Rate
Praha,CZ01,Total,Females,2014,Other ischaemic heart diseases,224.59,Rate
Praha,CZ01,Total,Females,2015,Other ischaemic heart diseases,210.8,Rate
Praha,CZ01,Total,Females,2016,Other ischaemic heart diseases,186.74,Rate
Praha,CZ01,Total,Females,2017,Other ischaemic heart diseases,195.65,Rate
Praha,CZ01,Total,Females,2018,Other ischaemic heart diseases,172.49,Rate
Praha,CZ01,Total,Females,2019,Other ischaemic heart diseases,168.36,Rate
Praha,CZ01,Total,Females,2020,Other ischaemic heart diseases,181.13,Rate
Praha,CZ01,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,38.05,Rate
Praha,CZ01,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,40.22,Rate
Praha,CZ01,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,30.75,Rate
Praha,CZ01,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,26.22,Rate
Praha,CZ01,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,26.2,Rate
Praha,CZ01,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,27.24,Rate
Praha,CZ01,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,27.92,Rate
Praha,CZ01,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,23.69,Rate
Praha,CZ01,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,21.96,Rate
Praha,CZ01,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,22.0,Rate
Praha,CZ01,Total,Females,2011,Cerebrovascular diseases,113.96,Rate
Praha,CZ01,Total,Females,2012,Cerebrovascular diseases,98.32,Rate
Praha,CZ01,Total,Females,2013,Cerebrovascular diseases,93.65,Rate
Praha,CZ01,Total,Females,2014,Cerebrovascular diseases,90.21,Rate
Praha,CZ01,Total,Females,2015,Cerebrovascular diseases,86.04,Rate
Praha,CZ01,Total,Females,2016,Cerebrovascular diseases,76.14,Rate
Praha,CZ01,Total,Females,2017,Cerebrovascular diseases,72.62,Rate
Praha,CZ01,Total,Females,2018,Cerebrovascular diseases,65.87,Rate
Praha,CZ01,Total,Females,2019,Cerebrovascular diseases,60.64,Rate
Praha,CZ01,Total,Females,2020,Cerebrovascular diseases,52.84,Rate
Praha,CZ01,Total,Females,2011,Chronic lower respiratory diseases,24.65,Rate
Praha,CZ01,Total,Females,2012,Chronic lower respiratory diseases,21.04,Rate
Praha,CZ01,Total,Females,2013,Chronic lower respiratory diseases,32.93,Rate
Praha,CZ01,Total,Females,2014,Chronic lower respiratory diseases,27.62,Rate
Praha,CZ01,Total,Females,2015,Chronic lower respiratory diseases,37.31,Rate
Praha,CZ01,Total,Females,2016,Chronic lower respiratory diseases,28.96,Rate
Praha,CZ01,Total,Females,2017,Chronic lower respiratory diseases,29.96,Rate
Praha,CZ01,Total,Females,2018,Chronic lower respiratory diseases,30.15,Rate
Praha,CZ01,Total,Females,2019,Chronic lower respiratory diseases,29.13,Rate
Praha,CZ01,Total,Females,2020,Chronic lower respiratory diseases,29.33,Rate
Praha,CZ01,Total,Females,2011,Asthma and status asthmaticus,1.1,Rate
Praha,CZ01,Total,Females,2012,Asthma and status asthmaticus,1.12,Rate
Praha,CZ01,Total,Females,2013,Asthma and status asthmaticus,0.49,Rate
Praha,CZ01,Total,Females,2014,Asthma and status asthmaticus,1.83,Rate
Praha,CZ01,Total,Females,2015,Asthma and status asthmaticus,0.88,Rate
Praha,CZ01,Total,Females,2016,Asthma and status asthmaticus,1.23,Rate
Praha,CZ01,Total,Females,2017,Asthma and status asthmaticus,1.2,Rate
Praha,CZ01,Total,Females,2018,Asthma and status asthmaticus,1.74,Rate
Praha,CZ01,Total,Females,2019,Asthma and status asthmaticus,1.14,Rate
Praha,CZ01,Total,Females,2020,Asthma and status asthmaticus,2.7,Rate
Praha,CZ01,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4476.42,Rate
Praha,CZ01,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4494.36,Rate
Praha,CZ01,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4379.7,Rate
Praha,CZ01,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,4275.15,Rate
Praha,CZ01,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4349.61,Rate
Praha,CZ01,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,4107.78,Rate
Praha,CZ01,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,4125.78,Rate
Praha,CZ01,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,4125.53,Rate
Praha,CZ01,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3958.17,Rate
Praha,CZ01,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4408.94,Rate
Praha,CZ01,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.56,Rate
Praha,CZ01,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.71,Rate
Praha,CZ01,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.88,Rate
Praha,CZ01,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.27,Rate
Praha,CZ01,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.57,Rate
Praha,CZ01,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.46,Rate
Praha,CZ01,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.21,Rate
Praha,CZ01,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.75,Rate
Praha,CZ01,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.56,Rate
Praha,CZ01,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.95,Rate
Praha,CZ01,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",164.74,Rate
Praha,CZ01,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",147.69,Rate
Praha,CZ01,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",141.92,Rate
Praha,CZ01,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",149.5,Rate
Praha,CZ01,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",140.31,Rate
Praha,CZ01,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",158.64,Rate
Praha,CZ01,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",149.89,Rate
Praha,CZ01,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",160.86,Rate
Praha,CZ01,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",156.92,Rate
Praha,CZ01,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",154.47,Rate
Praha,CZ01,65 years or over,Females,2011,Malignant melanoma of skin,7.37,Rate
Praha,CZ01,65 years or over,Females,2012,Malignant melanoma of skin,14.53,Rate
Praha,CZ01,65 years or over,Females,2013,Malignant melanoma of skin,7.45,Rate
Praha,CZ01,65 years or over,Females,2014,Malignant melanoma of skin,6.48,Rate
Praha,CZ01,65 years or over,Females,2015,Malignant melanoma of skin,10.9,Rate
Praha,CZ01,65 years or over,Females,2016,Malignant melanoma of skin,17.77,Rate
Praha,CZ01,65 years or over,Females,2017,Malignant melanoma of skin,19.36,Rate
Praha,CZ01,65 years or over,Females,2018,Malignant melanoma of skin,9.43,Rate
Praha,CZ01,65 years or over,Females,2019,Malignant melanoma of skin,12.2,Rate
Praha,CZ01,65 years or over,Females,2020,Malignant melanoma of skin,7.52,Rate
Praha,CZ01,65 years or over,Females,2011,Malignant neoplasm of breast,145.43,Rate
Praha,CZ01,65 years or over,Females,2012,Malignant neoplasm of breast,117.99,Rate
Praha,CZ01,65 years or over,Females,2013,Malignant neoplasm of breast,131.97,Rate
Praha,CZ01,65 years or over,Females,2014,Malignant neoplasm of breast,122.07,Rate
Praha,CZ01,65 years or over,Females,2015,Malignant neoplasm of breast,140.65,Rate
Praha,CZ01,65 years or over,Females,2016,Malignant neoplasm of breast,121.47,Rate
Praha,CZ01,65 years or over,Females,2017,Malignant neoplasm of breast,125.82,Rate
Praha,CZ01,65 years or over,Females,2018,Malignant neoplasm of breast,110.69,Rate
Praha,CZ01,65 years or over,Females,2019,Malignant neoplasm of breast,127.32,Rate
Praha,CZ01,65 years or over,Females,2020,Malignant neoplasm of breast,115.53,Rate
Praha,CZ01,65 years or over,Females,2011,Diabetes mellitus,70.8,Rate
Praha,CZ01,65 years or over,Females,2012,Diabetes mellitus,59.2,Rate
Praha,CZ01,65 years or over,Females,2013,Diabetes mellitus,149.83,Rate
Praha,CZ01,65 years or over,Females,2014,Diabetes mellitus,123.24,Rate
Praha,CZ01,65 years or over,Females,2015,Diabetes mellitus,135.68,Rate
Praha,CZ01,65 years or over,Females,2016,Diabetes mellitus,133.77,Rate
Praha,CZ01,65 years or over,Females,2017,Diabetes mellitus,112.02,Rate
Praha,CZ01,65 years or over,Females,2018,Diabetes mellitus,126.64,Rate
Praha,CZ01,65 years or over,Females,2019,Diabetes mellitus,119.42,Rate
Praha,CZ01,65 years or over,Females,2020,Diabetes mellitus,127.22,Rate
Praha,CZ01,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),60.35,Rate
Praha,CZ01,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),64.57,Rate
Praha,CZ01,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),94.65,Rate
Praha,CZ01,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),83.27,Rate
Praha,CZ01,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),97.21,Rate
Praha,CZ01,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),84.74,Rate
Praha,CZ01,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),137.08,Rate
Praha,CZ01,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),90.44,Rate
Praha,CZ01,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),111.05,Rate
Praha,CZ01,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),120.24,Rate
Praha,CZ01,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.09,Rate
Praha,CZ01,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.64,Rate
Praha,CZ01,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.51,Rate
Praha,CZ01,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Praha,CZ01,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.72,Rate
Praha,CZ01,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.71,Rate
Praha,CZ01,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.22,Rate
Praha,CZ01,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.31,Rate
Praha,CZ01,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),4.86,Rate
Praha,CZ01,65 years or over,Females,2011,Other ischaemic heart diseases,1060.03,Rate
Praha,CZ01,65 years or over,Females,2012,Other ischaemic heart diseases,1075.77,Rate
Praha,CZ01,65 years or over,Females,2013,Other ischaemic heart diseases,1157.7,Rate
Praha,CZ01,65 years or over,Females,2014,Other ischaemic heart diseases,1124.13,Rate
Praha,CZ01,65 years or over,Females,2015,Other ischaemic heart diseases,1054.18,Rate
Praha,CZ01,65 years or over,Females,2016,Other ischaemic heart diseases,929.19,Rate
Praha,CZ01,65 years or over,Females,2017,Other ischaemic heart diseases,975.29,Rate
Praha,CZ01,65 years or over,Females,2018,Other ischaemic heart diseases,860.82,Rate
Praha,CZ01,65 years or over,Females,2019,Other ischaemic heart diseases,840.16,Rate
Praha,CZ01,65 years or over,Females,2020,Other ischaemic heart diseases,905.49,Rate
Praha,CZ01,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,175.99,Rate
Praha,CZ01,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,188.06,Rate
Praha,CZ01,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,145.12,Rate
Praha,CZ01,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,121.67,Rate
Praha,CZ01,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,117.37,Rate
Praha,CZ01,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,127.33,Rate
Praha,CZ01,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,135.16,Rate
Praha,CZ01,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,115.1,Rate
Praha,CZ01,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,102.3,Rate
Praha,CZ01,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,103.84,Rate
Praha,CZ01,65 years or over,Females,2011,Cerebrovascular diseases,562.3,Rate
Praha,CZ01,65 years or over,Females,2012,Cerebrovascular diseases,479.55,Rate
Praha,CZ01,65 years or over,Females,2013,Cerebrovascular diseases,459.93,Rate
Praha,CZ01,65 years or over,Females,2014,Cerebrovascular diseases,446.26,Rate
Praha,CZ01,65 years or over,Females,2015,Cerebrovascular diseases,427.51,Rate
Praha,CZ01,65 years or over,Females,2016,Cerebrovascular diseases,373.86,Rate
Praha,CZ01,65 years or over,Females,2017,Cerebrovascular diseases,349.37,Rate
Praha,CZ01,65 years or over,Females,2018,Cerebrovascular diseases,316.06,Rate
Praha,CZ01,65 years or over,Females,2019,Cerebrovascular diseases,298.08,Rate
Praha,CZ01,65 years or over,Females,2020,Cerebrovascular diseases,256.79,Rate
Praha,CZ01,65 years or over,Females,2011,Chronic lower respiratory diseases,109.5,Rate
Praha,CZ01,65 years or over,Females,2012,Chronic lower respiratory diseases,93.15,Rate
Praha,CZ01,65 years or over,Females,2013,Chronic lower respiratory diseases,154.86,Rate
Praha,CZ01,65 years or over,Females,2014,Chronic lower respiratory diseases,123.93,Rate
Praha,CZ01,65 years or over,Females,2015,Chronic lower respiratory diseases,177.63,Rate
Praha,CZ01,65 years or over,Females,2016,Chronic lower respiratory diseases,134.53,Rate
Praha,CZ01,65 years or over,Females,2017,Chronic lower respiratory diseases,135.68,Rate
Praha,CZ01,65 years or over,Females,2018,Chronic lower respiratory diseases,140.1,Rate
Praha,CZ01,65 years or over,Females,2019,Chronic lower respiratory diseases,142.27,Rate
Praha,CZ01,65 years or over,Females,2020,Chronic lower respiratory diseases,143.93,Rate
Praha,CZ01,65 years or over,Females,2011,Asthma and status asthmaticus,5.65,Rate
Praha,CZ01,65 years or over,Females,2012,Asthma and status asthmaticus,5.05,Rate
Praha,CZ01,65 years or over,Females,2013,Asthma and status asthmaticus,2.5,Rate
Praha,CZ01,65 years or over,Females,2014,Asthma and status asthmaticus,5.76,Rate
Praha,CZ01,65 years or over,Females,2015,Asthma and status asthmaticus,3.79,Rate
Praha,CZ01,65 years or over,Females,2016,Asthma and status asthmaticus,6.32,Rate
Praha,CZ01,65 years or over,Females,2017,Asthma and status asthmaticus,5.39,Rate
Praha,CZ01,65 years or over,Females,2018,Asthma and status asthmaticus,8.34,Rate
Praha,CZ01,65 years or over,Females,2019,Asthma and status asthmaticus,5.87,Rate
Praha,CZ01,65 years or over,Females,2020,Asthma and status asthmaticus,13.2,Rate
Praha,CZ01,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,148.71,Rate
Praha,CZ01,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,146.62,Rate
Praha,CZ01,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,134.79,Rate
Praha,CZ01,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,135.92,Rate
Praha,CZ01,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,126.46,Rate
Praha,CZ01,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,135.56,Rate
Praha,CZ01,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,121.69,Rate
Praha,CZ01,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,116.52,Rate
Praha,CZ01,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,120.22,Rate
Praha,CZ01,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,119.95,Rate
Praha,CZ01,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.08,Rate
Praha,CZ01,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.22,Rate
Praha,CZ01,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.21,Rate
Praha,CZ01,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.75,Rate
Praha,CZ01,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.02,Rate
Praha,CZ01,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.41,Rate
Praha,CZ01,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.4,Rate
Praha,CZ01,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.79,Rate
Praha,CZ01,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.33,Rate
Praha,CZ01,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.79,Rate
Praha,CZ01,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",12.05,Rate
Praha,CZ01,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",12.4,Rate
Praha,CZ01,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",12.87,Rate
Praha,CZ01,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",10.16,Rate
Praha,CZ01,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",8.58,Rate
Praha,CZ01,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",11.55,Rate
Praha,CZ01,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",9.59,Rate
Praha,CZ01,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",10.14,Rate
Praha,CZ01,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.94,Rate
Praha,CZ01,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",7.93,Rate
Praha,CZ01,Less than 65 years,Females,2011,Malignant melanoma of skin,2.08,Rate
Praha,CZ01,Less than 65 years,Females,2012,Malignant melanoma of skin,0.99,Rate
Praha,CZ01,Less than 65 years,Females,2013,Malignant melanoma of skin,0.99,Rate
Praha,CZ01,Less than 65 years,Females,2014,Malignant melanoma of skin,0.99,Rate
Praha,CZ01,Less than 65 years,Females,2015,Malignant melanoma of skin,0.61,Rate
Praha,CZ01,Less than 65 years,Females,2016,Malignant melanoma of skin,1.3,Rate
Praha,CZ01,Less than 65 years,Females,2017,Malignant melanoma of skin,1.78,Rate
Praha,CZ01,Less than 65 years,Females,2018,Malignant melanoma of skin,0.9,Rate
Praha,CZ01,Less than 65 years,Females,2019,Malignant melanoma of skin,0.97,Rate
Praha,CZ01,Less than 65 years,Females,2020,Malignant melanoma of skin,0.71,Rate
Praha,CZ01,Less than 65 years,Females,2011,Malignant neoplasm of breast,12.86,Rate
Praha,CZ01,Less than 65 years,Females,2012,Malignant neoplasm of breast,12.21,Rate
Praha,CZ01,Less than 65 years,Females,2013,Malignant neoplasm of breast,10.77,Rate
Praha,CZ01,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.3,Rate
Praha,CZ01,Less than 65 years,Females,2015,Malignant neoplasm of breast,12.71,Rate
Praha,CZ01,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.31,Rate
Praha,CZ01,Less than 65 years,Females,2017,Malignant neoplasm of breast,11.57,Rate
Praha,CZ01,Less than 65 years,Females,2018,Malignant neoplasm of breast,10.82,Rate
Praha,CZ01,Less than 65 years,Females,2019,Malignant neoplasm of breast,12.47,Rate
Praha,CZ01,Less than 65 years,Females,2020,Malignant neoplasm of breast,11.0,Rate
Praha,CZ01,Less than 65 years,Females,2011,Diabetes mellitus,1.48,Rate
Praha,CZ01,Less than 65 years,Females,2012,Diabetes mellitus,2.71,Rate
Praha,CZ01,Less than 65 years,Females,2013,Diabetes mellitus,2.77,Rate
Praha,CZ01,Less than 65 years,Females,2014,Diabetes mellitus,1.94,Rate
Praha,CZ01,Less than 65 years,Females,2015,Diabetes mellitus,1.02,Rate
Praha,CZ01,Less than 65 years,Females,2016,Diabetes mellitus,2.6,Rate
Praha,CZ01,Less than 65 years,Females,2017,Diabetes mellitus,0.8,Rate
Praha,CZ01,Less than 65 years,Females,2018,Diabetes mellitus,1.02,Rate
Praha,CZ01,Less than 65 years,Females,2019,Diabetes mellitus,0.93,Rate
Praha,CZ01,Less than 65 years,Females,2020,Diabetes mellitus,0.98,Rate
Praha,CZ01,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.69,Rate
Praha,CZ01,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.4,Rate
Praha,CZ01,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.55,Rate
Praha,CZ01,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.64,Rate
Praha,CZ01,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.56,Rate
Praha,CZ01,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.48,Rate
Praha,CZ01,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.54,Rate
Praha,CZ01,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.75,Rate
Praha,CZ01,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.16,Rate
Praha,CZ01,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Praha,CZ01,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Praha,CZ01,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Praha,CZ01,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Praha,CZ01,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Praha,CZ01,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Praha,CZ01,Less than 65 years,Females,2011,Other ischaemic heart diseases,6.08,Rate
Praha,CZ01,Less than 65 years,Females,2012,Other ischaemic heart diseases,8.32,Rate
Praha,CZ01,Less than 65 years,Females,2013,Other ischaemic heart diseases,6.97,Rate
Praha,CZ01,Less than 65 years,Females,2014,Other ischaemic heart diseases,6.68,Rate
Praha,CZ01,Less than 65 years,Females,2015,Other ischaemic heart diseases,6.51,Rate
Praha,CZ01,Less than 65 years,Females,2016,Other ischaemic heart diseases,6.89,Rate
Praha,CZ01,Less than 65 years,Females,2017,Other ischaemic heart diseases,6.79,Rate
Praha,CZ01,Less than 65 years,Females,2018,Other ischaemic heart diseases,5.75,Rate
Praha,CZ01,Less than 65 years,Females,2019,Other ischaemic heart diseases,5.62,Rate
Praha,CZ01,Less than 65 years,Females,2020,Other ischaemic heart diseases,5.66,Rate
Praha,CZ01,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.63,Rate
Praha,CZ01,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,4.41,Rate
Praha,CZ01,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.05,Rate
Praha,CZ01,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.1,Rate
Praha,CZ01,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.11,Rate
Praha,CZ01,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.0,Rate
Praha,CZ01,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,1.94,Rate
Praha,CZ01,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.54,Rate
Praha,CZ01,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.5,Rate
Praha,CZ01,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.18,Rate
Praha,CZ01,Less than 65 years,Females,2011,Cerebrovascular diseases,5.36,Rate
Praha,CZ01,Less than 65 years,Females,2012,Cerebrovascular diseases,5.97,Rate
Praha,CZ01,Less than 65 years,Females,2013,Cerebrovascular diseases,4.92,Rate
Praha,CZ01,Less than 65 years,Females,2014,Cerebrovascular diseases,3.96,Rate
Praha,CZ01,Less than 65 years,Females,2015,Cerebrovascular diseases,3.32,Rate
Praha,CZ01,Less than 65 years,Females,2016,Cerebrovascular diseases,4.02,Rate
Praha,CZ01,Less than 65 years,Females,2017,Cerebrovascular diseases,5.59,Rate
Praha,CZ01,Less than 65 years,Females,2018,Cerebrovascular diseases,5.27,Rate
Praha,CZ01,Less than 65 years,Females,2019,Cerebrovascular diseases,3.12,Rate
Praha,CZ01,Less than 65 years,Females,2020,Cerebrovascular diseases,3.43,Rate
Praha,CZ01,Less than 65 years,Females,2011,Chronic lower respiratory diseases,4.09,Rate
Praha,CZ01,Less than 65 years,Females,2012,Chronic lower respiratory diseases,3.58,Rate
Praha,CZ01,Less than 65 years,Females,2013,Chronic lower respiratory diseases,3.4,Rate
Praha,CZ01,Less than 65 years,Females,2014,Chronic lower respiratory diseases,4.29,Rate
Praha,CZ01,Less than 65 years,Females,2015,Chronic lower respiratory diseases,3.32,Rate
Praha,CZ01,Less than 65 years,Females,2016,Chronic lower respiratory diseases,3.39,Rate
Praha,CZ01,Less than 65 years,Females,2017,Chronic lower respiratory diseases,4.35,Rate
Praha,CZ01,Less than 65 years,Females,2018,Chronic lower respiratory diseases,3.51,Rate
Praha,CZ01,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.72,Rate
Praha,CZ01,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.57,Rate
Praha,CZ01,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.16,Rate
Praha,CZ01,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.87,Rate
Praha,CZ01,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.17,Rate
Praha,CZ01,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.18,Rate
Praha,CZ01,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.15,Rate
Praha,CZ01,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.16,Rate
Praha,CZ01,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1442.34,Rate
Praha,CZ01,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1438.27,Rate
Praha,CZ01,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1414.46,Rate
Praha,CZ01,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1333.94,Rate
Praha,CZ01,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1386.6,Rate
Praha,CZ01,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1331.33,Rate
Praha,CZ01,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1283.36,Rate
Praha,CZ01,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1297.99,Rate
Praha,CZ01,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1268.8,Rate
Praha,CZ01,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1436.55,Rate
Praha,CZ01,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.35,Rate
Praha,CZ01,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.13,Rate
Praha,CZ01,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.99,Rate
Praha,CZ01,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.28,Rate
Praha,CZ01,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.05,Rate
Praha,CZ01,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.96,Rate
Praha,CZ01,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.22,Rate
Praha,CZ01,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.92,Rate
Praha,CZ01,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.69,Rate
Praha,CZ01,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.51,Rate
Praha,CZ01,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",78.51,Rate
Praha,CZ01,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",82.41,Rate
Praha,CZ01,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",76.36,Rate
Praha,CZ01,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",68.36,Rate
Praha,CZ01,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",76.06,Rate
Praha,CZ01,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",81.45,Rate
Praha,CZ01,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",76.21,Rate
Praha,CZ01,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",63.13,Rate
Praha,CZ01,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",68.61,Rate
Praha,CZ01,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",56.02,Rate
Praha,CZ01,Total,Males,2011,Malignant melanoma of skin,5.38,Rate
Praha,CZ01,Total,Males,2012,Malignant melanoma of skin,5.18,Rate
Praha,CZ01,Total,Males,2013,Malignant melanoma of skin,4.56,Rate
Praha,CZ01,Total,Males,2014,Malignant melanoma of skin,7.7,Rate
Praha,CZ01,Total,Males,2015,Malignant melanoma of skin,5.9,Rate
Praha,CZ01,Total,Males,2016,Malignant melanoma of skin,6.93,Rate
Praha,CZ01,Total,Males,2017,Malignant melanoma of skin,7.41,Rate
Praha,CZ01,Total,Males,2018,Malignant melanoma of skin,4.73,Rate
Praha,CZ01,Total,Males,2019,Malignant melanoma of skin,6.25,Rate
Praha,CZ01,Total,Males,2020,Malignant melanoma of skin,6.62,Rate
Praha,CZ01,Total,Males,2011,Malignant neoplasm of breast,0.58,Rate
Praha,CZ01,Total,Males,2013,Malignant neoplasm of breast,0.4,Rate
Praha,CZ01,Total,Males,2014,Malignant neoplasm of breast,0.5,Rate
Praha,CZ01,Total,Males,2015,Malignant neoplasm of breast,0.5,Rate
Praha,CZ01,Total,Males,2017,Malignant neoplasm of breast,0.41,Rate
Praha,CZ01,Total,Males,2018,Malignant neoplasm of breast,0.25,Rate
Praha,CZ01,Total,Males,2019,Malignant neoplasm of breast,0.25,Rate
Praha,CZ01,Total,Males,2020,Malignant neoplasm of breast,0.65,Rate
Praha,CZ01,Total,Males,2011,Diabetes mellitus,25.88,Rate
Praha,CZ01,Total,Males,2012,Diabetes mellitus,20.53,Rate
Praha,CZ01,Total,Males,2013,Diabetes mellitus,39.2,Rate
Praha,CZ01,Total,Males,2014,Diabetes mellitus,40.11,Rate
Praha,CZ01,Total,Males,2015,Diabetes mellitus,42.08,Rate
Praha,CZ01,Total,Males,2016,Diabetes mellitus,36.56,Rate
Praha,CZ01,Total,Males,2017,Diabetes mellitus,32.06,Rate
Praha,CZ01,Total,Males,2018,Diabetes mellitus,36.9,Rate
Praha,CZ01,Total,Males,2019,Diabetes mellitus,35.46,Rate
Praha,CZ01,Total,Males,2020,Diabetes mellitus,39.27,Rate
Praha,CZ01,Total,Males,2011,Mental and behavioural disorders (F00-F99),14.24,Rate
Praha,CZ01,Total,Males,2012,Mental and behavioural disorders (F00-F99),20.77,Rate
Praha,CZ01,Total,Males,2013,Mental and behavioural disorders (F00-F99),20.09,Rate
Praha,CZ01,Total,Males,2014,Mental and behavioural disorders (F00-F99),15.9,Rate
Praha,CZ01,Total,Males,2015,Mental and behavioural disorders (F00-F99),17.47,Rate
Praha,CZ01,Total,Males,2016,Mental and behavioural disorders (F00-F99),16.19,Rate
Praha,CZ01,Total,Males,2017,Mental and behavioural disorders (F00-F99),25.64,Rate
Praha,CZ01,Total,Males,2018,Mental and behavioural disorders (F00-F99),17.91,Rate
Praha,CZ01,Total,Males,2019,Mental and behavioural disorders (F00-F99),25.48,Rate
Praha,CZ01,Total,Males,2020,Mental and behavioural disorders (F00-F99),21.3,Rate
Praha,CZ01,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Praha,CZ01,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.62,Rate
Praha,CZ01,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.54,Rate
Praha,CZ01,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Praha,CZ01,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Praha,CZ01,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Praha,CZ01,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Praha,CZ01,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Praha,CZ01,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Praha,CZ01,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Praha,CZ01,Total,Males,2011,Other ischaemic heart diseases,323.59,Rate
Praha,CZ01,Total,Males,2012,Other ischaemic heart diseases,315.42,Rate
Praha,CZ01,Total,Males,2013,Other ischaemic heart diseases,320.28,Rate
Praha,CZ01,Total,Males,2014,Other ischaemic heart diseases,293.88,Rate
Praha,CZ01,Total,Males,2015,Other ischaemic heart diseases,318.72,Rate
Praha,CZ01,Total,Males,2016,Other ischaemic heart diseases,280.43,Rate
Praha,CZ01,Total,Males,2017,Other ischaemic heart diseases,265.45,Rate
Praha,CZ01,Total,Males,2018,Other ischaemic heart diseases,266.38,Rate
Praha,CZ01,Total,Males,2019,Other ischaemic heart diseases,247.48,Rate
Praha,CZ01,Total,Males,2020,Other ischaemic heart diseases,276.3,Rate
Praha,CZ01,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,70.96,Rate
Praha,CZ01,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,86.24,Rate
Praha,CZ01,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,61.2,Rate
Praha,CZ01,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,60.27,Rate
Praha,CZ01,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,55.19,Rate
Praha,CZ01,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,52.11,Rate
Praha,CZ01,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,50.87,Rate
Praha,CZ01,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,48.18,Rate
Praha,CZ01,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,38.71,Rate
Praha,CZ01,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,40.08,Rate
Praha,CZ01,Total,Males,2011,Cerebrovascular diseases,114.52,Rate
Praha,CZ01,Total,Males,2012,Cerebrovascular diseases,115.22,Rate
Praha,CZ01,Total,Males,2013,Cerebrovascular diseases,114.89,Rate
Praha,CZ01,Total,Males,2014,Cerebrovascular diseases,93.04,Rate
Praha,CZ01,Total,Males,2015,Cerebrovascular diseases,102.17,Rate
Praha,CZ01,Total,Males,2016,Cerebrovascular diseases,91.91,Rate
Praha,CZ01,Total,Males,2017,Cerebrovascular diseases,89.57,Rate
Praha,CZ01,Total,Males,2018,Cerebrovascular diseases,78.73,Rate
Praha,CZ01,Total,Males,2019,Cerebrovascular diseases,66.8,Rate
Praha,CZ01,Total,Males,2020,Cerebrovascular diseases,71.78,Rate
Praha,CZ01,Total,Males,2011,Chronic lower respiratory diseases,43.62,Rate
Praha,CZ01,Total,Males,2012,Chronic lower respiratory diseases,43.69,Rate
Praha,CZ01,Total,Males,2013,Chronic lower respiratory diseases,56.08,Rate
Praha,CZ01,Total,Males,2014,Chronic lower respiratory diseases,46.16,Rate
Praha,CZ01,Total,Males,2015,Chronic lower respiratory diseases,57.07,Rate
Praha,CZ01,Total,Males,2016,Chronic lower respiratory diseases,44.41,Rate
Praha,CZ01,Total,Males,2017,Chronic lower respiratory diseases,47.19,Rate
Praha,CZ01,Total,Males,2018,Chronic lower respiratory diseases,52.59,Rate
Praha,CZ01,Total,Males,2019,Chronic lower respiratory diseases,39.67,Rate
Praha,CZ01,Total,Males,2020,Chronic lower respiratory diseases,40.08,Rate
Praha,CZ01,Total,Males,2011,Asthma and status asthmaticus,0.53,Rate
Praha,CZ01,Total,Males,2012,Asthma and status asthmaticus,1.39,Rate
Praha,CZ01,Total,Males,2013,Asthma and status asthmaticus,0.9,Rate
Praha,CZ01,Total,Males,2014,Asthma and status asthmaticus,1.43,Rate
Praha,CZ01,Total,Males,2015,Asthma and status asthmaticus,0.69,Rate
Praha,CZ01,Total,Males,2016,Asthma and status asthmaticus,0.42,Rate
Praha,CZ01,Total,Males,2017,Asthma and status asthmaticus,1.76,Rate
Praha,CZ01,Total,Males,2018,Asthma and status asthmaticus,0.85,Rate
Praha,CZ01,Total,Males,2019,Asthma and status asthmaticus,0.9,Rate
Praha,CZ01,Total,Males,2020,Asthma and status asthmaticus,0.72,Rate
Praha,CZ01,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,6183.02,Rate
Praha,CZ01,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,6200.51,Rate
Praha,CZ01,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,6174.31,Rate
Praha,CZ01,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5751.24,Rate
Praha,CZ01,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,6051.8,Rate
Praha,CZ01,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5827.34,Rate
Praha,CZ01,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5604.02,Rate
Praha,CZ01,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5700.95,Rate
Praha,CZ01,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5584.63,Rate
Praha,CZ01,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6423.47,Rate
Praha,CZ01,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",211.03,Rate
Praha,CZ01,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",181.66,Rate
Praha,CZ01,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",216.14,Rate
Praha,CZ01,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",212.48,Rate
Praha,CZ01,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",195.58,Rate
Praha,CZ01,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",216.6,Rate
Praha,CZ01,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.13,Rate
Praha,CZ01,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.86,Rate
Praha,CZ01,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",214.06,Rate
Praha,CZ01,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",170.3,Rate
Praha,CZ01,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",298.72,Rate
Praha,CZ01,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",318.86,Rate
Praha,CZ01,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",316.0,Rate
Praha,CZ01,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",276.53,Rate
Praha,CZ01,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",311.69,Rate
Praha,CZ01,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",329.95,Rate
Praha,CZ01,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",326.38,Rate
Praha,CZ01,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",254.17,Rate
Praha,CZ01,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",302.17,Rate
Praha,CZ01,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",247.16,Rate
Praha,CZ01,65 years or over,Males,2011,Malignant melanoma of skin,21.77,Rate
Praha,CZ01,65 years or over,Males,2012,Malignant melanoma of skin,18.39,Rate
Praha,CZ01,65 years or over,Males,2013,Malignant melanoma of skin,19.2,Rate
Praha,CZ01,65 years or over,Males,2014,Malignant melanoma of skin,30.44,Rate
Praha,CZ01,65 years or over,Males,2015,Malignant melanoma of skin,22.38,Rate
Praha,CZ01,65 years or over,Males,2016,Malignant melanoma of skin,32.81,Rate
Praha,CZ01,65 years or over,Males,2017,Malignant melanoma of skin,32.18,Rate
Praha,CZ01,65 years or over,Males,2018,Malignant melanoma of skin,22.27,Rate
Praha,CZ01,65 years or over,Males,2019,Malignant melanoma of skin,24.13,Rate
Praha,CZ01,65 years or over,Males,2020,Malignant melanoma of skin,30.01,Rate
Praha,CZ01,65 years or over,Males,2011,Malignant neoplasm of breast,2.22,Rate
Praha,CZ01,65 years or over,Males,2013,Malignant neoplasm of breast,1.17,Rate
Praha,CZ01,65 years or over,Males,2014,Malignant neoplasm of breast,2.56,Rate
Praha,CZ01,65 years or over,Males,2015,Malignant neoplasm of breast,1.77,Rate
Praha,CZ01,65 years or over,Males,2017,Malignant neoplasm of breast,2.08,Rate
Praha,CZ01,65 years or over,Males,2018,Malignant neoplasm of breast,1.28,Rate
Praha,CZ01,65 years or over,Males,2019,Malignant neoplasm of breast,1.27,Rate
Praha,CZ01,65 years or over,Males,2020,Malignant neoplasm of breast,3.35,Rate
Praha,CZ01,65 years or over,Males,2011,Diabetes mellitus,120.05,Rate
Praha,CZ01,65 years or over,Males,2012,Diabetes mellitus,97.44,Rate
Praha,CZ01,65 years or over,Males,2013,Diabetes mellitus,178.7,Rate
Praha,CZ01,65 years or over,Males,2014,Diabetes mellitus,187.84,Rate
Praha,CZ01,65 years or over,Males,2015,Diabetes mellitus,203.33,Rate
Praha,CZ01,65 years or over,Males,2016,Diabetes mellitus,169.85,Rate
Praha,CZ01,65 years or over,Males,2017,Diabetes mellitus,153.87,Rate
Praha,CZ01,65 years or over,Males,2018,Diabetes mellitus,179.24,Rate
Praha,CZ01,65 years or over,Males,2019,Diabetes mellitus,162.59,Rate
Praha,CZ01,65 years or over,Males,2020,Diabetes mellitus,187.8,Rate
Praha,CZ01,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),65.73,Rate
Praha,CZ01,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),94.44,Rate
Praha,CZ01,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),94.34,Rate
Praha,CZ01,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),77.47,Rate
Praha,CZ01,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),85.71,Rate
Praha,CZ01,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),73.61,Rate
Praha,CZ01,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),128.96,Rate
Praha,CZ01,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),86.68,Rate
Praha,CZ01,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),124.0,Rate
Praha,CZ01,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),102.84,Rate
Praha,CZ01,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.49,Rate
Praha,CZ01,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),5.06,Rate
Praha,CZ01,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),7.0,Rate
Praha,CZ01,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.44,Rate
Praha,CZ01,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.59,Rate
Praha,CZ01,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Praha,CZ01,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Praha,CZ01,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.31,Rate
Praha,CZ01,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.23,Rate
Praha,CZ01,65 years or over,Males,2011,Other ischaemic heart diseases,1523.49,Rate
Praha,CZ01,65 years or over,Males,2012,Other ischaemic heart diseases,1488.98,Rate
Praha,CZ01,65 years or over,Males,2013,Other ischaemic heart diseases,1522.53,Rate
Praha,CZ01,65 years or over,Males,2014,Other ischaemic heart diseases,1395.25,Rate
Praha,CZ01,65 years or over,Males,2015,Other ischaemic heart diseases,1521.48,Rate
Praha,CZ01,65 years or over,Males,2016,Other ischaemic heart diseases,1344.83,Rate
Praha,CZ01,65 years or over,Males,2017,Other ischaemic heart diseases,1263.35,Rate
Praha,CZ01,65 years or over,Males,2018,Other ischaemic heart diseases,1259.94,Rate
Praha,CZ01,65 years or over,Males,2019,Other ischaemic heart diseases,1177.97,Rate
Praha,CZ01,65 years or over,Males,2020,Other ischaemic heart diseases,1322.13,Rate
Praha,CZ01,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,295.31,Rate
Praha,CZ01,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,356.76,Rate
Praha,CZ01,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,252.47,Rate
Praha,CZ01,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,240.85,Rate
Praha,CZ01,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,223.76,Rate
Praha,CZ01,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,217.5,Rate
Praha,CZ01,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,212.8,Rate
Praha,CZ01,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,200.86,Rate
Praha,CZ01,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,162.29,Rate
Praha,CZ01,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,173.17,Rate
Praha,CZ01,65 years or over,Males,2011,Cerebrovascular diseases,546.61,Rate
Praha,CZ01,65 years or over,Males,2012,Cerebrovascular diseases,549.69,Rate
Praha,CZ01,65 years or over,Males,2013,Cerebrovascular diseases,546.47,Rate
Praha,CZ01,65 years or over,Males,2014,Cerebrovascular diseases,433.68,Rate
Praha,CZ01,65 years or over,Males,2015,Cerebrovascular diseases,494.27,Rate
Praha,CZ01,65 years or over,Males,2016,Cerebrovascular diseases,426.27,Rate
Praha,CZ01,65 years or over,Males,2017,Cerebrovascular diseases,426.19,Rate
Praha,CZ01,65 years or over,Males,2018,Cerebrovascular diseases,373.49,Rate
Praha,CZ01,65 years or over,Males,2019,Cerebrovascular diseases,313.92,Rate
Praha,CZ01,65 years or over,Males,2020,Cerebrovascular diseases,338.38,Rate
Praha,CZ01,65 years or over,Males,2011,Chronic lower respiratory diseases,182.25,Rate
Praha,CZ01,65 years or over,Males,2012,Chronic lower respiratory diseases,194.13,Rate
Praha,CZ01,65 years or over,Males,2013,Chronic lower respiratory diseases,256.85,Rate
Praha,CZ01,65 years or over,Males,2014,Chronic lower respiratory diseases,205.15,Rate
Praha,CZ01,65 years or over,Males,2015,Chronic lower respiratory diseases,254.46,Rate
Praha,CZ01,65 years or over,Males,2016,Chronic lower respiratory diseases,194.63,Rate
Praha,CZ01,65 years or over,Males,2017,Chronic lower respiratory diseases,206.78,Rate
Praha,CZ01,65 years or over,Males,2018,Chronic lower respiratory diseases,246.11,Rate
Praha,CZ01,65 years or over,Males,2019,Chronic lower respiratory diseases,178.63,Rate
Praha,CZ01,65 years or over,Males,2020,Chronic lower respiratory diseases,180.78,Rate
Praha,CZ01,65 years or over,Males,2011,Asthma and status asthmaticus,2.71,Rate
Praha,CZ01,65 years or over,Males,2012,Asthma and status asthmaticus,6.12,Rate
Praha,CZ01,65 years or over,Males,2013,Asthma and status asthmaticus,3.23,Rate
Praha,CZ01,65 years or over,Males,2014,Asthma and status asthmaticus,5.28,Rate
Praha,CZ01,65 years or over,Males,2015,Asthma and status asthmaticus,2.0,Rate
Praha,CZ01,65 years or over,Males,2016,Asthma and status asthmaticus,2.16,Rate
Praha,CZ01,65 years or over,Males,2017,Asthma and status asthmaticus,7.18,Rate
Praha,CZ01,65 years or over,Males,2018,Asthma and status asthmaticus,2.48,Rate
Praha,CZ01,65 years or over,Males,2019,Asthma and status asthmaticus,3.7,Rate
Praha,CZ01,65 years or over,Males,2020,Asthma and status asthmaticus,3.72,Rate
Praha,CZ01,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,293.98,Rate
Praha,CZ01,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,284.68,Rate
Praha,CZ01,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,261.45,Rate
Praha,CZ01,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,263.91,Rate
Praha,CZ01,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,256.53,Rate
Praha,CZ01,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,242.23,Rate
Praha,CZ01,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,236.74,Rate
Praha,CZ01,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,231.43,Rate
Praha,CZ01,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,223.34,Rate
Praha,CZ01,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,228.53,Rate
Praha,CZ01,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.19,Rate
Praha,CZ01,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.57,Rate
Praha,CZ01,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.5,Rate
Praha,CZ01,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.02,Rate
Praha,CZ01,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.58,Rate
Praha,CZ01,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.83,Rate
Praha,CZ01,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.72,Rate
Praha,CZ01,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.2,Rate
Praha,CZ01,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.39,Rate
Praha,CZ01,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.83,Rate
Praha,CZ01,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",25.17,Rate
Praha,CZ01,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",25.13,Rate
Praha,CZ01,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",18.31,Rate
Praha,CZ01,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",17.93,Rate
Praha,CZ01,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",18.98,Rate
Praha,CZ01,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",21.25,Rate
Praha,CZ01,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",15.61,Rate
Praha,CZ01,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",16.86,Rate
Praha,CZ01,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",12.04,Rate
Praha,CZ01,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",9.72,Rate
Praha,CZ01,Less than 65 years,Males,2011,Malignant melanoma of skin,1.41,Rate
Praha,CZ01,Less than 65 years,Males,2012,Malignant melanoma of skin,1.98,Rate
Praha,CZ01,Less than 65 years,Males,2013,Malignant melanoma of skin,1.01,Rate
Praha,CZ01,Less than 65 years,Males,2014,Malignant melanoma of skin,2.19,Rate
Praha,CZ01,Less than 65 years,Males,2015,Malignant melanoma of skin,1.91,Rate
Praha,CZ01,Less than 65 years,Males,2016,Malignant melanoma of skin,0.66,Rate
Praha,CZ01,Less than 65 years,Males,2017,Malignant melanoma of skin,1.41,Rate
Praha,CZ01,Less than 65 years,Males,2018,Malignant melanoma of skin,0.48,Rate
Praha,CZ01,Less than 65 years,Males,2019,Malignant melanoma of skin,1.92,Rate
Praha,CZ01,Less than 65 years,Males,2020,Malignant melanoma of skin,0.96,Rate
Praha,CZ01,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.19,Rate
Praha,CZ01,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.21,Rate
Praha,CZ01,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.2,Rate
Praha,CZ01,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2011,Diabetes mellitus,3.07,Rate
Praha,CZ01,Less than 65 years,Males,2012,Diabetes mellitus,1.89,Rate
Praha,CZ01,Less than 65 years,Males,2013,Diabetes mellitus,5.41,Rate
Praha,CZ01,Less than 65 years,Males,2014,Diabetes mellitus,4.33,Rate
Praha,CZ01,Less than 65 years,Males,2015,Diabetes mellitus,3.02,Rate
Praha,CZ01,Less than 65 years,Males,2016,Diabetes mellitus,4.27,Rate
Praha,CZ01,Less than 65 years,Males,2017,Diabetes mellitus,2.55,Rate
Praha,CZ01,Less than 65 years,Males,2018,Diabetes mellitus,2.42,Rate
Praha,CZ01,Less than 65 years,Males,2019,Diabetes mellitus,4.66,Rate
Praha,CZ01,Less than 65 years,Males,2020,Diabetes mellitus,3.29,Rate
Praha,CZ01,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),1.76,Rate
Praha,CZ01,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),2.93,Rate
Praha,CZ01,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),2.1,Rate
Praha,CZ01,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.99,Rate
Praha,CZ01,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.94,Rate
Praha,CZ01,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),2.28,Rate
Praha,CZ01,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.61,Rate
Praha,CZ01,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.26,Rate
Praha,CZ01,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),1.61,Rate
Praha,CZ01,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),1.54,Rate
Praha,CZ01,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Praha,CZ01,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Praha,CZ01,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Praha,CZ01,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Praha,CZ01,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Praha,CZ01,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Praha,CZ01,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Praha,CZ01,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Praha,CZ01,Less than 65 years,Males,2011,Other ischaemic heart diseases,32.93,Rate
Praha,CZ01,Less than 65 years,Males,2012,Other ischaemic heart diseases,31.14,Rate
Praha,CZ01,Less than 65 years,Males,2013,Other ischaemic heart diseases,29.05,Rate
Praha,CZ01,Less than 65 years,Males,2014,Other ischaemic heart diseases,27.09,Rate
Praha,CZ01,Less than 65 years,Males,2015,Other ischaemic heart diseases,27.37,Rate
Praha,CZ01,Less than 65 years,Males,2016,Other ischaemic heart diseases,22.6,Rate
Praha,CZ01,Less than 65 years,Males,2017,Other ischaemic heart diseases,23.72,Rate
Praha,CZ01,Less than 65 years,Males,2018,Other ischaemic heart diseases,25.7,Rate
Praha,CZ01,Less than 65 years,Males,2019,Other ischaemic heart diseases,22.08,Rate
Praha,CZ01,Less than 65 years,Males,2020,Other ischaemic heart diseases,22.97,Rate
Praha,CZ01,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,16.61,Rate
Praha,CZ01,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,20.71,Rate
Praha,CZ01,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,14.87,Rate
Praha,CZ01,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,16.52,Rate
Praha,CZ01,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,14.36,Rate
Praha,CZ01,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,12.04,Rate
Praha,CZ01,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,11.64,Rate
Praha,CZ01,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,11.2,Rate
Praha,CZ01,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.77,Rate
Praha,CZ01,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,7.84,Rate
Praha,CZ01,Less than 65 years,Males,2011,Cerebrovascular diseases,9.85,Rate
Praha,CZ01,Less than 65 years,Males,2012,Cerebrovascular diseases,9.98,Rate
Praha,CZ01,Less than 65 years,Males,2013,Cerebrovascular diseases,10.35,Rate
Praha,CZ01,Less than 65 years,Males,2014,Cerebrovascular diseases,10.52,Rate
Praha,CZ01,Less than 65 years,Males,2015,Cerebrovascular diseases,7.19,Rate
Praha,CZ01,Less than 65 years,Males,2016,Cerebrovascular diseases,10.92,Rate
Praha,CZ01,Less than 65 years,Males,2017,Cerebrovascular diseases,8.03,Rate
Praha,CZ01,Less than 65 years,Males,2018,Cerebrovascular diseases,7.33,Rate
Praha,CZ01,Less than 65 years,Males,2019,Cerebrovascular diseases,6.94,Rate
Praha,CZ01,Less than 65 years,Males,2020,Cerebrovascular diseases,7.2,Rate
Praha,CZ01,Less than 65 years,Males,2011,Chronic lower respiratory diseases,10.03,Rate
Praha,CZ01,Less than 65 years,Males,2012,Chronic lower respiratory diseases,7.25,Rate
Praha,CZ01,Less than 65 years,Males,2013,Chronic lower respiratory diseases,7.45,Rate
Praha,CZ01,Less than 65 years,Males,2014,Chronic lower respiratory diseases,7.65,Rate
Praha,CZ01,Less than 65 years,Males,2015,Chronic lower respiratory diseases,9.25,Rate
Praha,CZ01,Less than 65 years,Males,2016,Chronic lower respiratory diseases,8.02,Rate
Praha,CZ01,Less than 65 years,Males,2017,Chronic lower respiratory diseases,8.53,Rate
Praha,CZ01,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.71,Rate
Praha,CZ01,Less than 65 years,Males,2019,Chronic lower respiratory diseases,6.01,Rate
Praha,CZ01,Less than 65 years,Males,2020,Chronic lower respiratory diseases,5.99,Rate
Praha,CZ01,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.25,Rate
Praha,CZ01,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.33,Rate
Praha,CZ01,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.49,Rate
Praha,CZ01,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.38,Rate
Praha,CZ01,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.45,Rate
Praha,CZ01,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.45,Rate
Praha,CZ01,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.22,Rate
Praha,CZ01,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1173.52,Rate
Praha,CZ01,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1175.13,Rate
Praha,CZ01,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1145.62,Rate
Praha,CZ01,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1108.08,Rate
Praha,CZ01,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1126.24,Rate
Praha,CZ01,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1082.48,Rate
Praha,CZ01,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1063.89,Rate
Praha,CZ01,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1066.1,Rate
Praha,CZ01,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1033.1,Rate
Praha,CZ01,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1152.15,Rate
Praha,CZ01,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.44,Rate
Praha,CZ01,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.11,Rate
Praha,CZ01,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.84,Rate
Praha,CZ01,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.39,Rate
Praha,CZ01,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.47,Rate
Praha,CZ01,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.34,Rate
Praha,CZ01,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.39,Rate
Praha,CZ01,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.35,Rate
Praha,CZ01,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.7,Rate
Praha,CZ01,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.17,Rate
Praha,CZ01,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",57.15,Rate
Praha,CZ01,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",57.39,Rate
Praha,CZ01,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",53.28,Rate
Praha,CZ01,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",50.43,Rate
Praha,CZ01,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",51.98,Rate
Praha,CZ01,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",57.5,Rate
Praha,CZ01,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",53.18,Rate
Praha,CZ01,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",49.64,Rate
Praha,CZ01,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",50.55,Rate
Praha,CZ01,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",44.63,Rate
Praha,CZ01,Total,Total,2011,Malignant melanoma of skin,3.95,Rate
Praha,CZ01,Total,Total,2012,Malignant melanoma of skin,4.32,Rate
Praha,CZ01,Total,Total,2013,Malignant melanoma of skin,3.29,Rate
Praha,CZ01,Total,Total,2014,Malignant melanoma of skin,4.24,Rate
Praha,CZ01,Total,Total,2015,Malignant melanoma of skin,3.94,Rate
Praha,CZ01,Total,Total,2016,Malignant melanoma of skin,5.41,Rate
Praha,CZ01,Total,Total,2017,Malignant melanoma of skin,6.19,Rate
Praha,CZ01,Total,Total,2018,Malignant melanoma of skin,3.52,Rate
Praha,CZ01,Total,Total,2019,Malignant melanoma of skin,4.41,Rate
Praha,CZ01,Total,Total,2020,Malignant melanoma of skin,3.87,Rate
Praha,CZ01,Total,Total,2011,Malignant neoplasm of breast,23.5,Rate
Praha,CZ01,Total,Total,2012,Malignant neoplasm of breast,19.41,Rate
Praha,CZ01,Total,Total,2013,Malignant neoplasm of breast,20.34,Rate
Praha,CZ01,Total,Total,2014,Malignant neoplasm of breast,20.88,Rate
Praha,CZ01,Total,Total,2015,Malignant neoplasm of breast,22.58,Rate
Praha,CZ01,Total,Total,2016,Malignant neoplasm of breast,19.19,Rate
Praha,CZ01,Total,Total,2017,Malignant neoplasm of breast,19.9,Rate
Praha,CZ01,Total,Total,2018,Malignant neoplasm of breast,17.9,Rate
Praha,CZ01,Total,Total,2019,Malignant neoplasm of breast,20.45,Rate
Praha,CZ01,Total,Total,2020,Malignant neoplasm of breast,18.55,Rate
Praha,CZ01,Total,Total,2011,Diabetes mellitus,18.62,Rate
Praha,CZ01,Total,Total,2012,Diabetes mellitus,16.35,Rate
Praha,CZ01,Total,Total,2013,Diabetes mellitus,35.13,Rate
Praha,CZ01,Total,Total,2014,Diabetes mellitus,31.71,Rate
Praha,CZ01,Total,Total,2015,Diabetes mellitus,32.85,Rate
Praha,CZ01,Total,Total,2016,Diabetes mellitus,31.6,Rate
Praha,CZ01,Total,Total,2017,Diabetes mellitus,26.11,Rate
Praha,CZ01,Total,Total,2018,Diabetes mellitus,29.99,Rate
Praha,CZ01,Total,Total,2019,Diabetes mellitus,28.69,Rate
Praha,CZ01,Total,Total,2020,Diabetes mellitus,31.31,Rate
Praha,CZ01,Total,Total,2011,Mental and behavioural disorders (F00-F99),13.11,Rate
Praha,CZ01,Total,Total,2012,Mental and behavioural disorders (F00-F99),15.64,Rate
Praha,CZ01,Total,Total,2013,Mental and behavioural disorders (F00-F99),19.51,Rate
Praha,CZ01,Total,Total,2014,Mental and behavioural disorders (F00-F99),16.57,Rate
Praha,CZ01,Total,Total,2015,Mental and behavioural disorders (F00-F99),18.86,Rate
Praha,CZ01,Total,Total,2016,Mental and behavioural disorders (F00-F99),17.09,Rate
Praha,CZ01,Total,Total,2017,Mental and behavioural disorders (F00-F99),26.83,Rate
Praha,CZ01,Total,Total,2018,Mental and behavioural disorders (F00-F99),18.44,Rate
Praha,CZ01,Total,Total,2019,Mental and behavioural disorders (F00-F99),23.87,Rate
Praha,CZ01,Total,Total,2020,Mental and behavioural disorders (F00-F99),23.48,Rate
Praha,CZ01,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Praha,CZ01,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Praha,CZ01,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Praha,CZ01,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Praha,CZ01,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Praha,CZ01,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.14,Rate
Praha,CZ01,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Praha,CZ01,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.65,Rate
Praha,CZ01,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Praha,CZ01,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Praha,CZ01,Total,Total,2011,Other ischaemic heart diseases,254.83,Rate
Praha,CZ01,Total,Total,2012,Other ischaemic heart diseases,254.5,Rate
Praha,CZ01,Total,Total,2013,Other ischaemic heart diseases,267.4,Rate
Praha,CZ01,Total,Total,2014,Other ischaemic heart diseases,255.17,Rate
Praha,CZ01,Total,Total,2015,Other ischaemic heart diseases,252.43,Rate
Praha,CZ01,Total,Total,2016,Other ischaemic heart diseases,224.95,Rate
Praha,CZ01,Total,Total,2017,Other ischaemic heart diseases,226.38,Rate
Praha,CZ01,Total,Total,2018,Other ischaemic heart diseases,210.81,Rate
Praha,CZ01,Total,Total,2019,Other ischaemic heart diseases,200.11,Rate
Praha,CZ01,Total,Total,2020,Other ischaemic heart diseases,218.93,Rate
Praha,CZ01,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,51.94,Rate
Praha,CZ01,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,59.47,Rate
Praha,CZ01,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,43.69,Rate
Praha,CZ01,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.04,Rate
Praha,CZ01,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,38.63,Rate
Praha,CZ01,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,37.96,Rate
Praha,CZ01,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,37.77,Rate
Praha,CZ01,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,34.01,Rate
Praha,CZ01,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,29.51,Rate
Praha,CZ01,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,30.02,Rate
Praha,CZ01,Total,Total,2011,Cerebrovascular diseases,116.39,Rate
Praha,CZ01,Total,Total,2012,Cerebrovascular diseases,104.77,Rate
Praha,CZ01,Total,Total,2013,Cerebrovascular diseases,102.68,Rate
Praha,CZ01,Total,Total,2014,Cerebrovascular diseases,93.59,Rate
Praha,CZ01,Total,Total,2015,Cerebrovascular diseases,91.2,Rate
Praha,CZ01,Total,Total,2016,Cerebrovascular diseases,83.22,Rate
Praha,CZ01,Total,Total,2017,Cerebrovascular diseases,79.55,Rate
Praha,CZ01,Total,Total,2018,Cerebrovascular diseases,71.59,Rate
Praha,CZ01,Total,Total,2019,Cerebrovascular diseases,64.1,Rate
Praha,CZ01,Total,Total,2020,Cerebrovascular diseases,61.06,Rate
Praha,CZ01,Total,Total,2011,Chronic lower respiratory diseases,31.82,Rate
Praha,CZ01,Total,Total,2012,Chronic lower respiratory diseases,30.28,Rate
Praha,CZ01,Total,Total,2013,Chronic lower respiratory diseases,41.76,Rate
Praha,CZ01,Total,Total,2014,Chronic lower respiratory diseases,35.01,Rate
Praha,CZ01,Total,Total,2015,Chronic lower respiratory diseases,45.25,Rate
Praha,CZ01,Total,Total,2016,Chronic lower respiratory diseases,35.74,Rate
Praha,CZ01,Total,Total,2017,Chronic lower respiratory diseases,37.2,Rate
Praha,CZ01,Total,Total,2018,Chronic lower respiratory diseases,39.24,Rate
Praha,CZ01,Total,Total,2019,Chronic lower respiratory diseases,34.05,Rate
Praha,CZ01,Total,Total,2020,Chronic lower respiratory diseases,33.86,Rate
Praha,CZ01,Total,Total,2011,Asthma and status asthmaticus,0.93,Rate
Praha,CZ01,Total,Total,2012,Asthma and status asthmaticus,1.33,Rate
Praha,CZ01,Total,Total,2013,Asthma and status asthmaticus,0.64,Rate
Praha,CZ01,Total,Total,2014,Asthma and status asthmaticus,1.66,Rate
Praha,CZ01,Total,Total,2015,Asthma and status asthmaticus,0.88,Rate
Praha,CZ01,Total,Total,2016,Asthma and status asthmaticus,0.93,Rate
Praha,CZ01,Total,Total,2017,Asthma and status asthmaticus,1.48,Rate
Praha,CZ01,Total,Total,2018,Asthma and status asthmaticus,1.42,Rate
Praha,CZ01,Total,Total,2019,Asthma and status asthmaticus,1.05,Rate
Praha,CZ01,Total,Total,2020,Asthma and status asthmaticus,1.96,Rate
Praha,CZ01,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,5117.17,Rate
Praha,CZ01,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,5147.32,Rate
Praha,CZ01,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,5067.86,Rate
Praha,CZ01,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4866.7,Rate
Praha,CZ01,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4994.2,Rate
Praha,CZ01,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4778.99,Rate
Praha,CZ01,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4722.65,Rate
Praha,CZ01,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4754.76,Rate
Praha,CZ01,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4593.58,Rate
Praha,CZ01,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5192.9,Rate
Praha,CZ01,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",148.66,Rate
Praha,CZ01,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.56,Rate
Praha,CZ01,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",158.79,Rate
Praha,CZ01,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.57,Rate
Praha,CZ01,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.66,Rate
Praha,CZ01,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",145.36,Rate
Praha,CZ01,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",128.26,Rate
Praha,CZ01,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.18,Rate
Praha,CZ01,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",153.93,Rate
Praha,CZ01,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",124.6,Rate
Praha,CZ01,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",218.02,Rate
Praha,CZ01,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",218.56,Rate
Praha,CZ01,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",209.68,Rate
Praha,CZ01,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",201.52,Rate
Praha,CZ01,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",210.86,Rate
Praha,CZ01,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",228.24,Rate
Praha,CZ01,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",221.33,Rate
Praha,CZ01,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",199.55,Rate
Praha,CZ01,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",216.17,Rate
Praha,CZ01,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",192.41,Rate
Praha,CZ01,65 years or over,Total,2011,Malignant melanoma of skin,12.99,Rate
Praha,CZ01,65 years or over,Total,2012,Malignant melanoma of skin,16.01,Rate
Praha,CZ01,65 years or over,Total,2013,Malignant melanoma of skin,12.76,Rate
Praha,CZ01,65 years or over,Total,2014,Malignant melanoma of skin,15.25,Rate
Praha,CZ01,65 years or over,Total,2015,Malignant melanoma of skin,15.19,Rate
Praha,CZ01,65 years or over,Total,2016,Malignant melanoma of skin,23.61,Rate
Praha,CZ01,65 years or over,Total,2017,Malignant melanoma of skin,25.15,Rate
Praha,CZ01,65 years or over,Total,2018,Malignant melanoma of skin,15.14,Rate
Praha,CZ01,65 years or over,Total,2019,Malignant melanoma of skin,16.75,Rate
Praha,CZ01,65 years or over,Total,2020,Malignant melanoma of skin,16.38,Rate
Praha,CZ01,65 years or over,Total,2011,Malignant neoplasm of breast,92.69,Rate
Praha,CZ01,65 years or over,Total,2012,Malignant neoplasm of breast,73.39,Rate
Praha,CZ01,65 years or over,Total,2013,Malignant neoplasm of breast,80.86,Rate
Praha,CZ01,65 years or over,Total,2014,Malignant neoplasm of breast,76.46,Rate
Praha,CZ01,65 years or over,Total,2015,Malignant neoplasm of breast,88.35,Rate
Praha,CZ01,65 years or over,Total,2016,Malignant neoplasm of breast,74.54,Rate
Praha,CZ01,65 years or over,Total,2017,Malignant neoplasm of breast,77.63,Rate
Praha,CZ01,65 years or over,Total,2018,Malignant neoplasm of breast,69.03,Rate
Praha,CZ01,65 years or over,Total,2019,Malignant neoplasm of breast,78.86,Rate
Praha,CZ01,65 years or over,Total,2020,Malignant neoplasm of breast,72.34,Rate
Praha,CZ01,65 years or over,Total,2011,Diabetes mellitus,86.16,Rate
Praha,CZ01,65 years or over,Total,2012,Diabetes mellitus,74.25,Rate
Praha,CZ01,65 years or over,Total,2013,Diabetes mellitus,163.63,Rate
Praha,CZ01,65 years or over,Total,2014,Diabetes mellitus,149.79,Rate
Praha,CZ01,65 years or over,Total,2015,Diabetes mellitus,160.34,Rate
Praha,CZ01,65 years or over,Total,2016,Diabetes mellitus,148.07,Rate
Praha,CZ01,65 years or over,Total,2017,Diabetes mellitus,127.05,Rate
Praha,CZ01,65 years or over,Total,2018,Diabetes mellitus,146.85,Rate
Praha,CZ01,65 years or over,Total,2019,Diabetes mellitus,135.86,Rate
Praha,CZ01,65 years or over,Total,2020,Diabetes mellitus,151.93,Rate
Praha,CZ01,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),62.36,Rate
Praha,CZ01,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),73.41,Rate
Praha,CZ01,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),94.75,Rate
Praha,CZ01,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),81.6,Rate
Praha,CZ01,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),93.65,Rate
Praha,CZ01,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),82.18,Rate
Praha,CZ01,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),135.28,Rate
Praha,CZ01,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),92.02,Rate
Praha,CZ01,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),117.61,Rate
Praha,CZ01,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),114.91,Rate
Praha,CZ01,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),3.1,Rate
Praha,CZ01,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.32,Rate
Praha,CZ01,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.27,Rate
Praha,CZ01,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.64,Rate
Praha,CZ01,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Praha,CZ01,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.01,Rate
Praha,CZ01,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Praha,CZ01,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Praha,CZ01,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.54,Rate
Praha,CZ01,65 years or over,Total,2011,Other ischaemic heart diseases,1229.32,Rate
Praha,CZ01,65 years or over,Total,2012,Other ischaemic heart diseases,1226.21,Rate
Praha,CZ01,65 years or over,Total,2013,Other ischaemic heart diseases,1299.41,Rate
Praha,CZ01,65 years or over,Total,2014,Other ischaemic heart diseases,1240.82,Rate
Praha,CZ01,65 years or over,Total,2015,Other ischaemic heart diseases,1226.54,Rate
Praha,CZ01,65 years or over,Total,2016,Other ischaemic heart diseases,1094.11,Rate
Praha,CZ01,65 years or over,Total,2017,Other ischaemic heart diseases,1099.24,Rate
Praha,CZ01,65 years or over,Total,2018,Other ischaemic heart diseases,1017.43,Rate
Praha,CZ01,65 years or over,Total,2019,Other ischaemic heart diseases,969.95,Rate
Praha,CZ01,65 years or over,Total,2020,Other ischaemic heart diseases,1064.27,Rate
Praha,CZ01,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,223.69,Rate
Praha,CZ01,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,254.79,Rate
Praha,CZ01,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,188.14,Rate
Praha,CZ01,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,171.08,Rate
Praha,CZ01,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,160.73,Rate
Praha,CZ01,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,164.33,Rate
Praha,CZ01,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,166.27,Rate
Praha,CZ01,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,148.75,Rate
Praha,CZ01,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,128.47,Rate
Praha,CZ01,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,133.48,Rate
Praha,CZ01,65 years or over,Total,2011,Cerebrovascular diseases,565.88,Rate
Praha,CZ01,65 years or over,Total,2012,Cerebrovascular diseases,504.77,Rate
Praha,CZ01,65 years or over,Total,2013,Cerebrovascular diseases,495.64,Rate
Praha,CZ01,65 years or over,Total,2014,Cerebrovascular diseases,450.45,Rate
Praha,CZ01,65 years or over,Total,2015,Cerebrovascular diseases,446.25,Rate
Praha,CZ01,65 years or over,Total,2016,Cerebrovascular diseases,396.33,Rate
Praha,CZ01,65 years or over,Total,2017,Cerebrovascular diseases,380.1,Rate
Praha,CZ01,65 years or over,Total,2018,Cerebrovascular diseases,341.43,Rate
Praha,CZ01,65 years or over,Total,2019,Cerebrovascular diseases,308.27,Rate
Praha,CZ01,65 years or over,Total,2020,Cerebrovascular diseases,291.38,Rate
Praha,CZ01,65 years or over,Total,2011,Chronic lower respiratory diseases,134.64,Rate
Praha,CZ01,65 years or over,Total,2012,Chronic lower respiratory diseases,133.27,Rate
Praha,CZ01,65 years or over,Total,2013,Chronic lower respiratory diseases,192.15,Rate
Praha,CZ01,65 years or over,Total,2014,Chronic lower respiratory diseases,155.19,Rate
Praha,CZ01,65 years or over,Total,2015,Chronic lower respiratory diseases,206.55,Rate
Praha,CZ01,65 years or over,Total,2016,Chronic lower respiratory diseases,160.09,Rate
Praha,CZ01,65 years or over,Total,2017,Chronic lower respiratory diseases,164.48,Rate
Praha,CZ01,65 years or over,Total,2018,Chronic lower respiratory diseases,182.29,Rate
Praha,CZ01,65 years or over,Total,2019,Chronic lower respiratory diseases,158.92,Rate
Praha,CZ01,65 years or over,Total,2020,Chronic lower respiratory diseases,158.3,Rate
Praha,CZ01,65 years or over,Total,2011,Asthma and status asthmaticus,4.75,Rate
Praha,CZ01,65 years or over,Total,2012,Asthma and status asthmaticus,5.98,Rate
Praha,CZ01,65 years or over,Total,2013,Asthma and status asthmaticus,2.63,Rate
Praha,CZ01,65 years or over,Total,2014,Asthma and status asthmaticus,5.69,Rate
Praha,CZ01,65 years or over,Total,2015,Asthma and status asthmaticus,3.34,Rate
Praha,CZ01,65 years or over,Total,2016,Asthma and status asthmaticus,4.76,Rate
Praha,CZ01,65 years or over,Total,2017,Asthma and status asthmaticus,6.3,Rate
Praha,CZ01,65 years or over,Total,2018,Asthma and status asthmaticus,6.11,Rate
Praha,CZ01,65 years or over,Total,2019,Asthma and status asthmaticus,4.93,Rate
Praha,CZ01,65 years or over,Total,2020,Asthma and status asthmaticus,9.73,Rate
Praha,CZ01,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,218.22,Rate
Praha,CZ01,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,212.92,Rate
Praha,CZ01,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,195.51,Rate
Praha,CZ01,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,197.61,Rate
Praha,CZ01,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,189.28,Rate
Praha,CZ01,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,187.05,Rate
Praha,CZ01,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,177.61,Rate
Praha,CZ01,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,172.57,Rate
Praha,CZ01,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,170.63,Rate
Praha,CZ01,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,173.34,Rate
Praha,CZ01,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.02,Rate
Praha,CZ01,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.81,Rate
Praha,CZ01,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.3,Rate
Praha,CZ01,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.43,Rate
Praha,CZ01,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.23,Rate
Praha,CZ01,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.45,Rate
Praha,CZ01,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.93,Rate
Praha,CZ01,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.48,Rate
Praha,CZ01,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.82,Rate
Praha,CZ01,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.29,Rate
Praha,CZ01,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",18.18,Rate
Praha,CZ01,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",18.35,Rate
Praha,CZ01,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",15.4,Rate
Praha,CZ01,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",13.83,Rate
Praha,CZ01,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",13.49,Rate
Praha,CZ01,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.15,Rate
Praha,CZ01,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",12.45,Rate
Praha,CZ01,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",13.32,Rate
Praha,CZ01,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",10.43,Rate
Praha,CZ01,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",8.84,Rate
Praha,CZ01,Less than 65 years,Total,2011,Malignant melanoma of skin,1.76,Rate
Praha,CZ01,Less than 65 years,Total,2012,Malignant melanoma of skin,1.49,Rate
Praha,CZ01,Less than 65 years,Total,2013,Malignant melanoma of skin,0.99,Rate
Praha,CZ01,Less than 65 years,Total,2014,Malignant melanoma of skin,1.57,Rate
Praha,CZ01,Less than 65 years,Total,2015,Malignant melanoma of skin,1.22,Rate
Praha,CZ01,Less than 65 years,Total,2016,Malignant melanoma of skin,1.0,Rate
Praha,CZ01,Less than 65 years,Total,2017,Malignant melanoma of skin,1.6,Rate
Praha,CZ01,Less than 65 years,Total,2018,Malignant melanoma of skin,0.71,Rate
Praha,CZ01,Less than 65 years,Total,2019,Malignant melanoma of skin,1.42,Rate
Praha,CZ01,Less than 65 years,Total,2020,Malignant melanoma of skin,0.83,Rate
Praha,CZ01,Less than 65 years,Total,2011,Malignant neoplasm of breast,6.74,Rate
Praha,CZ01,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.34,Rate
Praha,CZ01,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.68,Rate
Praha,CZ01,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.41,Rate
Praha,CZ01,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.64,Rate
Praha,CZ01,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.78,Rate
Praha,CZ01,Less than 65 years,Total,2017,Malignant neoplasm of breast,5.92,Rate
Praha,CZ01,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.51,Rate
Praha,CZ01,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.3,Rate
Praha,CZ01,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.52,Rate
Praha,CZ01,Less than 65 years,Total,2011,Diabetes mellitus,2.26,Rate
Praha,CZ01,Less than 65 years,Total,2012,Diabetes mellitus,2.33,Rate
Praha,CZ01,Less than 65 years,Total,2013,Diabetes mellitus,4.01,Rate
Praha,CZ01,Less than 65 years,Total,2014,Diabetes mellitus,3.11,Rate
Praha,CZ01,Less than 65 years,Total,2015,Diabetes mellitus,1.97,Rate
Praha,CZ01,Less than 65 years,Total,2016,Diabetes mellitus,3.38,Rate
Praha,CZ01,Less than 65 years,Total,2017,Diabetes mellitus,1.66,Rate
Praha,CZ01,Less than 65 years,Total,2018,Diabetes mellitus,1.68,Rate
Praha,CZ01,Less than 65 years,Total,2019,Diabetes mellitus,2.73,Rate
Praha,CZ01,Less than 65 years,Total,2020,Diabetes mellitus,2.09,Rate
Praha,CZ01,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),1.18,Rate
Praha,CZ01,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),1.64,Rate
Praha,CZ01,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),1.28,Rate
Praha,CZ01,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.82,Rate
Praha,CZ01,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.74,Rate
Praha,CZ01,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.32,Rate
Praha,CZ01,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.56,Rate
Praha,CZ01,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),0.62,Rate
Praha,CZ01,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.16,Rate
Praha,CZ01,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.33,Rate
Praha,CZ01,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Praha,CZ01,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Praha,CZ01,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Praha,CZ01,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Praha,CZ01,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Praha,CZ01,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Praha,CZ01,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Praha,CZ01,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Praha,CZ01,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Praha,CZ01,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Praha,CZ01,Less than 65 years,Total,2011,Other ischaemic heart diseases,18.78,Rate
Praha,CZ01,Less than 65 years,Total,2012,Other ischaemic heart diseases,19.11,Rate
Praha,CZ01,Less than 65 years,Total,2013,Other ischaemic heart diseases,17.41,Rate
Praha,CZ01,Less than 65 years,Total,2014,Other ischaemic heart diseases,16.41,Rate
Praha,CZ01,Less than 65 years,Total,2015,Other ischaemic heart diseases,16.47,Rate
Praha,CZ01,Less than 65 years,Total,2016,Other ischaemic heart diseases,14.41,Rate
Praha,CZ01,Less than 65 years,Total,2017,Other ischaemic heart diseases,14.94,Rate
Praha,CZ01,Less than 65 years,Total,2018,Other ischaemic heart diseases,15.41,Rate
Praha,CZ01,Less than 65 years,Total,2019,Other ischaemic heart diseases,13.62,Rate
Praha,CZ01,Less than 65 years,Total,2020,Other ischaemic heart diseases,14.15,Rate
Praha,CZ01,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,10.34,Rate
Praha,CZ01,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,12.15,Rate
Praha,CZ01,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,8.7,Rate
Praha,CZ01,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,9.54,Rate
Praha,CZ01,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,9.05,Rate
Praha,CZ01,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,7.34,Rate
Praha,CZ01,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,6.64,Rate
Praha,CZ01,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,6.21,Rate
Praha,CZ01,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,5.54,Rate
Praha,CZ01,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,4.96,Rate
Praha,CZ01,Less than 65 years,Total,2011,Cerebrovascular diseases,7.51,Rate
Praha,CZ01,Less than 65 years,Total,2012,Cerebrovascular diseases,7.87,Rate
Praha,CZ01,Less than 65 years,Total,2013,Cerebrovascular diseases,7.5,Rate
Praha,CZ01,Less than 65 years,Total,2014,Cerebrovascular diseases,7.15,Rate
Praha,CZ01,Less than 65 years,Total,2015,Cerebrovascular diseases,5.19,Rate
Praha,CZ01,Less than 65 years,Total,2016,Cerebrovascular diseases,7.38,Rate
Praha,CZ01,Less than 65 years,Total,2017,Cerebrovascular diseases,6.74,Rate
Praha,CZ01,Less than 65 years,Total,2018,Cerebrovascular diseases,6.23,Rate
Praha,CZ01,Less than 65 years,Total,2019,Cerebrovascular diseases,4.96,Rate
Praha,CZ01,Less than 65 years,Total,2020,Cerebrovascular diseases,5.27,Rate
Praha,CZ01,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.91,Rate
Praha,CZ01,Less than 65 years,Total,2012,Chronic lower respiratory diseases,5.33,Rate
Praha,CZ01,Less than 65 years,Total,2013,Chronic lower respiratory diseases,5.33,Rate
Praha,CZ01,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.9,Rate
Praha,CZ01,Less than 65 years,Total,2015,Chronic lower respiratory diseases,6.18,Rate
Praha,CZ01,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.61,Rate
Praha,CZ01,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.37,Rate
Praha,CZ01,Less than 65 years,Total,2018,Chronic lower respiratory diseases,4.58,Rate
Praha,CZ01,Less than 65 years,Total,2019,Chronic lower respiratory diseases,3.81,Rate
Praha,CZ01,Less than 65 years,Total,2020,Chronic lower respiratory diseases,3.72,Rate
Praha,CZ01,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.21,Rate
Praha,CZ01,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.16,Rate
Praha,CZ01,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.68,Rate
Praha,CZ01,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.28,Rate
Praha,CZ01,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Praha,CZ01,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.31,Rate
Praha,CZ01,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.29,Rate
Praha,CZ01,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.1,Rate
Praha,CZ01,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.08,Rate
Karlsruhe,DE12,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,839.91,Rate
Karlsruhe,DE12,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,839.62,Rate
Karlsruhe,DE12,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,834.24,Rate
Karlsruhe,DE12,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,803.7,Rate
Karlsruhe,DE12,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,856.48,Rate
Karlsruhe,DE12,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,808.36,Rate
Karlsruhe,DE12,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,812.01,Rate
Karlsruhe,DE12,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,817.83,Rate
Karlsruhe,DE12,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,807.68,Rate
Karlsruhe,DE12,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,806.47,Rate
Karlsruhe,DE12,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.64,Rate
Karlsruhe,DE12,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.36,Rate
Karlsruhe,DE12,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.0,Rate
Karlsruhe,DE12,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.97,Rate
Karlsruhe,DE12,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.72,Rate
Karlsruhe,DE12,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.05,Rate
Karlsruhe,DE12,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.51,Rate
Karlsruhe,DE12,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.84,Rate
Karlsruhe,DE12,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.13,Rate
Karlsruhe,DE12,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.33,Rate
Karlsruhe,DE12,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",27.59,Rate
Karlsruhe,DE12,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",30.55,Rate
Karlsruhe,DE12,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",27.36,Rate
Karlsruhe,DE12,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",28.22,Rate
Karlsruhe,DE12,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",29.27,Rate
Karlsruhe,DE12,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",30.08,Rate
Karlsruhe,DE12,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",30.25,Rate
Karlsruhe,DE12,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",29.94,Rate
Karlsruhe,DE12,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",32.86,Rate
Karlsruhe,DE12,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",31.78,Rate
Karlsruhe,DE12,Total,Females,2011,Malignant melanoma of skin,2.47,Rate
Karlsruhe,DE12,Total,Females,2012,Malignant melanoma of skin,3.06,Rate
Karlsruhe,DE12,Total,Females,2013,Malignant melanoma of skin,1.8,Rate
Karlsruhe,DE12,Total,Females,2014,Malignant melanoma of skin,2.04,Rate
Karlsruhe,DE12,Total,Females,2015,Malignant melanoma of skin,1.93,Rate
Karlsruhe,DE12,Total,Females,2016,Malignant melanoma of skin,2.02,Rate
Karlsruhe,DE12,Total,Females,2017,Malignant melanoma of skin,1.99,Rate
Karlsruhe,DE12,Total,Females,2018,Malignant melanoma of skin,2.39,Rate
Karlsruhe,DE12,Total,Females,2019,Malignant melanoma of skin,2.45,Rate
Karlsruhe,DE12,Total,Females,2020,Malignant melanoma of skin,1.83,Rate
Karlsruhe,DE12,Total,Females,2011,Malignant neoplasm of breast,36.06,Rate
Karlsruhe,DE12,Total,Females,2012,Malignant neoplasm of breast,34.87,Rate
Karlsruhe,DE12,Total,Females,2013,Malignant neoplasm of breast,38.36,Rate
Karlsruhe,DE12,Total,Females,2014,Malignant neoplasm of breast,40.93,Rate
Karlsruhe,DE12,Total,Females,2015,Malignant neoplasm of breast,40.8,Rate
Karlsruhe,DE12,Total,Females,2016,Malignant neoplasm of breast,37.89,Rate
Karlsruhe,DE12,Total,Females,2017,Malignant neoplasm of breast,34.93,Rate
Karlsruhe,DE12,Total,Females,2018,Malignant neoplasm of breast,37.25,Rate
Karlsruhe,DE12,Total,Females,2019,Malignant neoplasm of breast,37.96,Rate
Karlsruhe,DE12,Total,Females,2020,Malignant neoplasm of breast,34.5,Rate
Karlsruhe,DE12,Total,Females,2011,Diabetes mellitus,24.78,Rate
Karlsruhe,DE12,Total,Females,2012,Diabetes mellitus,26.36,Rate
Karlsruhe,DE12,Total,Females,2013,Diabetes mellitus,26.54,Rate
Karlsruhe,DE12,Total,Females,2014,Diabetes mellitus,25.0,Rate
Karlsruhe,DE12,Total,Females,2015,Diabetes mellitus,26.12,Rate
Karlsruhe,DE12,Total,Females,2016,Diabetes mellitus,21.18,Rate
Karlsruhe,DE12,Total,Females,2017,Diabetes mellitus,23.02,Rate
Karlsruhe,DE12,Total,Females,2018,Diabetes mellitus,22.43,Rate
Karlsruhe,DE12,Total,Females,2019,Diabetes mellitus,19.61,Rate
Karlsruhe,DE12,Total,Females,2020,Diabetes mellitus,24.01,Rate
Karlsruhe,DE12,Total,Females,2011,Mental and behavioural disorders (F00-F99),31.66,Rate
Karlsruhe,DE12,Total,Females,2012,Mental and behavioural disorders (F00-F99),43.54,Rate
Karlsruhe,DE12,Total,Females,2013,Mental and behavioural disorders (F00-F99),52.94,Rate
Karlsruhe,DE12,Total,Females,2014,Mental and behavioural disorders (F00-F99),51.71,Rate
Karlsruhe,DE12,Total,Females,2015,Mental and behavioural disorders (F00-F99),60.05,Rate
Karlsruhe,DE12,Total,Females,2016,Mental and behavioural disorders (F00-F99),58.21,Rate
Karlsruhe,DE12,Total,Females,2017,Mental and behavioural disorders (F00-F99),63.98,Rate
Karlsruhe,DE12,Total,Females,2018,Mental and behavioural disorders (F00-F99),67.2,Rate
Karlsruhe,DE12,Total,Females,2019,Mental and behavioural disorders (F00-F99),69.4,Rate
Karlsruhe,DE12,Total,Females,2020,Mental and behavioural disorders (F00-F99),62.77,Rate
Karlsruhe,DE12,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.38,Rate
Karlsruhe,DE12,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.92,Rate
Karlsruhe,DE12,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),3.33,Rate
Karlsruhe,DE12,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Karlsruhe,DE12,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.59,Rate
Karlsruhe,DE12,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),3.01,Rate
Karlsruhe,DE12,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.12,Rate
Karlsruhe,DE12,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.96,Rate
Karlsruhe,DE12,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.35,Rate
Karlsruhe,DE12,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.81,Rate
Karlsruhe,DE12,Total,Females,2011,Other ischaemic heart diseases,63.76,Rate
Karlsruhe,DE12,Total,Females,2012,Other ischaemic heart diseases,65.4,Rate
Karlsruhe,DE12,Total,Females,2013,Other ischaemic heart diseases,63.5,Rate
Karlsruhe,DE12,Total,Females,2014,Other ischaemic heart diseases,61.03,Rate
Karlsruhe,DE12,Total,Females,2015,Other ischaemic heart diseases,60.48,Rate
Karlsruhe,DE12,Total,Females,2016,Other ischaemic heart diseases,54.5,Rate
Karlsruhe,DE12,Total,Females,2017,Other ischaemic heart diseases,55.44,Rate
Karlsruhe,DE12,Total,Females,2018,Other ischaemic heart diseases,54.87,Rate
Karlsruhe,DE12,Total,Females,2019,Other ischaemic heart diseases,53.33,Rate
Karlsruhe,DE12,Total,Females,2020,Other ischaemic heart diseases,49.85,Rate
Karlsruhe,DE12,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,54.03,Rate
Karlsruhe,DE12,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,54.5,Rate
Karlsruhe,DE12,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,48.26,Rate
Karlsruhe,DE12,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,44.14,Rate
Karlsruhe,DE12,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,45.28,Rate
Karlsruhe,DE12,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,40.33,Rate
Karlsruhe,DE12,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,39.1,Rate
Karlsruhe,DE12,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,39.92,Rate
Karlsruhe,DE12,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,37.27,Rate
Karlsruhe,DE12,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,34.74,Rate
Karlsruhe,DE12,Total,Females,2011,Cerebrovascular diseases,74.45,Rate
Karlsruhe,DE12,Total,Females,2012,Cerebrovascular diseases,71.21,Rate
Karlsruhe,DE12,Total,Females,2013,Cerebrovascular diseases,66.29,Rate
Karlsruhe,DE12,Total,Females,2014,Cerebrovascular diseases,65.4,Rate
Karlsruhe,DE12,Total,Females,2015,Cerebrovascular diseases,67.68,Rate
Karlsruhe,DE12,Total,Females,2016,Cerebrovascular diseases,56.69,Rate
Karlsruhe,DE12,Total,Females,2017,Cerebrovascular diseases,56.72,Rate
Karlsruhe,DE12,Total,Females,2018,Cerebrovascular diseases,53.51,Rate
Karlsruhe,DE12,Total,Females,2019,Cerebrovascular diseases,48.92,Rate
Karlsruhe,DE12,Total,Females,2020,Cerebrovascular diseases,52.5,Rate
Karlsruhe,DE12,Total,Females,2011,Chronic lower respiratory diseases,23.08,Rate
Karlsruhe,DE12,Total,Females,2012,Chronic lower respiratory diseases,23.84,Rate
Karlsruhe,DE12,Total,Females,2013,Chronic lower respiratory diseases,27.35,Rate
Karlsruhe,DE12,Total,Females,2014,Chronic lower respiratory diseases,25.83,Rate
Karlsruhe,DE12,Total,Females,2015,Chronic lower respiratory diseases,25.6,Rate
Karlsruhe,DE12,Total,Females,2016,Chronic lower respiratory diseases,26.05,Rate
Karlsruhe,DE12,Total,Females,2017,Chronic lower respiratory diseases,28.12,Rate
Karlsruhe,DE12,Total,Females,2018,Chronic lower respiratory diseases,26.26,Rate
Karlsruhe,DE12,Total,Females,2019,Chronic lower respiratory diseases,26.39,Rate
Karlsruhe,DE12,Total,Females,2020,Chronic lower respiratory diseases,22.47,Rate
Karlsruhe,DE12,Total,Females,2011,Asthma and status asthmaticus,1.6,Rate
Karlsruhe,DE12,Total,Females,2012,Asthma and status asthmaticus,1.98,Rate
Karlsruhe,DE12,Total,Females,2013,Asthma and status asthmaticus,1.49,Rate
Karlsruhe,DE12,Total,Females,2014,Asthma and status asthmaticus,1.44,Rate
Karlsruhe,DE12,Total,Females,2015,Asthma and status asthmaticus,1.24,Rate
Karlsruhe,DE12,Total,Females,2016,Asthma and status asthmaticus,1.44,Rate
Karlsruhe,DE12,Total,Females,2017,Asthma and status asthmaticus,1.05,Rate
Karlsruhe,DE12,Total,Females,2018,Asthma and status asthmaticus,1.09,Rate
Karlsruhe,DE12,Total,Females,2019,Asthma and status asthmaticus,1.13,Rate
Karlsruhe,DE12,Total,Females,2020,Asthma and status asthmaticus,1.26,Rate
Karlsruhe,DE12,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3761.35,Rate
Karlsruhe,DE12,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3792.09,Rate
Karlsruhe,DE12,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3751.03,Rate
Karlsruhe,DE12,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3595.14,Rate
Karlsruhe,DE12,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3872.75,Rate
Karlsruhe,DE12,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3654.76,Rate
Karlsruhe,DE12,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3666.55,Rate
Karlsruhe,DE12,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3679.85,Rate
Karlsruhe,DE12,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3660.09,Rate
Karlsruhe,DE12,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3658.4,Rate
Karlsruhe,DE12,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.04,Rate
Karlsruhe,DE12,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.63,Rate
Karlsruhe,DE12,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.31,Rate
Karlsruhe,DE12,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.24,Rate
Karlsruhe,DE12,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.91,Rate
Karlsruhe,DE12,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.15,Rate
Karlsruhe,DE12,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.4,Rate
Karlsruhe,DE12,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.9,Rate
Karlsruhe,DE12,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.81,Rate
Karlsruhe,DE12,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.86,Rate
Karlsruhe,DE12,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",84.6,Rate
Karlsruhe,DE12,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",101.61,Rate
Karlsruhe,DE12,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",96.01,Rate
Karlsruhe,DE12,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",91.52,Rate
Karlsruhe,DE12,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",97.74,Rate
Karlsruhe,DE12,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",104.75,Rate
Karlsruhe,DE12,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",108.9,Rate
Karlsruhe,DE12,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",107.0,Rate
Karlsruhe,DE12,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",126.12,Rate
Karlsruhe,DE12,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",126.23,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Malignant melanoma of skin,8.16,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Malignant melanoma of skin,9.89,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Malignant melanoma of skin,6.35,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Malignant melanoma of skin,7.9,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Malignant melanoma of skin,7.46,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Malignant melanoma of skin,7.84,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Malignant melanoma of skin,7.36,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Malignant melanoma of skin,8.26,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Malignant melanoma of skin,9.27,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Malignant melanoma of skin,4.41,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Malignant neoplasm of breast,121.92,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Malignant neoplasm of breast,124.29,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Malignant neoplasm of breast,131.86,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Malignant neoplasm of breast,143.89,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Malignant neoplasm of breast,144.5,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Malignant neoplasm of breast,139.01,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Malignant neoplasm of breast,130.13,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Malignant neoplasm of breast,133.13,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Malignant neoplasm of breast,137.86,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Malignant neoplasm of breast,131.74,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Diabetes mellitus,118.77,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Diabetes mellitus,125.87,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Diabetes mellitus,130.81,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Diabetes mellitus,121.62,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Diabetes mellitus,129.31,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Diabetes mellitus,102.34,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Diabetes mellitus,112.0,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Diabetes mellitus,107.54,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Diabetes mellitus,95.45,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Diabetes mellitus,118.31,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),157.1,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),216.1,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),262.8,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),256.38,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),300.0,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),286.6,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),319.57,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),335.21,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),348.48,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),309.58,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),11.09,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),12.36,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),14.09,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),10.83,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),15.81,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),12.32,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),11.94,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),12.15,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),9.96,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),13.89,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Other ischaemic heart diseases,319.41,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Other ischaemic heart diseases,328.0,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Other ischaemic heart diseases,317.01,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Other ischaemic heart diseases,302.83,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Other ischaemic heart diseases,302.4,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Other ischaemic heart diseases,274.29,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Other ischaemic heart diseases,275.47,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Other ischaemic heart diseases,272.25,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Other ischaemic heart diseases,266.84,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Other ischaemic heart diseases,251.23,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,255.25,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,257.1,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,227.14,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,206.78,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,212.28,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,190.33,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,182.87,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,182.69,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,171.74,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,159.97,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Cerebrovascular diseases,367.24,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Cerebrovascular diseases,346.71,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Cerebrovascular diseases,321.56,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Cerebrovascular diseases,315.0,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Cerebrovascular diseases,327.48,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Cerebrovascular diseases,276.86,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Cerebrovascular diseases,273.84,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Cerebrovascular diseases,260.04,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Cerebrovascular diseases,237.12,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Cerebrovascular diseases,249.81,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Chronic lower respiratory diseases,105.91,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Chronic lower respiratory diseases,112.9,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Chronic lower respiratory diseases,124.13,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Chronic lower respiratory diseases,111.62,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Chronic lower respiratory diseases,121.44,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Chronic lower respiratory diseases,118.73,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Chronic lower respiratory diseases,128.06,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Chronic lower respiratory diseases,123.02,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Chronic lower respiratory diseases,119.84,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Chronic lower respiratory diseases,98.18,Rate
Karlsruhe,DE12,65 years or over,Females,2011,Asthma and status asthmaticus,7.08,Rate
Karlsruhe,DE12,65 years or over,Females,2012,Asthma and status asthmaticus,9.12,Rate
Karlsruhe,DE12,65 years or over,Females,2013,Asthma and status asthmaticus,6.98,Rate
Karlsruhe,DE12,65 years or over,Females,2014,Asthma and status asthmaticus,6.36,Rate
Karlsruhe,DE12,65 years or over,Females,2015,Asthma and status asthmaticus,6.36,Rate
Karlsruhe,DE12,65 years or over,Females,2016,Asthma and status asthmaticus,6.36,Rate
Karlsruhe,DE12,65 years or over,Females,2017,Asthma and status asthmaticus,3.7,Rate
Karlsruhe,DE12,65 years or over,Females,2018,Asthma and status asthmaticus,4.85,Rate
Karlsruhe,DE12,65 years or over,Females,2019,Asthma and status asthmaticus,3.49,Rate
Karlsruhe,DE12,65 years or over,Females,2020,Asthma and status asthmaticus,4.56,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,132.23,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,124.42,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,127.69,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,127.52,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,125.83,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,118.86,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,120.54,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,124.55,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,116.72,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,115.63,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.44,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.34,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.72,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.89,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.96,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.07,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.79,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.27,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.95,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.15,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",13.78,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",13.34,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",10.74,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",12.88,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",12.68,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",11.99,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",11.2,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",11.28,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",10.27,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",8.9,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Malignant melanoma of skin,1.09,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Malignant melanoma of skin,1.41,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Malignant melanoma of skin,0.7,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Malignant melanoma of skin,0.62,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Malignant melanoma of skin,0.59,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Malignant melanoma of skin,0.61,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Malignant melanoma of skin,0.69,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Malignant melanoma of skin,0.97,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Malignant melanoma of skin,0.8,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Malignant melanoma of skin,1.21,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Malignant neoplasm of breast,15.26,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Malignant neoplasm of breast,13.21,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.71,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Malignant neoplasm of breast,15.99,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Malignant neoplasm of breast,15.68,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Malignant neoplasm of breast,13.4,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Malignant neoplasm of breast,11.86,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.02,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.76,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.95,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Diabetes mellitus,2.01,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Diabetes mellitus,2.26,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Diabetes mellitus,1.29,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Diabetes mellitus,1.59,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Diabetes mellitus,1.12,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Diabetes mellitus,1.52,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Diabetes mellitus,1.47,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Diabetes mellitus,1.81,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Diabetes mellitus,1.24,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Diabetes mellitus,1.17,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.28,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),1.73,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),2.1,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.13,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.93,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.88,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.06,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.29,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.8,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.98,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.37,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.83,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.79,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Other ischaemic heart diseases,2.09,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.46,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.88,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.26,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Other ischaemic heart diseases,2.15,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.22,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.62,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.07,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.29,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.42,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.93,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.75,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.83,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.99,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.27,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,5.34,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.69,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.4,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Cerebrovascular diseases,3.52,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Cerebrovascular diseases,4.48,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Cerebrovascular diseases,4.46,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Cerebrovascular diseases,4.94,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Cerebrovascular diseases,4.74,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Cerebrovascular diseases,3.36,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Cerebrovascular diseases,4.13,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Cerebrovascular diseases,3.48,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Cerebrovascular diseases,3.34,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Cerebrovascular diseases,4.71,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Chronic lower respiratory diseases,3.02,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Chronic lower respiratory diseases,2.26,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Chronic lower respiratory diseases,3.91,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Chronic lower respiratory diseases,5.05,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Chronic lower respiratory diseases,2.39,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Chronic lower respiratory diseases,3.59,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Chronic lower respiratory diseases,3.91,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.82,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Chronic lower respiratory diseases,3.75,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Chronic lower respiratory diseases,4.13,Rate
Karlsruhe,DE12,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.27,Rate
Karlsruhe,DE12,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.26,Rate
Karlsruhe,DE12,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.16,Rate
Karlsruhe,DE12,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.24,Rate
Karlsruhe,DE12,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Karlsruhe,DE12,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.25,Rate
Karlsruhe,DE12,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.41,Rate
Karlsruhe,DE12,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.17,Rate
Karlsruhe,DE12,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.56,Rate
Karlsruhe,DE12,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.46,Rate
Karlsruhe,DE12,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1242.5,Rate
Karlsruhe,DE12,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1231.01,Rate
Karlsruhe,DE12,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1231.27,Rate
Karlsruhe,DE12,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1178.25,Rate
Karlsruhe,DE12,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1195.15,Rate
Karlsruhe,DE12,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1201.38,Rate
Karlsruhe,DE12,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1194.63,Rate
Karlsruhe,DE12,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1188.82,Rate
Karlsruhe,DE12,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1156.07,Rate
Karlsruhe,DE12,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1199.53,Rate
Karlsruhe,DE12,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.91,Rate
Karlsruhe,DE12,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.44,Rate
Karlsruhe,DE12,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.84,Rate
Karlsruhe,DE12,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.25,Rate
Karlsruhe,DE12,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.97,Rate
Karlsruhe,DE12,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.98,Rate
Karlsruhe,DE12,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.15,Rate
Karlsruhe,DE12,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.06,Rate
Karlsruhe,DE12,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.83,Rate
Karlsruhe,DE12,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.9,Rate
Karlsruhe,DE12,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",66.59,Rate
Karlsruhe,DE12,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",71.5,Rate
Karlsruhe,DE12,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",63.01,Rate
Karlsruhe,DE12,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",64.4,Rate
Karlsruhe,DE12,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",62.07,Rate
Karlsruhe,DE12,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",63.1,Rate
Karlsruhe,DE12,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",55.93,Rate
Karlsruhe,DE12,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",59.43,Rate
Karlsruhe,DE12,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",59.08,Rate
Karlsruhe,DE12,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",60.85,Rate
Karlsruhe,DE12,Total,Males,2011,Malignant melanoma of skin,4.22,Rate
Karlsruhe,DE12,Total,Males,2012,Malignant melanoma of skin,4.23,Rate
Karlsruhe,DE12,Total,Males,2013,Malignant melanoma of skin,4.44,Rate
Karlsruhe,DE12,Total,Males,2014,Malignant melanoma of skin,4.55,Rate
Karlsruhe,DE12,Total,Males,2015,Malignant melanoma of skin,4.51,Rate
Karlsruhe,DE12,Total,Males,2016,Malignant melanoma of skin,4.41,Rate
Karlsruhe,DE12,Total,Males,2017,Malignant melanoma of skin,3.86,Rate
Karlsruhe,DE12,Total,Males,2018,Malignant melanoma of skin,3.62,Rate
Karlsruhe,DE12,Total,Males,2019,Malignant melanoma of skin,3.47,Rate
Karlsruhe,DE12,Total,Males,2020,Malignant melanoma of skin,4.28,Rate
Karlsruhe,DE12,Total,Males,2011,Malignant neoplasm of breast,0.59,Rate
Karlsruhe,DE12,Total,Males,2012,Malignant neoplasm of breast,0.49,Rate
Karlsruhe,DE12,Total,Males,2013,Malignant neoplasm of breast,0.49,Rate
Karlsruhe,DE12,Total,Males,2014,Malignant neoplasm of breast,0.69,Rate
Karlsruhe,DE12,Total,Males,2015,Malignant neoplasm of breast,0.87,Rate
Karlsruhe,DE12,Total,Males,2016,Malignant neoplasm of breast,0.68,Rate
Karlsruhe,DE12,Total,Males,2017,Malignant neoplasm of breast,0.7,Rate
Karlsruhe,DE12,Total,Males,2018,Malignant neoplasm of breast,0.3,Rate
Karlsruhe,DE12,Total,Males,2019,Malignant neoplasm of breast,0.31,Rate
Karlsruhe,DE12,Total,Males,2020,Malignant neoplasm of breast,0.15,Rate
Karlsruhe,DE12,Total,Males,2011,Diabetes mellitus,32.02,Rate
Karlsruhe,DE12,Total,Males,2012,Diabetes mellitus,32.21,Rate
Karlsruhe,DE12,Total,Males,2013,Diabetes mellitus,31.51,Rate
Karlsruhe,DE12,Total,Males,2014,Diabetes mellitus,30.08,Rate
Karlsruhe,DE12,Total,Males,2015,Diabetes mellitus,33.15,Rate
Karlsruhe,DE12,Total,Males,2016,Diabetes mellitus,31.85,Rate
Karlsruhe,DE12,Total,Males,2017,Diabetes mellitus,32.4,Rate
Karlsruhe,DE12,Total,Males,2018,Diabetes mellitus,30.95,Rate
Karlsruhe,DE12,Total,Males,2019,Diabetes mellitus,31.35,Rate
Karlsruhe,DE12,Total,Males,2020,Diabetes mellitus,31.87,Rate
Karlsruhe,DE12,Total,Males,2011,Mental and behavioural disorders (F00-F99),35.6,Rate
Karlsruhe,DE12,Total,Males,2012,Mental and behavioural disorders (F00-F99),44.43,Rate
Karlsruhe,DE12,Total,Males,2013,Mental and behavioural disorders (F00-F99),64.07,Rate
Karlsruhe,DE12,Total,Males,2014,Mental and behavioural disorders (F00-F99),55.49,Rate
Karlsruhe,DE12,Total,Males,2015,Mental and behavioural disorders (F00-F99),61.93,Rate
Karlsruhe,DE12,Total,Males,2016,Mental and behavioural disorders (F00-F99),61.68,Rate
Karlsruhe,DE12,Total,Males,2017,Mental and behavioural disorders (F00-F99),62.29,Rate
Karlsruhe,DE12,Total,Males,2018,Mental and behavioural disorders (F00-F99),66.67,Rate
Karlsruhe,DE12,Total,Males,2019,Mental and behavioural disorders (F00-F99),62.84,Rate
Karlsruhe,DE12,Total,Males,2020,Mental and behavioural disorders (F00-F99),59.82,Rate
Karlsruhe,DE12,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.32,Rate
Karlsruhe,DE12,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.92,Rate
Karlsruhe,DE12,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.41,Rate
Karlsruhe,DE12,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Karlsruhe,DE12,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),5.12,Rate
Karlsruhe,DE12,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),3.96,Rate
Karlsruhe,DE12,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.37,Rate
Karlsruhe,DE12,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.74,Rate
Karlsruhe,DE12,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Karlsruhe,DE12,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),3.9,Rate
Karlsruhe,DE12,Total,Males,2011,Other ischaemic heart diseases,115.75,Rate
Karlsruhe,DE12,Total,Males,2012,Other ischaemic heart diseases,118.2,Rate
Karlsruhe,DE12,Total,Males,2013,Other ischaemic heart diseases,116.09,Rate
Karlsruhe,DE12,Total,Males,2014,Other ischaemic heart diseases,110.94,Rate
Karlsruhe,DE12,Total,Males,2015,Other ischaemic heart diseases,113.68,Rate
Karlsruhe,DE12,Total,Males,2016,Other ischaemic heart diseases,112.38,Rate
Karlsruhe,DE12,Total,Males,2017,Other ischaemic heart diseases,104.23,Rate
Karlsruhe,DE12,Total,Males,2018,Other ischaemic heart diseases,99.49,Rate
Karlsruhe,DE12,Total,Males,2019,Other ischaemic heart diseases,103.74,Rate
Karlsruhe,DE12,Total,Males,2020,Other ischaemic heart diseases,104.89,Rate
Karlsruhe,DE12,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,108.77,Rate
Karlsruhe,DE12,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,101.75,Rate
Karlsruhe,DE12,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,98.48,Rate
Karlsruhe,DE12,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,92.43,Rate
Karlsruhe,DE12,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,85.07,Rate
Karlsruhe,DE12,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,82.67,Rate
Karlsruhe,DE12,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,81.03,Rate
Karlsruhe,DE12,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,84.52,Rate
Karlsruhe,DE12,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,81.51,Rate
Karlsruhe,DE12,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,83.83,Rate
Karlsruhe,DE12,Total,Males,2011,Cerebrovascular diseases,90.71,Rate
Karlsruhe,DE12,Total,Males,2012,Cerebrovascular diseases,86.41,Rate
Karlsruhe,DE12,Total,Males,2013,Cerebrovascular diseases,83.41,Rate
Karlsruhe,DE12,Total,Males,2014,Cerebrovascular diseases,76.46,Rate
Karlsruhe,DE12,Total,Males,2015,Cerebrovascular diseases,78.05,Rate
Karlsruhe,DE12,Total,Males,2016,Cerebrovascular diseases,72.03,Rate
Karlsruhe,DE12,Total,Males,2017,Cerebrovascular diseases,70.35,Rate
Karlsruhe,DE12,Total,Males,2018,Cerebrovascular diseases,66.9,Rate
Karlsruhe,DE12,Total,Males,2019,Cerebrovascular diseases,65.96,Rate
Karlsruhe,DE12,Total,Males,2020,Cerebrovascular diseases,65.29,Rate
Karlsruhe,DE12,Total,Males,2011,Chronic lower respiratory diseases,43.38,Rate
Karlsruhe,DE12,Total,Males,2012,Chronic lower respiratory diseases,46.26,Rate
Karlsruhe,DE12,Total,Males,2013,Chronic lower respiratory diseases,47.1,Rate
Karlsruhe,DE12,Total,Males,2014,Chronic lower respiratory diseases,42.11,Rate
Karlsruhe,DE12,Total,Males,2015,Chronic lower respiratory diseases,45.97,Rate
Karlsruhe,DE12,Total,Males,2016,Chronic lower respiratory diseases,42.21,Rate
Karlsruhe,DE12,Total,Males,2017,Chronic lower respiratory diseases,45.12,Rate
Karlsruhe,DE12,Total,Males,2018,Chronic lower respiratory diseases,45.78,Rate
Karlsruhe,DE12,Total,Males,2019,Chronic lower respiratory diseases,40.66,Rate
Karlsruhe,DE12,Total,Males,2020,Chronic lower respiratory diseases,37.26,Rate
Karlsruhe,DE12,Total,Males,2011,Asthma and status asthmaticus,1.4,Rate
Karlsruhe,DE12,Total,Males,2012,Asthma and status asthmaticus,1.35,Rate
Karlsruhe,DE12,Total,Males,2013,Asthma and status asthmaticus,2.24,Rate
Karlsruhe,DE12,Total,Males,2014,Asthma and status asthmaticus,1.83,Rate
Karlsruhe,DE12,Total,Males,2015,Asthma and status asthmaticus,1.34,Rate
Karlsruhe,DE12,Total,Males,2016,Asthma and status asthmaticus,0.95,Rate
Karlsruhe,DE12,Total,Males,2017,Asthma and status asthmaticus,1.74,Rate
Karlsruhe,DE12,Total,Males,2018,Asthma and status asthmaticus,1.0,Rate
Karlsruhe,DE12,Total,Males,2019,Asthma and status asthmaticus,1.12,Rate
Karlsruhe,DE12,Total,Males,2020,Asthma and status asthmaticus,0.94,Rate
Karlsruhe,DE12,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5393.71,Rate
Karlsruhe,DE12,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5396.87,Rate
Karlsruhe,DE12,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5412.1,Rate
Karlsruhe,DE12,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5130.28,Rate
Karlsruhe,DE12,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5228.98,Rate
Karlsruhe,DE12,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5257.25,Rate
Karlsruhe,DE12,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5231.2,Rate
Karlsruhe,DE12,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5193.86,Rate
Karlsruhe,DE12,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5036.37,Rate
Karlsruhe,DE12,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5288.68,Rate
Karlsruhe,DE12,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.16,Rate
Karlsruhe,DE12,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",150.27,Rate
Karlsruhe,DE12,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",162.98,Rate
Karlsruhe,DE12,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.49,Rate
Karlsruhe,DE12,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",148.84,Rate
Karlsruhe,DE12,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.62,Rate
Karlsruhe,DE12,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.03,Rate
Karlsruhe,DE12,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",131.9,Rate
Karlsruhe,DE12,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.06,Rate
Karlsruhe,DE12,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.49,Rate
Karlsruhe,DE12,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",261.56,Rate
Karlsruhe,DE12,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",281.36,Rate
Karlsruhe,DE12,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",249.05,Rate
Karlsruhe,DE12,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",252.45,Rate
Karlsruhe,DE12,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",245.33,Rate
Karlsruhe,DE12,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",251.59,Rate
Karlsruhe,DE12,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",225.64,Rate
Karlsruhe,DE12,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",231.69,Rate
Karlsruhe,DE12,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",237.42,Rate
Karlsruhe,DE12,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",246.47,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Malignant melanoma of skin,13.29,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Malignant melanoma of skin,14.4,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Malignant melanoma of skin,13.4,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Malignant melanoma of skin,19.93,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Malignant melanoma of skin,18.53,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Malignant melanoma of skin,19.49,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Malignant melanoma of skin,13.94,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Malignant melanoma of skin,13.92,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Malignant melanoma of skin,14.63,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Malignant melanoma of skin,16.45,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Malignant neoplasm of breast,2.67,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Malignant neoplasm of breast,2.07,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Malignant neoplasm of breast,2.21,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Malignant neoplasm of breast,3.14,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Malignant neoplasm of breast,3.34,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Malignant neoplasm of breast,2.82,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Malignant neoplasm of breast,2.97,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Malignant neoplasm of breast,1.18,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Malignant neoplasm of breast,0.66,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Malignant neoplasm of breast,0.44,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Diabetes mellitus,148.29,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Diabetes mellitus,150.66,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Diabetes mellitus,144.34,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Diabetes mellitus,135.99,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Diabetes mellitus,152.17,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Diabetes mellitus,145.52,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Diabetes mellitus,148.44,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Diabetes mellitus,140.04,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Diabetes mellitus,141.2,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Diabetes mellitus,145.88,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),161.93,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),206.34,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),303.67,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),260.21,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),285.08,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),286.86,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),291.65,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),315.58,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),291.74,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),285.15,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),5.34,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),16.29,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),13.65,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),14.54,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),18.38,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),16.0,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),13.02,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),14.38,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),6.15,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),13.06,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Other ischaemic heart diseases,561.46,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Other ischaemic heart diseases,576.77,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Other ischaemic heart diseases,561.8,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Other ischaemic heart diseases,535.74,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Other ischaemic heart diseases,543.75,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Other ischaemic heart diseases,543.45,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Other ischaemic heart diseases,504.66,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Other ischaemic heart diseases,474.43,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Other ischaemic heart diseases,498.02,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Other ischaemic heart diseases,512.21,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,457.38,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,438.92,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,428.77,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,388.83,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,358.09,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,349.55,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,335.18,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,350.45,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,336.45,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,344.89,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Cerebrovascular diseases,441.68,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Cerebrovascular diseases,414.66,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Cerebrovascular diseases,400.39,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Cerebrovascular diseases,362.08,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Cerebrovascular diseases,375.5,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Cerebrovascular diseases,343.32,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Cerebrovascular diseases,337.38,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Cerebrovascular diseases,320.25,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Cerebrovascular diseases,310.9,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Cerebrovascular diseases,306.35,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Chronic lower respiratory diseases,200.37,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Chronic lower respiratory diseases,215.67,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Chronic lower respiratory diseases,221.62,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Chronic lower respiratory diseases,193.54,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Chronic lower respiratory diseases,212.9,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Chronic lower respiratory diseases,196.18,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Chronic lower respiratory diseases,205.5,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Chronic lower respiratory diseases,212.93,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Chronic lower respiratory diseases,187.05,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Chronic lower respiratory diseases,171.16,Rate
Karlsruhe,DE12,65 years or over,Males,2011,Asthma and status asthmaticus,5.94,Rate
Karlsruhe,DE12,65 years or over,Males,2012,Asthma and status asthmaticus,5.63,Rate
Karlsruhe,DE12,65 years or over,Males,2013,Asthma and status asthmaticus,9.56,Rate
Karlsruhe,DE12,65 years or over,Males,2014,Asthma and status asthmaticus,7.63,Rate
Karlsruhe,DE12,65 years or over,Males,2015,Asthma and status asthmaticus,5.62,Rate
Karlsruhe,DE12,65 years or over,Males,2016,Asthma and status asthmaticus,4.26,Rate
Karlsruhe,DE12,65 years or over,Males,2017,Asthma and status asthmaticus,7.27,Rate
Karlsruhe,DE12,65 years or over,Males,2018,Asthma and status asthmaticus,4.4,Rate
Karlsruhe,DE12,65 years or over,Males,2019,Asthma and status asthmaticus,3.36,Rate
Karlsruhe,DE12,65 years or over,Males,2020,Asthma and status asthmaticus,3.83,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,236.93,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,221.89,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,218.53,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,220.93,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,218.01,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,218.9,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,216.82,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,218.65,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,216.12,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,208.99,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.6,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.62,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.53,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.81,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.15,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.91,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.23,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.63,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.36,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.19,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",19.35,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",20.67,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",17.94,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",18.85,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",17.67,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",17.44,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",14.82,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",17.7,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",15.88,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",15.89,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Malignant melanoma of skin,2.02,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Malignant melanoma of skin,1.77,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Malignant melanoma of skin,2.27,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Malignant melanoma of skin,0.83,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Malignant melanoma of skin,1.11,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Malignant melanoma of skin,0.75,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Malignant melanoma of skin,1.41,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Malignant melanoma of skin,1.13,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Malignant melanoma of skin,0.77,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Malignant melanoma of skin,1.33,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.09,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.11,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.07,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.09,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.27,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.16,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.15,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.09,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.22,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.08,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Diabetes mellitus,3.85,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Diabetes mellitus,3.52,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Diabetes mellitus,4.18,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Diabetes mellitus,4.42,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Diabetes mellitus,4.32,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Diabetes mellitus,4.32,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Diabetes mellitus,4.29,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Diabetes mellitus,4.52,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Diabetes mellitus,4.74,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Diabetes mellitus,4.25,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),5.0,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),5.2,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),6.03,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),5.9,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),7.87,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),7.13,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),6.73,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),6.37,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),7.39,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),5.23,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.28,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.91,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.17,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.62,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.68,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Other ischaemic heart diseases,7.78,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Other ischaemic heart diseases,7.12,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Other ischaemic heart diseases,8.12,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Other ischaemic heart diseases,8.04,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Other ischaemic heart diseases,9.51,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Other ischaemic heart diseases,7.96,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Other ischaemic heart diseases,7.23,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Other ischaemic heart diseases,8.67,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Other ischaemic heart diseases,8.23,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Other ischaemic heart diseases,6.22,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,24.33,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,20.08,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,18.47,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,20.63,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,18.94,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,18.03,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,19.46,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,20.1,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,19.76,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,20.59,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Cerebrovascular diseases,5.7,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Cerebrovascular diseases,6.9,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Cerebrovascular diseases,6.62,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Cerebrovascular diseases,7.27,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Cerebrovascular diseases,5.99,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Cerebrovascular diseases,6.32,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Cerebrovascular diseases,5.67,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Cerebrovascular diseases,5.53,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Cerebrovascular diseases,6.63,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Cerebrovascular diseases,6.9,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Chronic lower respiratory diseases,5.36,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Chronic lower respiratory diseases,5.22,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Chronic lower respiratory diseases,4.83,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Chronic lower respiratory diseases,5.43,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Chronic lower respiratory diseases,5.54,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.92,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.27,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.29,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Chronic lower respiratory diseases,5.2,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Chronic lower respiratory diseases,4.82,Rate
Karlsruhe,DE12,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.3,Rate
Karlsruhe,DE12,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.32,Rate
Karlsruhe,DE12,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.47,Rate
Karlsruhe,DE12,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.43,Rate
Karlsruhe,DE12,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.3,Rate
Karlsruhe,DE12,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.15,Rate
Karlsruhe,DE12,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.4,Rate
Karlsruhe,DE12,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.18,Rate
Karlsruhe,DE12,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.58,Rate
Karlsruhe,DE12,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.24,Rate
Karlsruhe,DE12,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1006.25,Rate
Karlsruhe,DE12,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1001.85,Rate
Karlsruhe,DE12,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,999.13,Rate
Karlsruhe,DE12,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,959.63,Rate
Karlsruhe,DE12,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1003.41,Rate
Karlsruhe,DE12,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,976.96,Rate
Karlsruhe,DE12,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,977.49,Rate
Karlsruhe,DE12,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,977.53,Rate
Karlsruhe,DE12,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,962.41,Rate
Karlsruhe,DE12,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,975.94,Rate
Karlsruhe,DE12,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.25,Rate
Karlsruhe,DE12,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.6,Rate
Karlsruhe,DE12,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.26,Rate
Karlsruhe,DE12,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.44,Rate
Karlsruhe,DE12,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.22,Rate
Karlsruhe,DE12,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.88,Rate
Karlsruhe,DE12,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.16,Rate
Karlsruhe,DE12,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.15,Rate
Karlsruhe,DE12,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.35,Rate
Karlsruhe,DE12,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.4,Rate
Karlsruhe,DE12,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",44.05,Rate
Karlsruhe,DE12,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",47.67,Rate
Karlsruhe,DE12,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",42.75,Rate
Karlsruhe,DE12,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",44.04,Rate
Karlsruhe,DE12,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",43.22,Rate
Karlsruhe,DE12,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",44.36,Rate
Karlsruhe,DE12,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",41.43,Rate
Karlsruhe,DE12,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",43.03,Rate
Karlsruhe,DE12,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",44.46,Rate
Karlsruhe,DE12,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",44.63,Rate
Karlsruhe,DE12,Total,Total,2011,Malignant melanoma of skin,3.19,Rate
Karlsruhe,DE12,Total,Total,2012,Malignant melanoma of skin,3.66,Rate
Karlsruhe,DE12,Total,Total,2013,Malignant melanoma of skin,3.04,Rate
Karlsruhe,DE12,Total,Total,2014,Malignant melanoma of skin,3.08,Rate
Karlsruhe,DE12,Total,Total,2015,Malignant melanoma of skin,3.09,Rate
Karlsruhe,DE12,Total,Total,2016,Malignant melanoma of skin,3.04,Rate
Karlsruhe,DE12,Total,Total,2017,Malignant melanoma of skin,2.82,Rate
Karlsruhe,DE12,Total,Total,2018,Malignant melanoma of skin,2.82,Rate
Karlsruhe,DE12,Total,Total,2019,Malignant melanoma of skin,2.86,Rate
Karlsruhe,DE12,Total,Total,2020,Malignant melanoma of skin,2.78,Rate
Karlsruhe,DE12,Total,Total,2011,Malignant neoplasm of breast,20.84,Rate
Karlsruhe,DE12,Total,Total,2012,Malignant neoplasm of breast,19.97,Rate
Karlsruhe,DE12,Total,Total,2013,Malignant neoplasm of breast,21.77,Rate
Karlsruhe,DE12,Total,Total,2014,Malignant neoplasm of breast,23.26,Rate
Karlsruhe,DE12,Total,Total,2015,Malignant neoplasm of breast,23.26,Rate
Karlsruhe,DE12,Total,Total,2016,Malignant neoplasm of breast,21.64,Rate
Karlsruhe,DE12,Total,Total,2017,Malignant neoplasm of breast,20.12,Rate
Karlsruhe,DE12,Total,Total,2018,Malignant neoplasm of breast,21.09,Rate
Karlsruhe,DE12,Total,Total,2019,Malignant neoplasm of breast,21.44,Rate
Karlsruhe,DE12,Total,Total,2020,Malignant neoplasm of breast,19.53,Rate
Karlsruhe,DE12,Total,Total,2011,Diabetes mellitus,28.25,Rate
Karlsruhe,DE12,Total,Total,2012,Diabetes mellitus,29.13,Rate
Karlsruhe,DE12,Total,Total,2013,Diabetes mellitus,29.18,Rate
Karlsruhe,DE12,Total,Total,2014,Diabetes mellitus,27.75,Rate
Karlsruhe,DE12,Total,Total,2015,Diabetes mellitus,29.57,Rate
Karlsruhe,DE12,Total,Total,2016,Diabetes mellitus,26.07,Rate
Karlsruhe,DE12,Total,Total,2017,Diabetes mellitus,27.11,Rate
Karlsruhe,DE12,Total,Total,2018,Diabetes mellitus,26.41,Rate
Karlsruhe,DE12,Total,Total,2019,Diabetes mellitus,24.94,Rate
Karlsruhe,DE12,Total,Total,2020,Diabetes mellitus,27.88,Rate
Karlsruhe,DE12,Total,Total,2011,Mental and behavioural disorders (F00-F99),33.91,Rate
Karlsruhe,DE12,Total,Total,2012,Mental and behavioural disorders (F00-F99),45.41,Rate
Karlsruhe,DE12,Total,Total,2013,Mental and behavioural disorders (F00-F99),58.05,Rate
Karlsruhe,DE12,Total,Total,2014,Mental and behavioural disorders (F00-F99),54.63,Rate
Karlsruhe,DE12,Total,Total,2015,Mental and behavioural disorders (F00-F99),62.0,Rate
Karlsruhe,DE12,Total,Total,2016,Mental and behavioural disorders (F00-F99),61.23,Rate
Karlsruhe,DE12,Total,Total,2017,Mental and behavioural disorders (F00-F99),64.92,Rate
Karlsruhe,DE12,Total,Total,2018,Mental and behavioural disorders (F00-F99),68.46,Rate
Karlsruhe,DE12,Total,Total,2019,Mental and behavioural disorders (F00-F99),68.95,Rate
Karlsruhe,DE12,Total,Total,2020,Mental and behavioural disorders (F00-F99),62.92,Rate
Karlsruhe,DE12,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.09,Rate
Karlsruhe,DE12,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),3.3,Rate
Karlsruhe,DE12,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.33,Rate
Karlsruhe,DE12,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Karlsruhe,DE12,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),4.28,Rate
Karlsruhe,DE12,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.4,Rate
Karlsruhe,DE12,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.26,Rate
Karlsruhe,DE12,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.33,Rate
Karlsruhe,DE12,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Karlsruhe,DE12,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.91,Rate
Karlsruhe,DE12,Total,Total,2011,Other ischaemic heart diseases,83.0,Rate
Karlsruhe,DE12,Total,Total,2012,Other ischaemic heart diseases,85.7,Rate
Karlsruhe,DE12,Total,Total,2013,Other ischaemic heart diseases,83.69,Rate
Karlsruhe,DE12,Total,Total,2014,Other ischaemic heart diseases,80.04,Rate
Karlsruhe,DE12,Total,Total,2015,Other ischaemic heart diseases,82.03,Rate
Karlsruhe,DE12,Total,Total,2016,Other ischaemic heart diseases,76.41,Rate
Karlsruhe,DE12,Total,Total,2017,Other ischaemic heart diseases,74.66,Rate
Karlsruhe,DE12,Total,Total,2018,Other ischaemic heart diseases,72.44,Rate
Karlsruhe,DE12,Total,Total,2019,Other ischaemic heart diseases,72.93,Rate
Karlsruhe,DE12,Total,Total,2020,Other ischaemic heart diseases,71.64,Rate
Karlsruhe,DE12,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,77.57,Rate
Karlsruhe,DE12,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,74.91,Rate
Karlsruhe,DE12,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,68.9,Rate
Karlsruhe,DE12,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,64.51,Rate
Karlsruhe,DE12,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,62.97,Rate
Karlsruhe,DE12,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,58.41,Rate
Karlsruhe,DE12,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,57.43,Rate
Karlsruhe,DE12,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,59.41,Rate
Karlsruhe,DE12,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,57.02,Rate
Karlsruhe,DE12,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,56.07,Rate
Karlsruhe,DE12,Total,Total,2011,Cerebrovascular diseases,81.53,Rate
Karlsruhe,DE12,Total,Total,2012,Cerebrovascular diseases,78.08,Rate
Karlsruhe,DE12,Total,Total,2013,Cerebrovascular diseases,73.74,Rate
Karlsruhe,DE12,Total,Total,2014,Cerebrovascular diseases,70.44,Rate
Karlsruhe,DE12,Total,Total,2015,Cerebrovascular diseases,72.99,Rate
Karlsruhe,DE12,Total,Total,2016,Cerebrovascular diseases,63.5,Rate
Karlsruhe,DE12,Total,Total,2017,Cerebrovascular diseases,62.96,Rate
Karlsruhe,DE12,Total,Total,2018,Cerebrovascular diseases,59.14,Rate
Karlsruhe,DE12,Total,Total,2019,Cerebrovascular diseases,56.39,Rate
Karlsruhe,DE12,Total,Total,2020,Cerebrovascular diseases,58.51,Rate
Karlsruhe,DE12,Total,Total,2011,Chronic lower respiratory diseases,30.73,Rate
Karlsruhe,DE12,Total,Total,2012,Chronic lower respiratory diseases,32.48,Rate
Karlsruhe,DE12,Total,Total,2013,Chronic lower respiratory diseases,34.84,Rate
Karlsruhe,DE12,Total,Total,2014,Chronic lower respiratory diseases,31.75,Rate
Karlsruhe,DE12,Total,Total,2015,Chronic lower respiratory diseases,33.74,Rate
Karlsruhe,DE12,Total,Total,2016,Chronic lower respiratory diseases,32.15,Rate
Karlsruhe,DE12,Total,Total,2017,Chronic lower respiratory diseases,34.78,Rate
Karlsruhe,DE12,Total,Total,2018,Chronic lower respiratory diseases,34.04,Rate
Karlsruhe,DE12,Total,Total,2019,Chronic lower respiratory diseases,32.06,Rate
Karlsruhe,DE12,Total,Total,2020,Chronic lower respiratory diseases,28.7,Rate
Karlsruhe,DE12,Total,Total,2011,Asthma and status asthmaticus,1.46,Rate
Karlsruhe,DE12,Total,Total,2012,Asthma and status asthmaticus,1.86,Rate
Karlsruhe,DE12,Total,Total,2013,Asthma and status asthmaticus,1.73,Rate
Karlsruhe,DE12,Total,Total,2014,Asthma and status asthmaticus,1.62,Rate
Karlsruhe,DE12,Total,Total,2015,Asthma and status asthmaticus,1.31,Rate
Karlsruhe,DE12,Total,Total,2016,Asthma and status asthmaticus,1.27,Rate
Karlsruhe,DE12,Total,Total,2017,Asthma and status asthmaticus,1.29,Rate
Karlsruhe,DE12,Total,Total,2018,Asthma and status asthmaticus,1.09,Rate
Karlsruhe,DE12,Total,Total,2019,Asthma and status asthmaticus,1.15,Rate
Karlsruhe,DE12,Total,Total,2020,Asthma and status asthmaticus,1.12,Rate
Karlsruhe,DE12,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4401.25,Rate
Karlsruhe,DE12,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4425.16,Rate
Karlsruhe,DE12,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4411.59,Rate
Karlsruhe,DE12,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4204.12,Rate
Karlsruhe,DE12,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4437.3,Rate
Karlsruhe,DE12,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4313.26,Rate
Karlsruhe,DE12,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4316.82,Rate
Karlsruhe,DE12,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4304.55,Rate
Karlsruhe,DE12,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4247.99,Rate
Karlsruhe,DE12,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4334.56,Rate
Karlsruhe,DE12,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.41,Rate
Karlsruhe,DE12,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.99,Rate
Karlsruhe,DE12,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.79,Rate
Karlsruhe,DE12,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.47,Rate
Karlsruhe,DE12,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.75,Rate
Karlsruhe,DE12,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.15,Rate
Karlsruhe,DE12,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.33,Rate
Karlsruhe,DE12,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.35,Rate
Karlsruhe,DE12,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.25,Rate
Karlsruhe,DE12,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.53,Rate
Karlsruhe,DE12,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",157.81,Rate
Karlsruhe,DE12,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",174.56,Rate
Karlsruhe,DE12,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",160.41,Rate
Karlsruhe,DE12,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",160.7,Rate
Karlsruhe,DE12,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",159.19,Rate
Karlsruhe,DE12,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",167.0,Rate
Karlsruhe,DE12,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",158.8,Rate
Karlsruhe,DE12,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",160.97,Rate
Karlsruhe,DE12,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",174.11,Rate
Karlsruhe,DE12,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",177.82,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Malignant melanoma of skin,9.96,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Malignant melanoma of skin,12.22,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Malignant melanoma of skin,9.48,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Malignant melanoma of skin,12.8,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Malignant melanoma of skin,12.34,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Malignant melanoma of skin,12.77,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Malignant melanoma of skin,10.14,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Malignant melanoma of skin,10.12,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Malignant melanoma of skin,11.46,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Malignant melanoma of skin,9.03,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Malignant neoplasm of breast,74.79,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Malignant neoplasm of breast,74.54,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Malignant neoplasm of breast,78.86,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Malignant neoplasm of breast,85.76,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Malignant neoplasm of breast,86.16,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Malignant neoplasm of breast,82.85,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Malignant neoplasm of breast,78.34,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Malignant neoplasm of breast,79.01,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Malignant neoplasm of breast,81.14,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Malignant neoplasm of breast,77.49,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Diabetes mellitus,132.83,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Diabetes mellitus,137.56,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Diabetes mellitus,138.41,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Diabetes mellitus,129.88,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Diabetes mellitus,140.49,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Diabetes mellitus,121.65,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Diabetes mellitus,127.19,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Diabetes mellitus,122.4,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Diabetes mellitus,115.6,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Diabetes mellitus,131.79,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),161.05,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),218.59,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),280.97,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),263.55,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),297.79,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),293.4,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),314.7,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),333.22,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),334.61,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),305.71,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),9.47,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),13.69,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),13.66,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),12.35,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),16.71,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),13.73,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),12.58,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),13.15,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),8.46,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),13.79,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Other ischaemic heart diseases,406.0,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Other ischaemic heart diseases,421.28,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Other ischaemic heart diseases,408.38,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Other ischaemic heart diseases,388.98,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Other ischaemic heart diseases,397.35,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Other ischaemic heart diseases,372.95,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Other ischaemic heart diseases,363.65,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Other ischaemic heart diseases,349.08,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Other ischaemic heart diseases,353.71,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Other ischaemic heart diseases,352.37,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,337.27,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,332.01,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,305.42,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,278.86,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,274.14,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,254.29,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,245.71,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,252.28,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,242.04,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,236.02,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Cerebrovascular diseases,399.17,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Cerebrovascular diseases,377.01,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Cerebrovascular diseases,355.47,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Cerebrovascular diseases,336.17,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Cerebrovascular diseases,352.2,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Cerebrovascular diseases,305.71,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Cerebrovascular diseases,302.69,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Cerebrovascular diseases,284.73,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Cerebrovascular diseases,268.63,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Cerebrovascular diseases,276.14,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Chronic lower respiratory diseases,140.4,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Chronic lower respiratory diseases,151.25,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Chronic lower respiratory diseases,160.63,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Chronic lower respiratory diseases,141.25,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Chronic lower respiratory diseases,156.74,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Chronic lower respiratory diseases,147.34,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Chronic lower respiratory diseases,157.41,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Chronic lower respiratory diseases,157.8,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Chronic lower respiratory diseases,145.95,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Chronic lower respiratory diseases,128.66,Rate
Karlsruhe,DE12,65 years or over,Total,2011,Asthma and status asthmaticus,6.35,Rate
Karlsruhe,DE12,65 years or over,Total,2012,Asthma and status asthmaticus,8.33,Rate
Karlsruhe,DE12,65 years or over,Total,2013,Asthma and status asthmaticus,7.59,Rate
Karlsruhe,DE12,65 years or over,Total,2014,Asthma and status asthmaticus,6.92,Rate
Karlsruhe,DE12,65 years or over,Total,2015,Asthma and status asthmaticus,6.07,Rate
Karlsruhe,DE12,65 years or over,Total,2016,Asthma and status asthmaticus,5.64,Rate
Karlsruhe,DE12,65 years or over,Total,2017,Asthma and status asthmaticus,4.94,Rate
Karlsruhe,DE12,65 years or over,Total,2018,Asthma and status asthmaticus,4.84,Rate
Karlsruhe,DE12,65 years or over,Total,2019,Asthma and status asthmaticus,3.54,Rate
Karlsruhe,DE12,65 years or over,Total,2020,Asthma and status asthmaticus,4.3,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,183.86,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,172.6,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,172.51,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,173.7,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,171.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,168.79,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,168.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,171.61,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,166.53,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,162.36,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.5,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.94,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.6,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.33,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.02,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.99,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.5,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.93,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.66,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.16,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",16.49,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",16.93,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",14.25,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",15.79,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",15.13,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",14.66,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",13.0,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",14.46,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",13.06,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",12.37,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Malignant melanoma of skin,1.56,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Malignant melanoma of skin,1.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Malignant melanoma of skin,1.48,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Malignant melanoma of skin,0.72,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Malignant melanoma of skin,0.85,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Malignant melanoma of skin,0.68,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Malignant melanoma of skin,1.05,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Malignant melanoma of skin,1.05,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Malignant melanoma of skin,0.78,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Malignant melanoma of skin,1.26,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.78,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.75,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.95,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Malignant neoplasm of breast,8.11,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Malignant neoplasm of breast,8.03,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.82,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.02,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.06,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.98,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.49,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Diabetes mellitus,2.92,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Diabetes mellitus,2.87,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Diabetes mellitus,2.71,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Diabetes mellitus,3.01,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Diabetes mellitus,2.7,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Diabetes mellitus,2.91,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Diabetes mellitus,2.86,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Diabetes mellitus,3.16,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Diabetes mellitus,2.98,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Diabetes mellitus,2.71,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),3.11,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),3.46,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),4.05,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.03,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),4.89,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),4.99,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.41,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),4.33,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),4.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.11,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.27,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.01,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.52,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Other ischaemic heart diseases,4.76,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Other ischaemic heart diseases,4.41,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Other ischaemic heart diseases,5.04,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.2,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.65,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Other ischaemic heart diseases,4.58,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Other ischaemic heart diseases,4.66,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.43,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Other ischaemic heart diseases,4.92,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Other ischaemic heart diseases,3.64,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,14.66,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,12.63,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,11.61,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,12.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.82,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,10.96,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,11.82,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.69,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,12.21,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,12.48,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Cerebrovascular diseases,4.59,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Cerebrovascular diseases,5.67,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Cerebrovascular diseases,5.5,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Cerebrovascular diseases,6.07,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Cerebrovascular diseases,5.36,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Cerebrovascular diseases,4.83,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Cerebrovascular diseases,4.88,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Cerebrovascular diseases,4.5,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Cerebrovascular diseases,4.97,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Cerebrovascular diseases,5.79,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.16,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Chronic lower respiratory diseases,3.71,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Chronic lower respiratory diseases,4.36,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.22,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Chronic lower respiratory diseases,3.95,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Chronic lower respiratory diseases,4.25,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Chronic lower respiratory diseases,5.07,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Chronic lower respiratory diseases,4.05,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Chronic lower respiratory diseases,4.47,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Chronic lower respiratory diseases,4.48,Rate
Karlsruhe,DE12,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.28,Rate
Karlsruhe,DE12,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.29,Rate
Karlsruhe,DE12,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.31,Rate
Karlsruhe,DE12,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.34,Rate
Karlsruhe,DE12,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.16,Rate
Karlsruhe,DE12,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.21,Rate
Karlsruhe,DE12,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.41,Rate
Karlsruhe,DE12,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.18,Rate
Karlsruhe,DE12,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.57,Rate
Karlsruhe,DE12,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.35,Rate
Berlin,DE30,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,852.02,Rate
Berlin,DE30,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,873.58,Rate
Berlin,DE30,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,862.88,Rate
Berlin,DE30,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,821.51,Rate
Berlin,DE30,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,847.51,Rate
Berlin,DE30,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,819.93,Rate
Berlin,DE30,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,818.24,Rate
Berlin,DE30,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,841.01,Rate
Berlin,DE30,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,788.79,Rate
Berlin,DE30,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,841.16,Rate
Berlin,DE30,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.97,Rate
Berlin,DE30,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.34,Rate
Berlin,DE30,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.52,Rate
Berlin,DE30,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.85,Rate
Berlin,DE30,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.93,Rate
Berlin,DE30,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.33,Rate
Berlin,DE30,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.57,Rate
Berlin,DE30,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.09,Rate
Berlin,DE30,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.0,Rate
Berlin,DE30,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.39,Rate
Berlin,DE30,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",44.25,Rate
Berlin,DE30,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",42.98,Rate
Berlin,DE30,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",43.98,Rate
Berlin,DE30,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",40.73,Rate
Berlin,DE30,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",43.49,Rate
Berlin,DE30,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",43.37,Rate
Berlin,DE30,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",42.82,Rate
Berlin,DE30,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",42.44,Rate
Berlin,DE30,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",42.82,Rate
Berlin,DE30,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",44.28,Rate
Berlin,DE30,Total,Females,2011,Malignant melanoma of skin,2.25,Rate
Berlin,DE30,Total,Females,2012,Malignant melanoma of skin,1.92,Rate
Berlin,DE30,Total,Females,2013,Malignant melanoma of skin,2.19,Rate
Berlin,DE30,Total,Females,2014,Malignant melanoma of skin,2.68,Rate
Berlin,DE30,Total,Females,2015,Malignant melanoma of skin,2.28,Rate
Berlin,DE30,Total,Females,2016,Malignant melanoma of skin,1.91,Rate
Berlin,DE30,Total,Females,2017,Malignant melanoma of skin,2.07,Rate
Berlin,DE30,Total,Females,2018,Malignant melanoma of skin,2.0,Rate
Berlin,DE30,Total,Females,2019,Malignant melanoma of skin,2.12,Rate
Berlin,DE30,Total,Females,2020,Malignant melanoma of skin,2.18,Rate
Berlin,DE30,Total,Females,2011,Malignant neoplasm of breast,38.97,Rate
Berlin,DE30,Total,Females,2012,Malignant neoplasm of breast,37.52,Rate
Berlin,DE30,Total,Females,2013,Malignant neoplasm of breast,35.62,Rate
Berlin,DE30,Total,Females,2014,Malignant neoplasm of breast,35.55,Rate
Berlin,DE30,Total,Females,2015,Malignant neoplasm of breast,37.04,Rate
Berlin,DE30,Total,Females,2016,Malignant neoplasm of breast,36.97,Rate
Berlin,DE30,Total,Females,2017,Malignant neoplasm of breast,34.81,Rate
Berlin,DE30,Total,Females,2018,Malignant neoplasm of breast,36.03,Rate
Berlin,DE30,Total,Females,2019,Malignant neoplasm of breast,34.0,Rate
Berlin,DE30,Total,Females,2020,Malignant neoplasm of breast,35.18,Rate
Berlin,DE30,Total,Females,2011,Diabetes mellitus,32.75,Rate
Berlin,DE30,Total,Females,2012,Diabetes mellitus,30.16,Rate
Berlin,DE30,Total,Females,2013,Diabetes mellitus,29.37,Rate
Berlin,DE30,Total,Females,2014,Diabetes mellitus,24.66,Rate
Berlin,DE30,Total,Females,2015,Diabetes mellitus,29.31,Rate
Berlin,DE30,Total,Females,2016,Diabetes mellitus,28.57,Rate
Berlin,DE30,Total,Females,2017,Diabetes mellitus,24.2,Rate
Berlin,DE30,Total,Females,2018,Diabetes mellitus,20.52,Rate
Berlin,DE30,Total,Females,2019,Diabetes mellitus,21.8,Rate
Berlin,DE30,Total,Females,2020,Diabetes mellitus,23.3,Rate
Berlin,DE30,Total,Females,2011,Mental and behavioural disorders (F00-F99),18.84,Rate
Berlin,DE30,Total,Females,2012,Mental and behavioural disorders (F00-F99),19.98,Rate
Berlin,DE30,Total,Females,2013,Mental and behavioural disorders (F00-F99),25.76,Rate
Berlin,DE30,Total,Females,2014,Mental and behavioural disorders (F00-F99),23.13,Rate
Berlin,DE30,Total,Females,2015,Mental and behavioural disorders (F00-F99),32.56,Rate
Berlin,DE30,Total,Females,2016,Mental and behavioural disorders (F00-F99),35.64,Rate
Berlin,DE30,Total,Females,2017,Mental and behavioural disorders (F00-F99),46.37,Rate
Berlin,DE30,Total,Females,2018,Mental and behavioural disorders (F00-F99),58.7,Rate
Berlin,DE30,Total,Females,2019,Mental and behavioural disorders (F00-F99),50.43,Rate
Berlin,DE30,Total,Females,2020,Mental and behavioural disorders (F00-F99),55.18,Rate
Berlin,DE30,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Berlin,DE30,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Berlin,DE30,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Berlin,DE30,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Berlin,DE30,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Berlin,DE30,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.1,Rate
Berlin,DE30,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.07,Rate
Berlin,DE30,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.23,Rate
Berlin,DE30,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.85,Rate
Berlin,DE30,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.33,Rate
Berlin,DE30,Total,Females,2011,Other ischaemic heart diseases,64.89,Rate
Berlin,DE30,Total,Females,2012,Other ischaemic heart diseases,61.94,Rate
Berlin,DE30,Total,Females,2013,Other ischaemic heart diseases,56.79,Rate
Berlin,DE30,Total,Females,2014,Other ischaemic heart diseases,47.07,Rate
Berlin,DE30,Total,Females,2015,Other ischaemic heart diseases,45.2,Rate
Berlin,DE30,Total,Females,2016,Other ischaemic heart diseases,45.21,Rate
Berlin,DE30,Total,Females,2017,Other ischaemic heart diseases,47.93,Rate
Berlin,DE30,Total,Females,2018,Other ischaemic heart diseases,41.05,Rate
Berlin,DE30,Total,Females,2019,Other ischaemic heart diseases,34.56,Rate
Berlin,DE30,Total,Females,2020,Other ischaemic heart diseases,39.12,Rate
Berlin,DE30,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,50.01,Rate
Berlin,DE30,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,50.35,Rate
Berlin,DE30,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,38.36,Rate
Berlin,DE30,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,34.02,Rate
Berlin,DE30,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,39.09,Rate
Berlin,DE30,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,38.61,Rate
Berlin,DE30,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,38.75,Rate
Berlin,DE30,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,48.19,Rate
Berlin,DE30,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,49.72,Rate
Berlin,DE30,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,47.75,Rate
Berlin,DE30,Total,Females,2011,Cerebrovascular diseases,51.15,Rate
Berlin,DE30,Total,Females,2012,Cerebrovascular diseases,51.75,Rate
Berlin,DE30,Total,Females,2013,Cerebrovascular diseases,51.46,Rate
Berlin,DE30,Total,Females,2014,Cerebrovascular diseases,50.07,Rate
Berlin,DE30,Total,Females,2015,Cerebrovascular diseases,46.6,Rate
Berlin,DE30,Total,Females,2016,Cerebrovascular diseases,46.18,Rate
Berlin,DE30,Total,Females,2017,Cerebrovascular diseases,42.68,Rate
Berlin,DE30,Total,Females,2018,Cerebrovascular diseases,47.52,Rate
Berlin,DE30,Total,Females,2019,Cerebrovascular diseases,42.37,Rate
Berlin,DE30,Total,Females,2020,Cerebrovascular diseases,42.21,Rate
Berlin,DE30,Total,Females,2011,Chronic lower respiratory diseases,32.89,Rate
Berlin,DE30,Total,Females,2012,Chronic lower respiratory diseases,34.41,Rate
Berlin,DE30,Total,Females,2013,Chronic lower respiratory diseases,36.07,Rate
Berlin,DE30,Total,Females,2014,Chronic lower respiratory diseases,32.32,Rate
Berlin,DE30,Total,Females,2015,Chronic lower respiratory diseases,39.93,Rate
Berlin,DE30,Total,Females,2016,Chronic lower respiratory diseases,39.84,Rate
Berlin,DE30,Total,Females,2017,Chronic lower respiratory diseases,42.76,Rate
Berlin,DE30,Total,Females,2018,Chronic lower respiratory diseases,42.84,Rate
Berlin,DE30,Total,Females,2019,Chronic lower respiratory diseases,38.4,Rate
Berlin,DE30,Total,Females,2020,Chronic lower respiratory diseases,33.8,Rate
Berlin,DE30,Total,Females,2011,Asthma and status asthmaticus,1.5,Rate
Berlin,DE30,Total,Females,2012,Asthma and status asthmaticus,0.89,Rate
Berlin,DE30,Total,Females,2013,Asthma and status asthmaticus,1.19,Rate
Berlin,DE30,Total,Females,2014,Asthma and status asthmaticus,0.81,Rate
Berlin,DE30,Total,Females,2015,Asthma and status asthmaticus,0.51,Rate
Berlin,DE30,Total,Females,2016,Asthma and status asthmaticus,0.91,Rate
Berlin,DE30,Total,Females,2017,Asthma and status asthmaticus,1.26,Rate
Berlin,DE30,Total,Females,2018,Asthma and status asthmaticus,1.35,Rate
Berlin,DE30,Total,Females,2019,Asthma and status asthmaticus,0.67,Rate
Berlin,DE30,Total,Females,2020,Asthma and status asthmaticus,0.84,Rate
Berlin,DE30,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3724.75,Rate
Berlin,DE30,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3850.36,Rate
Berlin,DE30,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3816.84,Rate
Berlin,DE30,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3610.67,Rate
Berlin,DE30,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3706.65,Rate
Berlin,DE30,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3607.39,Rate
Berlin,DE30,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3610.97,Rate
Berlin,DE30,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3696.75,Rate
Berlin,DE30,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3481.79,Rate
Berlin,DE30,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3741.52,Rate
Berlin,DE30,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.03,Rate
Berlin,DE30,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.78,Rate
Berlin,DE30,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.31,Rate
Berlin,DE30,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.93,Rate
Berlin,DE30,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.64,Rate
Berlin,DE30,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.54,Rate
Berlin,DE30,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.22,Rate
Berlin,DE30,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.86,Rate
Berlin,DE30,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.66,Rate
Berlin,DE30,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.78,Rate
Berlin,DE30,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",145.69,Rate
Berlin,DE30,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",151.94,Rate
Berlin,DE30,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",155.08,Rate
Berlin,DE30,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",141.2,Rate
Berlin,DE30,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",161.4,Rate
Berlin,DE30,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",154.58,Rate
Berlin,DE30,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",163.13,Rate
Berlin,DE30,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",153.79,Rate
Berlin,DE30,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",156.05,Rate
Berlin,DE30,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",166.6,Rate
Berlin,DE30,65 years or over,Females,2011,Malignant melanoma of skin,9.81,Rate
Berlin,DE30,65 years or over,Females,2012,Malignant melanoma of skin,5.51,Rate
Berlin,DE30,65 years or over,Females,2013,Malignant melanoma of skin,7.16,Rate
Berlin,DE30,65 years or over,Females,2014,Malignant melanoma of skin,9.06,Rate
Berlin,DE30,65 years or over,Females,2015,Malignant melanoma of skin,7.0,Rate
Berlin,DE30,65 years or over,Females,2016,Malignant melanoma of skin,7.6,Rate
Berlin,DE30,65 years or over,Females,2017,Malignant melanoma of skin,7.4,Rate
Berlin,DE30,65 years or over,Females,2018,Malignant melanoma of skin,6.04,Rate
Berlin,DE30,65 years or over,Females,2019,Malignant melanoma of skin,8.14,Rate
Berlin,DE30,65 years or over,Females,2020,Malignant melanoma of skin,7.01,Rate
Berlin,DE30,65 years or over,Females,2011,Malignant neoplasm of breast,139.79,Rate
Berlin,DE30,65 years or over,Females,2012,Malignant neoplasm of breast,129.07,Rate
Berlin,DE30,65 years or over,Females,2013,Malignant neoplasm of breast,129.57,Rate
Berlin,DE30,65 years or over,Females,2014,Malignant neoplasm of breast,127.66,Rate
Berlin,DE30,65 years or over,Females,2015,Malignant neoplasm of breast,132.44,Rate
Berlin,DE30,65 years or over,Females,2016,Malignant neoplasm of breast,138.69,Rate
Berlin,DE30,65 years or over,Females,2017,Malignant neoplasm of breast,122.65,Rate
Berlin,DE30,65 years or over,Females,2018,Malignant neoplasm of breast,124.8,Rate
Berlin,DE30,65 years or over,Females,2019,Malignant neoplasm of breast,126.25,Rate
Berlin,DE30,65 years or over,Females,2020,Malignant neoplasm of breast,129.43,Rate
Berlin,DE30,65 years or over,Females,2011,Diabetes mellitus,155.6,Rate
Berlin,DE30,65 years or over,Females,2012,Diabetes mellitus,142.56,Rate
Berlin,DE30,65 years or over,Females,2013,Diabetes mellitus,141.96,Rate
Berlin,DE30,65 years or over,Females,2014,Diabetes mellitus,120.03,Rate
Berlin,DE30,65 years or over,Females,2015,Diabetes mellitus,138.52,Rate
Berlin,DE30,65 years or over,Females,2016,Diabetes mellitus,135.92,Rate
Berlin,DE30,65 years or over,Females,2017,Diabetes mellitus,114.93,Rate
Berlin,DE30,65 years or over,Females,2018,Diabetes mellitus,96.82,Rate
Berlin,DE30,65 years or over,Females,2019,Diabetes mellitus,102.75,Rate
Berlin,DE30,65 years or over,Females,2020,Diabetes mellitus,113.87,Rate
Berlin,DE30,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),86.28,Rate
Berlin,DE30,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),93.54,Rate
Berlin,DE30,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),121.1,Rate
Berlin,DE30,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),111.13,Rate
Berlin,DE30,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),159.68,Rate
Berlin,DE30,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),171.67,Rate
Berlin,DE30,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),228.83,Rate
Berlin,DE30,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),291.98,Rate
Berlin,DE30,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),252.38,Rate
Berlin,DE30,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),271.6,Rate
Berlin,DE30,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.89,Rate
Berlin,DE30,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),3.09,Rate
Berlin,DE30,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.3,Rate
Berlin,DE30,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.25,Rate
Berlin,DE30,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),4.36,Rate
Berlin,DE30,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),9.6,Rate
Berlin,DE30,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),14.1,Rate
Berlin,DE30,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),9.46,Rate
Berlin,DE30,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),8.09,Rate
Berlin,DE30,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),14.1,Rate
Berlin,DE30,65 years or over,Females,2011,Other ischaemic heart diseases,324.0,Rate
Berlin,DE30,65 years or over,Females,2012,Other ischaemic heart diseases,309.08,Rate
Berlin,DE30,65 years or over,Females,2013,Other ischaemic heart diseases,284.68,Rate
Berlin,DE30,65 years or over,Females,2014,Other ischaemic heart diseases,231.42,Rate
Berlin,DE30,65 years or over,Females,2015,Other ischaemic heart diseases,223.87,Rate
Berlin,DE30,65 years or over,Females,2016,Other ischaemic heart diseases,225.1,Rate
Berlin,DE30,65 years or over,Females,2017,Other ischaemic heart diseases,238.35,Rate
Berlin,DE30,65 years or over,Females,2018,Other ischaemic heart diseases,202.64,Rate
Berlin,DE30,65 years or over,Females,2019,Other ischaemic heart diseases,169.86,Rate
Berlin,DE30,65 years or over,Females,2020,Other ischaemic heart diseases,195.85,Rate
Berlin,DE30,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,235.53,Rate
Berlin,DE30,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,236.08,Rate
Berlin,DE30,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,181.06,Rate
Berlin,DE30,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,158.3,Rate
Berlin,DE30,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,180.96,Rate
Berlin,DE30,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,181.05,Rate
Berlin,DE30,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,182.17,Rate
Berlin,DE30,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,227.38,Rate
Berlin,DE30,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,237.04,Rate
Berlin,DE30,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,226.16,Rate
Berlin,DE30,65 years or over,Females,2011,Cerebrovascular diseases,241.61,Rate
Berlin,DE30,65 years or over,Females,2012,Cerebrovascular diseases,244.36,Rate
Berlin,DE30,65 years or over,Females,2013,Cerebrovascular diseases,248.53,Rate
Berlin,DE30,65 years or over,Females,2014,Cerebrovascular diseases,240.8,Rate
Berlin,DE30,65 years or over,Females,2015,Cerebrovascular diseases,220.8,Rate
Berlin,DE30,65 years or over,Females,2016,Cerebrovascular diseases,219.0,Rate
Berlin,DE30,65 years or over,Females,2017,Cerebrovascular diseases,203.87,Rate
Berlin,DE30,65 years or over,Females,2018,Cerebrovascular diseases,222.1,Rate
Berlin,DE30,65 years or over,Females,2019,Cerebrovascular diseases,201.27,Rate
Berlin,DE30,65 years or over,Females,2020,Cerebrovascular diseases,199.95,Rate
Berlin,DE30,65 years or over,Females,2011,Chronic lower respiratory diseases,150.75,Rate
Berlin,DE30,65 years or over,Females,2012,Chronic lower respiratory diseases,156.42,Rate
Berlin,DE30,65 years or over,Females,2013,Chronic lower respiratory diseases,160.31,Rate
Berlin,DE30,65 years or over,Females,2014,Chronic lower respiratory diseases,145.77,Rate
Berlin,DE30,65 years or over,Females,2015,Chronic lower respiratory diseases,181.76,Rate
Berlin,DE30,65 years or over,Females,2016,Chronic lower respiratory diseases,178.29,Rate
Berlin,DE30,65 years or over,Females,2017,Chronic lower respiratory diseases,190.89,Rate
Berlin,DE30,65 years or over,Females,2018,Chronic lower respiratory diseases,195.45,Rate
Berlin,DE30,65 years or over,Females,2019,Chronic lower respiratory diseases,174.86,Rate
Berlin,DE30,65 years or over,Females,2020,Chronic lower respiratory diseases,150.65,Rate
Berlin,DE30,65 years or over,Females,2011,Asthma and status asthmaticus,4.97,Rate
Berlin,DE30,65 years or over,Females,2012,Asthma and status asthmaticus,3.45,Rate
Berlin,DE30,65 years or over,Females,2013,Asthma and status asthmaticus,3.81,Rate
Berlin,DE30,65 years or over,Females,2014,Asthma and status asthmaticus,3.56,Rate
Berlin,DE30,65 years or over,Females,2015,Asthma and status asthmaticus,2.63,Rate
Berlin,DE30,65 years or over,Females,2016,Asthma and status asthmaticus,3.47,Rate
Berlin,DE30,65 years or over,Females,2017,Asthma and status asthmaticus,5.31,Rate
Berlin,DE30,65 years or over,Females,2018,Asthma and status asthmaticus,5.42,Rate
Berlin,DE30,65 years or over,Females,2019,Asthma and status asthmaticus,2.63,Rate
Berlin,DE30,65 years or over,Females,2020,Asthma and status asthmaticus,2.83,Rate
Berlin,DE30,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,156.15,Rate
Berlin,DE30,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,152.5,Rate
Berlin,DE30,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,147.33,Rate
Berlin,DE30,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,145.88,Rate
Berlin,DE30,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,154.92,Rate
Berlin,DE30,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,144.7,Rate
Berlin,DE30,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,141.74,Rate
Berlin,DE30,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,149.25,Rate
Berlin,DE30,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,136.45,Rate
Berlin,DE30,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,138.59,Rate
Berlin,DE30,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.3,Rate
Berlin,DE30,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.62,Rate
Berlin,DE30,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.64,Rate
Berlin,DE30,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.12,Rate
Berlin,DE30,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.59,Rate
Berlin,DE30,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.54,Rate
Berlin,DE30,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.19,Rate
Berlin,DE30,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.91,Rate
Berlin,DE30,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.27,Rate
Berlin,DE30,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.73,Rate
Berlin,DE30,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",19.67,Rate
Berlin,DE30,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.59,Rate
Berlin,DE30,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",17.07,Rate
Berlin,DE30,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",16.4,Rate
Berlin,DE30,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",14.93,Rate
Berlin,DE30,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",16.43,Rate
Berlin,DE30,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",13.68,Rate
Berlin,DE30,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",15.47,Rate
Berlin,DE30,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",15.4,Rate
Berlin,DE30,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",14.65,Rate
Berlin,DE30,Less than 65 years,Females,2011,Malignant melanoma of skin,0.42,Rate
Berlin,DE30,Less than 65 years,Females,2012,Malignant melanoma of skin,1.05,Rate
Berlin,DE30,Less than 65 years,Females,2013,Malignant melanoma of skin,0.99,Rate
Berlin,DE30,Less than 65 years,Females,2014,Malignant melanoma of skin,1.13,Rate
Berlin,DE30,Less than 65 years,Females,2015,Malignant melanoma of skin,1.13,Rate
Berlin,DE30,Less than 65 years,Females,2016,Malignant melanoma of skin,0.53,Rate
Berlin,DE30,Less than 65 years,Females,2017,Malignant melanoma of skin,0.77,Rate
Berlin,DE30,Less than 65 years,Females,2018,Malignant melanoma of skin,1.02,Rate
Berlin,DE30,Less than 65 years,Females,2019,Malignant melanoma of skin,0.67,Rate
Berlin,DE30,Less than 65 years,Females,2020,Malignant melanoma of skin,1.01,Rate
Berlin,DE30,Less than 65 years,Females,2011,Malignant neoplasm of breast,14.54,Rate
Berlin,DE30,Less than 65 years,Females,2012,Malignant neoplasm of breast,15.34,Rate
Berlin,DE30,Less than 65 years,Females,2013,Malignant neoplasm of breast,12.87,Rate
Berlin,DE30,Less than 65 years,Females,2014,Malignant neoplasm of breast,13.23,Rate
Berlin,DE30,Less than 65 years,Females,2015,Malignant neoplasm of breast,13.93,Rate
Berlin,DE30,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.33,Rate
Berlin,DE30,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.53,Rate
Berlin,DE30,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.53,Rate
Berlin,DE30,Less than 65 years,Females,2019,Malignant neoplasm of breast,11.66,Rate
Berlin,DE30,Less than 65 years,Females,2020,Malignant neoplasm of breast,12.35,Rate
Berlin,DE30,Less than 65 years,Females,2011,Diabetes mellitus,2.99,Rate
Berlin,DE30,Less than 65 years,Females,2012,Diabetes mellitus,2.93,Rate
Berlin,DE30,Less than 65 years,Females,2013,Diabetes mellitus,2.1,Rate
Berlin,DE30,Less than 65 years,Females,2014,Diabetes mellitus,1.56,Rate
Berlin,DE30,Less than 65 years,Females,2015,Diabetes mellitus,2.86,Rate
Berlin,DE30,Less than 65 years,Females,2016,Diabetes mellitus,2.56,Rate
Berlin,DE30,Less than 65 years,Females,2017,Diabetes mellitus,2.22,Rate
Berlin,DE30,Less than 65 years,Females,2018,Diabetes mellitus,2.04,Rate
Berlin,DE30,Less than 65 years,Females,2019,Diabetes mellitus,2.19,Rate
Berlin,DE30,Less than 65 years,Females,2020,Diabetes mellitus,1.36,Rate
Berlin,DE30,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.51,Rate
Berlin,DE30,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.16,Rate
Berlin,DE30,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),2.67,Rate
Berlin,DE30,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.81,Rate
Berlin,DE30,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.76,Rate
Berlin,DE30,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.69,Rate
Berlin,DE30,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.17,Rate
Berlin,DE30,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.19,Rate
Berlin,DE30,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.51,Rate
Berlin,DE30,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.76,Rate
Berlin,DE30,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Berlin,DE30,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Berlin,DE30,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Berlin,DE30,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.07,Rate
Berlin,DE30,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Berlin,DE30,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Berlin,DE30,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Berlin,DE30,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Berlin,DE30,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Berlin,DE30,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Berlin,DE30,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.12,Rate
Berlin,DE30,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.08,Rate
Berlin,DE30,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.59,Rate
Berlin,DE30,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.42,Rate
Berlin,DE30,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.92,Rate
Berlin,DE30,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.63,Rate
Berlin,DE30,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.8,Rate
Berlin,DE30,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.9,Rate
Berlin,DE30,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.78,Rate
Berlin,DE30,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.16,Rate
Berlin,DE30,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.08,Rate
Berlin,DE30,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.36,Rate
Berlin,DE30,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.8,Rate
Berlin,DE30,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.91,Rate
Berlin,DE30,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.73,Rate
Berlin,DE30,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.1,Rate
Berlin,DE30,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.01,Rate
Berlin,DE30,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,4.78,Rate
Berlin,DE30,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.35,Rate
Berlin,DE30,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.53,Rate
Berlin,DE30,Less than 65 years,Females,2011,Cerebrovascular diseases,5.01,Rate
Berlin,DE30,Less than 65 years,Females,2012,Cerebrovascular diseases,5.1,Rate
Berlin,DE30,Less than 65 years,Females,2013,Cerebrovascular diseases,3.72,Rate
Berlin,DE30,Less than 65 years,Females,2014,Cerebrovascular diseases,3.87,Rate
Berlin,DE30,Less than 65 years,Females,2015,Cerebrovascular diseases,4.4,Rate
Berlin,DE30,Less than 65 years,Females,2016,Cerebrovascular diseases,4.32,Rate
Berlin,DE30,Less than 65 years,Females,2017,Cerebrovascular diseases,3.63,Rate
Berlin,DE30,Less than 65 years,Females,2018,Cerebrovascular diseases,5.22,Rate
Berlin,DE30,Less than 65 years,Females,2019,Cerebrovascular diseases,3.88,Rate
Berlin,DE30,Less than 65 years,Females,2020,Cerebrovascular diseases,4.0,Rate
Berlin,DE30,Less than 65 years,Females,2011,Chronic lower respiratory diseases,4.34,Rate
Berlin,DE30,Less than 65 years,Females,2012,Chronic lower respiratory diseases,4.86,Rate
Berlin,DE30,Less than 65 years,Females,2013,Chronic lower respiratory diseases,5.97,Rate
Berlin,DE30,Less than 65 years,Females,2014,Chronic lower respiratory diseases,4.84,Rate
Berlin,DE30,Less than 65 years,Females,2015,Chronic lower respiratory diseases,5.58,Rate
Berlin,DE30,Less than 65 years,Females,2016,Chronic lower respiratory diseases,6.3,Rate
Berlin,DE30,Less than 65 years,Females,2017,Chronic lower respiratory diseases,6.88,Rate
Berlin,DE30,Less than 65 years,Females,2018,Chronic lower respiratory diseases,5.87,Rate
Berlin,DE30,Less than 65 years,Females,2019,Chronic lower respiratory diseases,5.34,Rate
Berlin,DE30,Less than 65 years,Females,2020,Chronic lower respiratory diseases,5.49,Rate
Berlin,DE30,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.65,Rate
Berlin,DE30,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.27,Rate
Berlin,DE30,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.56,Rate
Berlin,DE30,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.14,Rate
Berlin,DE30,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Berlin,DE30,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.28,Rate
Berlin,DE30,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.28,Rate
Berlin,DE30,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.37,Rate
Berlin,DE30,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.2,Rate
Berlin,DE30,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.35,Rate
Berlin,DE30,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1294.05,Rate
Berlin,DE30,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1287.06,Rate
Berlin,DE30,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1274.7,Rate
Berlin,DE30,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1235.78,Rate
Berlin,DE30,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1275.0,Rate
Berlin,DE30,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1223.26,Rate
Berlin,DE30,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1202.97,Rate
Berlin,DE30,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1233.24,Rate
Berlin,DE30,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1160.28,Rate
Berlin,DE30,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1261.86,Rate
Berlin,DE30,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.44,Rate
Berlin,DE30,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.58,Rate
Berlin,DE30,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.53,Rate
Berlin,DE30,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.05,Rate
Berlin,DE30,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.72,Rate
Berlin,DE30,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.63,Rate
Berlin,DE30,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.68,Rate
Berlin,DE30,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.15,Rate
Berlin,DE30,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.13,Rate
Berlin,DE30,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.02,Rate
Berlin,DE30,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",94.38,Rate
Berlin,DE30,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",94.34,Rate
Berlin,DE30,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",87.76,Rate
Berlin,DE30,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",81.67,Rate
Berlin,DE30,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",87.4,Rate
Berlin,DE30,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",86.06,Rate
Berlin,DE30,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",78.61,Rate
Berlin,DE30,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",75.42,Rate
Berlin,DE30,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",72.18,Rate
Berlin,DE30,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",71.68,Rate
Berlin,DE30,Total,Males,2011,Malignant melanoma of skin,4.99,Rate
Berlin,DE30,Total,Males,2012,Malignant melanoma of skin,4.09,Rate
Berlin,DE30,Total,Males,2013,Malignant melanoma of skin,4.43,Rate
Berlin,DE30,Total,Males,2014,Malignant melanoma of skin,4.08,Rate
Berlin,DE30,Total,Males,2015,Malignant melanoma of skin,3.98,Rate
Berlin,DE30,Total,Males,2016,Malignant melanoma of skin,4.8,Rate
Berlin,DE30,Total,Males,2017,Malignant melanoma of skin,3.56,Rate
Berlin,DE30,Total,Males,2018,Malignant melanoma of skin,4.22,Rate
Berlin,DE30,Total,Males,2019,Malignant melanoma of skin,4.02,Rate
Berlin,DE30,Total,Males,2020,Malignant melanoma of skin,3.88,Rate
Berlin,DE30,Total,Males,2011,Malignant neoplasm of breast,0.63,Rate
Berlin,DE30,Total,Males,2012,Malignant neoplasm of breast,0.2,Rate
Berlin,DE30,Total,Males,2013,Malignant neoplasm of breast,0.42,Rate
Berlin,DE30,Total,Males,2014,Malignant neoplasm of breast,0.13,Rate
Berlin,DE30,Total,Males,2015,Malignant neoplasm of breast,0.25,Rate
Berlin,DE30,Total,Males,2016,Malignant neoplasm of breast,0.27,Rate
Berlin,DE30,Total,Males,2017,Malignant neoplasm of breast,0.52,Rate
Berlin,DE30,Total,Males,2018,Malignant neoplasm of breast,0.23,Rate
Berlin,DE30,Total,Males,2019,Malignant neoplasm of breast,0.54,Rate
Berlin,DE30,Total,Males,2020,Malignant neoplasm of breast,0.38,Rate
Berlin,DE30,Total,Males,2011,Diabetes mellitus,46.77,Rate
Berlin,DE30,Total,Males,2012,Diabetes mellitus,38.2,Rate
Berlin,DE30,Total,Males,2013,Diabetes mellitus,37.82,Rate
Berlin,DE30,Total,Males,2014,Diabetes mellitus,36.07,Rate
Berlin,DE30,Total,Males,2015,Diabetes mellitus,42.1,Rate
Berlin,DE30,Total,Males,2016,Diabetes mellitus,36.14,Rate
Berlin,DE30,Total,Males,2017,Diabetes mellitus,33.98,Rate
Berlin,DE30,Total,Males,2018,Diabetes mellitus,24.16,Rate
Berlin,DE30,Total,Males,2019,Diabetes mellitus,29.36,Rate
Berlin,DE30,Total,Males,2020,Diabetes mellitus,31.3,Rate
Berlin,DE30,Total,Males,2011,Mental and behavioural disorders (F00-F99),26.04,Rate
Berlin,DE30,Total,Males,2012,Mental and behavioural disorders (F00-F99),27.37,Rate
Berlin,DE30,Total,Males,2013,Mental and behavioural disorders (F00-F99),33.16,Rate
Berlin,DE30,Total,Males,2014,Mental and behavioural disorders (F00-F99),30.79,Rate
Berlin,DE30,Total,Males,2015,Mental and behavioural disorders (F00-F99),38.36,Rate
Berlin,DE30,Total,Males,2016,Mental and behavioural disorders (F00-F99),40.15,Rate
Berlin,DE30,Total,Males,2017,Mental and behavioural disorders (F00-F99),52.48,Rate
Berlin,DE30,Total,Males,2018,Mental and behavioural disorders (F00-F99),59.41,Rate
Berlin,DE30,Total,Males,2019,Mental and behavioural disorders (F00-F99),52.32,Rate
Berlin,DE30,Total,Males,2020,Mental and behavioural disorders (F00-F99),55.47,Rate
Berlin,DE30,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Berlin,DE30,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.28,Rate
Berlin,DE30,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.57,Rate
Berlin,DE30,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Berlin,DE30,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Berlin,DE30,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Berlin,DE30,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.72,Rate
Berlin,DE30,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.81,Rate
Berlin,DE30,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.26,Rate
Berlin,DE30,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.11,Rate
Berlin,DE30,Total,Males,2011,Other ischaemic heart diseases,101.45,Rate
Berlin,DE30,Total,Males,2012,Other ischaemic heart diseases,99.42,Rate
Berlin,DE30,Total,Males,2013,Other ischaemic heart diseases,101.64,Rate
Berlin,DE30,Total,Males,2014,Other ischaemic heart diseases,89.12,Rate
Berlin,DE30,Total,Males,2015,Other ischaemic heart diseases,99.27,Rate
Berlin,DE30,Total,Males,2016,Other ischaemic heart diseases,89.18,Rate
Berlin,DE30,Total,Males,2017,Other ischaemic heart diseases,95.01,Rate
Berlin,DE30,Total,Males,2018,Other ischaemic heart diseases,92.64,Rate
Berlin,DE30,Total,Males,2019,Other ischaemic heart diseases,80.12,Rate
Berlin,DE30,Total,Males,2020,Other ischaemic heart diseases,86.28,Rate
Berlin,DE30,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,95.07,Rate
Berlin,DE30,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,89.12,Rate
Berlin,DE30,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,75.52,Rate
Berlin,DE30,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,66.7,Rate
Berlin,DE30,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,84.12,Rate
Berlin,DE30,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,81.22,Rate
Berlin,DE30,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,78.12,Rate
Berlin,DE30,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,84.77,Rate
Berlin,DE30,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,94.74,Rate
Berlin,DE30,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,93.92,Rate
Berlin,DE30,Total,Males,2011,Cerebrovascular diseases,64.23,Rate
Berlin,DE30,Total,Males,2012,Cerebrovascular diseases,61.96,Rate
Berlin,DE30,Total,Males,2013,Cerebrovascular diseases,59.61,Rate
Berlin,DE30,Total,Males,2014,Cerebrovascular diseases,53.89,Rate
Berlin,DE30,Total,Males,2015,Cerebrovascular diseases,55.12,Rate
Berlin,DE30,Total,Males,2016,Cerebrovascular diseases,55.8,Rate
Berlin,DE30,Total,Males,2017,Cerebrovascular diseases,60.09,Rate
Berlin,DE30,Total,Males,2018,Cerebrovascular diseases,59.34,Rate
Berlin,DE30,Total,Males,2019,Cerebrovascular diseases,54.48,Rate
Berlin,DE30,Total,Males,2020,Cerebrovascular diseases,53.3,Rate
Berlin,DE30,Total,Males,2011,Chronic lower respiratory diseases,51.67,Rate
Berlin,DE30,Total,Males,2012,Chronic lower respiratory diseases,53.1,Rate
Berlin,DE30,Total,Males,2013,Chronic lower respiratory diseases,59.48,Rate
Berlin,DE30,Total,Males,2014,Chronic lower respiratory diseases,47.12,Rate
Berlin,DE30,Total,Males,2015,Chronic lower respiratory diseases,62.44,Rate
Berlin,DE30,Total,Males,2016,Chronic lower respiratory diseases,57.59,Rate
Berlin,DE30,Total,Males,2017,Chronic lower respiratory diseases,64.18,Rate
Berlin,DE30,Total,Males,2018,Chronic lower respiratory diseases,61.05,Rate
Berlin,DE30,Total,Males,2019,Chronic lower respiratory diseases,52.87,Rate
Berlin,DE30,Total,Males,2020,Chronic lower respiratory diseases,49.48,Rate
Berlin,DE30,Total,Males,2011,Asthma and status asthmaticus,1.06,Rate
Berlin,DE30,Total,Males,2012,Asthma and status asthmaticus,1.13,Rate
Berlin,DE30,Total,Males,2013,Asthma and status asthmaticus,0.92,Rate
Berlin,DE30,Total,Males,2014,Asthma and status asthmaticus,0.66,Rate
Berlin,DE30,Total,Males,2015,Asthma and status asthmaticus,0.33,Rate
Berlin,DE30,Total,Males,2016,Asthma and status asthmaticus,0.68,Rate
Berlin,DE30,Total,Males,2017,Asthma and status asthmaticus,0.97,Rate
Berlin,DE30,Total,Males,2018,Asthma and status asthmaticus,0.46,Rate
Berlin,DE30,Total,Males,2019,Asthma and status asthmaticus,0.65,Rate
Berlin,DE30,Total,Males,2020,Asthma and status asthmaticus,0.91,Rate
Berlin,DE30,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5373.32,Rate
Berlin,DE30,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5428.02,Rate
Berlin,DE30,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5323.94,Rate
Berlin,DE30,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5129.15,Rate
Berlin,DE30,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5357.04,Rate
Berlin,DE30,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5139.57,Rate
Berlin,DE30,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5100.03,Rate
Berlin,DE30,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5251.78,Rate
Berlin,DE30,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4915.49,Rate
Berlin,DE30,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5375.46,Rate
Berlin,DE30,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.83,Rate
Berlin,DE30,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.72,Rate
Berlin,DE30,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.57,Rate
Berlin,DE30,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.26,Rate
Berlin,DE30,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.94,Rate
Berlin,DE30,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.02,Rate
Berlin,DE30,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.69,Rate
Berlin,DE30,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.21,Rate
Berlin,DE30,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.17,Rate
Berlin,DE30,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.58,Rate
Berlin,DE30,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",354.29,Rate
Berlin,DE30,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",365.43,Rate
Berlin,DE30,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",338.61,Rate
Berlin,DE30,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",308.04,Rate
Berlin,DE30,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",337.83,Rate
Berlin,DE30,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",331.94,Rate
Berlin,DE30,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",303.1,Rate
Berlin,DE30,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",293.64,Rate
Berlin,DE30,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",284.19,Rate
Berlin,DE30,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",289.38,Rate
Berlin,DE30,65 years or over,Males,2011,Malignant melanoma of skin,19.03,Rate
Berlin,DE30,65 years or over,Males,2012,Malignant melanoma of skin,17.06,Rate
Berlin,DE30,65 years or over,Males,2013,Malignant melanoma of skin,17.6,Rate
Berlin,DE30,65 years or over,Males,2014,Malignant melanoma of skin,13.28,Rate
Berlin,DE30,65 years or over,Males,2015,Malignant melanoma of skin,15.84,Rate
Berlin,DE30,65 years or over,Males,2016,Malignant melanoma of skin,18.91,Rate
Berlin,DE30,65 years or over,Males,2017,Malignant melanoma of skin,14.42,Rate
Berlin,DE30,65 years or over,Males,2018,Malignant melanoma of skin,15.7,Rate
Berlin,DE30,65 years or over,Males,2019,Malignant melanoma of skin,14.24,Rate
Berlin,DE30,65 years or over,Males,2020,Malignant melanoma of skin,14.93,Rate
Berlin,DE30,65 years or over,Males,2011,Malignant neoplasm of breast,2.87,Rate
Berlin,DE30,65 years or over,Males,2012,Malignant neoplasm of breast,1.04,Rate
Berlin,DE30,65 years or over,Males,2013,Malignant neoplasm of breast,2.14,Rate
Berlin,DE30,65 years or over,Males,2014,Malignant neoplasm of breast,0.69,Rate
Berlin,DE30,65 years or over,Males,2015,Malignant neoplasm of breast,0.74,Rate
Berlin,DE30,65 years or over,Males,2016,Malignant neoplasm of breast,1.07,Rate
Berlin,DE30,65 years or over,Males,2017,Malignant neoplasm of breast,2.42,Rate
Berlin,DE30,65 years or over,Males,2018,Malignant neoplasm of breast,0.92,Rate
Berlin,DE30,65 years or over,Males,2019,Malignant neoplasm of breast,2.2,Rate
Berlin,DE30,65 years or over,Males,2020,Malignant neoplasm of breast,1.45,Rate
Berlin,DE30,65 years or over,Males,2011,Diabetes mellitus,207.31,Rate
Berlin,DE30,65 years or over,Males,2012,Diabetes mellitus,168.97,Rate
Berlin,DE30,65 years or over,Males,2013,Diabetes mellitus,167.51,Rate
Berlin,DE30,65 years or over,Males,2014,Diabetes mellitus,162.42,Rate
Berlin,DE30,65 years or over,Males,2015,Diabetes mellitus,188.96,Rate
Berlin,DE30,65 years or over,Males,2016,Diabetes mellitus,158.24,Rate
Berlin,DE30,65 years or over,Males,2017,Diabetes mellitus,151.16,Rate
Berlin,DE30,65 years or over,Males,2018,Diabetes mellitus,107.36,Rate
Berlin,DE30,65 years or over,Males,2019,Diabetes mellitus,131.54,Rate
Berlin,DE30,65 years or over,Males,2020,Diabetes mellitus,142.12,Rate
Berlin,DE30,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),93.13,Rate
Berlin,DE30,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),106.75,Rate
Berlin,DE30,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),129.79,Rate
Berlin,DE30,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),123.53,Rate
Berlin,DE30,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),155.61,Rate
Berlin,DE30,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),176.35,Rate
Berlin,DE30,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),245.49,Rate
Berlin,DE30,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),285.14,Rate
Berlin,DE30,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),246.88,Rate
Berlin,DE30,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),258.8,Rate
Berlin,DE30,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),3.99,Rate
Berlin,DE30,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),5.57,Rate
Berlin,DE30,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),6.34,Rate
Berlin,DE30,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.35,Rate
Berlin,DE30,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),3.33,Rate
Berlin,DE30,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),4.61,Rate
Berlin,DE30,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),17.31,Rate
Berlin,DE30,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),12.19,Rate
Berlin,DE30,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),7.84,Rate
Berlin,DE30,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),16.96,Rate
Berlin,DE30,65 years or over,Males,2011,Other ischaemic heart diseases,482.5,Rate
Berlin,DE30,65 years or over,Males,2012,Other ischaemic heart diseases,472.88,Rate
Berlin,DE30,65 years or over,Males,2013,Other ischaemic heart diseases,486.6,Rate
Berlin,DE30,65 years or over,Males,2014,Other ischaemic heart diseases,416.36,Rate
Berlin,DE30,65 years or over,Males,2015,Other ischaemic heart diseases,464.16,Rate
Berlin,DE30,65 years or over,Males,2016,Other ischaemic heart diseases,423.94,Rate
Berlin,DE30,65 years or over,Males,2017,Other ischaemic heart diseases,452.37,Rate
Berlin,DE30,65 years or over,Males,2018,Other ischaemic heart diseases,438.24,Rate
Berlin,DE30,65 years or over,Males,2019,Other ischaemic heart diseases,382.65,Rate
Berlin,DE30,65 years or over,Males,2020,Other ischaemic heart diseases,413.85,Rate
Berlin,DE30,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,399.41,Rate
Berlin,DE30,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,370.13,Rate
Berlin,DE30,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,310.32,Rate
Berlin,DE30,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,284.96,Rate
Berlin,DE30,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,354.6,Rate
Berlin,DE30,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,343.0,Rate
Berlin,DE30,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,328.39,Rate
Berlin,DE30,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,353.41,Rate
Berlin,DE30,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,397.14,Rate
Berlin,DE30,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,386.52,Rate
Berlin,DE30,65 years or over,Males,2011,Cerebrovascular diseases,292.43,Rate
Berlin,DE30,65 years or over,Males,2012,Cerebrovascular diseases,280.89,Rate
Berlin,DE30,65 years or over,Males,2013,Cerebrovascular diseases,271.61,Rate
Berlin,DE30,65 years or over,Males,2014,Cerebrovascular diseases,242.08,Rate
Berlin,DE30,65 years or over,Males,2015,Cerebrovascular diseases,250.95,Rate
Berlin,DE30,65 years or over,Males,2016,Cerebrovascular diseases,258.18,Rate
Berlin,DE30,65 years or over,Males,2017,Cerebrovascular diseases,276.8,Rate
Berlin,DE30,65 years or over,Males,2018,Cerebrovascular diseases,270.09,Rate
Berlin,DE30,65 years or over,Males,2019,Cerebrovascular diseases,250.27,Rate
Berlin,DE30,65 years or over,Males,2020,Cerebrovascular diseases,244.95,Rate
Berlin,DE30,65 years or over,Males,2011,Chronic lower respiratory diseases,230.73,Rate
Berlin,DE30,65 years or over,Males,2012,Chronic lower respiratory diseases,243.7,Rate
Berlin,DE30,65 years or over,Males,2013,Chronic lower respiratory diseases,270.03,Rate
Berlin,DE30,65 years or over,Males,2014,Chronic lower respiratory diseases,210.67,Rate
Berlin,DE30,65 years or over,Males,2015,Chronic lower respiratory diseases,278.52,Rate
Berlin,DE30,65 years or over,Males,2016,Chronic lower respiratory diseases,254.53,Rate
Berlin,DE30,65 years or over,Males,2017,Chronic lower respiratory diseases,283.05,Rate
Berlin,DE30,65 years or over,Males,2018,Chronic lower respiratory diseases,272.15,Rate
Berlin,DE30,65 years or over,Males,2019,Chronic lower respiratory diseases,240.56,Rate
Berlin,DE30,65 years or over,Males,2020,Chronic lower respiratory diseases,215.51,Rate
Berlin,DE30,65 years or over,Males,2011,Asthma and status asthmaticus,2.23,Rate
Berlin,DE30,65 years or over,Males,2012,Asthma and status asthmaticus,4.36,Rate
Berlin,DE30,65 years or over,Males,2013,Asthma and status asthmaticus,1.5,Rate
Berlin,DE30,65 years or over,Males,2014,Asthma and status asthmaticus,1.07,Rate
Berlin,DE30,65 years or over,Males,2015,Asthma and status asthmaticus,0.59,Rate
Berlin,DE30,65 years or over,Males,2016,Asthma and status asthmaticus,2.87,Rate
Berlin,DE30,65 years or over,Males,2017,Asthma and status asthmaticus,3.9,Rate
Berlin,DE30,65 years or over,Males,2018,Asthma and status asthmaticus,0.61,Rate
Berlin,DE30,65 years or over,Males,2019,Asthma and status asthmaticus,2.41,Rate
Berlin,DE30,65 years or over,Males,2020,Asthma and status asthmaticus,3.03,Rate
Berlin,DE30,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,305.9,Rate
Berlin,DE30,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,283.96,Rate
Berlin,DE30,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,293.83,Rate
Berlin,DE30,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,292.66,Rate
Berlin,DE30,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,286.18,Rate
Berlin,DE30,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,274.59,Rate
Berlin,DE30,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,258.96,Rate
Berlin,DE30,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,259.81,Rate
Berlin,DE30,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,250.63,Rate
Berlin,DE30,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,265.39,Rate
Berlin,DE30,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.0,Rate
Berlin,DE30,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.21,Rate
Berlin,DE30,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.7,Rate
Berlin,DE30,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.59,Rate
Berlin,DE30,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.96,Rate
Berlin,DE30,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.1,Rate
Berlin,DE30,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.94,Rate
Berlin,DE30,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.36,Rate
Berlin,DE30,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.39,Rate
Berlin,DE30,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.81,Rate
Berlin,DE30,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",31.42,Rate
Berlin,DE30,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",28.67,Rate
Berlin,DE30,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",27.0,Rate
Berlin,DE30,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",26.84,Rate
Berlin,DE30,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",26.74,Rate
Berlin,DE30,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",26.49,Rate
Berlin,DE30,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",24.23,Rate
Berlin,DE30,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",22.56,Rate
Berlin,DE30,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",20.83,Rate
Berlin,DE30,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",18.94,Rate
Berlin,DE30,Less than 65 years,Males,2011,Malignant melanoma of skin,1.59,Rate
Berlin,DE30,Less than 65 years,Males,2012,Malignant melanoma of skin,0.95,Rate
Berlin,DE30,Less than 65 years,Males,2013,Malignant melanoma of skin,1.25,Rate
Berlin,DE30,Less than 65 years,Males,2014,Malignant melanoma of skin,1.85,Rate
Berlin,DE30,Less than 65 years,Males,2015,Malignant melanoma of skin,1.11,Rate
Berlin,DE30,Less than 65 years,Males,2016,Malignant melanoma of skin,1.38,Rate
Berlin,DE30,Less than 65 years,Males,2017,Malignant melanoma of skin,0.94,Rate
Berlin,DE30,Less than 65 years,Males,2018,Malignant melanoma of skin,1.44,Rate
Berlin,DE30,Less than 65 years,Males,2019,Malignant melanoma of skin,1.55,Rate
Berlin,DE30,Less than 65 years,Males,2020,Malignant melanoma of skin,1.2,Rate
Berlin,DE30,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.08,Rate
Berlin,DE30,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Berlin,DE30,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Berlin,DE30,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Berlin,DE30,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.13,Rate
Berlin,DE30,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.08,Rate
Berlin,DE30,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.06,Rate
Berlin,DE30,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.06,Rate
Berlin,DE30,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.14,Rate
Berlin,DE30,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.12,Rate
Berlin,DE30,Less than 65 years,Males,2011,Diabetes mellitus,7.89,Rate
Berlin,DE30,Less than 65 years,Males,2012,Diabetes mellitus,6.53,Rate
Berlin,DE30,Less than 65 years,Males,2013,Diabetes mellitus,6.41,Rate
Berlin,DE30,Less than 65 years,Males,2014,Diabetes mellitus,5.46,Rate
Berlin,DE30,Less than 65 years,Males,2015,Diabetes mellitus,6.53,Rate
Berlin,DE30,Less than 65 years,Males,2016,Diabetes mellitus,6.56,Rate
Berlin,DE30,Less than 65 years,Males,2017,Diabetes mellitus,5.6,Rate
Berlin,DE30,Less than 65 years,Males,2018,Diabetes mellitus,4.01,Rate
Berlin,DE30,Less than 65 years,Males,2019,Diabetes mellitus,4.61,Rate
Berlin,DE30,Less than 65 years,Males,2020,Diabetes mellitus,4.45,Rate
Berlin,DE30,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),9.78,Rate
Berlin,DE30,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),8.14,Rate
Berlin,DE30,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),9.75,Rate
Berlin,DE30,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),8.32,Rate
Berlin,DE30,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),9.96,Rate
Berlin,DE30,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),7.16,Rate
Berlin,DE30,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),5.73,Rate
Berlin,DE30,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),4.74,Rate
Berlin,DE30,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),5.19,Rate
Berlin,DE30,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),6.22,Rate
Berlin,DE30,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Berlin,DE30,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Berlin,DE30,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Berlin,DE30,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Berlin,DE30,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Berlin,DE30,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Berlin,DE30,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Berlin,DE30,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Berlin,DE30,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Berlin,DE30,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.0,Rate
Berlin,DE30,Less than 65 years,Males,2011,Other ischaemic heart diseases,9.15,Rate
Berlin,DE30,Less than 65 years,Males,2012,Other ischaemic heart diseases,8.96,Rate
Berlin,DE30,Less than 65 years,Males,2013,Other ischaemic heart diseases,8.39,Rate
Berlin,DE30,Less than 65 years,Males,2014,Other ischaemic heart diseases,9.85,Rate
Berlin,DE30,Less than 65 years,Males,2015,Other ischaemic heart diseases,10.88,Rate
Berlin,DE30,Less than 65 years,Males,2016,Other ischaemic heart diseases,8.09,Rate
Berlin,DE30,Less than 65 years,Males,2017,Other ischaemic heart diseases,8.44,Rate
Berlin,DE30,Less than 65 years,Males,2018,Other ischaemic heart diseases,8.92,Rate
Berlin,DE30,Less than 65 years,Males,2019,Other ischaemic heart diseases,6.84,Rate
Berlin,DE30,Less than 65 years,Males,2020,Other ischaemic heart diseases,6.93,Rate
Berlin,DE30,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,21.35,Rate
Berlin,DE30,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,21.05,Rate
Berlin,DE30,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,18.64,Rate
Berlin,DE30,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,13.83,Rate
Berlin,DE30,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,18.6,Rate
Berlin,DE30,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,17.81,Rate
Berlin,DE30,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,17.49,Rate
Berlin,DE30,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,19.7,Rate
Berlin,DE30,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,21.49,Rate
Berlin,DE30,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,23.04,Rate
Berlin,DE30,Less than 65 years,Males,2011,Cerebrovascular diseases,8.95,Rate
Berlin,DE30,Less than 65 years,Males,2012,Cerebrovascular diseases,8.92,Rate
Berlin,DE30,Less than 65 years,Males,2013,Cerebrovascular diseases,8.25,Rate
Berlin,DE30,Less than 65 years,Males,2014,Cerebrovascular diseases,8.3,Rate
Berlin,DE30,Less than 65 years,Males,2015,Cerebrovascular diseases,7.69,Rate
Berlin,DE30,Less than 65 years,Males,2016,Cerebrovascular diseases,6.78,Rate
Berlin,DE30,Less than 65 years,Males,2017,Cerebrovascular diseases,7.59,Rate
Berlin,DE30,Less than 65 years,Males,2018,Cerebrovascular diseases,8.29,Rate
Berlin,DE30,Less than 65 years,Males,2019,Cerebrovascular diseases,7.05,Rate
Berlin,DE30,Less than 65 years,Males,2020,Cerebrovascular diseases,6.87,Rate
Berlin,DE30,Less than 65 years,Males,2011,Chronic lower respiratory diseases,8.3,Rate
Berlin,DE30,Less than 65 years,Males,2012,Chronic lower respiratory diseases,6.92,Rate
Berlin,DE30,Less than 65 years,Males,2013,Chronic lower respiratory diseases,8.48,Rate
Berlin,DE30,Less than 65 years,Males,2014,Chronic lower respiratory diseases,7.5,Rate
Berlin,DE30,Less than 65 years,Males,2015,Chronic lower respiratory diseases,10.09,Rate
Berlin,DE30,Less than 65 years,Males,2016,Chronic lower respiratory diseases,9.89,Rate
Berlin,DE30,Less than 65 years,Males,2017,Chronic lower respiratory diseases,11.16,Rate
Berlin,DE30,Less than 65 years,Males,2018,Chronic lower respiratory diseases,9.92,Rate
Berlin,DE30,Less than 65 years,Males,2019,Chronic lower respiratory diseases,7.4,Rate
Berlin,DE30,Less than 65 years,Males,2020,Chronic lower respiratory diseases,9.26,Rate
Berlin,DE30,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.78,Rate
Berlin,DE30,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.35,Rate
Berlin,DE30,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.78,Rate
Berlin,DE30,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.56,Rate
Berlin,DE30,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.26,Rate
Berlin,DE30,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.15,Rate
Berlin,DE30,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.26,Rate
Berlin,DE30,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.43,Rate
Berlin,DE30,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.22,Rate
Berlin,DE30,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.39,Rate
Berlin,DE30,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1034.07,Rate
Berlin,DE30,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1042.54,Rate
Berlin,DE30,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1039.42,Rate
Berlin,DE30,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,998.99,Rate
Berlin,DE30,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1031.22,Rate
Berlin,DE30,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,996.47,Rate
Berlin,DE30,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,984.98,Rate
Berlin,DE30,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1011.32,Rate
Berlin,DE30,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,954.37,Rate
Berlin,DE30,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1027.16,Rate
Berlin,DE30,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.12,Rate
Berlin,DE30,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.02,Rate
Berlin,DE30,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.91,Rate
Berlin,DE30,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.85,Rate
Berlin,DE30,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.35,Rate
Berlin,DE30,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.77,Rate
Berlin,DE30,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.3,Rate
Berlin,DE30,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.89,Rate
Berlin,DE30,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.64,Rate
Berlin,DE30,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.76,Rate
Berlin,DE30,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",65.22,Rate
Berlin,DE30,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",64.44,Rate
Berlin,DE30,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",62.43,Rate
Berlin,DE30,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",58.23,Rate
Berlin,DE30,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",62.45,Rate
Berlin,DE30,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",61.55,Rate
Berlin,DE30,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",58.28,Rate
Berlin,DE30,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",57.08,Rate
Berlin,DE30,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",55.55,Rate
Berlin,DE30,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",56.26,Rate
Berlin,DE30,Total,Total,2011,Malignant melanoma of skin,3.44,Rate
Berlin,DE30,Total,Total,2012,Malignant melanoma of skin,2.65,Rate
Berlin,DE30,Total,Total,2013,Malignant melanoma of skin,3.07,Rate
Berlin,DE30,Total,Total,2014,Malignant melanoma of skin,3.27,Rate
Berlin,DE30,Total,Total,2015,Malignant melanoma of skin,2.97,Rate
Berlin,DE30,Total,Total,2016,Malignant melanoma of skin,3.16,Rate
Berlin,DE30,Total,Total,2017,Malignant melanoma of skin,2.75,Rate
Berlin,DE30,Total,Total,2018,Malignant melanoma of skin,2.95,Rate
Berlin,DE30,Total,Total,2019,Malignant melanoma of skin,2.91,Rate
Berlin,DE30,Total,Total,2020,Malignant melanoma of skin,2.91,Rate
Berlin,DE30,Total,Total,2011,Malignant neoplasm of breast,23.12,Rate
Berlin,DE30,Total,Total,2012,Malignant neoplasm of breast,21.92,Rate
Berlin,DE30,Total,Total,2013,Malignant neoplasm of breast,21.05,Rate
Berlin,DE30,Total,Total,2014,Malignant neoplasm of breast,20.73,Rate
Berlin,DE30,Total,Total,2015,Malignant neoplasm of breast,21.5,Rate
Berlin,DE30,Total,Total,2016,Malignant neoplasm of breast,21.56,Rate
Berlin,DE30,Total,Total,2017,Malignant neoplasm of breast,19.97,Rate
Berlin,DE30,Total,Total,2018,Malignant neoplasm of breast,20.38,Rate
Berlin,DE30,Total,Total,2019,Malignant neoplasm of breast,19.54,Rate
Berlin,DE30,Total,Total,2020,Malignant neoplasm of breast,19.98,Rate
Berlin,DE30,Total,Total,2011,Diabetes mellitus,38.57,Rate
Berlin,DE30,Total,Total,2012,Diabetes mellitus,33.86,Rate
Berlin,DE30,Total,Total,2013,Diabetes mellitus,33.53,Rate
Berlin,DE30,Total,Total,2014,Diabetes mellitus,29.6,Rate
Berlin,DE30,Total,Total,2015,Diabetes mellitus,34.89,Rate
Berlin,DE30,Total,Total,2016,Diabetes mellitus,32.49,Rate
Berlin,DE30,Total,Total,2017,Diabetes mellitus,28.75,Rate
Berlin,DE30,Total,Total,2018,Diabetes mellitus,22.79,Rate
Berlin,DE30,Total,Total,2019,Diabetes mellitus,25.36,Rate
Berlin,DE30,Total,Total,2020,Diabetes mellitus,26.99,Rate
Berlin,DE30,Total,Total,2011,Mental and behavioural disorders (F00-F99),22.87,Rate
Berlin,DE30,Total,Total,2012,Mental and behavioural disorders (F00-F99),23.58,Rate
Berlin,DE30,Total,Total,2013,Mental and behavioural disorders (F00-F99),29.99,Rate
Berlin,DE30,Total,Total,2014,Mental and behavioural disorders (F00-F99),26.73,Rate
Berlin,DE30,Total,Total,2015,Mental and behavioural disorders (F00-F99),36.52,Rate
Berlin,DE30,Total,Total,2016,Mental and behavioural disorders (F00-F99),38.38,Rate
Berlin,DE30,Total,Total,2017,Mental and behavioural disorders (F00-F99),49.39,Rate
Berlin,DE30,Total,Total,2018,Mental and behavioural disorders (F00-F99),60.14,Rate
Berlin,DE30,Total,Total,2019,Mental and behavioural disorders (F00-F99),52.29,Rate
Berlin,DE30,Total,Total,2020,Mental and behavioural disorders (F00-F99),56.72,Rate
Berlin,DE30,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Berlin,DE30,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Berlin,DE30,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Berlin,DE30,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Berlin,DE30,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Berlin,DE30,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.85,Rate
Berlin,DE30,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.18,Rate
Berlin,DE30,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Berlin,DE30,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.05,Rate
Berlin,DE30,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.63,Rate
Berlin,DE30,Total,Total,2011,Other ischaemic heart diseases,79.86,Rate
Berlin,DE30,Total,Total,2012,Other ischaemic heart diseases,76.28,Rate
Berlin,DE30,Total,Total,2013,Other ischaemic heart diseases,74.27,Rate
Berlin,DE30,Total,Total,2014,Other ischaemic heart diseases,64.15,Rate
Berlin,DE30,Total,Total,2015,Other ischaemic heart diseases,66.21,Rate
Berlin,DE30,Total,Total,2016,Other ischaemic heart diseases,63.21,Rate
Berlin,DE30,Total,Total,2017,Other ischaemic heart diseases,66.5,Rate
Berlin,DE30,Total,Total,2018,Other ischaemic heart diseases,61.95,Rate
Berlin,DE30,Total,Total,2019,Other ischaemic heart diseases,52.99,Rate
Berlin,DE30,Total,Total,2020,Other ischaemic heart diseases,57.74,Rate
Berlin,DE30,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,69.34,Rate
Berlin,DE30,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,66.86,Rate
Berlin,DE30,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,54.74,Rate
Berlin,DE30,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,47.51,Rate
Berlin,DE30,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,58.09,Rate
Berlin,DE30,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,56.73,Rate
Berlin,DE30,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,55.73,Rate
Berlin,DE30,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,64.74,Rate
Berlin,DE30,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,69.91,Rate
Berlin,DE30,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,68.45,Rate
Berlin,DE30,Total,Total,2011,Cerebrovascular diseases,56.35,Rate
Berlin,DE30,Total,Total,2012,Cerebrovascular diseases,56.01,Rate
Berlin,DE30,Total,Total,2013,Cerebrovascular diseases,55.78,Rate
Berlin,DE30,Total,Total,2014,Cerebrovascular diseases,53.67,Rate
Berlin,DE30,Total,Total,2015,Cerebrovascular diseases,50.95,Rate
Berlin,DE30,Total,Total,2016,Cerebrovascular diseases,50.61,Rate
Berlin,DE30,Total,Total,2017,Cerebrovascular diseases,50.06,Rate
Berlin,DE30,Total,Total,2018,Cerebrovascular diseases,53.01,Rate
Berlin,DE30,Total,Total,2019,Cerebrovascular diseases,47.83,Rate
Berlin,DE30,Total,Total,2020,Cerebrovascular diseases,47.67,Rate
Berlin,DE30,Total,Total,2011,Chronic lower respiratory diseases,40.12,Rate
Berlin,DE30,Total,Total,2012,Chronic lower respiratory diseases,41.12,Rate
Berlin,DE30,Total,Total,2013,Chronic lower respiratory diseases,44.81,Rate
Berlin,DE30,Total,Total,2014,Chronic lower respiratory diseases,38.48,Rate
Berlin,DE30,Total,Total,2015,Chronic lower respiratory diseases,49.04,Rate
Berlin,DE30,Total,Total,2016,Chronic lower respiratory diseases,47.25,Rate
Berlin,DE30,Total,Total,2017,Chronic lower respiratory diseases,51.87,Rate
Berlin,DE30,Total,Total,2018,Chronic lower respiratory diseases,50.22,Rate
Berlin,DE30,Total,Total,2019,Chronic lower respiratory diseases,44.51,Rate
Berlin,DE30,Total,Total,2020,Chronic lower respiratory diseases,40.42,Rate
Berlin,DE30,Total,Total,2011,Asthma and status asthmaticus,1.39,Rate
Berlin,DE30,Total,Total,2012,Asthma and status asthmaticus,0.98,Rate
Berlin,DE30,Total,Total,2013,Asthma and status asthmaticus,1.11,Rate
Berlin,DE30,Total,Total,2014,Asthma and status asthmaticus,0.81,Rate
Berlin,DE30,Total,Total,2015,Asthma and status asthmaticus,0.48,Rate
Berlin,DE30,Total,Total,2016,Asthma and status asthmaticus,0.79,Rate
Berlin,DE30,Total,Total,2017,Asthma and status asthmaticus,1.11,Rate
Berlin,DE30,Total,Total,2018,Asthma and status asthmaticus,1.02,Rate
Berlin,DE30,Total,Total,2019,Asthma and status asthmaticus,0.67,Rate
Berlin,DE30,Total,Total,2020,Asthma and status asthmaticus,0.87,Rate
Berlin,DE30,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4354.3,Rate
Berlin,DE30,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4450.42,Rate
Berlin,DE30,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4424.61,Rate
Berlin,DE30,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4222.47,Rate
Berlin,DE30,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4380.43,Rate
Berlin,DE30,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4246.06,Rate
Berlin,DE30,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4225.44,Rate
Berlin,DE30,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4342.66,Rate
Berlin,DE30,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4095.09,Rate
Berlin,DE30,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4433.5,Rate
Berlin,DE30,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.01,Rate
Berlin,DE30,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.72,Rate
Berlin,DE30,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.9,Rate
Berlin,DE30,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.57,Rate
Berlin,DE30,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.37,Rate
Berlin,DE30,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.17,Rate
Berlin,DE30,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.87,Rate
Berlin,DE30,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.41,Rate
Berlin,DE30,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",96.2,Rate
Berlin,DE30,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.95,Rate
Berlin,DE30,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",229.68,Rate
Berlin,DE30,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",237.65,Rate
Berlin,DE30,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",229.78,Rate
Berlin,DE30,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",210.04,Rate
Berlin,DE30,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",234.82,Rate
Berlin,DE30,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",227.35,Rate
Berlin,DE30,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",220.87,Rate
Berlin,DE30,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",214.43,Rate
Berlin,DE30,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",210.21,Rate
Berlin,DE30,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",219.15,Rate
Berlin,DE30,65 years or over,Total,2011,Malignant melanoma of skin,13.5,Rate
Berlin,DE30,65 years or over,Total,2012,Malignant melanoma of skin,9.51,Rate
Berlin,DE30,65 years or over,Total,2013,Malignant melanoma of skin,11.16,Rate
Berlin,DE30,65 years or over,Total,2014,Malignant melanoma of skin,10.63,Rate
Berlin,DE30,65 years or over,Total,2015,Malignant melanoma of skin,10.66,Rate
Berlin,DE30,65 years or over,Total,2016,Malignant melanoma of skin,12.25,Rate
Berlin,DE30,65 years or over,Total,2017,Malignant melanoma of skin,10.57,Rate
Berlin,DE30,65 years or over,Total,2018,Malignant melanoma of skin,10.05,Rate
Berlin,DE30,65 years or over,Total,2019,Malignant melanoma of skin,10.36,Rate
Berlin,DE30,65 years or over,Total,2020,Malignant melanoma of skin,10.35,Rate
Berlin,DE30,65 years or over,Total,2011,Malignant neoplasm of breast,87.96,Rate
Berlin,DE30,65 years or over,Total,2012,Malignant neoplasm of breast,80.38,Rate
Berlin,DE30,65 years or over,Total,2013,Malignant neoplasm of breast,81.03,Rate
Berlin,DE30,65 years or over,Total,2014,Malignant neoplasm of breast,78.76,Rate
Berlin,DE30,65 years or over,Total,2015,Malignant neoplasm of breast,81.1,Rate
Berlin,DE30,65 years or over,Total,2016,Malignant neoplasm of breast,84.94,Rate
Berlin,DE30,65 years or over,Total,2017,Malignant neoplasm of breast,74.31,Rate
Berlin,DE30,65 years or over,Total,2018,Malignant neoplasm of breast,74.49,Rate
Berlin,DE30,65 years or over,Total,2019,Malignant neoplasm of breast,75.99,Rate
Berlin,DE30,65 years or over,Total,2020,Malignant neoplasm of breast,76.83,Rate
Berlin,DE30,65 years or over,Total,2011,Diabetes mellitus,175.52,Rate
Berlin,DE30,65 years or over,Total,2012,Diabetes mellitus,154.22,Rate
Berlin,DE30,65 years or over,Total,2013,Diabetes mellitus,154.67,Rate
Berlin,DE30,65 years or over,Total,2014,Diabetes mellitus,137.43,Rate
Berlin,DE30,65 years or over,Total,2015,Diabetes mellitus,159.67,Rate
Berlin,DE30,65 years or over,Total,2016,Diabetes mellitus,147.87,Rate
Berlin,DE30,65 years or over,Total,2017,Diabetes mellitus,131.39,Rate
Berlin,DE30,65 years or over,Total,2018,Diabetes mellitus,104.4,Rate
Berlin,DE30,65 years or over,Total,2019,Diabetes mellitus,116.0,Rate
Berlin,DE30,65 years or over,Total,2020,Diabetes mellitus,126.43,Rate
Berlin,DE30,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),91.94,Rate
Berlin,DE30,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),99.82,Rate
Berlin,DE30,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),128.28,Rate
Berlin,DE30,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),116.2,Rate
Berlin,DE30,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),163.13,Rate
Berlin,DE30,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),176.54,Rate
Berlin,DE30,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),237.01,Rate
Berlin,DE30,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),294.05,Rate
Berlin,DE30,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),254.3,Rate
Berlin,DE30,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),272.36,Rate
Berlin,DE30,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.15,Rate
Berlin,DE30,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),4.36,Rate
Berlin,DE30,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),4.08,Rate
Berlin,DE30,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.98,Rate
Berlin,DE30,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.88,Rate
Berlin,DE30,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),8.18,Rate
Berlin,DE30,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),14.6,Rate
Berlin,DE30,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),10.71,Rate
Berlin,DE30,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),7.94,Rate
Berlin,DE30,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),15.1,Rate
Berlin,DE30,65 years or over,Total,2011,Other ischaemic heart diseases,386.64,Rate
Berlin,DE30,65 years or over,Total,2012,Other ischaemic heart diseases,368.91,Rate
Berlin,DE30,65 years or over,Total,2013,Other ischaemic heart diseases,360.66,Rate
Berlin,DE30,65 years or over,Total,2014,Other ischaemic heart diseases,304.12,Rate
Berlin,DE30,65 years or over,Total,2015,Other ischaemic heart diseases,313.5,Rate
Berlin,DE30,65 years or over,Total,2016,Other ischaemic heart diseases,304.26,Rate
Berlin,DE30,65 years or over,Total,2017,Other ischaemic heart diseases,320.11,Rate
Berlin,DE30,65 years or over,Total,2018,Other ischaemic heart diseases,295.48,Rate
Berlin,DE30,65 years or over,Total,2019,Other ischaemic heart diseases,254.03,Rate
Berlin,DE30,65 years or over,Total,2020,Other ischaemic heart diseases,279.48,Rate
Berlin,DE30,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,301.66,Rate
Berlin,DE30,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,289.01,Rate
Berlin,DE30,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,234.94,Rate
Berlin,DE30,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,207.26,Rate
Berlin,DE30,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,249.97,Rate
Berlin,DE30,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,245.93,Rate
Berlin,DE30,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,241.63,Rate
Berlin,DE30,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,281.59,Rate
Berlin,DE30,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,305.26,Rate
Berlin,DE30,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,294.1,Rate
Berlin,DE30,65 years or over,Total,2011,Cerebrovascular diseases,260.41,Rate
Berlin,DE30,65 years or over,Total,2012,Cerebrovascular diseases,258.48,Rate
Berlin,DE30,65 years or over,Total,2013,Cerebrovascular diseases,261.61,Rate
Berlin,DE30,65 years or over,Total,2014,Cerebrovascular diseases,250.35,Rate
Berlin,DE30,65 years or over,Total,2015,Cerebrovascular diseases,236.36,Rate
Berlin,DE30,65 years or over,Total,2016,Cerebrovascular diseases,236.71,Rate
Berlin,DE30,65 years or over,Total,2017,Cerebrovascular diseases,233.61,Rate
Berlin,DE30,65 years or over,Total,2018,Cerebrovascular diseases,244.13,Rate
Berlin,DE30,65 years or over,Total,2019,Cerebrovascular diseases,222.73,Rate
Berlin,DE30,65 years or over,Total,2020,Cerebrovascular diseases,222.05,Rate
Berlin,DE30,65 years or over,Total,2011,Chronic lower respiratory diseases,179.89,Rate
Berlin,DE30,65 years or over,Total,2012,Chronic lower respiratory diseases,186.7,Rate
Berlin,DE30,65 years or over,Total,2013,Chronic lower respiratory diseases,200.09,Rate
Berlin,DE30,65 years or over,Total,2014,Chronic lower respiratory diseases,172.06,Rate
Berlin,DE30,65 years or over,Total,2015,Chronic lower respiratory diseases,219.2,Rate
Berlin,DE30,65 years or over,Total,2016,Chronic lower respiratory diseases,208.89,Rate
Berlin,DE30,65 years or over,Total,2017,Chronic lower respiratory diseases,228.8,Rate
Berlin,DE30,65 years or over,Total,2018,Chronic lower respiratory diseases,225.02,Rate
Berlin,DE30,65 years or over,Total,2019,Chronic lower respiratory diseases,201.96,Rate
Berlin,DE30,65 years or over,Total,2020,Chronic lower respiratory diseases,176.86,Rate
Berlin,DE30,65 years or over,Total,2011,Asthma and status asthmaticus,4.17,Rate
Berlin,DE30,65 years or over,Total,2012,Asthma and status asthmaticus,3.77,Rate
Berlin,DE30,65 years or over,Total,2013,Asthma and status asthmaticus,2.94,Rate
Berlin,DE30,65 years or over,Total,2014,Asthma and status asthmaticus,2.72,Rate
Berlin,DE30,65 years or over,Total,2015,Asthma and status asthmaticus,1.9,Rate
Berlin,DE30,65 years or over,Total,2016,Asthma and status asthmaticus,3.14,Rate
Berlin,DE30,65 years or over,Total,2017,Asthma and status asthmaticus,4.58,Rate
Berlin,DE30,65 years or over,Total,2018,Asthma and status asthmaticus,3.62,Rate
Berlin,DE30,65 years or over,Total,2019,Asthma and status asthmaticus,2.6,Rate
Berlin,DE30,65 years or over,Total,2020,Asthma and status asthmaticus,2.93,Rate
Berlin,DE30,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,229.79,Rate
Berlin,DE30,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,217.03,Rate
Berlin,DE30,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,219.4,Rate
Berlin,DE30,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,218.15,Rate
Berlin,DE30,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,219.91,Rate
Berlin,DE30,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,209.3,Rate
Berlin,DE30,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,200.02,Rate
Berlin,DE30,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,204.36,Rate
Berlin,DE30,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,193.57,Rate
Berlin,DE30,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,202.03,Rate
Berlin,DE30,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.62,Rate
Berlin,DE30,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.83,Rate
Berlin,DE30,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.63,Rate
Berlin,DE30,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.84,Rate
Berlin,DE30,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.27,Rate
Berlin,DE30,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.81,Rate
Berlin,DE30,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.03,Rate
Berlin,DE30,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.63,Rate
Berlin,DE30,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.82,Rate
Berlin,DE30,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.75,Rate
Berlin,DE30,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",25.38,Rate
Berlin,DE30,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",22.48,Rate
Berlin,DE30,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",21.89,Rate
Berlin,DE30,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",21.45,Rate
Berlin,DE30,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",20.69,Rate
Berlin,DE30,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",21.39,Rate
Berlin,DE30,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",18.89,Rate
Berlin,DE30,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",18.96,Rate
Berlin,DE30,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",18.09,Rate
Berlin,DE30,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",16.8,Rate
Berlin,DE30,Less than 65 years,Total,2011,Malignant melanoma of skin,1.0,Rate
Berlin,DE30,Less than 65 years,Total,2012,Malignant melanoma of skin,0.99,Rate
Berlin,DE30,Less than 65 years,Total,2013,Malignant melanoma of skin,1.11,Rate
Berlin,DE30,Less than 65 years,Total,2014,Malignant melanoma of skin,1.49,Rate
Berlin,DE30,Less than 65 years,Total,2015,Malignant melanoma of skin,1.11,Rate
Berlin,DE30,Less than 65 years,Total,2016,Malignant melanoma of skin,0.96,Rate
Berlin,DE30,Less than 65 years,Total,2017,Malignant melanoma of skin,0.85,Rate
Berlin,DE30,Less than 65 years,Total,2018,Malignant melanoma of skin,1.23,Rate
Berlin,DE30,Less than 65 years,Total,2019,Malignant melanoma of skin,1.11,Rate
Berlin,DE30,Less than 65 years,Total,2020,Malignant melanoma of skin,1.1,Rate
Berlin,DE30,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.42,Rate
Berlin,DE30,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.76,Rate
Berlin,DE30,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.52,Rate
Berlin,DE30,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.67,Rate
Berlin,DE30,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.06,Rate
Berlin,DE30,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.21,Rate
Berlin,DE30,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.81,Rate
Berlin,DE30,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.28,Rate
Berlin,DE30,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.86,Rate
Berlin,DE30,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.21,Rate
Berlin,DE30,Less than 65 years,Total,2011,Diabetes mellitus,5.4,Rate
Berlin,DE30,Less than 65 years,Total,2012,Diabetes mellitus,4.71,Rate
Berlin,DE30,Less than 65 years,Total,2013,Diabetes mellitus,4.19,Rate
Berlin,DE30,Less than 65 years,Total,2014,Diabetes mellitus,3.49,Rate
Berlin,DE30,Less than 65 years,Total,2015,Diabetes mellitus,4.66,Rate
Berlin,DE30,Less than 65 years,Total,2016,Diabetes mellitus,4.54,Rate
Berlin,DE30,Less than 65 years,Total,2017,Diabetes mellitus,3.88,Rate
Berlin,DE30,Less than 65 years,Total,2018,Diabetes mellitus,3.01,Rate
Berlin,DE30,Less than 65 years,Total,2019,Diabetes mellitus,3.4,Rate
Berlin,DE30,Less than 65 years,Total,2020,Diabetes mellitus,2.91,Rate
Berlin,DE30,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),6.14,Rate
Berlin,DE30,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),5.12,Rate
Berlin,DE30,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),6.18,Rate
Berlin,DE30,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),5.05,Rate
Berlin,DE30,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.86,Rate
Berlin,DE30,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),4.92,Rate
Berlin,DE30,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),3.94,Rate
Berlin,DE30,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),3.47,Rate
Berlin,DE30,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.36,Rate
Berlin,DE30,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.48,Rate
Berlin,DE30,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Berlin,DE30,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Berlin,DE30,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Berlin,DE30,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Berlin,DE30,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Berlin,DE30,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Berlin,DE30,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Berlin,DE30,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Berlin,DE30,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Berlin,DE30,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.86,Rate
Berlin,DE30,Less than 65 years,Total,2011,Other ischaemic heart diseases,5.55,Rate
Berlin,DE30,Less than 65 years,Total,2012,Other ischaemic heart diseases,5.39,Rate
Berlin,DE30,Less than 65 years,Total,2013,Other ischaemic heart diseases,4.9,Rate
Berlin,DE30,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.03,Rate
Berlin,DE30,Less than 65 years,Total,2015,Other ischaemic heart diseases,6.3,Rate
Berlin,DE30,Less than 65 years,Total,2016,Other ischaemic heart diseases,4.82,Rate
Berlin,DE30,Less than 65 years,Total,2017,Other ischaemic heart diseases,5.07,Rate
Berlin,DE30,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.38,Rate
Berlin,DE30,Less than 65 years,Total,2019,Other ischaemic heart diseases,4.29,Rate
Berlin,DE30,Less than 65 years,Total,2020,Other ischaemic heart diseases,4.03,Rate
Berlin,DE30,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,13.06,Rate
Berlin,DE30,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,13.04,Rate
Berlin,DE30,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,11.09,Rate
Berlin,DE30,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,8.81,Rate
Berlin,DE30,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.61,Rate
Berlin,DE30,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,10.9,Rate
Berlin,DE30,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,10.69,Rate
Berlin,DE30,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.22,Rate
Berlin,DE30,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,12.9,Rate
Berlin,DE30,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,13.78,Rate
Berlin,DE30,Less than 65 years,Total,2011,Cerebrovascular diseases,6.92,Rate
Berlin,DE30,Less than 65 years,Total,2012,Cerebrovascular diseases,6.96,Rate
Berlin,DE30,Less than 65 years,Total,2013,Cerebrovascular diseases,5.92,Rate
Berlin,DE30,Less than 65 years,Total,2014,Cerebrovascular diseases,6.03,Rate
Berlin,DE30,Less than 65 years,Total,2015,Cerebrovascular diseases,6.04,Rate
Berlin,DE30,Less than 65 years,Total,2016,Cerebrovascular diseases,5.53,Rate
Berlin,DE30,Less than 65 years,Total,2017,Cerebrovascular diseases,5.59,Rate
Berlin,DE30,Less than 65 years,Total,2018,Cerebrovascular diseases,6.72,Rate
Berlin,DE30,Less than 65 years,Total,2019,Cerebrovascular diseases,5.46,Rate
Berlin,DE30,Less than 65 years,Total,2020,Cerebrovascular diseases,5.43,Rate
Berlin,DE30,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.27,Rate
Berlin,DE30,Less than 65 years,Total,2012,Chronic lower respiratory diseases,5.85,Rate
Berlin,DE30,Less than 65 years,Total,2013,Chronic lower respiratory diseases,7.2,Rate
Berlin,DE30,Less than 65 years,Total,2014,Chronic lower respiratory diseases,6.12,Rate
Berlin,DE30,Less than 65 years,Total,2015,Chronic lower respiratory diseases,7.82,Rate
Berlin,DE30,Less than 65 years,Total,2016,Chronic lower respiratory diseases,8.09,Rate
Berlin,DE30,Less than 65 years,Total,2017,Chronic lower respiratory diseases,9.02,Rate
Berlin,DE30,Less than 65 years,Total,2018,Chronic lower respiratory diseases,7.88,Rate
Berlin,DE30,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.36,Rate
Berlin,DE30,Less than 65 years,Total,2020,Chronic lower respiratory diseases,7.37,Rate
Berlin,DE30,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.71,Rate
Berlin,DE30,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.31,Rate
Berlin,DE30,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.66,Rate
Berlin,DE30,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.35,Rate
Berlin,DE30,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.14,Rate
Berlin,DE30,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.22,Rate
Berlin,DE30,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.27,Rate
Berlin,DE30,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.4,Rate
Berlin,DE30,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.21,Rate
Berlin,DE30,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.37,Rate
Bremen,DE50,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,891.15,Rate
Bremen,DE50,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,875.07,Rate
Bremen,DE50,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,900.81,Rate
Bremen,DE50,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,857.16,Rate
Bremen,DE50,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,869.88,Rate
Bremen,DE50,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,868.05,Rate
Bremen,DE50,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,854.23,Rate
Bremen,DE50,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,876.27,Rate
Bremen,DE50,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,814.56,Rate
Bremen,DE50,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,867.35,Rate
Bremen,DE50,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.79,Rate
Bremen,DE50,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.43,Rate
Bremen,DE50,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.66,Rate
Bremen,DE50,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.85,Rate
Bremen,DE50,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.7,Rate
Bremen,DE50,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.58,Rate
Bremen,DE50,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.0,Rate
Bremen,DE50,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.81,Rate
Bremen,DE50,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.96,Rate
Bremen,DE50,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.98,Rate
Bremen,DE50,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",42.99,Rate
Bremen,DE50,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",38.27,Rate
Bremen,DE50,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",47.53,Rate
Bremen,DE50,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",45.55,Rate
Bremen,DE50,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",42.62,Rate
Bremen,DE50,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",49.16,Rate
Bremen,DE50,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",41.55,Rate
Bremen,DE50,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",50.11,Rate
Bremen,DE50,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",43.77,Rate
Bremen,DE50,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",46.28,Rate
Bremen,DE50,Total,Females,2011,Malignant melanoma of skin,2.18,Rate
Bremen,DE50,Total,Females,2012,Malignant melanoma of skin,3.6,Rate
Bremen,DE50,Total,Females,2013,Malignant melanoma of skin,3.7,Rate
Bremen,DE50,Total,Females,2014,Malignant melanoma of skin,4.97,Rate
Bremen,DE50,Total,Females,2015,Malignant melanoma of skin,3.77,Rate
Bremen,DE50,Total,Females,2016,Malignant melanoma of skin,4.22,Rate
Bremen,DE50,Total,Females,2017,Malignant melanoma of skin,6.45,Rate
Bremen,DE50,Total,Females,2018,Malignant melanoma of skin,7.28,Rate
Bremen,DE50,Total,Females,2019,Malignant melanoma of skin,2.28,Rate
Bremen,DE50,Total,Females,2020,Malignant melanoma of skin,1.78,Rate
Bremen,DE50,Total,Females,2011,Malignant neoplasm of breast,46.67,Rate
Bremen,DE50,Total,Females,2012,Malignant neoplasm of breast,41.52,Rate
Bremen,DE50,Total,Females,2013,Malignant neoplasm of breast,42.02,Rate
Bremen,DE50,Total,Females,2014,Malignant neoplasm of breast,42.34,Rate
Bremen,DE50,Total,Females,2015,Malignant neoplasm of breast,37.01,Rate
Bremen,DE50,Total,Females,2016,Malignant neoplasm of breast,40.32,Rate
Bremen,DE50,Total,Females,2017,Malignant neoplasm of breast,38.06,Rate
Bremen,DE50,Total,Females,2018,Malignant neoplasm of breast,39.46,Rate
Bremen,DE50,Total,Females,2019,Malignant neoplasm of breast,36.42,Rate
Bremen,DE50,Total,Females,2020,Malignant neoplasm of breast,35.2,Rate
Bremen,DE50,Total,Females,2011,Diabetes mellitus,17.72,Rate
Bremen,DE50,Total,Females,2012,Diabetes mellitus,19.04,Rate
Bremen,DE50,Total,Females,2013,Diabetes mellitus,18.1,Rate
Bremen,DE50,Total,Females,2014,Diabetes mellitus,11.38,Rate
Bremen,DE50,Total,Females,2015,Diabetes mellitus,15.61,Rate
Bremen,DE50,Total,Females,2016,Diabetes mellitus,6.33,Rate
Bremen,DE50,Total,Females,2017,Diabetes mellitus,9.36,Rate
Bremen,DE50,Total,Females,2018,Diabetes mellitus,7.34,Rate
Bremen,DE50,Total,Females,2019,Diabetes mellitus,20.67,Rate
Bremen,DE50,Total,Females,2020,Diabetes mellitus,27.85,Rate
Bremen,DE50,Total,Females,2011,Mental and behavioural disorders (F00-F99),32.21,Rate
Bremen,DE50,Total,Females,2012,Mental and behavioural disorders (F00-F99),28.59,Rate
Bremen,DE50,Total,Females,2013,Mental and behavioural disorders (F00-F99),39.1,Rate
Bremen,DE50,Total,Females,2014,Mental and behavioural disorders (F00-F99),32.37,Rate
Bremen,DE50,Total,Females,2015,Mental and behavioural disorders (F00-F99),38.78,Rate
Bremen,DE50,Total,Females,2016,Mental and behavioural disorders (F00-F99),43.41,Rate
Bremen,DE50,Total,Females,2017,Mental and behavioural disorders (F00-F99),38.98,Rate
Bremen,DE50,Total,Females,2018,Mental and behavioural disorders (F00-F99),31.35,Rate
Bremen,DE50,Total,Females,2019,Mental and behavioural disorders (F00-F99),60.94,Rate
Bremen,DE50,Total,Females,2020,Mental and behavioural disorders (F00-F99),59.48,Rate
Bremen,DE50,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),4.7,Rate
Bremen,DE50,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Bremen,DE50,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),4.31,Rate
Bremen,DE50,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Bremen,DE50,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.3,Rate
Bremen,DE50,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.77,Rate
Bremen,DE50,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.0,Rate
Bremen,DE50,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.46,Rate
Bremen,DE50,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.78,Rate
Bremen,DE50,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.04,Rate
Bremen,DE50,Total,Females,2011,Other ischaemic heart diseases,50.87,Rate
Bremen,DE50,Total,Females,2012,Other ischaemic heart diseases,44.33,Rate
Bremen,DE50,Total,Females,2013,Other ischaemic heart diseases,41.76,Rate
Bremen,DE50,Total,Females,2014,Other ischaemic heart diseases,38.93,Rate
Bremen,DE50,Total,Females,2015,Other ischaemic heart diseases,49.96,Rate
Bremen,DE50,Total,Females,2016,Other ischaemic heart diseases,43.21,Rate
Bremen,DE50,Total,Females,2017,Other ischaemic heart diseases,23.68,Rate
Bremen,DE50,Total,Females,2018,Other ischaemic heart diseases,26.27,Rate
Bremen,DE50,Total,Females,2019,Other ischaemic heart diseases,43.68,Rate
Bremen,DE50,Total,Females,2020,Other ischaemic heart diseases,49.25,Rate
Bremen,DE50,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,21.75,Rate
Bremen,DE50,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,45.17,Rate
Bremen,DE50,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,60.43,Rate
Bremen,DE50,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,49.21,Rate
Bremen,DE50,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,41.81,Rate
Bremen,DE50,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,40.34,Rate
Bremen,DE50,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,38.54,Rate
Bremen,DE50,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,33.49,Rate
Bremen,DE50,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,30.89,Rate
Bremen,DE50,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,32.11,Rate
Bremen,DE50,Total,Females,2011,Cerebrovascular diseases,60.59,Rate
Bremen,DE50,Total,Females,2012,Cerebrovascular diseases,58.3,Rate
Bremen,DE50,Total,Females,2013,Cerebrovascular diseases,50.34,Rate
Bremen,DE50,Total,Females,2014,Cerebrovascular diseases,53.63,Rate
Bremen,DE50,Total,Females,2015,Cerebrovascular diseases,56.26,Rate
Bremen,DE50,Total,Females,2016,Cerebrovascular diseases,49.83,Rate
Bremen,DE50,Total,Females,2017,Cerebrovascular diseases,47.19,Rate
Bremen,DE50,Total,Females,2018,Cerebrovascular diseases,49.57,Rate
Bremen,DE50,Total,Females,2019,Cerebrovascular diseases,49.46,Rate
Bremen,DE50,Total,Females,2020,Cerebrovascular diseases,54.29,Rate
Bremen,DE50,Total,Females,2011,Chronic lower respiratory diseases,30.02,Rate
Bremen,DE50,Total,Females,2012,Chronic lower respiratory diseases,25.37,Rate
Bremen,DE50,Total,Females,2013,Chronic lower respiratory diseases,26.85,Rate
Bremen,DE50,Total,Females,2014,Chronic lower respiratory diseases,26.99,Rate
Bremen,DE50,Total,Females,2015,Chronic lower respiratory diseases,36.67,Rate
Bremen,DE50,Total,Females,2016,Chronic lower respiratory diseases,39.07,Rate
Bremen,DE50,Total,Females,2017,Chronic lower respiratory diseases,35.49,Rate
Bremen,DE50,Total,Females,2018,Chronic lower respiratory diseases,41.88,Rate
Bremen,DE50,Total,Females,2019,Chronic lower respiratory diseases,38.14,Rate
Bremen,DE50,Total,Females,2020,Chronic lower respiratory diseases,39.73,Rate
Bremen,DE50,Total,Females,2011,Asthma and status asthmaticus,0.54,Rate
Bremen,DE50,Total,Females,2012,Asthma and status asthmaticus,0.91,Rate
Bremen,DE50,Total,Females,2013,Asthma and status asthmaticus,2.09,Rate
Bremen,DE50,Total,Females,2014,Asthma and status asthmaticus,0.98,Rate
Bremen,DE50,Total,Females,2015,Asthma and status asthmaticus,1.73,Rate
Bremen,DE50,Total,Females,2016,Asthma and status asthmaticus,0.96,Rate
Bremen,DE50,Total,Females,2017,Asthma and status asthmaticus,0.86,Rate
Bremen,DE50,Total,Females,2018,Asthma and status asthmaticus,1.51,Rate
Bremen,DE50,Total,Females,2019,Asthma and status asthmaticus,0.8,Rate
Bremen,DE50,Total,Females,2020,Asthma and status asthmaticus,1.23,Rate
Bremen,DE50,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3848.91,Rate
Bremen,DE50,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3754.99,Rate
Bremen,DE50,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3927.67,Rate
Bremen,DE50,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3677.33,Rate
Bremen,DE50,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3758.29,Rate
Bremen,DE50,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3752.7,Rate
Bremen,DE50,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3778.53,Rate
Bremen,DE50,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3761.8,Rate
Bremen,DE50,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3554.16,Rate
Bremen,DE50,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3770.38,Rate
Bremen,DE50,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.73,Rate
Bremen,DE50,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.01,Rate
Bremen,DE50,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.02,Rate
Bremen,DE50,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.03,Rate
Bremen,DE50,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.79,Rate
Bremen,DE50,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.07,Rate
Bremen,DE50,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.93,Rate
Bremen,DE50,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.58,Rate
Bremen,DE50,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.45,Rate
Bremen,DE50,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.89,Rate
Bremen,DE50,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",155.97,Rate
Bremen,DE50,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",118.8,Rate
Bremen,DE50,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",149.17,Rate
Bremen,DE50,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",151.82,Rate
Bremen,DE50,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",153.43,Rate
Bremen,DE50,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",176.9,Rate
Bremen,DE50,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",145.61,Rate
Bremen,DE50,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",195.61,Rate
Bremen,DE50,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",157.11,Rate
Bremen,DE50,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",169.56,Rate
Bremen,DE50,65 years or over,Females,2011,Malignant melanoma of skin,9.62,Rate
Bremen,DE50,65 years or over,Females,2012,Malignant melanoma of skin,15.44,Rate
Bremen,DE50,65 years or over,Females,2013,Malignant melanoma of skin,16.05,Rate
Bremen,DE50,65 years or over,Females,2014,Malignant melanoma of skin,19.69,Rate
Bremen,DE50,65 years or over,Females,2015,Malignant melanoma of skin,17.86,Rate
Bremen,DE50,65 years or over,Females,2016,Malignant melanoma of skin,14.43,Rate
Bremen,DE50,65 years or over,Females,2017,Malignant melanoma of skin,23.06,Rate
Bremen,DE50,65 years or over,Females,2018,Malignant melanoma of skin,30.49,Rate
Bremen,DE50,65 years or over,Females,2019,Malignant melanoma of skin,7.46,Rate
Bremen,DE50,65 years or over,Females,2020,Malignant melanoma of skin,9.12,Rate
Bremen,DE50,65 years or over,Females,2011,Malignant neoplasm of breast,152.75,Rate
Bremen,DE50,65 years or over,Females,2012,Malignant neoplasm of breast,136.7,Rate
Bremen,DE50,65 years or over,Females,2013,Malignant neoplasm of breast,150.76,Rate
Bremen,DE50,65 years or over,Females,2014,Malignant neoplasm of breast,156.59,Rate
Bremen,DE50,65 years or over,Females,2015,Malignant neoplasm of breast,124.4,Rate
Bremen,DE50,65 years or over,Females,2016,Malignant neoplasm of breast,158.96,Rate
Bremen,DE50,65 years or over,Females,2017,Malignant neoplasm of breast,139.01,Rate
Bremen,DE50,65 years or over,Females,2018,Malignant neoplasm of breast,133.0,Rate
Bremen,DE50,65 years or over,Females,2019,Malignant neoplasm of breast,137.73,Rate
Bremen,DE50,65 years or over,Females,2020,Malignant neoplasm of breast,135.97,Rate
Bremen,DE50,65 years or over,Females,2011,Diabetes mellitus,80.01,Rate
Bremen,DE50,65 years or over,Females,2012,Diabetes mellitus,86.94,Rate
Bremen,DE50,65 years or over,Females,2013,Diabetes mellitus,82.26,Rate
Bremen,DE50,65 years or over,Females,2014,Diabetes mellitus,56.63,Rate
Bremen,DE50,65 years or over,Females,2015,Diabetes mellitus,72.36,Rate
Bremen,DE50,65 years or over,Females,2016,Diabetes mellitus,32.45,Rate
Bremen,DE50,65 years or over,Females,2017,Diabetes mellitus,43.64,Rate
Bremen,DE50,65 years or over,Females,2018,Diabetes mellitus,35.78,Rate
Bremen,DE50,65 years or over,Females,2019,Diabetes mellitus,99.07,Rate
Bremen,DE50,65 years or over,Females,2020,Diabetes mellitus,125.51,Rate
Bremen,DE50,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),130.28,Rate
Bremen,DE50,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),113.65,Rate
Bremen,DE50,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),150.31,Rate
Bremen,DE50,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),140.46,Rate
Bremen,DE50,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),167.19,Rate
Bremen,DE50,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),192.87,Rate
Bremen,DE50,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),170.35,Rate
Bremen,DE50,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),122.35,Rate
Bremen,DE50,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),284.98,Rate
Bremen,DE50,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),285.36,Rate
Bremen,DE50,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),16.5,Rate
Bremen,DE50,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),7.12,Rate
Bremen,DE50,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),14.19,Rate
Bremen,DE50,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),7.24,Rate
Bremen,DE50,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),8.79,Rate
Bremen,DE50,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),7.66,Rate
Bremen,DE50,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),13.97,Rate
Bremen,DE50,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),14.92,Rate
Bremen,DE50,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),11.14,Rate
Bremen,DE50,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),10.96,Rate
Bremen,DE50,65 years or over,Females,2011,Other ischaemic heart diseases,250.16,Rate
Bremen,DE50,65 years or over,Females,2012,Other ischaemic heart diseases,208.96,Rate
Bremen,DE50,65 years or over,Females,2013,Other ischaemic heart diseases,209.73,Rate
Bremen,DE50,65 years or over,Females,2014,Other ischaemic heart diseases,189.18,Rate
Bremen,DE50,65 years or over,Females,2015,Other ischaemic heart diseases,241.34,Rate
Bremen,DE50,65 years or over,Females,2016,Other ischaemic heart diseases,201.28,Rate
Bremen,DE50,65 years or over,Females,2017,Other ischaemic heart diseases,118.66,Rate
Bremen,DE50,65 years or over,Females,2018,Other ischaemic heart diseases,123.09,Rate
Bremen,DE50,65 years or over,Females,2019,Other ischaemic heart diseases,219.83,Rate
Bremen,DE50,65 years or over,Females,2020,Other ischaemic heart diseases,241.35,Rate
Bremen,DE50,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,99.13,Rate
Bremen,DE50,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,205.62,Rate
Bremen,DE50,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,262.48,Rate
Bremen,DE50,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,209.03,Rate
Bremen,DE50,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,191.88,Rate
Bremen,DE50,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,179.55,Rate
Bremen,DE50,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,168.54,Rate
Bremen,DE50,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,147.93,Rate
Bremen,DE50,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,141.44,Rate
Bremen,DE50,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,139.18,Rate
Bremen,DE50,65 years or over,Females,2011,Cerebrovascular diseases,284.1,Rate
Bremen,DE50,65 years or over,Females,2012,Cerebrovascular diseases,271.87,Rate
Bremen,DE50,65 years or over,Females,2013,Cerebrovascular diseases,228.51,Rate
Bremen,DE50,65 years or over,Females,2014,Cerebrovascular diseases,255.19,Rate
Bremen,DE50,65 years or over,Females,2015,Cerebrovascular diseases,255.74,Rate
Bremen,DE50,65 years or over,Females,2016,Cerebrovascular diseases,237.93,Rate
Bremen,DE50,65 years or over,Females,2017,Cerebrovascular diseases,228.29,Rate
Bremen,DE50,65 years or over,Females,2018,Cerebrovascular diseases,225.28,Rate
Bremen,DE50,65 years or over,Females,2019,Cerebrovascular diseases,227.02,Rate
Bremen,DE50,65 years or over,Females,2020,Cerebrovascular diseases,260.33,Rate
Bremen,DE50,65 years or over,Females,2011,Chronic lower respiratory diseases,126.14,Rate
Bremen,DE50,65 years or over,Females,2012,Chronic lower respiratory diseases,108.75,Rate
Bremen,DE50,65 years or over,Females,2013,Chronic lower respiratory diseases,121.13,Rate
Bremen,DE50,65 years or over,Females,2014,Chronic lower respiratory diseases,114.68,Rate
Bremen,DE50,65 years or over,Females,2015,Chronic lower respiratory diseases,159.98,Rate
Bremen,DE50,65 years or over,Females,2016,Chronic lower respiratory diseases,159.4,Rate
Bremen,DE50,65 years or over,Females,2017,Chronic lower respiratory diseases,147.45,Rate
Bremen,DE50,65 years or over,Females,2018,Chronic lower respiratory diseases,176.14,Rate
Bremen,DE50,65 years or over,Females,2019,Chronic lower respiratory diseases,161.46,Rate
Bremen,DE50,65 years or over,Females,2020,Chronic lower respiratory diseases,167.92,Rate
Bremen,DE50,65 years or over,Females,2011,Asthma and status asthmaticus,1.18,Rate
Bremen,DE50,65 years or over,Females,2012,Asthma and status asthmaticus,3.18,Rate
Bremen,DE50,65 years or over,Females,2013,Asthma and status asthmaticus,4.77,Rate
Bremen,DE50,65 years or over,Females,2014,Asthma and status asthmaticus,3.59,Rate
Bremen,DE50,65 years or over,Females,2015,Asthma and status asthmaticus,8.86,Rate
Bremen,DE50,65 years or over,Females,2016,Asthma and status asthmaticus,3.45,Rate
Bremen,DE50,65 years or over,Females,2017,Asthma and status asthmaticus,4.39,Rate
Bremen,DE50,65 years or over,Females,2018,Asthma and status asthmaticus,4.62,Rate
Bremen,DE50,65 years or over,Females,2019,Asthma and status asthmaticus,2.71,Rate
Bremen,DE50,65 years or over,Females,2020,Asthma and status asthmaticus,4.64,Rate
Bremen,DE50,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,174.67,Rate
Bremen,DE50,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,177.46,Rate
Bremen,DE50,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,167.6,Rate
Bremen,DE50,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,174.01,Rate
Bremen,DE50,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,170.2,Rate
Bremen,DE50,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,169.28,Rate
Bremen,DE50,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,145.86,Rate
Bremen,DE50,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,177.29,Rate
Bremen,DE50,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,150.94,Rate
Bremen,DE50,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,164.13,Rate
Bremen,DE50,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.1,Rate
Bremen,DE50,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.3,Rate
Bremen,DE50,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.89,Rate
Bremen,DE50,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.27,Rate
Bremen,DE50,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.12,Rate
Bremen,DE50,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.93,Rate
Bremen,DE50,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.51,Rate
Bremen,DE50,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.51,Rate
Bremen,DE50,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.55,Rate
Bremen,DE50,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.98,Rate
Bremen,DE50,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",15.63,Rate
Bremen,DE50,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",18.76,Rate
Bremen,DE50,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",22.91,Rate
Bremen,DE50,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",19.81,Rate
Bremen,DE50,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",15.78,Rate
Bremen,DE50,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",18.22,Rate
Bremen,DE50,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",16.34,Rate
Bremen,DE50,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",14.86,Rate
Bremen,DE50,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",16.32,Rate
Bremen,DE50,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",16.41,Rate
Bremen,DE50,Less than 65 years,Females,2011,Malignant melanoma of skin,0.37,Rate
Bremen,DE50,Less than 65 years,Females,2012,Malignant melanoma of skin,0.74,Rate
Bremen,DE50,Less than 65 years,Females,2013,Malignant melanoma of skin,0.7,Rate
Bremen,DE50,Less than 65 years,Females,2014,Malignant melanoma of skin,1.41,Rate
Bremen,DE50,Less than 65 years,Females,2015,Malignant melanoma of skin,0.35,Rate
Bremen,DE50,Less than 65 years,Females,2016,Malignant melanoma of skin,1.75,Rate
Bremen,DE50,Less than 65 years,Females,2017,Malignant melanoma of skin,2.43,Rate
Bremen,DE50,Less than 65 years,Females,2018,Malignant melanoma of skin,1.66,Rate
Bremen,DE50,Less than 65 years,Females,2019,Malignant melanoma of skin,1.02,Rate
Bremen,DE50,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Bremen,DE50,Less than 65 years,Females,2011,Malignant neoplasm of breast,20.97,Rate
Bremen,DE50,Less than 65 years,Females,2012,Malignant neoplasm of breast,18.46,Rate
Bremen,DE50,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.68,Rate
Bremen,DE50,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.66,Rate
Bremen,DE50,Less than 65 years,Females,2015,Malignant neoplasm of breast,15.83,Rate
Bremen,DE50,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.58,Rate
Bremen,DE50,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.6,Rate
Bremen,DE50,Less than 65 years,Females,2018,Malignant neoplasm of breast,16.8,Rate
Bremen,DE50,Less than 65 years,Females,2019,Malignant neoplasm of breast,11.87,Rate
Bremen,DE50,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.79,Rate
Bremen,DE50,Less than 65 years,Females,2011,Diabetes mellitus,2.63,Rate
Bremen,DE50,Less than 65 years,Females,2012,Diabetes mellitus,2.58,Rate
Bremen,DE50,Less than 65 years,Females,2013,Diabetes mellitus,2.56,Rate
Bremen,DE50,Less than 65 years,Females,2014,Diabetes mellitus,0.42,Rate
Bremen,DE50,Less than 65 years,Females,2015,Diabetes mellitus,1.86,Rate
Bremen,DE50,Less than 65 years,Females,2016,Diabetes mellitus,0.0,Rate
Bremen,DE50,Less than 65 years,Females,2017,Diabetes mellitus,1.06,Rate
Bremen,DE50,Less than 65 years,Females,2018,Diabetes mellitus,0.45,Rate
Bremen,DE50,Less than 65 years,Females,2019,Diabetes mellitus,1.68,Rate
Bremen,DE50,Less than 65 years,Females,2020,Diabetes mellitus,4.19,Rate
Bremen,DE50,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),8.45,Rate
Bremen,DE50,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),7.99,Rate
Bremen,DE50,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),12.16,Rate
Bremen,DE50,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),6.19,Rate
Bremen,DE50,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),7.67,Rate
Bremen,DE50,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),7.21,Rate
Bremen,DE50,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),7.16,Rate
Bremen,DE50,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),9.31,Rate
Bremen,DE50,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),6.67,Rate
Bremen,DE50,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),4.77,Rate
Bremen,DE50,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.84,Rate
Bremen,DE50,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Bremen,DE50,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.92,Rate
Bremen,DE50,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Bremen,DE50,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Bremen,DE50,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Bremen,DE50,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Bremen,DE50,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Bremen,DE50,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Bremen,DE50,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Bremen,DE50,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.59,Rate
Bremen,DE50,Less than 65 years,Females,2012,Other ischaemic heart diseases,4.46,Rate
Bremen,DE50,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.07,Rate
Bremen,DE50,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.54,Rate
Bremen,DE50,Less than 65 years,Females,2015,Other ischaemic heart diseases,3.6,Rate
Bremen,DE50,Less than 65 years,Females,2016,Other ischaemic heart diseases,4.92,Rate
Bremen,DE50,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.67,Rate
Bremen,DE50,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.81,Rate
Bremen,DE50,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.01,Rate
Bremen,DE50,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.72,Rate
Bremen,DE50,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,3.01,Rate
Bremen,DE50,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,6.31,Rate
Bremen,DE50,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,11.49,Rate
Bremen,DE50,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,10.49,Rate
Bremen,DE50,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,5.46,Rate
Bremen,DE50,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,6.61,Rate
Bremen,DE50,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,7.05,Rate
Bremen,DE50,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,5.77,Rate
Bremen,DE50,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.11,Rate
Bremen,DE50,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,6.18,Rate
Bremen,DE50,Less than 65 years,Females,2011,Cerebrovascular diseases,6.45,Rate
Bremen,DE50,Less than 65 years,Females,2012,Cerebrovascular diseases,6.56,Rate
Bremen,DE50,Less than 65 years,Females,2013,Cerebrovascular diseases,7.18,Rate
Bremen,DE50,Less than 65 years,Females,2014,Cerebrovascular diseases,4.8,Rate
Bremen,DE50,Less than 65 years,Females,2015,Cerebrovascular diseases,7.94,Rate
Bremen,DE50,Less than 65 years,Females,2016,Cerebrovascular diseases,4.26,Rate
Bremen,DE50,Less than 65 years,Females,2017,Cerebrovascular diseases,3.32,Rate
Bremen,DE50,Less than 65 years,Females,2018,Cerebrovascular diseases,7.0,Rate
Bremen,DE50,Less than 65 years,Females,2019,Cerebrovascular diseases,6.45,Rate
Bremen,DE50,Less than 65 years,Females,2020,Cerebrovascular diseases,4.37,Rate
Bremen,DE50,Less than 65 years,Females,2011,Chronic lower respiratory diseases,6.73,Rate
Bremen,DE50,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.17,Rate
Bremen,DE50,Less than 65 years,Females,2013,Chronic lower respiratory diseases,4.01,Rate
Bremen,DE50,Less than 65 years,Females,2014,Chronic lower respiratory diseases,5.75,Rate
Bremen,DE50,Less than 65 years,Females,2015,Chronic lower respiratory diseases,6.8,Rate
Bremen,DE50,Less than 65 years,Females,2016,Chronic lower respiratory diseases,9.92,Rate
Bremen,DE50,Less than 65 years,Females,2017,Chronic lower respiratory diseases,8.37,Rate
Bremen,DE50,Less than 65 years,Females,2018,Chronic lower respiratory diseases,9.35,Rate
Bremen,DE50,Less than 65 years,Females,2019,Chronic lower respiratory diseases,8.27,Rate
Bremen,DE50,Less than 65 years,Females,2020,Chronic lower respiratory diseases,8.68,Rate
Bremen,DE50,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.38,Rate
Bremen,DE50,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.36,Rate
Bremen,DE50,Less than 65 years,Females,2013,Asthma and status asthmaticus,1.44,Rate
Bremen,DE50,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.34,Rate
Bremen,DE50,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Bremen,DE50,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.36,Rate
Bremen,DE50,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Bremen,DE50,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.76,Rate
Bremen,DE50,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.34,Rate
Bremen,DE50,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.4,Rate
Bremen,DE50,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1334.76,Rate
Bremen,DE50,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1353.11,Rate
Bremen,DE50,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1426.55,Rate
Bremen,DE50,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1283.43,Rate
Bremen,DE50,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1347.89,Rate
Bremen,DE50,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1278.12,Rate
Bremen,DE50,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1313.79,Rate
Bremen,DE50,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1307.89,Rate
Bremen,DE50,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1265.32,Rate
Bremen,DE50,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1317.89,Rate
Bremen,DE50,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.33,Rate
Bremen,DE50,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.64,Rate
Bremen,DE50,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.25,Rate
Bremen,DE50,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.45,Rate
Bremen,DE50,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.96,Rate
Bremen,DE50,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.63,Rate
Bremen,DE50,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.71,Rate
Bremen,DE50,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.91,Rate
Bremen,DE50,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.63,Rate
Bremen,DE50,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.56,Rate
Bremen,DE50,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",89.89,Rate
Bremen,DE50,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",96.43,Rate
Bremen,DE50,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",92.94,Rate
Bremen,DE50,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",93.37,Rate
Bremen,DE50,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",96.07,Rate
Bremen,DE50,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",92.1,Rate
Bremen,DE50,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",86.93,Rate
Bremen,DE50,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",85.47,Rate
Bremen,DE50,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",81.03,Rate
Bremen,DE50,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",89.58,Rate
Bremen,DE50,Total,Males,2011,Malignant melanoma of skin,8.56,Rate
Bremen,DE50,Total,Males,2012,Malignant melanoma of skin,4.94,Rate
Bremen,DE50,Total,Males,2013,Malignant melanoma of skin,6.07,Rate
Bremen,DE50,Total,Males,2014,Malignant melanoma of skin,8.55,Rate
Bremen,DE50,Total,Males,2015,Malignant melanoma of skin,8.5,Rate
Bremen,DE50,Total,Males,2016,Malignant melanoma of skin,4.1,Rate
Bremen,DE50,Total,Males,2017,Malignant melanoma of skin,5.37,Rate
Bremen,DE50,Total,Males,2018,Malignant melanoma of skin,7.8,Rate
Bremen,DE50,Total,Males,2019,Malignant melanoma of skin,6.26,Rate
Bremen,DE50,Total,Males,2020,Malignant melanoma of skin,3.62,Rate
Bremen,DE50,Total,Males,2012,Malignant neoplasm of breast,1.69,Rate
Bremen,DE50,Total,Males,2014,Malignant neoplasm of breast,0.61,Rate
Bremen,DE50,Total,Males,2015,Malignant neoplasm of breast,0.31,Rate
Bremen,DE50,Total,Males,2017,Malignant neoplasm of breast,0.38,Rate
Bremen,DE50,Total,Males,2018,Malignant neoplasm of breast,0.62,Rate
Bremen,DE50,Total,Males,2020,Malignant neoplasm of breast,1.01,Rate
Bremen,DE50,Total,Males,2011,Diabetes mellitus,21.64,Rate
Bremen,DE50,Total,Males,2012,Diabetes mellitus,20.43,Rate
Bremen,DE50,Total,Males,2013,Diabetes mellitus,17.73,Rate
Bremen,DE50,Total,Males,2014,Diabetes mellitus,9.65,Rate
Bremen,DE50,Total,Males,2015,Diabetes mellitus,13.69,Rate
Bremen,DE50,Total,Males,2016,Diabetes mellitus,10.0,Rate
Bremen,DE50,Total,Males,2017,Diabetes mellitus,10.41,Rate
Bremen,DE50,Total,Males,2018,Diabetes mellitus,10.83,Rate
Bremen,DE50,Total,Males,2019,Diabetes mellitus,29.08,Rate
Bremen,DE50,Total,Males,2020,Diabetes mellitus,42.46,Rate
Bremen,DE50,Total,Males,2011,Mental and behavioural disorders (F00-F99),62.7,Rate
Bremen,DE50,Total,Males,2012,Mental and behavioural disorders (F00-F99),56.15,Rate
Bremen,DE50,Total,Males,2013,Mental and behavioural disorders (F00-F99),69.12,Rate
Bremen,DE50,Total,Males,2014,Mental and behavioural disorders (F00-F99),57.47,Rate
Bremen,DE50,Total,Males,2015,Mental and behavioural disorders (F00-F99),53.71,Rate
Bremen,DE50,Total,Males,2016,Mental and behavioural disorders (F00-F99),56.74,Rate
Bremen,DE50,Total,Males,2017,Mental and behavioural disorders (F00-F99),70.89,Rate
Bremen,DE50,Total,Males,2018,Mental and behavioural disorders (F00-F99),56.97,Rate
Bremen,DE50,Total,Males,2019,Mental and behavioural disorders (F00-F99),71.02,Rate
Bremen,DE50,Total,Males,2020,Mental and behavioural disorders (F00-F99),76.97,Rate
Bremen,DE50,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),10.7,Rate
Bremen,DE50,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),8.06,Rate
Bremen,DE50,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),8.96,Rate
Bremen,DE50,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),4.22,Rate
Bremen,DE50,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),7.67,Rate
Bremen,DE50,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),6.52,Rate
Bremen,DE50,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),4.84,Rate
Bremen,DE50,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.1,Rate
Bremen,DE50,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.68,Rate
Bremen,DE50,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Bremen,DE50,Total,Males,2011,Other ischaemic heart diseases,102.68,Rate
Bremen,DE50,Total,Males,2012,Other ischaemic heart diseases,94.0,Rate
Bremen,DE50,Total,Males,2013,Other ischaemic heart diseases,86.63,Rate
Bremen,DE50,Total,Males,2014,Other ischaemic heart diseases,105.71,Rate
Bremen,DE50,Total,Males,2015,Other ischaemic heart diseases,104.11,Rate
Bremen,DE50,Total,Males,2016,Other ischaemic heart diseases,78.5,Rate
Bremen,DE50,Total,Males,2017,Other ischaemic heart diseases,54.65,Rate
Bremen,DE50,Total,Males,2018,Other ischaemic heart diseases,55.88,Rate
Bremen,DE50,Total,Males,2019,Other ischaemic heart diseases,105.86,Rate
Bremen,DE50,Total,Males,2020,Other ischaemic heart diseases,104.16,Rate
Bremen,DE50,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,51.26,Rate
Bremen,DE50,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,98.31,Rate
Bremen,DE50,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,123.16,Rate
Bremen,DE50,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,90.37,Rate
Bremen,DE50,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,88.91,Rate
Bremen,DE50,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,96.17,Rate
Bremen,DE50,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,88.59,Rate
Bremen,DE50,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,82.66,Rate
Bremen,DE50,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,79.52,Rate
Bremen,DE50,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,78.91,Rate
Bremen,DE50,Total,Males,2011,Cerebrovascular diseases,70.54,Rate
Bremen,DE50,Total,Males,2012,Cerebrovascular diseases,70.06,Rate
Bremen,DE50,Total,Males,2013,Cerebrovascular diseases,67.57,Rate
Bremen,DE50,Total,Males,2014,Cerebrovascular diseases,64.84,Rate
Bremen,DE50,Total,Males,2015,Cerebrovascular diseases,62.62,Rate
Bremen,DE50,Total,Males,2016,Cerebrovascular diseases,56.81,Rate
Bremen,DE50,Total,Males,2017,Cerebrovascular diseases,56.01,Rate
Bremen,DE50,Total,Males,2018,Cerebrovascular diseases,60.66,Rate
Bremen,DE50,Total,Males,2019,Cerebrovascular diseases,59.37,Rate
Bremen,DE50,Total,Males,2020,Cerebrovascular diseases,72.18,Rate
Bremen,DE50,Total,Males,2011,Chronic lower respiratory diseases,59.67,Rate
Bremen,DE50,Total,Males,2012,Chronic lower respiratory diseases,57.28,Rate
Bremen,DE50,Total,Males,2013,Chronic lower respiratory diseases,58.91,Rate
Bremen,DE50,Total,Males,2014,Chronic lower respiratory diseases,48.97,Rate
Bremen,DE50,Total,Males,2015,Chronic lower respiratory diseases,52.79,Rate
Bremen,DE50,Total,Males,2016,Chronic lower respiratory diseases,52.14,Rate
Bremen,DE50,Total,Males,2017,Chronic lower respiratory diseases,47.17,Rate
Bremen,DE50,Total,Males,2018,Chronic lower respiratory diseases,54.33,Rate
Bremen,DE50,Total,Males,2019,Chronic lower respiratory diseases,59.1,Rate
Bremen,DE50,Total,Males,2020,Chronic lower respiratory diseases,49.89,Rate
Bremen,DE50,Total,Males,2011,Asthma and status asthmaticus,0.36,Rate
Bremen,DE50,Total,Males,2012,Asthma and status asthmaticus,2.35,Rate
Bremen,DE50,Total,Males,2013,Asthma and status asthmaticus,1.26,Rate
Bremen,DE50,Total,Males,2014,Asthma and status asthmaticus,0.93,Rate
Bremen,DE50,Total,Males,2015,Asthma and status asthmaticus,0.6,Rate
Bremen,DE50,Total,Males,2017,Asthma and status asthmaticus,0.6,Rate
Bremen,DE50,Total,Males,2018,Asthma and status asthmaticus,0.78,Rate
Bremen,DE50,Total,Males,2019,Asthma and status asthmaticus,1.4,Rate
Bremen,DE50,Total,Males,2020,Asthma and status asthmaticus,0.91,Rate
Bremen,DE50,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5599.86,Rate
Bremen,DE50,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5605.16,Rate
Bremen,DE50,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5923.1,Rate
Bremen,DE50,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5270.77,Rate
Bremen,DE50,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5593.94,Rate
Bremen,DE50,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5291.19,Rate
Bremen,DE50,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5512.0,Rate
Bremen,DE50,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5426.19,Rate
Bremen,DE50,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5311.36,Rate
Bremen,DE50,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5427.8,Rate
Bremen,DE50,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.88,Rate
Bremen,DE50,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.77,Rate
Bremen,DE50,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.36,Rate
Bremen,DE50,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.52,Rate
Bremen,DE50,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",176.29,Rate
Bremen,DE50,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",135.26,Rate
Bremen,DE50,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.79,Rate
Bremen,DE50,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.23,Rate
Bremen,DE50,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.78,Rate
Bremen,DE50,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.97,Rate
Bremen,DE50,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",358.04,Rate
Bremen,DE50,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",367.89,Rate
Bremen,DE50,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",343.24,Rate
Bremen,DE50,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",362.5,Rate
Bremen,DE50,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",365.5,Rate
Bremen,DE50,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",351.03,Rate
Bremen,DE50,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",333.23,Rate
Bremen,DE50,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",325.99,Rate
Bremen,DE50,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",330.81,Rate
Bremen,DE50,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",342.31,Rate
Bremen,DE50,65 years or over,Males,2011,Malignant melanoma of skin,39.25,Rate
Bremen,DE50,65 years or over,Males,2012,Malignant melanoma of skin,16.22,Rate
Bremen,DE50,65 years or over,Males,2013,Malignant melanoma of skin,27.88,Rate
Bremen,DE50,65 years or over,Males,2014,Malignant melanoma of skin,36.05,Rate
Bremen,DE50,65 years or over,Males,2015,Malignant melanoma of skin,33.07,Rate
Bremen,DE50,65 years or over,Males,2016,Malignant melanoma of skin,15.09,Rate
Bremen,DE50,65 years or over,Males,2017,Malignant melanoma of skin,24.88,Rate
Bremen,DE50,65 years or over,Males,2018,Malignant melanoma of skin,35.66,Rate
Bremen,DE50,65 years or over,Males,2019,Malignant melanoma of skin,20.38,Rate
Bremen,DE50,65 years or over,Males,2020,Malignant melanoma of skin,11.39,Rate
Bremen,DE50,65 years or over,Males,2012,Malignant neoplasm of breast,7.04,Rate
Bremen,DE50,65 years or over,Males,2014,Malignant neoplasm of breast,1.48,Rate
Bremen,DE50,65 years or over,Males,2015,Malignant neoplasm of breast,1.58,Rate
Bremen,DE50,65 years or over,Males,2017,Malignant neoplasm of breast,1.95,Rate
Bremen,DE50,65 years or over,Males,2018,Malignant neoplasm of breast,3.18,Rate
Bremen,DE50,65 years or over,Males,2020,Malignant neoplasm of breast,5.2,Rate
Bremen,DE50,65 years or over,Males,2011,Diabetes mellitus,83.46,Rate
Bremen,DE50,65 years or over,Males,2012,Diabetes mellitus,89.94,Rate
Bremen,DE50,65 years or over,Males,2013,Diabetes mellitus,73.25,Rate
Bremen,DE50,65 years or over,Males,2014,Diabetes mellitus,41.87,Rate
Bremen,DE50,65 years or over,Males,2015,Diabetes mellitus,59.79,Rate
Bremen,DE50,65 years or over,Males,2016,Diabetes mellitus,43.64,Rate
Bremen,DE50,65 years or over,Males,2017,Diabetes mellitus,40.34,Rate
Bremen,DE50,65 years or over,Males,2018,Diabetes mellitus,47.75,Rate
Bremen,DE50,65 years or over,Males,2019,Diabetes mellitus,134.62,Rate
Bremen,DE50,65 years or over,Males,2020,Diabetes mellitus,184.34,Rate
Bremen,DE50,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),186.9,Rate
Bremen,DE50,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),166.03,Rate
Bremen,DE50,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),202.67,Rate
Bremen,DE50,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),157.15,Rate
Bremen,DE50,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),164.38,Rate
Bremen,DE50,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),189.97,Rate
Bremen,DE50,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),216.99,Rate
Bremen,DE50,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),158.74,Rate
Bremen,DE50,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),280.65,Rate
Bremen,DE50,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),333.88,Rate
Bremen,DE50,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),35.82,Rate
Bremen,DE50,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),20.82,Rate
Bremen,DE50,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),30.73,Rate
Bremen,DE50,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),14.15,Rate
Bremen,DE50,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),22.2,Rate
Bremen,DE50,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),25.74,Rate
Bremen,DE50,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),23.19,Rate
Bremen,DE50,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),10.28,Rate
Bremen,DE50,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),18.47,Rate
Bremen,DE50,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bremen,DE50,65 years or over,Males,2011,Other ischaemic heart diseases,473.56,Rate
Bremen,DE50,65 years or over,Males,2012,Other ischaemic heart diseases,429.49,Rate
Bremen,DE50,65 years or over,Males,2013,Other ischaemic heart diseases,398.62,Rate
Bremen,DE50,65 years or over,Males,2014,Other ischaemic heart diseases,499.54,Rate
Bremen,DE50,65 years or over,Males,2015,Other ischaemic heart diseases,467.69,Rate
Bremen,DE50,65 years or over,Males,2016,Other ischaemic heart diseases,362.91,Rate
Bremen,DE50,65 years or over,Males,2017,Other ischaemic heart diseases,255.07,Rate
Bremen,DE50,65 years or over,Males,2018,Other ischaemic heart diseases,254.63,Rate
Bremen,DE50,65 years or over,Males,2019,Other ischaemic heart diseases,498.89,Rate
Bremen,DE50,65 years or over,Males,2020,Other ischaemic heart diseases,481.44,Rate
Bremen,DE50,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,176.96,Rate
Bremen,DE50,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,404.57,Rate
Bremen,DE50,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,476.89,Rate
Bremen,DE50,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,333.82,Rate
Bremen,DE50,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,342.38,Rate
Bremen,DE50,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,360.24,Rate
Bremen,DE50,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,354.05,Rate
Bremen,DE50,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,324.55,Rate
Bremen,DE50,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,314.04,Rate
Bremen,DE50,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,295.2,Rate
Bremen,DE50,65 years or over,Males,2011,Cerebrovascular diseases,327.84,Rate
Bremen,DE50,65 years or over,Males,2012,Cerebrovascular diseases,325.12,Rate
Bremen,DE50,65 years or over,Males,2013,Cerebrovascular diseases,290.0,Rate
Bremen,DE50,65 years or over,Males,2014,Cerebrovascular diseases,289.45,Rate
Bremen,DE50,65 years or over,Males,2015,Cerebrovascular diseases,286.67,Rate
Bremen,DE50,65 years or over,Males,2016,Cerebrovascular diseases,254.63,Rate
Bremen,DE50,65 years or over,Males,2017,Cerebrovascular diseases,246.24,Rate
Bremen,DE50,65 years or over,Males,2018,Cerebrovascular diseases,273.44,Rate
Bremen,DE50,65 years or over,Males,2019,Cerebrovascular diseases,271.11,Rate
Bremen,DE50,65 years or over,Males,2020,Cerebrovascular diseases,334.59,Rate
Bremen,DE50,65 years or over,Males,2011,Chronic lower respiratory diseases,259.29,Rate
Bremen,DE50,65 years or over,Males,2012,Chronic lower respiratory diseases,260.63,Rate
Bremen,DE50,65 years or over,Males,2013,Chronic lower respiratory diseases,259.22,Rate
Bremen,DE50,65 years or over,Males,2014,Chronic lower respiratory diseases,220.23,Rate
Bremen,DE50,65 years or over,Males,2015,Chronic lower respiratory diseases,214.8,Rate
Bremen,DE50,65 years or over,Males,2016,Chronic lower respiratory diseases,228.92,Rate
Bremen,DE50,65 years or over,Males,2017,Chronic lower respiratory diseases,206.64,Rate
Bremen,DE50,65 years or over,Males,2018,Chronic lower respiratory diseases,221.34,Rate
Bremen,DE50,65 years or over,Males,2019,Chronic lower respiratory diseases,253.67,Rate
Bremen,DE50,65 years or over,Males,2020,Chronic lower respiratory diseases,214.65,Rate
Bremen,DE50,65 years or over,Males,2011,Asthma and status asthmaticus,1.86,Rate
Bremen,DE50,65 years or over,Males,2012,Asthma and status asthmaticus,8.91,Rate
Bremen,DE50,65 years or over,Males,2013,Asthma and status asthmaticus,1.57,Rate
Bremen,DE50,65 years or over,Males,2014,Asthma and status asthmaticus,3.2,Rate
Bremen,DE50,65 years or over,Males,2015,Asthma and status asthmaticus,1.69,Rate
Bremen,DE50,65 years or over,Males,2017,Asthma and status asthmaticus,1.64,Rate
Bremen,DE50,65 years or over,Males,2018,Asthma and status asthmaticus,2.7,Rate
Bremen,DE50,65 years or over,Males,2019,Asthma and status asthmaticus,4.32,Rate
Bremen,DE50,65 years or over,Males,2020,Asthma and status asthmaticus,3.28,Rate
Bremen,DE50,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,301.61,Rate
Bremen,DE50,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,323.11,Rate
Bremen,DE50,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,337.32,Rate
Bremen,DE50,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,317.55,Rate
Bremen,DE50,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,319.34,Rate
Bremen,DE50,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,306.01,Rate
Bremen,DE50,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,296.83,Rate
Bremen,DE50,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,310.29,Rate
Bremen,DE50,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,285.22,Rate
Bremen,DE50,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,322.33,Rate
Bremen,DE50,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.86,Rate
Bremen,DE50,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.63,Rate
Bremen,DE50,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.06,Rate
Bremen,DE50,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.97,Rate
Bremen,DE50,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.17,Rate
Bremen,DE50,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.52,Rate
Bremen,DE50,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.14,Rate
Bremen,DE50,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.3,Rate
Bremen,DE50,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.67,Rate
Bremen,DE50,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.12,Rate
Bremen,DE50,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",24.93,Rate
Bremen,DE50,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",30.67,Rate
Bremen,DE50,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",32.31,Rate
Bremen,DE50,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",28.18,Rate
Bremen,DE50,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",30.8,Rate
Bremen,DE50,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",29.37,Rate
Bremen,DE50,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",27.27,Rate
Bremen,DE50,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",27.21,Rate
Bremen,DE50,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",20.52,Rate
Bremen,DE50,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",28.36,Rate
Bremen,DE50,Less than 65 years,Males,2011,Malignant melanoma of skin,1.13,Rate
Bremen,DE50,Less than 65 years,Males,2012,Malignant melanoma of skin,2.21,Rate
Bremen,DE50,Less than 65 years,Males,2013,Malignant melanoma of skin,0.79,Rate
Bremen,DE50,Less than 65 years,Males,2014,Malignant melanoma of skin,1.89,Rate
Bremen,DE50,Less than 65 years,Males,2015,Malignant melanoma of skin,2.55,Rate
Bremen,DE50,Less than 65 years,Males,2016,Malignant melanoma of skin,1.44,Rate
Bremen,DE50,Less than 65 years,Males,2017,Malignant melanoma of skin,0.64,Rate
Bremen,DE50,Less than 65 years,Males,2018,Malignant melanoma of skin,1.05,Rate
Bremen,DE50,Less than 65 years,Males,2019,Malignant melanoma of skin,2.84,Rate
Bremen,DE50,Less than 65 years,Males,2020,Malignant melanoma of skin,1.74,Rate
Bremen,DE50,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.4,Rate
Bremen,DE50,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.4,Rate
Bremen,DE50,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Bremen,DE50,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Bremen,DE50,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Bremen,DE50,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Bremen,DE50,Less than 65 years,Males,2011,Diabetes mellitus,6.66,Rate
Bremen,DE50,Less than 65 years,Males,2012,Diabetes mellitus,3.59,Rate
Bremen,DE50,Less than 65 years,Males,2013,Diabetes mellitus,4.28,Rate
Bremen,DE50,Less than 65 years,Males,2014,Diabetes mellitus,1.84,Rate
Bremen,DE50,Less than 65 years,Males,2015,Diabetes mellitus,2.53,Rate
Bremen,DE50,Less than 65 years,Males,2016,Diabetes mellitus,1.85,Rate
Bremen,DE50,Less than 65 years,Males,2017,Diabetes mellitus,3.16,Rate
Bremen,DE50,Less than 65 years,Males,2018,Diabetes mellitus,1.89,Rate
Bremen,DE50,Less than 65 years,Males,2019,Diabetes mellitus,3.51,Rate
Bremen,DE50,Less than 65 years,Males,2020,Diabetes mellitus,8.09,Rate
Bremen,DE50,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),32.62,Rate
Bremen,DE50,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),29.54,Rate
Bremen,DE50,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),36.77,Rate
Bremen,DE50,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),33.32,Rate
Bremen,DE50,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),26.9,Rate
Bremen,DE50,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),24.46,Rate
Bremen,DE50,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),35.5,Rate
Bremen,DE50,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),32.32,Rate
Bremen,DE50,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),20.24,Rate
Bremen,DE50,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),14.74,Rate
Bremen,DE50,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),4.62,Rate
Bremen,DE50,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),4.97,Rate
Bremen,DE50,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.69,Rate
Bremen,DE50,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.82,Rate
Bremen,DE50,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.16,Rate
Bremen,DE50,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.86,Rate
Bremen,DE50,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Bremen,DE50,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Bremen,DE50,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Bremen,DE50,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Bremen,DE50,Less than 65 years,Males,2011,Other ischaemic heart diseases,12.84,Rate
Bremen,DE50,Less than 65 years,Males,2012,Other ischaemic heart diseases,12.73,Rate
Bremen,DE50,Less than 65 years,Males,2013,Other ischaemic heart diseases,11.06,Rate
Bremen,DE50,Less than 65 years,Males,2014,Other ischaemic heart diseases,10.31,Rate
Bremen,DE50,Less than 65 years,Males,2015,Other ischaemic heart diseases,16.04,Rate
Bremen,DE50,Less than 65 years,Males,2016,Other ischaemic heart diseases,9.61,Rate
Bremen,DE50,Less than 65 years,Males,2017,Other ischaemic heart diseases,6.11,Rate
Bremen,DE50,Less than 65 years,Males,2018,Other ischaemic heart diseases,7.73,Rate
Bremen,DE50,Less than 65 years,Males,2019,Other ischaemic heart diseases,10.65,Rate
Bremen,DE50,Less than 65 years,Males,2020,Other ischaemic heart diseases,12.77,Rate
Bremen,DE50,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,20.82,Rate
Bremen,DE50,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,24.13,Rate
Bremen,DE50,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,37.47,Rate
Bremen,DE50,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,31.4,Rate
Bremen,DE50,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,27.52,Rate
Bremen,DE50,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,32.2,Rate
Bremen,DE50,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,24.28,Rate
Bremen,DE50,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,24.07,Rate
Bremen,DE50,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,22.71,Rate
Bremen,DE50,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,26.51,Rate
Bremen,DE50,Less than 65 years,Males,2011,Cerebrovascular diseases,8.21,Rate
Bremen,DE50,Less than 65 years,Males,2012,Cerebrovascular diseases,8.28,Rate
Bremen,DE50,Less than 65 years,Males,2013,Cerebrovascular diseases,13.69,Rate
Bremen,DE50,Less than 65 years,Males,2014,Cerebrovascular diseases,10.43,Rate
Bremen,DE50,Less than 65 years,Males,2015,Cerebrovascular diseases,8.35,Rate
Bremen,DE50,Less than 65 years,Males,2016,Cerebrovascular diseases,8.89,Rate
Bremen,DE50,Less than 65 years,Males,2017,Cerebrovascular diseases,9.93,Rate
Bremen,DE50,Less than 65 years,Males,2018,Cerebrovascular diseases,9.12,Rate
Bremen,DE50,Less than 65 years,Males,2019,Cerebrovascular diseases,8.08,Rate
Bremen,DE50,Less than 65 years,Males,2020,Cerebrovascular diseases,8.61,Rate
Bremen,DE50,Less than 65 years,Males,2011,Chronic lower respiratory diseases,11.32,Rate
Bremen,DE50,Less than 65 years,Males,2012,Chronic lower respiratory diseases,8.02,Rate
Bremen,DE50,Less than 65 years,Males,2013,Chronic lower respiratory diseases,10.39,Rate
Bremen,DE50,Less than 65 years,Males,2014,Chronic lower respiratory diseases,7.48,Rate
Bremen,DE50,Less than 65 years,Males,2015,Chronic lower respiratory diseases,13.54,Rate
Bremen,DE50,Less than 65 years,Males,2016,Chronic lower respiratory diseases,9.31,Rate
Bremen,DE50,Less than 65 years,Males,2017,Chronic lower respiratory diseases,8.55,Rate
Bremen,DE50,Less than 65 years,Males,2018,Chronic lower respiratory diseases,13.87,Rate
Bremen,DE50,Less than 65 years,Males,2019,Chronic lower respiratory diseases,11.97,Rate
Bremen,DE50,Less than 65 years,Males,2020,Chronic lower respiratory diseases,9.97,Rate
Bremen,DE50,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Bremen,DE50,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.76,Rate
Bremen,DE50,Less than 65 years,Males,2013,Asthma and status asthmaticus,1.19,Rate
Bremen,DE50,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.38,Rate
Bremen,DE50,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.33,Rate
Bremen,DE50,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.35,Rate
Bremen,DE50,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.32,Rate
Bremen,DE50,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.69,Rate
Bremen,DE50,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.33,Rate
Bremen,DE50,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1074.9,Rate
Bremen,DE50,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1071.91,Rate
Bremen,DE50,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1117.9,Rate
Bremen,DE50,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1037.47,Rate
Bremen,DE50,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1072.58,Rate
Bremen,DE50,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1044.67,Rate
Bremen,DE50,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1051.09,Rate
Bremen,DE50,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1065.26,Rate
Bremen,DE50,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1007.78,Rate
Bremen,DE50,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1064.54,Rate
Bremen,DE50,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.98,Rate
Bremen,DE50,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.53,Rate
Bremen,DE50,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.07,Rate
Bremen,DE50,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.99,Rate
Bremen,DE50,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.06,Rate
Bremen,DE50,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.35,Rate
Bremen,DE50,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.25,Rate
Bremen,DE50,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.78,Rate
Bremen,DE50,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.32,Rate
Bremen,DE50,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.34,Rate
Bremen,DE50,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",62.09,Rate
Bremen,DE50,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",61.61,Rate
Bremen,DE50,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",66.85,Rate
Bremen,DE50,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",64.94,Rate
Bremen,DE50,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",66.13,Rate
Bremen,DE50,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",67.2,Rate
Bremen,DE50,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",61.38,Rate
Bremen,DE50,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",65.4,Rate
Bremen,DE50,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",60.13,Rate
Bremen,DE50,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",65.06,Rate
Bremen,DE50,Total,Total,2011,Malignant melanoma of skin,4.55,Rate
Bremen,DE50,Total,Total,2012,Malignant melanoma of skin,4.26,Rate
Bremen,DE50,Total,Total,2013,Malignant melanoma of skin,4.57,Rate
Bremen,DE50,Total,Total,2014,Malignant melanoma of skin,6.23,Rate
Bremen,DE50,Total,Total,2015,Malignant melanoma of skin,5.88,Rate
Bremen,DE50,Total,Total,2016,Malignant melanoma of skin,4.34,Rate
Bremen,DE50,Total,Total,2017,Malignant melanoma of skin,5.98,Rate
Bremen,DE50,Total,Total,2018,Malignant melanoma of skin,7.31,Rate
Bremen,DE50,Total,Total,2019,Malignant melanoma of skin,4.07,Rate
Bremen,DE50,Total,Total,2020,Malignant melanoma of skin,2.69,Rate
Bremen,DE50,Total,Total,2011,Malignant neoplasm of breast,26.46,Rate
Bremen,DE50,Total,Total,2012,Malignant neoplasm of breast,24.11,Rate
Bremen,DE50,Total,Total,2013,Malignant neoplasm of breast,24.96,Rate
Bremen,DE50,Total,Total,2014,Malignant neoplasm of breast,24.79,Rate
Bremen,DE50,Total,Total,2015,Malignant neoplasm of breast,21.25,Rate
Bremen,DE50,Total,Total,2016,Malignant neoplasm of breast,23.1,Rate
Bremen,DE50,Total,Total,2017,Malignant neoplasm of breast,21.74,Rate
Bremen,DE50,Total,Total,2018,Malignant neoplasm of breast,22.14,Rate
Bremen,DE50,Total,Total,2019,Malignant neoplasm of breast,20.68,Rate
Bremen,DE50,Total,Total,2020,Malignant neoplasm of breast,20.44,Rate
Bremen,DE50,Total,Total,2011,Diabetes mellitus,19.82,Rate
Bremen,DE50,Total,Total,2012,Diabetes mellitus,19.82,Rate
Bremen,DE50,Total,Total,2013,Diabetes mellitus,17.94,Rate
Bremen,DE50,Total,Total,2014,Diabetes mellitus,11.05,Rate
Bremen,DE50,Total,Total,2015,Diabetes mellitus,15.43,Rate
Bremen,DE50,Total,Total,2016,Diabetes mellitus,7.83,Rate
Bremen,DE50,Total,Total,2017,Diabetes mellitus,10.24,Rate
Bremen,DE50,Total,Total,2018,Diabetes mellitus,9.28,Rate
Bremen,DE50,Total,Total,2019,Diabetes mellitus,24.15,Rate
Bremen,DE50,Total,Total,2020,Diabetes mellitus,34.12,Rate
Bremen,DE50,Total,Total,2011,Mental and behavioural disorders (F00-F99),46.45,Rate
Bremen,DE50,Total,Total,2012,Mental and behavioural disorders (F00-F99),41.51,Rate
Bremen,DE50,Total,Total,2013,Mental and behavioural disorders (F00-F99),54.41,Rate
Bremen,DE50,Total,Total,2014,Mental and behavioural disorders (F00-F99),45.88,Rate
Bremen,DE50,Total,Total,2015,Mental and behavioural disorders (F00-F99),47.28,Rate
Bremen,DE50,Total,Total,2016,Mental and behavioural disorders (F00-F99),52.53,Rate
Bremen,DE50,Total,Total,2017,Mental and behavioural disorders (F00-F99),55.33,Rate
Bremen,DE50,Total,Total,2018,Mental and behavioural disorders (F00-F99),44.45,Rate
Bremen,DE50,Total,Total,2019,Mental and behavioural disorders (F00-F99),67.54,Rate
Bremen,DE50,Total,Total,2020,Mental and behavioural disorders (F00-F99),67.34,Rate
Bremen,DE50,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),7.3,Rate
Bremen,DE50,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),4.97,Rate
Bremen,DE50,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),6.45,Rate
Bremen,DE50,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Bremen,DE50,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),4.6,Rate
Bremen,DE50,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Bremen,DE50,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.83,Rate
Bremen,DE50,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.37,Rate
Bremen,DE50,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.72,Rate
Bremen,DE50,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.25,Rate
Bremen,DE50,Total,Total,2011,Other ischaemic heart diseases,71.89,Rate
Bremen,DE50,Total,Total,2012,Other ischaemic heart diseases,63.62,Rate
Bremen,DE50,Total,Total,2013,Other ischaemic heart diseases,59.11,Rate
Bremen,DE50,Total,Total,2014,Other ischaemic heart diseases,63.74,Rate
Bremen,DE50,Total,Total,2015,Other ischaemic heart diseases,71.89,Rate
Bremen,DE50,Total,Total,2016,Other ischaemic heart diseases,58.12,Rate
Bremen,DE50,Total,Total,2017,Other ischaemic heart diseases,36.26,Rate
Bremen,DE50,Total,Total,2018,Other ischaemic heart diseases,38.69,Rate
Bremen,DE50,Total,Total,2019,Other ischaemic heart diseases,68.05,Rate
Bremen,DE50,Total,Total,2020,Other ischaemic heart diseases,71.28,Rate
Bremen,DE50,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,35.1,Rate
Bremen,DE50,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,66.75,Rate
Bremen,DE50,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,87.85,Rate
Bremen,DE50,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,67.34,Rate
Bremen,DE50,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,62.6,Rate
Bremen,DE50,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,64.64,Rate
Bremen,DE50,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,59.85,Rate
Bremen,DE50,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,55.55,Rate
Bremen,DE50,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,52.36,Rate
Bremen,DE50,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,52.98,Rate
Bremen,DE50,Total,Total,2011,Cerebrovascular diseases,66.07,Rate
Bremen,DE50,Total,Total,2012,Cerebrovascular diseases,63.09,Rate
Bremen,DE50,Total,Total,2013,Cerebrovascular diseases,57.95,Rate
Bremen,DE50,Total,Total,2014,Cerebrovascular diseases,59.17,Rate
Bremen,DE50,Total,Total,2015,Cerebrovascular diseases,60.19,Rate
Bremen,DE50,Total,Total,2016,Cerebrovascular diseases,53.05,Rate
Bremen,DE50,Total,Total,2017,Cerebrovascular diseases,51.81,Rate
Bremen,DE50,Total,Total,2018,Cerebrovascular diseases,55.07,Rate
Bremen,DE50,Total,Total,2019,Cerebrovascular diseases,54.27,Rate
Bremen,DE50,Total,Total,2020,Cerebrovascular diseases,63.37,Rate
Bremen,DE50,Total,Total,2011,Chronic lower respiratory diseases,41.48,Rate
Bremen,DE50,Total,Total,2012,Chronic lower respiratory diseases,37.73,Rate
Bremen,DE50,Total,Total,2013,Chronic lower respiratory diseases,38.54,Rate
Bremen,DE50,Total,Total,2014,Chronic lower respiratory diseases,35.19,Rate
Bremen,DE50,Total,Total,2015,Chronic lower respiratory diseases,43.2,Rate
Bremen,DE50,Total,Total,2016,Chronic lower respiratory diseases,44.21,Rate
Bremen,DE50,Total,Total,2017,Chronic lower respiratory diseases,40.17,Rate
Bremen,DE50,Total,Total,2018,Chronic lower respiratory diseases,47.08,Rate
Bremen,DE50,Total,Total,2019,Chronic lower respiratory diseases,46.35,Rate
Bremen,DE50,Total,Total,2020,Chronic lower respiratory diseases,44.05,Rate
Bremen,DE50,Total,Total,2011,Asthma and status asthmaticus,0.41,Rate
Bremen,DE50,Total,Total,2012,Asthma and status asthmaticus,1.43,Rate
Bremen,DE50,Total,Total,2013,Asthma and status asthmaticus,1.75,Rate
Bremen,DE50,Total,Total,2014,Asthma and status asthmaticus,0.99,Rate
Bremen,DE50,Total,Total,2015,Asthma and status asthmaticus,1.42,Rate
Bremen,DE50,Total,Total,2016,Asthma and status asthmaticus,0.57,Rate
Bremen,DE50,Total,Total,2017,Asthma and status asthmaticus,0.82,Rate
Bremen,DE50,Total,Total,2018,Asthma and status asthmaticus,1.23,Rate
Bremen,DE50,Total,Total,2019,Asthma and status asthmaticus,1.07,Rate
Bremen,DE50,Total,Total,2020,Asthma and status asthmaticus,1.08,Rate
Bremen,DE50,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4531.85,Rate
Bremen,DE50,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4468.17,Rate
Bremen,DE50,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4697.53,Rate
Bremen,DE50,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4309.38,Rate
Bremen,DE50,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4492.68,Rate
Bremen,DE50,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4380.16,Rate
Bremen,DE50,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4476.71,Rate
Bremen,DE50,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4456.31,Rate
Bremen,DE50,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4270.14,Rate
Bremen,DE50,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4457.82,Rate
Bremen,DE50,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.71,Rate
Bremen,DE50,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.42,Rate
Bremen,DE50,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.16,Rate
Bremen,DE50,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.9,Rate
Bremen,DE50,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.22,Rate
Bremen,DE50,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.45,Rate
Bremen,DE50,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.71,Rate
Bremen,DE50,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.45,Rate
Bremen,DE50,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.65,Rate
Bremen,DE50,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.96,Rate
Bremen,DE50,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",235.25,Rate
Bremen,DE50,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",214.82,Rate
Bremen,DE50,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",229.5,Rate
Bremen,DE50,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",234.69,Rate
Bremen,DE50,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",243.39,Rate
Bremen,DE50,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",247.17,Rate
Bremen,DE50,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",224.89,Rate
Bremen,DE50,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",249.15,Rate
Bremen,DE50,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",232.4,Rate
Bremen,DE50,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",241.8,Rate
Bremen,DE50,65 years or over,Total,2011,Malignant melanoma of skin,20.21,Rate
Bremen,DE50,65 years or over,Total,2012,Malignant melanoma of skin,15.79,Rate
Bremen,DE50,65 years or over,Total,2013,Malignant melanoma of skin,20.42,Rate
Bremen,DE50,65 years or over,Total,2014,Malignant melanoma of skin,25.23,Rate
Bremen,DE50,65 years or over,Total,2015,Malignant melanoma of skin,24.14,Rate
Bremen,DE50,65 years or over,Total,2016,Malignant melanoma of skin,15.63,Rate
Bremen,DE50,65 years or over,Total,2017,Malignant melanoma of skin,24.21,Rate
Bremen,DE50,65 years or over,Total,2018,Malignant melanoma of skin,31.9,Rate
Bremen,DE50,65 years or over,Total,2019,Malignant melanoma of skin,12.91,Rate
Bremen,DE50,65 years or over,Total,2020,Malignant melanoma of skin,10.28,Rate
Bremen,DE50,65 years or over,Total,2011,Malignant neoplasm of breast,91.56,Rate
Bremen,DE50,65 years or over,Total,2012,Malignant neoplasm of breast,84.31,Rate
Bremen,DE50,65 years or over,Total,2013,Malignant neoplasm of breast,95.11,Rate
Bremen,DE50,65 years or over,Total,2014,Malignant neoplasm of breast,95.62,Rate
Bremen,DE50,65 years or over,Total,2015,Malignant neoplasm of breast,75.86,Rate
Bremen,DE50,65 years or over,Total,2016,Malignant neoplasm of breast,94.41,Rate
Bremen,DE50,65 years or over,Total,2017,Malignant neoplasm of breast,83.31,Rate
Bremen,DE50,65 years or over,Total,2018,Malignant neoplasm of breast,78.57,Rate
Bremen,DE50,65 years or over,Total,2019,Malignant neoplasm of breast,81.49,Rate
Bremen,DE50,65 years or over,Total,2020,Malignant neoplasm of breast,82.29,Rate
Bremen,DE50,65 years or over,Total,2011,Diabetes mellitus,82.5,Rate
Bremen,DE50,65 years or over,Total,2012,Diabetes mellitus,88.87,Rate
Bremen,DE50,65 years or over,Total,2013,Diabetes mellitus,78.1,Rate
Bremen,DE50,65 years or over,Total,2014,Diabetes mellitus,52.1,Rate
Bremen,DE50,65 years or over,Total,2015,Diabetes mellitus,69.96,Rate
Bremen,DE50,65 years or over,Total,2016,Diabetes mellitus,36.35,Rate
Bremen,DE50,65 years or over,Total,2017,Diabetes mellitus,43.8,Rate
Bremen,DE50,65 years or over,Total,2018,Diabetes mellitus,42.73,Rate
Bremen,DE50,65 years or over,Total,2019,Diabetes mellitus,113.17,Rate
Bremen,DE50,65 years or over,Total,2020,Diabetes mellitus,149.68,Rate
Bremen,DE50,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),153.68,Rate
Bremen,DE50,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),136.17,Rate
Bremen,DE50,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),178.45,Rate
Bremen,DE50,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),154.27,Rate
Bremen,DE50,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),171.48,Rate
Bremen,DE50,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),204.05,Rate
Bremen,DE50,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),195.46,Rate
Bremen,DE50,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),141.33,Rate
Bremen,DE50,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),291.13,Rate
Bremen,DE50,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),305.02,Rate
Bremen,DE50,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),24.24,Rate
Bremen,DE50,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),12.52,Rate
Bremen,DE50,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),21.58,Rate
Bremen,DE50,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),10.56,Rate
Bremen,DE50,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),13.7,Rate
Bremen,DE50,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),15.4,Rate
Bremen,DE50,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),18.15,Rate
Bremen,DE50,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),12.98,Rate
Bremen,DE50,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),14.77,Rate
Bremen,DE50,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),6.51,Rate
Bremen,DE50,65 years or over,Total,2011,Other ischaemic heart diseases,337.32,Rate
Bremen,DE50,65 years or over,Total,2012,Other ischaemic heart diseases,291.06,Rate
Bremen,DE50,65 years or over,Total,2013,Other ischaemic heart diseases,278.6,Rate
Bremen,DE50,65 years or over,Total,2014,Other ischaemic heart diseases,300.74,Rate
Bremen,DE50,65 years or over,Total,2015,Other ischaemic heart diseases,328.61,Rate
Bremen,DE50,65 years or over,Total,2016,Other ischaemic heart diseases,268.06,Rate
Bremen,DE50,65 years or over,Total,2017,Other ischaemic heart diseases,172.21,Rate
Bremen,DE50,65 years or over,Total,2018,Other ischaemic heart diseases,177.05,Rate
Bremen,DE50,65 years or over,Total,2019,Other ischaemic heart diseases,325.26,Rate
Bremen,DE50,65 years or over,Total,2020,Other ischaemic heart diseases,333.94,Rate
Bremen,DE50,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,131.31,Rate
Bremen,DE50,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,280.24,Rate
Bremen,DE50,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,350.28,Rate
Bremen,DE50,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,259.66,Rate
Bremen,DE50,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,253.66,Rate
Bremen,DE50,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,252.38,Rate
Bremen,DE50,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,242.55,Rate
Bremen,DE50,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,223.46,Rate
Bremen,DE50,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,213.63,Rate
Bremen,DE50,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,204.71,Rate
Bremen,DE50,65 years or over,Total,2011,Cerebrovascular diseases,308.87,Rate
Bremen,DE50,65 years or over,Total,2012,Cerebrovascular diseases,293.14,Rate
Bremen,DE50,65 years or over,Total,2013,Cerebrovascular diseases,254.7,Rate
Bremen,DE50,65 years or over,Total,2014,Cerebrovascular diseases,272.29,Rate
Bremen,DE50,65 years or over,Total,2015,Cerebrovascular diseases,275.11,Rate
Bremen,DE50,65 years or over,Total,2016,Cerebrovascular diseases,245.48,Rate
Bremen,DE50,65 years or over,Total,2017,Cerebrovascular diseases,238.84,Rate
Bremen,DE50,65 years or over,Total,2018,Cerebrovascular diseases,248.87,Rate
Bremen,DE50,65 years or over,Total,2019,Cerebrovascular diseases,248.16,Rate
Bremen,DE50,65 years or over,Total,2020,Cerebrovascular diseases,298.25,Rate
Bremen,DE50,65 years or over,Total,2011,Chronic lower respiratory diseases,175.59,Rate
Bremen,DE50,65 years or over,Total,2012,Chronic lower respiratory diseases,166.22,Rate
Bremen,DE50,65 years or over,Total,2013,Chronic lower respiratory diseases,168.32,Rate
Bremen,DE50,65 years or over,Total,2014,Chronic lower respiratory diseases,153.16,Rate
Bremen,DE50,65 years or over,Total,2015,Chronic lower respiratory diseases,179.76,Rate
Bremen,DE50,65 years or over,Total,2016,Chronic lower respiratory diseases,187.02,Rate
Bremen,DE50,65 years or over,Total,2017,Chronic lower respiratory diseases,170.85,Rate
Bremen,DE50,65 years or over,Total,2018,Chronic lower respiratory diseases,193.49,Rate
Bremen,DE50,65 years or over,Total,2019,Chronic lower respiratory diseases,196.06,Rate
Bremen,DE50,65 years or over,Total,2020,Chronic lower respiratory diseases,187.64,Rate
Bremen,DE50,65 years or over,Total,2011,Asthma and status asthmaticus,1.31,Rate
Bremen,DE50,65 years or over,Total,2012,Asthma and status asthmaticus,5.04,Rate
Bremen,DE50,65 years or over,Total,2013,Asthma and status asthmaticus,3.51,Rate
Bremen,DE50,65 years or over,Total,2014,Asthma and status asthmaticus,3.6,Rate
Bremen,DE50,65 years or over,Total,2015,Asthma and status asthmaticus,6.56,Rate
Bremen,DE50,65 years or over,Total,2016,Asthma and status asthmaticus,2.2,Rate
Bremen,DE50,65 years or over,Total,2017,Asthma and status asthmaticus,3.52,Rate
Bremen,DE50,65 years or over,Total,2018,Asthma and status asthmaticus,4.04,Rate
Bremen,DE50,65 years or over,Total,2019,Asthma and status asthmaticus,3.38,Rate
Bremen,DE50,65 years or over,Total,2020,Asthma and status asthmaticus,4.02,Rate
Bremen,DE50,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,237.51,Rate
Bremen,DE50,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,249.22,Rate
Bremen,DE50,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,250.79,Rate
Bremen,DE50,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,244.9,Rate
Bremen,DE50,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,244.1,Rate
Bremen,DE50,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,236.69,Rate
Bremen,DE50,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,221.28,Rate
Bremen,DE50,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,243.83,Rate
Bremen,DE50,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,217.51,Rate
Bremen,DE50,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,242.56,Rate
Bremen,DE50,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.0,Rate
Bremen,DE50,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.45,Rate
Bremen,DE50,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.95,Rate
Bremen,DE50,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.6,Rate
Bremen,DE50,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.7,Rate
Bremen,DE50,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.19,Rate
Bremen,DE50,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.82,Rate
Bremen,DE50,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.39,Rate
Bremen,DE50,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.58,Rate
Bremen,DE50,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.99,Rate
Bremen,DE50,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",20.15,Rate
Bremen,DE50,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",24.5,Rate
Bremen,DE50,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",27.45,Rate
Bremen,DE50,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",23.82,Rate
Bremen,DE50,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",23.19,Rate
Bremen,DE50,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",23.6,Rate
Bremen,DE50,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",21.78,Rate
Bremen,DE50,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",20.9,Rate
Bremen,DE50,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",18.41,Rate
Bremen,DE50,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",22.24,Rate
Bremen,DE50,Less than 65 years,Total,2011,Malignant melanoma of skin,0.75,Rate
Bremen,DE50,Less than 65 years,Total,2012,Malignant melanoma of skin,1.47,Rate
Bremen,DE50,Less than 65 years,Total,2013,Malignant melanoma of skin,0.73,Rate
Bremen,DE50,Less than 65 years,Total,2014,Malignant melanoma of skin,1.63,Rate
Bremen,DE50,Less than 65 years,Total,2015,Malignant melanoma of skin,1.46,Rate
Bremen,DE50,Less than 65 years,Total,2016,Malignant melanoma of skin,1.6,Rate
Bremen,DE50,Less than 65 years,Total,2017,Malignant melanoma of skin,1.56,Rate
Bremen,DE50,Less than 65 years,Total,2018,Malignant melanoma of skin,1.35,Rate
Bremen,DE50,Less than 65 years,Total,2019,Malignant melanoma of skin,1.93,Rate
Bremen,DE50,Less than 65 years,Total,2020,Malignant melanoma of skin,0.86,Rate
Bremen,DE50,Less than 65 years,Total,2011,Malignant neoplasm of breast,10.69,Rate
Bremen,DE50,Less than 65 years,Total,2012,Malignant neoplasm of breast,9.53,Rate
Bremen,DE50,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.97,Rate
Bremen,DE50,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.63,Rate
Bremen,DE50,Less than 65 years,Total,2015,Malignant neoplasm of breast,8.02,Rate
Bremen,DE50,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.83,Rate
Bremen,DE50,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.83,Rate
Bremen,DE50,Less than 65 years,Total,2018,Malignant neoplasm of breast,8.47,Rate
Bremen,DE50,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.95,Rate
Bremen,DE50,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.46,Rate
Bremen,DE50,Less than 65 years,Total,2011,Diabetes mellitus,4.64,Rate
Bremen,DE50,Less than 65 years,Total,2012,Diabetes mellitus,3.1,Rate
Bremen,DE50,Less than 65 years,Total,2013,Diabetes mellitus,3.36,Rate
Bremen,DE50,Less than 65 years,Total,2014,Diabetes mellitus,1.11,Rate
Bremen,DE50,Less than 65 years,Total,2015,Diabetes mellitus,2.22,Rate
Bremen,DE50,Less than 65 years,Total,2016,Diabetes mellitus,0.92,Rate
Bremen,DE50,Less than 65 years,Total,2017,Diabetes mellitus,2.11,Rate
Bremen,DE50,Less than 65 years,Total,2018,Diabetes mellitus,1.18,Rate
Bremen,DE50,Less than 65 years,Total,2019,Diabetes mellitus,2.59,Rate
Bremen,DE50,Less than 65 years,Total,2020,Diabetes mellitus,6.13,Rate
Bremen,DE50,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),20.48,Rate
Bremen,DE50,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),18.59,Rate
Bremen,DE50,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),24.36,Rate
Bremen,DE50,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),19.62,Rate
Bremen,DE50,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),17.2,Rate
Bremen,DE50,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),15.82,Rate
Bremen,DE50,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),21.39,Rate
Bremen,DE50,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),20.98,Rate
Bremen,DE50,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),13.38,Rate
Bremen,DE50,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),9.76,Rate
Bremen,DE50,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),3.19,Rate
Bremen,DE50,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Bremen,DE50,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.78,Rate
Bremen,DE50,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Bremen,DE50,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.39,Rate
Bremen,DE50,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Bremen,DE50,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Bremen,DE50,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Bremen,DE50,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Bremen,DE50,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Bremen,DE50,Less than 65 years,Total,2011,Other ischaemic heart diseases,7.59,Rate
Bremen,DE50,Less than 65 years,Total,2012,Other ischaemic heart diseases,8.53,Rate
Bremen,DE50,Less than 65 years,Total,2013,Other ischaemic heart diseases,5.94,Rate
Bremen,DE50,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.33,Rate
Bremen,DE50,Less than 65 years,Total,2015,Other ischaemic heart diseases,9.71,Rate
Bremen,DE50,Less than 65 years,Total,2016,Other ischaemic heart diseases,7.26,Rate
Bremen,DE50,Less than 65 years,Total,2017,Other ischaemic heart diseases,3.32,Rate
Bremen,DE50,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.18,Rate
Bremen,DE50,Less than 65 years,Total,2019,Other ischaemic heart diseases,5.75,Rate
Bremen,DE50,Less than 65 years,Total,2020,Other ischaemic heart diseases,7.65,Rate
Bremen,DE50,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,11.8,Rate
Bremen,DE50,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,15.03,Rate
Bremen,DE50,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,24.28,Rate
Bremen,DE50,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,20.75,Rate
Bremen,DE50,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,16.32,Rate
Bremen,DE50,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,19.17,Rate
Bremen,DE50,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,15.6,Rate
Bremen,DE50,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,14.87,Rate
Bremen,DE50,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,13.3,Rate
Bremen,DE50,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,16.23,Rate
Bremen,DE50,Less than 65 years,Total,2011,Cerebrovascular diseases,7.25,Rate
Bremen,DE50,Less than 65 years,Total,2012,Cerebrovascular diseases,7.37,Rate
Bremen,DE50,Less than 65 years,Total,2013,Cerebrovascular diseases,10.28,Rate
Bremen,DE50,Less than 65 years,Total,2014,Cerebrovascular diseases,7.54,Rate
Bremen,DE50,Less than 65 years,Total,2015,Cerebrovascular diseases,8.13,Rate
Bremen,DE50,Less than 65 years,Total,2016,Cerebrovascular diseases,6.44,Rate
Bremen,DE50,Less than 65 years,Total,2017,Cerebrovascular diseases,6.5,Rate
Bremen,DE50,Less than 65 years,Total,2018,Cerebrovascular diseases,8.12,Rate
Bremen,DE50,Less than 65 years,Total,2019,Cerebrovascular diseases,7.3,Rate
Bremen,DE50,Less than 65 years,Total,2020,Cerebrovascular diseases,6.48,Rate
Bremen,DE50,Less than 65 years,Total,2011,Chronic lower respiratory diseases,9.0,Rate
Bremen,DE50,Less than 65 years,Total,2012,Chronic lower respiratory diseases,6.6,Rate
Bremen,DE50,Less than 65 years,Total,2013,Chronic lower respiratory diseases,7.1,Rate
Bremen,DE50,Less than 65 years,Total,2014,Chronic lower respiratory diseases,6.61,Rate
Bremen,DE50,Less than 65 years,Total,2015,Chronic lower respiratory diseases,10.12,Rate
Bremen,DE50,Less than 65 years,Total,2016,Chronic lower respiratory diseases,9.61,Rate
Bremen,DE50,Less than 65 years,Total,2017,Chronic lower respiratory diseases,8.51,Rate
Bremen,DE50,Less than 65 years,Total,2018,Chronic lower respiratory diseases,11.62,Rate
Bremen,DE50,Less than 65 years,Total,2019,Chronic lower respiratory diseases,10.09,Rate
Bremen,DE50,Less than 65 years,Total,2020,Chronic lower respiratory diseases,9.27,Rate
Bremen,DE50,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.2,Rate
Bremen,DE50,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.56,Rate
Bremen,DE50,Less than 65 years,Total,2013,Asthma and status asthmaticus,1.33,Rate
Bremen,DE50,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.36,Rate
Bremen,DE50,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.17,Rate
Bremen,DE50,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.17,Rate
Bremen,DE50,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.17,Rate
Bremen,DE50,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.55,Rate
Bremen,DE50,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.51,Rate
Bremen,DE50,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.37,Rate
Braunschweig,DE91,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,884.87,Rate
Braunschweig,DE91,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,865.86,Rate
Braunschweig,DE91,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,905.56,Rate
Braunschweig,DE91,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,862.18,Rate
Braunschweig,DE91,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,883.76,Rate
Braunschweig,DE91,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,879.0,Rate
Braunschweig,DE91,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,884.85,Rate
Braunschweig,DE91,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,894.0,Rate
Braunschweig,DE91,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,863.58,Rate
Braunschweig,DE91,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,860.88,Rate
Braunschweig,DE91,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.57,Rate
Braunschweig,DE91,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.73,Rate
Braunschweig,DE91,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.24,Rate
Braunschweig,DE91,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.79,Rate
Braunschweig,DE91,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.2,Rate
Braunschweig,DE91,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.36,Rate
Braunschweig,DE91,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.33,Rate
Braunschweig,DE91,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.25,Rate
Braunschweig,DE91,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.89,Rate
Braunschweig,DE91,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.88,Rate
Braunschweig,DE91,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",31.56,Rate
Braunschweig,DE91,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",32.71,Rate
Braunschweig,DE91,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",32.52,Rate
Braunschweig,DE91,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",34.29,Rate
Braunschweig,DE91,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",32.7,Rate
Braunschweig,DE91,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",35.09,Rate
Braunschweig,DE91,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",36.87,Rate
Braunschweig,DE91,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",34.63,Rate
Braunschweig,DE91,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",36.21,Rate
Braunschweig,DE91,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",37.39,Rate
Braunschweig,DE91,Total,Females,2011,Malignant melanoma of skin,2.27,Rate
Braunschweig,DE91,Total,Females,2012,Malignant melanoma of skin,2.05,Rate
Braunschweig,DE91,Total,Females,2013,Malignant melanoma of skin,3.25,Rate
Braunschweig,DE91,Total,Females,2014,Malignant melanoma of skin,1.76,Rate
Braunschweig,DE91,Total,Females,2015,Malignant melanoma of skin,2.14,Rate
Braunschweig,DE91,Total,Females,2016,Malignant melanoma of skin,2.74,Rate
Braunschweig,DE91,Total,Females,2017,Malignant melanoma of skin,2.7,Rate
Braunschweig,DE91,Total,Females,2018,Malignant melanoma of skin,1.97,Rate
Braunschweig,DE91,Total,Females,2019,Malignant melanoma of skin,2.2,Rate
Braunschweig,DE91,Total,Females,2020,Malignant melanoma of skin,3.01,Rate
Braunschweig,DE91,Total,Females,2011,Malignant neoplasm of breast,37.27,Rate
Braunschweig,DE91,Total,Females,2012,Malignant neoplasm of breast,37.62,Rate
Braunschweig,DE91,Total,Females,2013,Malignant neoplasm of breast,36.29,Rate
Braunschweig,DE91,Total,Females,2014,Malignant neoplasm of breast,33.91,Rate
Braunschweig,DE91,Total,Females,2015,Malignant neoplasm of breast,37.36,Rate
Braunschweig,DE91,Total,Females,2016,Malignant neoplasm of breast,39.94,Rate
Braunschweig,DE91,Total,Females,2017,Malignant neoplasm of breast,37.15,Rate
Braunschweig,DE91,Total,Females,2018,Malignant neoplasm of breast,40.15,Rate
Braunschweig,DE91,Total,Females,2019,Malignant neoplasm of breast,34.83,Rate
Braunschweig,DE91,Total,Females,2020,Malignant neoplasm of breast,35.22,Rate
Braunschweig,DE91,Total,Females,2011,Diabetes mellitus,23.69,Rate
Braunschweig,DE91,Total,Females,2012,Diabetes mellitus,24.19,Rate
Braunschweig,DE91,Total,Females,2013,Diabetes mellitus,21.74,Rate
Braunschweig,DE91,Total,Females,2014,Diabetes mellitus,22.81,Rate
Braunschweig,DE91,Total,Females,2015,Diabetes mellitus,21.16,Rate
Braunschweig,DE91,Total,Females,2016,Diabetes mellitus,23.26,Rate
Braunschweig,DE91,Total,Females,2017,Diabetes mellitus,24.39,Rate
Braunschweig,DE91,Total,Females,2018,Diabetes mellitus,24.07,Rate
Braunschweig,DE91,Total,Females,2019,Diabetes mellitus,21.65,Rate
Braunschweig,DE91,Total,Females,2020,Diabetes mellitus,21.43,Rate
Braunschweig,DE91,Total,Females,2011,Mental and behavioural disorders (F00-F99),31.5,Rate
Braunschweig,DE91,Total,Females,2012,Mental and behavioural disorders (F00-F99),37.13,Rate
Braunschweig,DE91,Total,Females,2013,Mental and behavioural disorders (F00-F99),48.4,Rate
Braunschweig,DE91,Total,Females,2014,Mental and behavioural disorders (F00-F99),48.12,Rate
Braunschweig,DE91,Total,Females,2015,Mental and behavioural disorders (F00-F99),51.38,Rate
Braunschweig,DE91,Total,Females,2016,Mental and behavioural disorders (F00-F99),54.81,Rate
Braunschweig,DE91,Total,Females,2017,Mental and behavioural disorders (F00-F99),58.36,Rate
Braunschweig,DE91,Total,Females,2018,Mental and behavioural disorders (F00-F99),62.29,Rate
Braunschweig,DE91,Total,Females,2019,Mental and behavioural disorders (F00-F99),59.84,Rate
Braunschweig,DE91,Total,Females,2020,Mental and behavioural disorders (F00-F99),60.91,Rate
Braunschweig,DE91,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Braunschweig,DE91,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Braunschweig,DE91,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.47,Rate
Braunschweig,DE91,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.14,Rate
Braunschweig,DE91,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.27,Rate
Braunschweig,DE91,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.55,Rate
Braunschweig,DE91,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.07,Rate
Braunschweig,DE91,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.82,Rate
Braunschweig,DE91,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.82,Rate
Braunschweig,DE91,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Braunschweig,DE91,Total,Females,2011,Other ischaemic heart diseases,83.41,Rate
Braunschweig,DE91,Total,Females,2012,Other ischaemic heart diseases,85.12,Rate
Braunschweig,DE91,Total,Females,2013,Other ischaemic heart diseases,85.19,Rate
Braunschweig,DE91,Total,Females,2014,Other ischaemic heart diseases,78.56,Rate
Braunschweig,DE91,Total,Females,2015,Other ischaemic heart diseases,74.96,Rate
Braunschweig,DE91,Total,Females,2016,Other ischaemic heart diseases,77.28,Rate
Braunschweig,DE91,Total,Females,2017,Other ischaemic heart diseases,73.55,Rate
Braunschweig,DE91,Total,Females,2018,Other ischaemic heart diseases,75.9,Rate
Braunschweig,DE91,Total,Females,2019,Other ischaemic heart diseases,70.17,Rate
Braunschweig,DE91,Total,Females,2020,Other ischaemic heart diseases,72.52,Rate
Braunschweig,DE91,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,48.73,Rate
Braunschweig,DE91,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,46.31,Rate
Braunschweig,DE91,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,46.3,Rate
Braunschweig,DE91,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,42.23,Rate
Braunschweig,DE91,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,41.5,Rate
Braunschweig,DE91,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,36.33,Rate
Braunschweig,DE91,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,35.68,Rate
Braunschweig,DE91,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,30.3,Rate
Braunschweig,DE91,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,29.61,Rate
Braunschweig,DE91,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,26.47,Rate
Braunschweig,DE91,Total,Females,2011,Cerebrovascular diseases,69.32,Rate
Braunschweig,DE91,Total,Females,2012,Cerebrovascular diseases,66.52,Rate
Braunschweig,DE91,Total,Females,2013,Cerebrovascular diseases,64.09,Rate
Braunschweig,DE91,Total,Females,2014,Cerebrovascular diseases,62.25,Rate
Braunschweig,DE91,Total,Females,2015,Cerebrovascular diseases,60.6,Rate
Braunschweig,DE91,Total,Females,2016,Cerebrovascular diseases,55.16,Rate
Braunschweig,DE91,Total,Females,2017,Cerebrovascular diseases,58.28,Rate
Braunschweig,DE91,Total,Females,2018,Cerebrovascular diseases,56.09,Rate
Braunschweig,DE91,Total,Females,2019,Cerebrovascular diseases,52.12,Rate
Braunschweig,DE91,Total,Females,2020,Cerebrovascular diseases,47.84,Rate
Braunschweig,DE91,Total,Females,2011,Chronic lower respiratory diseases,24.89,Rate
Braunschweig,DE91,Total,Females,2012,Chronic lower respiratory diseases,30.12,Rate
Braunschweig,DE91,Total,Females,2013,Chronic lower respiratory diseases,30.97,Rate
Braunschweig,DE91,Total,Females,2014,Chronic lower respiratory diseases,30.1,Rate
Braunschweig,DE91,Total,Females,2015,Chronic lower respiratory diseases,34.23,Rate
Braunschweig,DE91,Total,Females,2016,Chronic lower respiratory diseases,35.98,Rate
Braunschweig,DE91,Total,Females,2017,Chronic lower respiratory diseases,37.67,Rate
Braunschweig,DE91,Total,Females,2018,Chronic lower respiratory diseases,39.42,Rate
Braunschweig,DE91,Total,Females,2019,Chronic lower respiratory diseases,37.92,Rate
Braunschweig,DE91,Total,Females,2020,Chronic lower respiratory diseases,33.96,Rate
Braunschweig,DE91,Total,Females,2011,Asthma and status asthmaticus,1.3,Rate
Braunschweig,DE91,Total,Females,2012,Asthma and status asthmaticus,2.31,Rate
Braunschweig,DE91,Total,Females,2013,Asthma and status asthmaticus,1.22,Rate
Braunschweig,DE91,Total,Females,2014,Asthma and status asthmaticus,1.09,Rate
Braunschweig,DE91,Total,Females,2015,Asthma and status asthmaticus,1.33,Rate
Braunschweig,DE91,Total,Females,2016,Asthma and status asthmaticus,1.27,Rate
Braunschweig,DE91,Total,Females,2017,Asthma and status asthmaticus,1.54,Rate
Braunschweig,DE91,Total,Females,2018,Asthma and status asthmaticus,1.33,Rate
Braunschweig,DE91,Total,Females,2019,Asthma and status asthmaticus,0.96,Rate
Braunschweig,DE91,Total,Females,2020,Asthma and status asthmaticus,1.39,Rate
Braunschweig,DE91,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3895.35,Rate
Braunschweig,DE91,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3816.64,Rate
Braunschweig,DE91,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4029.26,Rate
Braunschweig,DE91,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3813.62,Rate
Braunschweig,DE91,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3900.18,Rate
Braunschweig,DE91,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3875.87,Rate
Braunschweig,DE91,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3933.24,Rate
Braunschweig,DE91,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3935.82,Rate
Braunschweig,DE91,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3805.64,Rate
Braunschweig,DE91,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3851.86,Rate
Braunschweig,DE91,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.44,Rate
Braunschweig,DE91,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.68,Rate
Braunschweig,DE91,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.54,Rate
Braunschweig,DE91,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.81,Rate
Braunschweig,DE91,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.73,Rate
Braunschweig,DE91,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.52,Rate
Braunschweig,DE91,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.14,Rate
Braunschweig,DE91,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.32,Rate
Braunschweig,DE91,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.09,Rate
Braunschweig,DE91,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.14,Rate
Braunschweig,DE91,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",110.96,Rate
Braunschweig,DE91,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",113.63,Rate
Braunschweig,DE91,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",107.43,Rate
Braunschweig,DE91,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",110.75,Rate
Braunschweig,DE91,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",107.7,Rate
Braunschweig,DE91,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",117.8,Rate
Braunschweig,DE91,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",125.79,Rate
Braunschweig,DE91,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",119.09,Rate
Braunschweig,DE91,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",124.17,Rate
Braunschweig,DE91,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",135.72,Rate
Braunschweig,DE91,65 years or over,Females,2011,Malignant melanoma of skin,6.06,Rate
Braunschweig,DE91,65 years or over,Females,2012,Malignant melanoma of skin,6.23,Rate
Braunschweig,DE91,65 years or over,Females,2013,Malignant melanoma of skin,9.55,Rate
Braunschweig,DE91,65 years or over,Females,2014,Malignant melanoma of skin,5.59,Rate
Braunschweig,DE91,65 years or over,Females,2015,Malignant melanoma of skin,6.77,Rate
Braunschweig,DE91,65 years or over,Females,2016,Malignant melanoma of skin,8.59,Rate
Braunschweig,DE91,65 years or over,Females,2017,Malignant melanoma of skin,9.82,Rate
Braunschweig,DE91,65 years or over,Females,2018,Malignant melanoma of skin,7.95,Rate
Braunschweig,DE91,65 years or over,Females,2019,Malignant melanoma of skin,8.06,Rate
Braunschweig,DE91,65 years or over,Females,2020,Malignant melanoma of skin,8.64,Rate
Braunschweig,DE91,65 years or over,Females,2011,Malignant neoplasm of breast,124.16,Rate
Braunschweig,DE91,65 years or over,Females,2012,Malignant neoplasm of breast,125.32,Rate
Braunschweig,DE91,65 years or over,Females,2013,Malignant neoplasm of breast,119.07,Rate
Braunschweig,DE91,65 years or over,Females,2014,Malignant neoplasm of breast,114.21,Rate
Braunschweig,DE91,65 years or over,Females,2015,Malignant neoplasm of breast,120.08,Rate
Braunschweig,DE91,65 years or over,Females,2016,Malignant neoplasm of breast,140.77,Rate
Braunschweig,DE91,65 years or over,Females,2017,Malignant neoplasm of breast,130.21,Rate
Braunschweig,DE91,65 years or over,Females,2018,Malignant neoplasm of breast,142.29,Rate
Braunschweig,DE91,65 years or over,Females,2019,Malignant neoplasm of breast,123.47,Rate
Braunschweig,DE91,65 years or over,Females,2020,Malignant neoplasm of breast,121.22,Rate
Braunschweig,DE91,65 years or over,Females,2011,Diabetes mellitus,113.9,Rate
Braunschweig,DE91,65 years or over,Females,2012,Diabetes mellitus,117.16,Rate
Braunschweig,DE91,65 years or over,Females,2013,Diabetes mellitus,102.94,Rate
Braunschweig,DE91,65 years or over,Females,2014,Diabetes mellitus,107.9,Rate
Braunschweig,DE91,65 years or over,Females,2015,Diabetes mellitus,99.27,Rate
Braunschweig,DE91,65 years or over,Females,2016,Diabetes mellitus,111.77,Rate
Braunschweig,DE91,65 years or over,Females,2017,Diabetes mellitus,119.76,Rate
Braunschweig,DE91,65 years or over,Females,2018,Diabetes mellitus,112.24,Rate
Braunschweig,DE91,65 years or over,Females,2019,Diabetes mellitus,103.78,Rate
Braunschweig,DE91,65 years or over,Females,2020,Diabetes mellitus,103.72,Rate
Braunschweig,DE91,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),152.49,Rate
Braunschweig,DE91,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),180.66,Rate
Braunschweig,DE91,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),231.92,Rate
Braunschweig,DE91,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),227.17,Rate
Braunschweig,DE91,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),243.91,Rate
Braunschweig,DE91,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),263.79,Rate
Braunschweig,DE91,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),283.09,Rate
Braunschweig,DE91,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),300.7,Rate
Braunschweig,DE91,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),291.07,Rate
Braunschweig,DE91,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),291.87,Rate
Braunschweig,DE91,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),5.62,Rate
Braunschweig,DE91,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),6.69,Rate
Braunschweig,DE91,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),8.9,Rate
Braunschweig,DE91,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),9.77,Rate
Braunschweig,DE91,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),7.35,Rate
Braunschweig,DE91,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),8.76,Rate
Braunschweig,DE91,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),9.8,Rate
Braunschweig,DE91,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),11.27,Rate
Braunschweig,DE91,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),10.95,Rate
Braunschweig,DE91,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),8.57,Rate
Braunschweig,DE91,65 years or over,Females,2011,Other ischaemic heart diseases,417.18,Rate
Braunschweig,DE91,65 years or over,Females,2012,Other ischaemic heart diseases,418.11,Rate
Braunschweig,DE91,65 years or over,Females,2013,Other ischaemic heart diseases,427.87,Rate
Braunschweig,DE91,65 years or over,Females,2014,Other ischaemic heart diseases,392.82,Rate
Braunschweig,DE91,65 years or over,Females,2015,Other ischaemic heart diseases,370.52,Rate
Braunschweig,DE91,65 years or over,Females,2016,Other ischaemic heart diseases,380.85,Rate
Braunschweig,DE91,65 years or over,Females,2017,Other ischaemic heart diseases,366.15,Rate
Braunschweig,DE91,65 years or over,Females,2018,Other ischaemic heart diseases,376.94,Rate
Braunschweig,DE91,65 years or over,Females,2019,Other ischaemic heart diseases,345.92,Rate
Braunschweig,DE91,65 years or over,Females,2020,Other ischaemic heart diseases,360.18,Rate
Braunschweig,DE91,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,225.98,Rate
Braunschweig,DE91,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,216.71,Rate
Braunschweig,DE91,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,218.24,Rate
Braunschweig,DE91,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,197.17,Rate
Braunschweig,DE91,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,197.69,Rate
Braunschweig,DE91,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,170.48,Rate
Braunschweig,DE91,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,169.07,Rate
Braunschweig,DE91,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,138.93,Rate
Braunschweig,DE91,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,133.52,Rate
Braunschweig,DE91,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,121.64,Rate
Braunschweig,DE91,65 years or over,Females,2011,Cerebrovascular diseases,325.18,Rate
Braunschweig,DE91,65 years or over,Females,2012,Cerebrovascular diseases,322.35,Rate
Braunschweig,DE91,65 years or over,Females,2013,Cerebrovascular diseases,306.52,Rate
Braunschweig,DE91,65 years or over,Females,2014,Cerebrovascular diseases,299.15,Rate
Braunschweig,DE91,65 years or over,Females,2015,Cerebrovascular diseases,293.57,Rate
Braunschweig,DE91,65 years or over,Females,2016,Cerebrovascular diseases,257.85,Rate
Braunschweig,DE91,65 years or over,Females,2017,Cerebrovascular diseases,278.41,Rate
Braunschweig,DE91,65 years or over,Females,2018,Cerebrovascular diseases,273.37,Rate
Braunschweig,DE91,65 years or over,Females,2019,Cerebrovascular diseases,249.37,Rate
Braunschweig,DE91,65 years or over,Females,2020,Cerebrovascular diseases,226.28,Rate
Braunschweig,DE91,65 years or over,Females,2011,Chronic lower respiratory diseases,103.23,Rate
Braunschweig,DE91,65 years or over,Females,2012,Chronic lower respiratory diseases,126.43,Rate
Braunschweig,DE91,65 years or over,Females,2013,Chronic lower respiratory diseases,146.82,Rate
Braunschweig,DE91,65 years or over,Females,2014,Chronic lower respiratory diseases,131.14,Rate
Braunschweig,DE91,65 years or over,Females,2015,Chronic lower respiratory diseases,154.12,Rate
Braunschweig,DE91,65 years or over,Females,2016,Chronic lower respiratory diseases,155.36,Rate
Braunschweig,DE91,65 years or over,Females,2017,Chronic lower respiratory diseases,171.9,Rate
Braunschweig,DE91,65 years or over,Females,2018,Chronic lower respiratory diseases,169.9,Rate
Braunschweig,DE91,65 years or over,Females,2019,Chronic lower respiratory diseases,163.1,Rate
Braunschweig,DE91,65 years or over,Females,2020,Chronic lower respiratory diseases,153.5,Rate
Braunschweig,DE91,65 years or over,Females,2011,Asthma and status asthmaticus,4.02,Rate
Braunschweig,DE91,65 years or over,Females,2012,Asthma and status asthmaticus,5.36,Rate
Braunschweig,DE91,65 years or over,Females,2013,Asthma and status asthmaticus,4.98,Rate
Braunschweig,DE91,65 years or over,Females,2014,Asthma and status asthmaticus,3.67,Rate
Braunschweig,DE91,65 years or over,Females,2015,Asthma and status asthmaticus,6.2,Rate
Braunschweig,DE91,65 years or over,Females,2016,Asthma and status asthmaticus,5.91,Rate
Braunschweig,DE91,65 years or over,Females,2017,Asthma and status asthmaticus,6.75,Rate
Braunschweig,DE91,65 years or over,Females,2018,Asthma and status asthmaticus,4.41,Rate
Braunschweig,DE91,65 years or over,Females,2019,Asthma and status asthmaticus,3.69,Rate
Braunschweig,DE91,65 years or over,Females,2020,Asthma and status asthmaticus,4.45,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,155.62,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,151.07,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,148.88,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,147.24,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,153.07,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,153.05,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,146.42,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,157.16,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,150.91,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,136.36,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.29,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.88,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.69,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.38,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.9,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.13,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.9,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.48,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.83,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.89,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",12.33,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",13.11,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",14.38,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",15.76,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",14.54,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",15.06,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",15.34,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",14.17,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",14.91,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",13.57,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Malignant melanoma of skin,1.35,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Malignant melanoma of skin,1.04,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Malignant melanoma of skin,1.73,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Malignant melanoma of skin,0.83,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Malignant melanoma of skin,1.01,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Malignant melanoma of skin,1.32,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Malignant melanoma of skin,0.97,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Malignant melanoma of skin,0.52,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Malignant melanoma of skin,0.78,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Malignant melanoma of skin,1.65,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Malignant neoplasm of breast,16.22,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Malignant neoplasm of breast,16.38,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Malignant neoplasm of breast,16.24,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.46,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Malignant neoplasm of breast,17.32,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.51,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Malignant neoplasm of breast,14.61,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Malignant neoplasm of breast,15.41,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.35,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Malignant neoplasm of breast,14.39,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Diabetes mellitus,1.83,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Diabetes mellitus,1.67,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Diabetes mellitus,2.07,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Diabetes mellitus,2.19,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Diabetes mellitus,2.24,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Diabetes mellitus,1.82,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Diabetes mellitus,1.29,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Diabetes mellitus,2.71,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Diabetes mellitus,1.75,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Diabetes mellitus,1.49,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.2,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.37,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),3.95,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),4.75,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),4.75,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),4.18,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),3.92,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),4.53,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.83,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),4.96,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.14,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.29,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.47,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.56,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Other ischaemic heart diseases,4.45,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Other ischaemic heart diseases,2.18,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.44,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Other ischaemic heart diseases,3.37,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.75,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Other ischaemic heart diseases,2.66,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.98,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Other ischaemic heart diseases,3.38,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.84,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.79,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.03,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.65,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.69,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.67,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.84,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.37,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.98,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.44,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.42,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Cerebrovascular diseases,7.34,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Cerebrovascular diseases,4.55,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Cerebrovascular diseases,5.37,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Cerebrovascular diseases,4.86,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Cerebrovascular diseases,4.17,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Cerebrovascular diseases,6.06,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Cerebrovascular diseases,4.95,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Cerebrovascular diseases,3.46,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Cerebrovascular diseases,4.34,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Cerebrovascular diseases,4.61,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Chronic lower respiratory diseases,5.91,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Chronic lower respiratory diseases,6.79,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.9,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Chronic lower respiratory diseases,5.62,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Chronic lower respiratory diseases,5.19,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Chronic lower respiratory diseases,7.06,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Chronic lower respiratory diseases,5.16,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Chronic lower respiratory diseases,7.81,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Chronic lower respiratory diseases,7.6,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Chronic lower respiratory diseases,5.0,Rate
Braunschweig,DE91,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.64,Rate
Braunschweig,DE91,Less than 65 years,Females,2012,Asthma and status asthmaticus,1.57,Rate
Braunschweig,DE91,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.31,Rate
Braunschweig,DE91,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.46,Rate
Braunschweig,DE91,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.14,Rate
Braunschweig,DE91,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.14,Rate
Braunschweig,DE91,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.28,Rate
Braunschweig,DE91,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.58,Rate
Braunschweig,DE91,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.29,Rate
Braunschweig,DE91,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.65,Rate
Braunschweig,DE91,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1304.61,Rate
Braunschweig,DE91,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1338.89,Rate
Braunschweig,DE91,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1374.4,Rate
Braunschweig,DE91,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1291.01,Rate
Braunschweig,DE91,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1344.85,Rate
Braunschweig,DE91,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1295.19,Rate
Braunschweig,DE91,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1290.11,Rate
Braunschweig,DE91,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1314.39,Rate
Braunschweig,DE91,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1252.03,Rate
Braunschweig,DE91,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1266.64,Rate
Braunschweig,DE91,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.8,Rate
Braunschweig,DE91,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.85,Rate
Braunschweig,DE91,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.39,Rate
Braunschweig,DE91,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.56,Rate
Braunschweig,DE91,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.98,Rate
Braunschweig,DE91,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.0,Rate
Braunschweig,DE91,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.91,Rate
Braunschweig,DE91,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.4,Rate
Braunschweig,DE91,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.76,Rate
Braunschweig,DE91,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.45,Rate
Braunschweig,DE91,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",80.67,Rate
Braunschweig,DE91,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",82.84,Rate
Braunschweig,DE91,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",79.16,Rate
Braunschweig,DE91,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",77.6,Rate
Braunschweig,DE91,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",85.54,Rate
Braunschweig,DE91,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",76.53,Rate
Braunschweig,DE91,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",78.37,Rate
Braunschweig,DE91,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",68.84,Rate
Braunschweig,DE91,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",71.46,Rate
Braunschweig,DE91,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",71.29,Rate
Braunschweig,DE91,Total,Males,2011,Malignant melanoma of skin,4.84,Rate
Braunschweig,DE91,Total,Males,2012,Malignant melanoma of skin,4.19,Rate
Braunschweig,DE91,Total,Males,2013,Malignant melanoma of skin,5.68,Rate
Braunschweig,DE91,Total,Males,2014,Malignant melanoma of skin,4.72,Rate
Braunschweig,DE91,Total,Males,2015,Malignant melanoma of skin,4.03,Rate
Braunschweig,DE91,Total,Males,2016,Malignant melanoma of skin,3.57,Rate
Braunschweig,DE91,Total,Males,2017,Malignant melanoma of skin,4.18,Rate
Braunschweig,DE91,Total,Males,2018,Malignant melanoma of skin,4.72,Rate
Braunschweig,DE91,Total,Males,2019,Malignant melanoma of skin,3.66,Rate
Braunschweig,DE91,Total,Males,2020,Malignant melanoma of skin,3.43,Rate
Braunschweig,DE91,Total,Males,2011,Malignant neoplasm of breast,0.27,Rate
Braunschweig,DE91,Total,Males,2013,Malignant neoplasm of breast,0.35,Rate
Braunschweig,DE91,Total,Males,2014,Malignant neoplasm of breast,0.14,Rate
Braunschweig,DE91,Total,Males,2015,Malignant neoplasm of breast,0.25,Rate
Braunschweig,DE91,Total,Males,2016,Malignant neoplasm of breast,0.61,Rate
Braunschweig,DE91,Total,Males,2017,Malignant neoplasm of breast,0.47,Rate
Braunschweig,DE91,Total,Males,2018,Malignant neoplasm of breast,0.1,Rate
Braunschweig,DE91,Total,Males,2019,Malignant neoplasm of breast,0.14,Rate
Braunschweig,DE91,Total,Males,2020,Malignant neoplasm of breast,0.57,Rate
Braunschweig,DE91,Total,Males,2011,Diabetes mellitus,29.43,Rate
Braunschweig,DE91,Total,Males,2012,Diabetes mellitus,29.51,Rate
Braunschweig,DE91,Total,Males,2013,Diabetes mellitus,32.49,Rate
Braunschweig,DE91,Total,Males,2014,Diabetes mellitus,28.69,Rate
Braunschweig,DE91,Total,Males,2015,Diabetes mellitus,33.01,Rate
Braunschweig,DE91,Total,Males,2016,Diabetes mellitus,33.37,Rate
Braunschweig,DE91,Total,Males,2017,Diabetes mellitus,33.47,Rate
Braunschweig,DE91,Total,Males,2018,Diabetes mellitus,34.35,Rate
Braunschweig,DE91,Total,Males,2019,Diabetes mellitus,33.76,Rate
Braunschweig,DE91,Total,Males,2020,Diabetes mellitus,36.3,Rate
Braunschweig,DE91,Total,Males,2011,Mental and behavioural disorders (F00-F99),43.03,Rate
Braunschweig,DE91,Total,Males,2012,Mental and behavioural disorders (F00-F99),45.42,Rate
Braunschweig,DE91,Total,Males,2013,Mental and behavioural disorders (F00-F99),59.61,Rate
Braunschweig,DE91,Total,Males,2014,Mental and behavioural disorders (F00-F99),55.65,Rate
Braunschweig,DE91,Total,Males,2015,Mental and behavioural disorders (F00-F99),69.03,Rate
Braunschweig,DE91,Total,Males,2016,Mental and behavioural disorders (F00-F99),62.79,Rate
Braunschweig,DE91,Total,Males,2017,Mental and behavioural disorders (F00-F99),61.21,Rate
Braunschweig,DE91,Total,Males,2018,Mental and behavioural disorders (F00-F99),74.41,Rate
Braunschweig,DE91,Total,Males,2019,Mental and behavioural disorders (F00-F99),67.61,Rate
Braunschweig,DE91,Total,Males,2020,Mental and behavioural disorders (F00-F99),66.85,Rate
Braunschweig,DE91,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Braunschweig,DE91,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),2.98,Rate
Braunschweig,DE91,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.37,Rate
Braunschweig,DE91,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.89,Rate
Braunschweig,DE91,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.13,Rate
Braunschweig,DE91,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.95,Rate
Braunschweig,DE91,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Braunschweig,DE91,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Braunschweig,DE91,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Braunschweig,DE91,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.96,Rate
Braunschweig,DE91,Total,Males,2011,Other ischaemic heart diseases,146.73,Rate
Braunschweig,DE91,Total,Males,2012,Other ischaemic heart diseases,147.65,Rate
Braunschweig,DE91,Total,Males,2013,Other ischaemic heart diseases,155.66,Rate
Braunschweig,DE91,Total,Males,2014,Other ischaemic heart diseases,140.8,Rate
Braunschweig,DE91,Total,Males,2015,Other ischaemic heart diseases,154.13,Rate
Braunschweig,DE91,Total,Males,2016,Other ischaemic heart diseases,143.98,Rate
Braunschweig,DE91,Total,Males,2017,Other ischaemic heart diseases,156.15,Rate
Braunschweig,DE91,Total,Males,2018,Other ischaemic heart diseases,157.52,Rate
Braunschweig,DE91,Total,Males,2019,Other ischaemic heart diseases,143.31,Rate
Braunschweig,DE91,Total,Males,2020,Other ischaemic heart diseases,145.41,Rate
Braunschweig,DE91,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,101.29,Rate
Braunschweig,DE91,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,101.88,Rate
Braunschweig,DE91,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,95.7,Rate
Braunschweig,DE91,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,80.33,Rate
Braunschweig,DE91,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,87.6,Rate
Braunschweig,DE91,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,78.34,Rate
Braunschweig,DE91,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,66.33,Rate
Braunschweig,DE91,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,64.14,Rate
Braunschweig,DE91,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,67.32,Rate
Braunschweig,DE91,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,62.18,Rate
Braunschweig,DE91,Total,Males,2011,Cerebrovascular diseases,76.41,Rate
Braunschweig,DE91,Total,Males,2012,Cerebrovascular diseases,73.1,Rate
Braunschweig,DE91,Total,Males,2013,Cerebrovascular diseases,84.96,Rate
Braunschweig,DE91,Total,Males,2014,Cerebrovascular diseases,75.08,Rate
Braunschweig,DE91,Total,Males,2015,Cerebrovascular diseases,67.58,Rate
Braunschweig,DE91,Total,Males,2016,Cerebrovascular diseases,61.17,Rate
Braunschweig,DE91,Total,Males,2017,Cerebrovascular diseases,66.29,Rate
Braunschweig,DE91,Total,Males,2018,Cerebrovascular diseases,64.47,Rate
Braunschweig,DE91,Total,Males,2019,Cerebrovascular diseases,61.17,Rate
Braunschweig,DE91,Total,Males,2020,Cerebrovascular diseases,57.75,Rate
Braunschweig,DE91,Total,Males,2011,Chronic lower respiratory diseases,54.75,Rate
Braunschweig,DE91,Total,Males,2012,Chronic lower respiratory diseases,53.58,Rate
Braunschweig,DE91,Total,Males,2013,Chronic lower respiratory diseases,55.51,Rate
Braunschweig,DE91,Total,Males,2014,Chronic lower respiratory diseases,49.22,Rate
Braunschweig,DE91,Total,Males,2015,Chronic lower respiratory diseases,56.51,Rate
Braunschweig,DE91,Total,Males,2016,Chronic lower respiratory diseases,56.08,Rate
Braunschweig,DE91,Total,Males,2017,Chronic lower respiratory diseases,52.93,Rate
Braunschweig,DE91,Total,Males,2018,Chronic lower respiratory diseases,58.12,Rate
Braunschweig,DE91,Total,Males,2019,Chronic lower respiratory diseases,53.35,Rate
Braunschweig,DE91,Total,Males,2020,Chronic lower respiratory diseases,49.91,Rate
Braunschweig,DE91,Total,Males,2011,Asthma and status asthmaticus,1.34,Rate
Braunschweig,DE91,Total,Males,2012,Asthma and status asthmaticus,1.67,Rate
Braunschweig,DE91,Total,Males,2013,Asthma and status asthmaticus,1.09,Rate
Braunschweig,DE91,Total,Males,2014,Asthma and status asthmaticus,1.88,Rate
Braunschweig,DE91,Total,Males,2015,Asthma and status asthmaticus,0.74,Rate
Braunschweig,DE91,Total,Males,2016,Asthma and status asthmaticus,0.81,Rate
Braunschweig,DE91,Total,Males,2017,Asthma and status asthmaticus,1.47,Rate
Braunschweig,DE91,Total,Males,2018,Asthma and status asthmaticus,0.81,Rate
Braunschweig,DE91,Total,Males,2019,Asthma and status asthmaticus,0.7,Rate
Braunschweig,DE91,Total,Males,2020,Asthma and status asthmaticus,1.11,Rate
Braunschweig,DE91,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5552.03,Rate
Braunschweig,DE91,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5700.91,Rate
Braunschweig,DE91,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5880.82,Rate
Braunschweig,DE91,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5485.97,Rate
Braunschweig,DE91,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5765.0,Rate
Braunschweig,DE91,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5512.16,Rate
Braunschweig,DE91,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5508.03,Rate
Braunschweig,DE91,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5649.79,Rate
Braunschweig,DE91,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5353.38,Rate
Braunschweig,DE91,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5428.64,Rate
Braunschweig,DE91,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",176.57,Rate
Braunschweig,DE91,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",161.87,Rate
Braunschweig,DE91,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.18,Rate
Braunschweig,DE91,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.09,Rate
Braunschweig,DE91,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.91,Rate
Braunschweig,DE91,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.93,Rate
Braunschweig,DE91,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.5,Rate
Braunschweig,DE91,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",160.22,Rate
Braunschweig,DE91,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",143.28,Rate
Braunschweig,DE91,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.64,Rate
Braunschweig,DE91,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",309.22,Rate
Braunschweig,DE91,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",316.74,Rate
Braunschweig,DE91,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",295.05,Rate
Braunschweig,DE91,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",290.86,Rate
Braunschweig,DE91,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",332.45,Rate
Braunschweig,DE91,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",289.94,Rate
Braunschweig,DE91,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",302.11,Rate
Braunschweig,DE91,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",259.87,Rate
Braunschweig,DE91,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",285.64,Rate
Braunschweig,DE91,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",286.62,Rate
Braunschweig,DE91,65 years or over,Males,2011,Malignant melanoma of skin,17.84,Rate
Braunschweig,DE91,65 years or over,Males,2012,Malignant melanoma of skin,17.05,Rate
Braunschweig,DE91,65 years or over,Males,2013,Malignant melanoma of skin,21.98,Rate
Braunschweig,DE91,65 years or over,Males,2014,Malignant melanoma of skin,19.85,Rate
Braunschweig,DE91,65 years or over,Males,2015,Malignant melanoma of skin,16.95,Rate
Braunschweig,DE91,65 years or over,Males,2016,Malignant melanoma of skin,11.72,Rate
Braunschweig,DE91,65 years or over,Males,2017,Malignant melanoma of skin,14.91,Rate
Braunschweig,DE91,65 years or over,Males,2018,Malignant melanoma of skin,16.09,Rate
Braunschweig,DE91,65 years or over,Males,2019,Malignant melanoma of skin,13.41,Rate
Braunschweig,DE91,65 years or over,Males,2020,Malignant melanoma of skin,12.59,Rate
Braunschweig,DE91,65 years or over,Males,2011,Malignant neoplasm of breast,1.36,Rate
Braunschweig,DE91,65 years or over,Males,2013,Malignant neoplasm of breast,1.8,Rate
Braunschweig,DE91,65 years or over,Males,2014,Malignant neoplasm of breast,0.72,Rate
Braunschweig,DE91,65 years or over,Males,2015,Malignant neoplasm of breast,0.72,Rate
Braunschweig,DE91,65 years or over,Males,2016,Malignant neoplasm of breast,1.74,Rate
Braunschweig,DE91,65 years or over,Males,2017,Malignant neoplasm of breast,1.28,Rate
Braunschweig,DE91,65 years or over,Males,2018,Malignant neoplasm of breast,0.54,Rate
Braunschweig,DE91,65 years or over,Males,2019,Malignant neoplasm of breast,0.74,Rate
Braunschweig,DE91,65 years or over,Males,2020,Malignant neoplasm of breast,2.37,Rate
Braunschweig,DE91,65 years or over,Males,2011,Diabetes mellitus,132.05,Rate
Braunschweig,DE91,65 years or over,Males,2012,Diabetes mellitus,130.54,Rate
Braunschweig,DE91,65 years or over,Males,2013,Diabetes mellitus,140.34,Rate
Braunschweig,DE91,65 years or over,Males,2014,Diabetes mellitus,128.13,Rate
Braunschweig,DE91,65 years or over,Males,2015,Diabetes mellitus,147.8,Rate
Braunschweig,DE91,65 years or over,Males,2016,Diabetes mellitus,152.17,Rate
Braunschweig,DE91,65 years or over,Males,2017,Diabetes mellitus,144.49,Rate
Braunschweig,DE91,65 years or over,Males,2018,Diabetes mellitus,162.74,Rate
Braunschweig,DE91,65 years or over,Males,2019,Diabetes mellitus,146.96,Rate
Braunschweig,DE91,65 years or over,Males,2020,Diabetes mellitus,159.3,Rate
Braunschweig,DE91,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),178.69,Rate
Braunschweig,DE91,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),187.91,Rate
Braunschweig,DE91,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),240.37,Rate
Braunschweig,DE91,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),225.86,Rate
Braunschweig,DE91,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),284.76,Rate
Braunschweig,DE91,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),260.0,Rate
Braunschweig,DE91,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),252.67,Rate
Braunschweig,DE91,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),320.41,Rate
Braunschweig,DE91,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),289.25,Rate
Braunschweig,DE91,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),283.85,Rate
Braunschweig,DE91,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Braunschweig,DE91,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),12.9,Rate
Braunschweig,DE91,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),9.65,Rate
Braunschweig,DE91,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),9.25,Rate
Braunschweig,DE91,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),14.6,Rate
Braunschweig,DE91,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),10.25,Rate
Braunschweig,DE91,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),11.25,Rate
Braunschweig,DE91,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),11.38,Rate
Braunschweig,DE91,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),6.37,Rate
Braunschweig,DE91,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),6.43,Rate
Braunschweig,DE91,65 years or over,Males,2011,Other ischaemic heart diseases,705.52,Rate
Braunschweig,DE91,65 years or over,Males,2012,Other ischaemic heart diseases,710.59,Rate
Braunschweig,DE91,65 years or over,Males,2013,Other ischaemic heart diseases,750.69,Rate
Braunschweig,DE91,65 years or over,Males,2014,Other ischaemic heart diseases,673.06,Rate
Braunschweig,DE91,65 years or over,Males,2015,Other ischaemic heart diseases,734.65,Rate
Braunschweig,DE91,65 years or over,Males,2016,Other ischaemic heart diseases,690.48,Rate
Braunschweig,DE91,65 years or over,Males,2017,Other ischaemic heart diseases,741.69,Rate
Braunschweig,DE91,65 years or over,Males,2018,Other ischaemic heart diseases,744.6,Rate
Braunschweig,DE91,65 years or over,Males,2019,Other ischaemic heart diseases,682.9,Rate
Braunschweig,DE91,65 years or over,Males,2020,Other ischaemic heart diseases,697.15,Rate
Braunschweig,DE91,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,424.08,Rate
Braunschweig,DE91,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,442.65,Rate
Braunschweig,DE91,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,393.82,Rate
Braunschweig,DE91,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,331.89,Rate
Braunschweig,DE91,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,360.6,Rate
Braunschweig,DE91,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,336.54,Rate
Braunschweig,DE91,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,274.84,Rate
Braunschweig,DE91,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,269.98,Rate
Braunschweig,DE91,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,275.07,Rate
Braunschweig,DE91,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,252.2,Rate
Braunschweig,DE91,65 years or over,Males,2011,Cerebrovascular diseases,361.39,Rate
Braunschweig,DE91,65 years or over,Males,2012,Cerebrovascular diseases,350.38,Rate
Braunschweig,DE91,65 years or over,Males,2013,Cerebrovascular diseases,399.17,Rate
Braunschweig,DE91,65 years or over,Males,2014,Cerebrovascular diseases,354.28,Rate
Braunschweig,DE91,65 years or over,Males,2015,Cerebrovascular diseases,323.34,Rate
Braunschweig,DE91,65 years or over,Males,2016,Cerebrovascular diseases,290.71,Rate
Braunschweig,DE91,65 years or over,Males,2017,Cerebrovascular diseases,314.74,Rate
Braunschweig,DE91,65 years or over,Males,2018,Cerebrovascular diseases,297.95,Rate
Braunschweig,DE91,65 years or over,Males,2019,Cerebrovascular diseases,283.0,Rate
Braunschweig,DE91,65 years or over,Males,2020,Cerebrovascular diseases,270.27,Rate
Braunschweig,DE91,65 years or over,Males,2011,Chronic lower respiratory diseases,251.84,Rate
Braunschweig,DE91,65 years or over,Males,2012,Chronic lower respiratory diseases,242.99,Rate
Braunschweig,DE91,65 years or over,Males,2013,Chronic lower respiratory diseases,253.35,Rate
Braunschweig,DE91,65 years or over,Males,2014,Chronic lower respiratory diseases,226.22,Rate
Braunschweig,DE91,65 years or over,Males,2015,Chronic lower respiratory diseases,256.6,Rate
Braunschweig,DE91,65 years or over,Males,2016,Chronic lower respiratory diseases,242.51,Rate
Braunschweig,DE91,65 years or over,Males,2017,Chronic lower respiratory diseases,237.48,Rate
Braunschweig,DE91,65 years or over,Males,2018,Chronic lower respiratory diseases,266.21,Rate
Braunschweig,DE91,65 years or over,Males,2019,Chronic lower respiratory diseases,238.99,Rate
Braunschweig,DE91,65 years or over,Males,2020,Chronic lower respiratory diseases,225.18,Rate
Braunschweig,DE91,65 years or over,Males,2011,Asthma and status asthmaticus,5.06,Rate
Braunschweig,DE91,65 years or over,Males,2012,Asthma and status asthmaticus,6.33,Rate
Braunschweig,DE91,65 years or over,Males,2013,Asthma and status asthmaticus,2.01,Rate
Braunschweig,DE91,65 years or over,Males,2014,Asthma and status asthmaticus,7.22,Rate
Braunschweig,DE91,65 years or over,Males,2015,Asthma and status asthmaticus,2.15,Rate
Braunschweig,DE91,65 years or over,Males,2016,Asthma and status asthmaticus,2.27,Rate
Braunschweig,DE91,65 years or over,Males,2017,Asthma and status asthmaticus,4.94,Rate
Braunschweig,DE91,65 years or over,Males,2018,Asthma and status asthmaticus,3.61,Rate
Braunschweig,DE91,65 years or over,Males,2019,Asthma and status asthmaticus,3.06,Rate
Braunschweig,DE91,65 years or over,Males,2020,Asthma and status asthmaticus,3.84,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,275.74,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,282.26,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,282.79,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,274.85,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,274.13,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,273.68,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,268.38,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,264.2,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,258.54,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,258.45,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.16,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.29,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.92,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.61,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.74,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.13,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.06,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.65,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.22,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.51,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",25.31,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",26.17,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",26.86,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",25.94,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",25.72,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",24.84,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",24.17,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",22.56,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",19.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",19.12,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Malignant melanoma of skin,1.69,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Malignant melanoma of skin,1.08,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Malignant melanoma of skin,1.73,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Malignant melanoma of skin,1.05,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Malignant melanoma of skin,0.89,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Malignant melanoma of skin,1.59,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Malignant melanoma of skin,1.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Malignant melanoma of skin,1.97,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Malignant melanoma of skin,1.3,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Malignant melanoma of skin,1.22,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.14,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.34,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.28,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.13,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Diabetes mellitus,4.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Diabetes mellitus,5.04,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Diabetes mellitus,6.37,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Diabetes mellitus,4.6,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Diabetes mellitus,5.21,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Diabetes mellitus,4.6,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Diabetes mellitus,6.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Diabetes mellitus,3.25,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Diabetes mellitus,6.34,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Diabetes mellitus,6.51,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),10.17,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),10.91,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),15.82,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),14.42,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),16.78,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),15.01,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),14.84,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),14.82,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),13.92,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),14.29,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.84,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.59,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.18,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.18,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.15,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.09,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.12,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Other ischaemic heart diseases,11.38,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Other ischaemic heart diseases,11.28,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Other ischaemic heart diseases,11.53,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Other ischaemic heart diseases,11.87,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Other ischaemic heart diseases,13.51,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Other ischaemic heart diseases,11.6,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Other ischaemic heart diseases,14.31,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Other ischaemic heart diseases,15.3,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Other ischaemic heart diseases,12.6,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Other ischaemic heart diseases,11.76,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,23.1,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,19.34,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,23.49,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,19.4,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,21.46,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,15.79,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,15.81,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,14.28,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,16.99,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,16.16,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Cerebrovascular diseases,7.38,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Cerebrovascular diseases,5.93,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Cerebrovascular diseases,8.85,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Cerebrovascular diseases,7.45,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Cerebrovascular diseases,5.62,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Cerebrovascular diseases,5.57,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Cerebrovascular diseases,6.1,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Cerebrovascular diseases,7.91,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Cerebrovascular diseases,7.44,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Cerebrovascular diseases,6.27,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Chronic lower respiratory diseases,7.01,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Chronic lower respiratory diseases,7.69,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Chronic lower respiratory diseases,7.58,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Chronic lower respiratory diseases,6.34,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Chronic lower respiratory diseases,8.04,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Chronic lower respiratory diseases,10.93,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Chronic lower respiratory diseases,8.23,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Chronic lower respiratory diseases,7.72,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Chronic lower respiratory diseases,8.39,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Chronic lower respiratory diseases,7.45,Rate
Braunschweig,DE91,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.44,Rate
Braunschweig,DE91,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.54,Rate
Braunschweig,DE91,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.86,Rate
Braunschweig,DE91,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.59,Rate
Braunschweig,DE91,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.4,Rate
Braunschweig,DE91,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.46,Rate
Braunschweig,DE91,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.63,Rate
Braunschweig,DE91,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.13,Rate
Braunschweig,DE91,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.12,Rate
Braunschweig,DE91,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.45,Rate
Braunschweig,DE91,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1059.96,Rate
Braunschweig,DE91,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1062.66,Rate
Braunschweig,DE91,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1100.94,Rate
Braunschweig,DE91,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1042.33,Rate
Braunschweig,DE91,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1076.89,Rate
Braunschweig,DE91,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1058.63,Rate
Braunschweig,DE91,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1061.8,Rate
Braunschweig,DE91,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1074.86,Rate
Braunschweig,DE91,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1033.7,Rate
Braunschweig,DE91,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1041.07,Rate
Braunschweig,DE91,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.85,Rate
Braunschweig,DE91,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.3,Rate
Braunschweig,DE91,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.82,Rate
Braunschweig,DE91,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.79,Rate
Braunschweig,DE91,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.14,Rate
Braunschweig,DE91,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.56,Rate
Braunschweig,DE91,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.04,Rate
Braunschweig,DE91,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.25,Rate
Braunschweig,DE91,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.53,Rate
Braunschweig,DE91,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.64,Rate
Braunschweig,DE91,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",53.01,Rate
Braunschweig,DE91,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",54.31,Rate
Braunschweig,DE91,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",53.01,Rate
Braunschweig,DE91,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",53.17,Rate
Braunschweig,DE91,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",55.49,Rate
Braunschweig,DE91,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",53.15,Rate
Braunschweig,DE91,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",55.8,Rate
Braunschweig,DE91,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",49.8,Rate
Braunschweig,DE91,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",51.83,Rate
Braunschweig,DE91,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",52.2,Rate
Braunschweig,DE91,Total,Total,2011,Malignant melanoma of skin,3.34,Rate
Braunschweig,DE91,Total,Total,2012,Malignant melanoma of skin,2.86,Rate
Braunschweig,DE91,Total,Total,2013,Malignant melanoma of skin,4.21,Rate
Braunschweig,DE91,Total,Total,2014,Malignant melanoma of skin,2.83,Rate
Braunschweig,DE91,Total,Total,2015,Malignant melanoma of skin,2.98,Rate
Braunschweig,DE91,Total,Total,2016,Malignant melanoma of skin,3.18,Rate
Braunschweig,DE91,Total,Total,2017,Malignant melanoma of skin,3.34,Rate
Braunschweig,DE91,Total,Total,2018,Malignant melanoma of skin,3.17,Rate
Braunschweig,DE91,Total,Total,2019,Malignant melanoma of skin,2.92,Rate
Braunschweig,DE91,Total,Total,2020,Malignant melanoma of skin,3.17,Rate
Braunschweig,DE91,Total,Total,2011,Malignant neoplasm of breast,21.16,Rate
Braunschweig,DE91,Total,Total,2012,Malignant neoplasm of breast,21.34,Rate
Braunschweig,DE91,Total,Total,2013,Malignant neoplasm of breast,20.45,Rate
Braunschweig,DE91,Total,Total,2014,Malignant neoplasm of breast,18.99,Rate
Braunschweig,DE91,Total,Total,2015,Malignant neoplasm of breast,21.1,Rate
Braunschweig,DE91,Total,Total,2016,Malignant neoplasm of breast,22.66,Rate
Braunschweig,DE91,Total,Total,2017,Malignant neoplasm of breast,20.88,Rate
Braunschweig,DE91,Total,Total,2018,Malignant neoplasm of breast,22.18,Rate
Braunschweig,DE91,Total,Total,2019,Malignant neoplasm of breast,19.33,Rate
Braunschweig,DE91,Total,Total,2020,Malignant neoplasm of breast,19.9,Rate
Braunschweig,DE91,Total,Total,2011,Diabetes mellitus,26.98,Rate
Braunschweig,DE91,Total,Total,2012,Diabetes mellitus,26.56,Rate
Braunschweig,DE91,Total,Total,2013,Diabetes mellitus,26.42,Rate
Braunschweig,DE91,Total,Total,2014,Diabetes mellitus,25.84,Rate
Braunschweig,DE91,Total,Total,2015,Diabetes mellitus,25.93,Rate
Braunschweig,DE91,Total,Total,2016,Diabetes mellitus,27.86,Rate
Braunschweig,DE91,Total,Total,2017,Diabetes mellitus,28.79,Rate
Braunschweig,DE91,Total,Total,2018,Diabetes mellitus,28.29,Rate
Braunschweig,DE91,Total,Total,2019,Diabetes mellitus,26.74,Rate
Braunschweig,DE91,Total,Total,2020,Diabetes mellitus,28.04,Rate
Braunschweig,DE91,Total,Total,2011,Mental and behavioural disorders (F00-F99),36.52,Rate
Braunschweig,DE91,Total,Total,2012,Mental and behavioural disorders (F00-F99),41.68,Rate
Braunschweig,DE91,Total,Total,2013,Mental and behavioural disorders (F00-F99),54.83,Rate
Braunschweig,DE91,Total,Total,2014,Mental and behavioural disorders (F00-F99),52.82,Rate
Braunschweig,DE91,Total,Total,2015,Mental and behavioural disorders (F00-F99),60.01,Rate
Braunschweig,DE91,Total,Total,2016,Mental and behavioural disorders (F00-F99),60.15,Rate
Braunschweig,DE91,Total,Total,2017,Mental and behavioural disorders (F00-F99),62.1,Rate
Braunschweig,DE91,Total,Total,2018,Mental and behavioural disorders (F00-F99),69.19,Rate
Braunschweig,DE91,Total,Total,2019,Mental and behavioural disorders (F00-F99),64.68,Rate
Braunschweig,DE91,Total,Total,2020,Mental and behavioural disorders (F00-F99),65.23,Rate
Braunschweig,DE91,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Braunschweig,DE91,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.97,Rate
Braunschweig,DE91,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.98,Rate
Braunschweig,DE91,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.64,Rate
Braunschweig,DE91,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.06,Rate
Braunschweig,DE91,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.78,Rate
Braunschweig,DE91,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.05,Rate
Braunschweig,DE91,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.03,Rate
Braunschweig,DE91,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.0,Rate
Braunschweig,DE91,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.96,Rate
Braunschweig,DE91,Total,Total,2011,Other ischaemic heart diseases,107.28,Rate
Braunschweig,DE91,Total,Total,2012,Other ischaemic heart diseases,110.69,Rate
Braunschweig,DE91,Total,Total,2013,Other ischaemic heart diseases,112.21,Rate
Braunschweig,DE91,Total,Total,2014,Other ischaemic heart diseases,103.12,Rate
Braunschweig,DE91,Total,Total,2015,Other ischaemic heart diseases,106.58,Rate
Braunschweig,DE91,Total,Total,2016,Other ischaemic heart diseases,104.87,Rate
Braunschweig,DE91,Total,Total,2017,Other ischaemic heart diseases,106.76,Rate
Braunschweig,DE91,Total,Total,2018,Other ischaemic heart diseases,108.37,Rate
Braunschweig,DE91,Total,Total,2019,Other ischaemic heart diseases,100.0,Rate
Braunschweig,DE91,Total,Total,2020,Other ischaemic heart diseases,102.3,Rate
Braunschweig,DE91,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,70.3,Rate
Braunschweig,DE91,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,69.48,Rate
Braunschweig,DE91,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,66.58,Rate
Braunschweig,DE91,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,59.07,Rate
Braunschweig,DE91,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,60.52,Rate
Braunschweig,DE91,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,53.87,Rate
Braunschweig,DE91,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,49.48,Rate
Braunschweig,DE91,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,44.89,Rate
Braunschweig,DE91,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,46.44,Rate
Braunschweig,DE91,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,42.06,Rate
Braunschweig,DE91,Total,Total,2011,Cerebrovascular diseases,72.89,Rate
Braunschweig,DE91,Total,Total,2012,Cerebrovascular diseases,69.99,Rate
Braunschweig,DE91,Total,Total,2013,Cerebrovascular diseases,72.29,Rate
Braunschweig,DE91,Total,Total,2014,Cerebrovascular diseases,67.62,Rate
Braunschweig,DE91,Total,Total,2015,Cerebrovascular diseases,64.36,Rate
Braunschweig,DE91,Total,Total,2016,Cerebrovascular diseases,57.82,Rate
Braunschweig,DE91,Total,Total,2017,Cerebrovascular diseases,61.95,Rate
Braunschweig,DE91,Total,Total,2018,Cerebrovascular diseases,60.88,Rate
Braunschweig,DE91,Total,Total,2019,Cerebrovascular diseases,56.45,Rate
Braunschweig,DE91,Total,Total,2020,Cerebrovascular diseases,52.77,Rate
Braunschweig,DE91,Total,Total,2011,Chronic lower respiratory diseases,36.17,Rate
Braunschweig,DE91,Total,Total,2012,Chronic lower respiratory diseases,38.64,Rate
Braunschweig,DE91,Total,Total,2013,Chronic lower respiratory diseases,41.19,Rate
Braunschweig,DE91,Total,Total,2014,Chronic lower respiratory diseases,36.97,Rate
Braunschweig,DE91,Total,Total,2015,Chronic lower respiratory diseases,42.74,Rate
Braunschweig,DE91,Total,Total,2016,Chronic lower respiratory diseases,44.95,Rate
Braunschweig,DE91,Total,Total,2017,Chronic lower respiratory diseases,43.88,Rate
Braunschweig,DE91,Total,Total,2018,Chronic lower respiratory diseases,46.81,Rate
Braunschweig,DE91,Total,Total,2019,Chronic lower respiratory diseases,44.16,Rate
Braunschweig,DE91,Total,Total,2020,Chronic lower respiratory diseases,40.51,Rate
Braunschweig,DE91,Total,Total,2011,Asthma and status asthmaticus,1.36,Rate
Braunschweig,DE91,Total,Total,2012,Asthma and status asthmaticus,1.83,Rate
Braunschweig,DE91,Total,Total,2013,Asthma and status asthmaticus,1.31,Rate
Braunschweig,DE91,Total,Total,2014,Asthma and status asthmaticus,1.38,Rate
Braunschweig,DE91,Total,Total,2015,Asthma and status asthmaticus,1.14,Rate
Braunschweig,DE91,Total,Total,2016,Asthma and status asthmaticus,1.07,Rate
Braunschweig,DE91,Total,Total,2017,Asthma and status asthmaticus,1.53,Rate
Braunschweig,DE91,Total,Total,2018,Asthma and status asthmaticus,1.04,Rate
Braunschweig,DE91,Total,Total,2019,Asthma and status asthmaticus,0.89,Rate
Braunschweig,DE91,Total,Total,2020,Asthma and status asthmaticus,1.2,Rate
Braunschweig,DE91,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4545.38,Rate
Braunschweig,DE91,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4555.13,Rate
Braunschweig,DE91,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4755.03,Rate
Braunschweig,DE91,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4474.3,Rate
Braunschweig,DE91,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4640.34,Rate
Braunschweig,DE91,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4548.35,Rate
Braunschweig,DE91,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4588.52,Rate
Braunschweig,DE91,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4642.48,Rate
Braunschweig,DE91,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4455.62,Rate
Braunschweig,DE91,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4523.49,Rate
Braunschweig,DE91,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.73,Rate
Braunschweig,DE91,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.22,Rate
Braunschweig,DE91,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.72,Rate
Braunschweig,DE91,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.86,Rate
Braunschweig,DE91,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.09,Rate
Braunschweig,DE91,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.03,Rate
Braunschweig,DE91,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.89,Rate
Braunschweig,DE91,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.83,Rate
Braunschweig,DE91,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.08,Rate
Braunschweig,DE91,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.26,Rate
Braunschweig,DE91,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",194.24,Rate
Braunschweig,DE91,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",197.61,Rate
Braunschweig,DE91,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",186.86,Rate
Braunschweig,DE91,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",186.72,Rate
Braunschweig,DE91,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",201.58,Rate
Braunschweig,DE91,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",190.34,Rate
Braunschweig,DE91,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",204.77,Rate
Braunschweig,DE91,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",179.64,Rate
Braunschweig,DE91,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",194.67,Rate
Braunschweig,DE91,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",200.27,Rate
Braunschweig,DE91,65 years or over,Total,2011,Malignant melanoma of skin,10.87,Rate
Braunschweig,DE91,65 years or over,Total,2012,Malignant melanoma of skin,10.3,Rate
Braunschweig,DE91,65 years or over,Total,2013,Malignant melanoma of skin,14.43,Rate
Braunschweig,DE91,65 years or over,Total,2014,Malignant melanoma of skin,10.65,Rate
Braunschweig,DE91,65 years or over,Total,2015,Malignant melanoma of skin,11.37,Rate
Braunschweig,DE91,65 years or over,Total,2016,Malignant melanoma of skin,10.32,Rate
Braunschweig,DE91,65 years or over,Total,2017,Malignant melanoma of skin,11.87,Rate
Braunschweig,DE91,65 years or over,Total,2018,Malignant melanoma of skin,11.12,Rate
Braunschweig,DE91,65 years or over,Total,2019,Malignant melanoma of skin,10.7,Rate
Braunschweig,DE91,65 years or over,Total,2020,Malignant melanoma of skin,10.37,Rate
Braunschweig,DE91,65 years or over,Total,2011,Malignant neoplasm of breast,75.02,Rate
Braunschweig,DE91,65 years or over,Total,2012,Malignant neoplasm of breast,75.6,Rate
Braunschweig,DE91,65 years or over,Total,2013,Malignant neoplasm of breast,71.29,Rate
Braunschweig,DE91,65 years or over,Total,2014,Malignant neoplasm of breast,67.53,Rate
Braunschweig,DE91,65 years or over,Total,2015,Malignant neoplasm of breast,72.14,Rate
Braunschweig,DE91,65 years or over,Total,2016,Malignant neoplasm of breast,83.45,Rate
Braunschweig,DE91,65 years or over,Total,2017,Malignant neoplasm of breast,76.34,Rate
Braunschweig,DE91,65 years or over,Total,2018,Malignant neoplasm of breast,82.02,Rate
Braunschweig,DE91,65 years or over,Total,2019,Malignant neoplasm of breast,71.55,Rate
Braunschweig,DE91,65 years or over,Total,2020,Malignant neoplasm of breast,72.08,Rate
Braunschweig,DE91,65 years or over,Total,2011,Diabetes mellitus,125.12,Rate
Braunschweig,DE91,65 years or over,Total,2012,Diabetes mellitus,122.37,Rate
Braunschweig,DE91,65 years or over,Total,2013,Diabetes mellitus,118.07,Rate
Braunschweig,DE91,65 years or over,Total,2014,Diabetes mellitus,118.46,Rate
Braunschweig,DE91,65 years or over,Total,2015,Diabetes mellitus,117.6,Rate
Braunschweig,DE91,65 years or over,Total,2016,Diabetes mellitus,129.69,Rate
Braunschweig,DE91,65 years or over,Total,2017,Diabetes mellitus,131.38,Rate
Braunschweig,DE91,65 years or over,Total,2018,Diabetes mellitus,132.75,Rate
Braunschweig,DE91,65 years or over,Total,2019,Diabetes mellitus,120.42,Rate
Braunschweig,DE91,65 years or over,Total,2020,Diabetes mellitus,127.29,Rate
Braunschweig,DE91,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),161.7,Rate
Braunschweig,DE91,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),186.29,Rate
Braunschweig,DE91,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),240.29,Rate
Braunschweig,DE91,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),231.22,Rate
Braunschweig,DE91,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),263.23,Rate
Braunschweig,DE91,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),268.92,Rate
Braunschweig,DE91,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),279.56,Rate
Braunschweig,DE91,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),314.84,Rate
Braunschweig,DE91,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),295.01,Rate
Braunschweig,DE91,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),294.84,Rate
Braunschweig,DE91,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.65,Rate
Braunschweig,DE91,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),8.57,Rate
Braunschweig,DE91,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),9.56,Rate
Braunschweig,DE91,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),10.11,Rate
Braunschweig,DE91,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),10.3,Rate
Braunschweig,DE91,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),9.72,Rate
Braunschweig,DE91,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),10.27,Rate
Braunschweig,DE91,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),11.63,Rate
Braunschweig,DE91,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),9.3,Rate
Braunschweig,DE91,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),7.79,Rate
Braunschweig,DE91,65 years or over,Total,2011,Other ischaemic heart diseases,521.46,Rate
Braunschweig,DE91,65 years or over,Total,2012,Other ischaemic heart diseases,535.2,Rate
Braunschweig,DE91,65 years or over,Total,2013,Other ischaemic heart diseases,547.21,Rate
Braunschweig,DE91,65 years or over,Total,2014,Other ischaemic heart diseases,499.49,Rate
Braunschweig,DE91,65 years or over,Total,2015,Other ischaemic heart diseases,511.8,Rate
Braunschweig,DE91,65 years or over,Total,2016,Other ischaemic heart diseases,506.21,Rate
Braunschweig,DE91,65 years or over,Total,2017,Other ischaemic heart diseases,512.61,Rate
Braunschweig,DE91,65 years or over,Total,2018,Other ischaemic heart diseases,518.15,Rate
Braunschweig,DE91,65 years or over,Total,2019,Other ischaemic heart diseases,479.88,Rate
Braunschweig,DE91,65 years or over,Total,2020,Other ischaemic heart diseases,494.53,Rate
Braunschweig,DE91,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,300.92,Rate
Braunschweig,DE91,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,306.07,Rate
Braunschweig,DE91,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,283.4,Rate
Braunschweig,DE91,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,253.32,Rate
Braunschweig,DE91,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,258.56,Rate
Braunschweig,DE91,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,235.84,Rate
Braunschweig,DE91,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,214.2,Rate
Braunschweig,DE91,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,192.63,Rate
Braunschweig,DE91,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,193.95,Rate
Braunschweig,DE91,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,175.39,Rate
Braunschweig,DE91,65 years or over,Total,2011,Cerebrovascular diseases,343.39,Rate
Braunschweig,DE91,65 years or over,Total,2012,Cerebrovascular diseases,337.31,Rate
Braunschweig,DE91,65 years or over,Total,2013,Cerebrovascular diseases,341.42,Rate
Braunschweig,DE91,65 years or over,Total,2014,Cerebrovascular diseases,321.37,Rate
Braunschweig,DE91,65 years or over,Total,2015,Cerebrovascular diseases,309.86,Rate
Braunschweig,DE91,65 years or over,Total,2016,Cerebrovascular diseases,272.54,Rate
Braunschweig,DE91,65 years or over,Total,2017,Cerebrovascular diseases,294.93,Rate
Braunschweig,DE91,65 years or over,Total,2018,Cerebrovascular diseases,288.77,Rate
Braunschweig,DE91,65 years or over,Total,2019,Cerebrovascular diseases,265.17,Rate
Braunschweig,DE91,65 years or over,Total,2020,Cerebrovascular diseases,248.18,Rate
Braunschweig,DE91,65 years or over,Total,2011,Chronic lower respiratory diseases,158.86,Rate
Braunschweig,DE91,65 years or over,Total,2012,Chronic lower respiratory diseases,168.25,Rate
Braunschweig,DE91,65 years or over,Total,2013,Chronic lower respiratory diseases,189.6,Rate
Braunschweig,DE91,65 years or over,Total,2014,Chronic lower respiratory diseases,164.84,Rate
Braunschweig,DE91,65 years or over,Total,2015,Chronic lower respiratory diseases,191.93,Rate
Braunschweig,DE91,65 years or over,Total,2016,Chronic lower respiratory diseases,193.43,Rate
Braunschweig,DE91,65 years or over,Total,2017,Chronic lower respiratory diseases,197.44,Rate
Braunschweig,DE91,65 years or over,Total,2018,Chronic lower respiratory diseases,207.99,Rate
Braunschweig,DE91,65 years or over,Total,2019,Chronic lower respiratory diseases,193.46,Rate
Braunschweig,DE91,65 years or over,Total,2020,Chronic lower respiratory diseases,182.03,Rate
Braunschweig,DE91,65 years or over,Total,2011,Asthma and status asthmaticus,4.78,Rate
Braunschweig,DE91,65 years or over,Total,2012,Asthma and status asthmaticus,4.98,Rate
Braunschweig,DE91,65 years or over,Total,2013,Asthma and status asthmaticus,4.25,Rate
Braunschweig,DE91,65 years or over,Total,2014,Asthma and status asthmaticus,4.88,Rate
Braunschweig,DE91,65 years or over,Total,2015,Asthma and status asthmaticus,4.69,Rate
Braunschweig,DE91,65 years or over,Total,2016,Asthma and status asthmaticus,4.25,Rate
Braunschweig,DE91,65 years or over,Total,2017,Asthma and status asthmaticus,5.98,Rate
Braunschweig,DE91,65 years or over,Total,2018,Asthma and status asthmaticus,3.9,Rate
Braunschweig,DE91,65 years or over,Total,2019,Asthma and status asthmaticus,3.7,Rate
Braunschweig,DE91,65 years or over,Total,2020,Asthma and status asthmaticus,3.87,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,215.67,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,216.66,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,215.79,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,210.98,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,213.69,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,213.3,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,207.5,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,210.65,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,204.79,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,197.51,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.71,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.58,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.8,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.48,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.81,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.61,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.97,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.55,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.02,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.69,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",18.8,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",19.6,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",20.59,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.82,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",20.1,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",19.92,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",19.72,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",18.35,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",17.23,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",16.33,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Malignant melanoma of skin,1.52,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Malignant melanoma of skin,1.06,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Malignant melanoma of skin,1.73,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Malignant melanoma of skin,0.94,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Malignant melanoma of skin,0.95,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Malignant melanoma of skin,1.45,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Malignant melanoma of skin,1.28,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Malignant melanoma of skin,1.25,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Malignant melanoma of skin,1.04,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Malignant melanoma of skin,1.43,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.11,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.2,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.13,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.23,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Malignant neoplasm of breast,8.73,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.93,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.45,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.69,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.68,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.26,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Diabetes mellitus,3.2,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Diabetes mellitus,3.35,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Diabetes mellitus,4.22,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Diabetes mellitus,3.4,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Diabetes mellitus,3.73,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Diabetes mellitus,3.2,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Diabetes mellitus,3.93,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Diabetes mellitus,2.98,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Diabetes mellitus,4.05,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Diabetes mellitus,3.99,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),6.19,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),6.65,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),9.9,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),9.6,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),10.78,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),9.58,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),9.42,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),9.69,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),8.88,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),9.61,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.37,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.31,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.31,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.79,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Other ischaemic heart diseases,6.95,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Other ischaemic heart diseases,7.86,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Other ischaemic heart diseases,6.83,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Other ischaemic heart diseases,7.11,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Other ischaemic heart diseases,8.42,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Other ischaemic heart diseases,7.65,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Other ischaemic heart diseases,8.45,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Other ischaemic heart diseases,9.11,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.98,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Other ischaemic heart diseases,7.29,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,14.44,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,12.17,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,14.07,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,12.02,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,12.54,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.79,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,9.58,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,9.11,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,10.71,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,9.76,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Cerebrovascular diseases,7.36,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Cerebrovascular diseases,5.23,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Cerebrovascular diseases,7.09,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Cerebrovascular diseases,6.16,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Cerebrovascular diseases,4.89,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Cerebrovascular diseases,5.8,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Cerebrovascular diseases,5.51,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Cerebrovascular diseases,5.67,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Cerebrovascular diseases,5.88,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Cerebrovascular diseases,5.44,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.45,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Chronic lower respiratory diseases,7.25,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Chronic lower respiratory diseases,5.24,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.99,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Chronic lower respiratory diseases,6.61,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Chronic lower respiratory diseases,8.98,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.69,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Chronic lower respiratory diseases,7.76,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Chronic lower respiratory diseases,7.99,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Chronic lower respiratory diseases,6.22,Rate
Braunschweig,DE91,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.54,Rate
Braunschweig,DE91,Less than 65 years,Total,2012,Asthma and status asthmaticus,1.06,Rate
Braunschweig,DE91,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.59,Rate
Braunschweig,DE91,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.53,Rate
Braunschweig,DE91,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.28,Rate
Braunschweig,DE91,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.3,Rate
Braunschweig,DE91,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.46,Rate
Braunschweig,DE91,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.35,Rate
Braunschweig,DE91,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.21,Rate
Braunschweig,DE91,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.55,Rate
Arnsberg,DEA5,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,912.44,Rate
Arnsberg,DEA5,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,935.94,Rate
Arnsberg,DEA5,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,958.42,Rate
Arnsberg,DEA5,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,898.23,Rate
Arnsberg,DEA5,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,945.32,Rate
Arnsberg,DEA5,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,905.7,Rate
Arnsberg,DEA5,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,893.32,Rate
Arnsberg,DEA5,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,925.05,Rate
Arnsberg,DEA5,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,882.9,Rate
Arnsberg,DEA5,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,902.7,Rate
Arnsberg,DEA5,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.21,Rate
Arnsberg,DEA5,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.55,Rate
Arnsberg,DEA5,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.91,Rate
Arnsberg,DEA5,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.84,Rate
Arnsberg,DEA5,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.92,Rate
Arnsberg,DEA5,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.17,Rate
Arnsberg,DEA5,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.19,Rate
Arnsberg,DEA5,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.0,Rate
Arnsberg,DEA5,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.04,Rate
Arnsberg,DEA5,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.83,Rate
Arnsberg,DEA5,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",36.56,Rate
Arnsberg,DEA5,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",38.77,Rate
Arnsberg,DEA5,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",40.79,Rate
Arnsberg,DEA5,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",40.44,Rate
Arnsberg,DEA5,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",41.39,Rate
Arnsberg,DEA5,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",43.28,Rate
Arnsberg,DEA5,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",42.82,Rate
Arnsberg,DEA5,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",45.31,Rate
Arnsberg,DEA5,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",42.39,Rate
Arnsberg,DEA5,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",43.6,Rate
Arnsberg,DEA5,Total,Females,2011,Malignant melanoma of skin,1.86,Rate
Arnsberg,DEA5,Total,Females,2012,Malignant melanoma of skin,2.44,Rate
Arnsberg,DEA5,Total,Females,2013,Malignant melanoma of skin,2.49,Rate
Arnsberg,DEA5,Total,Females,2014,Malignant melanoma of skin,3.13,Rate
Arnsberg,DEA5,Total,Females,2015,Malignant melanoma of skin,2.78,Rate
Arnsberg,DEA5,Total,Females,2016,Malignant melanoma of skin,2.85,Rate
Arnsberg,DEA5,Total,Females,2017,Malignant melanoma of skin,2.05,Rate
Arnsberg,DEA5,Total,Females,2018,Malignant melanoma of skin,2.16,Rate
Arnsberg,DEA5,Total,Females,2019,Malignant melanoma of skin,2.48,Rate
Arnsberg,DEA5,Total,Females,2020,Malignant melanoma of skin,2.47,Rate
Arnsberg,DEA5,Total,Females,2011,Malignant neoplasm of breast,40.34,Rate
Arnsberg,DEA5,Total,Females,2012,Malignant neoplasm of breast,40.35,Rate
Arnsberg,DEA5,Total,Females,2013,Malignant neoplasm of breast,39.14,Rate
Arnsberg,DEA5,Total,Females,2014,Malignant neoplasm of breast,39.6,Rate
Arnsberg,DEA5,Total,Females,2015,Malignant neoplasm of breast,40.03,Rate
Arnsberg,DEA5,Total,Females,2016,Malignant neoplasm of breast,41.3,Rate
Arnsberg,DEA5,Total,Females,2017,Malignant neoplasm of breast,35.48,Rate
Arnsberg,DEA5,Total,Females,2018,Malignant neoplasm of breast,38.8,Rate
Arnsberg,DEA5,Total,Females,2019,Malignant neoplasm of breast,37.88,Rate
Arnsberg,DEA5,Total,Females,2020,Malignant neoplasm of breast,35.58,Rate
Arnsberg,DEA5,Total,Females,2011,Diabetes mellitus,15.85,Rate
Arnsberg,DEA5,Total,Females,2012,Diabetes mellitus,15.1,Rate
Arnsberg,DEA5,Total,Females,2013,Diabetes mellitus,16.01,Rate
Arnsberg,DEA5,Total,Females,2014,Diabetes mellitus,14.24,Rate
Arnsberg,DEA5,Total,Females,2015,Diabetes mellitus,16.64,Rate
Arnsberg,DEA5,Total,Females,2016,Diabetes mellitus,15.72,Rate
Arnsberg,DEA5,Total,Females,2017,Diabetes mellitus,22.05,Rate
Arnsberg,DEA5,Total,Females,2018,Diabetes mellitus,22.78,Rate
Arnsberg,DEA5,Total,Females,2019,Diabetes mellitus,21.06,Rate
Arnsberg,DEA5,Total,Females,2020,Diabetes mellitus,21.92,Rate
Arnsberg,DEA5,Total,Females,2011,Mental and behavioural disorders (F00-F99),29.78,Rate
Arnsberg,DEA5,Total,Females,2012,Mental and behavioural disorders (F00-F99),28.79,Rate
Arnsberg,DEA5,Total,Females,2013,Mental and behavioural disorders (F00-F99),35.33,Rate
Arnsberg,DEA5,Total,Females,2014,Mental and behavioural disorders (F00-F99),33.76,Rate
Arnsberg,DEA5,Total,Females,2015,Mental and behavioural disorders (F00-F99),47.59,Rate
Arnsberg,DEA5,Total,Females,2016,Mental and behavioural disorders (F00-F99),57.0,Rate
Arnsberg,DEA5,Total,Females,2017,Mental and behavioural disorders (F00-F99),69.47,Rate
Arnsberg,DEA5,Total,Females,2018,Mental and behavioural disorders (F00-F99),73.28,Rate
Arnsberg,DEA5,Total,Females,2019,Mental and behavioural disorders (F00-F99),76.0,Rate
Arnsberg,DEA5,Total,Females,2020,Mental and behavioural disorders (F00-F99),75.5,Rate
Arnsberg,DEA5,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Arnsberg,DEA5,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Arnsberg,DEA5,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Arnsberg,DEA5,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Arnsberg,DEA5,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Arnsberg,DEA5,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Arnsberg,DEA5,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.43,Rate
Arnsberg,DEA5,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.1,Rate
Arnsberg,DEA5,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.96,Rate
Arnsberg,DEA5,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.66,Rate
Arnsberg,DEA5,Total,Females,2011,Other ischaemic heart diseases,52.73,Rate
Arnsberg,DEA5,Total,Females,2012,Other ischaemic heart diseases,56.19,Rate
Arnsberg,DEA5,Total,Females,2013,Other ischaemic heart diseases,52.59,Rate
Arnsberg,DEA5,Total,Females,2014,Other ischaemic heart diseases,44.63,Rate
Arnsberg,DEA5,Total,Females,2015,Other ischaemic heart diseases,48.46,Rate
Arnsberg,DEA5,Total,Females,2016,Other ischaemic heart diseases,45.15,Rate
Arnsberg,DEA5,Total,Females,2017,Other ischaemic heart diseases,59.17,Rate
Arnsberg,DEA5,Total,Females,2018,Other ischaemic heart diseases,52.57,Rate
Arnsberg,DEA5,Total,Females,2019,Other ischaemic heart diseases,48.15,Rate
Arnsberg,DEA5,Total,Females,2020,Other ischaemic heart diseases,48.94,Rate
Arnsberg,DEA5,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,45.09,Rate
Arnsberg,DEA5,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,43.75,Rate
Arnsberg,DEA5,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,43.05,Rate
Arnsberg,DEA5,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,40.05,Rate
Arnsberg,DEA5,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,34.78,Rate
Arnsberg,DEA5,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,33.37,Rate
Arnsberg,DEA5,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,27.55,Rate
Arnsberg,DEA5,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,28.28,Rate
Arnsberg,DEA5,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,24.17,Rate
Arnsberg,DEA5,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,23.32,Rate
Arnsberg,DEA5,Total,Females,2011,Cerebrovascular diseases,70.52,Rate
Arnsberg,DEA5,Total,Females,2012,Cerebrovascular diseases,65.04,Rate
Arnsberg,DEA5,Total,Females,2013,Cerebrovascular diseases,63.98,Rate
Arnsberg,DEA5,Total,Females,2014,Cerebrovascular diseases,59.98,Rate
Arnsberg,DEA5,Total,Females,2015,Cerebrovascular diseases,54.07,Rate
Arnsberg,DEA5,Total,Females,2016,Cerebrovascular diseases,54.19,Rate
Arnsberg,DEA5,Total,Females,2017,Cerebrovascular diseases,47.58,Rate
Arnsberg,DEA5,Total,Females,2018,Cerebrovascular diseases,53.02,Rate
Arnsberg,DEA5,Total,Females,2019,Cerebrovascular diseases,50.77,Rate
Arnsberg,DEA5,Total,Females,2020,Cerebrovascular diseases,47.41,Rate
Arnsberg,DEA5,Total,Females,2011,Chronic lower respiratory diseases,32.41,Rate
Arnsberg,DEA5,Total,Females,2012,Chronic lower respiratory diseases,34.31,Rate
Arnsberg,DEA5,Total,Females,2013,Chronic lower respiratory diseases,37.21,Rate
Arnsberg,DEA5,Total,Females,2014,Chronic lower respiratory diseases,31.26,Rate
Arnsberg,DEA5,Total,Females,2015,Chronic lower respiratory diseases,33.05,Rate
Arnsberg,DEA5,Total,Females,2016,Chronic lower respiratory diseases,32.25,Rate
Arnsberg,DEA5,Total,Females,2017,Chronic lower respiratory diseases,36.43,Rate
Arnsberg,DEA5,Total,Females,2018,Chronic lower respiratory diseases,38.13,Rate
Arnsberg,DEA5,Total,Females,2019,Chronic lower respiratory diseases,32.34,Rate
Arnsberg,DEA5,Total,Females,2020,Chronic lower respiratory diseases,31.09,Rate
Arnsberg,DEA5,Total,Females,2011,Asthma and status asthmaticus,1.31,Rate
Arnsberg,DEA5,Total,Females,2012,Asthma and status asthmaticus,1.66,Rate
Arnsberg,DEA5,Total,Females,2013,Asthma and status asthmaticus,1.7,Rate
Arnsberg,DEA5,Total,Females,2014,Asthma and status asthmaticus,1.2,Rate
Arnsberg,DEA5,Total,Females,2015,Asthma and status asthmaticus,1.35,Rate
Arnsberg,DEA5,Total,Females,2016,Asthma and status asthmaticus,1.0,Rate
Arnsberg,DEA5,Total,Females,2017,Asthma and status asthmaticus,1.5,Rate
Arnsberg,DEA5,Total,Females,2018,Asthma and status asthmaticus,1.25,Rate
Arnsberg,DEA5,Total,Females,2019,Asthma and status asthmaticus,1.34,Rate
Arnsberg,DEA5,Total,Females,2020,Asthma and status asthmaticus,1.03,Rate
Arnsberg,DEA5,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4011.88,Rate
Arnsberg,DEA5,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4136.13,Rate
Arnsberg,DEA5,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4221.8,Rate
Arnsberg,DEA5,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3949.11,Rate
Arnsberg,DEA5,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4167.75,Rate
Arnsberg,DEA5,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3997.74,Rate
Arnsberg,DEA5,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3937.04,Rate
Arnsberg,DEA5,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,4082.32,Rate
Arnsberg,DEA5,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3896.69,Rate
Arnsberg,DEA5,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3990.05,Rate
Arnsberg,DEA5,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.55,Rate
Arnsberg,DEA5,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",120.23,Rate
Arnsberg,DEA5,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.27,Rate
Arnsberg,DEA5,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.77,Rate
Arnsberg,DEA5,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.17,Rate
Arnsberg,DEA5,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.16,Rate
Arnsberg,DEA5,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.18,Rate
Arnsberg,DEA5,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.76,Rate
Arnsberg,DEA5,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.67,Rate
Arnsberg,DEA5,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.97,Rate
Arnsberg,DEA5,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",112.72,Rate
Arnsberg,DEA5,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",119.35,Rate
Arnsberg,DEA5,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",134.56,Rate
Arnsberg,DEA5,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",127.94,Rate
Arnsberg,DEA5,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",135.32,Rate
Arnsberg,DEA5,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",150.39,Rate
Arnsberg,DEA5,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",145.33,Rate
Arnsberg,DEA5,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",154.67,Rate
Arnsberg,DEA5,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",148.11,Rate
Arnsberg,DEA5,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",154.06,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Malignant melanoma of skin,6.89,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Malignant melanoma of skin,8.16,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Malignant melanoma of skin,7.92,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Malignant melanoma of skin,12.01,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Malignant melanoma of skin,10.52,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Malignant melanoma of skin,11.96,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Malignant melanoma of skin,7.06,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Malignant melanoma of skin,9.33,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Malignant melanoma of skin,9.68,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Malignant melanoma of skin,7.69,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Malignant neoplasm of breast,138.61,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Malignant neoplasm of breast,144.94,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Malignant neoplasm of breast,137.54,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Malignant neoplasm of breast,145.01,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Malignant neoplasm of breast,148.22,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Malignant neoplasm of breast,147.49,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Malignant neoplasm of breast,128.05,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Malignant neoplasm of breast,137.09,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Malignant neoplasm of breast,134.73,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Malignant neoplasm of breast,125.04,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Diabetes mellitus,76.01,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Diabetes mellitus,73.73,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Diabetes mellitus,74.29,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Diabetes mellitus,66.4,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Diabetes mellitus,80.9,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Diabetes mellitus,73.98,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Diabetes mellitus,103.52,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Diabetes mellitus,108.37,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Diabetes mellitus,99.57,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Diabetes mellitus,106.97,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),137.61,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),136.15,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),168.41,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),158.55,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),231.62,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),282.22,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),341.49,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),364.38,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),376.03,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),374.0,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.68,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.57,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.01,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.86,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),5.18,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),5.21,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),10.17,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),8.32,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),7.3,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),11.43,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Other ischaemic heart diseases,263.52,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Other ischaemic heart diseases,278.0,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Other ischaemic heart diseases,261.79,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Other ischaemic heart diseases,220.33,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Other ischaemic heart diseases,238.35,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Other ischaemic heart diseases,223.0,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Other ischaemic heart diseases,296.83,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Other ischaemic heart diseases,261.47,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Other ischaemic heart diseases,235.68,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Other ischaemic heart diseases,242.71,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,209.65,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,201.51,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,198.35,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,187.54,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,161.61,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,152.84,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,128.33,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,127.76,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,111.21,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,105.42,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Cerebrovascular diseases,339.17,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Cerebrovascular diseases,314.92,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Cerebrovascular diseases,306.9,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Cerebrovascular diseases,286.51,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Cerebrovascular diseases,257.02,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Cerebrovascular diseases,256.6,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Cerebrovascular diseases,230.7,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Cerebrovascular diseases,249.89,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Cerebrovascular diseases,242.76,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Cerebrovascular diseases,225.94,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Chronic lower respiratory diseases,143.3,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Chronic lower respiratory diseases,152.39,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Chronic lower respiratory diseases,165.55,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Chronic lower respiratory diseases,138.72,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Chronic lower respiratory diseases,143.31,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Chronic lower respiratory diseases,141.32,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Chronic lower respiratory diseases,158.96,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Chronic lower respiratory diseases,169.05,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Chronic lower respiratory diseases,141.35,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Chronic lower respiratory diseases,139.67,Rate
Arnsberg,DEA5,65 years or over,Females,2011,Asthma and status asthmaticus,5.95,Rate
Arnsberg,DEA5,65 years or over,Females,2012,Asthma and status asthmaticus,7.22,Rate
Arnsberg,DEA5,65 years or over,Females,2013,Asthma and status asthmaticus,7.14,Rate
Arnsberg,DEA5,65 years or over,Females,2014,Asthma and status asthmaticus,5.21,Rate
Arnsberg,DEA5,65 years or over,Females,2015,Asthma and status asthmaticus,5.87,Rate
Arnsberg,DEA5,65 years or over,Females,2016,Asthma and status asthmaticus,3.86,Rate
Arnsberg,DEA5,65 years or over,Females,2017,Asthma and status asthmaticus,4.86,Rate
Arnsberg,DEA5,65 years or over,Females,2018,Asthma and status asthmaticus,5.19,Rate
Arnsberg,DEA5,65 years or over,Females,2019,Asthma and status asthmaticus,5.21,Rate
Arnsberg,DEA5,65 years or over,Females,2020,Asthma and status asthmaticus,5.26,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,161.65,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,160.74,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,167.91,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,159.19,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,164.72,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,156.7,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,156.02,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,160.25,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,152.85,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,154.83,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.63,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.1,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.23,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.82,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.99,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.3,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.03,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.17,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.45,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.63,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",18.11,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",19.25,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.07,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",19.24,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",18.64,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",17.34,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",17.99,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",18.82,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",16.78,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",16.84,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Malignant melanoma of skin,0.64,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Malignant melanoma of skin,1.06,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Malignant melanoma of skin,1.18,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Malignant melanoma of skin,0.98,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Malignant melanoma of skin,0.91,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Malignant melanoma of skin,0.64,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Malignant melanoma of skin,0.83,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Malignant melanoma of skin,0.42,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Malignant melanoma of skin,0.73,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Malignant melanoma of skin,1.21,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Malignant neoplasm of breast,16.54,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Malignant neoplasm of breast,15.02,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.31,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.07,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Malignant neoplasm of breast,13.82,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.58,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.05,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.98,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Malignant neoplasm of breast,14.42,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Malignant neoplasm of breast,13.91,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Diabetes mellitus,1.28,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Diabetes mellitus,0.9,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Diabetes mellitus,1.89,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Diabetes mellitus,1.6,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Diabetes mellitus,1.07,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Diabetes mellitus,1.6,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Diabetes mellitus,2.32,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Diabetes mellitus,2.04,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Diabetes mellitus,2.04,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Diabetes mellitus,1.32,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),3.66,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.78,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),3.09,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),3.53,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),3.02,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.45,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),3.58,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.76,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.32,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.19,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.19,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.67,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.67,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.46,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.92,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.07,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.46,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Other ischaemic heart diseases,2.06,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.61,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.97,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.73,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.01,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.22,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.54,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.43,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.32,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.06,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.43,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.14,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,4.19,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,3.09,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.43,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Cerebrovascular diseases,5.45,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Cerebrovascular diseases,4.51,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Cerebrovascular diseases,5.13,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Cerebrovascular diseases,5.1,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Cerebrovascular diseases,4.91,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Cerebrovascular diseases,5.16,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Cerebrovascular diseases,3.22,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Cerebrovascular diseases,5.33,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Cerebrovascular diseases,4.26,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Cerebrovascular diseases,4.16,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Chronic lower respiratory diseases,5.54,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.7,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Chronic lower respiratory diseases,6.13,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Chronic lower respiratory diseases,5.23,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Chronic lower respiratory diseases,6.35,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Chronic lower respiratory diseases,5.82,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Chronic lower respiratory diseases,6.75,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Chronic lower respiratory diseases,6.42,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Chronic lower respiratory diseases,5.93,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Chronic lower respiratory diseases,4.79,Rate
Arnsberg,DEA5,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.19,Rate
Arnsberg,DEA5,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.31,Rate
Arnsberg,DEA5,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.38,Rate
Arnsberg,DEA5,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.23,Rate
Arnsberg,DEA5,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.26,Rate
Arnsberg,DEA5,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.3,Rate
Arnsberg,DEA5,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.68,Rate
Arnsberg,DEA5,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.3,Rate
Arnsberg,DEA5,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.4,Rate
Arnsberg,DEA5,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Arnsberg,DEA5,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1436.75,Rate
Arnsberg,DEA5,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1403.84,Rate
Arnsberg,DEA5,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1439.13,Rate
Arnsberg,DEA5,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1361.82,Rate
Arnsberg,DEA5,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1404.85,Rate
Arnsberg,DEA5,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1364.48,Rate
Arnsberg,DEA5,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1353.67,Rate
Arnsberg,DEA5,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1352.73,Rate
Arnsberg,DEA5,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1309.77,Rate
Arnsberg,DEA5,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1340.03,Rate
Arnsberg,DEA5,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.28,Rate
Arnsberg,DEA5,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.55,Rate
Arnsberg,DEA5,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.12,Rate
Arnsberg,DEA5,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.96,Rate
Arnsberg,DEA5,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.95,Rate
Arnsberg,DEA5,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.66,Rate
Arnsberg,DEA5,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.72,Rate
Arnsberg,DEA5,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.83,Rate
Arnsberg,DEA5,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.47,Rate
Arnsberg,DEA5,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.99,Rate
Arnsberg,DEA5,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",102.66,Rate
Arnsberg,DEA5,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",98.81,Rate
Arnsberg,DEA5,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",98.02,Rate
Arnsberg,DEA5,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",98.58,Rate
Arnsberg,DEA5,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",89.71,Rate
Arnsberg,DEA5,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",95.12,Rate
Arnsberg,DEA5,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",83.74,Rate
Arnsberg,DEA5,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",82.86,Rate
Arnsberg,DEA5,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",80.02,Rate
Arnsberg,DEA5,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",82.93,Rate
Arnsberg,DEA5,Total,Males,2011,Malignant melanoma of skin,5.26,Rate
Arnsberg,DEA5,Total,Males,2012,Malignant melanoma of skin,4.69,Rate
Arnsberg,DEA5,Total,Males,2013,Malignant melanoma of skin,5.15,Rate
Arnsberg,DEA5,Total,Males,2014,Malignant melanoma of skin,4.43,Rate
Arnsberg,DEA5,Total,Males,2015,Malignant melanoma of skin,4.98,Rate
Arnsberg,DEA5,Total,Males,2016,Malignant melanoma of skin,4.16,Rate
Arnsberg,DEA5,Total,Males,2017,Malignant melanoma of skin,4.36,Rate
Arnsberg,DEA5,Total,Males,2018,Malignant melanoma of skin,5.42,Rate
Arnsberg,DEA5,Total,Males,2019,Malignant melanoma of skin,3.89,Rate
Arnsberg,DEA5,Total,Males,2020,Malignant melanoma of skin,4.54,Rate
Arnsberg,DEA5,Total,Males,2011,Malignant neoplasm of breast,0.39,Rate
Arnsberg,DEA5,Total,Males,2012,Malignant neoplasm of breast,0.52,Rate
Arnsberg,DEA5,Total,Males,2013,Malignant neoplasm of breast,0.23,Rate
Arnsberg,DEA5,Total,Males,2014,Malignant neoplasm of breast,0.21,Rate
Arnsberg,DEA5,Total,Males,2015,Malignant neoplasm of breast,0.39,Rate
Arnsberg,DEA5,Total,Males,2016,Malignant neoplasm of breast,0.35,Rate
Arnsberg,DEA5,Total,Males,2017,Malignant neoplasm of breast,0.75,Rate
Arnsberg,DEA5,Total,Males,2018,Malignant neoplasm of breast,0.78,Rate
Arnsberg,DEA5,Total,Males,2019,Malignant neoplasm of breast,0.42,Rate
Arnsberg,DEA5,Total,Males,2020,Malignant neoplasm of breast,0.21,Rate
Arnsberg,DEA5,Total,Males,2011,Diabetes mellitus,20.91,Rate
Arnsberg,DEA5,Total,Males,2012,Diabetes mellitus,17.86,Rate
Arnsberg,DEA5,Total,Males,2013,Diabetes mellitus,21.33,Rate
Arnsberg,DEA5,Total,Males,2014,Diabetes mellitus,17.13,Rate
Arnsberg,DEA5,Total,Males,2015,Diabetes mellitus,21.01,Rate
Arnsberg,DEA5,Total,Males,2016,Diabetes mellitus,23.45,Rate
Arnsberg,DEA5,Total,Males,2017,Diabetes mellitus,34.1,Rate
Arnsberg,DEA5,Total,Males,2018,Diabetes mellitus,33.28,Rate
Arnsberg,DEA5,Total,Males,2019,Diabetes mellitus,27.94,Rate
Arnsberg,DEA5,Total,Males,2020,Diabetes mellitus,29.63,Rate
Arnsberg,DEA5,Total,Males,2011,Mental and behavioural disorders (F00-F99),34.76,Rate
Arnsberg,DEA5,Total,Males,2012,Mental and behavioural disorders (F00-F99),36.38,Rate
Arnsberg,DEA5,Total,Males,2013,Mental and behavioural disorders (F00-F99),37.77,Rate
Arnsberg,DEA5,Total,Males,2014,Mental and behavioural disorders (F00-F99),37.0,Rate
Arnsberg,DEA5,Total,Males,2015,Mental and behavioural disorders (F00-F99),48.29,Rate
Arnsberg,DEA5,Total,Males,2016,Mental and behavioural disorders (F00-F99),54.37,Rate
Arnsberg,DEA5,Total,Males,2017,Mental and behavioural disorders (F00-F99),68.67,Rate
Arnsberg,DEA5,Total,Males,2018,Mental and behavioural disorders (F00-F99),71.17,Rate
Arnsberg,DEA5,Total,Males,2019,Mental and behavioural disorders (F00-F99),69.25,Rate
Arnsberg,DEA5,Total,Males,2020,Mental and behavioural disorders (F00-F99),73.16,Rate
Arnsberg,DEA5,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Arnsberg,DEA5,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Arnsberg,DEA5,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Arnsberg,DEA5,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Arnsberg,DEA5,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Arnsberg,DEA5,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.24,Rate
Arnsberg,DEA5,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.59,Rate
Arnsberg,DEA5,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.89,Rate
Arnsberg,DEA5,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.38,Rate
Arnsberg,DEA5,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),3.16,Rate
Arnsberg,DEA5,Total,Males,2011,Other ischaemic heart diseases,102.59,Rate
Arnsberg,DEA5,Total,Males,2012,Other ischaemic heart diseases,93.66,Rate
Arnsberg,DEA5,Total,Males,2013,Other ischaemic heart diseases,89.8,Rate
Arnsberg,DEA5,Total,Males,2014,Other ischaemic heart diseases,85.45,Rate
Arnsberg,DEA5,Total,Males,2015,Other ischaemic heart diseases,93.03,Rate
Arnsberg,DEA5,Total,Males,2016,Other ischaemic heart diseases,93.3,Rate
Arnsberg,DEA5,Total,Males,2017,Other ischaemic heart diseases,119.56,Rate
Arnsberg,DEA5,Total,Males,2018,Other ischaemic heart diseases,114.32,Rate
Arnsberg,DEA5,Total,Males,2019,Other ischaemic heart diseases,103.97,Rate
Arnsberg,DEA5,Total,Males,2020,Other ischaemic heart diseases,95.03,Rate
Arnsberg,DEA5,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,92.2,Rate
Arnsberg,DEA5,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,94.82,Rate
Arnsberg,DEA5,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,91.42,Rate
Arnsberg,DEA5,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,77.36,Rate
Arnsberg,DEA5,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,73.28,Rate
Arnsberg,DEA5,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,70.1,Rate
Arnsberg,DEA5,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,59.86,Rate
Arnsberg,DEA5,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,58.13,Rate
Arnsberg,DEA5,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,51.12,Rate
Arnsberg,DEA5,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,48.84,Rate
Arnsberg,DEA5,Total,Males,2011,Cerebrovascular diseases,76.75,Rate
Arnsberg,DEA5,Total,Males,2012,Cerebrovascular diseases,74.93,Rate
Arnsberg,DEA5,Total,Males,2013,Cerebrovascular diseases,74.04,Rate
Arnsberg,DEA5,Total,Males,2014,Cerebrovascular diseases,69.26,Rate
Arnsberg,DEA5,Total,Males,2015,Cerebrovascular diseases,64.19,Rate
Arnsberg,DEA5,Total,Males,2016,Cerebrovascular diseases,64.39,Rate
Arnsberg,DEA5,Total,Males,2017,Cerebrovascular diseases,67.08,Rate
Arnsberg,DEA5,Total,Males,2018,Cerebrovascular diseases,63.47,Rate
Arnsberg,DEA5,Total,Males,2019,Cerebrovascular diseases,59.16,Rate
Arnsberg,DEA5,Total,Males,2020,Cerebrovascular diseases,60.48,Rate
Arnsberg,DEA5,Total,Males,2011,Chronic lower respiratory diseases,68.65,Rate
Arnsberg,DEA5,Total,Males,2012,Chronic lower respiratory diseases,71.54,Rate
Arnsberg,DEA5,Total,Males,2013,Chronic lower respiratory diseases,67.83,Rate
Arnsberg,DEA5,Total,Males,2014,Chronic lower respiratory diseases,60.56,Rate
Arnsberg,DEA5,Total,Males,2015,Chronic lower respiratory diseases,65.93,Rate
Arnsberg,DEA5,Total,Males,2016,Chronic lower respiratory diseases,58.99,Rate
Arnsberg,DEA5,Total,Males,2017,Chronic lower respiratory diseases,59.85,Rate
Arnsberg,DEA5,Total,Males,2018,Chronic lower respiratory diseases,64.08,Rate
Arnsberg,DEA5,Total,Males,2019,Chronic lower respiratory diseases,55.25,Rate
Arnsberg,DEA5,Total,Males,2020,Chronic lower respiratory diseases,50.77,Rate
Arnsberg,DEA5,Total,Males,2011,Asthma and status asthmaticus,1.7,Rate
Arnsberg,DEA5,Total,Males,2012,Asthma and status asthmaticus,1.55,Rate
Arnsberg,DEA5,Total,Males,2013,Asthma and status asthmaticus,1.36,Rate
Arnsberg,DEA5,Total,Males,2014,Asthma and status asthmaticus,1.37,Rate
Arnsberg,DEA5,Total,Males,2015,Asthma and status asthmaticus,1.29,Rate
Arnsberg,DEA5,Total,Males,2016,Asthma and status asthmaticus,1.18,Rate
Arnsberg,DEA5,Total,Males,2017,Asthma and status asthmaticus,0.77,Rate
Arnsberg,DEA5,Total,Males,2018,Asthma and status asthmaticus,0.9,Rate
Arnsberg,DEA5,Total,Males,2019,Asthma and status asthmaticus,1.04,Rate
Arnsberg,DEA5,Total,Males,2020,Asthma and status asthmaticus,0.96,Rate
Arnsberg,DEA5,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,6141.1,Rate
Arnsberg,DEA5,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5989.87,Rate
Arnsberg,DEA5,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,6180.65,Rate
Arnsberg,DEA5,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5790.13,Rate
Arnsberg,DEA5,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,6015.67,Rate
Arnsberg,DEA5,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5817.1,Rate
Arnsberg,DEA5,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5822.45,Rate
Arnsberg,DEA5,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5798.75,Rate
Arnsberg,DEA5,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5638.63,Rate
Arnsberg,DEA5,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5756.9,Rate
Arnsberg,DEA5,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",217.86,Rate
Arnsberg,DEA5,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",192.19,Rate
Arnsberg,DEA5,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",180.32,Rate
Arnsberg,DEA5,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.96,Rate
Arnsberg,DEA5,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.32,Rate
Arnsberg,DEA5,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",162.44,Rate
Arnsberg,DEA5,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",159.98,Rate
Arnsberg,DEA5,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.19,Rate
Arnsberg,DEA5,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.17,Rate
Arnsberg,DEA5,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",149.51,Rate
Arnsberg,DEA5,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",398.96,Rate
Arnsberg,DEA5,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",382.03,Rate
Arnsberg,DEA5,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",381.37,Rate
Arnsberg,DEA5,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",368.12,Rate
Arnsberg,DEA5,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",351.99,Rate
Arnsberg,DEA5,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",364.65,Rate
Arnsberg,DEA5,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",324.64,Rate
Arnsberg,DEA5,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",330.53,Rate
Arnsberg,DEA5,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",314.64,Rate
Arnsberg,DEA5,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",337.38,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Malignant melanoma of skin,21.13,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Malignant melanoma of skin,17.37,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Malignant melanoma of skin,21.36,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Malignant melanoma of skin,16.85,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Malignant melanoma of skin,19.9,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Malignant melanoma of skin,15.05,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Malignant melanoma of skin,17.4,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Malignant melanoma of skin,21.89,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Malignant melanoma of skin,14.6,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Malignant melanoma of skin,19.2,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Malignant neoplasm of breast,1.73,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Malignant neoplasm of breast,0.94,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Malignant neoplasm of breast,0.66,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Malignant neoplasm of breast,0.29,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Malignant neoplasm of breast,1.79,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Malignant neoplasm of breast,1.78,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Malignant neoplasm of breast,3.58,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Malignant neoplasm of breast,3.51,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Malignant neoplasm of breast,2.15,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Malignant neoplasm of breast,1.1,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Diabetes mellitus,90.42,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Diabetes mellitus,83.32,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Diabetes mellitus,97.19,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Diabetes mellitus,77.81,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Diabetes mellitus,94.15,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Diabetes mellitus,104.59,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Diabetes mellitus,154.38,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Diabetes mellitus,152.33,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Diabetes mellitus,126.37,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Diabetes mellitus,135.09,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),135.64,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),139.66,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),153.35,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),147.6,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),210.65,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),234.68,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),305.98,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),328.24,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),320.46,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),338.62,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.25,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.47,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.33,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),5.61,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),5.33,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),8.06,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),8.7,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),7.95,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),12.62,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Other ischaemic heart diseases,490.9,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Other ischaemic heart diseases,442.29,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Other ischaemic heart diseases,428.68,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Other ischaemic heart diseases,400.0,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Other ischaemic heart diseases,444.36,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Other ischaemic heart diseases,448.8,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Other ischaemic heart diseases,577.79,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Other ischaemic heart diseases,550.73,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Other ischaemic heart diseases,497.04,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Other ischaemic heart diseases,455.38,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,395.29,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,404.73,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,394.01,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,330.0,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,310.56,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,297.47,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,249.57,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,246.61,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,214.11,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,194.6,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Cerebrovascular diseases,360.91,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Cerebrovascular diseases,354.62,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Cerebrovascular diseases,347.53,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Cerebrovascular diseases,326.33,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Cerebrovascular diseases,300.43,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Cerebrovascular diseases,301.13,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Cerebrovascular diseases,315.42,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Cerebrovascular diseases,295.65,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Cerebrovascular diseases,278.35,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Cerebrovascular diseases,283.12,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Chronic lower respiratory diseases,316.88,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Chronic lower respiratory diseases,331.57,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Chronic lower respiratory diseases,306.04,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Chronic lower respiratory diseases,282.4,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Chronic lower respiratory diseases,305.37,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Chronic lower respiratory diseases,270.03,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Chronic lower respiratory diseases,273.05,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Chronic lower respiratory diseases,290.19,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Chronic lower respiratory diseases,250.82,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Chronic lower respiratory diseases,229.35,Rate
Arnsberg,DEA5,65 years or over,Males,2011,Asthma and status asthmaticus,7.52,Rate
Arnsberg,DEA5,65 years or over,Males,2012,Asthma and status asthmaticus,7.1,Rate
Arnsberg,DEA5,65 years or over,Males,2013,Asthma and status asthmaticus,4.08,Rate
Arnsberg,DEA5,65 years or over,Males,2014,Asthma and status asthmaticus,4.18,Rate
Arnsberg,DEA5,65 years or over,Males,2015,Asthma and status asthmaticus,5.28,Rate
Arnsberg,DEA5,65 years or over,Males,2016,Asthma and status asthmaticus,5.04,Rate
Arnsberg,DEA5,65 years or over,Males,2017,Asthma and status asthmaticus,2.54,Rate
Arnsberg,DEA5,65 years or over,Males,2018,Asthma and status asthmaticus,3.17,Rate
Arnsberg,DEA5,65 years or over,Males,2019,Asthma and status asthmaticus,2.55,Rate
Arnsberg,DEA5,65 years or over,Males,2020,Asthma and status asthmaticus,4.16,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,297.19,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,292.94,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,290.56,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,289.12,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,287.94,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,285.9,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,271.17,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,275.74,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,261.16,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,270.11,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.69,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.54,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.64,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.23,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.88,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.43,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.1,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.86,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.8,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.26,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",30.88,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",30.21,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",29.38,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",33.29,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",26.18,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",29.82,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",25.39,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",22.87,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",23.19,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",21.29,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Malignant melanoma of skin,1.42,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Malignant melanoma of skin,1.62,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Malignant melanoma of skin,1.23,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Malignant melanoma of skin,1.42,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Malignant melanoma of skin,1.36,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Malignant melanoma of skin,1.53,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Malignant melanoma of skin,1.2,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Malignant melanoma of skin,1.43,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Malignant melanoma of skin,1.3,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Malignant melanoma of skin,0.99,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.06,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.42,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.12,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.19,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.06,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.06,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.11,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Diabetes mellitus,4.07,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Diabetes mellitus,2.01,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Diabetes mellitus,2.95,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Diabetes mellitus,2.43,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Diabetes mellitus,3.29,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Diabetes mellitus,3.79,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Diabetes mellitus,4.96,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Diabetes mellitus,4.44,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Diabetes mellitus,4.09,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Diabetes mellitus,4.09,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),10.32,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),11.36,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),9.77,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),10.21,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),8.96,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),10.69,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),11.18,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),8.9,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),8.4,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),8.86,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.25,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.26,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Other ischaemic heart diseases,8.53,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Other ischaemic heart diseases,9.21,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Other ischaemic heart diseases,7.71,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Other ischaemic heart diseases,9.26,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Other ischaemic heart diseases,7.92,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Other ischaemic heart diseases,7.18,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Other ischaemic heart diseases,8.56,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Other ischaemic heart diseases,8.61,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Other ischaemic heart diseases,8.76,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Other ischaemic heart diseases,7.74,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,18.79,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,19.75,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,18.12,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,16.16,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,15.8,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,15.03,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,13.91,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,12.47,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,11.64,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,13.53,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Cerebrovascular diseases,7.92,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Cerebrovascular diseases,7.18,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Cerebrovascular diseases,7.79,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Cerebrovascular diseases,6.99,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Cerebrovascular diseases,6.97,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Cerebrovascular diseases,7.04,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Cerebrovascular diseases,6.92,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Cerebrovascular diseases,7.22,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Cerebrovascular diseases,6.07,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Cerebrovascular diseases,6.55,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Chronic lower respiratory diseases,8.52,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Chronic lower respiratory diseases,8.55,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Chronic lower respiratory diseases,10.12,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Chronic lower respiratory diseases,6.82,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Chronic lower respiratory diseases,7.94,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.87,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Chronic lower respiratory diseases,8.21,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Chronic lower respiratory diseases,9.31,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Chronic lower respiratory diseases,7.88,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Chronic lower respiratory diseases,7.52,Rate
Arnsberg,DEA5,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.29,Rate
Arnsberg,DEA5,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.2,Rate
Arnsberg,DEA5,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.7,Rate
Arnsberg,DEA5,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.69,Rate
Arnsberg,DEA5,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.33,Rate
Arnsberg,DEA5,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.25,Rate
Arnsberg,DEA5,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.35,Rate
Arnsberg,DEA5,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.35,Rate
Arnsberg,DEA5,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.68,Rate
Arnsberg,DEA5,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.18,Rate
Arnsberg,DEA5,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1121.61,Rate
Arnsberg,DEA5,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1128.76,Rate
Arnsberg,DEA5,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1155.04,Rate
Arnsberg,DEA5,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1088.02,Rate
Arnsberg,DEA5,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1136.4,Rate
Arnsberg,DEA5,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1098.47,Rate
Arnsberg,DEA5,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1085.25,Rate
Arnsberg,DEA5,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1106.04,Rate
Arnsberg,DEA5,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1063.99,Rate
Arnsberg,DEA5,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1090.52,Rate
Arnsberg,DEA5,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.12,Rate
Arnsberg,DEA5,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.47,Rate
Arnsberg,DEA5,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.21,Rate
Arnsberg,DEA5,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.02,Rate
Arnsberg,DEA5,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.16,Rate
Arnsberg,DEA5,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.64,Rate
Arnsberg,DEA5,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.11,Rate
Arnsberg,DEA5,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.86,Rate
Arnsberg,DEA5,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.92,Rate
Arnsberg,DEA5,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.85,Rate
Arnsberg,DEA5,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",64.01,Rate
Arnsberg,DEA5,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",63.79,Rate
Arnsberg,DEA5,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",64.72,Rate
Arnsberg,DEA5,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",64.83,Rate
Arnsberg,DEA5,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",61.78,Rate
Arnsberg,DEA5,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",65.55,Rate
Arnsberg,DEA5,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",60.26,Rate
Arnsberg,DEA5,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",61.34,Rate
Arnsberg,DEA5,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",58.63,Rate
Arnsberg,DEA5,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",60.5,Rate
Arnsberg,DEA5,Total,Total,2011,Malignant melanoma of skin,3.2,Rate
Arnsberg,DEA5,Total,Total,2012,Malignant melanoma of skin,3.45,Rate
Arnsberg,DEA5,Total,Total,2013,Malignant melanoma of skin,3.44,Rate
Arnsberg,DEA5,Total,Total,2014,Malignant melanoma of skin,3.7,Rate
Arnsberg,DEA5,Total,Total,2015,Malignant melanoma of skin,3.75,Rate
Arnsberg,DEA5,Total,Total,2016,Malignant melanoma of skin,3.51,Rate
Arnsberg,DEA5,Total,Total,2017,Malignant melanoma of skin,2.88,Rate
Arnsberg,DEA5,Total,Total,2018,Malignant melanoma of skin,3.45,Rate
Arnsberg,DEA5,Total,Total,2019,Malignant melanoma of skin,3.15,Rate
Arnsberg,DEA5,Total,Total,2020,Malignant melanoma of skin,3.36,Rate
Arnsberg,DEA5,Total,Total,2011,Malignant neoplasm of breast,23.5,Rate
Arnsberg,DEA5,Total,Total,2012,Malignant neoplasm of breast,23.81,Rate
Arnsberg,DEA5,Total,Total,2013,Malignant neoplasm of breast,22.76,Rate
Arnsberg,DEA5,Total,Total,2014,Malignant neoplasm of breast,23.11,Rate
Arnsberg,DEA5,Total,Total,2015,Malignant neoplasm of breast,23.06,Rate
Arnsberg,DEA5,Total,Total,2016,Malignant neoplasm of breast,23.73,Rate
Arnsberg,DEA5,Total,Total,2017,Malignant neoplasm of breast,20.59,Rate
Arnsberg,DEA5,Total,Total,2018,Malignant neoplasm of breast,22.38,Rate
Arnsberg,DEA5,Total,Total,2019,Malignant neoplasm of breast,21.66,Rate
Arnsberg,DEA5,Total,Total,2020,Malignant neoplasm of breast,20.24,Rate
Arnsberg,DEA5,Total,Total,2011,Diabetes mellitus,18.21,Rate
Arnsberg,DEA5,Total,Total,2012,Diabetes mellitus,16.8,Rate
Arnsberg,DEA5,Total,Total,2013,Diabetes mellitus,18.51,Rate
Arnsberg,DEA5,Total,Total,2014,Diabetes mellitus,15.62,Rate
Arnsberg,DEA5,Total,Total,2015,Diabetes mellitus,18.93,Rate
Arnsberg,DEA5,Total,Total,2016,Diabetes mellitus,19.04,Rate
Arnsberg,DEA5,Total,Total,2017,Diabetes mellitus,27.09,Rate
Arnsberg,DEA5,Total,Total,2018,Diabetes mellitus,27.16,Rate
Arnsberg,DEA5,Total,Total,2019,Diabetes mellitus,24.29,Rate
Arnsberg,DEA5,Total,Total,2020,Diabetes mellitus,25.58,Rate
Arnsberg,DEA5,Total,Total,2011,Mental and behavioural disorders (F00-F99),32.85,Rate
Arnsberg,DEA5,Total,Total,2012,Mental and behavioural disorders (F00-F99),33.46,Rate
Arnsberg,DEA5,Total,Total,2013,Mental and behavioural disorders (F00-F99),37.79,Rate
Arnsberg,DEA5,Total,Total,2014,Mental and behavioural disorders (F00-F99),36.78,Rate
Arnsberg,DEA5,Total,Total,2015,Mental and behavioural disorders (F00-F99),49.53,Rate
Arnsberg,DEA5,Total,Total,2016,Mental and behavioural disorders (F00-F99),58.63,Rate
Arnsberg,DEA5,Total,Total,2017,Mental and behavioural disorders (F00-F99),71.48,Rate
Arnsberg,DEA5,Total,Total,2018,Mental and behavioural disorders (F00-F99),74.47,Rate
Arnsberg,DEA5,Total,Total,2019,Mental and behavioural disorders (F00-F99),75.39,Rate
Arnsberg,DEA5,Total,Total,2020,Mental and behavioural disorders (F00-F99),75.91,Rate
Arnsberg,DEA5,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.81,Rate
Arnsberg,DEA5,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.69,Rate
Arnsberg,DEA5,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Arnsberg,DEA5,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Arnsberg,DEA5,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Arnsberg,DEA5,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Arnsberg,DEA5,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.59,Rate
Arnsberg,DEA5,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.05,Rate
Arnsberg,DEA5,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.08,Rate
Arnsberg,DEA5,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.9,Rate
Arnsberg,DEA5,Total,Total,2011,Other ischaemic heart diseases,70.76,Rate
Arnsberg,DEA5,Total,Total,2012,Other ischaemic heart diseases,70.54,Rate
Arnsberg,DEA5,Total,Total,2013,Other ischaemic heart diseases,67.29,Rate
Arnsberg,DEA5,Total,Total,2014,Other ischaemic heart diseases,60.95,Rate
Arnsberg,DEA5,Total,Total,2015,Other ischaemic heart diseases,65.34,Rate
Arnsberg,DEA5,Total,Total,2016,Other ischaemic heart diseases,63.61,Rate
Arnsberg,DEA5,Total,Total,2017,Other ischaemic heart diseases,82.53,Rate
Arnsberg,DEA5,Total,Total,2018,Other ischaemic heart diseases,75.9,Rate
Arnsberg,DEA5,Total,Total,2019,Other ischaemic heart diseases,70.18,Rate
Arnsberg,DEA5,Total,Total,2020,Other ischaemic heart diseases,67.55,Rate
Arnsberg,DEA5,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,64.28,Rate
Arnsberg,DEA5,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,63.95,Rate
Arnsberg,DEA5,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,62.5,Rate
Arnsberg,DEA5,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,55.52,Rate
Arnsberg,DEA5,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,51.1,Rate
Arnsberg,DEA5,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,48.72,Rate
Arnsberg,DEA5,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,41.11,Rate
Arnsberg,DEA5,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,41.37,Rate
Arnsberg,DEA5,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,35.97,Rate
Arnsberg,DEA5,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,34.62,Rate
Arnsberg,DEA5,Total,Total,2011,Cerebrovascular diseases,74.54,Rate
Arnsberg,DEA5,Total,Total,2012,Cerebrovascular diseases,70.53,Rate
Arnsberg,DEA5,Total,Total,2013,Cerebrovascular diseases,68.84,Rate
Arnsberg,DEA5,Total,Total,2014,Cerebrovascular diseases,64.05,Rate
Arnsberg,DEA5,Total,Total,2015,Cerebrovascular diseases,58.74,Rate
Arnsberg,DEA5,Total,Total,2016,Cerebrovascular diseases,58.52,Rate
Arnsberg,DEA5,Total,Total,2017,Cerebrovascular diseases,55.33,Rate
Arnsberg,DEA5,Total,Total,2018,Cerebrovascular diseases,57.6,Rate
Arnsberg,DEA5,Total,Total,2019,Cerebrovascular diseases,54.64,Rate
Arnsberg,DEA5,Total,Total,2020,Cerebrovascular diseases,53.1,Rate
Arnsberg,DEA5,Total,Total,2011,Chronic lower respiratory diseases,46.17,Rate
Arnsberg,DEA5,Total,Total,2012,Chronic lower respiratory diseases,47.52,Rate
Arnsberg,DEA5,Total,Total,2013,Chronic lower respiratory diseases,48.83,Rate
Arnsberg,DEA5,Total,Total,2014,Chronic lower respiratory diseases,42.32,Rate
Arnsberg,DEA5,Total,Total,2015,Chronic lower respiratory diseases,44.99,Rate
Arnsberg,DEA5,Total,Total,2016,Chronic lower respiratory diseases,42.32,Rate
Arnsberg,DEA5,Total,Total,2017,Chronic lower respiratory diseases,45.59,Rate
Arnsberg,DEA5,Total,Total,2018,Chronic lower respiratory diseases,48.22,Rate
Arnsberg,DEA5,Total,Total,2019,Chronic lower respiratory diseases,41.4,Rate
Arnsberg,DEA5,Total,Total,2020,Chronic lower respiratory diseases,39.08,Rate
Arnsberg,DEA5,Total,Total,2011,Asthma and status asthmaticus,1.49,Rate
Arnsberg,DEA5,Total,Total,2012,Asthma and status asthmaticus,1.6,Rate
Arnsberg,DEA5,Total,Total,2013,Asthma and status asthmaticus,1.63,Rate
Arnsberg,DEA5,Total,Total,2014,Asthma and status asthmaticus,1.37,Rate
Arnsberg,DEA5,Total,Total,2015,Asthma and status asthmaticus,1.29,Rate
Arnsberg,DEA5,Total,Total,2016,Asthma and status asthmaticus,0.99,Rate
Arnsberg,DEA5,Total,Total,2017,Asthma and status asthmaticus,1.2,Rate
Arnsberg,DEA5,Total,Total,2018,Asthma and status asthmaticus,1.11,Rate
Arnsberg,DEA5,Total,Total,2019,Asthma and status asthmaticus,1.25,Rate
Arnsberg,DEA5,Total,Total,2020,Asthma and status asthmaticus,1.03,Rate
Arnsberg,DEA5,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4807.76,Rate
Arnsberg,DEA5,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4854.92,Rate
Arnsberg,DEA5,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4979.86,Rate
Arnsberg,DEA5,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4657.43,Rate
Arnsberg,DEA5,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4895.79,Rate
Arnsberg,DEA5,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4722.07,Rate
Arnsberg,DEA5,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4685.24,Rate
Arnsberg,DEA5,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4773.82,Rate
Arnsberg,DEA5,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4602.9,Rate
Arnsberg,DEA5,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4716.11,Rate
Arnsberg,DEA5,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",158.86,Rate
Arnsberg,DEA5,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",145.63,Rate
Arnsberg,DEA5,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.75,Rate
Arnsberg,DEA5,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.48,Rate
Arnsberg,DEA5,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.32,Rate
Arnsberg,DEA5,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.99,Rate
Arnsberg,DEA5,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.26,Rate
Arnsberg,DEA5,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.25,Rate
Arnsberg,DEA5,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.14,Rate
Arnsberg,DEA5,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.33,Rate
Arnsberg,DEA5,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",227.57,Rate
Arnsberg,DEA5,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",225.51,Rate
Arnsberg,DEA5,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",234.44,Rate
Arnsberg,DEA5,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",224.77,Rate
Arnsberg,DEA5,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",224.57,Rate
Arnsberg,DEA5,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",239.38,Rate
Arnsberg,DEA5,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",219.74,Rate
Arnsberg,DEA5,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",228.64,Rate
Arnsberg,DEA5,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",218.36,Rate
Arnsberg,DEA5,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",231.68,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Malignant melanoma of skin,12.2,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Malignant melanoma of skin,12.19,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Malignant melanoma of skin,12.7,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Malignant melanoma of skin,14.07,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Malignant melanoma of skin,14.58,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Malignant melanoma of skin,13.57,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Malignant melanoma of skin,10.61,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Malignant melanoma of skin,13.89,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Malignant melanoma of skin,12.0,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Malignant melanoma of skin,12.68,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Malignant neoplasm of breast,85.99,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Malignant neoplasm of breast,89.95,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Malignant neoplasm of breast,84.55,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Malignant neoplasm of breast,88.77,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Malignant neoplasm of breast,89.35,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Malignant neoplasm of breast,89.32,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Malignant neoplasm of breast,78.35,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Malignant neoplasm of breast,83.44,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Malignant neoplasm of breast,81.15,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Malignant neoplasm of breast,74.97,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Diabetes mellitus,82.43,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Diabetes mellitus,80.22,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Diabetes mellitus,84.96,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Diabetes mellitus,71.82,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Diabetes mellitus,88.14,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Diabetes mellitus,86.56,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Diabetes mellitus,123.97,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Diabetes mellitus,125.92,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Diabetes mellitus,111.96,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Diabetes mellitus,120.04,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),139.68,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),142.55,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),167.31,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),160.3,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),229.33,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),273.65,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),336.12,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),357.98,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),362.49,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),364.37,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),3.31,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.25,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.13,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.67,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),5.16,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),5.31,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),9.51,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),8.81,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),7.17,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),12.01,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Other ischaemic heart diseases,342.04,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Other ischaemic heart diseases,337.88,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Other ischaemic heart diseases,325.42,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Other ischaemic heart diseases,289.44,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Other ischaemic heart diseases,313.81,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Other ischaemic heart diseases,307.31,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Other ischaemic heart diseases,402.44,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Other ischaemic heart diseases,367.6,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Other ischaemic heart diseases,336.34,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Other ischaemic heart diseases,326.41,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,280.42,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,276.09,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,272.14,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,242.78,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,221.35,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,209.96,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,175.86,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,177.94,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,154.14,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,142.65,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Cerebrovascular diseases,354.74,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Cerebrovascular diseases,337.68,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Cerebrovascular diseases,326.4,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Cerebrovascular diseases,303.53,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Cerebrovascular diseases,276.86,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Cerebrovascular diseases,275.03,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Cerebrovascular diseases,262.9,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Cerebrovascular diseases,269.57,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Cerebrovascular diseases,258.89,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Cerebrovascular diseases,250.26,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Chronic lower respiratory diseases,207.87,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Chronic lower respiratory diseases,214.41,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Chronic lower respiratory diseases,217.02,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Chronic lower respiratory diseases,192.18,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Chronic lower respiratory diseases,201.3,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Chronic lower respiratory diseases,188.82,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Chronic lower respiratory diseases,202.99,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Chronic lower respiratory diseases,214.9,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Chronic lower respiratory diseases,183.84,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Chronic lower respiratory diseases,175.09,Rate
Arnsberg,DEA5,65 years or over,Total,2011,Asthma and status asthmaticus,6.68,Rate
Arnsberg,DEA5,65 years or over,Total,2012,Asthma and status asthmaticus,7.17,Rate
Arnsberg,DEA5,65 years or over,Total,2013,Asthma and status asthmaticus,6.11,Rate
Arnsberg,DEA5,65 years or over,Total,2014,Asthma and status asthmaticus,5.12,Rate
Arnsberg,DEA5,65 years or over,Total,2015,Asthma and status asthmaticus,5.4,Rate
Arnsberg,DEA5,65 years or over,Total,2016,Asthma and status asthmaticus,3.91,Rate
Arnsberg,DEA5,65 years or over,Total,2017,Asthma and status asthmaticus,4.01,Rate
Arnsberg,DEA5,65 years or over,Total,2018,Asthma and status asthmaticus,4.33,Rate
Arnsberg,DEA5,65 years or over,Total,2019,Asthma and status asthmaticus,4.2,Rate
Arnsberg,DEA5,65 years or over,Total,2020,Asthma and status asthmaticus,4.92,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,228.69,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,226.14,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,228.53,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,223.38,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,225.74,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,220.71,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,213.2,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,217.57,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,206.73,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,212.28,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.63,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.3,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.4,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.99,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.42,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.33,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.54,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.48,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.61,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.93,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",24.39,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",24.62,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",23.61,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",26.09,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",22.34,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",23.44,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",21.63,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",20.81,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",19.94,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",19.03,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Malignant melanoma of skin,1.03,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Malignant melanoma of skin,1.33,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Malignant melanoma of skin,1.2,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Malignant melanoma of skin,1.19,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Malignant melanoma of skin,1.13,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Malignant melanoma of skin,1.08,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Malignant melanoma of skin,1.01,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Malignant melanoma of skin,0.92,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Malignant melanoma of skin,1.01,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Malignant melanoma of skin,1.1,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.37,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.78,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.8,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.2,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.01,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.84,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.6,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.59,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.24,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.98,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Diabetes mellitus,2.66,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Diabetes mellitus,1.44,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Diabetes mellitus,2.41,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Diabetes mellitus,2.01,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Diabetes mellitus,2.16,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Diabetes mellitus,2.68,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Diabetes mellitus,3.62,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Diabetes mellitus,3.23,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Diabetes mellitus,3.05,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Diabetes mellitus,2.7,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),6.97,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),7.04,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),6.42,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),6.86,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.97,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),6.55,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),7.37,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),5.8,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),5.84,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),6.03,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.19,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.7,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Other ischaemic heart diseases,5.05,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Other ischaemic heart diseases,5.78,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Other ischaemic heart diseases,4.76,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.61,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.15,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Other ischaemic heart diseases,4.58,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Other ischaemic heart diseases,5.03,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.23,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Other ischaemic heart diseases,5.71,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Other ischaemic heart diseases,4.85,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,11.92,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,12.56,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,11.71,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,10.16,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,9.86,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.66,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,8.46,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,8.28,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,7.35,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,8.45,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Cerebrovascular diseases,6.67,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Cerebrovascular diseases,5.82,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Cerebrovascular diseases,6.45,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Cerebrovascular diseases,6.05,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Cerebrovascular diseases,5.91,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Cerebrovascular diseases,6.07,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Cerebrovascular diseases,5.05,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Cerebrovascular diseases,6.25,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Cerebrovascular diseases,5.16,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Cerebrovascular diseases,5.34,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Chronic lower respiratory diseases,7.0,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Chronic lower respiratory diseases,7.1,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Chronic lower respiratory diseases,8.09,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Chronic lower respiratory diseases,6.01,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Chronic lower respiratory diseases,7.13,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Chronic lower respiratory diseases,6.83,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Chronic lower respiratory diseases,7.46,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Chronic lower respiratory diseases,7.85,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.89,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Chronic lower respiratory diseases,6.13,Rate
Arnsberg,DEA5,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.24,Rate
Arnsberg,DEA5,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.26,Rate
Arnsberg,DEA5,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.54,Rate
Arnsberg,DEA5,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.46,Rate
Arnsberg,DEA5,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.29,Rate
Arnsberg,DEA5,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.28,Rate
Arnsberg,DEA5,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.52,Rate
Arnsberg,DEA5,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.33,Rate
Arnsberg,DEA5,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.54,Rate
Arnsberg,DEA5,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.09,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,895.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,894.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,900.42,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,838.26,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,882.92,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,818.4,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,848.0,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,858.99,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,838.34,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,850.96,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.65,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.31,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.74,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.78,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.66,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.26,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",30.57,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",30.68,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",30.84,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",33.91,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",29.47,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",31.63,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",35.18,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",34.07,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",36.11,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",36.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Malignant melanoma of skin,2.41,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Malignant melanoma of skin,2.91,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Malignant melanoma of skin,2.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Malignant melanoma of skin,2.35,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Malignant melanoma of skin,3.04,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Malignant melanoma of skin,1.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Malignant melanoma of skin,2.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Malignant melanoma of skin,1.78,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Malignant melanoma of skin,2.57,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Malignant melanoma of skin,2.16,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Malignant neoplasm of breast,34.62,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Malignant neoplasm of breast,39.11,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Malignant neoplasm of breast,39.64,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Malignant neoplasm of breast,34.27,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Malignant neoplasm of breast,39.28,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Malignant neoplasm of breast,34.62,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Malignant neoplasm of breast,37.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Malignant neoplasm of breast,38.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Malignant neoplasm of breast,36.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Malignant neoplasm of breast,37.91,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Diabetes mellitus,31.28,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Diabetes mellitus,28.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Diabetes mellitus,33.98,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Diabetes mellitus,27.7,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Diabetes mellitus,26.95,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Diabetes mellitus,23.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Diabetes mellitus,25.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Diabetes mellitus,24.46,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Diabetes mellitus,23.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Diabetes mellitus,28.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Mental and behavioural disorders (F00-F99),39.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Mental and behavioural disorders (F00-F99),47.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Mental and behavioural disorders (F00-F99),44.99,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Mental and behavioural disorders (F00-F99),43.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Mental and behavioural disorders (F00-F99),52.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Mental and behavioural disorders (F00-F99),51.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Mental and behavioural disorders (F00-F99),57.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Mental and behavioural disorders (F00-F99),65.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Mental and behavioural disorders (F00-F99),59.37,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Mental and behavioural disorders (F00-F99),56.07,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.45,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.53,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.14,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.16,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),3.42,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.27,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Other ischaemic heart diseases,78.85,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Other ischaemic heart diseases,72.17,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Other ischaemic heart diseases,70.94,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Other ischaemic heart diseases,63.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Other ischaemic heart diseases,70.86,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Other ischaemic heart diseases,55.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Other ischaemic heart diseases,55.61,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Other ischaemic heart diseases,54.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Other ischaemic heart diseases,53.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Other ischaemic heart diseases,49.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,44.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,47.11,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,45.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,38.67,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,37.18,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,34.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,36.57,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,31.49,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,33.39,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,31.97,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Cerebrovascular diseases,74.61,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Cerebrovascular diseases,75.44,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Cerebrovascular diseases,71.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Cerebrovascular diseases,64.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Cerebrovascular diseases,64.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Cerebrovascular diseases,56.83,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Cerebrovascular diseases,54.67,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Cerebrovascular diseases,59.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Cerebrovascular diseases,57.01,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Cerebrovascular diseases,53.45,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Chronic lower respiratory diseases,24.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Chronic lower respiratory diseases,23.98,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Chronic lower respiratory diseases,25.87,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Chronic lower respiratory diseases,25.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Chronic lower respiratory diseases,28.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Chronic lower respiratory diseases,27.71,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Chronic lower respiratory diseases,30.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Chronic lower respiratory diseases,33.27,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Chronic lower respiratory diseases,32.9,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Chronic lower respiratory diseases,28.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2011,Asthma and status asthmaticus,1.92,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2012,Asthma and status asthmaticus,1.52,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2013,Asthma and status asthmaticus,2.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2014,Asthma and status asthmaticus,1.19,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2015,Asthma and status asthmaticus,1.59,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2016,Asthma and status asthmaticus,1.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2017,Asthma and status asthmaticus,0.95,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2018,Asthma and status asthmaticus,1.67,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2019,Asthma and status asthmaticus,1.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Females,2020,Asthma and status asthmaticus,1.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3967.86,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4010.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3998.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3730.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3985.71,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3669.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3800.14,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3842.09,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3740.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3798.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",96.97,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.76,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.33,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.82,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",91.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",92.98,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",104.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",109.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",96.75,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",105.21,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",127.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",116.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",131.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",134.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Malignant melanoma of skin,8.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Malignant melanoma of skin,9.94,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Malignant melanoma of skin,7.13,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Malignant melanoma of skin,5.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Malignant melanoma of skin,9.09,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Malignant melanoma of skin,6.36,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Malignant melanoma of skin,5.72,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Malignant melanoma of skin,4.41,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Malignant melanoma of skin,9.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Malignant melanoma of skin,7.83,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Malignant neoplasm of breast,117.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Malignant neoplasm of breast,136.73,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Malignant neoplasm of breast,134.21,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Malignant neoplasm of breast,122.28,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Malignant neoplasm of breast,145.93,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Malignant neoplasm of breast,124.24,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Malignant neoplasm of breast,132.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Malignant neoplasm of breast,142.35,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Malignant neoplasm of breast,129.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Malignant neoplasm of breast,135.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Diabetes mellitus,149.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Diabetes mellitus,137.26,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Diabetes mellitus,157.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Diabetes mellitus,132.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Diabetes mellitus,132.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Diabetes mellitus,112.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Diabetes mellitus,122.5,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Diabetes mellitus,117.26,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Diabetes mellitus,115.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Diabetes mellitus,135.59,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),189.36,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),233.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),216.7,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),212.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),260.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),252.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),284.55,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),327.2,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),294.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),280.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),9.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),9.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),8.62,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),10.01,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),15.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),9.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),10.22,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),13.57,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),13.0,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Other ischaemic heart diseases,393.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Other ischaemic heart diseases,364.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Other ischaemic heart diseases,356.57,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Other ischaemic heart diseases,315.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Other ischaemic heart diseases,353.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Other ischaemic heart diseases,275.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Other ischaemic heart diseases,278.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Other ischaemic heart diseases,269.77,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Other ischaemic heart diseases,262.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Other ischaemic heart diseases,243.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,209.47,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,212.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,215.53,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,179.13,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,171.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,161.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,170.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,148.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,158.04,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,146.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Cerebrovascular diseases,357.64,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Cerebrovascular diseases,369.86,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Cerebrovascular diseases,344.75,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Cerebrovascular diseases,316.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Cerebrovascular diseases,315.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Cerebrovascular diseases,276.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Cerebrovascular diseases,265.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Cerebrovascular diseases,284.1,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Cerebrovascular diseases,274.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Cerebrovascular diseases,255.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Chronic lower respiratory diseases,107.63,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Chronic lower respiratory diseases,107.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Chronic lower respiratory diseases,114.05,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Chronic lower respiratory diseases,107.88,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Chronic lower respiratory diseases,121.21,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Chronic lower respiratory diseases,122.04,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Chronic lower respiratory diseases,133.43,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Chronic lower respiratory diseases,146.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Chronic lower respiratory diseases,144.42,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Chronic lower respiratory diseases,125.92,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2011,Asthma and status asthmaticus,7.97,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2012,Asthma and status asthmaticus,5.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2013,Asthma and status asthmaticus,8.35,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2014,Asthma and status asthmaticus,3.68,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2015,Asthma and status asthmaticus,6.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2016,Asthma and status asthmaticus,6.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2017,Asthma and status asthmaticus,4.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2018,Asthma and status asthmaticus,7.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2019,Asthma and status asthmaticus,6.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Females,2020,Asthma and status asthmaticus,7.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,151.57,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,139.16,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,149.92,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,137.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,131.32,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,127.67,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,132.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,136.38,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,135.35,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,136.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.47,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.38,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.32,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.33,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.59,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.25,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",15.8,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",15.58,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",13.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",15.69,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",13.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",13.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",12.78,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",14.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",12.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Malignant melanoma of skin,1.04,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Malignant melanoma of skin,1.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Malignant melanoma of skin,0.85,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Malignant melanoma of skin,1.51,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Malignant melanoma of skin,1.57,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Malignant melanoma of skin,0.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Malignant melanoma of skin,1.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Malignant melanoma of skin,1.14,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Malignant melanoma of skin,0.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Malignant melanoma of skin,0.78,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Malignant neoplasm of breast,14.59,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Malignant neoplasm of breast,15.46,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Malignant neoplasm of breast,16.73,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Malignant neoplasm of breast,13.44,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Malignant neoplasm of breast,13.68,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.94,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Malignant neoplasm of breast,14.3,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Diabetes mellitus,2.56,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Diabetes mellitus,1.68,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Diabetes mellitus,4.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Diabetes mellitus,2.36,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Diabetes mellitus,1.43,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Diabetes mellitus,2.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Diabetes mellitus,2.32,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Diabetes mellitus,1.98,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Diabetes mellitus,1.62,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Diabetes mellitus,2.94,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),3.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),1.99,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),3.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.47,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.25,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.51,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.42,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.8,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.55,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.8,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.5,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Other ischaemic heart diseases,2.3,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.67,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.74,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.88,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.88,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,7.16,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.7,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.69,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,4.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.16,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,3.2,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Cerebrovascular diseases,6.05,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Cerebrovascular diseases,4.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Cerebrovascular diseases,5.22,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Cerebrovascular diseases,3.69,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Cerebrovascular diseases,3.4,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Cerebrovascular diseases,3.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Cerebrovascular diseases,3.63,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Cerebrovascular diseases,4.57,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Cerebrovascular diseases,4.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Cerebrovascular diseases,4.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Chronic lower respiratory diseases,4.22,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Chronic lower respiratory diseases,3.76,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Chronic lower respiratory diseases,4.52,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Chronic lower respiratory diseases,6.03,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Chronic lower respiratory diseases,5.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Chronic lower respiratory diseases,4.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Chronic lower respiratory diseases,5.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Chronic lower respiratory diseases,5.76,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Chronic lower respiratory diseases,5.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Chronic lower respiratory diseases,4.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.55,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.82,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.59,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.88,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.57,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.1,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1321.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1315.36,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1314.24,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1235.85,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1275.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1213.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1246.57,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1233.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1212.59,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1236.99,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.84,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.61,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.97,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.24,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.19,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.49,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",82.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",79.68,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",76.13,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",73.16,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",71.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",62.3,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",70.01,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",64.8,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",67.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",60.84,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Malignant melanoma of skin,4.56,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Malignant melanoma of skin,5.35,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Malignant melanoma of skin,5.42,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Malignant melanoma of skin,5.41,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Malignant melanoma of skin,5.61,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Malignant melanoma of skin,3.64,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Malignant melanoma of skin,4.49,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Malignant melanoma of skin,4.19,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Malignant melanoma of skin,4.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Malignant melanoma of skin,5.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Malignant neoplasm of breast,0.47,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Malignant neoplasm of breast,0.82,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Malignant neoplasm of breast,0.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Malignant neoplasm of breast,0.3,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Malignant neoplasm of breast,0.18,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Malignant neoplasm of breast,0.36,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Malignant neoplasm of breast,0.17,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Malignant neoplasm of breast,0.31,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Malignant neoplasm of breast,0.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Malignant neoplasm of breast,0.37,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Diabetes mellitus,40.24,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Diabetes mellitus,35.65,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Diabetes mellitus,37.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Diabetes mellitus,35.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Diabetes mellitus,36.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Diabetes mellitus,31.49,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Diabetes mellitus,32.21,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Diabetes mellitus,31.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Diabetes mellitus,30.14,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Diabetes mellitus,33.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Mental and behavioural disorders (F00-F99),44.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Mental and behavioural disorders (F00-F99),50.98,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Mental and behavioural disorders (F00-F99),54.75,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Mental and behavioural disorders (F00-F99),42.06,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Mental and behavioural disorders (F00-F99),57.94,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Mental and behavioural disorders (F00-F99),56.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Mental and behavioural disorders (F00-F99),60.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Mental and behavioural disorders (F00-F99),68.74,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Mental and behavioural disorders (F00-F99),58.02,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Mental and behavioural disorders (F00-F99),53.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.72,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),3.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.1,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.66,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),4.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),4.28,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.13,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.52,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Other ischaemic heart diseases,131.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Other ischaemic heart diseases,131.02,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Other ischaemic heart diseases,129.73,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Other ischaemic heart diseases,117.88,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Other ischaemic heart diseases,126.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Other ischaemic heart diseases,121.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Other ischaemic heart diseases,117.96,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Other ischaemic heart diseases,112.97,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Other ischaemic heart diseases,112.62,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Other ischaemic heart diseases,110.36,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,91.34,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,85.5,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,86.63,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,80.34,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,78.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,67.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,73.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,70.22,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,64.94,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,72.66,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Cerebrovascular diseases,87.33,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Cerebrovascular diseases,91.33,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Cerebrovascular diseases,80.1,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Cerebrovascular diseases,79.64,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Cerebrovascular diseases,78.89,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Cerebrovascular diseases,74.06,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Cerebrovascular diseases,75.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Cerebrovascular diseases,72.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Cerebrovascular diseases,73.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Cerebrovascular diseases,65.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Chronic lower respiratory diseases,46.21,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Chronic lower respiratory diseases,48.98,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Chronic lower respiratory diseases,49.53,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Chronic lower respiratory diseases,48.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Chronic lower respiratory diseases,52.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Chronic lower respiratory diseases,48.4,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Chronic lower respiratory diseases,50.35,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Chronic lower respiratory diseases,48.18,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Chronic lower respiratory diseases,49.35,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Chronic lower respiratory diseases,44.57,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2011,Asthma and status asthmaticus,1.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2012,Asthma and status asthmaticus,1.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2013,Asthma and status asthmaticus,1.52,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2014,Asthma and status asthmaticus,0.92,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2015,Asthma and status asthmaticus,1.27,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2016,Asthma and status asthmaticus,1.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2017,Asthma and status asthmaticus,0.95,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2018,Asthma and status asthmaticus,1.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2019,Asthma and status asthmaticus,1.47,Rate
Rheinhessen-Pfalz,DEB3,Total,Males,2020,Asthma and status asthmaticus,0.91,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5726.12,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5725.24,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5731.77,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5376.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5567.33,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5267.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5468.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5325.91,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5290.74,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5421.57,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",169.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",173.32,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.63,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",157.27,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",177.83,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.0,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.41,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.91,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.8,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",324.5,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",305.8,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",296.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",282.04,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",273.88,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",247.35,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",267.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",252.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",263.39,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",243.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Malignant melanoma of skin,18.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Malignant melanoma of skin,22.67,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Malignant melanoma of skin,22.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Malignant melanoma of skin,20.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Malignant melanoma of skin,24.61,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Malignant melanoma of skin,13.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Malignant melanoma of skin,18.44,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Malignant melanoma of skin,16.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Malignant melanoma of skin,17.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Malignant melanoma of skin,22.91,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Malignant neoplasm of breast,1.95,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Malignant neoplasm of breast,3.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Malignant neoplasm of breast,2.94,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Malignant neoplasm of breast,1.56,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Malignant neoplasm of breast,0.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Malignant neoplasm of breast,1.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Malignant neoplasm of breast,0.45,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Malignant neoplasm of breast,1.58,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Malignant neoplasm of breast,1.93,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Malignant neoplasm of breast,1.9,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Diabetes mellitus,188.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Diabetes mellitus,159.47,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Diabetes mellitus,168.05,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Diabetes mellitus,157.6,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Diabetes mellitus,161.57,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Diabetes mellitus,142.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Diabetes mellitus,138.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Diabetes mellitus,143.54,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Diabetes mellitus,139.19,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Diabetes mellitus,156.6,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),195.59,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),235.55,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),246.22,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),175.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),259.67,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),257.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),272.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),312.75,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),275.72,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),252.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),7.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),16.58,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),11.41,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),8.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),16.39,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),14.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),17.32,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),8.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),10.17,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),15.61,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Other ischaemic heart diseases,635.8,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Other ischaemic heart diseases,633.7,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Other ischaemic heart diseases,626.41,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Other ischaemic heart diseases,569.96,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Other ischaemic heart diseases,605.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Other ischaemic heart diseases,584.08,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Other ischaemic heart diseases,563.13,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Other ischaemic heart diseases,543.72,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Other ischaemic heart diseases,533.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Other ischaemic heart diseases,531.1,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,377.47,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,356.53,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,360.01,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,332.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,323.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,284.54,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,319.5,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,297.18,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,275.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,299.76,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Cerebrovascular diseases,419.97,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Cerebrovascular diseases,436.07,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Cerebrovascular diseases,379.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Cerebrovascular diseases,382.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Cerebrovascular diseases,372.9,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Cerebrovascular diseases,355.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Cerebrovascular diseases,362.96,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Cerebrovascular diseases,341.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Cerebrovascular diseases,351.36,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Cerebrovascular diseases,310.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Chronic lower respiratory diseases,214.57,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Chronic lower respiratory diseases,229.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Chronic lower respiratory diseases,220.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Chronic lower respiratory diseases,224.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Chronic lower respiratory diseases,239.71,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Chronic lower respiratory diseases,215.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Chronic lower respiratory diseases,231.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Chronic lower respiratory diseases,215.91,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Chronic lower respiratory diseases,223.37,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Chronic lower respiratory diseases,201.82,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2011,Asthma and status asthmaticus,4.55,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2012,Asthma and status asthmaticus,6.13,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2013,Asthma and status asthmaticus,5.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2014,Asthma and status asthmaticus,3.83,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2015,Asthma and status asthmaticus,4.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2016,Asthma and status asthmaticus,6.02,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2017,Asthma and status asthmaticus,2.09,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2018,Asthma and status asthmaticus,3.43,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2019,Asthma and status asthmaticus,4.98,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Males,2020,Asthma and status asthmaticus,2.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,253.98,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,247.13,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,244.15,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,232.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,235.6,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,231.2,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,223.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,242.53,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,224.71,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,223.34,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.01,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.78,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.33,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.58,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.7,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.71,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",24.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",24.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",22.79,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",22.57,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",22.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",17.48,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",22.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",19.43,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",20.38,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",16.68,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Malignant melanoma of skin,1.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Malignant melanoma of skin,1.16,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Malignant melanoma of skin,1.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Malignant melanoma of skin,1.79,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Malignant melanoma of skin,1.01,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Malignant melanoma of skin,1.36,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Malignant melanoma of skin,1.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Malignant melanoma of skin,1.09,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Malignant melanoma of skin,1.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Malignant melanoma of skin,1.6,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.23,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.1,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Diabetes mellitus,4.33,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Diabetes mellitus,5.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Diabetes mellitus,5.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Diabetes mellitus,5.34,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Diabetes mellitus,5.62,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Diabetes mellitus,4.53,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Diabetes mellitus,6.43,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Diabetes mellitus,4.72,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Diabetes mellitus,3.72,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Diabetes mellitus,3.92,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),8.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),6.27,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),8.36,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),9.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),9.08,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),8.3,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),8.68,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),9.64,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),5.28,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),5.71,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.09,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.32,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.49,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.42,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Other ischaemic heart diseases,9.67,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Other ischaemic heart diseases,9.25,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Other ischaemic heart diseases,9.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Other ischaemic heart diseases,8.36,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Other ischaemic heart diseases,10.36,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Other ischaemic heart diseases,9.93,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Other ischaemic heart diseases,10.13,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Other ischaemic heart diseases,8.63,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Other ischaemic heart diseases,10.59,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Other ischaemic heart diseases,8.44,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,22.03,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,19.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,20.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,19.26,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,19.05,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,15.31,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,13.83,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,15.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,13.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,17.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Cerebrovascular diseases,6.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Cerebrovascular diseases,7.82,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Cerebrovascular diseases,7.61,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Cerebrovascular diseases,6.2,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Cerebrovascular diseases,7.67,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Cerebrovascular diseases,5.97,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Cerebrovascular diseases,5.64,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Cerebrovascular diseases,7.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Cerebrovascular diseases,6.55,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Cerebrovascular diseases,6.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Chronic lower respiratory diseases,5.42,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Chronic lower respiratory diseases,5.16,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Chronic lower respiratory diseases,8.13,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Chronic lower respiratory diseases,5.78,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Chronic lower respiratory diseases,7.49,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.97,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.4,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Chronic lower respiratory diseases,7.55,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Chronic lower respiratory diseases,7.19,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Chronic lower respiratory diseases,6.48,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.42,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.61,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.37,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.73,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.67,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.6,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.62,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.6,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1071.68,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1069.33,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1073.21,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1005.53,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1050.81,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,987.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1018.02,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1025.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,999.5,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1018.68,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.24,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.72,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.25,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.83,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.56,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",52.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",52.01,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",50.74,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",51.16,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",47.83,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",44.95,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",50.25,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",47.64,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",50.19,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",47.18,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Malignant melanoma of skin,3.19,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Malignant melanoma of skin,3.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Malignant melanoma of skin,3.41,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Malignant melanoma of skin,3.37,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Malignant melanoma of skin,4.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Malignant melanoma of skin,2.68,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Malignant melanoma of skin,3.13,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Malignant melanoma of skin,2.69,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Malignant melanoma of skin,3.33,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Malignant melanoma of skin,3.54,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Malignant neoplasm of breast,19.83,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Malignant neoplasm of breast,22.44,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Malignant neoplasm of breast,22.74,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Malignant neoplasm of breast,19.37,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Malignant neoplasm of breast,22.14,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Malignant neoplasm of breast,19.47,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Malignant neoplasm of breast,20.77,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Malignant neoplasm of breast,21.7,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Malignant neoplasm of breast,20.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Malignant neoplasm of breast,21.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Diabetes mellitus,36.1,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Diabetes mellitus,31.83,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Diabetes mellitus,36.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Diabetes mellitus,31.21,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Diabetes mellitus,31.22,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Diabetes mellitus,27.53,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Diabetes mellitus,29.02,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Diabetes mellitus,28.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Diabetes mellitus,26.59,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Diabetes mellitus,31.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Mental and behavioural disorders (F00-F99),42.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Mental and behavioural disorders (F00-F99),49.58,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Mental and behavioural disorders (F00-F99),49.3,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Mental and behavioural disorders (F00-F99),45.04,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Mental and behavioural disorders (F00-F99),56.44,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Mental and behavioural disorders (F00-F99),54.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Mental and behavioural disorders (F00-F99),59.63,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Mental and behavioural disorders (F00-F99),69.13,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Mental and behavioural disorders (F00-F99),59.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Mental and behavioural disorders (F00-F99),56.48,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.49,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.79,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.87,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.65,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.12,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.92,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.27,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.67,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Other ischaemic heart diseases,99.31,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Other ischaemic heart diseases,95.85,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Other ischaemic heart diseases,94.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Other ischaemic heart diseases,85.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Other ischaemic heart diseases,93.06,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Other ischaemic heart diseases,81.43,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Other ischaemic heart diseases,80.5,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Other ischaemic heart diseases,78.62,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Other ischaemic heart diseases,77.36,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Other ischaemic heart diseases,73.66,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,63.9,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,64.08,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,63.29,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,56.98,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,54.55,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,49.09,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,52.14,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,48.38,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,47.59,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,49.95,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Cerebrovascular diseases,81.07,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Cerebrovascular diseases,82.8,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Cerebrovascular diseases,76.23,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Cerebrovascular diseases,71.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Cerebrovascular diseases,70.72,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Cerebrovascular diseases,64.41,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Cerebrovascular diseases,63.32,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Cerebrovascular diseases,65.44,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Cerebrovascular diseases,64.46,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Cerebrovascular diseases,59.7,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Chronic lower respiratory diseases,32.82,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Chronic lower respiratory diseases,33.02,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Chronic lower respiratory diseases,35.35,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Chronic lower respiratory diseases,34.05,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Chronic lower respiratory diseases,37.86,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Chronic lower respiratory diseases,36.07,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Chronic lower respiratory diseases,38.72,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Chronic lower respiratory diseases,39.36,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Chronic lower respiratory diseases,39.78,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Chronic lower respiratory diseases,35.15,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2011,Asthma and status asthmaticus,1.66,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2012,Asthma and status asthmaticus,1.4,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2013,Asthma and status asthmaticus,2.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2014,Asthma and status asthmaticus,1.04,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2015,Asthma and status asthmaticus,1.46,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2016,Asthma and status asthmaticus,1.8,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2017,Asthma and status asthmaticus,1.03,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2018,Asthma and status asthmaticus,1.51,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2019,Asthma and status asthmaticus,1.65,Rate
Rheinhessen-Pfalz,DEB3,Total,Total,2020,Asthma and status asthmaticus,1.36,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4659.98,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4687.67,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4691.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4393.22,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4632.8,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4325.79,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4485.07,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4475.71,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4383.48,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4481.47,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.55,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.32,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.1,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.9,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.05,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.75,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.92,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",186.9,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",183.38,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",186.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",183.62,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",172.88,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",166.07,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",185.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",175.26,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",188.83,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",182.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Malignant melanoma of skin,11.63,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Malignant melanoma of skin,14.02,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Malignant melanoma of skin,13.06,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Malignant melanoma of skin,10.51,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Malignant melanoma of skin,15.96,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Malignant melanoma of skin,9.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Malignant melanoma of skin,10.9,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Malignant melanoma of skin,9.21,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Malignant melanoma of skin,12.72,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Malignant melanoma of skin,13.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Malignant neoplasm of breast,71.11,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Malignant neoplasm of breast,82.69,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Malignant neoplasm of breast,81.42,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Malignant neoplasm of breast,72.42,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Malignant neoplasm of breast,85.4,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Malignant neoplasm of breast,73.03,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Malignant neoplasm of breast,77.54,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Malignant neoplasm of breast,82.88,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Malignant neoplasm of breast,75.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Malignant neoplasm of breast,79.55,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Diabetes mellitus,170.93,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Diabetes mellitus,148.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Diabetes mellitus,165.81,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Diabetes mellitus,144.17,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Diabetes mellitus,145.68,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Diabetes mellitus,127.14,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Diabetes mellitus,130.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Diabetes mellitus,131.43,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Diabetes mellitus,125.35,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Diabetes mellitus,146.0,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),195.95,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),237.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),228.64,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),204.82,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),265.7,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),257.12,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),282.76,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),329.69,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),288.38,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),274.16,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),9.6,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),11.31,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),9.73,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),5.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),11.69,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),14.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),12.32,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),9.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),12.25,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),13.66,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Other ischaemic heart diseases,484.2,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Other ischaemic heart diseases,469.97,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Other ischaemic heart diseases,459.44,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Other ischaemic heart diseases,415.59,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Other ischaemic heart diseases,450.84,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Other ischaemic heart diseases,392.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Other ischaemic heart diseases,388.6,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Other ischaemic heart diseases,379.82,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Other ischaemic heart diseases,369.92,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Other ischaemic heart diseases,356.6,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,272.46,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,273.02,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,272.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,243.08,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,230.97,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,211.89,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,230.49,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,210.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,208.85,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,211.15,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Cerebrovascular diseases,389.4,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Cerebrovascular diseases,400.07,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Cerebrovascular diseases,364.54,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Cerebrovascular diseases,344.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Cerebrovascular diseases,339.93,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Cerebrovascular diseases,310.52,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Cerebrovascular diseases,305.63,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Cerebrovascular diseases,311.3,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Cerebrovascular diseases,308.26,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Cerebrovascular diseases,284.74,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Chronic lower respiratory diseases,148.41,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Chronic lower respiratory diseases,150.98,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Chronic lower respiratory diseases,155.29,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Chronic lower respiratory diseases,150.23,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Chronic lower respiratory diseases,166.74,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Chronic lower respiratory diseases,158.5,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Chronic lower respiratory diseases,173.34,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Chronic lower respiratory diseases,174.44,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Chronic lower respiratory diseases,177.0,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Chronic lower respiratory diseases,156.75,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2011,Asthma and status asthmaticus,6.68,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2012,Asthma and status asthmaticus,5.82,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2013,Asthma and status asthmaticus,7.44,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2014,Asthma and status asthmaticus,3.68,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2015,Asthma and status asthmaticus,5.78,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2016,Asthma and status asthmaticus,5.87,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2017,Asthma and status asthmaticus,3.68,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2018,Asthma and status asthmaticus,5.92,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2019,Asthma and status asthmaticus,5.99,Rate
Rheinhessen-Pfalz,DEB3,65 years or over,Total,2020,Asthma and status asthmaticus,5.56,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,202.47,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,192.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,196.63,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,184.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,183.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,179.19,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,178.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,189.17,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,179.78,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,179.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.21,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.07,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.43,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.71,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.9,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.56,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",19.96,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",20.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",17.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",19.07,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",17.53,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.61,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",17.42,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",16.73,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",16.6,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.4,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Malignant melanoma of skin,1.14,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Malignant melanoma of skin,1.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Malignant melanoma of skin,1.07,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Malignant melanoma of skin,1.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Malignant melanoma of skin,1.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Malignant melanoma of skin,1.08,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Malignant melanoma of skin,1.25,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Malignant melanoma of skin,1.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Malignant melanoma of skin,1.05,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Malignant melanoma of skin,1.19,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.53,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.52,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.49,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.02,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.88,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.0,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Diabetes mellitus,3.44,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Diabetes mellitus,3.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Diabetes mellitus,5.02,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Diabetes mellitus,3.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Diabetes mellitus,3.5,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Diabetes mellitus,3.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Diabetes mellitus,4.37,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Diabetes mellitus,3.34,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Diabetes mellitus,2.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Diabetes mellitus,3.43,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),5.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),4.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),5.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),6.33,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),5.27,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),5.58,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),6.01,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.84,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),3.75,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.24,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.09,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.25,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Other ischaemic heart diseases,6.07,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Other ischaemic heart diseases,5.22,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Other ischaemic heart diseases,5.54,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.55,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Other ischaemic heart diseases,6.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Other ischaemic heart diseases,6.09,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Other ischaemic heart diseases,5.86,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.65,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Other ischaemic heart diseases,6.49,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Other ischaemic heart diseases,5.12,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,13.38,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,13.46,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,12.49,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,11.89,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.82,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.66,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,8.94,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,9.15,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,8.53,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,10.9,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Cerebrovascular diseases,6.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Cerebrovascular diseases,5.95,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Cerebrovascular diseases,6.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Cerebrovascular diseases,4.93,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Cerebrovascular diseases,5.51,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Cerebrovascular diseases,4.8,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Cerebrovascular diseases,4.62,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Cerebrovascular diseases,5.88,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Cerebrovascular diseases,5.4,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Cerebrovascular diseases,5.18,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Chronic lower respiratory diseases,4.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Chronic lower respiratory diseases,6.29,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.91,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Chronic lower respiratory diseases,6.64,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Chronic lower respiratory diseases,6.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.11,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Chronic lower respiratory diseases,6.64,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Chronic lower respiratory diseases,6.54,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Chronic lower respiratory diseases,5.69,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.44,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.33,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.72,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.4,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.41,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.81,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.39,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.45,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.6,Rate
Rheinhessen-Pfalz,DEB3,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.35,Rate
Chemnitz,DED4,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,883.1,Rate
Chemnitz,DED4,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,849.79,Rate
Chemnitz,DED4,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,892.78,Rate
Chemnitz,DED4,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,829.58,Rate
Chemnitz,DED4,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,864.84,Rate
Chemnitz,DED4,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,818.93,Rate
Chemnitz,DED4,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,820.13,Rate
Chemnitz,DED4,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,850.71,Rate
Chemnitz,DED4,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,810.12,Rate
Chemnitz,DED4,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,911.37,Rate
Chemnitz,DED4,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.98,Rate
Chemnitz,DED4,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.47,Rate
Chemnitz,DED4,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.22,Rate
Chemnitz,DED4,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.28,Rate
Chemnitz,DED4,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.89,Rate
Chemnitz,DED4,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.79,Rate
Chemnitz,DED4,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.14,Rate
Chemnitz,DED4,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.62,Rate
Chemnitz,DED4,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.68,Rate
Chemnitz,DED4,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.77,Rate
Chemnitz,DED4,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",17.14,Rate
Chemnitz,DED4,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.6,Rate
Chemnitz,DED4,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.9,Rate
Chemnitz,DED4,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",17.86,Rate
Chemnitz,DED4,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",17.59,Rate
Chemnitz,DED4,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",17.59,Rate
Chemnitz,DED4,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",18.28,Rate
Chemnitz,DED4,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",18.6,Rate
Chemnitz,DED4,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",18.72,Rate
Chemnitz,DED4,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",18.08,Rate
Chemnitz,DED4,Total,Females,2011,Malignant melanoma of skin,1.96,Rate
Chemnitz,DED4,Total,Females,2012,Malignant melanoma of skin,2.79,Rate
Chemnitz,DED4,Total,Females,2013,Malignant melanoma of skin,2.51,Rate
Chemnitz,DED4,Total,Females,2014,Malignant melanoma of skin,1.99,Rate
Chemnitz,DED4,Total,Females,2015,Malignant melanoma of skin,2.23,Rate
Chemnitz,DED4,Total,Females,2016,Malignant melanoma of skin,1.88,Rate
Chemnitz,DED4,Total,Females,2017,Malignant melanoma of skin,2.38,Rate
Chemnitz,DED4,Total,Females,2018,Malignant melanoma of skin,2.41,Rate
Chemnitz,DED4,Total,Females,2019,Malignant melanoma of skin,1.89,Rate
Chemnitz,DED4,Total,Females,2020,Malignant melanoma of skin,2.94,Rate
Chemnitz,DED4,Total,Females,2011,Malignant neoplasm of breast,29.74,Rate
Chemnitz,DED4,Total,Females,2012,Malignant neoplasm of breast,30.79,Rate
Chemnitz,DED4,Total,Females,2013,Malignant neoplasm of breast,28.22,Rate
Chemnitz,DED4,Total,Females,2014,Malignant neoplasm of breast,28.37,Rate
Chemnitz,DED4,Total,Females,2015,Malignant neoplasm of breast,26.06,Rate
Chemnitz,DED4,Total,Females,2016,Malignant neoplasm of breast,28.69,Rate
Chemnitz,DED4,Total,Females,2017,Malignant neoplasm of breast,29.34,Rate
Chemnitz,DED4,Total,Females,2018,Malignant neoplasm of breast,28.09,Rate
Chemnitz,DED4,Total,Females,2019,Malignant neoplasm of breast,26.21,Rate
Chemnitz,DED4,Total,Females,2020,Malignant neoplasm of breast,27.78,Rate
Chemnitz,DED4,Total,Females,2011,Diabetes mellitus,34.56,Rate
Chemnitz,DED4,Total,Females,2012,Diabetes mellitus,33.06,Rate
Chemnitz,DED4,Total,Females,2013,Diabetes mellitus,33.08,Rate
Chemnitz,DED4,Total,Females,2014,Diabetes mellitus,29.1,Rate
Chemnitz,DED4,Total,Females,2015,Diabetes mellitus,33.09,Rate
Chemnitz,DED4,Total,Females,2016,Diabetes mellitus,24.2,Rate
Chemnitz,DED4,Total,Females,2017,Diabetes mellitus,24.62,Rate
Chemnitz,DED4,Total,Females,2018,Diabetes mellitus,23.74,Rate
Chemnitz,DED4,Total,Females,2019,Diabetes mellitus,21.86,Rate
Chemnitz,DED4,Total,Females,2020,Diabetes mellitus,20.49,Rate
Chemnitz,DED4,Total,Females,2011,Mental and behavioural disorders (F00-F99),23.94,Rate
Chemnitz,DED4,Total,Females,2012,Mental and behavioural disorders (F00-F99),30.24,Rate
Chemnitz,DED4,Total,Females,2013,Mental and behavioural disorders (F00-F99),32.82,Rate
Chemnitz,DED4,Total,Females,2014,Mental and behavioural disorders (F00-F99),37.76,Rate
Chemnitz,DED4,Total,Females,2015,Mental and behavioural disorders (F00-F99),39.52,Rate
Chemnitz,DED4,Total,Females,2016,Mental and behavioural disorders (F00-F99),39.8,Rate
Chemnitz,DED4,Total,Females,2017,Mental and behavioural disorders (F00-F99),41.63,Rate
Chemnitz,DED4,Total,Females,2018,Mental and behavioural disorders (F00-F99),50.15,Rate
Chemnitz,DED4,Total,Females,2019,Mental and behavioural disorders (F00-F99),49.35,Rate
Chemnitz,DED4,Total,Females,2020,Mental and behavioural disorders (F00-F99),54.84,Rate
Chemnitz,DED4,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Chemnitz,DED4,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Chemnitz,DED4,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.44,Rate
Chemnitz,DED4,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.45,Rate
Chemnitz,DED4,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.51,Rate
Chemnitz,DED4,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.32,Rate
Chemnitz,DED4,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Chemnitz,DED4,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.92,Rate
Chemnitz,DED4,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.99,Rate
Chemnitz,DED4,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.99,Rate
Chemnitz,DED4,Total,Females,2011,Other ischaemic heart diseases,131.08,Rate
Chemnitz,DED4,Total,Females,2012,Other ischaemic heart diseases,116.17,Rate
Chemnitz,DED4,Total,Females,2013,Other ischaemic heart diseases,121.62,Rate
Chemnitz,DED4,Total,Females,2014,Other ischaemic heart diseases,112.26,Rate
Chemnitz,DED4,Total,Females,2015,Other ischaemic heart diseases,110.81,Rate
Chemnitz,DED4,Total,Females,2016,Other ischaemic heart diseases,103.96,Rate
Chemnitz,DED4,Total,Females,2017,Other ischaemic heart diseases,98.85,Rate
Chemnitz,DED4,Total,Females,2018,Other ischaemic heart diseases,95.55,Rate
Chemnitz,DED4,Total,Females,2019,Other ischaemic heart diseases,87.95,Rate
Chemnitz,DED4,Total,Females,2020,Other ischaemic heart diseases,99.16,Rate
Chemnitz,DED4,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,51.76,Rate
Chemnitz,DED4,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,50.85,Rate
Chemnitz,DED4,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,51.43,Rate
Chemnitz,DED4,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,45.56,Rate
Chemnitz,DED4,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,44.92,Rate
Chemnitz,DED4,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,40.32,Rate
Chemnitz,DED4,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,38.84,Rate
Chemnitz,DED4,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,39.48,Rate
Chemnitz,DED4,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,34.71,Rate
Chemnitz,DED4,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,35.99,Rate
Chemnitz,DED4,Total,Females,2011,Cerebrovascular diseases,90.0,Rate
Chemnitz,DED4,Total,Females,2012,Cerebrovascular diseases,84.67,Rate
Chemnitz,DED4,Total,Females,2013,Cerebrovascular diseases,89.26,Rate
Chemnitz,DED4,Total,Females,2014,Cerebrovascular diseases,80.74,Rate
Chemnitz,DED4,Total,Females,2015,Cerebrovascular diseases,81.57,Rate
Chemnitz,DED4,Total,Females,2016,Cerebrovascular diseases,72.94,Rate
Chemnitz,DED4,Total,Females,2017,Cerebrovascular diseases,69.28,Rate
Chemnitz,DED4,Total,Females,2018,Cerebrovascular diseases,66.34,Rate
Chemnitz,DED4,Total,Females,2019,Cerebrovascular diseases,64.96,Rate
Chemnitz,DED4,Total,Females,2020,Cerebrovascular diseases,72.05,Rate
Chemnitz,DED4,Total,Females,2011,Chronic lower respiratory diseases,12.32,Rate
Chemnitz,DED4,Total,Females,2012,Chronic lower respiratory diseases,14.0,Rate
Chemnitz,DED4,Total,Females,2013,Chronic lower respiratory diseases,18.82,Rate
Chemnitz,DED4,Total,Females,2014,Chronic lower respiratory diseases,15.67,Rate
Chemnitz,DED4,Total,Females,2015,Chronic lower respiratory diseases,18.15,Rate
Chemnitz,DED4,Total,Females,2016,Chronic lower respiratory diseases,17.86,Rate
Chemnitz,DED4,Total,Females,2017,Chronic lower respiratory diseases,17.44,Rate
Chemnitz,DED4,Total,Females,2018,Chronic lower respiratory diseases,18.06,Rate
Chemnitz,DED4,Total,Females,2019,Chronic lower respiratory diseases,15.65,Rate
Chemnitz,DED4,Total,Females,2020,Chronic lower respiratory diseases,15.13,Rate
Chemnitz,DED4,Total,Females,2011,Asthma and status asthmaticus,0.91,Rate
Chemnitz,DED4,Total,Females,2012,Asthma and status asthmaticus,1.3,Rate
Chemnitz,DED4,Total,Females,2013,Asthma and status asthmaticus,1.3,Rate
Chemnitz,DED4,Total,Females,2014,Asthma and status asthmaticus,0.99,Rate
Chemnitz,DED4,Total,Females,2015,Asthma and status asthmaticus,2.01,Rate
Chemnitz,DED4,Total,Females,2016,Asthma and status asthmaticus,1.07,Rate
Chemnitz,DED4,Total,Females,2017,Asthma and status asthmaticus,1.13,Rate
Chemnitz,DED4,Total,Females,2018,Asthma and status asthmaticus,0.92,Rate
Chemnitz,DED4,Total,Females,2019,Asthma and status asthmaticus,1.49,Rate
Chemnitz,DED4,Total,Females,2020,Asthma and status asthmaticus,0.67,Rate
Chemnitz,DED4,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3981.78,Rate
Chemnitz,DED4,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3831.46,Rate
Chemnitz,DED4,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4013.61,Rate
Chemnitz,DED4,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3743.88,Rate
Chemnitz,DED4,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3904.31,Rate
Chemnitz,DED4,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3677.88,Rate
Chemnitz,DED4,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3701.93,Rate
Chemnitz,DED4,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3815.81,Rate
Chemnitz,DED4,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3620.42,Rate
Chemnitz,DED4,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4136.92,Rate
Chemnitz,DED4,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.36,Rate
Chemnitz,DED4,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.48,Rate
Chemnitz,DED4,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.9,Rate
Chemnitz,DED4,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.61,Rate
Chemnitz,DED4,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.84,Rate
Chemnitz,DED4,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.8,Rate
Chemnitz,DED4,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.97,Rate
Chemnitz,DED4,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.23,Rate
Chemnitz,DED4,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.35,Rate
Chemnitz,DED4,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.61,Rate
Chemnitz,DED4,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",56.44,Rate
Chemnitz,DED4,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",54.88,Rate
Chemnitz,DED4,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",61.78,Rate
Chemnitz,DED4,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",56.16,Rate
Chemnitz,DED4,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",57.82,Rate
Chemnitz,DED4,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",54.23,Rate
Chemnitz,DED4,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",63.26,Rate
Chemnitz,DED4,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",61.45,Rate
Chemnitz,DED4,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",59.95,Rate
Chemnitz,DED4,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",60.63,Rate
Chemnitz,DED4,65 years or over,Females,2011,Malignant melanoma of skin,5.54,Rate
Chemnitz,DED4,65 years or over,Females,2012,Malignant melanoma of skin,9.88,Rate
Chemnitz,DED4,65 years or over,Females,2013,Malignant melanoma of skin,6.38,Rate
Chemnitz,DED4,65 years or over,Females,2014,Malignant melanoma of skin,6.39,Rate
Chemnitz,DED4,65 years or over,Females,2015,Malignant melanoma of skin,9.63,Rate
Chemnitz,DED4,65 years or over,Females,2016,Malignant melanoma of skin,7.93,Rate
Chemnitz,DED4,65 years or over,Females,2017,Malignant melanoma of skin,7.49,Rate
Chemnitz,DED4,65 years or over,Females,2018,Malignant melanoma of skin,8.83,Rate
Chemnitz,DED4,65 years or over,Females,2019,Malignant melanoma of skin,6.84,Rate
Chemnitz,DED4,65 years or over,Females,2020,Malignant melanoma of skin,8.26,Rate
Chemnitz,DED4,65 years or over,Females,2011,Malignant neoplasm of breast,94.67,Rate
Chemnitz,DED4,65 years or over,Females,2012,Malignant neoplasm of breast,97.33,Rate
Chemnitz,DED4,65 years or over,Females,2013,Malignant neoplasm of breast,95.21,Rate
Chemnitz,DED4,65 years or over,Females,2014,Malignant neoplasm of breast,89.59,Rate
Chemnitz,DED4,65 years or over,Females,2015,Malignant neoplasm of breast,88.96,Rate
Chemnitz,DED4,65 years or over,Females,2016,Malignant neoplasm of breast,98.99,Rate
Chemnitz,DED4,65 years or over,Females,2017,Malignant neoplasm of breast,97.74,Rate
Chemnitz,DED4,65 years or over,Females,2018,Malignant neoplasm of breast,101.6,Rate
Chemnitz,DED4,65 years or over,Females,2019,Malignant neoplasm of breast,85.3,Rate
Chemnitz,DED4,65 years or over,Females,2020,Malignant neoplasm of breast,92.58,Rate
Chemnitz,DED4,65 years or over,Females,2011,Diabetes mellitus,169.9,Rate
Chemnitz,DED4,65 years or over,Females,2012,Diabetes mellitus,159.99,Rate
Chemnitz,DED4,65 years or over,Females,2013,Diabetes mellitus,157.59,Rate
Chemnitz,DED4,65 years or over,Females,2014,Diabetes mellitus,139.46,Rate
Chemnitz,DED4,65 years or over,Females,2015,Diabetes mellitus,161.11,Rate
Chemnitz,DED4,65 years or over,Females,2016,Diabetes mellitus,115.98,Rate
Chemnitz,DED4,65 years or over,Females,2017,Diabetes mellitus,113.36,Rate
Chemnitz,DED4,65 years or over,Females,2018,Diabetes mellitus,111.76,Rate
Chemnitz,DED4,65 years or over,Females,2019,Diabetes mellitus,104.29,Rate
Chemnitz,DED4,65 years or over,Females,2020,Diabetes mellitus,96.02,Rate
Chemnitz,DED4,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),114.56,Rate
Chemnitz,DED4,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),148.55,Rate
Chemnitz,DED4,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),161.6,Rate
Chemnitz,DED4,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),176.51,Rate
Chemnitz,DED4,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),195.07,Rate
Chemnitz,DED4,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),195.18,Rate
Chemnitz,DED4,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),208.49,Rate
Chemnitz,DED4,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),246.65,Rate
Chemnitz,DED4,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),245.08,Rate
Chemnitz,DED4,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),271.72,Rate
Chemnitz,DED4,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.9,Rate
Chemnitz,DED4,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),3.34,Rate
Chemnitz,DED4,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),6.87,Rate
Chemnitz,DED4,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.79,Rate
Chemnitz,DED4,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),5.16,Rate
Chemnitz,DED4,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),9.53,Rate
Chemnitz,DED4,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),4.77,Rate
Chemnitz,DED4,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),5.78,Rate
Chemnitz,DED4,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),6.45,Rate
Chemnitz,DED4,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),7.63,Rate
Chemnitz,DED4,65 years or over,Females,2011,Other ischaemic heart diseases,665.14,Rate
Chemnitz,DED4,65 years or over,Females,2012,Other ischaemic heart diseases,583.69,Rate
Chemnitz,DED4,65 years or over,Females,2013,Other ischaemic heart diseases,616.29,Rate
Chemnitz,DED4,65 years or over,Females,2014,Other ischaemic heart diseases,567.5,Rate
Chemnitz,DED4,65 years or over,Females,2015,Other ischaemic heart diseases,557.14,Rate
Chemnitz,DED4,65 years or over,Females,2016,Other ischaemic heart diseases,521.09,Rate
Chemnitz,DED4,65 years or over,Females,2017,Other ischaemic heart diseases,497.99,Rate
Chemnitz,DED4,65 years or over,Females,2018,Other ischaemic heart diseases,479.6,Rate
Chemnitz,DED4,65 years or over,Females,2019,Other ischaemic heart diseases,439.66,Rate
Chemnitz,DED4,65 years or over,Females,2020,Other ischaemic heart diseases,496.2,Rate
Chemnitz,DED4,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,245.12,Rate
Chemnitz,DED4,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,241.6,Rate
Chemnitz,DED4,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,241.07,Rate
Chemnitz,DED4,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,214.14,Rate
Chemnitz,DED4,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,211.1,Rate
Chemnitz,DED4,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,179.16,Rate
Chemnitz,DED4,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,181.53,Rate
Chemnitz,DED4,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,187.56,Rate
Chemnitz,DED4,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,155.57,Rate
Chemnitz,DED4,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,164.51,Rate
Chemnitz,DED4,65 years or over,Females,2011,Cerebrovascular diseases,444.04,Rate
Chemnitz,DED4,65 years or over,Females,2012,Cerebrovascular diseases,415.54,Rate
Chemnitz,DED4,65 years or over,Females,2013,Cerebrovascular diseases,438.52,Rate
Chemnitz,DED4,65 years or over,Females,2014,Cerebrovascular diseases,397.25,Rate
Chemnitz,DED4,65 years or over,Females,2015,Cerebrovascular diseases,400.47,Rate
Chemnitz,DED4,65 years or over,Females,2016,Cerebrovascular diseases,361.87,Rate
Chemnitz,DED4,65 years or over,Females,2017,Cerebrovascular diseases,326.53,Rate
Chemnitz,DED4,65 years or over,Females,2018,Cerebrovascular diseases,322.29,Rate
Chemnitz,DED4,65 years or over,Females,2019,Cerebrovascular diseases,316.65,Rate
Chemnitz,DED4,65 years or over,Females,2020,Cerebrovascular diseases,345.61,Rate
Chemnitz,DED4,65 years or over,Females,2011,Chronic lower respiratory diseases,58.51,Rate
Chemnitz,DED4,65 years or over,Females,2012,Chronic lower respiratory diseases,66.24,Rate
Chemnitz,DED4,65 years or over,Females,2013,Chronic lower respiratory diseases,85.81,Rate
Chemnitz,DED4,65 years or over,Females,2014,Chronic lower respiratory diseases,72.2,Rate
Chemnitz,DED4,65 years or over,Females,2015,Chronic lower respiratory diseases,80.21,Rate
Chemnitz,DED4,65 years or over,Females,2016,Chronic lower respiratory diseases,80.71,Rate
Chemnitz,DED4,65 years or over,Females,2017,Chronic lower respiratory diseases,74.75,Rate
Chemnitz,DED4,65 years or over,Females,2018,Chronic lower respiratory diseases,85.94,Rate
Chemnitz,DED4,65 years or over,Females,2019,Chronic lower respiratory diseases,67.57,Rate
Chemnitz,DED4,65 years or over,Females,2020,Chronic lower respiratory diseases,65.06,Rate
Chemnitz,DED4,65 years or over,Females,2011,Asthma and status asthmaticus,3.27,Rate
Chemnitz,DED4,65 years or over,Females,2012,Asthma and status asthmaticus,3.82,Rate
Chemnitz,DED4,65 years or over,Females,2013,Asthma and status asthmaticus,5.57,Rate
Chemnitz,DED4,65 years or over,Females,2014,Asthma and status asthmaticus,2.54,Rate
Chemnitz,DED4,65 years or over,Females,2015,Asthma and status asthmaticus,9.39,Rate
Chemnitz,DED4,65 years or over,Females,2016,Asthma and status asthmaticus,4.91,Rate
Chemnitz,DED4,65 years or over,Females,2017,Asthma and status asthmaticus,5.24,Rate
Chemnitz,DED4,65 years or over,Females,2018,Asthma and status asthmaticus,4.73,Rate
Chemnitz,DED4,65 years or over,Females,2019,Asthma and status asthmaticus,5.64,Rate
Chemnitz,DED4,65 years or over,Females,2020,Asthma and status asthmaticus,2.71,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,132.49,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,127.52,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,136.8,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,123.63,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,128.57,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,126.39,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,122.06,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,132.46,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,129.36,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,130.03,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.3,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.66,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.43,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.04,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.25,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.44,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.21,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.83,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.58,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",7.62,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",7.32,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",8.51,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",8.58,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",7.85,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",8.72,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",7.38,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",8.22,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.73,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",7.77,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Malignant melanoma of skin,1.1,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Malignant melanoma of skin,1.07,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Malignant melanoma of skin,1.57,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Malignant melanoma of skin,0.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Malignant melanoma of skin,0.44,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Malignant melanoma of skin,0.42,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Malignant melanoma of skin,1.15,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Malignant melanoma of skin,0.85,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Malignant melanoma of skin,0.7,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Malignant melanoma of skin,1.65,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Malignant neoplasm of breast,14.01,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Malignant neoplasm of breast,14.67,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Malignant neoplasm of breast,11.99,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Malignant neoplasm of breast,13.55,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Malignant neoplasm of breast,10.82,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.66,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Malignant neoplasm of breast,12.77,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Malignant neoplasm of breast,10.29,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Malignant neoplasm of breast,11.9,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Malignant neoplasm of breast,12.08,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Diabetes mellitus,1.77,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Diabetes mellitus,2.31,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Diabetes mellitus,2.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Diabetes mellitus,2.37,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Diabetes mellitus,2.08,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Diabetes mellitus,1.97,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Diabetes mellitus,3.12,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Diabetes mellitus,2.42,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Diabetes mellitus,1.9,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Diabetes mellitus,2.19,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.99,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),1.59,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.62,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),4.15,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.84,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.16,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.21,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.55,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.94,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.3,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.99,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.71,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.79,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.98,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.69,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Other ischaemic heart diseases,2.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Other ischaemic heart diseases,2.17,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.51,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.75,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.99,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.92,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,4.65,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.49,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.73,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.66,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,6.68,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.27,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.61,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,5.44,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.85,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Cerebrovascular diseases,4.23,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Cerebrovascular diseases,4.53,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Cerebrovascular diseases,4.66,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Cerebrovascular diseases,4.07,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Cerebrovascular diseases,4.32,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Cerebrovascular diseases,2.96,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Cerebrovascular diseases,6.96,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Cerebrovascular diseases,4.34,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Cerebrovascular diseases,3.99,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Cerebrovascular diseases,5.79,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Chronic lower respiratory diseases,1.13,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Chronic lower respiratory diseases,1.35,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.6,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Chronic lower respiratory diseases,1.97,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Chronic lower respiratory diseases,3.12,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Chronic lower respiratory diseases,2.63,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Chronic lower respiratory diseases,3.55,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.62,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Chronic lower respiratory diseases,3.08,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Chronic lower respiratory diseases,3.04,Rate
Chemnitz,DED4,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.34,Rate
Chemnitz,DED4,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.69,Rate
Chemnitz,DED4,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.27,Rate
Chemnitz,DED4,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.62,Rate
Chemnitz,DED4,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.23,Rate
Chemnitz,DED4,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.14,Rate
Chemnitz,DED4,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.14,Rate
Chemnitz,DED4,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Chemnitz,DED4,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.48,Rate
Chemnitz,DED4,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.17,Rate
Chemnitz,DED4,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1403.6,Rate
Chemnitz,DED4,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1413.74,Rate
Chemnitz,DED4,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1414.19,Rate
Chemnitz,DED4,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1335.0,Rate
Chemnitz,DED4,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1375.85,Rate
Chemnitz,DED4,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1342.94,Rate
Chemnitz,DED4,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1333.62,Rate
Chemnitz,DED4,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1355.94,Rate
Chemnitz,DED4,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1325.68,Rate
Chemnitz,DED4,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1500.02,Rate
Chemnitz,DED4,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.64,Rate
Chemnitz,DED4,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.15,Rate
Chemnitz,DED4,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.41,Rate
Chemnitz,DED4,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.82,Rate
Chemnitz,DED4,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.12,Rate
Chemnitz,DED4,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.5,Rate
Chemnitz,DED4,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.49,Rate
Chemnitz,DED4,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.77,Rate
Chemnitz,DED4,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.82,Rate
Chemnitz,DED4,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.38,Rate
Chemnitz,DED4,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",75.97,Rate
Chemnitz,DED4,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",77.82,Rate
Chemnitz,DED4,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",72.42,Rate
Chemnitz,DED4,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",68.29,Rate
Chemnitz,DED4,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",66.35,Rate
Chemnitz,DED4,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",65.56,Rate
Chemnitz,DED4,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",64.54,Rate
Chemnitz,DED4,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",59.98,Rate
Chemnitz,DED4,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",61.43,Rate
Chemnitz,DED4,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",55.12,Rate
Chemnitz,DED4,Total,Males,2011,Malignant melanoma of skin,4.32,Rate
Chemnitz,DED4,Total,Males,2012,Malignant melanoma of skin,5.41,Rate
Chemnitz,DED4,Total,Males,2013,Malignant melanoma of skin,4.17,Rate
Chemnitz,DED4,Total,Males,2014,Malignant melanoma of skin,5.34,Rate
Chemnitz,DED4,Total,Males,2015,Malignant melanoma of skin,3.95,Rate
Chemnitz,DED4,Total,Males,2016,Malignant melanoma of skin,4.5,Rate
Chemnitz,DED4,Total,Males,2017,Malignant melanoma of skin,4.22,Rate
Chemnitz,DED4,Total,Males,2018,Malignant melanoma of skin,5.1,Rate
Chemnitz,DED4,Total,Males,2019,Malignant melanoma of skin,3.54,Rate
Chemnitz,DED4,Total,Males,2020,Malignant melanoma of skin,4.94,Rate
Chemnitz,DED4,Total,Males,2011,Malignant neoplasm of breast,0.66,Rate
Chemnitz,DED4,Total,Males,2012,Malignant neoplasm of breast,0.41,Rate
Chemnitz,DED4,Total,Males,2013,Malignant neoplasm of breast,0.33,Rate
Chemnitz,DED4,Total,Males,2014,Malignant neoplasm of breast,0.83,Rate
Chemnitz,DED4,Total,Males,2015,Malignant neoplasm of breast,0.52,Rate
Chemnitz,DED4,Total,Males,2016,Malignant neoplasm of breast,0.46,Rate
Chemnitz,DED4,Total,Males,2017,Malignant neoplasm of breast,0.65,Rate
Chemnitz,DED4,Total,Males,2018,Malignant neoplasm of breast,0.37,Rate
Chemnitz,DED4,Total,Males,2019,Malignant neoplasm of breast,0.51,Rate
Chemnitz,DED4,Total,Males,2020,Malignant neoplasm of breast,0.21,Rate
Chemnitz,DED4,Total,Males,2011,Diabetes mellitus,41.97,Rate
Chemnitz,DED4,Total,Males,2012,Diabetes mellitus,37.27,Rate
Chemnitz,DED4,Total,Males,2013,Diabetes mellitus,44.15,Rate
Chemnitz,DED4,Total,Males,2014,Diabetes mellitus,39.02,Rate
Chemnitz,DED4,Total,Males,2015,Diabetes mellitus,41.79,Rate
Chemnitz,DED4,Total,Males,2016,Diabetes mellitus,31.57,Rate
Chemnitz,DED4,Total,Males,2017,Diabetes mellitus,31.84,Rate
Chemnitz,DED4,Total,Males,2018,Diabetes mellitus,31.59,Rate
Chemnitz,DED4,Total,Males,2019,Diabetes mellitus,32.98,Rate
Chemnitz,DED4,Total,Males,2020,Diabetes mellitus,34.39,Rate
Chemnitz,DED4,Total,Males,2011,Mental and behavioural disorders (F00-F99),33.66,Rate
Chemnitz,DED4,Total,Males,2012,Mental and behavioural disorders (F00-F99),34.85,Rate
Chemnitz,DED4,Total,Males,2013,Mental and behavioural disorders (F00-F99),44.01,Rate
Chemnitz,DED4,Total,Males,2014,Mental and behavioural disorders (F00-F99),42.0,Rate
Chemnitz,DED4,Total,Males,2015,Mental and behavioural disorders (F00-F99),49.67,Rate
Chemnitz,DED4,Total,Males,2016,Mental and behavioural disorders (F00-F99),52.1,Rate
Chemnitz,DED4,Total,Males,2017,Mental and behavioural disorders (F00-F99),53.04,Rate
Chemnitz,DED4,Total,Males,2018,Mental and behavioural disorders (F00-F99),56.36,Rate
Chemnitz,DED4,Total,Males,2019,Mental and behavioural disorders (F00-F99),62.06,Rate
Chemnitz,DED4,Total,Males,2020,Mental and behavioural disorders (F00-F99),72.44,Rate
Chemnitz,DED4,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.09,Rate
Chemnitz,DED4,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Chemnitz,DED4,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),3.26,Rate
Chemnitz,DED4,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.93,Rate
Chemnitz,DED4,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.3,Rate
Chemnitz,DED4,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Chemnitz,DED4,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.25,Rate
Chemnitz,DED4,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.37,Rate
Chemnitz,DED4,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.01,Rate
Chemnitz,DED4,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),3.72,Rate
Chemnitz,DED4,Total,Males,2011,Other ischaemic heart diseases,187.76,Rate
Chemnitz,DED4,Total,Males,2012,Other ischaemic heart diseases,202.47,Rate
Chemnitz,DED4,Total,Males,2013,Other ischaemic heart diseases,180.71,Rate
Chemnitz,DED4,Total,Males,2014,Other ischaemic heart diseases,174.36,Rate
Chemnitz,DED4,Total,Males,2015,Other ischaemic heart diseases,180.14,Rate
Chemnitz,DED4,Total,Males,2016,Other ischaemic heart diseases,185.96,Rate
Chemnitz,DED4,Total,Males,2017,Other ischaemic heart diseases,172.57,Rate
Chemnitz,DED4,Total,Males,2018,Other ischaemic heart diseases,170.87,Rate
Chemnitz,DED4,Total,Males,2019,Other ischaemic heart diseases,162.11,Rate
Chemnitz,DED4,Total,Males,2020,Other ischaemic heart diseases,166.87,Rate
Chemnitz,DED4,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,115.58,Rate
Chemnitz,DED4,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,110.6,Rate
Chemnitz,DED4,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,113.2,Rate
Chemnitz,DED4,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,96.82,Rate
Chemnitz,DED4,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,99.87,Rate
Chemnitz,DED4,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,93.03,Rate
Chemnitz,DED4,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,96.2,Rate
Chemnitz,DED4,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,87.39,Rate
Chemnitz,DED4,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,87.35,Rate
Chemnitz,DED4,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,85.56,Rate
Chemnitz,DED4,Total,Males,2011,Cerebrovascular diseases,101.39,Rate
Chemnitz,DED4,Total,Males,2012,Cerebrovascular diseases,103.9,Rate
Chemnitz,DED4,Total,Males,2013,Cerebrovascular diseases,99.21,Rate
Chemnitz,DED4,Total,Males,2014,Cerebrovascular diseases,93.81,Rate
Chemnitz,DED4,Total,Males,2015,Cerebrovascular diseases,92.59,Rate
Chemnitz,DED4,Total,Males,2016,Cerebrovascular diseases,88.72,Rate
Chemnitz,DED4,Total,Males,2017,Cerebrovascular diseases,83.57,Rate
Chemnitz,DED4,Total,Males,2018,Cerebrovascular diseases,80.35,Rate
Chemnitz,DED4,Total,Males,2019,Cerebrovascular diseases,71.5,Rate
Chemnitz,DED4,Total,Males,2020,Cerebrovascular diseases,80.84,Rate
Chemnitz,DED4,Total,Males,2011,Chronic lower respiratory diseases,42.44,Rate
Chemnitz,DED4,Total,Males,2012,Chronic lower respiratory diseases,40.65,Rate
Chemnitz,DED4,Total,Males,2013,Chronic lower respiratory diseases,46.26,Rate
Chemnitz,DED4,Total,Males,2014,Chronic lower respiratory diseases,42.86,Rate
Chemnitz,DED4,Total,Males,2015,Chronic lower respiratory diseases,47.92,Rate
Chemnitz,DED4,Total,Males,2016,Chronic lower respiratory diseases,47.46,Rate
Chemnitz,DED4,Total,Males,2017,Chronic lower respiratory diseases,46.65,Rate
Chemnitz,DED4,Total,Males,2018,Chronic lower respiratory diseases,47.66,Rate
Chemnitz,DED4,Total,Males,2019,Chronic lower respiratory diseases,50.18,Rate
Chemnitz,DED4,Total,Males,2020,Chronic lower respiratory diseases,46.04,Rate
Chemnitz,DED4,Total,Males,2011,Asthma and status asthmaticus,0.57,Rate
Chemnitz,DED4,Total,Males,2012,Asthma and status asthmaticus,1.8,Rate
Chemnitz,DED4,Total,Males,2013,Asthma and status asthmaticus,0.87,Rate
Chemnitz,DED4,Total,Males,2014,Asthma and status asthmaticus,1.86,Rate
Chemnitz,DED4,Total,Males,2015,Asthma and status asthmaticus,0.54,Rate
Chemnitz,DED4,Total,Males,2016,Asthma and status asthmaticus,0.98,Rate
Chemnitz,DED4,Total,Males,2017,Asthma and status asthmaticus,0.34,Rate
Chemnitz,DED4,Total,Males,2018,Asthma and status asthmaticus,0.87,Rate
Chemnitz,DED4,Total,Males,2019,Asthma and status asthmaticus,1.52,Rate
Chemnitz,DED4,Total,Males,2020,Asthma and status asthmaticus,1.35,Rate
Chemnitz,DED4,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5945.37,Rate
Chemnitz,DED4,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,6048.38,Rate
Chemnitz,DED4,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5951.52,Rate
Chemnitz,DED4,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5609.5,Rate
Chemnitz,DED4,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5751.1,Rate
Chemnitz,DED4,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5644.98,Rate
Chemnitz,DED4,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5673.89,Rate
Chemnitz,DED4,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5757.72,Rate
Chemnitz,DED4,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5584.88,Rate
Chemnitz,DED4,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6486.0,Rate
Chemnitz,DED4,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",191.02,Rate
Chemnitz,DED4,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",196.8,Rate
Chemnitz,DED4,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",206.16,Rate
Chemnitz,DED4,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.49,Rate
Chemnitz,DED4,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",182.44,Rate
Chemnitz,DED4,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",184.59,Rate
Chemnitz,DED4,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",163.79,Rate
Chemnitz,DED4,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",179.82,Rate
Chemnitz,DED4,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",171.83,Rate
Chemnitz,DED4,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",159.05,Rate
Chemnitz,DED4,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",298.23,Rate
Chemnitz,DED4,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",309.02,Rate
Chemnitz,DED4,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",269.44,Rate
Chemnitz,DED4,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",268.31,Rate
Chemnitz,DED4,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",254.33,Rate
Chemnitz,DED4,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",244.63,Rate
Chemnitz,DED4,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",245.19,Rate
Chemnitz,DED4,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",225.25,Rate
Chemnitz,DED4,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",231.71,Rate
Chemnitz,DED4,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",203.61,Rate
Chemnitz,DED4,65 years or over,Males,2011,Malignant melanoma of skin,20.41,Rate
Chemnitz,DED4,65 years or over,Males,2012,Malignant melanoma of skin,22.4,Rate
Chemnitz,DED4,65 years or over,Males,2013,Malignant melanoma of skin,14.08,Rate
Chemnitz,DED4,65 years or over,Males,2014,Malignant melanoma of skin,17.16,Rate
Chemnitz,DED4,65 years or over,Males,2015,Malignant melanoma of skin,15.02,Rate
Chemnitz,DED4,65 years or over,Males,2016,Malignant melanoma of skin,19.94,Rate
Chemnitz,DED4,65 years or over,Males,2017,Malignant melanoma of skin,14.81,Rate
Chemnitz,DED4,65 years or over,Males,2018,Malignant melanoma of skin,18.74,Rate
Chemnitz,DED4,65 years or over,Males,2019,Malignant melanoma of skin,13.49,Rate
Chemnitz,DED4,65 years or over,Males,2020,Malignant melanoma of skin,19.45,Rate
Chemnitz,DED4,65 years or over,Males,2011,Malignant neoplasm of breast,2.79,Rate
Chemnitz,DED4,65 years or over,Males,2012,Malignant neoplasm of breast,2.09,Rate
Chemnitz,DED4,65 years or over,Males,2013,Malignant neoplasm of breast,0.52,Rate
Chemnitz,DED4,65 years or over,Males,2014,Malignant neoplasm of breast,3.76,Rate
Chemnitz,DED4,65 years or over,Males,2015,Malignant neoplasm of breast,1.58,Rate
Chemnitz,DED4,65 years or over,Males,2016,Malignant neoplasm of breast,2.35,Rate
Chemnitz,DED4,65 years or over,Males,2017,Malignant neoplasm of breast,2.77,Rate
Chemnitz,DED4,65 years or over,Males,2018,Malignant neoplasm of breast,0.99,Rate
Chemnitz,DED4,65 years or over,Males,2019,Malignant neoplasm of breast,2.59,Rate
Chemnitz,DED4,65 years or over,Males,2020,Malignant neoplasm of breast,0.51,Rate
Chemnitz,DED4,65 years or over,Males,2011,Diabetes mellitus,188.97,Rate
Chemnitz,DED4,65 years or over,Males,2012,Diabetes mellitus,163.53,Rate
Chemnitz,DED4,65 years or over,Males,2013,Diabetes mellitus,195.63,Rate
Chemnitz,DED4,65 years or over,Males,2014,Diabetes mellitus,173.26,Rate
Chemnitz,DED4,65 years or over,Males,2015,Diabetes mellitus,185.27,Rate
Chemnitz,DED4,65 years or over,Males,2016,Diabetes mellitus,139.26,Rate
Chemnitz,DED4,65 years or over,Males,2017,Diabetes mellitus,137.5,Rate
Chemnitz,DED4,65 years or over,Males,2018,Diabetes mellitus,142.29,Rate
Chemnitz,DED4,65 years or over,Males,2019,Diabetes mellitus,142.7,Rate
Chemnitz,DED4,65 years or over,Males,2020,Diabetes mellitus,150.83,Rate
Chemnitz,DED4,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),133.77,Rate
Chemnitz,DED4,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),141.21,Rate
Chemnitz,DED4,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),186.47,Rate
Chemnitz,DED4,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),167.0,Rate
Chemnitz,DED4,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),220.13,Rate
Chemnitz,DED4,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),231.09,Rate
Chemnitz,DED4,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),240.48,Rate
Chemnitz,DED4,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),260.71,Rate
Chemnitz,DED4,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),279.43,Rate
Chemnitz,DED4,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),326.89,Rate
Chemnitz,DED4,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),5.57,Rate
Chemnitz,DED4,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.11,Rate
Chemnitz,DED4,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),10.94,Rate
Chemnitz,DED4,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),4.26,Rate
Chemnitz,DED4,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),8.45,Rate
Chemnitz,DED4,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),9.2,Rate
Chemnitz,DED4,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),8.52,Rate
Chemnitz,DED4,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),5.9,Rate
Chemnitz,DED4,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.95,Rate
Chemnitz,DED4,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),10.85,Rate
Chemnitz,DED4,65 years or over,Males,2011,Other ischaemic heart diseases,915.13,Rate
Chemnitz,DED4,65 years or over,Males,2012,Other ischaemic heart diseases,989.22,Rate
Chemnitz,DED4,65 years or over,Males,2013,Other ischaemic heart diseases,881.05,Rate
Chemnitz,DED4,65 years or over,Males,2014,Other ischaemic heart diseases,851.23,Rate
Chemnitz,DED4,65 years or over,Males,2015,Other ischaemic heart diseases,868.36,Rate
Chemnitz,DED4,65 years or over,Males,2016,Other ischaemic heart diseases,907.34,Rate
Chemnitz,DED4,65 years or over,Males,2017,Other ischaemic heart diseases,835.7,Rate
Chemnitz,DED4,65 years or over,Males,2018,Other ischaemic heart diseases,833.32,Rate
Chemnitz,DED4,65 years or over,Males,2019,Other ischaemic heart diseases,776.92,Rate
Chemnitz,DED4,65 years or over,Males,2020,Other ischaemic heart diseases,804.27,Rate
Chemnitz,DED4,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,486.61,Rate
Chemnitz,DED4,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,450.02,Rate
Chemnitz,DED4,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,468.61,Rate
Chemnitz,DED4,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,381.71,Rate
Chemnitz,DED4,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,403.39,Rate
Chemnitz,DED4,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,380.05,Rate
Chemnitz,DED4,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,389.09,Rate
Chemnitz,DED4,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,360.93,Rate
Chemnitz,DED4,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,348.11,Rate
Chemnitz,DED4,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,349.57,Rate
Chemnitz,DED4,65 years or over,Males,2011,Cerebrovascular diseases,481.77,Rate
Chemnitz,DED4,65 years or over,Males,2012,Cerebrovascular diseases,499.54,Rate
Chemnitz,DED4,65 years or over,Males,2013,Cerebrovascular diseases,476.85,Rate
Chemnitz,DED4,65 years or over,Males,2014,Cerebrovascular diseases,450.06,Rate
Chemnitz,DED4,65 years or over,Males,2015,Cerebrovascular diseases,433.89,Rate
Chemnitz,DED4,65 years or over,Males,2016,Cerebrovascular diseases,413.18,Rate
Chemnitz,DED4,65 years or over,Males,2017,Cerebrovascular diseases,402.12,Rate
Chemnitz,DED4,65 years or over,Males,2018,Cerebrovascular diseases,376.16,Rate
Chemnitz,DED4,65 years or over,Males,2019,Cerebrovascular diseases,335.72,Rate
Chemnitz,DED4,65 years or over,Males,2020,Cerebrovascular diseases,383.06,Rate
Chemnitz,DED4,65 years or over,Males,2011,Chronic lower respiratory diseases,194.09,Rate
Chemnitz,DED4,65 years or over,Males,2012,Chronic lower respiratory diseases,186.12,Rate
Chemnitz,DED4,65 years or over,Males,2013,Chronic lower respiratory diseases,206.8,Rate
Chemnitz,DED4,65 years or over,Males,2014,Chronic lower respiratory diseases,193.15,Rate
Chemnitz,DED4,65 years or over,Males,2015,Chronic lower respiratory diseases,212.3,Rate
Chemnitz,DED4,65 years or over,Males,2016,Chronic lower respiratory diseases,213.33,Rate
Chemnitz,DED4,65 years or over,Males,2017,Chronic lower respiratory diseases,212.09,Rate
Chemnitz,DED4,65 years or over,Males,2018,Chronic lower respiratory diseases,210.34,Rate
Chemnitz,DED4,65 years or over,Males,2019,Chronic lower respiratory diseases,223.16,Rate
Chemnitz,DED4,65 years or over,Males,2020,Chronic lower respiratory diseases,214.08,Rate
Chemnitz,DED4,65 years or over,Males,2011,Asthma and status asthmaticus,1.76,Rate
Chemnitz,DED4,65 years or over,Males,2012,Asthma and status asthmaticus,6.61,Rate
Chemnitz,DED4,65 years or over,Males,2013,Asthma and status asthmaticus,2.74,Rate
Chemnitz,DED4,65 years or over,Males,2014,Asthma and status asthmaticus,8.46,Rate
Chemnitz,DED4,65 years or over,Males,2015,Asthma and status asthmaticus,2.25,Rate
Chemnitz,DED4,65 years or over,Males,2016,Asthma and status asthmaticus,5.05,Rate
Chemnitz,DED4,65 years or over,Males,2017,Asthma and status asthmaticus,1.19,Rate
Chemnitz,DED4,65 years or over,Males,2018,Asthma and status asthmaticus,1.29,Rate
Chemnitz,DED4,65 years or over,Males,2019,Asthma and status asthmaticus,3.04,Rate
Chemnitz,DED4,65 years or over,Males,2020,Asthma and status asthmaticus,4.11,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,303.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,291.06,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,315.08,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,299.56,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,316.01,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,300.83,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,282.25,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,289.68,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,293.95,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,292.23,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.43,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.9,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.2,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.62,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.37,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.8,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.87,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.82,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.33,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.39,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",22.13,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",21.81,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",24.7,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",19.84,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",20.82,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",22.19,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",20.78,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",19.95,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",20.19,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",19.15,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Malignant melanoma of skin,0.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Malignant melanoma of skin,1.3,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Malignant melanoma of skin,1.77,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Malignant melanoma of skin,2.47,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Malignant melanoma of skin,1.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Malignant melanoma of skin,0.75,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Malignant melanoma of skin,1.65,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Malignant melanoma of skin,1.8,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Malignant melanoma of skin,1.13,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Malignant melanoma of skin,1.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.15,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.28,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.12,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.13,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.21,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.14,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Diabetes mellitus,6.36,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Diabetes mellitus,6.68,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Diabetes mellitus,7.45,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Diabetes mellitus,6.51,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Diabetes mellitus,7.03,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Diabetes mellitus,5.49,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Diabetes mellitus,6.24,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Diabetes mellitus,4.77,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Diabetes mellitus,6.4,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Diabetes mellitus,6.18,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),9.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),9.09,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),9.5,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),11.71,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),8.37,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),8.74,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),7.64,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),6.85,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),9.41,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),10.8,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.44,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.99,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Other ischaemic heart diseases,11.57,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Other ischaemic heart diseases,11.89,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Other ischaemic heart diseases,11.06,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Other ischaemic heart diseases,10.4,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Other ischaemic heart diseases,13.43,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Other ischaemic heart diseases,11.22,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Other ischaemic heart diseases,11.93,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Other ischaemic heart diseases,10.4,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Other ischaemic heart diseases,13.18,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Other ischaemic heart diseases,12.47,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,25.71,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,28.37,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,27.1,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,27.8,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,26.35,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,23.5,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,25.25,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,21.13,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,24.18,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,21.6,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Cerebrovascular diseases,9.25,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Cerebrovascular diseases,8.06,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Cerebrovascular diseases,7.73,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Cerebrovascular diseases,7.52,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Cerebrovascular diseases,9.92,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Cerebrovascular diseases,10.12,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Cerebrovascular diseases,6.4,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Cerebrovascular diseases,8.69,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Cerebrovascular diseases,7.49,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Cerebrovascular diseases,7.63,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Chronic lower respiratory diseases,5.7,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Chronic lower respiratory diseases,5.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Chronic lower respiratory diseases,7.37,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Chronic lower respiratory diseases,6.45,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Chronic lower respiratory diseases,8.1,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.57,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Chronic lower respiratory diseases,8.26,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Chronic lower respiratory diseases,8.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Chronic lower respiratory diseases,5.33,Rate
Chemnitz,DED4,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.28,Rate
Chemnitz,DED4,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.63,Rate
Chemnitz,DED4,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.42,Rate
Chemnitz,DED4,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.27,Rate
Chemnitz,DED4,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.13,Rate
Chemnitz,DED4,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Chemnitz,DED4,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.14,Rate
Chemnitz,DED4,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.77,Rate
Chemnitz,DED4,Less than 65 years,Males,2019,Asthma and status asthmaticus,1.16,Rate
Chemnitz,DED4,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.68,Rate
Chemnitz,DED4,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1092.95,Rate
Chemnitz,DED4,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1073.59,Rate
Chemnitz,DED4,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1109.63,Rate
Chemnitz,DED4,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1040.91,Rate
Chemnitz,DED4,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1077.99,Rate
Chemnitz,DED4,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1037.23,Rate
Chemnitz,DED4,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1037.08,Rate
Chemnitz,DED4,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1064.27,Rate
Chemnitz,DED4,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1029.88,Rate
Chemnitz,DED4,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1157.72,Rate
Chemnitz,DED4,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.37,Rate
Chemnitz,DED4,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.68,Rate
Chemnitz,DED4,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.19,Rate
Chemnitz,DED4,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.53,Rate
Chemnitz,DED4,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.64,Rate
Chemnitz,DED4,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.86,Rate
Chemnitz,DED4,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.21,Rate
Chemnitz,DED4,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.57,Rate
Chemnitz,DED4,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.45,Rate
Chemnitz,DED4,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.96,Rate
Chemnitz,DED4,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",41.78,Rate
Chemnitz,DED4,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",41.84,Rate
Chemnitz,DED4,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",41.76,Rate
Chemnitz,DED4,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",39.25,Rate
Chemnitz,DED4,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",37.86,Rate
Chemnitz,DED4,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",37.91,Rate
Chemnitz,DED4,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",38.1,Rate
Chemnitz,DED4,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",36.44,Rate
Chemnitz,DED4,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",37.38,Rate
Chemnitz,DED4,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",34.52,Rate
Chemnitz,DED4,Total,Total,2011,Malignant melanoma of skin,2.75,Rate
Chemnitz,DED4,Total,Total,2012,Malignant melanoma of skin,3.49,Rate
Chemnitz,DED4,Total,Total,2013,Malignant melanoma of skin,3.25,Rate
Chemnitz,DED4,Total,Total,2014,Malignant melanoma of skin,3.5,Rate
Chemnitz,DED4,Total,Total,2015,Malignant melanoma of skin,3.09,Rate
Chemnitz,DED4,Total,Total,2016,Malignant melanoma of skin,2.82,Rate
Chemnitz,DED4,Total,Total,2017,Malignant melanoma of skin,3.16,Rate
Chemnitz,DED4,Total,Total,2018,Malignant melanoma of skin,3.38,Rate
Chemnitz,DED4,Total,Total,2019,Malignant melanoma of skin,2.64,Rate
Chemnitz,DED4,Total,Total,2020,Malignant melanoma of skin,3.75,Rate
Chemnitz,DED4,Total,Total,2011,Malignant neoplasm of breast,17.42,Rate
Chemnitz,DED4,Total,Total,2012,Malignant neoplasm of breast,17.94,Rate
Chemnitz,DED4,Total,Total,2013,Malignant neoplasm of breast,16.45,Rate
Chemnitz,DED4,Total,Total,2014,Malignant neoplasm of breast,16.53,Rate
Chemnitz,DED4,Total,Total,2015,Malignant neoplasm of breast,15.29,Rate
Chemnitz,DED4,Total,Total,2016,Malignant neoplasm of breast,16.56,Rate
Chemnitz,DED4,Total,Total,2017,Malignant neoplasm of breast,16.96,Rate
Chemnitz,DED4,Total,Total,2018,Malignant neoplasm of breast,16.03,Rate
Chemnitz,DED4,Total,Total,2019,Malignant neoplasm of breast,15.07,Rate
Chemnitz,DED4,Total,Total,2020,Malignant neoplasm of breast,15.81,Rate
Chemnitz,DED4,Total,Total,2011,Diabetes mellitus,38.43,Rate
Chemnitz,DED4,Total,Total,2012,Diabetes mellitus,36.45,Rate
Chemnitz,DED4,Total,Total,2013,Diabetes mellitus,38.54,Rate
Chemnitz,DED4,Total,Total,2014,Diabetes mellitus,33.58,Rate
Chemnitz,DED4,Total,Total,2015,Diabetes mellitus,37.0,Rate
Chemnitz,DED4,Total,Total,2016,Diabetes mellitus,27.47,Rate
Chemnitz,DED4,Total,Total,2017,Diabetes mellitus,27.78,Rate
Chemnitz,DED4,Total,Total,2018,Diabetes mellitus,27.31,Rate
Chemnitz,DED4,Total,Total,2019,Diabetes mellitus,26.9,Rate
Chemnitz,DED4,Total,Total,2020,Diabetes mellitus,26.19,Rate
Chemnitz,DED4,Total,Total,2011,Mental and behavioural disorders (F00-F99),29.0,Rate
Chemnitz,DED4,Total,Total,2012,Mental and behavioural disorders (F00-F99),33.18,Rate
Chemnitz,DED4,Total,Total,2013,Mental and behavioural disorders (F00-F99),37.65,Rate
Chemnitz,DED4,Total,Total,2014,Mental and behavioural disorders (F00-F99),40.71,Rate
Chemnitz,DED4,Total,Total,2015,Mental and behavioural disorders (F00-F99),43.98,Rate
Chemnitz,DED4,Total,Total,2016,Mental and behavioural disorders (F00-F99),44.95,Rate
Chemnitz,DED4,Total,Total,2017,Mental and behavioural disorders (F00-F99),47.44,Rate
Chemnitz,DED4,Total,Total,2018,Mental and behavioural disorders (F00-F99),53.39,Rate
Chemnitz,DED4,Total,Total,2019,Mental and behavioural disorders (F00-F99),55.11,Rate
Chemnitz,DED4,Total,Total,2020,Mental and behavioural disorders (F00-F99),62.29,Rate
Chemnitz,DED4,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Chemnitz,DED4,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Chemnitz,DED4,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.08,Rate
Chemnitz,DED4,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.67,Rate
Chemnitz,DED4,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.9,Rate
Chemnitz,DED4,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.35,Rate
Chemnitz,DED4,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.66,Rate
Chemnitz,DED4,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Chemnitz,DED4,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.04,Rate
Chemnitz,DED4,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Chemnitz,DED4,Total,Total,2011,Other ischaemic heart diseases,153.61,Rate
Chemnitz,DED4,Total,Total,2012,Other ischaemic heart diseases,146.09,Rate
Chemnitz,DED4,Total,Total,2013,Other ischaemic heart diseases,145.18,Rate
Chemnitz,DED4,Total,Total,2014,Other ischaemic heart diseases,135.55,Rate
Chemnitz,DED4,Total,Total,2015,Other ischaemic heart diseases,136.92,Rate
Chemnitz,DED4,Total,Total,2016,Other ischaemic heart diseases,132.8,Rate
Chemnitz,DED4,Total,Total,2017,Other ischaemic heart diseases,126.53,Rate
Chemnitz,DED4,Total,Total,2018,Other ischaemic heart diseases,124.3,Rate
Chemnitz,DED4,Total,Total,2019,Other ischaemic heart diseases,115.29,Rate
Chemnitz,DED4,Total,Total,2020,Other ischaemic heart diseases,126.51,Rate
Chemnitz,DED4,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,76.96,Rate
Chemnitz,DED4,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,75.88,Rate
Chemnitz,DED4,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,76.17,Rate
Chemnitz,DED4,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,67.72,Rate
Chemnitz,DED4,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,67.41,Rate
Chemnitz,DED4,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,62.21,Rate
Chemnitz,DED4,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,62.58,Rate
Chemnitz,DED4,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,60.01,Rate
Chemnitz,DED4,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,57.25,Rate
Chemnitz,DED4,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,56.98,Rate
Chemnitz,DED4,Total,Total,2011,Cerebrovascular diseases,94.99,Rate
Chemnitz,DED4,Total,Total,2012,Cerebrovascular diseases,92.57,Rate
Chemnitz,DED4,Total,Total,2013,Cerebrovascular diseases,94.57,Rate
Chemnitz,DED4,Total,Total,2014,Cerebrovascular diseases,87.34,Rate
Chemnitz,DED4,Total,Total,2015,Cerebrovascular diseases,87.24,Rate
Chemnitz,DED4,Total,Total,2016,Cerebrovascular diseases,80.91,Rate
Chemnitz,DED4,Total,Total,2017,Cerebrovascular diseases,75.66,Rate
Chemnitz,DED4,Total,Total,2018,Cerebrovascular diseases,73.84,Rate
Chemnitz,DED4,Total,Total,2019,Cerebrovascular diseases,68.97,Rate
Chemnitz,DED4,Total,Total,2020,Cerebrovascular diseases,77.06,Rate
Chemnitz,DED4,Total,Total,2011,Chronic lower respiratory diseases,23.14,Rate
Chemnitz,DED4,Total,Total,2012,Chronic lower respiratory diseases,23.58,Rate
Chemnitz,DED4,Total,Total,2013,Chronic lower respiratory diseases,29.33,Rate
Chemnitz,DED4,Total,Total,2014,Chronic lower respiratory diseases,26.34,Rate
Chemnitz,DED4,Total,Total,2015,Chronic lower respiratory diseases,29.7,Rate
Chemnitz,DED4,Total,Total,2016,Chronic lower respiratory diseases,29.1,Rate
Chemnitz,DED4,Total,Total,2017,Chronic lower respiratory diseases,28.75,Rate
Chemnitz,DED4,Total,Total,2018,Chronic lower respiratory diseases,29.8,Rate
Chemnitz,DED4,Total,Total,2019,Chronic lower respiratory diseases,29.57,Rate
Chemnitz,DED4,Total,Total,2020,Chronic lower respiratory diseases,27.15,Rate
Chemnitz,DED4,Total,Total,2011,Asthma and status asthmaticus,0.77,Rate
Chemnitz,DED4,Total,Total,2012,Asthma and status asthmaticus,1.34,Rate
Chemnitz,DED4,Total,Total,2013,Asthma and status asthmaticus,1.27,Rate
Chemnitz,DED4,Total,Total,2014,Asthma and status asthmaticus,1.16,Rate
Chemnitz,DED4,Total,Total,2015,Asthma and status asthmaticus,1.45,Rate
Chemnitz,DED4,Total,Total,2016,Asthma and status asthmaticus,0.92,Rate
Chemnitz,DED4,Total,Total,2017,Asthma and status asthmaticus,0.83,Rate
Chemnitz,DED4,Total,Total,2018,Asthma and status asthmaticus,0.97,Rate
Chemnitz,DED4,Total,Total,2019,Asthma and status asthmaticus,1.55,Rate
Chemnitz,DED4,Total,Total,2020,Asthma and status asthmaticus,1.05,Rate
Chemnitz,DED4,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4706.75,Rate
Chemnitz,DED4,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4643.27,Rate
Chemnitz,DED4,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4759.34,Rate
Chemnitz,DED4,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4466.68,Rate
Chemnitz,DED4,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4611.84,Rate
Chemnitz,DED4,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4437.5,Rate
Chemnitz,DED4,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4483.3,Rate
Chemnitz,DED4,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4587.1,Rate
Chemnitz,DED4,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4406.61,Rate
Chemnitz,DED4,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5063.77,Rate
Chemnitz,DED4,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",144.94,Rate
Chemnitz,DED4,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.99,Rate
Chemnitz,DED4,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",143.19,Rate
Chemnitz,DED4,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.51,Rate
Chemnitz,DED4,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.3,Rate
Chemnitz,DED4,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.15,Rate
Chemnitz,DED4,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.36,Rate
Chemnitz,DED4,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.81,Rate
Chemnitz,DED4,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",128.0,Rate
Chemnitz,DED4,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.86,Rate
Chemnitz,DED4,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",153.41,Rate
Chemnitz,DED4,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",155.01,Rate
Chemnitz,DED4,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",146.23,Rate
Chemnitz,DED4,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",143.25,Rate
Chemnitz,DED4,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",135.41,Rate
Chemnitz,DED4,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",131.09,Rate
Chemnitz,DED4,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",137.66,Rate
Chemnitz,DED4,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",129.03,Rate
Chemnitz,DED4,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",132.16,Rate
Chemnitz,DED4,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",121.65,Rate
Chemnitz,DED4,65 years or over,Total,2011,Malignant melanoma of skin,10.98,Rate
Chemnitz,DED4,65 years or over,Total,2012,Malignant melanoma of skin,13.0,Rate
Chemnitz,DED4,65 years or over,Total,2013,Malignant melanoma of skin,9.81,Rate
Chemnitz,DED4,65 years or over,Total,2014,Malignant melanoma of skin,11.0,Rate
Chemnitz,DED4,65 years or over,Total,2015,Malignant melanoma of skin,12.32,Rate
Chemnitz,DED4,65 years or over,Total,2016,Malignant melanoma of skin,12.05,Rate
Chemnitz,DED4,65 years or over,Total,2017,Malignant melanoma of skin,10.41,Rate
Chemnitz,DED4,65 years or over,Total,2018,Malignant melanoma of skin,11.87,Rate
Chemnitz,DED4,65 years or over,Total,2019,Malignant melanoma of skin,9.88,Rate
Chemnitz,DED4,65 years or over,Total,2020,Malignant melanoma of skin,12.97,Rate
Chemnitz,DED4,65 years or over,Total,2011,Malignant neoplasm of breast,59.86,Rate
Chemnitz,DED4,65 years or over,Total,2012,Malignant neoplasm of breast,61.64,Rate
Chemnitz,DED4,65 years or over,Total,2013,Malignant neoplasm of breast,59.02,Rate
Chemnitz,DED4,65 years or over,Total,2014,Malignant neoplasm of breast,56.74,Rate
Chemnitz,DED4,65 years or over,Total,2015,Malignant neoplasm of breast,55.7,Rate
Chemnitz,DED4,65 years or over,Total,2016,Malignant neoplasm of breast,61.12,Rate
Chemnitz,DED4,65 years or over,Total,2017,Malignant neoplasm of breast,60.51,Rate
Chemnitz,DED4,65 years or over,Total,2018,Malignant neoplasm of breast,60.55,Rate
Chemnitz,DED4,65 years or over,Total,2019,Malignant neoplasm of breast,52.91,Rate
Chemnitz,DED4,65 years or over,Total,2020,Malignant neoplasm of breast,56.4,Rate
Chemnitz,DED4,65 years or over,Total,2011,Diabetes mellitus,180.35,Rate
Chemnitz,DED4,65 years or over,Total,2012,Diabetes mellitus,168.37,Rate
Chemnitz,DED4,65 years or over,Total,2013,Diabetes mellitus,176.35,Rate
Chemnitz,DED4,65 years or over,Total,2014,Diabetes mellitus,154.07,Rate
Chemnitz,DED4,65 years or over,Total,2015,Diabetes mellitus,170.9,Rate
Chemnitz,DED4,65 years or over,Total,2016,Diabetes mellitus,125.64,Rate
Chemnitz,DED4,65 years or over,Total,2017,Diabetes mellitus,123.09,Rate
Chemnitz,DED4,65 years or over,Total,2018,Diabetes mellitus,125.21,Rate
Chemnitz,DED4,65 years or over,Total,2019,Diabetes mellitus,120.66,Rate
Chemnitz,DED4,65 years or over,Total,2020,Diabetes mellitus,117.06,Rate
Chemnitz,DED4,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),125.19,Rate
Chemnitz,DED4,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),148.2,Rate
Chemnitz,DED4,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),170.08,Rate
Chemnitz,DED4,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),176.07,Rate
Chemnitz,DED4,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),204.52,Rate
Chemnitz,DED4,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),208.07,Rate
Chemnitz,DED4,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),224.9,Rate
Chemnitz,DED4,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),254.39,Rate
Chemnitz,DED4,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),258.89,Rate
Chemnitz,DED4,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),291.98,Rate
Chemnitz,DED4,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),3.71,Rate
Chemnitz,DED4,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Chemnitz,DED4,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),7.5,Rate
Chemnitz,DED4,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.54,Rate
Chemnitz,DED4,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),6.86,Rate
Chemnitz,DED4,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),9.95,Rate
Chemnitz,DED4,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),6.33,Rate
Chemnitz,DED4,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),5.89,Rate
Chemnitz,DED4,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),5.82,Rate
Chemnitz,DED4,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),8.72,Rate
Chemnitz,DED4,65 years or over,Total,2011,Other ischaemic heart diseases,760.65,Rate
Chemnitz,DED4,65 years or over,Total,2012,Other ischaemic heart diseases,718.78,Rate
Chemnitz,DED4,65 years or over,Total,2013,Other ischaemic heart diseases,718.23,Rate
Chemnitz,DED4,65 years or over,Total,2014,Other ischaemic heart diseases,669.9,Rate
Chemnitz,DED4,65 years or over,Total,2015,Other ischaemic heart diseases,669.32,Rate
Chemnitz,DED4,65 years or over,Total,2016,Other ischaemic heart diseases,652.2,Rate
Chemnitz,DED4,65 years or over,Total,2017,Other ischaemic heart diseases,619.92,Rate
Chemnitz,DED4,65 years or over,Total,2018,Other ischaemic heart diseases,610.99,Rate
Chemnitz,DED4,65 years or over,Total,2019,Other ischaemic heart diseases,558.47,Rate
Chemnitz,DED4,65 years or over,Total,2020,Other ischaemic heart diseases,616.94,Rate
Chemnitz,DED4,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,331.95,Rate
Chemnitz,DED4,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,321.17,Rate
Chemnitz,DED4,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,323.76,Rate
Chemnitz,DED4,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,280.73,Rate
Chemnitz,DED4,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,282.23,Rate
Chemnitz,DED4,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,257.06,Rate
Chemnitz,DED4,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,260.07,Rate
Chemnitz,DED4,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,256.87,Rate
Chemnitz,DED4,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,232.5,Rate
Chemnitz,DED4,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,237.22,Rate
Chemnitz,DED4,65 years or over,Total,2011,Cerebrovascular diseases,459.41,Rate
Chemnitz,DED4,65 years or over,Total,2012,Cerebrovascular diseases,449.01,Rate
Chemnitz,DED4,65 years or over,Total,2013,Cerebrovascular diseases,459.42,Rate
Chemnitz,DED4,65 years or over,Total,2014,Cerebrovascular diseases,424.2,Rate
Chemnitz,DED4,65 years or over,Total,2015,Cerebrovascular diseases,418.12,Rate
Chemnitz,DED4,65 years or over,Total,2016,Cerebrovascular diseases,388.01,Rate
Chemnitz,DED4,65 years or over,Total,2017,Cerebrovascular diseases,360.64,Rate
Chemnitz,DED4,65 years or over,Total,2018,Cerebrovascular diseases,351.75,Rate
Chemnitz,DED4,65 years or over,Total,2019,Cerebrovascular diseases,329.93,Rate
Chemnitz,DED4,65 years or over,Total,2020,Cerebrovascular diseases,367.7,Rate
Chemnitz,DED4,65 years or over,Total,2011,Chronic lower respiratory diseases,104.79,Rate
Chemnitz,DED4,65 years or over,Total,2012,Chronic lower respiratory diseases,107.17,Rate
Chemnitz,DED4,65 years or over,Total,2013,Chronic lower respiratory diseases,130.04,Rate
Chemnitz,DED4,65 years or over,Total,2014,Chronic lower respiratory diseases,117.97,Rate
Chemnitz,DED4,65 years or over,Total,2015,Chronic lower respiratory diseases,129.44,Rate
Chemnitz,DED4,65 years or over,Total,2016,Chronic lower respiratory diseases,128.94,Rate
Chemnitz,DED4,65 years or over,Total,2017,Chronic lower respiratory diseases,126.71,Rate
Chemnitz,DED4,65 years or over,Total,2018,Chronic lower respiratory diseases,132.6,Rate
Chemnitz,DED4,65 years or over,Total,2019,Chronic lower respiratory diseases,128.34,Rate
Chemnitz,DED4,65 years or over,Total,2020,Chronic lower respiratory diseases,121.91,Rate
Chemnitz,DED4,65 years or over,Total,2011,Asthma and status asthmaticus,2.74,Rate
Chemnitz,DED4,65 years or over,Total,2012,Asthma and status asthmaticus,4.16,Rate
Chemnitz,DED4,65 years or over,Total,2013,Asthma and status asthmaticus,5.1,Rate
Chemnitz,DED4,65 years or over,Total,2014,Asthma and status asthmaticus,4.16,Rate
Chemnitz,DED4,65 years or over,Total,2015,Asthma and status asthmaticus,6.77,Rate
Chemnitz,DED4,65 years or over,Total,2016,Asthma and status asthmaticus,4.44,Rate
Chemnitz,DED4,65 years or over,Total,2017,Asthma and status asthmaticus,3.65,Rate
Chemnitz,DED4,65 years or over,Total,2018,Asthma and status asthmaticus,3.34,Rate
Chemnitz,DED4,65 years or over,Total,2019,Asthma and status asthmaticus,4.52,Rate
Chemnitz,DED4,65 years or over,Total,2020,Asthma and status asthmaticus,3.58,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,217.56,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,208.88,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,225.53,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,211.06,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,221.96,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,213.56,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,202.28,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,210.92,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,211.92,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,211.53,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.82,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.24,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.79,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.28,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.26,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.6,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.85,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.98,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.06,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.43,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",14.75,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",14.43,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",16.46,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",14.05,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",14.23,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.34,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",13.98,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",14.02,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",14.42,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",13.42,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Malignant melanoma of skin,0.75,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Malignant melanoma of skin,1.19,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Malignant melanoma of skin,1.67,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Malignant melanoma of skin,1.68,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Malignant melanoma of skin,0.85,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Malignant melanoma of skin,0.59,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Malignant melanoma of skin,1.41,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Malignant melanoma of skin,1.32,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Malignant melanoma of skin,0.89,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Malignant melanoma of skin,1.52,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.13,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Malignant neoplasm of breast,7.36,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.14,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.78,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Malignant neoplasm of breast,5.5,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.77,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.41,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.24,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.9,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.97,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Diabetes mellitus,4.05,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Diabetes mellitus,4.5,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Diabetes mellitus,5.16,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Diabetes mellitus,4.39,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Diabetes mellitus,4.57,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Diabetes mellitus,3.69,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Diabetes mellitus,4.69,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Diabetes mellitus,3.59,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Diabetes mellitus,4.18,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Diabetes mellitus,4.18,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),5.7,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),5.31,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),5.58,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),7.92,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.1,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),5.43,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.46,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),4.7,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),5.75,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),6.65,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.7,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.32,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Other ischaemic heart diseases,6.56,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Other ischaemic heart diseases,7.37,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Other ischaemic heart diseases,6.37,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.11,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Other ischaemic heart diseases,7.95,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Other ischaemic heart diseases,6.99,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.01,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Other ischaemic heart diseases,6.41,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.93,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Other ischaemic heart diseases,7.71,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,15.19,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,16.46,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,16.19,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,16.13,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,15.37,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,15.01,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,14.74,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.32,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,14.8,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,13.32,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Cerebrovascular diseases,6.72,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Cerebrovascular diseases,6.23,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Cerebrovascular diseases,6.19,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Cerebrovascular diseases,5.74,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Cerebrovascular diseases,7.09,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Cerebrovascular diseases,6.51,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Cerebrovascular diseases,6.62,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Cerebrovascular diseases,6.51,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Cerebrovascular diseases,5.76,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Cerebrovascular diseases,6.65,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Chronic lower respiratory diseases,3.36,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Chronic lower respiratory diseases,3.34,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Chronic lower respiratory diseases,4.93,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.14,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Chronic lower respiratory diseases,5.54,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Chronic lower respiratory diseases,4.91,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Chronic lower respiratory diseases,5.03,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Chronic lower respiratory diseases,4.9,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Chronic lower respiratory diseases,5.65,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Chronic lower respiratory diseases,4.19,Rate
Chemnitz,DED4,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.3,Rate
Chemnitz,DED4,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.65,Rate
Chemnitz,DED4,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.34,Rate
Chemnitz,DED4,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.43,Rate
Chemnitz,DED4,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.17,Rate
Chemnitz,DED4,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.07,Rate
Chemnitz,DED4,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.14,Rate
Chemnitz,DED4,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.39,Rate
Chemnitz,DED4,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.83,Rate
Chemnitz,DED4,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.44,Rate
Attiki,EL30,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,836.8,Rate
Attiki,EL30,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,854.55,Rate
Attiki,EL30,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,805.34,Rate
Attiki,EL30,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,802.25,Rate
Attiki,EL30,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,838.38,Rate
Attiki,EL30,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,811.21,Rate
Attiki,EL30,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,835.98,Rate
Attiki,EL30,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,791.68,Rate
Attiki,EL30,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,797.27,Rate
Attiki,EL30,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,839.03,Rate
Attiki,EL30,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.59,Rate
Attiki,EL30,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.43,Rate
Attiki,EL30,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.53,Rate
Attiki,EL30,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.3,Rate
Attiki,EL30,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.79,Rate
Attiki,EL30,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.36,Rate
Attiki,EL30,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.02,Rate
Attiki,EL30,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.48,Rate
Attiki,EL30,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.28,Rate
Attiki,EL30,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.75,Rate
Attiki,EL30,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",25.22,Rate
Attiki,EL30,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",26.76,Rate
Attiki,EL30,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",28.6,Rate
Attiki,EL30,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",29.08,Rate
Attiki,EL30,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",29.69,Rate
Attiki,EL30,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",31.46,Rate
Attiki,EL30,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",30.16,Rate
Attiki,EL30,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",31.52,Rate
Attiki,EL30,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",31.63,Rate
Attiki,EL30,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",32.74,Rate
Attiki,EL30,Total,Females,2011,Malignant melanoma of skin,1.65,Rate
Attiki,EL30,Total,Females,2012,Malignant melanoma of skin,1.61,Rate
Attiki,EL30,Total,Females,2013,Malignant melanoma of skin,1.65,Rate
Attiki,EL30,Total,Females,2014,Malignant melanoma of skin,1.83,Rate
Attiki,EL30,Total,Females,2015,Malignant melanoma of skin,1.7,Rate
Attiki,EL30,Total,Females,2016,Malignant melanoma of skin,1.39,Rate
Attiki,EL30,Total,Females,2017,Malignant melanoma of skin,1.46,Rate
Attiki,EL30,Total,Females,2018,Malignant melanoma of skin,1.7,Rate
Attiki,EL30,Total,Females,2019,Malignant melanoma of skin,1.46,Rate
Attiki,EL30,Total,Females,2020,Malignant melanoma of skin,2.06,Rate
Attiki,EL30,Total,Females,2011,Malignant neoplasm of breast,34.13,Rate
Attiki,EL30,Total,Females,2012,Malignant neoplasm of breast,36.18,Rate
Attiki,EL30,Total,Females,2013,Malignant neoplasm of breast,36.49,Rate
Attiki,EL30,Total,Females,2014,Malignant neoplasm of breast,35.75,Rate
Attiki,EL30,Total,Females,2015,Malignant neoplasm of breast,37.0,Rate
Attiki,EL30,Total,Females,2016,Malignant neoplasm of breast,37.14,Rate
Attiki,EL30,Total,Females,2017,Malignant neoplasm of breast,35.93,Rate
Attiki,EL30,Total,Females,2018,Malignant neoplasm of breast,35.85,Rate
Attiki,EL30,Total,Females,2019,Malignant neoplasm of breast,34.56,Rate
Attiki,EL30,Total,Females,2020,Malignant neoplasm of breast,34.93,Rate
Attiki,EL30,Total,Females,2011,Diabetes mellitus,6.04,Rate
Attiki,EL30,Total,Females,2012,Diabetes mellitus,7.89,Rate
Attiki,EL30,Total,Females,2013,Diabetes mellitus,7.7,Rate
Attiki,EL30,Total,Females,2014,Diabetes mellitus,10.09,Rate
Attiki,EL30,Total,Females,2015,Diabetes mellitus,10.48,Rate
Attiki,EL30,Total,Females,2016,Diabetes mellitus,9.81,Rate
Attiki,EL30,Total,Females,2017,Diabetes mellitus,13.61,Rate
Attiki,EL30,Total,Females,2018,Diabetes mellitus,12.6,Rate
Attiki,EL30,Total,Females,2019,Diabetes mellitus,13.13,Rate
Attiki,EL30,Total,Females,2020,Diabetes mellitus,12.65,Rate
Attiki,EL30,Total,Females,2011,Mental and behavioural disorders (F00-F99),0.78,Rate
Attiki,EL30,Total,Females,2012,Mental and behavioural disorders (F00-F99),0.58,Rate
Attiki,EL30,Total,Females,2013,Mental and behavioural disorders (F00-F99),0.96,Rate
Attiki,EL30,Total,Females,2014,Mental and behavioural disorders (F00-F99),5.36,Rate
Attiki,EL30,Total,Females,2015,Mental and behavioural disorders (F00-F99),9.24,Rate
Attiki,EL30,Total,Females,2016,Mental and behavioural disorders (F00-F99),10.7,Rate
Attiki,EL30,Total,Females,2017,Mental and behavioural disorders (F00-F99),14.42,Rate
Attiki,EL30,Total,Females,2018,Mental and behavioural disorders (F00-F99),15.45,Rate
Attiki,EL30,Total,Females,2019,Mental and behavioural disorders (F00-F99),17.31,Rate
Attiki,EL30,Total,Females,2020,Mental and behavioural disorders (F00-F99),21.5,Rate
Attiki,EL30,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.08,Rate
Attiki,EL30,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Attiki,EL30,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Attiki,EL30,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Attiki,EL30,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Attiki,EL30,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Attiki,EL30,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Attiki,EL30,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.51,Rate
Attiki,EL30,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.44,Rate
Attiki,EL30,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.16,Rate
Attiki,EL30,Total,Females,2011,Other ischaemic heart diseases,31.22,Rate
Attiki,EL30,Total,Females,2012,Other ischaemic heart diseases,35.53,Rate
Attiki,EL30,Total,Females,2013,Other ischaemic heart diseases,36.09,Rate
Attiki,EL30,Total,Females,2014,Other ischaemic heart diseases,47.05,Rate
Attiki,EL30,Total,Females,2015,Other ischaemic heart diseases,44.46,Rate
Attiki,EL30,Total,Females,2016,Other ischaemic heart diseases,41.07,Rate
Attiki,EL30,Total,Females,2017,Other ischaemic heart diseases,44.99,Rate
Attiki,EL30,Total,Females,2018,Other ischaemic heart diseases,47.04,Rate
Attiki,EL30,Total,Females,2019,Other ischaemic heart diseases,51.05,Rate
Attiki,EL30,Total,Females,2020,Other ischaemic heart diseases,51.83,Rate
Attiki,EL30,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,49.41,Rate
Attiki,EL30,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,44.63,Rate
Attiki,EL30,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,37.32,Rate
Attiki,EL30,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,33.57,Rate
Attiki,EL30,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,34.0,Rate
Attiki,EL30,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,34.72,Rate
Attiki,EL30,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,40.39,Rate
Attiki,EL30,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,36.09,Rate
Attiki,EL30,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,33.54,Rate
Attiki,EL30,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,34.3,Rate
Attiki,EL30,Total,Females,2011,Cerebrovascular diseases,115.32,Rate
Attiki,EL30,Total,Females,2012,Cerebrovascular diseases,115.17,Rate
Attiki,EL30,Total,Females,2013,Cerebrovascular diseases,112.65,Rate
Attiki,EL30,Total,Females,2014,Cerebrovascular diseases,100.86,Rate
Attiki,EL30,Total,Females,2015,Cerebrovascular diseases,95.81,Rate
Attiki,EL30,Total,Females,2016,Cerebrovascular diseases,90.06,Rate
Attiki,EL30,Total,Females,2017,Cerebrovascular diseases,90.17,Rate
Attiki,EL30,Total,Females,2018,Cerebrovascular diseases,80.84,Rate
Attiki,EL30,Total,Females,2019,Cerebrovascular diseases,77.09,Rate
Attiki,EL30,Total,Females,2020,Cerebrovascular diseases,77.43,Rate
Attiki,EL30,Total,Females,2011,Chronic lower respiratory diseases,12.82,Rate
Attiki,EL30,Total,Females,2012,Chronic lower respiratory diseases,11.84,Rate
Attiki,EL30,Total,Females,2013,Chronic lower respiratory diseases,12.43,Rate
Attiki,EL30,Total,Females,2014,Chronic lower respiratory diseases,16.74,Rate
Attiki,EL30,Total,Females,2015,Chronic lower respiratory diseases,21.32,Rate
Attiki,EL30,Total,Females,2016,Chronic lower respiratory diseases,18.39,Rate
Attiki,EL30,Total,Females,2017,Chronic lower respiratory diseases,19.75,Rate
Attiki,EL30,Total,Females,2018,Chronic lower respiratory diseases,17.37,Rate
Attiki,EL30,Total,Females,2019,Chronic lower respiratory diseases,17.42,Rate
Attiki,EL30,Total,Females,2020,Chronic lower respiratory diseases,18.32,Rate
Attiki,EL30,Total,Females,2011,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,Total,Females,2012,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,Total,Females,2014,Asthma and status asthmaticus,0.08,Rate
Attiki,EL30,Total,Females,2015,Asthma and status asthmaticus,0.25,Rate
Attiki,EL30,Total,Females,2016,Asthma and status asthmaticus,0.28,Rate
Attiki,EL30,Total,Females,2017,Asthma and status asthmaticus,0.24,Rate
Attiki,EL30,Total,Females,2018,Asthma and status asthmaticus,0.22,Rate
Attiki,EL30,Total,Females,2019,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Total,Females,2020,Asthma and status asthmaticus,0.13,Rate
Attiki,EL30,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3756.49,Rate
Attiki,EL30,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3863.47,Rate
Attiki,EL30,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3640.47,Rate
Attiki,EL30,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3611.65,Rate
Attiki,EL30,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3801.94,Rate
Attiki,EL30,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3645.22,Rate
Attiki,EL30,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3779.41,Rate
Attiki,EL30,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3577.63,Rate
Attiki,EL30,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3607.45,Rate
Attiki,EL30,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3782.7,Rate
Attiki,EL30,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.59,Rate
Attiki,EL30,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.51,Rate
Attiki,EL30,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.99,Rate
Attiki,EL30,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.55,Rate
Attiki,EL30,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.71,Rate
Attiki,EL30,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.71,Rate
Attiki,EL30,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.27,Rate
Attiki,EL30,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.56,Rate
Attiki,EL30,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.46,Rate
Attiki,EL30,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.16,Rate
Attiki,EL30,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",82.18,Rate
Attiki,EL30,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",88.99,Rate
Attiki,EL30,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",100.63,Rate
Attiki,EL30,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",100.71,Rate
Attiki,EL30,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",102.17,Rate
Attiki,EL30,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",109.17,Rate
Attiki,EL30,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",114.9,Rate
Attiki,EL30,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",116.15,Rate
Attiki,EL30,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",116.19,Rate
Attiki,EL30,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",116.89,Rate
Attiki,EL30,65 years or over,Females,2011,Malignant melanoma of skin,5.81,Rate
Attiki,EL30,65 years or over,Females,2012,Malignant melanoma of skin,5.07,Rate
Attiki,EL30,65 years or over,Females,2013,Malignant melanoma of skin,5.33,Rate
Attiki,EL30,65 years or over,Females,2014,Malignant melanoma of skin,5.8,Rate
Attiki,EL30,65 years or over,Females,2015,Malignant melanoma of skin,4.9,Rate
Attiki,EL30,65 years or over,Females,2016,Malignant melanoma of skin,4.01,Rate
Attiki,EL30,65 years or over,Females,2017,Malignant melanoma of skin,5.28,Rate
Attiki,EL30,65 years or over,Females,2018,Malignant melanoma of skin,4.82,Rate
Attiki,EL30,65 years or over,Females,2019,Malignant melanoma of skin,5.38,Rate
Attiki,EL30,65 years or over,Females,2020,Malignant melanoma of skin,6.73,Rate
Attiki,EL30,65 years or over,Females,2011,Malignant neoplasm of breast,116.27,Rate
Attiki,EL30,65 years or over,Females,2012,Malignant neoplasm of breast,124.12,Rate
Attiki,EL30,65 years or over,Females,2013,Malignant neoplasm of breast,132.44,Rate
Attiki,EL30,65 years or over,Females,2014,Malignant neoplasm of breast,129.1,Rate
Attiki,EL30,65 years or over,Females,2015,Malignant neoplasm of breast,135.18,Rate
Attiki,EL30,65 years or over,Females,2016,Malignant neoplasm of breast,127.32,Rate
Attiki,EL30,65 years or over,Females,2017,Malignant neoplasm of breast,128.8,Rate
Attiki,EL30,65 years or over,Females,2018,Malignant neoplasm of breast,128.66,Rate
Attiki,EL30,65 years or over,Females,2019,Malignant neoplasm of breast,123.48,Rate
Attiki,EL30,65 years or over,Females,2020,Malignant neoplasm of breast,122.03,Rate
Attiki,EL30,65 years or over,Females,2011,Diabetes mellitus,27.58,Rate
Attiki,EL30,65 years or over,Females,2012,Diabetes mellitus,37.28,Rate
Attiki,EL30,65 years or over,Females,2013,Diabetes mellitus,36.05,Rate
Attiki,EL30,65 years or over,Females,2014,Diabetes mellitus,45.92,Rate
Attiki,EL30,65 years or over,Females,2015,Diabetes mellitus,46.02,Rate
Attiki,EL30,65 years or over,Females,2016,Diabetes mellitus,42.18,Rate
Attiki,EL30,65 years or over,Females,2017,Diabetes mellitus,64.93,Rate
Attiki,EL30,65 years or over,Females,2018,Diabetes mellitus,59.14,Rate
Attiki,EL30,65 years or over,Females,2019,Diabetes mellitus,58.99,Rate
Attiki,EL30,65 years or over,Females,2020,Diabetes mellitus,58.75,Rate
Attiki,EL30,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),3.37,Rate
Attiki,EL30,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),2.07,Rate
Attiki,EL30,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),4.5,Rate
Attiki,EL30,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),25.81,Rate
Attiki,EL30,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),43.85,Rate
Attiki,EL30,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),52.28,Rate
Attiki,EL30,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),68.4,Rate
Attiki,EL30,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),73.19,Rate
Attiki,EL30,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),85.57,Rate
Attiki,EL30,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),103.91,Rate
Attiki,EL30,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Attiki,EL30,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Attiki,EL30,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.84,Rate
Attiki,EL30,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.52,Rate
Attiki,EL30,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.37,Rate
Attiki,EL30,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),4.93,Rate
Attiki,EL30,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),7.79,Rate
Attiki,EL30,65 years or over,Females,2011,Other ischaemic heart diseases,138.07,Rate
Attiki,EL30,65 years or over,Females,2012,Other ischaemic heart diseases,157.71,Rate
Attiki,EL30,65 years or over,Females,2013,Other ischaemic heart diseases,157.74,Rate
Attiki,EL30,65 years or over,Females,2014,Other ischaemic heart diseases,216.46,Rate
Attiki,EL30,65 years or over,Females,2015,Other ischaemic heart diseases,200.0,Rate
Attiki,EL30,65 years or over,Females,2016,Other ischaemic heart diseases,179.67,Rate
Attiki,EL30,65 years or over,Females,2017,Other ischaemic heart diseases,207.19,Rate
Attiki,EL30,65 years or over,Females,2018,Other ischaemic heart diseases,214.99,Rate
Attiki,EL30,65 years or over,Females,2019,Other ischaemic heart diseases,243.75,Rate
Attiki,EL30,65 years or over,Females,2020,Other ischaemic heart diseases,243.41,Rate
Attiki,EL30,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,211.62,Rate
Attiki,EL30,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,195.82,Rate
Attiki,EL30,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,167.87,Rate
Attiki,EL30,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,152.64,Rate
Attiki,EL30,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,156.53,Rate
Attiki,EL30,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,157.42,Rate
Attiki,EL30,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,182.91,Rate
Attiki,EL30,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,163.77,Rate
Attiki,EL30,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,152.32,Rate
Attiki,EL30,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,156.74,Rate
Attiki,EL30,65 years or over,Females,2011,Cerebrovascular diseases,563.7,Rate
Attiki,EL30,65 years or over,Females,2012,Cerebrovascular diseases,560.13,Rate
Attiki,EL30,65 years or over,Females,2013,Cerebrovascular diseases,552.06,Rate
Attiki,EL30,65 years or over,Females,2014,Cerebrovascular diseases,494.78,Rate
Attiki,EL30,65 years or over,Females,2015,Cerebrovascular diseases,471.52,Rate
Attiki,EL30,65 years or over,Females,2016,Cerebrovascular diseases,436.48,Rate
Attiki,EL30,65 years or over,Females,2017,Cerebrovascular diseases,436.67,Rate
Attiki,EL30,65 years or over,Females,2018,Cerebrovascular diseases,395.94,Rate
Attiki,EL30,65 years or over,Females,2019,Cerebrovascular diseases,372.17,Rate
Attiki,EL30,65 years or over,Females,2020,Cerebrovascular diseases,375.49,Rate
Attiki,EL30,65 years or over,Females,2011,Chronic lower respiratory diseases,59.98,Rate
Attiki,EL30,65 years or over,Females,2012,Chronic lower respiratory diseases,57.78,Rate
Attiki,EL30,65 years or over,Females,2013,Chronic lower respiratory diseases,60.5,Rate
Attiki,EL30,65 years or over,Females,2014,Chronic lower respiratory diseases,82.42,Rate
Attiki,EL30,65 years or over,Females,2015,Chronic lower respiratory diseases,104.37,Rate
Attiki,EL30,65 years or over,Females,2016,Chronic lower respiratory diseases,89.87,Rate
Attiki,EL30,65 years or over,Females,2017,Chronic lower respiratory diseases,96.71,Rate
Attiki,EL30,65 years or over,Females,2018,Chronic lower respiratory diseases,84.03,Rate
Attiki,EL30,65 years or over,Females,2019,Chronic lower respiratory diseases,84.33,Rate
Attiki,EL30,65 years or over,Females,2020,Chronic lower respiratory diseases,89.7,Rate
Attiki,EL30,65 years or over,Females,2011,Asthma and status asthmaticus,0.27,Rate
Attiki,EL30,65 years or over,Females,2012,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Females,2014,Asthma and status asthmaticus,0.18,Rate
Attiki,EL30,65 years or over,Females,2015,Asthma and status asthmaticus,1.26,Rate
Attiki,EL30,65 years or over,Females,2016,Asthma and status asthmaticus,1.18,Rate
Attiki,EL30,65 years or over,Females,2017,Asthma and status asthmaticus,0.79,Rate
Attiki,EL30,65 years or over,Females,2018,Asthma and status asthmaticus,0.66,Rate
Attiki,EL30,65 years or over,Females,2019,Asthma and status asthmaticus,0.17,Rate
Attiki,EL30,65 years or over,Females,2020,Asthma and status asthmaticus,0.66,Rate
Attiki,EL30,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,129.54,Rate
Attiki,EL30,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,125.69,Rate
Attiki,EL30,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,118.57,Rate
Attiki,EL30,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,121.72,Rate
Attiki,EL30,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,120.51,Rate
Attiki,EL30,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,124.71,Rate
Attiki,EL30,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,122.98,Rate
Attiki,EL30,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,116.82,Rate
Attiki,EL30,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,116.54,Rate
Attiki,EL30,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,125.97,Rate
Attiki,EL30,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.33,Rate
Attiki,EL30,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.6,Rate
Attiki,EL30,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.37,Rate
Attiki,EL30,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Attiki,EL30,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.79,Rate
Attiki,EL30,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Attiki,EL30,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.16,Rate
Attiki,EL30,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.65,Rate
Attiki,EL30,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.76,Rate
Attiki,EL30,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.36,Rate
Attiki,EL30,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",11.42,Rate
Attiki,EL30,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",11.68,Rate
Attiki,EL30,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",11.15,Rate
Attiki,EL30,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",11.73,Rate
Attiki,EL30,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",12.13,Rate
Attiki,EL30,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",12.64,Rate
Attiki,EL30,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",9.63,Rate
Attiki,EL30,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",11.02,Rate
Attiki,EL30,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",11.15,Rate
Attiki,EL30,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",12.35,Rate
Attiki,EL30,Less than 65 years,Females,2011,Malignant melanoma of skin,0.64,Rate
Attiki,EL30,Less than 65 years,Females,2012,Malignant melanoma of skin,0.77,Rate
Attiki,EL30,Less than 65 years,Females,2013,Malignant melanoma of skin,0.76,Rate
Attiki,EL30,Less than 65 years,Females,2014,Malignant melanoma of skin,0.86,Rate
Attiki,EL30,Less than 65 years,Females,2015,Malignant melanoma of skin,0.92,Rate
Attiki,EL30,Less than 65 years,Females,2016,Malignant melanoma of skin,0.76,Rate
Attiki,EL30,Less than 65 years,Females,2017,Malignant melanoma of skin,0.53,Rate
Attiki,EL30,Less than 65 years,Females,2018,Malignant melanoma of skin,0.94,Rate
Attiki,EL30,Less than 65 years,Females,2019,Malignant melanoma of skin,0.52,Rate
Attiki,EL30,Less than 65 years,Females,2020,Malignant melanoma of skin,0.92,Rate
Attiki,EL30,Less than 65 years,Females,2011,Malignant neoplasm of breast,14.23,Rate
Attiki,EL30,Less than 65 years,Females,2012,Malignant neoplasm of breast,14.88,Rate
Attiki,EL30,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.25,Rate
Attiki,EL30,Less than 65 years,Females,2014,Malignant neoplasm of breast,13.14,Rate
Attiki,EL30,Less than 65 years,Females,2015,Malignant neoplasm of breast,13.22,Rate
Attiki,EL30,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.3,Rate
Attiki,EL30,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.43,Rate
Attiki,EL30,Less than 65 years,Females,2018,Malignant neoplasm of breast,13.37,Rate
Attiki,EL30,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.02,Rate
Attiki,EL30,Less than 65 years,Females,2020,Malignant neoplasm of breast,13.84,Rate
Attiki,EL30,Less than 65 years,Females,2011,Diabetes mellitus,0.82,Rate
Attiki,EL30,Less than 65 years,Females,2012,Diabetes mellitus,0.76,Rate
Attiki,EL30,Less than 65 years,Females,2013,Diabetes mellitus,0.84,Rate
Attiki,EL30,Less than 65 years,Females,2014,Diabetes mellitus,1.42,Rate
Attiki,EL30,Less than 65 years,Females,2015,Diabetes mellitus,1.87,Rate
Attiki,EL30,Less than 65 years,Females,2016,Diabetes mellitus,1.97,Rate
Attiki,EL30,Less than 65 years,Females,2017,Diabetes mellitus,1.18,Rate
Attiki,EL30,Less than 65 years,Females,2018,Diabetes mellitus,1.33,Rate
Attiki,EL30,Less than 65 years,Females,2019,Diabetes mellitus,2.02,Rate
Attiki,EL30,Less than 65 years,Females,2020,Diabetes mellitus,1.49,Rate
Attiki,EL30,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.15,Rate
Attiki,EL30,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.22,Rate
Attiki,EL30,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.11,Rate
Attiki,EL30,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.4,Rate
Attiki,EL30,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.86,Rate
Attiki,EL30,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.62,Rate
Attiki,EL30,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.34,Rate
Attiki,EL30,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.47,Rate
Attiki,EL30,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.77,Rate
Attiki,EL30,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.54,Rate
Attiki,EL30,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Attiki,EL30,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Attiki,EL30,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Attiki,EL30,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Attiki,EL30,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.5,Rate
Attiki,EL30,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Attiki,EL30,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Attiki,EL30,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Attiki,EL30,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Attiki,EL30,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Attiki,EL30,Less than 65 years,Females,2011,Other ischaemic heart diseases,5.34,Rate
Attiki,EL30,Less than 65 years,Females,2012,Other ischaemic heart diseases,5.94,Rate
Attiki,EL30,Less than 65 years,Females,2013,Other ischaemic heart diseases,6.62,Rate
Attiki,EL30,Less than 65 years,Females,2014,Other ischaemic heart diseases,6.02,Rate
Attiki,EL30,Less than 65 years,Females,2015,Other ischaemic heart diseases,6.78,Rate
Attiki,EL30,Less than 65 years,Females,2016,Other ischaemic heart diseases,7.5,Rate
Attiki,EL30,Less than 65 years,Females,2017,Other ischaemic heart diseases,5.7,Rate
Attiki,EL30,Less than 65 years,Females,2018,Other ischaemic heart diseases,6.35,Rate
Attiki,EL30,Less than 65 years,Females,2019,Other ischaemic heart diseases,4.38,Rate
Attiki,EL30,Less than 65 years,Females,2020,Other ischaemic heart diseases,5.42,Rate
Attiki,EL30,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,10.11,Rate
Attiki,EL30,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,8.01,Rate
Attiki,EL30,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.69,Rate
Attiki,EL30,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.73,Rate
Attiki,EL30,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,4.32,Rate
Attiki,EL30,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,5.0,Rate
Attiki,EL30,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,5.86,Rate
Attiki,EL30,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,5.16,Rate
Attiki,EL30,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.77,Rate
Attiki,EL30,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.64,Rate
Attiki,EL30,Less than 65 years,Females,2011,Cerebrovascular diseases,6.71,Rate
Attiki,EL30,Less than 65 years,Females,2012,Cerebrovascular diseases,7.38,Rate
Attiki,EL30,Less than 65 years,Females,2013,Cerebrovascular diseases,6.21,Rate
Attiki,EL30,Less than 65 years,Females,2014,Cerebrovascular diseases,5.43,Rate
Attiki,EL30,Less than 65 years,Females,2015,Cerebrovascular diseases,4.8,Rate
Attiki,EL30,Less than 65 years,Females,2016,Cerebrovascular diseases,6.14,Rate
Attiki,EL30,Less than 65 years,Females,2017,Cerebrovascular diseases,6.24,Rate
Attiki,EL30,Less than 65 years,Females,2018,Cerebrovascular diseases,4.52,Rate
Attiki,EL30,Less than 65 years,Females,2019,Cerebrovascular diseases,5.62,Rate
Attiki,EL30,Less than 65 years,Females,2020,Cerebrovascular diseases,5.23,Rate
Attiki,EL30,Less than 65 years,Females,2011,Chronic lower respiratory diseases,1.39,Rate
Attiki,EL30,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.72,Rate
Attiki,EL30,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.79,Rate
Attiki,EL30,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.83,Rate
Attiki,EL30,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.2,Rate
Attiki,EL30,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.07,Rate
Attiki,EL30,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.11,Rate
Attiki,EL30,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.22,Rate
Attiki,EL30,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.21,Rate
Attiki,EL30,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.03,Rate
Attiki,EL30,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.06,Rate
Attiki,EL30,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.06,Rate
Attiki,EL30,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.11,Rate
Attiki,EL30,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.12,Rate
Attiki,EL30,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1230.87,Rate
Attiki,EL30,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1227.93,Rate
Attiki,EL30,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1177.92,Rate
Attiki,EL30,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1154.44,Rate
Attiki,EL30,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1217.25,Rate
Attiki,EL30,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1165.99,Rate
Attiki,EL30,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1197.42,Rate
Attiki,EL30,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1147.8,Rate
Attiki,EL30,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1173.44,Rate
Attiki,EL30,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1208.81,Rate
Attiki,EL30,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.56,Rate
Attiki,EL30,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.98,Rate
Attiki,EL30,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.18,Rate
Attiki,EL30,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.29,Rate
Attiki,EL30,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.73,Rate
Attiki,EL30,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.89,Rate
Attiki,EL30,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.49,Rate
Attiki,EL30,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.37,Rate
Attiki,EL30,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.47,Rate
Attiki,EL30,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.42,Rate
Attiki,EL30,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",106.39,Rate
Attiki,EL30,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",110.54,Rate
Attiki,EL30,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",111.55,Rate
Attiki,EL30,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",109.58,Rate
Attiki,EL30,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",113.93,Rate
Attiki,EL30,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",110.2,Rate
Attiki,EL30,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",109.34,Rate
Attiki,EL30,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",104.25,Rate
Attiki,EL30,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",102.95,Rate
Attiki,EL30,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",99.19,Rate
Attiki,EL30,Total,Males,2011,Malignant melanoma of skin,2.52,Rate
Attiki,EL30,Total,Males,2012,Malignant melanoma of skin,2.61,Rate
Attiki,EL30,Total,Males,2013,Malignant melanoma of skin,3.5,Rate
Attiki,EL30,Total,Males,2014,Malignant melanoma of skin,3.0,Rate
Attiki,EL30,Total,Males,2015,Malignant melanoma of skin,3.5,Rate
Attiki,EL30,Total,Males,2016,Malignant melanoma of skin,3.36,Rate
Attiki,EL30,Total,Males,2017,Malignant melanoma of skin,2.63,Rate
Attiki,EL30,Total,Males,2018,Malignant melanoma of skin,3.69,Rate
Attiki,EL30,Total,Males,2019,Malignant melanoma of skin,3.64,Rate
Attiki,EL30,Total,Males,2020,Malignant melanoma of skin,2.8,Rate
Attiki,EL30,Total,Males,2011,Malignant neoplasm of breast,1.26,Rate
Attiki,EL30,Total,Males,2012,Malignant neoplasm of breast,0.76,Rate
Attiki,EL30,Total,Males,2013,Malignant neoplasm of breast,0.48,Rate
Attiki,EL30,Total,Males,2014,Malignant neoplasm of breast,0.42,Rate
Attiki,EL30,Total,Males,2015,Malignant neoplasm of breast,0.4,Rate
Attiki,EL30,Total,Males,2016,Malignant neoplasm of breast,0.72,Rate
Attiki,EL30,Total,Males,2017,Malignant neoplasm of breast,0.22,Rate
Attiki,EL30,Total,Males,2018,Malignant neoplasm of breast,0.63,Rate
Attiki,EL30,Total,Males,2019,Malignant neoplasm of breast,0.3,Rate
Attiki,EL30,Total,Males,2020,Malignant neoplasm of breast,0.62,Rate
Attiki,EL30,Total,Males,2011,Diabetes mellitus,12.74,Rate
Attiki,EL30,Total,Males,2012,Diabetes mellitus,11.69,Rate
Attiki,EL30,Total,Males,2013,Diabetes mellitus,11.9,Rate
Attiki,EL30,Total,Males,2014,Diabetes mellitus,15.9,Rate
Attiki,EL30,Total,Males,2015,Diabetes mellitus,16.55,Rate
Attiki,EL30,Total,Males,2016,Diabetes mellitus,15.13,Rate
Attiki,EL30,Total,Males,2017,Diabetes mellitus,19.08,Rate
Attiki,EL30,Total,Males,2018,Diabetes mellitus,18.34,Rate
Attiki,EL30,Total,Males,2019,Diabetes mellitus,20.08,Rate
Attiki,EL30,Total,Males,2020,Diabetes mellitus,18.47,Rate
Attiki,EL30,Total,Males,2011,Mental and behavioural disorders (F00-F99),0.75,Rate
Attiki,EL30,Total,Males,2012,Mental and behavioural disorders (F00-F99),0.46,Rate
Attiki,EL30,Total,Males,2013,Mental and behavioural disorders (F00-F99),0.92,Rate
Attiki,EL30,Total,Males,2014,Mental and behavioural disorders (F00-F99),3.9,Rate
Attiki,EL30,Total,Males,2015,Mental and behavioural disorders (F00-F99),7.65,Rate
Attiki,EL30,Total,Males,2016,Mental and behavioural disorders (F00-F99),8.53,Rate
Attiki,EL30,Total,Males,2017,Mental and behavioural disorders (F00-F99),10.82,Rate
Attiki,EL30,Total,Males,2018,Mental and behavioural disorders (F00-F99),14.85,Rate
Attiki,EL30,Total,Males,2019,Mental and behavioural disorders (F00-F99),13.8,Rate
Attiki,EL30,Total,Males,2020,Mental and behavioural disorders (F00-F99),17.48,Rate
Attiki,EL30,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.06,Rate
Attiki,EL30,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.06,Rate
Attiki,EL30,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Attiki,EL30,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Attiki,EL30,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Attiki,EL30,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Attiki,EL30,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.27,Rate
Attiki,EL30,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.09,Rate
Attiki,EL30,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.82,Rate
Attiki,EL30,Total,Males,2011,Other ischaemic heart diseases,57.76,Rate
Attiki,EL30,Total,Males,2012,Other ischaemic heart diseases,67.21,Rate
Attiki,EL30,Total,Males,2013,Other ischaemic heart diseases,70.03,Rate
Attiki,EL30,Total,Males,2014,Other ischaemic heart diseases,82.87,Rate
Attiki,EL30,Total,Males,2015,Other ischaemic heart diseases,93.66,Rate
Attiki,EL30,Total,Males,2016,Other ischaemic heart diseases,82.42,Rate
Attiki,EL30,Total,Males,2017,Other ischaemic heart diseases,84.28,Rate
Attiki,EL30,Total,Males,2018,Other ischaemic heart diseases,78.51,Rate
Attiki,EL30,Total,Males,2019,Other ischaemic heart diseases,90.44,Rate
Attiki,EL30,Total,Males,2020,Other ischaemic heart diseases,92.24,Rate
Attiki,EL30,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,115.79,Rate
Attiki,EL30,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,104.17,Rate
Attiki,EL30,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,95.72,Rate
Attiki,EL30,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,92.45,Rate
Attiki,EL30,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,84.16,Rate
Attiki,EL30,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,80.48,Rate
Attiki,EL30,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,93.48,Rate
Attiki,EL30,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,92.87,Rate
Attiki,EL30,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,88.19,Rate
Attiki,EL30,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,84.74,Rate
Attiki,EL30,Total,Males,2011,Cerebrovascular diseases,120.99,Rate
Attiki,EL30,Total,Males,2012,Cerebrovascular diseases,125.02,Rate
Attiki,EL30,Total,Males,2013,Cerebrovascular diseases,115.69,Rate
Attiki,EL30,Total,Males,2014,Cerebrovascular diseases,99.29,Rate
Attiki,EL30,Total,Males,2015,Cerebrovascular diseases,104.51,Rate
Attiki,EL30,Total,Males,2016,Cerebrovascular diseases,97.98,Rate
Attiki,EL30,Total,Males,2017,Cerebrovascular diseases,93.47,Rate
Attiki,EL30,Total,Males,2018,Cerebrovascular diseases,82.54,Rate
Attiki,EL30,Total,Males,2019,Cerebrovascular diseases,90.65,Rate
Attiki,EL30,Total,Males,2020,Cerebrovascular diseases,88.8,Rate
Attiki,EL30,Total,Males,2011,Chronic lower respiratory diseases,23.53,Rate
Attiki,EL30,Total,Males,2012,Chronic lower respiratory diseases,23.14,Rate
Attiki,EL30,Total,Males,2013,Chronic lower respiratory diseases,21.06,Rate
Attiki,EL30,Total,Males,2014,Chronic lower respiratory diseases,29.25,Rate
Attiki,EL30,Total,Males,2015,Chronic lower respiratory diseases,37.67,Rate
Attiki,EL30,Total,Males,2016,Chronic lower respiratory diseases,30.32,Rate
Attiki,EL30,Total,Males,2017,Chronic lower respiratory diseases,35.28,Rate
Attiki,EL30,Total,Males,2018,Chronic lower respiratory diseases,27.48,Rate
Attiki,EL30,Total,Males,2019,Chronic lower respiratory diseases,31.87,Rate
Attiki,EL30,Total,Males,2020,Chronic lower respiratory diseases,31.44,Rate
Attiki,EL30,Total,Males,2013,Asthma and status asthmaticus,0.06,Rate
Attiki,EL30,Total,Males,2014,Asthma and status asthmaticus,0.31,Rate
Attiki,EL30,Total,Males,2015,Asthma and status asthmaticus,0.11,Rate
Attiki,EL30,Total,Males,2016,Asthma and status asthmaticus,0.11,Rate
Attiki,EL30,Total,Males,2017,Asthma and status asthmaticus,0.06,Rate
Attiki,EL30,Total,Males,2018,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,Total,Males,2019,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,Total,Males,2020,Asthma and status asthmaticus,0.05,Rate
Attiki,EL30,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5176.21,Rate
Attiki,EL30,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5172.23,Rate
Attiki,EL30,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4921.77,Rate
Attiki,EL30,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4808.97,Rate
Attiki,EL30,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5084.25,Rate
Attiki,EL30,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4852.59,Rate
Attiki,EL30,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5049.5,Rate
Attiki,EL30,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4816.2,Rate
Attiki,EL30,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4959.51,Rate
Attiki,EL30,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5123.38,Rate
Attiki,EL30,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.85,Rate
Attiki,EL30,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.95,Rate
Attiki,EL30,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.62,Rate
Attiki,EL30,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.66,Rate
Attiki,EL30,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",140.88,Rate
Attiki,EL30,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.22,Rate
Attiki,EL30,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.72,Rate
Attiki,EL30,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.36,Rate
Attiki,EL30,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.86,Rate
Attiki,EL30,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.82,Rate
Attiki,EL30,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",402.93,Rate
Attiki,EL30,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",414.78,Rate
Attiki,EL30,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",416.4,Rate
Attiki,EL30,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",413.84,Rate
Attiki,EL30,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",435.01,Rate
Attiki,EL30,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",426.43,Rate
Attiki,EL30,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",434.41,Rate
Attiki,EL30,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",413.15,Rate
Attiki,EL30,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",413.11,Rate
Attiki,EL30,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",401.8,Rate
Attiki,EL30,65 years or over,Males,2011,Malignant melanoma of skin,8.17,Rate
Attiki,EL30,65 years or over,Males,2012,Malignant melanoma of skin,8.47,Rate
Attiki,EL30,65 years or over,Males,2013,Malignant melanoma of skin,13.84,Rate
Attiki,EL30,65 years or over,Males,2014,Malignant melanoma of skin,11.66,Rate
Attiki,EL30,65 years or over,Males,2015,Malignant melanoma of skin,11.27,Rate
Attiki,EL30,65 years or over,Males,2016,Malignant melanoma of skin,12.63,Rate
Attiki,EL30,65 years or over,Males,2017,Malignant melanoma of skin,8.63,Rate
Attiki,EL30,65 years or over,Males,2018,Malignant melanoma of skin,12.86,Rate
Attiki,EL30,65 years or over,Males,2019,Malignant melanoma of skin,12.45,Rate
Attiki,EL30,65 years or over,Males,2020,Malignant melanoma of skin,9.59,Rate
Attiki,EL30,65 years or over,Males,2011,Malignant neoplasm of breast,5.07,Rate
Attiki,EL30,65 years or over,Males,2012,Malignant neoplasm of breast,2.59,Rate
Attiki,EL30,65 years or over,Males,2013,Malignant neoplasm of breast,1.88,Rate
Attiki,EL30,65 years or over,Males,2014,Malignant neoplasm of breast,1.87,Rate
Attiki,EL30,65 years or over,Males,2015,Malignant neoplasm of breast,1.75,Rate
Attiki,EL30,65 years or over,Males,2016,Malignant neoplasm of breast,3.1,Rate
Attiki,EL30,65 years or over,Males,2017,Malignant neoplasm of breast,1.12,Rate
Attiki,EL30,65 years or over,Males,2018,Malignant neoplasm of breast,2.39,Rate
Attiki,EL30,65 years or over,Males,2019,Malignant neoplasm of breast,1.23,Rate
Attiki,EL30,65 years or over,Males,2020,Malignant neoplasm of breast,2.9,Rate
Attiki,EL30,65 years or over,Males,2011,Diabetes mellitus,58.56,Rate
Attiki,EL30,65 years or over,Males,2012,Diabetes mellitus,53.48,Rate
Attiki,EL30,65 years or over,Males,2013,Diabetes mellitus,51.49,Rate
Attiki,EL30,65 years or over,Males,2014,Diabetes mellitus,66.97,Rate
Attiki,EL30,65 years or over,Males,2015,Diabetes mellitus,70.13,Rate
Attiki,EL30,65 years or over,Males,2016,Diabetes mellitus,61.26,Rate
Attiki,EL30,65 years or over,Males,2017,Diabetes mellitus,84.01,Rate
Attiki,EL30,65 years or over,Males,2018,Diabetes mellitus,76.55,Rate
Attiki,EL30,65 years or over,Males,2019,Diabetes mellitus,87.0,Rate
Attiki,EL30,65 years or over,Males,2020,Diabetes mellitus,81.23,Rate
Attiki,EL30,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),2.04,Rate
Attiki,EL30,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),1.57,Rate
Attiki,EL30,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),2.99,Rate
Attiki,EL30,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),17.37,Rate
Attiki,EL30,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),32.7,Rate
Attiki,EL30,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),39.65,Rate
Attiki,EL30,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),49.36,Rate
Attiki,EL30,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),69.66,Rate
Attiki,EL30,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),61.43,Rate
Attiki,EL30,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),77.76,Rate
Attiki,EL30,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Attiki,EL30,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.35,Rate
Attiki,EL30,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.12,Rate
Attiki,EL30,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.83,Rate
Attiki,EL30,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.43,Rate
Attiki,EL30,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),4.56,Rate
Attiki,EL30,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.53,Rate
Attiki,EL30,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),7.07,Rate
Attiki,EL30,65 years or over,Males,2011,Other ischaemic heart diseases,212.81,Rate
Attiki,EL30,65 years or over,Males,2012,Other ischaemic heart diseases,252.68,Rate
Attiki,EL30,65 years or over,Males,2013,Other ischaemic heart diseases,258.39,Rate
Attiki,EL30,65 years or over,Males,2014,Other ischaemic heart diseases,329.21,Rate
Attiki,EL30,65 years or over,Males,2015,Other ischaemic heart diseases,347.99,Rate
Attiki,EL30,65 years or over,Males,2016,Other ischaemic heart diseases,298.0,Rate
Attiki,EL30,65 years or over,Males,2017,Other ischaemic heart diseases,333.72,Rate
Attiki,EL30,65 years or over,Males,2018,Other ischaemic heart diseases,311.89,Rate
Attiki,EL30,65 years or over,Males,2019,Other ischaemic heart diseases,366.04,Rate
Attiki,EL30,65 years or over,Males,2020,Other ischaemic heart diseases,376.74,Rate
Attiki,EL30,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,425.68,Rate
Attiki,EL30,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,373.37,Rate
Attiki,EL30,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,351.14,Rate
Attiki,EL30,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,322.79,Rate
Attiki,EL30,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,310.11,Rate
Attiki,EL30,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,295.49,Rate
Attiki,EL30,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,344.27,Rate
Attiki,EL30,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,338.14,Rate
Attiki,EL30,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,323.19,Rate
Attiki,EL30,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,302.2,Rate
Attiki,EL30,65 years or over,Males,2011,Cerebrovascular diseases,567.11,Rate
Attiki,EL30,65 years or over,Males,2012,Cerebrovascular diseases,580.8,Rate
Attiki,EL30,65 years or over,Males,2013,Cerebrovascular diseases,544.51,Rate
Attiki,EL30,65 years or over,Males,2014,Cerebrovascular diseases,460.51,Rate
Attiki,EL30,65 years or over,Males,2015,Cerebrovascular diseases,480.69,Rate
Attiki,EL30,65 years or over,Males,2016,Cerebrovascular diseases,451.76,Rate
Attiki,EL30,65 years or over,Males,2017,Cerebrovascular diseases,429.33,Rate
Attiki,EL30,65 years or over,Males,2018,Cerebrovascular diseases,374.12,Rate
Attiki,EL30,65 years or over,Males,2019,Cerebrovascular diseases,417.44,Rate
Attiki,EL30,65 years or over,Males,2020,Cerebrovascular diseases,410.06,Rate
Attiki,EL30,65 years or over,Males,2011,Chronic lower respiratory diseases,111.49,Rate
Attiki,EL30,65 years or over,Males,2012,Chronic lower respiratory diseases,112.3,Rate
Attiki,EL30,65 years or over,Males,2013,Chronic lower respiratory diseases,99.89,Rate
Attiki,EL30,65 years or over,Males,2014,Chronic lower respiratory diseases,141.21,Rate
Attiki,EL30,65 years or over,Males,2015,Chronic lower respiratory diseases,182.65,Rate
Attiki,EL30,65 years or over,Males,2016,Chronic lower respiratory diseases,148.45,Rate
Attiki,EL30,65 years or over,Males,2017,Chronic lower respiratory diseases,172.05,Rate
Attiki,EL30,65 years or over,Males,2018,Chronic lower respiratory diseases,132.14,Rate
Attiki,EL30,65 years or over,Males,2019,Chronic lower respiratory diseases,156.76,Rate
Attiki,EL30,65 years or over,Males,2020,Chronic lower respiratory diseases,152.0,Rate
Attiki,EL30,65 years or over,Males,2013,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Males,2014,Asthma and status asthmaticus,0.98,Rate
Attiki,EL30,65 years or over,Males,2015,Asthma and status asthmaticus,0.58,Rate
Attiki,EL30,65 years or over,Males,2016,Asthma and status asthmaticus,0.57,Rate
Attiki,EL30,65 years or over,Males,2017,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Males,2018,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Males,2019,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Males,2020,Asthma and status asthmaticus,0.27,Rate
Attiki,EL30,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,275.16,Rate
Attiki,EL30,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,272.48,Rate
Attiki,EL30,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,271.03,Rate
Attiki,EL30,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,269.18,Rate
Attiki,EL30,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,280.53,Rate
Attiki,EL30,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,272.96,Rate
Attiki,EL30,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,264.31,Rate
Attiki,EL30,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,259.18,Rate
Attiki,EL30,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,256.32,Rate
Attiki,EL30,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,260.56,Rate
Attiki,EL30,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.03,Rate
Attiki,EL30,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.28,Rate
Attiki,EL30,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.82,Rate
Attiki,EL30,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.86,Rate
Attiki,EL30,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.53,Rate
Attiki,EL30,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.14,Rate
Attiki,EL30,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.15,Rate
Attiki,EL30,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.93,Rate
Attiki,EL30,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.95,Rate
Attiki,EL30,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.89,Rate
Attiki,EL30,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",34.56,Rate
Attiki,EL30,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",36.84,Rate
Attiki,EL30,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",37.71,Rate
Attiki,EL30,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",35.88,Rate
Attiki,EL30,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",36.15,Rate
Attiki,EL30,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",33.6,Rate
Attiki,EL30,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",30.59,Rate
Attiki,EL30,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",29.42,Rate
Attiki,EL30,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",27.82,Rate
Attiki,EL30,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",25.89,Rate
Attiki,EL30,Less than 65 years,Males,2011,Malignant melanoma of skin,1.15,Rate
Attiki,EL30,Less than 65 years,Males,2012,Malignant melanoma of skin,1.19,Rate
Attiki,EL30,Less than 65 years,Males,2013,Malignant melanoma of skin,0.99,Rate
Attiki,EL30,Less than 65 years,Males,2014,Malignant melanoma of skin,0.9,Rate
Attiki,EL30,Less than 65 years,Males,2015,Malignant melanoma of skin,1.62,Rate
Attiki,EL30,Less than 65 years,Males,2016,Malignant melanoma of skin,1.12,Rate
Attiki,EL30,Less than 65 years,Males,2017,Malignant melanoma of skin,1.17,Rate
Attiki,EL30,Less than 65 years,Males,2018,Malignant melanoma of skin,1.47,Rate
Attiki,EL30,Less than 65 years,Males,2019,Malignant melanoma of skin,1.51,Rate
Attiki,EL30,Less than 65 years,Males,2020,Malignant melanoma of skin,1.16,Rate
Attiki,EL30,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.33,Rate
Attiki,EL30,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.31,Rate
Attiki,EL30,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.14,Rate
Attiki,EL30,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.14,Rate
Attiki,EL30,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Attiki,EL30,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.21,Rate
Attiki,EL30,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2011,Diabetes mellitus,1.64,Rate
Attiki,EL30,Less than 65 years,Males,2012,Diabetes mellitus,1.56,Rate
Attiki,EL30,Less than 65 years,Males,2013,Diabetes mellitus,2.31,Rate
Attiki,EL30,Less than 65 years,Males,2014,Diabetes mellitus,3.53,Rate
Attiki,EL30,Less than 65 years,Males,2015,Diabetes mellitus,3.57,Rate
Attiki,EL30,Less than 65 years,Males,2016,Diabetes mellitus,3.95,Rate
Attiki,EL30,Less than 65 years,Males,2017,Diabetes mellitus,3.35,Rate
Attiki,EL30,Less than 65 years,Males,2018,Diabetes mellitus,4.24,Rate
Attiki,EL30,Less than 65 years,Males,2019,Diabetes mellitus,3.86,Rate
Attiki,EL30,Less than 65 years,Males,2020,Diabetes mellitus,3.27,Rate
Attiki,EL30,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.44,Rate
Attiki,EL30,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),0.2,Rate
Attiki,EL30,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.42,Rate
Attiki,EL30,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.64,Rate
Attiki,EL30,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.58,Rate
Attiki,EL30,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),1.0,Rate
Attiki,EL30,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.48,Rate
Attiki,EL30,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.57,Rate
Attiki,EL30,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),2.27,Rate
Attiki,EL30,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),2.87,Rate
Attiki,EL30,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.07,Rate
Attiki,EL30,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Attiki,EL30,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.63,Rate
Attiki,EL30,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Attiki,EL30,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Attiki,EL30,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Attiki,EL30,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.5,Rate
Attiki,EL30,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.79,Rate
Attiki,EL30,Less than 65 years,Males,2011,Other ischaemic heart diseases,20.2,Rate
Attiki,EL30,Less than 65 years,Males,2012,Other ischaemic heart diseases,22.28,Rate
Attiki,EL30,Less than 65 years,Males,2013,Other ischaemic heart diseases,24.41,Rate
Attiki,EL30,Less than 65 years,Males,2014,Other ischaemic heart diseases,23.19,Rate
Attiki,EL30,Less than 65 years,Males,2015,Other ischaemic heart diseases,32.05,Rate
Attiki,EL30,Less than 65 years,Males,2016,Other ischaemic heart diseases,30.2,Rate
Attiki,EL30,Less than 65 years,Males,2017,Other ischaemic heart diseases,23.86,Rate
Attiki,EL30,Less than 65 years,Males,2018,Other ischaemic heart diseases,21.98,Rate
Attiki,EL30,Less than 65 years,Males,2019,Other ischaemic heart diseases,23.68,Rate
Attiki,EL30,Less than 65 years,Males,2020,Other ischaemic heart diseases,23.32,Rate
Attiki,EL30,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,40.73,Rate
Attiki,EL30,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,38.96,Rate
Attiki,EL30,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,33.85,Rate
Attiki,EL30,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,36.66,Rate
Attiki,EL30,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,29.43,Rate
Attiki,EL30,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,28.4,Rate
Attiki,EL30,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,32.74,Rate
Attiki,EL30,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,33.46,Rate
Attiki,EL30,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,31.26,Rate
Attiki,EL30,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,32.06,Rate
Attiki,EL30,Less than 65 years,Males,2011,Cerebrovascular diseases,12.92,Rate
Attiki,EL30,Less than 65 years,Males,2012,Cerebrovascular diseases,14.62,Rate
Attiki,EL30,Less than 65 years,Males,2013,Cerebrovascular diseases,11.81,Rate
Attiki,EL30,Less than 65 years,Males,2014,Cerebrovascular diseases,11.79,Rate
Attiki,EL30,Less than 65 years,Males,2015,Cerebrovascular diseases,13.38,Rate
Attiki,EL30,Less than 65 years,Males,2016,Cerebrovascular diseases,12.29,Rate
Attiki,EL30,Less than 65 years,Males,2017,Cerebrovascular diseases,12.11,Rate
Attiki,EL30,Less than 65 years,Males,2018,Cerebrovascular diseases,11.91,Rate
Attiki,EL30,Less than 65 years,Males,2019,Cerebrovascular diseases,11.49,Rate
Attiki,EL30,Less than 65 years,Males,2020,Cerebrovascular diseases,10.98,Rate
Attiki,EL30,Less than 65 years,Males,2011,Chronic lower respiratory diseases,2.23,Rate
Attiki,EL30,Less than 65 years,Males,2012,Chronic lower respiratory diseases,1.54,Rate
Attiki,EL30,Less than 65 years,Males,2013,Chronic lower respiratory diseases,1.96,Rate
Attiki,EL30,Less than 65 years,Males,2014,Chronic lower respiratory diseases,2.12,Rate
Attiki,EL30,Less than 65 years,Males,2015,Chronic lower respiratory diseases,2.55,Rate
Attiki,EL30,Less than 65 years,Males,2016,Chronic lower respiratory diseases,1.71,Rate
Attiki,EL30,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.14,Rate
Attiki,EL30,Less than 65 years,Males,2018,Chronic lower respiratory diseases,2.13,Rate
Attiki,EL30,Less than 65 years,Males,2019,Chronic lower respiratory diseases,1.61,Rate
Attiki,EL30,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.24,Rate
Attiki,EL30,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.15,Rate
Attiki,EL30,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.08,Rate
Attiki,EL30,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.07,Rate
Attiki,EL30,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.06,Rate
Attiki,EL30,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1010.31,Rate
Attiki,EL30,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1019.88,Rate
Attiki,EL30,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,969.68,Rate
Attiki,EL30,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,957.95,Rate
Attiki,EL30,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1006.16,Rate
Attiki,EL30,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,967.19,Rate
Attiki,EL30,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,994.39,Rate
Attiki,EL30,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,946.91,Rate
Attiki,EL30,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,959.28,Rate
Attiki,EL30,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,996.67,Rate
Attiki,EL30,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.73,Rate
Attiki,EL30,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.19,Rate
Attiki,EL30,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.02,Rate
Attiki,EL30,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.2,Rate
Attiki,EL30,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.26,Rate
Attiki,EL30,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.11,Rate
Attiki,EL30,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.37,Rate
Attiki,EL30,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.72,Rate
Attiki,EL30,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.5,Rate
Attiki,EL30,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.99,Rate
Attiki,EL30,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",60.43,Rate
Attiki,EL30,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",63.14,Rate
Attiki,EL30,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",64.47,Rate
Attiki,EL30,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",64.08,Rate
Attiki,EL30,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",66.16,Rate
Attiki,EL30,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",65.43,Rate
Attiki,EL30,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",64.21,Rate
Attiki,EL30,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",62.81,Rate
Attiki,EL30,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",62.1,Rate
Attiki,EL30,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",61.15,Rate
Attiki,EL30,Total,Total,2011,Malignant melanoma of skin,2.04,Rate
Attiki,EL30,Total,Total,2012,Malignant melanoma of skin,2.04,Rate
Attiki,EL30,Total,Total,2013,Malignant melanoma of skin,2.43,Rate
Attiki,EL30,Total,Total,2014,Malignant melanoma of skin,2.31,Rate
Attiki,EL30,Total,Total,2015,Malignant melanoma of skin,2.48,Rate
Attiki,EL30,Total,Total,2016,Malignant melanoma of skin,2.22,Rate
Attiki,EL30,Total,Total,2017,Malignant melanoma of skin,1.98,Rate
Attiki,EL30,Total,Total,2018,Malignant melanoma of skin,2.54,Rate
Attiki,EL30,Total,Total,2019,Malignant melanoma of skin,2.4,Rate
Attiki,EL30,Total,Total,2020,Malignant melanoma of skin,2.35,Rate
Attiki,EL30,Total,Total,2011,Malignant neoplasm of breast,19.91,Rate
Attiki,EL30,Total,Total,2012,Malignant neoplasm of breast,21.0,Rate
Attiki,EL30,Total,Total,2013,Malignant neoplasm of breast,21.12,Rate
Attiki,EL30,Total,Total,2014,Malignant neoplasm of breast,20.6,Rate
Attiki,EL30,Total,Total,2015,Malignant neoplasm of breast,21.4,Rate
Attiki,EL30,Total,Total,2016,Malignant neoplasm of breast,21.51,Rate
Attiki,EL30,Total,Total,2017,Malignant neoplasm of breast,20.71,Rate
Attiki,EL30,Total,Total,2018,Malignant neoplasm of breast,20.79,Rate
Attiki,EL30,Total,Total,2019,Malignant neoplasm of breast,19.96,Rate
Attiki,EL30,Total,Total,2020,Malignant neoplasm of breast,20.31,Rate
Attiki,EL30,Total,Total,2011,Diabetes mellitus,8.83,Rate
Attiki,EL30,Total,Total,2012,Diabetes mellitus,9.54,Rate
Attiki,EL30,Total,Total,2013,Diabetes mellitus,9.58,Rate
Attiki,EL30,Total,Total,2014,Diabetes mellitus,12.61,Rate
Attiki,EL30,Total,Total,2015,Diabetes mellitus,13.14,Rate
Attiki,EL30,Total,Total,2016,Diabetes mellitus,12.15,Rate
Attiki,EL30,Total,Total,2017,Diabetes mellitus,15.95,Rate
Attiki,EL30,Total,Total,2018,Diabetes mellitus,15.11,Rate
Attiki,EL30,Total,Total,2019,Diabetes mellitus,16.12,Rate
Attiki,EL30,Total,Total,2020,Diabetes mellitus,15.24,Rate
Attiki,EL30,Total,Total,2011,Mental and behavioural disorders (F00-F99),0.79,Rate
Attiki,EL30,Total,Total,2012,Mental and behavioural disorders (F00-F99),0.53,Rate
Attiki,EL30,Total,Total,2013,Mental and behavioural disorders (F00-F99),0.97,Rate
Attiki,EL30,Total,Total,2014,Mental and behavioural disorders (F00-F99),4.8,Rate
Attiki,EL30,Total,Total,2015,Mental and behavioural disorders (F00-F99),8.67,Rate
Attiki,EL30,Total,Total,2016,Mental and behavioural disorders (F00-F99),9.85,Rate
Attiki,EL30,Total,Total,2017,Mental and behavioural disorders (F00-F99),13.04,Rate
Attiki,EL30,Total,Total,2018,Mental and behavioural disorders (F00-F99),15.25,Rate
Attiki,EL30,Total,Total,2019,Mental and behavioural disorders (F00-F99),16.05,Rate
Attiki,EL30,Total,Total,2020,Mental and behavioural disorders (F00-F99),20.0,Rate
Attiki,EL30,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.07,Rate
Attiki,EL30,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Attiki,EL30,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.07,Rate
Attiki,EL30,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Attiki,EL30,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Attiki,EL30,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Attiki,EL30,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Attiki,EL30,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Attiki,EL30,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.77,Rate
Attiki,EL30,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Attiki,EL30,Total,Total,2011,Other ischaemic heart diseases,43.13,Rate
Attiki,EL30,Total,Total,2012,Other ischaemic heart diseases,49.6,Rate
Attiki,EL30,Total,Total,2013,Other ischaemic heart diseases,51.04,Rate
Attiki,EL30,Total,Total,2014,Other ischaemic heart diseases,62.9,Rate
Attiki,EL30,Total,Total,2015,Other ischaemic heart diseases,66.06,Rate
Attiki,EL30,Total,Total,2016,Other ischaemic heart diseases,59.37,Rate
Attiki,EL30,Total,Total,2017,Other ischaemic heart diseases,62.18,Rate
Attiki,EL30,Total,Total,2018,Other ischaemic heart diseases,60.88,Rate
Attiki,EL30,Total,Total,2019,Other ischaemic heart diseases,68.33,Rate
Attiki,EL30,Total,Total,2020,Other ischaemic heart diseases,69.13,Rate
Attiki,EL30,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,78.48,Rate
Attiki,EL30,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,71.04,Rate
Attiki,EL30,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,62.98,Rate
Attiki,EL30,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,59.49,Rate
Attiki,EL30,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,56.11,Rate
Attiki,EL30,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,54.72,Rate
Attiki,EL30,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,63.68,Rate
Attiki,EL30,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,60.85,Rate
Attiki,EL30,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,57.19,Rate
Attiki,EL30,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,56.16,Rate
Attiki,EL30,Total,Total,2011,Cerebrovascular diseases,119.01,Rate
Attiki,EL30,Total,Total,2012,Cerebrovascular diseases,120.26,Rate
Attiki,EL30,Total,Total,2013,Cerebrovascular diseases,115.09,Rate
Attiki,EL30,Total,Total,2014,Cerebrovascular diseases,101.41,Rate
Attiki,EL30,Total,Total,2015,Cerebrovascular diseases,100.44,Rate
Attiki,EL30,Total,Total,2016,Cerebrovascular diseases,94.2,Rate
Attiki,EL30,Total,Total,2017,Cerebrovascular diseases,92.41,Rate
Attiki,EL30,Total,Total,2018,Cerebrovascular diseases,82.41,Rate
Attiki,EL30,Total,Total,2019,Cerebrovascular diseases,83.04,Rate
Attiki,EL30,Total,Total,2020,Cerebrovascular diseases,82.42,Rate
Attiki,EL30,Total,Total,2011,Chronic lower respiratory diseases,17.12,Rate
Attiki,EL30,Total,Total,2012,Chronic lower respiratory diseases,16.39,Rate
Attiki,EL30,Total,Total,2013,Chronic lower respiratory diseases,15.9,Rate
Attiki,EL30,Total,Total,2014,Chronic lower respiratory diseases,21.85,Rate
Attiki,EL30,Total,Total,2015,Chronic lower respiratory diseases,28.04,Rate
Attiki,EL30,Total,Total,2016,Chronic lower respiratory diseases,23.36,Rate
Attiki,EL30,Total,Total,2017,Chronic lower respiratory diseases,26.03,Rate
Attiki,EL30,Total,Total,2018,Chronic lower respiratory diseases,21.51,Rate
Attiki,EL30,Total,Total,2019,Chronic lower respiratory diseases,23.28,Rate
Attiki,EL30,Total,Total,2020,Chronic lower respiratory diseases,23.68,Rate
Attiki,EL30,Total,Total,2011,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Total,Total,2012,Asthma and status asthmaticus,0.02,Rate
Attiki,EL30,Total,Total,2013,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Total,Total,2014,Asthma and status asthmaticus,0.18,Rate
Attiki,EL30,Total,Total,2015,Asthma and status asthmaticus,0.19,Rate
Attiki,EL30,Total,Total,2016,Asthma and status asthmaticus,0.21,Rate
Attiki,EL30,Total,Total,2017,Asthma and status asthmaticus,0.17,Rate
Attiki,EL30,Total,Total,2018,Asthma and status asthmaticus,0.15,Rate
Attiki,EL30,Total,Total,2019,Asthma and status asthmaticus,0.04,Rate
Attiki,EL30,Total,Total,2020,Asthma and status asthmaticus,0.1,Rate
Attiki,EL30,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4359.99,Rate
Attiki,EL30,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4424.1,Rate
Attiki,EL30,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4187.59,Rate
Attiki,EL30,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4126.63,Rate
Attiki,EL30,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4355.9,Rate
Attiki,EL30,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4161.97,Rate
Attiki,EL30,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4322.68,Rate
Attiki,EL30,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4102.61,Rate
Attiki,EL30,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4173.18,Rate
Attiki,EL30,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4334.64,Rate
Attiki,EL30,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.7,Rate
Attiki,EL30,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.86,Rate
Attiki,EL30,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.22,Rate
Attiki,EL30,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.63,Rate
Attiki,EL30,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.48,Rate
Attiki,EL30,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.69,Rate
Attiki,EL30,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.88,Rate
Attiki,EL30,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.43,Rate
Attiki,EL30,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.98,Rate
Attiki,EL30,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.12,Rate
Attiki,EL30,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",217.92,Rate
Attiki,EL30,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",227.06,Rate
Attiki,EL30,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",233.84,Rate
Attiki,EL30,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",234.33,Rate
Attiki,EL30,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",243.87,Rate
Attiki,EL30,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",243.98,Rate
Attiki,EL30,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",250.18,Rate
Attiki,EL30,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",242.37,Rate
Attiki,EL30,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",241.47,Rate
Attiki,EL30,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",237.42,Rate
Attiki,EL30,65 years or over,Total,2011,Malignant melanoma of skin,6.81,Rate
Attiki,EL30,65 years or over,Total,2012,Malignant melanoma of skin,6.5,Rate
Attiki,EL30,65 years or over,Total,2013,Malignant melanoma of skin,8.87,Rate
Attiki,EL30,65 years or over,Total,2014,Malignant melanoma of skin,8.26,Rate
Attiki,EL30,65 years or over,Total,2015,Malignant melanoma of skin,7.57,Rate
Attiki,EL30,65 years or over,Total,2016,Malignant melanoma of skin,7.6,Rate
Attiki,EL30,65 years or over,Total,2017,Malignant melanoma of skin,6.78,Rate
Attiki,EL30,65 years or over,Total,2018,Malignant melanoma of skin,8.12,Rate
Attiki,EL30,65 years or over,Total,2019,Malignant melanoma of skin,8.29,Rate
Attiki,EL30,65 years or over,Total,2020,Malignant melanoma of skin,7.86,Rate
Attiki,EL30,65 years or over,Total,2011,Malignant neoplasm of breast,70.51,Rate
Attiki,EL30,65 years or over,Total,2012,Malignant neoplasm of breast,74.53,Rate
Attiki,EL30,65 years or over,Total,2013,Malignant neoplasm of breast,78.87,Rate
Attiki,EL30,65 years or over,Total,2014,Malignant neoplasm of breast,76.37,Rate
Attiki,EL30,65 years or over,Total,2015,Malignant neoplasm of breast,80.31,Rate
Attiki,EL30,65 years or over,Total,2016,Malignant neoplasm of breast,76.09,Rate
Attiki,EL30,65 years or over,Total,2017,Malignant neoplasm of breast,76.26,Rate
Attiki,EL30,65 years or over,Total,2018,Malignant neoplasm of breast,76.41,Rate
Attiki,EL30,65 years or over,Total,2019,Malignant neoplasm of breast,73.3,Rate
Attiki,EL30,65 years or over,Total,2020,Malignant neoplasm of breast,73.12,Rate
Attiki,EL30,65 years or over,Total,2011,Diabetes mellitus,40.28,Rate
Attiki,EL30,65 years or over,Total,2012,Diabetes mellitus,44.19,Rate
Attiki,EL30,65 years or over,Total,2013,Diabetes mellitus,42.85,Rate
Attiki,EL30,65 years or over,Total,2014,Diabetes mellitus,54.82,Rate
Attiki,EL30,65 years or over,Total,2015,Diabetes mellitus,56.44,Rate
Attiki,EL30,65 years or over,Total,2016,Diabetes mellitus,50.48,Rate
Attiki,EL30,65 years or over,Total,2017,Diabetes mellitus,72.81,Rate
Attiki,EL30,65 years or over,Total,2018,Diabetes mellitus,66.59,Rate
Attiki,EL30,65 years or over,Total,2019,Diabetes mellitus,70.92,Rate
Attiki,EL30,65 years or over,Total,2020,Diabetes mellitus,68.57,Rate
Attiki,EL30,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),2.88,Rate
Attiki,EL30,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),1.88,Rate
Attiki,EL30,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),3.92,Rate
Attiki,EL30,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),22.51,Rate
Attiki,EL30,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),39.55,Rate
Attiki,EL30,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),47.25,Rate
Attiki,EL30,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),61.01,Rate
Attiki,EL30,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),71.97,Rate
Attiki,EL30,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),76.25,Rate
Attiki,EL30,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),93.58,Rate
Attiki,EL30,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Attiki,EL30,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.13,Rate
Attiki,EL30,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.16,Rate
Attiki,EL30,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.35,Rate
Attiki,EL30,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.86,Rate
Attiki,EL30,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Attiki,EL30,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.85,Rate
Attiki,EL30,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),4.84,Rate
Attiki,EL30,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),7.59,Rate
Attiki,EL30,65 years or over,Total,2011,Other ischaemic heart diseases,169.91,Rate
Attiki,EL30,65 years or over,Total,2012,Other ischaemic heart diseases,197.83,Rate
Attiki,EL30,65 years or over,Total,2013,Other ischaemic heart diseases,200.04,Rate
Attiki,EL30,65 years or over,Total,2014,Other ischaemic heart diseases,264.73,Rate
Attiki,EL30,65 years or over,Total,2015,Other ischaemic heart diseases,262.63,Rate
Attiki,EL30,65 years or over,Total,2016,Other ischaemic heart diseases,230.34,Rate
Attiki,EL30,65 years or over,Total,2017,Other ischaemic heart diseases,260.96,Rate
Attiki,EL30,65 years or over,Total,2018,Other ischaemic heart diseases,256.41,Rate
Attiki,EL30,65 years or over,Total,2019,Other ischaemic heart diseases,295.73,Rate
Attiki,EL30,65 years or over,Total,2020,Other ischaemic heart diseases,298.45,Rate
Attiki,EL30,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,301.1,Rate
Attiki,EL30,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,271.32,Rate
Attiki,EL30,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,245.28,Rate
Attiki,EL30,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,224.62,Rate
Attiki,EL30,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,222.23,Rate
Attiki,EL30,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,215.79,Rate
Attiki,EL30,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,251.54,Rate
Attiki,EL30,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,237.37,Rate
Attiki,EL30,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,223.69,Rate
Attiki,EL30,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,216.97,Rate
Attiki,EL30,65 years or over,Total,2011,Cerebrovascular diseases,570.55,Rate
Attiki,EL30,65 years or over,Total,2012,Cerebrovascular diseases,572.3,Rate
Attiki,EL30,65 years or over,Total,2013,Cerebrovascular diseases,553.77,Rate
Attiki,EL30,65 years or over,Total,2014,Cerebrovascular diseases,485.49,Rate
Attiki,EL30,65 years or over,Total,2015,Cerebrovascular diseases,479.02,Rate
Attiki,EL30,65 years or over,Total,2016,Cerebrovascular diseases,446.15,Rate
Attiki,EL30,65 years or over,Total,2017,Cerebrovascular diseases,437.05,Rate
Attiki,EL30,65 years or over,Total,2018,Cerebrovascular diseases,390.03,Rate
Attiki,EL30,65 years or over,Total,2019,Cerebrovascular diseases,391.62,Rate
Attiki,EL30,65 years or over,Total,2020,Cerebrovascular diseases,390.22,Rate
Attiki,EL30,65 years or over,Total,2011,Chronic lower respiratory diseases,80.37,Rate
Attiki,EL30,65 years or over,Total,2012,Chronic lower respiratory diseases,79.52,Rate
Attiki,EL30,65 years or over,Total,2013,Chronic lower respiratory diseases,75.99,Rate
Attiki,EL30,65 years or over,Total,2014,Chronic lower respiratory diseases,106.14,Rate
Attiki,EL30,65 years or over,Total,2015,Chronic lower respiratory diseases,136.29,Rate
Attiki,EL30,65 years or over,Total,2016,Chronic lower respiratory diseases,114.2,Rate
Attiki,EL30,65 years or over,Total,2017,Chronic lower respiratory diseases,127.0,Rate
Attiki,EL30,65 years or over,Total,2018,Chronic lower respiratory diseases,103.59,Rate
Attiki,EL30,65 years or over,Total,2019,Chronic lower respiratory diseases,113.63,Rate
Attiki,EL30,65 years or over,Total,2020,Chronic lower respiratory diseases,114.95,Rate
Attiki,EL30,65 years or over,Total,2011,Asthma and status asthmaticus,0.15,Rate
Attiki,EL30,65 years or over,Total,2012,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Total,2013,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,65 years or over,Total,2014,Asthma and status asthmaticus,0.53,Rate
Attiki,EL30,65 years or over,Total,2015,Asthma and status asthmaticus,0.99,Rate
Attiki,EL30,65 years or over,Total,2016,Asthma and status asthmaticus,0.94,Rate
Attiki,EL30,65 years or over,Total,2017,Asthma and status asthmaticus,0.48,Rate
Attiki,EL30,65 years or over,Total,2018,Asthma and status asthmaticus,0.38,Rate
Attiki,EL30,65 years or over,Total,2019,Asthma and status asthmaticus,0.11,Rate
Attiki,EL30,65 years or over,Total,2020,Asthma and status asthmaticus,0.49,Rate
Attiki,EL30,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,198.89,Rate
Attiki,EL30,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,195.25,Rate
Attiki,EL30,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,190.18,Rate
Attiki,EL30,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,190.38,Rate
Attiki,EL30,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,194.73,Rate
Attiki,EL30,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,193.3,Rate
Attiki,EL30,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,188.15,Rate
Attiki,EL30,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,182.49,Rate
Attiki,EL30,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,180.76,Rate
Attiki,EL30,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,188.09,Rate
Attiki,EL30,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.6,Rate
Attiki,EL30,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.86,Rate
Attiki,EL30,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.04,Rate
Attiki,EL30,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.27,Rate
Attiki,EL30,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.59,Rate
Attiki,EL30,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.83,Rate
Attiki,EL30,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.05,Rate
Attiki,EL30,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.14,Rate
Attiki,EL30,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.28,Rate
Attiki,EL30,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.06,Rate
Attiki,EL30,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",22.29,Rate
Attiki,EL30,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",23.43,Rate
Attiki,EL30,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",23.44,Rate
Attiki,EL30,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",22.84,Rate
Attiki,EL30,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",23.11,Rate
Attiki,EL30,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",22.18,Rate
Attiki,EL30,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",19.16,Rate
Attiki,EL30,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",19.32,Rate
Attiki,EL30,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",18.66,Rate
Attiki,EL30,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",18.44,Rate
Attiki,EL30,Less than 65 years,Total,2011,Malignant melanoma of skin,0.88,Rate
Attiki,EL30,Less than 65 years,Total,2012,Malignant melanoma of skin,0.96,Rate
Attiki,EL30,Less than 65 years,Total,2013,Malignant melanoma of skin,0.88,Rate
Attiki,EL30,Less than 65 years,Total,2014,Malignant melanoma of skin,0.87,Rate
Attiki,EL30,Less than 65 years,Total,2015,Malignant melanoma of skin,1.24,Rate
Attiki,EL30,Less than 65 years,Total,2016,Malignant melanoma of skin,0.92,Rate
Attiki,EL30,Less than 65 years,Total,2017,Malignant melanoma of skin,0.82,Rate
Attiki,EL30,Less than 65 years,Total,2018,Malignant melanoma of skin,1.19,Rate
Attiki,EL30,Less than 65 years,Total,2019,Malignant melanoma of skin,0.97,Rate
Attiki,EL30,Less than 65 years,Total,2020,Malignant melanoma of skin,1.02,Rate
Attiki,EL30,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.66,Rate
Attiki,EL30,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.03,Rate
Attiki,EL30,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.13,Rate
Attiki,EL30,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.08,Rate
Attiki,EL30,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.14,Rate
Attiki,EL30,Less than 65 years,Total,2016,Malignant neoplasm of breast,8.29,Rate
Attiki,EL30,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.26,Rate
Attiki,EL30,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.32,Rate
Attiki,EL30,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.04,Rate
Attiki,EL30,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.51,Rate
Attiki,EL30,Less than 65 years,Total,2011,Diabetes mellitus,1.21,Rate
Attiki,EL30,Less than 65 years,Total,2012,Diabetes mellitus,1.15,Rate
Attiki,EL30,Less than 65 years,Total,2013,Diabetes mellitus,1.52,Rate
Attiki,EL30,Less than 65 years,Total,2014,Diabetes mellitus,2.39,Rate
Attiki,EL30,Less than 65 years,Total,2015,Diabetes mellitus,2.65,Rate
Attiki,EL30,Less than 65 years,Total,2016,Diabetes mellitus,2.86,Rate
Attiki,EL30,Less than 65 years,Total,2017,Diabetes mellitus,2.17,Rate
Attiki,EL30,Less than 65 years,Total,2018,Diabetes mellitus,2.64,Rate
Attiki,EL30,Less than 65 years,Total,2019,Diabetes mellitus,2.85,Rate
Attiki,EL30,Less than 65 years,Total,2020,Diabetes mellitus,2.32,Rate
Attiki,EL30,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.28,Rate
Attiki,EL30,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.2,Rate
Attiki,EL30,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.26,Rate
Attiki,EL30,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.51,Rate
Attiki,EL30,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.19,Rate
Attiki,EL30,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.8,Rate
Attiki,EL30,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.42,Rate
Attiki,EL30,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.51,Rate
Attiki,EL30,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.47,Rate
Attiki,EL30,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),2.18,Rate
Attiki,EL30,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.08,Rate
Attiki,EL30,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Attiki,EL30,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.06,Rate
Attiki,EL30,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Attiki,EL30,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Attiki,EL30,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Attiki,EL30,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Attiki,EL30,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Attiki,EL30,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Attiki,EL30,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.27,Rate
Attiki,EL30,Less than 65 years,Total,2011,Other ischaemic heart diseases,12.41,Rate
Attiki,EL30,Less than 65 years,Total,2012,Other ischaemic heart diseases,13.7,Rate
Attiki,EL30,Less than 65 years,Total,2013,Other ischaemic heart diseases,14.95,Rate
Attiki,EL30,Less than 65 years,Total,2014,Other ischaemic heart diseases,14.01,Rate
Attiki,EL30,Less than 65 years,Total,2015,Other ischaemic heart diseases,18.44,Rate
Attiki,EL30,Less than 65 years,Total,2016,Other ischaemic heart diseases,17.95,Rate
Attiki,EL30,Less than 65 years,Total,2017,Other ischaemic heart diseases,14.02,Rate
Attiki,EL30,Less than 65 years,Total,2018,Other ischaemic heart diseases,13.52,Rate
Attiki,EL30,Less than 65 years,Total,2019,Other ischaemic heart diseases,13.25,Rate
Attiki,EL30,Less than 65 years,Total,2020,Other ischaemic heart diseases,13.59,Rate
Attiki,EL30,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,24.55,Rate
Attiki,EL30,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,22.52,Rate
Attiki,EL30,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,18.82,Rate
Attiki,EL30,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,19.49,Rate
Attiki,EL30,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,15.87,Rate
Attiki,EL30,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,15.7,Rate
Attiki,EL30,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,18.17,Rate
Attiki,EL30,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,18.09,Rate
Attiki,EL30,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,16.86,Rate
Attiki,EL30,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,17.21,Rate
Attiki,EL30,Less than 65 years,Total,2011,Cerebrovascular diseases,9.63,Rate
Attiki,EL30,Less than 65 years,Total,2012,Cerebrovascular diseases,10.76,Rate
Attiki,EL30,Less than 65 years,Total,2013,Cerebrovascular diseases,8.83,Rate
Attiki,EL30,Less than 65 years,Total,2014,Cerebrovascular diseases,8.37,Rate
Attiki,EL30,Less than 65 years,Total,2015,Cerebrovascular diseases,8.74,Rate
Attiki,EL30,Less than 65 years,Total,2016,Cerebrovascular diseases,8.94,Rate
Attiki,EL30,Less than 65 years,Total,2017,Cerebrovascular diseases,8.92,Rate
Attiki,EL30,Less than 65 years,Total,2018,Cerebrovascular diseases,7.9,Rate
Attiki,EL30,Less than 65 years,Total,2019,Cerebrovascular diseases,8.28,Rate
Attiki,EL30,Less than 65 years,Total,2020,Cerebrovascular diseases,7.86,Rate
Attiki,EL30,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.79,Rate
Attiki,EL30,Less than 65 years,Total,2012,Chronic lower respiratory diseases,1.1,Rate
Attiki,EL30,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.34,Rate
Attiki,EL30,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.43,Rate
Attiki,EL30,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.82,Rate
Attiki,EL30,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.36,Rate
Attiki,EL30,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.58,Rate
Attiki,EL30,Less than 65 years,Total,2018,Chronic lower respiratory diseases,1.63,Rate
Attiki,EL30,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.39,Rate
Attiki,EL30,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.57,Rate
Attiki,EL30,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.04,Rate
Attiki,EL30,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.1,Rate
Attiki,EL30,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Attiki,EL30,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.1,Rate
Attiki,EL30,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.1,Rate
Attiki,EL30,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.03,Rate
Attiki,EL30,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,772.46,Rate
Voreio Aigaio,EL41,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,835.35,Rate
Voreio Aigaio,EL41,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,751.05,Rate
Voreio Aigaio,EL41,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,791.17,Rate
Voreio Aigaio,EL41,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,795.19,Rate
Voreio Aigaio,EL41,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,756.13,Rate
Voreio Aigaio,EL41,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,746.87,Rate
Voreio Aigaio,EL41,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,712.62,Rate
Voreio Aigaio,EL41,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,718.3,Rate
Voreio Aigaio,EL41,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,739.87,Rate
Voreio Aigaio,EL41,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.74,Rate
Voreio Aigaio,EL41,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.71,Rate
Voreio Aigaio,EL41,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.4,Rate
Voreio Aigaio,EL41,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.8,Rate
Voreio Aigaio,EL41,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.14,Rate
Voreio Aigaio,EL41,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.82,Rate
Voreio Aigaio,EL41,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.04,Rate
Voreio Aigaio,EL41,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.04,Rate
Voreio Aigaio,EL41,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.05,Rate
Voreio Aigaio,EL41,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.65,Rate
Voreio Aigaio,EL41,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",7.66,Rate
Voreio Aigaio,EL41,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",11.54,Rate
Voreio Aigaio,EL41,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.31,Rate
Voreio Aigaio,EL41,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",17.43,Rate
Voreio Aigaio,EL41,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",10.5,Rate
Voreio Aigaio,EL41,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",14.88,Rate
Voreio Aigaio,EL41,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",14.84,Rate
Voreio Aigaio,EL41,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",18.4,Rate
Voreio Aigaio,EL41,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",15.27,Rate
Voreio Aigaio,EL41,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",20.5,Rate
Voreio Aigaio,EL41,Total,Females,2011,Malignant melanoma of skin,2.68,Rate
Voreio Aigaio,EL41,Total,Females,2012,Malignant melanoma of skin,0.54,Rate
Voreio Aigaio,EL41,Total,Females,2013,Malignant melanoma of skin,0.74,Rate
Voreio Aigaio,EL41,Total,Females,2014,Malignant melanoma of skin,2.15,Rate
Voreio Aigaio,EL41,Total,Females,2015,Malignant melanoma of skin,0.8,Rate
Voreio Aigaio,EL41,Total,Females,2016,Malignant melanoma of skin,0.89,Rate
Voreio Aigaio,EL41,Total,Females,2017,Malignant melanoma of skin,2.2,Rate
Voreio Aigaio,EL41,Total,Females,2018,Malignant melanoma of skin,1.01,Rate
Voreio Aigaio,EL41,Total,Females,2020,Malignant melanoma of skin,0.8,Rate
Voreio Aigaio,EL41,Total,Females,2011,Malignant neoplasm of breast,28.2,Rate
Voreio Aigaio,EL41,Total,Females,2012,Malignant neoplasm of breast,21.22,Rate
Voreio Aigaio,EL41,Total,Females,2013,Malignant neoplasm of breast,29.8,Rate
Voreio Aigaio,EL41,Total,Females,2014,Malignant neoplasm of breast,28.28,Rate
Voreio Aigaio,EL41,Total,Females,2015,Malignant neoplasm of breast,26.78,Rate
Voreio Aigaio,EL41,Total,Females,2016,Malignant neoplasm of breast,32.17,Rate
Voreio Aigaio,EL41,Total,Females,2017,Malignant neoplasm of breast,24.13,Rate
Voreio Aigaio,EL41,Total,Females,2018,Malignant neoplasm of breast,31.66,Rate
Voreio Aigaio,EL41,Total,Females,2019,Malignant neoplasm of breast,24.1,Rate
Voreio Aigaio,EL41,Total,Females,2020,Malignant neoplasm of breast,31.7,Rate
Voreio Aigaio,EL41,Total,Females,2011,Diabetes mellitus,7.37,Rate
Voreio Aigaio,EL41,Total,Females,2012,Diabetes mellitus,7.03,Rate
Voreio Aigaio,EL41,Total,Females,2013,Diabetes mellitus,8.86,Rate
Voreio Aigaio,EL41,Total,Females,2014,Diabetes mellitus,11.87,Rate
Voreio Aigaio,EL41,Total,Females,2015,Diabetes mellitus,16.4,Rate
Voreio Aigaio,EL41,Total,Females,2016,Diabetes mellitus,8.33,Rate
Voreio Aigaio,EL41,Total,Females,2017,Diabetes mellitus,13.84,Rate
Voreio Aigaio,EL41,Total,Females,2018,Diabetes mellitus,11.18,Rate
Voreio Aigaio,EL41,Total,Females,2019,Diabetes mellitus,15.48,Rate
Voreio Aigaio,EL41,Total,Females,2020,Diabetes mellitus,15.88,Rate
Voreio Aigaio,EL41,Total,Females,2012,Mental and behavioural disorders (F00-F99),1.02,Rate
Voreio Aigaio,EL41,Total,Females,2014,Mental and behavioural disorders (F00-F99),4.64,Rate
Voreio Aigaio,EL41,Total,Females,2015,Mental and behavioural disorders (F00-F99),4.32,Rate
Voreio Aigaio,EL41,Total,Females,2016,Mental and behavioural disorders (F00-F99),7.67,Rate
Voreio Aigaio,EL41,Total,Females,2017,Mental and behavioural disorders (F00-F99),11.19,Rate
Voreio Aigaio,EL41,Total,Females,2018,Mental and behavioural disorders (F00-F99),14.19,Rate
Voreio Aigaio,EL41,Total,Females,2019,Mental and behavioural disorders (F00-F99),16.03,Rate
Voreio Aigaio,EL41,Total,Females,2020,Mental and behavioural disorders (F00-F99),11.89,Rate
Voreio Aigaio,EL41,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Voreio Aigaio,EL41,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Voreio Aigaio,EL41,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Voreio Aigaio,EL41,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.84,Rate
Voreio Aigaio,EL41,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.37,Rate
Voreio Aigaio,EL41,Total,Females,2011,Other ischaemic heart diseases,10.63,Rate
Voreio Aigaio,EL41,Total,Females,2012,Other ischaemic heart diseases,11.48,Rate
Voreio Aigaio,EL41,Total,Females,2013,Other ischaemic heart diseases,9.6,Rate
Voreio Aigaio,EL41,Total,Females,2014,Other ischaemic heart diseases,21.34,Rate
Voreio Aigaio,EL41,Total,Females,2015,Other ischaemic heart diseases,21.88,Rate
Voreio Aigaio,EL41,Total,Females,2016,Other ischaemic heart diseases,12.01,Rate
Voreio Aigaio,EL41,Total,Females,2017,Other ischaemic heart diseases,13.99,Rate
Voreio Aigaio,EL41,Total,Females,2018,Other ischaemic heart diseases,18.26,Rate
Voreio Aigaio,EL41,Total,Females,2019,Other ischaemic heart diseases,23.68,Rate
Voreio Aigaio,EL41,Total,Females,2020,Other ischaemic heart diseases,14.12,Rate
Voreio Aigaio,EL41,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,21.93,Rate
Voreio Aigaio,EL41,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,24.03,Rate
Voreio Aigaio,EL41,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,29.04,Rate
Voreio Aigaio,EL41,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,27.84,Rate
Voreio Aigaio,EL41,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,27.49,Rate
Voreio Aigaio,EL41,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,36.8,Rate
Voreio Aigaio,EL41,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,41.72,Rate
Voreio Aigaio,EL41,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,34.81,Rate
Voreio Aigaio,EL41,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,46.05,Rate
Voreio Aigaio,EL41,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,37.26,Rate
Voreio Aigaio,EL41,Total,Females,2011,Cerebrovascular diseases,106.44,Rate
Voreio Aigaio,EL41,Total,Females,2012,Cerebrovascular diseases,131.88,Rate
Voreio Aigaio,EL41,Total,Females,2013,Cerebrovascular diseases,100.69,Rate
Voreio Aigaio,EL41,Total,Females,2014,Cerebrovascular diseases,88.11,Rate
Voreio Aigaio,EL41,Total,Females,2015,Cerebrovascular diseases,94.6,Rate
Voreio Aigaio,EL41,Total,Females,2016,Cerebrovascular diseases,88.27,Rate
Voreio Aigaio,EL41,Total,Females,2017,Cerebrovascular diseases,82.14,Rate
Voreio Aigaio,EL41,Total,Females,2018,Cerebrovascular diseases,71.18,Rate
Voreio Aigaio,EL41,Total,Females,2019,Cerebrovascular diseases,82.27,Rate
Voreio Aigaio,EL41,Total,Females,2020,Cerebrovascular diseases,72.77,Rate
Voreio Aigaio,EL41,Total,Females,2011,Chronic lower respiratory diseases,12.88,Rate
Voreio Aigaio,EL41,Total,Females,2012,Chronic lower respiratory diseases,8.32,Rate
Voreio Aigaio,EL41,Total,Females,2013,Chronic lower respiratory diseases,7.05,Rate
Voreio Aigaio,EL41,Total,Females,2014,Chronic lower respiratory diseases,9.96,Rate
Voreio Aigaio,EL41,Total,Females,2015,Chronic lower respiratory diseases,11.43,Rate
Voreio Aigaio,EL41,Total,Females,2016,Chronic lower respiratory diseases,9.85,Rate
Voreio Aigaio,EL41,Total,Females,2017,Chronic lower respiratory diseases,10.6,Rate
Voreio Aigaio,EL41,Total,Females,2018,Chronic lower respiratory diseases,9.15,Rate
Voreio Aigaio,EL41,Total,Females,2019,Chronic lower respiratory diseases,7.48,Rate
Voreio Aigaio,EL41,Total,Females,2020,Chronic lower respiratory diseases,15.49,Rate
Voreio Aigaio,EL41,Total,Females,2012,Asthma and status asthmaticus,0.71,Rate
Voreio Aigaio,EL41,Total,Females,2013,Asthma and status asthmaticus,0.51,Rate
Voreio Aigaio,EL41,Total,Females,2019,Asthma and status asthmaticus,0.55,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3545.87,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3839.25,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3418.35,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3585.08,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3740.85,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3392.96,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3370.84,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3303.29,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3254.3,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3379.02,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.09,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.38,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.31,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.08,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",66.51,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.12,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.86,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.11,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.01,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.87,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",33.83,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",54.04,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",66.54,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",67.31,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",48.48,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",44.09,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",49.72,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",68.56,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",43.25,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",76.01,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Malignant melanoma of skin,13.74,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Malignant melanoma of skin,2.78,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Malignant melanoma of skin,3.79,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Malignant melanoma of skin,5.54,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Malignant melanoma of skin,4.1,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Malignant melanoma of skin,4.56,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Malignant melanoma of skin,5.98,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Malignant melanoma of skin,5.18,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Malignant melanoma of skin,4.11,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Malignant neoplasm of breast,116.98,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Malignant neoplasm of breast,65.59,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Malignant neoplasm of breast,92.3,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Malignant neoplasm of breast,96.37,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Malignant neoplasm of breast,115.58,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Malignant neoplasm of breast,79.69,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Malignant neoplasm of breast,92.0,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Malignant neoplasm of breast,115.38,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Malignant neoplasm of breast,73.32,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Malignant neoplasm of breast,127.92,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Diabetes mellitus,26.44,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Diabetes mellitus,24.97,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Diabetes mellitus,40.06,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Diabetes mellitus,50.05,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Diabetes mellitus,73.23,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Diabetes mellitus,37.43,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Diabetes mellitus,65.65,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Diabetes mellitus,57.35,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Diabetes mellitus,79.37,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Diabetes mellitus,71.23,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),5.22,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),23.8,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),22.13,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),39.33,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),52.07,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),67.59,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),77.23,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),55.97,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.88,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),4.31,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),4.24,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),7.17,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Other ischaemic heart diseases,43.29,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Other ischaemic heart diseases,47.56,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Other ischaemic heart diseases,49.22,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Other ischaemic heart diseases,82.09,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Other ischaemic heart diseases,106.72,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Other ischaemic heart diseases,45.45,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Other ischaemic heart diseases,66.6,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Other ischaemic heart diseases,73.09,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Other ischaemic heart diseases,111.37,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Other ischaemic heart diseases,67.54,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,68.5,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,97.21,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,127.06,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,131.75,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,124.87,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,162.03,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,182.27,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,168.23,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,216.11,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,161.34,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Cerebrovascular diseases,523.4,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Cerebrovascular diseases,654.49,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Cerebrovascular diseases,505.22,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Cerebrovascular diseases,419.33,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Cerebrovascular diseases,468.67,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Cerebrovascular diseases,430.85,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Cerebrovascular diseases,389.68,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Cerebrovascular diseases,350.07,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Cerebrovascular diseases,406.74,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Cerebrovascular diseases,363.45,Rate
Voreio Aigaio,EL41,65 years or over,Females,2011,Chronic lower respiratory diseases,49.88,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Chronic lower respiratory diseases,42.65,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Chronic lower respiratory diseases,30.47,Rate
Voreio Aigaio,EL41,65 years or over,Females,2014,Chronic lower respiratory diseases,51.1,Rate
Voreio Aigaio,EL41,65 years or over,Females,2015,Chronic lower respiratory diseases,53.24,Rate
Voreio Aigaio,EL41,65 years or over,Females,2016,Chronic lower respiratory diseases,50.51,Rate
Voreio Aigaio,EL41,65 years or over,Females,2017,Chronic lower respiratory diseases,43.95,Rate
Voreio Aigaio,EL41,65 years or over,Females,2018,Chronic lower respiratory diseases,41.74,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Chronic lower respiratory diseases,38.37,Rate
Voreio Aigaio,EL41,65 years or over,Females,2020,Chronic lower respiratory diseases,79.44,Rate
Voreio Aigaio,EL41,65 years or over,Females,2012,Asthma and status asthmaticus,3.66,Rate
Voreio Aigaio,EL41,65 years or over,Females,2013,Asthma and status asthmaticus,2.63,Rate
Voreio Aigaio,EL41,65 years or over,Females,2019,Asthma and status asthmaticus,2.84,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,100.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,107.69,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,104.94,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,114.38,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,81.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,117.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,111.25,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,85.07,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,103.99,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,100.57,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.46,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.93,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.48,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.78,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",1.32,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",1.24,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",6.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",5.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",1.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",7.8,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",6.39,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",6.25,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.5,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",7.05,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Malignant melanoma of skin,1.33,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Malignant melanoma of skin,1.28,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Malignant neoplasm of breast,6.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Malignant neoplasm of breast,10.47,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Malignant neoplasm of breast,14.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Malignant neoplasm of breast,11.78,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Malignant neoplasm of breast,5.27,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Malignant neoplasm of breast,20.65,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Malignant neoplasm of breast,7.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.38,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Malignant neoplasm of breast,12.18,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Malignant neoplasm of breast,8.39,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Diabetes mellitus,2.75,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Diabetes mellitus,2.68,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Diabetes mellitus,1.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Diabetes mellitus,2.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Diabetes mellitus,2.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Diabetes mellitus,1.28,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Diabetes mellitus,1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Diabetes mellitus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Diabetes mellitus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Diabetes mellitus,2.47,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.21,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.21,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.72,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.74,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Other ischaemic heart diseases,6.63,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.32,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.91,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.24,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Other ischaemic heart diseases,4.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.44,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.17,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,10.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,6.31,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.9,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,6.46,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,7.68,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.49,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.86,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,7.2,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Cerebrovascular diseases,5.44,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Cerebrovascular diseases,5.28,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Cerebrovascular diseases,2.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Cerebrovascular diseases,7.87,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Cerebrovascular diseases,3.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Cerebrovascular diseases,5.28,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Cerebrovascular diseases,7.65,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Cerebrovascular diseases,3.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Cerebrovascular diseases,3.67,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Cerebrovascular diseases,2.36,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2011,Chronic lower respiratory diseases,3.91,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Chronic lower respiratory diseases,1.38,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.52,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.25,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1198.68,Rate
Voreio Aigaio,EL41,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1291.29,Rate
Voreio Aigaio,EL41,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1185.89,Rate
Voreio Aigaio,EL41,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1149.19,Rate
Voreio Aigaio,EL41,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1188.04,Rate
Voreio Aigaio,EL41,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1125.72,Rate
Voreio Aigaio,EL41,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1161.06,Rate
Voreio Aigaio,EL41,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1090.64,Rate
Voreio Aigaio,EL41,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1056.15,Rate
Voreio Aigaio,EL41,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1069.39,Rate
Voreio Aigaio,EL41,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.9,Rate
Voreio Aigaio,EL41,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.05,Rate
Voreio Aigaio,EL41,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.53,Rate
Voreio Aigaio,EL41,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.03,Rate
Voreio Aigaio,EL41,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.39,Rate
Voreio Aigaio,EL41,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.65,Rate
Voreio Aigaio,EL41,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.6,Rate
Voreio Aigaio,EL41,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.09,Rate
Voreio Aigaio,EL41,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.85,Rate
Voreio Aigaio,EL41,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.03,Rate
Voreio Aigaio,EL41,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",114.04,Rate
Voreio Aigaio,EL41,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",88.05,Rate
Voreio Aigaio,EL41,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",110.72,Rate
Voreio Aigaio,EL41,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",95.96,Rate
Voreio Aigaio,EL41,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",111.84,Rate
Voreio Aigaio,EL41,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",106.26,Rate
Voreio Aigaio,EL41,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",103.48,Rate
Voreio Aigaio,EL41,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",94.26,Rate
Voreio Aigaio,EL41,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",93.42,Rate
Voreio Aigaio,EL41,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",99.68,Rate
Voreio Aigaio,EL41,Total,Males,2012,Malignant melanoma of skin,1.14,Rate
Voreio Aigaio,EL41,Total,Males,2013,Malignant melanoma of skin,4.58,Rate
Voreio Aigaio,EL41,Total,Males,2014,Malignant melanoma of skin,2.88,Rate
Voreio Aigaio,EL41,Total,Males,2015,Malignant melanoma of skin,3.17,Rate
Voreio Aigaio,EL41,Total,Males,2016,Malignant melanoma of skin,2.14,Rate
Voreio Aigaio,EL41,Total,Males,2017,Malignant melanoma of skin,4.84,Rate
Voreio Aigaio,EL41,Total,Males,2018,Malignant melanoma of skin,3.05,Rate
Voreio Aigaio,EL41,Total,Males,2019,Malignant melanoma of skin,0.89,Rate
Voreio Aigaio,EL41,Total,Males,2020,Malignant melanoma of skin,4.48,Rate
Voreio Aigaio,EL41,Total,Males,2011,Malignant neoplasm of breast,1.12,Rate
Voreio Aigaio,EL41,Total,Males,2012,Malignant neoplasm of breast,1.36,Rate
Voreio Aigaio,EL41,Total,Males,2013,Malignant neoplasm of breast,1.94,Rate
Voreio Aigaio,EL41,Total,Males,2014,Malignant neoplasm of breast,2.1,Rate
Voreio Aigaio,EL41,Total,Males,2018,Malignant neoplasm of breast,0.99,Rate
Voreio Aigaio,EL41,Total,Males,2011,Diabetes mellitus,6.74,Rate
Voreio Aigaio,EL41,Total,Males,2012,Diabetes mellitus,3.92,Rate
Voreio Aigaio,EL41,Total,Males,2013,Diabetes mellitus,14.85,Rate
Voreio Aigaio,EL41,Total,Males,2014,Diabetes mellitus,11.41,Rate
Voreio Aigaio,EL41,Total,Males,2015,Diabetes mellitus,17.23,Rate
Voreio Aigaio,EL41,Total,Males,2016,Diabetes mellitus,19.34,Rate
Voreio Aigaio,EL41,Total,Males,2017,Diabetes mellitus,16.69,Rate
Voreio Aigaio,EL41,Total,Males,2018,Diabetes mellitus,27.52,Rate
Voreio Aigaio,EL41,Total,Males,2019,Diabetes mellitus,18.08,Rate
Voreio Aigaio,EL41,Total,Males,2020,Diabetes mellitus,18.77,Rate
Voreio Aigaio,EL41,Total,Males,2012,Mental and behavioural disorders (F00-F99),2.09,Rate
Voreio Aigaio,EL41,Total,Males,2013,Mental and behavioural disorders (F00-F99),2.49,Rate
Voreio Aigaio,EL41,Total,Males,2014,Mental and behavioural disorders (F00-F99),3.05,Rate
Voreio Aigaio,EL41,Total,Males,2015,Mental and behavioural disorders (F00-F99),7.74,Rate
Voreio Aigaio,EL41,Total,Males,2016,Mental and behavioural disorders (F00-F99),5.9,Rate
Voreio Aigaio,EL41,Total,Males,2017,Mental and behavioural disorders (F00-F99),6.91,Rate
Voreio Aigaio,EL41,Total,Males,2018,Mental and behavioural disorders (F00-F99),10.87,Rate
Voreio Aigaio,EL41,Total,Males,2019,Mental and behavioural disorders (F00-F99),12.33,Rate
Voreio Aigaio,EL41,Total,Males,2020,Mental and behavioural disorders (F00-F99),13.05,Rate
Voreio Aigaio,EL41,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Voreio Aigaio,EL41,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Voreio Aigaio,EL41,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Voreio Aigaio,EL41,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Voreio Aigaio,EL41,Total,Males,2011,Other ischaemic heart diseases,24.64,Rate
Voreio Aigaio,EL41,Total,Males,2012,Other ischaemic heart diseases,26.51,Rate
Voreio Aigaio,EL41,Total,Males,2013,Other ischaemic heart diseases,37.89,Rate
Voreio Aigaio,EL41,Total,Males,2014,Other ischaemic heart diseases,35.14,Rate
Voreio Aigaio,EL41,Total,Males,2015,Other ischaemic heart diseases,42.38,Rate
Voreio Aigaio,EL41,Total,Males,2016,Other ischaemic heart diseases,38.25,Rate
Voreio Aigaio,EL41,Total,Males,2017,Other ischaemic heart diseases,38.47,Rate
Voreio Aigaio,EL41,Total,Males,2018,Other ischaemic heart diseases,54.55,Rate
Voreio Aigaio,EL41,Total,Males,2019,Other ischaemic heart diseases,48.4,Rate
Voreio Aigaio,EL41,Total,Males,2020,Other ischaemic heart diseases,41.61,Rate
Voreio Aigaio,EL41,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,55.11,Rate
Voreio Aigaio,EL41,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,80.25,Rate
Voreio Aigaio,EL41,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,63.92,Rate
Voreio Aigaio,EL41,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,81.23,Rate
Voreio Aigaio,EL41,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,76.15,Rate
Voreio Aigaio,EL41,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,91.08,Rate
Voreio Aigaio,EL41,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,97.3,Rate
Voreio Aigaio,EL41,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,71.58,Rate
Voreio Aigaio,EL41,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,80.46,Rate
Voreio Aigaio,EL41,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,58.97,Rate
Voreio Aigaio,EL41,Total,Males,2011,Cerebrovascular diseases,118.91,Rate
Voreio Aigaio,EL41,Total,Males,2012,Cerebrovascular diseases,143.75,Rate
Voreio Aigaio,EL41,Total,Males,2013,Cerebrovascular diseases,111.71,Rate
Voreio Aigaio,EL41,Total,Males,2014,Cerebrovascular diseases,99.53,Rate
Voreio Aigaio,EL41,Total,Males,2015,Cerebrovascular diseases,103.97,Rate
Voreio Aigaio,EL41,Total,Males,2016,Cerebrovascular diseases,81.74,Rate
Voreio Aigaio,EL41,Total,Males,2017,Cerebrovascular diseases,96.01,Rate
Voreio Aigaio,EL41,Total,Males,2018,Cerebrovascular diseases,92.32,Rate
Voreio Aigaio,EL41,Total,Males,2019,Cerebrovascular diseases,75.15,Rate
Voreio Aigaio,EL41,Total,Males,2020,Cerebrovascular diseases,92.77,Rate
Voreio Aigaio,EL41,Total,Males,2011,Chronic lower respiratory diseases,37.6,Rate
Voreio Aigaio,EL41,Total,Males,2012,Chronic lower respiratory diseases,40.56,Rate
Voreio Aigaio,EL41,Total,Males,2013,Chronic lower respiratory diseases,34.75,Rate
Voreio Aigaio,EL41,Total,Males,2014,Chronic lower respiratory diseases,42.73,Rate
Voreio Aigaio,EL41,Total,Males,2015,Chronic lower respiratory diseases,40.76,Rate
Voreio Aigaio,EL41,Total,Males,2016,Chronic lower respiratory diseases,48.02,Rate
Voreio Aigaio,EL41,Total,Males,2017,Chronic lower respiratory diseases,36.24,Rate
Voreio Aigaio,EL41,Total,Males,2018,Chronic lower respiratory diseases,34.37,Rate
Voreio Aigaio,EL41,Total,Males,2019,Chronic lower respiratory diseases,36.76,Rate
Voreio Aigaio,EL41,Total,Males,2020,Chronic lower respiratory diseases,23.62,Rate
Voreio Aigaio,EL41,Total,Males,2015,Asthma and status asthmaticus,1.1,Rate
Voreio Aigaio,EL41,Total,Males,2016,Asthma and status asthmaticus,1.79,Rate
Voreio Aigaio,EL41,Total,Males,2017,Asthma and status asthmaticus,1.08,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5150.47,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5519.18,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5048.49,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5009.5,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5101.65,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4854.94,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4859.74,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4691.03,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4495.64,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4613.61,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.89,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.23,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.44,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.79,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.84,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.68,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.86,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.33,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.81,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.15,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",437.3,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",320.79,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",427.81,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",380.22,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",455.62,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",439.17,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",393.31,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",354.85,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",369.73,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",408.41,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Malignant melanoma of skin,23.48,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Malignant melanoma of skin,9.15,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Malignant melanoma of skin,16.25,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Malignant melanoma of skin,10.97,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Malignant melanoma of skin,19.45,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Malignant melanoma of skin,10.26,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Malignant melanoma of skin,4.57,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Malignant melanoma of skin,14.43,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Malignant neoplasm of breast,5.75,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Malignant neoplasm of breast,6.95,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Malignant neoplasm of breast,9.96,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Malignant neoplasm of breast,10.75,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Malignant neoplasm of breast,5.09,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Diabetes mellitus,28.82,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Diabetes mellitus,10.44,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Diabetes mellitus,64.99,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Diabetes mellitus,36.21,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Diabetes mellitus,71.81,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Diabetes mellitus,87.88,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Diabetes mellitus,63.76,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Diabetes mellitus,130.46,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Diabetes mellitus,55.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Diabetes mellitus,75.41,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),4.87,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),7.32,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),15.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),11.6,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),24.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),30.07,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),55.72,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),47.6,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),66.93,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),8.72,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.54,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Other ischaemic heart diseases,93.22,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Other ischaemic heart diseases,126.07,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Other ischaemic heart diseases,155.59,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Other ischaemic heart diseases,152.19,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Other ischaemic heart diseases,178.2,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Other ischaemic heart diseases,165.2,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Other ischaemic heart diseases,137.18,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Other ischaemic heart diseases,199.62,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Other ischaemic heart diseases,194.47,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Other ischaemic heart diseases,156.72,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,138.5,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,284.55,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,179.03,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,310.12,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,272.38,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,313.93,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,334.49,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,254.77,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,319.05,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,230.57,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Cerebrovascular diseases,570.21,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Cerebrovascular diseases,647.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Cerebrovascular diseases,517.05,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Cerebrovascular diseases,482.41,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Cerebrovascular diseases,499.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Cerebrovascular diseases,391.26,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Cerebrovascular diseases,437.63,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Cerebrovascular diseases,414.38,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Cerebrovascular diseases,350.66,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Cerebrovascular diseases,450.15,Rate
Voreio Aigaio,EL41,65 years or over,Males,2011,Chronic lower respiratory diseases,192.81,Rate
Voreio Aigaio,EL41,65 years or over,Males,2012,Chronic lower respiratory diseases,196.88,Rate
Voreio Aigaio,EL41,65 years or over,Males,2013,Chronic lower respiratory diseases,178.21,Rate
Voreio Aigaio,EL41,65 years or over,Males,2014,Chronic lower respiratory diseases,219.1,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Chronic lower respiratory diseases,180.81,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Chronic lower respiratory diseases,240.77,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Chronic lower respiratory diseases,180.31,Rate
Voreio Aigaio,EL41,65 years or over,Males,2018,Chronic lower respiratory diseases,160.21,Rate
Voreio Aigaio,EL41,65 years or over,Males,2019,Chronic lower respiratory diseases,178.09,Rate
Voreio Aigaio,EL41,65 years or over,Males,2020,Chronic lower respiratory diseases,105.17,Rate
Voreio Aigaio,EL41,65 years or over,Males,2015,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,65 years or over,Males,2016,Asthma and status asthmaticus,9.16,Rate
Voreio Aigaio,EL41,65 years or over,Males,2017,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,241.41,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,267.14,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,250.23,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,214.09,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,240.02,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,222.37,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,265.11,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,218.49,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,222.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,210.85,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.38,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.93,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.36,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.89,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.21,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",35.73,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",31.67,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",33.91,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",27.11,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",28.57,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",25.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",33.27,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",31.14,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",26.49,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",24.89,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Malignant melanoma of skin,1.42,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Malignant melanoma of skin,1.37,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Malignant melanoma of skin,1.31,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Malignant melanoma of skin,1.31,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Malignant melanoma of skin,2.07,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Diabetes mellitus,1.39,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Diabetes mellitus,2.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Diabetes mellitus,2.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Diabetes mellitus,5.41,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Diabetes mellitus,4.01,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Diabetes mellitus,2.74,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Diabetes mellitus,5.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Diabetes mellitus,2.58,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Diabetes mellitus,8.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Diabetes mellitus,5.05,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),1.42,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.32,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),6.81,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),1.36,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),3.78,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Other ischaemic heart diseases,8.02,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Other ischaemic heart diseases,2.39,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Other ischaemic heart diseases,9.38,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Other ischaemic heart diseases,6.79,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Other ischaemic heart diseases,9.48,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Other ischaemic heart diseases,7.5,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Other ischaemic heart diseases,14.56,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Other ischaemic heart diseases,19.41,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Other ischaemic heart diseases,13.02,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Other ischaemic heart diseases,13.73,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,34.91,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,30.76,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,36.03,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,25.78,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,28.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,37.09,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,39.84,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,27.2,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,22.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,17.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Cerebrovascular diseases,9.59,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Cerebrovascular diseases,21.69,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Cerebrovascular diseases,13.53,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Cerebrovascular diseases,6.79,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Cerebrovascular diseases,8.12,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Cerebrovascular diseases,6.76,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Cerebrovascular diseases,13.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Cerebrovascular diseases,14.31,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Cerebrovascular diseases,8.41,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Cerebrovascular diseases,6.19,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2011,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2012,Chronic lower respiratory diseases,2.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2013,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Chronic lower respiratory diseases,6.84,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Chronic lower respiratory diseases,1.33,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Chronic lower respiratory diseases,1.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.89,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.53,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.87,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2015,Asthma and status asthmaticus,1.36,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Males,2017,Asthma and status asthmaticus,1.34,Rate
Voreio Aigaio,EL41,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,958.33,Rate
Voreio Aigaio,EL41,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1042.04,Rate
Voreio Aigaio,EL41,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,945.09,Rate
Voreio Aigaio,EL41,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,950.87,Rate
Voreio Aigaio,EL41,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,975.41,Rate
Voreio Aigaio,EL41,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,924.35,Rate
Voreio Aigaio,EL41,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,939.77,Rate
Voreio Aigaio,EL41,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,881.66,Rate
Voreio Aigaio,EL41,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,873.24,Rate
Voreio Aigaio,EL41,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,891.61,Rate
Voreio Aigaio,EL41,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.39,Rate
Voreio Aigaio,EL41,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.61,Rate
Voreio Aigaio,EL41,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.77,Rate
Voreio Aigaio,EL41,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.09,Rate
Voreio Aigaio,EL41,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.1,Rate
Voreio Aigaio,EL41,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.14,Rate
Voreio Aigaio,EL41,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.95,Rate
Voreio Aigaio,EL41,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.45,Rate
Voreio Aigaio,EL41,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.68,Rate
Voreio Aigaio,EL41,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.36,Rate
Voreio Aigaio,EL41,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",55.26,Rate
Voreio Aigaio,EL41,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",46.07,Rate
Voreio Aigaio,EL41,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",59.64,Rate
Voreio Aigaio,EL41,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",52.59,Rate
Voreio Aigaio,EL41,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",56.21,Rate
Voreio Aigaio,EL41,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",56.0,Rate
Voreio Aigaio,EL41,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",54.71,Rate
Voreio Aigaio,EL41,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",52.67,Rate
Voreio Aigaio,EL41,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",51.01,Rate
Voreio Aigaio,EL41,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",56.46,Rate
Voreio Aigaio,EL41,Total,Total,2011,Malignant melanoma of skin,1.45,Rate
Voreio Aigaio,EL41,Total,Total,2012,Malignant melanoma of skin,0.91,Rate
Voreio Aigaio,EL41,Total,Total,2013,Malignant melanoma of skin,2.38,Rate
Voreio Aigaio,EL41,Total,Total,2014,Malignant melanoma of skin,2.39,Rate
Voreio Aigaio,EL41,Total,Total,2015,Malignant melanoma of skin,1.88,Rate
Voreio Aigaio,EL41,Total,Total,2016,Malignant melanoma of skin,1.33,Rate
Voreio Aigaio,EL41,Total,Total,2017,Malignant melanoma of skin,3.37,Rate
Voreio Aigaio,EL41,Total,Total,2018,Malignant melanoma of skin,2.05,Rate
Voreio Aigaio,EL41,Total,Total,2019,Malignant melanoma of skin,0.42,Rate
Voreio Aigaio,EL41,Total,Total,2020,Malignant melanoma of skin,2.63,Rate
Voreio Aigaio,EL41,Total,Total,2011,Malignant neoplasm of breast,16.47,Rate
Voreio Aigaio,EL41,Total,Total,2012,Malignant neoplasm of breast,12.13,Rate
Voreio Aigaio,EL41,Total,Total,2013,Malignant neoplasm of breast,16.9,Rate
Voreio Aigaio,EL41,Total,Total,2014,Malignant neoplasm of breast,16.06,Rate
Voreio Aigaio,EL41,Total,Total,2015,Malignant neoplasm of breast,15.23,Rate
Voreio Aigaio,EL41,Total,Total,2016,Malignant neoplasm of breast,17.21,Rate
Voreio Aigaio,EL41,Total,Total,2017,Malignant neoplasm of breast,13.35,Rate
Voreio Aigaio,EL41,Total,Total,2018,Malignant neoplasm of breast,17.53,Rate
Voreio Aigaio,EL41,Total,Total,2019,Malignant neoplasm of breast,12.88,Rate
Voreio Aigaio,EL41,Total,Total,2020,Malignant neoplasm of breast,17.64,Rate
Voreio Aigaio,EL41,Total,Total,2011,Diabetes mellitus,6.91,Rate
Voreio Aigaio,EL41,Total,Total,2012,Diabetes mellitus,5.67,Rate
Voreio Aigaio,EL41,Total,Total,2013,Diabetes mellitus,11.52,Rate
Voreio Aigaio,EL41,Total,Total,2014,Diabetes mellitus,12.1,Rate
Voreio Aigaio,EL41,Total,Total,2015,Diabetes mellitus,17.04,Rate
Voreio Aigaio,EL41,Total,Total,2016,Diabetes mellitus,13.37,Rate
Voreio Aigaio,EL41,Total,Total,2017,Diabetes mellitus,15.39,Rate
Voreio Aigaio,EL41,Total,Total,2018,Diabetes mellitus,18.34,Rate
Voreio Aigaio,EL41,Total,Total,2019,Diabetes mellitus,17.52,Rate
Voreio Aigaio,EL41,Total,Total,2020,Diabetes mellitus,17.49,Rate
Voreio Aigaio,EL41,Total,Total,2012,Mental and behavioural disorders (F00-F99),1.52,Rate
Voreio Aigaio,EL41,Total,Total,2013,Mental and behavioural disorders (F00-F99),1.04,Rate
Voreio Aigaio,EL41,Total,Total,2014,Mental and behavioural disorders (F00-F99),3.91,Rate
Voreio Aigaio,EL41,Total,Total,2015,Mental and behavioural disorders (F00-F99),6.14,Rate
Voreio Aigaio,EL41,Total,Total,2016,Mental and behavioural disorders (F00-F99),7.09,Rate
Voreio Aigaio,EL41,Total,Total,2017,Mental and behavioural disorders (F00-F99),9.42,Rate
Voreio Aigaio,EL41,Total,Total,2018,Mental and behavioural disorders (F00-F99),12.66,Rate
Voreio Aigaio,EL41,Total,Total,2019,Mental and behavioural disorders (F00-F99),14.63,Rate
Voreio Aigaio,EL41,Total,Total,2020,Mental and behavioural disorders (F00-F99),12.7,Rate
Voreio Aigaio,EL41,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Voreio Aigaio,EL41,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Voreio Aigaio,EL41,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Voreio Aigaio,EL41,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Voreio Aigaio,EL41,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.72,Rate
Voreio Aigaio,EL41,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.67,Rate
Voreio Aigaio,EL41,Total,Total,2011,Other ischaemic heart diseases,16.77,Rate
Voreio Aigaio,EL41,Total,Total,2012,Other ischaemic heart diseases,17.98,Rate
Voreio Aigaio,EL41,Total,Total,2013,Other ischaemic heart diseases,22.29,Rate
Voreio Aigaio,EL41,Total,Total,2014,Other ischaemic heart diseases,27.95,Rate
Voreio Aigaio,EL41,Total,Total,2015,Other ischaemic heart diseases,31.14,Rate
Voreio Aigaio,EL41,Total,Total,2016,Other ischaemic heart diseases,23.87,Rate
Voreio Aigaio,EL41,Total,Total,2017,Other ischaemic heart diseases,24.89,Rate
Voreio Aigaio,EL41,Total,Total,2018,Other ischaemic heart diseases,34.63,Rate
Voreio Aigaio,EL41,Total,Total,2019,Other ischaemic heart diseases,34.89,Rate
Voreio Aigaio,EL41,Total,Total,2020,Other ischaemic heart diseases,27.01,Rate
Voreio Aigaio,EL41,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,37.68,Rate
Voreio Aigaio,EL41,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,49.64,Rate
Voreio Aigaio,EL41,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,46.17,Rate
Voreio Aigaio,EL41,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,51.79,Rate
Voreio Aigaio,EL41,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,50.24,Rate
Voreio Aigaio,EL41,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,62.31,Rate
Voreio Aigaio,EL41,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,68.11,Rate
Voreio Aigaio,EL41,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,51.25,Rate
Voreio Aigaio,EL41,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,61.88,Rate
Voreio Aigaio,EL41,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,47.93,Rate
Voreio Aigaio,EL41,Total,Total,2011,Cerebrovascular diseases,110.82,Rate
Voreio Aigaio,EL41,Total,Total,2012,Cerebrovascular diseases,138.79,Rate
Voreio Aigaio,EL41,Total,Total,2013,Cerebrovascular diseases,106.1,Rate
Voreio Aigaio,EL41,Total,Total,2014,Cerebrovascular diseases,93.45,Rate
Voreio Aigaio,EL41,Total,Total,2015,Cerebrovascular diseases,99.7,Rate
Voreio Aigaio,EL41,Total,Total,2016,Cerebrovascular diseases,85.52,Rate
Voreio Aigaio,EL41,Total,Total,2017,Cerebrovascular diseases,89.12,Rate
Voreio Aigaio,EL41,Total,Total,2018,Cerebrovascular diseases,82.24,Rate
Voreio Aigaio,EL41,Total,Total,2019,Cerebrovascular diseases,79.82,Rate
Voreio Aigaio,EL41,Total,Total,2020,Cerebrovascular diseases,82.41,Rate
Voreio Aigaio,EL41,Total,Total,2011,Chronic lower respiratory diseases,22.57,Rate
Voreio Aigaio,EL41,Total,Total,2012,Chronic lower respiratory diseases,21.37,Rate
Voreio Aigaio,EL41,Total,Total,2013,Chronic lower respiratory diseases,18.47,Rate
Voreio Aigaio,EL41,Total,Total,2014,Chronic lower respiratory diseases,22.95,Rate
Voreio Aigaio,EL41,Total,Total,2015,Chronic lower respiratory diseases,24.12,Rate
Voreio Aigaio,EL41,Total,Total,2016,Chronic lower respiratory diseases,26.13,Rate
Voreio Aigaio,EL41,Total,Total,2017,Chronic lower respiratory diseases,21.17,Rate
Voreio Aigaio,EL41,Total,Total,2018,Chronic lower respiratory diseases,19.34,Rate
Voreio Aigaio,EL41,Total,Total,2019,Chronic lower respiratory diseases,19.38,Rate
Voreio Aigaio,EL41,Total,Total,2020,Chronic lower respiratory diseases,19.13,Rate
Voreio Aigaio,EL41,Total,Total,2012,Asthma and status asthmaticus,0.41,Rate
Voreio Aigaio,EL41,Total,Total,2013,Asthma and status asthmaticus,0.3,Rate
Voreio Aigaio,EL41,Total,Total,2015,Asthma and status asthmaticus,0.54,Rate
Voreio Aigaio,EL41,Total,Total,2016,Asthma and status asthmaticus,0.77,Rate
Voreio Aigaio,EL41,Total,Total,2017,Asthma and status asthmaticus,0.53,Rate
Voreio Aigaio,EL41,Total,Total,2019,Asthma and status asthmaticus,0.36,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4207.18,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4566.17,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4111.32,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4195.92,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4343.64,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4039.8,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4042.93,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3899.57,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3803.3,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,3928.8,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.96,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",55.88,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.42,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.08,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.38,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",62.96,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.75,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.89,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.48,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",207.28,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",168.85,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",222.68,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",203.12,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",227.38,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",218.72,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",199.8,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",194.11,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",190.21,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",224.51,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Malignant melanoma of skin,7.43,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Malignant melanoma of skin,1.71,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Malignant melanoma of skin,12.23,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Malignant melanoma of skin,6.7,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Malignant melanoma of skin,9.65,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Malignant melanoma of skin,6.84,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Malignant melanoma of skin,11.94,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Malignant melanoma of skin,7.87,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Malignant melanoma of skin,2.16,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Malignant melanoma of skin,8.86,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Malignant neoplasm of breast,70.62,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Malignant neoplasm of breast,40.43,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Malignant neoplasm of breast,56.13,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Malignant neoplasm of breast,57.73,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Malignant neoplasm of breast,67.01,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Malignant neoplasm of breast,44.75,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Malignant neoplasm of breast,52.22,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Malignant neoplasm of breast,66.51,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Malignant neoplasm of breast,40.52,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Malignant neoplasm of breast,72.73,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Diabetes mellitus,26.98,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Diabetes mellitus,18.79,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Diabetes mellitus,50.84,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Diabetes mellitus,45.5,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Diabetes mellitus,73.77,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Diabetes mellitus,60.29,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Diabetes mellitus,65.57,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Diabetes mellitus,88.86,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Diabetes mellitus,71.7,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Diabetes mellitus,74.49,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),4.88,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),2.64,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),20.07,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),17.76,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),33.62,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),42.98,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),62.27,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),64.84,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),62.58,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.5,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.36,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),6.16,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),6.05,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Other ischaemic heart diseases,63.96,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Other ischaemic heart diseases,81.33,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Other ischaemic heart diseases,95.14,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Other ischaemic heart diseases,115.66,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Other ischaemic heart diseases,137.67,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Other ischaemic heart diseases,98.52,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Other ischaemic heart diseases,95.64,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Other ischaemic heart diseases,127.95,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Other ischaemic heart diseases,146.4,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Other ischaemic heart diseases,108.25,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,99.02,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,178.29,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,151.9,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,207.41,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,191.42,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,230.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,252.7,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,202.72,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,261.22,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,195.21,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Cerebrovascular diseases,537.27,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Cerebrovascular diseases,655.44,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Cerebrovascular diseases,510.86,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Cerebrovascular diseases,448.91,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Cerebrovascular diseases,486.4,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Cerebrovascular diseases,413.89,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Cerebrovascular diseases,414.08,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Cerebrovascular diseases,385.18,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Cerebrovascular diseases,384.15,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Cerebrovascular diseases,405.19,Rate
Voreio Aigaio,EL41,65 years or over,Total,2011,Chronic lower respiratory diseases,107.68,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Chronic lower respiratory diseases,104.03,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Chronic lower respiratory diseases,91.83,Rate
Voreio Aigaio,EL41,65 years or over,Total,2014,Chronic lower respiratory diseases,117.71,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Chronic lower respiratory diseases,107.03,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Chronic lower respiratory diseases,131.33,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Chronic lower respiratory diseases,100.49,Rate
Voreio Aigaio,EL41,65 years or over,Total,2018,Chronic lower respiratory diseases,88.65,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Chronic lower respiratory diseases,94.3,Rate
Voreio Aigaio,EL41,65 years or over,Total,2020,Chronic lower respiratory diseases,90.32,Rate
Voreio Aigaio,EL41,65 years or over,Total,2012,Asthma and status asthmaticus,2.09,Rate
Voreio Aigaio,EL41,65 years or over,Total,2013,Asthma and status asthmaticus,1.54,Rate
Voreio Aigaio,EL41,65 years or over,Total,2015,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2016,Asthma and status asthmaticus,3.97,Rate
Voreio Aigaio,EL41,65 years or over,Total,2017,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,65 years or over,Total,2019,Asthma and status asthmaticus,1.83,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,171.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,188.37,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,178.12,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,164.8,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,159.51,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,169.68,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,188.07,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,150.62,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,163.47,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,155.89,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.42,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.61,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.02,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.37,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.67,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.56,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.9,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.91,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.49,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",18.43,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",16.33,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",20.15,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",16.12,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",14.75,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.58,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",19.57,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",18.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",17.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.75,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Malignant melanoma of skin,0.71,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Malignant melanoma of skin,1.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Malignant melanoma of skin,1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Malignant melanoma of skin,0.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Malignant melanoma of skin,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Malignant melanoma of skin,1.13,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Malignant neoplasm of breast,3.36,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Malignant neoplasm of breast,5.27,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Malignant neoplasm of breast,5.97,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Malignant neoplasm of breast,2.69,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Malignant neoplasm of breast,10.54,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Malignant neoplasm of breast,3.93,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.19,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Diabetes mellitus,2.05,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Diabetes mellitus,2.49,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Diabetes mellitus,1.99,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Diabetes mellitus,4.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Diabetes mellitus,3.3,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Diabetes mellitus,2.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Diabetes mellitus,3.24,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Diabetes mellitus,1.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Diabetes mellitus,4.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Diabetes mellitus,3.68,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.71,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),3.33,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.67,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),0.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.47,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),0.61,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Other ischaemic heart diseases,5.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.63,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Other ischaemic heart diseases,4.65,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.7,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Other ischaemic heart diseases,5.78,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.75,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Other ischaemic heart diseases,12.02,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.88,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Other ischaemic heart diseases,7.33,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,22.83,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,18.47,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,20.56,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,14.1,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,16.04,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,21.69,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,23.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,14.56,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,13.6,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,12.26,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Cerebrovascular diseases,7.52,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Cerebrovascular diseases,13.64,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Cerebrovascular diseases,8.06,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Cerebrovascular diseases,7.35,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Cerebrovascular diseases,6.03,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Cerebrovascular diseases,5.98,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Cerebrovascular diseases,10.4,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Cerebrovascular diseases,8.86,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Cerebrovascular diseases,6.1,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Cerebrovascular diseases,4.23,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.95,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Chronic lower respiratory diseases,1.34,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Chronic lower respiratory diseases,0.69,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Chronic lower respiratory diseases,4.04,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Chronic lower respiratory diseases,0.65,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.95,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.55,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.24,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.89,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.67,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.66,Rate
Voreio Aigaio,EL41,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
Notio Aigaio,EL42,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,858.66,Rate
Notio Aigaio,EL42,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,861.64,Rate
Notio Aigaio,EL42,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,801.87,Rate
Notio Aigaio,EL42,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,835.99,Rate
Notio Aigaio,EL42,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,818.51,Rate
Notio Aigaio,EL42,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,813.57,Rate
Notio Aigaio,EL42,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,773.83,Rate
Notio Aigaio,EL42,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,731.93,Rate
Notio Aigaio,EL42,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,813.8,Rate
Notio Aigaio,EL42,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,823.04,Rate
Notio Aigaio,EL42,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.62,Rate
Notio Aigaio,EL42,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.23,Rate
Notio Aigaio,EL42,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.98,Rate
Notio Aigaio,EL42,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.2,Rate
Notio Aigaio,EL42,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.06,Rate
Notio Aigaio,EL42,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.68,Rate
Notio Aigaio,EL42,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.43,Rate
Notio Aigaio,EL42,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.0,Rate
Notio Aigaio,EL42,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.47,Rate
Notio Aigaio,EL42,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.87,Rate
Notio Aigaio,EL42,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",14.65,Rate
Notio Aigaio,EL42,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.56,Rate
Notio Aigaio,EL42,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",15.22,Rate
Notio Aigaio,EL42,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",21.36,Rate
Notio Aigaio,EL42,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",17.9,Rate
Notio Aigaio,EL42,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",15.96,Rate
Notio Aigaio,EL42,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",16.73,Rate
Notio Aigaio,EL42,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",18.45,Rate
Notio Aigaio,EL42,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",19.47,Rate
Notio Aigaio,EL42,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",15.67,Rate
Notio Aigaio,EL42,Total,Females,2011,Malignant melanoma of skin,2.12,Rate
Notio Aigaio,EL42,Total,Females,2012,Malignant melanoma of skin,2.15,Rate
Notio Aigaio,EL42,Total,Females,2013,Malignant melanoma of skin,2.94,Rate
Notio Aigaio,EL42,Total,Females,2014,Malignant melanoma of skin,0.57,Rate
Notio Aigaio,EL42,Total,Females,2015,Malignant melanoma of skin,1.09,Rate
Notio Aigaio,EL42,Total,Females,2016,Malignant melanoma of skin,1.28,Rate
Notio Aigaio,EL42,Total,Females,2017,Malignant melanoma of skin,1.2,Rate
Notio Aigaio,EL42,Total,Females,2018,Malignant melanoma of skin,3.05,Rate
Notio Aigaio,EL42,Total,Females,2019,Malignant melanoma of skin,1.14,Rate
Notio Aigaio,EL42,Total,Females,2020,Malignant melanoma of skin,1.24,Rate
Notio Aigaio,EL42,Total,Females,2011,Malignant neoplasm of breast,25.51,Rate
Notio Aigaio,EL42,Total,Females,2012,Malignant neoplasm of breast,25.73,Rate
Notio Aigaio,EL42,Total,Females,2013,Malignant neoplasm of breast,29.51,Rate
Notio Aigaio,EL42,Total,Females,2014,Malignant neoplasm of breast,26.48,Rate
Notio Aigaio,EL42,Total,Females,2015,Malignant neoplasm of breast,30.54,Rate
Notio Aigaio,EL42,Total,Females,2016,Malignant neoplasm of breast,33.45,Rate
Notio Aigaio,EL42,Total,Females,2017,Malignant neoplasm of breast,26.54,Rate
Notio Aigaio,EL42,Total,Females,2018,Malignant neoplasm of breast,32.38,Rate
Notio Aigaio,EL42,Total,Females,2019,Malignant neoplasm of breast,32.56,Rate
Notio Aigaio,EL42,Total,Females,2020,Malignant neoplasm of breast,30.43,Rate
Notio Aigaio,EL42,Total,Females,2011,Diabetes mellitus,8.88,Rate
Notio Aigaio,EL42,Total,Females,2012,Diabetes mellitus,9.78,Rate
Notio Aigaio,EL42,Total,Females,2013,Diabetes mellitus,15.17,Rate
Notio Aigaio,EL42,Total,Females,2014,Diabetes mellitus,15.31,Rate
Notio Aigaio,EL42,Total,Females,2015,Diabetes mellitus,16.23,Rate
Notio Aigaio,EL42,Total,Females,2016,Diabetes mellitus,23.99,Rate
Notio Aigaio,EL42,Total,Females,2017,Diabetes mellitus,16.05,Rate
Notio Aigaio,EL42,Total,Females,2018,Diabetes mellitus,16.95,Rate
Notio Aigaio,EL42,Total,Females,2019,Diabetes mellitus,21.96,Rate
Notio Aigaio,EL42,Total,Females,2020,Diabetes mellitus,17.26,Rate
Notio Aigaio,EL42,Total,Females,2011,Mental and behavioural disorders (F00-F99),1.1,Rate
Notio Aigaio,EL42,Total,Females,2012,Mental and behavioural disorders (F00-F99),1.34,Rate
Notio Aigaio,EL42,Total,Females,2013,Mental and behavioural disorders (F00-F99),3.49,Rate
Notio Aigaio,EL42,Total,Females,2014,Mental and behavioural disorders (F00-F99),11.79,Rate
Notio Aigaio,EL42,Total,Females,2015,Mental and behavioural disorders (F00-F99),5.54,Rate
Notio Aigaio,EL42,Total,Females,2016,Mental and behavioural disorders (F00-F99),14.13,Rate
Notio Aigaio,EL42,Total,Females,2017,Mental and behavioural disorders (F00-F99),14.31,Rate
Notio Aigaio,EL42,Total,Females,2018,Mental and behavioural disorders (F00-F99),16.87,Rate
Notio Aigaio,EL42,Total,Females,2019,Mental and behavioural disorders (F00-F99),28.03,Rate
Notio Aigaio,EL42,Total,Females,2020,Mental and behavioural disorders (F00-F99),16.18,Rate
Notio Aigaio,EL42,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Notio Aigaio,EL42,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Notio Aigaio,EL42,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.69,Rate
Notio Aigaio,EL42,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.05,Rate
Notio Aigaio,EL42,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.64,Rate
Notio Aigaio,EL42,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.73,Rate
Notio Aigaio,EL42,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Notio Aigaio,EL42,Total,Females,2011,Other ischaemic heart diseases,25.79,Rate
Notio Aigaio,EL42,Total,Females,2012,Other ischaemic heart diseases,31.57,Rate
Notio Aigaio,EL42,Total,Females,2013,Other ischaemic heart diseases,30.79,Rate
Notio Aigaio,EL42,Total,Females,2014,Other ischaemic heart diseases,39.18,Rate
Notio Aigaio,EL42,Total,Females,2015,Other ischaemic heart diseases,40.35,Rate
Notio Aigaio,EL42,Total,Females,2016,Other ischaemic heart diseases,29.41,Rate
Notio Aigaio,EL42,Total,Females,2017,Other ischaemic heart diseases,32.65,Rate
Notio Aigaio,EL42,Total,Females,2018,Other ischaemic heart diseases,36.73,Rate
Notio Aigaio,EL42,Total,Females,2019,Other ischaemic heart diseases,35.64,Rate
Notio Aigaio,EL42,Total,Females,2020,Other ischaemic heart diseases,42.28,Rate
Notio Aigaio,EL42,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,38.82,Rate
Notio Aigaio,EL42,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,30.37,Rate
Notio Aigaio,EL42,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,30.2,Rate
Notio Aigaio,EL42,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,23.86,Rate
Notio Aigaio,EL42,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,22.07,Rate
Notio Aigaio,EL42,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,31.12,Rate
Notio Aigaio,EL42,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,22.15,Rate
Notio Aigaio,EL42,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,26.21,Rate
Notio Aigaio,EL42,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.12,Rate
Notio Aigaio,EL42,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,27.7,Rate
Notio Aigaio,EL42,Total,Females,2011,Cerebrovascular diseases,95.47,Rate
Notio Aigaio,EL42,Total,Females,2012,Cerebrovascular diseases,124.04,Rate
Notio Aigaio,EL42,Total,Females,2013,Cerebrovascular diseases,126.14,Rate
Notio Aigaio,EL42,Total,Females,2014,Cerebrovascular diseases,120.55,Rate
Notio Aigaio,EL42,Total,Females,2015,Cerebrovascular diseases,95.52,Rate
Notio Aigaio,EL42,Total,Females,2016,Cerebrovascular diseases,104.15,Rate
Notio Aigaio,EL42,Total,Females,2017,Cerebrovascular diseases,96.8,Rate
Notio Aigaio,EL42,Total,Females,2018,Cerebrovascular diseases,81.56,Rate
Notio Aigaio,EL42,Total,Females,2019,Cerebrovascular diseases,89.94,Rate
Notio Aigaio,EL42,Total,Females,2020,Cerebrovascular diseases,100.16,Rate
Notio Aigaio,EL42,Total,Females,2011,Chronic lower respiratory diseases,15.8,Rate
Notio Aigaio,EL42,Total,Females,2012,Chronic lower respiratory diseases,11.73,Rate
Notio Aigaio,EL42,Total,Females,2013,Chronic lower respiratory diseases,9.79,Rate
Notio Aigaio,EL42,Total,Females,2014,Chronic lower respiratory diseases,15.16,Rate
Notio Aigaio,EL42,Total,Females,2015,Chronic lower respiratory diseases,17.11,Rate
Notio Aigaio,EL42,Total,Females,2016,Chronic lower respiratory diseases,11.16,Rate
Notio Aigaio,EL42,Total,Females,2017,Chronic lower respiratory diseases,14.42,Rate
Notio Aigaio,EL42,Total,Females,2018,Chronic lower respiratory diseases,15.27,Rate
Notio Aigaio,EL42,Total,Females,2019,Chronic lower respiratory diseases,13.12,Rate
Notio Aigaio,EL42,Total,Females,2020,Chronic lower respiratory diseases,17.4,Rate
Notio Aigaio,EL42,Total,Females,2017,Asthma and status asthmaticus,0.55,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3973.13,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4004.59,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3741.62,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3875.63,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3785.1,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3745.39,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3591.38,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3376.55,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3764.35,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3755.73,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.3,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",60.67,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",66.13,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.85,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.26,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.61,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.82,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.87,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.58,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.24,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",56.14,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",63.1,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",39.63,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",74.77,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",66.91,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",60.28,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",52.51,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",64.39,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",70.29,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",60.92,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Malignant melanoma of skin,7.41,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Malignant melanoma of skin,11.01,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Malignant melanoma of skin,6.59,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Malignant melanoma of skin,2.92,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Malignant melanoma of skin,2.93,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Malignant melanoma of skin,6.57,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Malignant melanoma of skin,12.66,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Malignant melanoma of skin,2.89,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Malignant neoplasm of breast,89.85,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Malignant neoplasm of breast,104.82,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Malignant neoplasm of breast,97.73,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Malignant neoplasm of breast,87.12,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Malignant neoplasm of breast,98.63,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Malignant neoplasm of breast,101.74,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Malignant neoplasm of breast,103.07,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Malignant neoplasm of breast,124.82,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Malignant neoplasm of breast,123.82,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Malignant neoplasm of breast,107.96,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Diabetes mellitus,39.02,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Diabetes mellitus,43.72,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Diabetes mellitus,64.8,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Diabetes mellitus,72.12,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Diabetes mellitus,73.72,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Diabetes mellitus,110.95,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Diabetes mellitus,79.24,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Diabetes mellitus,86.92,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Diabetes mellitus,100.82,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Diabetes mellitus,85.6,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),3.02,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),6.88,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),17.89,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),54.92,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),22.42,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),69.33,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),70.26,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),83.23,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),138.04,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),77.25,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.85,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),5.55,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),7.38,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),8.3,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Other ischaemic heart diseases,122.63,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Other ischaemic heart diseases,152.36,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Other ischaemic heart diseases,145.25,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Other ischaemic heart diseases,197.75,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Other ischaemic heart diseases,200.93,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Other ischaemic heart diseases,137.49,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Other ischaemic heart diseases,164.41,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Other ischaemic heart diseases,182.34,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Other ischaemic heart diseases,173.84,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Other ischaemic heart diseases,196.87,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,177.32,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,127.5,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,136.23,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,97.86,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,100.48,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,144.28,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,102.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,126.3,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,108.95,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,127.61,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Cerebrovascular diseases,470.67,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Cerebrovascular diseases,620.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Cerebrovascular diseases,630.92,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Cerebrovascular diseases,606.0,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Cerebrovascular diseases,471.78,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Cerebrovascular diseases,522.51,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Cerebrovascular diseases,472.48,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Cerebrovascular diseases,406.21,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Cerebrovascular diseases,437.95,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Cerebrovascular diseases,502.41,Rate
Notio Aigaio,EL42,65 years or over,Females,2011,Chronic lower respiratory diseases,77.54,Rate
Notio Aigaio,EL42,65 years or over,Females,2012,Chronic lower respiratory diseases,60.14,Rate
Notio Aigaio,EL42,65 years or over,Females,2013,Chronic lower respiratory diseases,43.51,Rate
Notio Aigaio,EL42,65 years or over,Females,2014,Chronic lower respiratory diseases,77.74,Rate
Notio Aigaio,EL42,65 years or over,Females,2015,Chronic lower respiratory diseases,84.58,Rate
Notio Aigaio,EL42,65 years or over,Females,2016,Chronic lower respiratory diseases,54.07,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Chronic lower respiratory diseases,70.8,Rate
Notio Aigaio,EL42,65 years or over,Females,2018,Chronic lower respiratory diseases,72.29,Rate
Notio Aigaio,EL42,65 years or over,Females,2019,Chronic lower respiratory diseases,67.26,Rate
Notio Aigaio,EL42,65 years or over,Females,2020,Chronic lower respiratory diseases,86.33,Rate
Notio Aigaio,EL42,65 years or over,Females,2017,Asthma and status asthmaticus,2.8,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,104.22,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,100.3,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,89.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,99.68,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,99.9,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,103.38,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,91.32,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,91.31,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,99.07,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,112.64,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.68,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.98,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.83,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.55,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.41,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.4,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.31,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.49,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.9,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.43,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",4.6,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",5.29,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",9.3,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",8.42,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",6.02,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",5.22,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",8.06,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",7.32,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",7.16,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",4.7,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Malignant melanoma of skin,0.84,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Malignant melanoma of skin,2.06,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Malignant melanoma of skin,0.64,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Malignant melanoma of skin,1.49,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Malignant melanoma of skin,0.72,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Malignant melanoma of skin,0.72,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Malignant melanoma of skin,1.54,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Malignant neoplasm of breast,9.93,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Malignant neoplasm of breast,6.58,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Malignant neoplasm of breast,12.99,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Malignant neoplasm of breast,11.8,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Malignant neoplasm of breast,14.05,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Malignant neoplasm of breast,16.91,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Malignant neoplasm of breast,7.99,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Malignant neoplasm of breast,9.99,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Malignant neoplasm of breast,10.45,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Malignant neoplasm of breast,11.65,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Diabetes mellitus,1.59,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Diabetes mellitus,1.55,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Diabetes mellitus,3.15,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Diabetes mellitus,1.55,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Diabetes mellitus,2.3,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Diabetes mellitus,2.93,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Diabetes mellitus,0.74,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Diabetes mellitus,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Diabetes mellitus,2.86,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Diabetes mellitus,0.71,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.63,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.34,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.45,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.79,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.38,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.38,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Other ischaemic heart diseases,2.33,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Other ischaemic heart diseases,2.31,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Other ischaemic heart diseases,3.06,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.77,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.45,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.23,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.73,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.46,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.16,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Other ischaemic heart diseases,4.83,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.27,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,6.84,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.52,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,5.94,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.08,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.71,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.8,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.97,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.82,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.5,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Cerebrovascular diseases,4.58,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Cerebrovascular diseases,3.9,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Cerebrovascular diseases,3.87,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Cerebrovascular diseases,2.96,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Cerebrovascular diseases,4.37,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Cerebrovascular diseases,2.81,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Cerebrovascular diseases,5.8,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Cerebrovascular diseases,2.92,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Cerebrovascular diseases,5.64,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Cerebrovascular diseases,2.72,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.84,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2013,Chronic lower respiratory diseases,1.62,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.77,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.46,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.7,Rate
Notio Aigaio,EL42,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Notio Aigaio,EL42,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1263.45,Rate
Notio Aigaio,EL42,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1178.31,Rate
Notio Aigaio,EL42,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1088.38,Rate
Notio Aigaio,EL42,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1138.43,Rate
Notio Aigaio,EL42,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1136.98,Rate
Notio Aigaio,EL42,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1071.23,Rate
Notio Aigaio,EL42,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1114.14,Rate
Notio Aigaio,EL42,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1036.28,Rate
Notio Aigaio,EL42,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1011.33,Rate
Notio Aigaio,EL42,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1005.49,Rate
Notio Aigaio,EL42,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.68,Rate
Notio Aigaio,EL42,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.83,Rate
Notio Aigaio,EL42,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.09,Rate
Notio Aigaio,EL42,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.74,Rate
Notio Aigaio,EL42,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.7,Rate
Notio Aigaio,EL42,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.06,Rate
Notio Aigaio,EL42,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.07,Rate
Notio Aigaio,EL42,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.66,Rate
Notio Aigaio,EL42,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.9,Rate
Notio Aigaio,EL42,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.21,Rate
Notio Aigaio,EL42,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",97.2,Rate
Notio Aigaio,EL42,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",108.46,Rate
Notio Aigaio,EL42,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",100.98,Rate
Notio Aigaio,EL42,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",100.67,Rate
Notio Aigaio,EL42,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",113.27,Rate
Notio Aigaio,EL42,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",95.67,Rate
Notio Aigaio,EL42,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",99.43,Rate
Notio Aigaio,EL42,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",97.41,Rate
Notio Aigaio,EL42,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",88.09,Rate
Notio Aigaio,EL42,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",85.71,Rate
Notio Aigaio,EL42,Total,Males,2011,Malignant melanoma of skin,1.87,Rate
Notio Aigaio,EL42,Total,Males,2012,Malignant melanoma of skin,2.13,Rate
Notio Aigaio,EL42,Total,Males,2013,Malignant melanoma of skin,2.68,Rate
Notio Aigaio,EL42,Total,Males,2014,Malignant melanoma of skin,1.26,Rate
Notio Aigaio,EL42,Total,Males,2015,Malignant melanoma of skin,4.1,Rate
Notio Aigaio,EL42,Total,Males,2016,Malignant melanoma of skin,0.63,Rate
Notio Aigaio,EL42,Total,Males,2018,Malignant melanoma of skin,1.79,Rate
Notio Aigaio,EL42,Total,Males,2019,Malignant melanoma of skin,3.27,Rate
Notio Aigaio,EL42,Total,Males,2020,Malignant melanoma of skin,1.97,Rate
Notio Aigaio,EL42,Total,Males,2012,Malignant neoplasm of breast,0.68,Rate
Notio Aigaio,EL42,Total,Males,2017,Malignant neoplasm of breast,0.63,Rate
Notio Aigaio,EL42,Total,Males,2011,Diabetes mellitus,14.09,Rate
Notio Aigaio,EL42,Total,Males,2012,Diabetes mellitus,16.39,Rate
Notio Aigaio,EL42,Total,Males,2013,Diabetes mellitus,8.02,Rate
Notio Aigaio,EL42,Total,Males,2014,Diabetes mellitus,21.87,Rate
Notio Aigaio,EL42,Total,Males,2015,Diabetes mellitus,15.81,Rate
Notio Aigaio,EL42,Total,Males,2016,Diabetes mellitus,14.04,Rate
Notio Aigaio,EL42,Total,Males,2017,Diabetes mellitus,21.57,Rate
Notio Aigaio,EL42,Total,Males,2018,Diabetes mellitus,20.19,Rate
Notio Aigaio,EL42,Total,Males,2019,Diabetes mellitus,15.41,Rate
Notio Aigaio,EL42,Total,Males,2020,Diabetes mellitus,15.87,Rate
Notio Aigaio,EL42,Total,Males,2011,Mental and behavioural disorders (F00-F99),0.9,Rate
Notio Aigaio,EL42,Total,Males,2012,Mental and behavioural disorders (F00-F99),4.69,Rate
Notio Aigaio,EL42,Total,Males,2013,Mental and behavioural disorders (F00-F99),2.6,Rate
Notio Aigaio,EL42,Total,Males,2014,Mental and behavioural disorders (F00-F99),4.42,Rate
Notio Aigaio,EL42,Total,Males,2015,Mental and behavioural disorders (F00-F99),11.05,Rate
Notio Aigaio,EL42,Total,Males,2016,Mental and behavioural disorders (F00-F99),5.28,Rate
Notio Aigaio,EL42,Total,Males,2017,Mental and behavioural disorders (F00-F99),13.4,Rate
Notio Aigaio,EL42,Total,Males,2018,Mental and behavioural disorders (F00-F99),19.39,Rate
Notio Aigaio,EL42,Total,Males,2019,Mental and behavioural disorders (F00-F99),12.7,Rate
Notio Aigaio,EL42,Total,Males,2020,Mental and behavioural disorders (F00-F99),18.9,Rate
Notio Aigaio,EL42,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Notio Aigaio,EL42,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.55,Rate
Notio Aigaio,EL42,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Notio Aigaio,EL42,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.76,Rate
Notio Aigaio,EL42,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.18,Rate
Notio Aigaio,EL42,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.36,Rate
Notio Aigaio,EL42,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),3.74,Rate
Notio Aigaio,EL42,Total,Males,2011,Other ischaemic heart diseases,48.67,Rate
Notio Aigaio,EL42,Total,Males,2012,Other ischaemic heart diseases,49.48,Rate
Notio Aigaio,EL42,Total,Males,2013,Other ischaemic heart diseases,54.92,Rate
Notio Aigaio,EL42,Total,Males,2014,Other ischaemic heart diseases,63.66,Rate
Notio Aigaio,EL42,Total,Males,2015,Other ischaemic heart diseases,55.18,Rate
Notio Aigaio,EL42,Total,Males,2016,Other ischaemic heart diseases,66.0,Rate
Notio Aigaio,EL42,Total,Males,2017,Other ischaemic heart diseases,59.42,Rate
Notio Aigaio,EL42,Total,Males,2018,Other ischaemic heart diseases,61.03,Rate
Notio Aigaio,EL42,Total,Males,2019,Other ischaemic heart diseases,70.97,Rate
Notio Aigaio,EL42,Total,Males,2020,Other ischaemic heart diseases,76.35,Rate
Notio Aigaio,EL42,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,86.98,Rate
Notio Aigaio,EL42,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,78.13,Rate
Notio Aigaio,EL42,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,59.81,Rate
Notio Aigaio,EL42,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,60.73,Rate
Notio Aigaio,EL42,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,67.06,Rate
Notio Aigaio,EL42,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,50.62,Rate
Notio Aigaio,EL42,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,54.82,Rate
Notio Aigaio,EL42,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,53.2,Rate
Notio Aigaio,EL42,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,69.08,Rate
Notio Aigaio,EL42,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,56.9,Rate
Notio Aigaio,EL42,Total,Males,2011,Cerebrovascular diseases,110.06,Rate
Notio Aigaio,EL42,Total,Males,2012,Cerebrovascular diseases,103.53,Rate
Notio Aigaio,EL42,Total,Males,2013,Cerebrovascular diseases,115.47,Rate
Notio Aigaio,EL42,Total,Males,2014,Cerebrovascular diseases,105.75,Rate
Notio Aigaio,EL42,Total,Males,2015,Cerebrovascular diseases,120.31,Rate
Notio Aigaio,EL42,Total,Males,2016,Cerebrovascular diseases,80.16,Rate
Notio Aigaio,EL42,Total,Males,2017,Cerebrovascular diseases,103.63,Rate
Notio Aigaio,EL42,Total,Males,2018,Cerebrovascular diseases,66.73,Rate
Notio Aigaio,EL42,Total,Males,2019,Cerebrovascular diseases,67.59,Rate
Notio Aigaio,EL42,Total,Males,2020,Cerebrovascular diseases,83.14,Rate
Notio Aigaio,EL42,Total,Males,2011,Chronic lower respiratory diseases,32.56,Rate
Notio Aigaio,EL42,Total,Males,2012,Chronic lower respiratory diseases,33.83,Rate
Notio Aigaio,EL42,Total,Males,2013,Chronic lower respiratory diseases,39.31,Rate
Notio Aigaio,EL42,Total,Males,2014,Chronic lower respiratory diseases,38.72,Rate
Notio Aigaio,EL42,Total,Males,2015,Chronic lower respiratory diseases,35.69,Rate
Notio Aigaio,EL42,Total,Males,2016,Chronic lower respiratory diseases,32.19,Rate
Notio Aigaio,EL42,Total,Males,2017,Chronic lower respiratory diseases,33.43,Rate
Notio Aigaio,EL42,Total,Males,2018,Chronic lower respiratory diseases,44.47,Rate
Notio Aigaio,EL42,Total,Males,2019,Chronic lower respiratory diseases,44.9,Rate
Notio Aigaio,EL42,Total,Males,2020,Chronic lower respiratory diseases,33.51,Rate
Notio Aigaio,EL42,Total,Males,2017,Asthma and status asthmaticus,0.69,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5478.05,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5035.06,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4586.3,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4842.24,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4866.72,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4484.6,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4815.24,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4339.37,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4290.08,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4378.07,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.95,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.32,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.36,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.29,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.1,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.77,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.38,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.41,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.47,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.53,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",399.68,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",408.92,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",370.28,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",384.38,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",450.08,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",363.56,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",422.4,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",344.21,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",374.42,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",360.38,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Malignant melanoma of skin,3.58,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Malignant melanoma of skin,8.56,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Malignant melanoma of skin,7.4,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Malignant melanoma of skin,3.18,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Malignant melanoma of skin,14.85,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Malignant melanoma of skin,3.25,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Malignant melanoma of skin,16.77,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Malignant melanoma of skin,6.99,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Malignant neoplasm of breast,0.0,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Malignant neoplasm of breast,3.25,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Diabetes mellitus,56.48,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Diabetes mellitus,59.73,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Diabetes mellitus,41.14,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Diabetes mellitus,79.5,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Diabetes mellitus,67.83,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Diabetes mellitus,58.86,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Diabetes mellitus,87.69,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Diabetes mellitus,91.2,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Diabetes mellitus,79.02,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Diabetes mellitus,75.25,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),4.62,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),17.43,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),6.77,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),19.37,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),50.09,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),24.34,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),59.96,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),90.21,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),49.86,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),90.74,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.86,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),7.96,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.54,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),6.22,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),12.99,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Other ischaemic heart diseases,204.84,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Other ischaemic heart diseases,196.85,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Other ischaemic heart diseases,206.73,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Other ischaemic heart diseases,283.44,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Other ischaemic heart diseases,215.08,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Other ischaemic heart diseases,266.72,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Other ischaemic heart diseases,267.2,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Other ischaemic heart diseases,266.07,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Other ischaemic heart diseases,298.83,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Other ischaemic heart diseases,318.14,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,305.02,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,268.26,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,178.03,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,174.86,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,242.22,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,136.38,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,171.72,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,166.65,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,237.34,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,209.29,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Cerebrovascular diseases,514.11,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Cerebrovascular diseases,505.84,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Cerebrovascular diseases,549.79,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Cerebrovascular diseases,507.47,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Cerebrovascular diseases,564.37,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Cerebrovascular diseases,372.09,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Cerebrovascular diseases,483.39,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Cerebrovascular diseases,307.53,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Cerebrovascular diseases,318.24,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Cerebrovascular diseases,396.53,Rate
Notio Aigaio,EL42,65 years or over,Males,2011,Chronic lower respiratory diseases,147.87,Rate
Notio Aigaio,EL42,65 years or over,Males,2012,Chronic lower respiratory diseases,164.02,Rate
Notio Aigaio,EL42,65 years or over,Males,2013,Chronic lower respiratory diseases,181.87,Rate
Notio Aigaio,EL42,65 years or over,Males,2014,Chronic lower respiratory diseases,195.27,Rate
Notio Aigaio,EL42,65 years or over,Males,2015,Chronic lower respiratory diseases,176.38,Rate
Notio Aigaio,EL42,65 years or over,Males,2016,Chronic lower respiratory diseases,145.41,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Chronic lower respiratory diseases,161.85,Rate
Notio Aigaio,EL42,65 years or over,Males,2018,Chronic lower respiratory diseases,215.24,Rate
Notio Aigaio,EL42,65 years or over,Males,2019,Chronic lower respiratory diseases,220.87,Rate
Notio Aigaio,EL42,65 years or over,Males,2020,Chronic lower respiratory diseases,162.7,Rate
Notio Aigaio,EL42,65 years or over,Males,2017,Asthma and status asthmaticus,3.54,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,242.53,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,244.06,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,241.06,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,241.23,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,233.5,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,244.39,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,217.6,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,236.16,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,217.1,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,188.53,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.35,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.27,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.35,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.81,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.58,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.32,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.49,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.8,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.75,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",23.93,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",35.68,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",35.74,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",31.94,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",31.68,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",30.78,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",21.19,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",37.62,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",18.74,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",19.18,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Malignant melanoma of skin,1.46,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Malignant melanoma of skin,0.57,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Malignant melanoma of skin,1.54,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Malignant melanoma of skin,0.8,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Malignant melanoma of skin,1.5,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Malignant melanoma of skin,2.22,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Malignant melanoma of skin,0.75,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.84,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Diabetes mellitus,3.83,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Diabetes mellitus,5.89,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Diabetes mellitus,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Diabetes mellitus,7.9,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Diabetes mellitus,3.2,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Diabetes mellitus,3.18,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Diabetes mellitus,5.56,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Diabetes mellitus,2.99,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Diabetes mellitus,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Diabetes mellitus,1.49,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),1.61,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.59,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.8,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.59,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.66,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),2.12,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),2.23,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),3.7,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),1.5,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.32,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.47,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.5,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Other ischaemic heart diseases,10.84,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Other ischaemic heart diseases,13.78,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Other ischaemic heart diseases,18.15,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Other ischaemic heart diseases,10.43,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Other ischaemic heart diseases,16.44,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Other ischaemic heart diseases,17.38,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Other ischaemic heart diseases,9.09,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Other ischaemic heart diseases,11.36,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Other ischaemic heart diseases,15.77,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Other ischaemic heart diseases,17.79,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,34.17,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,32.08,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,31.17,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,33.08,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,24.63,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,29.84,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,26.5,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,25.72,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,28.32,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,19.99,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Cerebrovascular diseases,12.19,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Cerebrovascular diseases,6.08,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Cerebrovascular diseases,10.27,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Cerebrovascular diseases,8.43,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Cerebrovascular diseases,12.74,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Cerebrovascular diseases,9.45,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Cerebrovascular diseases,11.63,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Cerebrovascular diseases,8.4,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Cerebrovascular diseases,6.87,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Cerebrovascular diseases,7.22,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2011,Chronic lower respiratory diseases,4.63,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2012,Chronic lower respiratory diseases,2.3,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2013,Chronic lower respiratory diseases,4.78,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.8,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2015,Chronic lower respiratory diseases,1.61,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.76,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.32,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.11,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.27,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.21,Rate
Notio Aigaio,EL42,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Notio Aigaio,EL42,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1045.66,Rate
Notio Aigaio,EL42,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1012.4,Rate
Notio Aigaio,EL42,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,940.52,Rate
Notio Aigaio,EL42,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,983.62,Rate
Notio Aigaio,EL42,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,972.24,Rate
Notio Aigaio,EL42,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,941.64,Rate
Notio Aigaio,EL42,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,937.69,Rate
Notio Aigaio,EL42,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,877.85,Rate
Notio Aigaio,EL42,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,911.62,Rate
Notio Aigaio,EL42,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,912.96,Rate
Notio Aigaio,EL42,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.13,Rate
Notio Aigaio,EL42,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.04,Rate
Notio Aigaio,EL42,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.04,Rate
Notio Aigaio,EL42,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.78,Rate
Notio Aigaio,EL42,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.59,Rate
Notio Aigaio,EL42,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.2,Rate
Notio Aigaio,EL42,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.73,Rate
Notio Aigaio,EL42,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.25,Rate
Notio Aigaio,EL42,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.82,Rate
Notio Aigaio,EL42,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.93,Rate
Notio Aigaio,EL42,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",54.22,Rate
Notio Aigaio,EL42,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",61.11,Rate
Notio Aigaio,EL42,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",56.3,Rate
Notio Aigaio,EL42,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",59.5,Rate
Notio Aigaio,EL42,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",63.09,Rate
Notio Aigaio,EL42,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",53.83,Rate
Notio Aigaio,EL42,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",56.16,Rate
Notio Aigaio,EL42,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",56.24,Rate
Notio Aigaio,EL42,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",52.32,Rate
Notio Aigaio,EL42,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",49.14,Rate
Notio Aigaio,EL42,Total,Total,2011,Malignant melanoma of skin,2.0,Rate
Notio Aigaio,EL42,Total,Total,2012,Malignant melanoma of skin,2.18,Rate
Notio Aigaio,EL42,Total,Total,2013,Malignant melanoma of skin,2.81,Rate
Notio Aigaio,EL42,Total,Total,2014,Malignant melanoma of skin,0.94,Rate
Notio Aigaio,EL42,Total,Total,2015,Malignant melanoma of skin,2.5,Rate
Notio Aigaio,EL42,Total,Total,2016,Malignant melanoma of skin,0.95,Rate
Notio Aigaio,EL42,Total,Total,2017,Malignant melanoma of skin,0.61,Rate
Notio Aigaio,EL42,Total,Total,2018,Malignant melanoma of skin,2.48,Rate
Notio Aigaio,EL42,Total,Total,2019,Malignant melanoma of skin,2.14,Rate
Notio Aigaio,EL42,Total,Total,2020,Malignant melanoma of skin,1.53,Rate
Notio Aigaio,EL42,Total,Total,2011,Malignant neoplasm of breast,13.37,Rate
Notio Aigaio,EL42,Total,Total,2012,Malignant neoplasm of breast,14.06,Rate
Notio Aigaio,EL42,Total,Total,2013,Malignant neoplasm of breast,15.65,Rate
Notio Aigaio,EL42,Total,Total,2014,Malignant neoplasm of breast,13.95,Rate
Notio Aigaio,EL42,Total,Total,2015,Malignant neoplasm of breast,16.13,Rate
Notio Aigaio,EL42,Total,Total,2016,Malignant neoplasm of breast,17.58,Rate
Notio Aigaio,EL42,Total,Total,2017,Malignant neoplasm of breast,14.35,Rate
Notio Aigaio,EL42,Total,Total,2018,Malignant neoplasm of breast,17.0,Rate
Notio Aigaio,EL42,Total,Total,2019,Malignant neoplasm of breast,17.27,Rate
Notio Aigaio,EL42,Total,Total,2020,Malignant neoplasm of breast,15.97,Rate
Notio Aigaio,EL42,Total,Total,2011,Diabetes mellitus,11.13,Rate
Notio Aigaio,EL42,Total,Total,2012,Diabetes mellitus,12.82,Rate
Notio Aigaio,EL42,Total,Total,2013,Diabetes mellitus,11.51,Rate
Notio Aigaio,EL42,Total,Total,2014,Diabetes mellitus,18.58,Rate
Notio Aigaio,EL42,Total,Total,2015,Diabetes mellitus,16.02,Rate
Notio Aigaio,EL42,Total,Total,2016,Diabetes mellitus,19.3,Rate
Notio Aigaio,EL42,Total,Total,2017,Diabetes mellitus,18.75,Rate
Notio Aigaio,EL42,Total,Total,2018,Diabetes mellitus,18.54,Rate
Notio Aigaio,EL42,Total,Total,2019,Diabetes mellitus,18.77,Rate
Notio Aigaio,EL42,Total,Total,2020,Diabetes mellitus,16.59,Rate
Notio Aigaio,EL42,Total,Total,2011,Mental and behavioural disorders (F00-F99),0.95,Rate
Notio Aigaio,EL42,Total,Total,2012,Mental and behavioural disorders (F00-F99),2.58,Rate
Notio Aigaio,EL42,Total,Total,2013,Mental and behavioural disorders (F00-F99),3.16,Rate
Notio Aigaio,EL42,Total,Total,2014,Mental and behavioural disorders (F00-F99),8.42,Rate
Notio Aigaio,EL42,Total,Total,2015,Mental and behavioural disorders (F00-F99),8.04,Rate
Notio Aigaio,EL42,Total,Total,2016,Mental and behavioural disorders (F00-F99),10.13,Rate
Notio Aigaio,EL42,Total,Total,2017,Mental and behavioural disorders (F00-F99),14.12,Rate
Notio Aigaio,EL42,Total,Total,2018,Mental and behavioural disorders (F00-F99),18.1,Rate
Notio Aigaio,EL42,Total,Total,2019,Mental and behavioural disorders (F00-F99),20.9,Rate
Notio Aigaio,EL42,Total,Total,2020,Mental and behavioural disorders (F00-F99),17.5,Rate
Notio Aigaio,EL42,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.15,Rate
Notio Aigaio,EL42,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Notio Aigaio,EL42,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.18,Rate
Notio Aigaio,EL42,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.93,Rate
Notio Aigaio,EL42,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Notio Aigaio,EL42,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.57,Rate
Notio Aigaio,EL42,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.07,Rate
Notio Aigaio,EL42,Total,Total,2011,Other ischaemic heart diseases,36.59,Rate
Notio Aigaio,EL42,Total,Total,2012,Other ischaemic heart diseases,40.64,Rate
Notio Aigaio,EL42,Total,Total,2013,Other ischaemic heart diseases,42.12,Rate
Notio Aigaio,EL42,Total,Total,2014,Other ischaemic heart diseases,50.67,Rate
Notio Aigaio,EL42,Total,Total,2015,Other ischaemic heart diseases,48.3,Rate
Notio Aigaio,EL42,Total,Total,2016,Other ischaemic heart diseases,46.84,Rate
Notio Aigaio,EL42,Total,Total,2017,Other ischaemic heart diseases,45.63,Rate
Notio Aigaio,EL42,Total,Total,2018,Other ischaemic heart diseases,48.26,Rate
Notio Aigaio,EL42,Total,Total,2019,Other ischaemic heart diseases,52.68,Rate
Notio Aigaio,EL42,Total,Total,2020,Other ischaemic heart diseases,58.6,Rate
Notio Aigaio,EL42,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,62.79,Rate
Notio Aigaio,EL42,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,53.03,Rate
Notio Aigaio,EL42,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,44.59,Rate
Notio Aigaio,EL42,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,41.85,Rate
Notio Aigaio,EL42,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,43.37,Rate
Notio Aigaio,EL42,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,40.69,Rate
Notio Aigaio,EL42,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,38.22,Rate
Notio Aigaio,EL42,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,39.45,Rate
Notio Aigaio,EL42,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,45.98,Rate
Notio Aigaio,EL42,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,41.86,Rate
Notio Aigaio,EL42,Total,Total,2011,Cerebrovascular diseases,101.44,Rate
Notio Aigaio,EL42,Total,Total,2012,Cerebrovascular diseases,117.0,Rate
Notio Aigaio,EL42,Total,Total,2013,Cerebrovascular diseases,122.3,Rate
Notio Aigaio,EL42,Total,Total,2014,Cerebrovascular diseases,115.36,Rate
Notio Aigaio,EL42,Total,Total,2015,Cerebrovascular diseases,106.44,Rate
Notio Aigaio,EL42,Total,Total,2016,Cerebrovascular diseases,94.25,Rate
Notio Aigaio,EL42,Total,Total,2017,Cerebrovascular diseases,100.41,Rate
Notio Aigaio,EL42,Total,Total,2018,Cerebrovascular diseases,75.14,Rate
Notio Aigaio,EL42,Total,Total,2019,Cerebrovascular diseases,80.02,Rate
Notio Aigaio,EL42,Total,Total,2020,Cerebrovascular diseases,92.55,Rate
Notio Aigaio,EL42,Total,Total,2011,Chronic lower respiratory diseases,23.67,Rate
Notio Aigaio,EL42,Total,Total,2012,Chronic lower respiratory diseases,21.83,Rate
Notio Aigaio,EL42,Total,Total,2013,Chronic lower respiratory diseases,23.21,Rate
Notio Aigaio,EL42,Total,Total,2014,Chronic lower respiratory diseases,25.24,Rate
Notio Aigaio,EL42,Total,Total,2015,Chronic lower respiratory diseases,25.27,Rate
Notio Aigaio,EL42,Total,Total,2016,Chronic lower respiratory diseases,21.34,Rate
Notio Aigaio,EL42,Total,Total,2017,Chronic lower respiratory diseases,23.21,Rate
Notio Aigaio,EL42,Total,Total,2018,Chronic lower respiratory diseases,28.57,Rate
Notio Aigaio,EL42,Total,Total,2019,Chronic lower respiratory diseases,28.03,Rate
Notio Aigaio,EL42,Total,Total,2020,Chronic lower respiratory diseases,25.02,Rate
Notio Aigaio,EL42,Total,Total,2017,Asthma and status asthmaticus,0.63,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4646.34,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4481.96,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4143.24,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4343.86,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4303.73,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4115.99,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4176.08,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3832.19,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4026.86,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4064.27,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.53,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.58,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.82,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.69,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.63,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.0,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.43,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.32,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",64.19,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.15,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",219.33,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",229.28,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",196.4,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",222.56,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",246.8,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",203.01,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",228.32,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",197.36,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",215.69,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",203.52,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Malignant melanoma of skin,5.55,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Malignant melanoma of skin,9.96,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Malignant melanoma of skin,6.97,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Malignant melanoma of skin,3.22,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Malignant melanoma of skin,8.52,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Malignant melanoma of skin,4.86,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Malignant melanoma of skin,6.64,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Malignant melanoma of skin,9.46,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Malignant melanoma of skin,3.26,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Malignant neoplasm of breast,48.01,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Malignant neoplasm of breast,56.8,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Malignant neoplasm of breast,53.13,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Malignant neoplasm of breast,46.71,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Malignant neoplasm of breast,53.13,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Malignant neoplasm of breast,54.44,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Malignant neoplasm of breast,56.66,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Malignant neoplasm of breast,65.94,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Malignant neoplasm of breast,66.27,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Malignant neoplasm of breast,57.09,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Diabetes mellitus,46.01,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Diabetes mellitus,50.41,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Diabetes mellitus,52.47,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Diabetes mellitus,76.04,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Diabetes mellitus,70.84,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Diabetes mellitus,86.37,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Diabetes mellitus,83.44,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Diabetes mellitus,89.11,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Diabetes mellitus,90.26,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Diabetes mellitus,80.58,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),3.55,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),9.94,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),12.97,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),38.81,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),34.92,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),48.97,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),66.42,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),86.83,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),96.77,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),83.79,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.19,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.91,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.07,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),5.52,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),7.35,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),7.61,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Other ischaemic heart diseases,160.51,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Other ischaemic heart diseases,175.26,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Other ischaemic heart diseases,172.76,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Other ischaemic heart diseases,237.09,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Other ischaemic heart diseases,211.31,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Other ischaemic heart diseases,198.5,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Other ischaemic heart diseases,214.2,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Other ischaemic heart diseases,221.35,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Other ischaemic heart diseases,234.02,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Other ischaemic heart diseases,254.98,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,240.68,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,191.84,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,155.77,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,134.97,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,166.34,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,140.55,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,137.01,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,146.6,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,168.97,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,167.36,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Cerebrovascular diseases,485.59,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Cerebrovascular diseases,579.47,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Cerebrovascular diseases,598.16,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Cerebrovascular diseases,568.27,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Cerebrovascular diseases,510.83,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Cerebrovascular diseases,458.31,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Cerebrovascular diseases,479.24,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Cerebrovascular diseases,362.26,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Cerebrovascular diseases,384.71,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Cerebrovascular diseases,454.22,Rate
Notio Aigaio,EL42,65 years or over,Total,2011,Chronic lower respiratory diseases,110.12,Rate
Notio Aigaio,EL42,65 years or over,Total,2012,Chronic lower respiratory diseases,107.23,Rate
Notio Aigaio,EL42,65 years or over,Total,2013,Chronic lower respiratory diseases,105.9,Rate
Notio Aigaio,EL42,65 years or over,Total,2014,Chronic lower respiratory diseases,127.83,Rate
Notio Aigaio,EL42,65 years or over,Total,2015,Chronic lower respiratory diseases,124.72,Rate
Notio Aigaio,EL42,65 years or over,Total,2016,Chronic lower respiratory diseases,98.18,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Chronic lower respiratory diseases,112.77,Rate
Notio Aigaio,EL42,65 years or over,Total,2018,Chronic lower respiratory diseases,137.18,Rate
Notio Aigaio,EL42,65 years or over,Total,2019,Chronic lower respiratory diseases,139.2,Rate
Notio Aigaio,EL42,65 years or over,Total,2020,Chronic lower respiratory diseases,122.36,Rate
Notio Aigaio,EL42,65 years or over,Total,2017,Asthma and status asthmaticus,3.22,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,173.45,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,171.95,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,164.7,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,169.66,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,165.23,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,172.7,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,153.24,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,162.2,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,156.99,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,149.59,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.53,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.1,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.08,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.15,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.6,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.57,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.33,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.09,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.34,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.13,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",14.22,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",20.37,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",22.36,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.0,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",18.59,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",17.7,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",14.45,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",22.06,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",12.74,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",11.74,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Malignant melanoma of skin,1.14,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Malignant melanoma of skin,0.29,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Malignant melanoma of skin,1.8,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Malignant melanoma of skin,0.39,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Malignant melanoma of skin,1.04,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Malignant melanoma of skin,0.0,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Malignant melanoma of skin,0.76,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Malignant melanoma of skin,1.47,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Malignant melanoma of skin,0.37,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Malignant melanoma of skin,1.11,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Malignant neoplasm of breast,4.98,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Malignant neoplasm of breast,3.7,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.57,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.02,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.17,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Malignant neoplasm of breast,8.65,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Malignant neoplasm of breast,4.1,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.15,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.4,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.01,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Diabetes mellitus,2.69,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Diabetes mellitus,3.71,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Diabetes mellitus,1.59,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Diabetes mellitus,4.67,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Diabetes mellitus,2.74,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Diabetes mellitus,3.05,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Diabetes mellitus,3.08,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Diabetes mellitus,1.45,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Diabetes mellitus,1.46,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Diabetes mellitus,1.09,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.32,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.8,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.78,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),1.06,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.53,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.72,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.44,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.45,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.51,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.45,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Other ischaemic heart diseases,6.57,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Other ischaemic heart diseases,8.02,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Other ischaemic heart diseases,10.48,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.51,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Other ischaemic heart diseases,8.81,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Other ischaemic heart diseases,10.1,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Other ischaemic heart diseases,4.8,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Other ischaemic heart diseases,6.34,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Other ischaemic heart diseases,8.75,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Other ischaemic heart diseases,11.03,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,19.7,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,19.41,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,17.66,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,19.3,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,13.58,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,16.5,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,14.29,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,13.5,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,16.19,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,11.46,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Cerebrovascular diseases,8.39,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Cerebrovascular diseases,4.97,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Cerebrovascular diseases,7.03,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Cerebrovascular diseases,5.64,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Cerebrovascular diseases,8.48,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Cerebrovascular diseases,6.05,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Cerebrovascular diseases,8.64,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Cerebrovascular diseases,5.59,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Cerebrovascular diseases,6.21,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Cerebrovascular diseases,4.94,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2011,Chronic lower respiratory diseases,2.73,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2012,Chronic lower respiratory diseases,1.14,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2013,Chronic lower respiratory diseases,3.18,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.39,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.18,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2016,Chronic lower respiratory diseases,2.72,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.51,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.25,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.1,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.44,Rate
Notio Aigaio,EL42,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,801.06,Rate
Kriti,EL43,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,812.47,Rate
Kriti,EL43,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,763.81,Rate
Kriti,EL43,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,757.41,Rate
Kriti,EL43,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,806.49,Rate
Kriti,EL43,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,781.93,Rate
Kriti,EL43,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,803.25,Rate
Kriti,EL43,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,734.09,Rate
Kriti,EL43,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,767.78,Rate
Kriti,EL43,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,818.79,Rate
Kriti,EL43,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.34,Rate
Kriti,EL43,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.49,Rate
Kriti,EL43,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.16,Rate
Kriti,EL43,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.59,Rate
Kriti,EL43,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.1,Rate
Kriti,EL43,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.55,Rate
Kriti,EL43,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.51,Rate
Kriti,EL43,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.58,Rate
Kriti,EL43,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.72,Rate
Kriti,EL43,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.75,Rate
Kriti,EL43,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",16.11,Rate
Kriti,EL43,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",15.74,Rate
Kriti,EL43,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",20.98,Rate
Kriti,EL43,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",19.08,Rate
Kriti,EL43,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",19.38,Rate
Kriti,EL43,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",18.02,Rate
Kriti,EL43,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",20.98,Rate
Kriti,EL43,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",23.12,Rate
Kriti,EL43,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",23.36,Rate
Kriti,EL43,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",24.14,Rate
Kriti,EL43,Total,Females,2011,Malignant melanoma of skin,1.1,Rate
Kriti,EL43,Total,Females,2012,Malignant melanoma of skin,2.78,Rate
Kriti,EL43,Total,Females,2013,Malignant melanoma of skin,1.26,Rate
Kriti,EL43,Total,Females,2014,Malignant melanoma of skin,1.93,Rate
Kriti,EL43,Total,Females,2015,Malignant melanoma of skin,1.44,Rate
Kriti,EL43,Total,Females,2016,Malignant melanoma of skin,1.48,Rate
Kriti,EL43,Total,Females,2017,Malignant melanoma of skin,1.51,Rate
Kriti,EL43,Total,Females,2018,Malignant melanoma of skin,1.77,Rate
Kriti,EL43,Total,Females,2019,Malignant melanoma of skin,2.36,Rate
Kriti,EL43,Total,Females,2020,Malignant melanoma of skin,2.08,Rate
Kriti,EL43,Total,Females,2011,Malignant neoplasm of breast,27.46,Rate
Kriti,EL43,Total,Females,2012,Malignant neoplasm of breast,29.1,Rate
Kriti,EL43,Total,Females,2013,Malignant neoplasm of breast,28.8,Rate
Kriti,EL43,Total,Females,2014,Malignant neoplasm of breast,26.52,Rate
Kriti,EL43,Total,Females,2015,Malignant neoplasm of breast,28.69,Rate
Kriti,EL43,Total,Females,2016,Malignant neoplasm of breast,31.87,Rate
Kriti,EL43,Total,Females,2017,Malignant neoplasm of breast,28.42,Rate
Kriti,EL43,Total,Females,2018,Malignant neoplasm of breast,22.94,Rate
Kriti,EL43,Total,Females,2019,Malignant neoplasm of breast,24.57,Rate
Kriti,EL43,Total,Females,2020,Malignant neoplasm of breast,27.92,Rate
Kriti,EL43,Total,Females,2011,Diabetes mellitus,8.84,Rate
Kriti,EL43,Total,Females,2012,Diabetes mellitus,4.01,Rate
Kriti,EL43,Total,Females,2013,Diabetes mellitus,9.13,Rate
Kriti,EL43,Total,Females,2014,Diabetes mellitus,5.43,Rate
Kriti,EL43,Total,Females,2015,Diabetes mellitus,8.79,Rate
Kriti,EL43,Total,Females,2016,Diabetes mellitus,9.21,Rate
Kriti,EL43,Total,Females,2017,Diabetes mellitus,10.67,Rate
Kriti,EL43,Total,Females,2018,Diabetes mellitus,15.13,Rate
Kriti,EL43,Total,Females,2019,Diabetes mellitus,17.69,Rate
Kriti,EL43,Total,Females,2020,Diabetes mellitus,11.58,Rate
Kriti,EL43,Total,Females,2011,Mental and behavioural disorders (F00-F99),0.63,Rate
Kriti,EL43,Total,Females,2012,Mental and behavioural disorders (F00-F99),0.84,Rate
Kriti,EL43,Total,Females,2013,Mental and behavioural disorders (F00-F99),0.47,Rate
Kriti,EL43,Total,Females,2014,Mental and behavioural disorders (F00-F99),6.65,Rate
Kriti,EL43,Total,Females,2015,Mental and behavioural disorders (F00-F99),7.26,Rate
Kriti,EL43,Total,Females,2016,Mental and behavioural disorders (F00-F99),10.83,Rate
Kriti,EL43,Total,Females,2017,Mental and behavioural disorders (F00-F99),16.26,Rate
Kriti,EL43,Total,Females,2018,Mental and behavioural disorders (F00-F99),9.23,Rate
Kriti,EL43,Total,Females,2019,Mental and behavioural disorders (F00-F99),17.22,Rate
Kriti,EL43,Total,Females,2020,Mental and behavioural disorders (F00-F99),16.49,Rate
Kriti,EL43,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Kriti,EL43,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Kriti,EL43,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Kriti,EL43,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Kriti,EL43,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Kriti,EL43,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Kriti,EL43,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Kriti,EL43,Total,Females,2011,Other ischaemic heart diseases,21.2,Rate
Kriti,EL43,Total,Females,2012,Other ischaemic heart diseases,24.67,Rate
Kriti,EL43,Total,Females,2013,Other ischaemic heart diseases,26.6,Rate
Kriti,EL43,Total,Females,2014,Other ischaemic heart diseases,36.83,Rate
Kriti,EL43,Total,Females,2015,Other ischaemic heart diseases,26.3,Rate
Kriti,EL43,Total,Females,2016,Other ischaemic heart diseases,25.22,Rate
Kriti,EL43,Total,Females,2017,Other ischaemic heart diseases,28.78,Rate
Kriti,EL43,Total,Females,2018,Other ischaemic heart diseases,19.76,Rate
Kriti,EL43,Total,Females,2019,Other ischaemic heart diseases,24.23,Rate
Kriti,EL43,Total,Females,2020,Other ischaemic heart diseases,27.08,Rate
Kriti,EL43,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,32.53,Rate
Kriti,EL43,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,25.62,Rate
Kriti,EL43,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,27.18,Rate
Kriti,EL43,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,20.72,Rate
Kriti,EL43,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,21.76,Rate
Kriti,EL43,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,20.61,Rate
Kriti,EL43,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,26.95,Rate
Kriti,EL43,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,23.85,Rate
Kriti,EL43,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.7,Rate
Kriti,EL43,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,27.64,Rate
Kriti,EL43,Total,Females,2011,Cerebrovascular diseases,115.79,Rate
Kriti,EL43,Total,Females,2012,Cerebrovascular diseases,107.62,Rate
Kriti,EL43,Total,Females,2013,Cerebrovascular diseases,92.56,Rate
Kriti,EL43,Total,Females,2014,Cerebrovascular diseases,93.86,Rate
Kriti,EL43,Total,Females,2015,Cerebrovascular diseases,91.18,Rate
Kriti,EL43,Total,Females,2016,Cerebrovascular diseases,84.28,Rate
Kriti,EL43,Total,Females,2017,Cerebrovascular diseases,83.29,Rate
Kriti,EL43,Total,Females,2018,Cerebrovascular diseases,70.17,Rate
Kriti,EL43,Total,Females,2019,Cerebrovascular diseases,79.38,Rate
Kriti,EL43,Total,Females,2020,Cerebrovascular diseases,73.2,Rate
Kriti,EL43,Total,Females,2011,Chronic lower respiratory diseases,17.77,Rate
Kriti,EL43,Total,Females,2012,Chronic lower respiratory diseases,18.1,Rate
Kriti,EL43,Total,Females,2013,Chronic lower respiratory diseases,16.74,Rate
Kriti,EL43,Total,Females,2014,Chronic lower respiratory diseases,19.14,Rate
Kriti,EL43,Total,Females,2015,Chronic lower respiratory diseases,22.06,Rate
Kriti,EL43,Total,Females,2016,Chronic lower respiratory diseases,17.33,Rate
Kriti,EL43,Total,Females,2017,Chronic lower respiratory diseases,22.21,Rate
Kriti,EL43,Total,Females,2018,Chronic lower respiratory diseases,19.8,Rate
Kriti,EL43,Total,Females,2019,Chronic lower respiratory diseases,19.53,Rate
Kriti,EL43,Total,Females,2020,Chronic lower respiratory diseases,16.2,Rate
Kriti,EL43,Total,Females,2012,Asthma and status asthmaticus,0.24,Rate
Kriti,EL43,Total,Females,2013,Asthma and status asthmaticus,0.24,Rate
Kriti,EL43,Total,Females,2014,Asthma and status asthmaticus,0.23,Rate
Kriti,EL43,Total,Females,2015,Asthma and status asthmaticus,0.51,Rate
Kriti,EL43,Total,Females,2019,Asthma and status asthmaticus,0.31,Rate
Kriti,EL43,Total,Females,2020,Asthma and status asthmaticus,0.62,Rate
Kriti,EL43,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3680.23,Rate
Kriti,EL43,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3732.16,Rate
Kriti,EL43,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3500.96,Rate
Kriti,EL43,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3452.69,Rate
Kriti,EL43,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3722.06,Rate
Kriti,EL43,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3569.16,Rate
Kriti,EL43,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3664.51,Rate
Kriti,EL43,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3355.26,Rate
Kriti,EL43,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3520.39,Rate
Kriti,EL43,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3780.99,Rate
Kriti,EL43,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",66.67,Rate
Kriti,EL43,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.96,Rate
Kriti,EL43,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.57,Rate
Kriti,EL43,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.84,Rate
Kriti,EL43,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.06,Rate
Kriti,EL43,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.59,Rate
Kriti,EL43,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.13,Rate
Kriti,EL43,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.59,Rate
Kriti,EL43,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.75,Rate
Kriti,EL43,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.12,Rate
Kriti,EL43,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",53.91,Rate
Kriti,EL43,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",44.23,Rate
Kriti,EL43,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",57.52,Rate
Kriti,EL43,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",51.1,Rate
Kriti,EL43,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",67.14,Rate
Kriti,EL43,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",53.06,Rate
Kriti,EL43,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",57.19,Rate
Kriti,EL43,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",63.79,Rate
Kriti,EL43,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",68.95,Rate
Kriti,EL43,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",82.68,Rate
Kriti,EL43,65 years or over,Females,2011,Malignant melanoma of skin,3.73,Rate
Kriti,EL43,65 years or over,Females,2012,Malignant melanoma of skin,9.55,Rate
Kriti,EL43,65 years or over,Females,2013,Malignant melanoma of skin,4.67,Rate
Kriti,EL43,65 years or over,Females,2014,Malignant melanoma of skin,1.52,Rate
Kriti,EL43,65 years or over,Females,2015,Malignant melanoma of skin,5.93,Rate
Kriti,EL43,65 years or over,Females,2016,Malignant melanoma of skin,5.88,Rate
Kriti,EL43,65 years or over,Females,2017,Malignant melanoma of skin,6.22,Rate
Kriti,EL43,65 years or over,Females,2018,Malignant melanoma of skin,4.21,Rate
Kriti,EL43,65 years or over,Females,2019,Malignant melanoma of skin,8.86,Rate
Kriti,EL43,65 years or over,Females,2020,Malignant melanoma of skin,10.66,Rate
Kriti,EL43,65 years or over,Females,2011,Malignant neoplasm of breast,103.55,Rate
Kriti,EL43,65 years or over,Females,2012,Malignant neoplasm of breast,106.19,Rate
Kriti,EL43,65 years or over,Females,2013,Malignant neoplasm of breast,106.96,Rate
Kriti,EL43,65 years or over,Females,2014,Malignant neoplasm of breast,86.3,Rate
Kriti,EL43,65 years or over,Females,2015,Malignant neoplasm of breast,118.16,Rate
Kriti,EL43,65 years or over,Females,2016,Malignant neoplasm of breast,109.98,Rate
Kriti,EL43,65 years or over,Females,2017,Malignant neoplasm of breast,100.62,Rate
Kriti,EL43,65 years or over,Females,2018,Malignant neoplasm of breast,84.44,Rate
Kriti,EL43,65 years or over,Females,2019,Malignant neoplasm of breast,91.49,Rate
Kriti,EL43,65 years or over,Females,2020,Malignant neoplasm of breast,101.21,Rate
Kriti,EL43,65 years or over,Females,2011,Diabetes mellitus,43.4,Rate
Kriti,EL43,65 years or over,Females,2012,Diabetes mellitus,18.7,Rate
Kriti,EL43,65 years or over,Females,2013,Diabetes mellitus,41.68,Rate
Kriti,EL43,65 years or over,Females,2014,Diabetes mellitus,22.62,Rate
Kriti,EL43,65 years or over,Females,2015,Diabetes mellitus,45.1,Rate
Kriti,EL43,65 years or over,Females,2016,Diabetes mellitus,43.76,Rate
Kriti,EL43,65 years or over,Females,2017,Diabetes mellitus,49.88,Rate
Kriti,EL43,65 years or over,Females,2018,Diabetes mellitus,75.94,Rate
Kriti,EL43,65 years or over,Females,2019,Diabetes mellitus,84.5,Rate
Kriti,EL43,65 years or over,Females,2020,Diabetes mellitus,59.38,Rate
Kriti,EL43,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),1.55,Rate
Kriti,EL43,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),4.33,Rate
Kriti,EL43,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),2.42,Rate
Kriti,EL43,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),30.45,Rate
Kriti,EL43,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),37.25,Rate
Kriti,EL43,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),55.55,Rate
Kriti,EL43,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),78.58,Rate
Kriti,EL43,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),42.6,Rate
Kriti,EL43,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),88.29,Rate
Kriti,EL43,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),82.77,Rate
Kriti,EL43,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),4.32,Rate
Kriti,EL43,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Kriti,EL43,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.68,Rate
Kriti,EL43,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.21,Rate
Kriti,EL43,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Kriti,EL43,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.88,Rate
Kriti,EL43,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),6.58,Rate
Kriti,EL43,65 years or over,Females,2011,Other ischaemic heart diseases,103.47,Rate
Kriti,EL43,65 years or over,Females,2012,Other ischaemic heart diseases,119.59,Rate
Kriti,EL43,65 years or over,Females,2013,Other ischaemic heart diseases,124.04,Rate
Kriti,EL43,65 years or over,Females,2014,Other ischaemic heart diseases,178.12,Rate
Kriti,EL43,65 years or over,Females,2015,Other ischaemic heart diseases,119.41,Rate
Kriti,EL43,65 years or over,Females,2016,Other ischaemic heart diseases,120.66,Rate
Kriti,EL43,65 years or over,Females,2017,Other ischaemic heart diseases,144.41,Rate
Kriti,EL43,65 years or over,Females,2018,Other ischaemic heart diseases,91.66,Rate
Kriti,EL43,65 years or over,Females,2019,Other ischaemic heart diseases,114.7,Rate
Kriti,EL43,65 years or over,Females,2020,Other ischaemic heart diseases,127.92,Rate
Kriti,EL43,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,143.4,Rate
Kriti,EL43,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,104.66,Rate
Kriti,EL43,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,107.65,Rate
Kriti,EL43,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,94.32,Rate
Kriti,EL43,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,106.29,Rate
Kriti,EL43,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,95.66,Rate
Kriti,EL43,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,118.15,Rate
Kriti,EL43,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,106.33,Rate
Kriti,EL43,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,114.09,Rate
Kriti,EL43,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,126.07,Rate
Kriti,EL43,65 years or over,Females,2011,Cerebrovascular diseases,565.93,Rate
Kriti,EL43,65 years or over,Females,2012,Cerebrovascular diseases,531.62,Rate
Kriti,EL43,65 years or over,Females,2013,Cerebrovascular diseases,453.92,Rate
Kriti,EL43,65 years or over,Females,2014,Cerebrovascular diseases,462.65,Rate
Kriti,EL43,65 years or over,Females,2015,Cerebrovascular diseases,447.21,Rate
Kriti,EL43,65 years or over,Females,2016,Cerebrovascular diseases,412.59,Rate
Kriti,EL43,65 years or over,Females,2017,Cerebrovascular diseases,413.93,Rate
Kriti,EL43,65 years or over,Females,2018,Cerebrovascular diseases,340.29,Rate
Kriti,EL43,65 years or over,Females,2019,Cerebrovascular diseases,386.23,Rate
Kriti,EL43,65 years or over,Females,2020,Cerebrovascular diseases,358.17,Rate
Kriti,EL43,65 years or over,Females,2011,Chronic lower respiratory diseases,87.48,Rate
Kriti,EL43,65 years or over,Females,2012,Chronic lower respiratory diseases,87.8,Rate
Kriti,EL43,65 years or over,Females,2013,Chronic lower respiratory diseases,84.02,Rate
Kriti,EL43,65 years or over,Females,2014,Chronic lower respiratory diseases,96.35,Rate
Kriti,EL43,65 years or over,Females,2015,Chronic lower respiratory diseases,97.34,Rate
Kriti,EL43,65 years or over,Females,2016,Chronic lower respiratory diseases,85.47,Rate
Kriti,EL43,65 years or over,Females,2017,Chronic lower respiratory diseases,107.35,Rate
Kriti,EL43,65 years or over,Females,2018,Chronic lower respiratory diseases,98.2,Rate
Kriti,EL43,65 years or over,Females,2019,Chronic lower respiratory diseases,87.04,Rate
Kriti,EL43,65 years or over,Females,2020,Chronic lower respiratory diseases,81.44,Rate
Kriti,EL43,65 years or over,Females,2012,Asthma and status asthmaticus,1.24,Rate
Kriti,EL43,65 years or over,Females,2013,Asthma and status asthmaticus,1.22,Rate
Kriti,EL43,65 years or over,Females,2014,Asthma and status asthmaticus,1.19,Rate
Kriti,EL43,65 years or over,Females,2015,Asthma and status asthmaticus,1.17,Rate
Kriti,EL43,65 years or over,Females,2019,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,65 years or over,Females,2020,Asthma and status asthmaticus,1.56,Rate
Kriti,EL43,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,103.62,Rate
Kriti,EL43,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,105.21,Rate
Kriti,EL43,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,100.77,Rate
Kriti,EL43,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,104.52,Rate
Kriti,EL43,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,100.23,Rate
Kriti,EL43,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,106.76,Rate
Kriti,EL43,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,110.15,Rate
Kriti,EL43,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,99.15,Rate
Kriti,EL43,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,101.0,Rate
Kriti,EL43,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,101.24,Rate
Kriti,EL43,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.9,Rate
Kriti,EL43,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.74,Rate
Kriti,EL43,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.1,Rate
Kriti,EL43,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.15,Rate
Kriti,EL43,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.12,Rate
Kriti,EL43,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.98,Rate
Kriti,EL43,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.25,Rate
Kriti,EL43,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.47,Rate
Kriti,EL43,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.45,Rate
Kriti,EL43,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.37,Rate
Kriti,EL43,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",6.95,Rate
Kriti,EL43,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",8.84,Rate
Kriti,EL43,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",12.13,Rate
Kriti,EL43,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",11.33,Rate
Kriti,EL43,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",7.82,Rate
Kriti,EL43,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",9.53,Rate
Kriti,EL43,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",12.21,Rate
Kriti,EL43,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",13.27,Rate
Kriti,EL43,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.32,Rate
Kriti,EL43,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",9.96,Rate
Kriti,EL43,Less than 65 years,Females,2011,Malignant melanoma of skin,0.47,Rate
Kriti,EL43,Less than 65 years,Females,2012,Malignant melanoma of skin,1.14,Rate
Kriti,EL43,Less than 65 years,Females,2013,Malignant melanoma of skin,0.43,Rate
Kriti,EL43,Less than 65 years,Females,2014,Malignant melanoma of skin,2.03,Rate
Kriti,EL43,Less than 65 years,Females,2015,Malignant melanoma of skin,0.35,Rate
Kriti,EL43,Less than 65 years,Females,2016,Malignant melanoma of skin,0.41,Rate
Kriti,EL43,Less than 65 years,Females,2017,Malignant melanoma of skin,0.37,Rate
Kriti,EL43,Less than 65 years,Females,2018,Malignant melanoma of skin,1.18,Rate
Kriti,EL43,Less than 65 years,Females,2019,Malignant melanoma of skin,0.79,Rate
Kriti,EL43,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2011,Malignant neoplasm of breast,9.03,Rate
Kriti,EL43,Less than 65 years,Females,2012,Malignant neoplasm of breast,10.43,Rate
Kriti,EL43,Less than 65 years,Females,2013,Malignant neoplasm of breast,9.86,Rate
Kriti,EL43,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.04,Rate
Kriti,EL43,Less than 65 years,Females,2015,Malignant neoplasm of breast,7.02,Rate
Kriti,EL43,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.95,Rate
Kriti,EL43,Less than 65 years,Females,2017,Malignant neoplasm of breast,10.93,Rate
Kriti,EL43,Less than 65 years,Females,2018,Malignant neoplasm of breast,8.04,Rate
Kriti,EL43,Less than 65 years,Females,2019,Malignant neoplasm of breast,8.36,Rate
Kriti,EL43,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.16,Rate
Kriti,EL43,Less than 65 years,Females,2011,Diabetes mellitus,0.47,Rate
Kriti,EL43,Less than 65 years,Females,2012,Diabetes mellitus,0.46,Rate
Kriti,EL43,Less than 65 years,Females,2013,Diabetes mellitus,1.25,Rate
Kriti,EL43,Less than 65 years,Females,2014,Diabetes mellitus,1.26,Rate
Kriti,EL43,Less than 65 years,Females,2015,Diabetes mellitus,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2016,Diabetes mellitus,0.84,Rate
Kriti,EL43,Less than 65 years,Females,2017,Diabetes mellitus,1.17,Rate
Kriti,EL43,Less than 65 years,Females,2018,Diabetes mellitus,0.4,Rate
Kriti,EL43,Less than 65 years,Females,2019,Diabetes mellitus,1.5,Rate
Kriti,EL43,Less than 65 years,Females,2020,Diabetes mellitus,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.41,Rate
Kriti,EL43,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.88,Rate
Kriti,EL43,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.16,Rate
Kriti,EL43,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.15,Rate
Kriti,EL43,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.43,Rate
Kriti,EL43,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.44,Rate
Kriti,EL43,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Kriti,EL43,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Kriti,EL43,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Kriti,EL43,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.27,Rate
Kriti,EL43,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.68,Rate
Kriti,EL43,Less than 65 years,Females,2013,Other ischaemic heart diseases,2.99,Rate
Kriti,EL43,Less than 65 years,Females,2014,Other ischaemic heart diseases,2.6,Rate
Kriti,EL43,Less than 65 years,Females,2015,Other ischaemic heart diseases,3.75,Rate
Kriti,EL43,Less than 65 years,Females,2016,Other ischaemic heart diseases,2.1,Rate
Kriti,EL43,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.77,Rate
Kriti,EL43,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.34,Rate
Kriti,EL43,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.31,Rate
Kriti,EL43,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.66,Rate
Kriti,EL43,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,5.68,Rate
Kriti,EL43,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,6.48,Rate
Kriti,EL43,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,7.69,Rate
Kriti,EL43,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.9,Rate
Kriti,EL43,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,1.28,Rate
Kriti,EL43,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.43,Rate
Kriti,EL43,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,4.86,Rate
Kriti,EL43,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.87,Rate
Kriti,EL43,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.28,Rate
Kriti,EL43,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.8,Rate
Kriti,EL43,Less than 65 years,Females,2011,Cerebrovascular diseases,6.74,Rate
Kriti,EL43,Less than 65 years,Females,2012,Cerebrovascular diseases,4.91,Rate
Kriti,EL43,Less than 65 years,Females,2013,Cerebrovascular diseases,5.02,Rate
Kriti,EL43,Less than 65 years,Females,2014,Cerebrovascular diseases,4.53,Rate
Kriti,EL43,Less than 65 years,Females,2015,Cerebrovascular diseases,4.94,Rate
Kriti,EL43,Less than 65 years,Females,2016,Cerebrovascular diseases,4.75,Rate
Kriti,EL43,Less than 65 years,Females,2017,Cerebrovascular diseases,3.19,Rate
Kriti,EL43,Less than 65 years,Females,2018,Cerebrovascular diseases,4.73,Rate
Kriti,EL43,Less than 65 years,Females,2019,Cerebrovascular diseases,5.05,Rate
Kriti,EL43,Less than 65 years,Females,2020,Cerebrovascular diseases,4.17,Rate
Kriti,EL43,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.88,Rate
Kriti,EL43,Less than 65 years,Females,2012,Chronic lower respiratory diseases,1.22,Rate
Kriti,EL43,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.45,Rate
Kriti,EL43,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.43,Rate
Kriti,EL43,Less than 65 years,Females,2015,Chronic lower respiratory diseases,3.82,Rate
Kriti,EL43,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.83,Rate
Kriti,EL43,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.59,Rate
Kriti,EL43,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.81,Rate
Kriti,EL43,Less than 65 years,Females,2019,Chronic lower respiratory diseases,3.17,Rate
Kriti,EL43,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.39,Rate
Kriti,EL43,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.35,Rate
Kriti,EL43,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.39,Rate
Kriti,EL43,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.39,Rate
Kriti,EL43,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1200.16,Rate
Kriti,EL43,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1202.28,Rate
Kriti,EL43,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1103.26,Rate
Kriti,EL43,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1131.56,Rate
Kriti,EL43,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1148.5,Rate
Kriti,EL43,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1065.2,Rate
Kriti,EL43,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1141.62,Rate
Kriti,EL43,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1054.5,Rate
Kriti,EL43,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1107.78,Rate
Kriti,EL43,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1055.87,Rate
Kriti,EL43,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.83,Rate
Kriti,EL43,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.09,Rate
Kriti,EL43,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.96,Rate
Kriti,EL43,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.32,Rate
Kriti,EL43,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.62,Rate
Kriti,EL43,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.48,Rate
Kriti,EL43,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.47,Rate
Kriti,EL43,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.76,Rate
Kriti,EL43,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.19,Rate
Kriti,EL43,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.59,Rate
Kriti,EL43,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",108.33,Rate
Kriti,EL43,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",110.1,Rate
Kriti,EL43,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",110.46,Rate
Kriti,EL43,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",113.27,Rate
Kriti,EL43,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",123.83,Rate
Kriti,EL43,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",122.73,Rate
Kriti,EL43,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",131.77,Rate
Kriti,EL43,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",106.13,Rate
Kriti,EL43,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",116.07,Rate
Kriti,EL43,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",98.66,Rate
Kriti,EL43,Total,Males,2011,Malignant melanoma of skin,2.91,Rate
Kriti,EL43,Total,Males,2012,Malignant melanoma of skin,3.04,Rate
Kriti,EL43,Total,Males,2013,Malignant melanoma of skin,2.03,Rate
Kriti,EL43,Total,Males,2014,Malignant melanoma of skin,4.08,Rate
Kriti,EL43,Total,Males,2015,Malignant melanoma of skin,2.19,Rate
Kriti,EL43,Total,Males,2016,Malignant melanoma of skin,3.05,Rate
Kriti,EL43,Total,Males,2017,Malignant melanoma of skin,3.34,Rate
Kriti,EL43,Total,Males,2018,Malignant melanoma of skin,2.68,Rate
Kriti,EL43,Total,Males,2019,Malignant melanoma of skin,2.98,Rate
Kriti,EL43,Total,Males,2020,Malignant melanoma of skin,1.63,Rate
Kriti,EL43,Total,Males,2011,Malignant neoplasm of breast,0.73,Rate
Kriti,EL43,Total,Males,2012,Malignant neoplasm of breast,1.06,Rate
Kriti,EL43,Total,Males,2013,Malignant neoplasm of breast,1.08,Rate
Kriti,EL43,Total,Males,2014,Malignant neoplasm of breast,1.08,Rate
Kriti,EL43,Total,Males,2016,Malignant neoplasm of breast,1.02,Rate
Kriti,EL43,Total,Males,2017,Malignant neoplasm of breast,0.38,Rate
Kriti,EL43,Total,Males,2018,Malignant neoplasm of breast,1.0,Rate
Kriti,EL43,Total,Males,2019,Malignant neoplasm of breast,0.77,Rate
Kriti,EL43,Total,Males,2020,Malignant neoplasm of breast,1.04,Rate
Kriti,EL43,Total,Males,2011,Diabetes mellitus,11.22,Rate
Kriti,EL43,Total,Males,2012,Diabetes mellitus,14.2,Rate
Kriti,EL43,Total,Males,2013,Diabetes mellitus,13.21,Rate
Kriti,EL43,Total,Males,2014,Diabetes mellitus,17.0,Rate
Kriti,EL43,Total,Males,2015,Diabetes mellitus,17.34,Rate
Kriti,EL43,Total,Males,2016,Diabetes mellitus,14.13,Rate
Kriti,EL43,Total,Males,2017,Diabetes mellitus,16.02,Rate
Kriti,EL43,Total,Males,2018,Diabetes mellitus,20.81,Rate
Kriti,EL43,Total,Males,2019,Diabetes mellitus,18.23,Rate
Kriti,EL43,Total,Males,2020,Diabetes mellitus,19.77,Rate
Kriti,EL43,Total,Males,2011,Mental and behavioural disorders (F00-F99),3.01,Rate
Kriti,EL43,Total,Males,2012,Mental and behavioural disorders (F00-F99),0.76,Rate
Kriti,EL43,Total,Males,2013,Mental and behavioural disorders (F00-F99),0.29,Rate
Kriti,EL43,Total,Males,2014,Mental and behavioural disorders (F00-F99),4.11,Rate
Kriti,EL43,Total,Males,2015,Mental and behavioural disorders (F00-F99),7.66,Rate
Kriti,EL43,Total,Males,2016,Mental and behavioural disorders (F00-F99),6.28,Rate
Kriti,EL43,Total,Males,2017,Mental and behavioural disorders (F00-F99),8.11,Rate
Kriti,EL43,Total,Males,2018,Mental and behavioural disorders (F00-F99),6.74,Rate
Kriti,EL43,Total,Males,2019,Mental and behavioural disorders (F00-F99),15.42,Rate
Kriti,EL43,Total,Males,2020,Mental and behavioural disorders (F00-F99),8.81,Rate
Kriti,EL43,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Kriti,EL43,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Kriti,EL43,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.37,Rate
Kriti,EL43,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.58,Rate
Kriti,EL43,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Kriti,EL43,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.17,Rate
Kriti,EL43,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Kriti,EL43,Total,Males,2011,Other ischaemic heart diseases,47.01,Rate
Kriti,EL43,Total,Males,2012,Other ischaemic heart diseases,50.37,Rate
Kriti,EL43,Total,Males,2013,Other ischaemic heart diseases,50.65,Rate
Kriti,EL43,Total,Males,2014,Other ischaemic heart diseases,61.27,Rate
Kriti,EL43,Total,Males,2015,Other ischaemic heart diseases,55.84,Rate
Kriti,EL43,Total,Males,2016,Other ischaemic heart diseases,59.26,Rate
Kriti,EL43,Total,Males,2017,Other ischaemic heart diseases,57.98,Rate
Kriti,EL43,Total,Males,2018,Other ischaemic heart diseases,50.58,Rate
Kriti,EL43,Total,Males,2019,Other ischaemic heart diseases,62.79,Rate
Kriti,EL43,Total,Males,2020,Other ischaemic heart diseases,49.01,Rate
Kriti,EL43,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,70.86,Rate
Kriti,EL43,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,60.08,Rate
Kriti,EL43,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,49.17,Rate
Kriti,EL43,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,48.43,Rate
Kriti,EL43,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,42.52,Rate
Kriti,EL43,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,31.84,Rate
Kriti,EL43,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,48.46,Rate
Kriti,EL43,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,59.06,Rate
Kriti,EL43,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,56.43,Rate
Kriti,EL43,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,51.73,Rate
Kriti,EL43,Total,Males,2011,Cerebrovascular diseases,109.02,Rate
Kriti,EL43,Total,Males,2012,Cerebrovascular diseases,102.06,Rate
Kriti,EL43,Total,Males,2013,Cerebrovascular diseases,83.51,Rate
Kriti,EL43,Total,Males,2014,Cerebrovascular diseases,91.19,Rate
Kriti,EL43,Total,Males,2015,Cerebrovascular diseases,98.78,Rate
Kriti,EL43,Total,Males,2016,Cerebrovascular diseases,77.26,Rate
Kriti,EL43,Total,Males,2017,Cerebrovascular diseases,85.58,Rate
Kriti,EL43,Total,Males,2018,Cerebrovascular diseases,78.3,Rate
Kriti,EL43,Total,Males,2019,Cerebrovascular diseases,79.1,Rate
Kriti,EL43,Total,Males,2020,Cerebrovascular diseases,77.8,Rate
Kriti,EL43,Total,Males,2011,Chronic lower respiratory diseases,50.3,Rate
Kriti,EL43,Total,Males,2012,Chronic lower respiratory diseases,42.04,Rate
Kriti,EL43,Total,Males,2013,Chronic lower respiratory diseases,41.6,Rate
Kriti,EL43,Total,Males,2014,Chronic lower respiratory diseases,57.11,Rate
Kriti,EL43,Total,Males,2015,Chronic lower respiratory diseases,54.01,Rate
Kriti,EL43,Total,Males,2016,Chronic lower respiratory diseases,44.52,Rate
Kriti,EL43,Total,Males,2017,Chronic lower respiratory diseases,51.65,Rate
Kriti,EL43,Total,Males,2018,Chronic lower respiratory diseases,46.02,Rate
Kriti,EL43,Total,Males,2019,Chronic lower respiratory diseases,55.7,Rate
Kriti,EL43,Total,Males,2020,Chronic lower respiratory diseases,42.71,Rate
Kriti,EL43,Total,Males,2019,Asthma and status asthmaticus,0.3,Rate
Kriti,EL43,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5172.5,Rate
Kriti,EL43,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5051.01,Rate
Kriti,EL43,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4652.15,Rate
Kriti,EL43,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4750.75,Rate
Kriti,EL43,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4861.74,Rate
Kriti,EL43,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4493.82,Rate
Kriti,EL43,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4861.78,Rate
Kriti,EL43,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4442.01,Rate
Kriti,EL43,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4675.35,Rate
Kriti,EL43,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4499.72,Rate
Kriti,EL43,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.0,Rate
Kriti,EL43,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.49,Rate
Kriti,EL43,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.85,Rate
Kriti,EL43,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.84,Rate
Kriti,EL43,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.3,Rate
Kriti,EL43,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.31,Rate
Kriti,EL43,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.75,Rate
Kriti,EL43,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.55,Rate
Kriti,EL43,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.76,Rate
Kriti,EL43,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.13,Rate
Kriti,EL43,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",410.34,Rate
Kriti,EL43,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",404.02,Rate
Kriti,EL43,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",401.83,Rate
Kriti,EL43,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",438.97,Rate
Kriti,EL43,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",459.56,Rate
Kriti,EL43,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",472.28,Rate
Kriti,EL43,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",523.43,Rate
Kriti,EL43,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",412.82,Rate
Kriti,EL43,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",450.33,Rate
Kriti,EL43,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",385.92,Rate
Kriti,EL43,65 years or over,Males,2011,Malignant melanoma of skin,7.72,Rate
Kriti,EL43,65 years or over,Males,2012,Malignant melanoma of skin,9.74,Rate
Kriti,EL43,65 years or over,Males,2013,Malignant melanoma of skin,8.51,Rate
Kriti,EL43,65 years or over,Males,2014,Malignant melanoma of skin,14.09,Rate
Kriti,EL43,65 years or over,Males,2015,Malignant melanoma of skin,7.86,Rate
Kriti,EL43,65 years or over,Males,2016,Malignant melanoma of skin,6.8,Rate
Kriti,EL43,65 years or over,Males,2017,Malignant melanoma of skin,10.78,Rate
Kriti,EL43,65 years or over,Males,2018,Malignant melanoma of skin,12.24,Rate
Kriti,EL43,65 years or over,Males,2019,Malignant melanoma of skin,10.21,Rate
Kriti,EL43,65 years or over,Males,2020,Malignant melanoma of skin,1.45,Rate
Kriti,EL43,65 years or over,Males,2011,Malignant neoplasm of breast,3.72,Rate
Kriti,EL43,65 years or over,Males,2012,Malignant neoplasm of breast,3.59,Rate
Kriti,EL43,65 years or over,Males,2013,Malignant neoplasm of breast,3.71,Rate
Kriti,EL43,65 years or over,Males,2014,Malignant neoplasm of breast,5.53,Rate
Kriti,EL43,65 years or over,Males,2016,Malignant neoplasm of breast,3.34,Rate
Kriti,EL43,65 years or over,Males,2017,Malignant neoplasm of breast,1.95,Rate
Kriti,EL43,65 years or over,Males,2018,Malignant neoplasm of breast,3.35,Rate
Kriti,EL43,65 years or over,Males,2019,Malignant neoplasm of breast,3.94,Rate
Kriti,EL43,65 years or over,Males,2020,Malignant neoplasm of breast,3.56,Rate
Kriti,EL43,65 years or over,Males,2011,Diabetes mellitus,42.95,Rate
Kriti,EL43,65 years or over,Males,2012,Diabetes mellitus,69.26,Rate
Kriti,EL43,65 years or over,Males,2013,Diabetes mellitus,53.02,Rate
Kriti,EL43,65 years or over,Males,2014,Diabetes mellitus,60.7,Rate
Kriti,EL43,65 years or over,Males,2015,Diabetes mellitus,64.33,Rate
Kriti,EL43,65 years or over,Males,2016,Diabetes mellitus,56.18,Rate
Kriti,EL43,65 years or over,Males,2017,Diabetes mellitus,70.02,Rate
Kriti,EL43,65 years or over,Males,2018,Diabetes mellitus,92.55,Rate
Kriti,EL43,65 years or over,Males,2019,Diabetes mellitus,86.41,Rate
Kriti,EL43,65 years or over,Males,2020,Diabetes mellitus,84.73,Rate
Kriti,EL43,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),5.82,Rate
Kriti,EL43,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),1.9,Rate
Kriti,EL43,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Kriti,EL43,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),17.59,Rate
Kriti,EL43,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),34.07,Rate
Kriti,EL43,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),28.79,Rate
Kriti,EL43,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),36.43,Rate
Kriti,EL43,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),29.69,Rate
Kriti,EL43,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),61.91,Rate
Kriti,EL43,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),39.83,Rate
Kriti,EL43,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.46,Rate
Kriti,EL43,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.5,Rate
Kriti,EL43,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.97,Rate
Kriti,EL43,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),7.36,Rate
Kriti,EL43,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Kriti,EL43,65 years or over,Males,2011,Other ischaemic heart diseases,200.42,Rate
Kriti,EL43,65 years or over,Males,2012,Other ischaemic heart diseases,187.94,Rate
Kriti,EL43,65 years or over,Males,2013,Other ischaemic heart diseases,219.74,Rate
Kriti,EL43,65 years or over,Males,2014,Other ischaemic heart diseases,243.28,Rate
Kriti,EL43,65 years or over,Males,2015,Other ischaemic heart diseases,202.21,Rate
Kriti,EL43,65 years or over,Males,2016,Other ischaemic heart diseases,231.33,Rate
Kriti,EL43,65 years or over,Males,2017,Other ischaemic heart diseases,234.26,Rate
Kriti,EL43,65 years or over,Males,2018,Other ischaemic heart diseases,214.14,Rate
Kriti,EL43,65 years or over,Males,2019,Other ischaemic heart diseases,251.16,Rate
Kriti,EL43,65 years or over,Males,2020,Other ischaemic heart diseases,205.74,Rate
Kriti,EL43,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,267.24,Rate
Kriti,EL43,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,190.3,Rate
Kriti,EL43,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,173.09,Rate
Kriti,EL43,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,176.62,Rate
Kriti,EL43,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,152.8,Rate
Kriti,EL43,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,111.07,Rate
Kriti,EL43,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,171.18,Rate
Kriti,EL43,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,217.99,Rate
Kriti,EL43,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,218.35,Rate
Kriti,EL43,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,197.28,Rate
Kriti,EL43,65 years or over,Males,2011,Cerebrovascular diseases,524.52,Rate
Kriti,EL43,65 years or over,Males,2012,Cerebrovascular diseases,479.56,Rate
Kriti,EL43,65 years or over,Males,2013,Cerebrovascular diseases,383.72,Rate
Kriti,EL43,65 years or over,Males,2014,Cerebrovascular diseases,431.36,Rate
Kriti,EL43,65 years or over,Males,2015,Cerebrovascular diseases,469.17,Rate
Kriti,EL43,65 years or over,Males,2016,Cerebrovascular diseases,362.58,Rate
Kriti,EL43,65 years or over,Males,2017,Cerebrovascular diseases,399.17,Rate
Kriti,EL43,65 years or over,Males,2018,Cerebrovascular diseases,352.92,Rate
Kriti,EL43,65 years or over,Males,2019,Cerebrovascular diseases,382.13,Rate
Kriti,EL43,65 years or over,Males,2020,Cerebrovascular diseases,360.98,Rate
Kriti,EL43,65 years or over,Males,2011,Chronic lower respiratory diseases,248.77,Rate
Kriti,EL43,65 years or over,Males,2012,Chronic lower respiratory diseases,200.23,Rate
Kriti,EL43,65 years or over,Males,2013,Chronic lower respiratory diseases,200.03,Rate
Kriti,EL43,65 years or over,Males,2014,Chronic lower respiratory diseases,269.01,Rate
Kriti,EL43,65 years or over,Males,2015,Chronic lower respiratory diseases,258.43,Rate
Kriti,EL43,65 years or over,Males,2016,Chronic lower respiratory diseases,218.82,Rate
Kriti,EL43,65 years or over,Males,2017,Chronic lower respiratory diseases,254.08,Rate
Kriti,EL43,65 years or over,Males,2018,Chronic lower respiratory diseases,222.02,Rate
Kriti,EL43,65 years or over,Males,2019,Chronic lower respiratory diseases,266.54,Rate
Kriti,EL43,65 years or over,Males,2020,Chronic lower respiratory diseases,207.17,Rate
Kriti,EL43,65 years or over,Males,2019,Asthma and status asthmaticus,1.53,Rate
Kriti,EL43,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,237.91,Rate
Kriti,EL43,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,269.97,Rate
Kriti,EL43,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,243.59,Rate
Kriti,EL43,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,254.86,Rate
Kriti,EL43,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,249.01,Rate
Kriti,EL43,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,234.67,Rate
Kriti,EL43,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,240.47,Rate
Kriti,EL43,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,233.92,Rate
Kriti,EL43,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,243.59,Rate
Kriti,EL43,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,221.65,Rate
Kriti,EL43,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.35,Rate
Kriti,EL43,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.65,Rate
Kriti,EL43,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.49,Rate
Kriti,EL43,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.31,Rate
Kriti,EL43,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.29,Rate
Kriti,EL43,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.48,Rate
Kriti,EL43,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.57,Rate
Kriti,EL43,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.73,Rate
Kriti,EL43,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.98,Rate
Kriti,EL43,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.42,Rate
Kriti,EL43,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",35.18,Rate
Kriti,EL43,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",38.91,Rate
Kriti,EL43,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",39.87,Rate
Kriti,EL43,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",34.37,Rate
Kriti,EL43,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",42.5,Rate
Kriti,EL43,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",38.05,Rate
Kriti,EL43,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",36.89,Rate
Kriti,EL43,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",31.84,Rate
Kriti,EL43,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",35.09,Rate
Kriti,EL43,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",29.08,Rate
Kriti,EL43,Less than 65 years,Males,2011,Malignant melanoma of skin,1.75,Rate
Kriti,EL43,Less than 65 years,Males,2012,Malignant melanoma of skin,1.41,Rate
Kriti,EL43,Less than 65 years,Males,2013,Malignant melanoma of skin,0.46,Rate
Kriti,EL43,Less than 65 years,Males,2014,Malignant melanoma of skin,1.66,Rate
Kriti,EL43,Less than 65 years,Males,2015,Malignant melanoma of skin,0.82,Rate
Kriti,EL43,Less than 65 years,Males,2016,Malignant melanoma of skin,2.14,Rate
Kriti,EL43,Less than 65 years,Males,2017,Malignant melanoma of skin,1.54,Rate
Kriti,EL43,Less than 65 years,Males,2018,Malignant melanoma of skin,0.36,Rate
Kriti,EL43,Less than 65 years,Males,2019,Malignant melanoma of skin,1.22,Rate
Kriti,EL43,Less than 65 years,Males,2020,Malignant melanoma of skin,1.67,Rate
Kriti,EL43,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Kriti,EL43,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.45,Rate
Kriti,EL43,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.45,Rate
Kriti,EL43,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Kriti,EL43,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.46,Rate
Kriti,EL43,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Kriti,EL43,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.43,Rate
Kriti,EL43,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Kriti,EL43,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.42,Rate
Kriti,EL43,Less than 65 years,Males,2011,Diabetes mellitus,3.53,Rate
Kriti,EL43,Less than 65 years,Males,2012,Diabetes mellitus,0.87,Rate
Kriti,EL43,Less than 65 years,Males,2013,Diabetes mellitus,3.57,Rate
Kriti,EL43,Less than 65 years,Males,2014,Diabetes mellitus,6.41,Rate
Kriti,EL43,Less than 65 years,Males,2015,Diabetes mellitus,5.96,Rate
Kriti,EL43,Less than 65 years,Males,2016,Diabetes mellitus,3.94,Rate
Kriti,EL43,Less than 65 years,Males,2017,Diabetes mellitus,2.94,Rate
Kriti,EL43,Less than 65 years,Males,2018,Diabetes mellitus,3.43,Rate
Kriti,EL43,Less than 65 years,Males,2019,Diabetes mellitus,1.72,Rate
Kriti,EL43,Less than 65 years,Males,2020,Diabetes mellitus,4.03,Rate
Kriti,EL43,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),2.34,Rate
Kriti,EL43,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),0.48,Rate
Kriti,EL43,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.36,Rate
Kriti,EL43,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.84,Rate
Kriti,EL43,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.27,Rate
Kriti,EL43,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.82,Rate
Kriti,EL43,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.25,Rate
Kriti,EL43,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.18,Rate
Kriti,EL43,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),4.16,Rate
Kriti,EL43,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),1.3,Rate
Kriti,EL43,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.38,Rate
Kriti,EL43,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Kriti,EL43,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Kriti,EL43,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Kriti,EL43,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.18,Rate
Kriti,EL43,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.16,Rate
Kriti,EL43,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Kriti,EL43,Less than 65 years,Males,2011,Other ischaemic heart diseases,9.85,Rate
Kriti,EL43,Less than 65 years,Males,2012,Other ischaemic heart diseases,17.04,Rate
Kriti,EL43,Less than 65 years,Males,2013,Other ischaemic heart diseases,9.69,Rate
Kriti,EL43,Less than 65 years,Males,2014,Other ischaemic heart diseases,17.18,Rate
Kriti,EL43,Less than 65 years,Males,2015,Other ischaemic heart diseases,20.38,Rate
Kriti,EL43,Less than 65 years,Males,2016,Other ischaemic heart diseases,17.57,Rate
Kriti,EL43,Less than 65 years,Males,2017,Other ischaemic heart diseases,15.28,Rate
Kriti,EL43,Less than 65 years,Males,2018,Other ischaemic heart diseases,10.96,Rate
Kriti,EL43,Less than 65 years,Males,2019,Other ischaemic heart diseases,17.16,Rate
Kriti,EL43,Less than 65 years,Males,2020,Other ischaemic heart diseases,11.04,Rate
Kriti,EL43,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,23.29,Rate
Kriti,EL43,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,28.54,Rate
Kriti,EL43,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,19.15,Rate
Kriti,EL43,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,17.37,Rate
Kriti,EL43,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,15.8,Rate
Kriti,EL43,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,12.65,Rate
Kriti,EL43,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,18.74,Rate
Kriti,EL43,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,20.56,Rate
Kriti,EL43,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,17.21,Rate
Kriti,EL43,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,16.48,Rate
Kriti,EL43,Less than 65 years,Males,2011,Cerebrovascular diseases,8.37,Rate
Kriti,EL43,Less than 65 years,Males,2012,Cerebrovascular diseases,10.62,Rate
Kriti,EL43,Less than 65 years,Males,2013,Cerebrovascular diseases,10.79,Rate
Kriti,EL43,Less than 65 years,Males,2014,Cerebrovascular diseases,8.79,Rate
Kriti,EL43,Less than 65 years,Males,2015,Cerebrovascular diseases,9.06,Rate
Kriti,EL43,Less than 65 years,Males,2016,Cerebrovascular diseases,8.14,Rate
Kriti,EL43,Less than 65 years,Males,2017,Cerebrovascular diseases,9.62,Rate
Kriti,EL43,Less than 65 years,Males,2018,Cerebrovascular diseases,11.77,Rate
Kriti,EL43,Less than 65 years,Males,2019,Cerebrovascular diseases,5.69,Rate
Kriti,EL43,Less than 65 years,Males,2020,Cerebrovascular diseases,9.2,Rate
Kriti,EL43,Less than 65 years,Males,2011,Chronic lower respiratory diseases,2.22,Rate
Kriti,EL43,Less than 65 years,Males,2012,Chronic lower respiratory diseases,3.73,Rate
Kriti,EL43,Less than 65 years,Males,2013,Chronic lower respiratory diseases,3.22,Rate
Kriti,EL43,Less than 65 years,Males,2014,Chronic lower respiratory diseases,5.78,Rate
Kriti,EL43,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.49,Rate
Kriti,EL43,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.3,Rate
Kriti,EL43,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.61,Rate
Kriti,EL43,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.39,Rate
Kriti,EL43,Less than 65 years,Males,2019,Chronic lower respiratory diseases,4.63,Rate
Kriti,EL43,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.87,Rate
Kriti,EL43,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,982.98,Rate
Kriti,EL43,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,993.02,Rate
Kriti,EL43,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,922.81,Rate
Kriti,EL43,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,933.97,Rate
Kriti,EL43,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,968.55,Rate
Kriti,EL43,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,917.57,Rate
Kriti,EL43,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,962.94,Rate
Kriti,EL43,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,884.21,Rate
Kriti,EL43,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,928.18,Rate
Kriti,EL43,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,930.13,Rate
Kriti,EL43,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.17,Rate
Kriti,EL43,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.04,Rate
Kriti,EL43,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.65,Rate
Kriti,EL43,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.17,Rate
Kriti,EL43,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.71,Rate
Kriti,EL43,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.02,Rate
Kriti,EL43,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.62,Rate
Kriti,EL43,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.26,Rate
Kriti,EL43,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.08,Rate
Kriti,EL43,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.23,Rate
Kriti,EL43,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",58.31,Rate
Kriti,EL43,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",59.37,Rate
Kriti,EL43,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",62.72,Rate
Kriti,EL43,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",62.81,Rate
Kriti,EL43,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",67.63,Rate
Kriti,EL43,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",66.54,Rate
Kriti,EL43,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",71.99,Rate
Kriti,EL43,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",61.62,Rate
Kriti,EL43,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",66.23,Rate
Kriti,EL43,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",58.64,Rate
Kriti,EL43,Total,Total,2011,Malignant melanoma of skin,1.99,Rate
Kriti,EL43,Total,Total,2012,Malignant melanoma of skin,2.92,Rate
Kriti,EL43,Total,Total,2013,Malignant melanoma of skin,1.6,Rate
Kriti,EL43,Total,Total,2014,Malignant melanoma of skin,2.85,Rate
Kriti,EL43,Total,Total,2015,Malignant melanoma of skin,1.81,Rate
Kriti,EL43,Total,Total,2016,Malignant melanoma of skin,2.22,Rate
Kriti,EL43,Total,Total,2017,Malignant melanoma of skin,2.4,Rate
Kriti,EL43,Total,Total,2018,Malignant melanoma of skin,2.21,Rate
Kriti,EL43,Total,Total,2019,Malignant melanoma of skin,2.64,Rate
Kriti,EL43,Total,Total,2020,Malignant melanoma of skin,1.93,Rate
Kriti,EL43,Total,Total,2011,Malignant neoplasm of breast,15.36,Rate
Kriti,EL43,Total,Total,2012,Malignant neoplasm of breast,16.38,Rate
Kriti,EL43,Total,Total,2013,Malignant neoplasm of breast,16.28,Rate
Kriti,EL43,Total,Total,2014,Malignant neoplasm of breast,14.89,Rate
Kriti,EL43,Total,Total,2015,Malignant neoplasm of breast,15.75,Rate
Kriti,EL43,Total,Total,2016,Malignant neoplasm of breast,17.76,Rate
Kriti,EL43,Total,Total,2017,Malignant neoplasm of breast,15.51,Rate
Kriti,EL43,Total,Total,2018,Malignant neoplasm of breast,12.86,Rate
Kriti,EL43,Total,Total,2019,Malignant neoplasm of breast,13.74,Rate
Kriti,EL43,Total,Total,2020,Malignant neoplasm of breast,15.53,Rate
Kriti,EL43,Total,Total,2011,Diabetes mellitus,10.09,Rate
Kriti,EL43,Total,Total,2012,Diabetes mellitus,8.47,Rate
Kriti,EL43,Total,Total,2013,Diabetes mellitus,11.08,Rate
Kriti,EL43,Total,Total,2014,Diabetes mellitus,10.71,Rate
Kriti,EL43,Total,Total,2015,Diabetes mellitus,12.81,Rate
Kriti,EL43,Total,Total,2016,Diabetes mellitus,11.51,Rate
Kriti,EL43,Total,Total,2017,Diabetes mellitus,13.14,Rate
Kriti,EL43,Total,Total,2018,Diabetes mellitus,17.92,Rate
Kriti,EL43,Total,Total,2019,Diabetes mellitus,17.86,Rate
Kriti,EL43,Total,Total,2020,Diabetes mellitus,15.32,Rate
Kriti,EL43,Total,Total,2011,Mental and behavioural disorders (F00-F99),1.76,Rate
Kriti,EL43,Total,Total,2012,Mental and behavioural disorders (F00-F99),0.8,Rate
Kriti,EL43,Total,Total,2013,Mental and behavioural disorders (F00-F99),0.42,Rate
Kriti,EL43,Total,Total,2014,Mental and behavioural disorders (F00-F99),5.57,Rate
Kriti,EL43,Total,Total,2015,Mental and behavioural disorders (F00-F99),7.52,Rate
Kriti,EL43,Total,Total,2016,Mental and behavioural disorders (F00-F99),8.82,Rate
Kriti,EL43,Total,Total,2017,Mental and behavioural disorders (F00-F99),12.74,Rate
Kriti,EL43,Total,Total,2018,Mental and behavioural disorders (F00-F99),8.13,Rate
Kriti,EL43,Total,Total,2019,Mental and behavioural disorders (F00-F99),16.74,Rate
Kriti,EL43,Total,Total,2020,Mental and behavioural disorders (F00-F99),13.1,Rate
Kriti,EL43,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Kriti,EL43,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Kriti,EL43,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Kriti,EL43,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Kriti,EL43,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Kriti,EL43,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.93,Rate
Kriti,EL43,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.39,Rate
Kriti,EL43,Total,Total,2011,Other ischaemic heart diseases,33.03,Rate
Kriti,EL43,Total,Total,2012,Other ischaemic heart diseases,37.16,Rate
Kriti,EL43,Total,Total,2013,Other ischaemic heart diseases,37.85,Rate
Kriti,EL43,Total,Total,2014,Other ischaemic heart diseases,48.45,Rate
Kriti,EL43,Total,Total,2015,Other ischaemic heart diseases,40.57,Rate
Kriti,EL43,Total,Total,2016,Other ischaemic heart diseases,41.31,Rate
Kriti,EL43,Total,Total,2017,Other ischaemic heart diseases,42.73,Rate
Kriti,EL43,Total,Total,2018,Other ischaemic heart diseases,33.79,Rate
Kriti,EL43,Total,Total,2019,Other ischaemic heart diseases,42.07,Rate
Kriti,EL43,Total,Total,2020,Other ischaemic heart diseases,37.18,Rate
Kriti,EL43,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,50.43,Rate
Kriti,EL43,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,42.47,Rate
Kriti,EL43,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,37.55,Rate
Kriti,EL43,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,33.71,Rate
Kriti,EL43,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,31.69,Rate
Kriti,EL43,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,26.18,Rate
Kriti,EL43,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,37.07,Rate
Kriti,EL43,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,40.23,Rate
Kriti,EL43,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,40.11,Rate
Kriti,EL43,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,39.08,Rate
Kriti,EL43,Total,Total,2011,Cerebrovascular diseases,113.92,Rate
Kriti,EL43,Total,Total,2012,Cerebrovascular diseases,106.17,Rate
Kriti,EL43,Total,Total,2013,Cerebrovascular diseases,89.95,Rate
Kriti,EL43,Total,Total,2014,Cerebrovascular diseases,93.83,Rate
Kriti,EL43,Total,Total,2015,Cerebrovascular diseases,95.58,Rate
Kriti,EL43,Total,Total,2016,Cerebrovascular diseases,82.08,Rate
Kriti,EL43,Total,Total,2017,Cerebrovascular diseases,84.84,Rate
Kriti,EL43,Total,Total,2018,Cerebrovascular diseases,74.5,Rate
Kriti,EL43,Total,Total,2019,Cerebrovascular diseases,79.66,Rate
Kriti,EL43,Total,Total,2020,Cerebrovascular diseases,75.69,Rate
Kriti,EL43,Total,Total,2011,Chronic lower respiratory diseases,31.55,Rate
Kriti,EL43,Total,Total,2012,Chronic lower respiratory diseases,28.46,Rate
Kriti,EL43,Total,Total,2013,Chronic lower respiratory diseases,27.39,Rate
Kriti,EL43,Total,Total,2014,Chronic lower respiratory diseases,35.87,Rate
Kriti,EL43,Total,Total,2015,Chronic lower respiratory diseases,35.9,Rate
Kriti,EL43,Total,Total,2016,Chronic lower respiratory diseases,29.19,Rate
Kriti,EL43,Total,Total,2017,Chronic lower respiratory diseases,35.03,Rate
Kriti,EL43,Total,Total,2018,Chronic lower respiratory diseases,31.33,Rate
Kriti,EL43,Total,Total,2019,Chronic lower respiratory diseases,35.5,Rate
Kriti,EL43,Total,Total,2020,Chronic lower respiratory diseases,27.85,Rate
Kriti,EL43,Total,Total,2012,Asthma and status asthmaticus,0.14,Rate
Kriti,EL43,Total,Total,2013,Asthma and status asthmaticus,0.13,Rate
Kriti,EL43,Total,Total,2014,Asthma and status asthmaticus,0.13,Rate
Kriti,EL43,Total,Total,2015,Asthma and status asthmaticus,0.27,Rate
Kriti,EL43,Total,Total,2019,Asthma and status asthmaticus,0.29,Rate
Kriti,EL43,Total,Total,2020,Asthma and status asthmaticus,0.33,Rate
Kriti,EL43,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4338.28,Rate
Kriti,EL43,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4322.6,Rate
Kriti,EL43,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4026.08,Rate
Kriti,EL43,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4054.16,Rate
Kriti,EL43,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4253.51,Rate
Kriti,EL43,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4007.34,Rate
Kriti,EL43,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4221.91,Rate
Kriti,EL43,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3855.02,Rate
Kriti,EL43,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4056.61,Rate
Kriti,EL43,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4112.03,Rate
Kriti,EL43,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",96.76,Rate
Kriti,EL43,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.95,Rate
Kriti,EL43,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.72,Rate
Kriti,EL43,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.37,Rate
Kriti,EL43,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.42,Rate
Kriti,EL43,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.67,Rate
Kriti,EL43,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.44,Rate
Kriti,EL43,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.03,Rate
Kriti,EL43,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.96,Rate
Kriti,EL43,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.24,Rate
Kriti,EL43,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",212.86,Rate
Kriti,EL43,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",206.87,Rate
Kriti,EL43,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",215.49,Rate
Kriti,EL43,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",228.94,Rate
Kriti,EL43,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",245.01,Rate
Kriti,EL43,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",244.86,Rate
Kriti,EL43,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",269.65,Rate
Kriti,EL43,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",224.15,Rate
Kriti,EL43,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",243.56,Rate
Kriti,EL43,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",221.72,Rate
Kriti,EL43,65 years or over,Total,2011,Malignant melanoma of skin,5.68,Rate
Kriti,EL43,65 years or over,Total,2012,Malignant melanoma of skin,9.76,Rate
Kriti,EL43,65 years or over,Total,2013,Malignant melanoma of skin,6.38,Rate
Kriti,EL43,65 years or over,Total,2014,Malignant melanoma of skin,7.04,Rate
Kriti,EL43,65 years or over,Total,2015,Malignant melanoma of skin,6.87,Rate
Kriti,EL43,65 years or over,Total,2016,Malignant melanoma of skin,6.21,Rate
Kriti,EL43,65 years or over,Total,2017,Malignant melanoma of skin,8.34,Rate
Kriti,EL43,65 years or over,Total,2018,Malignant melanoma of skin,8.05,Rate
Kriti,EL43,65 years or over,Total,2019,Malignant melanoma of skin,9.41,Rate
Kriti,EL43,65 years or over,Total,2020,Malignant melanoma of skin,6.56,Rate
Kriti,EL43,65 years or over,Total,2011,Malignant neoplasm of breast,60.03,Rate
Kriti,EL43,65 years or over,Total,2012,Malignant neoplasm of breast,61.35,Rate
Kriti,EL43,65 years or over,Total,2013,Malignant neoplasm of breast,61.95,Rate
Kriti,EL43,65 years or over,Total,2014,Malignant neoplasm of breast,50.97,Rate
Kriti,EL43,65 years or over,Total,2015,Malignant neoplasm of breast,65.93,Rate
Kriti,EL43,65 years or over,Total,2016,Malignant neoplasm of breast,62.77,Rate
Kriti,EL43,65 years or over,Total,2017,Malignant neoplasm of breast,56.29,Rate
Kriti,EL43,65 years or over,Total,2018,Malignant neoplasm of breast,48.08,Rate
Kriti,EL43,65 years or over,Total,2019,Malignant neoplasm of breast,52.69,Rate
Kriti,EL43,65 years or over,Total,2020,Malignant neoplasm of breast,57.19,Rate
Kriti,EL43,65 years or over,Total,2011,Diabetes mellitus,43.56,Rate
Kriti,EL43,65 years or over,Total,2012,Diabetes mellitus,40.71,Rate
Kriti,EL43,65 years or over,Total,2013,Diabetes mellitus,47.01,Rate
Kriti,EL43,65 years or over,Total,2014,Diabetes mellitus,39.36,Rate
Kriti,EL43,65 years or over,Total,2015,Diabetes mellitus,53.78,Rate
Kriti,EL43,65 years or over,Total,2016,Diabetes mellitus,49.36,Rate
Kriti,EL43,65 years or over,Total,2017,Diabetes mellitus,58.96,Rate
Kriti,EL43,65 years or over,Total,2018,Diabetes mellitus,84.18,Rate
Kriti,EL43,65 years or over,Total,2019,Diabetes mellitus,85.0,Rate
Kriti,EL43,65 years or over,Total,2020,Diabetes mellitus,70.5,Rate
Kriti,EL43,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),3.5,Rate
Kriti,EL43,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),3.15,Rate
Kriti,EL43,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),1.41,Rate
Kriti,EL43,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),25.02,Rate
Kriti,EL43,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),36.04,Rate
Kriti,EL43,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),43.55,Rate
Kriti,EL43,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),60.46,Rate
Kriti,EL43,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),36.86,Rate
Kriti,EL43,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),77.52,Rate
Kriti,EL43,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),63.78,Rate
Kriti,EL43,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.91,Rate
Kriti,EL43,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.18,Rate
Kriti,EL43,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Kriti,EL43,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.91,Rate
Kriti,EL43,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.8,Rate
Kriti,EL43,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),5.64,Rate
Kriti,EL43,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.68,Rate
Kriti,EL43,65 years or over,Total,2011,Other ischaemic heart diseases,146.65,Rate
Kriti,EL43,65 years or over,Total,2012,Other ischaemic heart diseases,152.44,Rate
Kriti,EL43,65 years or over,Total,2013,Other ischaemic heart diseases,168.17,Rate
Kriti,EL43,65 years or over,Total,2014,Other ischaemic heart diseases,208.25,Rate
Kriti,EL43,65 years or over,Total,2015,Other ischaemic heart diseases,159.07,Rate
Kriti,EL43,65 years or over,Total,2016,Other ischaemic heart diseases,172.03,Rate
Kriti,EL43,65 years or over,Total,2017,Other ischaemic heart diseases,187.05,Rate
Kriti,EL43,65 years or over,Total,2018,Other ischaemic heart diseases,146.41,Rate
Kriti,EL43,65 years or over,Total,2019,Other ischaemic heart diseases,176.49,Rate
Kriti,EL43,65 years or over,Total,2020,Other ischaemic heart diseases,163.05,Rate
Kriti,EL43,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,199.18,Rate
Kriti,EL43,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,145.99,Rate
Kriti,EL43,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,137.56,Rate
Kriti,EL43,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,131.85,Rate
Kriti,EL43,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,127.97,Rate
Kriti,EL43,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,103.63,Rate
Kriti,EL43,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,142.29,Rate
Kriti,EL43,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,156.77,Rate
Kriti,EL43,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,162.1,Rate
Kriti,EL43,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,159.29,Rate
Kriti,EL43,65 years or over,Total,2011,Cerebrovascular diseases,553.04,Rate
Kriti,EL43,65 years or over,Total,2012,Cerebrovascular diseases,512.6,Rate
Kriti,EL43,65 years or over,Total,2013,Cerebrovascular diseases,428.92,Rate
Kriti,EL43,65 years or over,Total,2014,Cerebrovascular diseases,453.92,Rate
Kriti,EL43,65 years or over,Total,2015,Cerebrovascular diseases,461.54,Rate
Kriti,EL43,65 years or over,Total,2016,Cerebrovascular diseases,394.5,Rate
Kriti,EL43,65 years or over,Total,2017,Cerebrovascular diseases,408.96,Rate
Kriti,EL43,65 years or over,Total,2018,Cerebrovascular diseases,348.48,Rate
Kriti,EL43,65 years or over,Total,2019,Cerebrovascular diseases,386.24,Rate
Kriti,EL43,65 years or over,Total,2020,Cerebrovascular diseases,360.8,Rate
Kriti,EL43,65 years or over,Total,2011,Chronic lower respiratory diseases,155.43,Rate
Kriti,EL43,65 years or over,Total,2012,Chronic lower respiratory diseases,135.83,Rate
Kriti,EL43,65 years or over,Total,2013,Chronic lower respiratory diseases,133.0,Rate
Kriti,EL43,65 years or over,Total,2014,Chronic lower respiratory diseases,171.36,Rate
Kriti,EL43,65 years or over,Total,2015,Chronic lower respiratory diseases,167.0,Rate
Kriti,EL43,65 years or over,Total,2016,Chronic lower respiratory diseases,143.37,Rate
Kriti,EL43,65 years or over,Total,2017,Chronic lower respiratory diseases,171.05,Rate
Kriti,EL43,65 years or over,Total,2018,Chronic lower respiratory diseases,152.14,Rate
Kriti,EL43,65 years or over,Total,2019,Chronic lower respiratory diseases,166.05,Rate
Kriti,EL43,65 years or over,Total,2020,Chronic lower respiratory diseases,136.25,Rate
Kriti,EL43,65 years or over,Total,2012,Asthma and status asthmaticus,0.7,Rate
Kriti,EL43,65 years or over,Total,2013,Asthma and status asthmaticus,0.68,Rate
Kriti,EL43,65 years or over,Total,2014,Asthma and status asthmaticus,0.67,Rate
Kriti,EL43,65 years or over,Total,2015,Asthma and status asthmaticus,0.67,Rate
Kriti,EL43,65 years or over,Total,2019,Asthma and status asthmaticus,0.65,Rate
Kriti,EL43,65 years or over,Total,2020,Asthma and status asthmaticus,0.86,Rate
Kriti,EL43,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,170.2,Rate
Kriti,EL43,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,186.47,Rate
Kriti,EL43,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,171.08,Rate
Kriti,EL43,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,178.14,Rate
Kriti,EL43,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,172.82,Rate
Kriti,EL43,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,169.11,Rate
Kriti,EL43,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,173.5,Rate
Kriti,EL43,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,164.57,Rate
Kriti,EL43,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,170.36,Rate
Kriti,EL43,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,159.36,Rate
Kriti,EL43,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.1,Rate
Kriti,EL43,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.16,Rate
Kriti,EL43,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.26,Rate
Kriti,EL43,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.71,Rate
Kriti,EL43,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.19,Rate
Kriti,EL43,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.67,Rate
Kriti,EL43,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.43,Rate
Kriti,EL43,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.08,Rate
Kriti,EL43,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.19,Rate
Kriti,EL43,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.31,Rate
Kriti,EL43,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",20.88,Rate
Kriti,EL43,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",23.64,Rate
Kriti,EL43,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",25.71,Rate
Kriti,EL43,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",22.57,Rate
Kriti,EL43,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",24.66,Rate
Kriti,EL43,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",23.35,Rate
Kriti,EL43,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",24.11,Rate
Kriti,EL43,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",22.26,Rate
Kriti,EL43,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",23.27,Rate
Kriti,EL43,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",19.14,Rate
Kriti,EL43,Less than 65 years,Total,2011,Malignant melanoma of skin,1.1,Rate
Kriti,EL43,Less than 65 years,Total,2012,Malignant melanoma of skin,1.27,Rate
Kriti,EL43,Less than 65 years,Total,2013,Malignant melanoma of skin,0.44,Rate
Kriti,EL43,Less than 65 years,Total,2014,Malignant melanoma of skin,1.84,Rate
Kriti,EL43,Less than 65 years,Total,2015,Malignant melanoma of skin,0.58,Rate
Kriti,EL43,Less than 65 years,Total,2016,Malignant melanoma of skin,1.26,Rate
Kriti,EL43,Less than 65 years,Total,2017,Malignant melanoma of skin,0.96,Rate
Kriti,EL43,Less than 65 years,Total,2018,Malignant melanoma of skin,0.79,Rate
Kriti,EL43,Less than 65 years,Total,2019,Malignant melanoma of skin,1.0,Rate
Kriti,EL43,Less than 65 years,Total,2020,Malignant melanoma of skin,0.81,Rate
Kriti,EL43,Less than 65 years,Total,2011,Malignant neoplasm of breast,4.54,Rate
Kriti,EL43,Less than 65 years,Total,2012,Malignant neoplasm of breast,5.49,Rate
Kriti,EL43,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.22,Rate
Kriti,EL43,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.15,Rate
Kriti,EL43,Less than 65 years,Total,2015,Malignant neoplasm of breast,3.59,Rate
Kriti,EL43,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.86,Rate
Kriti,EL43,Less than 65 years,Total,2017,Malignant neoplasm of breast,5.63,Rate
Kriti,EL43,Less than 65 years,Total,2018,Malignant neoplasm of breast,4.32,Rate
Kriti,EL43,Less than 65 years,Total,2019,Malignant neoplasm of breast,4.3,Rate
Kriti,EL43,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.44,Rate
Kriti,EL43,Less than 65 years,Total,2011,Diabetes mellitus,1.98,Rate
Kriti,EL43,Less than 65 years,Total,2012,Diabetes mellitus,0.66,Rate
Kriti,EL43,Less than 65 years,Total,2013,Diabetes mellitus,2.38,Rate
Kriti,EL43,Less than 65 years,Total,2014,Diabetes mellitus,3.77,Rate
Kriti,EL43,Less than 65 years,Total,2015,Diabetes mellitus,2.89,Rate
Kriti,EL43,Less than 65 years,Total,2016,Diabetes mellitus,2.35,Rate
Kriti,EL43,Less than 65 years,Total,2017,Diabetes mellitus,2.04,Rate
Kriti,EL43,Less than 65 years,Total,2018,Diabetes mellitus,1.87,Rate
Kriti,EL43,Less than 65 years,Total,2019,Diabetes mellitus,1.6,Rate
Kriti,EL43,Less than 65 years,Total,2020,Diabetes mellitus,1.96,Rate
Kriti,EL43,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),1.35,Rate
Kriti,EL43,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.23,Rate
Kriti,EL43,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.18,Rate
Kriti,EL43,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.86,Rate
Kriti,EL43,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.62,Rate
Kriti,EL43,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.4,Rate
Kriti,EL43,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.18,Rate
Kriti,EL43,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.17,Rate
Kriti,EL43,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.02,Rate
Kriti,EL43,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),0.83,Rate
Kriti,EL43,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Kriti,EL43,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Kriti,EL43,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Kriti,EL43,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Kriti,EL43,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Kriti,EL43,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Kriti,EL43,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Kriti,EL43,Less than 65 years,Total,2011,Other ischaemic heart diseases,5.5,Rate
Kriti,EL43,Less than 65 years,Total,2012,Other ischaemic heart diseases,9.23,Rate
Kriti,EL43,Less than 65 years,Total,2013,Other ischaemic heart diseases,6.28,Rate
Kriti,EL43,Less than 65 years,Total,2014,Other ischaemic heart diseases,9.75,Rate
Kriti,EL43,Less than 65 years,Total,2015,Other ischaemic heart diseases,11.87,Rate
Kriti,EL43,Less than 65 years,Total,2016,Other ischaemic heart diseases,9.64,Rate
Kriti,EL43,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.78,Rate
Kriti,EL43,Less than 65 years,Total,2018,Other ischaemic heart diseases,6.51,Rate
Kriti,EL43,Less than 65 years,Total,2019,Other ischaemic heart diseases,9.51,Rate
Kriti,EL43,Less than 65 years,Total,2020,Other ischaemic heart diseases,6.69,Rate
Kriti,EL43,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,14.4,Rate
Kriti,EL43,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,17.4,Rate
Kriti,EL43,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,13.32,Rate
Kriti,EL43,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,9.94,Rate
Kriti,EL43,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,8.37,Rate
Kriti,EL43,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,7.42,Rate
Kriti,EL43,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,11.58,Rate
Kriti,EL43,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.0,Rate
Kriti,EL43,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,10.56,Rate
Kriti,EL43,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,9.96,Rate
Kriti,EL43,Less than 65 years,Total,2011,Cerebrovascular diseases,7.55,Rate
Kriti,EL43,Less than 65 years,Total,2012,Cerebrovascular diseases,7.71,Rate
Kriti,EL43,Less than 65 years,Total,2013,Cerebrovascular diseases,7.84,Rate
Kriti,EL43,Less than 65 years,Total,2014,Cerebrovascular diseases,6.61,Rate
Kriti,EL43,Less than 65 years,Total,2015,Cerebrovascular diseases,6.93,Rate
Kriti,EL43,Less than 65 years,Total,2016,Cerebrovascular diseases,6.4,Rate
Kriti,EL43,Less than 65 years,Total,2017,Cerebrovascular diseases,6.32,Rate
Kriti,EL43,Less than 65 years,Total,2018,Cerebrovascular diseases,8.14,Rate
Kriti,EL43,Less than 65 years,Total,2019,Cerebrovascular diseases,5.39,Rate
Kriti,EL43,Less than 65 years,Total,2020,Cerebrovascular diseases,6.62,Rate
Kriti,EL43,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.54,Rate
Kriti,EL43,Less than 65 years,Total,2012,Chronic lower respiratory diseases,2.45,Rate
Kriti,EL43,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.8,Rate
Kriti,EL43,Less than 65 years,Total,2014,Chronic lower respiratory diseases,3.05,Rate
Kriti,EL43,Less than 65 years,Total,2015,Chronic lower respiratory diseases,4.15,Rate
Kriti,EL43,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.53,Rate
Kriti,EL43,Less than 65 years,Total,2017,Chronic lower respiratory diseases,2.08,Rate
Kriti,EL43,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.06,Rate
Kriti,EL43,Less than 65 years,Total,2019,Chronic lower respiratory diseases,3.88,Rate
Kriti,EL43,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.59,Rate
Kriti,EL43,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Kriti,EL43,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.18,Rate
Kriti,EL43,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.2,Rate
Kriti,EL43,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.2,Rate
Dytiki Makedonia,EL53,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,855.07,Rate
Dytiki Makedonia,EL53,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,790.64,Rate
Dytiki Makedonia,EL53,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,839.23,Rate
Dytiki Makedonia,EL53,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,767.81,Rate
Dytiki Makedonia,EL53,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,776.34,Rate
Dytiki Makedonia,EL53,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,713.16,Rate
Dytiki Makedonia,EL53,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,782.75,Rate
Dytiki Makedonia,EL53,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,877.66,Rate
Dytiki Makedonia,EL53,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.04,Rate
Dytiki Makedonia,EL53,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.83,Rate
Dytiki Makedonia,EL53,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.04,Rate
Dytiki Makedonia,EL53,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.83,Rate
Dytiki Makedonia,EL53,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.67,Rate
Dytiki Makedonia,EL53,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.91,Rate
Dytiki Makedonia,EL53,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.63,Rate
Dytiki Makedonia,EL53,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.84,Rate
Dytiki Makedonia,EL53,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",16.97,Rate
Dytiki Makedonia,EL53,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",13.34,Rate
Dytiki Makedonia,EL53,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",11.11,Rate
Dytiki Makedonia,EL53,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",11.86,Rate
Dytiki Makedonia,EL53,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",12.71,Rate
Dytiki Makedonia,EL53,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",15.61,Rate
Dytiki Makedonia,EL53,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",11.28,Rate
Dytiki Makedonia,EL53,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",19.39,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Malignant melanoma of skin,1.06,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Malignant melanoma of skin,3.85,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Malignant melanoma of skin,1.46,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Malignant melanoma of skin,1.64,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Malignant melanoma of skin,2.7,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Malignant melanoma of skin,3.21,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Malignant melanoma of skin,1.83,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Malignant neoplasm of breast,33.83,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Malignant neoplasm of breast,36.75,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Malignant neoplasm of breast,28.74,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Malignant neoplasm of breast,31.32,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Malignant neoplasm of breast,25.04,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Malignant neoplasm of breast,23.03,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Malignant neoplasm of breast,39.48,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Malignant neoplasm of breast,28.92,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Diabetes mellitus,12.56,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Diabetes mellitus,12.39,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Diabetes mellitus,13.58,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Diabetes mellitus,15.2,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Diabetes mellitus,12.69,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Diabetes mellitus,10.22,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Diabetes mellitus,14.84,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Diabetes mellitus,19.36,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Mental and behavioural disorders (F00-F99),3.82,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Mental and behavioural disorders (F00-F99),9.77,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Mental and behavioural disorders (F00-F99),14.32,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Mental and behavioural disorders (F00-F99),16.55,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Mental and behavioural disorders (F00-F99),15.87,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Mental and behavioural disorders (F00-F99),19.6,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Mental and behavioural disorders (F00-F99),20.87,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Mental and behavioural disorders (F00-F99),22.65,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.72,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.28,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.97,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.55,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.88,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Other ischaemic heart diseases,28.72,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Other ischaemic heart diseases,39.69,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Other ischaemic heart diseases,31.38,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Other ischaemic heart diseases,22.14,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Other ischaemic heart diseases,23.64,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Other ischaemic heart diseases,20.14,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Other ischaemic heart diseases,24.83,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Other ischaemic heart diseases,25.63,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,31.03,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,26.8,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,23.95,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,28.0,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,32.81,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,30.78,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,28.12,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,41.13,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Cerebrovascular diseases,155.58,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Cerebrovascular diseases,140.74,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Cerebrovascular diseases,130.65,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Cerebrovascular diseases,125.46,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Cerebrovascular diseases,123.59,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Cerebrovascular diseases,104.55,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Cerebrovascular diseases,110.26,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Cerebrovascular diseases,91.81,Rate
Dytiki Makedonia,EL53,Total,Females,2013,Chronic lower respiratory diseases,12.02,Rate
Dytiki Makedonia,EL53,Total,Females,2014,Chronic lower respiratory diseases,11.92,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Chronic lower respiratory diseases,19.06,Rate
Dytiki Makedonia,EL53,Total,Females,2016,Chronic lower respiratory diseases,12.79,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Chronic lower respiratory diseases,11.43,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Chronic lower respiratory diseases,14.2,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Chronic lower respiratory diseases,12.24,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Chronic lower respiratory diseases,13.44,Rate
Dytiki Makedonia,EL53,Total,Females,2015,Asthma and status asthmaticus,0.51,Rate
Dytiki Makedonia,EL53,Total,Females,2017,Asthma and status asthmaticus,0.38,Rate
Dytiki Makedonia,EL53,Total,Females,2018,Asthma and status asthmaticus,0.73,Rate
Dytiki Makedonia,EL53,Total,Females,2019,Asthma and status asthmaticus,0.35,Rate
Dytiki Makedonia,EL53,Total,Females,2020,Asthma and status asthmaticus,1.05,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3879.47,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3663.5,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3854.86,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3434.08,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3559.35,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3286.49,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3629.68,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4071.41,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.21,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.4,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.43,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.73,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",72.93,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.95,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.47,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",63.22,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",61.49,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",54.07,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",46.3,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",45.54,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",44.41,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",56.15,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",34.07,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",85.93,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Malignant melanoma of skin,5.45,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Malignant melanoma of skin,8.37,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Malignant melanoma of skin,8.41,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Malignant melanoma of skin,10.46,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Malignant melanoma of skin,16.44,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Malignant melanoma of skin,5.98,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Malignant neoplasm of breast,119.76,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Malignant neoplasm of breast,103.75,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Malignant neoplasm of breast,107.3,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Malignant neoplasm of breast,110.65,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Malignant neoplasm of breast,86.78,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Malignant neoplasm of breast,97.41,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Malignant neoplasm of breast,156.01,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Malignant neoplasm of breast,105.17,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Diabetes mellitus,53.08,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Diabetes mellitus,56.45,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Diabetes mellitus,69.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Diabetes mellitus,63.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Diabetes mellitus,61.68,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Diabetes mellitus,52.39,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Diabetes mellitus,69.19,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Diabetes mellitus,92.87,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),19.58,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),34.41,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),66.01,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),84.87,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),77.87,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),93.75,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),103.38,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),112.74,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.74,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),6.59,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),4.29,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),9.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Other ischaemic heart diseases,129.37,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Other ischaemic heart diseases,196.6,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Other ischaemic heart diseases,153.2,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Other ischaemic heart diseases,106.35,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Other ischaemic heart diseases,110.97,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Other ischaemic heart diseases,89.77,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Other ischaemic heart diseases,123.95,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Other ischaemic heart diseases,117.98,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,136.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,118.59,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,93.91,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,122.29,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,144.18,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,140.24,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,120.18,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,190.75,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Cerebrovascular diseases,780.48,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Cerebrovascular diseases,707.14,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Cerebrovascular diseases,634.3,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Cerebrovascular diseases,611.3,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Cerebrovascular diseases,615.49,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Cerebrovascular diseases,515.18,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Cerebrovascular diseases,541.98,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Cerebrovascular diseases,443.16,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2013,Chronic lower respiratory diseases,58.05,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2014,Chronic lower respiratory diseases,57.59,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Chronic lower respiratory diseases,94.12,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2016,Chronic lower respiratory diseases,65.6,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Chronic lower respiratory diseases,58.6,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Chronic lower respiratory diseases,72.8,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Chronic lower respiratory diseases,56.2,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Chronic lower respiratory diseases,62.51,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2015,Asthma and status asthmaticus,2.62,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2017,Asthma and status asthmaticus,1.96,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2018,Asthma and status asthmaticus,3.77,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2019,Asthma and status asthmaticus,1.8,Rate
Dytiki Makedonia,EL53,65 years or over,Females,2020,Asthma and status asthmaticus,5.37,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,122.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,94.73,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,108.74,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,121.95,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,102.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,89.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,93.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,104.02,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.56,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.13,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.71,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.77,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.9,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",6.18,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",3.47,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",2.59,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",3.7,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",5.03,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",5.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",5.76,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",3.28,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Malignant melanoma of skin,2.76,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Malignant melanoma of skin,1.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Malignant melanoma of skin,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Malignant melanoma of skin,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.02,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Malignant neoplasm of breast,20.52,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Malignant neoplasm of breast,9.71,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.1,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Malignant neoplasm of breast,10.09,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Malignant neoplasm of breast,5.02,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Malignant neoplasm of breast,11.25,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.45,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Diabetes mellitus,2.75,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Diabetes mellitus,1.72,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Diabetes mellitus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Diabetes mellitus,3.47,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Diabetes mellitus,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Diabetes mellitus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Diabetes mellitus,1.68,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Diabetes mellitus,1.56,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),3.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.8,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.85,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.64,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.83,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Other ischaemic heart diseases,4.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.68,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.87,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.74,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Other ischaemic heart diseases,2.48,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Other ischaemic heart diseases,3.28,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Other ischaemic heart diseases,3.25,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.57,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,7.01,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,5.16,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,5.83,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,4.27,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,5.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,4.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Cerebrovascular diseases,4.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Cerebrovascular diseases,3.54,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Cerebrovascular diseases,8.65,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Cerebrovascular diseases,7.78,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Cerebrovascular diseases,4.43,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Cerebrovascular diseases,5.08,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Cerebrovascular diseases,5.68,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Cerebrovascular diseases,6.7,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.87,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.87,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.59,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.56,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1173.2,Rate
Dytiki Makedonia,EL53,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1097.86,Rate
Dytiki Makedonia,EL53,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1148.24,Rate
Dytiki Makedonia,EL53,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1063.36,Rate
Dytiki Makedonia,EL53,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1096.66,Rate
Dytiki Makedonia,EL53,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1043.31,Rate
Dytiki Makedonia,EL53,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1044.76,Rate
Dytiki Makedonia,EL53,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1143.07,Rate
Dytiki Makedonia,EL53,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.3,Rate
Dytiki Makedonia,EL53,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.26,Rate
Dytiki Makedonia,EL53,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.7,Rate
Dytiki Makedonia,EL53,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.24,Rate
Dytiki Makedonia,EL53,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.33,Rate
Dytiki Makedonia,EL53,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.95,Rate
Dytiki Makedonia,EL53,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.5,Rate
Dytiki Makedonia,EL53,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.76,Rate
Dytiki Makedonia,EL53,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",100.88,Rate
Dytiki Makedonia,EL53,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",107.18,Rate
Dytiki Makedonia,EL53,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",82.8,Rate
Dytiki Makedonia,EL53,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",97.55,Rate
Dytiki Makedonia,EL53,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",113.57,Rate
Dytiki Makedonia,EL53,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",90.33,Rate
Dytiki Makedonia,EL53,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",93.51,Rate
Dytiki Makedonia,EL53,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",88.88,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Malignant melanoma of skin,4.02,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Malignant melanoma of skin,1.92,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Malignant melanoma of skin,3.76,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Malignant melanoma of skin,2.21,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Malignant melanoma of skin,3.16,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Malignant melanoma of skin,0.92,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Malignant melanoma of skin,5.42,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Malignant melanoma of skin,0.73,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Malignant neoplasm of breast,0.47,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Malignant neoplasm of breast,0.81,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Malignant neoplasm of breast,0.78,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Diabetes mellitus,13.25,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Diabetes mellitus,17.24,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Diabetes mellitus,15.9,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Diabetes mellitus,13.75,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Diabetes mellitus,15.88,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Diabetes mellitus,18.44,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Diabetes mellitus,21.01,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Diabetes mellitus,22.24,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Mental and behavioural disorders (F00-F99),1.21,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Mental and behavioural disorders (F00-F99),5.59,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Mental and behavioural disorders (F00-F99),13.24,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Mental and behavioural disorders (F00-F99),14.2,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Mental and behavioural disorders (F00-F99),16.99,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Mental and behavioural disorders (F00-F99),14.49,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Mental and behavioural disorders (F00-F99),19.37,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Mental and behavioural disorders (F00-F99),21.41,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.69,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.07,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.32,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),4.15,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.89,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),5.57,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Other ischaemic heart diseases,47.8,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Other ischaemic heart diseases,56.34,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Other ischaemic heart diseases,49.63,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Other ischaemic heart diseases,45.68,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Other ischaemic heart diseases,48.48,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Other ischaemic heart diseases,46.46,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Other ischaemic heart diseases,47.65,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Other ischaemic heart diseases,56.87,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,83.93,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,64.51,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,65.3,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,69.74,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,69.02,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,68.56,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,72.54,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,71.23,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Cerebrovascular diseases,151.1,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Cerebrovascular diseases,124.29,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Cerebrovascular diseases,136.07,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Cerebrovascular diseases,140.54,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Cerebrovascular diseases,114.08,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Cerebrovascular diseases,125.51,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Cerebrovascular diseases,99.23,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Cerebrovascular diseases,111.78,Rate
Dytiki Makedonia,EL53,Total,Males,2013,Chronic lower respiratory diseases,19.09,Rate
Dytiki Makedonia,EL53,Total,Males,2014,Chronic lower respiratory diseases,25.0,Rate
Dytiki Makedonia,EL53,Total,Males,2015,Chronic lower respiratory diseases,40.39,Rate
Dytiki Makedonia,EL53,Total,Males,2016,Chronic lower respiratory diseases,25.05,Rate
Dytiki Makedonia,EL53,Total,Males,2017,Chronic lower respiratory diseases,29.29,Rate
Dytiki Makedonia,EL53,Total,Males,2018,Chronic lower respiratory diseases,22.27,Rate
Dytiki Makedonia,EL53,Total,Males,2019,Chronic lower respiratory diseases,30.77,Rate
Dytiki Makedonia,EL53,Total,Males,2020,Chronic lower respiratory diseases,31.31,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4830.81,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4658.73,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4886.56,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4467.07,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4691.34,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4496.27,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4377.5,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4831.97,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.42,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.47,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",149.6,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",142.77,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.18,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.03,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.94,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.94,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",319.27,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",401.04,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",284.58,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",381.96,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",455.21,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",363.77,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",370.99,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",307.79,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Malignant melanoma of skin,13.28,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Malignant melanoma of skin,6.43,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Malignant melanoma of skin,12.29,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Malignant melanoma of skin,7.94,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Malignant melanoma of skin,16.18,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Malignant melanoma of skin,4.74,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Malignant melanoma of skin,24.55,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Malignant melanoma of skin,3.75,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Malignant neoplasm of breast,2.42,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Malignant neoplasm of breast,4.13,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Malignant neoplasm of breast,4.01,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Diabetes mellitus,60.53,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Diabetes mellitus,66.68,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Diabetes mellitus,60.56,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Diabetes mellitus,46.04,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Diabetes mellitus,67.89,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Diabetes mellitus,84.66,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Diabetes mellitus,94.35,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Diabetes mellitus,86.73,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),6.22,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),24.93,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),60.76,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),51.94,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),69.96,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),57.41,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),91.88,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),96.18,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),7.77,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.24,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),18.2,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Other ischaemic heart diseases,192.73,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Other ischaemic heart diseases,264.56,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Other ischaemic heart diseases,199.73,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Other ischaemic heart diseases,174.38,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Other ischaemic heart diseases,223.96,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Other ischaemic heart diseases,185.49,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Other ischaemic heart diseases,204.31,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Other ischaemic heart diseases,249.38,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,259.87,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,171.37,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,222.48,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,224.1,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,209.8,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,225.9,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,239.49,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,244.2,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Cerebrovascular diseases,739.09,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Cerebrovascular diseases,598.58,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Cerebrovascular diseases,651.9,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Cerebrovascular diseases,658.43,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Cerebrovascular diseases,530.21,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Cerebrovascular diseases,598.69,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Cerebrovascular diseases,456.1,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Cerebrovascular diseases,527.92,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2013,Chronic lower respiratory diseases,90.56,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2014,Chronic lower respiratory diseases,124.3,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2015,Chronic lower respiratory diseases,196.53,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2016,Chronic lower respiratory diseases,118.16,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2017,Chronic lower respiratory diseases,143.36,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2018,Chronic lower respiratory diseases,100.15,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2019,Chronic lower respiratory diseases,147.67,Rate
Dytiki Makedonia,EL53,65 years or over,Males,2020,Chronic lower respiratory diseases,157.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,287.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,235.29,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,242.69,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,238.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,225.9,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,206.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,237.45,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,249.49,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.23,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.1,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.87,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.19,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.38,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.98,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.68,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.25,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",47.98,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",35.99,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",33.92,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",28.65,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",30.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",24.1,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",26.3,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",35.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Malignant melanoma of skin,1.78,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Malignant melanoma of skin,0.83,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Malignant melanoma of skin,1.69,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Malignant melanoma of skin,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Malignant melanoma of skin,0.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Diabetes mellitus,1.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Diabetes mellitus,5.26,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Diabetes mellitus,5.08,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Diabetes mellitus,5.92,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Diabetes mellitus,3.29,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Diabetes mellitus,2.4,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Diabetes mellitus,3.24,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Diabetes mellitus,6.62,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.91,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.73,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),5.06,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),4.16,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),4.1,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),1.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),3.29,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.57,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.64,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),3.27,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.51,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Other ischaemic heart diseases,12.69,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Other ischaemic heart diseases,5.9,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Other ischaemic heart diseases,13.27,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Other ischaemic heart diseases,14.5,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Other ischaemic heart diseases,5.97,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Other ischaemic heart diseases,12.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Other ischaemic heart diseases,9.7,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Other ischaemic heart diseases,10.23,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,41.31,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,38.62,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,27.22,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,32.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,34.92,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,30.44,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,32.11,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,29.33,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Cerebrovascular diseases,8.67,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Cerebrovascular diseases,9.4,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Cerebrovascular diseases,11.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Cerebrovascular diseases,15.09,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Cerebrovascular diseases,13.27,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Cerebrovascular diseases,10.89,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Cerebrovascular diseases,12.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Cerebrovascular diseases,10.98,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2013,Chronic lower respiratory diseases,1.78,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.95,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2015,Chronic lower respiratory diseases,2.56,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.49,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2017,Chronic lower respiratory diseases,1.66,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.41,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.84,Rate
Dytiki Makedonia,EL53,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1004.6,Rate
Dytiki Makedonia,EL53,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,938.9,Rate
Dytiki Makedonia,EL53,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,986.46,Rate
Dytiki Makedonia,EL53,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,908.38,Rate
Dytiki Makedonia,EL53,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,929.53,Rate
Dytiki Makedonia,EL53,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,869.17,Rate
Dytiki Makedonia,EL53,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,910.54,Rate
Dytiki Makedonia,EL53,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1006.5,Rate
Dytiki Makedonia,EL53,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.94,Rate
Dytiki Makedonia,EL53,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.15,Rate
Dytiki Makedonia,EL53,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.97,Rate
Dytiki Makedonia,EL53,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.93,Rate
Dytiki Makedonia,EL53,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.31,Rate
Dytiki Makedonia,EL53,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.0,Rate
Dytiki Makedonia,EL53,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.92,Rate
Dytiki Makedonia,EL53,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.38,Rate
Dytiki Makedonia,EL53,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",57.01,Rate
Dytiki Makedonia,EL53,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",57.99,Rate
Dytiki Makedonia,EL53,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",45.43,Rate
Dytiki Makedonia,EL53,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",52.34,Rate
Dytiki Makedonia,EL53,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",60.12,Rate
Dytiki Makedonia,EL53,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",50.84,Rate
Dytiki Makedonia,EL53,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",50.2,Rate
Dytiki Makedonia,EL53,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",52.69,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Malignant melanoma of skin,2.35,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Malignant melanoma of skin,2.82,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Malignant melanoma of skin,2.56,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Malignant melanoma of skin,1.09,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Malignant melanoma of skin,2.31,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Malignant melanoma of skin,1.83,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Malignant melanoma of skin,4.22,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Malignant melanoma of skin,1.3,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Malignant neoplasm of breast,18.17,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Malignant neoplasm of breast,19.52,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Malignant neoplasm of breast,15.91,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Malignant neoplasm of breast,16.61,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Malignant neoplasm of breast,13.36,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Malignant neoplasm of breast,12.27,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Malignant neoplasm of breast,21.52,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Malignant neoplasm of breast,15.32,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Diabetes mellitus,12.87,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Diabetes mellitus,15.06,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Diabetes mellitus,14.92,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Diabetes mellitus,14.54,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Diabetes mellitus,14.22,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Diabetes mellitus,14.24,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Diabetes mellitus,17.89,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Diabetes mellitus,20.83,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Mental and behavioural disorders (F00-F99),2.67,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Mental and behavioural disorders (F00-F99),7.71,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Mental and behavioural disorders (F00-F99),13.69,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Mental and behavioural disorders (F00-F99),15.78,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Mental and behavioural disorders (F00-F99),16.49,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Mental and behavioural disorders (F00-F99),17.38,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Mental and behavioural disorders (F00-F99),20.3,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Mental and behavioural disorders (F00-F99),22.42,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.02,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.39,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.74,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.68,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Other ischaemic heart diseases,37.22,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Other ischaemic heart diseases,47.8,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Other ischaemic heart diseases,40.72,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Other ischaemic heart diseases,33.35,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Other ischaemic heart diseases,34.83,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Other ischaemic heart diseases,32.37,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Other ischaemic heart diseases,35.6,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Other ischaemic heart diseases,40.4,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,56.43,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,45.84,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,43.66,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,48.38,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,50.78,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,49.21,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,49.34,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,56.13,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Cerebrovascular diseases,153.67,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Cerebrovascular diseases,134.24,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Cerebrovascular diseases,134.15,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Cerebrovascular diseases,132.66,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Cerebrovascular diseases,120.38,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Cerebrovascular diseases,114.85,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Cerebrovascular diseases,105.86,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Cerebrovascular diseases,101.2,Rate
Dytiki Makedonia,EL53,Total,Total,2013,Chronic lower respiratory diseases,15.24,Rate
Dytiki Makedonia,EL53,Total,Total,2014,Chronic lower respiratory diseases,17.58,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Chronic lower respiratory diseases,28.5,Rate
Dytiki Makedonia,EL53,Total,Total,2016,Chronic lower respiratory diseases,18.55,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Chronic lower respiratory diseases,19.27,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Chronic lower respiratory diseases,17.91,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Chronic lower respiratory diseases,20.52,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Chronic lower respiratory diseases,21.42,Rate
Dytiki Makedonia,EL53,Total,Total,2015,Asthma and status asthmaticus,0.28,Rate
Dytiki Makedonia,EL53,Total,Total,2017,Asthma and status asthmaticus,0.21,Rate
Dytiki Makedonia,EL53,Total,Total,2018,Asthma and status asthmaticus,0.38,Rate
Dytiki Makedonia,EL53,Total,Total,2019,Asthma and status asthmaticus,0.19,Rate
Dytiki Makedonia,EL53,Total,Total,2020,Asthma and status asthmaticus,0.56,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4301.21,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4129.73,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4330.08,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3913.21,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4089.4,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3844.79,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3988.48,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4434.56,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.56,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.8,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.25,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.45,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.75,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.72,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.41,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.0,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",179.1,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",214.81,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",156.78,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",200.97,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",234.24,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",198.98,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",191.34,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",189.94,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Malignant melanoma of skin,8.31,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Malignant melanoma of skin,7.07,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Malignant melanoma of skin,5.95,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Malignant melanoma of skin,3.9,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Malignant melanoma of skin,11.86,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Malignant melanoma of skin,7.69,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Malignant melanoma of skin,20.01,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Malignant melanoma of skin,4.95,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Malignant neoplasm of breast,66.71,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Malignant neoplasm of breast,58.25,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Malignant neoplasm of breast,61.69,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Malignant neoplasm of breast,60.45,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Malignant neoplasm of breast,47.76,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Malignant neoplasm of breast,52.54,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Malignant neoplasm of breast,86.97,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Malignant neoplasm of breast,56.78,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Diabetes mellitus,56.74,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Diabetes mellitus,62.64,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Diabetes mellitus,65.9,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Diabetes mellitus,55.21,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Diabetes mellitus,64.4,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Diabetes mellitus,68.01,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Diabetes mellitus,81.56,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Diabetes mellitus,90.01,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),13.72,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),29.78,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),62.87,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),70.41,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),74.29,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),77.28,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),98.53,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),106.51,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.23,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.45,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.52,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.62,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.81,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.4,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),13.74,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Other ischaemic heart diseases,155.44,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Other ischaemic heart diseases,229.32,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Other ischaemic heart diseases,177.43,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Other ischaemic heart diseases,137.49,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Other ischaemic heart diseases,161.16,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Other ischaemic heart diseases,132.97,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Other ischaemic heart diseases,161.0,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Other ischaemic heart diseases,179.49,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,191.78,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,145.05,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,152.89,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,170.42,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,176.09,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,180.82,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,175.12,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,217.65,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Cerebrovascular diseases,761.3,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Cerebrovascular diseases,661.54,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Cerebrovascular diseases,647.06,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Cerebrovascular diseases,633.03,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Cerebrovascular diseases,580.83,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Cerebrovascular diseases,556.02,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Cerebrovascular diseases,504.93,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Cerebrovascular diseases,482.54,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2013,Chronic lower respiratory diseases,72.65,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2014,Chronic lower respiratory diseases,86.47,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Chronic lower respiratory diseases,138.99,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2016,Chronic lower respiratory diseases,89.91,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Chronic lower respiratory diseases,95.42,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Chronic lower respiratory diseases,84.8,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Chronic lower respiratory diseases,96.89,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Chronic lower respiratory diseases,104.91,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2015,Asthma and status asthmaticus,1.45,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2017,Asthma and status asthmaticus,1.08,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2018,Asthma and status asthmaticus,1.96,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2019,Asthma and status asthmaticus,1.0,Rate
Dytiki Makedonia,EL53,65 years or over,Total,2020,Asthma and status asthmaticus,2.86,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,206.04,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,165.96,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,176.51,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,180.5,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,164.09,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,148.37,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,164.95,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,176.1,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.42,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.58,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.51,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.9,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.29,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.66,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",27.44,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",18.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",17.95,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",14.96,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",16.01,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",19.45,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Malignant melanoma of skin,0.91,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Malignant melanoma of skin,1.79,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Malignant melanoma of skin,1.74,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Malignant melanoma of skin,0.41,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Malignant melanoma of skin,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Malignant melanoma of skin,0.4,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Malignant melanoma of skin,0.4,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Malignant melanoma of skin,0.41,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.42,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Malignant neoplasm of breast,10.13,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Malignant neoplasm of breast,4.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.99,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Malignant neoplasm of breast,5.02,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Malignant neoplasm of breast,2.51,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.67,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.28,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Diabetes mellitus,2.25,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Diabetes mellitus,3.53,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Diabetes mellitus,2.57,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Diabetes mellitus,4.69,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Diabetes mellitus,2.07,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Diabetes mellitus,1.21,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Diabetes mellitus,2.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Diabetes mellitus,4.07,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),2.36,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.78,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),2.55,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),2.49,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),2.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),2.05,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.44,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.24,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.05,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.24,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Other ischaemic heart diseases,8.59,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Other ischaemic heart diseases,3.83,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Other ischaemic heart diseases,7.6,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Other ischaemic heart diseases,8.12,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Other ischaemic heart diseases,4.23,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Other ischaemic heart diseases,8.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Other ischaemic heart diseases,5.23,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Other ischaemic heart diseases,6.71,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,23.64,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,21.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,17.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,18.81,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,20.43,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,17.33,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,18.88,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,17.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Cerebrovascular diseases,6.48,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Cerebrovascular diseases,6.51,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Cerebrovascular diseases,9.91,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Cerebrovascular diseases,11.46,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Cerebrovascular diseases,8.84,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Cerebrovascular diseases,7.98,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Cerebrovascular diseases,9.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Cerebrovascular diseases,8.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.34,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.9,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.74,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.27,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Chronic lower respiratory diseases,0.82,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Chronic lower respiratory diseases,1.7,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Chronic lower respiratory diseases,2.02,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.2,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
Dytiki Makedonia,EL53,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,723.26,Rate
Ipeiros,EL54,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,666.89,Rate
Ipeiros,EL54,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,725.59,Rate
Ipeiros,EL54,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,671.92,Rate
Ipeiros,EL54,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,675.78,Rate
Ipeiros,EL54,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,651.37,Rate
Ipeiros,EL54,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,652.17,Rate
Ipeiros,EL54,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,677.04,Rate
Ipeiros,EL54,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.46,Rate
Ipeiros,EL54,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.21,Rate
Ipeiros,EL54,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.18,Rate
Ipeiros,EL54,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.64,Rate
Ipeiros,EL54,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.49,Rate
Ipeiros,EL54,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.12,Rate
Ipeiros,EL54,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.97,Rate
Ipeiros,EL54,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.35,Rate
Ipeiros,EL54,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",14.99,Rate
Ipeiros,EL54,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",10.49,Rate
Ipeiros,EL54,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",8.92,Rate
Ipeiros,EL54,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",13.1,Rate
Ipeiros,EL54,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",16.53,Rate
Ipeiros,EL54,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",12.87,Rate
Ipeiros,EL54,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",13.51,Rate
Ipeiros,EL54,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",9.27,Rate
Ipeiros,EL54,Total,Females,2014,Malignant melanoma of skin,1.24,Rate
Ipeiros,EL54,Total,Females,2015,Malignant melanoma of skin,1.76,Rate
Ipeiros,EL54,Total,Females,2016,Malignant melanoma of skin,1.94,Rate
Ipeiros,EL54,Total,Females,2017,Malignant melanoma of skin,0.8,Rate
Ipeiros,EL54,Total,Females,2019,Malignant melanoma of skin,1.08,Rate
Ipeiros,EL54,Total,Females,2020,Malignant melanoma of skin,1.26,Rate
Ipeiros,EL54,Total,Females,2013,Malignant neoplasm of breast,28.31,Rate
Ipeiros,EL54,Total,Females,2014,Malignant neoplasm of breast,26.35,Rate
Ipeiros,EL54,Total,Females,2015,Malignant neoplasm of breast,21.2,Rate
Ipeiros,EL54,Total,Females,2016,Malignant neoplasm of breast,28.92,Rate
Ipeiros,EL54,Total,Females,2017,Malignant neoplasm of breast,19.96,Rate
Ipeiros,EL54,Total,Females,2018,Malignant neoplasm of breast,28.52,Rate
Ipeiros,EL54,Total,Females,2019,Malignant neoplasm of breast,28.42,Rate
Ipeiros,EL54,Total,Females,2020,Malignant neoplasm of breast,25.42,Rate
Ipeiros,EL54,Total,Females,2013,Diabetes mellitus,5.25,Rate
Ipeiros,EL54,Total,Females,2014,Diabetes mellitus,10.37,Rate
Ipeiros,EL54,Total,Females,2015,Diabetes mellitus,10.01,Rate
Ipeiros,EL54,Total,Females,2016,Diabetes mellitus,8.73,Rate
Ipeiros,EL54,Total,Females,2017,Diabetes mellitus,11.02,Rate
Ipeiros,EL54,Total,Females,2018,Diabetes mellitus,9.35,Rate
Ipeiros,EL54,Total,Females,2019,Diabetes mellitus,8.76,Rate
Ipeiros,EL54,Total,Females,2020,Diabetes mellitus,9.92,Rate
Ipeiros,EL54,Total,Females,2013,Mental and behavioural disorders (F00-F99),1.39,Rate
Ipeiros,EL54,Total,Females,2014,Mental and behavioural disorders (F00-F99),4.09,Rate
Ipeiros,EL54,Total,Females,2015,Mental and behavioural disorders (F00-F99),7.07,Rate
Ipeiros,EL54,Total,Females,2016,Mental and behavioural disorders (F00-F99),9.54,Rate
Ipeiros,EL54,Total,Females,2017,Mental and behavioural disorders (F00-F99),11.18,Rate
Ipeiros,EL54,Total,Females,2018,Mental and behavioural disorders (F00-F99),12.9,Rate
Ipeiros,EL54,Total,Females,2019,Mental and behavioural disorders (F00-F99),8.57,Rate
Ipeiros,EL54,Total,Females,2020,Mental and behavioural disorders (F00-F99),11.56,Rate
Ipeiros,EL54,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.69,Rate
Ipeiros,EL54,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Ipeiros,EL54,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Ipeiros,EL54,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Ipeiros,EL54,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.64,Rate
Ipeiros,EL54,Total,Females,2013,Other ischaemic heart diseases,27.86,Rate
Ipeiros,EL54,Total,Females,2014,Other ischaemic heart diseases,23.59,Rate
Ipeiros,EL54,Total,Females,2015,Other ischaemic heart diseases,26.54,Rate
Ipeiros,EL54,Total,Females,2016,Other ischaemic heart diseases,16.81,Rate
Ipeiros,EL54,Total,Females,2017,Other ischaemic heart diseases,27.29,Rate
Ipeiros,EL54,Total,Females,2018,Other ischaemic heart diseases,30.65,Rate
Ipeiros,EL54,Total,Females,2019,Other ischaemic heart diseases,27.84,Rate
Ipeiros,EL54,Total,Females,2020,Other ischaemic heart diseases,32.96,Rate
Ipeiros,EL54,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,21.81,Rate
Ipeiros,EL54,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,15.12,Rate
Ipeiros,EL54,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,20.08,Rate
Ipeiros,EL54,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,22.01,Rate
Ipeiros,EL54,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,20.57,Rate
Ipeiros,EL54,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,22.76,Rate
Ipeiros,EL54,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,22.49,Rate
Ipeiros,EL54,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,24.8,Rate
Ipeiros,EL54,Total,Females,2013,Cerebrovascular diseases,129.64,Rate
Ipeiros,EL54,Total,Females,2014,Cerebrovascular diseases,114.31,Rate
Ipeiros,EL54,Total,Females,2015,Cerebrovascular diseases,130.17,Rate
Ipeiros,EL54,Total,Females,2016,Cerebrovascular diseases,99.64,Rate
Ipeiros,EL54,Total,Females,2017,Cerebrovascular diseases,100.61,Rate
Ipeiros,EL54,Total,Females,2018,Cerebrovascular diseases,86.29,Rate
Ipeiros,EL54,Total,Females,2019,Cerebrovascular diseases,95.73,Rate
Ipeiros,EL54,Total,Females,2020,Cerebrovascular diseases,109.79,Rate
Ipeiros,EL54,Total,Females,2013,Chronic lower respiratory diseases,12.36,Rate
Ipeiros,EL54,Total,Females,2014,Chronic lower respiratory diseases,8.97,Rate
Ipeiros,EL54,Total,Females,2015,Chronic lower respiratory diseases,14.63,Rate
Ipeiros,EL54,Total,Females,2016,Chronic lower respiratory diseases,10.56,Rate
Ipeiros,EL54,Total,Females,2017,Chronic lower respiratory diseases,14.2,Rate
Ipeiros,EL54,Total,Females,2018,Chronic lower respiratory diseases,10.64,Rate
Ipeiros,EL54,Total,Females,2019,Chronic lower respiratory diseases,12.07,Rate
Ipeiros,EL54,Total,Females,2020,Chronic lower respiratory diseases,13.53,Rate
Ipeiros,EL54,Total,Females,2013,Asthma and status asthmaticus,0.46,Rate
Ipeiros,EL54,Total,Females,2014,Asthma and status asthmaticus,0.3,Rate
Ipeiros,EL54,Total,Females,2015,Asthma and status asthmaticus,0.29,Rate
Ipeiros,EL54,Total,Females,2016,Asthma and status asthmaticus,0.58,Rate
Ipeiros,EL54,Total,Females,2018,Asthma and status asthmaticus,0.29,Rate
Ipeiros,EL54,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3259.35,Rate
Ipeiros,EL54,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3086.88,Rate
Ipeiros,EL54,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3331.83,Rate
Ipeiros,EL54,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3082.84,Rate
Ipeiros,EL54,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3147.91,Rate
Ipeiros,EL54,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,2962.83,Rate
Ipeiros,EL54,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3024.95,Rate
Ipeiros,EL54,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3144.32,Rate
Ipeiros,EL54,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.16,Rate
Ipeiros,EL54,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.69,Rate
Ipeiros,EL54,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.52,Rate
Ipeiros,EL54,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.13,Rate
Ipeiros,EL54,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.99,Rate
Ipeiros,EL54,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.46,Rate
Ipeiros,EL54,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.14,Rate
Ipeiros,EL54,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.79,Rate
Ipeiros,EL54,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",44.1,Rate
Ipeiros,EL54,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",35.99,Rate
Ipeiros,EL54,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",30.89,Rate
Ipeiros,EL54,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",42.77,Rate
Ipeiros,EL54,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",56.4,Rate
Ipeiros,EL54,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",50.94,Rate
Ipeiros,EL54,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",56.72,Rate
Ipeiros,EL54,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",27.42,Rate
Ipeiros,EL54,65 years or over,Females,2014,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,65 years or over,Females,2015,Malignant melanoma of skin,3.54,Rate
Ipeiros,EL54,65 years or over,Females,2016,Malignant melanoma of skin,6.52,Rate
Ipeiros,EL54,65 years or over,Females,2017,Malignant melanoma of skin,4.1,Rate
Ipeiros,EL54,65 years or over,Females,2019,Malignant melanoma of skin,5.55,Rate
Ipeiros,EL54,65 years or over,Females,2020,Malignant melanoma of skin,6.48,Rate
Ipeiros,EL54,65 years or over,Females,2013,Malignant neoplasm of breast,79.45,Rate
Ipeiros,EL54,65 years or over,Females,2014,Malignant neoplasm of breast,95.82,Rate
Ipeiros,EL54,65 years or over,Females,2015,Malignant neoplasm of breast,81.01,Rate
Ipeiros,EL54,65 years or over,Females,2016,Malignant neoplasm of breast,84.89,Rate
Ipeiros,EL54,65 years or over,Females,2017,Malignant neoplasm of breast,69.33,Rate
Ipeiros,EL54,65 years or over,Females,2018,Malignant neoplasm of breast,97.38,Rate
Ipeiros,EL54,65 years or over,Females,2019,Malignant neoplasm of breast,106.14,Rate
Ipeiros,EL54,65 years or over,Females,2020,Malignant neoplasm of breast,93.35,Rate
Ipeiros,EL54,65 years or over,Females,2013,Diabetes mellitus,24.22,Rate
Ipeiros,EL54,65 years or over,Females,2014,Diabetes mellitus,46.82,Rate
Ipeiros,EL54,65 years or over,Females,2015,Diabetes mellitus,51.34,Rate
Ipeiros,EL54,65 years or over,Females,2016,Diabetes mellitus,38.83,Rate
Ipeiros,EL54,65 years or over,Females,2017,Diabetes mellitus,47.43,Rate
Ipeiros,EL54,65 years or over,Females,2018,Diabetes mellitus,42.19,Rate
Ipeiros,EL54,65 years or over,Females,2019,Diabetes mellitus,39.11,Rate
Ipeiros,EL54,65 years or over,Females,2020,Diabetes mellitus,42.02,Rate
Ipeiros,EL54,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),3.58,Rate
Ipeiros,EL54,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),20.95,Rate
Ipeiros,EL54,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),33.55,Rate
Ipeiros,EL54,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),43.22,Rate
Ipeiros,EL54,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),51.89,Rate
Ipeiros,EL54,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),57.23,Rate
Ipeiros,EL54,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),43.95,Rate
Ipeiros,EL54,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),56.16,Rate
Ipeiros,EL54,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.79,Rate
Ipeiros,EL54,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.46,Rate
Ipeiros,EL54,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),5.26,Rate
Ipeiros,EL54,65 years or over,Females,2013,Other ischaemic heart diseases,115.84,Rate
Ipeiros,EL54,65 years or over,Females,2014,Other ischaemic heart diseases,117.95,Rate
Ipeiros,EL54,65 years or over,Females,2015,Other ischaemic heart diseases,127.26,Rate
Ipeiros,EL54,65 years or over,Females,2016,Other ischaemic heart diseases,79.87,Rate
Ipeiros,EL54,65 years or over,Females,2017,Other ischaemic heart diseases,133.9,Rate
Ipeiros,EL54,65 years or over,Females,2018,Other ischaemic heart diseases,154.45,Rate
Ipeiros,EL54,65 years or over,Females,2019,Other ischaemic heart diseases,139.7,Rate
Ipeiros,EL54,65 years or over,Females,2020,Other ischaemic heart diseases,160.62,Rate
Ipeiros,EL54,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,111.85,Rate
Ipeiros,EL54,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,71.42,Rate
Ipeiros,EL54,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,90.85,Rate
Ipeiros,EL54,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,104.03,Rate
Ipeiros,EL54,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,89.85,Rate
Ipeiros,EL54,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,111.25,Rate
Ipeiros,EL54,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,106.1,Rate
Ipeiros,EL54,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,105.92,Rate
Ipeiros,EL54,65 years or over,Females,2013,Cerebrovascular diseases,658.61,Rate
Ipeiros,EL54,65 years or over,Females,2014,Cerebrovascular diseases,568.02,Rate
Ipeiros,EL54,65 years or over,Females,2015,Cerebrovascular diseases,642.45,Rate
Ipeiros,EL54,65 years or over,Females,2016,Cerebrovascular diseases,493.34,Rate
Ipeiros,EL54,65 years or over,Females,2017,Cerebrovascular diseases,506.3,Rate
Ipeiros,EL54,65 years or over,Females,2018,Cerebrovascular diseases,424.72,Rate
Ipeiros,EL54,65 years or over,Females,2019,Cerebrovascular diseases,476.3,Rate
Ipeiros,EL54,65 years or over,Females,2020,Cerebrovascular diseases,547.42,Rate
Ipeiros,EL54,65 years or over,Females,2013,Chronic lower respiratory diseases,63.38,Rate
Ipeiros,EL54,65 years or over,Females,2014,Chronic lower respiratory diseases,45.99,Rate
Ipeiros,EL54,65 years or over,Females,2015,Chronic lower respiratory diseases,72.02,Rate
Ipeiros,EL54,65 years or over,Females,2016,Chronic lower respiratory diseases,51.43,Rate
Ipeiros,EL54,65 years or over,Females,2017,Chronic lower respiratory diseases,72.8,Rate
Ipeiros,EL54,65 years or over,Females,2018,Chronic lower respiratory diseases,51.35,Rate
Ipeiros,EL54,65 years or over,Females,2019,Chronic lower respiratory diseases,61.89,Rate
Ipeiros,EL54,65 years or over,Females,2020,Chronic lower respiratory diseases,66.26,Rate
Ipeiros,EL54,65 years or over,Females,2013,Asthma and status asthmaticus,2.36,Rate
Ipeiros,EL54,65 years or over,Females,2014,Asthma and status asthmaticus,1.55,Rate
Ipeiros,EL54,65 years or over,Females,2015,Asthma and status asthmaticus,1.51,Rate
Ipeiros,EL54,65 years or over,Females,2016,Asthma and status asthmaticus,2.96,Rate
Ipeiros,EL54,65 years or over,Females,2018,Asthma and status asthmaticus,1.47,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,108.93,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,80.68,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,94.27,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,87.91,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,76.94,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,91.45,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,77.4,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,79.38,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.78,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.25,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.38,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.26,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.93,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.8,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.15,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.15,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",7.94,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",4.31,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",3.6,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",5.91,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",6.87,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",3.65,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",3.04,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",4.87,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Malignant melanoma of skin,1.54,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Malignant melanoma of skin,1.32,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Malignant melanoma of skin,0.83,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.92,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Malignant neoplasm of breast,9.52,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Malignant neoplasm of breast,6.7,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.37,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Malignant neoplasm of breast,8.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.84,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Malignant neoplasm of breast,9.59,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Malignant neoplasm of breast,8.97,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Diabetes mellitus,0.66,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Diabetes mellitus,1.54,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Diabetes mellitus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Diabetes mellitus,1.44,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Diabetes mellitus,2.2,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Diabetes mellitus,1.4,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Diabetes mellitus,1.41,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Diabetes mellitus,2.14,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.86,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.66,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),1.39,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.32,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.17,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.76,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.86,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.51,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Other ischaemic heart diseases,6.54,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.73,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.15,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.54,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.47,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.66,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.75,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.04,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,1.48,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.94,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.15,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.79,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.32,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.24,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,5.15,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Cerebrovascular diseases,1.5,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Cerebrovascular diseases,4.41,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Cerebrovascular diseases,6.08,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Cerebrovascular diseases,4.28,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Cerebrovascular diseases,2.34,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Cerebrovascular diseases,4.31,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Cerebrovascular diseases,3.54,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Cerebrovascular diseases,3.78,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.73,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.66,Rate
Ipeiros,EL54,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.78,Rate
Ipeiros,EL54,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.76,Rate
Ipeiros,EL54,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1051.31,Rate
Ipeiros,EL54,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,982.05,Rate
Ipeiros,EL54,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1031.28,Rate
Ipeiros,EL54,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,978.59,Rate
Ipeiros,EL54,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,986.95,Rate
Ipeiros,EL54,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,935.21,Rate
Ipeiros,EL54,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,953.14,Rate
Ipeiros,EL54,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,954.28,Rate
Ipeiros,EL54,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.3,Rate
Ipeiros,EL54,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.3,Rate
Ipeiros,EL54,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.3,Rate
Ipeiros,EL54,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.45,Rate
Ipeiros,EL54,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.87,Rate
Ipeiros,EL54,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.65,Rate
Ipeiros,EL54,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.93,Rate
Ipeiros,EL54,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.49,Rate
Ipeiros,EL54,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",102.52,Rate
Ipeiros,EL54,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",106.91,Rate
Ipeiros,EL54,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",99.59,Rate
Ipeiros,EL54,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",91.04,Rate
Ipeiros,EL54,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",103.21,Rate
Ipeiros,EL54,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",90.76,Rate
Ipeiros,EL54,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",94.93,Rate
Ipeiros,EL54,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",96.47,Rate
Ipeiros,EL54,Total,Males,2013,Malignant melanoma of skin,2.66,Rate
Ipeiros,EL54,Total,Males,2014,Malignant melanoma of skin,2.1,Rate
Ipeiros,EL54,Total,Males,2015,Malignant melanoma of skin,6.92,Rate
Ipeiros,EL54,Total,Males,2016,Malignant melanoma of skin,0.4,Rate
Ipeiros,EL54,Total,Males,2017,Malignant melanoma of skin,1.97,Rate
Ipeiros,EL54,Total,Males,2018,Malignant melanoma of skin,2.18,Rate
Ipeiros,EL54,Total,Males,2019,Malignant melanoma of skin,1.13,Rate
Ipeiros,EL54,Total,Males,2020,Malignant melanoma of skin,1.01,Rate
Ipeiros,EL54,Total,Males,2013,Malignant neoplasm of breast,1.1,Rate
Ipeiros,EL54,Total,Males,2014,Malignant neoplasm of breast,0.54,Rate
Ipeiros,EL54,Total,Males,2015,Malignant neoplasm of breast,0.83,Rate
Ipeiros,EL54,Total,Males,2017,Malignant neoplasm of breast,1.45,Rate
Ipeiros,EL54,Total,Males,2018,Malignant neoplasm of breast,0.38,Rate
Ipeiros,EL54,Total,Males,2019,Malignant neoplasm of breast,0.61,Rate
Ipeiros,EL54,Total,Males,2020,Malignant neoplasm of breast,1.0,Rate
Ipeiros,EL54,Total,Males,2013,Diabetes mellitus,15.02,Rate
Ipeiros,EL54,Total,Males,2014,Diabetes mellitus,8.57,Rate
Ipeiros,EL54,Total,Males,2015,Diabetes mellitus,9.86,Rate
Ipeiros,EL54,Total,Males,2016,Diabetes mellitus,8.6,Rate
Ipeiros,EL54,Total,Males,2017,Diabetes mellitus,14.1,Rate
Ipeiros,EL54,Total,Males,2018,Diabetes mellitus,15.86,Rate
Ipeiros,EL54,Total,Males,2019,Diabetes mellitus,12.64,Rate
Ipeiros,EL54,Total,Males,2020,Diabetes mellitus,14.65,Rate
Ipeiros,EL54,Total,Males,2013,Mental and behavioural disorders (F00-F99),0.49,Rate
Ipeiros,EL54,Total,Males,2014,Mental and behavioural disorders (F00-F99),1.83,Rate
Ipeiros,EL54,Total,Males,2015,Mental and behavioural disorders (F00-F99),5.4,Rate
Ipeiros,EL54,Total,Males,2016,Mental and behavioural disorders (F00-F99),8.33,Rate
Ipeiros,EL54,Total,Males,2017,Mental and behavioural disorders (F00-F99),4.96,Rate
Ipeiros,EL54,Total,Males,2018,Mental and behavioural disorders (F00-F99),9.2,Rate
Ipeiros,EL54,Total,Males,2019,Mental and behavioural disorders (F00-F99),7.24,Rate
Ipeiros,EL54,Total,Males,2020,Mental and behavioural disorders (F00-F99),13.68,Rate
Ipeiros,EL54,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.64,Rate
Ipeiros,EL54,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.65,Rate
Ipeiros,EL54,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Ipeiros,EL54,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.53,Rate
Ipeiros,EL54,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Ipeiros,EL54,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Ipeiros,EL54,Total,Males,2013,Other ischaemic heart diseases,52.83,Rate
Ipeiros,EL54,Total,Males,2014,Other ischaemic heart diseases,44.52,Rate
Ipeiros,EL54,Total,Males,2015,Other ischaemic heart diseases,48.44,Rate
Ipeiros,EL54,Total,Males,2016,Other ischaemic heart diseases,50.09,Rate
Ipeiros,EL54,Total,Males,2017,Other ischaemic heart diseases,56.21,Rate
Ipeiros,EL54,Total,Males,2018,Other ischaemic heart diseases,57.49,Rate
Ipeiros,EL54,Total,Males,2019,Other ischaemic heart diseases,65.33,Rate
Ipeiros,EL54,Total,Males,2020,Other ischaemic heart diseases,54.23,Rate
Ipeiros,EL54,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,58.72,Rate
Ipeiros,EL54,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,52.15,Rate
Ipeiros,EL54,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,50.18,Rate
Ipeiros,EL54,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,61.4,Rate
Ipeiros,EL54,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,50.77,Rate
Ipeiros,EL54,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,61.0,Rate
Ipeiros,EL54,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,51.91,Rate
Ipeiros,EL54,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,53.29,Rate
Ipeiros,EL54,Total,Males,2013,Cerebrovascular diseases,123.07,Rate
Ipeiros,EL54,Total,Males,2014,Cerebrovascular diseases,111.58,Rate
Ipeiros,EL54,Total,Males,2015,Cerebrovascular diseases,120.3,Rate
Ipeiros,EL54,Total,Males,2016,Cerebrovascular diseases,87.42,Rate
Ipeiros,EL54,Total,Males,2017,Cerebrovascular diseases,102.8,Rate
Ipeiros,EL54,Total,Males,2018,Cerebrovascular diseases,87.94,Rate
Ipeiros,EL54,Total,Males,2019,Cerebrovascular diseases,99.9,Rate
Ipeiros,EL54,Total,Males,2020,Cerebrovascular diseases,92.67,Rate
Ipeiros,EL54,Total,Males,2013,Chronic lower respiratory diseases,26.1,Rate
Ipeiros,EL54,Total,Males,2014,Chronic lower respiratory diseases,31.79,Rate
Ipeiros,EL54,Total,Males,2015,Chronic lower respiratory diseases,30.62,Rate
Ipeiros,EL54,Total,Males,2016,Chronic lower respiratory diseases,25.58,Rate
Ipeiros,EL54,Total,Males,2017,Chronic lower respiratory diseases,20.25,Rate
Ipeiros,EL54,Total,Males,2018,Chronic lower respiratory diseases,26.01,Rate
Ipeiros,EL54,Total,Males,2019,Chronic lower respiratory diseases,23.19,Rate
Ipeiros,EL54,Total,Males,2020,Chronic lower respiratory diseases,28.01,Rate
Ipeiros,EL54,Total,Males,2015,Asthma and status asthmaticus,0.42,Rate
Ipeiros,EL54,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4336.3,Rate
Ipeiros,EL54,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4122.23,Rate
Ipeiros,EL54,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4341.17,Rate
Ipeiros,EL54,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4075.82,Rate
Ipeiros,EL54,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4159.63,Rate
Ipeiros,EL54,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,3877.64,Rate
Ipeiros,EL54,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4075.68,Rate
Ipeiros,EL54,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4047.94,Rate
Ipeiros,EL54,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.05,Rate
Ipeiros,EL54,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",73.0,Rate
Ipeiros,EL54,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.65,Rate
Ipeiros,EL54,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",61.83,Rate
Ipeiros,EL54,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.85,Rate
Ipeiros,EL54,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.48,Rate
Ipeiros,EL54,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.19,Rate
Ipeiros,EL54,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.44,Rate
Ipeiros,EL54,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",390.38,Rate
Ipeiros,EL54,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",394.03,Rate
Ipeiros,EL54,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",389.55,Rate
Ipeiros,EL54,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",366.65,Rate
Ipeiros,EL54,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",401.67,Rate
Ipeiros,EL54,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",334.0,Rate
Ipeiros,EL54,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",389.14,Rate
Ipeiros,EL54,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",384.89,Rate
Ipeiros,EL54,65 years or over,Males,2013,Malignant melanoma of skin,5.01,Rate
Ipeiros,EL54,65 years or over,Males,2014,Malignant melanoma of skin,7.88,Rate
Ipeiros,EL54,65 years or over,Males,2015,Malignant melanoma of skin,15.96,Rate
Ipeiros,EL54,65 years or over,Males,2016,Malignant melanoma of skin,2.06,Rate
Ipeiros,EL54,65 years or over,Males,2017,Malignant melanoma of skin,4.03,Rate
Ipeiros,EL54,65 years or over,Males,2018,Malignant melanoma of skin,5.04,Rate
Ipeiros,EL54,65 years or over,Males,2019,Malignant melanoma of skin,2.45,Rate
Ipeiros,EL54,65 years or over,Males,2020,Malignant melanoma of skin,5.18,Rate
Ipeiros,EL54,65 years or over,Males,2013,Malignant neoplasm of breast,2.71,Rate
Ipeiros,EL54,65 years or over,Males,2014,Malignant neoplasm of breast,2.75,Rate
Ipeiros,EL54,65 years or over,Males,2015,Malignant neoplasm of breast,4.25,Rate
Ipeiros,EL54,65 years or over,Males,2017,Malignant neoplasm of breast,4.67,Rate
Ipeiros,EL54,65 years or over,Males,2018,Malignant neoplasm of breast,1.96,Rate
Ipeiros,EL54,65 years or over,Males,2019,Malignant neoplasm of breast,0.0,Rate
Ipeiros,EL54,65 years or over,Males,2020,Malignant neoplasm of breast,2.44,Rate
Ipeiros,EL54,65 years or over,Males,2013,Diabetes mellitus,65.19,Rate
Ipeiros,EL54,65 years or over,Males,2014,Diabetes mellitus,41.13,Rate
Ipeiros,EL54,65 years or over,Males,2015,Diabetes mellitus,50.54,Rate
Ipeiros,EL54,65 years or over,Males,2016,Diabetes mellitus,32.46,Rate
Ipeiros,EL54,65 years or over,Males,2017,Diabetes mellitus,69.03,Rate
Ipeiros,EL54,65 years or over,Males,2018,Diabetes mellitus,67.23,Rate
Ipeiros,EL54,65 years or over,Males,2019,Diabetes mellitus,59.38,Rate
Ipeiros,EL54,65 years or over,Males,2020,Diabetes mellitus,72.07,Rate
Ipeiros,EL54,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),2.51,Rate
Ipeiros,EL54,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),9.38,Rate
Ipeiros,EL54,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),15.56,Rate
Ipeiros,EL54,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),39.42,Rate
Ipeiros,EL54,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),22.52,Rate
Ipeiros,EL54,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),47.18,Rate
Ipeiros,EL54,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),34.43,Rate
Ipeiros,EL54,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),61.33,Rate
Ipeiros,EL54,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.65,Rate
Ipeiros,EL54,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.63,Rate
Ipeiros,EL54,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),7.86,Rate
Ipeiros,EL54,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Males,2013,Other ischaemic heart diseases,179.35,Rate
Ipeiros,EL54,65 years or over,Males,2014,Other ischaemic heart diseases,198.1,Rate
Ipeiros,EL54,65 years or over,Males,2015,Other ischaemic heart diseases,195.44,Rate
Ipeiros,EL54,65 years or over,Males,2016,Other ischaemic heart diseases,196.87,Rate
Ipeiros,EL54,65 years or over,Males,2017,Other ischaemic heart diseases,225.48,Rate
Ipeiros,EL54,65 years or over,Males,2018,Other ischaemic heart diseases,243.47,Rate
Ipeiros,EL54,65 years or over,Males,2019,Other ischaemic heart diseases,278.7,Rate
Ipeiros,EL54,65 years or over,Males,2020,Other ischaemic heart diseases,221.85,Rate
Ipeiros,EL54,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,167.49,Rate
Ipeiros,EL54,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,175.75,Rate
Ipeiros,EL54,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,171.64,Rate
Ipeiros,EL54,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,209.38,Rate
Ipeiros,EL54,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,173.61,Rate
Ipeiros,EL54,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,214.94,Rate
Ipeiros,EL54,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,179.44,Rate
Ipeiros,EL54,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,194.23,Rate
Ipeiros,EL54,65 years or over,Males,2013,Cerebrovascular diseases,578.31,Rate
Ipeiros,EL54,65 years or over,Males,2014,Cerebrovascular diseases,526.8,Rate
Ipeiros,EL54,65 years or over,Males,2015,Cerebrovascular diseases,543.93,Rate
Ipeiros,EL54,65 years or over,Males,2016,Cerebrovascular diseases,422.48,Rate
Ipeiros,EL54,65 years or over,Males,2017,Cerebrovascular diseases,491.38,Rate
Ipeiros,EL54,65 years or over,Males,2018,Cerebrovascular diseases,403.5,Rate
Ipeiros,EL54,65 years or over,Males,2019,Cerebrovascular diseases,486.27,Rate
Ipeiros,EL54,65 years or over,Males,2020,Cerebrovascular diseases,439.95,Rate
Ipeiros,EL54,65 years or over,Males,2013,Chronic lower respiratory diseases,125.09,Rate
Ipeiros,EL54,65 years or over,Males,2014,Chronic lower respiratory diseases,156.42,Rate
Ipeiros,EL54,65 years or over,Males,2015,Chronic lower respiratory diseases,154.22,Rate
Ipeiros,EL54,65 years or over,Males,2016,Chronic lower respiratory diseases,128.4,Rate
Ipeiros,EL54,65 years or over,Males,2017,Chronic lower respiratory diseases,92.8,Rate
Ipeiros,EL54,65 years or over,Males,2018,Chronic lower respiratory diseases,127.91,Rate
Ipeiros,EL54,65 years or over,Males,2019,Chronic lower respiratory diseases,115.8,Rate
Ipeiros,EL54,65 years or over,Males,2020,Chronic lower respiratory diseases,138.24,Rate
Ipeiros,EL54,65 years or over,Males,2015,Asthma and status asthmaticus,2.16,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,255.57,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,221.38,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,229.51,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,228.33,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,218.41,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,222.45,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,196.75,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,204.88,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.05,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.37,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.21,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.58,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.64,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.12,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.85,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",32.79,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",37.36,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",29.35,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",24.28,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",30.91,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",31.84,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",23.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",26.6,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Malignant melanoma of skin,2.09,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Malignant melanoma of skin,0.7,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Malignant melanoma of skin,4.73,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Malignant melanoma of skin,1.46,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Malignant melanoma of skin,1.49,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Malignant melanoma of skin,0.81,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.71,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.76,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.65,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Diabetes mellitus,2.87,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Diabetes mellitus,0.69,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Diabetes mellitus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Diabetes mellitus,2.81,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Diabetes mellitus,0.8,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Diabetes mellitus,3.42,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Diabetes mellitus,1.31,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Diabetes mellitus,0.74,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),2.93,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.8,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.71,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.66,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),2.14,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Other ischaemic heart diseases,22.19,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Other ischaemic heart diseases,7.32,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Other ischaemic heart diseases,12.83,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Other ischaemic heart diseases,14.53,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Other ischaemic heart diseases,15.21,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Other ischaemic heart diseases,12.44,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Other ischaemic heart diseases,13.65,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Other ischaemic heart diseases,13.63,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,32.37,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,22.2,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,20.75,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,25.56,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,21.02,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,23.71,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,21.02,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,19.15,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Cerebrovascular diseases,12.79,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Cerebrovascular diseases,10.99,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Cerebrovascular diseases,17.68,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Cerebrovascular diseases,6.26,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Cerebrovascular diseases,8.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Cerebrovascular diseases,11.5,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Cerebrovascular diseases,6.3,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Cerebrovascular diseases,8.55,Rate
Ipeiros,EL54,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.12,Rate
Ipeiros,EL54,Less than 65 years,Males,2014,Chronic lower respiratory diseases,1.6,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Chronic lower respiratory diseases,0.68,Rate
Ipeiros,EL54,Less than 65 years,Males,2016,Chronic lower respiratory diseases,0.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.67,Rate
Ipeiros,EL54,Less than 65 years,Males,2018,Chronic lower respiratory diseases,1.33,Rate
Ipeiros,EL54,Less than 65 years,Males,2019,Chronic lower respiratory diseases,0.76,Rate
Ipeiros,EL54,Less than 65 years,Males,2020,Chronic lower respiratory diseases,1.3,Rate
Ipeiros,EL54,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,878.31,Rate
Ipeiros,EL54,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,818.31,Rate
Ipeiros,EL54,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,872.67,Rate
Ipeiros,EL54,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,817.82,Rate
Ipeiros,EL54,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,824.22,Rate
Ipeiros,EL54,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,790.56,Rate
Ipeiros,EL54,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,798.26,Rate
Ipeiros,EL54,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,815.04,Rate
Ipeiros,EL54,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.69,Rate
Ipeiros,EL54,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.41,Rate
Ipeiros,EL54,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.02,Rate
Ipeiros,EL54,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.84,Rate
Ipeiros,EL54,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.89,Rate
Ipeiros,EL54,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.95,Rate
Ipeiros,EL54,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.85,Rate
Ipeiros,EL54,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.89,Rate
Ipeiros,EL54,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",55.93,Rate
Ipeiros,EL54,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",56.29,Rate
Ipeiros,EL54,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",51.66,Rate
Ipeiros,EL54,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",49.73,Rate
Ipeiros,EL54,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",57.47,Rate
Ipeiros,EL54,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",49.92,Rate
Ipeiros,EL54,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",52.57,Rate
Ipeiros,EL54,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",50.91,Rate
Ipeiros,EL54,Total,Total,2013,Malignant melanoma of skin,1.24,Rate
Ipeiros,EL54,Total,Total,2014,Malignant melanoma of skin,1.64,Rate
Ipeiros,EL54,Total,Total,2015,Malignant melanoma of skin,4.18,Rate
Ipeiros,EL54,Total,Total,2016,Malignant melanoma of skin,1.22,Rate
Ipeiros,EL54,Total,Total,2017,Malignant melanoma of skin,1.35,Rate
Ipeiros,EL54,Total,Total,2018,Malignant melanoma of skin,1.08,Rate
Ipeiros,EL54,Total,Total,2019,Malignant melanoma of skin,1.16,Rate
Ipeiros,EL54,Total,Total,2020,Malignant melanoma of skin,1.16,Rate
Ipeiros,EL54,Total,Total,2013,Malignant neoplasm of breast,15.8,Rate
Ipeiros,EL54,Total,Total,2014,Malignant neoplasm of breast,14.49,Rate
Ipeiros,EL54,Total,Total,2015,Malignant neoplasm of breast,11.77,Rate
Ipeiros,EL54,Total,Total,2016,Malignant neoplasm of breast,15.33,Rate
Ipeiros,EL54,Total,Total,2017,Malignant neoplasm of breast,11.16,Rate
Ipeiros,EL54,Total,Total,2018,Malignant neoplasm of breast,15.26,Rate
Ipeiros,EL54,Total,Total,2019,Malignant neoplasm of breast,15.35,Rate
Ipeiros,EL54,Total,Total,2020,Malignant neoplasm of breast,13.93,Rate
Ipeiros,EL54,Total,Total,2013,Diabetes mellitus,9.91,Rate
Ipeiros,EL54,Total,Total,2014,Diabetes mellitus,9.81,Rate
Ipeiros,EL54,Total,Total,2015,Diabetes mellitus,10.16,Rate
Ipeiros,EL54,Total,Total,2016,Diabetes mellitus,8.71,Rate
Ipeiros,EL54,Total,Total,2017,Diabetes mellitus,12.38,Rate
Ipeiros,EL54,Total,Total,2018,Diabetes mellitus,12.4,Rate
Ipeiros,EL54,Total,Total,2019,Diabetes mellitus,10.56,Rate
Ipeiros,EL54,Total,Total,2020,Diabetes mellitus,12.19,Rate
Ipeiros,EL54,Total,Total,2013,Mental and behavioural disorders (F00-F99),0.94,Rate
Ipeiros,EL54,Total,Total,2014,Mental and behavioural disorders (F00-F99),3.08,Rate
Ipeiros,EL54,Total,Total,2015,Mental and behavioural disorders (F00-F99),6.53,Rate
Ipeiros,EL54,Total,Total,2016,Mental and behavioural disorders (F00-F99),8.96,Rate
Ipeiros,EL54,Total,Total,2017,Mental and behavioural disorders (F00-F99),8.59,Rate
Ipeiros,EL54,Total,Total,2018,Mental and behavioural disorders (F00-F99),11.15,Rate
Ipeiros,EL54,Total,Total,2019,Mental and behavioural disorders (F00-F99),7.97,Rate
Ipeiros,EL54,Total,Total,2020,Mental and behavioural disorders (F00-F99),12.73,Rate
Ipeiros,EL54,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Ipeiros,EL54,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Ipeiros,EL54,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Ipeiros,EL54,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Ipeiros,EL54,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.38,Rate
Ipeiros,EL54,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Ipeiros,EL54,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Ipeiros,EL54,Total,Total,2013,Other ischaemic heart diseases,39.81,Rate
Ipeiros,EL54,Total,Total,2014,Other ischaemic heart diseases,33.54,Rate
Ipeiros,EL54,Total,Total,2015,Other ischaemic heart diseases,37.41,Rate
Ipeiros,EL54,Total,Total,2016,Other ischaemic heart diseases,32.75,Rate
Ipeiros,EL54,Total,Total,2017,Other ischaemic heart diseases,41.56,Rate
Ipeiros,EL54,Total,Total,2018,Other ischaemic heart diseases,43.78,Rate
Ipeiros,EL54,Total,Total,2019,Other ischaemic heart diseases,45.51,Rate
Ipeiros,EL54,Total,Total,2020,Other ischaemic heart diseases,43.42,Rate
Ipeiros,EL54,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,40.28,Rate
Ipeiros,EL54,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,32.86,Rate
Ipeiros,EL54,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,34.66,Rate
Ipeiros,EL54,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,41.08,Rate
Ipeiros,EL54,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,35.14,Rate
Ipeiros,EL54,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,41.34,Rate
Ipeiros,EL54,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,36.91,Rate
Ipeiros,EL54,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,39.05,Rate
Ipeiros,EL54,Total,Total,2013,Cerebrovascular diseases,128.19,Rate
Ipeiros,EL54,Total,Total,2014,Cerebrovascular diseases,115.18,Rate
Ipeiros,EL54,Total,Total,2015,Cerebrovascular diseases,127.08,Rate
Ipeiros,EL54,Total,Total,2016,Cerebrovascular diseases,94.78,Rate
Ipeiros,EL54,Total,Total,2017,Cerebrovascular diseases,102.76,Rate
Ipeiros,EL54,Total,Total,2018,Cerebrovascular diseases,87.98,Rate
Ipeiros,EL54,Total,Total,2019,Cerebrovascular diseases,98.67,Rate
Ipeiros,EL54,Total,Total,2020,Cerebrovascular diseases,103.71,Rate
Ipeiros,EL54,Total,Total,2013,Chronic lower respiratory diseases,18.16,Rate
Ipeiros,EL54,Total,Total,2014,Chronic lower respiratory diseases,18.59,Rate
Ipeiros,EL54,Total,Total,2015,Chronic lower respiratory diseases,21.48,Rate
Ipeiros,EL54,Total,Total,2016,Chronic lower respiratory diseases,16.81,Rate
Ipeiros,EL54,Total,Total,2017,Chronic lower respiratory diseases,17.17,Rate
Ipeiros,EL54,Total,Total,2018,Chronic lower respiratory diseases,17.56,Rate
Ipeiros,EL54,Total,Total,2019,Chronic lower respiratory diseases,17.07,Rate
Ipeiros,EL54,Total,Total,2020,Chronic lower respiratory diseases,20.24,Rate
Ipeiros,EL54,Total,Total,2013,Asthma and status asthmaticus,0.29,Rate
Ipeiros,EL54,Total,Total,2014,Asthma and status asthmaticus,0.17,Rate
Ipeiros,EL54,Total,Total,2015,Asthma and status asthmaticus,0.34,Rate
Ipeiros,EL54,Total,Total,2016,Asthma and status asthmaticus,0.34,Rate
Ipeiros,EL54,Total,Total,2018,Asthma and status asthmaticus,0.16,Rate
Ipeiros,EL54,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,3750.29,Rate
Ipeiros,EL54,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3574.2,Rate
Ipeiros,EL54,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3806.5,Rate
Ipeiros,EL54,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3542.77,Rate
Ipeiros,EL54,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3617.3,Rate
Ipeiros,EL54,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3406.54,Rate
Ipeiros,EL54,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3527.75,Rate
Ipeiros,EL54,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,3592.62,Rate
Ipeiros,EL54,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.1,Rate
Ipeiros,EL54,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.48,Rate
Ipeiros,EL54,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",60.06,Rate
Ipeiros,EL54,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.43,Rate
Ipeiros,EL54,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",62.88,Rate
Ipeiros,EL54,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",59.25,Rate
Ipeiros,EL54,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.67,Rate
Ipeiros,EL54,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",63.89,Rate
Ipeiros,EL54,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",202.59,Rate
Ipeiros,EL54,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",202.82,Rate
Ipeiros,EL54,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",196.79,Rate
Ipeiros,EL54,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",192.75,Rate
Ipeiros,EL54,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",216.6,Rate
Ipeiros,EL54,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",182.64,Rate
Ipeiros,EL54,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",214.36,Rate
Ipeiros,EL54,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",195.84,Rate
Ipeiros,EL54,65 years or over,Total,2013,Malignant melanoma of skin,2.08,Rate
Ipeiros,EL54,65 years or over,Total,2014,Malignant melanoma of skin,3.8,Rate
Ipeiros,EL54,65 years or over,Total,2015,Malignant melanoma of skin,9.05,Rate
Ipeiros,EL54,65 years or over,Total,2016,Malignant melanoma of skin,4.56,Rate
Ipeiros,EL54,65 years or over,Total,2017,Malignant melanoma of skin,3.87,Rate
Ipeiros,EL54,65 years or over,Total,2018,Malignant melanoma of skin,2.44,Rate
Ipeiros,EL54,65 years or over,Total,2019,Malignant melanoma of skin,4.26,Rate
Ipeiros,EL54,65 years or over,Total,2020,Malignant melanoma of skin,5.93,Rate
Ipeiros,EL54,65 years or over,Total,2013,Malignant neoplasm of breast,46.76,Rate
Ipeiros,EL54,65 years or over,Total,2014,Malignant neoplasm of breast,54.74,Rate
Ipeiros,EL54,65 years or over,Total,2015,Malignant neoplasm of breast,46.59,Rate
Ipeiros,EL54,65 years or over,Total,2016,Malignant neoplasm of breast,46.82,Rate
Ipeiros,EL54,65 years or over,Total,2017,Malignant neoplasm of breast,39.34,Rate
Ipeiros,EL54,65 years or over,Total,2018,Malignant neoplasm of breast,53.81,Rate
Ipeiros,EL54,65 years or over,Total,2019,Malignant neoplasm of breast,57.39,Rate
Ipeiros,EL54,65 years or over,Total,2020,Malignant neoplasm of breast,51.61,Rate
Ipeiros,EL54,65 years or over,Total,2013,Diabetes mellitus,43.49,Rate
Ipeiros,EL54,65 years or over,Total,2014,Diabetes mellitus,45.77,Rate
Ipeiros,EL54,65 years or over,Total,2015,Diabetes mellitus,52.08,Rate
Ipeiros,EL54,65 years or over,Total,2016,Diabetes mellitus,35.79,Rate
Ipeiros,EL54,65 years or over,Total,2017,Diabetes mellitus,57.31,Rate
Ipeiros,EL54,65 years or over,Total,2018,Diabetes mellitus,53.62,Rate
Ipeiros,EL54,65 years or over,Total,2019,Diabetes mellitus,48.55,Rate
Ipeiros,EL54,65 years or over,Total,2020,Diabetes mellitus,56.57,Rate
Ipeiros,EL54,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),3.05,Rate
Ipeiros,EL54,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),15.78,Rate
Ipeiros,EL54,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),26.0,Rate
Ipeiros,EL54,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),41.41,Rate
Ipeiros,EL54,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),39.82,Rate
Ipeiros,EL54,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),52.56,Rate
Ipeiros,EL54,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),39.54,Rate
Ipeiros,EL54,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),59.29,Rate
Ipeiros,EL54,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.69,Rate
Ipeiros,EL54,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ipeiros,EL54,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.28,Rate
Ipeiros,EL54,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),3.84,Rate
Ipeiros,EL54,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.26,Rate
Ipeiros,EL54,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Ipeiros,EL54,65 years or over,Total,2013,Other ischaemic heart diseases,144.79,Rate
Ipeiros,EL54,65 years or over,Total,2014,Other ischaemic heart diseases,155.36,Rate
Ipeiros,EL54,65 years or over,Total,2015,Other ischaemic heart diseases,160.88,Rate
Ipeiros,EL54,65 years or over,Total,2016,Other ischaemic heart diseases,134.53,Rate
Ipeiros,EL54,65 years or over,Total,2017,Other ischaemic heart diseases,178.5,Rate
Ipeiros,EL54,65 years or over,Total,2018,Other ischaemic heart diseases,197.6,Rate
Ipeiros,EL54,65 years or over,Total,2019,Other ischaemic heart diseases,203.5,Rate
Ipeiros,EL54,65 years or over,Total,2020,Other ischaemic heart diseases,190.21,Rate
Ipeiros,EL54,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,139.3,Rate
Ipeiros,EL54,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,119.56,Rate
Ipeiros,EL54,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,128.76,Rate
Ipeiros,EL54,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,153.25,Rate
Ipeiros,EL54,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,128.92,Rate
Ipeiros,EL54,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,160.34,Rate
Ipeiros,EL54,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,141.21,Rate
Ipeiros,EL54,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,150.01,Rate
Ipeiros,EL54,65 years or over,Total,2013,Cerebrovascular diseases,627.99,Rate
Ipeiros,EL54,65 years or over,Total,2014,Cerebrovascular diseases,558.79,Rate
Ipeiros,EL54,65 years or over,Total,2015,Cerebrovascular diseases,602.64,Rate
Ipeiros,EL54,65 years or over,Total,2016,Cerebrovascular diseases,464.28,Rate
Ipeiros,EL54,65 years or over,Total,2017,Cerebrovascular diseases,504.23,Rate
Ipeiros,EL54,65 years or over,Total,2018,Cerebrovascular diseases,418.51,Rate
Ipeiros,EL54,65 years or over,Total,2019,Cerebrovascular diseases,485.65,Rate
Ipeiros,EL54,65 years or over,Total,2020,Cerebrovascular diseases,506.35,Rate
Ipeiros,EL54,65 years or over,Total,2013,Chronic lower respiratory diseases,88.75,Rate
Ipeiros,EL54,65 years or over,Total,2014,Chronic lower respiratory diseases,92.07,Rate
Ipeiros,EL54,65 years or over,Total,2015,Chronic lower respiratory diseases,107.24,Rate
Ipeiros,EL54,65 years or over,Total,2016,Chronic lower respiratory diseases,83.48,Rate
Ipeiros,EL54,65 years or over,Total,2017,Chronic lower respiratory diseases,82.59,Rate
Ipeiros,EL54,65 years or over,Total,2018,Chronic lower respiratory diseases,85.69,Rate
Ipeiros,EL54,65 years or over,Total,2019,Chronic lower respiratory diseases,85.99,Rate
Ipeiros,EL54,65 years or over,Total,2020,Chronic lower respiratory diseases,99.55,Rate
Ipeiros,EL54,65 years or over,Total,2013,Asthma and status asthmaticus,1.51,Rate
Ipeiros,EL54,65 years or over,Total,2014,Asthma and status asthmaticus,0.89,Rate
Ipeiros,EL54,65 years or over,Total,2015,Asthma and status asthmaticus,1.76,Rate
Ipeiros,EL54,65 years or over,Total,2016,Asthma and status asthmaticus,1.72,Rate
Ipeiros,EL54,65 years or over,Total,2018,Asthma and status asthmaticus,0.84,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,182.61,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,150.74,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,161.98,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,157.73,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,147.63,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,156.87,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,137.08,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,142.21,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.72,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.67,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.36,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.26,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.22,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.62,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.5,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",20.4,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.8,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",16.5,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.09,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",18.93,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",17.77,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",13.38,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.81,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Malignant melanoma of skin,1.04,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Malignant melanoma of skin,1.11,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Malignant melanoma of skin,3.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Malignant melanoma of skin,0.41,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Malignant melanoma of skin,0.73,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Malignant melanoma of skin,0.75,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Malignant melanoma of skin,0.41,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Malignant melanoma of skin,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.3,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Malignant neoplasm of breast,4.73,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Malignant neoplasm of breast,3.33,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.7,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Malignant neoplasm of breast,4.33,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.92,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.17,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.8,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Diabetes mellitus,1.78,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Diabetes mellitus,1.1,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Diabetes mellitus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Diabetes mellitus,2.15,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Diabetes mellitus,1.49,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Diabetes mellitus,2.41,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Diabetes mellitus,1.35,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Diabetes mellitus,1.44,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.43,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.82,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.1,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.02,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.12,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.33,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.45,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.36,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Other ischaemic heart diseases,14.38,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Other ischaemic heart diseases,4.03,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Other ischaemic heart diseases,7.5,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Other ischaemic heart diseases,8.09,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Other ischaemic heart diseases,8.39,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Other ischaemic heart diseases,6.52,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Other ischaemic heart diseases,7.24,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Other ischaemic heart diseases,7.86,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,16.3,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,11.87,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.87,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,13.91,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,12.42,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.52,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,11.64,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,12.17,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Cerebrovascular diseases,7.13,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Cerebrovascular diseases,7.73,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Cerebrovascular diseases,11.88,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Cerebrovascular diseases,5.27,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Cerebrovascular diseases,5.51,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Cerebrovascular diseases,7.92,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Cerebrovascular diseases,4.93,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Cerebrovascular diseases,6.18,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.06,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.79,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Chronic lower respiratory diseases,0.7,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Chronic lower respiratory diseases,0.67,Rate
Ipeiros,EL54,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.33,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Chronic lower respiratory diseases,1.05,Rate
Ipeiros,EL54,Less than 65 years,Total,2019,Chronic lower respiratory diseases,0.38,Rate
Ipeiros,EL54,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.03,Rate
Ipeiros,EL54,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Ipeiros,EL54,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,840.32,Rate
Ionia Nisia,EL62,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,846.79,Rate
Ionia Nisia,EL62,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,988.84,Rate
Ionia Nisia,EL62,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,873.36,Rate
Ionia Nisia,EL62,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,944.73,Rate
Ionia Nisia,EL62,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,890.2,Rate
Ionia Nisia,EL62,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,925.87,Rate
Ionia Nisia,EL62,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,933.26,Rate
Ionia Nisia,EL62,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.82,Rate
Ionia Nisia,EL62,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.11,Rate
Ionia Nisia,EL62,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.19,Rate
Ionia Nisia,EL62,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.3,Rate
Ionia Nisia,EL62,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.02,Rate
Ionia Nisia,EL62,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.92,Rate
Ionia Nisia,EL62,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.12,Rate
Ionia Nisia,EL62,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.23,Rate
Ionia Nisia,EL62,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",17.22,Rate
Ionia Nisia,EL62,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",23.39,Rate
Ionia Nisia,EL62,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",24.52,Rate
Ionia Nisia,EL62,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",19.33,Rate
Ionia Nisia,EL62,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",22.12,Rate
Ionia Nisia,EL62,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",24.18,Rate
Ionia Nisia,EL62,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",27.01,Rate
Ionia Nisia,EL62,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",26.15,Rate
Ionia Nisia,EL62,Total,Females,2013,Malignant melanoma of skin,1.9,Rate
Ionia Nisia,EL62,Total,Females,2014,Malignant melanoma of skin,1.89,Rate
Ionia Nisia,EL62,Total,Females,2015,Malignant melanoma of skin,1.31,Rate
Ionia Nisia,EL62,Total,Females,2017,Malignant melanoma of skin,0.76,Rate
Ionia Nisia,EL62,Total,Females,2018,Malignant melanoma of skin,2.83,Rate
Ionia Nisia,EL62,Total,Females,2019,Malignant melanoma of skin,1.62,Rate
Ionia Nisia,EL62,Total,Females,2020,Malignant melanoma of skin,0.57,Rate
Ionia Nisia,EL62,Total,Females,2013,Malignant neoplasm of breast,23.34,Rate
Ionia Nisia,EL62,Total,Females,2014,Malignant neoplasm of breast,31.1,Rate
Ionia Nisia,EL62,Total,Females,2015,Malignant neoplasm of breast,30.14,Rate
Ionia Nisia,EL62,Total,Females,2016,Malignant neoplasm of breast,28.43,Rate
Ionia Nisia,EL62,Total,Females,2017,Malignant neoplasm of breast,40.33,Rate
Ionia Nisia,EL62,Total,Females,2018,Malignant neoplasm of breast,26.96,Rate
Ionia Nisia,EL62,Total,Females,2019,Malignant neoplasm of breast,34.57,Rate
Ionia Nisia,EL62,Total,Females,2020,Malignant neoplasm of breast,31.65,Rate
Ionia Nisia,EL62,Total,Females,2013,Diabetes mellitus,9.57,Rate
Ionia Nisia,EL62,Total,Females,2014,Diabetes mellitus,9.14,Rate
Ionia Nisia,EL62,Total,Females,2015,Diabetes mellitus,21.0,Rate
Ionia Nisia,EL62,Total,Females,2016,Diabetes mellitus,15.21,Rate
Ionia Nisia,EL62,Total,Females,2017,Diabetes mellitus,19.77,Rate
Ionia Nisia,EL62,Total,Females,2018,Diabetes mellitus,23.78,Rate
Ionia Nisia,EL62,Total,Females,2019,Diabetes mellitus,9.54,Rate
Ionia Nisia,EL62,Total,Females,2020,Diabetes mellitus,11.08,Rate
Ionia Nisia,EL62,Total,Females,2013,Mental and behavioural disorders (F00-F99),0.55,Rate
Ionia Nisia,EL62,Total,Females,2014,Mental and behavioural disorders (F00-F99),5.31,Rate
Ionia Nisia,EL62,Total,Females,2015,Mental and behavioural disorders (F00-F99),4.94,Rate
Ionia Nisia,EL62,Total,Females,2016,Mental and behavioural disorders (F00-F99),7.03,Rate
Ionia Nisia,EL62,Total,Females,2017,Mental and behavioural disorders (F00-F99),16.93,Rate
Ionia Nisia,EL62,Total,Females,2018,Mental and behavioural disorders (F00-F99),12.61,Rate
Ionia Nisia,EL62,Total,Females,2019,Mental and behavioural disorders (F00-F99),9.82,Rate
Ionia Nisia,EL62,Total,Females,2020,Mental and behavioural disorders (F00-F99),20.77,Rate
Ionia Nisia,EL62,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Ionia Nisia,EL62,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Ionia Nisia,EL62,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Ionia Nisia,EL62,Total,Females,2013,Other ischaemic heart diseases,10.6,Rate
Ionia Nisia,EL62,Total,Females,2014,Other ischaemic heart diseases,21.95,Rate
Ionia Nisia,EL62,Total,Females,2015,Other ischaemic heart diseases,27.05,Rate
Ionia Nisia,EL62,Total,Females,2016,Other ischaemic heart diseases,24.92,Rate
Ionia Nisia,EL62,Total,Females,2017,Other ischaemic heart diseases,28.68,Rate
Ionia Nisia,EL62,Total,Females,2018,Other ischaemic heart diseases,21.15,Rate
Ionia Nisia,EL62,Total,Females,2019,Other ischaemic heart diseases,31.88,Rate
Ionia Nisia,EL62,Total,Females,2020,Other ischaemic heart diseases,27.2,Rate
Ionia Nisia,EL62,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,24.92,Rate
Ionia Nisia,EL62,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,22.94,Rate
Ionia Nisia,EL62,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,24.23,Rate
Ionia Nisia,EL62,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,19.41,Rate
Ionia Nisia,EL62,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,20.95,Rate
Ionia Nisia,EL62,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,25.97,Rate
Ionia Nisia,EL62,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,30.33,Rate
Ionia Nisia,EL62,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,40.62,Rate
Ionia Nisia,EL62,Total,Females,2013,Cerebrovascular diseases,146.42,Rate
Ionia Nisia,EL62,Total,Females,2014,Cerebrovascular diseases,128.81,Rate
Ionia Nisia,EL62,Total,Females,2015,Cerebrovascular diseases,143.13,Rate
Ionia Nisia,EL62,Total,Females,2016,Cerebrovascular diseases,126.73,Rate
Ionia Nisia,EL62,Total,Females,2017,Cerebrovascular diseases,113.23,Rate
Ionia Nisia,EL62,Total,Females,2018,Cerebrovascular diseases,118.58,Rate
Ionia Nisia,EL62,Total,Females,2019,Cerebrovascular diseases,114.1,Rate
Ionia Nisia,EL62,Total,Females,2020,Cerebrovascular diseases,102.97,Rate
Ionia Nisia,EL62,Total,Females,2013,Chronic lower respiratory diseases,15.12,Rate
Ionia Nisia,EL62,Total,Females,2014,Chronic lower respiratory diseases,22.11,Rate
Ionia Nisia,EL62,Total,Females,2015,Chronic lower respiratory diseases,17.98,Rate
Ionia Nisia,EL62,Total,Females,2016,Chronic lower respiratory diseases,17.14,Rate
Ionia Nisia,EL62,Total,Females,2017,Chronic lower respiratory diseases,22.96,Rate
Ionia Nisia,EL62,Total,Females,2018,Chronic lower respiratory diseases,22.84,Rate
Ionia Nisia,EL62,Total,Females,2019,Chronic lower respiratory diseases,20.28,Rate
Ionia Nisia,EL62,Total,Females,2020,Chronic lower respiratory diseases,26.06,Rate
Ionia Nisia,EL62,Total,Females,2013,Asthma and status asthmaticus,0.57,Rate
Ionia Nisia,EL62,Total,Females,2015,Asthma and status asthmaticus,0.76,Rate
Ionia Nisia,EL62,Total,Females,2016,Asthma and status asthmaticus,0.54,Rate
Ionia Nisia,EL62,Total,Females,2019,Asthma and status asthmaticus,0.51,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3892.94,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3857.86,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4614.54,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3980.58,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,4372.09,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,4091.27,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,4254.43,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4371.2,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.24,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.36,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.16,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.65,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.59,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.63,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.68,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.18,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",49.57,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",62.38,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",83.2,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",75.56,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",72.4,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",70.27,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",94.14,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",92.74,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Malignant melanoma of skin,6.71,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Malignant melanoma of skin,3.91,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Malignant melanoma of skin,14.51,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Malignant melanoma of skin,8.29,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Malignant melanoma of skin,2.93,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Malignant neoplasm of breast,71.97,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Malignant neoplasm of breast,87.89,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Malignant neoplasm of breast,120.32,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Malignant neoplasm of breast,104.2,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Malignant neoplasm of breast,128.36,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Malignant neoplasm of breast,91.91,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Malignant neoplasm of breast,105.72,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Malignant neoplasm of breast,122.27,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Diabetes mellitus,44.18,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Diabetes mellitus,37.1,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Diabetes mellitus,88.51,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Diabetes mellitus,68.62,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Diabetes mellitus,101.37,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Diabetes mellitus,94.55,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Diabetes mellitus,40.12,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Diabetes mellitus,52.52,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),2.82,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),27.24,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),25.32,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),31.59,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),86.8,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),64.68,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),45.97,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),93.66,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.89,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Other ischaemic heart diseases,44.64,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Other ischaemic heart diseases,112.55,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Other ischaemic heart diseases,133.9,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Other ischaemic heart diseases,109.01,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Other ischaemic heart diseases,119.08,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Other ischaemic heart diseases,85.73,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Other ischaemic heart diseases,154.48,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Other ischaemic heart diseases,130.52,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,108.23,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,93.74,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,95.84,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,95.08,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,93.61,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,115.01,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,133.37,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,195.02,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Cerebrovascular diseases,741.1,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Cerebrovascular diseases,631.79,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Cerebrovascular diseases,714.92,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Cerebrovascular diseases,635.96,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Cerebrovascular diseases,557.45,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Cerebrovascular diseases,580.4,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Cerebrovascular diseases,546.89,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Cerebrovascular diseases,507.84,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Chronic lower respiratory diseases,72.64,Rate
Ionia Nisia,EL62,65 years or over,Females,2014,Chronic lower respiratory diseases,113.37,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Chronic lower respiratory diseases,87.56,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Chronic lower respiratory diseases,83.31,Rate
Ionia Nisia,EL62,65 years or over,Females,2017,Chronic lower respiratory diseases,108.74,Rate
Ionia Nisia,EL62,65 years or over,Females,2018,Chronic lower respiratory diseases,108.03,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Chronic lower respiratory diseases,104.02,Rate
Ionia Nisia,EL62,65 years or over,Females,2020,Chronic lower respiratory diseases,124.76,Rate
Ionia Nisia,EL62,65 years or over,Females,2013,Asthma and status asthmaticus,2.92,Rate
Ionia Nisia,EL62,65 years or over,Females,2015,Asthma and status asthmaticus,3.9,Rate
Ionia Nisia,EL62,65 years or over,Females,2016,Asthma and status asthmaticus,2.76,Rate
Ionia Nisia,EL62,65 years or over,Females,2019,Asthma and status asthmaticus,2.63,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,100.87,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,117.41,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,110.56,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,120.68,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,114.5,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,114.78,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,119.57,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,100.47,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.97,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.52,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.87,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.64,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.41,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.42,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.07,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",9.39,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",13.95,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",10.31,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",5.7,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",9.94,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",13.02,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",10.75,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",10.01,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Malignant melanoma of skin,2.36,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Malignant melanoma of skin,2.35,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Malignant neoplasm of breast,11.56,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Malignant neoplasm of breast,17.34,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Malignant neoplasm of breast,8.29,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Malignant neoplasm of breast,10.08,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Malignant neoplasm of breast,19.01,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.23,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Malignant neoplasm of breast,17.34,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Malignant neoplasm of breast,9.7,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Diabetes mellitus,1.19,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Diabetes mellitus,2.37,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Diabetes mellitus,4.65,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Diabetes mellitus,2.28,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Diabetes mellitus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Diabetes mellitus,6.64,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Diabetes mellitus,2.14,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Diabetes mellitus,1.04,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),1.08,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.06,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.11,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Other ischaemic heart diseases,2.36,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.17,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Other ischaemic heart diseases,4.54,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Other ischaemic heart diseases,6.78,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Other ischaemic heart diseases,5.51,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Other ischaemic heart diseases,2.18,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.17,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.74,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,5.79,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,6.89,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,1.08,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.35,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,4.41,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,5.37,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.21,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Cerebrovascular diseases,2.36,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Cerebrovascular diseases,6.98,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Cerebrovascular diseases,4.62,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Cerebrovascular diseases,3.38,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Cerebrovascular diseases,5.62,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Cerebrovascular diseases,6.71,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Cerebrovascular diseases,9.26,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Cerebrovascular diseases,4.89,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Chronic lower respiratory diseases,1.19,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.12,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.1,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.18,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.2,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2020,Chronic lower respiratory diseases,2.15,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1150.97,Rate
Ionia Nisia,EL62,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1139.92,Rate
Ionia Nisia,EL62,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1177.34,Rate
Ionia Nisia,EL62,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1170.77,Rate
Ionia Nisia,EL62,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1179.38,Rate
Ionia Nisia,EL62,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1158.93,Rate
Ionia Nisia,EL62,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1119.4,Rate
Ionia Nisia,EL62,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1161.9,Rate
Ionia Nisia,EL62,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.04,Rate
Ionia Nisia,EL62,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.47,Rate
Ionia Nisia,EL62,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.8,Rate
Ionia Nisia,EL62,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.2,Rate
Ionia Nisia,EL62,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.68,Rate
Ionia Nisia,EL62,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.45,Rate
Ionia Nisia,EL62,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.86,Rate
Ionia Nisia,EL62,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.51,Rate
Ionia Nisia,EL62,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",108.38,Rate
Ionia Nisia,EL62,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",108.4,Rate
Ionia Nisia,EL62,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",110.43,Rate
Ionia Nisia,EL62,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",96.67,Rate
Ionia Nisia,EL62,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",97.83,Rate
Ionia Nisia,EL62,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",109.62,Rate
Ionia Nisia,EL62,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",93.82,Rate
Ionia Nisia,EL62,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",96.24,Rate
Ionia Nisia,EL62,Total,Males,2013,Malignant melanoma of skin,2.36,Rate
Ionia Nisia,EL62,Total,Males,2014,Malignant melanoma of skin,1.88,Rate
Ionia Nisia,EL62,Total,Males,2015,Malignant melanoma of skin,4.41,Rate
Ionia Nisia,EL62,Total,Males,2016,Malignant melanoma of skin,1.89,Rate
Ionia Nisia,EL62,Total,Males,2017,Malignant melanoma of skin,0.98,Rate
Ionia Nisia,EL62,Total,Males,2018,Malignant melanoma of skin,4.64,Rate
Ionia Nisia,EL62,Total,Males,2019,Malignant melanoma of skin,1.56,Rate
Ionia Nisia,EL62,Total,Males,2020,Malignant melanoma of skin,2.37,Rate
Ionia Nisia,EL62,Total,Males,2016,Malignant neoplasm of breast,0.74,Rate
Ionia Nisia,EL62,Total,Males,2017,Malignant neoplasm of breast,0.98,Rate
Ionia Nisia,EL62,Total,Males,2013,Diabetes mellitus,18.49,Rate
Ionia Nisia,EL62,Total,Males,2014,Diabetes mellitus,19.19,Rate
Ionia Nisia,EL62,Total,Males,2015,Diabetes mellitus,20.0,Rate
Ionia Nisia,EL62,Total,Males,2016,Diabetes mellitus,21.48,Rate
Ionia Nisia,EL62,Total,Males,2017,Diabetes mellitus,23.93,Rate
Ionia Nisia,EL62,Total,Males,2018,Diabetes mellitus,20.26,Rate
Ionia Nisia,EL62,Total,Males,2019,Diabetes mellitus,14.58,Rate
Ionia Nisia,EL62,Total,Males,2020,Diabetes mellitus,24.18,Rate
Ionia Nisia,EL62,Total,Males,2013,Mental and behavioural disorders (F00-F99),1.74,Rate
Ionia Nisia,EL62,Total,Males,2014,Mental and behavioural disorders (F00-F99),3.51,Rate
Ionia Nisia,EL62,Total,Males,2015,Mental and behavioural disorders (F00-F99),9.8,Rate
Ionia Nisia,EL62,Total,Males,2016,Mental and behavioural disorders (F00-F99),11.51,Rate
Ionia Nisia,EL62,Total,Males,2017,Mental and behavioural disorders (F00-F99),16.23,Rate
Ionia Nisia,EL62,Total,Males,2018,Mental and behavioural disorders (F00-F99),9.39,Rate
Ionia Nisia,EL62,Total,Males,2019,Mental and behavioural disorders (F00-F99),13.66,Rate
Ionia Nisia,EL62,Total,Males,2020,Mental and behavioural disorders (F00-F99),14.82,Rate
Ionia Nisia,EL62,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Ionia Nisia,EL62,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Ionia Nisia,EL62,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Ionia Nisia,EL62,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.82,Rate
Ionia Nisia,EL62,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.64,Rate
Ionia Nisia,EL62,Total,Males,2013,Other ischaemic heart diseases,34.81,Rate
Ionia Nisia,EL62,Total,Males,2014,Other ischaemic heart diseases,45.92,Rate
Ionia Nisia,EL62,Total,Males,2015,Other ischaemic heart diseases,33.38,Rate
Ionia Nisia,EL62,Total,Males,2016,Other ischaemic heart diseases,41.56,Rate
Ionia Nisia,EL62,Total,Males,2017,Other ischaemic heart diseases,38.86,Rate
Ionia Nisia,EL62,Total,Males,2018,Other ischaemic heart diseases,36.48,Rate
Ionia Nisia,EL62,Total,Males,2019,Other ischaemic heart diseases,42.3,Rate
Ionia Nisia,EL62,Total,Males,2020,Other ischaemic heart diseases,60.32,Rate
Ionia Nisia,EL62,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,68.34,Rate
Ionia Nisia,EL62,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,52.96,Rate
Ionia Nisia,EL62,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,63.74,Rate
Ionia Nisia,EL62,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,76.55,Rate
Ionia Nisia,EL62,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,80.98,Rate
Ionia Nisia,EL62,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,64.7,Rate
Ionia Nisia,EL62,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,68.18,Rate
Ionia Nisia,EL62,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,79.01,Rate
Ionia Nisia,EL62,Total,Males,2013,Cerebrovascular diseases,125.1,Rate
Ionia Nisia,EL62,Total,Males,2014,Cerebrovascular diseases,105.25,Rate
Ionia Nisia,EL62,Total,Males,2015,Cerebrovascular diseases,110.22,Rate
Ionia Nisia,EL62,Total,Males,2016,Cerebrovascular diseases,104.71,Rate
Ionia Nisia,EL62,Total,Males,2017,Cerebrovascular diseases,123.57,Rate
Ionia Nisia,EL62,Total,Males,2018,Cerebrovascular diseases,88.77,Rate
Ionia Nisia,EL62,Total,Males,2019,Cerebrovascular diseases,96.67,Rate
Ionia Nisia,EL62,Total,Males,2020,Cerebrovascular diseases,108.5,Rate
Ionia Nisia,EL62,Total,Males,2013,Chronic lower respiratory diseases,19.63,Rate
Ionia Nisia,EL62,Total,Males,2014,Chronic lower respiratory diseases,42.39,Rate
Ionia Nisia,EL62,Total,Males,2015,Chronic lower respiratory diseases,49.51,Rate
Ionia Nisia,EL62,Total,Males,2016,Chronic lower respiratory diseases,43.45,Rate
Ionia Nisia,EL62,Total,Males,2017,Chronic lower respiratory diseases,51.98,Rate
Ionia Nisia,EL62,Total,Males,2018,Chronic lower respiratory diseases,37.99,Rate
Ionia Nisia,EL62,Total,Males,2019,Chronic lower respiratory diseases,46.13,Rate
Ionia Nisia,EL62,Total,Males,2020,Chronic lower respiratory diseases,33.18,Rate
Ionia Nisia,EL62,Total,Males,2019,Asthma and status asthmaticus,0.78,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4882.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4880.55,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4924.81,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4954.46,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5035.72,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4898.9,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4765.94,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4994.99,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.46,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.69,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.61,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.1,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.92,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.32,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.93,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.01,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",388.99,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",394.03,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",408.76,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",373.23,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",401.55,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",461.12,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",339.48,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",402.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Malignant melanoma of skin,12.09,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Malignant melanoma of skin,4.95,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Malignant melanoma of skin,17.97,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Malignant melanoma of skin,4.93,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Malignant melanoma of skin,3.56,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Malignant melanoma of skin,12.18,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Malignant neoplasm of breast,3.8,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Malignant neoplasm of breast,0.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Diabetes mellitus,75.72,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Diabetes mellitus,88.99,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Diabetes mellitus,88.16,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Diabetes mellitus,95.7,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Diabetes mellitus,113.32,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Diabetes mellitus,87.69,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Diabetes mellitus,52.17,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Diabetes mellitus,115.26,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),4.09,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),8.59,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),50.24,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),54.34,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),83.22,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),38.96,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),60.49,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),75.98,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),5.05,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),13.56,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Other ischaemic heart diseases,140.71,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Other ischaemic heart diseases,205.29,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Other ischaemic heart diseases,142.62,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Other ischaemic heart diseases,137.27,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Other ischaemic heart diseases,156.74,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Other ischaemic heart diseases,144.68,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Other ischaemic heart diseases,188.8,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Other ischaemic heart diseases,269.21,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,236.42,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,161.79,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,190.13,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,230.39,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,302.63,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,218.52,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,222.7,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,243.59,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Cerebrovascular diseases,594.09,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Cerebrovascular diseases,491.86,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Cerebrovascular diseases,537.21,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Cerebrovascular diseases,480.18,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Cerebrovascular diseases,576.86,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Cerebrovascular diseases,397.41,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Cerebrovascular diseases,439.74,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Cerebrovascular diseases,509.78,Rate
Ionia Nisia,EL62,65 years or over,Males,2013,Chronic lower respiratory diseases,91.25,Rate
Ionia Nisia,EL62,65 years or over,Males,2014,Chronic lower respiratory diseases,217.4,Rate
Ionia Nisia,EL62,65 years or over,Males,2015,Chronic lower respiratory diseases,239.92,Rate
Ionia Nisia,EL62,65 years or over,Males,2016,Chronic lower respiratory diseases,222.83,Rate
Ionia Nisia,EL62,65 years or over,Males,2017,Chronic lower respiratory diseases,247.59,Rate
Ionia Nisia,EL62,65 years or over,Males,2018,Chronic lower respiratory diseases,181.06,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Chronic lower respiratory diseases,218.48,Rate
Ionia Nisia,EL62,65 years or over,Males,2020,Chronic lower respiratory diseases,161.0,Rate
Ionia Nisia,EL62,65 years or over,Males,2019,Asthma and status asthmaticus,4.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,247.18,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,233.81,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,269.57,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,254.22,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,245.23,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,252.97,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,236.08,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,233.39,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.35,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.62,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.1,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.42,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.03,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.4,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.67,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.55,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",40.4,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",39.21,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",38.16,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",29.67,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",24.26,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",24.48,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",34.32,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",22.17,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Malignant melanoma of skin,1.14,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Malignant melanoma of skin,1.13,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Malignant melanoma of skin,2.35,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Malignant melanoma of skin,1.22,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Malignant melanoma of skin,4.57,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Malignant melanoma of skin,1.08,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Malignant neoplasm of breast,1.22,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Diabetes mellitus,4.63,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Diabetes mellitus,2.29,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Diabetes mellitus,3.48,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Diabetes mellitus,3.5,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Diabetes mellitus,2.27,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Diabetes mellitus,3.93,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Diabetes mellitus,5.48,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Diabetes mellitus,2.12,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.16,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),2.28,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),1.14,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),2.23,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),2.32,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.14,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.14,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Other ischaemic heart diseases,9.16,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Other ischaemic heart diseases,7.31,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Other ischaemic heart diseases,6.92,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Other ischaemic heart diseases,18.38,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Other ischaemic heart diseases,10.3,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Other ischaemic heart diseases,10.27,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Other ischaemic heart diseases,6.82,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Other ischaemic heart diseases,9.72,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,27.63,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,26.6,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,33.12,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,39.29,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,27.29,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,27.44,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,30.75,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,39.14,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Cerebrovascular diseases,11.49,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Cerebrovascular diseases,11.59,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Cerebrovascular diseases,6.78,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Cerebrovascular diseases,13.75,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Cerebrovascular diseases,13.76,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Cerebrovascular diseases,14.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Cerebrovascular diseases,13.56,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Cerebrovascular diseases,11.3,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.28,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2015,Chronic lower respiratory diseases,3.39,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2016,Chronic lower respiratory diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2017,Chronic lower respiratory diseases,4.6,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.33,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Chronic lower respiratory diseases,4.38,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.21,Rate
Ionia Nisia,EL62,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,991.96,Rate
Ionia Nisia,EL62,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,986.06,Rate
Ionia Nisia,EL62,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1084.8,Rate
Ionia Nisia,EL62,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1013.1,Rate
Ionia Nisia,EL62,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1056.79,Rate
Ionia Nisia,EL62,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1015.97,Rate
Ionia Nisia,EL62,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1013.74,Rate
Ionia Nisia,EL62,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1037.69,Rate
Ionia Nisia,EL62,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.32,Rate
Ionia Nisia,EL62,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.95,Rate
Ionia Nisia,EL62,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.49,Rate
Ionia Nisia,EL62,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.39,Rate
Ionia Nisia,EL62,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.38,Rate
Ionia Nisia,EL62,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.29,Rate
Ionia Nisia,EL62,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.35,Rate
Ionia Nisia,EL62,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.62,Rate
Ionia Nisia,EL62,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",59.47,Rate
Ionia Nisia,EL62,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",62.92,Rate
Ionia Nisia,EL62,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",64.43,Rate
Ionia Nisia,EL62,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",55.41,Rate
Ionia Nisia,EL62,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",57.12,Rate
Ionia Nisia,EL62,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",63.66,Rate
Ionia Nisia,EL62,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",58.43,Rate
Ionia Nisia,EL62,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",58.71,Rate
Ionia Nisia,EL62,Total,Total,2013,Malignant melanoma of skin,1.97,Rate
Ionia Nisia,EL62,Total,Total,2014,Malignant melanoma of skin,1.82,Rate
Ionia Nisia,EL62,Total,Total,2015,Malignant melanoma of skin,2.8,Rate
Ionia Nisia,EL62,Total,Total,2016,Malignant melanoma of skin,0.92,Rate
Ionia Nisia,EL62,Total,Total,2017,Malignant melanoma of skin,0.91,Rate
Ionia Nisia,EL62,Total,Total,2018,Malignant melanoma of skin,3.83,Rate
Ionia Nisia,EL62,Total,Total,2019,Malignant melanoma of skin,1.58,Rate
Ionia Nisia,EL62,Total,Total,2020,Malignant melanoma of skin,1.39,Rate
Ionia Nisia,EL62,Total,Total,2013,Malignant neoplasm of breast,12.46,Rate
Ionia Nisia,EL62,Total,Total,2014,Malignant neoplasm of breast,16.63,Rate
Ionia Nisia,EL62,Total,Total,2015,Malignant neoplasm of breast,16.31,Rate
Ionia Nisia,EL62,Total,Total,2016,Malignant neoplasm of breast,15.62,Rate
Ionia Nisia,EL62,Total,Total,2017,Malignant neoplasm of breast,22.13,Rate
Ionia Nisia,EL62,Total,Total,2018,Malignant neoplasm of breast,14.38,Rate
Ionia Nisia,EL62,Total,Total,2019,Malignant neoplasm of breast,18.32,Rate
Ionia Nisia,EL62,Total,Total,2020,Malignant neoplasm of breast,16.86,Rate
Ionia Nisia,EL62,Total,Total,2013,Diabetes mellitus,13.73,Rate
Ionia Nisia,EL62,Total,Total,2014,Diabetes mellitus,13.72,Rate
Ionia Nisia,EL62,Total,Total,2015,Diabetes mellitus,20.94,Rate
Ionia Nisia,EL62,Total,Total,2016,Diabetes mellitus,17.91,Rate
Ionia Nisia,EL62,Total,Total,2017,Diabetes mellitus,21.76,Rate
Ionia Nisia,EL62,Total,Total,2018,Diabetes mellitus,22.11,Rate
Ionia Nisia,EL62,Total,Total,2019,Diabetes mellitus,12.1,Rate
Ionia Nisia,EL62,Total,Total,2020,Diabetes mellitus,17.23,Rate
Ionia Nisia,EL62,Total,Total,2013,Mental and behavioural disorders (F00-F99),1.11,Rate
Ionia Nisia,EL62,Total,Total,2014,Mental and behavioural disorders (F00-F99),4.66,Rate
Ionia Nisia,EL62,Total,Total,2015,Mental and behavioural disorders (F00-F99),7.07,Rate
Ionia Nisia,EL62,Total,Total,2016,Mental and behavioural disorders (F00-F99),9.1,Rate
Ionia Nisia,EL62,Total,Total,2017,Mental and behavioural disorders (F00-F99),16.92,Rate
Ionia Nisia,EL62,Total,Total,2018,Mental and behavioural disorders (F00-F99),11.31,Rate
Ionia Nisia,EL62,Total,Total,2019,Mental and behavioural disorders (F00-F99),11.48,Rate
Ionia Nisia,EL62,Total,Total,2020,Mental and behavioural disorders (F00-F99),18.13,Rate
Ionia Nisia,EL62,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Ionia Nisia,EL62,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Ionia Nisia,EL62,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Ionia Nisia,EL62,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.44,Rate
Ionia Nisia,EL62,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Ionia Nisia,EL62,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Ionia Nisia,EL62,Total,Total,2013,Other ischaemic heart diseases,21.71,Rate
Ionia Nisia,EL62,Total,Total,2014,Other ischaemic heart diseases,32.76,Rate
Ionia Nisia,EL62,Total,Total,2015,Other ischaemic heart diseases,30.13,Rate
Ionia Nisia,EL62,Total,Total,2016,Other ischaemic heart diseases,33.15,Rate
Ionia Nisia,EL62,Total,Total,2017,Other ischaemic heart diseases,33.57,Rate
Ionia Nisia,EL62,Total,Total,2018,Other ischaemic heart diseases,28.53,Rate
Ionia Nisia,EL62,Total,Total,2019,Other ischaemic heart diseases,36.36,Rate
Ionia Nisia,EL62,Total,Total,2020,Other ischaemic heart diseases,42.08,Rate
Ionia Nisia,EL62,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,45.62,Rate
Ionia Nisia,EL62,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,37.78,Rate
Ionia Nisia,EL62,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,43.15,Rate
Ionia Nisia,EL62,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,46.59,Rate
Ionia Nisia,EL62,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,48.8,Rate
Ionia Nisia,EL62,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,44.64,Rate
Ionia Nisia,EL62,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,48.28,Rate
Ionia Nisia,EL62,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,59.64,Rate
Ionia Nisia,EL62,Total,Total,2013,Cerebrovascular diseases,139.14,Rate
Ionia Nisia,EL62,Total,Total,2014,Cerebrovascular diseases,120.01,Rate
Ionia Nisia,EL62,Total,Total,2015,Cerebrovascular diseases,129.28,Rate
Ionia Nisia,EL62,Total,Total,2016,Cerebrovascular diseases,118.23,Rate
Ionia Nisia,EL62,Total,Total,2017,Cerebrovascular diseases,118.31,Rate
Ionia Nisia,EL62,Total,Total,2018,Cerebrovascular diseases,105.12,Rate
Ionia Nisia,EL62,Total,Total,2019,Cerebrovascular diseases,105.97,Rate
Ionia Nisia,EL62,Total,Total,2020,Cerebrovascular diseases,105.96,Rate
Ionia Nisia,EL62,Total,Total,2013,Chronic lower respiratory diseases,17.26,Rate
Ionia Nisia,EL62,Total,Total,2014,Chronic lower respiratory diseases,30.7,Rate
Ionia Nisia,EL62,Total,Total,2015,Chronic lower respiratory diseases,31.6,Rate
Ionia Nisia,EL62,Total,Total,2016,Chronic lower respiratory diseases,28.69,Rate
Ionia Nisia,EL62,Total,Total,2017,Chronic lower respiratory diseases,35.96,Rate
Ionia Nisia,EL62,Total,Total,2018,Chronic lower respiratory diseases,29.68,Rate
Ionia Nisia,EL62,Total,Total,2019,Chronic lower respiratory diseases,32.2,Rate
Ionia Nisia,EL62,Total,Total,2020,Chronic lower respiratory diseases,29.07,Rate
Ionia Nisia,EL62,Total,Total,2013,Asthma and status asthmaticus,0.33,Rate
Ionia Nisia,EL62,Total,Total,2015,Asthma and status asthmaticus,0.43,Rate
Ionia Nisia,EL62,Total,Total,2016,Asthma and status asthmaticus,0.3,Rate
Ionia Nisia,EL62,Total,Total,2019,Asthma and status asthmaticus,0.62,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4366.4,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4331.04,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4779.16,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4424.53,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4680.38,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4455.62,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4469.1,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4637.75,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",74.8,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.89,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.17,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.96,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.99,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.64,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.67,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.01,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",202.02,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",212.58,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",230.53,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",211.4,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",222.84,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",249.24,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",207.25,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",235.09,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Malignant melanoma of skin,5.29,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Malignant melanoma of skin,2.16,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Malignant melanoma of skin,12.07,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Malignant melanoma of skin,2.22,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Malignant melanoma of skin,10.39,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Malignant melanoma of skin,5.89,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Malignant melanoma of skin,7.14,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Malignant neoplasm of breast,40.09,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Malignant neoplasm of breast,49.46,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Malignant neoplasm of breast,66.28,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Malignant neoplasm of breast,59.05,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Malignant neoplasm of breast,71.36,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Malignant neoplasm of breast,50.15,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Malignant neoplasm of breast,57.37,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Malignant neoplasm of breast,65.82,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Diabetes mellitus,58.33,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Diabetes mellitus,60.77,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Diabetes mellitus,90.69,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Diabetes mellitus,79.96,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Diabetes mellitus,106.89,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Diabetes mellitus,91.66,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Diabetes mellitus,46.39,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Diabetes mellitus,81.85,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),3.29,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),19.21,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),36.26,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),42.03,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),86.76,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),53.45,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),52.01,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),86.48,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.2,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.56,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.95,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),6.19,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Other ischaemic heart diseases,87.32,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Other ischaemic heart diseases,152.82,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Other ischaemic heart diseases,137.82,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Other ischaemic heart diseases,122.96,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Other ischaemic heart diseases,136.8,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Other ischaemic heart diseases,113.82,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Other ischaemic heart diseases,168.1,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Other ischaemic heart diseases,191.51,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,166.91,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,127.05,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,138.71,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,156.34,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,187.61,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,163.8,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,174.34,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,219.87,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Cerebrovascular diseases,684.66,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Cerebrovascular diseases,577.15,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Cerebrovascular diseases,639.45,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Cerebrovascular diseases,571.19,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Cerebrovascular diseases,566.83,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Cerebrovascular diseases,496.68,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Cerebrovascular diseases,496.41,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Cerebrovascular diseases,510.2,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Chronic lower respiratory diseases,81.32,Rate
Ionia Nisia,EL62,65 years or over,Total,2014,Chronic lower respiratory diseases,157.44,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Chronic lower respiratory diseases,152.71,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Chronic lower respiratory diseases,144.85,Rate
Ionia Nisia,EL62,65 years or over,Total,2017,Chronic lower respiratory diseases,170.46,Rate
Ionia Nisia,EL62,65 years or over,Total,2018,Chronic lower respiratory diseases,140.73,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Chronic lower respiratory diseases,156.22,Rate
Ionia Nisia,EL62,65 years or over,Total,2020,Chronic lower respiratory diseases,140.03,Rate
Ionia Nisia,EL62,65 years or over,Total,2013,Asthma and status asthmaticus,1.7,Rate
Ionia Nisia,EL62,65 years or over,Total,2015,Asthma and status asthmaticus,2.2,Rate
Ionia Nisia,EL62,65 years or over,Total,2016,Asthma and status asthmaticus,1.56,Rate
Ionia Nisia,EL62,65 years or over,Total,2019,Asthma and status asthmaticus,3.19,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,174.55,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,175.78,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,189.89,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,186.73,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,179.03,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,182.76,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,176.72,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,165.63,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.64,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.04,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.06,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.19,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.67,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.53,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.26,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",24.94,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",26.67,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",24.2,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",17.63,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",16.98,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",18.7,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",22.38,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.98,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Malignant melanoma of skin,1.17,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Malignant melanoma of skin,1.73,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Malignant melanoma of skin,0.56,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Malignant melanoma of skin,1.15,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Malignant melanoma of skin,0.59,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Malignant melanoma of skin,2.24,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Malignant melanoma of skin,0.53,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Malignant melanoma of skin,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.77,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Malignant neoplasm of breast,8.68,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Malignant neoplasm of breast,4.2,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.1,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Malignant neoplasm of breast,10.2,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.72,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Malignant neoplasm of breast,8.86,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Diabetes mellitus,2.92,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Diabetes mellitus,2.32,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Diabetes mellitus,4.04,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Diabetes mellitus,2.87,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Diabetes mellitus,1.13,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Diabetes mellitus,5.27,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Diabetes mellitus,3.8,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Diabetes mellitus,1.57,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.59,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),1.13,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.12,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.1,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.66,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.57,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Other ischaemic heart diseases,5.82,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Other ischaemic heart diseases,3.68,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Other ischaemic heart diseases,4.04,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Other ischaemic heart diseases,11.4,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Other ischaemic heart diseases,8.57,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Other ischaemic heart diseases,7.87,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Other ischaemic heart diseases,4.45,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Other ischaemic heart diseases,5.88,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,16.23,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,16.15,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,20.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,20.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,15.18,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,15.77,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,17.74,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,20.83,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Cerebrovascular diseases,6.99,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Cerebrovascular diseases,9.28,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Cerebrovascular diseases,5.7,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Cerebrovascular diseases,8.5,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Cerebrovascular diseases,9.66,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Cerebrovascular diseases,10.27,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Cerebrovascular diseases,11.39,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Cerebrovascular diseases,8.04,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.75,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Chronic lower respiratory diseases,2.26,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Chronic lower respiratory diseases,0.55,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.38,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.78,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Chronic lower respiratory diseases,2.16,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2020,Chronic lower respiratory diseases,2.19,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Ionia Nisia,EL62,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,644.11,Rate
Pas Vasco,ES21,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,646.73,Rate
Pas Vasco,ES21,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,604.52,Rate
Pas Vasco,ES21,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,613.99,Rate
Pas Vasco,ES21,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,636.46,Rate
Pas Vasco,ES21,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,603.61,Rate
Pas Vasco,ES21,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,605.63,Rate
Pas Vasco,ES21,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,595.59,Rate
Pas Vasco,ES21,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,575.0,Rate
Pas Vasco,ES21,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,643.83,Rate
Pas Vasco,ES21,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.83,Rate
Pas Vasco,ES21,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.83,Rate
Pas Vasco,ES21,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.95,Rate
Pas Vasco,ES21,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.55,Rate
Pas Vasco,ES21,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.57,Rate
Pas Vasco,ES21,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.59,Rate
Pas Vasco,ES21,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.74,Rate
Pas Vasco,ES21,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.71,Rate
Pas Vasco,ES21,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.93,Rate
Pas Vasco,ES21,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.74,Rate
Pas Vasco,ES21,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",20.02,Rate
Pas Vasco,ES21,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",18.05,Rate
Pas Vasco,ES21,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",20.26,Rate
Pas Vasco,ES21,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",21.45,Rate
Pas Vasco,ES21,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",24.24,Rate
Pas Vasco,ES21,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",20.38,Rate
Pas Vasco,ES21,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",23.14,Rate
Pas Vasco,ES21,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",21.66,Rate
Pas Vasco,ES21,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",23.43,Rate
Pas Vasco,ES21,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",22.26,Rate
Pas Vasco,ES21,Total,Females,2011,Malignant melanoma of skin,1.65,Rate
Pas Vasco,ES21,Total,Females,2012,Malignant melanoma of skin,1.49,Rate
Pas Vasco,ES21,Total,Females,2013,Malignant melanoma of skin,1.08,Rate
Pas Vasco,ES21,Total,Females,2014,Malignant melanoma of skin,2.51,Rate
Pas Vasco,ES21,Total,Females,2015,Malignant melanoma of skin,1.55,Rate
Pas Vasco,ES21,Total,Females,2016,Malignant melanoma of skin,1.6,Rate
Pas Vasco,ES21,Total,Females,2017,Malignant melanoma of skin,1.68,Rate
Pas Vasco,ES21,Total,Females,2018,Malignant melanoma of skin,1.68,Rate
Pas Vasco,ES21,Total,Females,2019,Malignant melanoma of skin,2.08,Rate
Pas Vasco,ES21,Total,Females,2020,Malignant melanoma of skin,1.45,Rate
Pas Vasco,ES21,Total,Females,2011,Malignant neoplasm of breast,26.04,Rate
Pas Vasco,ES21,Total,Females,2012,Malignant neoplasm of breast,25.07,Rate
Pas Vasco,ES21,Total,Females,2013,Malignant neoplasm of breast,24.63,Rate
Pas Vasco,ES21,Total,Females,2014,Malignant neoplasm of breast,25.03,Rate
Pas Vasco,ES21,Total,Females,2015,Malignant neoplasm of breast,23.24,Rate
Pas Vasco,ES21,Total,Females,2016,Malignant neoplasm of breast,21.38,Rate
Pas Vasco,ES21,Total,Females,2017,Malignant neoplasm of breast,23.94,Rate
Pas Vasco,ES21,Total,Females,2018,Malignant neoplasm of breast,22.25,Rate
Pas Vasco,ES21,Total,Females,2019,Malignant neoplasm of breast,19.84,Rate
Pas Vasco,ES21,Total,Females,2020,Malignant neoplasm of breast,20.1,Rate
Pas Vasco,ES21,Total,Females,2011,Diabetes mellitus,17.94,Rate
Pas Vasco,ES21,Total,Females,2012,Diabetes mellitus,16.96,Rate
Pas Vasco,ES21,Total,Females,2013,Diabetes mellitus,18.69,Rate
Pas Vasco,ES21,Total,Females,2014,Diabetes mellitus,14.32,Rate
Pas Vasco,ES21,Total,Females,2015,Diabetes mellitus,15.11,Rate
Pas Vasco,ES21,Total,Females,2016,Diabetes mellitus,12.52,Rate
Pas Vasco,ES21,Total,Females,2017,Diabetes mellitus,10.63,Rate
Pas Vasco,ES21,Total,Females,2018,Diabetes mellitus,12.83,Rate
Pas Vasco,ES21,Total,Females,2019,Diabetes mellitus,12.92,Rate
Pas Vasco,ES21,Total,Females,2020,Diabetes mellitus,13.18,Rate
Pas Vasco,ES21,Total,Females,2011,Mental and behavioural disorders (F00-F99),44.65,Rate
Pas Vasco,ES21,Total,Females,2012,Mental and behavioural disorders (F00-F99),47.76,Rate
Pas Vasco,ES21,Total,Females,2013,Mental and behavioural disorders (F00-F99),40.23,Rate
Pas Vasco,ES21,Total,Females,2014,Mental and behavioural disorders (F00-F99),43.74,Rate
Pas Vasco,ES21,Total,Females,2015,Mental and behavioural disorders (F00-F99),48.33,Rate
Pas Vasco,ES21,Total,Females,2016,Mental and behavioural disorders (F00-F99),47.73,Rate
Pas Vasco,ES21,Total,Females,2017,Mental and behavioural disorders (F00-F99),46.34,Rate
Pas Vasco,ES21,Total,Females,2018,Mental and behavioural disorders (F00-F99),48.51,Rate
Pas Vasco,ES21,Total,Females,2019,Mental and behavioural disorders (F00-F99),51.88,Rate
Pas Vasco,ES21,Total,Females,2020,Mental and behavioural disorders (F00-F99),56.44,Rate
Pas Vasco,ES21,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Pas Vasco,ES21,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Pas Vasco,ES21,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Pas Vasco,ES21,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.36,Rate
Pas Vasco,ES21,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Pas Vasco,ES21,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Pas Vasco,ES21,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Pas Vasco,ES21,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Pas Vasco,ES21,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.33,Rate
Pas Vasco,ES21,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.25,Rate
Pas Vasco,ES21,Total,Females,2011,Other ischaemic heart diseases,18.61,Rate
Pas Vasco,ES21,Total,Females,2012,Other ischaemic heart diseases,19.64,Rate
Pas Vasco,ES21,Total,Females,2013,Other ischaemic heart diseases,17.07,Rate
Pas Vasco,ES21,Total,Females,2014,Other ischaemic heart diseases,15.19,Rate
Pas Vasco,ES21,Total,Females,2015,Other ischaemic heart diseases,15.83,Rate
Pas Vasco,ES21,Total,Females,2016,Other ischaemic heart diseases,15.88,Rate
Pas Vasco,ES21,Total,Females,2017,Other ischaemic heart diseases,15.63,Rate
Pas Vasco,ES21,Total,Females,2018,Other ischaemic heart diseases,13.41,Rate
Pas Vasco,ES21,Total,Females,2019,Other ischaemic heart diseases,11.85,Rate
Pas Vasco,ES21,Total,Females,2020,Other ischaemic heart diseases,12.9,Rate
Pas Vasco,ES21,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,17.91,Rate
Pas Vasco,ES21,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,15.49,Rate
Pas Vasco,ES21,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,13.92,Rate
Pas Vasco,ES21,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,13.81,Rate
Pas Vasco,ES21,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,14.33,Rate
Pas Vasco,ES21,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,13.26,Rate
Pas Vasco,ES21,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,12.53,Rate
Pas Vasco,ES21,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,11.7,Rate
Pas Vasco,ES21,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,10.5,Rate
Pas Vasco,ES21,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,9.58,Rate
Pas Vasco,ES21,Total,Females,2011,Cerebrovascular diseases,52.14,Rate
Pas Vasco,ES21,Total,Females,2012,Cerebrovascular diseases,51.6,Rate
Pas Vasco,ES21,Total,Females,2013,Cerebrovascular diseases,45.99,Rate
Pas Vasco,ES21,Total,Females,2014,Cerebrovascular diseases,42.5,Rate
Pas Vasco,ES21,Total,Females,2015,Cerebrovascular diseases,45.24,Rate
Pas Vasco,ES21,Total,Females,2016,Cerebrovascular diseases,41.33,Rate
Pas Vasco,ES21,Total,Females,2017,Cerebrovascular diseases,42.47,Rate
Pas Vasco,ES21,Total,Females,2018,Cerebrovascular diseases,39.16,Rate
Pas Vasco,ES21,Total,Females,2019,Cerebrovascular diseases,37.28,Rate
Pas Vasco,ES21,Total,Females,2020,Cerebrovascular diseases,40.18,Rate
Pas Vasco,ES21,Total,Females,2011,Chronic lower respiratory diseases,17.01,Rate
Pas Vasco,ES21,Total,Females,2012,Chronic lower respiratory diseases,16.16,Rate
Pas Vasco,ES21,Total,Females,2013,Chronic lower respiratory diseases,14.32,Rate
Pas Vasco,ES21,Total,Females,2014,Chronic lower respiratory diseases,14.29,Rate
Pas Vasco,ES21,Total,Females,2015,Chronic lower respiratory diseases,14.53,Rate
Pas Vasco,ES21,Total,Females,2016,Chronic lower respiratory diseases,13.76,Rate
Pas Vasco,ES21,Total,Females,2017,Chronic lower respiratory diseases,15.16,Rate
Pas Vasco,ES21,Total,Females,2018,Chronic lower respiratory diseases,12.14,Rate
Pas Vasco,ES21,Total,Females,2019,Chronic lower respiratory diseases,13.16,Rate
Pas Vasco,ES21,Total,Females,2020,Chronic lower respiratory diseases,12.21,Rate
Pas Vasco,ES21,Total,Females,2011,Asthma and status asthmaticus,3.77,Rate
Pas Vasco,ES21,Total,Females,2012,Asthma and status asthmaticus,4.27,Rate
Pas Vasco,ES21,Total,Females,2013,Asthma and status asthmaticus,2.95,Rate
Pas Vasco,ES21,Total,Females,2014,Asthma and status asthmaticus,3.25,Rate
Pas Vasco,ES21,Total,Females,2015,Asthma and status asthmaticus,3.93,Rate
Pas Vasco,ES21,Total,Females,2016,Asthma and status asthmaticus,4.43,Rate
Pas Vasco,ES21,Total,Females,2017,Asthma and status asthmaticus,4.53,Rate
Pas Vasco,ES21,Total,Females,2018,Asthma and status asthmaticus,3.21,Rate
Pas Vasco,ES21,Total,Females,2019,Asthma and status asthmaticus,3.36,Rate
Pas Vasco,ES21,Total,Females,2020,Asthma and status asthmaticus,3.71,Rate
Pas Vasco,ES21,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,2847.07,Rate
Pas Vasco,ES21,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,2907.96,Rate
Pas Vasco,ES21,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,2675.12,Rate
Pas Vasco,ES21,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,2712.53,Rate
Pas Vasco,ES21,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,2823.25,Rate
Pas Vasco,ES21,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,2698.57,Rate
Pas Vasco,ES21,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,2693.68,Rate
Pas Vasco,ES21,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,2628.6,Rate
Pas Vasco,ES21,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,2564.7,Rate
Pas Vasco,ES21,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,2891.16,Rate
Pas Vasco,ES21,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.55,Rate
Pas Vasco,ES21,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.56,Rate
Pas Vasco,ES21,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.89,Rate
Pas Vasco,ES21,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.11,Rate
Pas Vasco,ES21,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.61,Rate
Pas Vasco,ES21,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.84,Rate
Pas Vasco,ES21,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.71,Rate
Pas Vasco,ES21,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.58,Rate
Pas Vasco,ES21,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.28,Rate
Pas Vasco,ES21,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.98,Rate
Pas Vasco,ES21,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",47.26,Rate
Pas Vasco,ES21,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",43.73,Rate
Pas Vasco,ES21,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",50.56,Rate
Pas Vasco,ES21,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",49.27,Rate
Pas Vasco,ES21,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",56.28,Rate
Pas Vasco,ES21,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",55.48,Rate
Pas Vasco,ES21,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",59.39,Rate
Pas Vasco,ES21,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",62.89,Rate
Pas Vasco,ES21,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",69.2,Rate
Pas Vasco,ES21,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",69.8,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Malignant melanoma of skin,5.01,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Malignant melanoma of skin,5.47,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Malignant melanoma of skin,1.23,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Malignant melanoma of skin,9.86,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Malignant melanoma of skin,5.39,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Malignant melanoma of skin,5.28,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Malignant melanoma of skin,5.14,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Malignant melanoma of skin,6.16,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Malignant melanoma of skin,7.86,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Malignant melanoma of skin,5.4,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Malignant neoplasm of breast,80.24,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Malignant neoplasm of breast,76.63,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Malignant neoplasm of breast,75.83,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Malignant neoplasm of breast,76.73,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Malignant neoplasm of breast,74.57,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Malignant neoplasm of breast,62.31,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Malignant neoplasm of breast,73.82,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Malignant neoplasm of breast,67.19,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Malignant neoplasm of breast,63.64,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Malignant neoplasm of breast,60.82,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Diabetes mellitus,89.32,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Diabetes mellitus,84.8,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Diabetes mellitus,91.07,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Diabetes mellitus,69.96,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Diabetes mellitus,73.65,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Diabetes mellitus,60.19,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Diabetes mellitus,53.64,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Diabetes mellitus,61.67,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Diabetes mellitus,63.44,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Diabetes mellitus,63.33,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),224.57,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),243.1,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),203.71,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),220.85,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),245.73,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),241.38,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),235.35,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),244.08,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),264.86,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),287.85,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.06,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),4.84,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.72,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),5.68,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.79,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),4.82,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.78,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),5.98,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),5.97,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Other ischaemic heart diseases,90.54,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Other ischaemic heart diseases,95.92,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Other ischaemic heart diseases,79.78,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Other ischaemic heart diseases,73.17,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Other ischaemic heart diseases,76.92,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Other ischaemic heart diseases,75.11,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Other ischaemic heart diseases,73.89,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Other ischaemic heart diseases,62.21,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Other ischaemic heart diseases,52.53,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Other ischaemic heart diseases,60.2,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,85.28,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,74.25,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,65.35,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,64.43,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,66.67,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,62.88,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,54.62,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,51.82,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,47.31,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,44.31,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Cerebrovascular diseases,251.55,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Cerebrovascular diseases,252.34,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Cerebrovascular diseases,218.63,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Cerebrovascular diseases,203.77,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Cerebrovascular diseases,217.43,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Cerebrovascular diseases,198.52,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Cerebrovascular diseases,200.15,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Cerebrovascular diseases,186.22,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Cerebrovascular diseases,174.78,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Cerebrovascular diseases,191.17,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Chronic lower respiratory diseases,83.63,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Chronic lower respiratory diseases,77.63,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Chronic lower respiratory diseases,70.31,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Chronic lower respiratory diseases,70.19,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Chronic lower respiratory diseases,68.58,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Chronic lower respiratory diseases,63.57,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Chronic lower respiratory diseases,71.46,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Chronic lower respiratory diseases,58.89,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Chronic lower respiratory diseases,62.66,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Chronic lower respiratory diseases,54.76,Rate
Pas Vasco,ES21,65 years or over,Females,2011,Asthma and status asthmaticus,19.35,Rate
Pas Vasco,ES21,65 years or over,Females,2012,Asthma and status asthmaticus,20.14,Rate
Pas Vasco,ES21,65 years or over,Females,2013,Asthma and status asthmaticus,15.14,Rate
Pas Vasco,ES21,65 years or over,Females,2014,Asthma and status asthmaticus,16.66,Rate
Pas Vasco,ES21,65 years or over,Females,2015,Asthma and status asthmaticus,18.87,Rate
Pas Vasco,ES21,65 years or over,Females,2016,Asthma and status asthmaticus,21.75,Rate
Pas Vasco,ES21,65 years or over,Females,2017,Asthma and status asthmaticus,22.43,Rate
Pas Vasco,ES21,65 years or over,Females,2018,Asthma and status asthmaticus,15.11,Rate
Pas Vasco,ES21,65 years or over,Females,2019,Asthma and status asthmaticus,16.4,Rate
Pas Vasco,ES21,65 years or over,Females,2020,Asthma and status asthmaticus,16.24,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,110.47,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,98.98,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,102.95,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,105.64,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,106.75,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,96.13,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,99.83,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,103.12,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,93.02,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,99.44,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.01,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.66,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.98,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.7,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.6,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.06,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.7,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.7,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.37,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.15,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",13.42,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",11.83,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",12.92,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",14.71,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",16.48,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",11.88,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",14.36,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",11.67,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.34,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",10.75,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Malignant melanoma of skin,0.83,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Malignant melanoma of skin,0.53,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Malignant melanoma of skin,1.04,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Malignant melanoma of skin,0.73,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Malignant melanoma of skin,0.62,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Malignant melanoma of skin,0.71,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Malignant melanoma of skin,0.84,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Malignant melanoma of skin,0.59,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Malignant melanoma of skin,0.68,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Malignant melanoma of skin,0.49,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Malignant neoplasm of breast,12.91,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Malignant neoplasm of breast,12.58,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Malignant neoplasm of breast,12.23,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.5,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Malignant neoplasm of breast,10.81,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Malignant neoplasm of breast,11.47,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Malignant neoplasm of breast,11.85,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.36,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Malignant neoplasm of breast,9.23,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Malignant neoplasm of breast,10.23,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Diabetes mellitus,0.64,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Diabetes mellitus,0.53,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Diabetes mellitus,1.16,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Diabetes mellitus,0.85,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Diabetes mellitus,0.93,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Diabetes mellitus,0.97,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Diabetes mellitus,0.2,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Diabetes mellitus,1.0,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Diabetes mellitus,0.68,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Diabetes mellitus,1.04,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.06,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.44,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.63,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.84,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.51,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.82,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.55,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),1.13,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.29,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.38,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.53,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.18,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.16,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.87,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.15,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.03,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.53,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.52,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.59,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.99,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.45,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,1.59,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,1.26,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,1.46,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,1.55,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,1.65,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,1.24,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.34,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.98,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,1.58,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,1.17,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Cerebrovascular diseases,3.84,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Cerebrovascular diseases,2.97,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Cerebrovascular diseases,4.17,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Cerebrovascular diseases,3.43,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Cerebrovascular diseases,3.52,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Cerebrovascular diseases,3.25,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Cerebrovascular diseases,4.28,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Cerebrovascular diseases,3.54,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Cerebrovascular diseases,3.98,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Cerebrovascular diseases,3.61,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.87,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Chronic lower respiratory diseases,1.27,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.75,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.74,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.44,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.7,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.52,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.82,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.17,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.91,Rate
Pas Vasco,ES21,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.43,Rate
Pas Vasco,ES21,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.31,Rate
Pas Vasco,ES21,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.23,Rate
Pas Vasco,ES21,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.2,Rate
Pas Vasco,ES21,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.33,Rate
Pas Vasco,ES21,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.2,Rate
Pas Vasco,ES21,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.67,Rate
Pas Vasco,ES21,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1178.79,Rate
Pas Vasco,ES21,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1161.34,Rate
Pas Vasco,ES21,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1110.97,Rate
Pas Vasco,ES21,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1074.27,Rate
Pas Vasco,ES21,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1109.75,Rate
Pas Vasco,ES21,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1081.14,Rate
Pas Vasco,ES21,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1061.24,Rate
Pas Vasco,ES21,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1042.41,Rate
Pas Vasco,ES21,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1006.01,Rate
Pas Vasco,ES21,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1109.96,Rate
Pas Vasco,ES21,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.64,Rate
Pas Vasco,ES21,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",58.47,Rate
Pas Vasco,ES21,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.2,Rate
Pas Vasco,ES21,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.5,Rate
Pas Vasco,ES21,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.26,Rate
Pas Vasco,ES21,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.51,Rate
Pas Vasco,ES21,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",44.99,Rate
Pas Vasco,ES21,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.09,Rate
Pas Vasco,ES21,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.19,Rate
Pas Vasco,ES21,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.18,Rate
Pas Vasco,ES21,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",92.91,Rate
Pas Vasco,ES21,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",85.64,Rate
Pas Vasco,ES21,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",89.11,Rate
Pas Vasco,ES21,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",91.28,Rate
Pas Vasco,ES21,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",83.29,Rate
Pas Vasco,ES21,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",83.84,Rate
Pas Vasco,ES21,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",83.58,Rate
Pas Vasco,ES21,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",81.95,Rate
Pas Vasco,ES21,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",83.31,Rate
Pas Vasco,ES21,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",78.9,Rate
Pas Vasco,ES21,Total,Males,2011,Malignant melanoma of skin,4.16,Rate
Pas Vasco,ES21,Total,Males,2012,Malignant melanoma of skin,3.08,Rate
Pas Vasco,ES21,Total,Males,2013,Malignant melanoma of skin,4.2,Rate
Pas Vasco,ES21,Total,Males,2014,Malignant melanoma of skin,3.06,Rate
Pas Vasco,ES21,Total,Males,2015,Malignant melanoma of skin,3.35,Rate
Pas Vasco,ES21,Total,Males,2016,Malignant melanoma of skin,3.73,Rate
Pas Vasco,ES21,Total,Males,2017,Malignant melanoma of skin,3.07,Rate
Pas Vasco,ES21,Total,Males,2018,Malignant melanoma of skin,2.78,Rate
Pas Vasco,ES21,Total,Males,2019,Malignant melanoma of skin,3.14,Rate
Pas Vasco,ES21,Total,Males,2020,Malignant melanoma of skin,3.14,Rate
Pas Vasco,ES21,Total,Males,2011,Malignant neoplasm of breast,0.76,Rate
Pas Vasco,ES21,Total,Males,2012,Malignant neoplasm of breast,0.57,Rate
Pas Vasco,ES21,Total,Males,2013,Malignant neoplasm of breast,0.68,Rate
Pas Vasco,ES21,Total,Males,2014,Malignant neoplasm of breast,0.19,Rate
Pas Vasco,ES21,Total,Males,2015,Malignant neoplasm of breast,0.39,Rate
Pas Vasco,ES21,Total,Males,2016,Malignant neoplasm of breast,0.2,Rate
Pas Vasco,ES21,Total,Males,2017,Malignant neoplasm of breast,0.33,Rate
Pas Vasco,ES21,Total,Males,2018,Malignant neoplasm of breast,0.45,Rate
Pas Vasco,ES21,Total,Males,2019,Malignant neoplasm of breast,0.36,Rate
Pas Vasco,ES21,Total,Males,2020,Malignant neoplasm of breast,0.19,Rate
Pas Vasco,ES21,Total,Males,2011,Diabetes mellitus,25.26,Rate
Pas Vasco,ES21,Total,Males,2012,Diabetes mellitus,23.95,Rate
Pas Vasco,ES21,Total,Males,2013,Diabetes mellitus,22.82,Rate
Pas Vasco,ES21,Total,Males,2014,Diabetes mellitus,19.98,Rate
Pas Vasco,ES21,Total,Males,2015,Diabetes mellitus,22.65,Rate
Pas Vasco,ES21,Total,Males,2016,Diabetes mellitus,20.31,Rate
Pas Vasco,ES21,Total,Males,2017,Diabetes mellitus,17.11,Rate
Pas Vasco,ES21,Total,Males,2018,Diabetes mellitus,18.85,Rate
Pas Vasco,ES21,Total,Males,2019,Diabetes mellitus,18.13,Rate
Pas Vasco,ES21,Total,Males,2020,Diabetes mellitus,22.42,Rate
Pas Vasco,ES21,Total,Males,2011,Mental and behavioural disorders (F00-F99),50.1,Rate
Pas Vasco,ES21,Total,Males,2012,Mental and behavioural disorders (F00-F99),51.93,Rate
Pas Vasco,ES21,Total,Males,2013,Mental and behavioural disorders (F00-F99),49.65,Rate
Pas Vasco,ES21,Total,Males,2014,Mental and behavioural disorders (F00-F99),44.89,Rate
Pas Vasco,ES21,Total,Males,2015,Mental and behavioural disorders (F00-F99),50.3,Rate
Pas Vasco,ES21,Total,Males,2016,Mental and behavioural disorders (F00-F99),50.56,Rate
Pas Vasco,ES21,Total,Males,2017,Mental and behavioural disorders (F00-F99),48.99,Rate
Pas Vasco,ES21,Total,Males,2018,Mental and behavioural disorders (F00-F99),52.71,Rate
Pas Vasco,ES21,Total,Males,2019,Mental and behavioural disorders (F00-F99),53.2,Rate
Pas Vasco,ES21,Total,Males,2020,Mental and behavioural disorders (F00-F99),52.99,Rate
Pas Vasco,ES21,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.44,Rate
Pas Vasco,ES21,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.9,Rate
Pas Vasco,ES21,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Pas Vasco,ES21,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.85,Rate
Pas Vasco,ES21,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Pas Vasco,ES21,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Pas Vasco,ES21,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.79,Rate
Pas Vasco,ES21,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Pas Vasco,ES21,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.7,Rate
Pas Vasco,ES21,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.8,Rate
Pas Vasco,ES21,Total,Males,2011,Other ischaemic heart diseases,56.82,Rate
Pas Vasco,ES21,Total,Males,2012,Other ischaemic heart diseases,56.71,Rate
Pas Vasco,ES21,Total,Males,2013,Other ischaemic heart diseases,57.12,Rate
Pas Vasco,ES21,Total,Males,2014,Other ischaemic heart diseases,51.87,Rate
Pas Vasco,ES21,Total,Males,2015,Other ischaemic heart diseases,53.4,Rate
Pas Vasco,ES21,Total,Males,2016,Other ischaemic heart diseases,49.72,Rate
Pas Vasco,ES21,Total,Males,2017,Other ischaemic heart diseases,51.53,Rate
Pas Vasco,ES21,Total,Males,2018,Other ischaemic heart diseases,43.73,Rate
Pas Vasco,ES21,Total,Males,2019,Other ischaemic heart diseases,42.95,Rate
Pas Vasco,ES21,Total,Males,2020,Other ischaemic heart diseases,42.06,Rate
Pas Vasco,ES21,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,39.52,Rate
Pas Vasco,ES21,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,35.13,Rate
Pas Vasco,ES21,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,36.86,Rate
Pas Vasco,ES21,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,30.7,Rate
Pas Vasco,ES21,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,31.48,Rate
Pas Vasco,ES21,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,29.9,Rate
Pas Vasco,ES21,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,25.43,Rate
Pas Vasco,ES21,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,26.72,Rate
Pas Vasco,ES21,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,22.94,Rate
Pas Vasco,ES21,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,24.99,Rate
Pas Vasco,ES21,Total,Males,2011,Cerebrovascular diseases,77.26,Rate
Pas Vasco,ES21,Total,Males,2012,Cerebrovascular diseases,71.33,Rate
Pas Vasco,ES21,Total,Males,2013,Cerebrovascular diseases,61.89,Rate
Pas Vasco,ES21,Total,Males,2014,Cerebrovascular diseases,61.16,Rate
Pas Vasco,ES21,Total,Males,2015,Cerebrovascular diseases,62.33,Rate
Pas Vasco,ES21,Total,Males,2016,Cerebrovascular diseases,62.34,Rate
Pas Vasco,ES21,Total,Males,2017,Cerebrovascular diseases,58.53,Rate
Pas Vasco,ES21,Total,Males,2018,Cerebrovascular diseases,58.04,Rate
Pas Vasco,ES21,Total,Males,2019,Cerebrovascular diseases,49.88,Rate
Pas Vasco,ES21,Total,Males,2020,Cerebrovascular diseases,49.46,Rate
Pas Vasco,ES21,Total,Males,2011,Chronic lower respiratory diseases,64.28,Rate
Pas Vasco,ES21,Total,Males,2012,Chronic lower respiratory diseases,65.43,Rate
Pas Vasco,ES21,Total,Males,2013,Chronic lower respiratory diseases,54.81,Rate
Pas Vasco,ES21,Total,Males,2014,Chronic lower respiratory diseases,54.07,Rate
Pas Vasco,ES21,Total,Males,2015,Chronic lower respiratory diseases,55.56,Rate
Pas Vasco,ES21,Total,Males,2016,Chronic lower respiratory diseases,45.04,Rate
Pas Vasco,ES21,Total,Males,2017,Chronic lower respiratory diseases,45.36,Rate
Pas Vasco,ES21,Total,Males,2018,Chronic lower respiratory diseases,42.89,Rate
Pas Vasco,ES21,Total,Males,2019,Chronic lower respiratory diseases,39.02,Rate
Pas Vasco,ES21,Total,Males,2020,Chronic lower respiratory diseases,34.5,Rate
Pas Vasco,ES21,Total,Males,2011,Asthma and status asthmaticus,1.72,Rate
Pas Vasco,ES21,Total,Males,2012,Asthma and status asthmaticus,1.37,Rate
Pas Vasco,ES21,Total,Males,2013,Asthma and status asthmaticus,0.93,Rate
Pas Vasco,ES21,Total,Males,2014,Asthma and status asthmaticus,1.44,Rate
Pas Vasco,ES21,Total,Males,2015,Asthma and status asthmaticus,2.19,Rate
Pas Vasco,ES21,Total,Males,2016,Asthma and status asthmaticus,1.79,Rate
Pas Vasco,ES21,Total,Males,2017,Asthma and status asthmaticus,1.77,Rate
Pas Vasco,ES21,Total,Males,2018,Asthma and status asthmaticus,1.65,Rate
Pas Vasco,ES21,Total,Males,2019,Asthma and status asthmaticus,1.47,Rate
Pas Vasco,ES21,Total,Males,2020,Asthma and status asthmaticus,1.87,Rate
Pas Vasco,ES21,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5056.55,Rate
Pas Vasco,ES21,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5012.99,Rate
Pas Vasco,ES21,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4777.13,Rate
Pas Vasco,ES21,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4668.45,Rate
Pas Vasco,ES21,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4826.62,Rate
Pas Vasco,ES21,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4712.06,Rate
Pas Vasco,ES21,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4646.37,Rate
Pas Vasco,ES21,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4561.77,Rate
Pas Vasco,ES21,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4382.16,Rate
Pas Vasco,ES21,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4885.81,Rate
Pas Vasco,ES21,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",232.52,Rate
Pas Vasco,ES21,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",254.84,Rate
Pas Vasco,ES21,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",226.24,Rate
Pas Vasco,ES21,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",220.04,Rate
Pas Vasco,ES21,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",208.75,Rate
Pas Vasco,ES21,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",209.59,Rate
Pas Vasco,ES21,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",199.26,Rate
Pas Vasco,ES21,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",191.99,Rate
Pas Vasco,ES21,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",176.69,Rate
Pas Vasco,ES21,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",177.91,Rate
Pas Vasco,ES21,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",327.28,Rate
Pas Vasco,ES21,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",301.33,Rate
Pas Vasco,ES21,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",316.84,Rate
Pas Vasco,ES21,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",327.65,Rate
Pas Vasco,ES21,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",312.24,Rate
Pas Vasco,ES21,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",301.72,Rate
Pas Vasco,ES21,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",318.97,Rate
Pas Vasco,ES21,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",306.33,Rate
Pas Vasco,ES21,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",310.63,Rate
Pas Vasco,ES21,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",301.69,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Malignant melanoma of skin,12.26,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Malignant melanoma of skin,11.03,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Malignant melanoma of skin,18.46,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Malignant melanoma of skin,11.18,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Malignant melanoma of skin,12.38,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Malignant melanoma of skin,13.49,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Malignant melanoma of skin,9.89,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Malignant melanoma of skin,8.18,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Malignant melanoma of skin,10.76,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Malignant melanoma of skin,13.61,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Malignant neoplasm of breast,3.89,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Malignant neoplasm of breast,2.12,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Malignant neoplasm of breast,2.58,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Malignant neoplasm of breast,0.5,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Malignant neoplasm of breast,2.01,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Malignant neoplasm of breast,0.58,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Malignant neoplasm of breast,1.71,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Malignant neoplasm of breast,1.04,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Malignant neoplasm of breast,1.82,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Malignant neoplasm of breast,0.95,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Diabetes mellitus,118.51,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Diabetes mellitus,114.91,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Diabetes mellitus,107.05,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Diabetes mellitus,92.45,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Diabetes mellitus,106.72,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Diabetes mellitus,95.89,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Diabetes mellitus,81.58,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Diabetes mellitus,88.04,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Diabetes mellitus,84.51,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Diabetes mellitus,103.74,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),252.44,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),256.74,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),248.74,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),226.63,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),249.98,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),255.83,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),246.03,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),264.73,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),266.05,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),266.35,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),6.09,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),8.43,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),5.86,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.89,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.27,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.9,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.47,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.77,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),5.07,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Other ischaemic heart diseases,236.95,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Other ischaemic heart diseases,236.87,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Other ischaemic heart diseases,233.37,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Other ischaemic heart diseases,214.56,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Other ischaemic heart diseases,231.4,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Other ischaemic heart diseases,212.72,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Other ischaemic heart diseases,215.35,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Other ischaemic heart diseases,181.57,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Other ischaemic heart diseases,185.19,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Other ischaemic heart diseases,178.57,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,161.81,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,147.83,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,151.54,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,126.61,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,128.82,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,123.49,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,96.33,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,101.52,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,90.29,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,96.38,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Cerebrovascular diseases,365.95,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Cerebrovascular diseases,337.01,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Cerebrovascular diseases,294.36,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Cerebrovascular diseases,285.26,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Cerebrovascular diseases,292.49,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Cerebrovascular diseases,293.95,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Cerebrovascular diseases,276.33,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Cerebrovascular diseases,273.25,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Cerebrovascular diseases,233.24,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Cerebrovascular diseases,233.95,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Chronic lower respiratory diseases,315.61,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Chronic lower respiratory diseases,321.26,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Chronic lower respiratory diseases,271.36,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Chronic lower respiratory diseases,266.76,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Chronic lower respiratory diseases,272.48,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Chronic lower respiratory diseases,217.62,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Chronic lower respiratory diseases,223.49,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Chronic lower respiratory diseases,204.97,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Chronic lower respiratory diseases,190.93,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Chronic lower respiratory diseases,167.03,Rate
Pas Vasco,ES21,65 years or over,Males,2011,Asthma and status asthmaticus,8.81,Rate
Pas Vasco,ES21,65 years or over,Males,2012,Asthma and status asthmaticus,4.28,Rate
Pas Vasco,ES21,65 years or over,Males,2013,Asthma and status asthmaticus,3.4,Rate
Pas Vasco,ES21,65 years or over,Males,2014,Asthma and status asthmaticus,6.02,Rate
Pas Vasco,ES21,65 years or over,Males,2015,Asthma and status asthmaticus,8.68,Rate
Pas Vasco,ES21,65 years or over,Males,2016,Asthma and status asthmaticus,7.39,Rate
Pas Vasco,ES21,65 years or over,Males,2017,Asthma and status asthmaticus,8.16,Rate
Pas Vasco,ES21,65 years or over,Males,2018,Asthma and status asthmaticus,6.53,Rate
Pas Vasco,ES21,65 years or over,Males,2019,Asthma and status asthmaticus,5.56,Rate
Pas Vasco,ES21,65 years or over,Males,2020,Asthma and status asthmaticus,6.81,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,239.46,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,228.33,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,222.9,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,203.63,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,209.39,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,201.6,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,192.79,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,189.9,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,188.19,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,195.31,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.55,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.9,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.04,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.67,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.15,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.49,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.63,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.01,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.37,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.57,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",36.14,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",33.39,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",33.94,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",34.03,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",27.83,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",31.06,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",26.56,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",27.6,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",28.25,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",24.93,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Malignant melanoma of skin,2.19,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Malignant melanoma of skin,1.16,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Malignant melanoma of skin,0.75,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Malignant melanoma of skin,1.1,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Malignant melanoma of skin,1.17,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Malignant melanoma of skin,1.36,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Malignant melanoma of skin,1.42,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Malignant melanoma of skin,1.47,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Malignant melanoma of skin,1.29,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Malignant melanoma of skin,0.61,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.2,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.22,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.12,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.1,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.31,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Diabetes mellitus,2.67,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Diabetes mellitus,1.92,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Diabetes mellitus,2.42,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Diabetes mellitus,2.43,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Diabetes mellitus,2.28,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Diabetes mellitus,2.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Diabetes mellitus,1.5,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Diabetes mellitus,2.09,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Diabetes mellitus,2.06,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Diabetes mellitus,2.73,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),1.09,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),2.32,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.43,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.87,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.93,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.84,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.26,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.35,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),1.65,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),1.31,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.75,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.01,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Other ischaemic heart diseases,13.19,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Other ischaemic heart diseases,13.08,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Other ischaemic heart diseases,14.43,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Other ischaemic heart diseases,12.46,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Other ischaemic heart diseases,10.28,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Other ischaemic heart diseases,10.24,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Other ischaemic heart diseases,11.84,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Other ischaemic heart diseases,10.34,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Other ischaemic heart diseases,8.49,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Other ischaemic heart diseases,9.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,9.9,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,7.83,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,9.08,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,7.47,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,7.91,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,7.24,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,8.25,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,8.6,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,6.63,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,7.7,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Cerebrovascular diseases,7.33,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Cerebrovascular diseases,6.98,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Cerebrovascular diseases,5.58,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Cerebrovascular diseases,6.87,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Cerebrovascular diseases,6.57,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Cerebrovascular diseases,6.23,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Cerebrovascular diseases,5.77,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Cerebrovascular diseases,5.91,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Cerebrovascular diseases,5.46,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Cerebrovascular diseases,4.77,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Chronic lower respiratory diseases,3.4,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Chronic lower respiratory diseases,3.46,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.35,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Chronic lower respiratory diseases,2.55,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Chronic lower respiratory diseases,3.01,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Chronic lower respiratory diseases,3.24,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.21,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.63,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.23,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.4,Rate
Pas Vasco,ES21,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.67,Rate
Pas Vasco,ES21,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.33,Rate
Pas Vasco,ES21,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.33,Rate
Pas Vasco,ES21,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.61,Rate
Pas Vasco,ES21,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.43,Rate
Pas Vasco,ES21,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.21,Rate
Pas Vasco,ES21,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.47,Rate
Pas Vasco,ES21,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.47,Rate
Pas Vasco,ES21,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.68,Rate
Pas Vasco,ES21,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,861.0,Rate
Pas Vasco,ES21,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,857.16,Rate
Pas Vasco,ES21,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,810.08,Rate
Pas Vasco,ES21,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,802.16,Rate
Pas Vasco,ES21,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,829.67,Rate
Pas Vasco,ES21,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,799.16,Rate
Pas Vasco,ES21,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,792.01,Rate
Pas Vasco,ES21,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,778.03,Rate
Pas Vasco,ES21,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,754.59,Rate
Pas Vasco,ES21,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,837.02,Rate
Pas Vasco,ES21,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.36,Rate
Pas Vasco,ES21,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.41,Rate
Pas Vasco,ES21,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.42,Rate
Pas Vasco,ES21,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.94,Rate
Pas Vasco,ES21,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.99,Rate
Pas Vasco,ES21,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.47,Rate
Pas Vasco,ES21,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.54,Rate
Pas Vasco,ES21,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.58,Rate
Pas Vasco,ES21,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.56,Rate
Pas Vasco,ES21,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.01,Rate
Pas Vasco,ES21,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",51.59,Rate
Pas Vasco,ES21,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",47.65,Rate
Pas Vasco,ES21,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",50.35,Rate
Pas Vasco,ES21,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",51.92,Rate
Pas Vasco,ES21,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",49.69,Rate
Pas Vasco,ES21,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",48.24,Rate
Pas Vasco,ES21,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",49.49,Rate
Pas Vasco,ES21,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",48.06,Rate
Pas Vasco,ES21,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",49.74,Rate
Pas Vasco,ES21,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",46.94,Rate
Pas Vasco,ES21,Total,Total,2011,Malignant melanoma of skin,2.78,Rate
Pas Vasco,ES21,Total,Total,2012,Malignant melanoma of skin,2.19,Rate
Pas Vasco,ES21,Total,Total,2013,Malignant melanoma of skin,2.21,Rate
Pas Vasco,ES21,Total,Total,2014,Malignant melanoma of skin,2.81,Rate
Pas Vasco,ES21,Total,Total,2015,Malignant melanoma of skin,2.37,Rate
Pas Vasco,ES21,Total,Total,2016,Malignant melanoma of skin,2.48,Rate
Pas Vasco,ES21,Total,Total,2017,Malignant melanoma of skin,2.34,Rate
Pas Vasco,ES21,Total,Total,2018,Malignant melanoma of skin,2.19,Rate
Pas Vasco,ES21,Total,Total,2019,Malignant melanoma of skin,2.58,Rate
Pas Vasco,ES21,Total,Total,2020,Malignant melanoma of skin,2.07,Rate
Pas Vasco,ES21,Total,Total,2011,Malignant neoplasm of breast,15.03,Rate
Pas Vasco,ES21,Total,Total,2012,Malignant neoplasm of breast,14.48,Rate
Pas Vasco,ES21,Total,Total,2013,Malignant neoplasm of breast,14.4,Rate
Pas Vasco,ES21,Total,Total,2014,Malignant neoplasm of breast,14.24,Rate
Pas Vasco,ES21,Total,Total,2015,Malignant neoplasm of breast,13.45,Rate
Pas Vasco,ES21,Total,Total,2016,Malignant neoplasm of breast,12.19,Rate
Pas Vasco,ES21,Total,Total,2017,Malignant neoplasm of breast,13.63,Rate
Pas Vasco,ES21,Total,Total,2018,Malignant neoplasm of breast,12.9,Rate
Pas Vasco,ES21,Total,Total,2019,Malignant neoplasm of breast,11.37,Rate
Pas Vasco,ES21,Total,Total,2020,Malignant neoplasm of breast,11.31,Rate
Pas Vasco,ES21,Total,Total,2011,Diabetes mellitus,20.97,Rate
Pas Vasco,ES21,Total,Total,2012,Diabetes mellitus,19.66,Rate
Pas Vasco,ES21,Total,Total,2013,Diabetes mellitus,20.51,Rate
Pas Vasco,ES21,Total,Total,2014,Diabetes mellitus,16.98,Rate
Pas Vasco,ES21,Total,Total,2015,Diabetes mellitus,17.84,Rate
Pas Vasco,ES21,Total,Total,2016,Diabetes mellitus,15.62,Rate
Pas Vasco,ES21,Total,Total,2017,Diabetes mellitus,13.3,Rate
Pas Vasco,ES21,Total,Total,2018,Diabetes mellitus,15.44,Rate
Pas Vasco,ES21,Total,Total,2019,Diabetes mellitus,15.31,Rate
Pas Vasco,ES21,Total,Total,2020,Diabetes mellitus,16.97,Rate
Pas Vasco,ES21,Total,Total,2011,Mental and behavioural disorders (F00-F99),47.51,Rate
Pas Vasco,ES21,Total,Total,2012,Mental and behavioural disorders (F00-F99),50.62,Rate
Pas Vasco,ES21,Total,Total,2013,Mental and behavioural disorders (F00-F99),43.86,Rate
Pas Vasco,ES21,Total,Total,2014,Mental and behavioural disorders (F00-F99),45.22,Rate
Pas Vasco,ES21,Total,Total,2015,Mental and behavioural disorders (F00-F99),50.21,Rate
Pas Vasco,ES21,Total,Total,2016,Mental and behavioural disorders (F00-F99),49.85,Rate
Pas Vasco,ES21,Total,Total,2017,Mental and behavioural disorders (F00-F99),48.17,Rate
Pas Vasco,ES21,Total,Total,2018,Mental and behavioural disorders (F00-F99),50.42,Rate
Pas Vasco,ES21,Total,Total,2019,Mental and behavioural disorders (F00-F99),53.55,Rate
Pas Vasco,ES21,Total,Total,2020,Mental and behavioural disorders (F00-F99),56.36,Rate
Pas Vasco,ES21,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Pas Vasco,ES21,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Pas Vasco,ES21,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.03,Rate
Pas Vasco,ES21,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Pas Vasco,ES21,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.0,Rate
Pas Vasco,ES21,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Pas Vasco,ES21,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Pas Vasco,ES21,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Pas Vasco,ES21,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Pas Vasco,ES21,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.56,Rate
Pas Vasco,ES21,Total,Total,2011,Other ischaemic heart diseases,34.21,Rate
Pas Vasco,ES21,Total,Total,2012,Other ischaemic heart diseases,34.8,Rate
Pas Vasco,ES21,Total,Total,2013,Other ischaemic heart diseases,33.1,Rate
Pas Vasco,ES21,Total,Total,2014,Other ischaemic heart diseases,29.85,Rate
Pas Vasco,ES21,Total,Total,2015,Other ischaemic heart diseases,30.76,Rate
Pas Vasco,ES21,Total,Total,2016,Other ischaemic heart diseases,29.87,Rate
Pas Vasco,ES21,Total,Total,2017,Other ischaemic heart diseases,30.02,Rate
Pas Vasco,ES21,Total,Total,2018,Other ischaemic heart diseases,25.75,Rate
Pas Vasco,ES21,Total,Total,2019,Other ischaemic heart diseases,24.25,Rate
Pas Vasco,ES21,Total,Total,2020,Other ischaemic heart diseases,25.09,Rate
Pas Vasco,ES21,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,26.97,Rate
Pas Vasco,ES21,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,23.63,Rate
Pas Vasco,ES21,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,23.3,Rate
Pas Vasco,ES21,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,21.24,Rate
Pas Vasco,ES21,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,21.6,Rate
Pas Vasco,ES21,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,20.38,Rate
Pas Vasco,ES21,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,18.14,Rate
Pas Vasco,ES21,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,18.18,Rate
Pas Vasco,ES21,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,16.02,Rate
Pas Vasco,ES21,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,16.3,Rate
Pas Vasco,ES21,Total,Total,2011,Cerebrovascular diseases,62.51,Rate
Pas Vasco,ES21,Total,Total,2012,Cerebrovascular diseases,59.75,Rate
Pas Vasco,ES21,Total,Total,2013,Cerebrovascular diseases,52.66,Rate
Pas Vasco,ES21,Total,Total,2014,Cerebrovascular diseases,50.62,Rate
Pas Vasco,ES21,Total,Total,2015,Cerebrovascular diseases,52.42,Rate
Pas Vasco,ES21,Total,Total,2016,Cerebrovascular diseases,49.72,Rate
Pas Vasco,ES21,Total,Total,2017,Cerebrovascular diseases,49.09,Rate
Pas Vasco,ES21,Total,Total,2018,Cerebrovascular diseases,47.01,Rate
Pas Vasco,ES21,Total,Total,2019,Cerebrovascular diseases,42.65,Rate
Pas Vasco,ES21,Total,Total,2020,Cerebrovascular diseases,43.94,Rate
Pas Vasco,ES21,Total,Total,2011,Chronic lower respiratory diseases,33.15,Rate
Pas Vasco,ES21,Total,Total,2012,Chronic lower respiratory diseases,33.74,Rate
Pas Vasco,ES21,Total,Total,2013,Chronic lower respiratory diseases,28.68,Rate
Pas Vasco,ES21,Total,Total,2014,Chronic lower respiratory diseases,28.54,Rate
Pas Vasco,ES21,Total,Total,2015,Chronic lower respiratory diseases,29.25,Rate
Pas Vasco,ES21,Total,Total,2016,Chronic lower respiratory diseases,25.08,Rate
Pas Vasco,ES21,Total,Total,2017,Chronic lower respiratory diseases,26.19,Rate
Pas Vasco,ES21,Total,Total,2018,Chronic lower respiratory diseases,23.25,Rate
Pas Vasco,ES21,Total,Total,2019,Chronic lower respiratory diseases,23.02,Rate
Pas Vasco,ES21,Total,Total,2020,Chronic lower respiratory diseases,20.43,Rate
Pas Vasco,ES21,Total,Total,2011,Asthma and status asthmaticus,3.09,Rate
Pas Vasco,ES21,Total,Total,2012,Asthma and status asthmaticus,3.34,Rate
Pas Vasco,ES21,Total,Total,2013,Asthma and status asthmaticus,2.21,Rate
Pas Vasco,ES21,Total,Total,2014,Asthma and status asthmaticus,2.71,Rate
Pas Vasco,ES21,Total,Total,2015,Asthma and status asthmaticus,3.37,Rate
Pas Vasco,ES21,Total,Total,2016,Asthma and status asthmaticus,3.52,Rate
Pas Vasco,ES21,Total,Total,2017,Asthma and status asthmaticus,3.54,Rate
Pas Vasco,ES21,Total,Total,2018,Asthma and status asthmaticus,2.67,Rate
Pas Vasco,ES21,Total,Total,2019,Asthma and status asthmaticus,2.76,Rate
Pas Vasco,ES21,Total,Total,2020,Asthma and status asthmaticus,3.06,Rate
Pas Vasco,ES21,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,3697.65,Rate
Pas Vasco,ES21,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,3724.61,Rate
Pas Vasco,ES21,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,3486.04,Rate
Pas Vasco,ES21,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3479.46,Rate
Pas Vasco,ES21,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3606.2,Rate
Pas Vasco,ES21,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3488.18,Rate
Pas Vasco,ES21,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3461.32,Rate
Pas Vasco,ES21,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3389.23,Rate
Pas Vasco,ES21,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3293.26,Rate
Pas Vasco,ES21,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,3688.32,Rate
Pas Vasco,ES21,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.6,Rate
Pas Vasco,ES21,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.79,Rate
Pas Vasco,ES21,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.62,Rate
Pas Vasco,ES21,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",143.56,Rate
Pas Vasco,ES21,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.8,Rate
Pas Vasco,ES21,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.74,Rate
Pas Vasco,ES21,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.18,Rate
Pas Vasco,ES21,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.55,Rate
Pas Vasco,ES21,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.43,Rate
Pas Vasco,ES21,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.59,Rate
Pas Vasco,ES21,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",163.38,Rate
Pas Vasco,ES21,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",152.09,Rate
Pas Vasco,ES21,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",162.51,Rate
Pas Vasco,ES21,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",166.66,Rate
Pas Vasco,ES21,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",163.99,Rate
Pas Vasco,ES21,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",159.81,Rate
Pas Vasco,ES21,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",170.03,Rate
Pas Vasco,ES21,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",166.28,Rate
Pas Vasco,ES21,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",172.12,Rate
Pas Vasco,ES21,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",167.92,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Malignant melanoma of skin,8.08,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Malignant melanoma of skin,7.72,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Malignant melanoma of skin,7.66,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Malignant melanoma of skin,10.63,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Malignant melanoma of skin,8.45,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Malignant melanoma of skin,8.5,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Malignant melanoma of skin,7.37,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Malignant melanoma of skin,7.02,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Malignant melanoma of skin,9.17,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Malignant melanoma of skin,8.39,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Malignant neoplasm of breast,50.13,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Malignant neoplasm of breast,47.55,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Malignant neoplasm of breast,47.78,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Malignant neoplasm of breast,46.63,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Malignant neoplasm of breast,46.3,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Malignant neoplasm of breast,38.3,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Malignant neoplasm of breast,45.08,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Malignant neoplasm of breast,41.7,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Malignant neoplasm of breast,38.98,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Malignant neoplasm of breast,36.54,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Diabetes mellitus,100.75,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Diabetes mellitus,95.88,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Diabetes mellitus,97.85,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Diabetes mellitus,80.39,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Diabetes mellitus,84.95,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Diabetes mellitus,74.01,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Diabetes mellitus,64.76,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Diabetes mellitus,72.88,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Diabetes mellitus,72.92,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Diabetes mellitus,79.31,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),239.21,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),253.99,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),220.74,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),228.37,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),252.51,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),252.19,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),243.33,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),253.46,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),270.71,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),285.52,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.03,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),6.36,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.95,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),4.78,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.75,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.39,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.62,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.75,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),4.96,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),5.71,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Other ischaemic heart diseases,146.2,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Other ischaemic heart diseases,149.49,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Other ischaemic heart diseases,136.6,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Other ischaemic heart diseases,125.39,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Other ischaemic heart diseases,134.79,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Other ischaemic heart diseases,129.22,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Other ischaemic heart diseases,126.78,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Other ischaemic heart diseases,107.87,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Other ischaemic heart diseases,103.02,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Other ischaemic heart diseases,107.4,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,114.81,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,102.64,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,97.99,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,90.51,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,91.28,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,87.28,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,71.34,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,71.67,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,65.42,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,65.62,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Cerebrovascular diseases,297.64,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Cerebrovascular diseases,286.06,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Cerebrovascular diseases,249.97,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Cerebrovascular diseases,238.48,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Cerebrovascular diseases,248.06,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Cerebrovascular diseases,235.5,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Cerebrovascular diseases,231.07,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Cerebrovascular diseases,221.64,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Cerebrovascular diseases,199.29,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Cerebrovascular diseases,208.15,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Chronic lower respiratory diseases,161.26,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Chronic lower respiratory diseases,163.31,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Chronic lower respiratory diseases,140.78,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Chronic lower respiratory diseases,139.67,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Chronic lower respiratory diseases,140.9,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Chronic lower respiratory diseases,118.53,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Chronic lower respiratory diseases,126.63,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Chronic lower respiratory diseases,110.16,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Chronic lower respiratory diseases,111.12,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Chronic lower respiratory diseases,95.92,Rate
Pas Vasco,ES21,65 years or over,Total,2011,Asthma and status asthmaticus,15.82,Rate
Pas Vasco,ES21,65 years or over,Total,2012,Asthma and status asthmaticus,14.84,Rate
Pas Vasco,ES21,65 years or over,Total,2013,Asthma and status asthmaticus,10.68,Rate
Pas Vasco,ES21,65 years or over,Total,2014,Asthma and status asthmaticus,13.23,Rate
Pas Vasco,ES21,65 years or over,Total,2015,Asthma and status asthmaticus,15.36,Rate
Pas Vasco,ES21,65 years or over,Total,2016,Asthma and status asthmaticus,16.7,Rate
Pas Vasco,ES21,65 years or over,Total,2017,Asthma and status asthmaticus,17.31,Rate
Pas Vasco,ES21,65 years or over,Total,2018,Asthma and status asthmaticus,12.07,Rate
Pas Vasco,ES21,65 years or over,Total,2019,Asthma and status asthmaticus,12.8,Rate
Pas Vasco,ES21,65 years or over,Total,2020,Asthma and status asthmaticus,12.88,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,173.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,162.55,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,161.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,153.62,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,157.09,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,147.78,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,145.41,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,145.51,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,139.63,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,146.34,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.2,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.22,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.45,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.63,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.36,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.13,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.82,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.82,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.83,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",24.51,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",22.36,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",23.18,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",24.12,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",22.0,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",21.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",20.29,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",19.42,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",20.09,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",17.64,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Malignant melanoma of skin,1.5,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Malignant melanoma of skin,0.85,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Malignant melanoma of skin,0.9,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Malignant melanoma of skin,0.91,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Malignant melanoma of skin,0.89,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Malignant melanoma of skin,1.03,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Malignant melanoma of skin,1.12,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Malignant melanoma of skin,1.02,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Malignant melanoma of skin,0.99,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Malignant melanoma of skin,0.54,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Malignant neoplasm of breast,6.53,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.47,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.31,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.39,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Malignant neoplasm of breast,5.49,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.01,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.93,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Malignant neoplasm of breast,4.69,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.2,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Diabetes mellitus,1.64,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Diabetes mellitus,1.2,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Diabetes mellitus,1.78,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Diabetes mellitus,1.61,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Diabetes mellitus,1.59,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Diabetes mellitus,1.47,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Diabetes mellitus,0.83,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Diabetes mellitus,1.53,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Diabetes mellitus,1.35,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Diabetes mellitus,1.87,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),1.08,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),1.36,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),1.02,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.83,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.89,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.24,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.95,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),0.84,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.37,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Other ischaemic heart diseases,7.08,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Other ischaemic heart diseases,7.02,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Other ischaemic heart diseases,8.03,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Other ischaemic heart diseases,6.7,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.56,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Other ischaemic heart diseases,5.81,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Other ischaemic heart diseases,6.58,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Other ischaemic heart diseases,5.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Other ischaemic heart diseases,5.17,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Other ischaemic heart diseases,5.15,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,5.69,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,4.49,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,5.2,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,4.46,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,4.72,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,4.18,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,5.25,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.23,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.06,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,4.36,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Cerebrovascular diseases,5.55,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Cerebrovascular diseases,4.93,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Cerebrovascular diseases,4.86,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Cerebrovascular diseases,5.11,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Cerebrovascular diseases,5.02,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Cerebrovascular diseases,4.72,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Cerebrovascular diseases,5.01,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Cerebrovascular diseases,4.7,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Cerebrovascular diseases,4.7,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Cerebrovascular diseases,4.16,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Chronic lower respiratory diseases,2.11,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Chronic lower respiratory diseases,2.35,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.53,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.62,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Chronic lower respiratory diseases,2.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Chronic lower respiratory diseases,2.45,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.87,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.19,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.68,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Chronic lower respiratory diseases,2.14,Rate
Pas Vasco,ES21,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Pas Vasco,ES21,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.55,Rate
Pas Vasco,ES21,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.16,Rate
Pas Vasco,ES21,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.16,Rate
Pas Vasco,ES21,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.46,Rate
Pas Vasco,ES21,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.33,Rate
Pas Vasco,ES21,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.21,Rate
Pas Vasco,ES21,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.4,Rate
Pas Vasco,ES21,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.33,Rate
Pas Vasco,ES21,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.68,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,962.27,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,914.39,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,897.34,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,843.24,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,755.28,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,803.22,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,816.3,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,814.71,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,818.99,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,991.51,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.55,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.46,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.58,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.8,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.02,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.59,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.71,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.79,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.93,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.67,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",9.9,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.97,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",10.55,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",21.03,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",28.97,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",10.33,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",13.1,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",10.93,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",15.61,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",16.43,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Malignant melanoma of skin,4.09,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Malignant melanoma of skin,2.21,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Malignant melanoma of skin,2.5,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Malignant melanoma of skin,3.88,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Malignant melanoma of skin,8.35,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Malignant melanoma of skin,3.84,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Malignant melanoma of skin,2.41,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Malignant melanoma of skin,2.94,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Malignant neoplasm of breast,24.09,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Malignant neoplasm of breast,33.94,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Malignant neoplasm of breast,30.18,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Malignant neoplasm of breast,29.0,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Malignant neoplasm of breast,13.35,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Malignant neoplasm of breast,31.96,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Malignant neoplasm of breast,41.75,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Malignant neoplasm of breast,49.59,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Malignant neoplasm of breast,14.97,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Malignant neoplasm of breast,39.14,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Diabetes mellitus,51.94,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Diabetes mellitus,49.39,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Diabetes mellitus,51.66,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Diabetes mellitus,19.48,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Diabetes mellitus,37.57,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Diabetes mellitus,38.72,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Diabetes mellitus,28.14,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Diabetes mellitus,16.36,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Diabetes mellitus,19.46,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Diabetes mellitus,42.58,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Mental and behavioural disorders (F00-F99),38.25,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Mental and behavioural disorders (F00-F99),16.76,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Mental and behavioural disorders (F00-F99),25.11,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Mental and behavioural disorders (F00-F99),3.36,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Mental and behavioural disorders (F00-F99),31.31,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Mental and behavioural disorders (F00-F99),49.63,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Mental and behavioural disorders (F00-F99),31.55,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Mental and behavioural disorders (F00-F99),59.04,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Mental and behavioural disorders (F00-F99),47.23,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Mental and behavioural disorders (F00-F99),23.85,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.92,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.84,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.96,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Other ischaemic heart diseases,75.44,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Other ischaemic heart diseases,67.34,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Other ischaemic heart diseases,51.94,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Other ischaemic heart diseases,41.02,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Other ischaemic heart diseases,29.91,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Other ischaemic heart diseases,33.81,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Other ischaemic heart diseases,29.24,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Other ischaemic heart diseases,19.38,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Other ischaemic heart diseases,20.26,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Other ischaemic heart diseases,47.43,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,37.81,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,43.01,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,36.72,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,15.72,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,30.88,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,43.84,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,41.45,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,24.98,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.62,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,37.5,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Cerebrovascular diseases,75.84,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Cerebrovascular diseases,73.38,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Cerebrovascular diseases,39.49,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Cerebrovascular diseases,93.24,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Cerebrovascular diseases,57.59,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Cerebrovascular diseases,18.85,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Cerebrovascular diseases,46.38,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Cerebrovascular diseases,45.95,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Cerebrovascular diseases,70.17,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Cerebrovascular diseases,61.64,Rate
Ciudad de Ceuta,ES63,Total,Females,2011,Chronic lower respiratory diseases,20.66,Rate
Ciudad de Ceuta,ES63,Total,Females,2012,Chronic lower respiratory diseases,14.22,Rate
Ciudad de Ceuta,ES63,Total,Females,2013,Chronic lower respiratory diseases,12.52,Rate
Ciudad de Ceuta,ES63,Total,Females,2014,Chronic lower respiratory diseases,3.36,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Chronic lower respiratory diseases,6.69,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Chronic lower respiratory diseases,7.09,Rate
Ciudad de Ceuta,ES63,Total,Females,2017,Chronic lower respiratory diseases,8.14,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Chronic lower respiratory diseases,7.98,Rate
Ciudad de Ceuta,ES63,Total,Females,2019,Chronic lower respiratory diseases,11.02,Rate
Ciudad de Ceuta,ES63,Total,Females,2020,Chronic lower respiratory diseases,11.31,Rate
Ciudad de Ceuta,ES63,Total,Females,2015,Asthma and status asthmaticus,3.88,Rate
Ciudad de Ceuta,ES63,Total,Females,2016,Asthma and status asthmaticus,3.13,Rate
Ciudad de Ceuta,ES63,Total,Females,2018,Asthma and status asthmaticus,2.17,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4341.94,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4281.32,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3946.63,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3767.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3465.45,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3712.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3629.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3578.42,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3689.34,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4498.02,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.54,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.27,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.88,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.52,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.89,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.52,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.95,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.11,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.06,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.73,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",20.6,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",55.2,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",14.88,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",36.29,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",93.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",28.7,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",39.42,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",19.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",41.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",32.54,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Malignant melanoma of skin,20.97,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Malignant melanoma of skin,19.89,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Malignant melanoma of skin,42.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Malignant melanoma of skin,19.7,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Malignant melanoma of skin,15.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Malignant neoplasm of breast,70.71,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Malignant neoplasm of breast,113.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Malignant neoplasm of breast,82.28,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Malignant neoplasm of breast,104.3,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Malignant neoplasm of breast,56.47,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Malignant neoplasm of breast,99.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Malignant neoplasm of breast,148.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Malignant neoplasm of breast,143.02,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Malignant neoplasm of breast,50.51,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Malignant neoplasm of breast,137.45,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Diabetes mellitus,266.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Diabetes mellitus,213.97,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Diabetes mellitus,246.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Diabetes mellitus,74.79,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Diabetes mellitus,192.68,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Diabetes mellitus,158.41,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Diabetes mellitus,129.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Diabetes mellitus,61.26,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Diabetes mellitus,99.77,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Diabetes mellitus,205.13,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),176.09,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),85.94,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),128.78,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),17.21,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),160.55,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),254.52,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),161.78,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),290.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),242.22,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),122.31,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),14.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),20.29,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Other ischaemic heart diseases,386.87,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Other ischaemic heart diseases,329.74,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Other ischaemic heart diseases,266.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Other ischaemic heart diseases,192.26,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Other ischaemic heart diseases,139.87,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Other ischaemic heart diseases,160.84,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Other ischaemic heart diseases,149.93,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Other ischaemic heart diseases,99.36,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Other ischaemic heart diseases,103.9,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Other ischaemic heart diseases,231.23,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,173.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,220.58,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,158.29,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,68.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,145.97,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,199.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,212.56,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,101.28,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,131.36,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,165.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Cerebrovascular diseases,358.78,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Cerebrovascular diseases,360.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Cerebrovascular diseases,154.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Cerebrovascular diseases,478.13,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Cerebrovascular diseases,265.83,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Cerebrovascular diseases,96.65,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Cerebrovascular diseases,225.33,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Cerebrovascular diseases,235.63,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Cerebrovascular diseases,320.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Cerebrovascular diseases,302.87,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2011,Chronic lower respiratory diseases,93.66,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2012,Chronic lower respiratory diseases,53.27,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2013,Chronic lower respiratory diseases,49.43,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2014,Chronic lower respiratory diseases,17.21,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Chronic lower respiratory diseases,34.29,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Chronic lower respiratory diseases,20.28,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2017,Chronic lower respiratory diseases,41.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Chronic lower respiratory diseases,29.8,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2019,Chronic lower respiratory diseases,44.4,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2020,Chronic lower respiratory diseases,58.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2015,Asthma and status asthmaticus,19.89,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2016,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Females,2018,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,143.59,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,98.79,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,158.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,134.87,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,98.78,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,98.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,134.83,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,145.24,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,123.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,142.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.31,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.88,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.75,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.02,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.75,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.93,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",7.31,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",7.7,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",9.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",17.34,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",13.33,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",5.88,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",6.73,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",8.95,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",9.45,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",12.52,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Malignant melanoma of skin,2.74,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Malignant melanoma of skin,3.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Malignant melanoma of skin,2.99,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Malignant neoplasm of breast,12.8,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Malignant neoplasm of breast,14.66,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Malignant neoplasm of breast,17.56,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Malignant neoplasm of breast,10.77,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Malignant neoplasm of breast,2.91,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Malignant neoplasm of breast,15.81,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Malignant neoplasm of breast,26.95,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Malignant neoplasm of breast,6.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Malignant neoplasm of breast,15.32,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Diabetes mellitus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Diabetes mellitus,9.52,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Diabetes mellitus,4.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Diabetes mellitus,6.08,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Diabetes mellitus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Diabetes mellitus,9.73,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Diabetes mellitus,3.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Diabetes mellitus,5.48,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Diabetes mellitus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Diabetes mellitus,3.21,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),4.87,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),4.87,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Other ischaemic heart diseases,3.77,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Other ischaemic heart diseases,4.38,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Other ischaemic heart diseases,3.28,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Other ischaemic heart diseases,3.04,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Other ischaemic heart diseases,2.9,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.87,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,7.27,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.04,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,6.26,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,6.49,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,6.42,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Cerebrovascular diseases,7.31,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Cerebrovascular diseases,3.77,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Cerebrovascular diseases,11.74,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Cerebrovascular diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Cerebrovascular diseases,7.15,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Cerebrovascular diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Cerebrovascular diseases,3.04,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Cerebrovascular diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Cerebrovascular diseases,9.43,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Cerebrovascular diseases,3.21,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2011,Chronic lower respiratory diseases,2.98,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2012,Chronic lower respiratory diseases,4.76,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2013,Chronic lower respiratory diseases,3.58,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Chronic lower respiratory diseases,3.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2019,Chronic lower respiratory diseases,2.93,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2016,Asthma and status asthmaticus,3.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Females,2018,Asthma and status asthmaticus,2.69,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1324.56,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1196.96,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1436.13,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1199.44,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1238.7,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1167.72,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1280.66,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1134.06,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1070.64,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1249.88,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.73,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.37,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.68,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.44,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.43,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.47,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.65,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.3,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.68,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.05,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",80.26,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",91.28,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",127.6,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",116.63,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",90.13,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",114.68,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",96.09,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",61.04,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",64.21,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",97.92,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Malignant melanoma of skin,4.11,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Malignant melanoma of skin,5.02,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Malignant melanoma of skin,2.25,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Malignant melanoma of skin,2.15,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Malignant melanoma of skin,2.18,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Malignant melanoma of skin,9.3,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Malignant neoplasm of breast,3.43,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Diabetes mellitus,51.19,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,Diabetes mellitus,97.28,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Diabetes mellitus,59.52,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Diabetes mellitus,28.67,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Diabetes mellitus,35.94,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Diabetes mellitus,76.07,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Diabetes mellitus,57.28,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Diabetes mellitus,47.11,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Diabetes mellitus,20.56,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Diabetes mellitus,53.93,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Mental and behavioural disorders (F00-F99),21.33,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Mental and behavioural disorders (F00-F99),29.01,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Mental and behavioural disorders (F00-F99),9.84,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Mental and behavioural disorders (F00-F99),70.11,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Mental and behavioural disorders (F00-F99),36.71,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Mental and behavioural disorders (F00-F99),32.82,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Mental and behavioural disorders (F00-F99),33.82,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Mental and behavioural disorders (F00-F99),40.85,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Mental and behavioural disorders (F00-F99),23.39,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),6.32,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),9.47,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.63,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Other ischaemic heart diseases,119.47,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,Other ischaemic heart diseases,79.84,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Other ischaemic heart diseases,70.02,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Other ischaemic heart diseases,57.22,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Other ischaemic heart diseases,32.05,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Other ischaemic heart diseases,75.52,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Other ischaemic heart diseases,50.69,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Other ischaemic heart diseases,54.95,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Other ischaemic heart diseases,46.1,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Other ischaemic heart diseases,78.46,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,42.75,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,86.12,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,49.47,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,43.39,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,57.5,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,58.6,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,55.44,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,26.42,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,38.14,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,63.22,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Cerebrovascular diseases,103.68,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,Cerebrovascular diseases,60.51,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Cerebrovascular diseases,85.52,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Cerebrovascular diseases,84.93,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Cerebrovascular diseases,75.71,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Cerebrovascular diseases,71.7,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Cerebrovascular diseases,58.54,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Cerebrovascular diseases,89.95,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Cerebrovascular diseases,47.92,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Cerebrovascular diseases,76.28,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Chronic lower respiratory diseases,60.77,Rate
Ciudad de Ceuta,ES63,Total,Males,2012,Chronic lower respiratory diseases,67.23,Rate
Ciudad de Ceuta,ES63,Total,Males,2013,Chronic lower respiratory diseases,53.21,Rate
Ciudad de Ceuta,ES63,Total,Males,2014,Chronic lower respiratory diseases,79.14,Rate
Ciudad de Ceuta,ES63,Total,Males,2015,Chronic lower respiratory diseases,49.4,Rate
Ciudad de Ceuta,ES63,Total,Males,2016,Chronic lower respiratory diseases,84.04,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Chronic lower respiratory diseases,68.78,Rate
Ciudad de Ceuta,ES63,Total,Males,2018,Chronic lower respiratory diseases,36.79,Rate
Ciudad de Ceuta,ES63,Total,Males,2019,Chronic lower respiratory diseases,50.52,Rate
Ciudad de Ceuta,ES63,Total,Males,2020,Chronic lower respiratory diseases,67.82,Rate
Ciudad de Ceuta,ES63,Total,Males,2011,Asthma and status asthmaticus,1.97,Rate
Ciudad de Ceuta,ES63,Total,Males,2017,Asthma and status asthmaticus,4.46,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5639.46,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5208.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,6365.28,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5022.81,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5169.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4933.89,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5358.51,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4798.63,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4383.09,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5274.45,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.36,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.67,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.28,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",263.15,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",148.16,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.24,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",124.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.98,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",186.19,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.06,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",255.18,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",325.99,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",476.11,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",509.14,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",369.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",486.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",337.31,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",204.51,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",280.22,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",384.21,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Malignant melanoma of skin,21.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Malignant melanoma of skin,25.74,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Malignant melanoma of skin,22.71,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Malignant neoplasm of breast,17.61,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Diabetes mellitus,250.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,Diabetes mellitus,463.51,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Diabetes mellitus,294.63,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Diabetes mellitus,135.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Diabetes mellitus,157.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Diabetes mellitus,390.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Diabetes mellitus,279.56,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Diabetes mellitus,218.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Diabetes mellitus,94.02,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Diabetes mellitus,252.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),109.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),148.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),50.47,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),347.33,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),173.52,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),146.09,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),173.43,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),209.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),119.97,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),32.39,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),48.55,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),18.59,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Other ischaemic heart diseases,553.44,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,Other ischaemic heart diseases,318.13,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Other ischaemic heart diseases,330.85,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Other ischaemic heart diseases,267.96,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Other ischaemic heart diseases,152.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Other ischaemic heart diseases,387.3,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Other ischaemic heart diseases,234.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Other ischaemic heart diseases,258.95,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Other ischaemic heart diseases,164.94,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Other ischaemic heart diseases,343.16,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,183.19,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,418.7,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,194.34,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,155.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,217.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,254.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,187.66,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,125.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,159.69,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,254.47,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Cerebrovascular diseases,495.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,Cerebrovascular diseases,228.46,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Cerebrovascular diseases,411.44,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Cerebrovascular diseases,378.44,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Cerebrovascular diseases,324.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Cerebrovascular diseases,300.59,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Cerebrovascular diseases,274.76,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Cerebrovascular diseases,411.83,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Cerebrovascular diseases,198.8,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Cerebrovascular diseases,333.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Chronic lower respiratory diseases,269.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2012,Chronic lower respiratory diseases,303.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2013,Chronic lower respiratory diseases,256.48,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2014,Chronic lower respiratory diseases,365.62,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2015,Chronic lower respiratory diseases,237.98,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2016,Chronic lower respiratory diseases,430.98,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Chronic lower respiratory diseases,305.42,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2018,Chronic lower respiratory diseases,175.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2019,Chronic lower respiratory diseases,223.18,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2020,Chronic lower respiratory diseases,336.56,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2011,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Males,2017,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,279.33,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,225.24,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,242.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,273.29,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,286.63,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,255.42,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,292.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,246.38,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,268.24,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,274.99,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.54,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.34,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.64,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.85,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.01,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.33,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.14,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.13,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.67,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",37.88,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",34.43,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",43.18,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",21.54,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",22.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",24.62,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",37.65,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",26.29,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",11.88,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",28.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Malignant melanoma of skin,2.8,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Malignant melanoma of skin,2.66,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Malignant melanoma of skin,2.71,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Malignant melanoma of skin,6.05,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Diabetes mellitus,3.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,Diabetes mellitus,8.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Diabetes mellitus,2.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Diabetes mellitus,2.82,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Diabetes mellitus,6.41,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Diabetes mellitus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Diabetes mellitus,3.44,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Diabetes mellitus,5.54,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Diabetes mellitus,2.76,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Diabetes mellitus,5.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),2.96,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),3.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),5.38,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Other ischaemic heart diseases,14.35,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,Other ischaemic heart diseases,22.12,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Other ischaemic heart diseases,6.84,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Other ischaemic heart diseases,6.17,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Other ischaemic heart diseases,2.96,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Other ischaemic heart diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Other ischaemic heart diseases,6.29,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Other ischaemic heart diseases,5.54,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Other ischaemic heart diseases,17.32,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Other ischaemic heart diseases,14.34,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,8.73,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,5.55,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,14.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,16.21,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,18.68,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,11.04,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,23.42,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,2.52,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.7,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,16.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Cerebrovascular diseases,8.69,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,Cerebrovascular diseases,19.83,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Cerebrovascular diseases,6.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Cerebrovascular diseases,13.83,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Cerebrovascular diseases,15.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Cerebrovascular diseases,16.25,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Cerebrovascular diseases,6.16,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Cerebrovascular diseases,11.97,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Cerebrovascular diseases,11.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Cerebrovascular diseases,14.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Chronic lower respiratory diseases,10.3,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2012,Chronic lower respiratory diseases,9.99,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2013,Chronic lower respiratory diseases,3.97,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2014,Chronic lower respiratory diseases,9.74,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2015,Chronic lower respiratory diseases,3.72,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2016,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Chronic lower respiratory diseases,11.45,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.31,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2019,Chronic lower respiratory diseases,8.7,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.73,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2011,Asthma and status asthmaticus,2.45,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Males,2017,Asthma and status asthmaticus,5.54,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1136.46,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1040.67,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1117.65,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1020.36,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,973.25,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,974.82,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1016.22,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,948.41,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,931.6,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1116.09,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.74,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.56,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.67,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.18,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.78,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.66,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.86,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.46,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.72,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.98,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",42.91,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",51.89,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",64.46,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",63.72,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",59.1,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",57.93,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",51.68,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",33.35,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",37.78,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",52.24,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Malignant melanoma of skin,4.19,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Malignant melanoma of skin,1.03,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Malignant melanoma of skin,3.04,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Malignant melanoma of skin,3.1,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Malignant melanoma of skin,5.12,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Malignant melanoma of skin,1.87,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Malignant melanoma of skin,2.31,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Malignant melanoma of skin,2.92,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Malignant melanoma of skin,4.29,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Malignant neoplasm of breast,13.06,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Malignant neoplasm of breast,18.14,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Malignant neoplasm of breast,16.62,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Malignant neoplasm of breast,17.27,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Malignant neoplasm of breast,8.28,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Malignant neoplasm of breast,18.27,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Malignant neoplasm of breast,23.3,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Malignant neoplasm of breast,27.76,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Malignant neoplasm of breast,8.33,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Malignant neoplasm of breast,21.05,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Diabetes mellitus,52.63,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Diabetes mellitus,65.58,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Diabetes mellitus,54.52,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Diabetes mellitus,24.07,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Diabetes mellitus,36.81,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Diabetes mellitus,51.97,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Diabetes mellitus,38.32,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Diabetes mellitus,27.98,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Diabetes mellitus,19.98,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Diabetes mellitus,46.86,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Mental and behavioural disorders (F00-F99),32.39,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Mental and behavioural disorders (F00-F99),10.63,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Mental and behavioural disorders (F00-F99),25.91,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Mental and behavioural disorders (F00-F99),6.19,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Mental and behavioural disorders (F00-F99),48.29,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Mental and behavioural disorders (F00-F99),45.47,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Mental and behavioural disorders (F00-F99),33.33,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Mental and behavioural disorders (F00-F99),49.55,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Mental and behavioural disorders (F00-F99),43.46,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Mental and behavioural disorders (F00-F99),24.06,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.85,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.05,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),4.9,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.87,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.04,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Other ischaemic heart diseases,93.67,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Other ischaemic heart diseases,74.78,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Other ischaemic heart diseases,60.96,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Other ischaemic heart diseases,50.64,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Other ischaemic heart diseases,31.14,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Other ischaemic heart diseases,49.54,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Other ischaemic heart diseases,37.68,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Other ischaemic heart diseases,33.2,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Other ischaemic heart diseases,31.37,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Other ischaemic heart diseases,60.97,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,41.71,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,60.23,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,44.14,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,29.0,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,42.55,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,49.64,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,48.68,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,24.75,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,30.22,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,49.33,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Cerebrovascular diseases,88.5,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Cerebrovascular diseases,71.96,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Cerebrovascular diseases,57.3,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Cerebrovascular diseases,90.63,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Cerebrovascular diseases,67.56,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Cerebrovascular diseases,42.58,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Cerebrovascular diseases,52.4,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Cerebrovascular diseases,65.03,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Cerebrovascular diseases,60.19,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Cerebrovascular diseases,68.33,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Chronic lower respiratory diseases,37.03,Rate
Ciudad de Ceuta,ES63,Total,Total,2012,Chronic lower respiratory diseases,34.19,Rate
Ciudad de Ceuta,ES63,Total,Total,2013,Chronic lower respiratory diseases,27.64,Rate
Ciudad de Ceuta,ES63,Total,Total,2014,Chronic lower respiratory diseases,32.48,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Chronic lower respiratory diseases,22.36,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Chronic lower respiratory diseases,35.1,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Chronic lower respiratory diseases,31.37,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Chronic lower respiratory diseases,18.43,Rate
Ciudad de Ceuta,ES63,Total,Total,2019,Chronic lower respiratory diseases,29.4,Rate
Ciudad de Ceuta,ES63,Total,Total,2020,Chronic lower respiratory diseases,34.79,Rate
Ciudad de Ceuta,ES63,Total,Total,2011,Asthma and status asthmaticus,1.06,Rate
Ciudad de Ceuta,ES63,Total,Total,2015,Asthma and status asthmaticus,1.93,Rate
Ciudad de Ceuta,ES63,Total,Total,2016,Asthma and status asthmaticus,1.5,Rate
Ciudad de Ceuta,ES63,Total,Total,2017,Asthma and status asthmaticus,2.33,Rate
Ciudad de Ceuta,ES63,Total,Total,2018,Asthma and status asthmaticus,1.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4938.91,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4653.2,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4893.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4376.49,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4177.7,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4255.07,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4314.55,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4050.18,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3959.83,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4851.65,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.71,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.36,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.81,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",161.15,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",88.52,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.79,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.99,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.3,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",123.03,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",175.95,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",217.41,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",246.05,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",228.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",232.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",170.81,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",97.46,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",149.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",181.63,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Malignant melanoma of skin,21.49,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Malignant melanoma of skin,9.43,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Malignant melanoma of skin,9.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Malignant melanoma of skin,26.24,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Malignant melanoma of skin,9.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Malignant melanoma of skin,9.17,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Malignant melanoma of skin,9.13,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Malignant neoplasm of breast,42.19,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Malignant neoplasm of breast,64.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Malignant neoplasm of breast,51.42,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Malignant neoplasm of breast,67.75,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Malignant neoplasm of breast,36.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Malignant neoplasm of breast,62.74,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Malignant neoplasm of breast,88.3,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Malignant neoplasm of breast,89.13,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Malignant neoplasm of breast,30.16,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Malignant neoplasm of breast,77.66,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Diabetes mellitus,263.41,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Diabetes mellitus,299.14,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Diabetes mellitus,265.11,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Diabetes mellitus,105.71,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Diabetes mellitus,174.77,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Diabetes mellitus,247.21,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Diabetes mellitus,181.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Diabetes mellitus,120.42,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Diabetes mellitus,96.6,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Diabetes mellitus,221.49,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),156.62,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),54.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),132.87,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),31.73,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),241.21,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),225.51,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),159.11,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),248.43,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),222.89,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),123.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),10.53,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),25.14,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),9.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),10.46,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Other ischaemic heart diseases,448.96,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Other ischaemic heart diseases,327.74,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Other ischaemic heart diseases,297.67,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Other ischaemic heart diseases,237.83,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Other ischaemic heart diseases,146.85,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Other ischaemic heart diseases,248.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Other ischaemic heart diseases,179.83,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Other ischaemic heart diseases,158.33,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Other ischaemic heart diseases,123.32,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Other ischaemic heart diseases,276.31,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,185.3,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,296.68,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,180.82,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,107.43,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,171.74,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,218.33,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,199.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,108.38,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,136.49,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,204.01,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Cerebrovascular diseases,420.7,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Cerebrovascular diseases,318.34,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Cerebrovascular diseases,256.62,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Cerebrovascular diseases,434.45,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Cerebrovascular diseases,298.6,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Cerebrovascular diseases,183.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Cerebrovascular diseases,249.4,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Cerebrovascular diseases,307.93,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Cerebrovascular diseases,265.45,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Cerebrovascular diseases,314.03,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Chronic lower respiratory diseases,161.47,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2012,Chronic lower respiratory diseases,144.5,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2013,Chronic lower respiratory diseases,125.98,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2014,Chronic lower respiratory diseases,145.37,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Chronic lower respiratory diseases,106.57,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Chronic lower respiratory diseases,172.29,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Chronic lower respiratory diseases,136.12,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Chronic lower respiratory diseases,82.1,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2019,Chronic lower respiratory diseases,126.44,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2020,Chronic lower respiratory diseases,172.6,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2011,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2015,Asthma and status asthmaticus,9.92,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2016,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2017,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,65 years or over,Total,2018,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,215.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,165.59,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,203.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,207.38,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,197.02,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,180.23,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,217.24,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,197.05,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,198.06,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,211.2,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.8,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.12,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.67,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.45,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.19,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.27,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.72,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.79,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.98,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",23.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",21.84,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",27.41,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",19.55,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",18.19,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",15.63,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",22.83,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",17.83,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",10.62,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",20.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Malignant melanoma of skin,1.28,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Malignant melanoma of skin,1.49,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Malignant melanoma of skin,1.45,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Malignant melanoma of skin,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Malignant melanoma of skin,2.87,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Malignant melanoma of skin,1.41,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Malignant melanoma of skin,3.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Malignant neoplasm of breast,6.01,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.9,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.19,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Malignant neoplasm of breast,5.04,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Malignant neoplasm of breast,1.35,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.55,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Malignant neoplasm of breast,12.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Malignant neoplasm of breast,3.05,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.34,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Diabetes mellitus,1.57,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Diabetes mellitus,9.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Diabetes mellitus,3.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Diabetes mellitus,4.29,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Diabetes mellitus,3.39,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Diabetes mellitus,4.67,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Diabetes mellitus,3.56,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Diabetes mellitus,5.58,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Diabetes mellitus,1.42,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Diabetes mellitus,4.56,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),2.3,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.56,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),2.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.37,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.3,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Other ischaemic heart diseases,7.61,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Other ischaemic heart diseases,13.5,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Other ischaemic heart diseases,3.62,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.3,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Other ischaemic heart diseases,3.11,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Other ischaemic heart diseases,1.43,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Other ischaemic heart diseases,3.25,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Other ischaemic heart diseases,9.09,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Other ischaemic heart diseases,8.81,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,6.92,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,2.95,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,11.03,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,10.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.25,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,8.77,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,12.18,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,4.49,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.47,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,11.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Cerebrovascular diseases,8.03,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Cerebrovascular diseases,12.27,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Cerebrovascular diseases,9.02,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Cerebrovascular diseases,7.34,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Cerebrovascular diseases,11.59,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Cerebrovascular diseases,8.48,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Cerebrovascular diseases,4.68,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Cerebrovascular diseases,6.19,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Cerebrovascular diseases,10.46,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Cerebrovascular diseases,8.81,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Chronic lower respiratory diseases,6.89,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2012,Chronic lower respiratory diseases,7.47,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2013,Chronic lower respiratory diseases,3.82,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2014,Chronic lower respiratory diseases,5.13,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.96,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Chronic lower respiratory diseases,6.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.01,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2019,Chronic lower respiratory diseases,5.9,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.41,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2011,Asthma and status asthmaticus,1.31,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2016,Asthma and status asthmaticus,1.86,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2017,Asthma and status asthmaticus,2.9,Rate
Ciudad de Ceuta,ES63,Less than 65 years,Total,2018,Asthma and status asthmaticus,1.31,Rate
Ciudad de Melilla,ES64,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,915.75,Rate
Ciudad de Melilla,ES64,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,876.59,Rate
Ciudad de Melilla,ES64,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,853.37,Rate
Ciudad de Melilla,ES64,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,825.63,Rate
Ciudad de Melilla,ES64,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,964.38,Rate
Ciudad de Melilla,ES64,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,820.26,Rate
Ciudad de Melilla,ES64,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,840.54,Rate
Ciudad de Melilla,ES64,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,888.48,Rate
Ciudad de Melilla,ES64,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,776.49,Rate
Ciudad de Melilla,ES64,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,1008.71,Rate
Ciudad de Melilla,ES64,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.15,Rate
Ciudad de Melilla,ES64,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.23,Rate
Ciudad de Melilla,ES64,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.23,Rate
Ciudad de Melilla,ES64,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.77,Rate
Ciudad de Melilla,ES64,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.35,Rate
Ciudad de Melilla,ES64,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.66,Rate
Ciudad de Melilla,ES64,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.53,Rate
Ciudad de Melilla,ES64,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.79,Rate
Ciudad de Melilla,ES64,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.12,Rate
Ciudad de Melilla,ES64,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.13,Rate
Ciudad de Melilla,ES64,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",24.84,Rate
Ciudad de Melilla,ES64,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",16.86,Rate
Ciudad de Melilla,ES64,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",15.79,Rate
Ciudad de Melilla,ES64,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",7.88,Rate
Ciudad de Melilla,ES64,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",20.56,Rate
Ciudad de Melilla,ES64,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",20.5,Rate
Ciudad de Melilla,ES64,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",16.39,Rate
Ciudad de Melilla,ES64,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",36.53,Rate
Ciudad de Melilla,ES64,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",24.64,Rate
Ciudad de Melilla,ES64,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",22.87,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Malignant melanoma of skin,8.05,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Malignant melanoma of skin,3.23,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Malignant melanoma of skin,2.92,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Malignant melanoma of skin,6.12,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Malignant melanoma of skin,3.08,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Malignant neoplasm of breast,25.24,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Malignant neoplasm of breast,31.12,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Malignant neoplasm of breast,31.53,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Malignant neoplasm of breast,18.33,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Malignant neoplasm of breast,45.99,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Malignant neoplasm of breast,29.51,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Malignant neoplasm of breast,44.77,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Malignant neoplasm of breast,36.98,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Malignant neoplasm of breast,37.02,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Malignant neoplasm of breast,29.68,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Diabetes mellitus,28.87,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Diabetes mellitus,57.49,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Diabetes mellitus,63.75,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Diabetes mellitus,36.76,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Diabetes mellitus,58.05,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Diabetes mellitus,50.82,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Diabetes mellitus,31.68,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Diabetes mellitus,58.5,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Diabetes mellitus,38.39,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Diabetes mellitus,56.74,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Mental and behavioural disorders (F00-F99),19.05,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Mental and behavioural disorders (F00-F99),10.66,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Mental and behavioural disorders (F00-F99),52.52,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Mental and behavioural disorders (F00-F99),12.7,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Mental and behavioural disorders (F00-F99),30.84,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Mental and behavioural disorders (F00-F99),14.93,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Mental and behavioural disorders (F00-F99),40.77,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Mental and behavioural disorders (F00-F99),37.07,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Mental and behavioural disorders (F00-F99),23.02,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Mental and behavioural disorders (F00-F99),20.74,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),4.59,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),8.62,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),4.55,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.83,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),6.81,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Other ischaemic heart diseases,38.45,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Other ischaemic heart diseases,28.19,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Other ischaemic heart diseases,49.77,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Other ischaemic heart diseases,20.54,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Other ischaemic heart diseases,45.49,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Other ischaemic heart diseases,33.98,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Other ischaemic heart diseases,22.98,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Other ischaemic heart diseases,34.09,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Other ischaemic heart diseases,30.47,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Other ischaemic heart diseases,36.25,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,31.66,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,39.58,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,22.72,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,14.63,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,18.6,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,44.24,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,20.52,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,23.46,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,17.1,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,27.3,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Cerebrovascular diseases,72.97,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Cerebrovascular diseases,49.36,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Cerebrovascular diseases,75.07,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Cerebrovascular diseases,61.71,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Cerebrovascular diseases,77.67,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Cerebrovascular diseases,63.67,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Cerebrovascular diseases,27.17,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Cerebrovascular diseases,48.21,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Cerebrovascular diseases,37.01,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Cerebrovascular diseases,56.51,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Chronic lower respiratory diseases,18.31,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Chronic lower respiratory diseases,31.14,Rate
Ciudad de Melilla,ES64,Total,Females,2013,Chronic lower respiratory diseases,7.33,Rate
Ciudad de Melilla,ES64,Total,Females,2014,Chronic lower respiratory diseases,4.59,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Chronic lower respiratory diseases,19.72,Rate
Ciudad de Melilla,ES64,Total,Females,2016,Chronic lower respiratory diseases,13.02,Rate
Ciudad de Melilla,ES64,Total,Females,2017,Chronic lower respiratory diseases,4.4,Rate
Ciudad de Melilla,ES64,Total,Females,2018,Chronic lower respiratory diseases,17.49,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Chronic lower respiratory diseases,10.87,Rate
Ciudad de Melilla,ES64,Total,Females,2020,Chronic lower respiratory diseases,3.64,Rate
Ciudad de Melilla,ES64,Total,Females,2011,Asthma and status asthmaticus,3.74,Rate
Ciudad de Melilla,ES64,Total,Females,2012,Asthma and status asthmaticus,12.47,Rate
Ciudad de Melilla,ES64,Total,Females,2015,Asthma and status asthmaticus,4.03,Rate
Ciudad de Melilla,ES64,Total,Females,2019,Asthma and status asthmaticus,4.71,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4295.8,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3965.98,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3773.74,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3679.72,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4307.07,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3600.93,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3904.53,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3937.74,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3306.76,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4414.13,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.07,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.86,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.2,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.85,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.17,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",230.38,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",124.95,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",98.08,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.35,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.79,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",104.13,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",55.29,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",44.15,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",40.41,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",23.53,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",38.28,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",54.06,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",101.47,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",56.89,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",77.35,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Malignant melanoma of skin,41.3,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Malignant melanoma of skin,16.56,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Malignant melanoma of skin,14.98,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Malignant melanoma of skin,15.77,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Malignant neoplasm of breast,129.45,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Malignant neoplasm of breast,78.57,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Malignant neoplasm of breast,44.15,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Malignant neoplasm of breast,57.19,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Malignant neoplasm of breast,90.36,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Malignant neoplasm of breast,125.01,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Malignant neoplasm of breast,213.03,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Malignant neoplasm of breast,150.42,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Malignant neoplasm of breast,112.83,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Malignant neoplasm of breast,62.15,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Diabetes mellitus,148.07,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Diabetes mellitus,294.81,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Diabetes mellitus,306.04,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Diabetes mellitus,188.53,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Diabetes mellitus,297.69,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Diabetes mellitus,260.59,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Diabetes mellitus,145.89,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Diabetes mellitus,274.75,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Diabetes mellitus,184.07,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Diabetes mellitus,277.63,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),97.7,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),54.64,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),269.35,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),65.13,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),158.14,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),76.56,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),209.07,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),190.09,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),103.57,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),106.35,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),23.53,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),44.18,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),23.35,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),34.93,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Other ischaemic heart diseases,197.17,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Other ischaemic heart diseases,144.56,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Other ischaemic heart diseases,255.24,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Other ischaemic heart diseases,105.34,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Other ischaemic heart diseases,214.34,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Other ischaemic heart diseases,174.26,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Other ischaemic heart diseases,117.82,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Other ischaemic heart diseases,174.83,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Other ischaemic heart diseases,129.5,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Other ischaemic heart diseases,158.83,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,120.7,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,202.98,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,116.52,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,75.04,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,81.29,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,186.56,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,105.23,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,104.86,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,87.69,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,113.32,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Cerebrovascular diseases,332.52,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Cerebrovascular diseases,236.1,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Cerebrovascular diseases,350.05,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Cerebrovascular diseases,304.84,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Cerebrovascular diseases,398.31,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Cerebrovascular diseases,326.5,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Cerebrovascular diseases,126.23,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Cerebrovascular diseases,221.48,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Cerebrovascular diseases,134.82,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Cerebrovascular diseases,250.44,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Chronic lower respiratory diseases,93.88,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Chronic lower respiratory diseases,159.71,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2013,Chronic lower respiratory diseases,37.61,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2014,Chronic lower respiratory diseases,23.53,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Chronic lower respiratory diseases,101.14,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2016,Chronic lower respiratory diseases,66.75,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2017,Chronic lower respiratory diseases,22.58,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2018,Chronic lower respiratory diseases,74.21,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Chronic lower respiratory diseases,55.72,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2020,Chronic lower respiratory diseases,18.69,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2011,Asthma and status asthmaticus,19.18,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2012,Asthma and status asthmaticus,63.95,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2015,Asthma and status asthmaticus,20.65,Rate
Ciudad de Melilla,ES64,65 years or over,Females,2019,Asthma and status asthmaticus,24.13,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,96.98,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,128.23,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,145.95,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,134.26,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,154.67,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,146.68,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,98.34,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,149.84,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,163.57,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,183.79,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.48,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.8,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.21,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.86,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.42,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.25,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.27,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.38,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",5.63,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",7.56,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",8.92,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",19.84,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",16.2,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",7.27,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",20.8,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",16.83,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",9.67,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Malignant melanoma of skin,7.6,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Malignant neoplasm of breast,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Malignant neoplasm of breast,19.63,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Malignant neoplasm of breast,28.47,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Malignant neoplasm of breast,8.91,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Malignant neoplasm of breast,35.24,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Malignant neoplasm of breast,6.38,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Malignant neoplasm of breast,4.01,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Malignant neoplasm of breast,9.5,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Malignant neoplasm of breast,18.65,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Malignant neoplasm of breast,21.81,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Diabetes mellitus,5.05,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Diabetes mellitus,4.01,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Diabetes mellitus,6.11,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Diabetes mellitus,3.1,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Diabetes mellitus,3.23,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.51,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.51,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Other ischaemic heart diseases,4.59,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Other ischaemic heart diseases,6.48,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Other ischaemic heart diseases,6.55,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,10.09,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.41,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,9.77,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,6.46,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Cerebrovascular diseases,10.09,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Cerebrovascular diseases,4.12,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Cerebrovascular diseases,8.46,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Cerebrovascular diseases,2.82,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Cerebrovascular diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Cerebrovascular diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Cerebrovascular diseases,3.17,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Cerebrovascular diseases,6.24,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Cerebrovascular diseases,13.32,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Cerebrovascular diseases,9.53,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2018,Chronic lower respiratory diseases,3.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1398.45,Rate
Ciudad de Melilla,ES64,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1363.54,Rate
Ciudad de Melilla,ES64,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1228.52,Rate
Ciudad de Melilla,ES64,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1414.91,Rate
Ciudad de Melilla,ES64,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1245.31,Rate
Ciudad de Melilla,ES64,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1212.05,Rate
Ciudad de Melilla,ES64,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1120.1,Rate
Ciudad de Melilla,ES64,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1149.37,Rate
Ciudad de Melilla,ES64,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1111.53,Rate
Ciudad de Melilla,ES64,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1309.94,Rate
Ciudad de Melilla,ES64,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",72.98,Rate
Ciudad de Melilla,ES64,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.23,Rate
Ciudad de Melilla,ES64,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.25,Rate
Ciudad de Melilla,ES64,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.94,Rate
Ciudad de Melilla,ES64,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.92,Rate
Ciudad de Melilla,ES64,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.17,Rate
Ciudad de Melilla,ES64,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.86,Rate
Ciudad de Melilla,ES64,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.28,Rate
Ciudad de Melilla,ES64,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.51,Rate
Ciudad de Melilla,ES64,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.99,Rate
Ciudad de Melilla,ES64,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",88.34,Rate
Ciudad de Melilla,ES64,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",115.65,Rate
Ciudad de Melilla,ES64,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",83.07,Rate
Ciudad de Melilla,ES64,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",111.3,Rate
Ciudad de Melilla,ES64,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",74.53,Rate
Ciudad de Melilla,ES64,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",77.97,Rate
Ciudad de Melilla,ES64,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",115.07,Rate
Ciudad de Melilla,ES64,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",100.48,Rate
Ciudad de Melilla,ES64,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",80.18,Rate
Ciudad de Melilla,ES64,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",88.43,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Malignant melanoma of skin,4.95,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Malignant melanoma of skin,5.04,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Malignant melanoma of skin,10.22,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Malignant melanoma of skin,6.41,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Diabetes mellitus,51.22,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Diabetes mellitus,11.61,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Diabetes mellitus,56.38,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Diabetes mellitus,32.3,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Diabetes mellitus,49.87,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Diabetes mellitus,34.11,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Diabetes mellitus,54.95,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Diabetes mellitus,42.03,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Diabetes mellitus,28.27,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Diabetes mellitus,56.89,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Mental and behavioural disorders (F00-F99),41.78,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Mental and behavioural disorders (F00-F99),23.91,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Mental and behavioural disorders (F00-F99),22.89,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Mental and behavioural disorders (F00-F99),41.16,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Mental and behavioural disorders (F00-F99),32.64,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Mental and behavioural disorders (F00-F99),27.85,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Mental and behavioural disorders (F00-F99),24.96,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Mental and behavioural disorders (F00-F99),24.47,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Mental and behavioural disorders (F00-F99),20.55,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),4.95,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),4.27,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.92,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Other ischaemic heart diseases,65.44,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Other ischaemic heart diseases,73.98,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Other ischaemic heart diseases,75.73,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Other ischaemic heart diseases,80.78,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Other ischaemic heart diseases,51.89,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Other ischaemic heart diseases,46.66,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Other ischaemic heart diseases,44.66,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Other ischaemic heart diseases,57.11,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Other ischaemic heart diseases,52.9,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Other ischaemic heart diseases,24.51,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,84.93,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,35.04,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,64.83,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,69.14,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,58.49,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,75.9,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,46.26,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,70.79,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,31.41,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,81.74,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Cerebrovascular diseases,84.5,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Cerebrovascular diseases,98.37,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Cerebrovascular diseases,60.47,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Cerebrovascular diseases,144.68,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Cerebrovascular diseases,82.27,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Cerebrovascular diseases,105.27,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Cerebrovascular diseases,80.23,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Cerebrovascular diseases,62.85,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Cerebrovascular diseases,71.56,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Cerebrovascular diseases,49.51,Rate
Ciudad de Melilla,ES64,Total,Males,2011,Chronic lower respiratory diseases,76.36,Rate
Ciudad de Melilla,ES64,Total,Males,2012,Chronic lower respiratory diseases,104.89,Rate
Ciudad de Melilla,ES64,Total,Males,2013,Chronic lower respiratory diseases,78.11,Rate
Ciudad de Melilla,ES64,Total,Males,2014,Chronic lower respiratory diseases,50.37,Rate
Ciudad de Melilla,ES64,Total,Males,2015,Chronic lower respiratory diseases,90.01,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Chronic lower respiratory diseases,47.94,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Chronic lower respiratory diseases,37.77,Rate
Ciudad de Melilla,ES64,Total,Males,2018,Chronic lower respiratory diseases,24.53,Rate
Ciudad de Melilla,ES64,Total,Males,2019,Chronic lower respiratory diseases,30.51,Rate
Ciudad de Melilla,ES64,Total,Males,2020,Chronic lower respiratory diseases,68.74,Rate
Ciudad de Melilla,ES64,Total,Males,2016,Asthma and status asthmaticus,4.27,Rate
Ciudad de Melilla,ES64,Total,Males,2017,Asthma and status asthmaticus,5.13,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,6031.45,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5985.25,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5529.81,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,6377.81,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5534.9,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5297.84,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4814.33,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4868.8,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4691.51,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5711.11,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",319.15,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.69,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",242.92,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",209.94,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",182.24,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.51,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.71,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.87,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.39,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",241.37,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",340.51,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",471.63,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",301.58,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",437.55,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",322.37,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",292.82,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",472.83,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",358.56,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",297.6,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",378.69,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Malignant melanoma of skin,25.36,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Malignant melanoma of skin,35.37,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Malignant melanoma of skin,32.87,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Diabetes mellitus,235.21,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Diabetes mellitus,39.96,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Diabetes mellitus,289.12,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Diabetes mellitus,165.66,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Diabetes mellitus,255.72,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Diabetes mellitus,150.81,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Diabetes mellitus,267.63,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Diabetes mellitus,191.23,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Diabetes mellitus,145.0,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Diabetes mellitus,291.77,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),214.27,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),122.61,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),93.18,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),198.89,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),167.38,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),142.8,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),127.99,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),125.5,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),67.63,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),25.36,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),21.91,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Other ischaemic heart diseases,323.37,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Other ischaemic heart diseases,326.29,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Other ischaemic heart diseases,388.38,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Other ischaemic heart diseases,402.36,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Other ischaemic heart diseases,250.22,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Other ischaemic heart diseases,239.3,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Other ischaemic heart diseases,216.83,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Other ischaemic heart diseases,279.26,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Other ischaemic heart diseases,245.8,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Other ischaemic heart diseases,101.0,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,423.92,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,160.08,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,314.4,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,342.68,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,287.95,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,323.32,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,172.07,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,275.1,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,125.81,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,316.05,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Cerebrovascular diseases,347.59,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Cerebrovascular diseases,492.52,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Cerebrovascular diseases,283.81,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Cerebrovascular diseases,670.79,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Cerebrovascular diseases,367.32,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Cerebrovascular diseases,473.92,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Cerebrovascular diseases,411.45,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Cerebrovascular diseases,310.29,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Cerebrovascular diseases,291.12,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Cerebrovascular diseases,217.06,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2011,Chronic lower respiratory diseases,357.96,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2012,Chronic lower respiratory diseases,537.89,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2013,Chronic lower respiratory diseases,364.47,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2014,Chronic lower respiratory diseases,258.29,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2015,Chronic lower respiratory diseases,405.86,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Chronic lower respiratory diseases,216.14,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Chronic lower respiratory diseases,167.61,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2018,Chronic lower respiratory diseases,113.48,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2019,Chronic lower respiratory diseases,118.41,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2020,Chronic lower respiratory diseases,352.52,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2016,Asthma and status asthmaticus,21.91,Rate
Ciudad de Melilla,ES64,65 years or over,Males,2017,Asthma and status asthmaticus,26.3,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,276.17,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,243.99,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,186.59,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,212.72,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,206.21,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,222.32,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,225.23,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,248.39,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,244.33,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,243.82,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.35,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.07,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.95,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.35,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.64,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.82,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.21,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.11,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",27.25,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",29.42,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",30.14,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",32.27,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",14.49,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",25.92,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",28.4,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",37.96,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",27.52,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",18.11,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Malignant melanoma of skin,6.26,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Malignant melanoma of skin,4.12,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Diabetes mellitus,6.65,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Diabetes mellitus,4.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Diabetes mellitus,5.84,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Diabetes mellitus,3.43,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Diabetes mellitus,5.89,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),5.86,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),2.95,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),9.15,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),6.11,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Other ischaemic heart diseases,2.96,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Other ischaemic heart diseases,12.86,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Other ischaemic heart diseases,2.88,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Other ischaemic heart diseases,3.85,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Other ischaemic heart diseases,2.96,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Other ischaemic heart diseases,3.29,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Other ischaemic heart diseases,6.17,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Other ischaemic heart diseases,5.98,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,2.82,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,4.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,4.37,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,2.88,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,2.91,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,15.97,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,15.78,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,21.3,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.54,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,24.98,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Cerebrovascular diseases,20.78,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Cerebrovascular diseases,2.89,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Cerebrovascular diseases,6.37,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Cerebrovascular diseases,17.24,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Cerebrovascular diseases,13.22,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Cerebrovascular diseases,15.98,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Cerebrovascular diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Cerebrovascular diseases,2.91,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Cerebrovascular diseases,18.38,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Cerebrovascular diseases,8.92,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2011,Chronic lower respiratory diseases,8.15,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2012,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2013,Chronic lower respiratory diseases,8.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2015,Chronic lower respiratory diseases,13.51,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Chronic lower respiratory diseases,7.19,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.32,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2018,Chronic lower respiratory diseases,2.99,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2019,Chronic lower respiratory diseases,9.21,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1133.51,Rate
Ciudad de Melilla,ES64,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1073.98,Rate
Ciudad de Melilla,ES64,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1015.74,Rate
Ciudad de Melilla,ES64,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1053.56,Rate
Ciudad de Melilla,ES64,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1086.57,Rate
Ciudad de Melilla,ES64,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,979.85,Rate
Ciudad de Melilla,ES64,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,983.11,Rate
Ciudad de Melilla,ES64,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1007.53,Rate
Ciudad de Melilla,ES64,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,926.61,Rate
Ciudad de Melilla,ES64,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1148.6,Rate
Ciudad de Melilla,ES64,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.92,Rate
Ciudad de Melilla,ES64,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.45,Rate
Ciudad de Melilla,ES64,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.26,Rate
Ciudad de Melilla,ES64,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.05,Rate
Ciudad de Melilla,ES64,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.05,Rate
Ciudad de Melilla,ES64,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.68,Rate
Ciudad de Melilla,ES64,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.96,Rate
Ciudad de Melilla,ES64,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.06,Rate
Ciudad de Melilla,ES64,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.01,Rate
Ciudad de Melilla,ES64,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.56,Rate
Ciudad de Melilla,ES64,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",51.62,Rate
Ciudad de Melilla,ES64,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",64.32,Rate
Ciudad de Melilla,ES64,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",47.11,Rate
Ciudad de Melilla,ES64,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",51.96,Rate
Ciudad de Melilla,ES64,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",41.72,Rate
Ciudad de Melilla,ES64,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",46.73,Rate
Ciudad de Melilla,ES64,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",64.5,Rate
Ciudad de Melilla,ES64,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",62.09,Rate
Ciudad de Melilla,ES64,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",50.39,Rate
Ciudad de Melilla,ES64,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",50.93,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Malignant melanoma of skin,2.38,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Malignant melanoma of skin,2.76,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Malignant melanoma of skin,4.64,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Malignant melanoma of skin,6.18,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Malignant melanoma of skin,2.04,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Malignant melanoma of skin,4.78,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Malignant melanoma of skin,1.92,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Malignant neoplasm of breast,15.76,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Malignant neoplasm of breast,16.46,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Malignant neoplasm of breast,15.6,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Malignant neoplasm of breast,10.27,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Malignant neoplasm of breast,25.03,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Malignant neoplasm of breast,16.47,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Malignant neoplasm of breast,24.24,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Malignant neoplasm of breast,20.27,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Malignant neoplasm of breast,20.3,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Malignant neoplasm of breast,15.79,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Diabetes mellitus,40.81,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Diabetes mellitus,40.14,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Diabetes mellitus,61.63,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Diabetes mellitus,36.45,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Diabetes mellitus,55.72,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Diabetes mellitus,44.3,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Diabetes mellitus,43.03,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Diabetes mellitus,53.31,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Diabetes mellitus,34.71,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Diabetes mellitus,57.13,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Mental and behavioural disorders (F00-F99),26.32,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Mental and behavioural disorders (F00-F99),7.73,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Mental and behavioural disorders (F00-F99),43.86,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Mental and behavioural disorders (F00-F99),16.8,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Mental and behavioural disorders (F00-F99),33.91,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Mental and behavioural disorders (F00-F99),21.88,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Mental and behavioural disorders (F00-F99),36.13,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Mental and behavioural disorders (F00-F99),31.94,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Mental and behavioural disorders (F00-F99),22.98,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Mental and behavioural disorders (F00-F99),20.27,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.38,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.28,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),4.84,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.18,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.43,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),6.23,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Other ischaemic heart diseases,47.61,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Other ischaemic heart diseases,47.47,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Other ischaemic heart diseases,62.5,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Other ischaemic heart diseases,42.43,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Other ischaemic heart diseases,49.81,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Other ischaemic heart diseases,41.06,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Other ischaemic heart diseases,31.69,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Other ischaemic heart diseases,45.18,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Other ischaemic heart diseases,38.23,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Other ischaemic heart diseases,32.85,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,53.53,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,36.13,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,41.08,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,34.46,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,35.29,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,56.42,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,32.91,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,43.74,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,25.13,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,49.58,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Cerebrovascular diseases,79.65,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Cerebrovascular diseases,66.27,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Cerebrovascular diseases,68.36,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Cerebrovascular diseases,89.95,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Cerebrovascular diseases,80.12,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Cerebrovascular diseases,83.27,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Cerebrovascular diseases,47.4,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Cerebrovascular diseases,56.97,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Cerebrovascular diseases,50.8,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Cerebrovascular diseases,56.33,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Chronic lower respiratory diseases,39.61,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Chronic lower respiratory diseases,53.56,Rate
Ciudad de Melilla,ES64,Total,Total,2013,Chronic lower respiratory diseases,36.22,Rate
Ciudad de Melilla,ES64,Total,Total,2014,Chronic lower respiratory diseases,20.18,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Chronic lower respiratory diseases,48.84,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Chronic lower respiratory diseases,27.66,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Chronic lower respiratory diseases,17.93,Rate
Ciudad de Melilla,ES64,Total,Total,2018,Chronic lower respiratory diseases,19.9,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Chronic lower respiratory diseases,18.69,Rate
Ciudad de Melilla,ES64,Total,Total,2020,Chronic lower respiratory diseases,28.44,Rate
Ciudad de Melilla,ES64,Total,Total,2011,Asthma and status asthmaticus,2.58,Rate
Ciudad de Melilla,ES64,Total,Total,2012,Asthma and status asthmaticus,8.74,Rate
Ciudad de Melilla,ES64,Total,Total,2015,Asthma and status asthmaticus,2.36,Rate
Ciudad de Melilla,ES64,Total,Total,2016,Asthma and status asthmaticus,2.18,Rate
Ciudad de Melilla,ES64,Total,Total,2017,Asthma and status asthmaticus,1.92,Rate
Ciudad de Melilla,ES64,Total,Total,2019,Asthma and status asthmaticus,2.42,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,5019.72,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4721.48,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4514.61,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4675.79,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4819.15,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4251.87,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4361.27,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4337.23,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3905.4,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5007.69,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",175.79,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.05,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.87,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",160.36,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",73.72,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",196.82,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.38,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.99,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.83,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.65,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",193.34,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",249.91,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",157.19,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",194.57,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",143.16,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",151.74,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",254.66,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",195.41,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",165.92,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",202.79,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Malignant melanoma of skin,12.22,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Malignant melanoma of skin,23.8,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Malignant melanoma of skin,22.56,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Malignant melanoma of skin,10.44,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Malignant melanoma of skin,10.05,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Malignant melanoma of skin,9.86,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Malignant neoplasm of breast,80.84,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Malignant neoplasm of breast,47.04,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Malignant neoplasm of breast,25.09,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Malignant neoplasm of breast,34.87,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Malignant neoplasm of breast,59.89,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Malignant neoplasm of breast,71.9,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Malignant neoplasm of breast,116.68,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Malignant neoplasm of breast,84.98,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Malignant neoplasm of breast,66.51,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Malignant neoplasm of breast,36.27,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Diabetes mellitus,194.29,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Diabetes mellitus,195.47,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Diabetes mellitus,306.36,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Diabetes mellitus,186.93,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Diabetes mellitus,285.73,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Diabetes mellitus,214.44,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Diabetes mellitus,205.4,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Diabetes mellitus,248.37,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Diabetes mellitus,171.68,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Diabetes mellitus,286.63,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),134.97,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),39.63,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),224.93,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),73.27,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),167.39,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),112.19,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),185.26,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),163.78,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),110.99,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),84.48,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),12.22,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),11.71,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),24.83,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),11.16,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),12.46,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),18.99,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Other ischaemic heart diseases,237.52,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Other ischaemic heart diseases,215.02,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Other ischaemic heart diseases,320.52,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Other ischaemic heart diseases,211.18,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Other ischaemic heart diseases,238.16,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Other ischaemic heart diseases,210.56,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Other ischaemic heart diseases,156.19,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Other ischaemic heart diseases,224.47,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Other ischaemic heart diseases,169.83,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Other ischaemic heart diseases,142.66,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,248.77,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,174.91,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,201.01,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,170.31,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,168.04,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,234.88,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,134.55,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,171.32,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,110.86,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,189.09,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Cerebrovascular diseases,344.35,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Cerebrovascular diseases,325.71,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Cerebrovascular diseases,320.0,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Cerebrovascular diseases,417.18,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Cerebrovascular diseases,381.73,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Cerebrovascular diseases,391.9,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Cerebrovascular diseases,236.75,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Cerebrovascular diseases,273.2,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Cerebrovascular diseases,195.64,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Cerebrovascular diseases,250.43,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Chronic lower respiratory diseases,185.35,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Chronic lower respiratory diseases,274.67,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2013,Chronic lower respiratory diseases,166.36,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2014,Chronic lower respiratory diseases,103.47,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Chronic lower respiratory diseases,220.55,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Chronic lower respiratory diseases,125.65,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Chronic lower respiratory diseases,77.97,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2018,Chronic lower respiratory diseases,88.51,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Chronic lower respiratory diseases,75.78,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2020,Chronic lower respiratory diseases,145.86,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2011,Asthma and status asthmaticus,13.21,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2012,Asthma and status asthmaticus,44.84,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2015,Asthma and status asthmaticus,12.09,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2016,Asthma and status asthmaticus,11.16,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2017,Asthma and status asthmaticus,9.86,Rate
Ciudad de Melilla,ES64,65 years or over,Total,2019,Asthma and status asthmaticus,12.39,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,192.14,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,190.43,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,168.19,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,176.13,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,182.41,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,187.25,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,164.8,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,200.96,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,205.04,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,213.79,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.01,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.38,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.31,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.22,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.56,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.55,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.06,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.06,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.4,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.35,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",17.3,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",19.37,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",20.45,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",17.41,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",17.15,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",21.29,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",18.43,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",29.8,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",22.4,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.15,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Malignant melanoma of skin,3.42,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Malignant melanoma of skin,2.22,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Malignant melanoma of skin,3.5,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Malignant melanoma of skin,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Malignant neoplasm of breast,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Malignant neoplasm of breast,9.06,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Malignant neoplasm of breast,13.3,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Malignant neoplasm of breast,4.32,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Malignant neoplasm of breast,16.59,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Malignant neoplasm of breast,3.04,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Malignant neoplasm of breast,1.85,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Malignant neoplasm of breast,4.59,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Malignant neoplasm of breast,9.11,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Malignant neoplasm of breast,10.83,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Diabetes mellitus,3.63,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Diabetes mellitus,2.51,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Diabetes mellitus,2.34,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Diabetes mellitus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Diabetes mellitus,3.09,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Diabetes mellitus,3.7,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Diabetes mellitus,6.06,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Diabetes mellitus,1.53,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Diabetes mellitus,1.54,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),3.12,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.58,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.66,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.72,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.66,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.13,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Other ischaemic heart diseases,1.61,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Other ischaemic heart diseases,6.88,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Other ischaemic heart diseases,1.55,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Other ischaemic heart diseases,4.18,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Other ischaemic heart diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Other ischaemic heart diseases,1.53,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Other ischaemic heart diseases,1.75,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Other ischaemic heart diseases,6.35,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Other ischaemic heart diseases,6.25,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,6.24,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,2.51,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,2.34,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,1.55,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,3.13,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,13.19,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,8.29,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,12.83,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.37,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,15.78,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Cerebrovascular diseases,15.53,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Cerebrovascular diseases,3.42,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Cerebrovascular diseases,7.4,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Cerebrovascular diseases,10.69,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Cerebrovascular diseases,7.06,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Cerebrovascular diseases,8.52,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Cerebrovascular diseases,1.53,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Cerebrovascular diseases,4.59,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Cerebrovascular diseases,15.71,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Cerebrovascular diseases,9.32,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.31,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2013,Chronic lower respiratory diseases,4.69,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Chronic lower respiratory diseases,7.24,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.92,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.38,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.28,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Chronic lower respiratory diseases,4.86,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Ciudad de Melilla,ES64,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
land,FI20,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,797.65,Rate
land,FI20,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,1011.08,Rate
land,FI20,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,698.26,Rate
land,FI20,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,756.0,Rate
land,FI20,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,792.21,Rate
land,FI20,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,798.06,Rate
land,FI20,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,659.31,Rate
land,FI20,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,690.95,Rate
land,FI20,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,658.32,Rate
land,FI20,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,673.12,Rate
land,FI20,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.26,Rate
land,FI20,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.88,Rate
land,FI20,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.96,Rate
land,FI20,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.73,Rate
land,FI20,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.05,Rate
land,FI20,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.38,Rate
land,FI20,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.93,Rate
land,FI20,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.37,Rate
land,FI20,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.28,Rate
land,FI20,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.3,Rate
land,FI20,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",35.38,Rate
land,FI20,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",53.75,Rate
land,FI20,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",12.32,Rate
land,FI20,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",38.33,Rate
land,FI20,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",11.85,Rate
land,FI20,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",56.52,Rate
land,FI20,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",23.55,Rate
land,FI20,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",38.18,Rate
land,FI20,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",46.81,Rate
land,FI20,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",71.38,Rate
land,FI20,Total,Females,2012,Malignant melanoma of skin,14.06,Rate
land,FI20,Total,Females,2014,Malignant melanoma of skin,10.94,Rate
land,FI20,Total,Females,2017,Malignant melanoma of skin,5.85,Rate
land,FI20,Total,Females,2018,Malignant melanoma of skin,5.38,Rate
land,FI20,Total,Females,2019,Malignant melanoma of skin,4.57,Rate
land,FI20,Total,Females,2011,Malignant neoplasm of breast,6.23,Rate
land,FI20,Total,Females,2012,Malignant neoplasm of breast,54.14,Rate
land,FI20,Total,Females,2013,Malignant neoplasm of breast,21.18,Rate
land,FI20,Total,Females,2014,Malignant neoplasm of breast,7.73,Rate
land,FI20,Total,Females,2015,Malignant neoplasm of breast,18.15,Rate
land,FI20,Total,Females,2016,Malignant neoplasm of breast,29.03,Rate
land,FI20,Total,Females,2017,Malignant neoplasm of breast,36.61,Rate
land,FI20,Total,Females,2018,Malignant neoplasm of breast,20.23,Rate
land,FI20,Total,Females,2019,Malignant neoplasm of breast,11.28,Rate
land,FI20,Total,Females,2020,Malignant neoplasm of breast,23.21,Rate
land,FI20,Total,Females,2011,Diabetes mellitus,16.21,Rate
land,FI20,Total,Females,2014,Diabetes mellitus,4.64,Rate
land,FI20,Total,Females,2015,Diabetes mellitus,16.58,Rate
land,FI20,Total,Females,2016,Diabetes mellitus,4.97,Rate
land,FI20,Total,Females,2019,Diabetes mellitus,4.3,Rate
land,FI20,Total,Females,2020,Diabetes mellitus,15.19,Rate
land,FI20,Total,Females,2011,Mental and behavioural disorders (F00-F99),21.78,Rate
land,FI20,Total,Females,2012,Mental and behavioural disorders (F00-F99),36.26,Rate
land,FI20,Total,Females,2013,Mental and behavioural disorders (F00-F99),25.09,Rate
land,FI20,Total,Females,2014,Mental and behavioural disorders (F00-F99),20.69,Rate
land,FI20,Total,Females,2015,Mental and behavioural disorders (F00-F99),16.55,Rate
land,FI20,Total,Females,2016,Mental and behavioural disorders (F00-F99),33.98,Rate
land,FI20,Total,Females,2017,Mental and behavioural disorders (F00-F99),25.69,Rate
land,FI20,Total,Females,2018,Mental and behavioural disorders (F00-F99),10.34,Rate
land,FI20,Total,Females,2019,Mental and behavioural disorders (F00-F99),52.86,Rate
land,FI20,Total,Females,2020,Mental and behavioural disorders (F00-F99),42.74,Rate
land,FI20,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),8.41,Rate
land,FI20,Total,Females,2011,Other ischaemic heart diseases,51.94,Rate
land,FI20,Total,Females,2012,Other ischaemic heart diseases,57.96,Rate
land,FI20,Total,Females,2013,Other ischaemic heart diseases,22.49,Rate
land,FI20,Total,Females,2014,Other ischaemic heart diseases,55.41,Rate
land,FI20,Total,Females,2015,Other ischaemic heart diseases,26.04,Rate
land,FI20,Total,Females,2016,Other ischaemic heart diseases,45.25,Rate
land,FI20,Total,Females,2017,Other ischaemic heart diseases,49.06,Rate
land,FI20,Total,Females,2018,Other ischaemic heart diseases,54.69,Rate
land,FI20,Total,Females,2019,Other ischaemic heart diseases,47.31,Rate
land,FI20,Total,Females,2020,Other ischaemic heart diseases,18.99,Rate
land,FI20,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,97.11,Rate
land,FI20,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,95.78,Rate
land,FI20,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,78.41,Rate
land,FI20,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,85.26,Rate
land,FI20,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,90.62,Rate
land,FI20,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,101.87,Rate
land,FI20,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,54.29,Rate
land,FI20,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,47.36,Rate
land,FI20,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,59.81,Rate
land,FI20,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,23.53,Rate
land,FI20,Total,Females,2011,Cerebrovascular diseases,55.37,Rate
land,FI20,Total,Females,2012,Cerebrovascular diseases,69.55,Rate
land,FI20,Total,Females,2013,Cerebrovascular diseases,86.2,Rate
land,FI20,Total,Females,2014,Cerebrovascular diseases,42.85,Rate
land,FI20,Total,Females,2015,Cerebrovascular diseases,87.64,Rate
land,FI20,Total,Females,2016,Cerebrovascular diseases,93.2,Rate
land,FI20,Total,Females,2017,Cerebrovascular diseases,83.25,Rate
land,FI20,Total,Females,2018,Cerebrovascular diseases,25.28,Rate
land,FI20,Total,Females,2019,Cerebrovascular diseases,57.5,Rate
land,FI20,Total,Females,2020,Cerebrovascular diseases,70.25,Rate
land,FI20,Total,Females,2011,Chronic lower respiratory diseases,22.3,Rate
land,FI20,Total,Females,2012,Chronic lower respiratory diseases,33.08,Rate
land,FI20,Total,Females,2013,Chronic lower respiratory diseases,47.21,Rate
land,FI20,Total,Females,2014,Chronic lower respiratory diseases,31.86,Rate
land,FI20,Total,Females,2015,Chronic lower respiratory diseases,28.86,Rate
land,FI20,Total,Females,2016,Chronic lower respiratory diseases,10.89,Rate
land,FI20,Total,Females,2017,Chronic lower respiratory diseases,7.29,Rate
land,FI20,Total,Females,2018,Chronic lower respiratory diseases,33.14,Rate
land,FI20,Total,Females,2019,Chronic lower respiratory diseases,22.84,Rate
land,FI20,Total,Females,2020,Chronic lower respiratory diseases,23.78,Rate
land,FI20,Total,Females,2013,Asthma and status asthmaticus,8.12,Rate
land,FI20,Total,Females,2014,Asthma and status asthmaticus,5.35,Rate
land,FI20,Total,Females,2015,Asthma and status asthmaticus,10.68,Rate
land,FI20,Total,Females,2018,Asthma and status asthmaticus,5.52,Rate
land,FI20,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3661.37,Rate
land,FI20,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4697.81,Rate
land,FI20,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3427.49,Rate
land,FI20,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3428.0,Rate
land,FI20,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3496.46,Rate
land,FI20,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3660.27,Rate
land,FI20,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,2896.85,Rate
land,FI20,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3158.6,Rate
land,FI20,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3000.72,Rate
land,FI20,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3195.56,Rate
land,FI20,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.46,Rate
land,FI20,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",215.56,Rate
land,FI20,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.6,Rate
land,FI20,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.16,Rate
land,FI20,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.33,Rate
land,FI20,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",166.03,Rate
land,FI20,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.1,Rate
land,FI20,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.3,Rate
land,FI20,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",186.46,Rate
land,FI20,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",73.35,Rate
land,FI20,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",150.41,Rate
land,FI20,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",239.89,Rate
land,FI20,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",63.2,Rate
land,FI20,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",163.95,Rate
land,FI20,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",28.05,Rate
land,FI20,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",232.27,Rate
land,FI20,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",58.31,Rate
land,FI20,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",165.79,Rate
land,FI20,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",177.0,Rate
land,FI20,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",366.04,Rate
land,FI20,65 years or over,Females,2012,Malignant melanoma of skin,0.0,Rate
land,FI20,65 years or over,Females,2014,Malignant melanoma of skin,56.09,Rate
land,FI20,65 years or over,Females,2017,Malignant melanoma of skin,30.02,Rate
land,FI20,65 years or over,Females,2018,Malignant melanoma of skin,27.57,Rate
land,FI20,65 years or over,Females,2019,Malignant melanoma of skin,23.44,Rate
land,FI20,65 years or over,Females,2011,Malignant neoplasm of breast,31.93,Rate
land,FI20,65 years or over,Females,2012,Malignant neoplasm of breast,183.45,Rate
land,FI20,65 years or over,Females,2013,Malignant neoplasm of breast,108.61,Rate
land,FI20,65 years or over,Females,2014,Malignant neoplasm of breast,39.66,Rate
land,FI20,65 years or over,Females,2015,Malignant neoplasm of breast,26.73,Rate
land,FI20,65 years or over,Females,2016,Malignant neoplasm of breast,81.73,Rate
land,FI20,65 years or over,Females,2017,Malignant neoplasm of breast,187.73,Rate
land,FI20,65 years or over,Females,2018,Malignant neoplasm of breast,71.6,Rate
land,FI20,65 years or over,Females,2019,Malignant neoplasm of breast,27.48,Rate
land,FI20,65 years or over,Females,2020,Malignant neoplasm of breast,51.66,Rate
land,FI20,65 years or over,Females,2011,Diabetes mellitus,83.11,Rate
land,FI20,65 years or over,Females,2014,Diabetes mellitus,23.78,Rate
land,FI20,65 years or over,Females,2015,Diabetes mellitus,56.28,Rate
land,FI20,65 years or over,Females,2016,Diabetes mellitus,25.48,Rate
land,FI20,65 years or over,Females,2019,Diabetes mellitus,22.06,Rate
land,FI20,65 years or over,Females,2020,Diabetes mellitus,77.89,Rate
land,FI20,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),111.71,Rate
land,FI20,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),185.96,Rate
land,FI20,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),96.61,Rate
land,FI20,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),106.1,Rate
land,FI20,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),84.88,Rate
land,FI20,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),174.25,Rate
land,FI20,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),131.74,Rate
land,FI20,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),53.05,Rate
land,FI20,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),271.06,Rate
land,FI20,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),219.19,Rate
land,FI20,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),43.13,Rate
land,FI20,65 years or over,Females,2011,Other ischaemic heart diseases,266.36,Rate
land,FI20,65 years or over,Females,2012,Other ischaemic heart diseases,297.22,Rate
land,FI20,65 years or over,Females,2013,Other ischaemic heart diseases,115.34,Rate
land,FI20,65 years or over,Females,2014,Other ischaemic heart diseases,284.16,Rate
land,FI20,65 years or over,Females,2015,Other ischaemic heart diseases,133.54,Rate
land,FI20,65 years or over,Females,2016,Other ischaemic heart diseases,203.25,Rate
land,FI20,65 years or over,Females,2017,Other ischaemic heart diseases,251.59,Rate
land,FI20,65 years or over,Females,2018,Other ischaemic heart diseases,247.33,Rate
land,FI20,65 years or over,Females,2019,Other ischaemic heart diseases,242.62,Rate
land,FI20,65 years or over,Females,2020,Other ischaemic heart diseases,97.37,Rate
land,FI20,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,497.99,Rate
land,FI20,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,491.16,Rate
land,FI20,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,402.09,Rate
land,FI20,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,401.21,Rate
land,FI20,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,464.71,Rate
land,FI20,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,522.41,Rate
land,FI20,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,278.4,Rate
land,FI20,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,242.87,Rate
land,FI20,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,306.74,Rate
land,FI20,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,120.66,Rate
land,FI20,65 years or over,Females,2011,Cerebrovascular diseases,283.96,Rate
land,FI20,65 years or over,Females,2012,Cerebrovascular diseases,326.66,Rate
land,FI20,65 years or over,Females,2013,Cerebrovascular diseases,412.76,Rate
land,FI20,65 years or over,Females,2014,Cerebrovascular diseases,219.76,Rate
land,FI20,65 years or over,Females,2015,Cerebrovascular diseases,420.7,Rate
land,FI20,65 years or over,Females,2016,Cerebrovascular diseases,477.94,Rate
land,FI20,65 years or over,Females,2017,Cerebrovascular diseases,426.92,Rate
land,FI20,65 years or over,Females,2018,Cerebrovascular diseases,129.62,Rate
land,FI20,65 years or over,Females,2019,Cerebrovascular diseases,229.46,Rate
land,FI20,65 years or over,Females,2020,Cerebrovascular diseases,360.25,Rate
land,FI20,65 years or over,Females,2011,Chronic lower respiratory diseases,84.49,Rate
land,FI20,65 years or over,Females,2012,Chronic lower respiratory diseases,169.63,Rate
land,FI20,65 years or over,Females,2013,Chronic lower respiratory diseases,242.12,Rate
land,FI20,65 years or over,Females,2014,Chronic lower respiratory diseases,163.4,Rate
land,FI20,65 years or over,Females,2015,Chronic lower respiratory diseases,148.01,Rate
land,FI20,65 years or over,Females,2016,Chronic lower respiratory diseases,27.04,Rate
land,FI20,65 years or over,Females,2017,Chronic lower respiratory diseases,37.4,Rate
land,FI20,65 years or over,Females,2018,Chronic lower respiratory diseases,169.93,Rate
land,FI20,65 years or over,Females,2019,Chronic lower respiratory diseases,117.13,Rate
land,FI20,65 years or over,Females,2020,Chronic lower respiratory diseases,121.93,Rate
land,FI20,65 years or over,Females,2013,Asthma and status asthmaticus,41.66,Rate
land,FI20,65 years or over,Females,2014,Asthma and status asthmaticus,27.44,Rate
land,FI20,65 years or over,Females,2015,Asthma and status asthmaticus,54.78,Rate
land,FI20,65 years or over,Females,2018,Asthma and status asthmaticus,28.3,Rate
land,FI20,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,103.96,Rate
land,FI20,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,118.02,Rate
land,FI20,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,37.14,Rate
land,FI20,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,108.75,Rate
land,FI20,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,137.15,Rate
land,FI20,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,104.73,Rate
land,FI20,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,117.3,Rate
land,FI20,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,93.19,Rate
land,FI20,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,90.91,Rate
land,FI20,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,62.1,Rate
land,FI20,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.23,Rate
land,FI20,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.26,Rate
land,FI20,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.73,Rate
land,FI20,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.96,Rate
land,FI20,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.07,Rate
land,FI20,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.27,Rate
land,FI20,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.35,Rate
land,FI20,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",7.51,Rate
land,FI20,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",8.66,Rate
land,FI20,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
land,FI20,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",7.91,Rate
land,FI20,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",7.93,Rate
land,FI20,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",13.95,Rate
land,FI20,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",15.13,Rate
land,FI20,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",7.27,Rate
land,FI20,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",15.28,Rate
land,FI20,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
land,FI20,Less than 65 years,Females,2012,Malignant melanoma of skin,17.46,Rate
land,FI20,Less than 65 years,Females,2014,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Females,2017,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Females,2011,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Females,2012,Malignant neoplasm of breast,22.82,Rate
land,FI20,Less than 65 years,Females,2013,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Malignant neoplasm of breast,16.08,Rate
land,FI20,Less than 65 years,Females,2016,Malignant neoplasm of breast,16.26,Rate
land,FI20,Less than 65 years,Females,2017,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Malignant neoplasm of breast,7.78,Rate
land,FI20,Less than 65 years,Females,2019,Malignant neoplasm of breast,7.35,Rate
land,FI20,Less than 65 years,Females,2020,Malignant neoplasm of breast,16.32,Rate
land,FI20,Less than 65 years,Females,2011,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Diabetes mellitus,6.96,Rate
land,FI20,Less than 65 years,Females,2016,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Females,2019,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Females,2020,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),7.76,Rate
land,FI20,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
land,FI20,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2016,Other ischaemic heart diseases,6.98,Rate
land,FI20,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Other ischaemic heart diseases,8.03,Rate
land,FI20,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,8.73,Rate
land,FI20,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Females,2011,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2012,Cerebrovascular diseases,7.26,Rate
land,FI20,Less than 65 years,Females,2013,Cerebrovascular diseases,7.09,Rate
land,FI20,Less than 65 years,Females,2014,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Cerebrovascular diseases,6.96,Rate
land,FI20,Less than 65 years,Females,2016,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2017,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2019,Cerebrovascular diseases,15.85,Rate
land,FI20,Less than 65 years,Females,2020,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2011,Chronic lower respiratory diseases,7.23,Rate
land,FI20,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2016,Chronic lower respiratory diseases,6.98,Rate
land,FI20,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
land,FI20,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1174.14,Rate
land,FI20,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1301.56,Rate
land,FI20,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1225.19,Rate
land,FI20,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1046.58,Rate
land,FI20,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1197.67,Rate
land,FI20,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1253.57,Rate
land,FI20,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,886.11,Rate
land,FI20,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1015.42,Rate
land,FI20,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,975.9,Rate
land,FI20,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1093.93,Rate
land,FI20,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.14,Rate
land,FI20,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",57.5,Rate
land,FI20,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.8,Rate
land,FI20,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.29,Rate
land,FI20,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.74,Rate
land,FI20,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.19,Rate
land,FI20,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.05,Rate
land,FI20,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.0,Rate
land,FI20,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.44,Rate
land,FI20,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",54.4,Rate
land,FI20,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",40.01,Rate
land,FI20,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",30.97,Rate
land,FI20,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",88.24,Rate
land,FI20,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",63.39,Rate
land,FI20,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",72.09,Rate
land,FI20,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",44.09,Rate
land,FI20,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",39.32,Rate
land,FI20,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",29.73,Rate
land,FI20,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",74.05,Rate
land,FI20,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",36.45,Rate
land,FI20,Total,Males,2011,Malignant melanoma of skin,9.17,Rate
land,FI20,Total,Males,2013,Malignant melanoma of skin,5.64,Rate
land,FI20,Total,Males,2015,Malignant melanoma of skin,20.37,Rate
land,FI20,Total,Males,2018,Malignant melanoma of skin,5.56,Rate
land,FI20,Total,Males,2019,Malignant melanoma of skin,13.97,Rate
land,FI20,Total,Males,2012,Diabetes mellitus,9.36,Rate
land,FI20,Total,Males,2013,Diabetes mellitus,13.09,Rate
land,FI20,Total,Males,2014,Diabetes mellitus,14.39,Rate
land,FI20,Total,Males,2017,Diabetes mellitus,5.91,Rate
land,FI20,Total,Males,2018,Diabetes mellitus,7.27,Rate
land,FI20,Total,Males,2019,Diabetes mellitus,6.29,Rate
land,FI20,Total,Males,2020,Diabetes mellitus,6.99,Rate
land,FI20,Total,Males,2011,Mental and behavioural disorders (F00-F99),34.55,Rate
land,FI20,Total,Males,2012,Mental and behavioural disorders (F00-F99),26.32,Rate
land,FI20,Total,Males,2013,Mental and behavioural disorders (F00-F99),84.17,Rate
land,FI20,Total,Males,2014,Mental and behavioural disorders (F00-F99),32.27,Rate
land,FI20,Total,Males,2016,Mental and behavioural disorders (F00-F99),15.7,Rate
land,FI20,Total,Males,2017,Mental and behavioural disorders (F00-F99),25.16,Rate
land,FI20,Total,Males,2018,Mental and behavioural disorders (F00-F99),28.54,Rate
land,FI20,Total,Males,2019,Mental and behavioural disorders (F00-F99),24.09,Rate
land,FI20,Total,Males,2020,Mental and behavioural disorders (F00-F99),62.43,Rate
land,FI20,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),7.77,Rate
land,FI20,Total,Males,2011,Other ischaemic heart diseases,129.54,Rate
land,FI20,Total,Males,2012,Other ischaemic heart diseases,43.41,Rate
land,FI20,Total,Males,2013,Other ischaemic heart diseases,75.37,Rate
land,FI20,Total,Males,2014,Other ischaemic heart diseases,64.8,Rate
land,FI20,Total,Males,2015,Other ischaemic heart diseases,124.21,Rate
land,FI20,Total,Males,2016,Other ischaemic heart diseases,124.79,Rate
land,FI20,Total,Males,2017,Other ischaemic heart diseases,113.47,Rate
land,FI20,Total,Males,2018,Other ischaemic heart diseases,127.53,Rate
land,FI20,Total,Males,2019,Other ischaemic heart diseases,121.18,Rate
land,FI20,Total,Males,2020,Other ischaemic heart diseases,95.94,Rate
land,FI20,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,137.11,Rate
land,FI20,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,165.66,Rate
land,FI20,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,139.97,Rate
land,FI20,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,150.31,Rate
land,FI20,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,238.59,Rate
land,FI20,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,160.17,Rate
land,FI20,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,103.62,Rate
land,FI20,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,47.86,Rate
land,FI20,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,78.28,Rate
land,FI20,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,103.9,Rate
land,FI20,Total,Males,2011,Cerebrovascular diseases,71.84,Rate
land,FI20,Total,Males,2012,Cerebrovascular diseases,84.87,Rate
land,FI20,Total,Males,2013,Cerebrovascular diseases,61.37,Rate
land,FI20,Total,Males,2014,Cerebrovascular diseases,162.05,Rate
land,FI20,Total,Males,2015,Cerebrovascular diseases,101.3,Rate
land,FI20,Total,Males,2016,Cerebrovascular diseases,94.53,Rate
land,FI20,Total,Males,2017,Cerebrovascular diseases,69.26,Rate
land,FI20,Total,Males,2018,Cerebrovascular diseases,97.74,Rate
land,FI20,Total,Males,2019,Cerebrovascular diseases,77.66,Rate
land,FI20,Total,Males,2020,Cerebrovascular diseases,74.44,Rate
land,FI20,Total,Males,2011,Chronic lower respiratory diseases,49.74,Rate
land,FI20,Total,Males,2012,Chronic lower respiratory diseases,16.63,Rate
land,FI20,Total,Males,2013,Chronic lower respiratory diseases,50.0,Rate
land,FI20,Total,Males,2014,Chronic lower respiratory diseases,51.95,Rate
land,FI20,Total,Males,2015,Chronic lower respiratory diseases,53.82,Rate
land,FI20,Total,Males,2016,Chronic lower respiratory diseases,26.93,Rate
land,FI20,Total,Males,2017,Chronic lower respiratory diseases,26.26,Rate
land,FI20,Total,Males,2018,Chronic lower respiratory diseases,52.66,Rate
land,FI20,Total,Males,2019,Chronic lower respiratory diseases,57.12,Rate
land,FI20,Total,Males,2020,Chronic lower respiratory diseases,42.75,Rate
land,FI20,Total,Males,2013,Asthma and status asthmaticus,8.31,Rate
land,FI20,Total,Males,2019,Asthma and status asthmaticus,7.21,Rate
land,FI20,Total,Males,2020,Asthma and status asthmaticus,6.99,Rate
land,FI20,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5266.8,Rate
land,FI20,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5413.61,Rate
land,FI20,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5490.61,Rate
land,FI20,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4632.21,Rate
land,FI20,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5505.65,Rate
land,FI20,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5454.23,Rate
land,FI20,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,3784.18,Rate
land,FI20,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4410.24,Rate
land,FI20,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4448.6,Rate
land,FI20,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4770.46,Rate
land,FI20,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",198.6,Rate
land,FI20,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",229.08,Rate
land,FI20,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.92,Rate
land,FI20,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.59,Rate
land,FI20,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",260.22,Rate
land,FI20,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.44,Rate
land,FI20,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.2,Rate
land,FI20,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",128.21,Rate
land,FI20,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",191.98,Rate
land,FI20,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",242.72,Rate
land,FI20,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",166.64,Rate
land,FI20,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",127.65,Rate
land,FI20,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",342.32,Rate
land,FI20,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",182.29,Rate
land,FI20,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",338.26,Rate
land,FI20,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",226.08,Rate
land,FI20,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",97.47,Rate
land,FI20,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",117.69,Rate
land,FI20,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",345.24,Rate
land,FI20,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",186.92,Rate
land,FI20,65 years or over,Males,2011,Malignant melanoma of skin,47.05,Rate
land,FI20,65 years or over,Males,2013,Malignant melanoma of skin,28.93,Rate
land,FI20,65 years or over,Males,2015,Malignant melanoma of skin,33.83,Rate
land,FI20,65 years or over,Males,2018,Malignant melanoma of skin,28.51,Rate
land,FI20,65 years or over,Males,2019,Malignant melanoma of skin,0.0,Rate
land,FI20,65 years or over,Males,2012,Diabetes mellitus,47.98,Rate
land,FI20,65 years or over,Males,2013,Diabetes mellitus,28.93,Rate
land,FI20,65 years or over,Males,2014,Diabetes mellitus,40.83,Rate
land,FI20,65 years or over,Males,2017,Diabetes mellitus,30.31,Rate
land,FI20,65 years or over,Males,2018,Diabetes mellitus,37.27,Rate
land,FI20,65 years or over,Males,2019,Diabetes mellitus,32.28,Rate
land,FI20,65 years or over,Males,2020,Diabetes mellitus,35.86,Rate
land,FI20,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),147.11,Rate
land,FI20,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),134.95,Rate
land,FI20,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),364.8,Rate
land,FI20,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),127.96,Rate
land,FI20,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),80.53,Rate
land,FI20,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),129.04,Rate
land,FI20,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),113.1,Rate
land,FI20,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),123.53,Rate
land,FI20,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),320.15,Rate
land,FI20,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),39.86,Rate
land,FI20,65 years or over,Males,2011,Other ischaemic heart diseases,664.3,Rate
land,FI20,65 years or over,Males,2012,Other ischaemic heart diseases,222.64,Rate
land,FI20,65 years or over,Males,2013,Other ischaemic heart diseases,386.5,Rate
land,FI20,65 years or over,Males,2014,Other ischaemic heart diseases,300.75,Rate
land,FI20,65 years or over,Males,2015,Other ischaemic heart diseases,600.8,Rate
land,FI20,65 years or over,Males,2016,Other ischaemic heart diseases,498.56,Rate
land,FI20,65 years or over,Males,2017,Other ischaemic heart diseases,514.21,Rate
land,FI20,65 years or over,Males,2018,Other ischaemic heart diseases,620.74,Rate
land,FI20,65 years or over,Males,2019,Other ischaemic heart diseases,621.41,Rate
land,FI20,65 years or over,Males,2020,Other ischaemic heart diseases,390.01,Rate
land,FI20,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,634.27,Rate
land,FI20,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,684.18,Rate
land,FI20,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,619.25,Rate
land,FI20,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,770.84,Rate
land,FI20,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,1088.25,Rate
land,FI20,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,821.37,Rate
land,FI20,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,531.38,Rate
land,FI20,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,212.19,Rate
land,FI20,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,368.19,Rate
land,FI20,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,464.98,Rate
land,FI20,65 years or over,Males,2011,Cerebrovascular diseases,274.69,Rate
land,FI20,65 years or over,Males,2012,Cerebrovascular diseases,435.23,Rate
land,FI20,65 years or over,Males,2013,Cerebrovascular diseases,275.85,Rate
land,FI20,65 years or over,Males,2014,Cerebrovascular diseases,794.82,Rate
land,FI20,65 years or over,Males,2015,Cerebrovascular diseases,519.49,Rate
land,FI20,65 years or over,Males,2016,Cerebrovascular diseases,385.26,Rate
land,FI20,65 years or over,Males,2017,Cerebrovascular diseases,355.18,Rate
land,FI20,65 years or over,Males,2018,Cerebrovascular diseases,466.42,Rate
land,FI20,65 years or over,Males,2019,Cerebrovascular diseases,398.23,Rate
land,FI20,65 years or over,Males,2020,Cerebrovascular diseases,381.76,Rate
land,FI20,65 years or over,Males,2011,Chronic lower respiratory diseases,221.48,Rate
land,FI20,65 years or over,Males,2012,Chronic lower respiratory diseases,85.27,Rate
land,FI20,65 years or over,Males,2013,Chronic lower respiratory diseases,256.39,Rate
land,FI20,65 years or over,Males,2014,Chronic lower respiratory diseases,266.4,Rate
land,FI20,65 years or over,Males,2015,Chronic lower respiratory diseases,275.99,Rate
land,FI20,65 years or over,Males,2016,Chronic lower respiratory diseases,138.09,Rate
land,FI20,65 years or over,Males,2017,Chronic lower respiratory diseases,134.69,Rate
land,FI20,65 years or over,Males,2018,Chronic lower respiratory diseases,236.79,Rate
land,FI20,65 years or over,Males,2019,Chronic lower respiratory diseases,292.91,Rate
land,FI20,65 years or over,Males,2020,Chronic lower respiratory diseases,219.24,Rate
land,FI20,65 years or over,Males,2013,Asthma and status asthmaticus,42.62,Rate
land,FI20,65 years or over,Males,2019,Asthma and status asthmaticus,36.98,Rate
land,FI20,65 years or over,Males,2020,Asthma and status asthmaticus,35.86,Rate
land,FI20,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,182.75,Rate
land,FI20,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,305.48,Rate
land,FI20,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,191.95,Rate
land,FI20,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,178.01,Rate
land,FI20,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,154.12,Rate
land,FI20,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,236.02,Rate
land,FI20,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,184.09,Rate
land,FI20,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,193.07,Rate
land,FI20,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,134.69,Rate
land,FI20,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,203.34,Rate
land,FI20,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.42,Rate
land,FI20,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.93,Rate
land,FI20,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.86,Rate
land,FI20,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.6,Rate
land,FI20,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.78,Rate
land,FI20,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",9.34,Rate
land,FI20,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",7.55,Rate
land,FI20,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",26.69,Rate
land,FI20,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",34.59,Rate
land,FI20,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",7.62,Rate
land,FI20,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
land,FI20,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",25.23,Rate
land,FI20,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",8.43,Rate
land,FI20,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",8.36,Rate
land,FI20,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
land,FI20,Less than 65 years,Males,2011,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Males,2015,Malignant melanoma of skin,17.1,Rate
land,FI20,Less than 65 years,Males,2018,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Males,2019,Malignant melanoma of skin,17.36,Rate
land,FI20,Less than 65 years,Males,2012,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Diabetes mellitus,9.25,Rate
land,FI20,Less than 65 years,Males,2014,Diabetes mellitus,7.99,Rate
land,FI20,Less than 65 years,Males,2017,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Males,2018,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Males,2019,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Males,2020,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),7.29,Rate
land,FI20,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),16.19,Rate
land,FI20,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),9.09,Rate
land,FI20,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),8.06,Rate
land,FI20,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
land,FI20,Less than 65 years,Males,2011,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2012,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2014,Other ischaemic heart diseases,7.65,Rate
land,FI20,Less than 65 years,Males,2015,Other ischaemic heart diseases,8.77,Rate
land,FI20,Less than 65 years,Males,2016,Other ischaemic heart diseases,34.24,Rate
land,FI20,Less than 65 years,Males,2017,Other ischaemic heart diseases,16.4,Rate
land,FI20,Less than 65 years,Males,2018,Other ischaemic heart diseases,8.06,Rate
land,FI20,Less than 65 years,Males,2019,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2020,Other ischaemic heart diseases,24.71,Rate
land,FI20,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,16.68,Rate
land,FI20,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,40.05,Rate
land,FI20,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,23.87,Rate
land,FI20,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,32.77,Rate
land,FI20,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,8.06,Rate
land,FI20,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.06,Rate
land,FI20,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,16.44,Rate
land,FI20,Less than 65 years,Males,2011,Cerebrovascular diseases,22.71,Rate
land,FI20,Less than 65 years,Males,2012,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Cerebrovascular diseases,9.42,Rate
land,FI20,Less than 65 years,Males,2014,Cerebrovascular diseases,8.77,Rate
land,FI20,Less than 65 years,Males,2015,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2016,Cerebrovascular diseases,24.1,Rate
land,FI20,Less than 65 years,Males,2017,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2018,Cerebrovascular diseases,8.43,Rate
land,FI20,Less than 65 years,Males,2019,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2020,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2011,Chronic lower respiratory diseases,8.14,Rate
land,FI20,Less than 65 years,Males,2012,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2015,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2016,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2017,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2018,Chronic lower respiratory diseases,8.06,Rate
land,FI20,Less than 65 years,Males,2019,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
land,FI20,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,975.04,Rate
land,FI20,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1161.26,Rate
land,FI20,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,943.52,Rate
land,FI20,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,870.96,Rate
land,FI20,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,951.34,Rate
land,FI20,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,985.08,Rate
land,FI20,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,761.96,Rate
land,FI20,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,848.99,Rate
land,FI20,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,802.46,Rate
land,FI20,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,864.3,Rate
land,FI20,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",44.59,Rate
land,FI20,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.8,Rate
land,FI20,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.82,Rate
land,FI20,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.5,Rate
land,FI20,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.19,Rate
land,FI20,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.61,Rate
land,FI20,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.14,Rate
land,FI20,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.7,Rate
land,FI20,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.95,Rate
land,FI20,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.6,Rate
land,FI20,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",37.2,Rate
land,FI20,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",41.44,Rate
land,FI20,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",49.27,Rate
land,FI20,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",43.53,Rate
land,FI20,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",39.8,Rate
land,FI20,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",49.19,Rate
land,FI20,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",31.47,Rate
land,FI20,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",33.58,Rate
land,FI20,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",59.31,Rate
land,FI20,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",54.36,Rate
land,FI20,Total,Total,2011,Malignant melanoma of skin,3.07,Rate
land,FI20,Total,Total,2012,Malignant melanoma of skin,7.04,Rate
land,FI20,Total,Total,2013,Malignant melanoma of skin,2.87,Rate
land,FI20,Total,Total,2014,Malignant melanoma of skin,6.59,Rate
land,FI20,Total,Total,2015,Malignant melanoma of skin,10.11,Rate
land,FI20,Total,Total,2017,Malignant melanoma of skin,2.94,Rate
land,FI20,Total,Total,2018,Malignant melanoma of skin,5.6,Rate
land,FI20,Total,Total,2019,Malignant melanoma of skin,10.15,Rate
land,FI20,Total,Total,2011,Malignant neoplasm of breast,3.57,Rate
land,FI20,Total,Total,2012,Malignant neoplasm of breast,28.57,Rate
land,FI20,Total,Total,2013,Malignant neoplasm of breast,11.22,Rate
land,FI20,Total,Total,2014,Malignant neoplasm of breast,3.7,Rate
land,FI20,Total,Total,2015,Malignant neoplasm of breast,10.42,Rate
land,FI20,Total,Total,2016,Malignant neoplasm of breast,16.03,Rate
land,FI20,Total,Total,2017,Malignant neoplasm of breast,19.33,Rate
land,FI20,Total,Total,2018,Malignant neoplasm of breast,10.07,Rate
land,FI20,Total,Total,2019,Malignant neoplasm of breast,5.97,Rate
land,FI20,Total,Total,2020,Malignant neoplasm of breast,12.57,Rate
land,FI20,Total,Total,2011,Diabetes mellitus,10.34,Rate
land,FI20,Total,Total,2012,Diabetes mellitus,4.26,Rate
land,FI20,Total,Total,2013,Diabetes mellitus,6.58,Rate
land,FI20,Total,Total,2014,Diabetes mellitus,9.72,Rate
land,FI20,Total,Total,2015,Diabetes mellitus,9.35,Rate
land,FI20,Total,Total,2016,Diabetes mellitus,3.64,Rate
land,FI20,Total,Total,2017,Diabetes mellitus,2.94,Rate
land,FI20,Total,Total,2018,Diabetes mellitus,3.14,Rate
land,FI20,Total,Total,2019,Diabetes mellitus,6.28,Rate
land,FI20,Total,Total,2020,Diabetes mellitus,11.13,Rate
land,FI20,Total,Total,2011,Mental and behavioural disorders (F00-F99),27.54,Rate
land,FI20,Total,Total,2012,Mental and behavioural disorders (F00-F99),32.75,Rate
land,FI20,Total,Total,2013,Mental and behavioural disorders (F00-F99),41.93,Rate
land,FI20,Total,Total,2014,Mental and behavioural disorders (F00-F99),29.15,Rate
land,FI20,Total,Total,2015,Mental and behavioural disorders (F00-F99),10.6,Rate
land,FI20,Total,Total,2016,Mental and behavioural disorders (F00-F99),29.61,Rate
land,FI20,Total,Total,2017,Mental and behavioural disorders (F00-F99),26.63,Rate
land,FI20,Total,Total,2018,Mental and behavioural disorders (F00-F99),18.54,Rate
land,FI20,Total,Total,2019,Mental and behavioural disorders (F00-F99),40.05,Rate
land,FI20,Total,Total,2020,Mental and behavioural disorders (F00-F99),50.97,Rate
land,FI20,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),4.06,Rate
land,FI20,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.18,Rate
land,FI20,Total,Total,2011,Other ischaemic heart diseases,83.44,Rate
land,FI20,Total,Total,2012,Other ischaemic heart diseases,55.39,Rate
land,FI20,Total,Total,2013,Other ischaemic heart diseases,43.28,Rate
land,FI20,Total,Total,2014,Other ischaemic heart diseases,61.98,Rate
land,FI20,Total,Total,2015,Other ischaemic heart diseases,57.37,Rate
land,FI20,Total,Total,2016,Other ischaemic heart diseases,83.98,Rate
land,FI20,Total,Total,2017,Other ischaemic heart diseases,76.84,Rate
land,FI20,Total,Total,2018,Other ischaemic heart diseases,86.15,Rate
land,FI20,Total,Total,2019,Other ischaemic heart diseases,74.04,Rate
land,FI20,Total,Total,2020,Other ischaemic heart diseases,54.18,Rate
land,FI20,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,115.77,Rate
land,FI20,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,135.89,Rate
land,FI20,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,103.21,Rate
land,FI20,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,105.08,Rate
land,FI20,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,144.54,Rate
land,FI20,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,124.05,Rate
land,FI20,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,74.51,Rate
land,FI20,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,53.87,Rate
land,FI20,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,69.96,Rate
land,FI20,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,60.39,Rate
land,FI20,Total,Total,2011,Cerebrovascular diseases,68.1,Rate
land,FI20,Total,Total,2012,Cerebrovascular diseases,80.73,Rate
land,FI20,Total,Total,2013,Cerebrovascular diseases,83.16,Rate
land,FI20,Total,Total,2014,Cerebrovascular diseases,83.87,Rate
land,FI20,Total,Total,2015,Cerebrovascular diseases,93.13,Rate
land,FI20,Total,Total,2016,Cerebrovascular diseases,99.51,Rate
land,FI20,Total,Total,2017,Cerebrovascular diseases,81.67,Rate
land,FI20,Total,Total,2018,Cerebrovascular diseases,56.24,Rate
land,FI20,Total,Total,2019,Cerebrovascular diseases,70.23,Rate
land,FI20,Total,Total,2020,Cerebrovascular diseases,70.89,Rate
land,FI20,Total,Total,2011,Chronic lower respiratory diseases,28.03,Rate
land,FI20,Total,Total,2012,Chronic lower respiratory diseases,25.76,Rate
land,FI20,Total,Total,2013,Chronic lower respiratory diseases,48.75,Rate
land,FI20,Total,Total,2014,Chronic lower respiratory diseases,43.79,Rate
land,FI20,Total,Total,2015,Chronic lower respiratory diseases,40.29,Rate
land,FI20,Total,Total,2016,Chronic lower respiratory diseases,18.65,Rate
land,FI20,Total,Total,2017,Chronic lower respiratory diseases,13.15,Rate
land,FI20,Total,Total,2018,Chronic lower respiratory diseases,43.21,Rate
land,FI20,Total,Total,2019,Chronic lower respiratory diseases,33.7,Rate
land,FI20,Total,Total,2020,Chronic lower respiratory diseases,30.11,Rate
land,FI20,Total,Total,2013,Asthma and status asthmaticus,6.82,Rate
land,FI20,Total,Total,2014,Asthma and status asthmaticus,3.83,Rate
land,FI20,Total,Total,2015,Asthma and status asthmaticus,6.49,Rate
land,FI20,Total,Total,2018,Asthma and status asthmaticus,3.14,Rate
land,FI20,Total,Total,2019,Asthma and status asthmaticus,2.95,Rate
land,FI20,Total,Total,2020,Asthma and status asthmaticus,3.0,Rate
land,FI20,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4409.91,Rate
land,FI20,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,5085.7,Rate
land,FI20,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4374.24,Rate
land,FI20,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3880.08,Rate
land,FI20,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4278.12,Rate
land,FI20,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4351.59,Rate
land,FI20,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3287.47,Rate
land,FI20,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3772.8,Rate
land,FI20,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3647.13,Rate
land,FI20,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,3891.3,Rate
land,FI20,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",182.56,Rate
land,FI20,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",217.84,Rate
land,FI20,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.87,Rate
land,FI20,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.24,Rate
land,FI20,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",170.57,Rate
land,FI20,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.98,Rate
land,FI20,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",135.89,Rate
land,FI20,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.01,Rate
land,FI20,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",193.87,Rate
land,FI20,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",159.09,Rate
land,FI20,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",156.23,Rate
land,FI20,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",178.85,Rate
land,FI20,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",199.03,Rate
land,FI20,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",137.68,Rate
land,FI20,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",171.87,Rate
land,FI20,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",222.06,Rate
land,FI20,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",77.95,Rate
land,FI20,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",139.46,Rate
land,FI20,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",254.99,Rate
land,FI20,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",278.76,Rate
land,FI20,65 years or over,Total,2011,Malignant melanoma of skin,15.73,Rate
land,FI20,65 years or over,Total,2012,Malignant melanoma of skin,0.0,Rate
land,FI20,65 years or over,Total,2013,Malignant melanoma of skin,14.71,Rate
land,FI20,65 years or over,Total,2014,Malignant melanoma of skin,33.8,Rate
land,FI20,65 years or over,Total,2015,Malignant melanoma of skin,17.66,Rate
land,FI20,65 years or over,Total,2017,Malignant melanoma of skin,15.08,Rate
land,FI20,65 years or over,Total,2018,Malignant melanoma of skin,28.71,Rate
land,FI20,65 years or over,Total,2019,Malignant melanoma of skin,16.22,Rate
land,FI20,65 years or over,Total,2011,Malignant neoplasm of breast,18.33,Rate
land,FI20,65 years or over,Total,2012,Malignant neoplasm of breast,98.72,Rate
land,FI20,65 years or over,Total,2013,Malignant neoplasm of breast,57.54,Rate
land,FI20,65 years or over,Total,2014,Malignant neoplasm of breast,18.96,Rate
land,FI20,65 years or over,Total,2015,Malignant neoplasm of breast,19.22,Rate
land,FI20,65 years or over,Total,2016,Malignant neoplasm of breast,47.72,Rate
land,FI20,65 years or over,Total,2017,Malignant neoplasm of breast,99.11,Rate
land,FI20,65 years or over,Total,2018,Malignant neoplasm of breast,35.22,Rate
land,FI20,65 years or over,Total,2019,Malignant neoplasm of breast,14.45,Rate
land,FI20,65 years or over,Total,2020,Malignant neoplasm of breast,29.95,Rate
land,FI20,65 years or over,Total,2011,Diabetes mellitus,53.04,Rate
land,FI20,65 years or over,Total,2012,Diabetes mellitus,21.82,Rate
land,FI20,65 years or over,Total,2013,Diabetes mellitus,14.71,Rate
land,FI20,65 years or over,Total,2014,Diabetes mellitus,33.12,Rate
land,FI20,65 years or over,Total,2015,Diabetes mellitus,32.96,Rate
land,FI20,65 years or over,Total,2016,Diabetes mellitus,18.65,Rate
land,FI20,65 years or over,Total,2017,Diabetes mellitus,15.08,Rate
land,FI20,65 years or over,Total,2018,Diabetes mellitus,16.09,Rate
land,FI20,65 years or over,Total,2019,Diabetes mellitus,32.19,Rate
land,FI20,65 years or over,Total,2020,Diabetes mellitus,57.1,Rate
land,FI20,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),126.26,Rate
land,FI20,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),167.94,Rate
land,FI20,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),166.3,Rate
land,FI20,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),131.1,Rate
land,FI20,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),54.36,Rate
land,FI20,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),151.83,Rate
land,FI20,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),136.57,Rate
land,FI20,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),79.32,Rate
land,FI20,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),205.38,Rate
land,FI20,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),261.37,Rate
land,FI20,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),20.83,Rate
land,FI20,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),16.33,Rate
land,FI20,65 years or over,Total,2011,Other ischaemic heart diseases,427.92,Rate
land,FI20,65 years or over,Total,2012,Other ischaemic heart diseases,284.03,Rate
land,FI20,65 years or over,Total,2013,Other ischaemic heart diseases,221.93,Rate
land,FI20,65 years or over,Total,2014,Other ischaemic heart diseases,302.81,Rate
land,FI20,65 years or over,Total,2015,Other ischaemic heart diseases,277.04,Rate
land,FI20,65 years or over,Total,2016,Other ischaemic heart diseases,345.44,Rate
land,FI20,65 years or over,Total,2017,Other ischaemic heart diseases,361.56,Rate
land,FI20,65 years or over,Total,2018,Other ischaemic heart diseases,409.06,Rate
land,FI20,65 years or over,Total,2019,Other ischaemic heart diseases,379.72,Rate
land,FI20,65 years or over,Total,2020,Other ischaemic heart diseases,228.81,Rate
land,FI20,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,559.79,Rate
land,FI20,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,616.32,Rate
land,FI20,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,482.08,Rate
land,FI20,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,520.48,Rate
land,FI20,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,676.82,Rate
land,FI20,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,636.18,Rate
land,FI20,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,382.08,Rate
land,FI20,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,260.47,Rate
land,FI20,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,342.36,Rate
land,FI20,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,276.42,Rate
land,FI20,65 years or over,Total,2011,Cerebrovascular diseases,303.15,Rate
land,FI20,65 years or over,Total,2012,Cerebrovascular diseases,398.74,Rate
land,FI20,65 years or over,Total,2013,Cerebrovascular diseases,391.27,Rate
land,FI20,65 years or over,Total,2014,Cerebrovascular diseases,412.98,Rate
land,FI20,65 years or over,Total,2015,Cerebrovascular diseases,462.58,Rate
land,FI20,65 years or over,Total,2016,Cerebrovascular diseases,462.94,Rate
land,FI20,65 years or over,Total,2017,Cerebrovascular diseases,418.82,Rate
land,FI20,65 years or over,Total,2018,Cerebrovascular diseases,271.42,Rate
land,FI20,65 years or over,Total,2019,Cerebrovascular diseases,326.49,Rate
land,FI20,65 years or over,Total,2020,Cerebrovascular diseases,363.56,Rate
land,FI20,65 years or over,Total,2011,Chronic lower respiratory diseases,112.64,Rate
land,FI20,65 years or over,Total,2012,Chronic lower respiratory diseases,132.08,Rate
land,FI20,65 years or over,Total,2013,Chronic lower respiratory diseases,249.99,Rate
land,FI20,65 years or over,Total,2014,Chronic lower respiratory diseases,224.57,Rate
land,FI20,65 years or over,Total,2015,Chronic lower respiratory diseases,206.62,Rate
land,FI20,65 years or over,Total,2016,Chronic lower respiratory diseases,80.53,Rate
land,FI20,65 years or over,Total,2017,Chronic lower respiratory diseases,67.46,Rate
land,FI20,65 years or over,Total,2018,Chronic lower respiratory diseases,205.84,Rate
land,FI20,65 years or over,Total,2019,Chronic lower respiratory diseases,172.81,Rate
land,FI20,65 years or over,Total,2020,Chronic lower respiratory diseases,154.42,Rate
land,FI20,65 years or over,Total,2013,Asthma and status asthmaticus,34.95,Rate
land,FI20,65 years or over,Total,2014,Asthma and status asthmaticus,19.63,Rate
land,FI20,65 years or over,Total,2015,Asthma and status asthmaticus,33.28,Rate
land,FI20,65 years or over,Total,2018,Asthma and status asthmaticus,16.09,Rate
land,FI20,65 years or over,Total,2019,Asthma and status asthmaticus,15.14,Rate
land,FI20,65 years or over,Total,2020,Asthma and status asthmaticus,15.39,Rate
land,FI20,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,142.99,Rate
land,FI20,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,210.62,Rate
land,FI20,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,112.47,Rate
land,FI20,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,142.04,Rate
land,FI20,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,145.48,Rate
land,FI20,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,169.59,Rate
land,FI20,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,150.19,Rate
land,FI20,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,140.73,Rate
land,FI20,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,113.38,Rate
land,FI20,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,131.05,Rate
land,FI20,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.16,Rate
land,FI20,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.57,Rate
land,FI20,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.06,Rate
land,FI20,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.64,Rate
land,FI20,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",0.0,Rate
land,FI20,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.25,Rate
land,FI20,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.82,Rate
land,FI20,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.91,Rate
land,FI20,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.45,Rate
land,FI20,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",8.37,Rate
land,FI20,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",8.16,Rate
land,FI20,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",12.99,Rate
land,FI20,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.72,Rate
land,FI20,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",7.8,Rate
land,FI20,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",7.31,Rate
land,FI20,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",20.21,Rate
land,FI20,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",7.93,Rate
land,FI20,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",11.9,Rate
land,FI20,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",0.0,Rate
land,FI20,Less than 65 years,Total,2011,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Total,2012,Malignant melanoma of skin,8.75,Rate
land,FI20,Less than 65 years,Total,2013,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Total,2014,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Total,2015,Malignant melanoma of skin,8.28,Rate
land,FI20,Less than 65 years,Total,2017,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Malignant melanoma of skin,0.0,Rate
land,FI20,Less than 65 years,Total,2019,Malignant melanoma of skin,8.67,Rate
land,FI20,Less than 65 years,Total,2011,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Total,2012,Malignant neoplasm of breast,11.57,Rate
land,FI20,Less than 65 years,Total,2013,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Total,2014,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Total,2015,Malignant neoplasm of breast,8.28,Rate
land,FI20,Less than 65 years,Total,2016,Malignant neoplasm of breast,8.35,Rate
land,FI20,Less than 65 years,Total,2017,Malignant neoplasm of breast,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Malignant neoplasm of breast,3.98,Rate
land,FI20,Less than 65 years,Total,2019,Malignant neoplasm of breast,3.91,Rate
land,FI20,Less than 65 years,Total,2020,Malignant neoplasm of breast,8.36,Rate
land,FI20,Less than 65 years,Total,2011,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2012,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2013,Diabetes mellitus,4.61,Rate
land,FI20,Less than 65 years,Total,2014,Diabetes mellitus,4.05,Rate
land,FI20,Less than 65 years,Total,2015,Diabetes mellitus,3.64,Rate
land,FI20,Less than 65 years,Total,2016,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2017,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2019,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2020,Diabetes mellitus,0.0,Rate
land,FI20,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),3.63,Rate
land,FI20,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),11.8,Rate
land,FI20,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.45,Rate
land,FI20,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),3.82,Rate
land,FI20,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
land,FI20,Less than 65 years,Total,2011,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2012,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2013,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2014,Other ischaemic heart diseases,3.65,Rate
land,FI20,Less than 65 years,Total,2015,Other ischaemic heart diseases,4.16,Rate
land,FI20,Less than 65 years,Total,2016,Other ischaemic heart diseases,20.65,Rate
land,FI20,Less than 65 years,Total,2017,Other ischaemic heart diseases,7.87,Rate
land,FI20,Less than 65 years,Total,2018,Other ischaemic heart diseases,7.93,Rate
land,FI20,Less than 65 years,Total,2019,Other ischaemic heart diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2020,Other ischaemic heart diseases,11.88,Rate
land,FI20,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.22,Rate
land,FI20,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,19.51,Rate
land,FI20,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,11.43,Rate
land,FI20,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,4.45,Rate
land,FI20,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,15.6,Rate
land,FI20,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,3.82,Rate
land,FI20,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,3.97,Rate
land,FI20,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,8.06,Rate
land,FI20,Less than 65 years,Total,2011,Cerebrovascular diseases,11.16,Rate
land,FI20,Less than 65 years,Total,2012,Cerebrovascular diseases,3.7,Rate
land,FI20,Less than 65 years,Total,2013,Cerebrovascular diseases,8.53,Rate
land,FI20,Less than 65 years,Total,2014,Cerebrovascular diseases,4.15,Rate
land,FI20,Less than 65 years,Total,2015,Cerebrovascular diseases,3.64,Rate
land,FI20,Less than 65 years,Total,2016,Cerebrovascular diseases,11.48,Rate
land,FI20,Less than 65 years,Total,2017,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Cerebrovascular diseases,4.11,Rate
land,FI20,Less than 65 years,Total,2019,Cerebrovascular diseases,8.16,Rate
land,FI20,Less than 65 years,Total,2020,Cerebrovascular diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2011,Chronic lower respiratory diseases,7.54,Rate
land,FI20,Less than 65 years,Total,2012,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2013,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2015,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.66,Rate
land,FI20,Less than 65 years,Total,2017,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.82,Rate
land,FI20,Less than 65 years,Total,2019,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.0,Rate
land,FI20,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
land,FI20,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Alsace,FRF1,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,712.0,Rate
Alsace,FRF1,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,728.12,Rate
Alsace,FRF1,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,732.46,Rate
Alsace,FRF1,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,677.5,Rate
Alsace,FRF1,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,728.49,Rate
Alsace,FRF1,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,686.67,Rate
Alsace,FRF1,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,670.77,Rate
Alsace,FRF1,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,688.28,Rate
Alsace,FRF1,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,655.69,Rate
Alsace,FRF1,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,759.15,Rate
Alsace,FRF1,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.77,Rate
Alsace,FRF1,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.83,Rate
Alsace,FRF1,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.94,Rate
Alsace,FRF1,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.13,Rate
Alsace,FRF1,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.37,Rate
Alsace,FRF1,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.34,Rate
Alsace,FRF1,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.01,Rate
Alsace,FRF1,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.81,Rate
Alsace,FRF1,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.49,Rate
Alsace,FRF1,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.69,Rate
Alsace,FRF1,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",21.22,Rate
Alsace,FRF1,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",24.98,Rate
Alsace,FRF1,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",23.85,Rate
Alsace,FRF1,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",28.54,Rate
Alsace,FRF1,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",25.97,Rate
Alsace,FRF1,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",26.61,Rate
Alsace,FRF1,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",27.61,Rate
Alsace,FRF1,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",27.52,Rate
Alsace,FRF1,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",31.06,Rate
Alsace,FRF1,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",26.7,Rate
Alsace,FRF1,Total,Females,2011,Malignant melanoma of skin,1.09,Rate
Alsace,FRF1,Total,Females,2012,Malignant melanoma of skin,2.62,Rate
Alsace,FRF1,Total,Females,2013,Malignant melanoma of skin,2.41,Rate
Alsace,FRF1,Total,Females,2014,Malignant melanoma of skin,1.57,Rate
Alsace,FRF1,Total,Females,2015,Malignant melanoma of skin,2.49,Rate
Alsace,FRF1,Total,Females,2016,Malignant melanoma of skin,2.61,Rate
Alsace,FRF1,Total,Females,2017,Malignant melanoma of skin,2.35,Rate
Alsace,FRF1,Total,Females,2018,Malignant melanoma of skin,2.54,Rate
Alsace,FRF1,Total,Females,2019,Malignant melanoma of skin,2.18,Rate
Alsace,FRF1,Total,Females,2020,Malignant melanoma of skin,1.47,Rate
Alsace,FRF1,Total,Females,2011,Malignant neoplasm of breast,31.06,Rate
Alsace,FRF1,Total,Females,2012,Malignant neoplasm of breast,34.36,Rate
Alsace,FRF1,Total,Females,2013,Malignant neoplasm of breast,32.69,Rate
Alsace,FRF1,Total,Females,2014,Malignant neoplasm of breast,31.26,Rate
Alsace,FRF1,Total,Females,2015,Malignant neoplasm of breast,32.23,Rate
Alsace,FRF1,Total,Females,2016,Malignant neoplasm of breast,29.79,Rate
Alsace,FRF1,Total,Females,2017,Malignant neoplasm of breast,33.6,Rate
Alsace,FRF1,Total,Females,2018,Malignant neoplasm of breast,29.0,Rate
Alsace,FRF1,Total,Females,2019,Malignant neoplasm of breast,32.86,Rate
Alsace,FRF1,Total,Females,2020,Malignant neoplasm of breast,32.24,Rate
Alsace,FRF1,Total,Females,2011,Diabetes mellitus,19.18,Rate
Alsace,FRF1,Total,Females,2012,Diabetes mellitus,18.84,Rate
Alsace,FRF1,Total,Females,2013,Diabetes mellitus,19.03,Rate
Alsace,FRF1,Total,Females,2014,Diabetes mellitus,17.46,Rate
Alsace,FRF1,Total,Females,2015,Diabetes mellitus,16.82,Rate
Alsace,FRF1,Total,Females,2016,Diabetes mellitus,16.42,Rate
Alsace,FRF1,Total,Females,2017,Diabetes mellitus,15.18,Rate
Alsace,FRF1,Total,Females,2018,Diabetes mellitus,16.55,Rate
Alsace,FRF1,Total,Females,2019,Diabetes mellitus,14.7,Rate
Alsace,FRF1,Total,Females,2020,Diabetes mellitus,13.16,Rate
Alsace,FRF1,Total,Females,2011,Mental and behavioural disorders (F00-F99),34.66,Rate
Alsace,FRF1,Total,Females,2012,Mental and behavioural disorders (F00-F99),36.69,Rate
Alsace,FRF1,Total,Females,2013,Mental and behavioural disorders (F00-F99),37.34,Rate
Alsace,FRF1,Total,Females,2014,Mental and behavioural disorders (F00-F99),35.67,Rate
Alsace,FRF1,Total,Females,2015,Mental and behavioural disorders (F00-F99),40.03,Rate
Alsace,FRF1,Total,Females,2016,Mental and behavioural disorders (F00-F99),38.03,Rate
Alsace,FRF1,Total,Females,2017,Mental and behavioural disorders (F00-F99),35.53,Rate
Alsace,FRF1,Total,Females,2018,Mental and behavioural disorders (F00-F99),41.31,Rate
Alsace,FRF1,Total,Females,2019,Mental and behavioural disorders (F00-F99),39.15,Rate
Alsace,FRF1,Total,Females,2020,Mental and behavioural disorders (F00-F99),34.31,Rate
Alsace,FRF1,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),4.64,Rate
Alsace,FRF1,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),5.3,Rate
Alsace,FRF1,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),4.3,Rate
Alsace,FRF1,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),5.08,Rate
Alsace,FRF1,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),6.0,Rate
Alsace,FRF1,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),4.76,Rate
Alsace,FRF1,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),5.94,Rate
Alsace,FRF1,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),6.68,Rate
Alsace,FRF1,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),7.59,Rate
Alsace,FRF1,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),5.64,Rate
Alsace,FRF1,Total,Females,2011,Other ischaemic heart diseases,28.57,Rate
Alsace,FRF1,Total,Females,2012,Other ischaemic heart diseases,25.44,Rate
Alsace,FRF1,Total,Females,2013,Other ischaemic heart diseases,24.71,Rate
Alsace,FRF1,Total,Females,2014,Other ischaemic heart diseases,24.76,Rate
Alsace,FRF1,Total,Females,2015,Other ischaemic heart diseases,23.53,Rate
Alsace,FRF1,Total,Females,2016,Other ischaemic heart diseases,22.22,Rate
Alsace,FRF1,Total,Females,2017,Other ischaemic heart diseases,19.89,Rate
Alsace,FRF1,Total,Females,2018,Other ischaemic heart diseases,21.68,Rate
Alsace,FRF1,Total,Females,2019,Other ischaemic heart diseases,20.37,Rate
Alsace,FRF1,Total,Females,2020,Other ischaemic heart diseases,19.14,Rate
Alsace,FRF1,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,16.73,Rate
Alsace,FRF1,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,16.08,Rate
Alsace,FRF1,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,15.71,Rate
Alsace,FRF1,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,14.17,Rate
Alsace,FRF1,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,13.51,Rate
Alsace,FRF1,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,12.98,Rate
Alsace,FRF1,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,11.78,Rate
Alsace,FRF1,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,11.21,Rate
Alsace,FRF1,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,9.54,Rate
Alsace,FRF1,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,9.76,Rate
Alsace,FRF1,Total,Females,2011,Cerebrovascular diseases,50.92,Rate
Alsace,FRF1,Total,Females,2012,Cerebrovascular diseases,47.95,Rate
Alsace,FRF1,Total,Females,2013,Cerebrovascular diseases,52.07,Rate
Alsace,FRF1,Total,Females,2014,Cerebrovascular diseases,40.62,Rate
Alsace,FRF1,Total,Females,2015,Cerebrovascular diseases,48.81,Rate
Alsace,FRF1,Total,Females,2016,Cerebrovascular diseases,45.76,Rate
Alsace,FRF1,Total,Females,2017,Cerebrovascular diseases,46.17,Rate
Alsace,FRF1,Total,Females,2018,Cerebrovascular diseases,42.25,Rate
Alsace,FRF1,Total,Females,2019,Cerebrovascular diseases,42.8,Rate
Alsace,FRF1,Total,Females,2020,Cerebrovascular diseases,39.67,Rate
Alsace,FRF1,Total,Females,2011,Chronic lower respiratory diseases,9.77,Rate
Alsace,FRF1,Total,Females,2012,Chronic lower respiratory diseases,10.33,Rate
Alsace,FRF1,Total,Females,2013,Chronic lower respiratory diseases,10.63,Rate
Alsace,FRF1,Total,Females,2014,Chronic lower respiratory diseases,11.11,Rate
Alsace,FRF1,Total,Females,2015,Chronic lower respiratory diseases,12.95,Rate
Alsace,FRF1,Total,Females,2016,Chronic lower respiratory diseases,11.41,Rate
Alsace,FRF1,Total,Females,2017,Chronic lower respiratory diseases,10.21,Rate
Alsace,FRF1,Total,Females,2018,Chronic lower respiratory diseases,13.6,Rate
Alsace,FRF1,Total,Females,2019,Chronic lower respiratory diseases,11.07,Rate
Alsace,FRF1,Total,Females,2020,Chronic lower respiratory diseases,12.05,Rate
Alsace,FRF1,Total,Females,2011,Asthma and status asthmaticus,1.48,Rate
Alsace,FRF1,Total,Females,2012,Asthma and status asthmaticus,2.08,Rate
Alsace,FRF1,Total,Females,2013,Asthma and status asthmaticus,1.18,Rate
Alsace,FRF1,Total,Females,2014,Asthma and status asthmaticus,1.51,Rate
Alsace,FRF1,Total,Females,2015,Asthma and status asthmaticus,0.99,Rate
Alsace,FRF1,Total,Females,2016,Asthma and status asthmaticus,1.28,Rate
Alsace,FRF1,Total,Females,2017,Asthma and status asthmaticus,0.93,Rate
Alsace,FRF1,Total,Females,2018,Asthma and status asthmaticus,1.31,Rate
Alsace,FRF1,Total,Females,2019,Asthma and status asthmaticus,0.95,Rate
Alsace,FRF1,Total,Females,2020,Asthma and status asthmaticus,1.29,Rate
Alsace,FRF1,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3151.52,Rate
Alsace,FRF1,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3234.65,Rate
Alsace,FRF1,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3246.43,Rate
Alsace,FRF1,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,2995.88,Rate
Alsace,FRF1,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3241.44,Rate
Alsace,FRF1,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3042.24,Rate
Alsace,FRF1,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,2957.82,Rate
Alsace,FRF1,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3042.38,Rate
Alsace,FRF1,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,2905.16,Rate
Alsace,FRF1,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3407.03,Rate
Alsace,FRF1,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.59,Rate
Alsace,FRF1,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.91,Rate
Alsace,FRF1,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.1,Rate
Alsace,FRF1,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",86.37,Rate
Alsace,FRF1,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.9,Rate
Alsace,FRF1,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",70.15,Rate
Alsace,FRF1,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.08,Rate
Alsace,FRF1,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",78.89,Rate
Alsace,FRF1,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",62.37,Rate
Alsace,FRF1,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",80.37,Rate
Alsace,FRF1,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",74.29,Rate
Alsace,FRF1,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",70.14,Rate
Alsace,FRF1,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",75.44,Rate
Alsace,FRF1,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",88.21,Rate
Alsace,FRF1,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",81.36,Rate
Alsace,FRF1,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",84.66,Rate
Alsace,FRF1,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",84.96,Rate
Alsace,FRF1,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",89.53,Rate
Alsace,FRF1,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",107.95,Rate
Alsace,FRF1,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",94.38,Rate
Alsace,FRF1,65 years or over,Females,2011,Malignant melanoma of skin,3.94,Rate
Alsace,FRF1,65 years or over,Females,2012,Malignant melanoma of skin,7.6,Rate
Alsace,FRF1,65 years or over,Females,2013,Malignant melanoma of skin,8.69,Rate
Alsace,FRF1,65 years or over,Females,2014,Malignant melanoma of skin,4.25,Rate
Alsace,FRF1,65 years or over,Females,2015,Malignant melanoma of skin,9.12,Rate
Alsace,FRF1,65 years or over,Females,2016,Malignant melanoma of skin,5.96,Rate
Alsace,FRF1,65 years or over,Females,2017,Malignant melanoma of skin,6.89,Rate
Alsace,FRF1,65 years or over,Females,2018,Malignant melanoma of skin,7.7,Rate
Alsace,FRF1,65 years or over,Females,2019,Malignant melanoma of skin,5.33,Rate
Alsace,FRF1,65 years or over,Females,2020,Malignant melanoma of skin,6.52,Rate
Alsace,FRF1,65 years or over,Females,2011,Malignant neoplasm of breast,102.27,Rate
Alsace,FRF1,65 years or over,Females,2012,Malignant neoplasm of breast,122.62,Rate
Alsace,FRF1,65 years or over,Females,2013,Malignant neoplasm of breast,107.79,Rate
Alsace,FRF1,65 years or over,Females,2014,Malignant neoplasm of breast,108.23,Rate
Alsace,FRF1,65 years or over,Females,2015,Malignant neoplasm of breast,108.82,Rate
Alsace,FRF1,65 years or over,Females,2016,Malignant neoplasm of breast,101.64,Rate
Alsace,FRF1,65 years or over,Females,2017,Malignant neoplasm of breast,111.95,Rate
Alsace,FRF1,65 years or over,Females,2018,Malignant neoplasm of breast,104.76,Rate
Alsace,FRF1,65 years or over,Females,2019,Malignant neoplasm of breast,111.92,Rate
Alsace,FRF1,65 years or over,Females,2020,Malignant neoplasm of breast,103.77,Rate
Alsace,FRF1,65 years or over,Females,2011,Diabetes mellitus,92.34,Rate
Alsace,FRF1,65 years or over,Females,2012,Diabetes mellitus,89.75,Rate
Alsace,FRF1,65 years or over,Females,2013,Diabetes mellitus,91.25,Rate
Alsace,FRF1,65 years or over,Females,2014,Diabetes mellitus,81.11,Rate
Alsace,FRF1,65 years or over,Females,2015,Diabetes mellitus,76.44,Rate
Alsace,FRF1,65 years or over,Females,2016,Diabetes mellitus,80.11,Rate
Alsace,FRF1,65 years or over,Females,2017,Diabetes mellitus,72.2,Rate
Alsace,FRF1,65 years or over,Females,2018,Diabetes mellitus,77.28,Rate
Alsace,FRF1,65 years or over,Females,2019,Diabetes mellitus,69.86,Rate
Alsace,FRF1,65 years or over,Females,2020,Diabetes mellitus,62.9,Rate
Alsace,FRF1,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),167.09,Rate
Alsace,FRF1,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),179.58,Rate
Alsace,FRF1,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),181.45,Rate
Alsace,FRF1,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),171.88,Rate
Alsace,FRF1,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),193.78,Rate
Alsace,FRF1,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),184.33,Rate
Alsace,FRF1,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),177.99,Rate
Alsace,FRF1,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),200.32,Rate
Alsace,FRF1,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),188.2,Rate
Alsace,FRF1,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),164.22,Rate
Alsace,FRF1,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),16.9,Rate
Alsace,FRF1,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),24.48,Rate
Alsace,FRF1,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),16.74,Rate
Alsace,FRF1,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),18.76,Rate
Alsace,FRF1,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),22.9,Rate
Alsace,FRF1,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),16.77,Rate
Alsace,FRF1,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),27.26,Rate
Alsace,FRF1,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),27.01,Rate
Alsace,FRF1,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),30.23,Rate
Alsace,FRF1,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),24.74,Rate
Alsace,FRF1,65 years or over,Females,2011,Other ischaemic heart diseases,143.26,Rate
Alsace,FRF1,65 years or over,Females,2012,Other ischaemic heart diseases,126.72,Rate
Alsace,FRF1,65 years or over,Females,2013,Other ischaemic heart diseases,122.48,Rate
Alsace,FRF1,65 years or over,Females,2014,Other ischaemic heart diseases,121.26,Rate
Alsace,FRF1,65 years or over,Females,2015,Other ischaemic heart diseases,118.13,Rate
Alsace,FRF1,65 years or over,Females,2016,Other ischaemic heart diseases,112.43,Rate
Alsace,FRF1,65 years or over,Females,2017,Other ischaemic heart diseases,99.97,Rate
Alsace,FRF1,65 years or over,Females,2018,Other ischaemic heart diseases,105.19,Rate
Alsace,FRF1,65 years or over,Females,2019,Other ischaemic heart diseases,97.95,Rate
Alsace,FRF1,65 years or over,Females,2020,Other ischaemic heart diseases,95.56,Rate
Alsace,FRF1,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,77.7,Rate
Alsace,FRF1,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,72.89,Rate
Alsace,FRF1,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,73.74,Rate
Alsace,FRF1,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,68.47,Rate
Alsace,FRF1,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,64.12,Rate
Alsace,FRF1,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,57.3,Rate
Alsace,FRF1,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,51.76,Rate
Alsace,FRF1,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,51.77,Rate
Alsace,FRF1,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,43.74,Rate
Alsace,FRF1,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,37.86,Rate
Alsace,FRF1,65 years or over,Females,2011,Cerebrovascular diseases,242.71,Rate
Alsace,FRF1,65 years or over,Females,2012,Cerebrovascular diseases,234.71,Rate
Alsace,FRF1,65 years or over,Females,2013,Cerebrovascular diseases,256.48,Rate
Alsace,FRF1,65 years or over,Females,2014,Cerebrovascular diseases,199.92,Rate
Alsace,FRF1,65 years or over,Females,2015,Cerebrovascular diseases,237.77,Rate
Alsace,FRF1,65 years or over,Females,2016,Cerebrovascular diseases,222.85,Rate
Alsace,FRF1,65 years or over,Females,2017,Cerebrovascular diseases,224.12,Rate
Alsace,FRF1,65 years or over,Females,2018,Cerebrovascular diseases,208.38,Rate
Alsace,FRF1,65 years or over,Females,2019,Cerebrovascular diseases,206.28,Rate
Alsace,FRF1,65 years or over,Females,2020,Cerebrovascular diseases,191.34,Rate
Alsace,FRF1,65 years or over,Females,2011,Chronic lower respiratory diseases,46.31,Rate
Alsace,FRF1,65 years or over,Females,2012,Chronic lower respiratory diseases,45.5,Rate
Alsace,FRF1,65 years or over,Females,2013,Chronic lower respiratory diseases,46.08,Rate
Alsace,FRF1,65 years or over,Females,2014,Chronic lower respiratory diseases,53.85,Rate
Alsace,FRF1,65 years or over,Females,2015,Chronic lower respiratory diseases,60.26,Rate
Alsace,FRF1,65 years or over,Females,2016,Chronic lower respiratory diseases,53.4,Rate
Alsace,FRF1,65 years or over,Females,2017,Chronic lower respiratory diseases,45.25,Rate
Alsace,FRF1,65 years or over,Females,2018,Chronic lower respiratory diseases,60.1,Rate
Alsace,FRF1,65 years or over,Females,2019,Chronic lower respiratory diseases,49.71,Rate
Alsace,FRF1,65 years or over,Females,2020,Chronic lower respiratory diseases,52.83,Rate
Alsace,FRF1,65 years or over,Females,2011,Asthma and status asthmaticus,7.03,Rate
Alsace,FRF1,65 years or over,Females,2012,Asthma and status asthmaticus,8.58,Rate
Alsace,FRF1,65 years or over,Females,2013,Asthma and status asthmaticus,4.45,Rate
Alsace,FRF1,65 years or over,Females,2014,Asthma and status asthmaticus,7.22,Rate
Alsace,FRF1,65 years or over,Females,2015,Asthma and status asthmaticus,4.06,Rate
Alsace,FRF1,65 years or over,Females,2016,Asthma and status asthmaticus,6.05,Rate
Alsace,FRF1,65 years or over,Females,2017,Asthma and status asthmaticus,4.2,Rate
Alsace,FRF1,65 years or over,Females,2018,Asthma and status asthmaticus,6.25,Rate
Alsace,FRF1,65 years or over,Females,2019,Asthma and status asthmaticus,4.35,Rate
Alsace,FRF1,65 years or over,Females,2020,Asthma and status asthmaticus,4.66,Rate
Alsace,FRF1,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,121.06,Rate
Alsace,FRF1,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,120.94,Rate
Alsace,FRF1,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,123.49,Rate
Alsace,FRF1,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,115.9,Rate
Alsace,FRF1,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,119.76,Rate
Alsace,FRF1,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,116.07,Rate
Alsace,FRF1,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,116.76,Rate
Alsace,FRF1,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,118.03,Rate
Alsace,FRF1,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,110.79,Rate
Alsace,FRF1,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,117.73,Rate
Alsace,FRF1,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.37,Rate
Alsace,FRF1,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.13,Rate
Alsace,FRF1,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.12,Rate
Alsace,FRF1,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.09,Rate
Alsace,FRF1,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.96,Rate
Alsace,FRF1,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.78,Rate
Alsace,FRF1,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.76,Rate
Alsace,FRF1,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.01,Rate
Alsace,FRF1,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.13,Rate
Alsace,FRF1,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.75,Rate
Alsace,FRF1,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",8.36,Rate
Alsace,FRF1,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",14.04,Rate
Alsace,FRF1,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",11.36,Rate
Alsace,FRF1,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",14.08,Rate
Alsace,FRF1,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",12.56,Rate
Alsace,FRF1,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",12.55,Rate
Alsace,FRF1,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",13.71,Rate
Alsace,FRF1,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",12.5,Rate
Alsace,FRF1,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.43,Rate
Alsace,FRF1,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",10.31,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Malignant melanoma of skin,0.4,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Malignant melanoma of skin,1.41,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Malignant melanoma of skin,0.9,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Malignant melanoma of skin,0.92,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Malignant melanoma of skin,0.88,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Malignant melanoma of skin,1.8,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Malignant melanoma of skin,1.25,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Malignant melanoma of skin,1.29,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Malignant melanoma of skin,1.41,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Malignant melanoma of skin,0.24,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Malignant neoplasm of breast,13.81,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Malignant neoplasm of breast,12.98,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Malignant neoplasm of breast,14.5,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.62,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Malignant neoplasm of breast,13.68,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Malignant neoplasm of breast,12.39,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Malignant neoplasm of breast,14.62,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Malignant neoplasm of breast,10.64,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.71,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Malignant neoplasm of breast,14.92,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Diabetes mellitus,1.46,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Diabetes mellitus,1.67,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Diabetes mellitus,1.53,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Diabetes mellitus,2.04,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Diabetes mellitus,2.38,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Diabetes mellitus,0.99,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Diabetes mellitus,1.36,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Diabetes mellitus,1.84,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Diabetes mellitus,1.34,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Diabetes mellitus,1.12,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.59,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),2.07,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),2.43,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.68,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.79,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.6,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.02,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.8,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.04,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.84,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.67,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.65,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.28,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.77,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.9,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.85,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.75,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.1,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.01,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.78,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.9,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.03,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.38,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Other ischaemic heart diseases,0.62,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.37,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.49,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.45,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.57,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.63,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,1.96,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,2.32,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,1.65,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,1.01,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,1.25,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.24,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.09,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.39,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,1.25,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.95,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Cerebrovascular diseases,4.45,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Cerebrovascular diseases,2.72,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Cerebrovascular diseases,2.56,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Cerebrovascular diseases,2.03,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Cerebrovascular diseases,3.04,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Cerebrovascular diseases,2.87,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Cerebrovascular diseases,3.07,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Cerebrovascular diseases,2.01,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Cerebrovascular diseases,3.19,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Cerebrovascular diseases,2.93,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.91,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Chronic lower respiratory diseases,1.8,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.04,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.75,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.49,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.24,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.73,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.33,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.72,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Chronic lower respiratory diseases,2.17,Rate
Alsace,FRF1,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.51,Rate
Alsace,FRF1,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.39,Rate
Alsace,FRF1,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.25,Rate
Alsace,FRF1,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.14,Rate
Alsace,FRF1,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.12,Rate
Alsace,FRF1,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.48,Rate
Alsace,FRF1,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1151.82,Rate
Alsace,FRF1,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1158.9,Rate
Alsace,FRF1,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1161.23,Rate
Alsace,FRF1,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1139.66,Rate
Alsace,FRF1,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1137.93,Rate
Alsace,FRF1,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1085.57,Rate
Alsace,FRF1,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1096.21,Rate
Alsace,FRF1,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1088.45,Rate
Alsace,FRF1,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1051.47,Rate
Alsace,FRF1,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1214.32,Rate
Alsace,FRF1,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.11,Rate
Alsace,FRF1,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.66,Rate
Alsace,FRF1,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.06,Rate
Alsace,FRF1,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.22,Rate
Alsace,FRF1,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.0,Rate
Alsace,FRF1,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.57,Rate
Alsace,FRF1,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.23,Rate
Alsace,FRF1,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.99,Rate
Alsace,FRF1,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.77,Rate
Alsace,FRF1,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.94,Rate
Alsace,FRF1,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",89.33,Rate
Alsace,FRF1,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",89.27,Rate
Alsace,FRF1,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",81.1,Rate
Alsace,FRF1,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",89.41,Rate
Alsace,FRF1,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",75.26,Rate
Alsace,FRF1,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",80.2,Rate
Alsace,FRF1,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",71.98,Rate
Alsace,FRF1,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",73.37,Rate
Alsace,FRF1,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",69.19,Rate
Alsace,FRF1,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",67.76,Rate
Alsace,FRF1,Total,Males,2011,Malignant melanoma of skin,2.66,Rate
Alsace,FRF1,Total,Males,2012,Malignant melanoma of skin,3.72,Rate
Alsace,FRF1,Total,Males,2013,Malignant melanoma of skin,4.58,Rate
Alsace,FRF1,Total,Males,2014,Malignant melanoma of skin,4.54,Rate
Alsace,FRF1,Total,Males,2015,Malignant melanoma of skin,3.85,Rate
Alsace,FRF1,Total,Males,2016,Malignant melanoma of skin,3.01,Rate
Alsace,FRF1,Total,Males,2017,Malignant melanoma of skin,2.99,Rate
Alsace,FRF1,Total,Males,2018,Malignant melanoma of skin,3.14,Rate
Alsace,FRF1,Total,Males,2019,Malignant melanoma of skin,2.86,Rate
Alsace,FRF1,Total,Males,2020,Malignant melanoma of skin,5.02,Rate
Alsace,FRF1,Total,Males,2011,Malignant neoplasm of breast,0.5,Rate
Alsace,FRF1,Total,Males,2012,Malignant neoplasm of breast,0.45,Rate
Alsace,FRF1,Total,Males,2013,Malignant neoplasm of breast,0.6,Rate
Alsace,FRF1,Total,Males,2014,Malignant neoplasm of breast,0.42,Rate
Alsace,FRF1,Total,Males,2015,Malignant neoplasm of breast,1.04,Rate
Alsace,FRF1,Total,Males,2016,Malignant neoplasm of breast,0.89,Rate
Alsace,FRF1,Total,Males,2017,Malignant neoplasm of breast,0.83,Rate
Alsace,FRF1,Total,Males,2018,Malignant neoplasm of breast,0.99,Rate
Alsace,FRF1,Total,Males,2019,Malignant neoplasm of breast,0.5,Rate
Alsace,FRF1,Total,Males,2020,Malignant neoplasm of breast,0.34,Rate
Alsace,FRF1,Total,Males,2011,Diabetes mellitus,22.83,Rate
Alsace,FRF1,Total,Males,2012,Diabetes mellitus,23.2,Rate
Alsace,FRF1,Total,Males,2013,Diabetes mellitus,24.54,Rate
Alsace,FRF1,Total,Males,2014,Diabetes mellitus,26.04,Rate
Alsace,FRF1,Total,Males,2015,Diabetes mellitus,26.33,Rate
Alsace,FRF1,Total,Males,2016,Diabetes mellitus,22.75,Rate
Alsace,FRF1,Total,Males,2017,Diabetes mellitus,23.62,Rate
Alsace,FRF1,Total,Males,2018,Diabetes mellitus,23.92,Rate
Alsace,FRF1,Total,Males,2019,Diabetes mellitus,20.16,Rate
Alsace,FRF1,Total,Males,2020,Diabetes mellitus,21.28,Rate
Alsace,FRF1,Total,Males,2011,Mental and behavioural disorders (F00-F99),42.46,Rate
Alsace,FRF1,Total,Males,2012,Mental and behavioural disorders (F00-F99),44.31,Rate
Alsace,FRF1,Total,Males,2013,Mental and behavioural disorders (F00-F99),44.99,Rate
Alsace,FRF1,Total,Males,2014,Mental and behavioural disorders (F00-F99),39.69,Rate
Alsace,FRF1,Total,Males,2015,Mental and behavioural disorders (F00-F99),47.08,Rate
Alsace,FRF1,Total,Males,2016,Mental and behavioural disorders (F00-F99),47.25,Rate
Alsace,FRF1,Total,Males,2017,Mental and behavioural disorders (F00-F99),47.8,Rate
Alsace,FRF1,Total,Males,2018,Mental and behavioural disorders (F00-F99),42.72,Rate
Alsace,FRF1,Total,Males,2019,Mental and behavioural disorders (F00-F99),43.35,Rate
Alsace,FRF1,Total,Males,2020,Mental and behavioural disorders (F00-F99),34.29,Rate
Alsace,FRF1,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),4.99,Rate
Alsace,FRF1,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),6.24,Rate
Alsace,FRF1,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),5.26,Rate
Alsace,FRF1,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),4.99,Rate
Alsace,FRF1,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),6.85,Rate
Alsace,FRF1,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),8.16,Rate
Alsace,FRF1,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),6.11,Rate
Alsace,FRF1,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),6.55,Rate
Alsace,FRF1,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),7.65,Rate
Alsace,FRF1,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),5.98,Rate
Alsace,FRF1,Total,Males,2011,Other ischaemic heart diseases,63.3,Rate
Alsace,FRF1,Total,Males,2012,Other ischaemic heart diseases,66.95,Rate
Alsace,FRF1,Total,Males,2013,Other ischaemic heart diseases,60.34,Rate
Alsace,FRF1,Total,Males,2014,Other ischaemic heart diseases,61.47,Rate
Alsace,FRF1,Total,Males,2015,Other ischaemic heart diseases,52.66,Rate
Alsace,FRF1,Total,Males,2016,Other ischaemic heart diseases,52.01,Rate
Alsace,FRF1,Total,Males,2017,Other ischaemic heart diseases,53.04,Rate
Alsace,FRF1,Total,Males,2018,Other ischaemic heart diseases,52.28,Rate
Alsace,FRF1,Total,Males,2019,Other ischaemic heart diseases,46.34,Rate
Alsace,FRF1,Total,Males,2020,Other ischaemic heart diseases,44.92,Rate
Alsace,FRF1,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,40.62,Rate
Alsace,FRF1,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,34.31,Rate
Alsace,FRF1,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,32.27,Rate
Alsace,FRF1,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,35.13,Rate
Alsace,FRF1,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,32.77,Rate
Alsace,FRF1,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,32.0,Rate
Alsace,FRF1,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,32.28,Rate
Alsace,FRF1,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,28.05,Rate
Alsace,FRF1,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,27.81,Rate
Alsace,FRF1,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,27.62,Rate
Alsace,FRF1,Total,Males,2011,Cerebrovascular diseases,58.45,Rate
Alsace,FRF1,Total,Males,2012,Cerebrovascular diseases,63.59,Rate
Alsace,FRF1,Total,Males,2013,Cerebrovascular diseases,70.2,Rate
Alsace,FRF1,Total,Males,2014,Cerebrovascular diseases,57.17,Rate
Alsace,FRF1,Total,Males,2015,Cerebrovascular diseases,57.03,Rate
Alsace,FRF1,Total,Males,2016,Cerebrovascular diseases,48.1,Rate
Alsace,FRF1,Total,Males,2017,Cerebrovascular diseases,57.76,Rate
Alsace,FRF1,Total,Males,2018,Cerebrovascular diseases,51.29,Rate
Alsace,FRF1,Total,Males,2019,Cerebrovascular diseases,51.84,Rate
Alsace,FRF1,Total,Males,2020,Cerebrovascular diseases,46.52,Rate
Alsace,FRF1,Total,Males,2011,Chronic lower respiratory diseases,32.51,Rate
Alsace,FRF1,Total,Males,2012,Chronic lower respiratory diseases,32.21,Rate
Alsace,FRF1,Total,Males,2013,Chronic lower respiratory diseases,28.56,Rate
Alsace,FRF1,Total,Males,2014,Chronic lower respiratory diseases,31.97,Rate
Alsace,FRF1,Total,Males,2015,Chronic lower respiratory diseases,34.7,Rate
Alsace,FRF1,Total,Males,2016,Chronic lower respiratory diseases,31.61,Rate
Alsace,FRF1,Total,Males,2017,Chronic lower respiratory diseases,29.52,Rate
Alsace,FRF1,Total,Males,2018,Chronic lower respiratory diseases,30.98,Rate
Alsace,FRF1,Total,Males,2019,Chronic lower respiratory diseases,30.8,Rate
Alsace,FRF1,Total,Males,2020,Chronic lower respiratory diseases,25.63,Rate
Alsace,FRF1,Total,Males,2011,Asthma and status asthmaticus,0.45,Rate
Alsace,FRF1,Total,Males,2012,Asthma and status asthmaticus,0.76,Rate
Alsace,FRF1,Total,Males,2013,Asthma and status asthmaticus,0.76,Rate
Alsace,FRF1,Total,Males,2014,Asthma and status asthmaticus,0.51,Rate
Alsace,FRF1,Total,Males,2015,Asthma and status asthmaticus,1.01,Rate
Alsace,FRF1,Total,Males,2016,Asthma and status asthmaticus,0.96,Rate
Alsace,FRF1,Total,Males,2017,Asthma and status asthmaticus,0.35,Rate
Alsace,FRF1,Total,Males,2018,Asthma and status asthmaticus,0.48,Rate
Alsace,FRF1,Total,Males,2019,Asthma and status asthmaticus,1.02,Rate
Alsace,FRF1,Total,Males,2020,Asthma and status asthmaticus,0.82,Rate
Alsace,FRF1,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,4863.21,Rate
Alsace,FRF1,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,4961.23,Rate
Alsace,FRF1,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4979.55,Rate
Alsace,FRF1,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4873.84,Rate
Alsace,FRF1,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4871.62,Rate
Alsace,FRF1,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4634.44,Rate
Alsace,FRF1,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4718.61,Rate
Alsace,FRF1,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4644.79,Rate
Alsace,FRF1,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4504.43,Rate
Alsace,FRF1,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5287.53,Rate
Alsace,FRF1,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.89,Rate
Alsace,FRF1,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",158.75,Rate
Alsace,FRF1,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",171.02,Rate
Alsace,FRF1,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",171.29,Rate
Alsace,FRF1,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",170.25,Rate
Alsace,FRF1,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.46,Rate
Alsace,FRF1,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",156.95,Rate
Alsace,FRF1,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",145.57,Rate
Alsace,FRF1,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.0,Rate
Alsace,FRF1,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.2,Rate
Alsace,FRF1,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",332.48,Rate
Alsace,FRF1,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",338.9,Rate
Alsace,FRF1,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",300.74,Rate
Alsace,FRF1,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",320.61,Rate
Alsace,FRF1,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",270.32,Rate
Alsace,FRF1,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",299.71,Rate
Alsace,FRF1,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",273.12,Rate
Alsace,FRF1,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",280.76,Rate
Alsace,FRF1,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",265.8,Rate
Alsace,FRF1,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",269.13,Rate
Alsace,FRF1,65 years or over,Males,2011,Malignant melanoma of skin,7.12,Rate
Alsace,FRF1,65 years or over,Males,2012,Malignant melanoma of skin,15.81,Rate
Alsace,FRF1,65 years or over,Males,2013,Malignant melanoma of skin,18.09,Rate
Alsace,FRF1,65 years or over,Males,2014,Malignant melanoma of skin,18.41,Rate
Alsace,FRF1,65 years or over,Males,2015,Malignant melanoma of skin,14.88,Rate
Alsace,FRF1,65 years or over,Males,2016,Malignant melanoma of skin,8.32,Rate
Alsace,FRF1,65 years or over,Males,2017,Malignant melanoma of skin,8.9,Rate
Alsace,FRF1,65 years or over,Males,2018,Malignant melanoma of skin,11.17,Rate
Alsace,FRF1,65 years or over,Males,2019,Malignant melanoma of skin,12.09,Rate
Alsace,FRF1,65 years or over,Males,2020,Malignant melanoma of skin,17.87,Rate
Alsace,FRF1,65 years or over,Males,2011,Malignant neoplasm of breast,2.55,Rate
Alsace,FRF1,65 years or over,Males,2012,Malignant neoplasm of breast,2.29,Rate
Alsace,FRF1,65 years or over,Males,2013,Malignant neoplasm of breast,1.46,Rate
Alsace,FRF1,65 years or over,Males,2014,Malignant neoplasm of breast,2.17,Rate
Alsace,FRF1,65 years or over,Males,2015,Malignant neoplasm of breast,4.78,Rate
Alsace,FRF1,65 years or over,Males,2016,Malignant neoplasm of breast,4.05,Rate
Alsace,FRF1,65 years or over,Males,2017,Malignant neoplasm of breast,4.25,Rate
Alsace,FRF1,65 years or over,Males,2018,Malignant neoplasm of breast,4.04,Rate
Alsace,FRF1,65 years or over,Males,2019,Malignant neoplasm of breast,2.02,Rate
Alsace,FRF1,65 years or over,Males,2020,Malignant neoplasm of breast,0.57,Rate
Alsace,FRF1,65 years or over,Males,2011,Diabetes mellitus,104.46,Rate
Alsace,FRF1,65 years or over,Males,2012,Diabetes mellitus,102.15,Rate
Alsace,FRF1,65 years or over,Males,2013,Diabetes mellitus,107.49,Rate
Alsace,FRF1,65 years or over,Males,2014,Diabetes mellitus,117.98,Rate
Alsace,FRF1,65 years or over,Males,2015,Diabetes mellitus,124.36,Rate
Alsace,FRF1,65 years or over,Males,2016,Diabetes mellitus,105.37,Rate
Alsace,FRF1,65 years or over,Males,2017,Diabetes mellitus,103.85,Rate
Alsace,FRF1,65 years or over,Males,2018,Diabetes mellitus,108.32,Rate
Alsace,FRF1,65 years or over,Males,2019,Diabetes mellitus,90.15,Rate
Alsace,FRF1,65 years or over,Males,2020,Diabetes mellitus,94.43,Rate
Alsace,FRF1,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),183.24,Rate
Alsace,FRF1,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),199.5,Rate
Alsace,FRF1,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),204.17,Rate
Alsace,FRF1,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),181.01,Rate
Alsace,FRF1,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),208.78,Rate
Alsace,FRF1,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),202.8,Rate
Alsace,FRF1,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),212.4,Rate
Alsace,FRF1,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),185.45,Rate
Alsace,FRF1,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),186.86,Rate
Alsace,FRF1,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),147.09,Rate
Alsace,FRF1,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),20.68,Rate
Alsace,FRF1,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),23.84,Rate
Alsace,FRF1,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),23.25,Rate
Alsace,FRF1,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),18.82,Rate
Alsace,FRF1,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),23.04,Rate
Alsace,FRF1,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),28.42,Rate
Alsace,FRF1,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),20.33,Rate
Alsace,FRF1,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),21.85,Rate
Alsace,FRF1,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),24.43,Rate
Alsace,FRF1,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),20.39,Rate
Alsace,FRF1,65 years or over,Males,2011,Other ischaemic heart diseases,302.24,Rate
Alsace,FRF1,65 years or over,Males,2012,Other ischaemic heart diseases,319.48,Rate
Alsace,FRF1,65 years or over,Males,2013,Other ischaemic heart diseases,291.11,Rate
Alsace,FRF1,65 years or over,Males,2014,Other ischaemic heart diseases,291.55,Rate
Alsace,FRF1,65 years or over,Males,2015,Other ischaemic heart diseases,250.75,Rate
Alsace,FRF1,65 years or over,Males,2016,Other ischaemic heart diseases,244.81,Rate
Alsace,FRF1,65 years or over,Males,2017,Other ischaemic heart diseases,249.59,Rate
Alsace,FRF1,65 years or over,Males,2018,Other ischaemic heart diseases,249.64,Rate
Alsace,FRF1,65 years or over,Males,2019,Other ischaemic heart diseases,214.32,Rate
Alsace,FRF1,65 years or over,Males,2020,Other ischaemic heart diseases,207.53,Rate
Alsace,FRF1,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,164.76,Rate
Alsace,FRF1,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,128.8,Rate
Alsace,FRF1,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,132.56,Rate
Alsace,FRF1,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,151.66,Rate
Alsace,FRF1,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,132.14,Rate
Alsace,FRF1,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,135.15,Rate
Alsace,FRF1,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,124.83,Rate
Alsace,FRF1,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,112.9,Rate
Alsace,FRF1,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,110.2,Rate
Alsace,FRF1,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,106.51,Rate
Alsace,FRF1,65 years or over,Males,2011,Cerebrovascular diseases,280.05,Rate
Alsace,FRF1,65 years or over,Males,2012,Cerebrovascular diseases,299.43,Rate
Alsace,FRF1,65 years or over,Males,2013,Cerebrovascular diseases,337.64,Rate
Alsace,FRF1,65 years or over,Males,2014,Cerebrovascular diseases,271.13,Rate
Alsace,FRF1,65 years or over,Males,2015,Cerebrovascular diseases,269.97,Rate
Alsace,FRF1,65 years or over,Males,2016,Cerebrovascular diseases,226.78,Rate
Alsace,FRF1,65 years or over,Males,2017,Cerebrovascular diseases,275.02,Rate
Alsace,FRF1,65 years or over,Males,2018,Cerebrovascular diseases,238.43,Rate
Alsace,FRF1,65 years or over,Males,2019,Cerebrovascular diseases,245.54,Rate
Alsace,FRF1,65 years or over,Males,2020,Cerebrovascular diseases,214.13,Rate
Alsace,FRF1,65 years or over,Males,2011,Chronic lower respiratory diseases,156.32,Rate
Alsace,FRF1,65 years or over,Males,2012,Chronic lower respiratory diseases,155.94,Rate
Alsace,FRF1,65 years or over,Males,2013,Chronic lower respiratory diseases,136.68,Rate
Alsace,FRF1,65 years or over,Males,2014,Chronic lower respiratory diseases,155.38,Rate
Alsace,FRF1,65 years or over,Males,2015,Chronic lower respiratory diseases,164.05,Rate
Alsace,FRF1,65 years or over,Males,2016,Chronic lower respiratory diseases,150.96,Rate
Alsace,FRF1,65 years or over,Males,2017,Chronic lower respiratory diseases,140.71,Rate
Alsace,FRF1,65 years or over,Males,2018,Chronic lower respiratory diseases,143.0,Rate
Alsace,FRF1,65 years or over,Males,2019,Chronic lower respiratory diseases,145.25,Rate
Alsace,FRF1,65 years or over,Males,2020,Chronic lower respiratory diseases,117.23,Rate
Alsace,FRF1,65 years or over,Males,2011,Asthma and status asthmaticus,1.74,Rate
Alsace,FRF1,65 years or over,Males,2012,Asthma and status asthmaticus,2.84,Rate
Alsace,FRF1,65 years or over,Males,2013,Asthma and status asthmaticus,2.24,Rate
Alsace,FRF1,65 years or over,Males,2014,Asthma and status asthmaticus,1.56,Rate
Alsace,FRF1,65 years or over,Males,2015,Asthma and status asthmaticus,4.09,Rate
Alsace,FRF1,65 years or over,Males,2016,Asthma and status asthmaticus,3.91,Rate
Alsace,FRF1,65 years or over,Males,2017,Asthma and status asthmaticus,1.26,Rate
Alsace,FRF1,65 years or over,Males,2018,Asthma and status asthmaticus,1.95,Rate
Alsace,FRF1,65 years or over,Males,2019,Asthma and status asthmaticus,3.62,Rate
Alsace,FRF1,65 years or over,Males,2020,Asthma and status asthmaticus,3.11,Rate
Alsace,FRF1,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,252.79,Rate
Alsace,FRF1,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,237.84,Rate
Alsace,FRF1,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,236.3,Rate
Alsace,FRF1,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,235.11,Rate
Alsace,FRF1,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,233.49,Rate
Alsace,FRF1,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,225.91,Rate
Alsace,FRF1,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,218.73,Rate
Alsace,FRF1,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,226.98,Rate
Alsace,FRF1,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,215.04,Rate
Alsace,FRF1,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,227.64,Rate
Alsace,FRF1,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.95,Rate
Alsace,FRF1,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.08,Rate
Alsace,FRF1,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.1,Rate
Alsace,FRF1,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.98,Rate
Alsace,FRF1,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.44,Rate
Alsace,FRF1,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.65,Rate
Alsace,FRF1,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.99,Rate
Alsace,FRF1,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.97,Rate
Alsace,FRF1,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.79,Rate
Alsace,FRF1,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.32,Rate
Alsace,FRF1,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",30.43,Rate
Alsace,FRF1,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",28.8,Rate
Alsace,FRF1,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",27.9,Rate
Alsace,FRF1,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",33.41,Rate
Alsace,FRF1,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",28.01,Rate
Alsace,FRF1,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",27.02,Rate
Alsace,FRF1,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",23.25,Rate
Alsace,FRF1,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",23.13,Rate
Alsace,FRF1,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",21.57,Rate
Alsace,FRF1,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",18.98,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Malignant melanoma of skin,1.58,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Malignant melanoma of skin,0.79,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Malignant melanoma of skin,1.3,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Malignant melanoma of skin,1.18,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Malignant melanoma of skin,1.18,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Malignant melanoma of skin,1.72,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Malignant melanoma of skin,1.55,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Malignant melanoma of skin,1.2,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Malignant melanoma of skin,0.63,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Malignant melanoma of skin,1.91,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.39,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.26,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.29,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Diabetes mellitus,3.06,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Diabetes mellitus,4.07,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Diabetes mellitus,4.44,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Diabetes mellitus,3.77,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Diabetes mellitus,2.59,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Diabetes mellitus,2.74,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Diabetes mellitus,4.18,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Diabetes mellitus,3.48,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Diabetes mellitus,3.21,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Diabetes mellitus,3.56,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),8.36,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),6.72,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),6.43,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),5.45,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),7.92,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),9.57,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),7.93,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),8.15,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),8.59,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),6.97,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.97,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.63,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.93,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),3.25,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.67,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.85,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.58,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.49,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Other ischaemic heart diseases,5.41,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Other ischaemic heart diseases,5.77,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Other ischaemic heart diseases,4.45,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Other ischaemic heart diseases,5.74,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Other ischaemic heart diseases,4.68,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Other ischaemic heart diseases,5.31,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Other ischaemic heart diseases,5.43,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Other ischaemic heart diseases,4.48,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Other ischaemic heart diseases,5.64,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Other ischaemic heart diseases,5.53,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,10.55,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,11.42,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,7.97,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,6.9,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,8.7,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,7.01,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,9.86,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,7.5,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,7.85,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,8.51,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Cerebrovascular diseases,4.77,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Cerebrovascular diseases,6.46,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Cerebrovascular diseases,5.42,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Cerebrovascular diseases,5.34,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Cerebrovascular diseases,5.45,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Cerebrovascular diseases,4.82,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Cerebrovascular diseases,5.13,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Cerebrovascular diseases,5.96,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Cerebrovascular diseases,4.92,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Cerebrovascular diseases,5.93,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Chronic lower respiratory diseases,2.52,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Chronic lower respiratory diseases,2.23,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.37,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Chronic lower respiratory diseases,2.08,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Chronic lower respiratory diseases,3.37,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.69,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Chronic lower respiratory diseases,2.58,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.84,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Chronic lower respiratory diseases,3.08,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.44,Rate
Alsace,FRF1,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.26,Rate
Alsace,FRF1,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.41,Rate
Alsace,FRF1,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.26,Rate
Alsace,FRF1,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.26,Rate
Alsace,FRF1,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.25,Rate
Alsace,FRF1,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.39,Rate
Alsace,FRF1,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.26,Rate
Alsace,FRF1,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,894.18,Rate
Alsace,FRF1,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,906.49,Rate
Alsace,FRF1,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,910.03,Rate
Alsace,FRF1,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,864.85,Rate
Alsace,FRF1,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,897.67,Rate
Alsace,FRF1,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,853.6,Rate
Alsace,FRF1,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,848.14,Rate
Alsace,FRF1,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,855.15,Rate
Alsace,FRF1,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,823.23,Rate
Alsace,FRF1,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,950.67,Rate
Alsace,FRF1,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.91,Rate
Alsace,FRF1,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.9,Rate
Alsace,FRF1,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.04,Rate
Alsace,FRF1,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.12,Rate
Alsace,FRF1,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.27,Rate
Alsace,FRF1,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.69,Rate
Alsace,FRF1,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.49,Rate
Alsace,FRF1,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.3,Rate
Alsace,FRF1,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.39,Rate
Alsace,FRF1,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.98,Rate
Alsace,FRF1,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",50.59,Rate
Alsace,FRF1,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",51.69,Rate
Alsace,FRF1,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",48.27,Rate
Alsace,FRF1,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",55.72,Rate
Alsace,FRF1,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",47.93,Rate
Alsace,FRF1,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",49.8,Rate
Alsace,FRF1,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",47.07,Rate
Alsace,FRF1,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",47.66,Rate
Alsace,FRF1,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",48.04,Rate
Alsace,FRF1,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",44.48,Rate
Alsace,FRF1,Total,Total,2011,Malignant melanoma of skin,1.82,Rate
Alsace,FRF1,Total,Total,2012,Malignant melanoma of skin,2.91,Rate
Alsace,FRF1,Total,Total,2013,Malignant melanoma of skin,3.22,Rate
Alsace,FRF1,Total,Total,2014,Malignant melanoma of skin,2.6,Rate
Alsace,FRF1,Total,Total,2015,Malignant melanoma of skin,3.03,Rate
Alsace,FRF1,Total,Total,2016,Malignant melanoma of skin,2.8,Rate
Alsace,FRF1,Total,Total,2017,Malignant melanoma of skin,2.62,Rate
Alsace,FRF1,Total,Total,2018,Malignant melanoma of skin,2.76,Rate
Alsace,FRF1,Total,Total,2019,Malignant melanoma of skin,2.46,Rate
Alsace,FRF1,Total,Total,2020,Malignant melanoma of skin,3.11,Rate
Alsace,FRF1,Total,Total,2011,Malignant neoplasm of breast,17.81,Rate
Alsace,FRF1,Total,Total,2012,Malignant neoplasm of breast,19.91,Rate
Alsace,FRF1,Total,Total,2013,Malignant neoplasm of breast,19.02,Rate
Alsace,FRF1,Total,Total,2014,Malignant neoplasm of breast,18.04,Rate
Alsace,FRF1,Total,Total,2015,Malignant neoplasm of breast,18.84,Rate
Alsace,FRF1,Total,Total,2016,Malignant neoplasm of breast,17.17,Rate
Alsace,FRF1,Total,Total,2017,Malignant neoplasm of breast,19.6,Rate
Alsace,FRF1,Total,Total,2018,Malignant neoplasm of breast,16.92,Rate
Alsace,FRF1,Total,Total,2019,Malignant neoplasm of breast,18.7,Rate
Alsace,FRF1,Total,Total,2020,Malignant neoplasm of breast,18.29,Rate
Alsace,FRF1,Total,Total,2011,Diabetes mellitus,21.09,Rate
Alsace,FRF1,Total,Total,2012,Diabetes mellitus,20.96,Rate
Alsace,FRF1,Total,Total,2013,Diabetes mellitus,21.83,Rate
Alsace,FRF1,Total,Total,2014,Diabetes mellitus,21.03,Rate
Alsace,FRF1,Total,Total,2015,Diabetes mellitus,20.7,Rate
Alsace,FRF1,Total,Total,2016,Diabetes mellitus,19.28,Rate
Alsace,FRF1,Total,Total,2017,Diabetes mellitus,18.71,Rate
Alsace,FRF1,Total,Total,2018,Diabetes mellitus,19.43,Rate
Alsace,FRF1,Total,Total,2019,Diabetes mellitus,17.35,Rate
Alsace,FRF1,Total,Total,2020,Diabetes mellitus,16.59,Rate
Alsace,FRF1,Total,Total,2011,Mental and behavioural disorders (F00-F99),38.53,Rate
Alsace,FRF1,Total,Total,2012,Mental and behavioural disorders (F00-F99),40.54,Rate
Alsace,FRF1,Total,Total,2013,Mental and behavioural disorders (F00-F99),41.44,Rate
Alsace,FRF1,Total,Total,2014,Mental and behavioural disorders (F00-F99),38.26,Rate
Alsace,FRF1,Total,Total,2015,Mental and behavioural disorders (F00-F99),43.6,Rate
Alsace,FRF1,Total,Total,2016,Mental and behavioural disorders (F00-F99),42.9,Rate
Alsace,FRF1,Total,Total,2017,Mental and behavioural disorders (F00-F99),41.23,Rate
Alsace,FRF1,Total,Total,2018,Mental and behavioural disorders (F00-F99),42.67,Rate
Alsace,FRF1,Total,Total,2019,Mental and behavioural disorders (F00-F99),41.96,Rate
Alsace,FRF1,Total,Total,2020,Mental and behavioural disorders (F00-F99),35.09,Rate
Alsace,FRF1,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.63,Rate
Alsace,FRF1,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),5.9,Rate
Alsace,FRF1,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),4.78,Rate
Alsace,FRF1,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),5.24,Rate
Alsace,FRF1,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),6.35,Rate
Alsace,FRF1,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),6.27,Rate
Alsace,FRF1,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),6.16,Rate
Alsace,FRF1,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),6.83,Rate
Alsace,FRF1,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),7.7,Rate
Alsace,FRF1,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),5.95,Rate
Alsace,FRF1,Total,Total,2011,Other ischaemic heart diseases,41.22,Rate
Alsace,FRF1,Total,Total,2012,Other ischaemic heart diseases,40.96,Rate
Alsace,FRF1,Total,Total,2013,Other ischaemic heart diseases,38.28,Rate
Alsace,FRF1,Total,Total,2014,Other ischaemic heart diseases,38.52,Rate
Alsace,FRF1,Total,Total,2015,Other ischaemic heart diseases,34.84,Rate
Alsace,FRF1,Total,Total,2016,Other ischaemic heart diseases,33.91,Rate
Alsace,FRF1,Total,Total,2017,Other ischaemic heart diseases,32.78,Rate
Alsace,FRF1,Total,Total,2018,Other ischaemic heart diseases,33.54,Rate
Alsace,FRF1,Total,Total,2019,Other ischaemic heart diseases,30.88,Rate
Alsace,FRF1,Total,Total,2020,Other ischaemic heart diseases,29.31,Rate
Alsace,FRF1,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,27.26,Rate
Alsace,FRF1,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,24.21,Rate
Alsace,FRF1,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,22.97,Rate
Alsace,FRF1,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,22.6,Rate
Alsace,FRF1,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,21.87,Rate
Alsace,FRF1,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,21.16,Rate
Alsace,FRF1,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,20.68,Rate
Alsace,FRF1,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,18.45,Rate
Alsace,FRF1,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,17.45,Rate
Alsace,FRF1,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,17.27,Rate
Alsace,FRF1,Total,Total,2011,Cerebrovascular diseases,55.23,Rate
Alsace,FRF1,Total,Total,2012,Cerebrovascular diseases,54.78,Rate
Alsace,FRF1,Total,Total,2013,Cerebrovascular diseases,59.01,Rate
Alsace,FRF1,Total,Total,2014,Cerebrovascular diseases,47.45,Rate
Alsace,FRF1,Total,Total,2015,Cerebrovascular diseases,52.98,Rate
Alsace,FRF1,Total,Total,2016,Cerebrovascular diseases,47.87,Rate
Alsace,FRF1,Total,Total,2017,Cerebrovascular diseases,50.67,Rate
Alsace,FRF1,Total,Total,2018,Cerebrovascular diseases,47.26,Rate
Alsace,FRF1,Total,Total,2019,Cerebrovascular diseases,46.84,Rate
Alsace,FRF1,Total,Total,2020,Cerebrovascular diseases,43.44,Rate
Alsace,FRF1,Total,Total,2011,Chronic lower respiratory diseases,17.73,Rate
Alsace,FRF1,Total,Total,2012,Chronic lower respiratory diseases,18.37,Rate
Alsace,FRF1,Total,Total,2013,Chronic lower respiratory diseases,17.27,Rate
Alsace,FRF1,Total,Total,2014,Chronic lower respiratory diseases,18.4,Rate
Alsace,FRF1,Total,Total,2015,Chronic lower respiratory diseases,20.87,Rate
Alsace,FRF1,Total,Total,2016,Chronic lower respiratory diseases,18.77,Rate
Alsace,FRF1,Total,Total,2017,Chronic lower respiratory diseases,16.92,Rate
Alsace,FRF1,Total,Total,2018,Chronic lower respiratory diseases,20.21,Rate
Alsace,FRF1,Total,Total,2019,Chronic lower respiratory diseases,18.89,Rate
Alsace,FRF1,Total,Total,2020,Chronic lower respiratory diseases,17.37,Rate
Alsace,FRF1,Total,Total,2011,Asthma and status asthmaticus,1.1,Rate
Alsace,FRF1,Total,Total,2012,Asthma and status asthmaticus,1.66,Rate
Alsace,FRF1,Total,Total,2013,Asthma and status asthmaticus,1.16,Rate
Alsace,FRF1,Total,Total,2014,Asthma and status asthmaticus,1.23,Rate
Alsace,FRF1,Total,Total,2015,Asthma and status asthmaticus,1.0,Rate
Alsace,FRF1,Total,Total,2016,Asthma and status asthmaticus,1.18,Rate
Alsace,FRF1,Total,Total,2017,Asthma and status asthmaticus,0.73,Rate
Alsace,FRF1,Total,Total,2018,Asthma and status asthmaticus,1.01,Rate
Alsace,FRF1,Total,Total,2019,Asthma and status asthmaticus,1.03,Rate
Alsace,FRF1,Total,Total,2020,Asthma and status asthmaticus,1.09,Rate
Alsace,FRF1,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,3815.23,Rate
Alsace,FRF1,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,3910.19,Rate
Alsace,FRF1,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,3926.59,Rate
Alsace,FRF1,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3714.04,Rate
Alsace,FRF1,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3877.81,Rate
Alsace,FRF1,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3675.37,Rate
Alsace,FRF1,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3660.64,Rate
Alsace,FRF1,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3677.79,Rate
Alsace,FRF1,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3553.7,Rate
Alsace,FRF1,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4167.2,Rate
Alsace,FRF1,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.92,Rate
Alsace,FRF1,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",119.98,Rate
Alsace,FRF1,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.59,Rate
Alsace,FRF1,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.35,Rate
Alsace,FRF1,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.42,Rate
Alsace,FRF1,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.88,Rate
Alsace,FRF1,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.81,Rate
Alsace,FRF1,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",104.23,Rate
Alsace,FRF1,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.47,Rate
Alsace,FRF1,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",94.1,Rate
Alsace,FRF1,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",179.57,Rate
Alsace,FRF1,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",176.99,Rate
Alsace,FRF1,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",166.98,Rate
Alsace,FRF1,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",188.34,Rate
Alsace,FRF1,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",162.72,Rate
Alsace,FRF1,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",174.39,Rate
Alsace,FRF1,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",165.49,Rate
Alsace,FRF1,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",171.45,Rate
Alsace,FRF1,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",176.8,Rate
Alsace,FRF1,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",168.12,Rate
Alsace,FRF1,65 years or over,Total,2011,Malignant melanoma of skin,5.27,Rate
Alsace,FRF1,65 years or over,Total,2012,Malignant melanoma of skin,10.34,Rate
Alsace,FRF1,65 years or over,Total,2013,Malignant melanoma of skin,12.0,Rate
Alsace,FRF1,65 years or over,Total,2014,Malignant melanoma of skin,9.01,Rate
Alsace,FRF1,65 years or over,Total,2015,Malignant melanoma of skin,11.28,Rate
Alsace,FRF1,65 years or over,Total,2016,Malignant melanoma of skin,7.08,Rate
Alsace,FRF1,65 years or over,Total,2017,Malignant melanoma of skin,7.65,Rate
Alsace,FRF1,65 years or over,Total,2018,Malignant melanoma of skin,9.03,Rate
Alsace,FRF1,65 years or over,Total,2019,Malignant melanoma of skin,8.38,Rate
Alsace,FRF1,65 years or over,Total,2020,Malignant melanoma of skin,11.58,Rate
Alsace,FRF1,65 years or over,Total,2011,Malignant neoplasm of breast,62.66,Rate
Alsace,FRF1,65 years or over,Total,2012,Malignant neoplasm of breast,75.11,Rate
Alsace,FRF1,65 years or over,Total,2013,Malignant neoplasm of breast,66.5,Rate
Alsace,FRF1,65 years or over,Total,2014,Malignant neoplasm of breast,66.14,Rate
Alsace,FRF1,65 years or over,Total,2015,Malignant neoplasm of breast,67.68,Rate
Alsace,FRF1,65 years or over,Total,2016,Malignant neoplasm of breast,61.84,Rate
Alsace,FRF1,65 years or over,Total,2017,Malignant neoplasm of breast,69.76,Rate
Alsace,FRF1,65 years or over,Total,2018,Malignant neoplasm of breast,63.86,Rate
Alsace,FRF1,65 years or over,Total,2019,Malignant neoplasm of breast,66.82,Rate
Alsace,FRF1,65 years or over,Total,2020,Malignant neoplasm of breast,61.87,Rate
Alsace,FRF1,65 years or over,Total,2011,Diabetes mellitus,98.87,Rate
Alsace,FRF1,65 years or over,Total,2012,Diabetes mellitus,95.66,Rate
Alsace,FRF1,65 years or over,Total,2013,Diabetes mellitus,99.68,Rate
Alsace,FRF1,65 years or over,Total,2014,Diabetes mellitus,95.88,Rate
Alsace,FRF1,65 years or over,Total,2015,Diabetes mellitus,95.91,Rate
Alsace,FRF1,65 years or over,Total,2016,Diabetes mellitus,91.24,Rate
Alsace,FRF1,65 years or over,Total,2017,Diabetes mellitus,84.61,Rate
Alsace,FRF1,65 years or over,Total,2018,Diabetes mellitus,88.76,Rate
Alsace,FRF1,65 years or over,Total,2019,Diabetes mellitus,79.7,Rate
Alsace,FRF1,65 years or over,Total,2020,Diabetes mellitus,75.59,Rate
Alsace,FRF1,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),175.06,Rate
Alsace,FRF1,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),189.85,Rate
Alsace,FRF1,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),194.29,Rate
Alsace,FRF1,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),179.45,Rate
Alsace,FRF1,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),201.63,Rate
Alsace,FRF1,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),195.01,Rate
Alsace,FRF1,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),193.18,Rate
Alsace,FRF1,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),196.37,Rate
Alsace,FRF1,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),191.35,Rate
Alsace,FRF1,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),159.94,Rate
Alsace,FRF1,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),17.84,Rate
Alsace,FRF1,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),24.85,Rate
Alsace,FRF1,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),19.95,Rate
Alsace,FRF1,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),19.82,Rate
Alsace,FRF1,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),22.64,Rate
Alsace,FRF1,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),21.63,Rate
Alsace,FRF1,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),24.54,Rate
Alsace,FRF1,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),25.55,Rate
Alsace,FRF1,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),27.82,Rate
Alsace,FRF1,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),23.4,Rate
Alsace,FRF1,65 years or over,Total,2011,Other ischaemic heart diseases,198.62,Rate
Alsace,FRF1,65 years or over,Total,2012,Other ischaemic heart diseases,196.36,Rate
Alsace,FRF1,65 years or over,Total,2013,Other ischaemic heart diseases,185.09,Rate
Alsace,FRF1,65 years or over,Total,2014,Other ischaemic heart diseases,182.98,Rate
Alsace,FRF1,65 years or over,Total,2015,Other ischaemic heart diseases,167.89,Rate
Alsace,FRF1,65 years or over,Total,2016,Other ischaemic heart diseases,162.37,Rate
Alsace,FRF1,65 years or over,Total,2017,Other ischaemic heart diseases,156.16,Rate
Alsace,FRF1,65 years or over,Total,2018,Other ischaemic heart diseases,159.89,Rate
Alsace,FRF1,65 years or over,Total,2019,Other ischaemic heart diseases,143.7,Rate
Alsace,FRF1,65 years or over,Total,2020,Other ischaemic heart diseases,137.85,Rate
Alsace,FRF1,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,114.07,Rate
Alsace,FRF1,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,95.93,Rate
Alsace,FRF1,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,98.1,Rate
Alsace,FRF1,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,99.76,Rate
Alsace,FRF1,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,91.79,Rate
Alsace,FRF1,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,89.55,Rate
Alsace,FRF1,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,81.65,Rate
Alsace,FRF1,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,76.56,Rate
Alsace,FRF1,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,71.03,Rate
Alsace,FRF1,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,65.11,Rate
Alsace,FRF1,65 years or over,Total,2011,Cerebrovascular diseases,264.16,Rate
Alsace,FRF1,65 years or over,Total,2012,Cerebrovascular diseases,262.09,Rate
Alsace,FRF1,65 years or over,Total,2013,Cerebrovascular diseases,286.21,Rate
Alsace,FRF1,65 years or over,Total,2014,Cerebrovascular diseases,228.22,Rate
Alsace,FRF1,65 years or over,Total,2015,Cerebrovascular diseases,254.25,Rate
Alsace,FRF1,65 years or over,Total,2016,Cerebrovascular diseases,229.69,Rate
Alsace,FRF1,65 years or over,Total,2017,Cerebrovascular diseases,243.06,Rate
Alsace,FRF1,65 years or over,Total,2018,Cerebrovascular diseases,226.13,Rate
Alsace,FRF1,65 years or over,Total,2019,Cerebrovascular diseases,223.52,Rate
Alsace,FRF1,65 years or over,Total,2020,Cerebrovascular diseases,204.62,Rate
Alsace,FRF1,65 years or over,Total,2011,Chronic lower respiratory diseases,83.86,Rate
Alsace,FRF1,65 years or over,Total,2012,Chronic lower respiratory diseases,85.89,Rate
Alsace,FRF1,65 years or over,Total,2013,Chronic lower respiratory diseases,79.48,Rate
Alsace,FRF1,65 years or over,Total,2014,Chronic lower respiratory diseases,88.57,Rate
Alsace,FRF1,65 years or over,Total,2015,Chronic lower respiratory diseases,97.04,Rate
Alsace,FRF1,65 years or over,Total,2016,Chronic lower respiratory diseases,88.22,Rate
Alsace,FRF1,65 years or over,Total,2017,Chronic lower respiratory diseases,77.88,Rate
Alsace,FRF1,65 years or over,Total,2018,Chronic lower respiratory diseases,90.97,Rate
Alsace,FRF1,65 years or over,Total,2019,Chronic lower respiratory diseases,87.04,Rate
Alsace,FRF1,65 years or over,Total,2020,Chronic lower respiratory diseases,77.59,Rate
Alsace,FRF1,65 years or over,Total,2011,Asthma and status asthmaticus,5.12,Rate
Alsace,FRF1,65 years or over,Total,2012,Asthma and status asthmaticus,6.91,Rate
Alsace,FRF1,65 years or over,Total,2013,Asthma and status asthmaticus,4.31,Rate
Alsace,FRF1,65 years or over,Total,2014,Asthma and status asthmaticus,5.51,Rate
Alsace,FRF1,65 years or over,Total,2015,Asthma and status asthmaticus,4.06,Rate
Alsace,FRF1,65 years or over,Total,2016,Asthma and status asthmaticus,5.28,Rate
Alsace,FRF1,65 years or over,Total,2017,Asthma and status asthmaticus,3.2,Rate
Alsace,FRF1,65 years or over,Total,2018,Asthma and status asthmaticus,4.68,Rate
Alsace,FRF1,65 years or over,Total,2019,Asthma and status asthmaticus,4.22,Rate
Alsace,FRF1,65 years or over,Total,2020,Asthma and status asthmaticus,4.07,Rate
Alsace,FRF1,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,186.59,Rate
Alsace,FRF1,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,178.88,Rate
Alsace,FRF1,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,179.31,Rate
Alsace,FRF1,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,174.67,Rate
Alsace,FRF1,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,175.78,Rate
Alsace,FRF1,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,170.06,Rate
Alsace,FRF1,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,166.85,Rate
Alsace,FRF1,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,171.4,Rate
Alsace,FRF1,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,161.82,Rate
Alsace,FRF1,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,171.51,Rate
Alsace,FRF1,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.65,Rate
Alsace,FRF1,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.6,Rate
Alsace,FRF1,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.59,Rate
Alsace,FRF1,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.02,Rate
Alsace,FRF1,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.16,Rate
Alsace,FRF1,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.21,Rate
Alsace,FRF1,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.34,Rate
Alsace,FRF1,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.94,Rate
Alsace,FRF1,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.93,Rate
Alsace,FRF1,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.52,Rate
Alsace,FRF1,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",19.34,Rate
Alsace,FRF1,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",21.34,Rate
Alsace,FRF1,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",19.51,Rate
Alsace,FRF1,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",23.59,Rate
Alsace,FRF1,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",20.13,Rate
Alsace,FRF1,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",19.62,Rate
Alsace,FRF1,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",18.39,Rate
Alsace,FRF1,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",17.67,Rate
Alsace,FRF1,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",16.85,Rate
Alsace,FRF1,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.53,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Malignant melanoma of skin,0.98,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Malignant melanoma of skin,1.11,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Malignant melanoma of skin,1.1,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Malignant melanoma of skin,1.04,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Malignant melanoma of skin,1.03,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Malignant melanoma of skin,1.76,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Malignant melanoma of skin,1.4,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Malignant melanoma of skin,1.25,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Malignant melanoma of skin,1.03,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Malignant melanoma of skin,1.05,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Malignant neoplasm of breast,6.94,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.54,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.52,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.38,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.01,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.35,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.44,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.54,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.04,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.73,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Diabetes mellitus,2.25,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Diabetes mellitus,2.86,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Diabetes mellitus,2.97,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Diabetes mellitus,2.9,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Diabetes mellitus,2.48,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Diabetes mellitus,1.85,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Diabetes mellitus,2.75,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Diabetes mellitus,2.64,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Diabetes mellitus,2.25,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Diabetes mellitus,2.3,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),5.45,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),4.37,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),4.41,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.05,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),5.31,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),6.05,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.42,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),5.44,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),5.77,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.85,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.43,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.1,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.4,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.55,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.29,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.83,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.72,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Other ischaemic heart diseases,3.09,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Other ischaemic heart diseases,3.32,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Other ischaemic heart diseases,2.72,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Other ischaemic heart diseases,3.52,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Other ischaemic heart diseases,2.61,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.79,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Other ischaemic heart diseases,2.9,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.94,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Other ischaemic heart diseases,3.55,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Other ischaemic heart diseases,3.02,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,6.24,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,6.83,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,4.77,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,3.91,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,4.93,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,4.6,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,5.91,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,4.38,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.47,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,5.68,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Cerebrovascular diseases,4.62,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Cerebrovascular diseases,4.57,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Cerebrovascular diseases,3.98,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Cerebrovascular diseases,3.66,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Cerebrovascular diseases,4.22,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Cerebrovascular diseases,3.83,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Cerebrovascular diseases,4.07,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Cerebrovascular diseases,3.93,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Cerebrovascular diseases,4.05,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Cerebrovascular diseases,4.4,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.71,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Chronic lower respiratory diseases,2.01,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Chronic lower respiratory diseases,2.2,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.4,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Chronic lower respiratory diseases,2.41,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.95,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Chronic lower respiratory diseases,2.15,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.06,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Chronic lower respiratory diseases,2.38,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Chronic lower respiratory diseases,2.79,Rate
Alsace,FRF1,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.39,Rate
Alsace,FRF1,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.4,Rate
Alsace,FRF1,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.19,Rate
Alsace,FRF1,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.25,Rate
Alsace,FRF1,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.19,Rate
Alsace,FRF1,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.13,Rate
Alsace,FRF1,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.26,Rate
Alsace,FRF1,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,669.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,706.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,648.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,651.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,649.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,626.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,620.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,629.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,603.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,745.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",27.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",26.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",23.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",20.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",22.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",21.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",25.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",22.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",23.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",26.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Malignant melanoma of skin,3.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Malignant melanoma of skin,2.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Malignant melanoma of skin,3.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Malignant melanoma of skin,2.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Malignant melanoma of skin,1.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Malignant melanoma of skin,3.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Malignant melanoma of skin,2.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Malignant melanoma of skin,1.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Malignant melanoma of skin,3.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Malignant melanoma of skin,2.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Malignant neoplasm of breast,31.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Malignant neoplasm of breast,28.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Malignant neoplasm of breast,28.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Malignant neoplasm of breast,30.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Malignant neoplasm of breast,31.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Malignant neoplasm of breast,29.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Malignant neoplasm of breast,22.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Malignant neoplasm of breast,26.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Malignant neoplasm of breast,27.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Malignant neoplasm of breast,30.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Diabetes mellitus,9.07,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Diabetes mellitus,9.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Diabetes mellitus,9.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Diabetes mellitus,12.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Diabetes mellitus,9.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Diabetes mellitus,11.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Diabetes mellitus,12.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Diabetes mellitus,9.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Diabetes mellitus,16.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Diabetes mellitus,13.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Mental and behavioural disorders (F00-F99),27.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Mental and behavioural disorders (F00-F99),33.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Mental and behavioural disorders (F00-F99),32.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Mental and behavioural disorders (F00-F99),31.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Mental and behavioural disorders (F00-F99),33.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Mental and behavioural disorders (F00-F99),32.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Mental and behavioural disorders (F00-F99),35.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Mental and behavioural disorders (F00-F99),39.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Mental and behavioural disorders (F00-F99),36.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Mental and behavioural disorders (F00-F99),45.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),1.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Other ischaemic heart diseases,48.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Other ischaemic heart diseases,48.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Other ischaemic heart diseases,34.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Other ischaemic heart diseases,38.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Other ischaemic heart diseases,37.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Other ischaemic heart diseases,25.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Other ischaemic heart diseases,35.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Other ischaemic heart diseases,35.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Other ischaemic heart diseases,26.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Other ischaemic heart diseases,24.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,33.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,33.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,30.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,25.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,25.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,24.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,23.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,19.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,17.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,19.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Cerebrovascular diseases,73.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Cerebrovascular diseases,79.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Cerebrovascular diseases,68.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Cerebrovascular diseases,60.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Cerebrovascular diseases,59.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Cerebrovascular diseases,50.25,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Cerebrovascular diseases,52.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Cerebrovascular diseases,49.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Cerebrovascular diseases,42.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Cerebrovascular diseases,51.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2011,Chronic lower respiratory diseases,18.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Chronic lower respiratory diseases,13.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Chronic lower respiratory diseases,14.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Chronic lower respiratory diseases,15.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Chronic lower respiratory diseases,15.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Chronic lower respiratory diseases,15.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Chronic lower respiratory diseases,15.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Chronic lower respiratory diseases,18.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Chronic lower respiratory diseases,14.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Chronic lower respiratory diseases,18.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2012,Asthma and status asthmaticus,1.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2013,Asthma and status asthmaticus,0.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2014,Asthma and status asthmaticus,0.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2015,Asthma and status asthmaticus,0.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2016,Asthma and status asthmaticus,0.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2017,Asthma and status asthmaticus,0.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2018,Asthma and status asthmaticus,0.25,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2019,Asthma and status asthmaticus,0.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Females,2020,Asthma and status asthmaticus,0.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3079.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3215.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,2948.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,2950.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,2970.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,2843.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,2881.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,2884.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,2698.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3456.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",90.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",72.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",82.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",68.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",98.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",94.98,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",85.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",75.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",71.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",71.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",102.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",88.98,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",84.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",93.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Malignant melanoma of skin,16.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Malignant melanoma of skin,9.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Malignant melanoma of skin,9.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Malignant melanoma of skin,6.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Malignant melanoma of skin,7.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Malignant melanoma of skin,14.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Malignant melanoma of skin,12.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Malignant melanoma of skin,6.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Malignant melanoma of skin,10.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Malignant melanoma of skin,10.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Malignant neoplasm of breast,102.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Malignant neoplasm of breast,92.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Malignant neoplasm of breast,90.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Malignant neoplasm of breast,93.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Malignant neoplasm of breast,120.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Malignant neoplasm of breast,94.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Malignant neoplasm of breast,86.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Malignant neoplasm of breast,93.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Malignant neoplasm of breast,99.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Malignant neoplasm of breast,116.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Diabetes mellitus,39.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Diabetes mellitus,47.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Diabetes mellitus,48.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Diabetes mellitus,55.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Diabetes mellitus,44.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Diabetes mellitus,57.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Diabetes mellitus,62.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Diabetes mellitus,43.6,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Diabetes mellitus,83.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Diabetes mellitus,65.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),143.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),169.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),166.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),155.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),167.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),167.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),174.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),197.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),176.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),231.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),6.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),8.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),8.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),9.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),7.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),7.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),12.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Other ischaemic heart diseases,247.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Other ischaemic heart diseases,245.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Other ischaemic heart diseases,170.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Other ischaemic heart diseases,199.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Other ischaemic heart diseases,185.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Other ischaemic heart diseases,128.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Other ischaemic heart diseases,177.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Other ischaemic heart diseases,178.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Other ischaemic heart diseases,133.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Other ischaemic heart diseases,120.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,163.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,157.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,140.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,117.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,117.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,112.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,110.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,98.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,84.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,89.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Cerebrovascular diseases,372.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Cerebrovascular diseases,393.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Cerebrovascular diseases,348.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Cerebrovascular diseases,299.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Cerebrovascular diseases,295.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Cerebrovascular diseases,253.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Cerebrovascular diseases,258.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Cerebrovascular diseases,236.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Cerebrovascular diseases,200.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Cerebrovascular diseases,254.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2011,Chronic lower respiratory diseases,90.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Chronic lower respiratory diseases,58.25,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Chronic lower respiratory diseases,69.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Chronic lower respiratory diseases,74.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Chronic lower respiratory diseases,73.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Chronic lower respiratory diseases,79.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Chronic lower respiratory diseases,78.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Chronic lower respiratory diseases,94.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Chronic lower respiratory diseases,74.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Chronic lower respiratory diseases,92.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2012,Asthma and status asthmaticus,3.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2013,Asthma and status asthmaticus,2.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2014,Asthma and status asthmaticus,1.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2015,Asthma and status asthmaticus,1.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2016,Asthma and status asthmaticus,2.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2017,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2018,Asthma and status asthmaticus,1.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2019,Asthma and status asthmaticus,2.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Females,2020,Asthma and status asthmaticus,3.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,85.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,99.07,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,91.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,95.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,86.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,89.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,72.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,83.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,95.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,88.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",9.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",9.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",8.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",6.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",10.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",9.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",6.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",5.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",8.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",10.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Malignant melanoma of skin,0.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Malignant melanoma of skin,1.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Malignant melanoma of skin,2.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Malignant melanoma of skin,1.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Malignant melanoma of skin,0.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Malignant melanoma of skin,0.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Malignant melanoma of skin,0.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Malignant melanoma of skin,0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Malignant melanoma of skin,1.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Malignant neoplasm of breast,14.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Malignant neoplasm of breast,13.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Malignant neoplasm of breast,13.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Malignant neoplasm of breast,15.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Malignant neoplasm of breast,10.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Malignant neoplasm of breast,13.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Malignant neoplasm of breast,6.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Malignant neoplasm of breast,10.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Malignant neoplasm of breast,9.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Malignant neoplasm of breast,9.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Diabetes mellitus,1.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Diabetes mellitus,0.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Diabetes mellitus,1.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Diabetes mellitus,1.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Diabetes mellitus,1.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Diabetes mellitus,0.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),1.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,1.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,3.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,3.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,1.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,0.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Cerebrovascular diseases,1.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Cerebrovascular diseases,3.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Cerebrovascular diseases,0.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Cerebrovascular diseases,2.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Cerebrovascular diseases,2.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Cerebrovascular diseases,1.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Cerebrovascular diseases,2.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Cerebrovascular diseases,3.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Cerebrovascular diseases,4.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Cerebrovascular diseases,1.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2011,Chronic lower respiratory diseases,1.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Chronic lower respiratory diseases,2.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1045.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1056.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1015.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,997.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1041.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,987.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,964.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,922.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,923.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1082.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",44.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",61.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",73.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",67.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",57.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",57.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",66.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",46.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",56.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",44.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",42.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Malignant melanoma of skin,3.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Malignant melanoma of skin,3.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Malignant melanoma of skin,6.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Malignant melanoma of skin,2.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Malignant melanoma of skin,6.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Malignant melanoma of skin,3.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Malignant melanoma of skin,6.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Malignant melanoma of skin,5.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Malignant melanoma of skin,5.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Malignant melanoma of skin,3.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Malignant neoplasm of breast,0.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Malignant neoplasm of breast,0.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Malignant neoplasm of breast,0.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Malignant neoplasm of breast,0.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Malignant neoplasm of breast,1.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Malignant neoplasm of breast,0.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Diabetes mellitus,14.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Diabetes mellitus,8.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Diabetes mellitus,12.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Diabetes mellitus,15.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Diabetes mellitus,17.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Diabetes mellitus,16.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Diabetes mellitus,18.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Diabetes mellitus,12.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Diabetes mellitus,16.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Diabetes mellitus,18.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Mental and behavioural disorders (F00-F99),27.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Mental and behavioural disorders (F00-F99),25.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Mental and behavioural disorders (F00-F99),21.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Mental and behavioural disorders (F00-F99),29.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Mental and behavioural disorders (F00-F99),26.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Mental and behavioural disorders (F00-F99),39.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Mental and behavioural disorders (F00-F99),44.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Mental and behavioural disorders (F00-F99),33.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Mental and behavioural disorders (F00-F99),40.07,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Mental and behavioural disorders (F00-F99),35.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),4.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Other ischaemic heart diseases,70.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Other ischaemic heart diseases,72.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Other ischaemic heart diseases,70.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Other ischaemic heart diseases,69.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Other ischaemic heart diseases,75.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Other ischaemic heart diseases,54.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Other ischaemic heart diseases,63.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Other ischaemic heart diseases,45.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Other ischaemic heart diseases,56.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Other ischaemic heart diseases,45.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,71.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,77.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,67.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,71.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,53.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,55.07,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,57.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,39.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,50.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,53.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Cerebrovascular diseases,96.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Cerebrovascular diseases,73.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Cerebrovascular diseases,71.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Cerebrovascular diseases,70.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Cerebrovascular diseases,72.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Cerebrovascular diseases,60.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Cerebrovascular diseases,69.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Cerebrovascular diseases,62.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Cerebrovascular diseases,46.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Cerebrovascular diseases,63.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2011,Chronic lower respiratory diseases,57.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Chronic lower respiratory diseases,56.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Chronic lower respiratory diseases,55.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2014,Chronic lower respiratory diseases,47.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Chronic lower respiratory diseases,48.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Chronic lower respiratory diseases,29.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Chronic lower respiratory diseases,50.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Chronic lower respiratory diseases,36.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2019,Chronic lower respiratory diseases,42.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2020,Chronic lower respiratory diseases,34.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2012,Asthma and status asthmaticus,0.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2013,Asthma and status asthmaticus,0.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2015,Asthma and status asthmaticus,0.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2016,Asthma and status asthmaticus,1.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2017,Asthma and status asthmaticus,0.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Males,2018,Asthma and status asthmaticus,0.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,4677.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,4675.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4552.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4461.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4627.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4360.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4311.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,4111.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4154.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,4890.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",170.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",183.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",144.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",162.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",194.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",131.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",135.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",269.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",282.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",298.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",252.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",225.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",294.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",199.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",239.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",197.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",176.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Malignant melanoma of skin,13.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Malignant melanoma of skin,12.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Malignant melanoma of skin,26.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Malignant melanoma of skin,11.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Malignant melanoma of skin,24.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Malignant melanoma of skin,8.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Malignant melanoma of skin,22.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Malignant melanoma of skin,23.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Malignant melanoma of skin,17.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Malignant melanoma of skin,13.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Malignant neoplasm of breast,2.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Malignant neoplasm of breast,2.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Malignant neoplasm of breast,3.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Malignant neoplasm of breast,4.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Malignant neoplasm of breast,6.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Malignant neoplasm of breast,2.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Diabetes mellitus,67.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Diabetes mellitus,37.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Diabetes mellitus,56.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Diabetes mellitus,68.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Diabetes mellitus,86.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Diabetes mellitus,78.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Diabetes mellitus,88.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Diabetes mellitus,61.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Diabetes mellitus,79.6,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Diabetes mellitus,83.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),135.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),129.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),107.83,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),144.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),133.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),193.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),221.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),166.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),201.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),168.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),2.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),4.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),6.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),16.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),5.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),11.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),6.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Other ischaemic heart diseases,345.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Other ischaemic heart diseases,344.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Other ischaemic heart diseases,340.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Other ischaemic heart diseases,348.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Other ischaemic heart diseases,364.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Other ischaemic heart diseases,263.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Other ischaemic heart diseases,313.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Other ischaemic heart diseases,227.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Other ischaemic heart diseases,266.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Other ischaemic heart diseases,222.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,298.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,316.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,291.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,313.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,217.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,236.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,236.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,160.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,215.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,216.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Cerebrovascular diseases,471.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Cerebrovascular diseases,366.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Cerebrovascular diseases,355.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Cerebrovascular diseases,353.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Cerebrovascular diseases,353.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Cerebrovascular diseases,302.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Cerebrovascular diseases,339.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Cerebrovascular diseases,307.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Cerebrovascular diseases,223.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Cerebrovascular diseases,312.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2011,Chronic lower respiratory diseases,288.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Chronic lower respiratory diseases,288.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Chronic lower respiratory diseases,273.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2014,Chronic lower respiratory diseases,233.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Chronic lower respiratory diseases,244.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Chronic lower respiratory diseases,141.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Chronic lower respiratory diseases,254.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Chronic lower respiratory diseases,173.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2019,Chronic lower respiratory diseases,210.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2020,Chronic lower respiratory diseases,171.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2012,Asthma and status asthmaticus,2.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2013,Asthma and status asthmaticus,4.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2015,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2016,Asthma and status asthmaticus,5.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2017,Asthma and status asthmaticus,2.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Males,2018,Asthma and status asthmaticus,1.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,166.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,179.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,158.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,158.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,173.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,170.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,154.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,150.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,141.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,160.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",11.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",23.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",11.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",10.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",16.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",11.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",9.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",11.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",7.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",10.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Malignant melanoma of skin,1.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Malignant melanoma of skin,1.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Malignant melanoma of skin,1.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Malignant melanoma of skin,0.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Malignant melanoma of skin,2.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Malignant melanoma of skin,1.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Malignant melanoma of skin,2.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Malignant melanoma of skin,0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Malignant melanoma of skin,2.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Malignant melanoma of skin,0.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Diabetes mellitus,1.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Diabetes mellitus,1.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Diabetes mellitus,2.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Diabetes mellitus,2.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Diabetes mellitus,1.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Diabetes mellitus,1.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Diabetes mellitus,1.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Diabetes mellitus,1.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Diabetes mellitus,0.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Diabetes mellitus,2.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),1.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),0.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),1.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),2.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),3.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Other ischaemic heart diseases,4.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Other ischaemic heart diseases,6.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Other ischaemic heart diseases,4.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Other ischaemic heart diseases,1.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Other ischaemic heart diseases,5.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Other ischaemic heart diseases,4.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Other ischaemic heart diseases,3.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Other ischaemic heart diseases,1.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Other ischaemic heart diseases,5.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,16.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,20.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,13.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,12.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,13.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,11.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,13.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,9.98,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,10.07,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,14.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Cerebrovascular diseases,4.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Cerebrovascular diseases,2.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Cerebrovascular diseases,2.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Cerebrovascular diseases,2.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Cerebrovascular diseases,4.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Cerebrovascular diseases,2.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Cerebrovascular diseases,3.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Cerebrovascular diseases,3.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Cerebrovascular diseases,3.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Cerebrovascular diseases,3.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2011,Chronic lower respiratory diseases,1.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Chronic lower respiratory diseases,0.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2014,Chronic lower respiratory diseases,2.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Chronic lower respiratory diseases,1.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Chronic lower respiratory diseases,0.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2019,Chronic lower respiratory diseases,1.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2020,Chronic lower respiratory diseases,1.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,825.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,851.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,800.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,794.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,807.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,775.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,767.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,753.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,737.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,895.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",41.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",46.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",41.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",36.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",37.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",41.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",34.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",37.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",32.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",33.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Malignant melanoma of skin,3.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Malignant melanoma of skin,3.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Malignant melanoma of skin,4.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Malignant melanoma of skin,2.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Malignant melanoma of skin,4.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Malignant melanoma of skin,3.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Malignant melanoma of skin,4.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Malignant melanoma of skin,2.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Malignant melanoma of skin,3.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Malignant melanoma of skin,2.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Malignant neoplasm of breast,18.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Malignant neoplasm of breast,16.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Malignant neoplasm of breast,16.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Malignant neoplasm of breast,17.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Malignant neoplasm of breast,17.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Malignant neoplasm of breast,16.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Malignant neoplasm of breast,12.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Malignant neoplasm of breast,14.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Malignant neoplasm of breast,15.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Malignant neoplasm of breast,17.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Diabetes mellitus,11.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Diabetes mellitus,9.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Diabetes mellitus,11.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Diabetes mellitus,13.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Diabetes mellitus,11.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Diabetes mellitus,13.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Diabetes mellitus,14.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Diabetes mellitus,11.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Diabetes mellitus,16.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Diabetes mellitus,15.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Mental and behavioural disorders (F00-F99),28.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Mental and behavioural disorders (F00-F99),31.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Mental and behavioural disorders (F00-F99),28.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Mental and behavioural disorders (F00-F99),31.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Mental and behavioural disorders (F00-F99),31.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Mental and behavioural disorders (F00-F99),35.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Mental and behavioural disorders (F00-F99),39.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Mental and behavioural disorders (F00-F99),37.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Mental and behavioural disorders (F00-F99),37.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Mental and behavioural disorders (F00-F99),43.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Other ischaemic heart diseases,58.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Other ischaemic heart diseases,57.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Other ischaemic heart diseases,47.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Other ischaemic heart diseases,51.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Other ischaemic heart diseases,50.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Other ischaemic heart diseases,36.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Other ischaemic heart diseases,46.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Other ischaemic heart diseases,39.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Other ischaemic heart diseases,38.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Other ischaemic heart diseases,32.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,50.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,52.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,46.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,43.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,36.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,36.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,37.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,28.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,31.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,34.53,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Cerebrovascular diseases,82.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Cerebrovascular diseases,77.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Cerebrovascular diseases,72.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Cerebrovascular diseases,63.89,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Cerebrovascular diseases,64.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Cerebrovascular diseases,54.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Cerebrovascular diseases,59.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Cerebrovascular diseases,55.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Cerebrovascular diseases,44.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Cerebrovascular diseases,56.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2011,Chronic lower respiratory diseases,32.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Chronic lower respiratory diseases,27.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Chronic lower respiratory diseases,28.38,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Chronic lower respiratory diseases,27.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Chronic lower respiratory diseases,26.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Chronic lower respiratory diseases,22.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Chronic lower respiratory diseases,27.98,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Chronic lower respiratory diseases,25.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Chronic lower respiratory diseases,24.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Chronic lower respiratory diseases,24.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2012,Asthma and status asthmaticus,0.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2013,Asthma and status asthmaticus,0.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2014,Asthma and status asthmaticus,0.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2015,Asthma and status asthmaticus,0.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2016,Asthma and status asthmaticus,0.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2017,Asthma and status asthmaticus,0.31,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2018,Asthma and status asthmaticus,0.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2019,Asthma and status asthmaticus,0.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Total,Total,2020,Asthma and status asthmaticus,0.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,3715.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,3792.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,3586.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3553.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3604.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3443.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3466.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3380.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3292.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4078.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",125.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",127.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.32,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.25,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",89.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",171.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",171.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",171.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",148.93,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",137.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",168.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",142.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",155.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",134.72,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",129.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Malignant melanoma of skin,14.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Malignant melanoma of skin,11.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Malignant melanoma of skin,17.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Malignant melanoma of skin,8.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Malignant melanoma of skin,14.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Malignant melanoma of skin,12.45,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Malignant melanoma of skin,16.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Malignant melanoma of skin,12.43,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Malignant melanoma of skin,11.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Malignant melanoma of skin,11.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Malignant neoplasm of breast,62.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Malignant neoplasm of breast,57.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Malignant neoplasm of breast,54.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Malignant neoplasm of breast,55.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Malignant neoplasm of breast,71.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Malignant neoplasm of breast,57.75,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Malignant neoplasm of breast,51.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Malignant neoplasm of breast,54.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Malignant neoplasm of breast,61.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Malignant neoplasm of breast,68.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Diabetes mellitus,49.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Diabetes mellitus,45.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Diabetes mellitus,52.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Diabetes mellitus,62.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Diabetes mellitus,55.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Diabetes mellitus,67.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Diabetes mellitus,74.06,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Diabetes mellitus,53.29,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Diabetes mellitus,84.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Diabetes mellitus,74.56,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),143.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),156.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),145.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),156.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),159.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),178.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),194.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),187.86,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),185.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),211.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),4.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),6.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),4.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),7.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),12.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),6.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),8.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),10.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Other ischaemic heart diseases,291.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Other ischaemic heart diseases,280.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Other ischaemic heart diseases,231.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Other ischaemic heart diseases,260.48,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Other ischaemic heart diseases,244.12,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Other ischaemic heart diseases,178.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Other ischaemic heart diseases,230.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Other ischaemic heart diseases,200.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Other ischaemic heart diseases,185.34,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Other ischaemic heart diseases,160.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,222.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,222.03,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,204.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,190.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,155.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,158.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,160.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,125.6,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,138.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,143.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Cerebrovascular diseases,409.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Cerebrovascular diseases,384.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Cerebrovascular diseases,362.22,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Cerebrovascular diseases,317.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Cerebrovascular diseases,314.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Cerebrovascular diseases,275.7,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Cerebrovascular diseases,290.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Cerebrovascular diseases,267.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Cerebrovascular diseases,214.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Cerebrovascular diseases,279.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2011,Chronic lower respiratory diseases,159.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Chronic lower respiratory diseases,133.8,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Chronic lower respiratory diseases,139.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Chronic lower respiratory diseases,133.41,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Chronic lower respiratory diseases,132.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Chronic lower respiratory diseases,107.81,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Chronic lower respiratory diseases,141.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Chronic lower respiratory diseases,123.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Chronic lower respiratory diseases,122.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Chronic lower respiratory diseases,121.58,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2012,Asthma and status asthmaticus,3.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2013,Asthma and status asthmaticus,4.01,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2014,Asthma and status asthmaticus,0.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2015,Asthma and status asthmaticus,1.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2016,Asthma and status asthmaticus,3.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2017,Asthma and status asthmaticus,0.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2018,Asthma and status asthmaticus,1.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2019,Asthma and status asthmaticus,1.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,65 years or over,Total,2020,Asthma and status asthmaticus,2.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,125.54,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,138.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,125.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,126.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,129.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,129.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,113.16,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,116.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,118.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,124.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.78,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.65,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.4,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.61,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.26,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",10.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",16.23,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",9.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",8.64,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",13.69,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",10.74,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",8.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",8.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",8.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",10.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Malignant melanoma of skin,1.13,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Malignant melanoma of skin,1.67,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Malignant melanoma of skin,1.66,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Malignant melanoma of skin,0.82,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Malignant melanoma of skin,1.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Malignant melanoma of skin,1.19,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Malignant melanoma of skin,1.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Malignant melanoma of skin,0.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Malignant melanoma of skin,2.08,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Malignant melanoma of skin,0.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Malignant neoplasm of breast,7.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Malignant neoplasm of breast,6.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Malignant neoplasm of breast,5.02,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Malignant neoplasm of breast,6.96,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Malignant neoplasm of breast,3.37,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Malignant neoplasm of breast,4.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Malignant neoplasm of breast,4.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Diabetes mellitus,1.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Diabetes mellitus,0.94,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Diabetes mellitus,1.35,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Diabetes mellitus,2.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Diabetes mellitus,1.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Diabetes mellitus,0.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Diabetes mellitus,0.68,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Diabetes mellitus,1.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Diabetes mellitus,0.44,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Diabetes mellitus,1.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.9,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.49,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),1.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.14,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.88,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),1.59,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),2.17,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Other ischaemic heart diseases,2.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Other ischaemic heart diseases,3.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Other ischaemic heart diseases,2.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Other ischaemic heart diseases,0.77,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Other ischaemic heart diseases,3.3,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.04,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Other ischaemic heart diseases,2.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Other ischaemic heart diseases,1.05,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.84,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.63,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.95,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,11.85,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,8.62,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,7.83,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,8.1,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,6.71,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,7.79,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,5.5,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,8.11,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Cerebrovascular diseases,2.99,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Cerebrovascular diseases,3.09,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Cerebrovascular diseases,1.97,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Cerebrovascular diseases,2.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Cerebrovascular diseases,3.76,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Cerebrovascular diseases,1.52,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Cerebrovascular diseases,3.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Cerebrovascular diseases,3.57,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Cerebrovascular diseases,3.92,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Cerebrovascular diseases,2.55,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.39,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Chronic lower respiratory diseases,1.36,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.42,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.27,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.51,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Chronic lower respiratory diseases,0.47,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.15,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.18,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.91,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.46,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.2,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.24,Rate
Provincia Autonoma di Bolzano/Bozen,ITH1,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,642.5,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,641.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,641.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,612.75,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,645.99,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,602.58,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,619.77,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,605.4,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,577.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,743.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.81,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.37,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.55,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.62,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.95,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.42,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.95,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",29.8,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",24.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",20.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",21.3,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",21.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",24.16,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",22.1,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",21.35,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",19.82,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",22.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Malignant melanoma of skin,2.19,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Malignant melanoma of skin,2.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Malignant melanoma of skin,3.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Malignant melanoma of skin,3.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Malignant melanoma of skin,4.29,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Malignant melanoma of skin,1.35,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Malignant melanoma of skin,2.07,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Malignant melanoma of skin,0.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Malignant melanoma of skin,0.97,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Malignant melanoma of skin,1.79,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Malignant neoplasm of breast,32.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Malignant neoplasm of breast,28.47,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Malignant neoplasm of breast,33.99,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Malignant neoplasm of breast,26.84,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Malignant neoplasm of breast,33.18,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Malignant neoplasm of breast,25.84,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Malignant neoplasm of breast,31.49,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Malignant neoplasm of breast,31.39,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Malignant neoplasm of breast,30.82,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Malignant neoplasm of breast,30.25,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Diabetes mellitus,15.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Diabetes mellitus,17.36,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Diabetes mellitus,16.6,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Diabetes mellitus,15.75,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Diabetes mellitus,16.01,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Diabetes mellitus,12.37,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Diabetes mellitus,14.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Diabetes mellitus,14.18,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Diabetes mellitus,14.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Diabetes mellitus,19.28,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Mental and behavioural disorders (F00-F99),23.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Mental and behavioural disorders (F00-F99),26.71,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Mental and behavioural disorders (F00-F99),26.84,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Mental and behavioural disorders (F00-F99),24.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Mental and behavioural disorders (F00-F99),22.53,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Mental and behavioural disorders (F00-F99),25.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Mental and behavioural disorders (F00-F99),30.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Mental and behavioural disorders (F00-F99),29.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Mental and behavioural disorders (F00-F99),29.6,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Mental and behavioural disorders (F00-F99),31.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.94,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),2.52,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.02,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.11,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),3.21,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),4.18,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Other ischaemic heart diseases,59.8,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Other ischaemic heart diseases,60.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Other ischaemic heart diseases,52.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Other ischaemic heart diseases,46.47,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Other ischaemic heart diseases,55.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Other ischaemic heart diseases,46.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Other ischaemic heart diseases,47.85,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Other ischaemic heart diseases,44.21,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Other ischaemic heart diseases,38.77,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Other ischaemic heart diseases,38.18,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,26.1,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,27.62,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,27.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,30.13,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,26.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,20.6,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,18.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,15.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,14.08,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,14.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Cerebrovascular diseases,49.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Cerebrovascular diseases,50.95,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Cerebrovascular diseases,42.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Cerebrovascular diseases,45.3,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Cerebrovascular diseases,51.93,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Cerebrovascular diseases,44.52,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Cerebrovascular diseases,42.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Cerebrovascular diseases,43.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Cerebrovascular diseases,43.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Cerebrovascular diseases,42.38,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Chronic lower respiratory diseases,16.69,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Chronic lower respiratory diseases,16.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Chronic lower respiratory diseases,17.37,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Chronic lower respiratory diseases,10.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Chronic lower respiratory diseases,10.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Chronic lower respiratory diseases,13.49,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2017,Chronic lower respiratory diseases,13.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Chronic lower respiratory diseases,14.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2019,Chronic lower respiratory diseases,10.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2020,Chronic lower respiratory diseases,15.1,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2011,Asthma and status asthmaticus,0.37,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2012,Asthma and status asthmaticus,0.25,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2013,Asthma and status asthmaticus,0.69,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2014,Asthma and status asthmaticus,0.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2015,Asthma and status asthmaticus,0.89,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2016,Asthma and status asthmaticus,0.19,Rate
Provincia Autonoma di Trento,ITH2,Total,Females,2018,Asthma and status asthmaticus,0.19,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,2896.91,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,2893.96,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,2926.87,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,2824.71,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,2958.33,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,2784.98,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,2856.26,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,2751.2,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,2678.71,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3467.53,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.92,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",76.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.08,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.6,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.85,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.31,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.44,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",62.1,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.19,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",75.18,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",121.64,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",94.31,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",76.79,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",83.57,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",83.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",90.15,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",89.21,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",83.79,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",81.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",94.41,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Malignant melanoma of skin,7.59,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Malignant melanoma of skin,9.78,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Malignant melanoma of skin,12.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Malignant melanoma of skin,8.94,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Malignant melanoma of skin,14.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Malignant melanoma of skin,5.15,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Malignant melanoma of skin,8.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Malignant melanoma of skin,3.05,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Malignant melanoma of skin,3.26,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Malignant melanoma of skin,5.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Malignant neoplasm of breast,115.19,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Malignant neoplasm of breast,93.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Malignant neoplasm of breast,125.76,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Malignant neoplasm of breast,94.8,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Malignant neoplasm of breast,112.27,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Malignant neoplasm of breast,96.83,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Malignant neoplasm of breast,107.12,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Malignant neoplasm of breast,113.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Malignant neoplasm of breast,111.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Malignant neoplasm of breast,105.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Diabetes mellitus,79.16,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Diabetes mellitus,85.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Diabetes mellitus,81.55,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Diabetes mellitus,76.95,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Diabetes mellitus,78.32,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Diabetes mellitus,63.42,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Diabetes mellitus,75.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Diabetes mellitus,71.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Diabetes mellitus,64.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Diabetes mellitus,97.18,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),112.22,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),133.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),133.57,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),124.68,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),111.89,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),128.56,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),152.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),151.5,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),151.79,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),159.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),11.09,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),8.99,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),8.44,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),8.86,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),15.97,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),14.59,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),10.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),21.43,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),13.63,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),11.92,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Other ischaemic heart diseases,304.74,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Other ischaemic heart diseases,306.19,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Other ischaemic heart diseases,271.26,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Other ischaemic heart diseases,234.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Other ischaemic heart diseases,278.74,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Other ischaemic heart diseases,237.06,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Other ischaemic heart diseases,241.9,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Other ischaemic heart diseases,223.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Other ischaemic heart diseases,191.97,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Other ischaemic heart diseases,190.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,127.95,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,128.78,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,135.14,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,143.05,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,123.06,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,103.79,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,91.78,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,71.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,68.85,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,64.67,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Cerebrovascular diseases,242.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Cerebrovascular diseases,249.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Cerebrovascular diseases,205.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Cerebrovascular diseases,219.47,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Cerebrovascular diseases,255.63,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Cerebrovascular diseases,223.09,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Cerebrovascular diseases,209.37,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Cerebrovascular diseases,206.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Cerebrovascular diseases,209.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Cerebrovascular diseases,210.34,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Chronic lower respiratory diseases,85.57,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Chronic lower respiratory diseases,82.1,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Chronic lower respiratory diseases,85.18,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Chronic lower respiratory diseases,54.59,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Chronic lower respiratory diseases,48.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Chronic lower respiratory diseases,69.19,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2017,Chronic lower respiratory diseases,67.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Chronic lower respiratory diseases,75.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2019,Chronic lower respiratory diseases,55.98,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2020,Chronic lower respiratory diseases,77.45,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2011,Asthma and status asthmaticus,1.91,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2012,Asthma and status asthmaticus,1.27,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2013,Asthma and status asthmaticus,3.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2014,Asthma and status asthmaticus,2.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2015,Asthma and status asthmaticus,2.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2016,Asthma and status asthmaticus,0.99,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Females,2018,Asthma and status asthmaticus,0.99,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,96.4,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,95.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,88.23,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,76.93,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,85.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,73.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,78.01,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,85.61,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,69.03,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,84.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.67,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.85,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.11,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.15,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.98,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.93,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.87,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",1.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",2.78,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",7.55,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",7.01,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",6.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",6.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",6.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",8.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",5.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",6.23,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",4.87,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",5.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Malignant melanoma of skin,0.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Malignant melanoma of skin,0.87,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Malignant melanoma of skin,1.79,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Malignant melanoma of skin,1.67,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Malignant melanoma of skin,1.75,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Malignant melanoma of skin,0.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Malignant melanoma of skin,0.55,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Malignant melanoma of skin,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Malignant melanoma of skin,0.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Malignant melanoma of skin,0.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Malignant neoplasm of breast,12.67,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Malignant neoplasm of breast,12.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Malignant neoplasm of breast,11.76,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Malignant neoplasm of breast,10.38,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Malignant neoplasm of breast,14.02,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Malignant neoplasm of breast,8.64,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Malignant neoplasm of breast,13.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.44,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Malignant neoplasm of breast,11.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Malignant neoplasm of breast,11.99,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Diabetes mellitus,0.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Diabetes mellitus,0.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Diabetes mellitus,0.93,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Diabetes mellitus,0.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Diabetes mellitus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Diabetes mellitus,0.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Diabetes mellitus,2.12,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Diabetes mellitus,0.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.95,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.98,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.52,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.28,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.83,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.95,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.47,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.48,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Other ischaemic heart diseases,0.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.66,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Other ischaemic heart diseases,1.28,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,1.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,3.11,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,1.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.78,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.54,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,0.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.12,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,0.81,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.07,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Cerebrovascular diseases,3.26,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Cerebrovascular diseases,2.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Cerebrovascular diseases,2.68,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Cerebrovascular diseases,3.11,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Cerebrovascular diseases,2.59,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Cerebrovascular diseases,1.26,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Cerebrovascular diseases,2.36,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Cerebrovascular diseases,3.48,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Cerebrovascular diseases,3.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Cerebrovascular diseases,1.69,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Chronic lower respiratory diseases,1.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2017,Chronic lower respiratory diseases,0.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1081.85,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1040.56,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1053.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,998.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,999.98,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,975.58,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,969.14,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,880.87,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,923.34,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1206.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.88,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.53,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.68,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.68,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.51,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.06,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.96,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.02,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",78.85,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",77.52,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",79.34,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",73.41,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",61.89,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",65.05,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",65.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",57.29,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",57.8,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",52.11,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Malignant melanoma of skin,3.53,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Malignant melanoma of skin,6.62,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Malignant melanoma of skin,4.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Malignant melanoma of skin,4.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Malignant melanoma of skin,4.11,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Malignant melanoma of skin,4.26,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Malignant melanoma of skin,3.11,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Malignant melanoma of skin,3.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Malignant melanoma of skin,4.87,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Malignant melanoma of skin,3.74,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Malignant neoplasm of breast,0.89,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Malignant neoplasm of breast,0.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Malignant neoplasm of breast,0.77,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Malignant neoplasm of breast,1.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Malignant neoplasm of breast,0.71,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Malignant neoplasm of breast,0.36,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Diabetes mellitus,29.32,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Diabetes mellitus,24.62,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Diabetes mellitus,25.2,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Diabetes mellitus,19.1,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Diabetes mellitus,26.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Diabetes mellitus,20.98,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Diabetes mellitus,19.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Diabetes mellitus,19.87,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Diabetes mellitus,20.5,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Diabetes mellitus,24.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Mental and behavioural disorders (F00-F99),19.13,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Mental and behavioural disorders (F00-F99),27.42,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Mental and behavioural disorders (F00-F99),27.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Mental and behavioural disorders (F00-F99),27.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Mental and behavioural disorders (F00-F99),18.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Mental and behavioural disorders (F00-F99),24.51,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Mental and behavioural disorders (F00-F99),30.46,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Mental and behavioural disorders (F00-F99),34.12,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Mental and behavioural disorders (F00-F99),29.78,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Mental and behavioural disorders (F00-F99),33.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),1.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),4.97,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),6.76,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.78,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.95,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),4.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.37,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.51,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Other ischaemic heart diseases,112.96,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Other ischaemic heart diseases,103.63,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Other ischaemic heart diseases,102.79,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Other ischaemic heart diseases,85.26,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Other ischaemic heart diseases,90.8,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Other ischaemic heart diseases,75.77,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Other ischaemic heart diseases,80.63,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Other ischaemic heart diseases,64.72,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Other ischaemic heart diseases,65.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Other ischaemic heart diseases,72.72,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,68.58,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,62.01,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,63.75,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,53.07,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,54.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,46.17,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,41.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,30.71,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,35.87,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,32.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Cerebrovascular diseases,68.31,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Cerebrovascular diseases,61.97,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Cerebrovascular diseases,60.43,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Cerebrovascular diseases,48.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Cerebrovascular diseases,56.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Cerebrovascular diseases,64.6,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Cerebrovascular diseases,58.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Cerebrovascular diseases,50.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Cerebrovascular diseases,56.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Cerebrovascular diseases,54.2,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Chronic lower respiratory diseases,54.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Chronic lower respiratory diseases,38.89,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2013,Chronic lower respiratory diseases,30.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2014,Chronic lower respiratory diseases,36.42,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Chronic lower respiratory diseases,30.56,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2016,Chronic lower respiratory diseases,47.68,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2017,Chronic lower respiratory diseases,31.99,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Chronic lower respiratory diseases,30.41,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2019,Chronic lower respiratory diseases,31.82,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Chronic lower respiratory diseases,36.74,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2011,Asthma and status asthmaticus,1.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2012,Asthma and status asthmaticus,0.41,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2015,Asthma and status asthmaticus,0.4,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2018,Asthma and status asthmaticus,1.24,Rate
Provincia Autonoma di Trento,ITH2,Total,Males,2020,Asthma and status asthmaticus,0.34,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,4838.98,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,4632.98,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,4744.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4530.9,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,4464.62,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,4370.38,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4381.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,3934.87,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4102.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5569.9,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",196.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",144.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.2,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.42,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.94,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.09,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.2,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.57,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",323.33,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",339.46,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",333.37,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",327.69,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",275.4,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",276.34,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",269.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",245.65,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",255.02,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",238.12,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Malignant melanoma of skin,8.86,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Malignant melanoma of skin,18.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Malignant melanoma of skin,17.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Malignant melanoma of skin,19.43,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Malignant melanoma of skin,10.16,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Malignant melanoma of skin,12.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Malignant melanoma of skin,14.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Malignant melanoma of skin,16.05,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Malignant melanoma of skin,13.42,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Malignant melanoma of skin,15.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Malignant neoplasm of breast,4.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Malignant neoplasm of breast,2.27,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Malignant neoplasm of breast,2.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Malignant neoplasm of breast,4.65,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Malignant neoplasm of breast,3.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Malignant neoplasm of breast,1.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Diabetes mellitus,141.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Diabetes mellitus,111.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Diabetes mellitus,119.86,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Diabetes mellitus,88.83,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Diabetes mellitus,131.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Diabetes mellitus,96.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Diabetes mellitus,99.91,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Diabetes mellitus,100.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Diabetes mellitus,98.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Diabetes mellitus,108.77,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),92.73,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),133.88,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),128.49,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),122.16,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),95.05,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),118.16,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),147.08,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),165.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),147.47,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),159.35,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),9.67,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),6.89,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),19.99,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),25.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),8.28,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),7.47,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),12.95,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),20.8,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),13.96,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),14.04,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Other ischaemic heart diseases,568.26,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Other ischaemic heart diseases,513.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Other ischaemic heart diseases,515.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Other ischaemic heart diseases,424.32,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Other ischaemic heart diseases,445.07,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Other ischaemic heart diseases,372.09,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Other ischaemic heart diseases,404.6,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Other ischaemic heart diseases,317.37,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Other ischaemic heart diseases,324.11,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Other ischaemic heart diseases,362.86,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,284.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,265.12,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,293.73,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,235.68,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,229.18,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,196.97,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,174.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,131.34,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,142.99,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,134.61,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Cerebrovascular diseases,339.46,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Cerebrovascular diseases,310.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Cerebrovascular diseases,304.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Cerebrovascular diseases,240.44,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Cerebrovascular diseases,273.8,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Cerebrovascular diseases,314.55,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Cerebrovascular diseases,276.58,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Cerebrovascular diseases,237.46,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Cerebrovascular diseases,277.94,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Cerebrovascular diseases,251.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Chronic lower respiratory diseases,270.3,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Chronic lower respiratory diseases,195.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2013,Chronic lower respiratory diseases,150.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2014,Chronic lower respiratory diseases,182.93,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Chronic lower respiratory diseases,151.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2016,Chronic lower respiratory diseases,235.35,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2017,Chronic lower respiratory diseases,158.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Chronic lower respiratory diseases,141.3,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2019,Chronic lower respiratory diseases,158.21,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Chronic lower respiratory diseases,186.67,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2011,Asthma and status asthmaticus,7.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2012,Asthma and status asthmaticus,2.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2015,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2018,Asthma and status asthmaticus,2.71,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Males,2020,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,171.74,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,170.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,159.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,143.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,160.72,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,153.23,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,142.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,141.08,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,153.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,149.09,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.97,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.24,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.68,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.28,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.98,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.09,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",19.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",14.06,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",17.81,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",11.81,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",10.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",13.87,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",15.72,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",11.66,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",10.03,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",7.06,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Malignant melanoma of skin,2.24,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Malignant melanoma of skin,3.79,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Malignant melanoma of skin,1.65,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Malignant melanoma of skin,1.29,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Malignant melanoma of skin,2.64,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Malignant melanoma of skin,2.18,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Malignant melanoma of skin,0.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Malignant melanoma of skin,0.91,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Malignant melanoma of skin,2.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Malignant melanoma of skin,0.82,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Diabetes mellitus,2.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Diabetes mellitus,3.69,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Diabetes mellitus,2.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Diabetes mellitus,2.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Diabetes mellitus,1.38,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Diabetes mellitus,2.71,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Diabetes mellitus,0.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Diabetes mellitus,0.46,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Diabetes mellitus,1.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Diabetes mellitus,3.65,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),1.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),1.64,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),2.7,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),4.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),1.83,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),2.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),2.26,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),1.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),3.12,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.81,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),1.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),2.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.77,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),2.2,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Other ischaemic heart diseases,2.67,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Other ischaemic heart diseases,4.27,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Other ischaemic heart diseases,2.73,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.12,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Other ischaemic heart diseases,4.98,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Other ischaemic heart diseases,4.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Other ischaemic heart diseases,2.15,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Other ischaemic heart diseases,3.51,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Other ischaemic heart diseases,3.38,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.44,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,16.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,12.81,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,8.04,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,8.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,12.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,9.64,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,8.96,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,6.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,9.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,8.28,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Cerebrovascular diseases,2.62,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Cerebrovascular diseases,1.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Cerebrovascular diseases,1.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Cerebrovascular diseases,2.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Cerebrovascular diseases,3.24,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Cerebrovascular diseases,4.05,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Cerebrovascular diseases,5.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Cerebrovascular diseases,4.6,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Cerebrovascular diseases,2.97,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Cerebrovascular diseases,6.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Chronic lower respiratory diseases,2.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Chronic lower respiratory diseases,0.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2013,Chronic lower respiratory diseases,1.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2014,Chronic lower respiratory diseases,0.93,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Chronic lower respiratory diseases,1.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2016,Chronic lower respiratory diseases,2.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2017,Chronic lower respiratory diseases,1.41,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Chronic lower respiratory diseases,3.54,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2019,Chronic lower respiratory diseases,1.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.52,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.5,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.42,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,809.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,800.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,804.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,763.94,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,793.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,755.74,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,759.78,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,726.0,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,720.47,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,931.68,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.71,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.16,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.48,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.14,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.91,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.29,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",19.05,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.84,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",50.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",46.36,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",45.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",42.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",38.39,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",41.16,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",40.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",36.33,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",36.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",35.83,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Malignant melanoma of skin,2.94,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Malignant melanoma of skin,4.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Malignant melanoma of skin,4.36,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Malignant melanoma of skin,3.72,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Malignant melanoma of skin,4.39,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Malignant melanoma of skin,2.68,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Malignant melanoma of skin,2.5,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Malignant melanoma of skin,2.07,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Malignant melanoma of skin,2.74,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Malignant melanoma of skin,2.57,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Malignant neoplasm of breast,19.3,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Malignant neoplasm of breast,16.56,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Malignant neoplasm of breast,19.86,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Malignant neoplasm of breast,15.94,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Malignant neoplasm of breast,18.81,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Malignant neoplasm of breast,15.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Malignant neoplasm of breast,18.56,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Malignant neoplasm of breast,18.26,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Malignant neoplasm of breast,17.55,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Malignant neoplasm of breast,17.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Diabetes mellitus,21.14,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Diabetes mellitus,21.07,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Diabetes mellitus,20.49,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Diabetes mellitus,17.97,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Diabetes mellitus,19.67,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Diabetes mellitus,16.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Diabetes mellitus,16.79,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Diabetes mellitus,17.11,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Diabetes mellitus,16.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Diabetes mellitus,21.46,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Mental and behavioural disorders (F00-F99),22.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Mental and behavioural disorders (F00-F99),27.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Mental and behavioural disorders (F00-F99),28.72,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Mental and behavioural disorders (F00-F99),26.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Mental and behavioural disorders (F00-F99),21.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Mental and behavioural disorders (F00-F99),26.06,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Mental and behavioural disorders (F00-F99),31.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Mental and behavioural disorders (F00-F99),32.21,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Mental and behavioural disorders (F00-F99),29.88,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Mental and behavioural disorders (F00-F99),33.18,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.7,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.36,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),3.92,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.75,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),4.44,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.57,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Other ischaemic heart diseases,77.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Other ischaemic heart diseases,75.6,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Other ischaemic heart diseases,69.27,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Other ischaemic heart diseases,60.28,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Other ischaemic heart diseases,69.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Other ischaemic heart diseases,57.77,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Other ischaemic heart diseases,60.15,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Other ischaemic heart diseases,52.95,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Other ischaemic heart diseases,48.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Other ischaemic heart diseases,51.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,43.55,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,41.51,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,41.54,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,38.45,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,38.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,32.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,28.49,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,22.65,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,23.4,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,22.61,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Cerebrovascular diseases,56.33,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Cerebrovascular diseases,55.99,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Cerebrovascular diseases,49.66,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Cerebrovascular diseases,47.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Cerebrovascular diseases,54.35,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Cerebrovascular diseases,52.69,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Cerebrovascular diseases,48.59,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Cerebrovascular diseases,46.32,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Cerebrovascular diseases,48.73,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Cerebrovascular diseases,47.23,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Chronic lower respiratory diseases,28.31,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Chronic lower respiratory diseases,23.53,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Chronic lower respiratory diseases,22.04,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Chronic lower respiratory diseases,19.09,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Chronic lower respiratory diseases,16.84,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Chronic lower respiratory diseases,25.51,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2017,Chronic lower respiratory diseases,20.03,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Chronic lower respiratory diseases,20.69,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2019,Chronic lower respiratory diseases,17.81,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Chronic lower respiratory diseases,22.88,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2011,Asthma and status asthmaticus,0.9,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2012,Asthma and status asthmaticus,0.31,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2013,Asthma and status asthmaticus,0.39,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2014,Asthma and status asthmaticus,0.34,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2015,Asthma and status asthmaticus,0.78,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2016,Asthma and status asthmaticus,0.13,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2018,Asthma and status asthmaticus,0.62,Rate
Provincia Autonoma di Trento,ITH2,Total,Total,2020,Asthma and status asthmaticus,0.17,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,3597.17,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,3555.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,3610.93,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,3463.06,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,3559.35,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,3407.08,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,3441.45,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3255.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3236.46,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4296.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",131.26,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.41,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.86,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",113.87,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.76,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",202.49,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",194.23,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",180.17,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",180.53,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",163.15,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",165.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",163.13,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",149.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",157.32,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",158.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Malignant melanoma of skin,8.62,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Malignant melanoma of skin,13.9,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Malignant melanoma of skin,15.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Malignant melanoma of skin,13.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Malignant melanoma of skin,13.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Malignant melanoma of skin,8.38,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Malignant melanoma of skin,10.88,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Malignant melanoma of skin,8.72,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Malignant melanoma of skin,7.41,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Malignant melanoma of skin,9.61,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Malignant neoplasm of breast,72.9,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Malignant neoplasm of breast,58.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Malignant neoplasm of breast,77.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Malignant neoplasm of breast,59.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Malignant neoplasm of breast,67.42,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Malignant neoplasm of breast,59.2,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Malignant neoplasm of breast,66.93,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Malignant neoplasm of breast,69.91,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Malignant neoplasm of breast,66.49,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Malignant neoplasm of breast,62.47,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Diabetes mellitus,103.72,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Diabetes mellitus,98.54,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Diabetes mellitus,98.6,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Diabetes mellitus,85.67,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Diabetes mellitus,96.14,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Diabetes mellitus,80.22,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Diabetes mellitus,85.25,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Diabetes mellitus,85.96,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Diabetes mellitus,78.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Diabetes mellitus,101.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),107.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),133.31,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),139.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),127.42,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),109.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),128.1,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),154.06,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),160.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),150.62,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),161.99,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),10.17,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),9.3,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),12.12,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),14.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),14.09,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),11.62,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),11.39,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),21.03,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),13.22,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),12.91,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Other ischaemic heart diseases,393.0,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Other ischaemic heart diseases,377.88,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Other ischaemic heart diseases,349.6,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Other ischaemic heart diseases,300.87,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Other ischaemic heart diseases,341.84,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Other ischaemic heart diseases,287.08,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Other ischaemic heart diseases,302.3,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Other ischaemic heart diseases,262.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Other ischaemic heart diseases,239.15,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Other ischaemic heart diseases,257.22,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,186.6,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,180.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,192.52,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,173.24,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,167.01,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,143.77,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,125.96,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,98.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,97.92,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,94.66,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Cerebrovascular diseases,276.74,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Cerebrovascular diseases,277.51,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Cerebrovascular diseases,246.43,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Cerebrovascular diseases,230.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Cerebrovascular diseases,266.72,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Cerebrovascular diseases,259.29,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Cerebrovascular diseases,233.44,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Cerebrovascular diseases,220.93,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Cerebrovascular diseases,237.06,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Cerebrovascular diseases,225.57,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Chronic lower respiratory diseases,140.17,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Chronic lower respiratory diseases,116.81,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Chronic lower respiratory diseases,108.2,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Chronic lower respiratory diseases,95.96,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Chronic lower respiratory diseases,80.77,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Chronic lower respiratory diseases,126.28,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2017,Chronic lower respiratory diseases,98.05,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Chronic lower respiratory diseases,98.88,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2019,Chronic lower respiratory diseases,88.83,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Chronic lower respiratory diseases,116.46,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2011,Asthma and status asthmaticus,3.55,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2012,Asthma and status asthmaticus,1.59,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2013,Asthma and status asthmaticus,2.02,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2014,Asthma and status asthmaticus,1.75,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2015,Asthma and status asthmaticus,2.12,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2016,Asthma and status asthmaticus,0.67,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2018,Asthma and status asthmaticus,1.36,Rate
Provincia Autonoma di Trento,ITH2,65 years or over,Total,2020,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,134.15,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,133.08,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,124.18,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,110.12,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,123.23,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,113.5,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,110.18,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,113.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,111.01,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,116.53,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.59,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.07,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.02,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.74,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.83,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.07,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.08,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",13.6,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",10.54,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",12.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",9.01,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",8.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",11.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",10.73,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",8.92,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",7.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",6.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Malignant melanoma of skin,1.56,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Malignant melanoma of skin,2.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Malignant melanoma of skin,1.73,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Malignant melanoma of skin,1.48,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Malignant melanoma of skin,2.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Malignant melanoma of skin,1.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Malignant melanoma of skin,0.47,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Malignant melanoma of skin,0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Malignant melanoma of skin,1.61,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Malignant melanoma of skin,0.86,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Malignant neoplasm of breast,6.31,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Malignant neoplasm of breast,6.31,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Malignant neoplasm of breast,5.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.03,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Malignant neoplasm of breast,4.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Malignant neoplasm of breast,6.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.74,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Malignant neoplasm of breast,5.7,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.04,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Diabetes mellitus,1.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Diabetes mellitus,2.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Diabetes mellitus,1.56,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Diabetes mellitus,1.57,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Diabetes mellitus,1.15,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Diabetes mellitus,1.35,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Diabetes mellitus,0.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Diabetes mellitus,0.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Diabetes mellitus,1.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Diabetes mellitus,2.02,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),1.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),1.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),1.84,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),2.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.45,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.34,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.75,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),1.13,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.98,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.89,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.9,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.31,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.42,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.3,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Other ischaemic heart diseases,1.57,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Other ischaemic heart diseases,1.37,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Other ischaemic heart diseases,2.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Other ischaemic heart diseases,1.49,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Other ischaemic heart diseases,2.18,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.51,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.85,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,8.9,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,7.96,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,4.96,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,5.8,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,7.56,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,5.03,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,4.88,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,4.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,5.35,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,5.15,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Cerebrovascular diseases,2.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Cerebrovascular diseases,2.33,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Cerebrovascular diseases,1.99,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Cerebrovascular diseases,2.63,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Cerebrovascular diseases,2.91,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Cerebrovascular diseases,2.65,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Cerebrovascular diseases,3.82,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Cerebrovascular diseases,4.02,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Cerebrovascular diseases,3.11,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Cerebrovascular diseases,4.03,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.22,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Chronic lower respiratory diseases,0.94,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.17,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Chronic lower respiratory diseases,0.46,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.35,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Chronic lower respiratory diseases,1.1,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.14,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Chronic lower respiratory diseases,1.75,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2019,Chronic lower respiratory diseases,0.6,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.21,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.26,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.46,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.44,Rate
Provincia Autonoma di Trento,ITH2,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.21,Rate
Overijssel,NL21,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,876.26,Rate
Overijssel,NL21,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,864.65,Rate
Overijssel,NL21,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,897.27,Rate
Overijssel,NL21,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,855.76,Rate
Overijssel,NL21,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,879.62,Rate
Overijssel,NL21,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,870.33,Rate
Overijssel,NL21,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,835.57,Rate
Overijssel,NL21,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,866.5,Rate
Overijssel,NL21,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,834.79,Rate
Overijssel,NL21,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,889.59,Rate
Overijssel,NL21,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.43,Rate
Overijssel,NL21,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.34,Rate
Overijssel,NL21,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.67,Rate
Overijssel,NL21,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.07,Rate
Overijssel,NL21,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.75,Rate
Overijssel,NL21,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.59,Rate
Overijssel,NL21,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.53,Rate
Overijssel,NL21,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.6,Rate
Overijssel,NL21,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.86,Rate
Overijssel,NL21,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.97,Rate
Overijssel,NL21,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",40.53,Rate
Overijssel,NL21,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",42.75,Rate
Overijssel,NL21,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",45.83,Rate
Overijssel,NL21,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",43.29,Rate
Overijssel,NL21,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",47.06,Rate
Overijssel,NL21,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",50.22,Rate
Overijssel,NL21,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",43.43,Rate
Overijssel,NL21,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",48.75,Rate
Overijssel,NL21,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",46.36,Rate
Overijssel,NL21,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",43.71,Rate
Overijssel,NL21,Total,Females,2011,Malignant melanoma of skin,4.97,Rate
Overijssel,NL21,Total,Females,2012,Malignant melanoma of skin,5.71,Rate
Overijssel,NL21,Total,Females,2013,Malignant melanoma of skin,3.93,Rate
Overijssel,NL21,Total,Females,2014,Malignant melanoma of skin,5.22,Rate
Overijssel,NL21,Total,Females,2015,Malignant melanoma of skin,3.42,Rate
Overijssel,NL21,Total,Females,2016,Malignant melanoma of skin,3.92,Rate
Overijssel,NL21,Total,Females,2017,Malignant melanoma of skin,3.72,Rate
Overijssel,NL21,Total,Females,2018,Malignant melanoma of skin,3.62,Rate
Overijssel,NL21,Total,Females,2019,Malignant melanoma of skin,4.07,Rate
Overijssel,NL21,Total,Females,2020,Malignant melanoma of skin,3.27,Rate
Overijssel,NL21,Total,Females,2011,Malignant neoplasm of breast,43.04,Rate
Overijssel,NL21,Total,Females,2012,Malignant neoplasm of breast,41.3,Rate
Overijssel,NL21,Total,Females,2013,Malignant neoplasm of breast,36.2,Rate
Overijssel,NL21,Total,Females,2014,Malignant neoplasm of breast,38.0,Rate
Overijssel,NL21,Total,Females,2015,Malignant neoplasm of breast,44.54,Rate
Overijssel,NL21,Total,Females,2016,Malignant neoplasm of breast,38.52,Rate
Overijssel,NL21,Total,Females,2017,Malignant neoplasm of breast,38.03,Rate
Overijssel,NL21,Total,Females,2018,Malignant neoplasm of breast,36.2,Rate
Overijssel,NL21,Total,Females,2019,Malignant neoplasm of breast,37.0,Rate
Overijssel,NL21,Total,Females,2020,Malignant neoplasm of breast,36.21,Rate
Overijssel,NL21,Total,Females,2011,Diabetes mellitus,21.46,Rate
Overijssel,NL21,Total,Females,2012,Diabetes mellitus,18.91,Rate
Overijssel,NL21,Total,Females,2013,Diabetes mellitus,22.92,Rate
Overijssel,NL21,Total,Females,2014,Diabetes mellitus,20.06,Rate
Overijssel,NL21,Total,Females,2015,Diabetes mellitus,22.26,Rate
Overijssel,NL21,Total,Females,2016,Diabetes mellitus,18.72,Rate
Overijssel,NL21,Total,Females,2017,Diabetes mellitus,16.37,Rate
Overijssel,NL21,Total,Females,2018,Diabetes mellitus,17.24,Rate
Overijssel,NL21,Total,Females,2019,Diabetes mellitus,15.59,Rate
Overijssel,NL21,Total,Females,2020,Diabetes mellitus,17.63,Rate
Overijssel,NL21,Total,Females,2011,Mental and behavioural disorders (F00-F99),69.89,Rate
Overijssel,NL21,Total,Females,2012,Mental and behavioural disorders (F00-F99),72.1,Rate
Overijssel,NL21,Total,Females,2013,Mental and behavioural disorders (F00-F99),93.04,Rate
Overijssel,NL21,Total,Females,2014,Mental and behavioural disorders (F00-F99),83.81,Rate
Overijssel,NL21,Total,Females,2015,Mental and behavioural disorders (F00-F99),83.56,Rate
Overijssel,NL21,Total,Females,2016,Mental and behavioural disorders (F00-F99),81.01,Rate
Overijssel,NL21,Total,Females,2017,Mental and behavioural disorders (F00-F99),91.64,Rate
Overijssel,NL21,Total,Females,2018,Mental and behavioural disorders (F00-F99),103.24,Rate
Overijssel,NL21,Total,Females,2019,Mental and behavioural disorders (F00-F99),98.86,Rate
Overijssel,NL21,Total,Females,2020,Mental and behavioural disorders (F00-F99),93.72,Rate
Overijssel,NL21,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),2.6,Rate
Overijssel,NL21,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.14,Rate
Overijssel,NL21,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.94,Rate
Overijssel,NL21,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.53,Rate
Overijssel,NL21,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),2.4,Rate
Overijssel,NL21,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),2.61,Rate
Overijssel,NL21,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.8,Rate
Overijssel,NL21,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),3.39,Rate
Overijssel,NL21,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),3.4,Rate
Overijssel,NL21,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.91,Rate
Overijssel,NL21,Total,Females,2011,Other ischaemic heart diseases,18.41,Rate
Overijssel,NL21,Total,Females,2012,Other ischaemic heart diseases,12.26,Rate
Overijssel,NL21,Total,Females,2013,Other ischaemic heart diseases,15.67,Rate
Overijssel,NL21,Total,Females,2014,Other ischaemic heart diseases,15.29,Rate
Overijssel,NL21,Total,Females,2015,Other ischaemic heart diseases,13.87,Rate
Overijssel,NL21,Total,Females,2016,Other ischaemic heart diseases,14.86,Rate
Overijssel,NL21,Total,Females,2017,Other ischaemic heart diseases,12.66,Rate
Overijssel,NL21,Total,Females,2018,Other ischaemic heart diseases,13.21,Rate
Overijssel,NL21,Total,Females,2019,Other ischaemic heart diseases,12.73,Rate
Overijssel,NL21,Total,Females,2020,Other ischaemic heart diseases,14.12,Rate
Overijssel,NL21,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,32.34,Rate
Overijssel,NL21,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,24.96,Rate
Overijssel,NL21,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,30.77,Rate
Overijssel,NL21,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,24.44,Rate
Overijssel,NL21,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,26.52,Rate
Overijssel,NL21,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,26.94,Rate
Overijssel,NL21,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,20.36,Rate
Overijssel,NL21,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,22.91,Rate
Overijssel,NL21,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,20.93,Rate
Overijssel,NL21,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,17.39,Rate
Overijssel,NL21,Total,Females,2011,Cerebrovascular diseases,58.59,Rate
Overijssel,NL21,Total,Females,2012,Cerebrovascular diseases,63.83,Rate
Overijssel,NL21,Total,Females,2013,Cerebrovascular diseases,68.69,Rate
Overijssel,NL21,Total,Females,2014,Cerebrovascular diseases,66.77,Rate
Overijssel,NL21,Total,Females,2015,Cerebrovascular diseases,65.3,Rate
Overijssel,NL21,Total,Females,2016,Cerebrovascular diseases,61.84,Rate
Overijssel,NL21,Total,Females,2017,Cerebrovascular diseases,57.17,Rate
Overijssel,NL21,Total,Females,2018,Cerebrovascular diseases,58.92,Rate
Overijssel,NL21,Total,Females,2019,Cerebrovascular diseases,57.0,Rate
Overijssel,NL21,Total,Females,2020,Cerebrovascular diseases,56.51,Rate
Overijssel,NL21,Total,Females,2011,Chronic lower respiratory diseases,41.21,Rate
Overijssel,NL21,Total,Females,2012,Chronic lower respiratory diseases,40.05,Rate
Overijssel,NL21,Total,Females,2013,Chronic lower respiratory diseases,41.39,Rate
Overijssel,NL21,Total,Females,2014,Chronic lower respiratory diseases,31.7,Rate
Overijssel,NL21,Total,Females,2015,Chronic lower respiratory diseases,42.5,Rate
Overijssel,NL21,Total,Females,2016,Chronic lower respiratory diseases,37.85,Rate
Overijssel,NL21,Total,Females,2017,Chronic lower respiratory diseases,36.32,Rate
Overijssel,NL21,Total,Females,2018,Chronic lower respiratory diseases,39.68,Rate
Overijssel,NL21,Total,Females,2019,Chronic lower respiratory diseases,37.54,Rate
Overijssel,NL21,Total,Females,2020,Chronic lower respiratory diseases,27.16,Rate
Overijssel,NL21,Total,Females,2011,Asthma and status asthmaticus,0.93,Rate
Overijssel,NL21,Total,Females,2012,Asthma and status asthmaticus,0.66,Rate
Overijssel,NL21,Total,Females,2013,Asthma and status asthmaticus,1.06,Rate
Overijssel,NL21,Total,Females,2015,Asthma and status asthmaticus,1.06,Rate
Overijssel,NL21,Total,Females,2016,Asthma and status asthmaticus,1.17,Rate
Overijssel,NL21,Total,Females,2017,Asthma and status asthmaticus,0.94,Rate
Overijssel,NL21,Total,Females,2018,Asthma and status asthmaticus,0.74,Rate
Overijssel,NL21,Total,Females,2019,Asthma and status asthmaticus,1.12,Rate
Overijssel,NL21,Total,Females,2020,Asthma and status asthmaticus,0.9,Rate
Overijssel,NL21,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3878.11,Rate
Overijssel,NL21,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3838.8,Rate
Overijssel,NL21,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4019.2,Rate
Overijssel,NL21,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3850.8,Rate
Overijssel,NL21,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3908.66,Rate
Overijssel,NL21,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3875.11,Rate
Overijssel,NL21,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3746.89,Rate
Overijssel,NL21,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3897.34,Rate
Overijssel,NL21,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3726.68,Rate
Overijssel,NL21,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4054.03,Rate
Overijssel,NL21,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",142.84,Rate
Overijssel,NL21,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",135.63,Rate
Overijssel,NL21,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.5,Rate
Overijssel,NL21,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",133.63,Rate
Overijssel,NL21,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",121.19,Rate
Overijssel,NL21,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",115.59,Rate
Overijssel,NL21,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",110.52,Rate
Overijssel,NL21,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",85.61,Rate
Overijssel,NL21,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.91,Rate
Overijssel,NL21,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",87.39,Rate
Overijssel,NL21,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",131.63,Rate
Overijssel,NL21,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",132.16,Rate
Overijssel,NL21,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",144.1,Rate
Overijssel,NL21,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",149.19,Rate
Overijssel,NL21,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",169.2,Rate
Overijssel,NL21,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",178.59,Rate
Overijssel,NL21,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",153.78,Rate
Overijssel,NL21,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",178.75,Rate
Overijssel,NL21,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",166.48,Rate
Overijssel,NL21,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",168.85,Rate
Overijssel,NL21,65 years or over,Females,2011,Malignant melanoma of skin,13.72,Rate
Overijssel,NL21,65 years or over,Females,2012,Malignant melanoma of skin,18.61,Rate
Overijssel,NL21,65 years or over,Females,2013,Malignant melanoma of skin,11.26,Rate
Overijssel,NL21,65 years or over,Females,2014,Malignant melanoma of skin,13.29,Rate
Overijssel,NL21,65 years or over,Females,2015,Malignant melanoma of skin,10.44,Rate
Overijssel,NL21,65 years or over,Females,2016,Malignant melanoma of skin,15.24,Rate
Overijssel,NL21,65 years or over,Females,2017,Malignant melanoma of skin,13.71,Rate
Overijssel,NL21,65 years or over,Females,2018,Malignant melanoma of skin,12.54,Rate
Overijssel,NL21,65 years or over,Females,2019,Malignant melanoma of skin,11.5,Rate
Overijssel,NL21,65 years or over,Females,2020,Malignant melanoma of skin,7.99,Rate
Overijssel,NL21,65 years or over,Females,2011,Malignant neoplasm of breast,134.58,Rate
Overijssel,NL21,65 years or over,Females,2012,Malignant neoplasm of breast,141.03,Rate
Overijssel,NL21,65 years or over,Females,2013,Malignant neoplasm of breast,123.84,Rate
Overijssel,NL21,65 years or over,Females,2014,Malignant neoplasm of breast,128.84,Rate
Overijssel,NL21,65 years or over,Females,2015,Malignant neoplasm of breast,143.32,Rate
Overijssel,NL21,65 years or over,Females,2016,Malignant neoplasm of breast,133.69,Rate
Overijssel,NL21,65 years or over,Females,2017,Malignant neoplasm of breast,121.23,Rate
Overijssel,NL21,65 years or over,Females,2018,Malignant neoplasm of breast,124.77,Rate
Overijssel,NL21,65 years or over,Females,2019,Malignant neoplasm of breast,125.03,Rate
Overijssel,NL21,65 years or over,Females,2020,Malignant neoplasm of breast,121.96,Rate
Overijssel,NL21,65 years or over,Females,2011,Diabetes mellitus,97.57,Rate
Overijssel,NL21,65 years or over,Females,2012,Diabetes mellitus,87.84,Rate
Overijssel,NL21,65 years or over,Females,2013,Diabetes mellitus,110.34,Rate
Overijssel,NL21,65 years or over,Females,2014,Diabetes mellitus,96.43,Rate
Overijssel,NL21,65 years or over,Females,2015,Diabetes mellitus,112.39,Rate
Overijssel,NL21,65 years or over,Females,2016,Diabetes mellitus,92.51,Rate
Overijssel,NL21,65 years or over,Females,2017,Diabetes mellitus,81.2,Rate
Overijssel,NL21,65 years or over,Females,2018,Diabetes mellitus,78.98,Rate
Overijssel,NL21,65 years or over,Females,2019,Diabetes mellitus,72.74,Rate
Overijssel,NL21,65 years or over,Females,2020,Diabetes mellitus,86.22,Rate
Overijssel,NL21,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),348.43,Rate
Overijssel,NL21,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),366.19,Rate
Overijssel,NL21,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),470.05,Rate
Overijssel,NL21,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),423.58,Rate
Overijssel,NL21,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),418.79,Rate
Overijssel,NL21,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),406.48,Rate
Overijssel,NL21,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),464.46,Rate
Overijssel,NL21,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),511.84,Rate
Overijssel,NL21,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),491.45,Rate
Overijssel,NL21,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),465.79,Rate
Overijssel,NL21,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),6.96,Rate
Overijssel,NL21,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),4.95,Rate
Overijssel,NL21,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),14.31,Rate
Overijssel,NL21,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),11.26,Rate
Overijssel,NL21,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),10.55,Rate
Overijssel,NL21,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),8.78,Rate
Overijssel,NL21,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),10.6,Rate
Overijssel,NL21,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),6.63,Rate
Overijssel,NL21,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),10.49,Rate
Overijssel,NL21,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),10.26,Rate
Overijssel,NL21,65 years or over,Females,2011,Other ischaemic heart diseases,89.83,Rate
Overijssel,NL21,65 years or over,Females,2012,Other ischaemic heart diseases,56.37,Rate
Overijssel,NL21,65 years or over,Females,2013,Other ischaemic heart diseases,77.66,Rate
Overijssel,NL21,65 years or over,Females,2014,Other ischaemic heart diseases,76.62,Rate
Overijssel,NL21,65 years or over,Females,2015,Other ischaemic heart diseases,65.84,Rate
Overijssel,NL21,65 years or over,Females,2016,Other ischaemic heart diseases,71.72,Rate
Overijssel,NL21,65 years or over,Females,2017,Other ischaemic heart diseases,63.17,Rate
Overijssel,NL21,65 years or over,Females,2018,Other ischaemic heart diseases,66.06,Rate
Overijssel,NL21,65 years or over,Females,2019,Other ischaemic heart diseases,62.74,Rate
Overijssel,NL21,65 years or over,Females,2020,Other ischaemic heart diseases,69.1,Rate
Overijssel,NL21,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,148.08,Rate
Overijssel,NL21,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,115.54,Rate
Overijssel,NL21,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,140.75,Rate
Overijssel,NL21,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,114.69,Rate
Overijssel,NL21,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,119.96,Rate
Overijssel,NL21,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,131.2,Rate
Overijssel,NL21,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,94.75,Rate
Overijssel,NL21,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,101.41,Rate
Overijssel,NL21,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,90.49,Rate
Overijssel,NL21,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,79.55,Rate
Overijssel,NL21,65 years or over,Females,2011,Cerebrovascular diseases,275.36,Rate
Overijssel,NL21,65 years or over,Females,2012,Cerebrovascular diseases,301.42,Rate
Overijssel,NL21,65 years or over,Females,2013,Cerebrovascular diseases,328.85,Rate
Overijssel,NL21,65 years or over,Females,2014,Cerebrovascular diseases,320.02,Rate
Overijssel,NL21,65 years or over,Females,2015,Cerebrovascular diseases,324.13,Rate
Overijssel,NL21,65 years or over,Females,2016,Cerebrovascular diseases,297.55,Rate
Overijssel,NL21,65 years or over,Females,2017,Cerebrovascular diseases,278.38,Rate
Overijssel,NL21,65 years or over,Females,2018,Cerebrovascular diseases,289.28,Rate
Overijssel,NL21,65 years or over,Females,2019,Cerebrovascular diseases,272.7,Rate
Overijssel,NL21,65 years or over,Females,2020,Cerebrovascular diseases,276.09,Rate
Overijssel,NL21,65 years or over,Females,2011,Chronic lower respiratory diseases,188.02,Rate
Overijssel,NL21,65 years or over,Females,2012,Chronic lower respiratory diseases,183.65,Rate
Overijssel,NL21,65 years or over,Females,2013,Chronic lower respiratory diseases,186.06,Rate
Overijssel,NL21,65 years or over,Females,2014,Chronic lower respiratory diseases,140.27,Rate
Overijssel,NL21,65 years or over,Females,2015,Chronic lower respiratory diseases,189.68,Rate
Overijssel,NL21,65 years or over,Females,2016,Chronic lower respiratory diseases,160.76,Rate
Overijssel,NL21,65 years or over,Females,2017,Chronic lower respiratory diseases,168.96,Rate
Overijssel,NL21,65 years or over,Females,2018,Chronic lower respiratory diseases,181.1,Rate
Overijssel,NL21,65 years or over,Females,2019,Chronic lower respiratory diseases,171.34,Rate
Overijssel,NL21,65 years or over,Females,2020,Chronic lower respiratory diseases,122.71,Rate
Overijssel,NL21,65 years or over,Females,2011,Asthma and status asthmaticus,4.76,Rate
Overijssel,NL21,65 years or over,Females,2012,Asthma and status asthmaticus,3.37,Rate
Overijssel,NL21,65 years or over,Females,2013,Asthma and status asthmaticus,4.52,Rate
Overijssel,NL21,65 years or over,Females,2015,Asthma and status asthmaticus,3.68,Rate
Overijssel,NL21,65 years or over,Females,2016,Asthma and status asthmaticus,5.03,Rate
Overijssel,NL21,65 years or over,Females,2017,Asthma and status asthmaticus,4.84,Rate
Overijssel,NL21,65 years or over,Females,2018,Asthma and status asthmaticus,2.94,Rate
Overijssel,NL21,65 years or over,Females,2019,Asthma and status asthmaticus,5.75,Rate
Overijssel,NL21,65 years or over,Females,2020,Asthma and status asthmaticus,4.6,Rate
Overijssel,NL21,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,149.11,Rate
Overijssel,NL21,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,144.2,Rate
Overijssel,NL21,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,141.02,Rate
Overijssel,NL21,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,130.25,Rate
Overijssel,NL21,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,145.87,Rate
Overijssel,NL21,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,142.46,Rate
Overijssel,NL21,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,130.34,Rate
Overijssel,NL21,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,132.32,Rate
Overijssel,NL21,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,134.27,Rate
Overijssel,NL21,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,123.05,Rate
Overijssel,NL21,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.17,Rate
Overijssel,NL21,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.56,Rate
Overijssel,NL21,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.75,Rate
Overijssel,NL21,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.99,Rate
Overijssel,NL21,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.84,Rate
Overijssel,NL21,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.0,Rate
Overijssel,NL21,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.94,Rate
Overijssel,NL21,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.86,Rate
Overijssel,NL21,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.2,Rate
Overijssel,NL21,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.37,Rate
Overijssel,NL21,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",18.47,Rate
Overijssel,NL21,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",21.09,Rate
Overijssel,NL21,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",22.02,Rate
Overijssel,NL21,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",17.64,Rate
Overijssel,NL21,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",17.47,Rate
Overijssel,NL21,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",19.12,Rate
Overijssel,NL21,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",16.7,Rate
Overijssel,NL21,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",17.26,Rate
Overijssel,NL21,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",17.26,Rate
Overijssel,NL21,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",13.39,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Malignant melanoma of skin,2.85,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Malignant melanoma of skin,2.58,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Malignant melanoma of skin,2.15,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Malignant melanoma of skin,3.27,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Malignant melanoma of skin,1.72,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Malignant melanoma of skin,1.18,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Malignant melanoma of skin,1.3,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Malignant melanoma of skin,1.46,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Malignant melanoma of skin,2.27,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Malignant melanoma of skin,2.12,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Malignant neoplasm of breast,20.87,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Malignant neoplasm of breast,17.14,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Malignant neoplasm of breast,14.97,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Malignant neoplasm of breast,16.0,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Malignant neoplasm of breast,20.61,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Malignant neoplasm of breast,15.47,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Malignant neoplasm of breast,17.88,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.75,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Malignant neoplasm of breast,15.67,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Malignant neoplasm of breast,15.44,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Diabetes mellitus,3.02,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Diabetes mellitus,2.21,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Diabetes mellitus,1.74,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Diabetes mellitus,1.57,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Diabetes mellitus,0.43,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Diabetes mellitus,0.84,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Diabetes mellitus,0.67,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Diabetes mellitus,2.29,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Diabetes mellitus,1.74,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Diabetes mellitus,1.01,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),2.42,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.86,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.72,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.5,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.35,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),2.17,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.32,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),4.27,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.76,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.59,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.54,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.19,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.91,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.6,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.69,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.37,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.11,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Other ischaemic heart diseases,1.57,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.66,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.44,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.28,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Other ischaemic heart diseases,1.09,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.42,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.41,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.61,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.8,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.3,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,3.01,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.13,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,2.58,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.89,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,1.69,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.34,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.89,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,4.09,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.33,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Cerebrovascular diseases,6.07,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Cerebrovascular diseases,6.28,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Cerebrovascular diseases,5.67,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Cerebrovascular diseases,5.42,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Cerebrovascular diseases,2.6,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Cerebrovascular diseases,4.74,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Cerebrovascular diseases,3.58,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Cerebrovascular diseases,3.12,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Cerebrovascular diseases,4.75,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Cerebrovascular diseases,3.32,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Chronic lower respiratory diseases,5.64,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.26,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Chronic lower respiratory diseases,6.34,Rate
Overijssel,NL21,Less than 65 years,Females,2014,Chronic lower respiratory diseases,5.41,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Chronic lower respiratory diseases,6.84,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Chronic lower respiratory diseases,8.08,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Chronic lower respiratory diseases,4.19,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Chronic lower respiratory diseases,5.42,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Chronic lower respiratory diseases,5.13,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Chronic lower respiratory diseases,4.02,Rate
Overijssel,NL21,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.22,Rate
Overijssel,NL21,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.43,Rate
Overijssel,NL21,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.24,Rate
Overijssel,NL21,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.2,Rate
Overijssel,NL21,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1237.82,Rate
Overijssel,NL21,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1245.17,Rate
Overijssel,NL21,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1268.7,Rate
Overijssel,NL21,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1197.16,Rate
Overijssel,NL21,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1184.92,Rate
Overijssel,NL21,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1173.69,Rate
Overijssel,NL21,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1186.11,Rate
Overijssel,NL21,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1160.66,Rate
Overijssel,NL21,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1127.71,Rate
Overijssel,NL21,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1264.56,Rate
Overijssel,NL21,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.51,Rate
Overijssel,NL21,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.72,Rate
Overijssel,NL21,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.83,Rate
Overijssel,NL21,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.75,Rate
Overijssel,NL21,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.11,Rate
Overijssel,NL21,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.06,Rate
Overijssel,NL21,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.62,Rate
Overijssel,NL21,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.67,Rate
Overijssel,NL21,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.91,Rate
Overijssel,NL21,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.25,Rate
Overijssel,NL21,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",105.58,Rate
Overijssel,NL21,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",96.42,Rate
Overijssel,NL21,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",90.35,Rate
Overijssel,NL21,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",88.95,Rate
Overijssel,NL21,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",96.91,Rate
Overijssel,NL21,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",84.89,Rate
Overijssel,NL21,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",89.42,Rate
Overijssel,NL21,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",83.71,Rate
Overijssel,NL21,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",77.03,Rate
Overijssel,NL21,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",73.62,Rate
Overijssel,NL21,Total,Males,2011,Malignant melanoma of skin,5.15,Rate
Overijssel,NL21,Total,Males,2012,Malignant melanoma of skin,5.46,Rate
Overijssel,NL21,Total,Males,2013,Malignant melanoma of skin,5.52,Rate
Overijssel,NL21,Total,Males,2014,Malignant melanoma of skin,5.7,Rate
Overijssel,NL21,Total,Males,2015,Malignant melanoma of skin,6.7,Rate
Overijssel,NL21,Total,Males,2016,Malignant melanoma of skin,5.17,Rate
Overijssel,NL21,Total,Males,2017,Malignant melanoma of skin,7.46,Rate
Overijssel,NL21,Total,Males,2018,Malignant melanoma of skin,4.81,Rate
Overijssel,NL21,Total,Males,2019,Malignant melanoma of skin,4.88,Rate
Overijssel,NL21,Total,Males,2020,Malignant melanoma of skin,6.01,Rate
Overijssel,NL21,Total,Males,2011,Malignant neoplasm of breast,0.26,Rate
Overijssel,NL21,Total,Males,2012,Malignant neoplasm of breast,0.25,Rate
Overijssel,NL21,Total,Males,2014,Malignant neoplasm of breast,0.34,Rate
Overijssel,NL21,Total,Males,2015,Malignant neoplasm of breast,0.87,Rate
Overijssel,NL21,Total,Males,2017,Malignant neoplasm of breast,1.27,Rate
Overijssel,NL21,Total,Males,2018,Malignant neoplasm of breast,0.21,Rate
Overijssel,NL21,Total,Males,2019,Malignant neoplasm of breast,0.41,Rate
Overijssel,NL21,Total,Males,2020,Malignant neoplasm of breast,0.38,Rate
Overijssel,NL21,Total,Males,2011,Diabetes mellitus,23.24,Rate
Overijssel,NL21,Total,Males,2012,Diabetes mellitus,32.7,Rate
Overijssel,NL21,Total,Males,2013,Diabetes mellitus,30.54,Rate
Overijssel,NL21,Total,Males,2014,Diabetes mellitus,21.28,Rate
Overijssel,NL21,Total,Males,2015,Diabetes mellitus,26.05,Rate
Overijssel,NL21,Total,Males,2016,Diabetes mellitus,23.87,Rate
Overijssel,NL21,Total,Males,2017,Diabetes mellitus,24.97,Rate
Overijssel,NL21,Total,Males,2018,Diabetes mellitus,23.0,Rate
Overijssel,NL21,Total,Males,2019,Diabetes mellitus,22.65,Rate
Overijssel,NL21,Total,Males,2020,Diabetes mellitus,25.1,Rate
Overijssel,NL21,Total,Males,2011,Mental and behavioural disorders (F00-F99),58.19,Rate
Overijssel,NL21,Total,Males,2012,Mental and behavioural disorders (F00-F99),60.67,Rate
Overijssel,NL21,Total,Males,2013,Mental and behavioural disorders (F00-F99),77.05,Rate
Overijssel,NL21,Total,Males,2014,Mental and behavioural disorders (F00-F99),91.75,Rate
Overijssel,NL21,Total,Males,2015,Mental and behavioural disorders (F00-F99),84.21,Rate
Overijssel,NL21,Total,Males,2016,Mental and behavioural disorders (F00-F99),92.29,Rate
Overijssel,NL21,Total,Males,2017,Mental and behavioural disorders (F00-F99),93.06,Rate
Overijssel,NL21,Total,Males,2018,Mental and behavioural disorders (F00-F99),93.69,Rate
Overijssel,NL21,Total,Males,2019,Mental and behavioural disorders (F00-F99),91.34,Rate
Overijssel,NL21,Total,Males,2020,Mental and behavioural disorders (F00-F99),80.34,Rate
Overijssel,NL21,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.57,Rate
Overijssel,NL21,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),2.91,Rate
Overijssel,NL21,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.16,Rate
Overijssel,NL21,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.02,Rate
Overijssel,NL21,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.47,Rate
Overijssel,NL21,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.12,Rate
Overijssel,NL21,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.46,Rate
Overijssel,NL21,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.88,Rate
Overijssel,NL21,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),2.18,Rate
Overijssel,NL21,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.22,Rate
Overijssel,NL21,Total,Males,2011,Other ischaemic heart diseases,44.08,Rate
Overijssel,NL21,Total,Males,2012,Other ischaemic heart diseases,39.52,Rate
Overijssel,NL21,Total,Males,2013,Other ischaemic heart diseases,40.68,Rate
Overijssel,NL21,Total,Males,2014,Other ischaemic heart diseases,37.16,Rate
Overijssel,NL21,Total,Males,2015,Other ischaemic heart diseases,40.29,Rate
Overijssel,NL21,Total,Males,2016,Other ischaemic heart diseases,38.72,Rate
Overijssel,NL21,Total,Males,2017,Other ischaemic heart diseases,38.74,Rate
Overijssel,NL21,Total,Males,2018,Other ischaemic heart diseases,37.12,Rate
Overijssel,NL21,Total,Males,2019,Other ischaemic heart diseases,37.27,Rate
Overijssel,NL21,Total,Males,2020,Other ischaemic heart diseases,35.03,Rate
Overijssel,NL21,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,58.64,Rate
Overijssel,NL21,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,57.87,Rate
Overijssel,NL21,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,47.49,Rate
Overijssel,NL21,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,44.73,Rate
Overijssel,NL21,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,39.99,Rate
Overijssel,NL21,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,49.29,Rate
Overijssel,NL21,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,46.07,Rate
Overijssel,NL21,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,44.15,Rate
Overijssel,NL21,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,37.33,Rate
Overijssel,NL21,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,35.58,Rate
Overijssel,NL21,Total,Males,2011,Cerebrovascular diseases,66.58,Rate
Overijssel,NL21,Total,Males,2012,Cerebrovascular diseases,62.53,Rate
Overijssel,NL21,Total,Males,2013,Cerebrovascular diseases,71.02,Rate
Overijssel,NL21,Total,Males,2014,Cerebrovascular diseases,67.52,Rate
Overijssel,NL21,Total,Males,2015,Cerebrovascular diseases,66.06,Rate
Overijssel,NL21,Total,Males,2016,Cerebrovascular diseases,76.67,Rate
Overijssel,NL21,Total,Males,2017,Cerebrovascular diseases,74.15,Rate
Overijssel,NL21,Total,Males,2018,Cerebrovascular diseases,69.35,Rate
Overijssel,NL21,Total,Males,2019,Cerebrovascular diseases,71.57,Rate
Overijssel,NL21,Total,Males,2020,Cerebrovascular diseases,63.28,Rate
Overijssel,NL21,Total,Males,2011,Chronic lower respiratory diseases,87.07,Rate
Overijssel,NL21,Total,Males,2012,Chronic lower respiratory diseases,83.54,Rate
Overijssel,NL21,Total,Males,2013,Chronic lower respiratory diseases,86.32,Rate
Overijssel,NL21,Total,Males,2014,Chronic lower respiratory diseases,64.83,Rate
Overijssel,NL21,Total,Males,2015,Chronic lower respiratory diseases,73.56,Rate
Overijssel,NL21,Total,Males,2016,Chronic lower respiratory diseases,63.4,Rate
Overijssel,NL21,Total,Males,2017,Chronic lower respiratory diseases,62.85,Rate
Overijssel,NL21,Total,Males,2018,Chronic lower respiratory diseases,54.82,Rate
Overijssel,NL21,Total,Males,2019,Chronic lower respiratory diseases,55.93,Rate
Overijssel,NL21,Total,Males,2020,Chronic lower respiratory diseases,48.36,Rate
Overijssel,NL21,Total,Males,2011,Asthma and status asthmaticus,0.26,Rate
Overijssel,NL21,Total,Males,2012,Asthma and status asthmaticus,0.26,Rate
Overijssel,NL21,Total,Males,2013,Asthma and status asthmaticus,0.8,Rate
Overijssel,NL21,Total,Males,2014,Asthma and status asthmaticus,1.22,Rate
Overijssel,NL21,Total,Males,2015,Asthma and status asthmaticus,0.82,Rate
Overijssel,NL21,Total,Males,2016,Asthma and status asthmaticus,0.87,Rate
Overijssel,NL21,Total,Males,2017,Asthma and status asthmaticus,1.2,Rate
Overijssel,NL21,Total,Males,2018,Asthma and status asthmaticus,0.37,Rate
Overijssel,NL21,Total,Males,2019,Asthma and status asthmaticus,0.33,Rate
Overijssel,NL21,Total,Males,2020,Asthma and status asthmaticus,1.78,Rate
Overijssel,NL21,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5561.4,Rate
Overijssel,NL21,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5562.33,Rate
Overijssel,NL21,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5691.09,Rate
Overijssel,NL21,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5374.8,Rate
Overijssel,NL21,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5363.22,Rate
Overijssel,NL21,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5314.21,Rate
Overijssel,NL21,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5347.91,Rate
Overijssel,NL21,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5265.17,Rate
Overijssel,NL21,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5045.99,Rate
Overijssel,NL21,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5741.53,Rate
Overijssel,NL21,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",216.04,Rate
Overijssel,NL21,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",204.26,Rate
Overijssel,NL21,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",197.03,Rate
Overijssel,NL21,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",220.65,Rate
Overijssel,NL21,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",194.32,Rate
Overijssel,NL21,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",166.62,Rate
Overijssel,NL21,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",191.83,Rate
Overijssel,NL21,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.49,Rate
Overijssel,NL21,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",161.57,Rate
Overijssel,NL21,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",143.04,Rate
Overijssel,NL21,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",447.8,Rate
Overijssel,NL21,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",396.11,Rate
Overijssel,NL21,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",369.64,Rate
Overijssel,NL21,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",375.92,Rate
Overijssel,NL21,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",410.64,Rate
Overijssel,NL21,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",366.83,Rate
Overijssel,NL21,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",370.52,Rate
Overijssel,NL21,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",370.08,Rate
Overijssel,NL21,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",330.2,Rate
Overijssel,NL21,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",313.01,Rate
Overijssel,NL21,65 years or over,Males,2011,Malignant melanoma of skin,12.43,Rate
Overijssel,NL21,65 years or over,Males,2012,Malignant melanoma of skin,13.02,Rate
Overijssel,NL21,65 years or over,Males,2013,Malignant melanoma of skin,17.68,Rate
Overijssel,NL21,65 years or over,Males,2014,Malignant melanoma of skin,18.74,Rate
Overijssel,NL21,65 years or over,Males,2015,Malignant melanoma of skin,21.44,Rate
Overijssel,NL21,65 years or over,Males,2016,Malignant melanoma of skin,19.35,Rate
Overijssel,NL21,65 years or over,Males,2017,Malignant melanoma of skin,26.49,Rate
Overijssel,NL21,65 years or over,Males,2018,Malignant melanoma of skin,18.8,Rate
Overijssel,NL21,65 years or over,Males,2019,Malignant melanoma of skin,17.48,Rate
Overijssel,NL21,65 years or over,Males,2020,Malignant melanoma of skin,24.77,Rate
Overijssel,NL21,65 years or over,Males,2011,Malignant neoplasm of breast,1.34,Rate
Overijssel,NL21,65 years or over,Males,2012,Malignant neoplasm of breast,1.26,Rate
Overijssel,NL21,65 years or over,Males,2014,Malignant neoplasm of breast,1.72,Rate
Overijssel,NL21,65 years or over,Males,2015,Malignant neoplasm of breast,4.47,Rate
Overijssel,NL21,65 years or over,Males,2017,Malignant neoplasm of breast,6.53,Rate
Overijssel,NL21,65 years or over,Males,2018,Malignant neoplasm of breast,1.07,Rate
Overijssel,NL21,65 years or over,Males,2019,Malignant neoplasm of breast,1.03,Rate
Overijssel,NL21,65 years or over,Males,2020,Malignant neoplasm of breast,1.96,Rate
Overijssel,NL21,65 years or over,Males,2011,Diabetes mellitus,111.26,Rate
Overijssel,NL21,65 years or over,Males,2012,Diabetes mellitus,154.52,Rate
Overijssel,NL21,65 years or over,Males,2013,Diabetes mellitus,136.95,Rate
Overijssel,NL21,65 years or over,Males,2014,Diabetes mellitus,93.38,Rate
Overijssel,NL21,65 years or over,Males,2015,Diabetes mellitus,117.68,Rate
Overijssel,NL21,65 years or over,Males,2016,Diabetes mellitus,110.16,Rate
Overijssel,NL21,65 years or over,Males,2017,Diabetes mellitus,116.7,Rate
Overijssel,NL21,65 years or over,Males,2018,Diabetes mellitus,106.01,Rate
Overijssel,NL21,65 years or over,Males,2019,Diabetes mellitus,109.4,Rate
Overijssel,NL21,65 years or over,Males,2020,Diabetes mellitus,123.08,Rate
Overijssel,NL21,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),284.17,Rate
Overijssel,NL21,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),302.16,Rate
Overijssel,NL21,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),377.66,Rate
Overijssel,NL21,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),440.75,Rate
Overijssel,NL21,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),416.07,Rate
Overijssel,NL21,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),453.45,Rate
Overijssel,NL21,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),449.0,Rate
Overijssel,NL21,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),457.09,Rate
Overijssel,NL21,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),441.75,Rate
Overijssel,NL21,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),387.74,Rate
Overijssel,NL21,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),3.69,Rate
Overijssel,NL21,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),11.3,Rate
Overijssel,NL21,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),7.64,Rate
Overijssel,NL21,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),11.18,Rate
Overijssel,NL21,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),7.31,Rate
Overijssel,NL21,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),7.45,Rate
Overijssel,NL21,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),7.64,Rate
Overijssel,NL21,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),6.88,Rate
Overijssel,NL21,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),4.13,Rate
Overijssel,NL21,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),15.02,Rate
Overijssel,NL21,65 years or over,Males,2011,Other ischaemic heart diseases,207.4,Rate
Overijssel,NL21,65 years or over,Males,2012,Other ischaemic heart diseases,185.91,Rate
Overijssel,NL21,65 years or over,Males,2013,Other ischaemic heart diseases,195.99,Rate
Overijssel,NL21,65 years or over,Males,2014,Other ischaemic heart diseases,174.93,Rate
Overijssel,NL21,65 years or over,Males,2015,Other ischaemic heart diseases,198.66,Rate
Overijssel,NL21,65 years or over,Males,2016,Other ischaemic heart diseases,183.14,Rate
Overijssel,NL21,65 years or over,Males,2017,Other ischaemic heart diseases,188.47,Rate
Overijssel,NL21,65 years or over,Males,2018,Other ischaemic heart diseases,175.86,Rate
Overijssel,NL21,65 years or over,Males,2019,Other ischaemic heart diseases,172.76,Rate
Overijssel,NL21,65 years or over,Males,2020,Other ischaemic heart diseases,170.01,Rate
Overijssel,NL21,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,257.11,Rate
Overijssel,NL21,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,242.88,Rate
Overijssel,NL21,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,195.6,Rate
Overijssel,NL21,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,186.45,Rate
Overijssel,NL21,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,171.99,Rate
Overijssel,NL21,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,210.19,Rate
Overijssel,NL21,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,206.33,Rate
Overijssel,NL21,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,177.75,Rate
Overijssel,NL21,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,158.24,Rate
Overijssel,NL21,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,151.42,Rate
Overijssel,NL21,65 years or over,Males,2011,Cerebrovascular diseases,313.66,Rate
Overijssel,NL21,65 years or over,Males,2012,Cerebrovascular diseases,295.77,Rate
Overijssel,NL21,65 years or over,Males,2013,Cerebrovascular diseases,337.14,Rate
Overijssel,NL21,65 years or over,Males,2014,Cerebrovascular diseases,319.05,Rate
Overijssel,NL21,65 years or over,Males,2015,Cerebrovascular diseases,324.89,Rate
Overijssel,NL21,65 years or over,Males,2016,Cerebrovascular diseases,368.12,Rate
Overijssel,NL21,65 years or over,Males,2017,Cerebrovascular diseases,362.11,Rate
Overijssel,NL21,65 years or over,Males,2018,Cerebrovascular diseases,342.2,Rate
Overijssel,NL21,65 years or over,Males,2019,Cerebrovascular diseases,343.64,Rate
Overijssel,NL21,65 years or over,Males,2020,Cerebrovascular diseases,302.07,Rate
Overijssel,NL21,65 years or over,Males,2011,Chronic lower respiratory diseases,427.18,Rate
Overijssel,NL21,65 years or over,Males,2012,Chronic lower respiratory diseases,404.54,Rate
Overijssel,NL21,65 years or over,Males,2013,Chronic lower respiratory diseases,421.38,Rate
Overijssel,NL21,65 years or over,Males,2014,Chronic lower respiratory diseases,315.66,Rate
Overijssel,NL21,65 years or over,Males,2015,Chronic lower respiratory diseases,358.05,Rate
Overijssel,NL21,65 years or over,Males,2016,Chronic lower respiratory diseases,305.72,Rate
Overijssel,NL21,65 years or over,Males,2017,Chronic lower respiratory diseases,297.51,Rate
Overijssel,NL21,65 years or over,Males,2018,Chronic lower respiratory diseases,264.24,Rate
Overijssel,NL21,65 years or over,Males,2019,Chronic lower respiratory diseases,268.64,Rate
Overijssel,NL21,65 years or over,Males,2020,Chronic lower respiratory diseases,231.71,Rate
Overijssel,NL21,65 years or over,Males,2011,Asthma and status asthmaticus,1.34,Rate
Overijssel,NL21,65 years or over,Males,2012,Asthma and status asthmaticus,1.31,Rate
Overijssel,NL21,65 years or over,Males,2013,Asthma and status asthmaticus,4.09,Rate
Overijssel,NL21,65 years or over,Males,2014,Asthma and status asthmaticus,6.25,Rate
Overijssel,NL21,65 years or over,Males,2015,Asthma and status asthmaticus,2.51,Rate
Overijssel,NL21,65 years or over,Males,2016,Asthma and status asthmaticus,3.5,Rate
Overijssel,NL21,65 years or over,Males,2017,Asthma and status asthmaticus,4.44,Rate
Overijssel,NL21,65 years or over,Males,2018,Asthma and status asthmaticus,1.07,Rate
Overijssel,NL21,65 years or over,Males,2019,Asthma and status asthmaticus,1.71,Rate
Overijssel,NL21,65 years or over,Males,2020,Asthma and status asthmaticus,8.31,Rate
Overijssel,NL21,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,190.5,Rate
Overijssel,NL21,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,199.4,Rate
Overijssel,NL21,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,197.43,Rate
Overijssel,NL21,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,185.18,Rate
Overijssel,NL21,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,172.78,Rate
Overijssel,NL21,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,170.71,Rate
Overijssel,NL21,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,177.98,Rate
Overijssel,NL21,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,166.4,Rate
Overijssel,NL21,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,178.56,Rate
Overijssel,NL21,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,180.08,Rate
Overijssel,NL21,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.17,Rate
Overijssel,NL21,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.81,Rate
Overijssel,NL21,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.2,Rate
Overijssel,NL21,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.59,Rate
Overijssel,NL21,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.96,Rate
Overijssel,NL21,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.16,Rate
Overijssel,NL21,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.2,Rate
Overijssel,NL21,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.23,Rate
Overijssel,NL21,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.2,Rate
Overijssel,NL21,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.66,Rate
Overijssel,NL21,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",22.68,Rate
Overijssel,NL21,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",23.83,Rate
Overijssel,NL21,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",22.7,Rate
Overijssel,NL21,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",19.43,Rate
Overijssel,NL21,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",20.91,Rate
Overijssel,NL21,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",16.59,Rate
Overijssel,NL21,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",21.33,Rate
Overijssel,NL21,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",14.34,Rate
Overijssel,NL21,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",15.71,Rate
Overijssel,NL21,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",15.63,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Malignant melanoma of skin,3.39,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Malignant melanoma of skin,3.62,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Malignant melanoma of skin,2.58,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Malignant melanoma of skin,2.54,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Malignant melanoma of skin,3.14,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Malignant melanoma of skin,1.74,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Malignant melanoma of skin,2.85,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Malignant melanoma of skin,1.42,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Malignant melanoma of skin,1.83,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Malignant melanoma of skin,1.46,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.25,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Diabetes mellitus,1.91,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Diabetes mellitus,3.2,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Diabetes mellitus,4.76,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Diabetes mellitus,3.81,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Diabetes mellitus,3.85,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Diabetes mellitus,2.97,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Diabetes mellitus,2.75,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Diabetes mellitus,2.89,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Diabetes mellitus,1.63,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Diabetes mellitus,1.37,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),3.45,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),2.17,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),4.24,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),7.21,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),3.82,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),4.81,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),6.85,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),5.67,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),6.46,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),5.87,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.87,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.05,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.83,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.71,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.6,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Other ischaemic heart diseases,4.52,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Other ischaemic heart diseases,4.05,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Other ischaemic heart diseases,3.06,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.79,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Other ischaemic heart diseases,1.93,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Other ischaemic heart diseases,3.74,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Other ischaemic heart diseases,2.47,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Other ischaemic heart diseases,3.52,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Other ischaemic heart diseases,4.45,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.33,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,10.56,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,13.05,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,11.62,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,10.4,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,8.01,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,10.32,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,7.25,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,11.78,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,8.05,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,7.51,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Cerebrovascular diseases,6.73,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Cerebrovascular diseases,6.04,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Cerebrovascular diseases,6.55,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Cerebrovascular diseases,6.58,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Cerebrovascular diseases,3.36,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Cerebrovascular diseases,6.07,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Cerebrovascular diseases,4.39,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Cerebrovascular diseases,3.26,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Cerebrovascular diseases,5.66,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Cerebrovascular diseases,5.43,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Chronic lower respiratory diseases,4.69,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Chronic lower respiratory diseases,5.78,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Chronic lower respiratory diseases,5.16,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Chronic lower respiratory diseases,4.07,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.65,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.71,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Chronic lower respiratory diseases,6.01,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Chronic lower respiratory diseases,4.09,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Chronic lower respiratory diseases,4.41,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.95,Rate
Overijssel,NL21,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.41,Rate
Overijssel,NL21,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.23,Rate
Overijssel,NL21,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.42,Rate
Overijssel,NL21,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.2,Rate
Overijssel,NL21,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.19,Rate
Overijssel,NL21,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1021.55,Rate
Overijssel,NL21,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1016.99,Rate
Overijssel,NL21,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1043.21,Rate
Overijssel,NL21,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,992.43,Rate
Overijssel,NL21,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1005.64,Rate
Overijssel,NL21,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,997.26,Rate
Overijssel,NL21,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,984.34,Rate
Overijssel,NL21,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,990.54,Rate
Overijssel,NL21,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,958.64,Rate
Overijssel,NL21,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1051.29,Rate
Overijssel,NL21,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.63,Rate
Overijssel,NL21,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.47,Rate
Overijssel,NL21,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.31,Rate
Overijssel,NL21,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.62,Rate
Overijssel,NL21,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.35,Rate
Overijssel,NL21,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.85,Rate
Overijssel,NL21,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.6,Rate
Overijssel,NL21,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.93,Rate
Overijssel,NL21,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.24,Rate
Overijssel,NL21,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.5,Rate
Overijssel,NL21,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",67.52,Rate
Overijssel,NL21,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",64.59,Rate
Overijssel,NL21,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",63.87,Rate
Overijssel,NL21,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",62.34,Rate
Overijssel,NL21,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",68.23,Rate
Overijssel,NL21,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",65.02,Rate
Overijssel,NL21,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",63.16,Rate
Overijssel,NL21,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",63.32,Rate
Overijssel,NL21,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",58.59,Rate
Overijssel,NL21,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",56.59,Rate
Overijssel,NL21,Total,Total,2011,Malignant melanoma of skin,5.22,Rate
Overijssel,NL21,Total,Total,2012,Malignant melanoma of skin,5.79,Rate
Overijssel,NL21,Total,Total,2013,Malignant melanoma of skin,4.76,Rate
Overijssel,NL21,Total,Total,2014,Malignant melanoma of skin,5.27,Rate
Overijssel,NL21,Total,Total,2015,Malignant melanoma of skin,4.86,Rate
Overijssel,NL21,Total,Total,2016,Malignant melanoma of skin,4.5,Rate
Overijssel,NL21,Total,Total,2017,Malignant melanoma of skin,5.29,Rate
Overijssel,NL21,Total,Total,2018,Malignant melanoma of skin,4.05,Rate
Overijssel,NL21,Total,Total,2019,Malignant melanoma of skin,4.43,Rate
Overijssel,NL21,Total,Total,2020,Malignant melanoma of skin,4.46,Rate
Overijssel,NL21,Total,Total,2011,Malignant neoplasm of breast,24.84,Rate
Overijssel,NL21,Total,Total,2012,Malignant neoplasm of breast,23.5,Rate
Overijssel,NL21,Total,Total,2013,Malignant neoplasm of breast,20.25,Rate
Overijssel,NL21,Total,Total,2014,Malignant neoplasm of breast,21.19,Rate
Overijssel,NL21,Total,Total,2015,Malignant neoplasm of breast,25.23,Rate
Overijssel,NL21,Total,Total,2016,Malignant neoplasm of breast,21.55,Rate
Overijssel,NL21,Total,Total,2017,Malignant neoplasm of breast,21.29,Rate
Overijssel,NL21,Total,Total,2018,Malignant neoplasm of breast,20.41,Rate
Overijssel,NL21,Total,Total,2019,Malignant neoplasm of breast,20.49,Rate
Overijssel,NL21,Total,Total,2020,Malignant neoplasm of breast,19.89,Rate
Overijssel,NL21,Total,Total,2011,Diabetes mellitus,22.67,Rate
Overijssel,NL21,Total,Total,2012,Diabetes mellitus,24.46,Rate
Overijssel,NL21,Total,Total,2013,Diabetes mellitus,26.38,Rate
Overijssel,NL21,Total,Total,2014,Diabetes mellitus,21.07,Rate
Overijssel,NL21,Total,Total,2015,Diabetes mellitus,24.28,Rate
Overijssel,NL21,Total,Total,2016,Diabetes mellitus,20.66,Rate
Overijssel,NL21,Total,Total,2017,Diabetes mellitus,20.2,Rate
Overijssel,NL21,Total,Total,2018,Diabetes mellitus,19.5,Rate
Overijssel,NL21,Total,Total,2019,Diabetes mellitus,18.56,Rate
Overijssel,NL21,Total,Total,2020,Diabetes mellitus,20.72,Rate
Overijssel,NL21,Total,Total,2011,Mental and behavioural disorders (F00-F99),67.31,Rate
Overijssel,NL21,Total,Total,2012,Mental and behavioural disorders (F00-F99),70.82,Rate
Overijssel,NL21,Total,Total,2013,Mental and behavioural disorders (F00-F99),88.66,Rate
Overijssel,NL21,Total,Total,2014,Mental and behavioural disorders (F00-F99),87.8,Rate
Overijssel,NL21,Total,Total,2015,Mental and behavioural disorders (F00-F99),83.58,Rate
Overijssel,NL21,Total,Total,2016,Mental and behavioural disorders (F00-F99),85.86,Rate
Overijssel,NL21,Total,Total,2017,Mental and behavioural disorders (F00-F99),94.58,Rate
Overijssel,NL21,Total,Total,2018,Mental and behavioural disorders (F00-F99),101.96,Rate
Overijssel,NL21,Total,Total,2019,Mental and behavioural disorders (F00-F99),97.16,Rate
Overijssel,NL21,Total,Total,2020,Mental and behavioural disorders (F00-F99),89.55,Rate
Overijssel,NL21,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),2.29,Rate
Overijssel,NL21,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.03,Rate
Overijssel,NL21,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.85,Rate
Overijssel,NL21,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.79,Rate
Overijssel,NL21,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),2.41,Rate
Overijssel,NL21,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),2.28,Rate
Overijssel,NL21,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.78,Rate
Overijssel,NL21,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.76,Rate
Overijssel,NL21,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.91,Rate
Overijssel,NL21,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),3.88,Rate
Overijssel,NL21,Total,Total,2011,Other ischaemic heart diseases,28.59,Rate
Overijssel,NL21,Total,Total,2012,Other ischaemic heart diseases,22.83,Rate
Overijssel,NL21,Total,Total,2013,Other ischaemic heart diseases,25.31,Rate
Overijssel,NL21,Total,Total,2014,Other ischaemic heart diseases,23.72,Rate
Overijssel,NL21,Total,Total,2015,Other ischaemic heart diseases,24.06,Rate
Overijssel,NL21,Total,Total,2016,Other ischaemic heart diseases,24.58,Rate
Overijssel,NL21,Total,Total,2017,Other ischaemic heart diseases,23.18,Rate
Overijssel,NL21,Total,Total,2018,Other ischaemic heart diseases,23.08,Rate
Overijssel,NL21,Total,Total,2019,Other ischaemic heart diseases,23.39,Rate
Overijssel,NL21,Total,Total,2020,Other ischaemic heart diseases,22.94,Rate
Overijssel,NL21,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,43.43,Rate
Overijssel,NL21,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,39.19,Rate
Overijssel,NL21,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,38.33,Rate
Overijssel,NL21,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,32.7,Rate
Overijssel,NL21,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,33.46,Rate
Overijssel,NL21,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,36.34,Rate
Overijssel,NL21,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,31.16,Rate
Overijssel,NL21,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,32.31,Rate
Overijssel,NL21,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,28.55,Rate
Overijssel,NL21,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,25.39,Rate
Overijssel,NL21,Total,Total,2011,Cerebrovascular diseases,61.91,Rate
Overijssel,NL21,Total,Total,2012,Cerebrovascular diseases,63.6,Rate
Overijssel,NL21,Total,Total,2013,Cerebrovascular diseases,70.55,Rate
Overijssel,NL21,Total,Total,2014,Cerebrovascular diseases,68.07,Rate
Overijssel,NL21,Total,Total,2015,Cerebrovascular diseases,66.02,Rate
Overijssel,NL21,Total,Total,2016,Cerebrovascular diseases,68.17,Rate
Overijssel,NL21,Total,Total,2017,Cerebrovascular diseases,63.55,Rate
Overijssel,NL21,Total,Total,2018,Cerebrovascular diseases,63.32,Rate
Overijssel,NL21,Total,Total,2019,Cerebrovascular diseases,62.81,Rate
Overijssel,NL21,Total,Total,2020,Cerebrovascular diseases,60.19,Rate
Overijssel,NL21,Total,Total,2011,Chronic lower respiratory diseases,56.8,Rate
Overijssel,NL21,Total,Total,2012,Chronic lower respiratory diseases,54.64,Rate
Overijssel,NL21,Total,Total,2013,Chronic lower respiratory diseases,56.05,Rate
Overijssel,NL21,Total,Total,2014,Chronic lower respiratory diseases,42.73,Rate
Overijssel,NL21,Total,Total,2015,Chronic lower respiratory diseases,52.96,Rate
Overijssel,NL21,Total,Total,2016,Chronic lower respiratory diseases,46.18,Rate
Overijssel,NL21,Total,Total,2017,Chronic lower respiratory diseases,46.22,Rate
Overijssel,NL21,Total,Total,2018,Chronic lower respiratory diseases,45.41,Rate
Overijssel,NL21,Total,Total,2019,Chronic lower respiratory diseases,43.46,Rate
Overijssel,NL21,Total,Total,2020,Chronic lower respiratory diseases,35.03,Rate
Overijssel,NL21,Total,Total,2011,Asthma and status asthmaticus,0.66,Rate
Overijssel,NL21,Total,Total,2012,Asthma and status asthmaticus,0.57,Rate
Overijssel,NL21,Total,Total,2013,Asthma and status asthmaticus,0.92,Rate
Overijssel,NL21,Total,Total,2014,Asthma and status asthmaticus,0.26,Rate
Overijssel,NL21,Total,Total,2015,Asthma and status asthmaticus,1.0,Rate
Overijssel,NL21,Total,Total,2016,Asthma and status asthmaticus,1.1,Rate
Overijssel,NL21,Total,Total,2017,Asthma and status asthmaticus,1.05,Rate
Overijssel,NL21,Total,Total,2018,Asthma and status asthmaticus,0.65,Rate
Overijssel,NL21,Total,Total,2019,Asthma and status asthmaticus,0.8,Rate
Overijssel,NL21,Total,Total,2020,Asthma and status asthmaticus,1.31,Rate
Overijssel,NL21,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4536.47,Rate
Overijssel,NL21,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4504.6,Rate
Overijssel,NL21,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4649.73,Rate
Overijssel,NL21,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4437.07,Rate
Overijssel,NL21,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4498.75,Rate
Overijssel,NL21,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4466.97,Rate
Overijssel,NL21,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4410.3,Rate
Overijssel,NL21,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4462.14,Rate
Overijssel,NL21,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4269.6,Rate
Overijssel,NL21,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4764.18,Rate
Overijssel,NL21,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.59,Rate
Overijssel,NL21,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",164.47,Rate
Overijssel,NL21,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",163.49,Rate
Overijssel,NL21,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",167.89,Rate
Overijssel,NL21,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",149.67,Rate
Overijssel,NL21,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",136.18,Rate
Overijssel,NL21,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.09,Rate
Overijssel,NL21,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.22,Rate
Overijssel,NL21,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.31,Rate
Overijssel,NL21,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.1,Rate
Overijssel,NL21,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",261.31,Rate
Overijssel,NL21,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",238.48,Rate
Overijssel,NL21,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",235.2,Rate
Overijssel,NL21,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",243.15,Rate
Overijssel,NL21,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",270.58,Rate
Overijssel,NL21,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",259.79,Rate
Overijssel,NL21,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",245.32,Rate
Overijssel,NL21,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",259.5,Rate
Overijssel,NL21,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",232.47,Rate
Overijssel,NL21,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",230.26,Rate
Overijssel,NL21,65 years or over,Total,2011,Malignant melanoma of skin,13.87,Rate
Overijssel,NL21,65 years or over,Total,2012,Malignant melanoma of skin,16.85,Rate
Overijssel,NL21,65 years or over,Total,2013,Malignant melanoma of skin,14.65,Rate
Overijssel,NL21,65 years or over,Total,2014,Malignant melanoma of skin,15.04,Rate
Overijssel,NL21,65 years or over,Total,2015,Malignant melanoma of skin,14.84,Rate
Overijssel,NL21,65 years or over,Total,2016,Malignant melanoma of skin,17.05,Rate
Overijssel,NL21,65 years or over,Total,2017,Malignant melanoma of skin,18.5,Rate
Overijssel,NL21,65 years or over,Total,2018,Malignant melanoma of skin,14.82,Rate
Overijssel,NL21,65 years or over,Total,2019,Malignant melanoma of skin,14.29,Rate
Overijssel,NL21,65 years or over,Total,2020,Malignant melanoma of skin,15.49,Rate
Overijssel,NL21,65 years or over,Total,2011,Malignant neoplasm of breast,84.84,Rate
Overijssel,NL21,65 years or over,Total,2012,Malignant neoplasm of breast,85.55,Rate
Overijssel,NL21,65 years or over,Total,2013,Malignant neoplasm of breast,73.31,Rate
Overijssel,NL21,65 years or over,Total,2014,Malignant neoplasm of breast,76.03,Rate
Overijssel,NL21,65 years or over,Total,2015,Malignant neoplasm of breast,87.28,Rate
Overijssel,NL21,65 years or over,Total,2016,Malignant neoplasm of breast,78.95,Rate
Overijssel,NL21,65 years or over,Total,2017,Malignant neoplasm of breast,72.65,Rate
Overijssel,NL21,65 years or over,Total,2018,Malignant neoplasm of breast,74.51,Rate
Overijssel,NL21,65 years or over,Total,2019,Malignant neoplasm of breast,72.51,Rate
Overijssel,NL21,65 years or over,Total,2020,Malignant neoplasm of breast,70.42,Rate
Overijssel,NL21,65 years or over,Total,2011,Diabetes mellitus,106.08,Rate
Overijssel,NL21,65 years or over,Total,2012,Diabetes mellitus,114.26,Rate
Overijssel,NL21,65 years or over,Total,2013,Diabetes mellitus,121.78,Rate
Overijssel,NL21,65 years or over,Total,2014,Diabetes mellitus,96.88,Rate
Overijssel,NL21,65 years or over,Total,2015,Diabetes mellitus,115.65,Rate
Overijssel,NL21,65 years or over,Total,2016,Diabetes mellitus,98.02,Rate
Overijssel,NL21,65 years or over,Total,2017,Diabetes mellitus,96.53,Rate
Overijssel,NL21,65 years or over,Total,2018,Diabetes mellitus,89.26,Rate
Overijssel,NL21,65 years or over,Total,2019,Diabetes mellitus,88.25,Rate
Overijssel,NL21,65 years or over,Total,2020,Diabetes mellitus,101.35,Rate
Overijssel,NL21,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),333.06,Rate
Overijssel,NL21,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),356.89,Rate
Overijssel,NL21,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),442.3,Rate
Overijssel,NL21,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),432.17,Rate
Overijssel,NL21,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),415.79,Rate
Overijssel,NL21,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),425.85,Rate
Overijssel,NL21,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),468.03,Rate
Overijssel,NL21,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),502.4,Rate
Overijssel,NL21,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),477.15,Rate
Overijssel,NL21,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),439.66,Rate
Overijssel,NL21,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),6.41,Rate
Overijssel,NL21,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),8.17,Rate
Overijssel,NL21,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),12.48,Rate
Overijssel,NL21,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),11.28,Rate
Overijssel,NL21,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),8.72,Rate
Overijssel,NL21,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),7.68,Rate
Overijssel,NL21,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),9.88,Rate
Overijssel,NL21,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),7.55,Rate
Overijssel,NL21,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),7.9,Rate
Overijssel,NL21,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),11.73,Rate
Overijssel,NL21,65 years or over,Total,2011,Other ischaemic heart diseases,134.92,Rate
Overijssel,NL21,65 years or over,Total,2012,Other ischaemic heart diseases,105.4,Rate
Overijssel,NL21,65 years or over,Total,2013,Other ischaemic heart diseases,122.1,Rate
Overijssel,NL21,65 years or over,Total,2014,Other ischaemic heart diseases,112.85,Rate
Overijssel,NL21,65 years or over,Total,2015,Other ischaemic heart diseases,116.75,Rate
Overijssel,NL21,65 years or over,Total,2016,Other ischaemic heart diseases,116.04,Rate
Overijssel,NL21,65 years or over,Total,2017,Other ischaemic heart diseases,112.85,Rate
Overijssel,NL21,65 years or over,Total,2018,Other ischaemic heart diseases,110.2,Rate
Overijssel,NL21,65 years or over,Total,2019,Other ischaemic heart diseases,109.43,Rate
Overijssel,NL21,65 years or over,Total,2020,Other ischaemic heart diseases,111.12,Rate
Overijssel,NL21,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,191.95,Rate
Overijssel,NL21,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,167.6,Rate
Overijssel,NL21,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,163.94,Rate
Overijssel,NL21,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,140.74,Rate
Overijssel,NL21,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,146.94,Rate
Overijssel,NL21,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,161.4,Rate
Overijssel,NL21,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,139.9,Rate
Overijssel,NL21,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,133.19,Rate
Overijssel,NL21,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,121.27,Rate
Overijssel,NL21,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,109.82,Rate
Overijssel,NL21,65 years or over,Total,2011,Cerebrovascular diseases,291.04,Rate
Overijssel,NL21,65 years or over,Total,2012,Cerebrovascular diseases,300.79,Rate
Overijssel,NL21,65 years or over,Total,2013,Cerebrovascular diseases,336.54,Rate
Overijssel,NL21,65 years or over,Total,2014,Cerebrovascular diseases,324.27,Rate
Overijssel,NL21,65 years or over,Total,2015,Cerebrovascular diseases,326.27,Rate
Overijssel,NL21,65 years or over,Total,2016,Cerebrovascular diseases,327.3,Rate
Overijssel,NL21,65 years or over,Total,2017,Cerebrovascular diseases,309.43,Rate
Overijssel,NL21,65 years or over,Total,2018,Cerebrovascular diseases,311.52,Rate
Overijssel,NL21,65 years or over,Total,2019,Cerebrovascular diseases,300.66,Rate
Overijssel,NL21,65 years or over,Total,2020,Cerebrovascular diseases,290.59,Rate
Overijssel,NL21,65 years or over,Total,2011,Chronic lower respiratory diseases,269.99,Rate
Overijssel,NL21,65 years or over,Total,2012,Chronic lower respiratory diseases,257.42,Rate
Overijssel,NL21,65 years or over,Total,2013,Chronic lower respiratory diseases,263.72,Rate
Overijssel,NL21,65 years or over,Total,2014,Chronic lower respiratory diseases,199.63,Rate
Overijssel,NL21,65 years or over,Total,2015,Chronic lower respiratory diseases,247.94,Rate
Overijssel,NL21,65 years or over,Total,2016,Chronic lower respiratory diseases,210.5,Rate
Overijssel,NL21,65 years or over,Total,2017,Chronic lower respiratory diseases,215.96,Rate
Overijssel,NL21,65 years or over,Total,2018,Chronic lower respiratory diseases,213.26,Rate
Overijssel,NL21,65 years or over,Total,2019,Chronic lower respiratory diseases,203.18,Rate
Overijssel,NL21,65 years or over,Total,2020,Chronic lower respiratory diseases,163.16,Rate
Overijssel,NL21,65 years or over,Total,2011,Asthma and status asthmaticus,3.4,Rate
Overijssel,NL21,65 years or over,Total,2012,Asthma and status asthmaticus,2.95,Rate
Overijssel,NL21,65 years or over,Total,2013,Asthma and status asthmaticus,4.28,Rate
Overijssel,NL21,65 years or over,Total,2014,Asthma and status asthmaticus,1.34,Rate
Overijssel,NL21,65 years or over,Total,2015,Asthma and status asthmaticus,3.36,Rate
Overijssel,NL21,65 years or over,Total,2016,Asthma and status asthmaticus,4.66,Rate
Overijssel,NL21,65 years or over,Total,2017,Asthma and status asthmaticus,4.51,Rate
Overijssel,NL21,65 years or over,Total,2018,Asthma and status asthmaticus,2.51,Rate
Overijssel,NL21,65 years or over,Total,2019,Asthma and status asthmaticus,4.09,Rate
Overijssel,NL21,65 years or over,Total,2020,Asthma and status asthmaticus,6.29,Rate
Overijssel,NL21,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,170.11,Rate
Overijssel,NL21,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,172.16,Rate
Overijssel,NL21,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,169.58,Rate
Overijssel,NL21,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,158.02,Rate
Overijssel,NL21,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,159.49,Rate
Overijssel,NL21,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,156.77,Rate
Overijssel,NL21,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,154.44,Rate
Overijssel,NL21,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,149.6,Rate
Overijssel,NL21,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,156.61,Rate
Overijssel,NL21,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,151.89,Rate
Overijssel,NL21,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.67,Rate
Overijssel,NL21,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.18,Rate
Overijssel,NL21,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.99,Rate
Overijssel,NL21,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.31,Rate
Overijssel,NL21,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.9,Rate
Overijssel,NL21,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.07,Rate
Overijssel,NL21,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.59,Rate
Overijssel,NL21,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.06,Rate
Overijssel,NL21,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.21,Rate
Overijssel,NL21,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.01,Rate
Overijssel,NL21,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",20.58,Rate
Overijssel,NL21,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",22.46,Rate
Overijssel,NL21,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",22.36,Rate
Overijssel,NL21,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",18.55,Rate
Overijssel,NL21,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",19.21,Rate
Overijssel,NL21,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",17.84,Rate
Overijssel,NL21,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",19.03,Rate
Overijssel,NL21,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",15.79,Rate
Overijssel,NL21,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",16.47,Rate
Overijssel,NL21,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",14.52,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Malignant melanoma of skin,3.13,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Malignant melanoma of skin,3.11,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Malignant melanoma of skin,2.37,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Malignant melanoma of skin,2.9,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Malignant melanoma of skin,2.44,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Malignant melanoma of skin,1.46,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Malignant melanoma of skin,2.09,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Malignant melanoma of skin,1.44,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Malignant melanoma of skin,2.04,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Malignant melanoma of skin,1.79,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Malignant neoplasm of breast,10.3,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Malignant neoplasm of breast,8.47,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.4,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.91,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Malignant neoplasm of breast,10.2,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.64,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Malignant neoplasm of breast,8.85,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.3,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.89,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.65,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Diabetes mellitus,2.46,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Diabetes mellitus,2.71,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Diabetes mellitus,3.27,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Diabetes mellitus,2.7,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Diabetes mellitus,2.15,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Diabetes mellitus,1.92,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Diabetes mellitus,1.72,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Diabetes mellitus,2.6,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Diabetes mellitus,1.68,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Diabetes mellitus,1.19,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),2.94,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),1.52,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),2.99,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.38,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),3.11,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),3.51,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),4.12,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),4.95,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),5.12,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.74,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.55,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.06,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.61,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.98,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Other ischaemic heart diseases,2.83,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.83,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Other ischaemic heart diseases,1.87,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.13,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Other ischaemic heart diseases,1.61,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.43,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Other ischaemic heart diseases,1.45,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Other ischaemic heart diseases,1.97,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Other ischaemic heart diseases,2.55,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.58,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,7.46,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,8.08,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,7.91,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,6.53,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,5.97,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,6.05,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,4.82,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,7.87,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,6.09,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,4.94,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Cerebrovascular diseases,6.4,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Cerebrovascular diseases,6.15,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Cerebrovascular diseases,6.12,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Cerebrovascular diseases,6.01,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Cerebrovascular diseases,2.98,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Cerebrovascular diseases,5.4,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Cerebrovascular diseases,3.99,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Cerebrovascular diseases,3.2,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Cerebrovascular diseases,5.2,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Cerebrovascular diseases,4.38,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Chronic lower respiratory diseases,5.16,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Chronic lower respiratory diseases,5.52,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Chronic lower respiratory diseases,5.74,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.73,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Chronic lower respiratory diseases,5.73,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Chronic lower respiratory diseases,6.38,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Chronic lower respiratory diseases,5.1,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Chronic lower respiratory diseases,4.75,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Chronic lower respiratory diseases,4.77,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Chronic lower respiratory diseases,3.99,Rate
Overijssel,NL21,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.11,Rate
Overijssel,NL21,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.42,Rate
Overijssel,NL21,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.24,Rate
Overijssel,NL21,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.21,Rate
Overijssel,NL21,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.2,Rate
Overijssel,NL21,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
Overijssel,NL21,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,838.4,Rate
Zuid-Holland,NL33,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,845.65,Rate
Zuid-Holland,NL33,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,854.28,Rate
Zuid-Holland,NL33,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,805.85,Rate
Zuid-Holland,NL33,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,837.71,Rate
Zuid-Holland,NL33,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,833.66,Rate
Zuid-Holland,NL33,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,831.25,Rate
Zuid-Holland,NL33,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,822.46,Rate
Zuid-Holland,NL33,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,790.16,Rate
Zuid-Holland,NL33,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,885.68,Rate
Zuid-Holland,NL33,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.7,Rate
Zuid-Holland,NL33,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.02,Rate
Zuid-Holland,NL33,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.27,Rate
Zuid-Holland,NL33,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.95,Rate
Zuid-Holland,NL33,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",28.48,Rate
Zuid-Holland,NL33,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.13,Rate
Zuid-Holland,NL33,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.05,Rate
Zuid-Holland,NL33,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.88,Rate
Zuid-Holland,NL33,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.12,Rate
Zuid-Holland,NL33,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.1,Rate
Zuid-Holland,NL33,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",53.57,Rate
Zuid-Holland,NL33,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",52.98,Rate
Zuid-Holland,NL33,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",54.15,Rate
Zuid-Holland,NL33,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",49.18,Rate
Zuid-Holland,NL33,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",49.72,Rate
Zuid-Holland,NL33,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",50.57,Rate
Zuid-Holland,NL33,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",50.0,Rate
Zuid-Holland,NL33,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",48.36,Rate
Zuid-Holland,NL33,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",47.19,Rate
Zuid-Holland,NL33,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",48.41,Rate
Zuid-Holland,NL33,Total,Females,2011,Malignant melanoma of skin,4.54,Rate
Zuid-Holland,NL33,Total,Females,2012,Malignant melanoma of skin,4.2,Rate
Zuid-Holland,NL33,Total,Females,2013,Malignant melanoma of skin,4.25,Rate
Zuid-Holland,NL33,Total,Females,2014,Malignant melanoma of skin,4.01,Rate
Zuid-Holland,NL33,Total,Females,2015,Malignant melanoma of skin,3.74,Rate
Zuid-Holland,NL33,Total,Females,2016,Malignant melanoma of skin,3.89,Rate
Zuid-Holland,NL33,Total,Females,2017,Malignant melanoma of skin,3.53,Rate
Zuid-Holland,NL33,Total,Females,2018,Malignant melanoma of skin,3.57,Rate
Zuid-Holland,NL33,Total,Females,2019,Malignant melanoma of skin,2.98,Rate
Zuid-Holland,NL33,Total,Females,2020,Malignant melanoma of skin,4.05,Rate
Zuid-Holland,NL33,Total,Females,2011,Malignant neoplasm of breast,39.07,Rate
Zuid-Holland,NL33,Total,Females,2012,Malignant neoplasm of breast,37.36,Rate
Zuid-Holland,NL33,Total,Females,2013,Malignant neoplasm of breast,36.39,Rate
Zuid-Holland,NL33,Total,Females,2014,Malignant neoplasm of breast,34.79,Rate
Zuid-Holland,NL33,Total,Females,2015,Malignant neoplasm of breast,39.1,Rate
Zuid-Holland,NL33,Total,Females,2016,Malignant neoplasm of breast,36.52,Rate
Zuid-Holland,NL33,Total,Females,2017,Malignant neoplasm of breast,35.16,Rate
Zuid-Holland,NL33,Total,Females,2018,Malignant neoplasm of breast,34.33,Rate
Zuid-Holland,NL33,Total,Females,2019,Malignant neoplasm of breast,33.45,Rate
Zuid-Holland,NL33,Total,Females,2020,Malignant neoplasm of breast,31.97,Rate
Zuid-Holland,NL33,Total,Females,2011,Diabetes mellitus,19.71,Rate
Zuid-Holland,NL33,Total,Females,2012,Diabetes mellitus,17.64,Rate
Zuid-Holland,NL33,Total,Females,2013,Diabetes mellitus,18.24,Rate
Zuid-Holland,NL33,Total,Females,2014,Diabetes mellitus,16.28,Rate
Zuid-Holland,NL33,Total,Females,2015,Diabetes mellitus,14.53,Rate
Zuid-Holland,NL33,Total,Females,2016,Diabetes mellitus,15.38,Rate
Zuid-Holland,NL33,Total,Females,2017,Diabetes mellitus,14.98,Rate
Zuid-Holland,NL33,Total,Females,2018,Diabetes mellitus,13.97,Rate
Zuid-Holland,NL33,Total,Females,2019,Diabetes mellitus,14.55,Rate
Zuid-Holland,NL33,Total,Females,2020,Diabetes mellitus,13.4,Rate
Zuid-Holland,NL33,Total,Females,2011,Mental and behavioural disorders (F00-F99),63.95,Rate
Zuid-Holland,NL33,Total,Females,2012,Mental and behavioural disorders (F00-F99),72.21,Rate
Zuid-Holland,NL33,Total,Females,2013,Mental and behavioural disorders (F00-F99),83.84,Rate
Zuid-Holland,NL33,Total,Females,2014,Mental and behavioural disorders (F00-F99),77.25,Rate
Zuid-Holland,NL33,Total,Females,2015,Mental and behavioural disorders (F00-F99),87.89,Rate
Zuid-Holland,NL33,Total,Females,2016,Mental and behavioural disorders (F00-F99),89.79,Rate
Zuid-Holland,NL33,Total,Females,2017,Mental and behavioural disorders (F00-F99),89.26,Rate
Zuid-Holland,NL33,Total,Females,2018,Mental and behavioural disorders (F00-F99),90.01,Rate
Zuid-Holland,NL33,Total,Females,2019,Mental and behavioural disorders (F00-F99),82.12,Rate
Zuid-Holland,NL33,Total,Females,2020,Mental and behavioural disorders (F00-F99),73.05,Rate
Zuid-Holland,NL33,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.46,Rate
Zuid-Holland,NL33,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.85,Rate
Zuid-Holland,NL33,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.81,Rate
Zuid-Holland,NL33,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.38,Rate
Zuid-Holland,NL33,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),3.34,Rate
Zuid-Holland,NL33,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),4.05,Rate
Zuid-Holland,NL33,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),3.62,Rate
Zuid-Holland,NL33,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),2.64,Rate
Zuid-Holland,NL33,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.74,Rate
Zuid-Holland,NL33,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),4.23,Rate
Zuid-Holland,NL33,Total,Females,2011,Other ischaemic heart diseases,14.91,Rate
Zuid-Holland,NL33,Total,Females,2012,Other ischaemic heart diseases,14.62,Rate
Zuid-Holland,NL33,Total,Females,2013,Other ischaemic heart diseases,15.1,Rate
Zuid-Holland,NL33,Total,Females,2014,Other ischaemic heart diseases,14.88,Rate
Zuid-Holland,NL33,Total,Females,2015,Other ischaemic heart diseases,14.39,Rate
Zuid-Holland,NL33,Total,Females,2016,Other ischaemic heart diseases,14.27,Rate
Zuid-Holland,NL33,Total,Females,2017,Other ischaemic heart diseases,13.9,Rate
Zuid-Holland,NL33,Total,Females,2018,Other ischaemic heart diseases,10.41,Rate
Zuid-Holland,NL33,Total,Females,2019,Other ischaemic heart diseases,10.82,Rate
Zuid-Holland,NL33,Total,Females,2020,Other ischaemic heart diseases,10.5,Rate
Zuid-Holland,NL33,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,35.04,Rate
Zuid-Holland,NL33,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,31.63,Rate
Zuid-Holland,NL33,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,26.61,Rate
Zuid-Holland,NL33,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.32,Rate
Zuid-Holland,NL33,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,27.24,Rate
Zuid-Holland,NL33,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,25.52,Rate
Zuid-Holland,NL33,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,24.35,Rate
Zuid-Holland,NL33,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,22.33,Rate
Zuid-Holland,NL33,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,19.43,Rate
Zuid-Holland,NL33,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,20.09,Rate
Zuid-Holland,NL33,Total,Females,2011,Cerebrovascular diseases,58.72,Rate
Zuid-Holland,NL33,Total,Females,2012,Cerebrovascular diseases,61.14,Rate
Zuid-Holland,NL33,Total,Females,2013,Cerebrovascular diseases,64.12,Rate
Zuid-Holland,NL33,Total,Females,2014,Cerebrovascular diseases,61.6,Rate
Zuid-Holland,NL33,Total,Females,2015,Cerebrovascular diseases,60.44,Rate
Zuid-Holland,NL33,Total,Females,2016,Cerebrovascular diseases,58.65,Rate
Zuid-Holland,NL33,Total,Females,2017,Cerebrovascular diseases,58.85,Rate
Zuid-Holland,NL33,Total,Females,2018,Cerebrovascular diseases,53.04,Rate
Zuid-Holland,NL33,Total,Females,2019,Cerebrovascular diseases,50.35,Rate
Zuid-Holland,NL33,Total,Females,2020,Cerebrovascular diseases,48.8,Rate
Zuid-Holland,NL33,Total,Females,2011,Chronic lower respiratory diseases,35.98,Rate
Zuid-Holland,NL33,Total,Females,2012,Chronic lower respiratory diseases,40.83,Rate
Zuid-Holland,NL33,Total,Females,2013,Chronic lower respiratory diseases,35.66,Rate
Zuid-Holland,NL33,Total,Females,2014,Chronic lower respiratory diseases,33.31,Rate
Zuid-Holland,NL33,Total,Females,2015,Chronic lower respiratory diseases,39.53,Rate
Zuid-Holland,NL33,Total,Females,2016,Chronic lower respiratory diseases,37.33,Rate
Zuid-Holland,NL33,Total,Females,2017,Chronic lower respiratory diseases,39.1,Rate
Zuid-Holland,NL33,Total,Females,2018,Chronic lower respiratory diseases,37.82,Rate
Zuid-Holland,NL33,Total,Females,2019,Chronic lower respiratory diseases,35.98,Rate
Zuid-Holland,NL33,Total,Females,2020,Chronic lower respiratory diseases,29.51,Rate
Zuid-Holland,NL33,Total,Females,2011,Asthma and status asthmaticus,0.4,Rate
Zuid-Holland,NL33,Total,Females,2012,Asthma and status asthmaticus,0.63,Rate
Zuid-Holland,NL33,Total,Females,2013,Asthma and status asthmaticus,0.73,Rate
Zuid-Holland,NL33,Total,Females,2014,Asthma and status asthmaticus,0.82,Rate
Zuid-Holland,NL33,Total,Females,2015,Asthma and status asthmaticus,0.8,Rate
Zuid-Holland,NL33,Total,Females,2016,Asthma and status asthmaticus,1.27,Rate
Zuid-Holland,NL33,Total,Females,2017,Asthma and status asthmaticus,0.81,Rate
Zuid-Holland,NL33,Total,Females,2018,Asthma and status asthmaticus,1.49,Rate
Zuid-Holland,NL33,Total,Females,2019,Asthma and status asthmaticus,1.45,Rate
Zuid-Holland,NL33,Total,Females,2020,Asthma and status asthmaticus,1.52,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3704.89,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3748.62,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3783.25,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3586.34,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3753.03,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3719.26,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3733.63,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3683.75,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3548.72,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4016.46,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",126.13,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",120.16,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",108.49,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.64,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.6,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",112.21,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",102.7,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",91.92,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.44,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.03,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",182.19,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",184.15,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",186.11,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",172.9,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",182.64,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",182.24,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",185.12,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",178.31,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",178.18,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",184.85,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Malignant melanoma of skin,11.49,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Malignant melanoma of skin,14.23,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Malignant melanoma of skin,12.17,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Malignant melanoma of skin,13.49,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Malignant melanoma of skin,11.35,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Malignant melanoma of skin,13.47,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Malignant melanoma of skin,12.12,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Malignant melanoma of skin,11.66,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Malignant melanoma of skin,11.45,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Malignant melanoma of skin,15.19,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Malignant neoplasm of breast,126.77,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Malignant neoplasm of breast,118.63,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Malignant neoplasm of breast,121.63,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Malignant neoplasm of breast,118.53,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Malignant neoplasm of breast,137.36,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Malignant neoplasm of breast,118.71,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Malignant neoplasm of breast,117.9,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Malignant neoplasm of breast,123.42,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Malignant neoplasm of breast,117.12,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Malignant neoplasm of breast,105.97,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Diabetes mellitus,94.9,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Diabetes mellitus,84.8,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Diabetes mellitus,88.09,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Diabetes mellitus,76.99,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Diabetes mellitus,69.48,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Diabetes mellitus,72.81,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Diabetes mellitus,68.76,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Diabetes mellitus,66.69,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Diabetes mellitus,69.13,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Diabetes mellitus,60.48,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),322.88,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),365.25,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),421.08,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),389.18,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),442.06,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),447.56,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),446.44,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),449.46,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),408.02,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),360.05,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),6.38,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),6.98,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),11.85,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),9.22,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),13.54,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),15.66,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),12.75,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),9.92,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),7.96,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),12.42,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Other ischaemic heart diseases,72.28,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Other ischaemic heart diseases,71.54,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Other ischaemic heart diseases,74.01,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Other ischaemic heart diseases,73.46,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Other ischaemic heart diseases,68.73,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Other ischaemic heart diseases,69.28,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Other ischaemic heart diseases,68.56,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Other ischaemic heart diseases,50.11,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Other ischaemic heart diseases,53.33,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Other ischaemic heart diseases,50.35,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,160.76,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,144.6,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,125.14,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,130.56,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,129.08,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,118.59,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,114.94,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,106.06,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,90.81,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,94.06,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Cerebrovascular diseases,283.78,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Cerebrovascular diseases,290.72,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Cerebrovascular diseases,307.38,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Cerebrovascular diseases,296.0,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Cerebrovascular diseases,292.55,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Cerebrovascular diseases,282.75,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Cerebrovascular diseases,286.88,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Cerebrovascular diseases,256.77,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Cerebrovascular diseases,242.03,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Cerebrovascular diseases,234.9,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Chronic lower respiratory diseases,163.36,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Chronic lower respiratory diseases,186.85,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Chronic lower respiratory diseases,157.16,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Chronic lower respiratory diseases,151.76,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Chronic lower respiratory diseases,181.05,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Chronic lower respiratory diseases,166.67,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Chronic lower respiratory diseases,180.82,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Chronic lower respiratory diseases,172.0,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Chronic lower respiratory diseases,166.15,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Chronic lower respiratory diseases,135.11,Rate
Zuid-Holland,NL33,65 years or over,Females,2011,Asthma and status asthmaticus,1.79,Rate
Zuid-Holland,NL33,65 years or over,Females,2012,Asthma and status asthmaticus,2.68,Rate
Zuid-Holland,NL33,65 years or over,Females,2013,Asthma and status asthmaticus,2.64,Rate
Zuid-Holland,NL33,65 years or over,Females,2014,Asthma and status asthmaticus,3.67,Rate
Zuid-Holland,NL33,65 years or over,Females,2015,Asthma and status asthmaticus,3.85,Rate
Zuid-Holland,NL33,65 years or over,Females,2016,Asthma and status asthmaticus,5.95,Rate
Zuid-Holland,NL33,65 years or over,Females,2017,Asthma and status asthmaticus,3.62,Rate
Zuid-Holland,NL33,65 years or over,Females,2018,Asthma and status asthmaticus,6.81,Rate
Zuid-Holland,NL33,65 years or over,Females,2019,Asthma and status asthmaticus,6.84,Rate
Zuid-Holland,NL33,65 years or over,Females,2020,Asthma and status asthmaticus,7.01,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,144.03,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,142.44,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,144.77,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,132.31,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,131.52,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,134.67,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,128.19,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,129.35,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,121.94,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,127.29,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.58,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.95,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.59,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.65,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.89,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.52,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.24,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.4,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.39,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.23,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",22.41,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",21.21,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",22.18,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",19.21,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",17.52,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",18.67,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",17.27,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",16.88,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",15.46,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",15.36,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Malignant melanoma of skin,2.86,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Malignant melanoma of skin,1.77,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Malignant melanoma of skin,2.32,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Malignant melanoma of skin,1.72,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Malignant melanoma of skin,1.9,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Malignant melanoma of skin,1.56,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Malignant melanoma of skin,1.45,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Malignant melanoma of skin,1.61,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Malignant melanoma of skin,0.92,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Malignant melanoma of skin,1.36,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Malignant neoplasm of breast,17.83,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Malignant neoplasm of breast,17.68,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.74,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.5,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Malignant neoplasm of breast,15.29,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Malignant neoplasm of breast,16.61,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Malignant neoplasm of breast,15.11,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Malignant neoplasm of breast,12.75,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.18,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Malignant neoplasm of breast,14.04,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Diabetes mellitus,1.5,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Diabetes mellitus,1.38,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Diabetes mellitus,1.31,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Diabetes mellitus,1.58,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Diabetes mellitus,1.22,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Diabetes mellitus,1.47,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Diabetes mellitus,1.95,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Diabetes mellitus,1.19,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Diabetes mellitus,1.34,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Diabetes mellitus,1.99,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),1.22,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),1.23,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),2.15,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.69,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),2.09,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),3.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.74,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.94,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),3.18,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),3.53,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.73,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.86,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.24,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.88,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),1.48,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.24,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Other ischaemic heart diseases,1.01,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.83,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.83,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.69,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Other ischaemic heart diseases,1.23,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.94,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.66,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.8,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.52,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.85,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.59,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,4.27,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,2.75,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.56,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,2.57,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,2.98,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.41,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.05,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.14,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.17,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Cerebrovascular diseases,4.2,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Cerebrovascular diseases,5.52,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Cerebrovascular diseases,5.19,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Cerebrovascular diseases,4.82,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Cerebrovascular diseases,4.21,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Cerebrovascular diseases,4.36,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Cerebrovascular diseases,3.61,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Cerebrovascular diseases,3.69,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Cerebrovascular diseases,3.93,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Cerebrovascular diseases,3.72,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Chronic lower respiratory diseases,5.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Chronic lower respiratory diseases,5.46,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Chronic lower respiratory diseases,6.22,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Chronic lower respiratory diseases,4.61,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Chronic lower respiratory diseases,5.25,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Chronic lower respiratory diseases,6.0,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Chronic lower respiratory diseases,4.78,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Chronic lower respiratory diseases,5.31,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Chronic lower respiratory diseases,4.44,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Chronic lower respiratory diseases,3.93,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.06,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.27,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.2,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.15,Rate
Zuid-Holland,NL33,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.19,Rate
Zuid-Holland,NL33,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1194.55,Rate
Zuid-Holland,NL33,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1225.65,Rate
Zuid-Holland,NL33,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1182.54,Rate
Zuid-Holland,NL33,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1111.93,Rate
Zuid-Holland,NL33,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1149.05,Rate
Zuid-Holland,NL33,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1139.68,Rate
Zuid-Holland,NL33,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1108.73,Rate
Zuid-Holland,NL33,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1127.4,Rate
Zuid-Holland,NL33,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1082.41,Rate
Zuid-Holland,NL33,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1228.94,Rate
Zuid-Holland,NL33,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.91,Rate
Zuid-Holland,NL33,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.88,Rate
Zuid-Holland,NL33,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.67,Rate
Zuid-Holland,NL33,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.94,Rate
Zuid-Holland,NL33,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.44,Rate
Zuid-Holland,NL33,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.13,Rate
Zuid-Holland,NL33,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.51,Rate
Zuid-Holland,NL33,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.85,Rate
Zuid-Holland,NL33,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.02,Rate
Zuid-Holland,NL33,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.39,Rate
Zuid-Holland,NL33,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",107.94,Rate
Zuid-Holland,NL33,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",99.0,Rate
Zuid-Holland,NL33,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",97.31,Rate
Zuid-Holland,NL33,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",92.17,Rate
Zuid-Holland,NL33,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",82.27,Rate
Zuid-Holland,NL33,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",85.11,Rate
Zuid-Holland,NL33,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",82.29,Rate
Zuid-Holland,NL33,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",78.26,Rate
Zuid-Holland,NL33,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",71.46,Rate
Zuid-Holland,NL33,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",69.83,Rate
Zuid-Holland,NL33,Total,Males,2011,Malignant melanoma of skin,6.5,Rate
Zuid-Holland,NL33,Total,Males,2012,Malignant melanoma of skin,7.39,Rate
Zuid-Holland,NL33,Total,Males,2013,Malignant melanoma of skin,6.12,Rate
Zuid-Holland,NL33,Total,Males,2014,Malignant melanoma of skin,7.22,Rate
Zuid-Holland,NL33,Total,Males,2015,Malignant melanoma of skin,6.19,Rate
Zuid-Holland,NL33,Total,Males,2016,Malignant melanoma of skin,7.26,Rate
Zuid-Holland,NL33,Total,Males,2017,Malignant melanoma of skin,6.05,Rate
Zuid-Holland,NL33,Total,Males,2018,Malignant melanoma of skin,6.07,Rate
Zuid-Holland,NL33,Total,Males,2019,Malignant melanoma of skin,5.95,Rate
Zuid-Holland,NL33,Total,Males,2020,Malignant melanoma of skin,6.87,Rate
Zuid-Holland,NL33,Total,Males,2011,Malignant neoplasm of breast,0.38,Rate
Zuid-Holland,NL33,Total,Males,2012,Malignant neoplasm of breast,0.46,Rate
Zuid-Holland,NL33,Total,Males,2013,Malignant neoplasm of breast,0.31,Rate
Zuid-Holland,NL33,Total,Males,2014,Malignant neoplasm of breast,0.16,Rate
Zuid-Holland,NL33,Total,Males,2015,Malignant neoplasm of breast,0.56,Rate
Zuid-Holland,NL33,Total,Males,2016,Malignant neoplasm of breast,0.49,Rate
Zuid-Holland,NL33,Total,Males,2017,Malignant neoplasm of breast,0.3,Rate
Zuid-Holland,NL33,Total,Males,2018,Malignant neoplasm of breast,0.36,Rate
Zuid-Holland,NL33,Total,Males,2020,Malignant neoplasm of breast,0.19,Rate
Zuid-Holland,NL33,Total,Males,2011,Diabetes mellitus,23.07,Rate
Zuid-Holland,NL33,Total,Males,2012,Diabetes mellitus,24.42,Rate
Zuid-Holland,NL33,Total,Males,2013,Diabetes mellitus,23.76,Rate
Zuid-Holland,NL33,Total,Males,2014,Diabetes mellitus,19.07,Rate
Zuid-Holland,NL33,Total,Males,2015,Diabetes mellitus,22.78,Rate
Zuid-Holland,NL33,Total,Males,2016,Diabetes mellitus,23.09,Rate
Zuid-Holland,NL33,Total,Males,2017,Diabetes mellitus,19.04,Rate
Zuid-Holland,NL33,Total,Males,2018,Diabetes mellitus,21.93,Rate
Zuid-Holland,NL33,Total,Males,2019,Diabetes mellitus,21.18,Rate
Zuid-Holland,NL33,Total,Males,2020,Diabetes mellitus,21.17,Rate
Zuid-Holland,NL33,Total,Males,2011,Mental and behavioural disorders (F00-F99),49.43,Rate
Zuid-Holland,NL33,Total,Males,2012,Mental and behavioural disorders (F00-F99),60.96,Rate
Zuid-Holland,NL33,Total,Males,2013,Mental and behavioural disorders (F00-F99),73.12,Rate
Zuid-Holland,NL33,Total,Males,2014,Mental and behavioural disorders (F00-F99),74.55,Rate
Zuid-Holland,NL33,Total,Males,2015,Mental and behavioural disorders (F00-F99),80.86,Rate
Zuid-Holland,NL33,Total,Males,2016,Mental and behavioural disorders (F00-F99),81.31,Rate
Zuid-Holland,NL33,Total,Males,2017,Mental and behavioural disorders (F00-F99),82.89,Rate
Zuid-Holland,NL33,Total,Males,2018,Mental and behavioural disorders (F00-F99),86.28,Rate
Zuid-Holland,NL33,Total,Males,2019,Mental and behavioural disorders (F00-F99),82.83,Rate
Zuid-Holland,NL33,Total,Males,2020,Mental and behavioural disorders (F00-F99),72.08,Rate
Zuid-Holland,NL33,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.7,Rate
Zuid-Holland,NL33,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),2.57,Rate
Zuid-Holland,NL33,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.15,Rate
Zuid-Holland,NL33,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),3.47,Rate
Zuid-Holland,NL33,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),3.03,Rate
Zuid-Holland,NL33,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),3.29,Rate
Zuid-Holland,NL33,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),3.74,Rate
Zuid-Holland,NL33,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),2.49,Rate
Zuid-Holland,NL33,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.22,Rate
Zuid-Holland,NL33,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),4.07,Rate
Zuid-Holland,NL33,Total,Males,2011,Other ischaemic heart diseases,36.65,Rate
Zuid-Holland,NL33,Total,Males,2012,Other ischaemic heart diseases,37.96,Rate
Zuid-Holland,NL33,Total,Males,2013,Other ischaemic heart diseases,34.89,Rate
Zuid-Holland,NL33,Total,Males,2014,Other ischaemic heart diseases,34.04,Rate
Zuid-Holland,NL33,Total,Males,2015,Other ischaemic heart diseases,38.51,Rate
Zuid-Holland,NL33,Total,Males,2016,Other ischaemic heart diseases,31.35,Rate
Zuid-Holland,NL33,Total,Males,2017,Other ischaemic heart diseases,35.4,Rate
Zuid-Holland,NL33,Total,Males,2018,Other ischaemic heart diseases,31.47,Rate
Zuid-Holland,NL33,Total,Males,2019,Other ischaemic heart diseases,33.21,Rate
Zuid-Holland,NL33,Total,Males,2020,Other ischaemic heart diseases,29.88,Rate
Zuid-Holland,NL33,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,65.87,Rate
Zuid-Holland,NL33,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,62.38,Rate
Zuid-Holland,NL33,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,57.0,Rate
Zuid-Holland,NL33,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,50.15,Rate
Zuid-Holland,NL33,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,53.02,Rate
Zuid-Holland,NL33,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,44.2,Rate
Zuid-Holland,NL33,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,42.64,Rate
Zuid-Holland,NL33,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,42.89,Rate
Zuid-Holland,NL33,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,39.19,Rate
Zuid-Holland,NL33,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,35.62,Rate
Zuid-Holland,NL33,Total,Males,2011,Cerebrovascular diseases,64.84,Rate
Zuid-Holland,NL33,Total,Males,2012,Cerebrovascular diseases,64.03,Rate
Zuid-Holland,NL33,Total,Males,2013,Cerebrovascular diseases,70.18,Rate
Zuid-Holland,NL33,Total,Males,2014,Cerebrovascular diseases,64.14,Rate
Zuid-Holland,NL33,Total,Males,2015,Cerebrovascular diseases,69.22,Rate
Zuid-Holland,NL33,Total,Males,2016,Cerebrovascular diseases,62.67,Rate
Zuid-Holland,NL33,Total,Males,2017,Cerebrovascular diseases,53.9,Rate
Zuid-Holland,NL33,Total,Males,2018,Cerebrovascular diseases,59.89,Rate
Zuid-Holland,NL33,Total,Males,2019,Cerebrovascular diseases,57.59,Rate
Zuid-Holland,NL33,Total,Males,2020,Cerebrovascular diseases,49.75,Rate
Zuid-Holland,NL33,Total,Males,2011,Chronic lower respiratory diseases,68.82,Rate
Zuid-Holland,NL33,Total,Males,2012,Chronic lower respiratory diseases,70.38,Rate
Zuid-Holland,NL33,Total,Males,2013,Chronic lower respiratory diseases,61.6,Rate
Zuid-Holland,NL33,Total,Males,2014,Chronic lower respiratory diseases,51.13,Rate
Zuid-Holland,NL33,Total,Males,2015,Chronic lower respiratory diseases,57.26,Rate
Zuid-Holland,NL33,Total,Males,2016,Chronic lower respiratory diseases,50.15,Rate
Zuid-Holland,NL33,Total,Males,2017,Chronic lower respiratory diseases,55.86,Rate
Zuid-Holland,NL33,Total,Males,2018,Chronic lower respiratory diseases,54.36,Rate
Zuid-Holland,NL33,Total,Males,2019,Chronic lower respiratory diseases,51.98,Rate
Zuid-Holland,NL33,Total,Males,2020,Chronic lower respiratory diseases,42.94,Rate
Zuid-Holland,NL33,Total,Males,2011,Asthma and status asthmaticus,0.71,Rate
Zuid-Holland,NL33,Total,Males,2012,Asthma and status asthmaticus,0.62,Rate
Zuid-Holland,NL33,Total,Males,2013,Asthma and status asthmaticus,0.88,Rate
Zuid-Holland,NL33,Total,Males,2014,Asthma and status asthmaticus,0.69,Rate
Zuid-Holland,NL33,Total,Males,2015,Asthma and status asthmaticus,0.58,Rate
Zuid-Holland,NL33,Total,Males,2016,Asthma and status asthmaticus,0.67,Rate
Zuid-Holland,NL33,Total,Males,2017,Asthma and status asthmaticus,0.98,Rate
Zuid-Holland,NL33,Total,Males,2018,Asthma and status asthmaticus,0.77,Rate
Zuid-Holland,NL33,Total,Males,2019,Asthma and status asthmaticus,0.94,Rate
Zuid-Holland,NL33,Total,Males,2020,Asthma and status asthmaticus,0.55,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5334.33,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5472.28,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5297.28,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,4952.81,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5140.57,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5109.3,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,4982.79,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5045.38,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4874.74,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5573.69,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",185.15,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",184.37,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",160.69,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",177.73,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",172.86,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.38,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.31,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.52,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.43,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.01,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",457.87,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",421.79,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",406.51,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",383.81,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",346.32,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",357.03,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",345.68,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",331.22,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",303.44,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",292.1,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Malignant melanoma of skin,23.95,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Malignant melanoma of skin,23.78,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Malignant melanoma of skin,18.83,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Malignant melanoma of skin,25.84,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Malignant melanoma of skin,25.52,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Malignant melanoma of skin,27.66,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Malignant melanoma of skin,23.19,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Malignant melanoma of skin,25.26,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Malignant melanoma of skin,22.5,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Malignant melanoma of skin,24.58,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Malignant neoplasm of breast,1.64,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Malignant neoplasm of breast,1.25,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Malignant neoplasm of breast,1.33,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Malignant neoplasm of breast,0.81,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Malignant neoplasm of breast,2.63,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Malignant neoplasm of breast,2.51,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Malignant neoplasm of breast,0.7,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Malignant neoplasm of breast,1.56,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Malignant neoplasm of breast,0.99,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Diabetes mellitus,100.19,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Diabetes mellitus,106.94,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Diabetes mellitus,108.59,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Diabetes mellitus,82.94,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Diabetes mellitus,101.55,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Diabetes mellitus,103.75,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Diabetes mellitus,85.66,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Diabetes mellitus,96.15,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Diabetes mellitus,91.8,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Diabetes mellitus,89.69,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),243.23,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),302.69,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),356.14,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),364.51,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),389.58,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),392.2,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),406.71,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),418.9,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),405.0,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),347.38,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),5.95,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),10.66,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),8.2,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),13.15,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),11.07,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),11.85,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),14.39,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),6.49,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),11.49,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),12.88,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Other ischaemic heart diseases,173.89,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Other ischaemic heart diseases,178.36,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Other ischaemic heart diseases,162.53,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Other ischaemic heart diseases,160.54,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Other ischaemic heart diseases,181.78,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Other ischaemic heart diseases,147.27,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Other ischaemic heart diseases,166.09,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Other ischaemic heart diseases,150.03,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Other ischaemic heart diseases,160.44,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Other ischaemic heart diseases,139.37,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,276.67,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,266.48,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,244.6,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,217.01,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,230.45,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,193.1,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,184.3,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,183.25,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,169.01,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,153.68,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Cerebrovascular diseases,305.41,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Cerebrovascular diseases,302.17,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Cerebrovascular diseases,331.79,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Cerebrovascular diseases,306.56,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Cerebrovascular diseases,331.68,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Cerebrovascular diseases,298.65,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Cerebrovascular diseases,258.31,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Cerebrovascular diseases,283.91,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Cerebrovascular diseases,276.25,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Cerebrovascular diseases,237.74,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Chronic lower respiratory diseases,337.44,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Chronic lower respiratory diseases,342.2,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Chronic lower respiratory diseases,300.94,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Chronic lower respiratory diseases,247.54,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Chronic lower respiratory diseases,275.38,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Chronic lower respiratory diseases,239.94,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Chronic lower respiratory diseases,267.19,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Chronic lower respiratory diseases,254.58,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Chronic lower respiratory diseases,248.58,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Chronic lower respiratory diseases,208.69,Rate
Zuid-Holland,NL33,65 years or over,Males,2011,Asthma and status asthmaticus,3.07,Rate
Zuid-Holland,NL33,65 years or over,Males,2012,Asthma and status asthmaticus,2.9,Rate
Zuid-Holland,NL33,65 years or over,Males,2013,Asthma and status asthmaticus,3.41,Rate
Zuid-Holland,NL33,65 years or over,Males,2014,Asthma and status asthmaticus,3.55,Rate
Zuid-Holland,NL33,65 years or over,Males,2015,Asthma and status asthmaticus,2.41,Rate
Zuid-Holland,NL33,65 years or over,Males,2016,Asthma and status asthmaticus,3.15,Rate
Zuid-Holland,NL33,65 years or over,Males,2017,Asthma and status asthmaticus,4.51,Rate
Zuid-Holland,NL33,65 years or over,Males,2018,Asthma and status asthmaticus,3.93,Rate
Zuid-Holland,NL33,65 years or over,Males,2019,Asthma and status asthmaticus,4.28,Rate
Zuid-Holland,NL33,65 years or over,Males,2020,Asthma and status asthmaticus,2.58,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,191.75,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,196.96,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,185.81,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,181.53,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,182.16,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,178.09,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,170.29,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,178.32,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,163.77,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,176.49,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.22,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.61,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.63,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.8,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.36,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.31,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.07,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.59,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.72,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.53,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",23.17,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",20.81,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",22.41,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",21.52,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",18.31,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",19.24,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",18.48,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",16.99,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",15.26,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",15.99,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Malignant melanoma of skin,2.27,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Malignant melanoma of skin,3.41,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Malignant melanoma of skin,3.04,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Malignant melanoma of skin,2.7,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Malignant melanoma of skin,1.51,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Malignant melanoma of skin,2.32,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Malignant melanoma of skin,1.9,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Malignant melanoma of skin,1.42,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Malignant melanoma of skin,1.94,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Malignant melanoma of skin,2.58,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.27,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.06,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.06,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.2,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Diabetes mellitus,4.38,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Diabetes mellitus,4.44,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Diabetes mellitus,3.21,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Diabetes mellitus,3.6,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Diabetes mellitus,3.69,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Diabetes mellitus,3.55,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Diabetes mellitus,2.9,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Diabetes mellitus,3.96,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Diabetes mellitus,4.08,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Diabetes mellitus,4.58,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),2.49,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),2.4,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),4.56,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),4.3,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),6.08,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),6.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),4.46,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),5.71,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),4.79,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),5.39,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),1.13,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),1.09,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),1.16,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.52,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),1.21,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.94,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Other ischaemic heart diseases,3.41,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Other ischaemic heart diseases,3.95,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Other ischaemic heart diseases,3.97,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.4,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Other ischaemic heart diseases,3.8,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Other ischaemic heart diseases,3.27,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Other ischaemic heart diseases,3.74,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Other ischaemic heart diseases,2.75,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Other ischaemic heart diseases,2.39,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Other ischaemic heart diseases,3.36,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,14.8,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,12.95,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,11.55,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,9.73,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,10.04,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,8.13,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,8.32,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,8.89,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,7.74,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,7.02,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Cerebrovascular diseases,6.57,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Cerebrovascular diseases,6.35,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Cerebrovascular diseases,6.81,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Cerebrovascular diseases,5.42,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Cerebrovascular diseases,5.65,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Cerebrovascular diseases,5.5,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Cerebrovascular diseases,4.39,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Cerebrovascular diseases,5.62,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Cerebrovascular diseases,4.62,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Cerebrovascular diseases,4.21,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Chronic lower respiratory diseases,3.75,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Chronic lower respiratory diseases,4.54,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Chronic lower respiratory diseases,3.63,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Chronic lower respiratory diseases,3.56,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.43,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.18,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Chronic lower respiratory diseases,4.66,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.87,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Chronic lower respiratory diseases,4.36,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.79,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.14,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.27,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.14,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.06,Rate
Zuid-Holland,NL33,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,981.21,Rate
Zuid-Holland,NL33,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,997.15,Rate
Zuid-Holland,NL33,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,986.95,Rate
Zuid-Holland,NL33,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,932.64,Rate
Zuid-Holland,NL33,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,967.9,Rate
Zuid-Holland,NL33,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,961.34,Rate
Zuid-Holland,NL33,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,948.37,Rate
Zuid-Holland,NL33,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,950.35,Rate
Zuid-Holland,NL33,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,912.88,Rate
Zuid-Holland,NL33,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1029.98,Rate
Zuid-Holland,NL33,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.42,Rate
Zuid-Holland,NL33,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.86,Rate
Zuid-Holland,NL33,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.09,Rate
Zuid-Holland,NL33,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.09,Rate
Zuid-Holland,NL33,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.55,Rate
Zuid-Holland,NL33,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.83,Rate
Zuid-Holland,NL33,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",30.66,Rate
Zuid-Holland,NL33,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.96,Rate
Zuid-Holland,NL33,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.97,Rate
Zuid-Holland,NL33,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.47,Rate
Zuid-Holland,NL33,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",75.66,Rate
Zuid-Holland,NL33,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",71.29,Rate
Zuid-Holland,NL33,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",71.56,Rate
Zuid-Holland,NL33,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",66.83,Rate
Zuid-Holland,NL33,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",63.32,Rate
Zuid-Holland,NL33,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",64.68,Rate
Zuid-Holland,NL33,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",63.21,Rate
Zuid-Holland,NL33,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",60.56,Rate
Zuid-Holland,NL33,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",57.5,Rate
Zuid-Holland,NL33,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",57.11,Rate
Zuid-Holland,NL33,Total,Total,2011,Malignant melanoma of skin,5.35,Rate
Zuid-Holland,NL33,Total,Total,2012,Malignant melanoma of skin,5.65,Rate
Zuid-Holland,NL33,Total,Total,2013,Malignant melanoma of skin,5.15,Rate
Zuid-Holland,NL33,Total,Total,2014,Malignant melanoma of skin,5.48,Rate
Zuid-Holland,NL33,Total,Total,2015,Malignant melanoma of skin,4.7,Rate
Zuid-Holland,NL33,Total,Total,2016,Malignant melanoma of skin,5.35,Rate
Zuid-Holland,NL33,Total,Total,2017,Malignant melanoma of skin,4.56,Rate
Zuid-Holland,NL33,Total,Total,2018,Malignant melanoma of skin,4.65,Rate
Zuid-Holland,NL33,Total,Total,2019,Malignant melanoma of skin,4.27,Rate
Zuid-Holland,NL33,Total,Total,2020,Malignant melanoma of skin,5.37,Rate
Zuid-Holland,NL33,Total,Total,2011,Malignant neoplasm of breast,22.16,Rate
Zuid-Holland,NL33,Total,Total,2012,Malignant neoplasm of breast,21.18,Rate
Zuid-Holland,NL33,Total,Total,2013,Malignant neoplasm of breast,20.56,Rate
Zuid-Holland,NL33,Total,Total,2014,Malignant neoplasm of breast,19.57,Rate
Zuid-Holland,NL33,Total,Total,2015,Malignant neoplasm of breast,22.02,Rate
Zuid-Holland,NL33,Total,Total,2016,Malignant neoplasm of breast,20.44,Rate
Zuid-Holland,NL33,Total,Total,2017,Malignant neoplasm of breast,19.56,Rate
Zuid-Holland,NL33,Total,Total,2018,Malignant neoplasm of breast,19.26,Rate
Zuid-Holland,NL33,Total,Total,2019,Malignant neoplasm of breast,18.44,Rate
Zuid-Holland,NL33,Total,Total,2020,Malignant neoplasm of breast,17.54,Rate
Zuid-Holland,NL33,Total,Total,2011,Diabetes mellitus,21.63,Rate
Zuid-Holland,NL33,Total,Total,2012,Diabetes mellitus,20.69,Rate
Zuid-Holland,NL33,Total,Total,2013,Diabetes mellitus,20.6,Rate
Zuid-Holland,NL33,Total,Total,2014,Diabetes mellitus,17.93,Rate
Zuid-Holland,NL33,Total,Total,2015,Diabetes mellitus,18.03,Rate
Zuid-Holland,NL33,Total,Total,2016,Diabetes mellitus,18.82,Rate
Zuid-Holland,NL33,Total,Total,2017,Diabetes mellitus,17.1,Rate
Zuid-Holland,NL33,Total,Total,2018,Diabetes mellitus,17.7,Rate
Zuid-Holland,NL33,Total,Total,2019,Diabetes mellitus,17.67,Rate
Zuid-Holland,NL33,Total,Total,2020,Diabetes mellitus,17.06,Rate
Zuid-Holland,NL33,Total,Total,2011,Mental and behavioural disorders (F00-F99),60.75,Rate
Zuid-Holland,NL33,Total,Total,2012,Mental and behavioural disorders (F00-F99),69.38,Rate
Zuid-Holland,NL33,Total,Total,2013,Mental and behavioural disorders (F00-F99),82.2,Rate
Zuid-Holland,NL33,Total,Total,2014,Mental and behavioural disorders (F00-F99),77.73,Rate
Zuid-Holland,NL33,Total,Total,2015,Mental and behavioural disorders (F00-F99),86.98,Rate
Zuid-Holland,NL33,Total,Total,2016,Mental and behavioural disorders (F00-F99),88.3,Rate
Zuid-Holland,NL33,Total,Total,2017,Mental and behavioural disorders (F00-F99),87.78,Rate
Zuid-Holland,NL33,Total,Total,2018,Mental and behavioural disorders (F00-F99),89.96,Rate
Zuid-Holland,NL33,Total,Total,2019,Mental and behavioural disorders (F00-F99),83.09,Rate
Zuid-Holland,NL33,Total,Total,2020,Mental and behavioural disorders (F00-F99),73.49,Rate
Zuid-Holland,NL33,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),1.64,Rate
Zuid-Holland,NL33,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),2.01,Rate
Zuid-Holland,NL33,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),2.59,Rate
Zuid-Holland,NL33,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.83,Rate
Zuid-Holland,NL33,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),3.16,Rate
Zuid-Holland,NL33,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),3.8,Rate
Zuid-Holland,NL33,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),3.7,Rate
Zuid-Holland,NL33,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.65,Rate
Zuid-Holland,NL33,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),2.98,Rate
Zuid-Holland,NL33,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),4.06,Rate
Zuid-Holland,NL33,Total,Total,2011,Other ischaemic heart diseases,23.38,Rate
Zuid-Holland,NL33,Total,Total,2012,Other ischaemic heart diseases,23.37,Rate
Zuid-Holland,NL33,Total,Total,2013,Other ischaemic heart diseases,23.17,Rate
Zuid-Holland,NL33,Total,Total,2014,Other ischaemic heart diseases,22.72,Rate
Zuid-Holland,NL33,Total,Total,2015,Other ischaemic heart diseases,24.1,Rate
Zuid-Holland,NL33,Total,Total,2016,Other ischaemic heart diseases,21.34,Rate
Zuid-Holland,NL33,Total,Total,2017,Other ischaemic heart diseases,22.57,Rate
Zuid-Holland,NL33,Total,Total,2018,Other ischaemic heart diseases,18.86,Rate
Zuid-Holland,NL33,Total,Total,2019,Other ischaemic heart diseases,19.81,Rate
Zuid-Holland,NL33,Total,Total,2020,Other ischaemic heart diseases,18.63,Rate
Zuid-Holland,NL33,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,47.36,Rate
Zuid-Holland,NL33,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,44.7,Rate
Zuid-Holland,NL33,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,39.22,Rate
Zuid-Holland,NL33,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,37.65,Rate
Zuid-Holland,NL33,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,38.26,Rate
Zuid-Holland,NL33,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,33.66,Rate
Zuid-Holland,NL33,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,32.59,Rate
Zuid-Holland,NL33,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,31.16,Rate
Zuid-Holland,NL33,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,27.83,Rate
Zuid-Holland,NL33,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,27.25,Rate
Zuid-Holland,NL33,Total,Total,2011,Cerebrovascular diseases,62.21,Rate
Zuid-Holland,NL33,Total,Total,2012,Cerebrovascular diseases,62.59,Rate
Zuid-Holland,NL33,Total,Total,2013,Cerebrovascular diseases,67.58,Rate
Zuid-Holland,NL33,Total,Total,2014,Cerebrovascular diseases,63.42,Rate
Zuid-Holland,NL33,Total,Total,2015,Cerebrovascular diseases,64.71,Rate
Zuid-Holland,NL33,Total,Total,2016,Cerebrovascular diseases,61.24,Rate
Zuid-Holland,NL33,Total,Total,2017,Cerebrovascular diseases,57.9,Rate
Zuid-Holland,NL33,Total,Total,2018,Cerebrovascular diseases,56.35,Rate
Zuid-Holland,NL33,Total,Total,2019,Cerebrovascular diseases,54.2,Rate
Zuid-Holland,NL33,Total,Total,2020,Cerebrovascular diseases,49.88,Rate
Zuid-Holland,NL33,Total,Total,2011,Chronic lower respiratory diseases,46.93,Rate
Zuid-Holland,NL33,Total,Total,2012,Chronic lower respiratory diseases,50.69,Rate
Zuid-Holland,NL33,Total,Total,2013,Chronic lower respiratory diseases,43.8,Rate
Zuid-Holland,NL33,Total,Total,2014,Chronic lower respiratory diseases,39.22,Rate
Zuid-Holland,NL33,Total,Total,2015,Chronic lower respiratory diseases,45.26,Rate
Zuid-Holland,NL33,Total,Total,2016,Chronic lower respiratory diseases,41.95,Rate
Zuid-Holland,NL33,Total,Total,2017,Chronic lower respiratory diseases,45.19,Rate
Zuid-Holland,NL33,Total,Total,2018,Chronic lower respiratory diseases,43.62,Rate
Zuid-Holland,NL33,Total,Total,2019,Chronic lower respiratory diseases,41.72,Rate
Zuid-Holland,NL33,Total,Total,2020,Chronic lower respiratory diseases,34.52,Rate
Zuid-Holland,NL33,Total,Total,2011,Asthma and status asthmaticus,0.55,Rate
Zuid-Holland,NL33,Total,Total,2012,Asthma and status asthmaticus,0.55,Rate
Zuid-Holland,NL33,Total,Total,2013,Asthma and status asthmaticus,0.83,Rate
Zuid-Holland,NL33,Total,Total,2014,Asthma and status asthmaticus,0.73,Rate
Zuid-Holland,NL33,Total,Total,2015,Asthma and status asthmaticus,0.73,Rate
Zuid-Holland,NL33,Total,Total,2016,Asthma and status asthmaticus,1.08,Rate
Zuid-Holland,NL33,Total,Total,2017,Asthma and status asthmaticus,0.89,Rate
Zuid-Holland,NL33,Total,Total,2018,Asthma and status asthmaticus,1.18,Rate
Zuid-Holland,NL33,Total,Total,2019,Asthma and status asthmaticus,1.29,Rate
Zuid-Holland,NL33,Total,Total,2020,Asthma and status asthmaticus,1.14,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4338.87,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4413.13,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4379.29,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4135.44,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4316.79,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4284.86,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4247.8,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4239.15,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4092.22,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4655.41,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.1,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",146.69,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.09,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.77,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",140.6,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.68,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.8,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",118.64,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.41,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.57,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",293.91,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",278.88,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",274.98,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",258.69,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",250.78,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",253.46,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",250.39,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",240.69,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",231.45,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",228.15,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Malignant melanoma of skin,16.85,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Malignant melanoma of skin,18.31,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Malignant melanoma of skin,15.34,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Malignant melanoma of skin,18.98,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Malignant melanoma of skin,17.08,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Malignant melanoma of skin,19.46,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Malignant melanoma of skin,16.5,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Malignant melanoma of skin,17.59,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Malignant melanoma of skin,16.0,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Malignant melanoma of skin,19.45,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Malignant neoplasm of breast,76.67,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Malignant neoplasm of breast,71.47,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Malignant neoplasm of breast,72.7,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Malignant neoplasm of breast,70.26,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Malignant neoplasm of breast,81.03,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Malignant neoplasm of breast,70.31,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Malignant neoplasm of breast,68.51,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Malignant neoplasm of breast,72.14,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Malignant neoplasm of breast,67.18,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Malignant neoplasm of breast,60.77,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Diabetes mellitus,98.78,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Diabetes mellitus,94.11,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Diabetes mellitus,96.33,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Diabetes mellitus,81.28,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Diabetes mellitus,82.36,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Diabetes mellitus,86.19,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Diabetes mellitus,77.67,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Diabetes mellitus,80.18,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Diabetes mellitus,79.48,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Diabetes mellitus,73.92,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),303.87,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),348.32,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),407.69,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),386.26,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),429.24,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),434.03,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),435.33,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),443.5,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),409.65,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),358.52,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),6.48,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),7.83,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),10.61,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),10.7,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),12.2,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),14.43,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),13.68,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),8.62,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),9.73,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),12.18,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Other ischaemic heart diseases,110.75,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Other ischaemic heart diseases,109.98,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Other ischaemic heart diseases,108.94,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Other ischaemic heart diseases,108.11,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Other ischaemic heart diseases,113.24,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Other ischaemic heart diseases,100.78,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Other ischaemic heart diseases,106.72,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Other ischaemic heart diseases,89.43,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Other ischaemic heart diseases,95.63,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Other ischaemic heart diseases,86.91,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,202.88,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,193.74,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,171.71,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,165.7,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,170.3,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,149.77,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,145.09,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,137.36,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,122.39,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,120.8,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Cerebrovascular diseases,296.78,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Cerebrovascular diseases,296.5,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Cerebrovascular diseases,321.81,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Cerebrovascular diseases,304.1,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Cerebrovascular diseases,311.5,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Cerebrovascular diseases,293.74,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Cerebrovascular diseases,280.43,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Cerebrovascular diseases,269.78,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Cerebrovascular diseases,260.3,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Cerebrovascular diseases,239.39,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Chronic lower respiratory diseases,222.32,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Chronic lower respiratory diseases,239.33,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Chronic lower respiratory diseases,204.26,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Chronic lower respiratory diseases,184.25,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Chronic lower respiratory diseases,212.11,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Chronic lower respiratory diseases,194.08,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Chronic lower respiratory diseases,212.23,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Chronic lower respiratory diseases,200.62,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Chronic lower respiratory diseases,195.8,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Chronic lower respiratory diseases,163.17,Rate
Zuid-Holland,NL33,65 years or over,Total,2011,Asthma and status asthmaticus,2.42,Rate
Zuid-Holland,NL33,65 years or over,Total,2012,Asthma and status asthmaticus,2.43,Rate
Zuid-Holland,NL33,65 years or over,Total,2013,Asthma and status asthmaticus,3.12,Rate
Zuid-Holland,NL33,65 years or over,Total,2014,Asthma and status asthmaticus,3.49,Rate
Zuid-Holland,NL33,65 years or over,Total,2015,Asthma and status asthmaticus,3.31,Rate
Zuid-Holland,NL33,65 years or over,Total,2016,Asthma and status asthmaticus,5.13,Rate
Zuid-Holland,NL33,65 years or over,Total,2017,Asthma and status asthmaticus,4.03,Rate
Zuid-Holland,NL33,65 years or over,Total,2018,Asthma and status asthmaticus,5.65,Rate
Zuid-Holland,NL33,65 years or over,Total,2019,Asthma and status asthmaticus,6.02,Rate
Zuid-Holland,NL33,65 years or over,Total,2020,Asthma and status asthmaticus,5.3,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,167.86,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,169.68,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,165.2,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,156.81,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,156.68,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,156.26,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,149.13,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,153.68,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,142.72,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,151.77,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.4,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.77,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.11,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.22,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.62,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.91,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.65,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.48,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.54,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.38,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",22.79,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",21.01,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",22.29,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",20.36,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",17.91,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",18.95,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",17.87,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",16.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",15.36,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.68,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Malignant melanoma of skin,2.56,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Malignant melanoma of skin,2.59,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Malignant melanoma of skin,2.68,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Malignant melanoma of skin,2.21,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Malignant melanoma of skin,1.7,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Malignant melanoma of skin,1.94,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Malignant melanoma of skin,1.67,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Malignant melanoma of skin,1.52,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Malignant melanoma of skin,1.43,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Malignant melanoma of skin,1.96,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.96,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Malignant neoplasm of breast,9.0,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.29,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.72,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Malignant neoplasm of breast,8.36,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.7,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.45,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.64,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.07,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Diabetes mellitus,2.94,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Diabetes mellitus,2.9,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Diabetes mellitus,2.26,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Diabetes mellitus,2.58,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Diabetes mellitus,2.45,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Diabetes mellitus,2.5,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Diabetes mellitus,2.42,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Diabetes mellitus,2.56,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Diabetes mellitus,2.7,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Diabetes mellitus,3.28,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),1.86,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),1.81,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),3.35,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),2.99,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),4.07,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),4.55,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),3.59,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),4.32,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),3.98,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.45,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.47,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.65,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.22,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.29,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),1.34,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.09,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Other ischaemic heart diseases,2.21,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Other ischaemic heart diseases,2.38,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Other ischaemic heart diseases,2.39,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.04,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Other ischaemic heart diseases,2.5,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Other ischaemic heart diseases,2.09,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Other ischaemic heart diseases,2.19,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Other ischaemic heart diseases,1.77,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Other ischaemic heart diseases,1.45,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Other ischaemic heart diseases,2.09,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,9.69,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,8.59,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,7.13,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,6.63,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,6.28,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,5.54,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,5.34,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,5.44,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,4.92,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,4.58,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Cerebrovascular diseases,5.38,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Cerebrovascular diseases,5.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Cerebrovascular diseases,5.99,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Cerebrovascular diseases,5.12,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Cerebrovascular diseases,4.92,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Cerebrovascular diseases,4.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Cerebrovascular diseases,4.0,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Cerebrovascular diseases,4.65,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Cerebrovascular diseases,4.27,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Cerebrovascular diseases,3.97,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Chronic lower respiratory diseases,4.44,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Chronic lower respiratory diseases,5.0,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Chronic lower respiratory diseases,4.93,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Chronic lower respiratory diseases,4.09,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Chronic lower respiratory diseases,4.84,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Chronic lower respiratory diseases,5.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Chronic lower respiratory diseases,4.72,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Chronic lower respiratory diseases,5.58,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Chronic lower respiratory diseases,4.4,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Chronic lower respiratory diseases,3.36,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.27,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.07,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.13,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.1,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.14,Rate
Zuid-Holland,NL33,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.13,Rate
Warszawski stoleczny,PL91,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,920.56,Rate
Warszawski stoleczny,PL91,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,886.95,Rate
Warszawski stoleczny,PL91,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,901.15,Rate
Warszawski stoleczny,PL91,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,860.99,Rate
Warszawski stoleczny,PL91,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,895.03,Rate
Warszawski stoleczny,PL91,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,902.26,Rate
Warszawski stoleczny,PL91,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,862.55,Rate
Warszawski stoleczny,PL91,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,995.12,Rate
Warszawski stoleczny,PL91,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.65,Rate
Warszawski stoleczny,PL91,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.73,Rate
Warszawski stoleczny,PL91,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.65,Rate
Warszawski stoleczny,PL91,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.04,Rate
Warszawski stoleczny,PL91,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.91,Rate
Warszawski stoleczny,PL91,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.45,Rate
Warszawski stoleczny,PL91,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.09,Rate
Warszawski stoleczny,PL91,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.79,Rate
Warszawski stoleczny,PL91,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",43.73,Rate
Warszawski stoleczny,PL91,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",44.97,Rate
Warszawski stoleczny,PL91,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",48.58,Rate
Warszawski stoleczny,PL91,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",46.68,Rate
Warszawski stoleczny,PL91,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",44.32,Rate
Warszawski stoleczny,PL91,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",43.28,Rate
Warszawski stoleczny,PL91,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",42.48,Rate
Warszawski stoleczny,PL91,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",40.15,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Malignant melanoma of skin,3.92,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Malignant melanoma of skin,3.36,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Malignant melanoma of skin,3.68,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Malignant melanoma of skin,3.75,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Malignant melanoma of skin,4.3,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Malignant melanoma of skin,3.79,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Malignant melanoma of skin,2.8,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Malignant melanoma of skin,3.3,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Malignant neoplasm of breast,34.72,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Malignant neoplasm of breast,33.77,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Malignant neoplasm of breast,37.41,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Malignant neoplasm of breast,37.8,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Malignant neoplasm of breast,36.64,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Malignant neoplasm of breast,38.66,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Malignant neoplasm of breast,36.6,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Malignant neoplasm of breast,37.51,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Diabetes mellitus,11.97,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Diabetes mellitus,13.78,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Diabetes mellitus,17.01,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Diabetes mellitus,16.02,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Diabetes mellitus,15.21,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Diabetes mellitus,14.41,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Diabetes mellitus,15.15,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Diabetes mellitus,20.65,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Mental and behavioural disorders (F00-F99),0.44,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Mental and behavioural disorders (F00-F99),0.4,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Mental and behavioural disorders (F00-F99),0.35,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Mental and behavioural disorders (F00-F99),2.22,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Mental and behavioural disorders (F00-F99),3.42,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Mental and behavioural disorders (F00-F99),2.31,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Mental and behavioural disorders (F00-F99),1.17,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Mental and behavioural disorders (F00-F99),1.61,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.15,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.07,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Other ischaemic heart diseases,100.0,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Other ischaemic heart diseases,97.51,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Other ischaemic heart diseases,63.91,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Other ischaemic heart diseases,68.34,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Other ischaemic heart diseases,64.75,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Other ischaemic heart diseases,23.54,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Other ischaemic heart diseases,23.18,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Other ischaemic heart diseases,10.62,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,31.48,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,31.56,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,32.37,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,21.33,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,18.77,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,19.64,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,20.76,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,25.97,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Cerebrovascular diseases,96.53,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Cerebrovascular diseases,88.58,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Cerebrovascular diseases,90.82,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Cerebrovascular diseases,76.44,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Cerebrovascular diseases,67.69,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Cerebrovascular diseases,67.16,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Cerebrovascular diseases,57.31,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Cerebrovascular diseases,65.22,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Chronic lower respiratory diseases,16.79,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Chronic lower respiratory diseases,14.4,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Chronic lower respiratory diseases,16.37,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Chronic lower respiratory diseases,17.54,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Chronic lower respiratory diseases,18.17,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Chronic lower respiratory diseases,18.27,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Chronic lower respiratory diseases,15.82,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Chronic lower respiratory diseases,14.36,Rate
Warszawski stoleczny,PL91,Total,Females,2013,Asthma and status asthmaticus,1.09,Rate
Warszawski stoleczny,PL91,Total,Females,2014,Asthma and status asthmaticus,0.57,Rate
Warszawski stoleczny,PL91,Total,Females,2015,Asthma and status asthmaticus,1.73,Rate
Warszawski stoleczny,PL91,Total,Females,2016,Asthma and status asthmaticus,1.91,Rate
Warszawski stoleczny,PL91,Total,Females,2017,Asthma and status asthmaticus,0.56,Rate
Warszawski stoleczny,PL91,Total,Females,2018,Asthma and status asthmaticus,0.69,Rate
Warszawski stoleczny,PL91,Total,Females,2019,Asthma and status asthmaticus,0.72,Rate
Warszawski stoleczny,PL91,Total,Females,2020,Asthma and status asthmaticus,0.25,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3981.18,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3864.41,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3915.54,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3743.17,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3936.4,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3967.75,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3770.42,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4406.46,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",106.92,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.29,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",117.24,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.73,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",97.97,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",100.48,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",101.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",103.38,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",146.73,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",167.19,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",179.96,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",172.66,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",164.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",166.24,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",165.27,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",159.63,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Malignant melanoma of skin,12.09,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Malignant melanoma of skin,10.91,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Malignant melanoma of skin,15.64,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Malignant melanoma of skin,14.18,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Malignant melanoma of skin,17.68,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Malignant melanoma of skin,14.32,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Malignant melanoma of skin,11.6,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Malignant melanoma of skin,12.94,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Malignant neoplasm of breast,109.77,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Malignant neoplasm of breast,114.2,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Malignant neoplasm of breast,130.98,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Malignant neoplasm of breast,122.53,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Malignant neoplasm of breast,125.13,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Malignant neoplasm of breast,138.59,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Malignant neoplasm of breast,128.27,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Malignant neoplasm of breast,136.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Diabetes mellitus,54.41,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Diabetes mellitus,61.87,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Diabetes mellitus,80.67,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Diabetes mellitus,72.81,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Diabetes mellitus,69.36,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Diabetes mellitus,69.11,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Diabetes mellitus,69.71,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Diabetes mellitus,93.3,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),1.55,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),1.7,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),0.76,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),9.02,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),14.83,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),10.43,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),2.09,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),3.21,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.34,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.25,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Other ischaemic heart diseases,502.22,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Other ischaemic heart diseases,492.63,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Other ischaemic heart diseases,319.39,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Other ischaemic heart diseases,342.16,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Other ischaemic heart diseases,322.11,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Other ischaemic heart diseases,114.93,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Other ischaemic heart diseases,114.09,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Other ischaemic heart diseases,51.26,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,140.78,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,132.88,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,121.07,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,85.7,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,86.01,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,90.82,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,90.81,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,117.4,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Cerebrovascular diseases,462.21,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Cerebrovascular diseases,419.46,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Cerebrovascular diseases,428.73,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Cerebrovascular diseases,363.33,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Cerebrovascular diseases,321.06,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Cerebrovascular diseases,314.75,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Cerebrovascular diseases,264.41,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Cerebrovascular diseases,305.51,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Chronic lower respiratory diseases,76.64,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Chronic lower respiratory diseases,65.56,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Chronic lower respiratory diseases,71.73,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Chronic lower respiratory diseases,78.19,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Chronic lower respiratory diseases,80.64,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Chronic lower respiratory diseases,82.91,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Chronic lower respiratory diseases,74.86,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Chronic lower respiratory diseases,65.74,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2013,Asthma and status asthmaticus,5.6,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2014,Asthma and status asthmaticus,2.37,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2015,Asthma and status asthmaticus,5.22,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2016,Asthma and status asthmaticus,8.08,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2017,Asthma and status asthmaticus,2.62,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2018,Asthma and status asthmaticus,2.67,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2019,Asthma and status asthmaticus,3.26,Rate
Warszawski stoleczny,PL91,65 years or over,Females,2020,Asthma and status asthmaticus,1.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,179.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,165.71,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,170.96,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,162.83,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,158.3,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,159.69,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,158.16,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,168.77,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.97,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.18,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.94,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.46,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.97,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.03,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.46,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.51,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",18.78,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",15.37,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",16.76,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",16.16,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",15.33,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",13.49,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",12.74,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",11.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Malignant melanoma of skin,1.94,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Malignant melanoma of skin,1.54,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Malignant melanoma of skin,0.78,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Malignant melanoma of skin,1.22,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Malignant melanoma of skin,1.06,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Malignant melanoma of skin,1.24,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Malignant melanoma of skin,0.67,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Malignant melanoma of skin,0.96,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Malignant neoplasm of breast,16.55,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Malignant neoplasm of breast,14.29,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Malignant neoplasm of breast,14.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Malignant neoplasm of breast,17.27,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Malignant neoplasm of breast,15.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.46,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Malignant neoplasm of breast,14.39,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Malignant neoplasm of breast,13.65,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Diabetes mellitus,1.69,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Diabetes mellitus,2.13,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Diabetes mellitus,1.59,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Diabetes mellitus,2.27,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Diabetes mellitus,2.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Diabetes mellitus,1.16,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Diabetes mellitus,1.94,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Diabetes mellitus,3.05,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.25,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.66,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.34,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.94,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),1.23,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Other ischaemic heart diseases,2.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Other ischaemic heart diseases,1.8,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Other ischaemic heart diseases,2.03,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Other ischaemic heart diseases,2.01,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Other ischaemic heart diseases,2.41,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Other ischaemic heart diseases,1.4,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Other ischaemic heart diseases,1.15,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.78,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,5.01,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,7.02,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,10.88,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,5.74,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,2.48,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,2.4,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,3.79,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.82,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Cerebrovascular diseases,7.95,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Cerebrovascular diseases,8.43,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Cerebrovascular diseases,8.97,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Cerebrovascular diseases,6.95,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Cerebrovascular diseases,6.32,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Cerebrovascular diseases,7.18,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Cerebrovascular diseases,7.14,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Cerebrovascular diseases,7.01,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.29,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Chronic lower respiratory diseases,2.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Chronic lower respiratory diseases,2.97,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Chronic lower respiratory diseases,2.85,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Chronic lower respiratory diseases,3.04,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.62,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.52,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.91,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.13,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.89,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.42,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.06,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.11,Rate
Warszawski stoleczny,PL91,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.07,Rate
Warszawski stoleczny,PL91,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1448.88,Rate
Warszawski stoleczny,PL91,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1423.59,Rate
Warszawski stoleczny,PL91,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1423.95,Rate
Warszawski stoleczny,PL91,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1414.81,Rate
Warszawski stoleczny,PL91,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1423.74,Rate
Warszawski stoleczny,PL91,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1445.41,Rate
Warszawski stoleczny,PL91,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1384.72,Rate
Warszawski stoleczny,PL91,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1606.7,Rate
Warszawski stoleczny,PL91,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.42,Rate
Warszawski stoleczny,PL91,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.35,Rate
Warszawski stoleczny,PL91,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.51,Rate
Warszawski stoleczny,PL91,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",49.01,Rate
Warszawski stoleczny,PL91,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.09,Rate
Warszawski stoleczny,PL91,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.27,Rate
Warszawski stoleczny,PL91,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",46.09,Rate
Warszawski stoleczny,PL91,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",44.01,Rate
Warszawski stoleczny,PL91,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",117.0,Rate
Warszawski stoleczny,PL91,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",107.74,Rate
Warszawski stoleczny,PL91,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",115.19,Rate
Warszawski stoleczny,PL91,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",110.16,Rate
Warszawski stoleczny,PL91,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",96.76,Rate
Warszawski stoleczny,PL91,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",103.19,Rate
Warszawski stoleczny,PL91,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",89.28,Rate
Warszawski stoleczny,PL91,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",81.13,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Malignant melanoma of skin,6.47,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Malignant melanoma of skin,4.69,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Malignant melanoma of skin,6.98,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Malignant melanoma of skin,6.28,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Malignant melanoma of skin,6.01,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Malignant melanoma of skin,6.34,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Malignant melanoma of skin,6.55,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Malignant melanoma of skin,6.56,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Malignant neoplasm of breast,0.27,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Malignant neoplasm of breast,0.18,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Malignant neoplasm of breast,0.25,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Malignant neoplasm of breast,0.63,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Malignant neoplasm of breast,0.88,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Malignant neoplasm of breast,0.73,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Malignant neoplasm of breast,0.47,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Malignant neoplasm of breast,0.84,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Diabetes mellitus,21.36,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Diabetes mellitus,19.01,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Diabetes mellitus,23.91,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Diabetes mellitus,22.44,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Diabetes mellitus,21.5,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Diabetes mellitus,25.83,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Diabetes mellitus,23.2,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Diabetes mellitus,31.79,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Mental and behavioural disorders (F00-F99),0.8,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Mental and behavioural disorders (F00-F99),1.03,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Mental and behavioural disorders (F00-F99),1.19,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Mental and behavioural disorders (F00-F99),6.15,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Mental and behavioural disorders (F00-F99),6.12,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Mental and behavioural disorders (F00-F99),6.86,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Mental and behavioural disorders (F00-F99),4.61,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Mental and behavioural disorders (F00-F99),9.42,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.11,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Other ischaemic heart diseases,129.46,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Other ischaemic heart diseases,128.62,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Other ischaemic heart diseases,80.52,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Other ischaemic heart diseases,99.51,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Other ischaemic heart diseases,97.91,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Other ischaemic heart diseases,40.21,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Other ischaemic heart diseases,46.03,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Other ischaemic heart diseases,19.54,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,70.03,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,78.46,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,91.5,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,57.88,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,40.22,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,51.63,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,47.61,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,54.66,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Cerebrovascular diseases,107.83,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Cerebrovascular diseases,102.61,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Cerebrovascular diseases,111.71,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Cerebrovascular diseases,96.41,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Cerebrovascular diseases,86.35,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Cerebrovascular diseases,86.21,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Cerebrovascular diseases,74.75,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Cerebrovascular diseases,88.98,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Chronic lower respiratory diseases,29.81,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Chronic lower respiratory diseases,28.27,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Chronic lower respiratory diseases,28.48,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Chronic lower respiratory diseases,29.03,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Chronic lower respiratory diseases,32.64,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Chronic lower respiratory diseases,26.77,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Chronic lower respiratory diseases,27.54,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Chronic lower respiratory diseases,26.41,Rate
Warszawski stoleczny,PL91,Total,Males,2013,Asthma and status asthmaticus,1.45,Rate
Warszawski stoleczny,PL91,Total,Males,2014,Asthma and status asthmaticus,1.08,Rate
Warszawski stoleczny,PL91,Total,Males,2015,Asthma and status asthmaticus,0.74,Rate
Warszawski stoleczny,PL91,Total,Males,2016,Asthma and status asthmaticus,0.92,Rate
Warszawski stoleczny,PL91,Total,Males,2017,Asthma and status asthmaticus,0.22,Rate
Warszawski stoleczny,PL91,Total,Males,2018,Asthma and status asthmaticus,1.1,Rate
Warszawski stoleczny,PL91,Total,Males,2019,Asthma and status asthmaticus,0.84,Rate
Warszawski stoleczny,PL91,Total,Males,2020,Asthma and status asthmaticus,0.74,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5656.31,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5626.27,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5645.35,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5595.67,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5649.48,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5742.08,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5499.24,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6449.83,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",191.86,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",201.72,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",223.5,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",211.59,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",195.07,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",183.91,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",192.62,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",180.21,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",450.51,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",407.78,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",439.32,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",435.6,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",371.86,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",413.5,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",359.04,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",330.63,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Malignant melanoma of skin,24.98,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Malignant melanoma of skin,18.42,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Malignant melanoma of skin,25.91,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Malignant melanoma of skin,23.88,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Malignant melanoma of skin,24.84,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Malignant melanoma of skin,27.77,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Malignant melanoma of skin,25.9,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Malignant melanoma of skin,27.43,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Malignant neoplasm of breast,0.93,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Malignant neoplasm of breast,0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Malignant neoplasm of breast,1.29,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Malignant neoplasm of breast,2.57,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Malignant neoplasm of breast,4.52,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Malignant neoplasm of breast,3.32,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Malignant neoplasm of breast,2.43,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Malignant neoplasm of breast,3.65,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Diabetes mellitus,81.3,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Diabetes mellitus,76.02,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Diabetes mellitus,99.64,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Diabetes mellitus,89.4,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Diabetes mellitus,79.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Diabetes mellitus,101.88,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Diabetes mellitus,91.72,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Diabetes mellitus,126.73,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),1.05,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),1.91,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),4.09,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),19.16,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),16.28,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),16.69,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),9.25,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),18.04,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.27,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Other ischaemic heart diseases,613.43,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Other ischaemic heart diseases,616.34,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Other ischaemic heart diseases,374.76,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Other ischaemic heart diseases,458.22,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Other ischaemic heart diseases,452.58,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Other ischaemic heart diseases,177.15,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Other ischaemic heart diseases,208.7,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Other ischaemic heart diseases,90.02,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,240.92,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,256.6,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,246.85,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,184.2,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,154.22,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,190.95,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,174.84,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,214.82,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Cerebrovascular diseases,476.01,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Cerebrovascular diseases,455.41,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Cerebrovascular diseases,486.73,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Cerebrovascular diseases,419.79,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Cerebrovascular diseases,371.49,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Cerebrovascular diseases,365.51,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Cerebrovascular diseases,321.06,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Cerebrovascular diseases,373.7,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Chronic lower respiratory diseases,133.29,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Chronic lower respiratory diseases,130.76,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Chronic lower respiratory diseases,128.73,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Chronic lower respiratory diseases,128.9,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Chronic lower respiratory diseases,148.25,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Chronic lower respiratory diseases,120.06,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Chronic lower respiratory diseases,125.47,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Chronic lower respiratory diseases,119.3,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2013,Asthma and status asthmaticus,6.03,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2014,Asthma and status asthmaticus,4.52,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2015,Asthma and status asthmaticus,2.93,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2016,Asthma and status asthmaticus,4.38,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2017,Asthma and status asthmaticus,0.85,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2018,Asthma and status asthmaticus,3.82,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2019,Asthma and status asthmaticus,3.62,Rate
Warszawski stoleczny,PL91,65 years or over,Males,2020,Asthma and status asthmaticus,3.11,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,429.69,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,405.55,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,401.37,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,402.06,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,400.11,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,404.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,388.03,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,433.52,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.62,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.76,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.2,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.02,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",36.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",35.06,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",36.67,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",31.33,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",30.12,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",28.02,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",23.93,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",20.69,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Malignant melanoma of skin,1.98,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Malignant melanoma of skin,1.36,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Malignant melanoma of skin,2.4,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Malignant melanoma of skin,2.02,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Malignant melanoma of skin,1.45,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Malignant melanoma of skin,1.14,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Malignant melanoma of skin,1.86,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Malignant melanoma of skin,1.5,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.11,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.23,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.16,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.1,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.16,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Diabetes mellitus,6.84,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Diabetes mellitus,5.2,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Diabetes mellitus,5.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Diabetes mellitus,6.22,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Diabetes mellitus,7.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Diabetes mellitus,7.4,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Diabetes mellitus,6.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Diabetes mellitus,8.8,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),0.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),0.81,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),0.49,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),3.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),3.66,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),4.47,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),3.49,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),7.34,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.14,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Other ischaemic heart diseases,12.23,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Other ischaemic heart diseases,10.48,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Other ischaemic heart diseases,9.24,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Other ischaemic heart diseases,12.62,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Other ischaemic heart diseases,11.99,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Other ischaemic heart diseases,7.04,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Other ischaemic heart diseases,6.63,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Other ischaemic heart diseases,2.47,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,28.63,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,35.31,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,53.86,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,27.28,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,12.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,17.88,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,16.79,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,15.86,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Cerebrovascular diseases,18.65,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Cerebrovascular diseases,17.15,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Cerebrovascular diseases,20.86,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Cerebrovascular diseases,18.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Cerebrovascular diseases,17.28,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Cerebrovascular diseases,18.55,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Cerebrovascular diseases,15.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Cerebrovascular diseases,20.01,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Chronic lower respiratory diseases,4.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Chronic lower respiratory diseases,3.44,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Chronic lower respiratory diseases,4.84,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Chronic lower respiratory diseases,4.64,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Chronic lower respiratory diseases,4.18,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Chronic lower respiratory diseases,3.82,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Chronic lower respiratory diseases,3.91,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.34,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.25,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.07,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.43,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.17,Rate
Warszawski stoleczny,PL91,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1136.87,Rate
Warszawski stoleczny,PL91,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1106.11,Rate
Warszawski stoleczny,PL91,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1113.81,Rate
Warszawski stoleczny,PL91,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1085.78,Rate
Warszawski stoleczny,PL91,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1112.24,Rate
Warszawski stoleczny,PL91,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1125.08,Rate
Warszawski stoleczny,PL91,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1078.0,Rate
Warszawski stoleczny,PL91,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1245.88,Rate
Warszawski stoleczny,PL91,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.6,Rate
Warszawski stoleczny,PL91,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.94,Rate
Warszawski stoleczny,PL91,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.94,Rate
Warszawski stoleczny,PL91,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",33.33,Rate
Warszawski stoleczny,PL91,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.7,Rate
Warszawski stoleczny,PL91,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.43,Rate
Warszawski stoleczny,PL91,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.61,Rate
Warszawski stoleczny,PL91,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.92,Rate
Warszawski stoleczny,PL91,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",72.35,Rate
Warszawski stoleczny,PL91,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",69.49,Rate
Warszawski stoleczny,PL91,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",74.6,Rate
Warszawski stoleczny,PL91,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",71.64,Rate
Warszawski stoleczny,PL91,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",65.12,Rate
Warszawski stoleczny,PL91,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",67.01,Rate
Warszawski stoleczny,PL91,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",60.88,Rate
Warszawski stoleczny,PL91,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",56.53,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Malignant melanoma of skin,4.77,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Malignant melanoma of skin,3.86,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Malignant melanoma of skin,5.02,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Malignant melanoma of skin,4.75,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Malignant melanoma of skin,4.98,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Malignant melanoma of skin,4.69,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Malignant melanoma of skin,4.28,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Malignant melanoma of skin,4.46,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Malignant neoplasm of breast,20.75,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Malignant neoplasm of breast,20.29,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Malignant neoplasm of breast,22.69,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Malignant neoplasm of breast,22.86,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Malignant neoplasm of breast,22.38,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Malignant neoplasm of breast,23.62,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Malignant neoplasm of breast,22.14,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Malignant neoplasm of breast,22.87,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Diabetes mellitus,15.79,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Diabetes mellitus,15.99,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Diabetes mellitus,19.83,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Diabetes mellitus,18.78,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Diabetes mellitus,18.13,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Diabetes mellitus,19.13,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Diabetes mellitus,18.57,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Diabetes mellitus,25.31,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Mental and behavioural disorders (F00-F99),0.61,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Mental and behavioural disorders (F00-F99),0.71,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Mental and behavioural disorders (F00-F99),0.72,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Mental and behavioural disorders (F00-F99),3.9,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Mental and behavioural disorders (F00-F99),4.76,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Mental and behavioural disorders (F00-F99),4.45,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Mental and behavioural disorders (F00-F99),2.72,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Mental and behavioural disorders (F00-F99),5.13,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.04,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.08,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.16,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.14,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.04,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.08,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Other ischaemic heart diseases,112.17,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Other ischaemic heart diseases,109.81,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Other ischaemic heart diseases,71.45,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Other ischaemic heart diseases,81.12,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Other ischaemic heart diseases,78.19,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Other ischaemic heart diseases,30.36,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Other ischaemic heart diseases,32.17,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Other ischaemic heart diseases,14.03,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,47.52,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,51.43,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,57.84,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,36.6,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,27.54,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,32.86,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,31.94,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,37.75,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Cerebrovascular diseases,103.15,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Cerebrovascular diseases,95.46,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Cerebrovascular diseases,100.73,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Cerebrovascular diseases,85.46,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Cerebrovascular diseases,76.09,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Cerebrovascular diseases,75.61,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Cerebrovascular diseases,65.05,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Cerebrovascular diseases,75.63,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Chronic lower respiratory diseases,21.37,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Chronic lower respiratory diseases,19.47,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Chronic lower respiratory diseases,20.76,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Chronic lower respiratory diseases,21.75,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Chronic lower respiratory diseases,23.44,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Chronic lower respiratory diseases,21.36,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Chronic lower respiratory diseases,20.22,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Chronic lower respiratory diseases,18.78,Rate
Warszawski stoleczny,PL91,Total,Total,2013,Asthma and status asthmaticus,1.2,Rate
Warszawski stoleczny,PL91,Total,Total,2014,Asthma and status asthmaticus,0.77,Rate
Warszawski stoleczny,PL91,Total,Total,2015,Asthma and status asthmaticus,1.33,Rate
Warszawski stoleczny,PL91,Total,Total,2016,Asthma and status asthmaticus,1.5,Rate
Warszawski stoleczny,PL91,Total,Total,2017,Asthma and status asthmaticus,0.45,Rate
Warszawski stoleczny,PL91,Total,Total,2018,Asthma and status asthmaticus,0.86,Rate
Warszawski stoleczny,PL91,Total,Total,2019,Asthma and status asthmaticus,0.75,Rate
Warszawski stoleczny,PL91,Total,Total,2020,Asthma and status asthmaticus,0.44,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4608.29,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4526.79,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4561.75,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4434.21,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4582.92,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4636.52,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4430.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5178.77,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.75,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.99,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",155.21,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",140.39,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.82,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",130.4,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",134.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",132.66,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",260.64,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",255.91,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",275.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",272.13,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",242.74,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",260.39,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",238.36,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",225.5,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Malignant melanoma of skin,16.45,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Malignant melanoma of skin,13.87,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Malignant melanoma of skin,19.4,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Malignant melanoma of skin,17.75,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Malignant melanoma of skin,20.44,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Malignant melanoma of skin,19.12,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Malignant melanoma of skin,16.84,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Malignant melanoma of skin,17.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Malignant neoplasm of breast,69.66,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Malignant neoplasm of breast,72.05,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Malignant neoplasm of breast,83.83,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Malignant neoplasm of breast,79.02,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Malignant neoplasm of breast,81.43,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Malignant neoplasm of breast,89.23,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Malignant neoplasm of breast,81.97,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Malignant neoplasm of breast,87.16,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Diabetes mellitus,64.16,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Diabetes mellitus,67.29,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Diabetes mellitus,87.49,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Diabetes mellitus,79.36,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Diabetes mellitus,73.81,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Diabetes mellitus,81.32,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Diabetes mellitus,78.36,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Diabetes mellitus,106.03,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),1.35,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),1.88,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),2.21,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),12.91,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),15.92,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),13.4,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),5.14,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),9.34,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Other ischaemic heart diseases,546.42,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Other ischaemic heart diseases,539.35,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Other ischaemic heart diseases,344.44,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Other ischaemic heart diseases,387.67,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Other ischaemic heart diseases,372.8,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Other ischaemic heart diseases,139.13,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Other ischaemic heart diseases,149.85,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Other ischaemic heart diseases,65.54,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,177.83,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,180.62,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,169.12,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,122.47,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,111.7,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,128.81,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,122.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,154.5,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Cerebrovascular diseases,475.61,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Cerebrovascular diseases,438.04,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Cerebrovascular diseases,456.75,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Cerebrovascular diseases,388.33,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Cerebrovascular diseases,343.14,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Cerebrovascular diseases,336.21,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Cerebrovascular diseases,288.87,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Cerebrovascular diseases,333.83,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Chronic lower respiratory diseases,95.44,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Chronic lower respiratory diseases,88.86,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Chronic lower respiratory diseases,91.89,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Chronic lower respiratory diseases,96.06,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Chronic lower respiratory diseases,104.6,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Chronic lower respiratory diseases,95.74,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Chronic lower respiratory diseases,93.06,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Chronic lower respiratory diseases,84.66,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2013,Asthma and status asthmaticus,5.45,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2014,Asthma and status asthmaticus,3.16,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2015,Asthma and status asthmaticus,4.45,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2016,Asthma and status asthmaticus,6.66,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2017,Asthma and status asthmaticus,2.0,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2018,Asthma and status asthmaticus,3.13,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2019,Asthma and status asthmaticus,3.29,Rate
Warszawski stoleczny,PL91,65 years or over,Total,2020,Asthma and status asthmaticus,1.76,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,295.97,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,277.5,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,278.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,274.66,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,271.51,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,274.48,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,265.81,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,293.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.38,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.5,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.29,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.39,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.46,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.84,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.52,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",26.74,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",24.33,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",25.84,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",23.07,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",22.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",20.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",17.89,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",15.6,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Malignant melanoma of skin,1.95,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Malignant melanoma of skin,1.44,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Malignant melanoma of skin,1.54,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Malignant melanoma of skin,1.59,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Malignant melanoma of skin,1.24,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Malignant melanoma of skin,1.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Malignant melanoma of skin,1.23,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Malignant melanoma of skin,1.21,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.9,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Malignant neoplasm of breast,7.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Malignant neoplasm of breast,7.87,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Malignant neoplasm of breast,9.26,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Malignant neoplasm of breast,8.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.73,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.65,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Malignant neoplasm of breast,7.29,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Diabetes mellitus,4.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Diabetes mellitus,3.56,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Diabetes mellitus,3.44,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Diabetes mellitus,4.1,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Diabetes mellitus,4.64,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Diabetes mellitus,4.07,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Diabetes mellitus,4.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Diabetes mellitus,5.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.44,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.42,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.36,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),1.71,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),2.06,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),2.28,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.13,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),4.12,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.05,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.05,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.09,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.04,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.1,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Other ischaemic heart diseases,6.98,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Other ischaemic heart diseases,5.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Other ischaemic heart diseases,5.32,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Other ischaemic heart diseases,6.87,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Other ischaemic heart diseases,6.83,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Other ischaemic heart diseases,4.01,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Other ischaemic heart diseases,3.66,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.55,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,15.95,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,20.14,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,30.88,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,15.8,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,7.15,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,9.61,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,9.9,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,9.47,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Cerebrovascular diseases,12.92,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Cerebrovascular diseases,12.47,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Cerebrovascular diseases,14.49,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Cerebrovascular diseases,12.1,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Cerebrovascular diseases,11.4,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Cerebrovascular diseases,12.48,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Cerebrovascular diseases,10.83,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Cerebrovascular diseases,13.08,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Chronic lower respiratory diseases,3.42,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Chronic lower respiratory diseases,2.67,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Chronic lower respiratory diseases,3.53,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.75,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.79,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.34,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Chronic lower respiratory diseases,2.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Chronic lower respiratory diseases,2.83,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.17,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.19,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.57,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.25,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.07,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.31,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.13,Rate
Warszawski stoleczny,PL91,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.11,Rate
Algarve,PT15,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,810.2,Rate
Algarve,PT15,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,832.08,Rate
Algarve,PT15,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,835.89,Rate
Algarve,PT15,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,744.37,Rate
Algarve,PT15,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,764.47,Rate
Algarve,PT15,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,825.15,Rate
Algarve,PT15,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,840.63,Rate
Algarve,PT15,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,808.91,Rate
Algarve,PT15,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,759.86,Rate
Algarve,PT15,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,828.88,Rate
Algarve,PT15,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.71,Rate
Algarve,PT15,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.03,Rate
Algarve,PT15,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.87,Rate
Algarve,PT15,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.69,Rate
Algarve,PT15,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",24.06,Rate
Algarve,PT15,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.67,Rate
Algarve,PT15,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.02,Rate
Algarve,PT15,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.26,Rate
Algarve,PT15,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",22.23,Rate
Algarve,PT15,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",20.9,Rate
Algarve,PT15,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",12.39,Rate
Algarve,PT15,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",14.46,Rate
Algarve,PT15,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",15.67,Rate
Algarve,PT15,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",13.9,Rate
Algarve,PT15,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",18.02,Rate
Algarve,PT15,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",18.69,Rate
Algarve,PT15,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",22.61,Rate
Algarve,PT15,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",13.84,Rate
Algarve,PT15,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",20.38,Rate
Algarve,PT15,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",20.4,Rate
Algarve,PT15,Total,Females,2011,Malignant melanoma of skin,3.08,Rate
Algarve,PT15,Total,Females,2012,Malignant melanoma of skin,2.25,Rate
Algarve,PT15,Total,Females,2013,Malignant melanoma of skin,2.0,Rate
Algarve,PT15,Total,Females,2014,Malignant melanoma of skin,2.78,Rate
Algarve,PT15,Total,Females,2015,Malignant melanoma of skin,1.92,Rate
Algarve,PT15,Total,Females,2016,Malignant melanoma of skin,1.9,Rate
Algarve,PT15,Total,Females,2017,Malignant melanoma of skin,3.57,Rate
Algarve,PT15,Total,Females,2018,Malignant melanoma of skin,2.59,Rate
Algarve,PT15,Total,Females,2019,Malignant melanoma of skin,4.81,Rate
Algarve,PT15,Total,Females,2020,Malignant melanoma of skin,4.08,Rate
Algarve,PT15,Total,Females,2011,Malignant neoplasm of breast,34.27,Rate
Algarve,PT15,Total,Females,2012,Malignant neoplasm of breast,34.06,Rate
Algarve,PT15,Total,Females,2013,Malignant neoplasm of breast,32.79,Rate
Algarve,PT15,Total,Females,2014,Malignant neoplasm of breast,28.78,Rate
Algarve,PT15,Total,Females,2015,Malignant neoplasm of breast,27.36,Rate
Algarve,PT15,Total,Females,2016,Malignant neoplasm of breast,27.92,Rate
Algarve,PT15,Total,Females,2017,Malignant neoplasm of breast,34.94,Rate
Algarve,PT15,Total,Females,2018,Malignant neoplasm of breast,26.31,Rate
Algarve,PT15,Total,Females,2019,Malignant neoplasm of breast,32.02,Rate
Algarve,PT15,Total,Females,2020,Malignant neoplasm of breast,30.68,Rate
Algarve,PT15,Total,Females,2011,Diabetes mellitus,30.39,Rate
Algarve,PT15,Total,Females,2012,Diabetes mellitus,27.42,Rate
Algarve,PT15,Total,Females,2013,Diabetes mellitus,32.04,Rate
Algarve,PT15,Total,Females,2014,Diabetes mellitus,27.02,Rate
Algarve,PT15,Total,Females,2015,Diabetes mellitus,31.32,Rate
Algarve,PT15,Total,Females,2016,Diabetes mellitus,26.0,Rate
Algarve,PT15,Total,Females,2017,Diabetes mellitus,25.3,Rate
Algarve,PT15,Total,Females,2018,Diabetes mellitus,25.14,Rate
Algarve,PT15,Total,Females,2019,Diabetes mellitus,20.47,Rate
Algarve,PT15,Total,Females,2020,Diabetes mellitus,24.28,Rate
Algarve,PT15,Total,Females,2011,Mental and behavioural disorders (F00-F99),0.32,Rate
Algarve,PT15,Total,Females,2012,Mental and behavioural disorders (F00-F99),0.31,Rate
Algarve,PT15,Total,Females,2013,Mental and behavioural disorders (F00-F99),24.92,Rate
Algarve,PT15,Total,Females,2014,Mental and behavioural disorders (F00-F99),28.15,Rate
Algarve,PT15,Total,Females,2015,Mental and behavioural disorders (F00-F99),25.76,Rate
Algarve,PT15,Total,Females,2016,Mental and behavioural disorders (F00-F99),33.45,Rate
Algarve,PT15,Total,Females,2017,Mental and behavioural disorders (F00-F99),29.03,Rate
Algarve,PT15,Total,Females,2018,Mental and behavioural disorders (F00-F99),38.62,Rate
Algarve,PT15,Total,Females,2019,Mental and behavioural disorders (F00-F99),41.26,Rate
Algarve,PT15,Total,Females,2020,Mental and behavioural disorders (F00-F99),50.11,Rate
Algarve,PT15,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Algarve,PT15,Total,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.31,Rate
Algarve,PT15,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Algarve,PT15,Total,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.33,Rate
Algarve,PT15,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Algarve,PT15,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Algarve,PT15,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.98,Rate
Algarve,PT15,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),2.67,Rate
Algarve,PT15,Total,Females,2011,Other ischaemic heart diseases,21.28,Rate
Algarve,PT15,Total,Females,2012,Other ischaemic heart diseases,17.52,Rate
Algarve,PT15,Total,Females,2013,Other ischaemic heart diseases,14.52,Rate
Algarve,PT15,Total,Females,2014,Other ischaemic heart diseases,10.96,Rate
Algarve,PT15,Total,Females,2015,Other ischaemic heart diseases,13.78,Rate
Algarve,PT15,Total,Females,2016,Other ischaemic heart diseases,17.12,Rate
Algarve,PT15,Total,Females,2017,Other ischaemic heart diseases,15.89,Rate
Algarve,PT15,Total,Females,2018,Other ischaemic heart diseases,12.84,Rate
Algarve,PT15,Total,Females,2019,Other ischaemic heart diseases,10.72,Rate
Algarve,PT15,Total,Females,2020,Other ischaemic heart diseases,10.19,Rate
Algarve,PT15,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,32.5,Rate
Algarve,PT15,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,28.57,Rate
Algarve,PT15,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,32.87,Rate
Algarve,PT15,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,36.56,Rate
Algarve,PT15,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,35.99,Rate
Algarve,PT15,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,28.54,Rate
Algarve,PT15,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,30.03,Rate
Algarve,PT15,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,36.17,Rate
Algarve,PT15,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,36.03,Rate
Algarve,PT15,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,40.05,Rate
Algarve,PT15,Total,Females,2011,Cerebrovascular diseases,99.09,Rate
Algarve,PT15,Total,Females,2012,Cerebrovascular diseases,90.08,Rate
Algarve,PT15,Total,Females,2013,Cerebrovascular diseases,78.82,Rate
Algarve,PT15,Total,Females,2014,Cerebrovascular diseases,75.54,Rate
Algarve,PT15,Total,Females,2015,Cerebrovascular diseases,71.61,Rate
Algarve,PT15,Total,Females,2016,Cerebrovascular diseases,80.06,Rate
Algarve,PT15,Total,Females,2017,Cerebrovascular diseases,65.04,Rate
Algarve,PT15,Total,Females,2018,Cerebrovascular diseases,65.56,Rate
Algarve,PT15,Total,Females,2019,Cerebrovascular diseases,60.83,Rate
Algarve,PT15,Total,Females,2020,Cerebrovascular diseases,74.35,Rate
Algarve,PT15,Total,Females,2011,Chronic lower respiratory diseases,9.83,Rate
Algarve,PT15,Total,Females,2012,Chronic lower respiratory diseases,7.92,Rate
Algarve,PT15,Total,Females,2013,Chronic lower respiratory diseases,11.87,Rate
Algarve,PT15,Total,Females,2014,Chronic lower respiratory diseases,6.06,Rate
Algarve,PT15,Total,Females,2015,Chronic lower respiratory diseases,9.23,Rate
Algarve,PT15,Total,Females,2016,Chronic lower respiratory diseases,13.35,Rate
Algarve,PT15,Total,Females,2017,Chronic lower respiratory diseases,11.68,Rate
Algarve,PT15,Total,Females,2018,Chronic lower respiratory diseases,8.73,Rate
Algarve,PT15,Total,Females,2019,Chronic lower respiratory diseases,9.55,Rate
Algarve,PT15,Total,Females,2020,Chronic lower respiratory diseases,8.3,Rate
Algarve,PT15,Total,Females,2011,Asthma and status asthmaticus,1.47,Rate
Algarve,PT15,Total,Females,2012,Asthma and status asthmaticus,0.31,Rate
Algarve,PT15,Total,Females,2013,Asthma and status asthmaticus,1.94,Rate
Algarve,PT15,Total,Females,2014,Asthma and status asthmaticus,0.98,Rate
Algarve,PT15,Total,Females,2015,Asthma and status asthmaticus,0.66,Rate
Algarve,PT15,Total,Females,2016,Asthma and status asthmaticus,2.01,Rate
Algarve,PT15,Total,Females,2017,Asthma and status asthmaticus,2.56,Rate
Algarve,PT15,Total,Females,2018,Asthma and status asthmaticus,0.66,Rate
Algarve,PT15,Total,Females,2019,Asthma and status asthmaticus,0.8,Rate
Algarve,PT15,Total,Females,2020,Asthma and status asthmaticus,2.54,Rate
Algarve,PT15,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,3598.0,Rate
Algarve,PT15,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,3733.69,Rate
Algarve,PT15,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3689.59,Rate
Algarve,PT15,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3328.8,Rate
Algarve,PT15,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3436.6,Rate
Algarve,PT15,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3694.67,Rate
Algarve,PT15,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3718.87,Rate
Algarve,PT15,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3623.53,Rate
Algarve,PT15,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3380.76,Rate
Algarve,PT15,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3659.63,Rate
Algarve,PT15,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",120.52,Rate
Algarve,PT15,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.69,Rate
Algarve,PT15,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.1,Rate
Algarve,PT15,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",92.06,Rate
Algarve,PT15,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",99.32,Rate
Algarve,PT15,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",96.95,Rate
Algarve,PT15,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",79.65,Rate
Algarve,PT15,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.46,Rate
Algarve,PT15,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",93.77,Rate
Algarve,PT15,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",81.77,Rate
Algarve,PT15,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",38.12,Rate
Algarve,PT15,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",51.31,Rate
Algarve,PT15,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",42.43,Rate
Algarve,PT15,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",32.83,Rate
Algarve,PT15,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",50.79,Rate
Algarve,PT15,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",43.11,Rate
Algarve,PT15,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",68.13,Rate
Algarve,PT15,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",49.91,Rate
Algarve,PT15,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",63.66,Rate
Algarve,PT15,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",58.25,Rate
Algarve,PT15,65 years or over,Females,2011,Malignant melanoma of skin,4.09,Rate
Algarve,PT15,65 years or over,Females,2012,Malignant melanoma of skin,9.22,Rate
Algarve,PT15,65 years or over,Females,2013,Malignant melanoma of skin,7.97,Rate
Algarve,PT15,65 years or over,Females,2014,Malignant melanoma of skin,9.36,Rate
Algarve,PT15,65 years or over,Females,2015,Malignant melanoma of skin,7.59,Rate
Algarve,PT15,65 years or over,Females,2016,Malignant melanoma of skin,5.38,Rate
Algarve,PT15,65 years or over,Females,2017,Malignant melanoma of skin,11.72,Rate
Algarve,PT15,65 years or over,Females,2018,Malignant melanoma of skin,11.35,Rate
Algarve,PT15,65 years or over,Females,2019,Malignant melanoma of skin,20.4,Rate
Algarve,PT15,65 years or over,Females,2020,Malignant melanoma of skin,13.66,Rate
Algarve,PT15,65 years or over,Females,2011,Malignant neoplasm of breast,89.94,Rate
Algarve,PT15,65 years or over,Females,2012,Malignant neoplasm of breast,93.78,Rate
Algarve,PT15,65 years or over,Females,2013,Malignant neoplasm of breast,105.46,Rate
Algarve,PT15,65 years or over,Females,2014,Malignant neoplasm of breast,80.69,Rate
Algarve,PT15,65 years or over,Females,2015,Malignant neoplasm of breast,93.72,Rate
Algarve,PT15,65 years or over,Females,2016,Malignant neoplasm of breast,102.09,Rate
Algarve,PT15,65 years or over,Females,2017,Malignant neoplasm of breast,88.09,Rate
Algarve,PT15,65 years or over,Females,2018,Malignant neoplasm of breast,84.66,Rate
Algarve,PT15,65 years or over,Females,2019,Malignant neoplasm of breast,104.56,Rate
Algarve,PT15,65 years or over,Females,2020,Malignant neoplasm of breast,105.35,Rate
Algarve,PT15,65 years or over,Females,2011,Diabetes mellitus,139.68,Rate
Algarve,PT15,65 years or over,Females,2012,Diabetes mellitus,133.83,Rate
Algarve,PT15,65 years or over,Females,2013,Diabetes mellitus,159.74,Rate
Algarve,PT15,65 years or over,Females,2014,Diabetes mellitus,129.71,Rate
Algarve,PT15,65 years or over,Females,2015,Diabetes mellitus,149.42,Rate
Algarve,PT15,65 years or over,Females,2016,Diabetes mellitus,122.26,Rate
Algarve,PT15,65 years or over,Females,2017,Diabetes mellitus,125.4,Rate
Algarve,PT15,65 years or over,Females,2018,Diabetes mellitus,120.24,Rate
Algarve,PT15,65 years or over,Females,2019,Diabetes mellitus,100.72,Rate
Algarve,PT15,65 years or over,Females,2020,Diabetes mellitus,122.44,Rate
Algarve,PT15,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),1.65,Rate
Algarve,PT15,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),1.6,Rate
Algarve,PT15,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),127.79,Rate
Algarve,PT15,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),140.15,Rate
Algarve,PT15,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),132.13,Rate
Algarve,PT15,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),164.85,Rate
Algarve,PT15,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),146.72,Rate
Algarve,PT15,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),198.07,Rate
Algarve,PT15,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),211.57,Rate
Algarve,PT15,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),246.24,Rate
Algarve,PT15,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),1.65,Rate
Algarve,PT15,65 years or over,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),1.6,Rate
Algarve,PT15,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),2.06,Rate
Algarve,PT15,65 years or over,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),1.69,Rate
Algarve,PT15,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),2.77,Rate
Algarve,PT15,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),1.41,Rate
Algarve,PT15,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),5.0,Rate
Algarve,PT15,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),9.29,Rate
Algarve,PT15,65 years or over,Females,2011,Other ischaemic heart diseases,109.11,Rate
Algarve,PT15,65 years or over,Females,2012,Other ischaemic heart diseases,89.83,Rate
Algarve,PT15,65 years or over,Females,2013,Other ischaemic heart diseases,69.85,Rate
Algarve,PT15,65 years or over,Females,2014,Other ischaemic heart diseases,53.96,Rate
Algarve,PT15,65 years or over,Females,2015,Other ischaemic heart diseases,68.47,Rate
Algarve,PT15,65 years or over,Females,2016,Other ischaemic heart diseases,85.62,Rate
Algarve,PT15,65 years or over,Females,2017,Other ischaemic heart diseases,77.19,Rate
Algarve,PT15,65 years or over,Females,2018,Other ischaemic heart diseases,57.19,Rate
Algarve,PT15,65 years or over,Females,2019,Other ischaemic heart diseases,54.99,Rate
Algarve,PT15,65 years or over,Females,2020,Other ischaemic heart diseases,50.25,Rate
Algarve,PT15,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,141.43,Rate
Algarve,PT15,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,125.41,Rate
Algarve,PT15,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,139.06,Rate
Algarve,PT15,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,149.92,Rate
Algarve,PT15,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,149.81,Rate
Algarve,PT15,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,121.88,Rate
Algarve,PT15,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,129.49,Rate
Algarve,PT15,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,159.44,Rate
Algarve,PT15,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,143.49,Rate
Algarve,PT15,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,159.68,Rate
Algarve,PT15,65 years or over,Females,2011,Cerebrovascular diseases,487.46,Rate
Algarve,PT15,65 years or over,Females,2012,Cerebrovascular diseases,432.92,Rate
Algarve,PT15,65 years or over,Females,2013,Cerebrovascular diseases,377.76,Rate
Algarve,PT15,65 years or over,Females,2014,Cerebrovascular diseases,360.68,Rate
Algarve,PT15,65 years or over,Females,2015,Cerebrovascular diseases,347.12,Rate
Algarve,PT15,65 years or over,Females,2016,Cerebrovascular diseases,379.31,Rate
Algarve,PT15,65 years or over,Females,2017,Cerebrovascular diseases,316.11,Rate
Algarve,PT15,65 years or over,Females,2018,Cerebrovascular diseases,306.53,Rate
Algarve,PT15,65 years or over,Females,2019,Cerebrovascular diseases,284.2,Rate
Algarve,PT15,65 years or over,Females,2020,Cerebrovascular diseases,348.87,Rate
Algarve,PT15,65 years or over,Females,2011,Chronic lower respiratory diseases,48.03,Rate
Algarve,PT15,65 years or over,Females,2012,Chronic lower respiratory diseases,38.27,Rate
Algarve,PT15,65 years or over,Females,2013,Chronic lower respiratory diseases,58.58,Rate
Algarve,PT15,65 years or over,Females,2014,Chronic lower respiratory diseases,28.79,Rate
Algarve,PT15,65 years or over,Females,2015,Chronic lower respiratory diseases,47.32,Rate
Algarve,PT15,65 years or over,Females,2016,Chronic lower respiratory diseases,64.03,Rate
Algarve,PT15,65 years or over,Females,2017,Chronic lower respiratory diseases,48.36,Rate
Algarve,PT15,65 years or over,Females,2018,Chronic lower respiratory diseases,40.46,Rate
Algarve,PT15,65 years or over,Females,2019,Chronic lower respiratory diseases,44.73,Rate
Algarve,PT15,65 years or over,Females,2020,Chronic lower respiratory diseases,40.45,Rate
Algarve,PT15,65 years or over,Females,2011,Asthma and status asthmaticus,7.52,Rate
Algarve,PT15,65 years or over,Females,2012,Asthma and status asthmaticus,1.6,Rate
Algarve,PT15,65 years or over,Females,2013,Asthma and status asthmaticus,7.66,Rate
Algarve,PT15,65 years or over,Females,2014,Asthma and status asthmaticus,5.02,Rate
Algarve,PT15,65 years or over,Females,2015,Asthma and status asthmaticus,3.39,Rate
Algarve,PT15,65 years or over,Females,2016,Asthma and status asthmaticus,5.86,Rate
Algarve,PT15,65 years or over,Females,2017,Asthma and status asthmaticus,8.22,Rate
Algarve,PT15,65 years or over,Females,2018,Asthma and status asthmaticus,3.37,Rate
Algarve,PT15,65 years or over,Females,2019,Asthma and status asthmaticus,4.13,Rate
Algarve,PT15,65 years or over,Females,2020,Asthma and status asthmaticus,10.92,Rate
Algarve,PT15,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,134.89,Rate
Algarve,PT15,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,129.21,Rate
Algarve,PT15,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,144.62,Rate
Algarve,PT15,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,118.33,Rate
Algarve,PT15,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,117.18,Rate
Algarve,PT15,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,130.05,Rate
Algarve,PT15,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,143.41,Rate
Algarve,PT15,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,127.1,Rate
Algarve,PT15,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,124.99,Rate
Algarve,PT15,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,143.17,Rate
Algarve,PT15,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.72,Rate
Algarve,PT15,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.01,Rate
Algarve,PT15,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.13,Rate
Algarve,PT15,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.13,Rate
Algarve,PT15,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.83,Rate
Algarve,PT15,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.41,Rate
Algarve,PT15,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.3,Rate
Algarve,PT15,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.1,Rate
Algarve,PT15,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.9,Rate
Algarve,PT15,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.16,Rate
Algarve,PT15,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",6.16,Rate
Algarve,PT15,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",5.54,Rate
Algarve,PT15,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",9.19,Rate
Algarve,PT15,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",9.31,Rate
Algarve,PT15,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",10.08,Rate
Algarve,PT15,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",12.77,Rate
Algarve,PT15,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",11.58,Rate
Algarve,PT15,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",5.1,Rate
Algarve,PT15,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",9.89,Rate
Algarve,PT15,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",11.23,Rate
Algarve,PT15,Less than 65 years,Females,2011,Malignant melanoma of skin,2.84,Rate
Algarve,PT15,Less than 65 years,Females,2012,Malignant melanoma of skin,0.56,Rate
Algarve,PT15,Less than 65 years,Females,2013,Malignant melanoma of skin,0.56,Rate
Algarve,PT15,Less than 65 years,Females,2014,Malignant melanoma of skin,1.19,Rate
Algarve,PT15,Less than 65 years,Females,2015,Malignant melanoma of skin,0.55,Rate
Algarve,PT15,Less than 65 years,Females,2016,Malignant melanoma of skin,1.06,Rate
Algarve,PT15,Less than 65 years,Females,2017,Malignant melanoma of skin,1.59,Rate
Algarve,PT15,Less than 65 years,Females,2018,Malignant melanoma of skin,0.46,Rate
Algarve,PT15,Less than 65 years,Females,2019,Malignant melanoma of skin,1.03,Rate
Algarve,PT15,Less than 65 years,Females,2020,Malignant melanoma of skin,1.76,Rate
Algarve,PT15,Less than 65 years,Females,2011,Malignant neoplasm of breast,20.78,Rate
Algarve,PT15,Less than 65 years,Females,2012,Malignant neoplasm of breast,19.59,Rate
Algarve,PT15,Less than 65 years,Females,2013,Malignant neoplasm of breast,15.19,Rate
Algarve,PT15,Less than 65 years,Females,2014,Malignant neoplasm of breast,16.2,Rate
Algarve,PT15,Less than 65 years,Females,2015,Malignant neoplasm of breast,11.29,Rate
Algarve,PT15,Less than 65 years,Females,2016,Malignant neoplasm of breast,9.95,Rate
Algarve,PT15,Less than 65 years,Females,2017,Malignant neoplasm of breast,22.07,Rate
Algarve,PT15,Less than 65 years,Females,2018,Malignant neoplasm of breast,12.17,Rate
Algarve,PT15,Less than 65 years,Females,2019,Malignant neoplasm of breast,14.45,Rate
Algarve,PT15,Less than 65 years,Females,2020,Malignant neoplasm of breast,12.59,Rate
Algarve,PT15,Less than 65 years,Females,2011,Diabetes mellitus,3.92,Rate
Algarve,PT15,Less than 65 years,Females,2012,Diabetes mellitus,1.65,Rate
Algarve,PT15,Less than 65 years,Females,2013,Diabetes mellitus,1.11,Rate
Algarve,PT15,Less than 65 years,Females,2014,Diabetes mellitus,2.14,Rate
Algarve,PT15,Less than 65 years,Females,2015,Diabetes mellitus,2.71,Rate
Algarve,PT15,Less than 65 years,Females,2016,Diabetes mellitus,2.68,Rate
Algarve,PT15,Less than 65 years,Females,2017,Diabetes mellitus,1.05,Rate
Algarve,PT15,Less than 65 years,Females,2018,Diabetes mellitus,2.11,Rate
Algarve,PT15,Less than 65 years,Females,2019,Diabetes mellitus,1.03,Rate
Algarve,PT15,Less than 65 years,Females,2020,Diabetes mellitus,0.51,Rate
Algarve,PT15,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),1.03,Rate
Algarve,PT15,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),1.62,Rate
Algarve,PT15,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),0.52,Rate
Algarve,PT15,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.59,Rate
Algarve,PT15,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.52,Rate
Algarve,PT15,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),1.07,Rate
Algarve,PT15,Less than 65 years,Females,2011,Other ischaemic heart diseases,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2012,Other ischaemic heart diseases,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2013,Other ischaemic heart diseases,1.11,Rate
Algarve,PT15,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.54,Rate
Algarve,PT15,Less than 65 years,Females,2015,Other ischaemic heart diseases,0.53,Rate
Algarve,PT15,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.52,Rate
Algarve,PT15,Less than 65 years,Females,2017,Other ischaemic heart diseases,1.04,Rate
Algarve,PT15,Less than 65 years,Females,2018,Other ischaemic heart diseases,2.1,Rate
Algarve,PT15,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.48,Rate
Algarve,PT15,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,6.12,Rate
Algarve,PT15,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,5.12,Rate
Algarve,PT15,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,7.14,Rate
Algarve,PT15,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,9.1,Rate
Algarve,PT15,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,8.41,Rate
Algarve,PT15,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,5.93,Rate
Algarve,PT15,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,5.94,Rate
Algarve,PT15,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,6.3,Rate
Algarve,PT15,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,10.0,Rate
Algarve,PT15,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,11.07,Rate
Algarve,PT15,Less than 65 years,Females,2011,Cerebrovascular diseases,5.01,Rate
Algarve,PT15,Less than 65 years,Females,2012,Cerebrovascular diseases,7.04,Rate
Algarve,PT15,Less than 65 years,Females,2013,Cerebrovascular diseases,6.41,Rate
Algarve,PT15,Less than 65 years,Females,2014,Cerebrovascular diseases,6.46,Rate
Algarve,PT15,Less than 65 years,Females,2015,Cerebrovascular diseases,4.87,Rate
Algarve,PT15,Less than 65 years,Females,2016,Cerebrovascular diseases,7.58,Rate
Algarve,PT15,Less than 65 years,Females,2017,Cerebrovascular diseases,4.23,Rate
Algarve,PT15,Less than 65 years,Females,2018,Cerebrovascular diseases,7.19,Rate
Algarve,PT15,Less than 65 years,Females,2019,Cerebrovascular diseases,6.72,Rate
Algarve,PT15,Less than 65 years,Females,2020,Cerebrovascular diseases,7.85,Rate
Algarve,PT15,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.57,Rate
Algarve,PT15,Less than 65 years,Females,2012,Chronic lower respiratory diseases,0.56,Rate
Algarve,PT15,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.55,Rate
Algarve,PT15,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.55,Rate
Algarve,PT15,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2016,Chronic lower respiratory diseases,1.08,Rate
Algarve,PT15,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.8,Rate
Algarve,PT15,Less than 65 years,Females,2018,Chronic lower respiratory diseases,1.04,Rate
Algarve,PT15,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.03,Rate
Algarve,PT15,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.51,Rate
Algarve,PT15,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.55,Rate
Algarve,PT15,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2016,Asthma and status asthmaticus,1.08,Rate
Algarve,PT15,Less than 65 years,Females,2017,Asthma and status asthmaticus,1.19,Rate
Algarve,PT15,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.51,Rate
Algarve,PT15,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1312.48,Rate
Algarve,PT15,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1356.47,Rate
Algarve,PT15,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1297.27,Rate
Algarve,PT15,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1356.08,Rate
Algarve,PT15,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1313.38,Rate
Algarve,PT15,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1392.68,Rate
Algarve,PT15,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1383.46,Rate
Algarve,PT15,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1405.36,Rate
Algarve,PT15,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1350.11,Rate
Algarve,PT15,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1421.48,Rate
Algarve,PT15,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.7,Rate
Algarve,PT15,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.86,Rate
Algarve,PT15,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",60.97,Rate
Algarve,PT15,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.54,Rate
Algarve,PT15,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.95,Rate
Algarve,PT15,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",69.61,Rate
Algarve,PT15,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",48.87,Rate
Algarve,PT15,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.76,Rate
Algarve,PT15,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",52.41,Rate
Algarve,PT15,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",56.45,Rate
Algarve,PT15,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",76.19,Rate
Algarve,PT15,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",69.45,Rate
Algarve,PT15,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",73.2,Rate
Algarve,PT15,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",87.14,Rate
Algarve,PT15,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",81.36,Rate
Algarve,PT15,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",87.16,Rate
Algarve,PT15,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",73.64,Rate
Algarve,PT15,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",73.63,Rate
Algarve,PT15,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",76.28,Rate
Algarve,PT15,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",72.3,Rate
Algarve,PT15,Total,Males,2011,Malignant melanoma of skin,5.02,Rate
Algarve,PT15,Total,Males,2012,Malignant melanoma of skin,2.36,Rate
Algarve,PT15,Total,Males,2013,Malignant melanoma of skin,1.96,Rate
Algarve,PT15,Total,Males,2014,Malignant melanoma of skin,4.35,Rate
Algarve,PT15,Total,Males,2015,Malignant melanoma of skin,2.82,Rate
Algarve,PT15,Total,Males,2016,Malignant melanoma of skin,3.75,Rate
Algarve,PT15,Total,Males,2017,Malignant melanoma of skin,3.28,Rate
Algarve,PT15,Total,Males,2018,Malignant melanoma of skin,2.28,Rate
Algarve,PT15,Total,Males,2019,Malignant melanoma of skin,5.48,Rate
Algarve,PT15,Total,Males,2020,Malignant melanoma of skin,3.52,Rate
Algarve,PT15,Total,Males,2011,Malignant neoplasm of breast,2.37,Rate
Algarve,PT15,Total,Males,2012,Malignant neoplasm of breast,0.51,Rate
Algarve,PT15,Total,Males,2014,Malignant neoplasm of breast,0.41,Rate
Algarve,PT15,Total,Males,2015,Malignant neoplasm of breast,1.28,Rate
Algarve,PT15,Total,Males,2018,Malignant neoplasm of breast,0.91,Rate
Algarve,PT15,Total,Males,2019,Malignant neoplasm of breast,1.32,Rate
Algarve,PT15,Total,Males,2020,Malignant neoplasm of breast,0.46,Rate
Algarve,PT15,Total,Males,2011,Diabetes mellitus,32.18,Rate
Algarve,PT15,Total,Males,2012,Diabetes mellitus,42.85,Rate
Algarve,PT15,Total,Males,2013,Diabetes mellitus,37.55,Rate
Algarve,PT15,Total,Males,2014,Diabetes mellitus,36.19,Rate
Algarve,PT15,Total,Males,2015,Diabetes mellitus,34.43,Rate
Algarve,PT15,Total,Males,2016,Diabetes mellitus,33.2,Rate
Algarve,PT15,Total,Males,2017,Diabetes mellitus,30.13,Rate
Algarve,PT15,Total,Males,2018,Diabetes mellitus,30.14,Rate
Algarve,PT15,Total,Males,2019,Diabetes mellitus,27.34,Rate
Algarve,PT15,Total,Males,2020,Diabetes mellitus,29.11,Rate
Algarve,PT15,Total,Males,2011,Mental and behavioural disorders (F00-F99),2.73,Rate
Algarve,PT15,Total,Males,2013,Mental and behavioural disorders (F00-F99),21.91,Rate
Algarve,PT15,Total,Males,2014,Mental and behavioural disorders (F00-F99),26.83,Rate
Algarve,PT15,Total,Males,2015,Mental and behavioural disorders (F00-F99),30.86,Rate
Algarve,PT15,Total,Males,2016,Mental and behavioural disorders (F00-F99),44.98,Rate
Algarve,PT15,Total,Males,2017,Mental and behavioural disorders (F00-F99),33.36,Rate
Algarve,PT15,Total,Males,2018,Mental and behavioural disorders (F00-F99),39.53,Rate
Algarve,PT15,Total,Males,2019,Mental and behavioural disorders (F00-F99),41.74,Rate
Algarve,PT15,Total,Males,2020,Mental and behavioural disorders (F00-F99),47.26,Rate
Algarve,PT15,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),1.76,Rate
Algarve,PT15,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),2.33,Rate
Algarve,PT15,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.43,Rate
Algarve,PT15,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Algarve,PT15,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.97,Rate
Algarve,PT15,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.11,Rate
Algarve,PT15,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Algarve,PT15,Total,Males,2011,Other ischaemic heart diseases,36.95,Rate
Algarve,PT15,Total,Males,2012,Other ischaemic heart diseases,19.95,Rate
Algarve,PT15,Total,Males,2013,Other ischaemic heart diseases,25.57,Rate
Algarve,PT15,Total,Males,2014,Other ischaemic heart diseases,26.46,Rate
Algarve,PT15,Total,Males,2015,Other ischaemic heart diseases,28.83,Rate
Algarve,PT15,Total,Males,2016,Other ischaemic heart diseases,19.76,Rate
Algarve,PT15,Total,Males,2017,Other ischaemic heart diseases,21.35,Rate
Algarve,PT15,Total,Males,2018,Other ischaemic heart diseases,19.01,Rate
Algarve,PT15,Total,Males,2019,Other ischaemic heart diseases,19.7,Rate
Algarve,PT15,Total,Males,2020,Other ischaemic heart diseases,16.41,Rate
Algarve,PT15,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,76.24,Rate
Algarve,PT15,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,66.95,Rate
Algarve,PT15,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,64.99,Rate
Algarve,PT15,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,81.22,Rate
Algarve,PT15,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,75.88,Rate
Algarve,PT15,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,72.13,Rate
Algarve,PT15,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,87.44,Rate
Algarve,PT15,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,98.26,Rate
Algarve,PT15,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,94.55,Rate
Algarve,PT15,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,104.89,Rate
Algarve,PT15,Total,Males,2011,Cerebrovascular diseases,129.32,Rate
Algarve,PT15,Total,Males,2012,Cerebrovascular diseases,128.22,Rate
Algarve,PT15,Total,Males,2013,Cerebrovascular diseases,99.19,Rate
Algarve,PT15,Total,Males,2014,Cerebrovascular diseases,123.37,Rate
Algarve,PT15,Total,Males,2015,Cerebrovascular diseases,111.66,Rate
Algarve,PT15,Total,Males,2016,Cerebrovascular diseases,111.38,Rate
Algarve,PT15,Total,Males,2017,Cerebrovascular diseases,109.05,Rate
Algarve,PT15,Total,Males,2018,Cerebrovascular diseases,102.34,Rate
Algarve,PT15,Total,Males,2019,Cerebrovascular diseases,99.44,Rate
Algarve,PT15,Total,Males,2020,Cerebrovascular diseases,116.34,Rate
Algarve,PT15,Total,Males,2011,Chronic lower respiratory diseases,32.26,Rate
Algarve,PT15,Total,Males,2012,Chronic lower respiratory diseases,41.78,Rate
Algarve,PT15,Total,Males,2013,Chronic lower respiratory diseases,32.8,Rate
Algarve,PT15,Total,Males,2014,Chronic lower respiratory diseases,34.29,Rate
Algarve,PT15,Total,Males,2015,Chronic lower respiratory diseases,35.19,Rate
Algarve,PT15,Total,Males,2016,Chronic lower respiratory diseases,35.72,Rate
Algarve,PT15,Total,Males,2017,Chronic lower respiratory diseases,34.67,Rate
Algarve,PT15,Total,Males,2018,Chronic lower respiratory diseases,39.43,Rate
Algarve,PT15,Total,Males,2019,Chronic lower respiratory diseases,28.82,Rate
Algarve,PT15,Total,Males,2020,Chronic lower respiratory diseases,26.13,Rate
Algarve,PT15,Total,Males,2011,Asthma and status asthmaticus,0.48,Rate
Algarve,PT15,Total,Males,2012,Asthma and status asthmaticus,2.4,Rate
Algarve,PT15,Total,Males,2013,Asthma and status asthmaticus,0.52,Rate
Algarve,PT15,Total,Males,2014,Asthma and status asthmaticus,1.25,Rate
Algarve,PT15,Total,Males,2015,Asthma and status asthmaticus,0.98,Rate
Algarve,PT15,Total,Males,2016,Asthma and status asthmaticus,2.67,Rate
Algarve,PT15,Total,Males,2017,Asthma and status asthmaticus,1.71,Rate
Algarve,PT15,Total,Males,2018,Asthma and status asthmaticus,0.42,Rate
Algarve,PT15,Total,Males,2019,Asthma and status asthmaticus,2.65,Rate
Algarve,PT15,Total,Males,2020,Asthma and status asthmaticus,1.97,Rate
Algarve,PT15,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,5368.0,Rate
Algarve,PT15,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,5630.78,Rate
Algarve,PT15,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5397.15,Rate
Algarve,PT15,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5625.88,Rate
Algarve,PT15,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5496.26,Rate
Algarve,PT15,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5755.68,Rate
Algarve,PT15,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5727.04,Rate
Algarve,PT15,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5860.86,Rate
Algarve,PT15,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5440.75,Rate
Algarve,PT15,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5962.05,Rate
Algarve,PT15,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",163.87,Rate
Algarve,PT15,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",237.76,Rate
Algarve,PT15,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",257.85,Rate
Algarve,PT15,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",214.25,Rate
Algarve,PT15,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",206.0,Rate
Algarve,PT15,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",268.98,Rate
Algarve,PT15,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",196.07,Rate
Algarve,PT15,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",210.79,Rate
Algarve,PT15,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",209.36,Rate
Algarve,PT15,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",228.65,Rate
Algarve,PT15,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",241.96,Rate
Algarve,PT15,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",217.46,Rate
Algarve,PT15,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",225.58,Rate
Algarve,PT15,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",305.14,Rate
Algarve,PT15,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",278.45,Rate
Algarve,PT15,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",289.69,Rate
Algarve,PT15,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",254.8,Rate
Algarve,PT15,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",268.73,Rate
Algarve,PT15,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",265.66,Rate
Algarve,PT15,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",265.5,Rate
Algarve,PT15,65 years or over,Males,2011,Malignant melanoma of skin,18.46,Rate
Algarve,PT15,65 years or over,Males,2012,Malignant melanoma of skin,5.09,Rate
Algarve,PT15,65 years or over,Males,2013,Malignant melanoma of skin,7.64,Rate
Algarve,PT15,65 years or over,Males,2014,Malignant melanoma of skin,17.53,Rate
Algarve,PT15,65 years or over,Males,2015,Malignant melanoma of skin,5.07,Rate
Algarve,PT15,65 years or over,Males,2016,Malignant melanoma of skin,12.05,Rate
Algarve,PT15,65 years or over,Males,2017,Malignant melanoma of skin,4.8,Rate
Algarve,PT15,65 years or over,Males,2018,Malignant melanoma of skin,9.25,Rate
Algarve,PT15,65 years or over,Males,2019,Malignant melanoma of skin,23.45,Rate
Algarve,PT15,65 years or over,Males,2020,Malignant melanoma of skin,13.35,Rate
Algarve,PT15,65 years or over,Males,2011,Malignant neoplasm of breast,12.17,Rate
Algarve,PT15,65 years or over,Males,2012,Malignant neoplasm of breast,2.64,Rate
Algarve,PT15,65 years or over,Males,2014,Malignant neoplasm of breast,2.11,Rate
Algarve,PT15,65 years or over,Males,2015,Malignant neoplasm of breast,4.16,Rate
Algarve,PT15,65 years or over,Males,2018,Malignant neoplasm of breast,2.33,Rate
Algarve,PT15,65 years or over,Males,2019,Malignant neoplasm of breast,6.77,Rate
Algarve,PT15,65 years or over,Males,2020,Malignant neoplasm of breast,2.35,Rate
Algarve,PT15,65 years or over,Males,2011,Diabetes mellitus,143.35,Rate
Algarve,PT15,65 years or over,Males,2012,Diabetes mellitus,205.32,Rate
Algarve,PT15,65 years or over,Males,2013,Diabetes mellitus,175.73,Rate
Algarve,PT15,65 years or over,Males,2014,Diabetes mellitus,171.51,Rate
Algarve,PT15,65 years or over,Males,2015,Diabetes mellitus,167.02,Rate
Algarve,PT15,65 years or over,Males,2016,Diabetes mellitus,162.95,Rate
Algarve,PT15,65 years or over,Males,2017,Diabetes mellitus,135.51,Rate
Algarve,PT15,65 years or over,Males,2018,Diabetes mellitus,140.21,Rate
Algarve,PT15,65 years or over,Males,2019,Diabetes mellitus,134.92,Rate
Algarve,PT15,65 years or over,Males,2020,Diabetes mellitus,136.98,Rate
Algarve,PT15,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),11.66,Rate
Algarve,PT15,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),107.56,Rate
Algarve,PT15,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),132.91,Rate
Algarve,PT15,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),151.38,Rate
Algarve,PT15,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),208.9,Rate
Algarve,PT15,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),163.77,Rate
Algarve,PT15,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),195.57,Rate
Algarve,PT15,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),211.59,Rate
Algarve,PT15,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),232.85,Rate
Algarve,PT15,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),9.01,Rate
Algarve,PT15,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),9.56,Rate
Algarve,PT15,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),2.54,Rate
Algarve,PT15,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.48,Rate
Algarve,PT15,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),5.7,Rate
Algarve,PT15,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,65 years or over,Males,2011,Other ischaemic heart diseases,179.73,Rate
Algarve,PT15,65 years or over,Males,2012,Other ischaemic heart diseases,95.15,Rate
Algarve,PT15,65 years or over,Males,2013,Other ischaemic heart diseases,112.07,Rate
Algarve,PT15,65 years or over,Males,2014,Other ischaemic heart diseases,121.3,Rate
Algarve,PT15,65 years or over,Males,2015,Other ischaemic heart diseases,131.0,Rate
Algarve,PT15,65 years or over,Males,2016,Other ischaemic heart diseases,94.23,Rate
Algarve,PT15,65 years or over,Males,2017,Other ischaemic heart diseases,105.06,Rate
Algarve,PT15,65 years or over,Males,2018,Other ischaemic heart diseases,80.86,Rate
Algarve,PT15,65 years or over,Males,2019,Other ischaemic heart diseases,89.3,Rate
Algarve,PT15,65 years or over,Males,2020,Other ischaemic heart diseases,77.24,Rate
Algarve,PT15,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,266.78,Rate
Algarve,PT15,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,233.21,Rate
Algarve,PT15,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,230.53,Rate
Algarve,PT15,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,265.71,Rate
Algarve,PT15,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,292.0,Rate
Algarve,PT15,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,248.26,Rate
Algarve,PT15,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,279.74,Rate
Algarve,PT15,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,345.23,Rate
Algarve,PT15,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,326.02,Rate
Algarve,PT15,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,387.49,Rate
Algarve,PT15,65 years or over,Males,2011,Cerebrovascular diseases,600.87,Rate
Algarve,PT15,65 years or over,Males,2012,Cerebrovascular diseases,590.81,Rate
Algarve,PT15,65 years or over,Males,2013,Cerebrovascular diseases,456.68,Rate
Algarve,PT15,65 years or over,Males,2014,Cerebrovascular diseases,563.11,Rate
Algarve,PT15,65 years or over,Males,2015,Cerebrovascular diseases,513.39,Rate
Algarve,PT15,65 years or over,Males,2016,Cerebrovascular diseases,518.92,Rate
Algarve,PT15,65 years or over,Males,2017,Cerebrovascular diseases,494.86,Rate
Algarve,PT15,65 years or over,Males,2018,Cerebrovascular diseases,458.5,Rate
Algarve,PT15,65 years or over,Males,2019,Cerebrovascular diseases,444.09,Rate
Algarve,PT15,65 years or over,Males,2020,Cerebrovascular diseases,561.36,Rate
Algarve,PT15,65 years or over,Males,2011,Chronic lower respiratory diseases,148.42,Rate
Algarve,PT15,65 years or over,Males,2012,Chronic lower respiratory diseases,207.09,Rate
Algarve,PT15,65 years or over,Males,2013,Chronic lower respiratory diseases,165.81,Rate
Algarve,PT15,65 years or over,Males,2014,Chronic lower respiratory diseases,168.91,Rate
Algarve,PT15,65 years or over,Males,2015,Chronic lower respiratory diseases,163.59,Rate
Algarve,PT15,65 years or over,Males,2016,Chronic lower respiratory diseases,168.74,Rate
Algarve,PT15,65 years or over,Males,2017,Chronic lower respiratory diseases,161.02,Rate
Algarve,PT15,65 years or over,Males,2018,Chronic lower respiratory diseases,181.01,Rate
Algarve,PT15,65 years or over,Males,2019,Chronic lower respiratory diseases,135.99,Rate
Algarve,PT15,65 years or over,Males,2020,Chronic lower respiratory diseases,122.38,Rate
Algarve,PT15,65 years or over,Males,2011,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,65 years or over,Males,2012,Asthma and status asthmaticus,12.33,Rate
Algarve,PT15,65 years or over,Males,2013,Asthma and status asthmaticus,2.67,Rate
Algarve,PT15,65 years or over,Males,2014,Asthma and status asthmaticus,4.34,Rate
Algarve,PT15,65 years or over,Males,2015,Asthma and status asthmaticus,5.02,Rate
Algarve,PT15,65 years or over,Males,2016,Asthma and status asthmaticus,13.7,Rate
Algarve,PT15,65 years or over,Males,2017,Asthma and status asthmaticus,8.78,Rate
Algarve,PT15,65 years or over,Males,2018,Asthma and status asthmaticus,2.15,Rate
Algarve,PT15,65 years or over,Males,2019,Asthma and status asthmaticus,11.06,Rate
Algarve,PT15,65 years or over,Males,2020,Asthma and status asthmaticus,10.1,Rate
Algarve,PT15,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,330.09,Rate
Algarve,PT15,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,321.07,Rate
Algarve,PT15,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,304.13,Rate
Algarve,PT15,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,321.78,Rate
Algarve,PT15,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,300.13,Rate
Algarve,PT15,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,335.8,Rate
Algarve,PT15,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,331.29,Rate
Algarve,PT15,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,326.08,Rate
Algarve,PT15,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,359.22,Rate
Algarve,PT15,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,321.59,Rate
Algarve,PT15,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.6,Rate
Algarve,PT15,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.31,Rate
Algarve,PT15,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.28,Rate
Algarve,PT15,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.88,Rate
Algarve,PT15,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.91,Rate
Algarve,PT15,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.32,Rate
Algarve,PT15,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.21,Rate
Algarve,PT15,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.0,Rate
Algarve,PT15,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.4,Rate
Algarve,PT15,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.74,Rate
Algarve,PT15,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",36.04,Rate
Algarve,PT15,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",33.6,Rate
Algarve,PT15,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",36.29,Rate
Algarve,PT15,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",34.33,Rate
Algarve,PT15,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",33.61,Rate
Algarve,PT15,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",38.1,Rate
Algarve,PT15,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",29.76,Rate
Algarve,PT15,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",26.37,Rate
Algarve,PT15,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",30.41,Rate
Algarve,PT15,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",25.49,Rate
Algarve,PT15,Less than 65 years,Males,2011,Malignant melanoma of skin,1.77,Rate
Algarve,PT15,Less than 65 years,Males,2012,Malignant melanoma of skin,1.7,Rate
Algarve,PT15,Less than 65 years,Males,2013,Malignant melanoma of skin,0.58,Rate
Algarve,PT15,Less than 65 years,Males,2014,Malignant melanoma of skin,1.16,Rate
Algarve,PT15,Less than 65 years,Males,2015,Malignant melanoma of skin,2.27,Rate
Algarve,PT15,Less than 65 years,Males,2016,Malignant melanoma of skin,1.74,Rate
Algarve,PT15,Less than 65 years,Males,2017,Malignant melanoma of skin,2.92,Rate
Algarve,PT15,Less than 65 years,Males,2018,Malignant melanoma of skin,0.6,Rate
Algarve,PT15,Less than 65 years,Males,2019,Malignant melanoma of skin,1.13,Rate
Algarve,PT15,Less than 65 years,Males,2020,Malignant melanoma of skin,1.14,Rate
Algarve,PT15,Less than 65 years,Males,2011,Malignant neoplasm of breast,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.58,Rate
Algarve,PT15,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.57,Rate
Algarve,PT15,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2011,Diabetes mellitus,5.25,Rate
Algarve,PT15,Less than 65 years,Males,2012,Diabetes mellitus,3.49,Rate
Algarve,PT15,Less than 65 years,Males,2013,Diabetes mellitus,4.08,Rate
Algarve,PT15,Less than 65 years,Males,2014,Diabetes mellitus,3.41,Rate
Algarve,PT15,Less than 65 years,Males,2015,Diabetes mellitus,2.31,Rate
Algarve,PT15,Less than 65 years,Males,2016,Diabetes mellitus,1.77,Rate
Algarve,PT15,Less than 65 years,Males,2017,Diabetes mellitus,4.61,Rate
Algarve,PT15,Less than 65 years,Males,2018,Diabetes mellitus,3.48,Rate
Algarve,PT15,Less than 65 years,Males,2019,Diabetes mellitus,1.28,Rate
Algarve,PT15,Less than 65 years,Males,2020,Diabetes mellitus,2.98,Rate
Algarve,PT15,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.57,Rate
Algarve,PT15,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.17,Rate
Algarve,PT15,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),1.13,Rate
Algarve,PT15,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),1.67,Rate
Algarve,PT15,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),5.27,Rate
Algarve,PT15,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),1.77,Rate
Algarve,PT15,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.74,Rate
Algarve,PT15,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),0.59,Rate
Algarve,PT15,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),2.3,Rate
Algarve,PT15,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Algarve,PT15,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.54,Rate
Algarve,PT15,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.6,Rate
Algarve,PT15,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.16,Rate
Algarve,PT15,Less than 65 years,Males,2011,Other ischaemic heart diseases,2.36,Rate
Algarve,PT15,Less than 65 years,Males,2012,Other ischaemic heart diseases,1.73,Rate
Algarve,PT15,Less than 65 years,Males,2013,Other ischaemic heart diseases,4.61,Rate
Algarve,PT15,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.49,Rate
Algarve,PT15,Less than 65 years,Males,2015,Other ischaemic heart diseases,4.08,Rate
Algarve,PT15,Less than 65 years,Males,2016,Other ischaemic heart diseases,1.73,Rate
Algarve,PT15,Less than 65 years,Males,2017,Other ischaemic heart diseases,1.07,Rate
Algarve,PT15,Less than 65 years,Males,2018,Other ischaemic heart diseases,4.03,Rate
Algarve,PT15,Less than 65 years,Males,2019,Other ischaemic heart diseases,2.84,Rate
Algarve,PT15,Less than 65 years,Males,2020,Other ischaemic heart diseases,1.67,Rate
Algarve,PT15,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,30.09,Rate
Algarve,PT15,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,26.68,Rate
Algarve,PT15,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,24.89,Rate
Algarve,PT15,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,36.53,Rate
Algarve,PT15,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,23.53,Rate
Algarve,PT15,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,29.46,Rate
Algarve,PT15,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,40.85,Rate
Algarve,PT15,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,38.43,Rate
Algarve,PT15,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,38.48,Rate
Algarve,PT15,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,36.44,Rate
Algarve,PT15,Less than 65 years,Males,2011,Cerebrovascular diseases,15.09,Rate
Algarve,PT15,Less than 65 years,Males,2012,Cerebrovascular diseases,16.16,Rate
Algarve,PT15,Less than 65 years,Males,2013,Cerebrovascular diseases,12.6,Rate
Algarve,PT15,Less than 65 years,Males,2014,Cerebrovascular diseases,16.86,Rate
Algarve,PT15,Less than 65 years,Males,2015,Cerebrovascular diseases,14.34,Rate
Algarve,PT15,Less than 65 years,Males,2016,Cerebrovascular diseases,12.65,Rate
Algarve,PT15,Less than 65 years,Males,2017,Cerebrovascular diseases,15.59,Rate
Algarve,PT15,Less than 65 years,Males,2018,Cerebrovascular diseases,16.07,Rate
Algarve,PT15,Less than 65 years,Males,2019,Cerebrovascular diseases,15.96,Rate
Algarve,PT15,Less than 65 years,Males,2020,Cerebrovascular diseases,8.54,Rate
Algarve,PT15,Less than 65 years,Males,2011,Chronic lower respiratory diseases,4.12,Rate
Algarve,PT15,Less than 65 years,Males,2012,Chronic lower respiratory diseases,1.74,Rate
Algarve,PT15,Less than 65 years,Males,2013,Chronic lower respiratory diseases,0.57,Rate
Algarve,PT15,Less than 65 years,Males,2014,Chronic lower respiratory diseases,1.68,Rate
Algarve,PT15,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.09,Rate
Algarve,PT15,Less than 65 years,Males,2016,Chronic lower respiratory diseases,3.5,Rate
Algarve,PT15,Less than 65 years,Males,2017,Chronic lower respiratory diseases,4.06,Rate
Algarve,PT15,Less than 65 years,Males,2018,Chronic lower respiratory diseases,5.13,Rate
Algarve,PT15,Less than 65 years,Males,2019,Chronic lower respiratory diseases,2.86,Rate
Algarve,PT15,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.81,Rate
Algarve,PT15,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.59,Rate
Algarve,PT15,Less than 65 years,Males,2012,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.5,Rate
Algarve,PT15,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.61,Rate
Algarve,PT15,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1035.43,Rate
Algarve,PT15,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1064.49,Rate
Algarve,PT15,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1039.99,Rate
Algarve,PT15,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1007.72,Rate
Algarve,PT15,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1003.76,Rate
Algarve,PT15,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1073.83,Rate
Algarve,PT15,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1074.66,Rate
Algarve,PT15,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1067.2,Rate
Algarve,PT15,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1015.34,Rate
Algarve,PT15,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1079.71,Rate
Algarve,PT15,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.17,Rate
Algarve,PT15,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.23,Rate
Algarve,PT15,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.39,Rate
Algarve,PT15,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.38,Rate
Algarve,PT15,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.99,Rate
Algarve,PT15,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",44.34,Rate
Algarve,PT15,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.23,Rate
Algarve,PT15,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.8,Rate
Algarve,PT15,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.27,Rate
Algarve,PT15,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.69,Rate
Algarve,PT15,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",41.56,Rate
Algarve,PT15,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",39.41,Rate
Algarve,PT15,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",41.91,Rate
Algarve,PT15,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",46.54,Rate
Algarve,PT15,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",46.08,Rate
Algarve,PT15,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",49.52,Rate
Algarve,PT15,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",45.72,Rate
Algarve,PT15,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",40.91,Rate
Algarve,PT15,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",45.27,Rate
Algarve,PT15,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",43.01,Rate
Algarve,PT15,Total,Total,2011,Malignant melanoma of skin,3.69,Rate
Algarve,PT15,Total,Total,2012,Malignant melanoma of skin,2.37,Rate
Algarve,PT15,Total,Total,2013,Malignant melanoma of skin,1.99,Rate
Algarve,PT15,Total,Total,2014,Malignant melanoma of skin,3.53,Rate
Algarve,PT15,Total,Total,2015,Malignant melanoma of skin,2.41,Rate
Algarve,PT15,Total,Total,2016,Malignant melanoma of skin,2.68,Rate
Algarve,PT15,Total,Total,2017,Malignant melanoma of skin,3.52,Rate
Algarve,PT15,Total,Total,2018,Malignant melanoma of skin,2.46,Rate
Algarve,PT15,Total,Total,2019,Malignant melanoma of skin,5.18,Rate
Algarve,PT15,Total,Total,2020,Malignant melanoma of skin,3.76,Rate
Algarve,PT15,Total,Total,2011,Malignant neoplasm of breast,19.67,Rate
Algarve,PT15,Total,Total,2012,Malignant neoplasm of breast,18.8,Rate
Algarve,PT15,Total,Total,2013,Malignant neoplasm of breast,18.15,Rate
Algarve,PT15,Total,Total,2014,Malignant neoplasm of breast,16.16,Rate
Algarve,PT15,Total,Total,2015,Malignant neoplasm of breast,15.73,Rate
Algarve,PT15,Total,Total,2016,Malignant neoplasm of breast,15.85,Rate
Algarve,PT15,Total,Total,2017,Malignant neoplasm of breast,19.61,Rate
Algarve,PT15,Total,Total,2018,Malignant neoplasm of breast,15.2,Rate
Algarve,PT15,Total,Total,2019,Malignant neoplasm of breast,18.69,Rate
Algarve,PT15,Total,Total,2020,Malignant neoplasm of breast,17.43,Rate
Algarve,PT15,Total,Total,2011,Diabetes mellitus,31.69,Rate
Algarve,PT15,Total,Total,2012,Diabetes mellitus,33.93,Rate
Algarve,PT15,Total,Total,2013,Diabetes mellitus,34.7,Rate
Algarve,PT15,Total,Total,2014,Diabetes mellitus,31.19,Rate
Algarve,PT15,Total,Total,2015,Diabetes mellitus,33.04,Rate
Algarve,PT15,Total,Total,2016,Diabetes mellitus,29.57,Rate
Algarve,PT15,Total,Total,2017,Diabetes mellitus,27.7,Rate
Algarve,PT15,Total,Total,2018,Diabetes mellitus,27.74,Rate
Algarve,PT15,Total,Total,2019,Diabetes mellitus,23.52,Rate
Algarve,PT15,Total,Total,2020,Diabetes mellitus,27.24,Rate
Algarve,PT15,Total,Total,2011,Mental and behavioural disorders (F00-F99),1.25,Rate
Algarve,PT15,Total,Total,2012,Mental and behavioural disorders (F00-F99),0.18,Rate
Algarve,PT15,Total,Total,2013,Mental and behavioural disorders (F00-F99),24.15,Rate
Algarve,PT15,Total,Total,2014,Mental and behavioural disorders (F00-F99),27.68,Rate
Algarve,PT15,Total,Total,2015,Mental and behavioural disorders (F00-F99),27.61,Rate
Algarve,PT15,Total,Total,2016,Mental and behavioural disorders (F00-F99),38.44,Rate
Algarve,PT15,Total,Total,2017,Mental and behavioural disorders (F00-F99),30.88,Rate
Algarve,PT15,Total,Total,2018,Mental and behavioural disorders (F00-F99),39.3,Rate
Algarve,PT15,Total,Total,2019,Mental and behavioural disorders (F00-F99),41.4,Rate
Algarve,PT15,Total,Total,2020,Mental and behavioural disorders (F00-F99),49.9,Rate
Algarve,PT15,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Algarve,PT15,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Algarve,PT15,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.93,Rate
Algarve,PT15,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Algarve,PT15,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Algarve,PT15,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Algarve,PT15,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),1.0,Rate
Algarve,PT15,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.57,Rate
Algarve,PT15,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.67,Rate
Algarve,PT15,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.96,Rate
Algarve,PT15,Total,Total,2011,Other ischaemic heart diseases,27.92,Rate
Algarve,PT15,Total,Total,2012,Other ischaemic heart diseases,19.0,Rate
Algarve,PT15,Total,Total,2013,Other ischaemic heart diseases,19.19,Rate
Algarve,PT15,Total,Total,2014,Other ischaemic heart diseases,17.23,Rate
Algarve,PT15,Total,Total,2015,Other ischaemic heart diseases,20.16,Rate
Algarve,PT15,Total,Total,2016,Other ischaemic heart diseases,18.58,Rate
Algarve,PT15,Total,Total,2017,Other ischaemic heart diseases,18.46,Rate
Algarve,PT15,Total,Total,2018,Other ischaemic heart diseases,15.73,Rate
Algarve,PT15,Total,Total,2019,Other ischaemic heart diseases,14.4,Rate
Algarve,PT15,Total,Total,2020,Other ischaemic heart diseases,12.53,Rate
Algarve,PT15,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,52.51,Rate
Algarve,PT15,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,46.5,Rate
Algarve,PT15,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,47.59,Rate
Algarve,PT15,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,56.72,Rate
Algarve,PT15,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,53.54,Rate
Algarve,PT15,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,48.62,Rate
Algarve,PT15,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,55.84,Rate
Algarve,PT15,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,64.08,Rate
Algarve,PT15,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,62.85,Rate
Algarve,PT15,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,68.45,Rate
Algarve,PT15,Total,Total,2011,Cerebrovascular diseases,112.84,Rate
Algarve,PT15,Total,Total,2012,Cerebrovascular diseases,106.62,Rate
Algarve,PT15,Total,Total,2013,Cerebrovascular diseases,88.32,Rate
Algarve,PT15,Total,Total,2014,Cerebrovascular diseases,95.8,Rate
Algarve,PT15,Total,Total,2015,Cerebrovascular diseases,89.68,Rate
Algarve,PT15,Total,Total,2016,Cerebrovascular diseases,92.73,Rate
Algarve,PT15,Total,Total,2017,Cerebrovascular diseases,82.83,Rate
Algarve,PT15,Total,Total,2018,Cerebrovascular diseases,80.99,Rate
Algarve,PT15,Total,Total,2019,Cerebrovascular diseases,77.05,Rate
Algarve,PT15,Total,Total,2020,Cerebrovascular diseases,91.26,Rate
Algarve,PT15,Total,Total,2011,Chronic lower respiratory diseases,19.4,Rate
Algarve,PT15,Total,Total,2012,Chronic lower respiratory diseases,21.21,Rate
Algarve,PT15,Total,Total,2013,Chronic lower respiratory diseases,19.78,Rate
Algarve,PT15,Total,Total,2014,Chronic lower respiratory diseases,16.91,Rate
Algarve,PT15,Total,Total,2015,Chronic lower respiratory diseases,20.03,Rate
Algarve,PT15,Total,Total,2016,Chronic lower respiratory diseases,22.51,Rate
Algarve,PT15,Total,Total,2017,Chronic lower respiratory diseases,20.51,Rate
Algarve,PT15,Total,Total,2018,Chronic lower respiratory diseases,20.96,Rate
Algarve,PT15,Total,Total,2019,Chronic lower respiratory diseases,17.23,Rate
Algarve,PT15,Total,Total,2020,Chronic lower respiratory diseases,15.54,Rate
Algarve,PT15,Total,Total,2011,Asthma and status asthmaticus,1.09,Rate
Algarve,PT15,Total,Total,2012,Asthma and status asthmaticus,1.09,Rate
Algarve,PT15,Total,Total,2013,Asthma and status asthmaticus,1.42,Rate
Algarve,PT15,Total,Total,2014,Asthma and status asthmaticus,1.1,Rate
Algarve,PT15,Total,Total,2015,Asthma and status asthmaticus,0.82,Rate
Algarve,PT15,Total,Total,2016,Asthma and status asthmaticus,2.22,Rate
Algarve,PT15,Total,Total,2017,Asthma and status asthmaticus,2.04,Rate
Algarve,PT15,Total,Total,2018,Asthma and status asthmaticus,0.55,Rate
Algarve,PT15,Total,Total,2019,Asthma and status asthmaticus,1.63,Rate
Algarve,PT15,Total,Total,2020,Asthma and status asthmaticus,2.23,Rate
Algarve,PT15,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,4357.01,Rate
Algarve,PT15,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,4537.97,Rate
Algarve,PT15,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4415.21,Rate
Algarve,PT15,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4272.02,Rate
Algarve,PT15,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4298.76,Rate
Algarve,PT15,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4561.98,Rate
Algarve,PT15,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4548.13,Rate
Algarve,PT15,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,4556.75,Rate
Algarve,PT15,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4228.31,Rate
Algarve,PT15,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4597.61,Rate
Algarve,PT15,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",139.71,Rate
Algarve,PT15,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",161.54,Rate
Algarve,PT15,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.3,Rate
Algarve,PT15,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",144.47,Rate
Algarve,PT15,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",145.19,Rate
Algarve,PT15,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",167.21,Rate
Algarve,PT15,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",129.46,Rate
Algarve,PT15,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",128.41,Rate
Algarve,PT15,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",137.01,Rate
Algarve,PT15,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",140.9,Rate
Algarve,PT15,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",127.15,Rate
Algarve,PT15,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",122.56,Rate
Algarve,PT15,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",122.38,Rate
Algarve,PT15,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",150.22,Rate
Algarve,PT15,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",147.91,Rate
Algarve,PT15,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",151.13,Rate
Algarve,PT15,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",150.8,Rate
Algarve,PT15,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",146.96,Rate
Algarve,PT15,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",151.11,Rate
Algarve,PT15,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",146.49,Rate
Algarve,PT15,65 years or over,Total,2011,Malignant melanoma of skin,9.37,Rate
Algarve,PT15,65 years or over,Total,2012,Malignant melanoma of skin,7.56,Rate
Algarve,PT15,65 years or over,Total,2013,Malignant melanoma of skin,7.84,Rate
Algarve,PT15,65 years or over,Total,2014,Malignant melanoma of skin,13.28,Rate
Algarve,PT15,65 years or over,Total,2015,Malignant melanoma of skin,6.7,Rate
Algarve,PT15,65 years or over,Total,2016,Malignant melanoma of skin,8.03,Rate
Algarve,PT15,65 years or over,Total,2017,Malignant melanoma of skin,8.87,Rate
Algarve,PT15,65 years or over,Total,2018,Malignant melanoma of skin,10.46,Rate
Algarve,PT15,65 years or over,Total,2019,Malignant melanoma of skin,22.09,Rate
Algarve,PT15,65 years or over,Total,2020,Malignant melanoma of skin,13.2,Rate
Algarve,PT15,65 years or over,Total,2011,Malignant neoplasm of breast,57.18,Rate
Algarve,PT15,65 years or over,Total,2012,Malignant neoplasm of breast,55.03,Rate
Algarve,PT15,65 years or over,Total,2013,Malignant neoplasm of breast,60.88,Rate
Algarve,PT15,65 years or over,Total,2014,Malignant neoplasm of breast,48.37,Rate
Algarve,PT15,65 years or over,Total,2015,Malignant neoplasm of breast,55.29,Rate
Algarve,PT15,65 years or over,Total,2016,Malignant neoplasm of breast,59.89,Rate
Algarve,PT15,65 years or over,Total,2017,Malignant neoplasm of breast,52.96,Rate
Algarve,PT15,65 years or over,Total,2018,Malignant neoplasm of breast,50.55,Rate
Algarve,PT15,65 years or over,Total,2019,Malignant neoplasm of breast,64.69,Rate
Algarve,PT15,65 years or over,Total,2020,Malignant neoplasm of breast,62.09,Rate
Algarve,PT15,65 years or over,Total,2011,Diabetes mellitus,143.61,Rate
Algarve,PT15,65 years or over,Total,2012,Diabetes mellitus,163.46,Rate
Algarve,PT15,65 years or over,Total,2013,Diabetes mellitus,167.37,Rate
Algarve,PT15,65 years or over,Total,2014,Diabetes mellitus,148.59,Rate
Algarve,PT15,65 years or over,Total,2015,Diabetes mellitus,159.05,Rate
Algarve,PT15,65 years or over,Total,2016,Diabetes mellitus,142.36,Rate
Algarve,PT15,65 years or over,Total,2017,Diabetes mellitus,130.73,Rate
Algarve,PT15,65 years or over,Total,2018,Diabetes mellitus,130.83,Rate
Algarve,PT15,65 years or over,Total,2019,Diabetes mellitus,115.82,Rate
Algarve,PT15,65 years or over,Total,2020,Diabetes mellitus,132.7,Rate
Algarve,PT15,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),5.26,Rate
Algarve,PT15,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),0.94,Rate
Algarve,PT15,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),121.52,Rate
Algarve,PT15,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),137.49,Rate
Algarve,PT15,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),138.26,Rate
Algarve,PT15,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),183.19,Rate
Algarve,PT15,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),153.76,Rate
Algarve,PT15,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),198.13,Rate
Algarve,PT15,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),211.13,Rate
Algarve,PT15,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),245.79,Rate
Algarve,PT15,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),4.01,Rate
Algarve,PT15,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.94,Rate
Algarve,PT15,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),3.6,Rate
Algarve,PT15,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),1.4,Rate
Algarve,PT15,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.92,Rate
Algarve,PT15,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Algarve,PT15,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),2.82,Rate
Algarve,PT15,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),2.9,Rate
Algarve,PT15,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.43,Rate
Algarve,PT15,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),5.48,Rate
Algarve,PT15,65 years or over,Total,2011,Other ischaemic heart diseases,138.41,Rate
Algarve,PT15,65 years or over,Total,2012,Other ischaemic heart diseases,93.9,Rate
Algarve,PT15,65 years or over,Total,2013,Other ischaemic heart diseases,86.77,Rate
Algarve,PT15,65 years or over,Total,2014,Other ischaemic heart diseases,80.21,Rate
Algarve,PT15,65 years or over,Total,2015,Other ischaemic heart diseases,94.12,Rate
Algarve,PT15,65 years or over,Total,2016,Other ischaemic heart diseases,90.76,Rate
Algarve,PT15,65 years or over,Total,2017,Other ischaemic heart diseases,90.29,Rate
Algarve,PT15,65 years or over,Total,2018,Other ischaemic heart diseases,68.18,Rate
Algarve,PT15,65 years or over,Total,2019,Other ischaemic heart diseases,68.28,Rate
Algarve,PT15,65 years or over,Total,2020,Other ischaemic heart diseases,59.93,Rate
Algarve,PT15,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,195.46,Rate
Algarve,PT15,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,173.89,Rate
Algarve,PT15,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,178.9,Rate
Algarve,PT15,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,198.54,Rate
Algarve,PT15,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,209.77,Rate
Algarve,PT15,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,178.22,Rate
Algarve,PT15,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,193.02,Rate
Algarve,PT15,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,239.41,Rate
Algarve,PT15,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,224.96,Rate
Algarve,PT15,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,255.93,Rate
Algarve,PT15,65 years or over,Total,2011,Cerebrovascular diseases,537.51,Rate
Algarve,PT15,65 years or over,Total,2012,Cerebrovascular diseases,499.3,Rate
Algarve,PT15,65 years or over,Total,2013,Cerebrovascular diseases,414.02,Rate
Algarve,PT15,65 years or over,Total,2014,Cerebrovascular diseases,443.82,Rate
Algarve,PT15,65 years or over,Total,2015,Cerebrovascular diseases,420.95,Rate
Algarve,PT15,65 years or over,Total,2016,Cerebrovascular diseases,434.32,Rate
Algarve,PT15,65 years or over,Total,2017,Cerebrovascular diseases,384.85,Rate
Algarve,PT15,65 years or over,Total,2018,Cerebrovascular diseases,368.21,Rate
Algarve,PT15,65 years or over,Total,2019,Cerebrovascular diseases,349.23,Rate
Algarve,PT15,65 years or over,Total,2020,Cerebrovascular diseases,434.34,Rate
Algarve,PT15,65 years or over,Total,2011,Chronic lower respiratory diseases,89.96,Rate
Algarve,PT15,65 years or over,Total,2012,Chronic lower respiratory diseases,104.09,Rate
Algarve,PT15,65 years or over,Total,2013,Chronic lower respiratory diseases,99.11,Rate
Algarve,PT15,65 years or over,Total,2014,Chronic lower respiratory diseases,82.18,Rate
Algarve,PT15,65 years or over,Total,2015,Chronic lower respiratory diseases,94.59,Rate
Algarve,PT15,65 years or over,Total,2016,Chronic lower respiratory diseases,106.19,Rate
Algarve,PT15,65 years or over,Total,2017,Chronic lower respiratory diseases,91.21,Rate
Algarve,PT15,65 years or over,Total,2018,Chronic lower respiratory diseases,95.15,Rate
Algarve,PT15,65 years or over,Total,2019,Chronic lower respiratory diseases,80.54,Rate
Algarve,PT15,65 years or over,Total,2020,Chronic lower respiratory diseases,73.1,Rate
Algarve,PT15,65 years or over,Total,2011,Asthma and status asthmaticus,4.39,Rate
Algarve,PT15,65 years or over,Total,2012,Asthma and status asthmaticus,5.61,Rate
Algarve,PT15,65 years or over,Total,2013,Asthma and status asthmaticus,6.12,Rate
Algarve,PT15,65 years or over,Total,2014,Asthma and status asthmaticus,4.61,Rate
Algarve,PT15,65 years or over,Total,2015,Asthma and status asthmaticus,4.2,Rate
Algarve,PT15,65 years or over,Total,2016,Asthma and status asthmaticus,9.04,Rate
Algarve,PT15,65 years or over,Total,2017,Asthma and status asthmaticus,7.94,Rate
Algarve,PT15,65 years or over,Total,2018,Asthma and status asthmaticus,2.8,Rate
Algarve,PT15,65 years or over,Total,2019,Asthma and status asthmaticus,7.17,Rate
Algarve,PT15,65 years or over,Total,2020,Asthma and status asthmaticus,10.33,Rate
Algarve,PT15,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,230.83,Rate
Algarve,PT15,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,223.08,Rate
Algarve,PT15,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,222.39,Rate
Algarve,PT15,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,216.99,Rate
Algarve,PT15,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,205.6,Rate
Algarve,PT15,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,228.87,Rate
Algarve,PT15,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,233.26,Rate
Algarve,PT15,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,221.9,Rate
Algarve,PT15,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,237.04,Rate
Algarve,PT15,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,227.55,Rate
Algarve,PT15,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.09,Rate
Algarve,PT15,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.11,Rate
Algarve,PT15,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.65,Rate
Algarve,PT15,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.95,Rate
Algarve,PT15,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.29,Rate
Algarve,PT15,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.58,Rate
Algarve,PT15,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.17,Rate
Algarve,PT15,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.4,Rate
Algarve,PT15,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.38,Rate
Algarve,PT15,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.21,Rate
Algarve,PT15,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",20.82,Rate
Algarve,PT15,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",19.27,Rate
Algarve,PT15,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",22.41,Rate
Algarve,PT15,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",21.42,Rate
Algarve,PT15,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",21.42,Rate
Algarve,PT15,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",24.9,Rate
Algarve,PT15,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",20.27,Rate
Algarve,PT15,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",15.22,Rate
Algarve,PT15,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",19.63,Rate
Algarve,PT15,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",17.94,Rate
Algarve,PT15,Less than 65 years,Total,2011,Malignant melanoma of skin,2.31,Rate
Algarve,PT15,Less than 65 years,Total,2012,Malignant melanoma of skin,1.12,Rate
Algarve,PT15,Less than 65 years,Total,2013,Malignant melanoma of skin,0.57,Rate
Algarve,PT15,Less than 65 years,Total,2014,Malignant melanoma of skin,1.16,Rate
Algarve,PT15,Less than 65 years,Total,2015,Malignant melanoma of skin,1.38,Rate
Algarve,PT15,Less than 65 years,Total,2016,Malignant melanoma of skin,1.39,Rate
Algarve,PT15,Less than 65 years,Total,2017,Malignant melanoma of skin,2.22,Rate
Algarve,PT15,Less than 65 years,Total,2018,Malignant melanoma of skin,0.52,Rate
Algarve,PT15,Less than 65 years,Total,2019,Malignant melanoma of skin,1.08,Rate
Algarve,PT15,Less than 65 years,Total,2020,Malignant melanoma of skin,1.47,Rate
Algarve,PT15,Less than 65 years,Total,2011,Malignant neoplasm of breast,10.58,Rate
Algarve,PT15,Less than 65 years,Total,2012,Malignant neoplasm of breast,10.03,Rate
Algarve,PT15,Less than 65 years,Total,2013,Malignant neoplasm of breast,7.8,Rate
Algarve,PT15,Less than 65 years,Total,2014,Malignant neoplasm of breast,8.35,Rate
Algarve,PT15,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.14,Rate
Algarve,PT15,Less than 65 years,Total,2016,Malignant neoplasm of breast,5.19,Rate
Algarve,PT15,Less than 65 years,Total,2017,Malignant neoplasm of breast,11.53,Rate
Algarve,PT15,Less than 65 years,Total,2018,Malignant neoplasm of breast,6.63,Rate
Algarve,PT15,Less than 65 years,Total,2019,Malignant neoplasm of breast,7.55,Rate
Algarve,PT15,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.61,Rate
Algarve,PT15,Less than 65 years,Total,2011,Diabetes mellitus,4.58,Rate
Algarve,PT15,Less than 65 years,Total,2012,Diabetes mellitus,2.55,Rate
Algarve,PT15,Less than 65 years,Total,2013,Diabetes mellitus,2.56,Rate
Algarve,PT15,Less than 65 years,Total,2014,Diabetes mellitus,2.75,Rate
Algarve,PT15,Less than 65 years,Total,2015,Diabetes mellitus,2.51,Rate
Algarve,PT15,Less than 65 years,Total,2016,Diabetes mellitus,2.25,Rate
Algarve,PT15,Less than 65 years,Total,2017,Diabetes mellitus,2.74,Rate
Algarve,PT15,Less than 65 years,Total,2018,Diabetes mellitus,2.76,Rate
Algarve,PT15,Less than 65 years,Total,2019,Diabetes mellitus,1.16,Rate
Algarve,PT15,Less than 65 years,Total,2020,Diabetes mellitus,1.69,Rate
Algarve,PT15,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.28,Rate
Algarve,PT15,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.57,Rate
Algarve,PT15,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),1.08,Rate
Algarve,PT15,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),0.8,Rate
Algarve,PT15,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),3.38,Rate
Algarve,PT15,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),1.11,Rate
Algarve,PT15,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),0.83,Rate
Algarve,PT15,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),0.28,Rate
Algarve,PT15,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),2.45,Rate
Algarve,PT15,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Algarve,PT15,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.26,Rate
Algarve,PT15,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Algarve,PT15,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Algarve,PT15,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),1.11,Rate
Algarve,PT15,Less than 65 years,Total,2011,Other ischaemic heart diseases,1.16,Rate
Algarve,PT15,Less than 65 years,Total,2012,Other ischaemic heart diseases,0.85,Rate
Algarve,PT15,Less than 65 years,Total,2013,Other ischaemic heart diseases,2.82,Rate
Algarve,PT15,Less than 65 years,Total,2014,Other ischaemic heart diseases,1.97,Rate
Algarve,PT15,Less than 65 years,Total,2015,Other ischaemic heart diseases,2.24,Rate
Algarve,PT15,Less than 65 years,Total,2016,Other ischaemic heart diseases,1.1,Rate
Algarve,PT15,Less than 65 years,Total,2017,Other ischaemic heart diseases,1.06,Rate
Algarve,PT15,Less than 65 years,Total,2018,Other ischaemic heart diseases,3.02,Rate
Algarve,PT15,Less than 65 years,Total,2019,Other ischaemic heart diseases,1.35,Rate
Algarve,PT15,Less than 65 years,Total,2020,Other ischaemic heart diseases,1.04,Rate
Algarve,PT15,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,17.88,Rate
Algarve,PT15,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,15.65,Rate
Algarve,PT15,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,15.78,Rate
Algarve,PT15,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,22.37,Rate
Algarve,PT15,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,15.69,Rate
Algarve,PT15,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,17.23,Rate
Algarve,PT15,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,22.61,Rate
Algarve,PT15,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,21.6,Rate
Algarve,PT15,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,23.58,Rate
Algarve,PT15,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,23.04,Rate
Algarve,PT15,Less than 65 years,Total,2011,Cerebrovascular diseases,9.97,Rate
Algarve,PT15,Less than 65 years,Total,2012,Cerebrovascular diseases,11.5,Rate
Algarve,PT15,Less than 65 years,Total,2013,Cerebrovascular diseases,9.42,Rate
Algarve,PT15,Less than 65 years,Total,2014,Cerebrovascular diseases,11.5,Rate
Algarve,PT15,Less than 65 years,Total,2015,Cerebrovascular diseases,9.44,Rate
Algarve,PT15,Less than 65 years,Total,2016,Cerebrovascular diseases,9.99,Rate
Algarve,PT15,Less than 65 years,Total,2017,Cerebrovascular diseases,9.67,Rate
Algarve,PT15,Less than 65 years,Total,2018,Cerebrovascular diseases,11.41,Rate
Algarve,PT15,Less than 65 years,Total,2019,Cerebrovascular diseases,11.12,Rate
Algarve,PT15,Less than 65 years,Total,2020,Cerebrovascular diseases,8.15,Rate
Algarve,PT15,Less than 65 years,Total,2011,Chronic lower respiratory diseases,2.31,Rate
Algarve,PT15,Less than 65 years,Total,2012,Chronic lower respiratory diseases,1.14,Rate
Algarve,PT15,Less than 65 years,Total,2013,Chronic lower respiratory diseases,0.56,Rate
Algarve,PT15,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.1,Rate
Algarve,PT15,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.97,Rate
Algarve,PT15,Less than 65 years,Total,2016,Chronic lower respiratory diseases,2.24,Rate
Algarve,PT15,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.39,Rate
Algarve,PT15,Less than 65 years,Total,2018,Chronic lower respiratory diseases,2.99,Rate
Algarve,PT15,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.9,Rate
Algarve,PT15,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.6,Rate
Algarve,PT15,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.29,Rate
Algarve,PT15,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.28,Rate
Algarve,PT15,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.24,Rate
Algarve,PT15,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.56,Rate
Algarve,PT15,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.61,Rate
Algarve,PT15,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Algarve,PT15,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.29,Rate
Algarve,PT15,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.27,Rate
Zahodna Slovenija,SI04,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,786.14,Rate
Zahodna Slovenija,SI04,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,755.02,Rate
Zahodna Slovenija,SI04,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,752.7,Rate
Zahodna Slovenija,SI04,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,727.52,Rate
Zahodna Slovenija,SI04,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,739.72,Rate
Zahodna Slovenija,SI04,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,707.7,Rate
Zahodna Slovenija,SI04,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,715.65,Rate
Zahodna Slovenija,SI04,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,800.26,Rate
Zahodna Slovenija,SI04,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.47,Rate
Zahodna Slovenija,SI04,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.53,Rate
Zahodna Slovenija,SI04,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",25.5,Rate
Zahodna Slovenija,SI04,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.7,Rate
Zahodna Slovenija,SI04,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",17.77,Rate
Zahodna Slovenija,SI04,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",23.81,Rate
Zahodna Slovenija,SI04,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",18.83,Rate
Zahodna Slovenija,SI04,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",21.42,Rate
Zahodna Slovenija,SI04,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",33.26,Rate
Zahodna Slovenija,SI04,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",39.77,Rate
Zahodna Slovenija,SI04,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",34.12,Rate
Zahodna Slovenija,SI04,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",37.02,Rate
Zahodna Slovenija,SI04,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",42.13,Rate
Zahodna Slovenija,SI04,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",43.15,Rate
Zahodna Slovenija,SI04,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",39.23,Rate
Zahodna Slovenija,SI04,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",38.05,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Malignant melanoma of skin,6.9,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Malignant melanoma of skin,4.72,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Malignant melanoma of skin,6.55,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Malignant melanoma of skin,4.58,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Malignant melanoma of skin,4.62,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Malignant melanoma of skin,4.41,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Malignant melanoma of skin,4.71,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Malignant melanoma of skin,4.56,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Malignant neoplasm of breast,36.05,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Malignant neoplasm of breast,33.47,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Malignant neoplasm of breast,37.44,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Malignant neoplasm of breast,29.79,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Malignant neoplasm of breast,40.14,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Malignant neoplasm of breast,34.92,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Malignant neoplasm of breast,34.49,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Malignant neoplasm of breast,35.58,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Diabetes mellitus,14.83,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Diabetes mellitus,12.15,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Diabetes mellitus,11.97,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Diabetes mellitus,12.01,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Diabetes mellitus,12.42,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Diabetes mellitus,11.32,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Diabetes mellitus,17.28,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Diabetes mellitus,15.4,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Mental and behavioural disorders (F00-F99),3.71,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Mental and behavioural disorders (F00-F99),2.94,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Mental and behavioural disorders (F00-F99),5.42,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Mental and behavioural disorders (F00-F99),2.41,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Mental and behavioural disorders (F00-F99),4.25,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Mental and behavioural disorders (F00-F99),5.41,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Mental and behavioural disorders (F00-F99),6.39,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Mental and behavioural disorders (F00-F99),6.59,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.61,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.39,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.74,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.68,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Other ischaemic heart diseases,49.77,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Other ischaemic heart diseases,41.55,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Other ischaemic heart diseases,35.71,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Other ischaemic heart diseases,34.38,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Other ischaemic heart diseases,32.63,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Other ischaemic heart diseases,27.61,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Other ischaemic heart diseases,25.66,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Other ischaemic heart diseases,23.68,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,27.48,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.67,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,30.92,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,24.87,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,25.11,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,23.53,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,25.32,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,23.44,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Cerebrovascular diseases,86.35,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Cerebrovascular diseases,84.28,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Cerebrovascular diseases,85.31,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Cerebrovascular diseases,79.51,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Cerebrovascular diseases,78.73,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Cerebrovascular diseases,69.77,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Cerebrovascular diseases,75.23,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Cerebrovascular diseases,72.74,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Chronic lower respiratory diseases,11.3,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Chronic lower respiratory diseases,10.44,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Chronic lower respiratory diseases,14.46,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Chronic lower respiratory diseases,10.38,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Chronic lower respiratory diseases,15.55,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Chronic lower respiratory diseases,13.02,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Chronic lower respiratory diseases,16.5,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Chronic lower respiratory diseases,9.05,Rate
Zahodna Slovenija,SI04,Total,Females,2013,Asthma and status asthmaticus,0.69,Rate
Zahodna Slovenija,SI04,Total,Females,2014,Asthma and status asthmaticus,0.79,Rate
Zahodna Slovenija,SI04,Total,Females,2015,Asthma and status asthmaticus,1.64,Rate
Zahodna Slovenija,SI04,Total,Females,2016,Asthma and status asthmaticus,0.83,Rate
Zahodna Slovenija,SI04,Total,Females,2017,Asthma and status asthmaticus,1.16,Rate
Zahodna Slovenija,SI04,Total,Females,2018,Asthma and status asthmaticus,0.83,Rate
Zahodna Slovenija,SI04,Total,Females,2019,Asthma and status asthmaticus,0.57,Rate
Zahodna Slovenija,SI04,Total,Females,2020,Asthma and status asthmaticus,0.33,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,3518.76,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,3396.27,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,3416.26,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,3314.76,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,3316.02,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,3197.44,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,3247.53,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,3706.87,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",95.9,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.47,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",109.23,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",122.11,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",72.82,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",105.34,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",83.52,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",84.57,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",110.35,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",137.58,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",111.88,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",134.54,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",145.81,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",161.75,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",157.39,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",156.12,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Malignant melanoma of skin,23.39,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Malignant melanoma of skin,15.95,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Malignant melanoma of skin,22.83,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Malignant melanoma of skin,16.54,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Malignant melanoma of skin,13.75,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Malignant melanoma of skin,16.21,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Malignant melanoma of skin,18.17,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Malignant melanoma of skin,17.63,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Malignant neoplasm of breast,137.34,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Malignant neoplasm of breast,120.6,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Malignant neoplasm of breast,141.7,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Malignant neoplasm of breast,113.02,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Malignant neoplasm of breast,139.61,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Malignant neoplasm of breast,130.31,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Malignant neoplasm of breast,122.31,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Malignant neoplasm of breast,135.68,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Diabetes mellitus,73.16,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Diabetes mellitus,61.39,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Diabetes mellitus,59.56,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Diabetes mellitus,57.74,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Diabetes mellitus,60.91,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Diabetes mellitus,55.97,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Diabetes mellitus,83.68,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Diabetes mellitus,76.06,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),11.15,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),6.28,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),13.86,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),10.29,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),12.71,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),16.8,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),23.06,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),23.91,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),1.2,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.19,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),2.86,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),3.47,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Other ischaemic heart diseases,251.4,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Other ischaemic heart diseases,212.16,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Other ischaemic heart diseases,180.37,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Other ischaemic heart diseases,174.47,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Other ischaemic heart diseases,167.34,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Other ischaemic heart diseases,141.58,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Other ischaemic heart diseases,131.6,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Other ischaemic heart diseases,121.44,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,123.11,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,128.33,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,136.97,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,112.11,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,112.54,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,108.24,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,118.16,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,106.69,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Cerebrovascular diseases,422.48,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Cerebrovascular diseases,414.59,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Cerebrovascular diseases,421.77,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Cerebrovascular diseases,386.14,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Cerebrovascular diseases,387.11,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Cerebrovascular diseases,343.95,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Cerebrovascular diseases,371.19,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Cerebrovascular diseases,360.15,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Chronic lower respiratory diseases,55.09,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Chronic lower respiratory diseases,49.69,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Chronic lower respiratory diseases,70.31,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Chronic lower respiratory diseases,50.39,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Chronic lower respiratory diseases,74.03,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Chronic lower respiratory diseases,64.0,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Chronic lower respiratory diseases,81.65,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Chronic lower respiratory diseases,43.5,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2013,Asthma and status asthmaticus,3.56,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2014,Asthma and status asthmaticus,4.03,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2015,Asthma and status asthmaticus,7.41,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2016,Asthma and status asthmaticus,4.26,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2017,Asthma and status asthmaticus,5.96,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2018,Asthma and status asthmaticus,4.24,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2019,Asthma and status asthmaticus,2.93,Rate
Zahodna Slovenija,SI04,65 years or over,Females,2020,Asthma and status asthmaticus,1.67,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,124.2,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,115.21,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,107.49,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,100.79,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,115.65,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,104.59,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,102.33,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,96.18,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.68,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.22,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.59,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.43,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",4.06,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",3.16,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",14.59,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",16.08,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",15.28,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",13.4,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",17.01,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",14.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",10.6,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",9.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Malignant melanoma of skin,2.91,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Malignant melanoma of skin,2.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Malignant melanoma of skin,2.6,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Malignant melanoma of skin,1.68,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Malignant melanoma of skin,2.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Malignant melanoma of skin,1.55,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Malignant melanoma of skin,1.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Malignant melanoma of skin,1.4,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Malignant neoplasm of breast,11.52,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Malignant neoplasm of breast,12.36,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Malignant neoplasm of breast,12.18,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Malignant neoplasm of breast,9.63,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Malignant neoplasm of breast,16.04,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Malignant neoplasm of breast,11.81,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Malignant neoplasm of breast,13.21,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Malignant neoplasm of breast,11.33,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Diabetes mellitus,0.7,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Diabetes mellitus,0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Diabetes mellitus,0.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Diabetes mellitus,0.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Diabetes mellitus,0.67,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Diabetes mellitus,0.5,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Diabetes mellitus,1.2,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Diabetes mellitus,0.71,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),1.91,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),2.13,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),3.37,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),0.5,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),2.2,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),2.65,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),2.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),2.4,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.46,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Other ischaemic heart diseases,0.92,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Other ischaemic heart diseases,0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Other ischaemic heart diseases,0.67,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Other ischaemic heart diseases,0.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Other ischaemic heart diseases,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Other ischaemic heart diseases,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Other ischaemic heart diseases,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Other ischaemic heart diseases,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,4.31,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,4.53,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,5.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.74,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,3.01,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.83,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,3.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Cerebrovascular diseases,4.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Cerebrovascular diseases,4.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Cerebrovascular diseases,3.8,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Cerebrovascular diseases,5.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Cerebrovascular diseases,4.03,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Cerebrovascular diseases,3.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Cerebrovascular diseases,3.54,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Cerebrovascular diseases,3.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Chronic lower respiratory diseases,0.69,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Chronic lower respiratory diseases,0.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Chronic lower respiratory diseases,0.69,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Chronic lower respiratory diseases,1.38,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Chronic lower respiratory diseases,0.67,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Chronic lower respiratory diseases,0.72,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Chronic lower respiratory diseases,0.71,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.24,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Females,2020,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1250.03,Rate
Zahodna Slovenija,SI04,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1173.11,Rate
Zahodna Slovenija,SI04,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1194.48,Rate
Zahodna Slovenija,SI04,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1172.61,Rate
Zahodna Slovenija,SI04,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1179.44,Rate
Zahodna Slovenija,SI04,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1151.05,Rate
Zahodna Slovenija,SI04,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1098.32,Rate
Zahodna Slovenija,SI04,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1291.06,Rate
Zahodna Slovenija,SI04,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",56.34,Rate
Zahodna Slovenija,SI04,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.04,Rate
Zahodna Slovenija,SI04,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.41,Rate
Zahodna Slovenija,SI04,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.67,Rate
Zahodna Slovenija,SI04,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",43.71,Rate
Zahodna Slovenija,SI04,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.45,Rate
Zahodna Slovenija,SI04,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",38.98,Rate
Zahodna Slovenija,SI04,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.58,Rate
Zahodna Slovenija,SI04,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",91.37,Rate
Zahodna Slovenija,SI04,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",95.61,Rate
Zahodna Slovenija,SI04,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",94.15,Rate
Zahodna Slovenija,SI04,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",95.53,Rate
Zahodna Slovenija,SI04,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",80.08,Rate
Zahodna Slovenija,SI04,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",79.33,Rate
Zahodna Slovenija,SI04,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",78.61,Rate
Zahodna Slovenija,SI04,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",78.39,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Malignant melanoma of skin,6.8,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Malignant melanoma of skin,7.68,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Malignant melanoma of skin,7.89,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Malignant melanoma of skin,9.18,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Malignant melanoma of skin,6.98,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Malignant melanoma of skin,10.96,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Malignant melanoma of skin,7.12,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Malignant melanoma of skin,8.14,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Malignant neoplasm of breast,1.47,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Malignant neoplasm of breast,0.45,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Malignant neoplasm of breast,1.26,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Malignant neoplasm of breast,0.28,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Malignant neoplasm of breast,0.9,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Malignant neoplasm of breast,0.22,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Diabetes mellitus,19.31,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Diabetes mellitus,15.14,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Diabetes mellitus,18.12,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Diabetes mellitus,15.11,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Diabetes mellitus,18.58,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Diabetes mellitus,17.41,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Diabetes mellitus,22.24,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Diabetes mellitus,28.83,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Mental and behavioural disorders (F00-F99),11.94,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Mental and behavioural disorders (F00-F99),14.12,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Mental and behavioural disorders (F00-F99),19.92,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Mental and behavioural disorders (F00-F99),19.47,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Mental and behavioural disorders (F00-F99),26.17,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Mental and behavioural disorders (F00-F99),23.14,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Mental and behavioural disorders (F00-F99),37.07,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Mental and behavioural disorders (F00-F99),27.84,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.45,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.19,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Other ischaemic heart diseases,86.76,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Other ischaemic heart diseases,72.69,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Other ischaemic heart diseases,61.99,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Other ischaemic heart diseases,58.0,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Other ischaemic heart diseases,57.04,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Other ischaemic heart diseases,59.2,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Other ischaemic heart diseases,48.41,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Other ischaemic heart diseases,45.09,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,60.91,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,57.85,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,74.32,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,72.75,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,80.92,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,77.26,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,77.33,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,62.69,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Cerebrovascular diseases,103.36,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Cerebrovascular diseases,107.32,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Cerebrovascular diseases,97.03,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Cerebrovascular diseases,97.87,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Cerebrovascular diseases,91.32,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Cerebrovascular diseases,90.61,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Cerebrovascular diseases,84.22,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Cerebrovascular diseases,94.05,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Chronic lower respiratory diseases,35.83,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Chronic lower respiratory diseases,33.86,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Chronic lower respiratory diseases,30.85,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Chronic lower respiratory diseases,30.96,Rate
Zahodna Slovenija,SI04,Total,Males,2017,Chronic lower respiratory diseases,36.37,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Chronic lower respiratory diseases,28.0,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Chronic lower respiratory diseases,31.27,Rate
Zahodna Slovenija,SI04,Total,Males,2020,Chronic lower respiratory diseases,24.14,Rate
Zahodna Slovenija,SI04,Total,Males,2013,Asthma and status asthmaticus,1.94,Rate
Zahodna Slovenija,SI04,Total,Males,2014,Asthma and status asthmaticus,0.69,Rate
Zahodna Slovenija,SI04,Total,Males,2015,Asthma and status asthmaticus,1.71,Rate
Zahodna Slovenija,SI04,Total,Males,2016,Asthma and status asthmaticus,0.26,Rate
Zahodna Slovenija,SI04,Total,Males,2018,Asthma and status asthmaticus,1.06,Rate
Zahodna Slovenija,SI04,Total,Males,2019,Asthma and status asthmaticus,0.69,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,5375.77,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,5061.46,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,5132.91,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,5161.83,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,5135.99,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,5103.81,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,4838.08,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,5837.94,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",236.85,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",233.16,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",221.33,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",226.46,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",190.53,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",232.32,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",165.71,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",185.65,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",341.67,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",366.32,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",368.24,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",377.16,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",307.66,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",327.25,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",329.65,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",337.55,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Malignant melanoma of skin,24.07,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Malignant melanoma of skin,28.63,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Malignant melanoma of skin,26.58,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Malignant melanoma of skin,32.18,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Malignant melanoma of skin,22.95,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Malignant melanoma of skin,45.29,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Malignant melanoma of skin,30.79,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Malignant melanoma of skin,32.87,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Malignant neoplasm of breast,7.51,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Malignant neoplasm of breast,1.34,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Malignant neoplasm of breast,5.51,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Malignant neoplasm of breast,1.42,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Malignant neoplasm of breast,4.63,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Malignant neoplasm of breast,1.12,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Diabetes mellitus,91.0,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Diabetes mellitus,67.81,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Diabetes mellitus,81.11,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Diabetes mellitus,72.5,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Diabetes mellitus,85.41,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Diabetes mellitus,86.28,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Diabetes mellitus,106.13,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Diabetes mellitus,139.09,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),29.46,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),46.58,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),51.4,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),60.34,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),69.82,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),72.34,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),117.55,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),78.49,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),2.29,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),1.0,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),3.62,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),1.12,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Other ischaemic heart diseases,420.95,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Other ischaemic heart diseases,356.95,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Other ischaemic heart diseases,307.15,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Other ischaemic heart diseases,291.47,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Other ischaemic heart diseases,284.68,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Other ischaemic heart diseases,299.7,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Other ischaemic heart diseases,247.28,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Other ischaemic heart diseases,228.35,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,220.29,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,209.66,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,277.95,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,292.84,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,302.27,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,313.67,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,321.81,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,236.79,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Cerebrovascular diseases,500.04,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Cerebrovascular diseases,513.8,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Cerebrovascular diseases,468.01,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Cerebrovascular diseases,479.23,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Cerebrovascular diseases,445.94,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Cerebrovascular diseases,443.24,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Cerebrovascular diseases,418.25,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Cerebrovascular diseases,459.92,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Chronic lower respiratory diseases,176.81,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Chronic lower respiratory diseases,165.77,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Chronic lower respiratory diseases,152.3,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Chronic lower respiratory diseases,153.8,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2017,Chronic lower respiratory diseases,182.61,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Chronic lower respiratory diseases,137.74,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Chronic lower respiratory diseases,153.48,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2020,Chronic lower respiratory diseases,119.89,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2013,Asthma and status asthmaticus,8.93,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2014,Asthma and status asthmaticus,3.53,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2015,Asthma and status asthmaticus,8.76,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2016,Asthma and status asthmaticus,1.34,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2018,Asthma and status asthmaticus,5.41,Rate
Zahodna Slovenija,SI04,65 years or over,Males,2019,Asthma and status asthmaticus,3.52,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,250.62,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,231.21,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,240.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,206.28,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,221.02,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,193.55,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,192.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,189.64,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.74,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.08,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.14,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.64,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.68,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",30.74,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",30.04,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",27.75,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",27.31,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",24.95,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",19.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",17.8,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",15.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Malignant melanoma of skin,2.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Malignant melanoma of skin,2.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Malignant melanoma of skin,3.36,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Malignant melanoma of skin,3.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Malignant melanoma of skin,3.11,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Malignant melanoma of skin,2.65,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Malignant melanoma of skin,1.39,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Malignant melanoma of skin,2.15,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Malignant neoplasm of breast,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Malignant neoplasm of breast,0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Diabetes mellitus,1.95,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Diabetes mellitus,2.38,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Diabetes mellitus,2.86,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Diabetes mellitus,1.2,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Diabetes mellitus,2.39,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Diabetes mellitus,0.73,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Diabetes mellitus,1.91,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Diabetes mellitus,2.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),7.69,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),6.26,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),12.3,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),9.57,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),15.59,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),11.22,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),17.57,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),15.57,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Other mental and behavioural disorders (remainder of F00-F99),0.24,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Other ischaemic heart diseases,5.81,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Other ischaemic heart diseases,3.83,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Other ischaemic heart diseases,2.6,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Other ischaemic heart diseases,1.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Other ischaemic heart diseases,1.89,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Other ischaemic heart diseases,0.94,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Other ischaemic heart diseases,0.24,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Other ischaemic heart diseases,0.7,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,22.31,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,21.08,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,24.99,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,19.44,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,27.3,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,20.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,18.1,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,20.52,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Cerebrovascular diseases,7.28,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Cerebrovascular diseases,8.86,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Cerebrovascular diseases,7.17,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Cerebrovascular diseases,5.49,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Cerebrovascular diseases,5.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Cerebrovascular diseases,5.19,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Cerebrovascular diseases,3.31,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Cerebrovascular diseases,5.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Chronic lower respiratory diseases,1.68,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Chronic lower respiratory diseases,1.91,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Chronic lower respiratory diseases,1.43,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Chronic lower respiratory diseases,1.2,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2017,Chronic lower respiratory diseases,0.94,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Chronic lower respiratory diseases,1.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Chronic lower respiratory diseases,1.66,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2020,Chronic lower respiratory diseases,0.95,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.24,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2014,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2016,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Males,2019,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,970.02,Rate
Zahodna Slovenija,SI04,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,925.88,Rate
Zahodna Slovenija,SI04,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,933.0,Rate
Zahodna Slovenija,SI04,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,905.72,Rate
Zahodna Slovenija,SI04,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,916.99,Rate
Zahodna Slovenija,SI04,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,884.04,Rate
Zahodna Slovenija,SI04,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,872.99,Rate
Zahodna Slovenija,SI04,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,995.27,Rate
Zahodna Slovenija,SI04,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",37.13,Rate
Zahodna Slovenija,SI04,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.26,Rate
Zahodna Slovenija,SI04,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.47,Rate
Zahodna Slovenija,SI04,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.5,Rate
Zahodna Slovenija,SI04,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.79,Rate
Zahodna Slovenija,SI04,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.18,Rate
Zahodna Slovenija,SI04,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.02,Rate
Zahodna Slovenija,SI04,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",29.1,Rate
Zahodna Slovenija,SI04,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",57.56,Rate
Zahodna Slovenija,SI04,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",63.02,Rate
Zahodna Slovenija,SI04,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",58.87,Rate
Zahodna Slovenija,SI04,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",61.97,Rate
Zahodna Slovenija,SI04,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",57.78,Rate
Zahodna Slovenija,SI04,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",57.87,Rate
Zahodna Slovenija,SI04,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",56.28,Rate
Zahodna Slovenija,SI04,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",55.33,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Malignant melanoma of skin,7.12,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Malignant melanoma of skin,5.9,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Malignant melanoma of skin,6.94,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Malignant melanoma of skin,6.31,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Malignant melanoma of skin,5.63,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Malignant melanoma of skin,6.93,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Malignant melanoma of skin,5.66,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Malignant melanoma of skin,6.21,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Malignant neoplasm of breast,22.39,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Malignant neoplasm of breast,19.92,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Malignant neoplasm of breast,22.58,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Malignant neoplasm of breast,18.19,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Malignant neoplasm of breast,23.33,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Malignant neoplasm of breast,21.08,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Malignant neoplasm of breast,20.68,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Malignant neoplasm of breast,20.68,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Diabetes mellitus,16.98,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Diabetes mellitus,13.87,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Diabetes mellitus,14.21,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Diabetes mellitus,13.56,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Diabetes mellitus,14.85,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Diabetes mellitus,13.83,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Diabetes mellitus,19.26,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Diabetes mellitus,20.24,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Mental and behavioural disorders (F00-F99),7.64,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Mental and behavioural disorders (F00-F99),7.71,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Mental and behavioural disorders (F00-F99),12.17,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Mental and behavioural disorders (F00-F99),10.06,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Mental and behavioural disorders (F00-F99),14.43,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Mental and behavioural disorders (F00-F99),13.52,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Mental and behavioural disorders (F00-F99),20.47,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Mental and behavioural disorders (F00-F99),16.31,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.22,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.41,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.71,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Other ischaemic heart diseases,63.8,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Other ischaemic heart diseases,53.19,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Other ischaemic heart diseases,46.18,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Other ischaemic heart diseases,43.12,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Other ischaemic heart diseases,41.07,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Other ischaemic heart diseases,38.47,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Other ischaemic heart diseases,32.86,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Other ischaemic heart diseases,30.49,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,42.73,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,42.25,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,50.46,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,45.15,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,49.07,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,46.93,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,47.17,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,41.42,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Cerebrovascular diseases,93.1,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Cerebrovascular diseases,93.48,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Cerebrovascular diseases,89.2,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Cerebrovascular diseases,87.34,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Cerebrovascular diseases,85.54,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Cerebrovascular diseases,78.53,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Cerebrovascular diseases,78.83,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Cerebrovascular diseases,81.17,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Chronic lower respiratory diseases,19.62,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Chronic lower respiratory diseases,18.36,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Chronic lower respiratory diseases,19.76,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Chronic lower respiratory diseases,17.38,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Chronic lower respiratory diseases,22.55,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Chronic lower respiratory diseases,17.8,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Chronic lower respiratory diseases,21.91,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Chronic lower respiratory diseases,14.51,Rate
Zahodna Slovenija,SI04,Total,Total,2013,Asthma and status asthmaticus,0.88,Rate
Zahodna Slovenija,SI04,Total,Total,2014,Asthma and status asthmaticus,0.6,Rate
Zahodna Slovenija,SI04,Total,Total,2015,Asthma and status asthmaticus,1.43,Rate
Zahodna Slovenija,SI04,Total,Total,2016,Asthma and status asthmaticus,0.67,Rate
Zahodna Slovenija,SI04,Total,Total,2017,Asthma and status asthmaticus,0.82,Rate
Zahodna Slovenija,SI04,Total,Total,2018,Asthma and status asthmaticus,0.85,Rate
Zahodna Slovenija,SI04,Total,Total,2019,Asthma and status asthmaticus,0.57,Rate
Zahodna Slovenija,SI04,Total,Total,2020,Asthma and status asthmaticus,0.2,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,4201.8,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,4033.97,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,4066.84,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,4011.41,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,4007.27,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,3918.01,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,3867.19,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,4512.19,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",147.1,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",154.77,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",150.02,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",158.07,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",116.62,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",151.21,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",114.98,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",123.03,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",202.12,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",228.28,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",213.41,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",234.21,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",209.79,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",227.4,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",230.26,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",232.12,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Malignant melanoma of skin,25.15,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Malignant melanoma of skin,20.7,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Malignant melanoma of skin,23.39,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Malignant melanoma of skin,21.41,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Malignant melanoma of skin,17.49,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Malignant melanoma of skin,27.0,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Malignant melanoma of skin,23.15,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Malignant melanoma of skin,24.44,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Malignant neoplasm of breast,90.99,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Malignant neoplasm of breast,76.79,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Malignant neoplasm of breast,90.1,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Malignant neoplasm of breast,73.03,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Malignant neoplasm of breast,86.63,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Malignant neoplasm of breast,84.0,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Malignant neoplasm of breast,78.92,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Malignant neoplasm of breast,83.1,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Diabetes mellitus,81.61,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Diabetes mellitus,65.81,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Diabetes mellitus,66.07,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Diabetes mellitus,65.16,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Diabetes mellitus,69.87,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Diabetes mellitus,68.38,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Diabetes mellitus,92.41,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Diabetes mellitus,97.95,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),19.36,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),22.25,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),30.13,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),30.94,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),37.28,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),40.69,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),63.73,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),46.45,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.64,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.96,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.48,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),3.14,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),2.45,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Other ischaemic heart diseases,313.38,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Other ischaemic heart diseases,264.5,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Other ischaemic heart diseases,230.13,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Other ischaemic heart diseases,217.24,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Other ischaemic heart diseases,206.78,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Other ischaemic heart diseases,195.31,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Other ischaemic heart diseases,168.06,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Other ischaemic heart diseases,154.9,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,164.36,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,164.11,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,196.54,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,183.81,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,187.22,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,193.15,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,198.46,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,162.9,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Cerebrovascular diseases,452.15,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Cerebrovascular diseases,452.45,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Cerebrovascular diseases,434.95,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Cerebrovascular diseases,425.84,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Cerebrovascular diseases,419.25,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Cerebrovascular diseases,385.25,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Cerebrovascular diseases,390.13,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Cerebrovascular diseases,398.6,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Chronic lower respiratory diseases,95.73,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Chronic lower respiratory diseases,88.3,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Chronic lower respiratory diseases,96.48,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Chronic lower respiratory diseases,85.26,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Chronic lower respiratory diseases,110.84,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Chronic lower respiratory diseases,86.98,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Chronic lower respiratory diseases,107.47,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Chronic lower respiratory diseases,71.03,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2013,Asthma and status asthmaticus,4.01,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2014,Asthma and status asthmaticus,3.07,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2015,Asthma and status asthmaticus,6.86,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2016,Asthma and status asthmaticus,3.45,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2017,Asthma and status asthmaticus,4.2,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2018,Asthma and status asthmaticus,4.38,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2019,Asthma and status asthmaticus,2.94,Rate
Zahodna Slovenija,SI04,65 years or over,Total,2020,Asthma and status asthmaticus,1.03,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,187.17,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,172.98,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,173.87,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,153.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,168.41,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,149.11,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,147.69,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,143.34,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.49,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.56,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",8.96,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.81,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.83,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.71,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",22.54,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",22.98,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",21.44,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",20.25,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",20.95,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",16.8,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",14.14,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",12.5,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Malignant melanoma of skin,2.76,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Malignant melanoma of skin,2.31,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Malignant melanoma of skin,2.96,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Malignant melanoma of skin,2.65,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Malignant melanoma of skin,2.76,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Malignant melanoma of skin,2.07,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Malignant melanoma of skin,1.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Malignant melanoma of skin,1.79,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Malignant neoplasm of breast,5.78,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Malignant neoplasm of breast,6.15,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Malignant neoplasm of breast,6.22,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Malignant neoplasm of breast,4.91,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Malignant neoplasm of breast,7.99,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Malignant neoplasm of breast,5.84,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Malignant neoplasm of breast,6.58,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Malignant neoplasm of breast,5.57,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Diabetes mellitus,1.32,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Diabetes mellitus,1.29,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Diabetes mellitus,1.65,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Diabetes mellitus,1.06,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Diabetes mellitus,1.53,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Diabetes mellitus,0.61,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Diabetes mellitus,1.54,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Diabetes mellitus,1.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),4.8,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),4.19,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),7.83,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),5.01,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),8.9,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),6.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),9.99,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),9.01,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.27,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Other mental and behavioural disorders (remainder of F00-F99),0.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Other ischaemic heart diseases,3.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Other ischaemic heart diseases,2.01,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Other ischaemic heart diseases,1.62,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Other ischaemic heart diseases,0.95,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Other ischaemic heart diseases,0.93,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Other ischaemic heart diseases,0.48,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Other ischaemic heart diseases,0.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Other ischaemic heart diseases,0.35,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,13.26,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,12.73,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,15.07,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,11.57,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,15.6,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,11.51,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,10.52,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,11.99,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Cerebrovascular diseases,6.13,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Cerebrovascular diseases,6.52,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Cerebrovascular diseases,5.45,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Cerebrovascular diseases,5.34,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Cerebrovascular diseases,4.7,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Cerebrovascular diseases,4.23,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Cerebrovascular diseases,3.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Cerebrovascular diseases,4.28,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Chronic lower respiratory diseases,1.18,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.42,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Chronic lower respiratory diseases,1.18,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Chronic lower respiratory diseases,0.94,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Chronic lower respiratory diseases,1.16,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Chronic lower respiratory diseases,1.04,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.18,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Chronic lower respiratory diseases,0.82,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.12,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.11,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.0,Rate
Zahodna Slovenija,SI04,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Total,Females,2011,All causes of death (A00-Y89) excluding S00-T98,1057.94,Rate
Bratislavsk kraj,SK01,Total,Females,2012,All causes of death (A00-Y89) excluding S00-T98,1049.17,Rate
Bratislavsk kraj,SK01,Total,Females,2013,All causes of death (A00-Y89) excluding S00-T98,1069.55,Rate
Bratislavsk kraj,SK01,Total,Females,2014,All causes of death (A00-Y89) excluding S00-T98,1010.31,Rate
Bratislavsk kraj,SK01,Total,Females,2015,All causes of death (A00-Y89) excluding S00-T98,1038.81,Rate
Bratislavsk kraj,SK01,Total,Females,2016,All causes of death (A00-Y89) excluding S00-T98,988.78,Rate
Bratislavsk kraj,SK01,Total,Females,2017,All causes of death (A00-Y89) excluding S00-T98,986.89,Rate
Bratislavsk kraj,SK01,Total,Females,2018,All causes of death (A00-Y89) excluding S00-T98,995.54,Rate
Bratislavsk kraj,SK01,Total,Females,2019,All causes of death (A00-Y89) excluding S00-T98,935.75,Rate
Bratislavsk kraj,SK01,Total,Females,2020,All causes of death (A00-Y89) excluding S00-T98,971.61,Rate
Bratislavsk kraj,SK01,Total,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",36.25,Rate
Bratislavsk kraj,SK01,Total,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.38,Rate
Bratislavsk kraj,SK01,Total,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.15,Rate
Bratislavsk kraj,SK01,Total,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",41.92,Rate
Bratislavsk kraj,SK01,Total,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",34.38,Rate
Bratislavsk kraj,SK01,Total,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",35.48,Rate
Bratislavsk kraj,SK01,Total,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",32.91,Rate
Bratislavsk kraj,SK01,Total,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",31.24,Rate
Bratislavsk kraj,SK01,Total,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",26.43,Rate
Bratislavsk kraj,SK01,Total,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",27.12,Rate
Bratislavsk kraj,SK01,Total,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",26.18,Rate
Bratislavsk kraj,SK01,Total,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",20.82,Rate
Bratislavsk kraj,SK01,Total,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",24.97,Rate
Bratislavsk kraj,SK01,Total,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",28.24,Rate
Bratislavsk kraj,SK01,Total,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",24.69,Rate
Bratislavsk kraj,SK01,Total,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",31.58,Rate
Bratislavsk kraj,SK01,Total,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",23.72,Rate
Bratislavsk kraj,SK01,Total,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",27.79,Rate
Bratislavsk kraj,SK01,Total,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",24.47,Rate
Bratislavsk kraj,SK01,Total,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",26.78,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Malignant melanoma of skin,4.45,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Malignant melanoma of skin,3.45,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Malignant melanoma of skin,4.19,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Malignant melanoma of skin,4.4,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Malignant melanoma of skin,5.47,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Malignant melanoma of skin,5.17,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Malignant melanoma of skin,2.11,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Malignant melanoma of skin,3.31,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Malignant melanoma of skin,2.98,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Malignant melanoma of skin,0.59,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Malignant neoplasm of breast,43.97,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Malignant neoplasm of breast,42.69,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Malignant neoplasm of breast,43.68,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Malignant neoplasm of breast,46.87,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Malignant neoplasm of breast,37.51,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Malignant neoplasm of breast,43.27,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Malignant neoplasm of breast,43.33,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Malignant neoplasm of breast,47.18,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Malignant neoplasm of breast,41.02,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Malignant neoplasm of breast,43.65,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Diabetes mellitus,14.24,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Diabetes mellitus,17.86,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Diabetes mellitus,16.65,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Diabetes mellitus,14.02,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Diabetes mellitus,13.0,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Diabetes mellitus,12.22,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Diabetes mellitus,8.66,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Diabetes mellitus,16.1,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Diabetes mellitus,6.81,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Diabetes mellitus,11.05,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Mental and behavioural disorders (F00-F99),2.17,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Mental and behavioural disorders (F00-F99),19.49,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Mental and behavioural disorders (F00-F99),10.7,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Mental and behavioural disorders (F00-F99),15.72,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Mental and behavioural disorders (F00-F99),11.22,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Mental and behavioural disorders (F00-F99),15.63,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Mental and behavioural disorders (F00-F99),12.68,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Mental and behavioural disorders (F00-F99),14.37,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Mental and behavioural disorders (F00-F99),8.95,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Mental and behavioural disorders (F00-F99),12.05,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.72,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.49,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Other ischaemic heart diseases,284.88,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Other ischaemic heart diseases,287.21,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Other ischaemic heart diseases,270.48,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Other ischaemic heart diseases,311.77,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Other ischaemic heart diseases,311.67,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Other ischaemic heart diseases,266.2,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Other ischaemic heart diseases,262.05,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Other ischaemic heart diseases,227.64,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Other ischaemic heart diseases,227.76,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Other ischaemic heart diseases,241.87,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,35.14,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,44.28,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,47.93,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,28.08,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,31.6,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,29.42,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,32.32,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,37.24,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,27.94,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,31.93,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Cerebrovascular diseases,85.34,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Cerebrovascular diseases,93.47,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Cerebrovascular diseases,86.03,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Cerebrovascular diseases,70.16,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Cerebrovascular diseases,74.35,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Cerebrovascular diseases,84.43,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Cerebrovascular diseases,66.71,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Cerebrovascular diseases,71.71,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Cerebrovascular diseases,63.63,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Cerebrovascular diseases,66.12,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Chronic lower respiratory diseases,10.93,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Chronic lower respiratory diseases,8.77,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Chronic lower respiratory diseases,11.42,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Chronic lower respiratory diseases,8.47,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Chronic lower respiratory diseases,15.0,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Chronic lower respiratory diseases,11.03,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Chronic lower respiratory diseases,12.42,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Chronic lower respiratory diseases,12.2,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Chronic lower respiratory diseases,8.33,Rate
Bratislavsk kraj,SK01,Total,Females,2020,Chronic lower respiratory diseases,9.14,Rate
Bratislavsk kraj,SK01,Total,Females,2011,Asthma and status asthmaticus,0.8,Rate
Bratislavsk kraj,SK01,Total,Females,2012,Asthma and status asthmaticus,0.31,Rate
Bratislavsk kraj,SK01,Total,Females,2013,Asthma and status asthmaticus,0.75,Rate
Bratislavsk kraj,SK01,Total,Females,2014,Asthma and status asthmaticus,0.31,Rate
Bratislavsk kraj,SK01,Total,Females,2015,Asthma and status asthmaticus,1.4,Rate
Bratislavsk kraj,SK01,Total,Females,2016,Asthma and status asthmaticus,1.17,Rate
Bratislavsk kraj,SK01,Total,Females,2017,Asthma and status asthmaticus,0.81,Rate
Bratislavsk kraj,SK01,Total,Females,2018,Asthma and status asthmaticus,0.33,Rate
Bratislavsk kraj,SK01,Total,Females,2019,Asthma and status asthmaticus,0.85,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,All causes of death (A00-Y89) excluding S00-T98,4764.18,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,All causes of death (A00-Y89) excluding S00-T98,4705.15,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,All causes of death (A00-Y89) excluding S00-T98,4783.56,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,All causes of death (A00-Y89) excluding S00-T98,4521.32,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,All causes of death (A00-Y89) excluding S00-T98,4641.31,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,All causes of death (A00-Y89) excluding S00-T98,4421.53,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,All causes of death (A00-Y89) excluding S00-T98,4443.44,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,All causes of death (A00-Y89) excluding S00-T98,4439.52,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,All causes of death (A00-Y89) excluding S00-T98,4175.47,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,All causes of death (A00-Y89) excluding S00-T98,4403.52,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",159.37,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",177.65,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",162.39,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",182.15,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.73,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",152.42,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",141.0,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",138.66,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",107.62,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",111.86,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",96.5,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",76.17,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",94.66,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",98.67,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",97.28,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",120.9,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",94.05,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",107.61,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",95.78,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",113.0,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Malignant melanoma of skin,13.01,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Malignant melanoma of skin,9.77,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Malignant melanoma of skin,16.33,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Malignant melanoma of skin,17.14,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Malignant melanoma of skin,19.05,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Malignant melanoma of skin,14.35,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Malignant melanoma of skin,5.3,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Malignant melanoma of skin,12.24,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Malignant melanoma of skin,15.28,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Malignant melanoma of skin,3.02,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Malignant neoplasm of breast,163.22,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Malignant neoplasm of breast,139.92,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Malignant neoplasm of breast,162.85,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Malignant neoplasm of breast,144.87,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Malignant neoplasm of breast,127.16,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Malignant neoplasm of breast,165.3,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Malignant neoplasm of breast,148.68,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Malignant neoplasm of breast,181.92,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Malignant neoplasm of breast,147.25,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Malignant neoplasm of breast,175.28,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Diabetes mellitus,63.47,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Diabetes mellitus,81.9,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Diabetes mellitus,74.73,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Diabetes mellitus,63.47,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Diabetes mellitus,58.18,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Diabetes mellitus,55.17,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Diabetes mellitus,34.34,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Diabetes mellitus,71.49,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Diabetes mellitus,28.46,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Diabetes mellitus,41.96,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Mental and behavioural disorders (F00-F99),11.11,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Mental and behavioural disorders (F00-F99),98.36,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Mental and behavioural disorders (F00-F99),53.54,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Mental and behavioural disorders (F00-F99),80.62,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Mental and behavioural disorders (F00-F99),53.67,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Mental and behavioural disorders (F00-F99),75.42,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Mental and behavioural disorders (F00-F99),59.56,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Mental and behavioural disorders (F00-F99),73.71,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Mental and behavioural disorders (F00-F99),41.18,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Mental and behavioural disorders (F00-F99),60.44,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),3.67,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),2.51,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),1.8,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Other ischaemic heart diseases,1402.03,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Other ischaemic heart diseases,1448.36,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Other ischaemic heart diseases,1355.44,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Other ischaemic heart diseases,1563.22,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Other ischaemic heart diseases,1546.91,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Other ischaemic heart diseases,1318.81,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Other ischaemic heart diseases,1314.88,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Other ischaemic heart diseases,1137.54,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Other ischaemic heart diseases,1125.52,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Other ischaemic heart diseases,1205.31,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,161.21,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,183.24,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,213.34,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,128.49,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,148.45,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,136.76,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,150.26,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,184.74,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,132.23,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,152.58,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Cerebrovascular diseases,410.35,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Cerebrovascular diseases,458.98,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Cerebrovascular diseases,411.64,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Cerebrovascular diseases,324.96,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Cerebrovascular diseases,345.8,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Cerebrovascular diseases,413.79,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Cerebrovascular diseases,318.52,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Cerebrovascular diseases,334.64,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Cerebrovascular diseases,298.1,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Cerebrovascular diseases,317.48,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Chronic lower respiratory diseases,53.37,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Chronic lower respiratory diseases,38.36,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Chronic lower respiratory diseases,50.08,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Chronic lower respiratory diseases,40.84,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Chronic lower respiratory diseases,67.63,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Chronic lower respiratory diseases,43.99,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Chronic lower respiratory diseases,52.03,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Chronic lower respiratory diseases,53.84,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Chronic lower respiratory diseases,36.33,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2020,Chronic lower respiratory diseases,41.03,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2011,Asthma and status asthmaticus,4.09,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2012,Asthma and status asthmaticus,1.59,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2013,Asthma and status asthmaticus,2.17,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2014,Asthma and status asthmaticus,1.6,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2015,Asthma and status asthmaticus,7.19,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2016,Asthma and status asthmaticus,6.0,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2017,Asthma and status asthmaticus,1.7,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2018,Asthma and status asthmaticus,1.7,Rate
Bratislavsk kraj,SK01,65 years or over,Females,2019,Asthma and status asthmaticus,1.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,All causes of death (A00-Y89) excluding S00-T98,160.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,All causes of death (A00-Y89) excluding S00-T98,163.56,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,All causes of death (A00-Y89) excluding S00-T98,169.88,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,All causes of death (A00-Y89) excluding S00-T98,159.82,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,All causes of death (A00-Y89) excluding S00-T98,166.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,All causes of death (A00-Y89) excluding S00-T98,157.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,All causes of death (A00-Y89) excluding S00-T98,149.59,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,All causes of death (A00-Y89) excluding S00-T98,161.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,All causes of death (A00-Y89) excluding S00-T98,150.97,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,All causes of death (A00-Y89) excluding S00-T98,140.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.43,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.62,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.78,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.95,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.73,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",5.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",6.59,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,"Malignant neoplasm of trachea, bronchus and lung",9.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,"Malignant neoplasm of trachea, bronchus and lung",7.41,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,"Malignant neoplasm of trachea, bronchus and lung",8.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,"Malignant neoplasm of trachea, bronchus and lung",11.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,"Malignant neoplasm of trachea, bronchus and lung",7.1,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,"Malignant neoplasm of trachea, bronchus and lung",9.94,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,"Malignant neoplasm of trachea, bronchus and lung",6.68,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,"Malignant neoplasm of trachea, bronchus and lung",8.46,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,"Malignant neoplasm of trachea, bronchus and lung",7.2,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,"Malignant neoplasm of trachea, bronchus and lung",5.89,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Malignant melanoma of skin,2.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Malignant melanoma of skin,1.92,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Malignant melanoma of skin,1.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Malignant melanoma of skin,1.31,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Malignant melanoma of skin,2.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Malignant melanoma of skin,2.95,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Malignant melanoma of skin,1.33,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Malignant melanoma of skin,1.14,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Malignant melanoma of skin,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Malignant melanoma of skin,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Malignant neoplasm of breast,15.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Malignant neoplasm of breast,19.14,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Malignant neoplasm of breast,14.81,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Malignant neoplasm of breast,23.13,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Malignant neoplasm of breast,15.79,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Malignant neoplasm of breast,13.7,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Malignant neoplasm of breast,17.8,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Malignant neoplasm of breast,14.55,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Malignant neoplasm of breast,15.29,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Malignant neoplasm of breast,11.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Diabetes mellitus,2.31,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Diabetes mellitus,2.35,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Diabetes mellitus,2.58,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Diabetes mellitus,2.04,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Diabetes mellitus,2.06,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Diabetes mellitus,1.82,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Diabetes mellitus,2.44,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Diabetes mellitus,2.68,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Diabetes mellitus,1.57,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Diabetes mellitus,3.56,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Mental and behavioural disorders (F00-F99),0.39,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Mental and behavioural disorders (F00-F99),0.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Mental and behavioural disorders (F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Mental and behavioural disorders (F00-F99),0.93,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Mental and behavioural disorders (F00-F99),1.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Mental and behavioural disorders (F00-F99),1.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Mental and behavioural disorders (F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Mental and behavioural disorders (F00-F99),1.14,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Mental and behavioural disorders (F00-F99),0.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Other ischaemic heart diseases,14.26,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Other ischaemic heart diseases,5.93,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Other ischaemic heart diseases,7.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Other ischaemic heart diseases,8.62,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Other ischaemic heart diseases,12.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Other ischaemic heart diseases,11.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Other ischaemic heart diseases,7.02,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Other ischaemic heart diseases,7.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Other ischaemic heart diseases,10.29,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Other ischaemic heart diseases,8.5,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Acute myocardial infarction including subsequent myocardial infarction,4.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Acute myocardial infarction including subsequent myocardial infarction,10.61,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Acute myocardial infarction including subsequent myocardial infarction,7.86,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Acute myocardial infarction including subsequent myocardial infarction,3.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Acute myocardial infarction including subsequent myocardial infarction,3.29,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Acute myocardial infarction including subsequent myocardial infarction,3.42,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Acute myocardial infarction including subsequent myocardial infarction,3.75,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Acute myocardial infarction including subsequent myocardial infarction,1.52,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Acute myocardial infarction including subsequent myocardial infarction,2.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Acute myocardial infarction including subsequent myocardial infarction,2.7,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Cerebrovascular diseases,6.61,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Cerebrovascular diseases,4.93,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Cerebrovascular diseases,7.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Cerebrovascular diseases,8.44,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Cerebrovascular diseases,8.59,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Cerebrovascular diseases,4.65,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Cerebrovascular diseases,5.72,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Cerebrovascular diseases,8.03,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Cerebrovascular diseases,6.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Cerebrovascular diseases,5.23,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Chronic lower respiratory diseases,0.65,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Chronic lower respiratory diseases,1.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Chronic lower respiratory diseases,2.05,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Chronic lower respiratory diseases,0.63,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Chronic lower respiratory diseases,2.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Chronic lower respiratory diseases,3.04,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Chronic lower respiratory diseases,2.82,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Chronic lower respiratory diseases,2.11,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Chronic lower respiratory diseases,1.55,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2020,Chronic lower respiratory diseases,1.42,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2011,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2012,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2013,Asthma and status asthmaticus,0.4,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2014,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2015,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2016,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2017,Asthma and status asthmaticus,0.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2018,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Females,2019,Asthma and status asthmaticus,0.65,Rate
Bratislavsk kraj,SK01,Total,Males,2011,All causes of death (A00-Y89) excluding S00-T98,1663.47,Rate
Bratislavsk kraj,SK01,Total,Males,2012,All causes of death (A00-Y89) excluding S00-T98,1629.81,Rate
Bratislavsk kraj,SK01,Total,Males,2013,All causes of death (A00-Y89) excluding S00-T98,1625.2,Rate
Bratislavsk kraj,SK01,Total,Males,2014,All causes of death (A00-Y89) excluding S00-T98,1506.27,Rate
Bratislavsk kraj,SK01,Total,Males,2015,All causes of death (A00-Y89) excluding S00-T98,1503.66,Rate
Bratislavsk kraj,SK01,Total,Males,2016,All causes of death (A00-Y89) excluding S00-T98,1491.63,Rate
Bratislavsk kraj,SK01,Total,Males,2017,All causes of death (A00-Y89) excluding S00-T98,1557.42,Rate
Bratislavsk kraj,SK01,Total,Males,2018,All causes of death (A00-Y89) excluding S00-T98,1509.09,Rate
Bratislavsk kraj,SK01,Total,Males,2019,All causes of death (A00-Y89) excluding S00-T98,1408.24,Rate
Bratislavsk kraj,SK01,Total,Males,2020,All causes of death (A00-Y89) excluding S00-T98,1543.7,Rate
Bratislavsk kraj,SK01,Total,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",72.84,Rate
Bratislavsk kraj,SK01,Total,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",67.55,Rate
Bratislavsk kraj,SK01,Total,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",71.94,Rate
Bratislavsk kraj,SK01,Total,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",57.31,Rate
Bratislavsk kraj,SK01,Total,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",59.88,Rate
Bratislavsk kraj,SK01,Total,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",77.34,Rate
Bratislavsk kraj,SK01,Total,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",56.95,Rate
Bratislavsk kraj,SK01,Total,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",65.98,Rate
Bratislavsk kraj,SK01,Total,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",64.15,Rate
Bratislavsk kraj,SK01,Total,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",59.78,Rate
Bratislavsk kraj,SK01,Total,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",99.74,Rate
Bratislavsk kraj,SK01,Total,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",84.77,Rate
Bratislavsk kraj,SK01,Total,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",83.21,Rate
Bratislavsk kraj,SK01,Total,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",85.96,Rate
Bratislavsk kraj,SK01,Total,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",76.76,Rate
Bratislavsk kraj,SK01,Total,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",80.26,Rate
Bratislavsk kraj,SK01,Total,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",75.58,Rate
Bratislavsk kraj,SK01,Total,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",71.09,Rate
Bratislavsk kraj,SK01,Total,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",69.0,Rate
Bratislavsk kraj,SK01,Total,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",77.09,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Malignant melanoma of skin,6.73,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Malignant melanoma of skin,8.74,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Malignant melanoma of skin,11.81,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Malignant melanoma of skin,9.28,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Malignant melanoma of skin,8.5,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Malignant melanoma of skin,8.96,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Malignant melanoma of skin,10.08,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Malignant melanoma of skin,8.48,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Malignant melanoma of skin,5.21,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Malignant melanoma of skin,13.9,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Malignant neoplasm of breast,0.3,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Malignant neoplasm of breast,0.69,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Malignant neoplasm of breast,0.63,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Malignant neoplasm of breast,3.91,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Malignant neoplasm of breast,1.93,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Malignant neoplasm of breast,0.22,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Malignant neoplasm of breast,0.3,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Diabetes mellitus,16.61,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Diabetes mellitus,18.04,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Diabetes mellitus,24.41,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Diabetes mellitus,12.94,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Diabetes mellitus,16.85,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Diabetes mellitus,24.17,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Diabetes mellitus,19.85,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Diabetes mellitus,24.22,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Diabetes mellitus,15.11,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Diabetes mellitus,25.97,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Mental and behavioural disorders (F00-F99),3.41,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Mental and behavioural disorders (F00-F99),27.65,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Mental and behavioural disorders (F00-F99),15.8,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Mental and behavioural disorders (F00-F99),11.77,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Mental and behavioural disorders (F00-F99),6.53,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Mental and behavioural disorders (F00-F99),16.36,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Mental and behavioural disorders (F00-F99),19.56,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Mental and behavioural disorders (F00-F99),14.25,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Mental and behavioural disorders (F00-F99),10.59,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Mental and behavioural disorders (F00-F99),10.15,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.62,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.78,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.3,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.51,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.56,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.32,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Other ischaemic heart diseases,364.04,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Other ischaemic heart diseases,366.83,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Other ischaemic heart diseases,348.75,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Other ischaemic heart diseases,413.43,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Other ischaemic heart diseases,367.49,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Other ischaemic heart diseases,361.24,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Other ischaemic heart diseases,334.75,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Other ischaemic heart diseases,294.13,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Other ischaemic heart diseases,327.74,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Other ischaemic heart diseases,368.14,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,77.69,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,110.41,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,117.72,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,65.76,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,63.95,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,54.8,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,74.58,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,84.67,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,45.78,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,73.66,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Cerebrovascular diseases,136.38,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Cerebrovascular diseases,120.21,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Cerebrovascular diseases,101.67,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Cerebrovascular diseases,97.67,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Cerebrovascular diseases,93.48,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Cerebrovascular diseases,117.61,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Cerebrovascular diseases,102.73,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Cerebrovascular diseases,100.02,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Cerebrovascular diseases,86.95,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Cerebrovascular diseases,82.91,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Chronic lower respiratory diseases,23.17,Rate
Bratislavsk kraj,SK01,Total,Males,2012,Chronic lower respiratory diseases,27.2,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Chronic lower respiratory diseases,21.05,Rate
Bratislavsk kraj,SK01,Total,Males,2014,Chronic lower respiratory diseases,18.57,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Chronic lower respiratory diseases,19.92,Rate
Bratislavsk kraj,SK01,Total,Males,2016,Chronic lower respiratory diseases,25.34,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Chronic lower respiratory diseases,22.82,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Chronic lower respiratory diseases,19.08,Rate
Bratislavsk kraj,SK01,Total,Males,2019,Chronic lower respiratory diseases,14.25,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Chronic lower respiratory diseases,17.53,Rate
Bratislavsk kraj,SK01,Total,Males,2011,Asthma and status asthmaticus,0.35,Rate
Bratislavsk kraj,SK01,Total,Males,2013,Asthma and status asthmaticus,0.31,Rate
Bratislavsk kraj,SK01,Total,Males,2015,Asthma and status asthmaticus,0.29,Rate
Bratislavsk kraj,SK01,Total,Males,2017,Asthma and status asthmaticus,0.33,Rate
Bratislavsk kraj,SK01,Total,Males,2018,Asthma and status asthmaticus,1.03,Rate
Bratislavsk kraj,SK01,Total,Males,2020,Asthma and status asthmaticus,0.4,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,All causes of death (A00-Y89) excluding S00-T98,6797.55,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,All causes of death (A00-Y89) excluding S00-T98,6787.67,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,All causes of death (A00-Y89) excluding S00-T98,6760.02,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,All causes of death (A00-Y89) excluding S00-T98,6301.02,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,All causes of death (A00-Y89) excluding S00-T98,6193.44,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,All causes of death (A00-Y89) excluding S00-T98,6277.62,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,All causes of death (A00-Y89) excluding S00-T98,6509.03,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,All causes of death (A00-Y89) excluding S00-T98,6277.5,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,All causes of death (A00-Y89) excluding S00-T98,5864.25,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,All causes of death (A00-Y89) excluding S00-T98,6505.22,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",305.53,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",282.32,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",302.84,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",232.02,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",245.86,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",327.62,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",240.71,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",273.29,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",276.7,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",266.35,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",395.54,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",337.87,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",305.14,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",348.97,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",309.95,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",313.12,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",315.3,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",290.97,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",278.43,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",330.82,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Malignant melanoma of skin,19.42,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Malignant melanoma of skin,39.39,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Malignant melanoma of skin,49.06,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Malignant melanoma of skin,40.52,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Malignant melanoma of skin,35.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Malignant melanoma of skin,29.61,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Malignant melanoma of skin,43.11,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Malignant melanoma of skin,29.83,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Malignant melanoma of skin,21.13,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Malignant melanoma of skin,62.91,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Malignant neoplasm of breast,3.52,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Malignant neoplasm of breast,3.22,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Malignant neoplasm of breast,18.55,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Malignant neoplasm of breast,9.91,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Malignant neoplasm of breast,1.54,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Diabetes mellitus,60.73,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Diabetes mellitus,79.34,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Diabetes mellitus,101.16,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Diabetes mellitus,45.28,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Diabetes mellitus,67.02,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Diabetes mellitus,97.63,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Diabetes mellitus,77.36,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Diabetes mellitus,90.44,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Diabetes mellitus,53.65,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Diabetes mellitus,99.88,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Mental and behavioural disorders (F00-F99),17.51,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Mental and behavioural disorders (F00-F99),136.75,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Mental and behavioural disorders (F00-F99),76.27,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Mental and behavioural disorders (F00-F99),52.99,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Mental and behavioural disorders (F00-F99),24.74,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Mental and behavioural disorders (F00-F99),65.52,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Mental and behavioural disorders (F00-F99),85.71,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Mental and behavioural disorders (F00-F99),65.51,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Mental and behavioural disorders (F00-F99),36.14,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Mental and behavioural disorders (F00-F99),43.82,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),3.16,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),4.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),2.59,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Other ischaemic heart diseases,1690.41,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Other ischaemic heart diseases,1793.68,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Other ischaemic heart diseases,1656.32,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Other ischaemic heart diseases,1942.72,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Other ischaemic heart diseases,1702.47,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Other ischaemic heart diseases,1707.62,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Other ischaemic heart diseases,1559.68,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Other ischaemic heart diseases,1407.3,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Other ischaemic heart diseases,1546.13,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Other ischaemic heart diseases,1727.29,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,261.03,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,354.92,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,459.32,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,238.65,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,244.12,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,208.77,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,312.11,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,347.46,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,192.14,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,316.09,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Cerebrovascular diseases,611.56,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Cerebrovascular diseases,549.51,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Cerebrovascular diseases,450.13,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Cerebrovascular diseases,428.19,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Cerebrovascular diseases,411.07,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Cerebrovascular diseases,533.24,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Cerebrovascular diseases,461.3,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Cerebrovascular diseases,443.25,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Cerebrovascular diseases,386.7,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Cerebrovascular diseases,359.72,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Chronic lower respiratory diseases,106.84,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2012,Chronic lower respiratory diseases,121.76,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Chronic lower respiratory diseases,99.69,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2014,Chronic lower respiratory diseases,87.46,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Chronic lower respiratory diseases,83.18,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2016,Chronic lower respiratory diseases,116.15,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Chronic lower respiratory diseases,101.55,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Chronic lower respiratory diseases,79.67,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2019,Chronic lower respiratory diseases,68.04,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Chronic lower respiratory diseases,81.04,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2011,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2013,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2015,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2017,Asthma and status asthmaticus,1.69,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2018,Asthma and status asthmaticus,3.29,Rate
Bratislavsk kraj,SK01,65 years or over,Males,2020,Asthma and status asthmaticus,2.04,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,All causes of death (A00-Y89) excluding S00-T98,419.81,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,All causes of death (A00-Y89) excluding S00-T98,380.38,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,All causes of death (A00-Y89) excluding S00-T98,381.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,All causes of death (A00-Y89) excluding S00-T98,344.81,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,All causes of death (A00-Y89) excluding S00-T98,367.63,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,All causes of death (A00-Y89) excluding S00-T98,332.29,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,All causes of death (A00-Y89) excluding S00-T98,357.97,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,All causes of death (A00-Y89) excluding S00-T98,354.01,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,All causes of death (A00-Y89) excluding S00-T98,328.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,All causes of death (A00-Y89) excluding S00-T98,341.84,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.47,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.53,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.99,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",14.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",16.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.44,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",15.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.74,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,"Malignant neoplasm of trachea, bronchus and lung",28.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,"Malignant neoplasm of trachea, bronchus and lung",23.46,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,"Malignant neoplasm of trachea, bronchus and lung",29.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,"Malignant neoplasm of trachea, bronchus and lung",22.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,"Malignant neoplasm of trachea, bronchus and lung",20.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,"Malignant neoplasm of trachea, bronchus and lung",23.85,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,"Malignant neoplasm of trachea, bronchus and lung",17.51,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,"Malignant neoplasm of trachea, bronchus and lung",17.82,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,"Malignant neoplasm of trachea, bronchus and lung",18.27,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,"Malignant neoplasm of trachea, bronchus and lung",15.63,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Malignant melanoma of skin,3.65,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Malignant melanoma of skin,1.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Malignant melanoma of skin,2.79,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Malignant melanoma of skin,1.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Malignant melanoma of skin,2.08,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Malignant melanoma of skin,3.96,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Malignant melanoma of skin,2.08,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Malignant melanoma of skin,3.31,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Malignant melanoma of skin,1.35,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Malignant melanoma of skin,2.02,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Malignant neoplasm of breast,0.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Malignant neoplasm of breast,0.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Malignant neoplasm of breast,0.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Malignant neoplasm of breast,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Diabetes mellitus,5.92,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Diabetes mellitus,3.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Diabetes mellitus,5.82,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Diabetes mellitus,5.11,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Diabetes mellitus,4.7,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Diabetes mellitus,6.38,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Diabetes mellitus,5.92,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Diabetes mellitus,8.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Diabetes mellitus,5.78,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Diabetes mellitus,8.06,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Mental and behavioural disorders (F00-F99),1.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Mental and behavioural disorders (F00-F99),1.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Mental and behavioural disorders (F00-F99),1.78,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Mental and behavioural disorders (F00-F99),2.12,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Mental and behavioural disorders (F00-F99),4.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Mental and behavioural disorders (F00-F99),3.53,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Mental and behavioural disorders (F00-F99),1.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Mental and behavioural disorders (F00-F99),4.4,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Mental and behavioural disorders (F00-F99),2.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Other mental and behavioural disorders (remainder of F00-F99),0.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Other mental and behavioural disorders (remainder of F00-F99),0.7,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Other mental and behavioural disorders (remainder of F00-F99),0.4,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Other ischaemic heart diseases,42.75,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Other ischaemic heart diseases,21.2,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Other ischaemic heart diseases,32.01,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Other ischaemic heart diseases,42.98,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Other ischaemic heart diseases,44.1,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Other ischaemic heart diseases,35.1,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Other ischaemic heart diseases,38.03,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Other ischaemic heart diseases,24.48,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Other ischaemic heart diseases,32.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Other ischaemic heart diseases,38.91,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Acute myocardial infarction including subsequent myocardial infarction,33.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Acute myocardial infarction including subsequent myocardial infarction,51.17,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Acute myocardial infarction including subsequent myocardial infarction,34.97,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Acute myocardial infarction including subsequent myocardial infarction,23.88,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Acute myocardial infarction including subsequent myocardial infarction,20.3,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Acute myocardial infarction including subsequent myocardial infarction,17.5,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Acute myocardial infarction including subsequent myocardial infarction,17.04,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Acute myocardial infarction including subsequent myocardial infarction,21.02,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Acute myocardial infarction including subsequent myocardial infarction,10.33,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Acute myocardial infarction including subsequent myocardial infarction,14.94,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Cerebrovascular diseases,21.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Cerebrovascular diseases,16.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Cerebrovascular diseases,17.26,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Cerebrovascular diseases,17.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Cerebrovascular diseases,16.55,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Cerebrovascular diseases,16.93,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Cerebrovascular diseases,15.88,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Cerebrovascular diseases,16.87,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Cerebrovascular diseases,14.34,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Cerebrovascular diseases,15.85,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Chronic lower respiratory diseases,2.9,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2012,Chronic lower respiratory diseases,4.29,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Chronic lower respiratory diseases,2.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2014,Chronic lower respiratory diseases,1.89,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Chronic lower respiratory diseases,4.59,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2016,Chronic lower respiratory diseases,3.35,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Chronic lower respiratory diseases,3.75,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Chronic lower respiratory diseases,4.4,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2019,Chronic lower respiratory diseases,1.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Chronic lower respiratory diseases,2.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2011,Asthma and status asthmaticus,0.44,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2013,Asthma and status asthmaticus,0.38,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2015,Asthma and status asthmaticus,0.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2017,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2018,Asthma and status asthmaticus,0.48,Rate
Bratislavsk kraj,SK01,Less than 65 years,Males,2020,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Total,Total,2011,All causes of death (A00-Y89) excluding S00-T98,1302.38,Rate
Bratislavsk kraj,SK01,Total,Total,2012,All causes of death (A00-Y89) excluding S00-T98,1282.18,Rate
Bratislavsk kraj,SK01,Total,Total,2013,All causes of death (A00-Y89) excluding S00-T98,1294.09,Rate
Bratislavsk kraj,SK01,Total,Total,2014,All causes of death (A00-Y89) excluding S00-T98,1209.94,Rate
Bratislavsk kraj,SK01,Total,Total,2015,All causes of death (A00-Y89) excluding S00-T98,1232.67,Rate
Bratislavsk kraj,SK01,Total,Total,2016,All causes of death (A00-Y89) excluding S00-T98,1191.25,Rate
Bratislavsk kraj,SK01,Total,Total,2017,All causes of death (A00-Y89) excluding S00-T98,1215.64,Rate
Bratislavsk kraj,SK01,Total,Total,2018,All causes of death (A00-Y89) excluding S00-T98,1203.47,Rate
Bratislavsk kraj,SK01,Total,Total,2019,All causes of death (A00-Y89) excluding S00-T98,1130.23,Rate
Bratislavsk kraj,SK01,Total,Total,2020,All causes of death (A00-Y89) excluding S00-T98,1203.39,Rate
Bratislavsk kraj,SK01,Total,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.65,Rate
Bratislavsk kraj,SK01,Total,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",51.51,Rate
Bratislavsk kraj,SK01,Total,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",53.14,Rate
Bratislavsk kraj,SK01,Total,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",47.74,Rate
Bratislavsk kraj,SK01,Total,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.0,Rate
Bratislavsk kraj,SK01,Total,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",50.68,Rate
Bratislavsk kraj,SK01,Total,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",42.41,Rate
Bratislavsk kraj,SK01,Total,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",45.02,Rate
Bratislavsk kraj,SK01,Total,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",40.45,Rate
Bratislavsk kraj,SK01,Total,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",39.3,Rate
Bratislavsk kraj,SK01,Total,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",55.67,Rate
Bratislavsk kraj,SK01,Total,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",46.18,Rate
Bratislavsk kraj,SK01,Total,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",48.64,Rate
Bratislavsk kraj,SK01,Total,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",50.69,Rate
Bratislavsk kraj,SK01,Total,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",45.58,Rate
Bratislavsk kraj,SK01,Total,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",50.5,Rate
Bratislavsk kraj,SK01,Total,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",44.18,Rate
Bratislavsk kraj,SK01,Total,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",44.97,Rate
Bratislavsk kraj,SK01,Total,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",42.06,Rate
Bratislavsk kraj,SK01,Total,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",46.4,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Malignant melanoma of skin,5.42,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Malignant melanoma of skin,5.33,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Malignant melanoma of skin,7.08,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Malignant melanoma of skin,6.11,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Malignant melanoma of skin,6.46,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Malignant melanoma of skin,6.61,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Malignant melanoma of skin,4.95,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Malignant melanoma of skin,5.59,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Malignant melanoma of skin,3.95,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Malignant melanoma of skin,5.41,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Malignant neoplasm of breast,26.96,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Malignant neoplasm of breast,25.88,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Malignant neoplasm of breast,26.96,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Malignant neoplasm of breast,28.04,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Malignant neoplasm of breast,22.84,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Malignant neoplasm of breast,25.94,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Malignant neoplasm of breast,27.18,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Malignant neoplasm of breast,29.21,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Malignant neoplasm of breast,24.92,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Malignant neoplasm of breast,27.13,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Diabetes mellitus,15.14,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Diabetes mellitus,18.36,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Diabetes mellitus,19.7,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Diabetes mellitus,14.08,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Diabetes mellitus,14.49,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Diabetes mellitus,16.81,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Diabetes mellitus,12.77,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Diabetes mellitus,19.48,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Diabetes mellitus,10.2,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Diabetes mellitus,16.95,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Mental and behavioural disorders (F00-F99),2.67,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Mental and behavioural disorders (F00-F99),22.14,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Mental and behavioural disorders (F00-F99),12.36,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Mental and behavioural disorders (F00-F99),15.05,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Mental and behavioural disorders (F00-F99),10.13,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Mental and behavioural disorders (F00-F99),16.49,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Mental and behavioural disorders (F00-F99),15.26,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Mental and behavioural disorders (F00-F99),14.73,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Mental and behavioural disorders (F00-F99),10.15,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Mental and behavioural disorders (F00-F99),11.8,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.76,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.23,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.66,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.21,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.2,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.28,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.14,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Other ischaemic heart diseases,317.03,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Other ischaemic heart diseases,317.65,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Other ischaemic heart diseases,302.94,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Other ischaemic heart diseases,352.48,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Other ischaemic heart diseases,339.5,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Other ischaemic heart diseases,305.67,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Other ischaemic heart diseases,293.29,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Other ischaemic heart diseases,255.11,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Other ischaemic heart diseases,266.26,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Other ischaemic heart diseases,290.93,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,53.79,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,72.54,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,76.06,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,44.09,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,45.16,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,39.84,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,49.14,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,56.29,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,35.65,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,47.58,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Cerebrovascular diseases,105.42,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Cerebrovascular diseases,104.69,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Cerebrovascular diseases,93.69,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Cerebrovascular diseases,81.75,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Cerebrovascular diseases,83.02,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Cerebrovascular diseases,98.35,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Cerebrovascular diseases,80.95,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Cerebrovascular diseases,83.61,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Cerebrovascular diseases,73.35,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Cerebrovascular diseases,73.61,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Chronic lower respiratory diseases,15.49,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Chronic lower respiratory diseases,15.34,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Chronic lower respiratory diseases,14.59,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Chronic lower respiratory diseases,12.35,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Chronic lower respiratory diseases,17.09,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Chronic lower respiratory diseases,16.29,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Chronic lower respiratory diseases,16.27,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Chronic lower respiratory diseases,15.23,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Chronic lower respiratory diseases,10.44,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Chronic lower respiratory diseases,12.26,Rate
Bratislavsk kraj,SK01,Total,Total,2011,Asthma and status asthmaticus,0.75,Rate
Bratislavsk kraj,SK01,Total,Total,2012,Asthma and status asthmaticus,0.21,Rate
Bratislavsk kraj,SK01,Total,Total,2013,Asthma and status asthmaticus,0.56,Rate
Bratislavsk kraj,SK01,Total,Total,2014,Asthma and status asthmaticus,0.22,Rate
Bratislavsk kraj,SK01,Total,Total,2015,Asthma and status asthmaticus,1.02,Rate
Bratislavsk kraj,SK01,Total,Total,2016,Asthma and status asthmaticus,0.71,Rate
Bratislavsk kraj,SK01,Total,Total,2017,Asthma and status asthmaticus,0.63,Rate
Bratislavsk kraj,SK01,Total,Total,2018,Asthma and status asthmaticus,0.62,Rate
Bratislavsk kraj,SK01,Total,Total,2019,Asthma and status asthmaticus,0.49,Rate
Bratislavsk kraj,SK01,Total,Total,2020,Asthma and status asthmaticus,0.16,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,All causes of death (A00-Y89) excluding S00-T98,5524.62,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,All causes of death (A00-Y89) excluding S00-T98,5485.08,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,All causes of death (A00-Y89) excluding S00-T98,5532.26,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,All causes of death (A00-Y89) excluding S00-T98,5191.48,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,All causes of death (A00-Y89) excluding S00-T98,5247.16,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,All causes of death (A00-Y89) excluding S00-T98,5124.81,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,All causes of death (A00-Y89) excluding S00-T98,5214.06,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,All causes of death (A00-Y89) excluding S00-T98,5134.84,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,All causes of death (A00-Y89) excluding S00-T98,4829.49,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,All causes of death (A00-Y89) excluding S00-T98,5203.29,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",214.46,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",213.3,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",215.8,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",198.88,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",189.87,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",212.61,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",179.2,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",189.47,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.05,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",168.61,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",212.26,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",176.12,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",176.28,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",193.15,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",179.52,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",191.54,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",178.35,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",177.97,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",165.25,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",195.23,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Malignant melanoma of skin,15.46,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Malignant melanoma of skin,20.45,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Malignant melanoma of skin,28.09,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Malignant melanoma of skin,25.25,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Malignant melanoma of skin,24.32,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Malignant melanoma of skin,19.81,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Malignant melanoma of skin,18.52,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Malignant melanoma of skin,19.75,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Malignant melanoma of skin,17.67,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Malignant melanoma of skin,23.82,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Malignant neoplasm of breast,104.62,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Malignant neoplasm of breast,89.5,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Malignant neoplasm of breast,105.22,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Malignant neoplasm of breast,92.2,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Malignant neoplasm of breast,82.16,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Malignant neoplasm of breast,103.09,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Malignant neoplasm of breast,99.64,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Malignant neoplasm of breast,117.6,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Malignant neoplasm of breast,93.82,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Malignant neoplasm of breast,113.35,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Diabetes mellitus,61.2,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Diabetes mellitus,82.85,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Diabetes mellitus,84.32,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Diabetes mellitus,57.9,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Diabetes mellitus,60.89,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Diabetes mellitus,69.9,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Diabetes mellitus,48.94,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Diabetes mellitus,77.93,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Diabetes mellitus,37.48,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Diabetes mellitus,63.63,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Mental and behavioural disorders (F00-F99),13.71,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Mental and behavioural disorders (F00-F99),110.38,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Mental and behavioural disorders (F00-F99),60.35,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Mental and behavioural disorders (F00-F99),73.75,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Mental and behavioural disorders (F00-F99),45.73,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Mental and behavioural disorders (F00-F99),73.37,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Mental and behavioural disorders (F00-F99),68.42,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Mental and behavioural disorders (F00-F99),71.97,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Mental and behavioural disorders (F00-F99),40.91,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Mental and behavioural disorders (F00-F99),55.95,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),3.87,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),1.16,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),1.78,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),2.68,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),1.08,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),1.04,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Other ischaemic heart diseases,1513.07,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Other ischaemic heart diseases,1575.66,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Other ischaemic heart diseases,1475.96,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Other ischaemic heart diseases,1707.48,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Other ischaemic heart diseases,1629.32,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Other ischaemic heart diseases,1476.04,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Other ischaemic heart diseases,1416.1,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Other ischaemic heart diseases,1245.59,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Other ischaemic heart diseases,1280.4,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Other ischaemic heart diseases,1399.02,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,202.56,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,251.74,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,306.67,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,172.35,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,185.77,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,163.6,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,210.92,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,245.06,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,157.18,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,209.35,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Cerebrovascular diseases,485.66,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Cerebrovascular diseases,495.23,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Cerebrovascular diseases,431.74,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Cerebrovascular diseases,366.97,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Cerebrovascular diseases,375.13,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Cerebrovascular diseases,462.02,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Cerebrovascular diseases,371.99,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Cerebrovascular diseases,378.84,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Cerebrovascular diseases,333.89,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Cerebrovascular diseases,335.76,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Chronic lower respiratory diseases,72.58,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Chronic lower respiratory diseases,66.95,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Chronic lower respiratory diseases,66.57,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Chronic lower respiratory diseases,58.41,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Chronic lower respiratory diseases,74.01,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Chronic lower respiratory diseases,70.48,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Chronic lower respiratory diseases,69.79,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Chronic lower respiratory diseases,65.11,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Chronic lower respiratory diseases,47.83,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Chronic lower respiratory diseases,55.62,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2011,Asthma and status asthmaticus,3.03,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2012,Asthma and status asthmaticus,1.05,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2013,Asthma and status asthmaticus,1.36,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2014,Asthma and status asthmaticus,1.13,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2015,Asthma and status asthmaticus,4.55,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2016,Asthma and status asthmaticus,3.66,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2017,Asthma and status asthmaticus,1.85,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2018,Asthma and status asthmaticus,2.25,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2019,Asthma and status asthmaticus,1.09,Rate
Bratislavsk kraj,SK01,65 years or over,Total,2020,Asthma and status asthmaticus,0.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,All causes of death (A00-Y89) excluding S00-T98,279.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,All causes of death (A00-Y89) excluding S00-T98,264.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,All causes of death (A00-Y89) excluding S00-T98,267.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,All causes of death (A00-Y89) excluding S00-T98,245.47,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,All causes of death (A00-Y89) excluding S00-T98,260.21,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,All causes of death (A00-Y89) excluding S00-T98,238.4,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,All causes of death (A00-Y89) excluding S00-T98,247.08,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,All causes of death (A00-Y89) excluding S00-T98,251.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,All causes of death (A00-Y89) excluding S00-T98,234.13,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,All causes of death (A00-Y89) excluding S00-T98,234.47,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.97,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",12.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",13.74,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.12,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.91,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",11.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.28,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",10.03,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",9.54,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,"Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal",7.98,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,"Malignant neoplasm of trachea, bronchus and lung",17.74,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,"Malignant neoplasm of trachea, bronchus and lung",14.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,"Malignant neoplasm of trachea, bronchus and lung",17.72,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,"Malignant neoplasm of trachea, bronchus and lung",16.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,"Malignant neoplasm of trachea, bronchus and lung",13.13,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,"Malignant neoplasm of trachea, bronchus and lung",16.34,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,"Malignant neoplasm of trachea, bronchus and lung",11.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,"Malignant neoplasm of trachea, bronchus and lung",12.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,"Malignant neoplasm of trachea, bronchus and lung",12.22,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,"Malignant neoplasm of trachea, bronchus and lung",10.34,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Malignant melanoma of skin,2.99,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Malignant melanoma of skin,1.67,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Malignant melanoma of skin,1.99,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Malignant melanoma of skin,1.48,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Malignant melanoma of skin,2.13,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Malignant melanoma of skin,3.42,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Malignant melanoma of skin,1.66,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Malignant melanoma of skin,2.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Malignant melanoma of skin,0.63,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Malignant melanoma of skin,0.95,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Malignant neoplasm of breast,8.14,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Malignant neoplasm of breast,10.47,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Malignant neoplasm of breast,8.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Malignant neoplasm of breast,12.5,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Malignant neoplasm of breast,8.47,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Malignant neoplasm of breast,7.26,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Malignant neoplasm of breast,9.63,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Malignant neoplasm of breast,7.8,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Malignant neoplasm of breast,8.23,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Malignant neoplasm of breast,6.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Diabetes mellitus,3.98,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Diabetes mellitus,2.74,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Diabetes mellitus,4.05,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Diabetes mellitus,3.46,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Diabetes mellitus,3.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Diabetes mellitus,3.95,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Diabetes mellitus,4.01,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Diabetes mellitus,5.32,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Diabetes mellitus,3.59,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Diabetes mellitus,5.65,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Mental and behavioural disorders (F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Mental and behavioural disorders (F00-F99),0.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Mental and behavioural disorders (F00-F99),0.74,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Mental and behavioural disorders (F00-F99),0.83,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Mental and behavioural disorders (F00-F99),1.5,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Mental and behavioural disorders (F00-F99),2.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Mental and behavioural disorders (F00-F99),2.38,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Mental and behavioural disorders (F00-F99),0.86,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Mental and behavioural disorders (F00-F99),2.71,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Mental and behavioural disorders (F00-F99),1.11,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Other mental and behavioural disorders (remainder of F00-F99),0.17,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Other mental and behavioural disorders (remainder of F00-F99),0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Other mental and behavioural disorders (remainder of F00-F99),0.35,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Other mental and behavioural disorders (remainder of F00-F99),0.18,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Other ischaemic heart diseases,27.3,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Other ischaemic heart diseases,12.92,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Other ischaemic heart diseases,18.79,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Other ischaemic heart diseases,24.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Other ischaemic heart diseases,27.06,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Other ischaemic heart diseases,22.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Other ischaemic heart diseases,21.3,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Other ischaemic heart diseases,15.17,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Other ischaemic heart diseases,20.6,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Other ischaemic heart diseases,22.51,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Acute myocardial infarction including subsequent myocardial infarction,17.76,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Acute myocardial infarction including subsequent myocardial infarction,29.13,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Acute myocardial infarction including subsequent myocardial infarction,20.2,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Acute myocardial infarction including subsequent myocardial infarction,13.02,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Acute myocardial infarction including subsequent myocardial infarction,11.1,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Acute myocardial infarction including subsequent myocardial infarction,9.86,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Acute myocardial infarction including subsequent myocardial infarction,9.95,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Acute myocardial infarction including subsequent myocardial infarction,10.56,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Acute myocardial infarction including subsequent myocardial infarction,6.21,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Acute myocardial infarction including subsequent myocardial infarction,8.39,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Cerebrovascular diseases,13.31,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Cerebrovascular diseases,10.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Cerebrovascular diseases,11.8,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Cerebrovascular diseases,12.66,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Cerebrovascular diseases,12.26,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Cerebrovascular diseases,10.25,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Cerebrovascular diseases,10.45,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Cerebrovascular diseases,12.09,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Cerebrovascular diseases,10.24,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Cerebrovascular diseases,10.11,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Chronic lower respiratory diseases,1.66,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Chronic lower respiratory diseases,2.84,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Chronic lower respiratory diseases,2.01,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Chronic lower respiratory diseases,1.19,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Chronic lower respiratory diseases,3.3,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Chronic lower respiratory diseases,3.17,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Chronic lower respiratory diseases,3.31,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Chronic lower respiratory diseases,3.15,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Chronic lower respiratory diseases,1.38,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Chronic lower respiratory diseases,1.75,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2011,Asthma and status asthmaticus,0.2,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2012,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2013,Asthma and status asthmaticus,0.37,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2014,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2015,Asthma and status asthmaticus,0.16,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2016,Asthma and status asthmaticus,0.0,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2017,Asthma and status asthmaticus,0.33,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2018,Asthma and status asthmaticus,0.23,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2019,Asthma and status asthmaticus,0.34,Rate
Bratislavsk kraj,SK01,Less than 65 years,Total,2020,Asthma and status asthmaticus,0.0,Rate
